data_6prj_residue ############################ # Computer software used # ############################ save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 6prj _Structure_validation_residue.Date_analyzed 2019-09-13 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 172' ' ' LEU . . . . . 0.535 HD23 ' H ' ' A' ' 222' ' ' ALA . 25.9 mt . . . . . 0 N--CA 1.479 1.021 0 CA-C-O 120.976 0.417 . . . . 73.23 110.256 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 173' ' ' PHE . . . . . 0.445 ' CD1' HD22 ' A' ' 235' ' ' LEU . 31.4 m-85 -126.21 -59.14 1.33 Allowed 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 124.135 0.974 . . . . 74.35 109.828 -170.017 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 174' ' ' TYR . . . . . 0.522 ' CD2' ' HB3' ' A' ' 233' ' ' LEU . 1.7 p90 -82.41 15.51 2.46 Favored 'General case' 0 CA--C 1.548 0.868 0 CA-C-N 114.381 -1.281 . . . . 71.54 112.898 -171.533 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 4.6 p -62.66 -19.87 64.25 Favored 'General case' 0 CA--C 1.555 1.141 0 C-N-CA 122.805 0.442 . . . . 74.31 111.354 173.77 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 176' ' ' MET . . . . . . . . . . . . . 22.9 ptt? -65.86 -52.89 46.48 Favored 'General case' 0 CA--C 1.558 1.276 0 C-N-CA 124.214 1.006 . . . . 74.33 111.361 168.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -155.28 119.61 4.67 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 125.016 1.326 . . . . 71.54 108.223 -173.568 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 178' ' ' ALA . . . . . 0.488 ' HB2' ' HG3' ' A' ' 224' ' ' PRO . . . -154.68 -68.07 0.13 Allowed 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 123.926 0.89 . . . . 74.35 109.093 -174.524 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -83.37 82.22 8.37 Favored 'General case' 0 C--O 1.24 0.566 0 N-CA-C 107.723 -1.214 . . . . 73.45 107.723 168.782 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.342 0.892 0 CA-C-N 115.369 -0.832 . . . . 75.44 111.909 -175.219 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 191' ' ' GLN . . . . . 0.703 ' HB3' ' HD2' ' A' ' 243' ' ' PRO . 8.1 pt20 . . . . . 0 N--CA 1.471 0.609 0 CA-C-O 120.985 0.421 . . . . 74.43 110.589 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 66.6 m-20 -76.88 162.51 27.56 Favored 'General case' 0 C--O 1.24 0.562 0 CA-C-N 115.111 -0.95 . . . . 74.41 110.815 -172.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 28.8 mt -135.97 176.91 8.26 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 124.509 1.123 . . . . 75.13 110.014 -175.302 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 60.8 m-85 -134.0 136.9 44.41 Favored 'General case' 0 C--O 1.239 0.527 0 C-N-CA 123.871 0.868 . . . . 72.41 110.136 177.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . 0.454 ' HB1' HD12 ' A' ' 249' ' ' LEU . . . -140.04 171.08 14.69 Favored 'General case' 0 C--O 1.236 0.371 0 C-N-CA 124.632 1.173 . . . . 75.21 108.561 176.069 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 26.1 m -119.02 123.44 44.53 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 108.652 -0.87 . . . . 63.41 108.652 177.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . 0.631 HD22 HD11 ' A' ' 251' ' ' LEU . 16.3 tp -107.47 111.08 23.21 Favored 'General case' 0 N--CA 1.467 0.382 0 N-CA-C 108.583 -0.895 . . . . 73.21 108.583 -179.56 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -84.0 121.48 27.45 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 123.414 0.686 . . . . 73.43 109.256 179.735 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 199' ' ' VAL . . . . . 0.449 ' O ' ' HA ' ' A' ' 255' ' ' ILE . 4.8 p -142.99 129.85 10.71 Favored Pre-proline 0 CA--C 1.548 0.903 0 C-N-CA 123.707 0.803 . . . . 73.4 109.414 -176.737 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_endo -72.37 162.0 42.76 Favored 'Trans proline' 0 C--N 1.369 1.613 0 C-N-CA 121.801 1.667 . . . . 60.32 111.189 172.341 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 201' ' ' ALA . . . . . 0.457 ' O ' HG22 ' A' ' 205' ' ' VAL . . . -50.6 -55.27 27.69 Favored Pre-proline 0 CA--C 1.562 1.439 0 CA-C-O 117.828 -1.082 . . . . 74.15 113.109 -177.839 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -68.1 -32.4 27.8 Favored 'Trans proline' 0 C--N 1.396 3.03 0 CA-C-N 121.433 1.548 . . . . 74.52 113.678 -174.157 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 36.1 mt -67.69 -32.02 54.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 N-CA-C 109.744 -0.465 . . . . 75.44 109.744 175.219 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -72.28 -40.33 67.68 Favored 'General case' 0 CA--C 1.551 1.011 0 C-N-CA 122.679 0.392 . . . . 73.52 111.347 176.425 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 205' ' ' VAL . . . . . 0.457 HG22 ' O ' ' A' ' 201' ' ' ALA . 84.7 t -66.66 -53.35 36.04 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.29 0 C-N-CA 123.647 0.779 . . . . 73.41 111.507 -177.825 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 16.5 m -80.04 -33.39 14.44 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 CA-C-N 116.227 -0.442 . . . . 72.14 110.986 -177.533 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 85.81 73.93 1.27 Allowed Glycine 0 C--N 1.342 0.901 0 CA-C-N 115.9 -0.591 . . . . 75.11 111.761 -172.44 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -91.14 -126.86 3.6 Favored Glycine 0 C--N 1.353 1.505 0 CA-C-O 119.43 -0.65 . . . . 45.11 111.876 177.324 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 209' ' ' LYS . . . . . 0.424 ' HG2' ' HA ' ' A' ' 222' ' ' ALA . 49.3 mtmt -137.81 155.28 49.18 Favored 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 123.604 0.762 . . . . 74.52 111.609 176.247 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 6.9 m -148.62 170.34 2.65 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.056 0 C-N-CA 125.88 1.672 . . . . 74.4 108.601 175.738 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 42.0 ttp180 -99.4 119.17 37.54 Favored 'General case' 0 CA--C 1.549 0.904 0 C-N-CA 122.822 0.449 . . . . 74.32 109.99 177.491 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -100.97 127.4 47.47 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 123.7 0.8 . . . . 62.15 109.63 175.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 88.0 mmm -96.06 122.5 38.96 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 123.336 0.654 . . . . 72.54 109.85 -177.261 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 21.8 p -129.21 -176.01 3.74 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 124.015 0.926 . . . . 75.41 110.886 -168.188 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 86.5 mt -65.22 -24.15 67.27 Favored 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 123.178 0.591 . . . . 73.25 112.062 175.67 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -98.99 6.68 46.57 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.454 0.702 . . . . 70.05 111.093 179.171 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 98.98 -151.44 19.49 Favored Glycine 0 C--N 1.352 1.455 0 CA-C-O 119.317 -0.713 . . . . 74.42 112.3 -179.667 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -79.85 149.65 20.6 Favored 'Trans proline' 0 C--N 1.365 1.422 0 C-N-CA 122.536 2.157 . . . . 75.3 113.672 -176.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 5.4 p -143.17 130.83 18.72 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 C-N-CA 123.613 0.765 . . . . 74.13 109.143 175.12 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -75.89 101.89 5.33 Favored 'General case' 0 N--CA 1.476 0.872 0 N-CA-C 108.539 -0.912 . . . . 73.5 108.539 175.149 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 1.4 p -107.06 123.08 61.97 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.047 0 N-CA-C 108.755 -0.832 . . . . 72.32 108.755 -173.108 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 222' ' ' ALA . . . . . 0.535 ' H ' HD23 ' A' ' 172' ' ' LEU . . . -77.36 109.96 11.7 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 123.194 0.598 . . . . 64.1 111.075 -178.376 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 63.1 t -54.97 139.47 63.25 Favored Pre-proline 0 N--CA 1.48 1.061 0 C-N-CA 125.43 1.492 . . . . 73.21 110.445 179.705 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 224' ' ' PRO . . . . . 0.488 ' HG3' ' HB2' ' A' ' 178' ' ' ALA . 72.0 Cg_endo -72.05 159.34 50.35 Favored 'Trans proline' 0 C--N 1.374 1.905 0 C-N-CA 121.939 1.759 . . . . 74.31 111.566 173.3 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -69.83 147.37 62.28 Favored 'Trans proline' 0 C--N 1.369 1.61 0 C-N-CA 121.507 1.471 . . . . 71.22 111.194 172.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 65.6 mtm180 63.55 47.08 3.93 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 124.578 1.151 . . . . 74.04 110.868 174.39 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 227' ' ' THR . . . . . 0.456 ' HA ' ' HE ' ' A' ' 231' ' ' ARG . 53.4 m -87.12 125.62 34.26 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 114.84 -1.073 . . . . 72.2 108.895 174.108 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -115.01 151.86 33.45 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 108.286 -1.005 . . . . 72.44 108.286 176.037 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -55.73 118.24 4.37 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 124.158 0.983 . . . . 71.13 111.075 -176.063 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 115.84 -5.06 20.65 Favored Glycine 0 C--N 1.342 0.868 0 CA-C-O 118.773 -1.015 . . . . 64.32 114.744 -177.399 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 231' ' ' ARG . . . . . 0.456 ' HE ' ' HA ' ' A' ' 227' ' ' THR . 65.2 mtt-85 -62.7 144.23 56.57 Favored 'General case' 0 N--CA 1.484 1.251 0 CA-C-N 118.28 1.04 . . . . 74.34 110.879 172.844 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 232' ' ' LYS . . . . . 0.414 ' HE3' ' HA ' ' A' ' 232' ' ' LYS . 0.0 OUTLIER -109.08 99.32 8.65 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 114.995 -1.002 . . . . 71.5 108.804 177.435 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 233' ' ' LEU . . . . . 0.637 ' HB2' ' HB2' ' A' ' 251' ' ' LEU . 39.2 mt -82.78 152.5 25.67 Favored 'General case' 0 CA--C 1.544 0.712 0 N-CA-C 108.589 -0.893 . . . . 74.52 108.589 175.344 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 22.3 ttt85 -125.61 111.25 14.77 Favored 'General case' 0 N--CA 1.481 1.103 0 CA-C-N 118.117 0.417 . . . . 74.22 111.043 -171.147 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 235' ' ' LEU . . . . . 0.477 ' HB2' ' HB3' ' A' ' 249' ' ' LEU . 16.2 mt -99.6 111.03 23.43 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 123.402 0.681 . . . . 75.51 110.683 179.213 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 16.2 mtmt -70.73 139.57 51.15 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 122.938 0.495 . . . . 74.0 111.695 -179.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 77.94 -2.69 63.77 Favored Glycine 0 N--CA 1.477 1.414 0 CA-C-N 115.508 -0.769 . . . . 72.42 114.292 177.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 70.9 mmtt -99.17 3.15 46.38 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 123.394 0.678 . . . . 74.52 110.717 -177.272 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -108.49 -176.24 21.86 Favored Glycine 0 C--N 1.347 1.183 0 N-CA-C 110.028 -1.229 . . . . 74.34 110.028 161.71 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 90.6 m-85 -85.46 147.09 45.96 Favored Pre-proline 0 N--CA 1.483 1.204 0 C-N-CA 123.261 0.625 . . . . 73.54 110.714 -178.095 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -59.78 132.9 47.81 Favored 'Trans proline' 0 C--N 1.37 1.704 0 C-N-CA 122.177 1.918 . . . . 73.43 112.282 171.572 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -159.27 -124.79 0.77 Allowed Glycine 0 CA--C 1.538 1.528 0 CA-C-O 118.692 -1.06 . . . . 63.13 112.729 -179.602 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 243' ' ' PRO . . . . . 0.703 ' HD2' ' HB3' ' A' ' 191' ' ' GLN . 35.9 Cg_endo -57.34 -44.13 45.76 Favored 'Trans proline' 0 C--N 1.381 2.286 0 C-N-CA 124.415 3.41 . . . . 74.43 113.638 -174.319 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -85.81 -14.45 45.06 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 123.389 0.676 . . . . 75.41 110.745 176.724 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 92.34 -23.34 27.94 Favored Glycine 0 C--N 1.348 1.224 0 CA-C-N 116.126 -0.488 . . . . 75.24 112.498 -176.104 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 11.4 ttm180 -128.86 111.75 13.41 Favored 'General case' 0 C--O 1.238 0.493 0 C-N-CA 124.575 1.15 . . . . 74.13 109.18 176.849 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -73.53 155.55 50.11 Favored Glycine 0 C--N 1.351 1.399 0 C-N-CA 121.693 -0.289 . . . . 72.14 112.769 170.632 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -125.43 145.62 49.99 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 123.376 0.67 . . . . 70.22 109.871 -173.837 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 249' ' ' LEU . . . . . 0.477 ' HB3' ' HB2' ' A' ' 235' ' ' LEU . 32.7 tp -100.32 119.25 38.13 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 123.3 0.64 . . . . 73.12 109.62 -178.563 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 250' ' ' TYR . . . . . . . . . . . . . 2.4 m-30 -89.65 110.09 21.0 Favored 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 108.753 -0.832 . . . . 72.21 108.753 -178.278 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 251' ' ' LEU . . . . . 0.637 ' HB2' ' HB2' ' A' ' 233' ' ' LEU . 85.3 mt -87.6 118.03 26.81 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 123.921 0.889 . . . . 71.4 109.294 -177.275 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 252' ' ' GLU . . . . . 0.416 ' HG3' ' HD3' ' A' ' 254' ' ' ARG . 10.1 tp10 -83.78 98.62 9.8 Favored 'General case' 0 C--O 1.239 0.506 0 N-CA-C 108.585 -0.895 . . . . 75.13 108.585 175.918 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 6.1 m -71.71 129.64 35.3 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 CA-C-O 121.498 0.666 . . . . 73.34 110.03 -176.526 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 254' ' ' ARG . . . . . 0.416 ' HD3' ' HG3' ' A' ' 252' ' ' GLU . 15.2 mmm180 -122.43 99.36 6.37 Favored 'General case' 0 C--O 1.238 0.483 0 CA-C-N 115.131 -0.94 . . . . 74.42 108.993 -173.803 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 255' ' ' ILE . . . . . 0.449 ' HA ' ' O ' ' A' ' 199' ' ' VAL . 15.7 mt -76.61 120.07 26.1 Favored 'Isoleucine or valine' 0 C--O 1.24 0.595 0 CA-C-O 121.443 0.64 . . . . 73.23 110.231 179.789 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 8.9 t . . . . . 0 CA--C 1.566 1.592 0 C-N-CA 125.198 1.399 . . . . 71.23 108.06 -178.267 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 172' ' ' LEU . . . . . 0.563 HD21 ' H ' ' A' ' 222' ' ' ALA . 25.8 mt . . . . . 0 N--CA 1.482 1.128 0 CA-C-O 120.998 0.428 . . . . 72.2 110.345 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 173' ' ' PHE . . . . . 0.471 ' CE2' ' HE3' ' A' ' 238' ' ' LYS . 4.1 m-85 -134.74 -60.85 0.77 Allowed 'General case' 0 N--CA 1.481 1.091 0 CA-C-N 115.367 -0.833 . . . . 72.12 109.955 -155.767 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 174' ' ' TYR . . . . . 0.464 ' CD2' ' HB3' ' A' ' 233' ' ' LEU . 4.9 p90 -85.68 11.99 9.77 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 114.508 -1.223 . . . . 72.24 112.18 -175.852 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 175' ' ' THR . . . . . 0.484 ' OG1' ' HB3' ' A' ' 172' ' ' LEU . 0.2 OUTLIER -68.96 -17.5 63.95 Favored 'General case' 0 CA--C 1.551 1.0 0 C-N-CA 123.556 0.742 . . . . 73.32 112.324 -166.238 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 176' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -73.59 -28.53 61.88 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 123.631 0.773 . . . . 63.34 111.088 176.038 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . 0.437 ' HG2' ' HA3' ' A' ' 180' ' ' GLY . 23.2 ttpp -151.87 62.46 0.85 Allowed 'General case' 0 CA--C 1.551 0.988 0 CA-C-O 122.276 1.036 . . . . 70.34 108.942 -177.21 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 178' ' ' ALA . . . . . 0.415 ' HB1' ' HB3' ' A' ' 224' ' ' PRO . . . -81.01 126.3 31.23 Favored 'General case' 0 N--CA 1.476 0.864 0 CA-C-N 114.457 -1.247 . . . . 74.32 110.794 -175.763 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . 0.48 ' HB1' HH11 ' A' ' 231' ' ' ARG . . . 66.57 9.92 6.97 Favored 'General case' 0 N--CA 1.497 1.924 0 C-N-CA 124.955 1.302 . . . . 62.33 111.501 -170.031 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . 0.437 ' HA3' ' HG2' ' A' ' 177' ' ' LYS . . . . . . . . 0 N--CA 1.468 0.786 0 CA-C-N 116.267 -0.424 . . . . 71.41 112.268 -173.411 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 191' ' ' GLN . . . . . 0.625 ' HB3' ' HD2' ' A' ' 243' ' ' PRO . 9.5 pt20 . . . . . 0 N--CA 1.477 0.905 0 CA-C-O 121.438 0.637 . . . . 71.32 109.915 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 65.7 m-20 -78.32 152.99 32.11 Favored 'General case' 0 C--O 1.239 0.521 0 CA-C-N 114.65 -1.159 . . . . 64.21 110.955 -173.598 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . 0.486 HD11 ' HA2' ' A' ' 239' ' ' GLY . 59.3 mt -128.68 175.76 8.33 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 114.547 -1.206 . . . . 63.25 110.297 -174.374 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 17.5 m-85 -139.67 122.73 16.78 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 123.915 0.886 . . . . 73.54 110.046 -177.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . 0.401 ' HB1' HD11 ' A' ' 249' ' ' LEU . . . -129.4 128.2 42.52 Favored 'General case' 0 C--N 1.341 0.209 0 N-CA-C 108.318 -0.993 . . . . 71.43 108.318 173.331 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 61.7 m -77.72 123.89 27.26 Favored 'General case' 0 CA--C 1.546 0.799 0 N-CA-C 109.344 -0.613 . . . . 74.21 109.344 176.888 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . 0.626 HD21 HD11 ' A' ' 251' ' ' LEU . 18.9 tp -107.69 110.87 22.83 Favored 'General case' 0 N--CA 1.474 0.775 0 N-CA-C 108.562 -0.903 . . . . 74.41 108.562 -178.532 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -78.43 132.52 37.34 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 109.321 -0.622 . . . . 73.33 109.321 173.286 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 199' ' ' VAL . . . . . 0.482 ' O ' ' HA ' ' A' ' 255' ' ' ILE . 4.1 p -144.18 127.3 8.72 Favored Pre-proline 0 CA--C 1.546 0.804 0 N-CA-C 108.453 -0.943 . . . . 74.13 108.453 177.745 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -69.59 156.09 64.72 Favored 'Trans proline' 0 C--N 1.367 1.517 0 C-N-CA 121.962 1.775 . . . . 72.15 111.48 170.774 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 201' ' ' ALA . . . . . 0.438 ' O ' HG23 ' A' ' 205' ' ' VAL . . . -51.05 -51.96 62.88 Favored Pre-proline 0 CA--C 1.555 1.166 0 N-CA-C 113.996 1.11 . . . . 63.35 113.996 -177.354 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -65.39 -32.63 49.79 Favored 'Trans proline' 0 C--N 1.382 2.309 0 CA-C-N 121.181 1.458 . . . . 63.01 113.253 -176.072 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 27.3 mt -68.48 -34.86 67.88 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.229 0 C-N-CA 122.664 0.386 . . . . 75.34 110.152 174.307 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -71.54 -33.12 68.88 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 122.295 0.238 . . . . 71.35 111.369 178.414 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 205' ' ' VAL . . . . . 0.438 HG23 ' O ' ' A' ' 201' ' ' ALA . 80.7 t -71.05 -57.76 6.86 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 C-N-CA 123.349 0.66 . . . . 64.2 111.041 178.643 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 10.6 m -82.37 -17.26 11.46 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.055 0 CA-C-N 116.272 -0.422 . . . . 74.34 111.588 -172.798 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 74.86 66.17 1.98 Allowed Glycine 0 C--N 1.342 0.883 0 O-C-N 123.667 0.604 . . . . 52.21 112.327 -177.422 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -85.57 -130.0 2.33 Favored Glycine 0 C--N 1.346 1.091 0 C-N-CA 122.694 0.188 . . . . 55.51 112.806 179.522 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 209' ' ' LYS . . . . . 0.425 ' HG2' ' HA ' ' A' ' 222' ' ' ALA . 46.8 mtmt -138.24 155.48 48.6 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.753 0.821 . . . . 71.03 111.005 176.363 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 11.0 m -144.23 168.93 10.15 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 C-N-CA 125.155 1.382 . . . . 74.32 108.66 172.406 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 48.9 ttp180 -97.06 114.34 25.97 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 123.227 0.611 . . . . 75.23 109.939 178.552 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -100.74 139.66 36.1 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 123.667 0.787 . . . . 74.52 110.208 179.52 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 23.9 mmt -98.46 116.02 29.79 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 123.021 0.528 . . . . 75.4 109.716 178.707 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 48.9 p -109.46 -175.58 2.79 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 123.928 0.891 . . . . 73.35 109.182 175.527 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 93.3 mt -63.3 -22.3 66.79 Favored 'General case' 0 CA--C 1.552 1.02 0 C-N-CA 122.71 0.404 . . . . 63.13 111.356 173.685 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 20.9 mt-10 -81.93 -22.89 36.48 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 123.672 0.789 . . . . 63.21 110.99 -178.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 118.18 -150.06 18.27 Favored Glycine 0 CA--C 1.533 1.16 0 N-CA-C 110.911 -0.876 . . . . 73.01 110.911 -170.822 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_endo -78.26 144.73 20.94 Favored 'Trans proline' 0 C--N 1.369 1.628 0 C-N-CA 122.463 2.109 . . . . 75.42 113.19 -176.424 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 7.6 p -144.02 133.03 19.34 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 C-N-CA 123.914 0.886 . . . . 65.41 109.366 177.363 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 40.0 mm-40 -78.69 104.59 9.41 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 109.658 -0.497 . . . . 72.23 109.658 177.47 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 4.1 p -107.31 130.19 59.88 Favored 'Isoleucine or valine' 0 C--O 1.244 0.808 0 CA-C-N 115.418 -0.81 . . . . 71.2 109.224 -174.423 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 222' ' ' ALA . . . . . 0.563 ' H ' HD21 ' A' ' 172' ' ' LEU . . . -81.09 104.64 11.71 Favored 'General case' 0 C--O 1.239 0.536 0 C-N-CA 123.419 0.688 . . . . 75.01 111.061 -177.16 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 59.9 t -55.6 135.64 71.12 Favored Pre-proline 0 N--CA 1.476 0.865 0 O-C-N 124.423 1.077 . . . . 74.41 110.056 178.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 224' ' ' PRO . . . . . 0.415 ' HB3' ' HB1' ' A' ' 178' ' ' ALA . 17.1 Cg_endo -65.23 148.76 88.98 Favored 'Trans proline' 0 C--N 1.365 1.416 0 C-N-CA 121.747 1.631 . . . . 65.14 111.801 170.326 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -65.35 150.17 87.46 Favored 'Trans proline' 0 C--N 1.364 1.35 0 C-N-CA 121.499 1.466 . . . . 73.23 111.612 169.763 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 59.6 mtm180 61.72 35.83 16.68 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 124.654 1.182 . . . . 73.1 112.484 170.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 227' ' ' THR . . . . . 0.409 HG21 HG22 ' A' ' 253' ' ' VAL . 26.6 m -83.04 133.94 35.06 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 115.342 -0.845 . . . . 75.13 109.262 174.365 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 28.3 mp0 -111.2 149.63 30.69 Favored 'General case' 0 N--CA 1.485 1.319 0 N-CA-C 109.398 -0.593 . . . . 73.44 109.398 175.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 229' ' ' ALA . . . . . 0.449 ' HA ' HG23 ' A' ' 253' ' ' VAL . . . -58.47 125.99 25.66 Favored 'General case' 0 N--CA 1.47 0.556 0 O-C-N 124.305 1.003 . . . . 63.13 111.46 -176.548 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 113.98 -15.46 21.14 Favored Glycine 0 CA--C 1.523 0.551 0 CA-C-N 115.206 -0.907 . . . . 44.22 113.035 -176.58 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 231' ' ' ARG . . . . . 0.48 HH11 ' HB1' ' A' ' 179' ' ' ALA . 75.0 mtt180 -67.66 152.81 45.0 Favored 'General case' 0 C--N 1.363 1.158 0 CA-C-N 117.751 0.775 . . . . 73.32 109.457 172.547 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 232' ' ' LYS . . . . . 0.475 ' HA ' ' O ' ' A' ' 251' ' ' LEU . 54.0 mtmt -130.05 128.01 41.06 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-O 121.324 0.583 . . . . 74.32 110.602 179.201 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 233' ' ' LEU . . . . . 0.491 ' HB2' ' HB2' ' A' ' 251' ' ' LEU . 20.1 mt -98.49 148.1 24.08 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 114.354 -1.293 . . . . 75.23 108.887 -174.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 21.2 ttt180 -106.82 110.24 22.35 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 122.851 0.46 . . . . 74.23 111.263 -170.401 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 235' ' ' LEU . . . . . 0.603 ' HB2' ' HB3' ' A' ' 249' ' ' LEU . 17.1 mt -98.56 103.9 15.89 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 122.641 0.376 . . . . 75.35 110.092 177.963 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 13.6 mtmt -70.72 134.84 47.82 Favored 'General case' 0 C--O 1.238 0.495 0 CA-C-N 116.231 -0.44 . . . . 75.44 111.896 -178.154 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 73.72 10.51 80.09 Favored Glycine 0 C--N 1.344 0.996 0 CA-C-N 114.973 -1.012 . . . . 72.4 114.808 177.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . 0.471 ' HE3' ' CE2' ' A' ' 173' ' ' PHE . 69.7 mmtt -104.6 5.36 33.69 Favored 'General case' 0 N--CA 1.478 0.957 0 CA-C-N 117.393 0.596 . . . . 63.55 110.0 179.785 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 239' ' ' GLY . . . . . 0.486 ' HA2' HD11 ' A' ' 193' ' ' LEU . . . -105.7 -168.37 23.5 Favored Glycine 0 C--N 1.35 1.325 0 CA-C-N 115.25 -0.886 . . . . 73.45 111.294 166.733 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -93.73 167.75 13.19 Favored Pre-proline 0 CA--C 1.559 1.319 0 C-N-CA 123.998 0.919 . . . . 74.13 110.233 178.337 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -71.65 171.51 16.25 Favored 'Trans proline' 0 C--N 1.376 2.001 0 C-N-CA 122.437 2.091 . . . . 63.43 112.926 172.203 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 155.36 -117.25 0.77 Allowed Glycine 0 CA--C 1.537 1.461 0 CA-C-O 119.312 -0.715 . . . . 73.44 113.219 173.507 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 243' ' ' PRO . . . . . 0.625 ' HD2' ' HB3' ' A' ' 191' ' ' GLN . 60.5 Cg_endo -63.25 -40.65 31.29 Favored 'Trans proline' 0 C--N 1.375 1.966 0 C-N-CA 124.638 3.559 . . . . 72.53 113.506 -169.348 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 244' ' ' ALA . . . . . 0.406 ' HB2' HE22 ' A' ' 191' ' ' GLN . . . -101.27 -13.99 17.84 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 123.393 0.677 . . . . 72.33 110.316 177.292 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 96.32 -31.71 7.16 Favored Glycine 0 C--N 1.352 1.464 0 CA-C-N 116.109 -0.496 . . . . 73.11 112.908 179.66 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 50.5 ttt180 -126.65 110.56 13.31 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 124.17 0.988 . . . . 71.5 109.102 -178.663 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -75.96 151.07 40.22 Favored Glycine 0 C--N 1.347 1.161 0 O-C-N 123.684 0.615 . . . . 62.34 113.532 179.011 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 18.4 m-20 -118.89 137.65 53.3 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 124.144 0.978 . . . . 70.5 109.67 -175.744 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 249' ' ' LEU . . . . . 0.603 ' HB3' ' HB2' ' A' ' 235' ' ' LEU . 51.6 tp -98.93 118.06 34.84 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 109.049 -0.723 . . . . 75.01 109.049 179.521 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 250' ' ' TYR . . . . . . . . . . . . . 3.4 m-85 -90.64 112.78 24.64 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 123.62 0.768 . . . . 73.41 110.331 -175.615 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 251' ' ' LEU . . . . . 0.626 HD11 HD21 ' A' ' 197' ' ' LEU . 83.4 mt -87.57 105.24 17.19 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 124.209 1.004 . . . . 74.45 109.408 -177.453 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 252' ' ' GLU . . . . . 0.4 ' O ' ' HG2' ' A' ' 254' ' ' ARG . 29.4 mt-10 -78.74 93.94 5.02 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 108.327 -0.99 . . . . 75.42 108.327 -178.425 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 253' ' ' VAL . . . . . 0.449 HG23 ' HA ' ' A' ' 229' ' ' ALA . 3.9 m -64.19 127.98 25.77 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.871 0 CA-C-O 121.334 0.587 . . . . 62.14 109.786 -176.701 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 254' ' ' ARG . . . . . 0.4 ' HG2' ' O ' ' A' ' 252' ' ' GLU . 26.6 mmt85 -127.46 98.97 5.43 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 108.713 -0.847 . . . . 73.34 108.713 -175.194 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 255' ' ' ILE . . . . . 0.482 ' HA ' ' O ' ' A' ' 199' ' ' VAL . 24.8 mt -80.31 110.56 16.02 Favored 'Isoleucine or valine' 0 C--O 1.238 0.473 0 CA-C-N 115.25 -0.886 . . . . 75.52 110.415 -176.922 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 10.2 t . . . . . 0 C--O 1.257 1.475 0 CA-C-N 115.059 -0.973 . . . . 75.55 109.708 174.037 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 172' ' ' LEU . . . . . 0.604 HD23 ' H ' ' A' ' 222' ' ' ALA . 22.3 mt . . . . . 0 N--CA 1.483 1.19 0 CA-C-O 120.855 0.359 . . . . 72.21 110.454 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 173' ' ' PHE . . . . . 0.463 ' CD1' HD21 ' A' ' 235' ' ' LEU . 26.2 m-85 -123.99 -62.78 1.26 Allowed 'General case' 0 N--CA 1.475 0.777 0 CA-C-N 115.519 -0.764 . . . . 75.12 110.189 -169.661 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 174' ' ' TYR . . . . . 0.453 ' CD2' ' HB3' ' A' ' 233' ' ' LEU . 1.8 p90 -75.8 -11.38 59.97 Favored 'General case' 0 C--O 1.219 -0.503 0 CA-C-N 114.587 -1.188 . . . . 71.3 112.815 -172.158 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 175' ' ' THR . . . . . 0.599 HG21 HD11 ' A' ' 172' ' ' LEU . 42.9 p -70.61 -2.18 13.47 Favored 'General case' 0 CA--C 1.548 0.9 0 N-CA-C 112.558 0.577 . . . . 73.0 112.558 -176.45 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 176' ' ' MET . . . . . . . . . . . . . 24.9 ptt? -57.1 -41.97 79.89 Favored 'General case' 0 CA--C 1.559 1.299 0 C-N-CA 123.67 0.788 . . . . 75.13 110.261 161.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 14.5 tmtt? 179.51 108.52 0.03 OUTLIER 'General case' 0 CA--C 1.553 1.08 0 C-N-CA 126.18 1.792 . . . . 74.14 106.321 179.463 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 178' ' ' ALA . . . . . 0.495 ' HB2' HD21 ' A' ' 233' ' ' LEU . . . -128.08 -58.77 1.2 Allowed 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 123.081 0.552 . . . . 72.12 112.025 -173.017 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . 0.478 ' HB3' ' HB2' ' A' ' 224' ' ' PRO . . . -71.55 85.22 0.86 Allowed 'General case' 0 CA--C 1.546 0.81 0 CA-C-O 121.57 0.7 . . . . 71.12 109.48 179.463 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.337 0.591 0 CA-C-N 114.298 -1.319 . . . . 75.43 109.889 -172.546 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 191' ' ' GLN . . . . . 0.592 ' HB3' ' HD2' ' A' ' 243' ' ' PRO . 6.8 pt20 . . . . . 0 N--CA 1.483 1.178 0 CA-C-O 121.302 0.572 . . . . 72.13 110.768 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -76.05 135.61 39.92 Favored 'General case' 0 C--O 1.241 0.624 0 CA-C-N 114.387 -1.279 . . . . 74.43 110.048 -177.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 43.6 mt -117.87 168.26 10.66 Favored 'General case' 0 C--O 1.24 0.589 0 CA-C-N 114.701 -1.136 . . . . 72.53 109.204 177.796 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 31.8 m-85 -138.6 121.86 17.01 Favored 'General case' 0 C--O 1.238 0.466 0 C-N-CA 123.483 0.713 . . . . 74.23 109.656 -179.49 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . 0.468 ' HB1' HD23 ' A' ' 251' ' ' LEU . . . -126.9 133.67 50.62 Favored 'General case' 0 CA--C 1.516 -0.342 0 C-N-CA 123.962 0.905 . . . . 70.04 108.607 177.448 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 2.2 m -81.45 125.59 30.62 Favored 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 108.82 -0.808 . . . . 73.33 108.82 176.234 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . 0.561 HD21 HD13 ' A' ' 251' ' ' LEU . 15.7 tp -109.55 111.39 22.88 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 108.672 -0.862 . . . . 74.14 108.672 -176.624 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -76.19 127.93 33.91 Favored 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 108.55 -0.907 . . . . 73.13 108.55 174.491 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 199' ' ' VAL . . . . . 0.493 ' O ' ' HA ' ' A' ' 255' ' ' ILE . 7.7 p -145.29 133.58 10.74 Favored Pre-proline 0 CA--C 1.544 0.716 0 N-CA-C 108.475 -0.935 . . . . 70.21 108.475 176.112 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 200' ' ' PRO . . . . . 0.455 ' HB2' ' HD2' ' A' ' 202' ' ' PRO . 75.4 Cg_endo -75.74 160.98 37.19 Favored 'Trans proline' 0 C--N 1.361 1.191 0 C-N-CA 121.737 1.625 . . . . 64.33 111.25 167.97 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -55.75 -47.25 99.12 Favored Pre-proline 0 CA--C 1.558 1.282 0 CA-C-O 117.695 -1.145 . . . . 71.35 113.786 -178.323 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 202' ' ' PRO . . . . . 0.455 ' HD2' ' HB2' ' A' ' 200' ' ' PRO . 56.1 Cg_endo -64.47 -37.95 35.95 Favored 'Trans proline' 0 C--N 1.396 3.057 0 C-N-CA 121.691 1.594 . . . . 75.02 112.964 -177.861 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 45.1 mt -67.93 -34.93 70.04 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.062 0 CA-C-O 120.817 0.341 . . . . 75.4 110.436 176.248 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 204' ' ' ALA . . . . . 0.41 ' HA ' HG11 ' A' ' 223' ' ' VAL . . . -67.45 -40.61 85.39 Favored 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 123.048 0.539 . . . . 72.44 112.239 179.382 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 17.1 m -80.27 -45.98 22.0 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.793 0 N-CA-C 112.919 0.711 . . . . 72.51 112.919 -175.543 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 206' ' ' VAL . . . . . 0.422 HG23 ' O ' ' A' ' 202' ' ' PRO . 11.1 m -78.04 -25.57 14.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 C-N-CA 122.213 0.205 . . . . 74.13 111.516 178.477 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 82.24 66.25 1.58 Allowed Glycine 0 C--N 1.344 1.026 0 N-CA-C 111.944 -0.462 . . . . 72.25 111.944 -177.318 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -86.47 -130.93 2.85 Favored Glycine 0 C--N 1.352 1.442 0 C-N-CA 123.262 0.458 . . . . 74.12 112.217 177.494 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 209' ' ' LYS . . . . . 0.43 ' HG2' ' HA ' ' A' ' 222' ' ' ALA . 48.4 mtmt -137.89 155.72 48.64 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 124.063 0.945 . . . . 73.12 111.084 177.001 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 9.5 m -147.51 151.89 13.32 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.793 0 C-N-CA 125.288 1.435 . . . . 74.55 108.682 169.763 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 211' ' ' ARG . . . . . 0.439 ' HD2' ' HB2' ' A' ' 218' ' ' PRO . 54.5 ttp180 -87.55 116.9 25.99 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 123.069 0.548 . . . . 73.31 110.501 179.749 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -100.87 129.01 46.67 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 123.95 0.9 . . . . 74.34 109.769 177.557 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 22.4 mmt -86.29 120.86 28.1 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 108.96 -0.755 . . . . 71.12 108.96 175.49 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 24.0 p -123.41 -174.71 3.02 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 123.928 0.891 . . . . 73.43 109.835 -174.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 77.0 mt -65.77 -29.36 69.85 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 122.752 0.421 . . . . 75.41 110.894 172.259 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 18.6 mm-40 -90.6 6.77 42.4 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 123.859 0.864 . . . . 61.53 110.971 -179.589 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 96.79 -160.34 21.71 Favored Glycine 0 C--N 1.352 1.47 0 CA-C-O 119.581 -0.566 . . . . 74.32 112.636 177.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 218' ' ' PRO . . . . . 0.439 ' HB2' ' HD2' ' A' ' 211' ' ' ARG . 71.8 Cg_endo -75.11 144.25 29.67 Favored 'Trans proline' 0 C--N 1.368 1.565 0 C-N-CA 122.336 2.024 . . . . 74.02 112.471 -179.665 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 7.5 p -146.92 131.27 10.46 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 C-N-CA 123.199 0.599 . . . . 72.01 109.778 177.663 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -69.73 103.09 2.05 Favored 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 108.114 -1.069 . . . . 72.12 108.114 169.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 1.7 p -103.58 120.61 53.88 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.133 0 N-CA-C 108.263 -1.014 . . . . 63.45 108.263 179.74 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 222' ' ' ALA . . . . . 0.604 ' H ' HD23 ' A' ' 172' ' ' LEU . . . -76.11 109.91 10.15 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 123.382 0.673 . . . . 62.23 111.558 -175.441 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 223' ' ' VAL . . . . . 0.41 HG11 ' HA ' ' A' ' 204' ' ' ALA . 51.9 t -55.2 138.4 66.52 Favored Pre-proline 0 N--CA 1.48 1.054 0 C-N-CA 125.636 1.574 . . . . 73.31 111.029 -177.087 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 224' ' ' PRO . . . . . 0.478 ' HB2' ' HB3' ' A' ' 179' ' ' ALA . 36.8 Cg_endo -66.42 147.79 83.16 Favored 'Trans proline' 0 C--N 1.377 2.03 0 C-N-CA 121.61 1.54 . . . . 73.0 110.843 170.918 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_exo -69.1 149.33 70.97 Favored 'Trans proline' 0 C--N 1.364 1.378 0 C-N-CA 121.725 1.617 . . . . 75.24 111.672 174.287 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 82.4 mtt180 63.94 39.56 7.99 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 124.79 1.236 . . . . 73.41 111.099 173.09 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 227' ' ' THR . . . . . 0.404 ' OG1' ' HG2' ' A' ' 224' ' ' PRO . 91.3 m -83.08 139.15 33.39 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 115.349 -0.841 . . . . 74.5 109.881 177.436 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 27.3 mp0 -112.36 148.31 34.55 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 124.325 1.05 . . . . 73.22 109.208 176.413 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -59.2 128.65 38.21 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 123.546 0.738 . . . . 65.24 110.854 -179.615 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 105.6 -3.56 39.58 Favored Glycine 0 N--CA 1.471 1.023 0 O-C-N 123.828 0.705 . . . . 72.01 113.18 -177.55 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 231' ' ' ARG . . . . . 0.403 ' HD2' HG23 ' A' ' 227' ' ' THR . 62.8 mtt-85 -71.68 149.96 45.0 Favored 'General case' 0 C--N 1.359 1.006 0 CA-C-N 117.43 0.615 . . . . 73.12 109.839 171.851 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -127.45 103.35 7.31 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 123.263 0.625 . . . . 73.32 109.341 -174.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 233' ' ' LEU . . . . . 0.532 ' HB2' ' HB2' ' A' ' 251' ' ' LEU . 28.9 mt -80.38 149.34 30.25 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 114.16 -1.382 . . . . 75.42 109.121 -177.213 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 56.5 ttt180 -115.39 109.04 17.3 Favored 'General case' 0 N--CA 1.481 1.11 0 O-C-N 121.926 -0.484 . . . . 74.34 111.349 -171.755 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 235' ' ' LEU . . . . . 0.557 ' HB2' ' HB3' ' A' ' 249' ' ' LEU . 19.2 mt -95.68 107.02 19.19 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 123.125 0.57 . . . . 71.35 110.116 176.565 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 21.2 mttt -73.25 137.69 45.08 Favored 'General case' 0 CA--C 1.535 0.393 0 O-C-N 123.214 0.321 . . . . 74.33 110.208 174.114 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 74.01 19.17 79.79 Favored Glycine 0 C--N 1.34 0.78 0 CA-C-N 115.567 -0.742 . . . . 73.31 114.017 179.661 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 34.9 mmtm -121.19 6.93 10.22 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 123.367 0.667 . . . . 60.23 110.616 174.171 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -109.0 -170.5 20.79 Favored Glycine 0 C--N 1.347 1.175 0 N-CA-C 110.534 -1.026 . . . . 72.43 110.534 163.053 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 89.0 m-85 -89.96 147.64 37.77 Favored Pre-proline 0 N--CA 1.478 0.95 0 C-N-CA 123.169 0.588 . . . . 71.52 110.972 -177.66 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 17.6 Cg_exo -68.02 128.2 17.29 Favored 'Trans proline' 0 C--N 1.365 1.404 0 C-N-CA 121.771 1.648 . . . . 75.03 111.137 172.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -158.97 -121.66 0.63 Allowed Glycine 0 C--N 1.347 1.16 0 CA-C-O 118.351 -1.249 . . . . 63.24 112.313 -177.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 243' ' ' PRO . . . . . 0.592 ' HD2' ' HB3' ' A' ' 191' ' ' GLN . 25.2 Cg_endo -55.21 -45.58 39.32 Favored 'Trans proline' 0 C--N 1.38 2.23 0 C-N-CA 124.414 3.409 . . . . 75.14 113.489 -174.599 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -86.64 -13.22 46.21 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 123.156 0.582 . . . . 72.1 111.539 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 92.54 -30.64 6.71 Favored Glycine 0 C--N 1.348 1.21 0 N-CA-C 112.068 -0.413 . . . . 73.24 112.068 -174.402 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 46.0 ttm-85 -128.28 112.47 14.5 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 124.364 1.065 . . . . 70.42 109.114 176.066 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -72.73 154.78 50.43 Favored Glycine 0 C--N 1.347 1.192 0 O-C-N 123.181 0.301 . . . . 71.22 113.584 172.883 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 20.9 m-20 -110.24 165.49 11.72 Favored 'General case' 0 C--O 1.237 0.398 0 C-N-CA 123.996 0.918 . . . . 75.41 110.088 -177.689 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 249' ' ' LEU . . . . . 0.557 ' HB3' ' HB2' ' A' ' 235' ' ' LEU . 34.7 tp -129.47 113.32 14.75 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 123.758 0.823 . . . . 74.52 108.877 176.16 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 250' ' ' TYR . . . . . 0.449 ' HA ' ' O ' ' A' ' 233' ' ' LEU . 7.5 m-85 -91.04 110.55 21.82 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 115.664 -0.698 . . . . 74.54 110.627 -177.452 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 251' ' ' LEU . . . . . 0.561 HD13 HD21 ' A' ' 197' ' ' LEU . 84.6 mt -88.39 105.36 17.54 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 114.139 -1.391 . . . . 75.14 109.143 -178.644 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -80.12 100.83 8.42 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 108.687 -0.857 . . . . 74.14 108.687 175.849 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 12.1 m -63.58 133.97 28.92 Favored 'Isoleucine or valine' 0 C--O 1.246 0.895 0 O-C-N 123.775 0.672 . . . . 64.24 110.094 -179.777 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 20.5 mmm-85 -127.64 94.22 3.91 Favored 'General case' 0 C--O 1.24 0.59 0 N-CA-C 107.815 -1.179 . . . . 75.35 107.815 -177.257 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 255' ' ' ILE . . . . . 0.493 ' HA ' ' O ' ' A' ' 199' ' ' VAL . 22.4 mt -76.76 133.75 30.27 Favored 'Isoleucine or valine' 0 C--O 1.238 0.469 0 O-C-N 124.482 1.114 . . . . 75.24 110.836 -173.909 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 9.7 t . . . . . 0 CA--C 1.569 1.698 0 CA-C-O 117.589 -1.196 . . . . 74.15 108.832 179.824 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 172' ' ' LEU . . . . . 0.567 HD22 ' H ' ' A' ' 222' ' ' ALA . 53.3 mt . . . . . 0 N--CA 1.485 1.32 0 CA-C-O 120.985 0.422 . . . . 74.24 110.188 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 173' ' ' PHE . . . . . 0.478 ' CD1' HD22 ' A' ' 235' ' ' LEU . 52.3 m-85 -140.66 -58.27 0.52 Allowed 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.829 0.852 . . . . 74.13 109.191 -164.067 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 174' ' ' TYR . . . . . 0.478 ' OH ' ' HB ' ' A' ' 221' ' ' VAL . 7.2 p90 -70.53 -14.96 62.72 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 114.347 -1.297 . . . . 73.12 113.089 -177.806 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -45.73 -29.02 1.16 Allowed 'General case' 0 N--CA 1.49 1.574 0 C-N-CA 126.172 1.789 . . . . 71.22 114.076 -173.157 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 176' ' ' MET . . . . . . . . . . . . . 66.5 mtm -55.7 -38.95 70.38 Favored 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 124.736 1.214 . . . . 75.34 112.934 -178.58 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 14.3 ptmm? -160.42 34.48 0.16 Allowed 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 123.503 0.721 . . . . 75.22 110.848 -170.766 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -64.16 -46.24 84.88 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 124.764 1.226 . . . . 64.12 113.479 -169.705 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . 0.448 ' HB3' ' HB2' ' A' ' 224' ' ' PRO . . . -82.65 65.79 7.95 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-O 122.124 0.964 . . . . 75.55 109.629 -179.71 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.243 0.685 0 CA-C-N 114.19 -1.368 . . . . 71.34 110.48 -179.327 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 191' ' ' GLN . . . . . 0.646 HE22 ' HB3' ' A' ' 244' ' ' ALA . 5.8 pt20 . . . . . 0 CA--C 1.542 0.665 0 N-CA-C 109.235 -0.654 . . . . 72.11 109.235 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 192' ' ' ASP . . . . . 0.504 ' N ' ' HG3' ' A' ' 191' ' ' GLN . 31.3 m-20 -80.27 137.33 36.61 Favored 'General case' 0 C--N 1.354 0.778 0 CA-C-N 115.229 -0.896 . . . . 63.04 109.003 -176.125 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 32.2 mt -113.05 174.83 5.71 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 115.85 -0.614 . . . . 74.12 111.379 -173.438 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 48.5 m-85 -136.93 124.15 21.78 Favored 'General case' 0 C--O 1.238 0.492 0 C-N-CA 124.552 1.141 . . . . 74.0 109.466 -179.771 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . 0.41 ' O ' ' HA ' ' A' ' 251' ' ' LEU . . . -135.42 128.29 31.26 Favored 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 107.269 -1.382 . . . . 73.41 107.269 171.429 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 44.9 m -82.77 125.8 31.68 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 109.188 -0.671 . . . . 74.13 109.188 -179.839 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . 0.5 HD23 HD12 ' A' ' 251' ' ' LEU . 15.9 tp -106.65 110.8 23.09 Favored 'General case' 0 N--CA 1.466 0.333 0 N-CA-C 107.916 -1.142 . . . . 75.24 107.916 -176.743 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -87.69 126.61 35.07 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 123.272 0.629 . . . . 65.52 109.345 -179.336 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 199' ' ' VAL . . . . . 0.479 ' O ' ' HA ' ' A' ' 255' ' ' ILE . 5.5 p -144.83 132.63 10.52 Favored Pre-proline 0 CA--C 1.55 0.969 0 N-CA-C 108.409 -0.96 . . . . 74.42 108.409 -178.792 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -72.74 159.35 48.72 Favored 'Trans proline' 0 C--N 1.368 1.583 0 C-N-CA 121.987 1.792 . . . . 71.44 111.023 171.031 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 201' ' ' ALA . . . . . 0.471 ' O ' HG22 ' A' ' 205' ' ' VAL . . . -50.95 -53.71 45.0 Favored Pre-proline 0 CA--C 1.558 1.264 0 CA-C-O 117.659 -1.162 . . . . 71.32 113.361 -176.466 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -63.95 -35.31 55.73 Favored 'Trans proline' 0 C--N 1.389 2.677 0 C-N-CA 121.598 1.532 . . . . 75.03 113.504 -175.799 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 41.0 mt -68.73 -33.82 61.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 N-CA-C 109.702 -0.481 . . . . 74.41 109.702 176.005 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 204' ' ' ALA . . . . . 0.458 ' HB1' ' HB ' ' A' ' 227' ' ' THR . . . -70.14 -35.66 74.22 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 123.228 0.611 . . . . 73.35 111.305 178.47 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 205' ' ' VAL . . . . . 0.471 HG22 ' O ' ' A' ' 201' ' ' ALA . 90.2 t -70.94 -56.44 10.65 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 C-N-CA 123.398 0.679 . . . . 73.44 110.522 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 17.3 m -73.32 -27.57 24.11 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.956 0 C-N-CA 122.862 0.465 . . . . 71.32 111.334 -174.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 81.36 69.62 1.39 Allowed Glycine 0 C--N 1.341 0.85 0 CA-C-N 115.839 -0.619 . . . . 74.42 112.262 -175.622 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -87.56 -140.05 6.44 Favored Glycine 0 C--N 1.355 1.618 0 CA-C-O 119.593 -0.56 . . . . 72.53 112.236 177.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 47.8 mtmt -137.35 147.47 45.57 Favored 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 123.66 0.784 . . . . 75.02 110.97 179.662 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 5.6 m -143.39 160.17 17.12 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 C-N-CA 125.271 1.428 . . . . 75.51 109.369 176.804 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 24.3 ttt180 -90.49 114.58 26.8 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 123.929 0.892 . . . . 73.34 110.449 179.587 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -102.18 131.87 48.43 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 124.753 1.221 . . . . 73.12 109.841 174.772 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 37.2 tpp -88.28 130.96 34.97 Favored 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 109.87 -0.418 . . . . 70.13 109.87 176.506 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 63.4 p -120.24 -171.68 2.21 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 124.309 1.043 . . . . 75.1 109.279 177.425 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 89.9 mt -67.93 -22.21 65.07 Favored 'General case' 0 CA--C 1.55 0.971 0 C-N-CA 123.315 0.646 . . . . 73.13 111.789 172.347 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 58.6 mt-10 -90.68 -21.12 21.79 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 123.578 0.751 . . . . 74.41 111.258 -177.685 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 124.48 -156.34 18.52 Favored Glycine 0 C--N 1.34 0.779 0 N-CA-C 111.092 -0.803 . . . . 54.1 111.092 -173.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -76.3 140.16 21.75 Favored 'Trans proline' 0 CA--C 1.551 1.356 0 C-N-CA 122.219 1.946 . . . . 75.23 113.932 -176.821 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 2.4 p -131.98 128.98 60.2 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.451 0 C-N-CA 124.678 1.191 . . . . 74.15 108.015 172.109 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -81.75 102.09 10.54 Favored 'General case' 0 C--O 1.236 0.376 0 N-CA-C 108.349 -0.982 . . . . 72.33 108.349 174.011 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 221' ' ' VAL . . . . . 0.478 ' HB ' ' OH ' ' A' ' 174' ' ' TYR . 13.9 m -97.65 138.85 21.33 Favored 'Isoleucine or valine' 0 C--O 1.242 0.679 0 CA-C-N 115.431 -0.804 . . . . 74.33 109.459 179.57 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 222' ' ' ALA . . . . . 0.567 ' H ' HD22 ' A' ' 172' ' ' LEU . . . -88.85 107.83 19.2 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-N 115.05 -0.977 . . . . 63.41 109.624 -177.355 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 61.2 t -54.09 134.3 59.15 Favored Pre-proline 0 N--CA 1.482 1.137 0 C-N-CA 124.302 1.041 . . . . 65.14 109.532 -179.332 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 224' ' ' PRO . . . . . 0.448 ' HB2' ' HB3' ' A' ' 179' ' ' ALA . 26.1 Cg_endo -60.52 151.23 76.8 Favored 'Trans proline' 0 C--N 1.373 1.858 0 C-N-CA 121.922 1.748 . . . . 72.34 112.647 177.29 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -64.56 133.76 38.37 Favored 'Trans proline' 0 C--N 1.368 1.601 0 C-N-CA 121.485 1.457 . . . . 74.1 110.677 169.505 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 55.3 mtt180 67.03 62.64 0.48 Allowed 'General case' 0 C--O 1.241 0.629 0 C-N-CA 124.797 1.239 . . . . 72.2 109.831 175.668 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 227' ' ' THR . . . . . 0.65 ' HA ' ' HE ' ' A' ' 231' ' ' ARG . 56.1 m -89.87 140.51 29.54 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 113.866 -1.515 . . . . 74.33 109.173 176.582 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -116.64 141.54 48.07 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.736 0.814 . . . . 72.21 108.862 171.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 229' ' ' ALA . . . . . 0.437 ' HB3' ' HB ' ' A' ' 255' ' ' ILE . . . -58.91 116.99 4.15 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 123.651 0.781 . . . . 62.0 110.217 179.911 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 115.16 -2.2 22.51 Favored Glycine 0 CA--C 1.526 0.754 0 CA-C-O 119.123 -0.821 . . . . 73.11 113.542 -173.07 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 231' ' ' ARG . . . . . 0.65 ' HE ' ' HA ' ' A' ' 227' ' ' THR . 77.5 mtt-85 -66.38 145.49 55.64 Favored 'General case' 0 N--CA 1.483 1.203 0 CA-C-N 118.042 0.921 . . . . 62.52 109.183 169.55 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -121.38 98.81 6.15 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 107.899 -1.149 . . . . 74.34 107.899 -174.477 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 233' ' ' LEU . . . . . 0.798 ' HB2' ' HB2' ' A' ' 251' ' ' LEU . 53.7 mt -79.79 152.27 29.86 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 115.36 -0.836 . . . . 73.23 109.371 179.843 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 59.4 ttm-85 -122.29 106.49 11.15 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 122.937 0.495 . . . . 73.23 110.542 -175.464 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 235' ' ' LEU . . . . . 0.594 ' HB2' ' HB3' ' A' ' 249' ' ' LEU . 10.3 mt -91.58 100.17 12.96 Favored 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 109.043 -0.725 . . . . 74.34 109.043 171.376 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 19.4 mttt -67.34 132.91 48.63 Favored 'General case' 0 C--O 1.241 0.61 0 O-C-N 123.365 0.416 . . . . 73.42 111.347 -178.042 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 73.89 18.2 79.55 Favored Glycine 0 C--N 1.347 1.193 0 CA-C-N 115.03 -0.986 . . . . 71.43 115.034 177.248 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 68.9 mmtt -106.4 12.41 29.78 Favored 'General case' 0 N--CA 1.488 1.455 0 CA-C-N 117.405 0.603 . . . . 75.15 110.514 174.749 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -113.9 -165.66 15.73 Favored Glycine 0 CA--C 1.527 0.811 0 CA-C-N 114.822 -1.081 . . . . 71.21 110.732 167.802 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -95.17 168.01 11.84 Favored Pre-proline 0 N--CA 1.479 1.022 0 C-N-CA 124.278 1.031 . . . . 72.44 110.097 -177.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -81.27 149.14 16.97 Favored 'Trans proline' 0 C--N 1.372 1.786 0 C-N-CA 121.599 1.533 . . . . 74.14 112.859 171.63 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 179.52 -119.75 0.66 Allowed Glycine 0 CA--C 1.54 1.598 0 CA-C-O 119.004 -0.887 . . . . 70.22 113.28 176.021 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 243' ' ' PRO . . . . . 0.445 ' HD2' ' HB3' ' A' ' 191' ' ' GLN . 34.1 Cg_endo -55.62 -46.67 30.23 Favored 'Trans proline' 0 C--N 1.382 2.306 1 C-N-CA 125.364 4.043 . . . . 71.0 114.055 -172.241 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 244' ' ' ALA . . . . . 0.646 ' HB3' HE22 ' A' ' 191' ' ' GLN . . . -100.19 -2.21 34.55 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 123.315 0.646 . . . . 74.3 110.952 -179.133 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 87.8 -51.51 4.1 Favored Glycine 0 C--N 1.353 1.489 0 N-CA-C 111.833 -0.507 . . . . 73.02 111.833 -178.461 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 10.2 ttm180 -101.05 109.63 21.55 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 123.947 0.899 . . . . 72.13 109.879 176.679 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -75.98 130.41 10.94 Favored Glycine 0 C--N 1.351 1.373 0 N-CA-C 110.661 -0.976 . . . . 45.53 110.661 169.264 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 67.4 m-20 -112.31 145.65 39.65 Favored 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 109.332 -0.618 . . . . 72.04 109.332 -176.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 249' ' ' LEU . . . . . 0.594 ' HB3' ' HB2' ' A' ' 235' ' ' LEU . 31.4 tp -97.87 118.68 34.99 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 123.677 0.791 . . . . 62.05 109.207 -175.239 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 250' ' ' TYR . . . . . 0.41 ' HA ' ' O ' ' A' ' 233' ' ' LEU . 1.6 m-85 -89.34 108.87 19.88 Favored 'General case' 0 C--O 1.243 0.739 0 N-CA-C 108.727 -0.842 . . . . 75.1 108.727 -177.337 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 251' ' ' LEU . . . . . 0.798 ' HB2' ' HB2' ' A' ' 233' ' ' LEU . 79.7 mt -87.36 104.03 16.04 Favored 'General case' 0 C--O 1.241 0.61 0 N-CA-C 107.94 -1.133 . . . . 74.05 107.94 177.41 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -84.1 100.15 10.93 Favored 'General case' 0 C--O 1.238 0.457 0 CA-C-N 115.063 -0.972 . . . . 72.44 108.918 -177.535 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 11.7 m -72.04 135.59 27.53 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 CA-C-O 121.53 0.681 . . . . 71.43 110.67 -172.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 49.7 mmm-85 -127.42 98.92 5.42 Favored 'General case' 0 C--O 1.237 0.431 0 C-N-CA 124.608 1.163 . . . . 73.44 108.299 -178.594 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 255' ' ' ILE . . . . . 0.479 ' HA ' ' O ' ' A' ' 199' ' ' VAL . 27.2 mt -77.95 128.59 38.14 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 O-C-N 124.169 0.918 . . . . 73.44 109.754 179.735 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 4.2 t . . . . . 0 CA--C 1.559 1.327 0 CA-C-O 117.273 -1.346 . . . . 72.42 107.957 179.486 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 172' ' ' LEU . . . . . 0.426 HD21 ' HB2' ' A' ' 222' ' ' ALA . 43.4 mt . . . . . 0 N--CA 1.486 1.352 0 CA-C-O 120.97 0.415 . . . . 71.2 112.035 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 173' ' ' PHE . . . . . 0.484 ' CD1' HD22 ' A' ' 235' ' ' LEU . 11.9 m-85 -137.65 -44.95 0.54 Allowed 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 124.028 0.931 . . . . 64.25 109.519 -173.042 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 174' ' ' TYR . . . . . 0.504 ' CD2' ' HB3' ' A' ' 233' ' ' LEU . 0.7 OUTLIER -81.97 13.44 3.34 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-N 114.832 -1.076 . . . . 70.32 112.899 -175.689 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 175' ' ' THR . . . . . 0.412 HG21 ' HB3' ' A' ' 172' ' ' LEU . 11.6 p -63.37 -9.12 10.76 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.867 0.867 . . . . 71.24 113.308 -179.857 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 176' ' ' MET . . . . . . . . . . . . . 44.9 mtm -58.41 -63.96 1.09 Allowed 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 123.595 0.758 . . . . 63.53 109.104 166.36 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 44.8 pttt -168.1 119.06 0.81 Allowed 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 125.094 1.358 . . . . 74.42 108.337 -179.053 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 178' ' ' ALA . . . . . 0.571 ' HB2' HD22 ' A' ' 233' ' ' LEU . . . -124.04 -54.5 1.71 Allowed 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 123.916 0.886 . . . . 65.14 109.82 -173.641 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . 0.417 ' HA ' ' HD3' ' A' ' 231' ' ' ARG . . . -79.42 65.13 4.5 Favored 'General case' 0 CA--C 1.543 0.702 0 CA-C-O 121.918 0.866 . . . . 74.11 108.742 169.986 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.336 0.568 0 N-CA-C 110.148 -1.181 . . . . 42.22 110.148 -171.672 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 191' ' ' GLN . . . . . 0.431 ' HG3' ' N ' ' A' ' 192' ' ' ASP . 6.5 pt20 . . . . . 0 N--CA 1.47 0.552 0 N-CA-C 110.278 -0.267 . . . . 73.23 110.278 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 192' ' ' ASP . . . . . 0.431 ' N ' ' HG3' ' A' ' 191' ' ' GLN . 73.5 m-20 -84.94 121.0 27.13 Favored 'General case' 0 C--N 1.347 0.482 0 C-N-CA 123.998 0.919 . . . . 73.24 109.404 -175.722 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . 0.427 HD13 ' HA2' ' A' ' 239' ' ' GLY . 78.5 mt -108.17 177.67 4.73 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 124.351 1.06 . . . . 72.34 110.479 -170.383 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 47.3 m-85 -129.61 123.59 31.65 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 123.426 0.691 . . . . 75.44 110.736 -179.546 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . 0.414 ' HB1' HD11 ' A' ' 249' ' ' LEU . . . -128.29 171.98 11.48 Favored 'General case' 0 C--O 1.238 0.496 0 C-N-CA 125.64 1.576 . . . . 75.25 108.43 173.401 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 48.6 m -119.05 134.03 55.44 Favored 'General case' 0 C--O 1.237 0.446 0 C-N-CA 123.126 0.571 . . . . 71.53 109.675 175.57 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . 0.694 HD22 HD12 ' A' ' 251' ' ' LEU . 17.1 tp -116.37 110.87 19.25 Favored 'General case' 0 C--O 1.234 0.288 0 N-CA-C 108.178 -1.045 . . . . 71.33 108.178 175.477 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -90.14 122.56 33.21 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 108.68 -0.859 . . . . 74.02 108.68 -179.632 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 199' ' ' VAL . . . . . 0.417 ' O ' ' HA ' ' A' ' 255' ' ' ILE . 5.0 p -136.18 132.4 19.08 Favored Pre-proline 0 CA--C 1.549 0.917 0 C-N-CA 124.287 1.035 . . . . 72.21 108.835 -174.795 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 200' ' ' PRO . . . . . 0.403 ' HB2' ' HD2' ' A' ' 202' ' ' PRO . 60.5 Cg_endo -71.73 158.87 52.3 Favored 'Trans proline' 0 C--N 1.367 1.551 0 C-N-CA 122.025 1.817 . . . . 74.21 111.256 171.422 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -53.0 -46.06 97.81 Favored Pre-proline 0 CA--C 1.558 1.257 0 N-CA-C 114.208 1.188 . . . . 73.14 114.208 -179.675 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 202' ' ' PRO . . . . . 0.433 ' O ' HG22 ' A' ' 206' ' ' VAL . 34.3 Cg_endo -62.8 -43.45 20.47 Favored 'Trans proline' 0 C--N 1.385 2.494 0 C-N-CA 121.918 1.745 . . . . 64.43 113.675 177.527 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 43.5 mt -66.01 -30.73 50.89 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.351 0 CA-C-N 118.746 0.703 . . . . 74.4 110.5 177.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -68.74 -49.38 59.26 Favored 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 122.769 0.428 . . . . 73.42 111.587 177.26 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 205' ' ' VAL . . . . . 0.412 HG23 ' HA ' ' A' ' 202' ' ' PRO . 22.7 m -70.92 -47.83 60.09 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.848 0 C-N-CA 123.542 0.737 . . . . 74.44 112.411 -174.905 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 206' ' ' VAL . . . . . 0.433 HG22 ' O ' ' A' ' 202' ' ' PRO . 11.0 m -76.22 -34.19 25.45 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.235 0 C-N-CA 122.552 0.341 . . . . 61.42 110.979 179.712 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 87.47 61.06 1.57 Allowed Glycine 0 C--N 1.35 1.31 0 CA-C-N 116.251 -0.431 . . . . 70.11 112.135 -175.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -81.59 -133.93 1.64 Allowed Glycine 0 C--N 1.346 1.132 0 N-CA-C 112.511 -0.236 . . . . 74.1 112.511 177.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 209' ' ' LYS . . . . . 0.414 ' HG2' ' HA ' ' A' ' 222' ' ' ALA . 48.0 mtmt -136.21 152.67 51.01 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 123.895 0.878 . . . . 74.35 110.839 178.741 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 4.5 m -144.76 163.52 13.48 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 C-N-CA 125.412 1.485 . . . . 75.32 108.363 172.238 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 42.0 ttp180 -98.94 115.36 28.71 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 123.622 0.769 . . . . 74.14 109.26 179.277 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -101.92 120.81 41.0 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 124.145 0.978 . . . . 73.41 110.429 -179.489 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 74.6 mtp -84.26 137.28 33.56 Favored 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 110.125 -0.324 . . . . 74.24 110.125 175.708 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 38.0 p -130.54 -172.9 2.92 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 124.592 1.157 . . . . 74.02 109.551 -175.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 82.6 mt -58.29 -35.0 71.17 Favored 'General case' 0 N--CA 1.488 1.465 0 CA-C-O 121.152 0.501 . . . . 73.31 110.565 172.723 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -92.29 -8.49 45.05 Favored 'General case' 0 CA--C 1.545 0.754 0 CA-C-N 115.166 -0.925 . . . . 72.01 111.378 -177.8 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 113.61 -159.32 13.75 Favored Glycine 0 C--N 1.348 1.224 0 CA-C-O 119.575 -0.569 . . . . 62.21 113.329 174.111 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -77.86 136.66 15.19 Favored 'Trans proline' 0 C--N 1.368 1.566 0 C-N-CA 123.24 2.627 . . . . 72.44 113.217 -171.584 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 6.2 p -132.8 133.09 59.4 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 C-N-CA 124.403 1.081 . . . . 75.22 109.376 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -76.61 102.06 5.97 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 108.534 -0.913 . . . . 63.04 108.534 176.173 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 6.1 p -110.06 127.25 67.1 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.975 0 N-CA-C 109.242 -0.651 . . . . 70.51 109.242 -174.06 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 222' ' ' ALA . . . . . 0.426 ' HB2' HD21 ' A' ' 172' ' ' LEU . . . -81.76 108.36 15.24 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 122.991 0.516 . . . . 64.43 110.755 -177.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 65.1 t -54.34 135.25 61.15 Favored Pre-proline 0 N--CA 1.484 1.245 0 C-N-CA 124.671 1.188 . . . . 72.43 110.61 179.8 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -65.41 147.69 87.43 Favored 'Trans proline' 0 C--N 1.378 2.119 0 C-N-CA 122.012 1.808 . . . . 63.13 110.873 174.219 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -60.89 138.0 76.17 Favored 'Trans proline' 0 C--N 1.368 1.592 0 C-N-CA 121.66 1.573 . . . . 73.13 111.058 174.238 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 30.9 mtm105 63.24 51.23 2.76 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 124.597 1.159 . . . . 64.5 110.953 174.632 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 90.4 m -77.7 137.05 38.28 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 115.299 -0.864 . . . . 73.04 109.087 170.457 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 28.1 mp0 -114.65 147.02 40.18 Favored 'General case' 0 N--CA 1.479 0.993 0 N-CA-C 108.939 -0.763 . . . . 64.01 108.939 174.534 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -57.91 124.54 19.58 Favored 'General case' 0 C--O 1.24 0.557 0 O-C-N 123.903 0.752 . . . . 73.11 111.017 -178.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 114.87 -14.53 19.52 Favored Glycine 0 N--CA 1.468 0.816 0 CA-C-O 119.076 -0.847 . . . . 61.13 113.858 -176.776 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 231' ' ' ARG . . . . . 0.417 ' HD3' ' HA ' ' A' ' 179' ' ' ALA . 88.9 mtt-85 -62.95 146.61 52.64 Favored 'General case' 0 N--CA 1.478 0.967 0 CA-C-N 117.759 0.779 . . . . 75.25 111.113 178.12 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 71.7 mmtt -118.84 97.49 5.73 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 123.996 0.918 . . . . 75.22 109.029 -172.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 233' ' ' LEU . . . . . 0.651 ' HB2' ' HB2' ' A' ' 251' ' ' LEU . 21.2 mt -85.52 137.96 32.53 Favored 'General case' 0 CA--C 1.546 0.807 0 N-CA-C 109.126 -0.694 . . . . 73.32 109.126 -175.316 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 36.3 ttm-85 -110.86 114.31 27.55 Favored 'General case' 0 CA--C 1.558 1.25 0 C-N-CA 123.054 0.542 . . . . 75.44 111.377 -169.027 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 235' ' ' LEU . . . . . 0.538 HD11 HD11 ' A' ' 251' ' ' LEU . 16.5 mt -108.63 113.56 26.65 Favored 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 123.929 0.891 . . . . 74.4 111.641 -176.535 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 34.8 mttp -72.91 148.94 43.86 Favored 'General case' 0 N--CA 1.481 1.114 0 CA-C-O 121.338 0.589 . . . . 73.55 111.76 174.164 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 78.17 0.59 77.6 Favored Glycine 0 C--N 1.344 1.02 0 CA-C-N 114.107 -1.406 . . . . 72.11 113.87 179.775 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 73.4 mmtt -112.85 3.43 16.38 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.177 0.591 . . . . 75.01 111.457 -174.646 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 239' ' ' GLY . . . . . 0.427 ' HA2' HD13 ' A' ' 193' ' ' LEU . . . -113.27 -170.15 17.49 Favored Glycine 0 C--N 1.348 1.241 0 N-CA-C 111.328 -0.709 . . . . 41.1 111.328 166.834 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 79.8 m-85 -88.3 151.71 49.08 Favored Pre-proline 0 N--CA 1.481 1.114 0 C-N-CA 123.084 0.553 . . . . 60.51 110.803 -178.114 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_exo -67.44 168.03 19.06 Favored 'Trans proline' 0 C--N 1.371 1.741 0 C-N-CA 122.361 2.04 . . . . 73.12 112.614 172.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 144.06 -104.78 0.35 Allowed Glycine 0 C--N 1.348 1.212 0 CA-C-O 119.332 -0.704 . . . . 72.21 113.982 172.149 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -64.22 -30.86 64.47 Favored 'Trans proline' 0 C--N 1.375 1.94 0 C-N-CA 124.012 3.141 . . . . 74.21 114.313 -168.0 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -117.15 5.83 12.77 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 122.924 0.489 . . . . 63.15 110.701 173.593 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 87.81 -46.23 3.42 Favored Glycine 0 C--N 1.35 1.353 0 CA-C-N 116.905 -0.134 . . . . 63.33 113.131 178.234 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 31.3 ttm180 -123.99 112.02 16.7 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 124.369 1.068 . . . . 74.5 109.299 177.479 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -73.57 159.56 53.19 Favored Glycine 0 C--N 1.349 1.253 0 O-C-N 123.431 0.457 . . . . 52.12 114.17 176.119 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 248' ' ' ASP . . . . . 0.413 ' HA ' ' O ' ' A' ' 235' ' ' LEU . 12.4 m-20 -111.56 171.52 7.44 Favored 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 124.026 0.93 . . . . 72.23 111.4 -177.838 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 249' ' ' LEU . . . . . 0.414 HD11 ' HB1' ' A' ' 195' ' ' ALA . 25.9 tp -130.6 126.33 36.43 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 115.021 -0.99 . . . . 72.04 109.748 174.107 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 250' ' ' TYR . . . . . . . . . . . . . 2.8 m-30 -89.85 113.0 24.51 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 124.235 1.014 . . . . 73.35 110.516 179.76 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 251' ' ' LEU . . . . . 0.694 HD12 HD22 ' A' ' 197' ' ' LEU . 86.0 mt -87.2 103.34 15.33 Favored 'General case' 0 C--O 1.24 0.578 0 N-CA-C 107.243 -1.391 . . . . 75.2 107.243 176.091 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -80.77 101.54 9.39 Favored 'General case' 0 C--O 1.241 0.625 0 N-CA-C 108.542 -0.91 . . . . 75.1 108.542 177.594 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 17.9 m -73.59 135.56 27.3 Favored 'Isoleucine or valine' 0 C--O 1.244 0.808 0 CA-C-N 115.695 -0.684 . . . . 74.22 110.831 -172.678 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 31.3 mmm180 -125.93 99.23 5.85 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 114.559 -1.2 . . . . 71.1 108.13 -176.734 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 255' ' ' ILE . . . . . 0.417 ' HA ' ' O ' ' A' ' 199' ' ' VAL . 23.5 mt -79.35 123.06 35.77 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 O-C-N 123.565 0.541 . . . . 73.13 110.438 -179.562 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 2.0 t . . . . . 0 CA--C 1.563 1.466 0 N-CA-C 107.673 -1.232 . . . . 71.31 107.673 176.372 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 172' ' ' LEU . . . . . 0.407 HD21 ' O ' ' A' ' 222' ' ' ALA . 26.4 mt . . . . . 0 N--CA 1.489 1.496 0 N-CA-C 112.524 0.565 . . . . 65.44 112.524 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 173' ' ' PHE . . . . . 0.494 ' HE1' HG22 ' A' ' 219' ' ' VAL . 38.6 m-85 -150.45 -40.98 0.13 Allowed 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 124.765 1.226 . . . . 74.01 109.411 -171.396 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 174' ' ' TYR . . . . . 0.426 ' CD2' ' HB3' ' A' ' 233' ' ' LEU . 0.7 OUTLIER -96.22 6.69 48.24 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 124.141 0.976 . . . . 74.41 112.785 -172.748 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -50.72 -35.21 30.24 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 125.096 1.358 . . . . 75.13 113.036 -162.446 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 176' ' ' MET . . . . . . . . . . . . . 7.0 ptm -58.39 93.62 0.02 OUTLIER 'General case' 0 CA--C 1.564 1.487 0 C-N-CA 124.638 1.175 . . . . 72.44 112.111 172.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 48.8 mtmt 57.05 42.08 26.5 Favored 'General case' 0 N--CA 1.491 1.61 0 C-N-CA 124.858 1.263 . . . . 72.14 111.873 171.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 178' ' ' ALA . . . . . 0.478 ' HB2' HD23 ' A' ' 233' ' ' LEU . . . -62.19 -42.61 99.45 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.572 1.149 . . . . 74.32 111.56 -179.675 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . 0.482 ' HB2' ' HB2' ' A' ' 224' ' ' PRO . . . -80.68 14.4 2.13 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 123.489 0.716 . . . . 64.43 111.42 176.347 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.342 0.878 0 N-CA-C 109.914 -1.274 . . . . 72.54 109.914 169.496 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 191' ' ' GLN . . . . . 0.636 ' HB3' ' HD2' ' A' ' 243' ' ' PRO . 8.0 pt20 . . . . . 0 N--CA 1.469 0.514 0 N-CA-C 109.74 -0.467 . . . . 73.45 109.74 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 192' ' ' ASP . . . . . 0.413 ' N ' ' HG3' ' A' ' 191' ' ' GLN . 80.9 m-20 -78.77 157.58 28.43 Favored 'General case' 0 C--O 1.239 0.548 0 CA-C-N 115.479 -0.782 . . . . 70.54 110.42 -175.601 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 46.0 mt -127.68 169.35 13.89 Favored 'General case' 0 C--O 1.238 0.493 0 CA-C-N 114.594 -1.185 . . . . 74.33 109.415 -178.297 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 64.5 m-85 -135.23 139.22 44.3 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 124.253 1.021 . . . . 71.25 109.422 179.705 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . 0.424 ' HB2' HD13 ' A' ' 249' ' ' LEU . . . -150.19 171.67 16.55 Favored 'General case' 0 C--O 1.24 0.56 0 C-N-CA 124.861 1.264 . . . . 75.1 108.973 -177.602 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 17.6 m -115.31 137.64 51.82 Favored 'General case' 0 C--O 1.238 0.464 0 C-N-CA 122.966 0.507 . . . . 64.15 109.636 179.013 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . 0.56 HD22 HD12 ' A' ' 251' ' ' LEU . 14.6 tp -115.43 110.64 19.62 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 108.914 -0.773 . . . . 75.12 108.914 177.371 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -79.58 122.79 26.93 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 108.742 -0.836 . . . . 70.5 108.742 174.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 199' ' ' VAL . . . . . 0.47 ' O ' ' HA ' ' A' ' 255' ' ' ILE . 4.1 p -142.58 123.32 8.3 Favored Pre-proline 0 CA--C 1.543 0.694 0 N-CA-C 108.771 -0.826 . . . . 74.32 108.771 178.697 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -67.57 158.48 56.95 Favored 'Trans proline' 0 C--N 1.364 1.365 0 C-N-CA 121.955 1.77 . . . . 74.2 111.049 171.883 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 201' ' ' ALA . . . . . 0.497 ' HA ' HG22 ' A' ' 255' ' ' ILE . . . -47.3 -53.82 25.99 Favored Pre-proline 0 CA--C 1.562 1.42 0 CA-C-O 117.903 -1.046 . . . . 74.22 112.988 -179.093 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -62.45 -39.88 42.9 Favored 'Trans proline' 0 C--N 1.399 3.199 0 C-N-CA 121.997 1.798 . . . . 74.3 113.698 -176.267 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 36.5 mt -66.36 -32.63 58.94 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.252 0 C-N-CA 122.701 0.4 . . . . 75.2 110.091 178.783 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -71.23 -36.02 71.67 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 122.742 0.417 . . . . 74.51 111.63 177.222 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 205' ' ' VAL . . . . . 0.48 HG23 ' O ' ' A' ' 201' ' ' ALA . 94.9 t -68.58 -57.03 10.22 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.11 0 C-N-CA 123.126 0.57 . . . . 74.31 111.215 -178.979 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 32.8 m -80.05 -27.55 12.16 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 CA-C-N 116.109 -0.496 . . . . 71.3 111.605 -175.373 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 81.96 65.1 1.67 Allowed Glycine 0 C--N 1.342 0.902 0 CA-C-N 116.177 -0.465 . . . . 74.14 111.956 -175.188 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -81.32 -131.99 1.28 Allowed Glycine 0 C--N 1.356 1.655 0 N-CA-C 111.804 -0.519 . . . . 72.32 111.804 177.397 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 21.0 mtmm -137.94 143.37 40.71 Favored 'General case' 0 N--CA 1.481 1.107 0 CA-C-N 117.569 0.685 . . . . 72.04 111.136 177.372 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 11.1 m -135.93 166.37 27.29 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 C-N-CA 125.032 1.333 . . . . 74.43 109.755 176.65 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 58.4 ttp180 -100.25 114.65 28.27 Favored 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 123.545 0.738 . . . . 73.4 110.309 -178.174 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -101.6 139.2 37.57 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 124.035 0.934 . . . . 74.01 110.06 175.402 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 25.2 mmt -96.33 115.17 27.01 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 123.186 0.595 . . . . 64.02 109.68 179.408 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 214' ' ' THR . . . . . 0.429 ' HB ' ' HD2' ' A' ' 238' ' ' LYS . 43.9 p -122.23 -173.47 2.68 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 124.146 0.978 . . . . 73.55 111.038 -175.016 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 82.8 mt -69.25 -22.76 63.82 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 123.475 0.71 . . . . 75.04 111.019 172.771 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 20.4 mm-40 -86.45 -6.07 59.0 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 123.814 0.846 . . . . 74.32 110.663 173.146 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 94.82 -149.9 19.52 Favored Glycine 0 C--N 1.344 1.025 0 CA-C-O 119.331 -0.705 . . . . 63.23 112.303 -177.605 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -73.28 122.05 7.68 Favored 'Trans proline' 0 CA--C 1.555 1.537 0 C-N-CA 122.254 1.969 . . . . 75.24 112.754 -178.559 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 219' ' ' VAL . . . . . 0.494 HG22 ' HE1' ' A' ' 173' ' ' PHE . 2.4 p -116.84 131.15 70.34 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 C-N-CA 124.647 1.179 . . . . 75.14 109.164 173.649 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 -81.12 101.29 9.53 Favored 'General case' 0 C--O 1.24 0.576 0 N-CA-C 107.454 -1.313 . . . . 75.13 107.454 168.688 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 4.6 p -100.63 131.32 48.44 Favored 'Isoleucine or valine' 0 C--O 1.246 0.897 0 N-CA-C 108.872 -0.788 . . . . 72.2 108.872 -176.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 222' ' ' ALA . . . . . 0.407 ' O ' HD21 ' A' ' 172' ' ' LEU . . . -77.68 106.95 9.81 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 122.759 0.424 . . . . 70.43 110.394 -176.723 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 59.9 t -54.24 135.49 60.08 Favored Pre-proline 0 N--CA 1.48 1.04 0 C-N-CA 124.054 0.942 . . . . 73.42 109.989 178.454 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 224' ' ' PRO . . . . . 0.482 ' HB2' ' HB2' ' A' ' 179' ' ' ALA . 53.8 Cg_endo -67.85 148.76 77.42 Favored 'Trans proline' 0 C--N 1.37 1.672 0 C-N-CA 121.605 1.537 . . . . 74.41 110.688 173.145 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 16.3 Cg_endo -59.78 139.85 90.47 Favored 'Trans proline' 0 C--N 1.366 1.449 0 C-N-CA 121.591 1.528 . . . . 71.03 110.698 172.014 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 69.5 mtm180 66.28 50.52 1.33 Allowed 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 124.194 0.998 . . . . 71.01 111.065 171.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 54.0 m -85.85 136.96 33.09 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.922 0.889 . . . . 65.21 109.415 173.481 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 27.2 mp0 -113.24 144.52 42.56 Favored 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 123.929 0.892 . . . . 62.44 109.634 178.127 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 229' ' ' ALA . . . . . 0.408 ' HB3' ' HB ' ' A' ' 255' ' ' ILE . . . -58.48 120.97 9.77 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 123.92 0.888 . . . . 72.35 110.257 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 113.88 -7.01 23.82 Favored Glycine 0 C--O 1.239 0.44 0 CA-C-O 119.268 -0.74 . . . . 73.31 113.213 -176.013 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 69.0 mtt-85 -67.27 146.67 53.91 Favored 'General case' 0 C--N 1.355 0.821 0 CA-C-N 117.909 0.854 . . . . 75.04 109.689 172.521 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 232' ' ' LYS . . . . . 0.429 ' HB3' ' HD1' ' A' ' 250' ' ' TYR . 13.1 mtmm -126.28 99.45 5.87 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 123.823 0.849 . . . . 75.51 108.874 -178.803 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 233' ' ' LEU . . . . . 0.478 HD23 ' HB2' ' A' ' 178' ' ' ALA . 21.4 mt -83.56 135.78 34.5 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 113.844 -1.525 . . . . 74.52 109.491 -175.243 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 29.9 ttt85 -104.84 101.01 10.63 Favored 'General case' 0 N--CA 1.476 0.837 0 CA-C-O 121.15 0.5 . . . . 73.31 111.131 -172.815 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 235' ' ' LEU . . . . . 0.51 HD12 HD21 ' A' ' 249' ' ' LEU . 46.7 mt -77.28 100.78 5.99 Favored 'General case' 0 C--O 1.238 0.455 0 C-N-CA 124.512 1.125 . . . . 75.45 110.028 176.079 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 11.7 mtmt -68.11 134.43 50.56 Favored 'General case' 0 C--O 1.241 0.654 0 O-C-N 123.32 0.388 . . . . 72.51 111.535 177.702 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 82.1 18.95 65.98 Favored Glycine 0 C--N 1.35 1.31 0 O-C-N 124.316 1.01 . . . . 72.41 113.612 179.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . 0.429 ' HD2' ' HB ' ' A' ' 214' ' ' THR . 39.4 mmtm -121.38 27.81 8.11 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 123.452 0.701 . . . . 74.54 111.299 -179.002 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -138.4 -171.11 12.05 Favored Glycine 0 CA--C 1.525 0.697 0 N-CA-C 110.272 -1.131 . . . . 61.34 110.272 167.498 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 61.7 m-85 -90.2 155.83 46.61 Favored Pre-proline 0 CA--C 1.545 0.755 0 C-N-CA 123.802 0.841 . . . . 73.22 109.782 -175.711 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -68.28 169.6 16.53 Favored 'Trans proline' 0 C--N 1.365 1.446 0 C-N-CA 121.978 1.786 . . . . 75.05 111.461 169.706 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 163.21 -108.27 0.33 Allowed Glycine 0 CA--C 1.531 1.066 0 CA-C-O 119.043 -0.865 . . . . 60.12 112.533 176.318 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 243' ' ' PRO . . . . . 0.636 ' HD2' ' HB3' ' A' ' 191' ' ' GLN . 84.5 Cg_endo -68.94 -46.92 1.36 Allowed 'Trans proline' 0 C--N 1.372 1.808 0 C-N-CA 123.885 3.056 . . . . 60.31 113.146 -173.656 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -100.67 -0.82 36.71 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 123.658 0.783 . . . . 74.34 111.305 -175.704 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 92.5 -43.79 2.62 Favored Glycine 0 C--N 1.352 1.43 0 O-C-N 123.028 0.205 . . . . 65.22 112.859 -179.665 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 13.3 ttm180 -120.36 112.27 18.8 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 124.153 0.981 . . . . 75.42 110.826 179.24 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -82.84 149.98 27.42 Favored Glycine 0 C--N 1.347 1.169 0 N-CA-C 111.156 -0.778 . . . . 74.35 111.156 167.859 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 38.6 m-20 -135.27 152.38 51.46 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 123.677 0.791 . . . . 72.0 109.675 -172.002 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 249' ' ' LEU . . . . . 0.51 HD21 HD12 ' A' ' 235' ' ' LEU . 61.9 tp -96.88 138.97 33.61 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.158 0.583 . . . . 73.45 110.134 -175.702 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 250' ' ' TYR . . . . . 0.429 ' HD1' ' HB3' ' A' ' 232' ' ' LYS . 7.4 m-85 -99.02 140.2 33.52 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.091 0.556 . . . . 71.23 110.026 173.887 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 251' ' ' LEU . . . . . 0.56 HD12 HD22 ' A' ' 197' ' ' LEU . 76.9 mt -115.67 103.86 11.11 Favored 'General case' 0 C--O 1.236 0.38 0 N-CA-C 108.647 -0.871 . . . . 71.32 108.647 179.763 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -79.54 96.37 6.1 Favored 'General case' 0 C--O 1.242 0.666 0 N-CA-C 108.109 -1.071 . . . . 74.25 108.109 177.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 13.0 m -70.55 136.77 25.28 Favored 'Isoleucine or valine' 0 C--O 1.245 0.848 0 CA-C-O 121.389 0.614 . . . . 64.43 110.59 -173.768 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 11.1 mmt180 -125.78 101.38 6.83 Favored 'General case' 0 C--O 1.241 0.62 0 C-N-CA 124.587 1.155 . . . . 74.22 108.308 -177.652 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 255' ' ' ILE . . . . . 0.497 HG22 ' HA ' ' A' ' 201' ' ' ALA . 22.7 mt -77.43 107.88 9.71 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.745 0 O-C-N 124.027 0.83 . . . . 65.22 109.785 179.341 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 7.2 t . . . . . 0 CA--C 1.567 1.621 0 CA-C-O 117.36 -1.305 . . . . 74.43 108.191 179.122 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 172' ' ' LEU . . . . . 0.44 HD21 ' HB2' ' A' ' 222' ' ' ALA . 21.1 mt . . . . . 0 N--CA 1.488 1.427 0 CA-C-O 120.735 0.302 . . . . 74.31 111.317 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 173' ' ' PHE . . . . . 0.435 ' CD1' HD23 ' A' ' 235' ' ' LEU . 45.0 m-85 -126.79 -57.83 1.33 Allowed 'General case' 0 N--CA 1.49 1.574 0 CA-C-O 121.679 0.752 . . . . 72.02 110.65 -170.445 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 174' ' ' TYR . . . . . 0.47 ' CD2' ' HB3' ' A' ' 233' ' ' LEU . 4.6 p90 -79.3 4.48 15.02 Favored 'General case' 0 N--CA 1.479 0.994 0 CA-C-N 114.76 -1.109 . . . . 74.25 113.352 -172.776 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 175' ' ' THR . . . . . 0.412 HG22 HD13 ' A' ' 172' ' ' LEU . 15.0 p -69.18 -5.18 20.92 Favored 'General case' 0 N--CA 1.479 0.995 0 N-CA-C 112.681 0.623 . . . . 74.1 112.681 -179.259 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 176' ' ' MET . . . . . . . . . . . . . 24.6 ptt? -61.24 -34.5 75.25 Favored 'General case' 0 CA--C 1.555 1.168 0 C-N-CA 123.632 0.773 . . . . 73.43 110.383 168.029 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 84.6 tttt -165.04 92.77 0.59 Allowed 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 124.869 1.268 . . . . 75.34 108.105 -178.427 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -128.71 142.65 50.94 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 123.877 0.871 . . . . 74.2 110.229 -171.582 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . 0.478 ' HB2' ' HB2' ' A' ' 224' ' ' PRO . . . 59.98 21.56 10.64 Favored 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 124.849 1.26 . . . . 73.11 112.104 -175.961 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.34 0.772 0 N-CA-C 110.768 -0.933 . . . . 55.01 110.768 176.288 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 191' ' ' GLN . . . . . 0.529 ' HB2' ' HA2' ' A' ' 247' ' ' GLY . 4.8 pt20 . . . . . 0 N--CA 1.475 0.816 0 CA-C-O 120.415 0.15 . . . . 73.21 110.99 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -75.73 142.35 42.43 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-O 121.41 0.624 . . . . 73.14 111.341 -171.592 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 45.0 mt -130.91 170.96 13.73 Favored 'General case' 0 C--O 1.239 0.501 0 CA-C-N 114.216 -1.356 . . . . 74.3 108.994 174.122 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 26.6 m-85 -143.44 122.27 12.69 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 124.03 0.932 . . . . 75.43 109.503 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . 0.416 ' HB2' HD13 ' A' ' 249' ' ' LEU . . . -124.69 128.89 49.51 Favored 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 107.67 -1.233 . . . . 75.31 107.67 174.154 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 6.1 m -81.47 119.47 23.78 Favored 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 108.203 -1.036 . . . . 63.33 108.203 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . 0.591 HD21 HD11 ' A' ' 251' ' ' LEU . 17.2 tp -104.74 110.55 22.93 Favored 'General case' 0 N--CA 1.466 0.374 0 N-CA-C 108.404 -0.962 . . . . 75.31 108.404 -172.984 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -77.48 125.53 29.48 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 108.482 -0.933 . . . . 73.42 108.482 177.234 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 199' ' ' VAL . . . . . 0.498 ' O ' ' HA ' ' A' ' 255' ' ' ILE . 5.4 p -144.15 129.45 9.62 Favored Pre-proline 0 CA--C 1.545 0.767 0 N-CA-C 108.488 -0.931 . . . . 71.44 108.488 176.465 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -71.86 157.15 55.64 Favored 'Trans proline' 0 C--O 1.248 1.02 0 C-N-CA 121.655 1.57 . . . . 75.41 111.342 170.309 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 201' ' ' ALA . . . . . 0.429 ' O ' HG23 ' A' ' 205' ' ' VAL . . . -51.29 -53.46 49.0 Favored Pre-proline 0 CA--C 1.556 1.2 0 O-C-N 124.32 1.013 . . . . 74.31 113.078 -176.501 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -67.01 -33.5 31.98 Favored 'Trans proline' 0 C--N 1.403 3.438 0 C-N-CA 121.678 1.585 . . . . 73.33 112.854 -175.044 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 203' ' ' ILE . . . . . 0.462 HG22 ' HA3' ' A' ' 208' ' ' GLY . 27.6 mt -66.03 -35.45 75.09 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.311 0 C-N-CA 122.586 0.354 . . . . 71.22 110.064 176.05 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 204' ' ' ALA . . . . . 0.494 ' HA ' HG13 ' A' ' 223' ' ' VAL . . . -71.01 -31.88 68.51 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 122.656 0.382 . . . . 74.31 111.51 178.617 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 205' ' ' VAL . . . . . 0.429 HG23 ' O ' ' A' ' 201' ' ' ALA . 92.8 t -73.77 -55.64 11.79 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 C-N-CA 122.896 0.478 . . . . 74.4 111.104 178.43 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 13.7 m -78.86 -26.41 13.44 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.003 0 C-N-CA 122.979 0.512 . . . . 73.24 111.927 -172.248 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 87.9 76.08 1.28 Allowed Glycine 0 CA--C 1.529 0.951 0 N-CA-C 111.972 -0.451 . . . . 73.51 111.972 -175.531 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 208' ' ' GLY . . . . . 0.462 ' HA3' HG22 ' A' ' 203' ' ' ILE . . . -95.37 -147.13 22.15 Favored Glycine 0 N--CA 1.477 1.369 0 CA-C-O 119.537 -0.591 . . . . 74.13 111.793 175.961 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 49.9 mtmt -132.86 145.63 51.12 Favored 'General case' 0 N--CA 1.482 1.125 0 CA-C-N 117.52 0.66 . . . . 73.21 111.151 176.742 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 12.0 m -139.25 164.91 24.14 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 C-N-CA 125.672 1.589 . . . . 73.11 108.93 175.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 23.9 ttm180 -103.44 117.13 33.75 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 123.386 0.674 . . . . 73.51 109.894 -174.246 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -103.69 123.33 46.82 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 124.729 1.212 . . . . 73.5 109.914 178.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 89.1 mmm -87.49 115.38 24.87 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 123.362 0.665 . . . . 74.45 110.166 -178.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 17.6 p -113.9 -178.71 3.44 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 123.976 0.91 . . . . 71.43 110.607 -175.856 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 81.0 mt -63.27 -23.94 67.64 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 122.842 0.457 . . . . 72.05 111.549 172.713 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -103.54 23.2 13.0 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 124.071 0.948 . . . . 63.43 110.893 179.867 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 87.88 -163.82 33.67 Favored Glycine 0 C--N 1.344 1.005 0 CA-C-N 116.299 -0.409 . . . . 61.21 113.141 175.59 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -72.12 144.73 42.83 Favored 'Trans proline' 0 C--N 1.362 1.244 0 C-N-CA 122.156 1.904 . . . . 73.0 112.804 -178.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 5.4 p -139.67 127.74 26.24 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 N-CA-C 108.083 -1.08 . . . . 73.24 108.083 170.047 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -82.19 103.3 11.69 Favored 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 108.461 -0.94 . . . . 73.34 108.461 176.264 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 2.8 p -100.3 133.62 42.75 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.841 0 O-C-N 124.149 0.906 . . . . 75.01 108.654 -174.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 222' ' ' ALA . . . . . 0.44 ' HB2' HD21 ' A' ' 172' ' ' LEU . . . -78.91 111.67 15.31 Favored 'General case' 0 C--O 1.24 0.6 0 C-N-CA 122.8 0.44 . . . . 74.21 110.541 -177.874 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 223' ' ' VAL . . . . . 0.494 HG13 ' HA ' ' A' ' 204' ' ' ALA . 48.9 t -54.61 131.63 64.29 Favored Pre-proline 0 CA--C 1.542 0.643 0 O-C-N 124.509 1.13 . . . . 74.41 109.909 177.496 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 224' ' ' PRO . . . . . 0.478 ' HB2' ' HB2' ' A' ' 179' ' ' ALA . 43.1 Cg_endo -67.3 152.5 79.14 Favored 'Trans proline' 0 CA--C 1.555 1.545 0 C-N-CA 121.657 1.571 . . . . 74.43 111.312 175.546 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -65.6 141.99 69.08 Favored 'Trans proline' 0 C--N 1.371 1.712 0 C-N-CA 121.941 1.761 . . . . 75.23 112.219 179.811 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 96.6 mtt180 65.42 32.15 9.82 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 124.827 1.251 . . . . 71.31 111.834 168.863 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 227' ' ' THR . . . . . 0.451 HG22 ' HD2' ' A' ' 231' ' ' ARG . 98.6 m -72.84 139.02 46.69 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 123.969 0.907 . . . . 74.25 109.89 174.946 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -111.66 155.53 23.28 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 123.113 0.565 . . . . 73.51 109.686 174.595 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 229' ' ' ALA . . . . . 0.573 ' HB3' ' HB ' ' A' ' 255' ' ' ILE . . . -54.99 122.63 11.33 Favored 'General case' 0 CA--C 1.536 0.442 0 O-C-N 124.896 1.372 . . . . 75.51 111.338 -179.302 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 112.57 -10.61 25.91 Favored Glycine 0 C--N 1.341 0.831 0 CA-C-O 119.568 -0.573 . . . . 61.31 113.718 177.029 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 231' ' ' ARG . . . . . 0.451 ' HD2' HG22 ' A' ' 227' ' ' THR . 53.0 mtt-85 -62.1 141.45 58.13 Favored 'General case' 0 N--CA 1.478 0.941 0 CA-C-N 117.246 0.523 . . . . 73.43 111.1 176.418 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 31.5 mmtp -112.47 103.58 11.67 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 108.585 -0.895 . . . . 74.3 108.585 -175.64 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 233' ' ' LEU . . . . . 0.729 ' HB2' ' HB2' ' A' ' 251' ' ' LEU . 41.7 mt -83.08 149.47 26.89 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 115.295 -0.866 . . . . 75.11 108.849 177.181 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 62.0 ttt180 -118.6 102.42 8.86 Favored 'General case' 0 N--CA 1.478 0.926 0 CA-C-N 117.958 0.345 . . . . 74.51 110.482 -173.404 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 235' ' ' LEU . . . . . 0.533 ' HB2' ' HB3' ' A' ' 249' ' ' LEU . 14.8 mt -85.92 94.84 9.29 Favored 'General case' 0 C--O 1.242 0.706 0 C-N-CA 123.197 0.599 . . . . 74.34 109.81 175.507 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 20.2 mttt -69.02 138.12 54.22 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 115.648 -0.706 . . . . 73.44 110.466 175.443 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 85.68 3.03 86.48 Favored Glycine 0 C--N 1.338 0.644 0 O-C-N 123.908 0.755 . . . . 62.11 113.348 -179.355 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 76.0 mmtt -116.78 9.24 13.88 Favored 'General case' 0 N--CA 1.485 1.323 0 CA-C-N 117.414 0.607 . . . . 74.44 111.919 -176.274 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -109.68 -165.65 19.94 Favored Glycine 0 C--N 1.346 1.09 0 N-CA-C 111.139 -0.784 . . . . 65.11 111.139 167.419 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 68.7 m-85 -86.82 158.79 53.13 Favored Pre-proline 0 N--CA 1.484 1.272 0 C-N-CA 123.446 0.698 . . . . 73.4 112.371 -176.291 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_exo -64.21 165.4 19.71 Favored 'Trans proline' 0 C--N 1.371 1.715 0 C-N-CA 122.24 1.96 . . . . 63.3 112.73 166.716 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 157.45 -107.94 0.34 Allowed Glycine 0 C--N 1.34 0.789 0 CA-C-O 118.806 -0.997 . . . . 71.44 111.999 173.431 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -68.65 -57.08 0.15 Allowed 'Trans proline' 0 C--N 1.378 2.09 0 C-N-CA 123.616 2.878 . . . . 72.55 112.666 -170.201 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -80.87 -22.39 39.87 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 123.417 0.687 . . . . 74.32 110.615 175.244 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 96.48 -33.53 5.6 Favored Glycine 0 C--N 1.352 1.437 0 N-CA-C 111.283 -0.727 . . . . 74.23 111.283 -169.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 29.2 ttm180 -106.7 111.89 24.63 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 124.68 1.192 . . . . 74.25 109.981 178.794 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 247' ' ' GLY . . . . . 0.529 ' HA2' ' HB2' ' A' ' 191' ' ' GLN . . . -79.53 162.97 47.94 Favored Glycine 0 C--O 1.247 0.919 0 O-C-N 123.528 0.518 . . . . 70.14 113.748 169.249 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 17.6 m-20 -128.16 129.23 46.19 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 123.814 0.846 . . . . 74.4 109.173 -169.456 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 249' ' ' LEU . . . . . 0.533 ' HB3' ' HB2' ' A' ' 235' ' ' LEU . 49.3 tp -99.54 113.62 26.13 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 124.005 0.922 . . . . 73.44 109.089 177.715 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 250' ' ' TYR . . . . . 0.416 ' HA ' ' O ' ' A' ' 233' ' ' LEU . 8.8 m-85 -90.28 114.59 26.66 Favored 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 123.593 0.757 . . . . 70.25 110.933 -176.467 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 251' ' ' LEU . . . . . 0.729 ' HB2' ' HB2' ' A' ' 233' ' ' LEU . 89.9 mt -88.05 106.3 18.06 Favored 'General case' 0 C--O 1.241 0.638 0 C-N-CA 124.846 1.258 . . . . 74.22 109.162 -179.013 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -82.3 99.95 9.64 Favored 'General case' 0 C--O 1.242 0.704 0 N-CA-C 108.463 -0.94 . . . . 73.24 108.463 175.386 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 11.5 m -67.23 132.73 32.25 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.853 0 O-C-N 123.782 0.676 . . . . 73.3 109.351 -177.498 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 17.9 mmt85 -123.11 95.21 4.52 Favored 'General case' 0 C--O 1.239 0.502 0 C-N-CA 124.517 1.127 . . . . 75.02 108.216 -177.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 255' ' ' ILE . . . . . 0.573 ' HB ' ' HB3' ' A' ' 229' ' ' ALA . 12.9 mt -76.43 125.25 36.0 Favored 'Isoleucine or valine' 0 C--O 1.233 0.208 0 O-C-N 123.945 0.778 . . . . 63.43 110.21 179.406 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 1.6 t . . . . . 0 CA--C 1.561 1.402 0 CA-C-O 117.546 -1.216 . . . . 71.3 107.768 173.877 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 172' ' ' LEU . . . . . 0.547 ' HB3' HG21 ' A' ' 175' ' ' THR . 55.7 mt . . . . . 0 N--CA 1.467 0.419 0 CA-C-O 121.134 0.493 . . . . 65.31 111.27 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 173' ' ' PHE . . . . . 0.516 ' CD1' HD21 ' A' ' 235' ' ' LEU . 7.5 m-85 -140.13 -44.1 0.42 Allowed 'General case' 0 N--CA 1.482 1.142 0 CA-C-N 114.966 -1.015 . . . . 74.14 109.118 -171.21 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 174' ' ' TYR . . . . . . . . . . . . . 1.9 p90 -86.18 19.3 2.73 Favored 'General case' 0 CA--C 1.547 0.83 0 CA-C-N 114.502 -1.226 . . . . 72.32 112.394 -176.158 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 175' ' ' THR . . . . . 0.547 HG21 ' HB3' ' A' ' 172' ' ' LEU . 17.6 p -62.87 -21.63 66.11 Favored 'General case' 0 N--CA 1.493 1.692 0 CA-C-N 118.909 0.777 . . . . 73.14 112.853 -179.2 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 176' ' ' MET . . . . . . . . . . . . . 21.4 ptt? -52.4 -42.45 64.04 Favored 'General case' 0 CA--C 1.558 1.287 0 C-N-CA 124.367 1.067 . . . . 75.4 110.95 171.016 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 19.7 tptm -167.42 100.07 0.5 Allowed 'General case' 0 C--N 1.349 0.553 0 C-N-CA 125.532 1.533 . . . . 72.23 107.017 176.844 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -74.65 -74.42 0.2 Allowed 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 115.556 -0.747 . . . . 72.12 112.096 -168.306 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -69.65 95.53 0.87 Allowed 'General case' 0 CA--C 1.541 0.629 0 O-C-N 123.381 0.425 . . . . 74.24 110.19 -177.328 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.348 1.243 0 CA-C-N 115.489 -0.778 . . . . 54.21 112.063 -178.328 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 191' ' ' GLN . . . . . 0.487 ' HG3' ' N ' ' A' ' 192' ' ' ASP . 5.0 pt20 . . . . . 0 CA--C 1.544 0.724 0 CA-C-O 120.617 0.246 . . . . 74.41 110.758 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 192' ' ' ASP . . . . . 0.487 ' N ' ' HG3' ' A' ' 191' ' ' GLN . 24.4 m-20 -77.55 123.87 27.16 Favored 'General case' 0 C--N 1.351 0.643 0 C-N-CA 123.76 0.824 . . . . 73.15 109.096 -177.125 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . 0.501 HD11 ' HA2' ' A' ' 239' ' ' GLY . 41.0 mt -111.71 173.57 6.29 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 124.612 1.165 . . . . 72.43 109.987 -178.186 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 45.8 m-85 -130.15 129.28 43.28 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 123.778 0.831 . . . . 73.4 109.57 176.33 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . 0.42 ' HB1' HD11 ' A' ' 249' ' ' LEU . . . -129.65 167.49 17.91 Favored 'General case' 0 C--O 1.239 0.549 0 C-N-CA 124.989 1.316 . . . . 73.35 107.47 170.237 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 31.4 m -117.27 124.17 48.37 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 108.731 -0.84 . . . . 71.25 108.731 179.335 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . 0.568 HD21 HD13 ' A' ' 251' ' ' LEU . 15.3 tp -107.7 109.81 21.49 Favored 'General case' 0 CA--C 1.53 0.211 0 N-CA-C 107.823 -1.177 . . . . 72.22 107.823 -177.711 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -83.42 128.63 34.66 Favored 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 109.05 -0.722 . . . . 75.01 109.05 178.156 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 199' ' ' VAL . . . . . 0.536 ' O ' ' HA ' ' A' ' 255' ' ' ILE . 4.0 p -143.78 129.57 9.96 Favored Pre-proline 0 CA--C 1.543 0.699 0 N-CA-C 108.201 -1.037 . . . . 75.31 108.201 179.765 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -69.1 157.9 59.91 Favored 'Trans proline' 0 C--N 1.364 1.383 0 C-N-CA 121.905 1.737 . . . . 62.01 111.502 170.038 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 201' ' ' ALA . . . . . 0.465 ' O ' HG23 ' A' ' 205' ' ' VAL . . . -49.74 -53.7 39.17 Favored Pre-proline 0 CA--C 1.561 1.385 0 O-C-N 124.768 1.292 . . . . 74.43 112.792 -178.195 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -61.94 -35.38 77.81 Favored 'Trans proline' 0 C--N 1.401 3.314 0 C-N-CA 121.988 1.792 . . . . 74.1 113.339 -176.388 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 38.1 mt -71.35 -31.94 45.21 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.104 0 C-N-CA 123.068 0.547 . . . . 75.44 110.321 179.145 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -72.95 -34.05 66.27 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 122.463 0.305 . . . . 75.15 111.516 176.18 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 205' ' ' VAL . . . . . 0.465 HG23 ' O ' ' A' ' 201' ' ' ALA . 90.6 t -67.72 -55.77 15.67 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 C-N-CA 123.836 0.854 . . . . 75.03 110.874 177.936 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 18.4 m -80.87 -27.96 11.2 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.079 0 C-N-CA 122.753 0.421 . . . . 74.22 111.744 -174.469 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 82.02 67.9 1.48 Allowed Glycine 0 C--N 1.347 1.176 0 O-C-N 123.736 0.647 . . . . 52.32 112.113 -173.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -84.35 -131.88 2.25 Favored Glycine 0 C--N 1.352 1.435 0 CA-C-O 119.68 -0.511 . . . . 54.04 111.953 179.436 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 209' ' ' LYS . . . . . 0.44 ' HG2' ' HA ' ' A' ' 222' ' ' ALA . 48.0 mtmt -139.99 150.92 45.05 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 123.908 0.883 . . . . 73.42 111.425 178.258 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 15.2 m -146.04 168.92 6.61 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 C-N-CA 126.005 1.722 . . . . 73.23 108.388 176.584 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 37.0 ptt180 -95.03 128.65 42.02 Favored 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 109.371 -0.603 . . . . 74.02 109.371 172.626 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -102.31 112.36 25.02 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 123.895 0.878 . . . . 64.32 108.631 174.175 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 74.8 mtp -82.98 108.78 16.54 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 109.382 -0.599 . . . . 75.42 109.382 -175.746 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 26.7 p -111.39 -172.47 2.04 Favored 'General case' 0 C--O 1.242 0.686 0 C-N-CA 124.174 0.989 . . . . 74.43 110.224 -173.179 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 84.2 mt -61.97 -28.84 69.84 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 123.439 0.696 . . . . 72.41 111.368 173.386 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -100.22 7.94 44.14 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 123.656 0.783 . . . . 74.35 111.427 179.424 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 100.84 -173.11 24.28 Favored Glycine 0 C--N 1.347 1.16 0 CA-C-O 119.929 -0.373 . . . . 74.03 113.819 175.763 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_endo -71.57 127.59 13.36 Favored 'Trans proline' 0 C--N 1.368 1.579 0 C-N-CA 122.855 2.37 . . . . 74.24 112.351 -176.852 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 5.0 p -119.77 130.76 73.75 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 C-N-CA 123.714 0.806 . . . . 65.23 108.846 178.436 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -70.52 101.63 2.04 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 108.751 -0.833 . . . . 75.44 108.751 177.755 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 3.0 p -106.64 134.38 48.45 Favored 'Isoleucine or valine' 0 C--O 1.244 0.774 0 N-CA-C 108.377 -0.971 . . . . 74.04 108.377 -176.304 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 222' ' ' ALA . . . . . 0.44 ' HA ' ' HG2' ' A' ' 209' ' ' LYS . . . -82.19 108.74 15.89 Favored 'General case' 0 N--CA 1.467 0.414 0 N-CA-C 109.975 -0.38 . . . . 64.32 109.975 -179.358 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 43.0 t -54.54 134.74 63.22 Favored Pre-proline 0 N--CA 1.478 0.945 0 C-N-CA 124.753 1.221 . . . . 74.32 110.436 -178.14 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -58.22 150.46 66.13 Favored 'Trans proline' 0 C--N 1.37 1.699 0 C-N-CA 122.221 1.947 . . . . 64.22 111.942 169.779 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -78.41 148.51 23.67 Favored 'Trans proline' 0 C--N 1.366 1.497 0 C-N-CA 122.065 1.843 . . . . 72.5 110.937 174.136 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 45.8 mtm180 59.56 41.28 19.23 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 124.302 1.041 . . . . 72.43 111.271 174.122 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 227' ' ' THR . . . . . 0.526 HG23 ' HD2' ' A' ' 231' ' ' ARG . 55.5 m -82.29 141.64 32.75 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 114.334 -1.303 . . . . 74.05 109.438 177.097 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 27.7 mp0 -115.96 145.18 43.15 Favored 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 123.764 0.826 . . . . 74.15 109.245 176.381 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 229' ' ' ALA . . . . . 0.43 ' HB3' ' HB ' ' A' ' 255' ' ' ILE . . . -57.04 119.42 6.27 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.986 0.914 . . . . 73.41 111.119 -178.079 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 114.38 -5.33 23.25 Favored Glycine 0 C--N 1.342 0.869 0 O-C-N 123.825 0.703 . . . . 42.41 112.696 -176.768 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 231' ' ' ARG . . . . . 0.526 ' HD2' HG23 ' A' ' 227' ' ' THR . 55.0 mtt-85 -69.67 148.68 48.97 Favored 'General case' 0 C--N 1.363 1.194 0 CA-C-N 117.704 0.752 . . . . 74.32 109.124 169.724 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 36.5 mtmt -130.2 118.26 21.12 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 123.166 0.586 . . . . 73.34 109.56 -174.334 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 233' ' ' LEU . . . . . . . . . . . . . 9.0 mt -101.47 138.94 37.81 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 124.318 1.047 . . . . 65.34 108.487 -172.307 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 234' ' ' ARG . . . . . 0.493 ' HG3' ' HB3' ' A' ' 248' ' ' ASP . 35.8 ttm-85 -102.04 118.45 36.94 Favored 'General case' 0 N--CA 1.479 0.982 0 CA-C-N 118.013 0.37 . . . . 74.51 111.434 -173.83 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 235' ' ' LEU . . . . . 0.516 HD21 ' CD1' ' A' ' 173' ' ' PHE . 13.7 mt -103.87 111.62 24.23 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 123.492 0.717 . . . . 74.45 110.271 179.069 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 65.1 mttt -69.66 144.59 52.86 Favored 'General case' 0 N--CA 1.471 0.578 0 O-C-N 123.205 0.316 . . . . 73.42 111.196 176.178 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 73.88 -5.72 23.25 Favored Glycine 0 N--CA 1.472 1.05 0 O-C-N 124.624 1.203 . . . . 75.32 114.578 179.065 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -101.24 0.89 38.23 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 123.043 0.537 . . . . 74.43 110.896 -176.498 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 239' ' ' GLY . . . . . 0.501 ' HA2' HD11 ' A' ' 193' ' ' LEU . . . -102.9 -168.26 26.18 Favored Glycine 0 C--N 1.347 1.157 0 N-CA-C 110.322 -1.111 . . . . 74.23 110.322 163.184 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 58.0 m-85 -92.78 154.64 42.11 Favored Pre-proline 0 N--CA 1.477 0.918 0 C-N-CA 123.033 0.533 . . . . 74.01 111.028 -176.627 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_exo -72.9 161.92 42.4 Favored 'Trans proline' 0 C--N 1.366 1.498 0 C-N-CA 122.202 1.935 . . . . 64.12 111.865 172.342 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 157.2 -104.25 0.25 Allowed Glycine 0 CA--C 1.527 0.842 0 CA-C-O 119.072 -0.849 . . . . 55.25 112.155 177.8 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 243' ' ' PRO . . . . . 0.421 ' HD2' ' HB3' ' A' ' 191' ' ' GLN . 41.8 Cg_endo -63.67 -52.22 1.97 Allowed 'Trans proline' 0 C--N 1.37 1.663 0 C-N-CA 123.642 2.895 . . . . 65.23 113.241 -169.985 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -93.11 -5.08 51.1 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 123.304 0.642 . . . . 73.02 111.447 179.753 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 92.38 -46.52 2.59 Favored Glycine 0 C--N 1.354 1.572 0 N-CA-C 111.945 -0.462 . . . . 50.13 111.945 -175.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 20.1 ttm180 -116.3 112.4 21.51 Favored 'General case' 0 C--O 1.238 0.486 0 C-N-CA 124.367 1.067 . . . . 70.53 109.127 178.119 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -80.65 168.31 51.16 Favored Glycine 0 C--N 1.348 1.249 0 CA-C-O 121.503 0.502 . . . . 64.21 113.88 172.191 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 248' ' ' ASP . . . . . 0.493 ' HB3' ' HG3' ' A' ' 234' ' ' ARG . 19.4 m-20 -124.65 162.2 24.64 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 114.009 -1.096 . . . . 64.11 110.469 -169.466 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 249' ' ' LEU . . . . . 0.431 ' HB3' ' HB2' ' A' ' 235' ' ' LEU . 41.6 tp -125.9 121.8 34.21 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 123.528 0.731 . . . . 74.42 109.405 178.305 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 250' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -90.47 112.43 24.07 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 123.816 0.846 . . . . 74.3 110.607 -178.733 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 251' ' ' LEU . . . . . 0.568 HD13 HD21 ' A' ' 197' ' ' LEU . 90.7 mt -87.85 104.02 16.19 Favored 'General case' 0 C--O 1.239 0.504 0 N-CA-C 107.889 -1.152 . . . . 74.41 107.889 179.915 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -79.91 98.58 7.19 Favored 'General case' 0 C--O 1.239 0.521 0 N-CA-C 108.145 -1.058 . . . . 72.23 108.145 177.106 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 6.2 m -66.67 125.88 24.94 Favored 'Isoleucine or valine' 0 C--O 1.243 0.759 0 CA-C-O 122.021 0.915 . . . . 63.12 109.362 -178.169 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 17.9 mmm180 -122.2 99.34 6.38 Favored 'General case' 0 C--O 1.239 0.535 0 N-CA-C 107.742 -1.207 . . . . 74.51 107.742 -178.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 255' ' ' ILE . . . . . 0.536 ' HA ' ' O ' ' A' ' 199' ' ' VAL . 55.3 mt -83.29 119.55 32.87 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 CA-C-N 114.103 -1.408 . . . . 73.51 110.267 -175.114 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 CA--C 1.559 1.309 0 C-N-CA 124.6 1.16 . . . . 72.52 108.964 175.547 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 172' ' ' LEU . . . . . 0.411 ' HB3' ' OG1' ' A' ' 175' ' ' THR . 21.0 mt . . . . . 0 N--CA 1.485 1.323 0 CA-C-O 121.219 0.533 . . . . 64.44 111.71 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 173' ' ' PHE . . . . . 0.537 ' CD1' HD22 ' A' ' 235' ' ' LEU . 16.7 m-85 -146.14 -59.28 0.31 Allowed 'General case' 0 N--CA 1.479 1.022 0 CA-C-O 122.123 0.963 . . . . 73.13 108.692 -166.986 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 174' ' ' TYR . . . . . 0.472 ' CD2' ' HB3' ' A' ' 233' ' ' LEU . 0.6 OUTLIER -78.53 14.45 1.27 Allowed 'General case' 0 CA--C 1.547 0.829 0 CA-C-N 113.744 -1.571 . . . . 74.44 112.533 -176.025 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 175' ' ' THR . . . . . 0.411 ' OG1' ' HB3' ' A' ' 172' ' ' LEU . 0.2 OUTLIER -63.95 -19.32 65.05 Favored 'General case' 0 CA--C 1.555 1.152 0 C-N-CA 124.459 1.104 . . . . 72.44 111.432 -173.843 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 176' ' ' MET . . . . . . . . . . . . . 25.1 ptt? -71.45 -40.89 70.04 Favored 'General case' 0 CA--C 1.562 1.409 0 C-N-CA 124.644 1.177 . . . . 74.5 111.72 173.081 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 1.6 ttmp? -164.58 118.45 1.36 Allowed 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 124.644 1.178 . . . . 72.05 109.296 -175.623 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 178' ' ' ALA . . . . . 0.49 ' HB3' HD23 ' A' ' 233' ' ' LEU . . . -152.61 -49.39 0.1 Allowed 'General case' 0 C--O 1.24 0.58 0 C-N-CA 123.309 0.644 . . . . 73.31 110.289 -173.808 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -81.02 37.66 0.44 Allowed 'General case' 0 CA--C 1.554 1.127 0 C-N-CA 123.486 0.715 . . . . 72.21 111.07 178.785 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.347 1.154 0 C-N-CA 123.839 0.733 . . . . 71.11 111.76 -177.307 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 191' ' ' GLN . . . . . 0.56 ' HB3' ' HD2' ' A' ' 243' ' ' PRO . 3.6 pt20 . . . . . 0 N--CA 1.477 0.915 0 CA-C-O 121.143 0.497 . . . . 74.24 109.858 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 86.9 m-20 -77.41 153.46 33.63 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 115.39 -0.823 . . . . 64.04 111.504 -174.646 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 26.7 mt -125.74 175.93 7.27 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 124.439 1.096 . . . . 72.52 110.665 -179.226 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 194' ' ' TYR . . . . . 0.456 ' HE2' ' HZ3' ' A' ' 232' ' ' LYS . 32.1 m-85 -140.98 136.67 32.38 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 124.305 1.042 . . . . 75.0 109.905 177.457 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -152.98 131.67 12.33 Favored 'General case' 0 C--O 1.238 0.497 0 C-N-CA 124.651 1.18 . . . . 72.42 108.128 177.064 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 14.9 m -82.61 129.25 34.91 Favored 'General case' 0 CA--C 1.546 0.8 0 CA-C-N 116.267 -0.424 . . . . 72.04 109.974 -176.464 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . 0.556 HD22 HD12 ' A' ' 251' ' ' LEU . 16.0 tp -107.79 111.05 23.02 Favored 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 108.758 -0.83 . . . . 74.02 108.758 -175.878 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -79.63 123.56 27.74 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 123.232 0.613 . . . . 74.2 109.412 176.147 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 199' ' ' VAL . . . . . 0.404 ' O ' ' HA ' ' A' ' 255' ' ' ILE . 6.4 p -142.36 128.95 10.94 Favored Pre-proline 0 CA--C 1.544 0.729 0 N-CA-C 108.675 -0.861 . . . . 73.25 108.675 179.308 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 200' ' ' PRO . . . . . 0.4 ' HB2' ' HD2' ' A' ' 202' ' ' PRO . 66.2 Cg_endo -72.04 159.24 50.62 Favored 'Trans proline' 0 C--N 1.366 1.498 0 C-N-CA 121.825 1.684 . . . . 73.1 111.185 170.711 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 201' ' ' ALA . . . . . 0.414 ' O ' HG21 ' A' ' 205' ' ' VAL . . . -50.61 -50.61 71.56 Favored Pre-proline 0 CA--C 1.556 1.201 0 CA-C-N 114.94 -1.027 . . . . 62.31 113.72 -178.526 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 202' ' ' PRO . . . . . 0.4 ' HD2' ' HB2' ' A' ' 200' ' ' PRO . 52.0 Cg_endo -65.74 -35.82 34.99 Favored 'Trans proline' 0 C--N 1.385 2.469 0 C-N-CA 121.438 1.425 . . . . 72.44 114.697 -178.789 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 50.0 mt -68.88 -29.35 43.13 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.25 0 N-CA-C 110.163 -0.31 . . . . 75.23 110.163 176.812 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -70.96 -41.84 70.52 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 122.62 0.368 . . . . 72.04 111.313 175.448 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 205' ' ' VAL . . . . . 0.414 HG21 ' O ' ' A' ' 201' ' ' ALA . 85.4 t -64.59 -55.96 18.56 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.283 0 C-N-CA 123.864 0.866 . . . . 72.32 111.644 -179.06 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 25.2 m -76.41 -31.45 20.6 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 CA-C-O 120.635 0.255 . . . . 75.33 111.241 -176.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 82.84 64.17 1.69 Allowed Glycine 0 C--N 1.343 0.928 0 CA-C-N 115.903 -0.59 . . . . 73.32 111.836 -173.394 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -79.98 -134.29 1.22 Allowed Glycine 0 C--N 1.346 1.101 0 CA-C-O 119.752 -0.471 . . . . 72.43 111.96 177.072 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 48.4 mtmt -137.19 148.07 46.3 Favored 'General case' 0 N--CA 1.485 1.296 0 CA-C-N 117.711 0.756 . . . . 72.2 111.061 178.471 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 5.7 m -143.12 158.28 17.65 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 C-N-CA 125.169 1.387 . . . . 74.2 108.436 174.584 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 42.0 ttp-105 -94.9 113.38 25.1 Favored 'General case' 0 CA--C 1.544 0.732 0 CA-C-O 121.167 0.508 . . . . 72.2 110.781 -175.171 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -101.37 113.56 26.76 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 124.283 1.033 . . . . 63.3 109.469 175.786 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 39.9 ttm -88.67 116.88 27.24 Favored 'General case' 0 N--CA 1.477 0.882 0 CA-C-O 121.022 0.439 . . . . 74.35 110.018 -179.161 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 17.5 p -111.55 -171.78 1.91 Allowed 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 124.463 1.105 . . . . 63.44 110.062 -173.216 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 84.0 mt -63.59 -37.58 87.86 Favored 'General case' 0 N--CA 1.489 1.485 0 CA-C-O 121.133 0.492 . . . . 71.22 110.606 171.672 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -80.36 -11.46 59.7 Favored 'General case' 0 N--CA 1.476 0.845 0 CA-C-N 114.797 -1.092 . . . . 72.11 111.087 -174.362 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 123.09 -173.02 16.13 Favored Glycine 0 C--N 1.344 1.01 0 N-CA-C 111.447 -0.661 . . . . 73.31 111.447 -179.614 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -73.1 147.55 43.07 Favored 'Trans proline' 0 CA--C 1.552 1.376 0 C-N-CA 122.384 2.056 . . . . 74.21 111.978 177.527 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 3.8 p -139.78 131.36 33.19 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 N-CA-C 108.976 -0.75 . . . . 71.34 108.976 174.346 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -80.86 100.03 8.63 Favored 'General case' 0 C--O 1.239 0.508 0 N-CA-C 107.012 -1.477 . . . . 73.41 107.012 172.258 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 3.8 p -101.67 129.57 52.67 Favored 'Isoleucine or valine' 0 C--O 1.242 0.699 0 N-CA-C 108.602 -0.888 . . . . 73.42 108.602 -172.245 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -76.92 109.39 10.68 Favored 'General case' 0 C--O 1.236 0.386 0 C-N-CA 122.374 0.269 . . . . 75.15 110.523 -177.434 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 58.3 t -52.69 135.04 45.5 Favored Pre-proline 0 CA--C 1.55 0.943 0 O-C-N 124.478 1.111 . . . . 73.23 109.342 178.155 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -61.33 143.5 97.99 Favored 'Trans proline' 0 C--N 1.369 1.642 0 C-N-CA 121.763 1.642 . . . . 72.31 110.495 174.79 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 16.2 Cg_endo -60.35 132.22 42.63 Favored 'Trans proline' 0 C--N 1.37 1.677 0 C-N-CA 121.448 1.432 . . . . 45.42 110.759 175.828 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 65.9 mtm180 65.12 53.05 1.4 Allowed 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.939 1.296 . . . . 72.23 110.834 173.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 26.5 m -75.77 147.48 39.21 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-N 114.886 -1.052 . . . . 75.54 109.651 172.472 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 25.3 mp0 -117.65 145.11 44.6 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 108.301 -1.0 . . . . 64.45 108.301 175.082 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -58.91 134.03 56.57 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 123.684 0.794 . . . . 74.22 111.938 -176.201 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 97.07 -1.33 60.87 Favored Glycine 0 C--N 1.346 1.137 0 CA-C-O 119.079 -0.845 . . . . 63.53 113.934 178.772 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 80.8 mtt-85 -67.28 156.36 36.58 Favored 'General case' 0 N--CA 1.481 1.105 0 CA-C-N 117.862 0.831 . . . . 74.25 111.327 176.781 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 232' ' ' LYS . . . . . 0.456 ' HZ3' ' HE2' ' A' ' 194' ' ' TYR . 70.7 mmtt -119.86 98.93 6.34 Favored 'General case' 0 C--O 1.239 0.548 0 CA-C-N 114.416 -1.265 . . . . 72.2 108.995 -172.641 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 233' ' ' LEU . . . . . 0.639 ' HB2' ' HB2' ' A' ' 251' ' ' LEU . 8.6 mt -86.88 150.28 24.22 Favored 'General case' 0 CA--C 1.542 0.668 0 N-CA-C 107.978 -1.119 . . . . 72.54 107.978 178.105 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 47.2 ttt85 -124.25 108.66 12.49 Favored 'General case' 0 CA--C 1.551 1.017 0 CA-C-N 118.637 0.653 . . . . 73.14 110.736 -176.382 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 235' ' ' LEU . . . . . 0.537 HD22 ' CD1' ' A' ' 173' ' ' PHE . 11.9 mt -86.99 106.5 17.87 Favored 'General case' 0 C--N 1.352 0.702 0 C-N-CA 124.699 1.199 . . . . 75.14 110.524 179.45 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 236' ' ' LYS . . . . . 0.498 ' H ' ' HB3' ' A' ' 173' ' ' PHE . 12.8 mtmt -74.35 132.37 41.97 Favored 'General case' 0 CA--C 1.539 0.549 0 O-C-N 123.531 0.519 . . . . 75.15 112.229 -178.736 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 81.24 19.57 66.56 Favored Glycine 0 C--N 1.35 1.314 0 CA-C-N 114.711 -1.131 . . . . 55.43 113.818 -178.843 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 75.9 mmtt -122.27 13.21 10.32 Favored 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 122.981 0.512 . . . . 74.5 112.229 -175.124 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -124.32 -172.03 13.54 Favored Glycine 0 C--N 1.344 0.981 0 N-CA-C 111.243 -0.743 . . . . 75.22 111.243 173.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 60.5 m-85 -84.99 160.46 55.19 Favored Pre-proline 0 N--CA 1.485 1.317 0 C-N-CA 123.983 0.913 . . . . 73.42 112.171 -173.538 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 241' ' ' PRO . . . . . 0.441 ' HA ' ' O ' ' A' ' 245' ' ' GLY . 17.2 Cg_exo -68.53 148.64 73.22 Favored 'Trans proline' 0 C--N 1.376 1.983 0 C-N-CA 122.115 1.877 . . . . 74.13 112.395 169.72 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -173.2 -119.91 0.55 Allowed Glycine 0 C--N 1.35 1.335 0 CA-C-O 119.141 -0.811 . . . . 54.23 112.529 177.355 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 243' ' ' PRO . . . . . 0.56 ' HD2' ' HB3' ' A' ' 191' ' ' GLN . 44.8 Cg_endo -59.67 -65.59 0.08 OUTLIER 'Trans proline' 0 C--N 1.378 2.104 0 C-N-CA 124.587 3.525 . . . . 75.4 112.648 -172.651 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -90.7 20.54 4.61 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 123.168 0.587 . . . . 63.5 110.903 175.309 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 245' ' ' GLY . . . . . 0.441 ' O ' ' HA ' ' A' ' 241' ' ' PRO . . . 75.0 -96.92 0.99 Allowed Glycine 0 C--N 1.349 1.29 0 N-CA-C 110.47 -1.052 . . . . 70.43 110.47 -173.033 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 21.5 ttm180 -48.46 108.89 0.19 Allowed 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 124.57 1.148 . . . . 72.32 112.32 -178.238 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -88.52 156.21 26.61 Favored Glycine 0 C--O 1.249 1.091 0 N-CA-C 110.814 -0.915 . . . . 75.11 110.814 167.334 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 40.6 m-20 -130.57 155.2 46.92 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-O 120.912 0.386 . . . . 75.42 110.351 -173.297 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 249' ' ' LEU . . . . . 0.492 ' HB3' ' HB2' ' A' ' 235' ' ' LEU . 47.4 tp -98.01 138.08 35.87 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 123.925 0.89 . . . . 74.44 110.755 -173.165 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 250' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -98.89 113.51 25.69 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 122.808 0.443 . . . . 74.32 110.395 177.384 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 251' ' ' LEU . . . . . 0.639 ' HB2' ' HB2' ' A' ' 233' ' ' LEU . 82.7 mt -88.67 105.18 17.51 Favored 'General case' 0 C--O 1.241 0.646 0 N-CA-C 108.541 -0.911 . . . . 75.41 108.541 174.867 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -88.5 103.86 16.27 Favored 'General case' 0 C--O 1.239 0.528 0 N-CA-C 108.385 -0.969 . . . . 72.15 108.385 177.818 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 19.7 m -72.01 143.1 14.5 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 CA-C-O 121.29 0.567 . . . . 75.51 111.084 -172.18 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 19.0 mmt85 -130.39 101.18 5.63 Favored 'General case' 0 C--O 1.237 0.438 0 C-N-CA 124.228 1.011 . . . . 74.12 108.377 177.452 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 255' ' ' ILE . . . . . 0.404 ' HA ' ' O ' ' A' ' 199' ' ' VAL . 30.9 mt -78.89 124.14 36.84 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 O-C-N 123.893 0.745 . . . . 74.43 110.175 178.81 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 1.4 t . . . . . 0 CA--C 1.558 1.271 0 N-CA-C 107.513 -1.292 . . . . 74.53 107.513 173.797 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 172' ' ' LEU . . . . . 0.464 HD21 ' O ' ' A' ' 222' ' ' ALA . 25.0 mt . . . . . 0 N--CA 1.482 1.142 0 CA-C-O 121.523 0.678 . . . . 74.24 112.013 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 173' ' ' PHE . . . . . 0.537 ' CD1' HD21 ' A' ' 235' ' ' LEU . 26.4 m-85 -136.78 -48.77 0.63 Allowed 'General case' 0 N--CA 1.477 0.879 0 CA-C-N 114.911 -1.041 . . . . 75.01 109.76 -169.578 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 174' ' ' TYR . . . . . 0.435 ' CD2' ' HB3' ' A' ' 233' ' ' LEU . 7.9 p90 -84.22 13.6 5.09 Favored 'General case' 0 N--CA 1.48 1.07 0 CA-C-N 114.824 -1.08 . . . . 74.02 113.087 -176.928 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 1.8 p -65.06 -10.58 31.29 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 123.107 0.563 . . . . 71.33 112.504 175.189 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 176' ' ' MET . . . . . 0.549 ' HE3' ' HD2' ' A' ' 234' ' ' ARG . 41.8 mtm -53.18 -42.11 65.9 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 124.316 1.047 . . . . 72.24 110.302 169.053 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . 0.538 ' HB2' ' HZ1' ' A' ' 177' ' ' LYS . 2.8 ttmp? -167.41 97.38 0.49 Allowed 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 124.709 1.204 . . . . 65.31 108.301 176.307 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 178' ' ' ALA . . . . . 0.434 ' HB1' ' HB3' ' A' ' 224' ' ' PRO . . . -109.38 146.3 34.65 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 124.149 0.98 . . . . 75.43 110.456 -175.738 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . 0.475 ' HB3' ' HB2' ' A' ' 224' ' ' PRO . . . 59.75 28.86 18.39 Favored 'General case' 0 N--CA 1.492 1.668 0 C-N-CA 124.388 1.075 . . . . 64.33 111.574 -174.362 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.348 1.25 0 CA-C-N 115.522 -0.763 . . . . 43.21 111.674 -179.578 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 191' ' ' GLN . . . . . 0.682 ' HB2' ' HA2' ' A' ' 247' ' ' GLY . 3.4 pt20 . . . . . 0 CA--C 1.547 0.829 0 CA-C-O 121.735 0.779 . . . . 70.33 110.296 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -76.53 148.28 37.21 Favored 'General case' 0 C--O 1.237 0.403 0 C-N-CA 125.05 1.34 . . . . 73.44 111.255 -162.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . 0.544 HD13 ' HA2' ' A' ' 239' ' ' GLY . 16.3 mt -143.87 170.97 14.89 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 123.607 0.763 . . . . 73.35 110.315 172.11 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 74.6 m-85 -135.74 141.58 44.87 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 124.146 0.978 . . . . 73.12 109.815 179.036 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . 0.462 ' O ' ' HA ' ' A' ' 251' ' ' LEU . . . -154.23 132.77 12.09 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 123.787 0.835 . . . . 64.13 108.758 176.983 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 26.9 m -82.5 127.2 33.08 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.274 -0.639 . . . . 74.43 109.274 178.581 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . 0.68 HD21 HD11 ' A' ' 251' ' ' LEU . 18.1 tp -105.54 107.42 18.4 Favored 'General case' 0 N--CA 1.465 0.306 0 N-CA-C 107.549 -1.278 . . . . 74.11 107.549 -179.469 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -77.81 123.57 26.89 Favored 'General case' 0 C--O 1.237 0.439 0 N-CA-C 107.828 -1.175 . . . . 71.12 107.828 174.072 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 199' ' ' VAL . . . . . 0.533 ' O ' ' HA ' ' A' ' 255' ' ' ILE . 2.8 p -141.62 125.6 10.1 Favored Pre-proline 0 CA--C 1.541 0.625 0 N-CA-C 108.205 -1.035 . . . . 74.21 108.205 -179.652 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -69.98 158.08 57.83 Favored 'Trans proline' 0 C--N 1.365 1.42 0 C-N-CA 122.048 1.832 . . . . 73.42 111.728 171.758 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -49.73 -50.32 67.92 Favored Pre-proline 0 CA--C 1.56 1.329 0 N-CA-C 114.001 1.111 . . . . 73.32 114.001 -178.769 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -63.48 -37.5 48.11 Favored 'Trans proline' 0 C--N 1.393 2.874 0 C-N-CA 122.115 1.877 . . . . 73.24 113.484 -178.507 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 38.3 mt -67.99 -36.11 74.34 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.173 0 CA-C-N 117.995 0.361 . . . . 73.24 110.448 176.102 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 204' ' ' ALA . . . . . 0.448 ' HA ' HG12 ' A' ' 223' ' ' VAL . . . -67.09 -41.78 85.72 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 123.06 0.544 . . . . 74.23 112.231 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 20.9 m -77.81 -51.37 18.14 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.993 0 C-N-CA 123.472 0.709 . . . . 61.2 112.448 -175.592 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 7.9 m -73.4 -30.06 29.32 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.402 0 C-N-CA 122.357 0.263 . . . . 73.33 111.249 -178.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 89.66 63.09 1.29 Allowed Glycine 0 C--N 1.352 1.432 0 CA-C-N 116.216 -0.447 . . . . 44.15 112.373 -175.858 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -86.71 -139.09 5.52 Favored Glycine 0 C--N 1.352 1.429 0 CA-C-O 119.873 -0.404 . . . . 65.33 112.734 -179.833 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 46.4 mtmt -137.89 147.87 44.83 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 123.972 0.909 . . . . 73.3 110.287 178.012 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 5.2 m -140.81 166.34 18.93 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 C-N-CA 124.771 1.229 . . . . 73.2 109.807 174.475 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 29.0 ttp180 -90.06 113.91 25.71 Favored 'General case' 0 CA--C 1.546 0.827 0 C-N-CA 123.63 0.772 . . . . 74.31 109.843 -179.601 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -100.39 117.19 34.07 Favored 'General case' 0 C--O 1.24 0.562 0 N-CA-C 108.586 -0.894 . . . . 75.13 108.586 171.073 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 47.8 tpp -84.0 116.04 22.63 Favored 'General case' 0 C--O 1.241 0.637 0 N-CA-C 109.408 -0.59 . . . . 75.13 109.408 177.58 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 16.6 p -111.47 -173.67 2.3 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 124.59 1.156 . . . . 74.14 109.614 -176.515 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 56.2 mt -61.99 -36.09 80.45 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 122.986 0.514 . . . . 71.14 111.911 175.295 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 27.2 mt-10 -89.81 -8.65 51.59 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.721 0.808 . . . . 62.2 111.435 -172.452 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 124.39 -161.4 18.84 Favored Glycine 0 C--N 1.345 1.058 0 CA-C-O 119.282 -0.732 . . . . 62.45 111.458 -178.08 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -77.71 159.91 31.45 Favored 'Trans proline' 0 CA--C 1.549 1.257 0 C-N-CA 122.525 2.15 . . . . 65.44 112.794 -177.218 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 2.9 p -148.34 129.7 5.65 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 N-CA-C 108.674 -0.862 . . . . 73.32 108.674 171.02 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -76.81 100.29 5.44 Favored 'General case' 0 C--O 1.239 0.544 0 N-CA-C 107.478 -1.305 . . . . 75.22 107.478 169.613 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 9.1 p -100.34 128.36 52.41 Favored 'Isoleucine or valine' 0 C--O 1.245 0.845 0 N-CA-C 108.012 -1.107 . . . . 71.51 108.012 -176.417 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 222' ' ' ALA . . . . . 0.464 ' O ' HD21 ' A' ' 172' ' ' LEU . . . -77.85 105.19 8.87 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 116.466 -0.334 . . . . 74.3 110.648 -174.696 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 223' ' ' VAL . . . . . 0.448 HG12 ' HA ' ' A' ' 204' ' ' ALA . 62.6 t -53.8 133.03 56.9 Favored Pre-proline 0 N--CA 1.472 0.662 0 C-N-CA 124.13 0.972 . . . . 63.3 109.54 179.239 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 224' ' ' PRO . . . . . 0.475 ' HB2' ' HB3' ' A' ' 179' ' ' ALA . 30.8 Cg_endo -64.75 150.53 88.02 Favored 'Trans proline' 0 C--N 1.369 1.629 0 C-N-CA 121.327 1.352 . . . . 73.54 110.663 175.561 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -63.48 140.51 76.27 Favored 'Trans proline' 0 C--N 1.366 1.482 0 C-N-CA 121.452 1.435 . . . . 73.11 110.694 176.449 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 56.6 mtm180 64.79 42.44 4.54 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 124.248 1.019 . . . . 75.52 111.074 170.137 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 63.4 m -76.9 143.48 39.56 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-N 115.464 -0.789 . . . . 74.1 109.444 173.537 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 27.8 mp0 -117.22 143.84 45.44 Favored 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 124.144 0.978 . . . . 65.51 109.039 176.475 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -62.35 123.93 19.55 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 123.757 0.823 . . . . 75.22 110.628 -178.282 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 115.15 -6.5 21.52 Favored Glycine 0 C--N 1.338 0.659 0 O-C-N 123.75 0.656 . . . . 75.03 113.178 -175.34 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 95.2 mtt-85 -74.79 157.2 35.58 Favored 'General case' 0 N--CA 1.478 0.954 0 CA-C-N 117.634 0.717 . . . . 75.04 110.055 172.655 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 232' ' ' LYS . . . . . 0.444 ' HA ' ' O ' ' A' ' 251' ' ' LEU . 12.5 mtmm -131.42 120.95 23.76 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.269 0.628 . . . . 75.4 110.53 -179.681 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 233' ' ' LEU . . . . . 0.503 ' HB2' ' HB2' ' A' ' 251' ' ' LEU . 26.7 mt -101.99 154.31 19.08 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 125.138 1.375 . . . . 73.13 109.264 -176.274 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 234' ' ' ARG . . . . . 0.549 ' HD2' ' HE3' ' A' ' 176' ' ' MET . 15.1 ttm180 -111.99 110.87 21.41 Favored 'General case' 0 N--CA 1.48 1.065 0 CA-C-N 118.144 0.429 . . . . 74.14 111.099 -179.736 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 235' ' ' LEU . . . . . 0.576 ' HB2' ' HB3' ' A' ' 249' ' ' LEU . 11.2 mt -88.11 99.56 12.28 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 122.919 0.487 . . . . 61.0 110.023 172.014 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 236' ' ' LYS . . . . . 0.457 ' H ' ' HB3' ' A' ' 173' ' ' PHE . 11.7 mtmt -72.52 130.47 40.71 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 115.967 -0.56 . . . . 65.14 111.304 -179.789 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 83.69 21.11 58.57 Favored Glycine 0 C--N 1.344 0.995 0 CA-C-N 115.059 -0.973 . . . . 73.15 113.612 -178.182 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt -127.2 17.86 7.11 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 123.012 0.525 . . . . 73.42 111.329 -178.495 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 239' ' ' GLY . . . . . 0.544 ' HA2' HD13 ' A' ' 193' ' ' LEU . . . -118.81 -159.96 11.26 Favored Glycine 0 C--N 1.347 1.146 0 N-CA-C 111.278 -0.729 . . . . 63.03 111.278 170.256 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 60.4 m-85 -92.55 165.37 19.47 Favored Pre-proline 0 CA--C 1.553 1.061 0 C-N-CA 123.713 0.805 . . . . 74.14 110.376 -177.187 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 241' ' ' PRO . . . . . 0.461 ' HA ' ' O ' ' A' ' 245' ' ' GLY . 40.4 Cg_exo -61.17 166.25 11.19 Favored 'Trans proline' 0 C--N 1.374 1.877 0 C-N-CA 121.732 1.621 . . . . 73.52 113.473 170.333 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 167.32 -123.72 1.15 Allowed Glycine 0 CA--C 1.529 0.968 0 CA-C-O 118.874 -0.959 . . . . 70.11 111.862 177.209 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 243' ' ' PRO . . . . . 0.466 ' HD2' ' HB3' ' A' ' 191' ' ' GLN . 30.9 Cg_endo -59.68 -60.78 0.27 Allowed 'Trans proline' 0 C--N 1.379 2.136 0 C-N-CA 123.925 3.083 . . . . 70.02 112.976 -170.001 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -90.93 2.85 55.89 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 123.185 0.594 . . . . 74.53 111.43 177.373 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 245' ' ' GLY . . . . . 0.461 ' O ' ' HA ' ' A' ' 241' ' ' PRO . . . 85.35 -34.57 3.26 Favored Glycine 0 C--N 1.358 1.757 0 N-CA-C 112.319 -0.312 . . . . 54.33 112.319 -173.746 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 10.8 ttm180 -88.66 112.53 23.21 Favored 'General case' 0 CA--C 1.529 0.149 0 C-N-CA 124.79 1.236 . . . . 74.21 111.404 177.557 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 247' ' ' GLY . . . . . 0.682 ' HA2' ' HB2' ' A' ' 191' ' ' GLN . . . -84.31 163.57 39.37 Favored Glycine 0 C--N 1.345 1.074 0 C-N-CA 121.27 -0.491 . . . . 74.23 114.055 162.855 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 34.6 m-20 -132.65 143.79 49.9 Favored 'General case' 0 C--O 1.241 0.638 0 C-N-CA 123.866 0.866 . . . . 73.24 110.133 -169.063 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 249' ' ' LEU . . . . . 0.576 ' HB3' ' HB2' ' A' ' 235' ' ' LEU . 61.4 tp -106.98 117.86 35.18 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 124.361 1.065 . . . . 74.1 110.087 -177.084 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 250' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 -91.5 110.62 21.93 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 123.245 0.618 . . . . 74.23 110.034 -174.299 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 251' ' ' LEU . . . . . 0.68 HD11 HD21 ' A' ' 197' ' ' LEU . 74.6 mt -86.73 106.35 17.59 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 114.839 -1.073 . . . . 64.45 110.574 -175.037 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -79.63 97.07 6.37 Favored 'General case' 0 C--O 1.241 0.643 0 N-CA-C 108.439 -0.948 . . . . 74.31 108.439 173.746 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 4.6 m -69.42 130.35 34.16 Favored 'Isoleucine or valine' 0 C--O 1.244 0.776 0 CA-C-O 121.762 0.792 . . . . 75.35 110.251 -176.338 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 21.8 mmm180 -126.9 115.13 18.82 Favored 'General case' 0 C--O 1.237 0.44 0 N-CA-C 107.657 -1.238 . . . . 73.05 107.657 178.576 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 255' ' ' ILE . . . . . 0.533 ' HA ' ' O ' ' A' ' 199' ' ' VAL . 49.0 mt -98.82 111.88 29.53 Favored 'Isoleucine or valine' 0 C--O 1.24 0.589 0 O-C-N 123.574 0.546 . . . . 71.54 110.443 -175.09 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 3.1 t . . . . . 0 CA--C 1.56 1.34 0 CA-C-N 115.523 -0.762 . . . . 74.42 108.984 177.276 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 172' ' ' LEU . . . . . 0.448 HD22 ' HB3' ' A' ' 222' ' ' ALA . 77.5 mt . . . . . 0 N--CA 1.48 1.059 0 CA-C-O 120.73 0.3 . . . . 74.45 111.654 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 173' ' ' PHE . . . . . 0.423 ' CD1' HD22 ' A' ' 235' ' ' LEU . 45.4 m-85 -144.59 -66.95 0.33 Allowed 'General case' 0 N--CA 1.486 1.336 0 N-CA-C 109.391 -0.596 . . . . 75.52 109.391 -166.545 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 174' ' ' TYR . . . . . 0.467 ' CD2' ' HB3' ' A' ' 233' ' ' LEU . 7.7 p90 -64.77 -13.24 54.49 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 123.841 0.857 . . . . 75.34 112.301 177.655 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 175' ' ' THR . . . . . 0.444 HG22 HD12 ' A' ' 172' ' ' LEU . 4.2 m -65.73 0.97 1.45 Allowed 'General case' 0 CA--C 1.565 1.535 0 C-N-CA 125.133 1.373 . . . . 73.52 112.217 -178.154 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 176' ' ' MET . . . . . 0.443 ' HE3' ' HZ2' ' A' ' 236' ' ' LYS . 37.3 mtm -64.85 -59.88 3.7 Favored 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 123.604 0.762 . . . . 75.03 109.148 161.543 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.98 100.32 3.38 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 124.477 1.111 . . . . 71.55 108.651 175.024 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -109.44 -178.38 3.54 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 124.194 0.998 . . . . 73.01 111.612 -170.169 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . 62.14 -91.05 0.03 OUTLIER 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 125.088 1.355 . . . . 72.13 111.044 -177.43 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.877 0 N-CA-C 112.461 -0.256 . . . . 73.54 112.461 -178.225 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 191' ' ' GLN . . . . . 0.618 ' HB3' ' HD2' ' A' ' 243' ' ' PRO . 9.9 pt20 . . . . . 0 N--CA 1.478 0.962 0 CA-C-O 120.949 0.404 . . . . 73.41 110.347 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -77.56 157.58 30.26 Favored 'General case' 0 C--O 1.241 0.617 0 CA-C-N 115.091 -0.959 . . . . 71.22 110.904 -168.539 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 32.7 mt -134.25 171.13 14.68 Favored 'General case' 0 C--O 1.239 0.529 0 CA-C-N 114.284 -1.325 . . . . 70.22 108.69 176.282 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 59.6 m-85 -136.49 126.63 26.24 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 123.768 0.827 . . . . 62.12 110.317 -177.165 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . 0.415 ' O ' ' HA ' ' A' ' 251' ' ' LEU . . . -141.65 130.66 23.21 Favored 'General case' 0 N--CA 1.466 0.344 0 N-CA-C 107.951 -1.129 . . . . 74.13 107.951 175.636 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 30.4 m -83.07 127.78 33.89 Favored 'General case' 0 C--O 1.24 0.559 0 N-CA-C 108.577 -0.897 . . . . 73.21 108.577 176.865 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . 0.679 HD22 HD11 ' A' ' 251' ' ' LEU . 16.7 tp -106.35 110.05 22.17 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 108.331 -0.989 . . . . 74.23 108.331 -178.974 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -80.72 118.42 22.25 Favored 'General case' 0 C--O 1.238 0.475 0 N-CA-C 108.233 -1.025 . . . . 74.3 108.233 -179.817 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 5.1 p -136.89 128.45 16.74 Favored Pre-proline 0 CA--C 1.543 0.691 0 N-CA-C 108.948 -0.76 . . . . 74.44 108.948 -176.28 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 200' ' ' PRO . . . . . 0.436 ' HB2' ' HD2' ' A' ' 202' ' ' PRO . 62.0 Cg_endo -69.69 158.25 57.72 Favored 'Trans proline' 0 C--N 1.365 1.404 0 C-N-CA 121.924 1.749 . . . . 74.32 111.246 172.717 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 201' ' ' ALA . . . . . 0.496 ' HA ' HG22 ' A' ' 255' ' ' ILE . . . -47.34 -54.8 19.16 Favored Pre-proline 0 CA--C 1.562 1.417 0 CA-C-O 117.547 -1.216 . . . . 72.54 113.044 179.88 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 202' ' ' PRO . . . . . 0.436 ' HD2' ' HB2' ' A' ' 200' ' ' PRO . 52.9 Cg_endo -64.74 -37.25 36.85 Favored 'Trans proline' 0 C--N 1.4 3.289 0 C-N-CA 121.9 1.733 . . . . 71.31 113.323 -174.124 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 44.1 mt -65.67 -34.64 71.7 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 C-N-CA 122.54 0.336 . . . . 72.34 110.141 177.604 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -70.53 -39.75 73.86 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 122.518 0.327 . . . . 65.31 111.093 177.277 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 205' ' ' VAL . . . . . 0.483 HG21 ' O ' ' A' ' 201' ' ' ALA . 83.9 t -67.44 -56.43 13.41 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 C-N-CA 123.565 0.746 . . . . 74.34 111.193 -177.852 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 10.5 m -82.06 -29.49 9.68 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 CA-C-N 116.002 -0.544 . . . . 72.05 111.455 -172.821 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 88.5 65.43 1.31 Allowed Glycine 0 C--N 1.345 1.074 0 CA-C-N 116.093 -0.503 . . . . 73.54 112.129 -174.875 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -87.11 -134.69 4.18 Favored Glycine 0 C--N 1.357 1.726 0 N-CA-C 111.794 -0.523 . . . . 44.54 111.794 177.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 46.6 mtmt -136.61 154.93 50.53 Favored 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 123.524 0.729 . . . . 62.52 110.908 178.602 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 6.3 m -144.94 169.66 7.77 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 C-N-CA 125.597 1.559 . . . . 74.2 108.473 172.319 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 56.0 ttp180 -104.23 119.43 38.94 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 123.573 0.749 . . . . 74.44 109.499 177.487 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -103.57 141.08 36.63 Favored 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 123.894 0.878 . . . . 74.4 109.667 175.402 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 46.9 tpp -100.27 128.32 46.37 Favored 'General case' 0 N--CA 1.475 0.808 0 N-CA-C 109.179 -0.675 . . . . 75.23 109.179 178.389 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 19.6 p -129.27 -171.68 2.55 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 123.818 0.847 . . . . 73.33 110.52 -171.55 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 91.9 mt -62.18 -27.75 69.18 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 123.831 0.853 . . . . 74.02 111.839 173.869 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -99.49 6.48 45.89 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 123.573 0.749 . . . . 70.12 111.52 -179.464 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 94.48 -153.42 20.99 Favored Glycine 0 C--N 1.347 1.146 0 CA-C-O 119.589 -0.562 . . . . 70.51 112.655 -177.807 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_endo -70.35 153.4 66.26 Favored 'Trans proline' 0 C--N 1.37 1.672 0 C-N-CA 122.582 2.188 . . . . 72.11 113.25 -174.489 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 4.6 p -145.52 135.81 18.74 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 C-N-CA 124.368 1.067 . . . . 74.11 109.048 174.245 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -83.6 104.23 13.56 Favored 'General case' 0 C--O 1.239 0.546 0 N-CA-C 107.883 -1.154 . . . . 71.02 107.883 172.659 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 2.9 p -114.39 126.07 71.84 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.018 0 N-CA-C 109.41 -0.589 . . . . 64.35 109.41 -174.476 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 222' ' ' ALA . . . . . 0.448 ' HB3' HD22 ' A' ' 172' ' ' LEU . . . -78.82 108.43 12.26 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 123.39 0.676 . . . . 55.55 110.69 -179.333 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 84.7 t -55.46 136.17 70.01 Favored Pre-proline 0 N--CA 1.478 0.961 0 C-N-CA 124.754 1.222 . . . . 71.33 109.857 177.12 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -66.31 159.4 50.26 Favored 'Trans proline' 0 C--N 1.373 1.839 0 C-N-CA 121.711 1.607 . . . . 63.51 111.455 174.835 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -69.28 153.13 71.62 Favored 'Trans proline' 0 C--N 1.365 1.428 0 C-N-CA 121.544 1.496 . . . . 73.11 111.08 171.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 39.7 mtm180 60.69 34.41 20.0 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 124.773 1.229 . . . . 71.41 111.578 172.702 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 227' ' ' THR . . . . . 0.478 ' O ' HD13 ' A' ' 255' ' ' ILE . 85.4 m -73.73 120.78 19.8 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 115.049 -0.978 . . . . 71.0 109.547 175.52 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 228' ' ' GLN . . . . . 0.465 ' NE2' HH21 ' A' ' 231' ' ' ARG . 2.2 mp0 -102.59 147.86 26.27 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 124.414 1.086 . . . . 75.42 109.035 177.908 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 229' ' ' ALA . . . . . 0.441 ' HB2' ' HB ' ' A' ' 255' ' ' ILE . . . -59.21 115.03 2.92 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 123.81 0.844 . . . . 71.52 111.274 -177.237 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 113.42 0.2 24.94 Favored Glycine 0 C--N 1.343 0.97 0 O-C-N 123.685 0.616 . . . . 51.24 113.599 -178.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 231' ' ' ARG . . . . . 0.465 HH21 ' NE2' ' A' ' 228' ' ' GLN . 87.5 mtt-85 -65.72 150.77 47.95 Favored 'General case' 0 N--CA 1.486 1.36 0 CA-C-N 117.591 0.696 . . . . 74.44 110.478 173.471 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 71.7 mmtt -118.67 102.22 8.69 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 124.097 0.959 . . . . 74.12 109.488 -171.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 233' ' ' LEU . . . . . 0.764 ' HB2' ' HB2' ' A' ' 251' ' ' LEU . 58.7 mt -88.89 152.21 21.87 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 115.415 -0.812 . . . . 72.5 109.534 178.344 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 234' ' ' ARG . . . . . 0.443 ' HG3' ' HB3' ' A' ' 248' ' ' ASP . 38.6 ttm-85 -119.32 121.12 38.87 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.512 0.725 . . . . 71.23 110.902 -174.673 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 235' ' ' LEU . . . . . 0.624 ' HB2' ' HB3' ' A' ' 249' ' ' LEU . 16.0 mt -110.43 100.38 9.23 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 122.464 0.306 . . . . 74.44 110.662 176.874 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 236' ' ' LYS . . . . . 0.543 ' HB3' ' HD2' ' A' ' 246' ' ' ARG . 13.2 mttp -69.13 139.84 54.71 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 110.345 -0.243 . . . . 73.23 110.345 173.323 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 86.85 -3.13 87.22 Favored Glycine 0 N--CA 1.473 1.11 0 CA-C-N 115.757 -0.656 . . . . 72.0 113.193 179.857 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -112.79 5.25 17.45 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 123.573 0.749 . . . . 74.21 111.061 -179.085 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -113.35 -173.82 18.77 Favored Glycine 0 C--N 1.347 1.184 0 N-CA-C 110.997 -0.841 . . . . 72.14 110.997 164.584 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 93.8 m-85 -91.56 160.98 35.51 Favored Pre-proline 0 N--CA 1.483 1.216 0 C-N-CA 123.84 0.856 . . . . 74.12 110.331 -178.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_exo -62.07 158.69 37.81 Favored 'Trans proline' 0 C--N 1.374 1.881 0 C-N-CA 122.136 1.891 . . . . 74.35 112.951 173.724 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 169.19 -128.12 1.62 Allowed Glycine 0 C--N 1.349 1.251 0 CA-C-O 118.766 -1.019 . . . . 65.34 112.307 176.113 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 243' ' ' PRO . . . . . 0.618 ' HD2' ' HB3' ' A' ' 191' ' ' GLN . 18.6 Cg_endo -52.62 -49.66 16.73 Favored 'Trans proline' 0 C--N 1.38 2.199 0 C-N-CA 124.96 3.773 . . . . 73.44 113.826 -173.963 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -95.92 -1.83 48.45 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.295 0.638 . . . . 53.12 111.69 -179.024 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 90.01 -37.76 3.31 Favored Glycine 0 C--N 1.352 1.438 0 CA-C-O 120.955 0.197 . . . . 62.41 113.014 178.1 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 246' ' ' ARG . . . . . 0.543 ' HD2' ' HB3' ' A' ' 236' ' ' LYS . 16.5 ttm180 -120.38 111.73 18.12 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 124.17 0.988 . . . . 72.31 108.593 178.831 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -69.3 155.12 53.44 Favored Glycine 0 C--O 1.25 1.133 0 O-C-N 123.504 0.503 . . . . 74.43 114.255 178.289 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 248' ' ' ASP . . . . . 0.443 ' HB3' ' HG3' ' A' ' 234' ' ' ARG . 40.3 m-20 -112.19 138.87 48.26 Favored 'General case' 0 C--O 1.225 -0.224 0 CA-C-N 114.152 -1.024 . . . . 73.43 109.591 -173.446 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 249' ' ' LEU . . . . . 0.624 ' HB3' ' HB2' ' A' ' 235' ' ' LEU . 44.4 tp -100.12 117.58 34.67 Favored 'General case' 0 C--O 1.238 0.485 0 N-CA-C 108.088 -1.078 . . . . 75.04 108.088 172.051 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 250' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -88.56 108.95 19.69 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 123.651 0.78 . . . . 74.54 108.898 -176.419 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 251' ' ' LEU . . . . . 0.764 ' HB2' ' HB2' ' A' ' 233' ' ' LEU . 85.6 mt -88.38 104.83 17.14 Favored 'General case' 0 C--O 1.24 0.566 0 N-CA-C 108.135 -1.061 . . . . 74.32 108.135 178.281 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -84.36 101.87 12.3 Favored 'General case' 0 C--O 1.241 0.647 0 N-CA-C 107.864 -1.161 . . . . 73.43 107.864 175.222 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 11.2 m -69.45 139.31 20.57 Favored 'Isoleucine or valine' 0 C--O 1.244 0.772 0 O-C-N 123.87 0.731 . . . . 75.31 110.03 -175.774 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 14.4 mmt85 -128.18 105.63 8.5 Favored 'General case' 0 C--O 1.238 0.487 0 C-N-CA 124.073 0.949 . . . . 75.51 108.608 178.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 255' ' ' ILE . . . . . 0.496 HG22 ' HA ' ' A' ' 201' ' ' ALA . 34.0 mt -76.4 123.95 33.7 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 O-C-N 123.932 0.77 . . . . 75.33 109.615 178.582 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 1.8 t . . . . . 0 CA--C 1.554 1.104 0 N-CA-C 107.426 -1.324 . . . . 71.03 107.426 178.773 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 172' ' ' LEU . . . . . 0.677 HD22 ' H ' ' A' ' 222' ' ' ALA . 59.9 mt . . . . . 0 N--CA 1.48 1.055 0 N-CA-C 110.449 -0.204 . . . . 75.11 110.449 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 173' ' ' PHE . . . . . 0.414 ' CD1' HD22 ' A' ' 235' ' ' LEU . 40.1 m-85 -125.8 -52.26 1.57 Allowed 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 123.927 0.891 . . . . 75.1 108.638 -176.106 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 174' ' ' TYR . . . . . . . . . . . . . 17.3 p90 -68.93 -2.67 10.32 Favored 'General case' 0 C--N 1.345 0.388 0 CA-C-N 113.894 -1.503 . . . . 74.42 114.198 -174.241 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 2.4 p -57.71 -16.06 9.8 Favored 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 123.775 0.83 . . . . 74.53 112.62 173.15 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 176' ' ' MET . . . . . . . . . . . . . 9.4 ptm -52.57 -40.75 62.93 Favored 'General case' 0 CA--C 1.56 1.359 0 C-N-CA 123.988 0.915 . . . . 73.52 111.825 167.519 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 46.5 tptt -153.78 48.28 0.65 Allowed 'General case' 0 N--CA 1.479 1.006 0 CA-C-O 122.019 0.914 . . . . 72.5 109.438 -177.523 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 178' ' ' ALA . . . . . 0.486 ' HB2' ' HB3' ' A' ' 224' ' ' PRO . . . -74.41 131.89 41.48 Favored 'General case' 0 N--CA 1.478 0.958 0 CA-C-N 115.21 -0.904 . . . . 75.34 110.62 -178.271 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . 0.512 ' HB3' ' HB2' ' A' ' 224' ' ' PRO . . . 69.54 14.09 8.3 Favored 'General case' 0 N--CA 1.492 1.639 0 C-N-CA 124.888 1.275 . . . . 74.03 111.448 -171.838 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.352 1.452 0 N-CA-C 110.851 -0.9 . . . . 54.45 110.851 171.518 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 191' ' ' GLN . . . . . 0.573 ' HB3' ' HD2' ' A' ' 243' ' ' PRO . 10.5 pt20 . . . . . 0 N--CA 1.48 1.031 0 CA-C-O 121.084 0.469 . . . . 71.1 110.209 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -76.83 150.16 36.13 Favored 'General case' 0 C--O 1.241 0.657 0 CA-C-N 114.971 -1.013 . . . . 60.13 110.304 -171.031 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 29.5 mt -128.82 168.2 16.25 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 124.549 1.14 . . . . 70.02 109.4 177.872 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 71.6 m-85 -126.17 140.56 52.47 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 123.621 0.768 . . . . 75.33 109.731 179.125 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . 0.472 ' HB3' HD12 ' A' ' 249' ' ' LEU . . . -153.32 129.59 10.5 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 108.09 -1.078 . . . . 70.21 108.09 177.974 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 18.0 m -85.22 125.2 32.67 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 109.237 -0.653 . . . . 75.23 109.237 177.752 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . 0.496 HD22 HD13 ' A' ' 251' ' ' LEU . 20.7 tp -106.54 109.13 20.95 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 108.382 -0.97 . . . . 75.23 108.382 -178.878 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -78.04 127.51 32.43 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 123.388 0.675 . . . . 51.41 109.416 177.285 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 199' ' ' VAL . . . . . 0.486 ' O ' ' HA ' ' A' ' 255' ' ' ILE . 3.3 p -142.75 124.68 8.72 Favored Pre-proline 0 CA--C 1.543 0.693 0 C-N-CA 123.585 0.754 . . . . 73.43 108.971 178.767 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -67.36 153.35 77.17 Favored 'Trans proline' 0 C--N 1.368 1.588 0 C-N-CA 122.146 1.897 . . . . 71.04 111.805 171.545 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 201' ' ' ALA . . . . . 0.417 ' HA ' HG22 ' A' ' 255' ' ' ILE . . . -47.91 -49.53 58.08 Favored Pre-proline 0 CA--C 1.562 1.431 0 N-CA-C 114.433 1.271 . . . . 73.22 114.433 -176.654 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 202' ' ' PRO . . . . . 0.41 ' O ' HG22 ' A' ' 206' ' ' VAL . 54.2 Cg_endo -66.17 -38.71 20.48 Favored 'Trans proline' 0 C--N 1.393 2.908 0 C-N-CA 121.603 1.535 . . . . 75.12 112.701 -179.333 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 29.6 mt -65.06 -32.28 57.59 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.139 0 CA-C-N 118.348 0.522 . . . . 71.41 110.209 177.343 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -68.05 -48.73 64.82 Favored 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 122.994 0.518 . . . . 61.54 111.612 179.004 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 17.6 m -71.82 -50.56 37.55 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.848 0 C-N-CA 123.243 0.617 . . . . 71.22 112.238 -177.67 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 206' ' ' VAL . . . . . 0.41 HG22 ' O ' ' A' ' 202' ' ' PRO . 4.5 m -74.4 -25.96 19.94 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.2 0 C-N-CA 122.746 0.419 . . . . 74.43 111.504 -177.699 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 80.09 70.02 1.36 Allowed Glycine 0 C--N 1.345 1.047 0 O-C-N 123.312 0.382 . . . . 64.45 112.181 -177.59 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -93.44 -131.4 5.91 Favored Glycine 0 C--N 1.35 1.348 0 C-N-CA 123.152 0.406 . . . . 73.23 112.267 179.208 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 209' ' ' LYS . . . . . 0.487 ' HG2' ' HA ' ' A' ' 222' ' ' ALA . 47.4 mtmt -138.26 156.53 47.58 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 123.865 0.866 . . . . 73.41 111.199 177.564 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 9.6 m -147.61 167.18 5.16 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.1 0 C-N-CA 125.519 1.528 . . . . 73.15 108.972 173.332 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 58.6 ttp180 -99.8 119.09 37.62 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 123.096 0.558 . . . . 75.51 110.557 178.918 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -101.58 131.15 47.93 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 124.409 1.084 . . . . 65.43 110.16 176.28 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 50.5 tpp -94.7 129.93 41.41 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 123.22 0.608 . . . . 75.41 109.59 177.389 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 17.3 p -126.48 -172.48 2.64 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 124.199 1.0 . . . . 72.11 109.747 -175.141 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 80.3 mt -61.92 -37.44 84.68 Favored 'General case' 0 N--CA 1.482 1.135 0 CA-C-O 121.133 0.492 . . . . 72.42 110.875 171.063 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -92.05 10.66 28.2 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 124.253 1.021 . . . . 74.22 111.677 -173.163 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 101.67 -158.84 18.53 Favored Glycine 0 C--N 1.351 1.4 0 CA-C-O 119.504 -0.609 . . . . 73.43 112.348 178.403 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -80.46 154.31 21.16 Favored 'Trans proline' 0 C--N 1.368 1.561 0 C-N-CA 122.728 2.285 . . . . 63.13 112.843 -177.584 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 4.2 p -150.8 129.18 2.75 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 N-CA-C 108.328 -0.99 . . . . 74.14 108.328 175.498 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -85.34 103.24 14.08 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 108.982 -0.747 . . . . 73.24 108.982 -178.872 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 15.9 m -97.78 137.91 24.04 Favored 'Isoleucine or valine' 0 C--O 1.241 0.623 0 C-N-CA 123.669 0.787 . . . . 73.04 110.442 -176.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 222' ' ' ALA . . . . . 0.677 ' H ' HD22 ' A' ' 172' ' ' LEU . . . -84.46 104.79 14.77 Favored 'General case' 0 C--O 1.243 0.722 0 CA-C-N 115.159 -0.928 . . . . 72.53 110.451 -179.016 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 66.5 t -54.7 129.8 64.16 Favored Pre-proline 0 N--CA 1.475 0.792 0 C-N-CA 124.771 1.228 . . . . 70.41 109.669 -179.223 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 224' ' ' PRO . . . . . 0.512 ' HB2' ' HB3' ' A' ' 179' ' ' ALA . 28.6 Cg_endo -62.13 154.79 60.19 Favored 'Trans proline' 0 C--N 1.369 1.656 0 C-N-CA 121.914 1.742 . . . . 71.14 111.514 176.035 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -67.13 143.9 67.03 Favored 'Trans proline' 0 C--N 1.364 1.361 0 C-N-CA 121.152 1.234 . . . . 70.3 111.28 173.453 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 75.3 mtt180 65.61 38.41 5.44 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 124.726 1.21 . . . . 73.2 111.752 172.888 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 55.5 m -74.95 137.95 41.97 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 122.973 0.509 . . . . 75.33 110.45 175.694 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 26.8 mp0 -113.63 146.56 39.57 Favored 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 124.055 0.942 . . . . 74.15 109.994 175.169 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -58.94 119.79 7.88 Favored 'General case' 0 C--N 1.354 0.799 0 C-N-CA 124.276 1.03 . . . . 63.31 111.051 -178.788 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 114.11 -5.06 23.75 Favored Glycine 0 N--CA 1.466 0.689 0 O-C-N 123.834 0.709 . . . . 73.03 112.711 -178.883 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 85.9 mtt-85 -70.36 148.5 48.35 Favored 'General case' 0 C--N 1.358 0.976 0 CA-C-N 117.654 0.727 . . . . 74.5 109.333 172.411 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 41.2 mtmt -125.19 116.1 21.47 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 121.547 0.689 . . . . 73.51 109.599 -175.213 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 233' ' ' LEU . . . . . 0.632 ' HB2' ' HB2' ' A' ' 251' ' ' LEU . 56.7 mt -93.45 141.2 28.73 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 114.211 -1.358 . . . . 74.23 108.575 -177.887 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 14.5 ttp180 -109.26 112.44 24.59 Favored 'General case' 0 N--CA 1.474 0.774 0 O-C-N 122.055 -0.403 . . . . 74.43 111.264 -172.02 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 235' ' ' LEU . . . . . 0.586 ' HB2' ' HB3' ' A' ' 249' ' ' LEU . 12.9 mt -102.07 107.54 18.68 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.542 0.737 . . . . 74.25 110.432 176.228 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 236' ' ' LYS . . . . . 0.5 ' HB3' ' HD2' ' A' ' 246' ' ' ARG . 40.9 mttm -76.52 151.9 36.22 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-O 120.999 0.428 . . . . 75.44 110.556 172.14 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 77.21 -6.9 40.37 Favored Glycine 0 N--CA 1.476 1.365 0 CA-C-N 115.47 -0.787 . . . . 61.13 113.908 -177.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 72.8 mmtt -104.12 -7.56 20.11 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 123.748 0.819 . . . . 74.53 110.077 -179.695 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -97.14 -167.73 33.03 Favored Glycine 0 C--N 1.358 1.769 0 N-CA-C 111.278 -0.729 . . . . 60.03 111.278 164.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 74.3 m-85 -91.59 157.31 42.16 Favored Pre-proline 0 N--CA 1.481 1.09 0 C-N-CA 123.772 0.829 . . . . 74.33 110.874 179.821 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -70.6 154.77 64.19 Favored 'Trans proline' 0 C--N 1.369 1.63 0 C-N-CA 121.311 1.341 . . . . 74.41 111.059 169.857 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 173.59 -119.63 0.76 Allowed Glycine 0 CA--C 1.527 0.826 0 CA-C-O 118.601 -1.11 . . . . 74.2 111.842 -179.47 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 243' ' ' PRO . . . . . 0.573 ' HD2' ' HB3' ' A' ' 191' ' ' GLN . 40.8 Cg_endo -60.66 -57.24 0.72 Allowed 'Trans proline' 0 C--N 1.38 2.232 0 C-N-CA 123.784 2.989 . . . . 74.01 112.54 -173.117 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -80.24 -12.86 59.58 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 123.167 0.587 . . . . 74.1 111.207 179.845 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 95.78 -34.8 4.67 Favored Glycine 0 C--N 1.353 1.512 0 C-N-CA 122.986 0.327 . . . . 54.31 112.311 179.698 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 246' ' ' ARG . . . . . 0.5 ' HD2' ' HB3' ' A' ' 236' ' ' LYS . 22.3 ttm180 -125.81 111.77 15.25 Favored 'General case' 0 C--O 1.244 0.77 0 C-N-CA 123.727 0.811 . . . . 75.43 108.986 177.751 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -72.12 155.31 51.58 Favored Glycine 0 C--N 1.347 1.182 0 N-CA-C 115.253 0.861 . . . . 73.44 115.253 -177.698 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 38.9 m-20 -100.21 155.43 17.76 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 113.654 -1.273 . . . . 72.34 109.96 -175.515 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 249' ' ' LEU . . . . . 0.586 ' HB3' ' HB2' ' A' ' 235' ' ' LEU . 48.8 tp -129.77 114.87 16.48 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 108.191 -1.04 . . . . 73.53 108.191 173.326 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 250' ' ' TYR . . . . . . . . . . . . . 19.7 m-30 -90.55 109.14 20.3 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 116.191 -0.458 . . . . 72.34 110.191 -174.757 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 251' ' ' LEU . . . . . 0.632 ' HB2' ' HB2' ' A' ' 233' ' ' LEU . 82.4 mt -87.45 102.43 14.55 Favored 'General case' 0 C--O 1.239 0.522 0 N-CA-C 107.923 -1.14 . . . . 75.24 107.923 177.254 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -83.38 99.72 10.24 Favored 'General case' 0 C--O 1.243 0.718 0 N-CA-C 108.257 -1.016 . . . . 73.35 108.257 178.002 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 10.1 m -61.32 132.34 26.83 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.768 0 CA-C-N 115.572 -0.74 . . . . 75.04 110.004 179.63 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 20.3 mmm180 -125.34 105.42 9.08 Favored 'General case' 0 C--O 1.241 0.606 0 N-CA-C 107.273 -1.38 . . . . 73.22 107.273 178.292 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 255' ' ' ILE . . . . . 0.486 ' HA ' ' O ' ' A' ' 199' ' ' VAL . 45.6 mt -77.93 107.54 9.95 Favored 'Isoleucine or valine' 0 C--O 1.239 0.505 0 CA-C-N 115.797 -0.638 . . . . 74.24 109.766 -179.254 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 2.4 t . . . . . 0 CA--C 1.555 1.159 0 CA-C-N 115.035 -0.984 . . . . 74.04 108.462 174.302 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 172' ' ' LEU . . . . . 0.43 HD21 ' HB3' ' A' ' 222' ' ' ALA . 22.7 mt . . . . . 0 N--CA 1.491 1.589 0 CA-C-O 120.799 0.333 . . . . 75.41 111.759 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 173' ' ' PHE . . . . . 0.475 ' CD1' HD23 ' A' ' 235' ' ' LEU . 19.4 m-85 -129.62 -53.8 1.16 Allowed 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 124.124 0.97 . . . . 71.34 109.177 -171.439 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 174' ' ' TYR . . . . . 0.437 ' CD2' ' HB3' ' A' ' 233' ' ' LEU . 0.8 OUTLIER -77.98 14.05 1.24 Allowed 'General case' 0 CA--C 1.547 0.828 0 CA-C-N 114.477 -1.238 . . . . 75.45 113.058 -174.257 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 20.6 p -61.38 -20.26 62.83 Favored 'General case' 0 N--CA 1.484 1.24 0 CA-C-N 118.772 0.715 . . . . 72.32 111.391 173.326 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 176' ' ' MET . . . . . . . . . . . . . 26.5 ptt? -59.03 -37.67 77.52 Favored 'General case' 0 CA--C 1.55 0.969 0 C-N-CA 124.149 0.979 . . . . 71.42 111.494 171.141 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 37.7 ttpt -167.19 87.6 0.29 Allowed 'General case' 0 CA--C 1.55 0.966 0 C-N-CA 124.451 1.1 . . . . 70.23 108.936 179.342 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -106.44 127.39 53.25 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 124.291 1.037 . . . . 74.44 109.246 -178.149 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . 59.93 39.45 20.22 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 124.117 0.967 . . . . 72.52 110.391 -172.773 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.056 0 CA-C-N 115.192 -0.913 . . . . 74.54 113.006 -173.149 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 191' ' ' GLN . . . . . 0.455 ' HB2' ' HA2' ' A' ' 247' ' ' GLY . 7.6 pt20 . . . . . 0 N--CA 1.471 0.602 0 CA-C-O 120.938 0.399 . . . . 74.54 110.271 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -78.03 138.56 38.86 Favored 'General case' 0 C--N 1.351 0.651 0 CA-C-N 115.524 -0.762 . . . . 73.2 109.148 -174.699 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 25.1 mt -120.18 177.18 5.11 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 124.483 1.113 . . . . 75.34 109.158 175.112 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -139.08 121.02 15.55 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 123.413 0.685 . . . . 73.41 110.396 177.185 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -125.13 128.6 48.68 Favored 'General case' 0 C--O 1.241 0.607 0 N-CA-C 106.942 -1.503 . . . . 75.2 106.942 168.566 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 10.6 m -81.26 119.45 23.65 Favored 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 108.363 -0.977 . . . . 74.33 108.363 179.621 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . 0.63 HD21 HD13 ' A' ' 251' ' ' LEU . 20.5 tp -103.96 110.69 22.93 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 108.48 -0.933 . . . . 72.53 108.48 -173.996 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -79.86 127.23 31.99 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 115.219 -0.901 . . . . 74.32 108.92 179.209 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 199' ' ' VAL . . . . . 0.457 ' O ' ' HA ' ' A' ' 255' ' ' ILE . 6.2 p -143.9 128.72 9.51 Favored Pre-proline 0 CA--C 1.547 0.85 0 C-N-CA 123.729 0.812 . . . . 75.31 109.03 178.802 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -69.76 158.47 56.85 Favored 'Trans proline' 0 C--N 1.362 1.285 0 C-N-CA 121.769 1.646 . . . . 72.34 111.595 170.782 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 201' ' ' ALA . . . . . 0.442 ' O ' HG23 ' A' ' 205' ' ' VAL . . . -49.84 -53.99 36.71 Favored Pre-proline 0 CA--C 1.558 1.265 0 CA-C-N 114.744 -1.116 . . . . 72.24 112.863 -176.49 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -65.52 -34.29 43.13 Favored 'Trans proline' 0 C--N 1.399 3.208 0 C-N-CA 121.736 1.624 . . . . 72.12 113.237 -175.527 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 24.7 mt -67.2 -34.05 66.87 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.413 0 N-CA-C 109.975 -0.38 . . . . 71.1 109.975 177.529 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -69.46 -38.09 77.6 Favored 'General case' 0 CA--C 1.549 0.904 0 C-N-CA 122.535 0.334 . . . . 64.33 111.339 177.422 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 205' ' ' VAL . . . . . 0.442 HG23 ' O ' ' A' ' 201' ' ' ALA . 99.7 t -70.86 -56.55 10.36 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.122 0 C-N-CA 123.168 0.587 . . . . 73.55 111.576 -178.039 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 10.9 m -78.37 -25.42 13.84 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 CA-C-N 116.134 -0.485 . . . . 75.52 110.948 -174.918 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 84.15 60.55 1.92 Allowed Glycine 0 C--N 1.345 1.043 0 CA-C-N 116.04 -0.527 . . . . 61.32 112.615 -179.578 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -78.77 -138.03 1.38 Allowed Glycine 0 N--CA 1.477 1.374 0 CA-C-O 119.696 -0.502 . . . . 60.54 112.168 177.663 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 209' ' ' LYS . . . . . 0.467 ' HG2' ' HA ' ' A' ' 222' ' ' ALA . 29.0 mtmm -134.58 157.3 46.93 Favored 'General case' 0 N--CA 1.481 1.124 0 CA-C-N 117.607 0.704 . . . . 74.12 110.718 176.38 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 7.1 m -142.86 165.75 15.72 Favored 'Isoleucine or valine' 0 C--O 1.241 0.631 0 C-N-CA 126.068 1.747 . . . . 65.1 107.894 173.601 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 31.1 ttm180 -105.07 116.61 32.25 Favored 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 109.396 -0.594 . . . . 74.01 109.396 179.273 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -101.74 113.74 27.18 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.379 1.072 . . . . 73.32 109.563 179.003 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 61.6 tpp -76.22 125.04 28.44 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 108.187 -1.042 . . . . 65.33 108.187 173.702 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 18.4 p -125.24 -175.8 3.41 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.723 0.809 . . . . 72.22 109.721 -175.702 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 71.1 mt -57.01 -40.79 77.28 Favored 'General case' 0 N--CA 1.481 1.079 0 CA-C-O 121.504 0.669 . . . . 75.23 110.415 172.5 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 216' ' ' GLU . . . . . 0.477 ' HB2' ' HZ2' ' A' ' 238' ' ' LYS . 6.0 mm-40 -87.72 15.02 7.43 Favored 'General case' 0 CA--C 1.551 0.994 0 CA-C-N 114.538 -1.21 . . . . 71.11 111.371 -174.751 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 94.73 -171.1 30.02 Favored Glycine 0 C--N 1.35 1.346 0 N-CA-C 112.086 -0.406 . . . . 75.21 112.086 -179.686 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -68.42 149.37 74.89 Favored 'Trans proline' 0 C--N 1.362 1.276 0 C-N-CA 122.205 1.936 . . . . 62.31 111.991 178.129 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 7.1 p -143.27 134.87 23.61 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 N-CA-C 108.543 -0.91 . . . . 72.44 108.543 173.593 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 -86.37 103.27 14.78 Favored 'General case' 0 C--O 1.238 0.475 0 N-CA-C 107.76 -1.2 . . . . 74.52 107.76 179.501 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 2.6 p -108.61 131.35 59.44 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.967 0 C-N-CA 123.615 0.766 . . . . 72.13 109.355 -172.108 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 222' ' ' ALA . . . . . 0.467 ' HA ' ' HG2' ' A' ' 209' ' ' LYS . . . -83.11 111.25 18.73 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 123.126 0.571 . . . . 74.41 110.62 -176.788 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 58.4 t -54.66 132.65 64.78 Favored Pre-proline 0 N--CA 1.473 0.721 0 O-C-N 124.716 1.26 . . . . 62.43 109.354 177.067 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_endo -63.41 144.95 91.98 Favored 'Trans proline' 0 C--N 1.367 1.541 0 C-N-CA 121.482 1.455 . . . . 62.41 111.266 172.817 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -62.67 139.11 73.55 Favored 'Trans proline' 0 C--N 1.37 1.698 0 C-N-CA 121.572 1.515 . . . . 74.31 110.971 171.816 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 54.2 mtt180 69.64 60.49 0.28 Allowed 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 124.982 1.313 . . . . 73.2 110.74 173.161 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 227' ' ' THR . . . . . 0.561 ' HA ' ' HE ' ' A' ' 231' ' ' ARG . 55.9 m -103.85 142.12 34.94 Favored 'General case' 0 CA--C 1.544 0.74 0 CA-C-N 113.669 -1.605 . . . . 71.21 110.051 -179.857 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -116.66 148.14 41.29 Favored 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 124.074 0.95 . . . . 74.12 109.732 177.527 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 229' ' ' ALA . . . . . 0.491 ' HB1' ' HB ' ' A' ' 255' ' ' ILE . . . -58.77 116.5 3.78 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 123.982 0.913 . . . . 71.43 110.762 -179.84 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 113.21 2.44 24.79 Favored Glycine 0 CA--C 1.524 0.656 0 CA-C-N 115.744 -0.662 . . . . 74.01 112.968 179.238 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 231' ' ' ARG . . . . . 0.561 ' HE ' ' HA ' ' A' ' 227' ' ' THR . 75.0 mtt-85 -66.39 147.44 53.3 Favored 'General case' 0 C--N 1.364 1.206 0 CA-C-N 117.175 0.488 . . . . 74.44 109.757 172.358 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 69.7 mmtt -115.2 98.38 6.74 Favored 'General case' 0 C--O 1.241 0.605 0 CA-C-N 115.139 -0.937 . . . . 73.14 108.757 -174.591 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 233' ' ' LEU . . . . . 0.709 ' HB2' ' HB2' ' A' ' 251' ' ' LEU . 60.1 mt -85.5 151.69 23.76 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 115.3 -0.864 . . . . 73.44 108.883 177.514 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 234' ' ' ARG . . . . . 0.431 HH11 ' HE2' ' A' ' 250' ' ' TYR . 41.0 ttt85 -126.63 109.19 11.83 Favored 'General case' 0 N--CA 1.478 0.963 0 CA-C-O 120.679 0.275 . . . . 72.41 110.63 -172.114 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 235' ' ' LEU . . . . . 0.534 HD13 HD12 ' A' ' 251' ' ' LEU . 23.3 mt -94.98 117.71 30.6 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 123.761 0.824 . . . . 73.12 110.765 -179.571 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 20.9 mttt -69.86 138.51 52.59 Favored 'General case' 0 C--O 1.238 0.468 0 O-C-N 123.415 0.447 . . . . 75.1 111.401 175.74 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 73.94 10.35 80.64 Favored Glycine 0 C--N 1.345 1.029 0 CA-C-N 115.608 -0.723 . . . . 72.23 114.36 175.452 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . 0.477 ' HZ2' ' HB2' ' A' ' 216' ' ' GLU . 72.7 mmtt -112.51 5.28 17.89 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 122.765 0.426 . . . . 74.42 111.062 -179.707 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -107.37 -161.93 21.57 Favored Glycine 0 C--N 1.348 1.216 0 N-CA-C 110.896 -0.881 . . . . 74.05 110.896 168.244 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 40.1 m-85 -94.25 147.25 33.03 Favored Pre-proline 0 N--CA 1.477 0.905 0 C-N-CA 123.045 0.538 . . . . 75.25 110.935 -179.049 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_exo -64.76 167.47 15.45 Favored 'Trans proline' 0 C--N 1.369 1.617 0 C-N-CA 122.333 2.022 . . . . 75.44 112.385 169.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 144.63 -106.02 0.38 Allowed Glycine 0 C--N 1.339 0.75 0 CA-C-O 118.727 -1.041 . . . . 63.32 112.077 175.769 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -61.95 -51.18 4.04 Favored 'Trans proline' 0 C--N 1.38 2.223 0 C-N-CA 123.632 2.888 . . . . 73.33 113.01 -168.855 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -87.13 -10.3 53.13 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 123.06 0.544 . . . . 74.53 111.312 176.466 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 90.76 -44.9 2.88 Favored Glycine 0 C--N 1.352 1.427 0 N-CA-C 111.383 -0.687 . . . . 65.53 111.383 -173.118 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 10.2 ttm180 -115.8 111.94 21.24 Favored 'General case' 0 C--O 1.24 0.59 0 C-N-CA 125.137 1.375 . . . . 64.31 109.281 175.373 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 247' ' ' GLY . . . . . 0.455 ' HA2' ' HB2' ' A' ' 191' ' ' GLN . . . -80.61 168.43 51.35 Favored Glycine 0 C--N 1.349 1.276 0 CA-C-O 121.766 0.648 . . . . 43.45 113.698 170.987 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -125.38 160.77 28.58 Favored 'General case' 0 N--CA 1.465 0.31 0 C-N-CA 124.19 0.996 . . . . 64.24 110.396 -170.274 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 249' ' ' LEU . . . . . 0.471 ' HB3' ' HB2' ' A' ' 235' ' ' LEU . 41.1 tp -115.84 124.86 51.76 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 123.948 0.899 . . . . 75.11 109.501 177.143 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 250' ' ' TYR . . . . . 0.431 ' HE2' HH11 ' A' ' 234' ' ' ARG . 2.2 m-85 -88.26 109.54 20.02 Favored 'General case' 0 C--O 1.232 0.158 0 N-CA-C 109.268 -0.641 . . . . 74.33 109.268 176.912 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 251' ' ' LEU . . . . . 0.709 ' HB2' ' HB2' ' A' ' 233' ' ' LEU . 86.4 mt -87.2 104.19 16.14 Favored 'General case' 0 C--O 1.241 0.64 0 N-CA-C 106.736 -1.579 . . . . 74.32 106.736 173.945 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -85.05 103.43 14.07 Favored 'General case' 0 C--O 1.24 0.575 0 N-CA-C 107.71 -1.219 . . . . 63.03 107.71 176.037 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 16.7 m -68.43 137.71 23.92 Favored 'Isoleucine or valine' 0 C--O 1.241 0.646 0 O-C-N 124.181 0.926 . . . . 74.32 109.596 -177.193 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 18.1 mmm180 -128.48 106.18 8.81 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 107.774 -1.195 . . . . 75.25 107.774 -179.906 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 255' ' ' ILE . . . . . 0.491 ' HB ' ' HB1' ' A' ' 229' ' ' ALA . 29.6 mt -77.47 123.5 34.23 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.58 0 O-C-N 123.924 0.765 . . . . 73.44 110.086 178.301 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 3.3 t . . . . . 0 CA--C 1.563 1.452 0 C-N-CA 124.143 0.977 . . . . 72.1 109.081 173.729 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 172' ' ' LEU . . . . . 0.693 HD21 ' H ' ' A' ' 222' ' ' ALA . 78.2 mt . . . . . 0 N--CA 1.479 0.992 0 CA-C-O 121.16 0.505 . . . . 72.53 111.49 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 50.1 m-85 -147.62 -68.94 0.24 Allowed 'General case' 0 N--CA 1.479 0.986 0 N-CA-C 108.337 -0.986 . . . . 75.21 108.337 -164.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 174' ' ' TYR . . . . . 0.468 ' OH ' ' HB ' ' A' ' 221' ' ' VAL . 19.9 p90 -62.97 -21.86 66.4 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 113.921 -1.491 . . . . 74.54 112.523 -178.888 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 19.5 m -59.28 -12.59 5.81 Favored 'General case' 0 CA--C 1.56 1.339 0 C-N-CA 125.773 1.629 . . . . 72.35 112.889 -176.277 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 176' ' ' MET . . . . . . . . . . . . . 50.8 mtm -56.36 -50.62 71.02 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 123.773 0.829 . . . . 74.43 110.075 166.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . 0.46 ' HZ3' ' HB2' ' A' ' 177' ' ' LYS . 0.1 OUTLIER -163.84 104.54 0.91 Allowed 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 124.428 1.091 . . . . 72.03 109.475 174.775 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 178' ' ' ALA . . . . . 0.462 ' HB3' HD21 ' A' ' 233' ' ' LEU . . . -125.84 -59.39 1.35 Allowed 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 123.936 0.894 . . . . 70.3 111.224 -171.67 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -72.26 81.8 1.01 Allowed 'General case' 0 CA--C 1.544 0.716 0 CA-C-O 121.86 0.838 . . . . 70.53 109.258 174.765 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.337 0.586 0 N-CA-C 109.974 -1.25 . . . . 61.23 109.974 -169.663 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 191' ' ' GLN . . . . . 0.699 ' HB2' ' HA2' ' A' ' 247' ' ' GLY . 3.4 pt20 . . . . . 0 CA--C 1.545 0.755 0 CA-C-O 121.41 0.624 . . . . 75.51 110.088 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 192' ' ' ASP . . . . . 0.447 ' HA ' ' O ' ' A' ' 248' ' ' ASP . 9.9 m-20 -78.1 152.75 32.71 Favored 'General case' 0 C--N 1.347 0.464 0 CA-C-N 114.438 -1.256 . . . . 71.1 111.797 -167.907 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . 0.431 HD11 ' HA2' ' A' ' 239' ' ' GLY . 22.9 mt -133.86 175.01 9.85 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 124.265 1.026 . . . . 73.3 109.773 177.517 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 77.6 m-85 -136.35 131.43 34.27 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.579 0.752 . . . . 72.44 110.545 179.835 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -144.29 128.99 18.23 Favored 'General case' 0 C--O 1.234 0.28 0 N-CA-C 107.326 -1.361 . . . . 74.4 107.326 176.823 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 3.5 m -81.47 121.35 26.16 Favored 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 109.524 -0.547 . . . . 65.44 109.524 -176.571 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . 0.506 HD22 HD12 ' A' ' 251' ' ' LEU . 20.3 tp -106.35 108.96 20.73 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 107.188 -1.412 . . . . 72.45 107.188 -178.124 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -86.92 132.37 33.83 Favored 'General case' 0 C--O 1.241 0.606 0 N-CA-C 109.223 -0.658 . . . . 65.14 109.223 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 199' ' ' VAL . . . . . 0.425 ' O ' ' HA ' ' A' ' 255' ' ' ILE . 4.0 p -141.92 129.53 11.61 Favored Pre-proline 0 CA--C 1.543 0.694 0 N-CA-C 108.305 -0.998 . . . . 65.43 108.305 -176.626 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -70.23 155.1 65.13 Favored 'Trans proline' 0 C--N 1.364 1.36 0 C-N-CA 121.431 1.421 . . . . 74.34 110.376 170.814 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 201' ' ' ALA . . . . . 0.436 ' HA ' HG22 ' A' ' 255' ' ' ILE . . . -50.64 -49.39 78.98 Favored Pre-proline 0 CA--C 1.556 1.2 0 CA-C-O 117.804 -1.093 . . . . 64.4 112.885 179.871 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -58.74 -39.59 80.71 Favored 'Trans proline' 0 C--N 1.399 3.216 0 C-N-CA 122.312 2.008 . . . . 74.52 113.991 -179.884 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 39.3 mt -68.28 -37.54 78.15 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.395 0 CA-C-N 118.625 0.648 . . . . 75.2 110.475 177.684 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -66.46 -42.8 87.02 Favored 'General case' 0 N--CA 1.479 0.98 0 N-CA-C 112.101 0.408 . . . . 74.14 112.101 179.706 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 26.9 m -77.69 -45.02 28.96 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.917 0 C-N-CA 123.777 0.831 . . . . 74.12 112.722 -172.713 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 5.2 m -81.19 -26.22 10.52 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.325 0 C-N-CA 122.42 0.288 . . . . 75.21 111.338 178.541 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 82.89 77.89 1.07 Allowed Glycine 0 C--N 1.348 1.226 0 N-CA-C 111.858 -0.497 . . . . 74.34 111.858 -176.445 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -102.1 -137.34 9.6 Favored Glycine 0 C--N 1.347 1.186 0 N-CA-C 111.51 -0.636 . . . . 63.42 111.51 177.427 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 48.5 mtmt -136.16 155.46 50.13 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 123.592 0.757 . . . . 74.1 111.088 179.124 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 7.4 m -142.43 168.75 13.81 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.908 0 C-N-CA 125.948 1.699 . . . . 73.55 108.385 172.827 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 44.1 ttm180 -103.25 120.02 39.97 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 122.902 0.481 . . . . 74.1 109.858 177.508 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -102.21 133.55 46.9 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 124.127 0.971 . . . . 75.54 110.213 177.688 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 23.5 mmt -97.24 121.63 39.35 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 123.319 0.648 . . . . 74.14 109.595 178.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 18.2 p -120.17 174.85 6.24 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 124.172 0.989 . . . . 63.13 110.082 -177.095 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 56.5 mt -59.0 -31.48 68.84 Favored 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 123.079 0.551 . . . . 75.32 112.248 179.241 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -87.59 -20.26 26.67 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 123.106 0.563 . . . . 63.32 111.475 -177.4 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 139.33 -161.66 26.06 Favored Glycine 0 C--N 1.35 1.314 0 CA-C-O 119.445 -0.642 . . . . 63.34 111.962 -178.469 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_endo -82.28 155.86 16.87 Favored 'Trans proline' 0 C--N 1.367 1.541 0 C-N-CA 122.53 2.154 . . . . 71.33 112.766 -177.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 5.5 p -146.93 134.88 15.0 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.92 0 C-N-CA 123.746 0.819 . . . . 74.55 109.354 177.268 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -83.34 104.16 13.28 Favored 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 108.444 -0.947 . . . . 64.44 108.444 176.243 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 221' ' ' VAL . . . . . 0.468 ' HB ' ' OH ' ' A' ' 174' ' ' TYR . 6.4 m -106.27 132.12 54.21 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 CA-C-O 121.64 0.733 . . . . 74.24 110.578 -178.027 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 222' ' ' ALA . . . . . 0.693 ' H ' HD21 ' A' ' 172' ' ' LEU . . . -85.74 105.8 16.53 Favored 'General case' 0 C--O 1.238 0.46 0 CA-C-N 114.365 -1.289 . . . . 72.31 110.311 -178.732 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 66.7 t -57.43 128.76 79.56 Favored Pre-proline 0 N--CA 1.478 0.962 0 O-C-N 124.532 1.145 . . . . 64.5 109.124 179.089 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 224' ' ' PRO . . . . . 0.44 ' HD3' ' HE1' ' A' ' 174' ' ' TYR . 24.3 Cg_endo -61.22 146.56 97.3 Favored 'Trans proline' 0 C--N 1.375 1.922 0 C-N-CA 121.892 1.728 . . . . 73.32 110.926 177.559 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_endo -62.36 141.95 89.15 Favored 'Trans proline' 0 C--N 1.37 1.674 0 C-N-CA 121.607 1.538 . . . . 72.34 111.808 175.864 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 77.9 mtt180 64.64 38.96 6.8 Favored 'General case' 0 CA--C 1.554 1.13 0 C-N-CA 125.031 1.333 . . . . 74.13 111.908 172.524 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 227' ' ' THR . . . . . 0.48 HG21 ' HD2' ' A' ' 231' ' ' ARG . 86.7 m -76.17 146.85 38.87 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 123.648 0.779 . . . . 71.43 110.427 176.178 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -111.05 149.41 30.79 Favored 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 123.813 0.845 . . . . 75.13 109.249 174.927 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 229' ' ' ALA . . . . . 0.468 ' HA ' HG21 ' A' ' 253' ' ' VAL . . . -61.19 138.74 58.21 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 124.02 0.928 . . . . 64.14 111.394 -179.325 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 94.11 -3.81 70.3 Favored Glycine 0 C--N 1.339 0.73 0 CA-C-N 115.843 -0.617 . . . . 55.14 112.712 -178.846 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 231' ' ' ARG . . . . . 0.48 ' HD2' HG21 ' A' ' 227' ' ' THR . 57.4 mtt-85 -69.38 143.58 53.65 Favored 'General case' 0 C--N 1.363 1.195 0 N-CA-C 108.924 -0.769 . . . . 75.45 108.924 171.72 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 232' ' ' LYS . . . . . 0.514 ' HG2' ' HB3' ' A' ' 250' ' ' TYR . 13.4 ttmt -126.29 101.36 6.7 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 108.707 -0.849 . . . . 71.34 108.707 -167.309 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 233' ' ' LEU . . . . . 0.68 ' HB2' ' HB2' ' A' ' 251' ' ' LEU . 24.1 mt -76.28 151.72 36.68 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-N 114.011 -1.45 . . . . 71.34 109.172 -176.528 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 47.8 ttt180 -125.14 120.82 32.46 Favored 'General case' 0 N--CA 1.485 1.291 0 CA-C-N 118.998 0.817 . . . . 73.51 110.484 -175.433 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 235' ' ' LEU . . . . . 0.485 HD11 HD11 ' A' ' 251' ' ' LEU . 18.6 mt -108.78 116.45 32.01 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 124.397 1.079 . . . . 74.35 110.768 -175.696 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 31.4 mttp -72.94 141.54 47.82 Favored 'General case' 0 N--CA 1.479 1.004 0 N-CA-C 112.226 0.454 . . . . 72.42 112.226 176.795 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 76.51 10.37 85.75 Favored Glycine 0 C--N 1.349 1.269 0 CA-C-N 115.151 -0.931 . . . . 72.42 114.49 178.582 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt -115.26 10.29 15.92 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 122.736 0.414 . . . . 72.15 111.069 -173.79 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 239' ' ' GLY . . . . . 0.431 ' HA2' HD11 ' A' ' 193' ' ' LEU . . . -119.86 -161.98 11.74 Favored Glycine 0 C--N 1.345 1.06 0 N-CA-C 111.456 -0.657 . . . . 75.21 111.456 172.779 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 37.7 m-85 -93.02 169.3 10.64 Favored Pre-proline 0 N--CA 1.485 1.286 0 C-N-CA 123.79 0.836 . . . . 71.23 111.105 -175.208 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 241' ' ' PRO . . . . . 0.503 ' HA ' ' O ' ' A' ' 245' ' ' GLY . 77.7 Cg_exo -55.01 149.63 42.13 Favored 'Trans proline' 0 C--N 1.376 2.001 0 C-N-CA 121.762 1.641 . . . . 73.1 112.813 165.68 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -174.54 -136.51 2.26 Favored Glycine 0 CA--C 1.526 0.75 0 CA-C-O 119.053 -0.859 . . . . 74.44 111.871 179.085 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 243' ' ' PRO . . . . . 0.671 ' HD2' ' HB3' ' A' ' 191' ' ' GLN . 43.1 Cg_endo -60.34 -40.89 54.5 Favored 'Trans proline' 0 C--N 1.371 1.744 0 C-N-CA 124.158 3.238 . . . . 75.41 113.108 -172.53 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -104.12 0.87 30.16 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 124.05 0.94 . . . . 74.43 111.482 179.013 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 245' ' ' GLY . . . . . 0.503 ' O ' ' HA ' ' A' ' 241' ' ' PRO . . . 81.83 -41.22 2.7 Favored Glycine 0 C--N 1.36 1.885 0 N-CA-C 112.386 -0.286 . . . . 75.23 112.386 -175.584 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 9.9 ttm180 -89.02 110.1 20.84 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 124.301 1.04 . . . . 74.24 109.705 175.61 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 247' ' ' GLY . . . . . 0.699 ' HA2' ' HB2' ' A' ' 191' ' ' GLN . . . -83.11 167.48 45.6 Favored Glycine 0 C--N 1.351 1.417 0 N-CA-C 114.407 0.523 . . . . 73.35 114.407 171.69 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 248' ' ' ASP . . . . . 0.447 ' O ' ' HA ' ' A' ' 192' ' ' ASP . 41.6 m-20 -131.31 135.92 47.69 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 123.482 0.713 . . . . 63.32 111.092 -168.729 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 249' ' ' LEU . . . . . . . . . . . . . 47.5 tp -99.97 129.9 46.09 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 123.497 0.719 . . . . 74.33 110.739 -177.921 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 250' ' ' TYR . . . . . 0.514 ' HB3' ' HG2' ' A' ' 232' ' ' LYS . 2.4 m-85 -95.77 115.49 27.5 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 123.801 0.84 . . . . 70.0 110.522 -178.83 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 251' ' ' LEU . . . . . 0.68 ' HB2' ' HB2' ' A' ' 233' ' ' LEU . 85.8 mt -94.14 105.22 17.22 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 108.711 -0.848 . . . . 74.54 108.711 178.257 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -84.15 104.25 14.04 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 109.743 -0.466 . . . . 72.41 109.743 178.736 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 253' ' ' VAL . . . . . 0.468 HG21 ' HA ' ' A' ' 229' ' ' ALA . 6.1 m -66.1 131.66 31.8 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.937 0 CA-C-O 121.237 0.541 . . . . 75.25 109.687 -179.299 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 10.8 mmm180 -123.96 97.32 5.3 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 108.744 -0.835 . . . . 73.42 108.744 179.057 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 255' ' ' ILE . . . . . 0.436 HG22 ' HA ' ' A' ' 201' ' ' ALA . 32.2 mt -78.46 127.36 38.79 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 O-C-N 124.026 0.829 . . . . 71.31 111.014 -175.172 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 1.9 t . . . . . 0 CA--C 1.561 1.367 0 C-N-CA 124.064 0.946 . . . . 71.43 109.418 175.379 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 172' ' ' LEU . . . . . 0.594 HD22 ' H ' ' A' ' 222' ' ' ALA . 72.8 mt . . . . . 0 CA--C 1.54 0.584 0 CA-C-O 120.622 0.249 . . . . 74.0 110.979 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 34.9 m-85 -109.38 -57.93 2.1 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 123.7 0.8 . . . . 74.13 109.805 -174.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 174' ' ' TYR . . . . . 0.415 ' CD2' ' HB3' ' A' ' 233' ' ' LEU . 0.8 OUTLIER -71.17 -6.03 36.34 Favored 'General case' 0 C--N 1.348 0.508 0 CA-C-N 114.724 -1.126 . . . . 72.54 113.446 -173.201 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 175' ' ' THR . . . . . 0.422 HG23 HD12 ' A' ' 172' ' ' LEU . 2.9 p -68.2 -2.12 7.47 Favored 'General case' 0 CA--C 1.549 0.908 0 N-CA-C 114.052 1.131 . . . . 74.34 114.052 -177.328 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 176' ' ' MET . . . . . . . . . . . . . 21.8 ptt? -60.34 -41.93 94.61 Favored 'General case' 0 CA--C 1.559 1.296 0 C-N-CA 123.038 0.535 . . . . 74.22 110.369 163.756 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -178.55 114.03 0.07 Allowed 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 126.425 1.89 . . . . 74.55 106.956 179.337 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 178' ' ' ALA . . . . . 0.402 ' HB1' HD22 ' A' ' 233' ' ' LEU . . . -132.2 -42.04 0.98 Allowed 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 122.799 0.44 . . . . 62.23 111.881 -170.809 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -72.7 81.6 1.13 Allowed 'General case' 0 N--CA 1.472 0.669 0 CA-C-O 121.708 0.766 . . . . 64.42 109.58 179.045 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . 0.432 ' H ' ' HD3' ' A' ' 231' ' ' ARG . . . . . . . . 0 C--N 1.332 0.332 0 N-CA-C 108.944 -1.663 . . . . 51.14 108.944 -175.693 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 191' ' ' GLN . . . . . 0.526 ' HB3' ' HD2' ' A' ' 243' ' ' PRO . 5.4 pt20 . . . . . 0 N--CA 1.474 0.738 0 CA-C-O 121.075 0.464 . . . . 73.41 110.763 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 21.5 m-20 -77.3 161.33 28.17 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 115.743 -0.662 . . . . 71.2 111.312 -170.536 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 24.2 mt -141.08 166.31 25.13 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 124.375 1.07 . . . . 72.24 110.294 -178.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 61.0 m-85 -136.94 123.02 20.33 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 124.324 1.049 . . . . 74.33 109.771 178.206 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . 0.449 ' O ' ' HA ' ' A' ' 251' ' ' LEU . . . -133.89 132.61 40.51 Favored 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 108.389 -0.967 . . . . 61.35 108.389 176.301 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 41.8 m -86.11 124.06 32.11 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 123.145 0.578 . . . . 73.23 109.87 -179.134 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . 0.591 HD23 HD12 ' A' ' 251' ' ' LEU . 19.7 tp -107.16 109.93 21.88 Favored 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 108.665 -0.865 . . . . 74.2 108.665 -175.367 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -79.75 125.58 29.85 Favored 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 123.441 0.696 . . . . 74.11 109.174 179.219 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 199' ' ' VAL . . . . . 0.454 ' O ' ' HA ' ' A' ' 255' ' ' ILE . 4.4 p -144.02 129.37 9.7 Favored Pre-proline 0 CA--C 1.547 0.829 0 C-N-CA 124.044 0.937 . . . . 74.44 108.93 -178.083 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -67.76 158.55 56.72 Favored 'Trans proline' 0 C--N 1.37 1.682 0 C-N-CA 121.809 1.673 . . . . 75.2 112.264 170.26 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 201' ' ' ALA . . . . . 0.476 ' O ' HG21 ' A' ' 205' ' ' VAL . . . -50.62 -52.91 51.74 Favored Pre-proline 0 CA--C 1.553 1.09 0 N-CA-C 113.692 0.997 . . . . 65.34 113.692 -179.185 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -64.97 -38.6 28.15 Favored 'Trans proline' 0 C--N 1.381 2.258 0 CA-C-N 121.147 1.445 . . . . 75.22 113.835 -177.39 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 31.5 mt -64.04 -30.9 51.27 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 N-CA-C 109.944 -0.391 . . . . 74.43 109.944 175.743 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -72.77 -40.74 65.71 Favored 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 122.578 0.351 . . . . 72.44 111.453 176.765 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 205' ' ' VAL . . . . . 0.476 HG21 ' O ' ' A' ' 201' ' ' ALA . 91.6 t -70.73 -55.96 12.43 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.239 0 C-N-CA 123.199 0.6 . . . . 71.51 111.035 -176.483 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 14.7 m -81.3 -27.3 10.46 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 CA-C-N 116.532 -0.304 . . . . 73.23 111.188 -176.796 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 85.18 71.56 1.31 Allowed Glycine 0 C--N 1.351 1.393 0 O-C-N 123.439 0.462 . . . . 60.42 113.016 -179.367 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -86.81 -127.8 2.33 Favored Glycine 0 C--N 1.348 1.218 0 CA-C-O 119.736 -0.48 . . . . 64.4 112.808 176.908 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 45.1 mtmt -137.66 152.12 48.98 Favored 'General case' 0 N--CA 1.486 1.336 0 CA-C-N 117.525 0.662 . . . . 73.43 111.128 178.45 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 6.2 m -146.91 159.52 9.67 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 C-N-CA 125.108 1.363 . . . . 72.53 108.536 170.702 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 51.0 ttp180 -97.53 121.18 39.14 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 123.394 0.678 . . . . 75.23 110.675 -179.681 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -102.29 123.18 45.64 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 123.494 0.718 . . . . 72.44 110.192 176.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 49.1 tpp -81.28 126.75 31.93 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 108.893 -0.78 . . . . 73.22 108.893 172.747 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 24.1 p -129.74 -174.31 3.27 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 123.848 0.859 . . . . 75.34 109.673 -173.506 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 67.4 mt -62.29 -27.65 69.18 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 122.809 0.444 . . . . 75.14 111.196 172.781 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 216' ' ' GLU . . . . . 0.403 ' HB2' ' NZ ' ' A' ' 238' ' ' LYS . 34.4 mt-10 -102.87 22.12 14.39 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 123.826 0.851 . . . . 72.43 110.691 -178.84 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 85.85 -156.03 29.62 Favored Glycine 0 C--N 1.354 1.555 0 CA-C-O 119.13 -0.817 . . . . 61.31 113.291 176.628 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -75.71 148.0 32.08 Favored 'Trans proline' 0 C--N 1.369 1.613 0 C-N-CA 122.79 2.327 . . . . 74.03 113.024 -178.151 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 3.8 p -141.5 128.77 21.09 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 N-CA-C 108.735 -0.839 . . . . 54.41 108.735 174.464 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -79.45 102.88 9.0 Favored 'General case' 0 C--O 1.241 0.606 0 N-CA-C 108.453 -0.943 . . . . 74.41 108.453 174.564 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 1.8 p -111.13 115.88 51.03 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.214 0 CA-C-N 115.457 -0.792 . . . . 73.34 108.968 -170.497 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 222' ' ' ALA . . . . . 0.594 ' H ' HD22 ' A' ' 172' ' ' LEU . . . -67.78 109.17 3.25 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 115.365 -0.834 . . . . 71.11 111.699 179.143 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 57.5 t -55.4 136.86 69.43 Favored Pre-proline 0 CA--C 1.551 1.008 0 C-N-CA 124.975 1.31 . . . . 65.41 110.382 178.29 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -66.42 160.71 44.25 Favored 'Trans proline' 0 C--N 1.371 1.726 0 C-N-CA 122.233 1.956 . . . . 74.21 111.567 173.009 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo -69.92 151.26 68.08 Favored 'Trans proline' 0 C--N 1.363 1.336 0 C-N-CA 121.406 1.404 . . . . 74.21 110.973 171.427 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 49.6 mtt180 61.98 43.76 8.79 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 124.535 1.134 . . . . 74.44 111.054 170.119 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 227' ' ' THR . . . . . 0.428 ' HA ' ' HE ' ' A' ' 231' ' ' ARG . 91.8 m -85.11 124.63 32.01 Favored 'General case' 0 CA--C 1.544 0.739 0 CA-C-N 114.14 -1.391 . . . . 74.4 109.808 178.095 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -104.81 151.62 23.57 Favored 'General case' 0 N--CA 1.492 1.644 0 C-N-CA 123.602 0.761 . . . . 75.15 109.496 176.292 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -58.01 116.25 3.39 Favored 'General case' 0 C--N 1.353 0.75 0 O-C-N 123.915 0.76 . . . . 72.22 110.397 178.895 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 114.21 -2.24 23.9 Favored Glycine 0 C--N 1.338 0.651 0 CA-C-O 119.194 -0.781 . . . . 61.31 113.211 -178.302 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 231' ' ' ARG . . . . . 0.432 ' HD3' ' H ' ' A' ' 180' ' ' GLY . 25.6 mtt-85 -63.41 129.95 42.37 Favored 'General case' 0 C--N 1.361 1.065 0 CA-C-N 117.989 0.894 . . . . 74.33 109.344 171.817 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 77.2 mttt -110.69 96.75 6.37 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 107.83 -1.174 . . . . 75.24 107.83 -175.301 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 233' ' ' LEU . . . . . 0.599 ' HB2' ' HB2' ' A' ' 251' ' ' LEU . 34.0 mt -79.81 151.33 30.34 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 114.137 -1.392 . . . . 73.22 109.42 -174.747 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 45.8 ttt180 -117.05 103.05 9.85 Favored 'General case' 0 N--CA 1.483 1.21 0 CA-C-N 118.654 0.661 . . . . 72.55 111.579 -170.135 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 235' ' ' LEU . . . . . 0.557 ' HB2' ' HB3' ' A' ' 249' ' ' LEU . 18.7 mt -94.13 101.14 13.14 Favored 'General case' 0 C--O 1.24 0.594 0 C-N-CA 123.239 0.616 . . . . 74.44 109.68 172.442 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 57.5 mttt -72.97 147.84 44.81 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 110.088 -0.338 . . . . 74.32 110.088 173.857 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 79.32 -6.61 56.7 Favored Glycine 0 C--N 1.341 0.834 0 CA-C-N 115.545 -0.752 . . . . 70.2 113.927 -177.367 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . 0.403 ' NZ ' ' HB2' ' A' ' 216' ' ' GLU . 71.8 mmtt -100.4 2.8 42.66 Favored 'General case' 0 C--O 1.239 0.531 0 C-N-CA 123.491 0.716 . . . . 74.5 111.083 179.351 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -103.62 -175.85 25.98 Favored Glycine 0 C--N 1.357 1.74 0 O-C-N 123.528 0.518 . . . . 65.42 112.09 166.477 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 79.9 m-85 -86.89 167.71 20.99 Favored Pre-proline 0 CA--C 1.563 1.462 0 C-N-CA 124.416 1.087 . . . . 74.03 110.812 179.181 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_endo -73.0 168.53 24.5 Favored 'Trans proline' 0 C--N 1.382 2.294 0 C-N-CA 122.187 1.924 . . . . 75.14 113.198 173.747 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 163.03 -120.14 0.93 Allowed Glycine 0 CA--C 1.538 1.529 0 CA-C-O 118.911 -0.938 . . . . 60.03 112.106 176.854 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 243' ' ' PRO . . . . . 0.526 ' HD2' ' HB3' ' A' ' 191' ' ' GLN . 37.1 Cg_endo -59.83 -59.04 0.44 Allowed 'Trans proline' 0 C--N 1.379 2.133 0 C-N-CA 124.563 3.509 . . . . 73.21 112.892 -173.976 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -83.5 -9.28 59.07 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 123.381 0.672 . . . . 73.12 111.066 178.645 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 85.39 -22.82 9.47 Favored Glycine 0 C--N 1.356 1.649 0 C-N-CA 123.175 0.417 . . . . 72.54 113.134 -177.161 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 10.0 ttm180 -125.33 111.56 15.32 Favored 'General case' 0 C--O 1.241 0.649 0 C-N-CA 124.545 1.138 . . . . 73.44 109.21 -179.7 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -76.75 151.46 39.4 Favored Glycine 0 C--N 1.348 1.198 0 O-C-N 123.726 0.641 . . . . 70.52 114.006 178.006 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -103.98 140.95 37.02 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.062 0.945 . . . . 73.34 109.747 -177.727 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 249' ' ' LEU . . . . . 0.557 ' HB3' ' HB2' ' A' ' 235' ' ' LEU . 45.7 tp -109.04 111.9 23.79 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 108.93 -0.767 . . . . 72.01 108.93 176.439 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 250' ' ' TYR . . . . . 0.456 ' HA ' ' O ' ' A' ' 233' ' ' LEU . 4.8 m-85 -89.58 109.28 20.24 Favored 'General case' 0 C--O 1.242 0.703 0 CA-C-O 121.36 0.6 . . . . 74.24 110.163 -179.531 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 251' ' ' LEU . . . . . 0.599 ' HB2' ' HB2' ' A' ' 233' ' ' LEU . 80.1 mt -87.35 104.02 16.03 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-N 114.382 -1.281 . . . . 74.44 108.289 179.865 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 56.3 mt-10 -85.42 94.19 8.92 Favored 'General case' 0 C--O 1.241 0.621 0 N-CA-C 108.572 -0.899 . . . . 73.45 108.572 -178.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 11.4 m -63.36 138.5 22.85 Favored 'Isoleucine or valine' 0 C--N 1.352 0.699 0 O-C-N 123.858 0.724 . . . . 72.21 110.374 -176.403 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 15.4 mmm180 -126.14 108.78 11.66 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 107.272 -1.381 . . . . 74.24 107.272 179.225 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 255' ' ' ILE . . . . . 0.454 ' HA ' ' O ' ' A' ' 199' ' ' VAL . 29.0 mt -78.92 121.15 31.45 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 O-C-N 123.9 0.75 . . . . 62.31 110.116 179.29 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 2.5 t . . . . . 0 C--O 1.254 1.294 0 C-N-CA 123.922 0.889 . . . . 74.32 109.42 174.727 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 172' ' ' LEU . . . . . 0.641 HD21 ' H ' ' A' ' 222' ' ' ALA . 41.4 mt . . . . . 0 N--CA 1.481 1.114 0 CA-C-O 121.418 0.627 . . . . 74.41 111.277 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 27.5 m-85 -130.94 -47.51 1.02 Allowed 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 114.623 -1.171 . . . . 74.23 109.095 -167.918 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 174' ' ' TYR . . . . . . . . . . . . . 8.2 p90 -84.23 8.07 17.04 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-N 114.36 -1.291 . . . . 75.12 113.324 -173.889 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 14.8 p -60.09 -23.29 63.69 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 123.158 0.583 . . . . 72.15 112.216 177.293 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 176' ' ' MET . . . . . . . . . . . . . 40.1 mtm -54.89 -49.92 70.02 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 124.216 1.006 . . . . 75.3 110.655 173.849 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -169.54 122.28 0.74 Allowed 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 124.834 1.254 . . . . 75.43 108.037 179.295 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 178' ' ' ALA . . . . . 0.613 ' HB1' HD22 ' A' ' 233' ' ' LEU . . . -146.71 -56.94 0.27 Allowed 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 123.209 0.604 . . . . 72.01 110.946 -175.288 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . 0.584 ' HB2' ' HB2' ' A' ' 224' ' ' PRO . . . -75.46 78.55 2.5 Favored 'General case' 0 C--N 1.353 0.754 0 CA-C-O 122.256 1.027 . . . . 74.14 108.832 172.715 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.487 0 CA-C-N 113.255 -1.793 . . . . 74.32 110.128 -173.759 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 191' ' ' GLN . . . . . 0.639 ' HB3' ' HD2' ' A' ' 243' ' ' PRO . 9.6 pt20 . . . . . 0 N--CA 1.473 0.719 0 CA-C-O 120.849 0.357 . . . . 74.32 110.64 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 17.7 m-20 -74.99 150.62 38.93 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-N 115.367 -0.833 . . . . 72.2 110.704 -174.812 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . 0.617 HD11 ' HA2' ' A' ' 239' ' ' GLY . 32.6 mt -140.79 170.82 15.04 Favored 'General case' 0 C--O 1.241 0.608 0 CA-C-N 114.592 -1.186 . . . . 74.24 109.176 -179.399 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 55.1 m-85 -138.41 122.07 17.47 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 123.491 0.717 . . . . 72.44 109.689 178.846 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . 0.431 ' HB2' HD11 ' A' ' 249' ' ' LEU . . . -126.3 135.98 52.18 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 107.834 -1.172 . . . . 64.01 107.834 174.993 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 9.1 m -83.55 130.63 35.01 Favored 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 109.742 -0.466 . . . . 74.33 109.742 -176.374 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . 0.481 HD23 HD11 ' A' ' 251' ' ' LEU . 15.5 tp -109.35 108.53 19.12 Favored 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 108.663 -0.866 . . . . 74.4 108.663 -179.479 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -81.21 113.23 19.21 Favored 'General case' 0 CA--C 1.542 0.648 0 N-CA-C 108.92 -0.77 . . . . 71.42 108.92 176.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 199' ' ' VAL . . . . . 0.429 ' O ' ' HA ' ' A' ' 255' ' ' ILE . 6.5 p -132.18 128.99 21.53 Favored Pre-proline 0 CA--C 1.55 0.976 0 C-N-CA 124.035 0.934 . . . . 74.12 109.34 -178.706 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -70.58 159.06 54.07 Favored 'Trans proline' 0 C--N 1.37 1.709 0 C-N-CA 122.035 1.823 . . . . 74.05 111.691 170.101 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -51.18 -49.7 79.9 Favored Pre-proline 0 CA--C 1.564 1.497 0 CA-C-O 117.775 -1.107 . . . . 64.51 113.619 -179.56 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 202' ' ' PRO . . . . . 0.434 ' O ' HG22 ' A' ' 206' ' ' VAL . 42.6 Cg_endo -64.24 -43.01 15.79 Favored 'Trans proline' 0 C--N 1.396 3.074 0 C-N-CA 121.861 1.708 . . . . 75.32 113.702 -179.035 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 51.8 mt -63.48 -34.17 65.81 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.386 0 CA-C-N 118.152 0.433 . . . . 73.42 110.351 176.628 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -66.2 -52.68 45.66 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 122.821 0.448 . . . . 73.45 111.622 179.245 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 20.2 m -69.45 -49.67 57.84 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.924 0 C-N-CA 123.618 0.767 . . . . 71.0 112.577 -173.444 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 206' ' ' VAL . . . . . 0.434 HG22 ' O ' ' A' ' 202' ' ' PRO . 6.7 m -76.99 -31.0 18.34 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.181 0 CA-C-O 120.714 0.292 . . . . 71.01 110.909 -179.736 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 85.63 70.26 1.33 Allowed Glycine 0 C--N 1.345 1.066 0 CA-C-N 115.943 -0.571 . . . . 73.21 112.022 -176.826 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -87.51 -126.4 2.29 Favored Glycine 0 C--N 1.352 1.466 0 N-CA-C 111.902 -0.479 . . . . 65.34 111.902 176.403 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 209' ' ' LYS . . . . . 0.405 ' HG2' ' HA ' ' A' ' 222' ' ' ALA . 46.5 mtmt -139.45 151.65 46.39 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 123.695 0.798 . . . . 71.55 111.12 177.234 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 5.8 m -144.81 169.92 7.77 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 C-N-CA 125.335 1.454 . . . . 73.42 109.532 175.664 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 55.4 ttp180 -102.25 117.05 33.93 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 124.1 0.96 . . . . 72.35 110.048 -179.831 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -100.73 128.92 46.6 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 124.104 0.962 . . . . 71.41 110.207 177.439 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 90.8 mmm -92.55 115.57 28.22 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 123.369 0.667 . . . . 73.4 109.413 179.572 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 17.4 p -111.71 -179.39 3.69 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 124.288 1.035 . . . . 73.24 109.907 -176.687 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 89.0 mt -56.77 -29.69 62.88 Favored 'General case' 0 N--CA 1.491 1.583 0 CA-C-O 121.082 0.467 . . . . 74.11 111.216 171.883 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -101.29 23.2 11.29 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 124.476 1.11 . . . . 73.3 111.144 -178.252 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 83.42 -159.42 36.89 Favored Glycine 0 C--N 1.348 1.246 0 CA-C-O 119.508 -0.607 . . . . 55.11 113.303 176.314 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -71.29 157.03 58.0 Favored 'Trans proline' 0 C--N 1.367 1.524 0 C-N-CA 122.665 2.244 . . . . 74.24 113.21 -173.232 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 7.3 p -151.58 136.9 10.96 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 C-N-CA 124.142 0.977 . . . . 72.1 108.869 174.656 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -80.64 103.43 10.48 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 108.832 -0.803 . . . . 74.41 108.832 175.573 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 10.8 m -104.08 133.75 47.25 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 CA-C-O 121.451 0.644 . . . . 72.55 110.057 177.95 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 222' ' ' ALA . . . . . 0.641 ' H ' HD21 ' A' ' 172' ' ' LEU . . . -86.7 105.66 17.09 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 114.743 -1.117 . . . . 74.42 110.427 -178.731 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 90.6 t -54.49 134.14 62.87 Favored Pre-proline 0 N--CA 1.481 1.112 0 C-N-CA 125.355 1.462 . . . . 74.41 111.179 -176.763 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 224' ' ' PRO . . . . . 0.584 ' HB2' ' HB2' ' A' ' 179' ' ' ALA . 72.4 Cg_endo -70.33 159.84 51.61 Favored 'Trans proline' 0 C--N 1.376 2.022 0 C-N-CA 122.209 1.939 . . . . 72.14 111.924 175.912 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 22.8 Cg_endo -64.6 136.41 49.89 Favored 'Trans proline' 0 C--N 1.38 2.204 0 C-N-CA 121.981 1.788 . . . . 75.43 111.554 176.189 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 44.3 mtm-85 63.72 64.9 0.75 Allowed 'General case' 0 C--O 1.244 0.775 0 C-N-CA 124.7 1.2 . . . . 74.55 110.074 175.672 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 227' ' ' THR . . . . . 0.429 ' HA ' ' HE ' ' A' ' 231' ' ' ARG . 88.5 m -96.68 123.19 40.28 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 108.214 -1.032 . . . . 72.22 108.214 174.458 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -109.7 148.24 31.73 Favored 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 123.49 0.716 . . . . 74.25 109.085 -179.382 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -57.66 114.29 2.2 Favored 'General case' 0 C--N 1.352 0.674 0 O-C-N 124.278 0.986 . . . . 72.41 110.494 -178.685 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 113.76 5.94 21.68 Favored Glycine 0 CA--C 1.528 0.902 0 O-C-N 124.051 0.844 . . . . 75.32 113.402 -175.48 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 231' ' ' ARG . . . . . 0.429 ' HE ' ' HA ' ' A' ' 227' ' ' THR . 40.7 mtt-85 -71.89 149.57 45.02 Favored 'General case' 0 N--CA 1.481 1.095 0 CA-C-N 117.72 0.76 . . . . 72.54 109.074 165.891 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 232' ' ' LYS . . . . . 0.417 ' HA ' ' O ' ' A' ' 251' ' ' LEU . 43.5 mtmt -128.72 99.48 5.36 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 123.513 0.725 . . . . 73.35 109.344 178.404 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 233' ' ' LEU . . . . . 0.613 HD22 ' HB1' ' A' ' 178' ' ' ALA . 24.1 mt -81.65 132.75 35.31 Favored 'General case' 0 CA--C 1.552 1.044 0 C-N-CA 124.088 0.955 . . . . 74.41 110.266 -173.467 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 40.1 ttt180 -89.53 102.97 15.65 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 123.4 0.68 . . . . 63.42 112.35 -169.654 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 235' ' ' LEU . . . . . 0.592 ' HB2' ' HB3' ' A' ' 249' ' ' LEU . 18.0 mt -93.35 97.08 10.35 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 123.057 0.543 . . . . 73.12 110.483 174.679 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 40.8 mtmt -69.49 144.46 53.21 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-O 120.85 0.357 . . . . 74.12 111.192 177.002 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 73.68 1.03 57.48 Favored Glycine 0 N--CA 1.473 1.137 0 CA-C-N 115.237 -0.892 . . . . 72.32 114.949 -177.816 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 76.1 mmtt -106.04 3.87 28.68 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 117.418 0.609 . . . . 72.35 110.525 179.229 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 239' ' ' GLY . . . . . 0.617 ' HA2' HD11 ' A' ' 193' ' ' LEU . . . -101.93 -160.33 26.57 Favored Glycine 0 C--N 1.35 1.318 0 N-CA-C 111.063 -0.815 . . . . 73.44 111.063 164.025 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 71.4 m-85 -95.04 155.03 39.48 Favored Pre-proline 0 N--CA 1.485 1.314 0 C-N-CA 123.826 0.85 . . . . 71.32 110.981 -179.597 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_exo -71.09 130.62 17.98 Favored 'Trans proline' 0 C--N 1.371 1.735 0 C-N-CA 121.764 1.642 . . . . 73.02 111.197 170.933 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -163.54 -121.35 0.56 Allowed Glycine 0 CA--C 1.535 1.325 0 CA-C-O 118.776 -1.013 . . . . 50.42 113.401 -177.829 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 243' ' ' PRO . . . . . 0.639 ' HD2' ' HB3' ' A' ' 191' ' ' GLN . 37.3 Cg_endo -58.96 -42.85 47.99 Favored 'Trans proline' 0 C--N 1.385 2.462 0 C-N-CA 124.379 3.386 . . . . 75.52 112.935 -172.399 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -96.59 -4.88 40.37 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 123.551 0.74 . . . . 65.14 111.044 177.152 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 84.27 -23.39 7.22 Favored Glycine 0 C--N 1.361 1.939 0 C-N-CA 123.142 0.401 . . . . 75.45 113.423 -178.827 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 43.1 ttt85 -128.0 111.58 13.69 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.97 1.308 . . . . 75.34 108.901 -179.649 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -72.48 151.3 46.36 Favored Glycine 0 C--N 1.347 1.145 0 N-CA-C 115.064 0.785 . . . . 61.3 115.064 178.694 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 38.2 m-20 -111.64 127.78 55.86 Favored 'General case' 0 C--O 1.233 0.221 0 C-N-CA 124.295 1.038 . . . . 71.22 109.382 -176.487 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 249' ' ' LEU . . . . . 0.592 ' HB3' ' HB2' ' A' ' 235' ' ' LEU . 58.8 tp -103.76 109.83 21.69 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 108.323 -0.992 . . . . 73.52 108.323 178.526 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 250' ' ' TYR . . . . . . . . . . . . . 4.4 m-85 -88.21 118.65 27.95 Favored 'General case' 0 C--O 1.241 0.646 0 N-CA-C 109.271 -0.64 . . . . 74.23 109.271 -176.267 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 251' ' ' LEU . . . . . 0.481 HD11 HD23 ' A' ' 197' ' ' LEU . 74.3 mt -88.14 103.31 15.64 Favored 'General case' 0 C--N 1.343 0.302 0 N-CA-C 107.935 -1.135 . . . . 65.42 107.935 -177.061 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -83.07 93.11 7.53 Favored 'General case' 0 C--O 1.241 0.638 0 N-CA-C 107.329 -1.36 . . . . 65.01 107.329 -175.53 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 4.9 m -71.94 136.84 24.86 Favored 'Isoleucine or valine' 0 C--N 1.351 0.648 0 CA-C-N 114.959 -1.018 . . . . 73.33 110.819 -170.746 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 24.4 mmm180 -122.05 112.54 18.38 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 106.913 -1.514 . . . . 74.34 106.913 179.737 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 255' ' ' ILE . . . . . 0.429 ' HA ' ' O ' ' A' ' 199' ' ' VAL . 35.2 mt -80.4 115.98 23.8 Favored 'Isoleucine or valine' 0 C--O 1.236 0.382 0 N-CA-C 108.758 -0.83 . . . . 73.24 108.758 173.569 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 9.5 t . . . . . 0 C--O 1.26 1.655 0 N-CA-C 108.349 -0.982 . . . . 74.11 108.349 168.614 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 172' ' ' LEU . . . . . 0.48 HD22 ' H ' ' A' ' 222' ' ' ALA . 63.6 mt . . . . . 0 N--CA 1.484 1.273 0 CA-C-O 122.039 0.923 . . . . 74.42 112.068 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 173' ' ' PHE . . . . . 0.46 ' CD1' HD22 ' A' ' 235' ' ' LEU . 19.8 m-85 -136.71 -51.67 0.69 Allowed 'General case' 0 N--CA 1.477 0.919 0 CA-C-N 114.586 -1.188 . . . . 73.02 108.609 -171.343 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 174' ' ' TYR . . . . . 0.432 ' OH ' ' HB ' ' A' ' 221' ' ' VAL . 2.9 p90 -79.3 17.87 0.76 Allowed 'General case' 0 CA--C 1.552 1.04 0 CA-C-N 113.446 -1.706 . . . . 73.41 112.551 -179.213 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 175' ' ' THR . . . . . 0.412 HG22 HD13 ' A' ' 172' ' ' LEU . 0.2 OUTLIER -66.1 -18.57 65.43 Favored 'General case' 0 CA--C 1.552 1.032 0 C-N-CA 124.1 0.96 . . . . 71.41 111.888 -174.936 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 176' ' ' MET . . . . . 0.51 ' SD ' ' N ' ' A' ' 177' ' ' LYS . 0.0 OUTLIER -70.74 -45.36 64.98 Favored 'General case' 0 CA--C 1.554 1.126 0 C-N-CA 123.978 0.911 . . . . 75.21 111.45 173.509 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . 0.51 ' N ' ' SD ' ' A' ' 176' ' ' MET . 35.7 mttp -162.91 134.15 4.93 Favored 'General case' 0 N--CA 1.491 1.599 0 C-N-CA 125.702 1.601 . . . . 74.44 108.681 175.277 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 178' ' ' ALA . . . . . 0.489 ' HB3' HD23 ' A' ' 233' ' ' LEU . . . -147.99 -53.54 0.2 Allowed 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 123.934 0.893 . . . . 75.03 109.839 -172.859 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -85.48 36.9 0.66 Allowed 'General case' 0 CA--C 1.558 1.259 0 C-N-CA 123.876 0.87 . . . . 75.41 109.957 171.341 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.354 1.53 0 N-CA-C 110.638 -0.985 . . . . 72.44 110.638 176.766 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 191' ' ' GLN . . . . . 0.503 ' HB3' ' HD2' ' A' ' 243' ' ' PRO . 2.3 pt20 . . . . . 0 N--CA 1.479 1.008 0 CA-C-O 121.391 0.615 . . . . 71.45 111.092 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -86.32 144.67 27.26 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 124.35 1.06 . . . . 70.03 110.201 -163.501 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . 0.468 HD12 ' HA2' ' A' ' 239' ' ' GLY . 25.4 mt -138.69 163.63 31.62 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 124.27 1.028 . . . . 73.4 109.391 174.363 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 50.6 m-85 -139.36 122.82 17.24 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 123.779 0.832 . . . . 63.12 109.761 -177.543 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . 0.439 ' HB2' HD11 ' A' ' 249' ' ' LEU . . . -133.02 129.13 37.73 Favored 'General case' 0 N--CA 1.466 0.335 0 O-C-N 124.343 1.027 . . . . 52.22 108.6 175.654 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 33.6 m -76.79 130.82 38.2 Favored 'General case' 0 CA--C 1.541 0.617 0 N-CA-C 109.694 -0.484 . . . . 74.42 109.694 178.157 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . 0.565 HD22 HD11 ' A' ' 251' ' ' LEU . 15.1 tp -112.21 108.79 18.15 Favored 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 107.61 -1.256 . . . . 72.51 107.61 176.645 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -83.76 132.32 34.85 Favored 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 108.841 -0.8 . . . . 74.45 108.841 174.838 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 199' ' ' VAL . . . . . 0.454 ' O ' ' HA ' ' A' ' 255' ' ' ILE . 4.1 p -144.61 129.88 9.44 Favored Pre-proline 0 CA--C 1.549 0.934 0 C-N-CA 123.866 0.866 . . . . 74.41 108.671 -179.983 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -70.35 153.7 65.98 Favored 'Trans proline' 0 C--N 1.367 1.536 0 C-N-CA 122.21 1.94 . . . . 72.31 110.836 168.49 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 201' ' ' ALA . . . . . 0.447 ' O ' HG21 ' A' ' 205' ' ' VAL . . . -49.88 -51.4 61.28 Favored Pre-proline 0 CA--C 1.555 1.153 0 C-N-CA 124.754 1.222 . . . . 71.51 113.361 -177.729 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_endo -60.85 -35.85 86.58 Favored 'Trans proline' 0 C--N 1.397 3.118 0 C-N-CA 121.771 1.647 . . . . 73.11 113.896 -178.487 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 38.1 mt -70.02 -34.14 58.33 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 C-N-CA 122.587 0.355 . . . . 72.32 110.461 177.418 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -67.1 -38.36 85.52 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 122.342 0.257 . . . . 74.33 111.22 175.838 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 205' ' ' VAL . . . . . 0.447 HG21 ' O ' ' A' ' 201' ' ' ALA . 92.1 t -69.25 -56.49 11.62 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.125 0 C-N-CA 123.963 0.905 . . . . 74.24 111.083 -179.423 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 18.0 m -75.59 -24.07 16.93 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.133 0 CA-C-N 116.09 -0.504 . . . . 62.51 111.574 -174.883 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 76.15 66.21 1.89 Allowed Glycine 0 C--N 1.345 1.042 0 CA-C-N 115.251 -0.886 . . . . 63.24 111.83 -173.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -83.74 -140.46 4.29 Favored Glycine 0 C--N 1.352 1.443 0 N-CA-C 112.161 -0.376 . . . . 41.01 112.161 178.628 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 49.4 mtmt -137.43 137.5 38.83 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.606 0.763 . . . . 74.02 110.414 177.915 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 11.0 m -127.82 165.39 27.03 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 C-N-CA 125.119 1.368 . . . . 72.0 108.742 172.903 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 50.6 ttp180 -101.59 117.47 34.98 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 123.25 0.62 . . . . 74.32 110.323 -178.564 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -101.99 132.59 47.73 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 123.958 0.903 . . . . 73.24 110.239 175.721 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 25.3 mmt -90.91 121.32 32.65 Favored 'General case' 0 N--CA 1.48 1.075 0 N-CA-C 109.343 -0.614 . . . . 74.31 109.343 175.306 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 214' ' ' THR . . . . . 0.416 ' HB ' ' HD2' ' A' ' 238' ' ' LYS . 30.5 p -121.97 -173.54 2.68 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 124.484 1.114 . . . . 74.43 110.371 -174.779 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 83.2 mt -61.65 -30.95 71.05 Favored 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 123.216 0.606 . . . . 74.03 111.097 171.588 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -98.76 21.28 11.65 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 123.498 0.719 . . . . 74.13 111.282 179.791 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 84.49 -159.15 34.76 Favored Glycine 0 C--N 1.356 1.658 0 CA-C-O 119.411 -0.66 . . . . 65.01 113.012 175.359 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -64.76 142.25 75.63 Favored 'Trans proline' 0 C--N 1.369 1.633 0 C-N-CA 122.817 2.345 . . . . 74.01 112.58 178.687 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 4.8 p -140.81 128.53 23.01 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 N-CA-C 108.333 -0.988 . . . . 75.55 108.333 174.323 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 3.8 mp0 -79.28 101.6 8.12 Favored 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 107.28 -1.378 . . . . 72.33 107.28 175.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 221' ' ' VAL . . . . . 0.432 ' HB ' ' OH ' ' A' ' 174' ' ' TYR . 2.8 m -99.39 128.25 51.32 Favored 'Isoleucine or valine' 0 C--O 1.24 0.586 0 CA-C-O 121.602 0.715 . . . . 71.21 109.544 -179.675 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 222' ' ' ALA . . . . . 0.48 ' H ' HD22 ' A' ' 172' ' ' LEU . . . -80.26 104.81 11.07 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 114.407 -1.27 . . . . 63.12 109.26 179.63 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 61.3 t -53.99 134.9 57.93 Favored Pre-proline 0 CA--C 1.558 1.283 0 O-C-N 124.567 1.167 . . . . 71.0 109.707 178.549 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -63.87 149.85 89.73 Favored 'Trans proline' 0 C--N 1.371 1.722 0 C-N-CA 122.068 1.845 . . . . 73.31 111.452 173.474 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -63.23 134.12 43.99 Favored 'Trans proline' 0 C--N 1.373 1.854 0 C-N-CA 121.907 1.738 . . . . 71.1 110.983 174.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 33.6 mtm-85 63.82 53.39 1.96 Allowed 'General case' 0 CA--C 1.546 0.817 0 O-C-N 124.68 1.237 . . . . 74.13 111.043 175.858 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 30.6 m -78.24 145.17 35.62 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 115.444 -0.798 . . . . 73.41 108.945 170.391 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 27.0 mp0 -116.22 145.54 43.04 Favored 'General case' 0 N--CA 1.48 1.061 0 N-CA-C 108.563 -0.902 . . . . 73.23 108.563 176.916 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 229' ' ' ALA . . . . . 0.532 ' HB3' ' HB ' ' A' ' 255' ' ' ILE . . . -60.2 130.72 48.06 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.543 0.737 . . . . 72.2 109.762 -179.48 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 97.85 12.08 48.0 Favored Glycine 0 CA--C 1.522 0.504 0 O-C-N 123.857 0.723 . . . . 74.31 112.852 -178.248 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 95.1 mtt-85 -84.24 156.14 22.14 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 109.256 -0.646 . . . . 74.4 109.256 165.049 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 232' ' ' LYS . . . . . 0.417 ' HA ' ' O ' ' A' ' 251' ' ' LEU . 42.3 mtmt -130.38 106.84 8.82 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.583 0.753 . . . . 73.44 109.312 -179.735 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 233' ' ' LEU . . . . . 0.523 ' HB2' ' HB2' ' A' ' 251' ' ' LEU . 26.3 mt -80.27 134.04 36.04 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 115.218 -0.901 . . . . 74.45 109.526 -176.677 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 75.3 ttt180 -97.33 109.95 22.6 Favored 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 122.808 0.443 . . . . 73.43 110.93 -170.732 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 235' ' ' LEU . . . . . 0.519 HD13 HD22 ' A' ' 249' ' ' LEU . 15.0 mt -99.77 105.87 17.7 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.265 0.626 . . . . 72.24 111.099 179.522 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 1.9 mtpp -72.09 153.79 41.49 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-O 120.719 0.295 . . . . 72.13 110.563 171.707 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 65.63 13.83 59.4 Favored Glycine 0 N--CA 1.473 1.141 0 O-C-N 124.486 1.116 . . . . 75.43 114.359 -177.198 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . 0.416 ' HD2' ' HB ' ' A' ' 214' ' ' THR . 41.1 mmtm -125.53 4.58 7.59 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 123.782 0.833 . . . . 75.23 111.823 -177.968 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 239' ' ' GLY . . . . . 0.468 ' HA2' HD12 ' A' ' 193' ' ' LEU . . . -107.66 -167.64 21.75 Favored Glycine 0 C--N 1.345 1.028 0 N-CA-C 110.879 -0.888 . . . . 70.44 110.879 165.644 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 66.7 m-85 -92.44 166.55 16.78 Favored Pre-proline 0 CA--C 1.548 0.892 0 C-N-CA 123.794 0.837 . . . . 73.44 110.777 178.807 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -70.88 146.47 53.33 Favored 'Trans proline' 0 C--N 1.374 1.887 0 C-N-CA 121.756 1.637 . . . . 71.13 111.577 168.068 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -169.74 -117.3 0.41 Allowed Glycine 0 CA--C 1.532 1.103 0 CA-C-O 119.039 -0.867 . . . . 52.11 111.587 178.923 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 243' ' ' PRO . . . . . 0.503 ' HD2' ' HB3' ' A' ' 191' ' ' GLN . 65.6 Cg_endo -66.15 -57.36 0.23 Allowed 'Trans proline' 0 C--N 1.375 1.96 0 C-N-CA 124.246 3.298 . . . . 74.33 112.617 -169.574 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -96.39 18.88 12.99 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.899 0.88 . . . . 74.03 110.463 176.415 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 74.66 -103.33 1.52 Allowed Glycine 0 C--N 1.354 1.558 0 N-CA-C 110.322 -1.111 . . . . 71.31 110.322 -170.835 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 31.0 ttm180 -50.42 110.63 0.43 Allowed 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 125.203 1.401 . . . . 74.04 112.559 -176.408 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -89.04 179.46 45.39 Favored Glycine 0 C--N 1.344 0.991 0 CA-C-N 115.898 -0.592 . . . . 72.34 113.478 178.322 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 20.9 m-20 -126.83 152.53 46.86 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 114.598 -0.801 . . . . 71.54 112.504 -168.795 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 249' ' ' LEU . . . . . 0.519 HD22 HD13 ' A' ' 235' ' ' LEU . 55.7 tp -110.17 117.08 32.75 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 114.354 -1.293 . . . . 75.43 108.095 171.117 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 250' ' ' TYR . . . . . . . . . . . . . 3.7 m-85 -90.24 115.16 27.25 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 123.188 0.595 . . . . 75.32 109.404 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 251' ' ' LEU . . . . . 0.565 HD11 HD22 ' A' ' 197' ' ' LEU . 77.2 mt -88.5 105.35 17.56 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-N 114.685 -1.143 . . . . 74.11 108.486 -177.973 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 252' ' ' GLU . . . . . 0.416 ' HG3' ' HD3' ' A' ' 254' ' ' ARG . 12.0 tp10 -79.56 94.06 5.57 Favored 'General case' 0 C--O 1.238 0.486 0 N-CA-C 108.55 -0.907 . . . . 73.12 108.55 -178.746 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 4.4 m -71.67 127.48 33.67 Favored 'Isoleucine or valine' 0 C--N 1.352 0.694 0 CA-C-O 121.619 0.723 . . . . 73.41 109.664 -174.839 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 254' ' ' ARG . . . . . 0.416 ' HD3' ' HG3' ' A' ' 252' ' ' GLU . 22.9 mmm180 -122.87 95.1 4.49 Favored 'General case' 0 C--O 1.239 0.517 0 N-CA-C 107.971 -1.122 . . . . 74.23 107.971 -176.7 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 255' ' ' ILE . . . . . 0.532 ' HB ' ' HB3' ' A' ' 229' ' ' ALA . 40.3 mt -76.6 121.08 28.03 Favored 'Isoleucine or valine' 0 C--O 1.238 0.465 0 CA-C-N 115.589 -0.732 . . . . 74.44 109.669 178.054 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 9.4 t . . . . . 0 C--O 1.254 1.303 0 C-N-CA 123.97 0.908 . . . . 72.44 108.657 175.885 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 172' ' ' LEU . . . . . 0.499 ' HB3' ' OG1' ' A' ' 175' ' ' THR . 26.0 mt . . . . . 0 N--CA 1.478 0.963 0 CA-C-O 121.147 0.498 . . . . 73.24 112.012 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 173' ' ' PHE . . . . . 0.525 ' CD1' HD22 ' A' ' 235' ' ' LEU . 20.2 m-85 -141.1 -71.03 0.36 Allowed 'General case' 0 N--CA 1.481 1.099 0 CA-C-O 121.182 0.515 . . . . 75.33 111.297 -163.799 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 174' ' ' TYR . . . . . 0.458 ' CD2' ' HB3' ' A' ' 233' ' ' LEU . 2.1 p90 -83.25 7.2 17.05 Favored 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 124.589 1.156 . . . . 74.34 112.038 -171.364 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 175' ' ' THR . . . . . 0.499 ' OG1' ' HB3' ' A' ' 172' ' ' LEU . 1.5 m -60.23 -36.82 78.59 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 124.365 1.066 . . . . 74.23 113.149 -160.71 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 176' ' ' MET . . . . . . . . . . . . . 3.0 mpp? -68.08 -27.25 66.33 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 123.676 0.79 . . . . 72.14 111.192 -179.774 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 20.8 tptm -122.56 25.92 8.56 Favored 'General case' 0 CA--C 1.556 1.205 0 C-N-CA 124.367 1.067 . . . . 74.44 109.872 -177.459 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 178' ' ' ALA . . . . . 0.609 ' HB1' ' HB3' ' A' ' 224' ' ' PRO . . . -69.46 132.42 46.29 Favored 'General case' 0 N--CA 1.476 0.867 0 CA-C-N 115.865 -0.607 . . . . 74.11 110.053 -179.761 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . 0.538 ' HB2' ' HB2' ' A' ' 224' ' ' PRO . . . 60.89 30.34 19.58 Favored 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 124.315 1.046 . . . . 75.51 110.779 -170.858 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.345 1.063 0 CA-C-N 115.198 -0.91 . . . . 60.41 112.496 178.711 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 . . . . . 0 N--CA 1.479 1.016 0 CA-C-O 120.594 0.235 . . . . 65.51 111.278 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 -75.58 134.98 40.56 Favored 'General case' 0 N--CA 1.47 0.525 0 C-N-CA 123.834 0.854 . . . . 64.33 109.887 -178.294 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 24.2 mt -117.6 162.69 17.6 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 123.568 0.747 . . . . 73.44 110.215 175.46 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 77.0 m-85 -133.17 135.0 44.85 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 123.77 0.828 . . . . 73.41 110.382 -177.751 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . 0.418 ' HB1' HD13 ' A' ' 249' ' ' LEU . . . -147.8 171.16 16.15 Favored 'General case' 0 C--O 1.239 0.53 0 C-N-CA 125.417 1.487 . . . . 73.25 108.494 -179.607 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 34.1 m -129.63 124.42 33.64 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 123.826 0.851 . . . . 71.12 108.717 -178.604 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . 0.6 HD22 HD13 ' A' ' 251' ' ' LEU . 15.7 tp -106.66 110.2 22.32 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 108.681 -0.859 . . . . 74.51 108.681 -173.044 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -82.51 122.77 28.49 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 123.091 0.556 . . . . 73.34 109.774 177.703 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 199' ' ' VAL . . . . . 0.44 ' O ' ' HA ' ' A' ' 255' ' ' ILE . 4.3 p -140.71 128.34 12.32 Favored Pre-proline 0 CA--C 1.545 0.764 0 N-CA-C 108.228 -1.027 . . . . 73.41 108.228 -177.927 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -69.39 156.2 65.0 Favored 'Trans proline' 0 C--N 1.366 1.49 0 C-N-CA 121.917 1.745 . . . . 61.42 111.034 171.15 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 201' ' ' ALA . . . . . 0.492 ' HA ' HG22 ' A' ' 255' ' ' ILE . . . -48.52 -54.2 28.6 Favored Pre-proline 0 CA--C 1.559 1.321 0 CA-C-O 117.754 -1.117 . . . . 75.41 113.122 -177.761 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -60.69 -37.6 77.9 Favored 'Trans proline' 0 C--N 1.391 2.803 0 C-N-CA 121.94 1.76 . . . . 73.22 113.466 -176.376 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 39.7 mt -68.37 -33.94 63.12 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.389 0 C-N-CA 122.51 0.324 . . . . 73.44 110.404 178.056 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -71.66 -33.54 68.96 Favored 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 122.863 0.465 . . . . 63.32 111.47 176.893 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 205' ' ' VAL . . . . . 0.465 HG23 ' O ' ' A' ' 201' ' ' ALA . 73.5 t -71.8 -52.43 25.51 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 C-N-CA 123.909 0.884 . . . . 74.2 110.951 -179.776 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 16.2 m -82.89 -27.21 8.1 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.096 0 CA-C-N 116.304 -0.407 . . . . 63.43 111.465 -173.493 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 83.74 62.09 1.8 Allowed Glycine 0 C--N 1.343 0.969 0 CA-C-N 116.121 -0.491 . . . . 61.3 112.224 -174.589 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -83.19 -134.38 2.29 Favored Glycine 0 C--N 1.35 1.346 0 CA-C-O 119.9 -0.389 . . . . 62.34 112.462 177.947 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 46.5 mtmt -138.59 153.11 48.65 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 123.917 0.887 . . . . 75.2 110.916 178.037 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 9.7 m -145.37 170.0 6.72 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.092 0 C-N-CA 125.732 1.613 . . . . 74.35 109.096 175.184 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 29.8 ttp180 -97.8 110.57 23.11 Favored 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 123.72 0.808 . . . . 74.32 110.306 -177.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -102.33 112.22 24.83 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 123.485 0.714 . . . . 71.24 109.311 174.121 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 213' ' ' MET . . . . . 0.494 ' HE1' ' HG3' ' A' ' 218' ' ' PRO . 65.5 mtp -86.75 123.47 31.95 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 122.744 0.418 . . . . 63.4 110.071 -178.746 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 31.4 p -127.72 -171.14 2.37 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 124.38 1.072 . . . . 75.15 110.954 -168.4 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 76.9 mt -63.71 -27.91 69.53 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 123.217 0.607 . . . . 74.45 111.236 172.107 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -100.93 21.95 12.92 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.716 0.806 . . . . 75.21 110.615 178.328 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 85.38 -168.56 42.43 Favored Glycine 0 C--N 1.348 1.232 0 CA-C-N 116.008 -0.542 . . . . 60.14 113.702 173.94 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 218' ' ' PRO . . . . . 0.494 ' HG3' ' HE1' ' A' ' 213' ' ' MET . 2.7 Cg_exo -74.19 121.04 6.59 Favored 'Trans proline' 0 C--N 1.366 1.494 0 C-N-CA 122.975 2.45 . . . . 71.52 112.047 -179.625 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 6.7 p -114.4 134.76 56.32 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 C-N-CA 123.799 0.84 . . . . 74.14 109.39 175.488 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -75.56 102.31 5.23 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 107.741 -1.207 . . . . 74.41 107.741 172.382 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 3.8 p -103.91 130.08 55.05 Favored 'Isoleucine or valine' 0 C--O 1.243 0.72 0 N-CA-C 109.149 -0.686 . . . . 73.04 109.149 -175.058 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 222' ' ' ALA . . . . . 0.485 ' H ' HD22 ' A' ' 172' ' ' LEU . . . -76.03 106.64 7.74 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 123.261 0.624 . . . . 45.42 110.676 -177.427 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 53.5 t -54.71 137.87 62.81 Favored Pre-proline 0 N--CA 1.477 0.888 0 O-C-N 124.522 1.139 . . . . 74.23 109.994 179.626 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 224' ' ' PRO . . . . . 0.609 ' HB3' ' HB1' ' A' ' 178' ' ' ALA . 12.3 Cg_endo -57.77 152.96 46.2 Favored 'Trans proline' 0 C--N 1.369 1.617 0 C-N-CA 122.355 2.037 . . . . 72.33 112.714 171.343 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -76.18 149.54 32.17 Favored 'Trans proline' 0 C--N 1.367 1.527 0 C-N-CA 121.999 1.799 . . . . 63.31 110.741 171.443 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 35.9 mtm105 60.09 36.23 21.26 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 124.305 1.042 . . . . 74.34 111.143 168.563 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 227' ' ' THR . . . . . 0.449 HG22 ' HD2' ' A' ' 231' ' ' ARG . 21.5 m -76.53 150.03 36.62 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 124.587 1.155 . . . . 63.1 110.576 -178.259 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 27.0 mp0 -120.96 143.01 49.23 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 123.606 0.762 . . . . 72.22 109.151 175.066 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 229' ' ' ALA . . . . . 0.442 ' HB1' ' HB ' ' A' ' 255' ' ' ILE . . . -60.02 125.52 23.99 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 123.859 0.864 . . . . 74.31 111.002 -178.528 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 109.25 -2.02 31.19 Favored Glycine 0 CA--C 1.528 0.844 0 O-C-N 123.774 0.671 . . . . 74.03 113.287 -177.776 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 231' ' ' ARG . . . . . 0.449 ' HD2' HG22 ' A' ' 227' ' ' THR . 89.7 mtt-85 -72.35 157.59 37.38 Favored 'General case' 0 N--CA 1.479 0.985 0 CA-C-N 117.701 0.751 . . . . 74.51 109.854 170.484 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 45.7 mtmt -128.97 122.78 30.86 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 123.189 0.596 . . . . 74.14 110.068 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 233' ' ' LEU . . . . . 0.458 ' HB3' ' CD2' ' A' ' 174' ' ' TYR . 19.5 mt -101.77 153.34 19.89 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 124.949 1.3 . . . . 71.01 108.634 -178.043 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 19.5 ttt180 -120.78 103.17 8.89 Favored 'General case' 0 CA--C 1.546 0.801 0 O-C-N 122.188 -0.32 . . . . 74.42 111.486 -171.85 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 235' ' ' LEU . . . . . 0.562 ' HB2' ' HB3' ' A' ' 249' ' ' LEU . 15.6 mt -82.39 102.58 11.36 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 123.585 0.754 . . . . 72.32 110.582 176.966 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 236' ' ' LYS . . . . . 0.411 ' H ' ' HB3' ' A' ' 173' ' ' PHE . 43.8 mtmt -71.97 144.44 48.87 Favored 'General case' 0 C--O 1.242 0.68 0 CA-C-O 121.529 0.681 . . . . 72.25 112.421 179.967 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 72.14 3.36 56.45 Favored Glycine 0 CA--C 1.531 1.089 0 CA-C-N 114.183 -1.371 . . . . 61.12 114.283 -176.108 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 47.2 mmtm -107.96 13.85 25.8 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 123.538 0.735 . . . . 75.42 111.63 -176.311 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -116.36 -171.0 15.89 Favored Glycine 0 CA--C 1.528 0.877 0 N-CA-C 110.274 -1.13 . . . . 73.42 110.274 166.51 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 68.9 m-85 -87.73 159.13 49.9 Favored Pre-proline 0 N--CA 1.481 1.079 0 C-N-CA 123.264 0.626 . . . . 74.34 112.149 -173.778 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -71.72 164.21 36.43 Favored 'Trans proline' 0 C--N 1.373 1.858 0 C-N-CA 122.04 1.827 . . . . 72.14 112.732 171.595 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 158.35 -109.09 0.39 Allowed Glycine 0 CA--C 1.532 1.123 0 CA-C-O 118.784 -1.009 . . . . 74.13 112.722 174.244 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -65.16 -49.58 2.61 Favored 'Trans proline' 0 C--N 1.381 2.249 0 C-N-CA 123.454 2.769 . . . . 75.15 112.722 -170.385 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -90.61 -8.53 49.85 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 123.976 0.91 . . . . 72.22 111.151 178.349 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 83.68 -42.58 3.06 Favored Glycine 0 C--N 1.359 1.828 0 N-CA-C 111.922 -0.471 . . . . 72.35 111.922 -170.864 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 17.3 ttm180 -103.17 114.82 29.42 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 125.077 1.351 . . . . 73.53 110.639 173.17 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -91.1 158.99 26.13 Favored Glycine 0 C--N 1.341 0.843 0 N-CA-C 110.841 -0.904 . . . . 75.45 110.841 163.664 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 26.9 m-20 -134.52 152.55 51.86 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 122.606 0.363 . . . . 74.54 110.065 -171.531 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 249' ' ' LEU . . . . . 0.562 ' HB3' ' HB2' ' A' ' 235' ' ' LEU . 57.2 tp -99.05 139.97 33.91 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 124.543 1.137 . . . . 73.53 109.844 -176.506 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 250' ' ' TYR . . . . . . . . . . . . . 4.3 m-85 -103.66 123.0 46.19 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 123.856 0.862 . . . . 71.11 110.064 177.837 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 251' ' ' LEU . . . . . 0.6 HD13 HD22 ' A' ' 197' ' ' LEU . 92.1 mt -103.7 103.91 13.88 Favored 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 108.211 -1.033 . . . . 74.41 108.211 179.464 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -81.33 100.99 9.5 Favored 'General case' 0 CA--C 1.543 0.691 0 N-CA-C 108.187 -1.042 . . . . 74.12 108.187 175.371 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 10.2 m -65.68 137.34 25.12 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.788 0 CA-C-O 121.359 0.599 . . . . 73.34 110.801 -175.031 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 24.1 mmt85 -128.79 97.65 4.73 Favored 'General case' 0 C--O 1.238 0.468 0 C-N-CA 124.576 1.151 . . . . 75.12 108.246 179.844 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 255' ' ' ILE . . . . . 0.492 HG22 ' HA ' ' A' ' 201' ' ' ALA . 34.5 mt -77.42 120.79 28.62 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 CA-C-N 115.422 -0.808 . . . . 73.44 109.679 179.376 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 7.1 t . . . . . 0 CA--C 1.562 1.412 0 C-N-CA 123.675 0.79 . . . . 74.34 109.497 -179.43 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 172' ' ' LEU . . . . . 0.468 HD21 ' HB1' ' A' ' 222' ' ' ALA . 62.9 mt . . . . . 0 N--CA 1.478 0.97 0 CA-C-O 120.948 0.404 . . . . 74.31 110.802 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 173' ' ' PHE . . . . . 0.517 ' CD1' HD22 ' A' ' 235' ' ' LEU . 5.4 m-85 -138.24 -56.24 0.65 Allowed 'General case' 0 N--CA 1.482 1.131 0 CA-C-O 122.023 0.916 . . . . 74.41 108.974 -165.846 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 174' ' ' TYR . . . . . 0.459 ' CD2' ' HB3' ' A' ' 233' ' ' LEU . 1.4 p90 -74.82 4.2 6.8 Favored 'General case' 0 CA--C 1.547 0.865 0 CA-C-N 113.448 -1.705 . . . . 74.33 113.316 -178.79 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 6.2 p -67.29 82.52 0.14 Allowed 'General case' 0 CA--C 1.547 0.853 0 CA-C-O 122.334 1.064 . . . . 62.31 110.705 174.751 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 176' ' ' MET . . . . . 0.449 ' HG3' ' HG2' ' A' ' 177' ' ' LYS . 23.1 ptt? -161.91 -39.61 0.04 OUTLIER 'General case' 0 CA--C 1.541 0.608 0 CA-C-N 113.639 -1.619 . . . . 64.44 108.202 -174.809 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . 0.449 ' HG2' ' HG3' ' A' ' 176' ' ' MET . 18.3 pttp -177.27 34.64 0.0 OUTLIER 'General case' 0 CA--C 1.556 1.179 0 C-N-CA 124.637 1.175 . . . . 72.22 110.052 -178.906 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 178' ' ' ALA . . . . . 0.449 ' HB2' ' HG3' ' A' ' 224' ' ' PRO . . . -59.21 150.44 25.59 Favored 'General case' 0 N--CA 1.487 1.379 0 C-N-CA 124.036 0.935 . . . . 74.01 111.705 178.315 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . 0.412 ' HB1' ' NH1' ' A' ' 231' ' ' ARG . . . 61.75 25.55 15.4 Favored 'General case' 0 N--CA 1.489 1.517 0 C-N-CA 124.169 0.988 . . . . 61.14 110.758 -167.886 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.34 0.771 0 CA-C-N 115.43 -0.804 . . . . 73.11 111.128 -176.897 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 191' ' ' GLN . . . . . 0.536 ' HB3' ' HD2' ' A' ' 243' ' ' PRO . 7.5 pt20 . . . . . 0 N--CA 1.476 0.829 0 CA-C-O 120.952 0.406 . . . . 65.1 111.445 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 -75.31 141.61 43.37 Favored 'General case' 0 C--O 1.242 0.691 0 C-N-CA 124.666 1.186 . . . . 73.32 109.827 -176.475 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 23.3 mt -126.62 176.41 7.23 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 123.922 0.889 . . . . 75.2 110.802 -178.009 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 15.6 m-85 -138.23 122.93 18.69 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 124.33 1.052 . . . . 74.45 110.307 179.945 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -139.64 127.5 22.07 Favored 'General case' 0 C--O 1.239 0.509 0 N-CA-C 107.605 -1.257 . . . . 64.33 107.605 170.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 58.6 m -73.66 131.31 41.51 Favored 'General case' 0 C--O 1.241 0.657 0 CA-C-N 115.981 -0.554 . . . . 73.25 109.695 179.475 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . 0.528 HD22 HD11 ' A' ' 251' ' ' LEU . 15.8 tp -106.72 108.88 20.61 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 107.884 -1.154 . . . . 73.24 107.884 -179.588 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -78.4 121.09 24.05 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 108.468 -0.938 . . . . 62.13 108.468 177.114 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 199' ' ' VAL . . . . . 0.46 ' O ' ' HA ' ' A' ' 255' ' ' ILE . 4.1 p -140.98 128.53 12.1 Favored Pre-proline 0 CA--C 1.544 0.736 0 C-N-CA 123.733 0.813 . . . . 74.1 108.968 -177.956 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -70.53 156.78 60.62 Favored 'Trans proline' 0 C--N 1.365 1.402 0 C-N-CA 121.914 1.743 . . . . 72.1 111.006 170.919 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 201' ' ' ALA . . . . . 0.467 ' O ' HG22 ' A' ' 205' ' ' VAL . . . -50.97 -51.84 63.62 Favored Pre-proline 0 CA--C 1.56 1.349 0 CA-C-O 117.719 -1.134 . . . . 73.13 112.688 -179.257 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -61.58 -38.99 58.04 Favored 'Trans proline' 0 C--N 1.394 2.935 0 C-N-CA 121.672 1.581 . . . . 73.42 113.48 -177.535 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 34.4 mt -65.52 -34.01 67.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 CA-C-N 118.082 0.401 . . . . 65.15 110.398 176.382 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -71.34 -35.12 71.08 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 122.372 0.269 . . . . 72.32 111.371 177.428 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 205' ' ' VAL . . . . . 0.467 HG22 ' O ' ' A' ' 201' ' ' ALA . 96.6 t -71.74 -55.78 12.43 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.153 0 C-N-CA 123.588 0.755 . . . . 74.24 110.984 -179.544 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 18.9 m -79.74 -25.53 12.21 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 C-N-CA 122.863 0.465 . . . . 71.45 111.433 -174.607 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 80.1 72.18 1.22 Allowed Glycine 0 C--N 1.342 0.905 0 N-CA-C 111.647 -0.581 . . . . 74.11 111.647 -173.116 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -93.48 -134.21 6.98 Favored Glycine 0 C--N 1.349 1.298 0 N-CA-C 111.361 -0.695 . . . . 52.35 111.361 178.033 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 46.2 mtmt -138.1 152.78 49.08 Favored 'General case' 0 N--CA 1.486 1.37 0 CA-C-N 117.725 0.763 . . . . 74.22 111.662 179.35 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 15.6 m -147.72 158.67 8.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 C-N-CA 124.881 1.272 . . . . 71.53 109.268 178.403 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 43.5 ttm180 -98.3 114.01 26.16 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 123.089 0.556 . . . . 75.11 111.092 -175.627 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -100.3 124.93 46.37 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 124.509 1.123 . . . . 71.31 110.74 178.559 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 22.2 mmt -85.37 110.74 19.33 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 123.466 0.707 . . . . 61.5 109.49 176.841 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 22.2 p -110.94 -178.63 3.52 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 123.973 0.909 . . . . 64.24 109.73 -176.803 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 82.6 mt -57.67 -36.73 72.3 Favored 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 123.375 0.67 . . . . 62.33 112.709 -179.151 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -96.02 -19.33 19.55 Favored 'General case' 0 N--CA 1.482 1.154 0 N-CA-C 112.63 0.604 . . . . 65.31 112.63 -172.468 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 152.6 -168.33 31.6 Favored Glycine 0 C--N 1.352 1.423 0 CA-C-O 119.956 -0.358 . . . . 70.42 113.009 -178.825 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -85.39 132.24 4.3 Favored 'Trans proline' 0 C--N 1.367 1.543 0 C-N-CA 123.058 2.505 . . . . 75.1 112.566 179.086 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 4.1 p -126.44 126.09 68.51 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 N-CA-C 108.563 -0.903 . . . . 72.34 108.563 171.07 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -84.15 102.58 12.68 Favored 'General case' 0 C--O 1.238 0.455 0 N-CA-C 108.212 -1.033 . . . . 74.1 108.212 173.486 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 4.1 p -97.39 139.52 19.63 Favored 'Isoleucine or valine' 0 C--O 1.25 1.093 0 CA-C-N 114.732 -1.122 . . . . 75.32 109.218 -170.723 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 222' ' ' ALA . . . . . 0.468 ' HB1' HD21 ' A' ' 172' ' ' LEU . . . -78.42 101.27 7.19 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 122.794 0.437 . . . . 75.45 110.684 -177.493 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 47.5 t -53.9 133.08 57.77 Favored Pre-proline 0 N--CA 1.48 1.029 0 C-N-CA 124.28 1.032 . . . . 75.15 109.746 -179.338 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 224' ' ' PRO . . . . . 0.449 ' HG3' ' HB2' ' A' ' 178' ' ' ALA . 35.2 Cg_endo -63.25 147.08 94.15 Favored 'Trans proline' 0 C--N 1.371 1.725 0 C-N-CA 121.574 1.516 . . . . 71.25 110.46 172.029 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -67.33 156.95 64.04 Favored 'Trans proline' 0 C--N 1.361 1.201 0 C-N-CA 121.747 1.631 . . . . 70.42 111.541 177.005 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 40.7 mtt180 64.39 25.61 13.43 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 124.373 1.069 . . . . 72.22 111.634 168.424 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 227' ' ' THR . . . . . 0.593 ' HA ' HH11 ' A' ' 231' ' ' ARG . 94.1 m -75.81 133.99 40.5 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 123.835 0.854 . . . . 74.1 110.628 -179.896 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -99.83 148.71 24.14 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 123.872 0.869 . . . . 75.54 109.746 176.904 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 229' ' ' ALA . . . . . 0.532 ' HB3' ' HB ' ' A' ' 255' ' ' ILE . . . -59.63 128.08 35.23 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 123.989 0.915 . . . . 74.13 111.175 178.028 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 106.1 -5.84 39.43 Favored Glycine 0 N--CA 1.47 0.914 0 O-C-N 123.737 0.648 . . . . 73.53 113.135 -179.8 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 231' ' ' ARG . . . . . 0.593 HH11 ' HA ' ' A' ' 227' ' ' THR . 89.5 mtt180 -72.57 153.99 41.01 Favored 'General case' 0 N--CA 1.479 1.005 0 CA-C-N 117.325 0.563 . . . . 75.2 110.224 173.686 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 232' ' ' LYS . . . . . 0.412 ' HA ' ' O ' ' A' ' 251' ' ' LEU . 53.8 mtmt -130.3 127.32 39.25 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-N 115.99 -0.55 . . . . 75.25 110.044 -178.538 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 233' ' ' LEU . . . . . 0.49 ' HB2' ' HB2' ' A' ' 251' ' ' LEU . 24.1 mt -104.48 150.24 24.75 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 124.852 1.261 . . . . 75.14 108.614 -175.837 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 234' ' ' ARG . . . . . 0.418 ' HG3' ' HB3' ' A' ' 248' ' ' ASP . 56.7 ttm-85 -112.1 120.87 43.3 Favored 'General case' 0 N--CA 1.484 1.254 0 CA-C-N 118.361 0.528 . . . . 72.02 111.404 -170.483 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 235' ' ' LEU . . . . . 0.517 HD22 ' CD1' ' A' ' 173' ' ' PHE . 14.2 mt -110.95 111.73 23.06 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 123.787 0.835 . . . . 74.41 111.621 -176.754 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 31.3 mttp -68.72 141.65 55.22 Favored 'General case' 0 N--CA 1.476 0.875 0 CA-C-O 120.852 0.358 . . . . 64.22 110.914 172.707 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 79.7 -0.58 81.41 Favored Glycine 0 C--N 1.347 1.188 0 CA-C-N 115.18 -0.918 . . . . 72.1 114.658 176.706 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 72.5 mmtt -109.21 1.93 20.59 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 122.788 0.435 . . . . 72.25 110.223 -175.78 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -112.33 -172.78 18.98 Favored Glycine 0 C--N 1.353 1.52 0 N-CA-C 111.289 -0.724 . . . . 74.23 111.289 166.423 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 86.3 m-85 -86.09 157.39 56.87 Favored Pre-proline 0 N--CA 1.491 1.584 0 C-N-CA 123.361 0.664 . . . . 75.14 111.576 -174.424 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -65.95 131.37 26.99 Favored 'Trans proline' 0 C--N 1.376 2.008 0 C-N-CA 121.826 1.684 . . . . 64.32 111.011 170.614 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -160.43 -125.29 0.77 Allowed Glycine 0 C--N 1.34 0.77 0 CA-C-O 118.629 -1.095 . . . . 73.31 112.28 -179.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 243' ' ' PRO . . . . . 0.536 ' HD2' ' HB3' ' A' ' 191' ' ' GLN . 21.4 Cg_endo -54.55 -50.68 12.59 Favored 'Trans proline' 0 C--N 1.377 2.077 0 C-N-CA 124.344 3.363 . . . . 75.44 112.542 -176.589 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -86.59 -11.02 52.67 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 123.254 0.622 . . . . 73.4 111.463 179.938 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 85.43 -21.45 13.39 Favored Glycine 0 C--N 1.357 1.718 0 C-N-CA 122.888 0.28 . . . . 73.45 113.146 -177.941 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 12.7 ttm180 -126.56 113.72 17.14 Favored 'General case' 0 C--O 1.234 0.268 0 C-N-CA 125.038 1.335 . . . . 74.03 107.688 174.219 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -76.79 163.11 52.34 Favored Glycine 0 C--O 1.245 0.794 0 N-CA-C 115.055 0.782 . . . . 45.52 115.055 177.575 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 248' ' ' ASP . . . . . 0.448 ' HA ' ' O ' ' A' ' 235' ' ' LEU . 55.3 m-20 -110.06 159.16 17.56 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 114.101 -1.049 . . . . 75.24 110.354 -176.714 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 249' ' ' LEU . . . . . 0.512 ' HB3' ' HB2' ' A' ' 235' ' ' LEU . 31.3 tp -126.1 126.65 44.53 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 123.457 0.703 . . . . 75.05 109.242 174.452 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 250' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 -90.25 112.19 23.63 Favored 'General case' 0 C--O 1.239 0.532 0 N-CA-C 108.552 -0.907 . . . . 64.45 108.552 -179.628 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 251' ' ' LEU . . . . . 0.528 HD11 HD22 ' A' ' 197' ' ' LEU . 81.2 mt -87.56 101.21 13.41 Favored 'General case' 0 C--O 1.239 0.513 0 N-CA-C 107.072 -1.455 . . . . 73.24 107.072 176.069 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -85.79 91.98 8.48 Favored 'General case' 0 C--O 1.242 0.683 0 N-CA-C 108.013 -1.106 . . . . 75.03 108.013 -176.199 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 4.1 m -61.51 135.76 25.8 Favored 'Isoleucine or valine' 0 C--O 1.243 0.724 0 CA-C-N 115.02 -0.991 . . . . 63.32 109.9 -174.605 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 14.8 mmm180 -131.85 111.22 11.41 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 107.21 -1.404 . . . . 72.23 107.21 178.599 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 255' ' ' ILE . . . . . 0.532 ' HB ' ' HB3' ' A' ' 229' ' ' ALA . 41.8 mt -86.64 116.08 28.69 Favored 'Isoleucine or valine' 0 C--O 1.239 0.531 0 C-N-CA 123.865 0.866 . . . . 73.03 110.086 -176.993 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 2.0 t . . . . . 0 CA--C 1.556 1.201 0 C-N-CA 124.497 1.119 . . . . 73.41 109.577 176.992 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 31.9 mt . . . . . 0 N--CA 1.481 1.116 0 CA-C-O 121.356 0.598 . . . . 75.1 111.697 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 3.9 m-85 -130.06 -56.09 1.11 Allowed 'General case' 0 N--CA 1.475 0.807 0 CA-C-N 114.85 -1.068 . . . . 73.1 109.105 -171.447 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 174' ' ' TYR . . . . . 0.448 ' CD2' ' HB3' ' A' ' 233' ' ' LEU . 0.6 OUTLIER -80.93 3.32 23.24 Favored 'General case' 0 N--CA 1.476 0.83 0 N-CA-C 114.24 1.2 . . . . 75.55 114.24 -167.711 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 24.0 p -53.49 -23.1 9.32 Favored 'General case' 0 N--CA 1.489 1.522 0 C-N-CA 123.955 0.902 . . . . 61.12 113.158 -176.021 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 176' ' ' MET . . . . . . . . . . . . . 13.9 ptm -56.29 85.03 0.01 OUTLIER 'General case' 0 CA--C 1.56 1.351 0 C-N-CA 124.272 1.029 . . . . 72.41 111.119 165.67 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 66.1 mttm 55.73 47.29 20.76 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 125.15 1.38 . . . . 75.53 111.862 178.003 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -63.89 -32.4 73.91 Favored 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 124.891 1.276 . . . . 44.12 111.856 178.108 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -88.52 24.44 1.96 Allowed 'General case' 0 CA--C 1.55 0.966 0 C-N-CA 123.758 0.823 . . . . 64.52 110.816 175.705 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.346 1.117 0 N-CA-C 109.455 -1.458 . . . . 73.53 109.455 166.162 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 191' ' ' GLN . . . . . 0.692 ' HB3' ' HD2' ' A' ' 243' ' ' PRO . 9.6 pt20 . . . . . 0 N--CA 1.482 1.153 0 CA-C-O 121.588 0.709 . . . . 73.15 109.984 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -79.15 145.95 33.42 Favored 'General case' 0 C--O 1.241 0.618 0 CA-C-N 114.51 -1.223 . . . . 73.42 109.761 -171.435 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 33.5 mt -111.01 173.27 6.41 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 123.925 0.89 . . . . 75.5 110.331 -179.102 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 65.3 m-85 -134.0 121.37 21.51 Favored 'General case' 0 C--O 1.237 0.439 0 C-N-CA 123.596 0.758 . . . . 73.12 110.054 -179.442 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . 0.453 ' O ' ' HA ' ' A' ' 251' ' ' LEU . . . -140.61 146.76 38.4 Favored 'General case' 0 C--O 1.234 0.287 0 N-CA-C 107.538 -1.282 . . . . 63.5 107.538 173.759 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 61.3 m -96.77 140.02 31.96 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 109.918 -0.401 . . . . 74.2 109.918 178.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . 0.61 HD23 HD12 ' A' ' 251' ' ' LEU . 16.5 tp -117.45 108.65 15.79 Favored 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 107.749 -1.204 . . . . 75.3 107.749 177.005 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -82.78 132.01 35.18 Favored 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 109.481 -0.563 . . . . 73.33 109.481 177.513 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 199' ' ' VAL . . . . . 0.539 ' O ' ' HA ' ' A' ' 255' ' ' ILE . 7.5 p -144.07 131.59 10.62 Favored Pre-proline 0 CA--C 1.548 0.894 0 N-CA-C 107.461 -1.311 . . . . 75.33 107.461 179.988 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -72.45 161.17 44.97 Favored 'Trans proline' 0 C--N 1.358 1.03 0 C-N-CA 121.829 1.686 . . . . 75.14 111.346 169.172 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -50.13 -50.12 71.59 Favored Pre-proline 0 CA--C 1.564 1.483 0 N-CA-C 114.021 1.119 . . . . 65.14 114.021 -178.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -64.26 -41.38 21.65 Favored 'Trans proline' 0 C--N 1.396 3.043 0 C-N-CA 121.736 1.624 . . . . 74.32 113.576 -178.779 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 53.2 mt -67.08 -28.25 42.13 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.295 0 CA-C-N 117.898 0.317 . . . . 63.34 110.21 177.296 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -72.83 -50.37 24.5 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 123.209 0.604 . . . . 70.44 111.783 178.534 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 17.1 m -68.62 -43.02 83.67 Favored 'Isoleucine or valine' 0 C--N 1.353 0.729 0 C-N-CA 123.864 0.866 . . . . 73.14 112.574 -173.642 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 14.2 m -80.01 -36.38 16.82 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.226 0 CA-C-O 120.805 0.336 . . . . 74.34 110.746 175.239 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 83.77 80.05 1.04 Allowed Glycine 0 CA--C 1.528 0.885 0 N-CA-C 111.805 -0.518 . . . . 74.13 111.805 -173.064 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -90.78 -128.81 4.04 Favored Glycine 0 C--N 1.354 1.54 0 N-CA-C 111.447 -0.661 . . . . 64.33 111.447 175.789 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 45.3 mtmt -137.87 147.69 44.69 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 123.598 0.759 . . . . 75.5 110.806 174.599 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 3.6 m -139.94 165.18 22.22 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 C-N-CA 125.277 1.431 . . . . 74.11 109.212 175.033 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 45.0 ttp180 -100.97 122.76 44.08 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 123.179 0.591 . . . . 73.5 110.431 -177.807 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -114.68 112.31 22.67 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 124.05 0.94 . . . . 73.31 109.654 177.607 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 213' ' ' MET . . . . . 0.435 ' HA ' ' HA ' ' A' ' 218' ' ' PRO . 55.7 ttm -82.96 123.45 29.44 Favored 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 109.6 -0.518 . . . . 74.35 109.6 176.547 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 23.1 p -115.6 -171.22 1.93 Allowed 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 125.23 1.412 . . . . 74.31 109.568 -174.658 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 94.8 mt -60.75 -32.17 71.47 Favored 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 123.17 0.588 . . . . 71.54 111.016 170.459 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -99.27 19.28 15.71 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 124.107 0.963 . . . . 73.22 111.316 -175.691 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 93.79 -172.51 32.67 Favored Glycine 0 C--N 1.352 1.472 0 CA-C-O 119.683 -0.509 . . . . 75.25 113.175 177.864 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 218' ' ' PRO . . . . . 0.435 ' HA ' ' HA ' ' A' ' 213' ' ' MET . 73.2 Cg_endo -71.59 143.53 42.55 Favored 'Trans proline' 0 C--N 1.363 1.29 0 C-N-CA 122.622 2.214 . . . . 75.13 112.286 179.287 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 5.1 p -131.19 127.87 61.11 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 N-CA-C 108.605 -0.887 . . . . 73.42 108.605 172.943 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -78.28 100.76 6.83 Favored 'General case' 0 C--O 1.242 0.667 0 N-CA-C 106.66 -1.608 . . . . 73.42 106.66 174.79 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 6.2 p -108.35 129.65 62.32 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.844 0 CA-C-N 115.706 -0.679 . . . . 75.13 109.744 -168.745 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -79.66 110.49 15.05 Favored 'General case' 0 C--O 1.239 0.506 0 C-N-CA 123.714 0.805 . . . . 64.11 111.019 -174.903 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 52.7 t -55.12 136.47 67.68 Favored Pre-proline 0 CA--C 1.556 1.211 0 C-N-CA 125.006 1.322 . . . . 74.2 110.247 177.857 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -69.18 159.24 54.61 Favored 'Trans proline' 0 C--N 1.377 2.061 0 C-N-CA 122.293 1.995 . . . . 75.41 111.784 174.021 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -64.29 142.87 81.38 Favored 'Trans proline' 0 C--N 1.37 1.707 0 C-N-CA 121.75 1.633 . . . . 72.25 111.077 169.799 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 43.0 mtm180 62.78 48.21 4.24 Favored 'General case' 0 C--O 1.241 0.645 0 C-N-CA 124.417 1.087 . . . . 72.13 111.443 171.593 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 227' ' ' THR . . . . . 0.45 ' HA ' ' HE ' ' A' ' 231' ' ' ARG . 28.9 m -81.06 121.66 26.35 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 114.945 -1.025 . . . . 61.34 109.507 175.556 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 2.7 mp0 -106.41 148.4 28.15 Favored 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 123.992 0.917 . . . . 64.33 108.909 177.045 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -57.36 125.44 22.84 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 123.474 0.71 . . . . 64.35 111.88 -176.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 104.41 -2.55 43.07 Favored Glycine 0 C--N 1.34 0.786 0 CA-C-N 115.25 -0.886 . . . . 70.13 112.871 -179.619 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 231' ' ' ARG . . . . . 0.45 ' HE ' ' HA ' ' A' ' 227' ' ' THR . 56.4 mtt-85 -59.07 133.61 56.25 Favored 'General case' 0 C--N 1.371 1.505 0 CA-C-N 117.801 0.8 . . . . 73.32 109.695 173.22 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 69.5 mmtt -105.73 97.44 7.26 Favored 'General case' 0 C--O 1.239 0.536 0 CA-C-N 115.072 -0.967 . . . . 74.44 108.476 -172.858 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 233' ' ' LEU . . . . . 0.684 ' HB2' ' HB2' ' A' ' 251' ' ' LEU . 57.5 mt -81.73 142.29 32.79 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 114.713 -1.13 . . . . 75.35 109.046 179.229 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 22.0 ttt180 -122.84 101.28 7.35 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 122.492 0.317 . . . . 75.24 110.547 -171.475 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 235' ' ' LEU . . . . . 0.518 ' HB2' ' HB3' ' A' ' 249' ' ' LEU . 33.3 mt -86.74 105.62 17.1 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 123.57 0.748 . . . . 74.13 110.07 179.132 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 20.8 mttt -67.6 138.43 56.42 Favored 'General case' 0 CA--C 1.541 0.613 0 O-C-N 123.344 0.402 . . . . 75.41 110.921 175.41 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 73.11 16.62 78.51 Favored Glycine 0 C--N 1.348 1.207 0 O-C-N 123.895 0.747 . . . . 74.42 114.577 178.054 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 72.4 mmtt -115.58 7.4 14.83 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 123.211 0.605 . . . . 75.45 111.023 178.639 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -117.81 -167.83 14.31 Favored Glycine 0 C--N 1.348 1.216 0 N-CA-C 111.149 -0.781 . . . . 72.24 111.149 168.727 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 76.0 m-85 -91.34 157.89 41.8 Favored Pre-proline 0 N--CA 1.48 1.031 0 C-N-CA 123.781 0.833 . . . . 72.53 110.797 -175.567 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -64.03 145.38 89.64 Favored 'Trans proline' 0 C--N 1.366 1.487 0 C-N-CA 121.928 1.752 . . . . 74.52 112.833 170.167 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -176.4 -123.78 0.79 Allowed Glycine 0 CA--C 1.536 1.373 0 CA-C-O 118.964 -0.909 . . . . 61.45 112.221 178.161 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 243' ' ' PRO . . . . . 0.692 ' HD2' ' HB3' ' A' ' 191' ' ' GLN . 33.0 Cg_endo -57.75 -46.86 23.9 Favored 'Trans proline' 0 C--N 1.382 2.339 0 C-N-CA 124.889 3.726 . . . . 73.23 113.792 -173.499 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -90.72 -6.09 54.89 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 123.512 0.725 . . . . 72.23 111.153 179.778 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 87.17 -43.73 3.24 Favored Glycine 0 C--N 1.357 1.74 0 N-CA-C 111.966 -0.453 . . . . 74.15 111.966 -176.099 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 26.7 ttm180 -106.37 112.38 25.36 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 125.212 1.405 . . . . 72.12 109.163 175.167 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -74.83 154.27 46.65 Favored Glycine 0 C--N 1.358 1.804 0 N-CA-C 114.388 0.515 . . . . 75.11 114.388 171.282 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -107.43 171.13 7.55 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 124.854 1.262 . . . . 74.14 110.623 -178.52 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 249' ' ' LEU . . . . . 0.518 ' HB3' ' HB2' ' A' ' 235' ' ' LEU . 27.1 tp -128.78 116.76 19.99 Favored 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 108.17 -1.048 . . . . 75.41 108.17 171.009 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 250' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -88.78 108.08 19.31 Favored 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 108.845 -0.798 . . . . 73.42 108.845 -178.31 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 251' ' ' LEU . . . . . 0.684 ' HB2' ' HB2' ' A' ' 233' ' ' LEU . 87.3 mt -90.36 104.83 17.37 Favored 'General case' 0 C--O 1.238 0.453 0 N-CA-C 107.784 -1.191 . . . . 74.21 107.784 174.726 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -82.79 113.06 20.17 Favored 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 108.059 -1.089 . . . . 75.12 108.059 173.685 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 253' ' ' VAL . . . . . 0.44 ' HA ' ' O ' ' A' ' 197' ' ' LEU . 14.0 m -71.67 137.2 24.16 Favored 'Isoleucine or valine' 0 C--O 1.239 0.503 0 N-CA-C 109.677 -0.49 . . . . 74.3 109.677 179.685 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 8.5 mmm180 -123.38 108.54 12.83 Favored 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 108.092 -1.077 . . . . 74.43 108.092 175.902 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 255' ' ' ILE . . . . . 0.539 ' HA ' ' O ' ' A' ' 199' ' ' VAL . 27.3 mt -77.22 127.15 38.2 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 O-C-N 123.566 0.541 . . . . 62.43 109.864 177.792 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 10.7 t . . . . . 0 C--O 1.26 1.608 0 C-N-CA 123.974 0.91 . . . . 75.0 110.073 176.308 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 16.8 ptm . . . . . 0 N--CA 1.486 1.335 0 N-CA-C 110.15 -0.315 . . . . 73.33 110.15 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' GLN . . . . . 0.524 ' HG3' HG22 ' A' ' 170' ' ' THR . 23.0 pt20 -57.04 -32.66 66.42 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 113.966 1.099 . . . . 74.32 113.966 -167.611 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 170' ' ' THR . . . . . 0.524 HG22 ' HG3' ' A' ' 169' ' ' GLN . 15.1 t -167.41 -176.72 3.33 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 122.963 0.505 . . . . 75.21 111.0 -174.84 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -121.93 -75.7 0.59 Allowed 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 124.772 1.229 . . . . 62.13 108.421 173.295 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 172' ' ' LEU . . . . . 0.535 HD23 ' H ' ' A' ' 222' ' ' ALA . 25.9 mt -150.16 162.58 40.18 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 124.357 1.063 . . . . 73.23 110.256 -178.773 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 173' ' ' PHE . . . . . 0.445 ' CD1' HD22 ' A' ' 235' ' ' LEU . 31.4 m-85 -126.21 -59.14 1.33 Allowed 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 124.135 0.974 . . . . 74.35 109.828 -170.017 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 174' ' ' TYR . . . . . 0.522 ' CD2' ' HB3' ' A' ' 233' ' ' LEU . 1.7 p90 -82.41 15.51 2.46 Favored 'General case' 0 CA--C 1.548 0.868 0 CA-C-N 114.381 -1.281 . . . . 71.54 112.898 -171.533 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 4.6 p -62.66 -19.87 64.25 Favored 'General case' 0 CA--C 1.555 1.141 0 C-N-CA 122.805 0.442 . . . . 74.31 111.354 173.77 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 176' ' ' MET . . . . . . . . . . . . . 22.9 ptt? -65.86 -52.89 46.48 Favored 'General case' 0 CA--C 1.558 1.276 0 C-N-CA 124.214 1.006 . . . . 74.33 111.361 168.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . 0.652 ' HB3' ' HA ' ' A' ' 181' ' ' SER . 96.2 mttt -155.28 119.61 4.67 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 125.016 1.326 . . . . 71.54 108.223 -173.568 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 178' ' ' ALA . . . . . 0.488 ' HB2' ' HG3' ' A' ' 224' ' ' PRO . . . -154.68 -68.07 0.13 Allowed 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 123.926 0.89 . . . . 74.35 109.093 -174.524 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -83.37 82.22 8.37 Favored 'General case' 0 C--O 1.24 0.566 0 N-CA-C 107.723 -1.214 . . . . 73.45 107.723 168.782 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 103.09 58.62 0.74 Allowed Glycine 0 C--N 1.342 0.892 0 CA-C-N 115.369 -0.832 . . . . 75.44 111.909 -175.219 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 181' ' ' SER . . . . . 0.652 ' HA ' ' HB3' ' A' ' 177' ' ' LYS . 38.5 m -73.34 -38.42 65.77 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 123.514 0.726 . . . . 61.45 111.8 178.952 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . 81.31 -69.89 3.19 Favored Glycine 0 C--N 1.345 1.05 0 CA-C-N 116.199 -0.455 . . . . 64.43 112.056 -177.697 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 150.88 139.16 2.96 Favored Glycine 0 C--N 1.342 0.875 0 N-CA-C 111.163 -0.775 . . . . 74.22 111.163 177.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 25.1 t -149.04 141.13 23.89 Favored 'General case' 0 C--O 1.241 0.629 0 C-N-CA 123.485 0.714 . . . . 72.12 109.104 177.236 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 88.99 -135.12 12.81 Favored Glycine 0 C--N 1.344 0.993 0 O-C-N 123.494 0.496 . . . . 73.4 112.247 -178.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 84.23 12.19 76.75 Favored Glycine 0 CA--C 1.531 1.041 0 CA-C-O 119.736 -0.48 . . . . 73.12 113.268 -176.782 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 56.6 p -158.43 172.75 17.76 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 123.366 0.666 . . . . 73.21 110.988 -179.626 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 85.12 -149.32 23.87 Favored Glycine 0 C--N 1.349 1.293 0 N-CA-C 111.564 -0.614 . . . . 71.42 111.564 -171.834 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -75.13 159.01 51.48 Favored Glycine 0 C--N 1.349 1.266 0 CA-C-N 117.453 0.626 . . . . 72.21 111.82 172.743 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 38.4 m -81.49 63.52 5.83 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 123.602 0.761 . . . . 62.22 110.969 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 191' ' ' GLN . . . . . 0.703 ' HB3' ' HD2' ' A' ' 243' ' ' PRO . 8.1 pt20 -74.03 -36.4 64.41 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 115.471 -0.786 . . . . 74.43 110.589 -179.002 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 66.6 m-20 -76.88 162.51 27.56 Favored 'General case' 0 C--O 1.24 0.562 0 CA-C-N 115.111 -0.95 . . . . 74.41 110.815 -172.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 28.8 mt -135.97 176.91 8.26 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 124.509 1.123 . . . . 75.13 110.014 -175.302 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 60.8 m-85 -134.0 136.9 44.41 Favored 'General case' 0 C--O 1.239 0.527 0 C-N-CA 123.871 0.868 . . . . 72.41 110.136 177.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . 0.454 ' HB1' HD12 ' A' ' 249' ' ' LEU . . . -140.04 171.08 14.69 Favored 'General case' 0 C--O 1.236 0.371 0 C-N-CA 124.632 1.173 . . . . 75.21 108.561 176.069 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 26.1 m -119.02 123.44 44.53 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 108.652 -0.87 . . . . 63.41 108.652 177.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . 0.631 HD22 HD11 ' A' ' 251' ' ' LEU . 16.3 tp -107.47 111.08 23.21 Favored 'General case' 0 N--CA 1.467 0.382 0 N-CA-C 108.583 -0.895 . . . . 73.21 108.583 -179.56 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -84.0 121.48 27.45 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 123.414 0.686 . . . . 73.43 109.256 179.735 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 199' ' ' VAL . . . . . 0.449 ' O ' ' HA ' ' A' ' 255' ' ' ILE . 4.8 p -142.99 129.85 10.71 Favored Pre-proline 0 CA--C 1.548 0.903 0 C-N-CA 123.707 0.803 . . . . 73.4 109.414 -176.737 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_endo -72.37 162.0 42.76 Favored 'Trans proline' 0 C--N 1.369 1.613 0 C-N-CA 121.801 1.667 . . . . 60.32 111.189 172.341 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 201' ' ' ALA . . . . . 0.457 ' O ' HG22 ' A' ' 205' ' ' VAL . . . -50.6 -55.27 27.69 Favored Pre-proline 0 CA--C 1.562 1.439 0 CA-C-O 117.828 -1.082 . . . . 74.15 113.109 -177.839 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -68.1 -32.4 27.8 Favored 'Trans proline' 0 C--N 1.396 3.03 0 CA-C-N 121.433 1.548 . . . . 74.52 113.678 -174.157 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 36.1 mt -67.69 -32.02 54.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 N-CA-C 109.744 -0.465 . . . . 75.44 109.744 175.219 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -72.28 -40.33 67.68 Favored 'General case' 0 CA--C 1.551 1.011 0 C-N-CA 122.679 0.392 . . . . 73.52 111.347 176.425 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . 0.457 HG22 ' O ' ' A' ' 201' ' ' ALA . 84.7 t -66.66 -53.35 36.04 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.29 0 C-N-CA 123.647 0.779 . . . . 73.41 111.507 -177.825 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 16.5 m -80.04 -33.39 14.44 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 CA-C-N 116.227 -0.442 . . . . 72.14 110.986 -177.533 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 85.81 73.93 1.27 Allowed Glycine 0 C--N 1.342 0.901 0 CA-C-N 115.9 -0.591 . . . . 75.11 111.761 -172.44 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -91.14 -126.86 3.6 Favored Glycine 0 C--N 1.353 1.505 0 CA-C-O 119.43 -0.65 . . . . 45.11 111.876 177.324 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 209' ' ' LYS . . . . . 0.424 ' HG2' ' HA ' ' A' ' 222' ' ' ALA . 49.3 mtmt -137.81 155.28 49.18 Favored 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 123.604 0.762 . . . . 74.52 111.609 176.247 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 6.9 m -148.62 170.34 2.65 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.056 0 C-N-CA 125.88 1.672 . . . . 74.4 108.601 175.738 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 42.0 ttp180 -99.4 119.17 37.54 Favored 'General case' 0 CA--C 1.549 0.904 0 C-N-CA 122.822 0.449 . . . . 74.32 109.99 177.491 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -100.97 127.4 47.47 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 123.7 0.8 . . . . 62.15 109.63 175.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 88.0 mmm -96.06 122.5 38.96 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 123.336 0.654 . . . . 72.54 109.85 -177.261 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 21.8 p -129.21 -176.01 3.74 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 124.015 0.926 . . . . 75.41 110.886 -168.188 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 86.5 mt -65.22 -24.15 67.27 Favored 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 123.178 0.591 . . . . 73.25 112.062 175.67 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -98.99 6.68 46.57 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.454 0.702 . . . . 70.05 111.093 179.171 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 98.98 -151.44 19.49 Favored Glycine 0 C--N 1.352 1.455 0 CA-C-O 119.317 -0.713 . . . . 74.42 112.3 -179.667 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -79.85 149.65 20.6 Favored 'Trans proline' 0 C--N 1.365 1.422 0 C-N-CA 122.536 2.157 . . . . 75.3 113.672 -176.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 5.4 p -143.17 130.83 18.72 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 C-N-CA 123.613 0.765 . . . . 74.13 109.143 175.12 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -75.89 101.89 5.33 Favored 'General case' 0 N--CA 1.476 0.872 0 N-CA-C 108.539 -0.912 . . . . 73.5 108.539 175.149 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 1.4 p -107.06 123.08 61.97 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.047 0 N-CA-C 108.755 -0.832 . . . . 72.32 108.755 -173.108 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . 0.535 ' H ' HD23 ' A' ' 172' ' ' LEU . . . -77.36 109.96 11.7 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 123.194 0.598 . . . . 64.1 111.075 -178.376 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 63.1 t -54.97 139.47 63.25 Favored Pre-proline 0 N--CA 1.48 1.061 0 C-N-CA 125.43 1.492 . . . . 73.21 110.445 179.705 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 224' ' ' PRO . . . . . 0.488 ' HG3' ' HB2' ' A' ' 178' ' ' ALA . 72.0 Cg_endo -72.05 159.34 50.35 Favored 'Trans proline' 0 C--N 1.374 1.905 0 C-N-CA 121.939 1.759 . . . . 74.31 111.566 173.3 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -69.83 147.37 62.28 Favored 'Trans proline' 0 C--N 1.369 1.61 0 C-N-CA 121.507 1.471 . . . . 71.22 111.194 172.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 65.6 mtm180 63.55 47.08 3.93 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 124.578 1.151 . . . . 74.04 110.868 174.39 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 227' ' ' THR . . . . . 0.456 ' HA ' ' HE ' ' A' ' 231' ' ' ARG . 53.4 m -87.12 125.62 34.26 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 114.84 -1.073 . . . . 72.2 108.895 174.108 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -115.01 151.86 33.45 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 108.286 -1.005 . . . . 72.44 108.286 176.037 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -55.73 118.24 4.37 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 124.158 0.983 . . . . 71.13 111.075 -176.063 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 115.84 -5.06 20.65 Favored Glycine 0 C--N 1.342 0.868 0 CA-C-O 118.773 -1.015 . . . . 64.32 114.744 -177.399 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 231' ' ' ARG . . . . . 0.456 ' HE ' ' HA ' ' A' ' 227' ' ' THR . 65.2 mtt-85 -62.7 144.23 56.57 Favored 'General case' 0 N--CA 1.484 1.251 0 CA-C-N 118.28 1.04 . . . . 74.34 110.879 172.844 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 232' ' ' LYS . . . . . 0.414 ' HE3' ' HA ' ' A' ' 232' ' ' LYS . 0.0 OUTLIER -109.08 99.32 8.65 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 114.995 -1.002 . . . . 71.5 108.804 177.435 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 233' ' ' LEU . . . . . 0.637 ' HB2' ' HB2' ' A' ' 251' ' ' LEU . 39.2 mt -82.78 152.5 25.67 Favored 'General case' 0 CA--C 1.544 0.712 0 N-CA-C 108.589 -0.893 . . . . 74.52 108.589 175.344 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 22.3 ttt85 -125.61 111.25 14.77 Favored 'General case' 0 N--CA 1.481 1.103 0 CA-C-N 118.117 0.417 . . . . 74.22 111.043 -171.147 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 235' ' ' LEU . . . . . 0.477 ' HB2' ' HB3' ' A' ' 249' ' ' LEU . 16.2 mt -99.6 111.03 23.43 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 123.402 0.681 . . . . 75.51 110.683 179.213 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 16.2 mtmt -70.73 139.57 51.15 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 122.938 0.495 . . . . 74.0 111.695 -179.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 77.94 -2.69 63.77 Favored Glycine 0 N--CA 1.477 1.414 0 CA-C-N 115.508 -0.769 . . . . 72.42 114.292 177.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 70.9 mmtt -99.17 3.15 46.38 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 123.394 0.678 . . . . 74.52 110.717 -177.272 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -108.49 -176.24 21.86 Favored Glycine 0 C--N 1.347 1.183 0 N-CA-C 110.028 -1.229 . . . . 74.34 110.028 161.71 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 90.6 m-85 -85.46 147.09 45.96 Favored Pre-proline 0 N--CA 1.483 1.204 0 C-N-CA 123.261 0.625 . . . . 73.54 110.714 -178.095 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -59.78 132.9 47.81 Favored 'Trans proline' 0 C--N 1.37 1.704 0 C-N-CA 122.177 1.918 . . . . 73.43 112.282 171.572 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -159.27 -124.79 0.77 Allowed Glycine 0 CA--C 1.538 1.528 0 CA-C-O 118.692 -1.06 . . . . 63.13 112.729 -179.602 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 243' ' ' PRO . . . . . 0.703 ' HD2' ' HB3' ' A' ' 191' ' ' GLN . 35.9 Cg_endo -57.34 -44.13 45.76 Favored 'Trans proline' 0 C--N 1.381 2.286 0 C-N-CA 124.415 3.41 . . . . 74.43 113.638 -174.319 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -85.81 -14.45 45.06 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 123.389 0.676 . . . . 75.41 110.745 176.724 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 92.34 -23.34 27.94 Favored Glycine 0 C--N 1.348 1.224 0 CA-C-N 116.126 -0.488 . . . . 75.24 112.498 -176.104 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 11.4 ttm180 -128.86 111.75 13.41 Favored 'General case' 0 C--O 1.238 0.493 0 C-N-CA 124.575 1.15 . . . . 74.13 109.18 176.849 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -73.53 155.55 50.11 Favored Glycine 0 C--N 1.351 1.399 0 C-N-CA 121.693 -0.289 . . . . 72.14 112.769 170.632 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -125.43 145.62 49.99 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 123.376 0.67 . . . . 70.22 109.871 -173.837 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 249' ' ' LEU . . . . . 0.477 ' HB3' ' HB2' ' A' ' 235' ' ' LEU . 32.7 tp -100.32 119.25 38.13 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 123.3 0.64 . . . . 73.12 109.62 -178.563 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 250' ' ' TYR . . . . . . . . . . . . . 2.4 m-30 -89.65 110.09 21.0 Favored 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 108.753 -0.832 . . . . 72.21 108.753 -178.278 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 251' ' ' LEU . . . . . 0.637 ' HB2' ' HB2' ' A' ' 233' ' ' LEU . 85.3 mt -87.6 118.03 26.81 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 123.921 0.889 . . . . 71.4 109.294 -177.275 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 252' ' ' GLU . . . . . 0.416 ' HG3' ' HD3' ' A' ' 254' ' ' ARG . 10.1 tp10 -83.78 98.62 9.8 Favored 'General case' 0 C--O 1.239 0.506 0 N-CA-C 108.585 -0.895 . . . . 75.13 108.585 175.918 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 6.1 m -71.71 129.64 35.3 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 CA-C-O 121.498 0.666 . . . . 73.34 110.03 -176.526 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 254' ' ' ARG . . . . . 0.416 ' HD3' ' HG3' ' A' ' 252' ' ' GLU . 15.2 mmm180 -122.43 99.36 6.37 Favored 'General case' 0 C--O 1.238 0.483 0 CA-C-N 115.131 -0.94 . . . . 74.42 108.993 -173.803 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 255' ' ' ILE . . . . . 0.449 ' HA ' ' O ' ' A' ' 199' ' ' VAL . 15.7 mt -76.61 120.07 26.1 Favored 'Isoleucine or valine' 0 C--O 1.24 0.595 0 CA-C-O 121.443 0.64 . . . . 73.23 110.231 179.789 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 8.9 t . . . . . 0 CA--C 1.566 1.592 0 C-N-CA 125.198 1.399 . . . . 71.23 108.06 -178.267 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 23.9 ptt? . . . . . 0 N--CA 1.49 1.564 0 N-CA-C 111.684 0.253 . . . . 72.51 111.684 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -112.44 -172.47 2.05 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 123.631 0.773 . . . . 75.01 110.293 179.377 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 4.5 t -83.67 163.66 20.15 Favored 'General case' 0 CA--C 1.557 1.231 0 C-N-CA 123.438 0.695 . . . . 73.02 110.178 177.311 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -129.97 -82.89 0.55 Allowed 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 123.19 0.596 . . . . 63.44 111.244 -169.385 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 172' ' ' LEU . . . . . 0.563 HD21 ' H ' ' A' ' 222' ' ' ALA . 25.8 mt -139.1 151.88 47.06 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 123.516 0.726 . . . . 72.2 110.345 -174.469 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 173' ' ' PHE . . . . . 0.471 ' CE2' ' HE3' ' A' ' 238' ' ' LYS . 4.1 m-85 -134.74 -60.85 0.77 Allowed 'General case' 0 N--CA 1.481 1.091 0 CA-C-N 115.367 -0.833 . . . . 72.12 109.955 -155.767 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 174' ' ' TYR . . . . . 0.464 ' CD2' ' HB3' ' A' ' 233' ' ' LEU . 4.9 p90 -85.68 11.99 9.77 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 114.508 -1.223 . . . . 72.24 112.18 -175.852 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 175' ' ' THR . . . . . 0.484 ' OG1' ' HB3' ' A' ' 172' ' ' LEU . 0.2 OUTLIER -68.96 -17.5 63.95 Favored 'General case' 0 CA--C 1.551 1.0 0 C-N-CA 123.556 0.742 . . . . 73.32 112.324 -166.238 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 176' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -73.59 -28.53 61.88 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 123.631 0.773 . . . . 63.34 111.088 176.038 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . 0.437 ' HG2' ' HA3' ' A' ' 180' ' ' GLY . 23.2 ttpp -151.87 62.46 0.85 Allowed 'General case' 0 CA--C 1.551 0.988 0 CA-C-O 122.276 1.036 . . . . 70.34 108.942 -177.21 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 178' ' ' ALA . . . . . 0.415 ' HB1' ' HB3' ' A' ' 224' ' ' PRO . . . -81.01 126.3 31.23 Favored 'General case' 0 N--CA 1.476 0.864 0 CA-C-N 114.457 -1.247 . . . . 74.32 110.794 -175.763 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . 0.48 ' HB1' HH11 ' A' ' 231' ' ' ARG . . . 66.57 9.92 6.97 Favored 'General case' 0 N--CA 1.497 1.924 0 C-N-CA 124.955 1.302 . . . . 62.33 111.501 -170.031 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . 0.437 ' HA3' ' HG2' ' A' ' 177' ' ' LYS . . . -89.6 55.02 3.82 Favored Glycine 0 N--CA 1.468 0.786 0 CA-C-N 116.267 -0.424 . . . . 71.41 112.268 -173.411 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 16.4 m -77.78 93.78 4.37 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 123.865 0.866 . . . . 72.22 109.657 -179.289 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -112.54 -63.58 0.46 Allowed Glycine 0 C--N 1.343 0.932 0 CA-C-N 115.416 -0.811 . . . . 72.52 112.521 -173.622 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -170.7 83.63 0.08 OUTLIER Glycine 0 C--N 1.347 1.158 0 N-CA-C 112.384 -0.286 . . . . 61.34 112.384 -177.609 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 19.4 m -97.71 97.59 9.14 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 123.312 0.645 . . . . 73.44 110.412 -178.259 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -81.13 108.33 2.82 Favored Glycine 0 C--N 1.344 0.977 0 CA-C-N 116.21 -0.45 . . . . 74.2 112.977 179.587 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -66.24 133.69 33.6 Favored Glycine 0 CA--C 1.533 1.175 0 N-CA-C 111.327 -0.709 . . . . 72.43 111.327 170.222 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 187' ' ' SER . . . . . 0.541 ' HB2' ' HB2' ' A' ' 243' ' ' PRO . 15.1 m -92.96 44.99 1.16 Allowed 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 123.857 0.863 . . . . 70.1 112.998 -167.358 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 88.12 -66.25 3.32 Favored Glycine 0 N--CA 1.472 1.087 0 CA-C-N 116.34 -0.391 . . . . 70.23 113.49 174.791 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -63.99 136.72 40.8 Favored Glycine 0 C--N 1.349 1.26 0 N-CA-C 111.905 -0.478 . . . . 43.13 111.905 177.502 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 25.1 t -87.53 58.79 5.12 Favored 'General case' 0 CA--C 1.551 0.999 0 CA-C-O 121.35 0.595 . . . . 73.31 110.889 -175.592 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 191' ' ' GLN . . . . . 0.625 ' HB3' ' HD2' ' A' ' 243' ' ' PRO . 9.5 pt20 -69.07 -32.5 72.01 Favored 'General case' 0 N--CA 1.477 0.905 0 CA-C-N 115.653 -0.703 . . . . 71.32 109.915 171.377 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 65.7 m-20 -78.32 152.99 32.11 Favored 'General case' 0 C--O 1.239 0.521 0 CA-C-N 114.65 -1.159 . . . . 64.21 110.955 -173.598 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . 0.486 HD11 ' HA2' ' A' ' 239' ' ' GLY . 59.3 mt -128.68 175.76 8.33 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 114.547 -1.206 . . . . 63.25 110.297 -174.374 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 17.5 m-85 -139.67 122.73 16.78 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 123.915 0.886 . . . . 73.54 110.046 -177.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . 0.401 ' HB1' HD11 ' A' ' 249' ' ' LEU . . . -129.4 128.2 42.52 Favored 'General case' 0 C--N 1.341 0.209 0 N-CA-C 108.318 -0.993 . . . . 71.43 108.318 173.331 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 61.7 m -77.72 123.89 27.26 Favored 'General case' 0 CA--C 1.546 0.799 0 N-CA-C 109.344 -0.613 . . . . 74.21 109.344 176.888 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . 0.626 HD21 HD11 ' A' ' 251' ' ' LEU . 18.9 tp -107.69 110.87 22.83 Favored 'General case' 0 N--CA 1.474 0.775 0 N-CA-C 108.562 -0.903 . . . . 74.41 108.562 -178.532 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -78.43 132.52 37.34 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 109.321 -0.622 . . . . 73.33 109.321 173.286 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 199' ' ' VAL . . . . . 0.482 ' O ' ' HA ' ' A' ' 255' ' ' ILE . 4.1 p -144.18 127.3 8.72 Favored Pre-proline 0 CA--C 1.546 0.804 0 N-CA-C 108.453 -0.943 . . . . 74.13 108.453 177.745 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -69.59 156.09 64.72 Favored 'Trans proline' 0 C--N 1.367 1.517 0 C-N-CA 121.962 1.775 . . . . 72.15 111.48 170.774 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 201' ' ' ALA . . . . . 0.438 ' O ' HG23 ' A' ' 205' ' ' VAL . . . -51.05 -51.96 62.88 Favored Pre-proline 0 CA--C 1.555 1.166 0 N-CA-C 113.996 1.11 . . . . 63.35 113.996 -177.354 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -65.39 -32.63 49.79 Favored 'Trans proline' 0 C--N 1.382 2.309 0 CA-C-N 121.181 1.458 . . . . 63.01 113.253 -176.072 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 27.3 mt -68.48 -34.86 67.88 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.229 0 C-N-CA 122.664 0.386 . . . . 75.34 110.152 174.307 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -71.54 -33.12 68.88 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 122.295 0.238 . . . . 71.35 111.369 178.414 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . 0.438 HG23 ' O ' ' A' ' 201' ' ' ALA . 80.7 t -71.05 -57.76 6.86 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 C-N-CA 123.349 0.66 . . . . 64.2 111.041 178.643 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 10.6 m -82.37 -17.26 11.46 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.055 0 CA-C-N 116.272 -0.422 . . . . 74.34 111.588 -172.798 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 74.86 66.17 1.98 Allowed Glycine 0 C--N 1.342 0.883 0 O-C-N 123.667 0.604 . . . . 52.21 112.327 -177.422 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -85.57 -130.0 2.33 Favored Glycine 0 C--N 1.346 1.091 0 C-N-CA 122.694 0.188 . . . . 55.51 112.806 179.522 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 209' ' ' LYS . . . . . 0.425 ' HG2' ' HA ' ' A' ' 222' ' ' ALA . 46.8 mtmt -138.24 155.48 48.6 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.753 0.821 . . . . 71.03 111.005 176.363 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 11.0 m -144.23 168.93 10.15 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 C-N-CA 125.155 1.382 . . . . 74.32 108.66 172.406 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 48.9 ttp180 -97.06 114.34 25.97 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 123.227 0.611 . . . . 75.23 109.939 178.552 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -100.74 139.66 36.1 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 123.667 0.787 . . . . 74.52 110.208 179.52 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 23.9 mmt -98.46 116.02 29.79 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 123.021 0.528 . . . . 75.4 109.716 178.707 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 48.9 p -109.46 -175.58 2.79 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 123.928 0.891 . . . . 73.35 109.182 175.527 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 93.3 mt -63.3 -22.3 66.79 Favored 'General case' 0 CA--C 1.552 1.02 0 C-N-CA 122.71 0.404 . . . . 63.13 111.356 173.685 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 20.9 mt-10 -81.93 -22.89 36.48 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 123.672 0.789 . . . . 63.21 110.99 -178.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 118.18 -150.06 18.27 Favored Glycine 0 CA--C 1.533 1.16 0 N-CA-C 110.911 -0.876 . . . . 73.01 110.911 -170.822 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_endo -78.26 144.73 20.94 Favored 'Trans proline' 0 C--N 1.369 1.628 0 C-N-CA 122.463 2.109 . . . . 75.42 113.19 -176.424 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 7.6 p -144.02 133.03 19.34 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 C-N-CA 123.914 0.886 . . . . 65.41 109.366 177.363 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 40.0 mm-40 -78.69 104.59 9.41 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 109.658 -0.497 . . . . 72.23 109.658 177.47 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 4.1 p -107.31 130.19 59.88 Favored 'Isoleucine or valine' 0 C--O 1.244 0.808 0 CA-C-N 115.418 -0.81 . . . . 71.2 109.224 -174.423 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . 0.563 ' H ' HD21 ' A' ' 172' ' ' LEU . . . -81.09 104.64 11.71 Favored 'General case' 0 C--O 1.239 0.536 0 C-N-CA 123.419 0.688 . . . . 75.01 111.061 -177.16 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 59.9 t -55.6 135.64 71.12 Favored Pre-proline 0 N--CA 1.476 0.865 0 O-C-N 124.423 1.077 . . . . 74.41 110.056 178.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 224' ' ' PRO . . . . . 0.415 ' HB3' ' HB1' ' A' ' 178' ' ' ALA . 17.1 Cg_endo -65.23 148.76 88.98 Favored 'Trans proline' 0 C--N 1.365 1.416 0 C-N-CA 121.747 1.631 . . . . 65.14 111.801 170.326 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -65.35 150.17 87.46 Favored 'Trans proline' 0 C--N 1.364 1.35 0 C-N-CA 121.499 1.466 . . . . 73.23 111.612 169.763 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 59.6 mtm180 61.72 35.83 16.68 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 124.654 1.182 . . . . 73.1 112.484 170.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 227' ' ' THR . . . . . 0.409 HG21 HG22 ' A' ' 253' ' ' VAL . 26.6 m -83.04 133.94 35.06 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 115.342 -0.845 . . . . 75.13 109.262 174.365 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 28.3 mp0 -111.2 149.63 30.69 Favored 'General case' 0 N--CA 1.485 1.319 0 N-CA-C 109.398 -0.593 . . . . 73.44 109.398 175.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 229' ' ' ALA . . . . . 0.449 ' HA ' HG23 ' A' ' 253' ' ' VAL . . . -58.47 125.99 25.66 Favored 'General case' 0 N--CA 1.47 0.556 0 O-C-N 124.305 1.003 . . . . 63.13 111.46 -176.548 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 113.98 -15.46 21.14 Favored Glycine 0 CA--C 1.523 0.551 0 CA-C-N 115.206 -0.907 . . . . 44.22 113.035 -176.58 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 231' ' ' ARG . . . . . 0.48 HH11 ' HB1' ' A' ' 179' ' ' ALA . 75.0 mtt180 -67.66 152.81 45.0 Favored 'General case' 0 C--N 1.363 1.158 0 CA-C-N 117.751 0.775 . . . . 73.32 109.457 172.547 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 232' ' ' LYS . . . . . 0.475 ' HA ' ' O ' ' A' ' 251' ' ' LEU . 54.0 mtmt -130.05 128.01 41.06 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-O 121.324 0.583 . . . . 74.32 110.602 179.201 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 233' ' ' LEU . . . . . 0.491 ' HB2' ' HB2' ' A' ' 251' ' ' LEU . 20.1 mt -98.49 148.1 24.08 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 114.354 -1.293 . . . . 75.23 108.887 -174.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 21.2 ttt180 -106.82 110.24 22.35 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 122.851 0.46 . . . . 74.23 111.263 -170.401 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 235' ' ' LEU . . . . . 0.603 ' HB2' ' HB3' ' A' ' 249' ' ' LEU . 17.1 mt -98.56 103.9 15.89 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 122.641 0.376 . . . . 75.35 110.092 177.963 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 13.6 mtmt -70.72 134.84 47.82 Favored 'General case' 0 C--O 1.238 0.495 0 CA-C-N 116.231 -0.44 . . . . 75.44 111.896 -178.154 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 73.72 10.51 80.09 Favored Glycine 0 C--N 1.344 0.996 0 CA-C-N 114.973 -1.012 . . . . 72.4 114.808 177.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . 0.471 ' HE3' ' CE2' ' A' ' 173' ' ' PHE . 69.7 mmtt -104.6 5.36 33.69 Favored 'General case' 0 N--CA 1.478 0.957 0 CA-C-N 117.393 0.596 . . . . 63.55 110.0 179.785 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 239' ' ' GLY . . . . . 0.486 ' HA2' HD11 ' A' ' 193' ' ' LEU . . . -105.7 -168.37 23.5 Favored Glycine 0 C--N 1.35 1.325 0 CA-C-N 115.25 -0.886 . . . . 73.45 111.294 166.733 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -93.73 167.75 13.19 Favored Pre-proline 0 CA--C 1.559 1.319 0 C-N-CA 123.998 0.919 . . . . 74.13 110.233 178.337 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -71.65 171.51 16.25 Favored 'Trans proline' 0 C--N 1.376 2.001 0 C-N-CA 122.437 2.091 . . . . 63.43 112.926 172.203 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 155.36 -117.25 0.77 Allowed Glycine 0 CA--C 1.537 1.461 0 CA-C-O 119.312 -0.715 . . . . 73.44 113.219 173.507 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 243' ' ' PRO . . . . . 0.625 ' HD2' ' HB3' ' A' ' 191' ' ' GLN . 60.5 Cg_endo -63.25 -40.65 31.29 Favored 'Trans proline' 0 C--N 1.375 1.966 0 C-N-CA 124.638 3.559 . . . . 72.53 113.506 -169.348 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 244' ' ' ALA . . . . . 0.406 ' HB2' HE22 ' A' ' 191' ' ' GLN . . . -101.27 -13.99 17.84 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 123.393 0.677 . . . . 72.33 110.316 177.292 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 96.32 -31.71 7.16 Favored Glycine 0 C--N 1.352 1.464 0 CA-C-N 116.109 -0.496 . . . . 73.11 112.908 179.66 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 50.5 ttt180 -126.65 110.56 13.31 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 124.17 0.988 . . . . 71.5 109.102 -178.663 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -75.96 151.07 40.22 Favored Glycine 0 C--N 1.347 1.161 0 O-C-N 123.684 0.615 . . . . 62.34 113.532 179.011 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 18.4 m-20 -118.89 137.65 53.3 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 124.144 0.978 . . . . 70.5 109.67 -175.744 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 249' ' ' LEU . . . . . 0.603 ' HB3' ' HB2' ' A' ' 235' ' ' LEU . 51.6 tp -98.93 118.06 34.84 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 109.049 -0.723 . . . . 75.01 109.049 179.521 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 250' ' ' TYR . . . . . . . . . . . . . 3.4 m-85 -90.64 112.78 24.64 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 123.62 0.768 . . . . 73.41 110.331 -175.615 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 251' ' ' LEU . . . . . 0.626 HD11 HD21 ' A' ' 197' ' ' LEU . 83.4 mt -87.57 105.24 17.19 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 124.209 1.004 . . . . 74.45 109.408 -177.453 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 252' ' ' GLU . . . . . 0.4 ' O ' ' HG2' ' A' ' 254' ' ' ARG . 29.4 mt-10 -78.74 93.94 5.02 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 108.327 -0.99 . . . . 75.42 108.327 -178.425 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 253' ' ' VAL . . . . . 0.449 HG23 ' HA ' ' A' ' 229' ' ' ALA . 3.9 m -64.19 127.98 25.77 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.871 0 CA-C-O 121.334 0.587 . . . . 62.14 109.786 -176.701 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 254' ' ' ARG . . . . . 0.4 ' HG2' ' O ' ' A' ' 252' ' ' GLU . 26.6 mmt85 -127.46 98.97 5.43 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 108.713 -0.847 . . . . 73.34 108.713 -175.194 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 255' ' ' ILE . . . . . 0.482 ' HA ' ' O ' ' A' ' 199' ' ' VAL . 24.8 mt -80.31 110.56 16.02 Favored 'Isoleucine or valine' 0 C--O 1.238 0.473 0 CA-C-N 115.25 -0.886 . . . . 75.52 110.415 -176.922 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 10.2 t . . . . . 0 C--O 1.257 1.475 0 CA-C-N 115.059 -0.973 . . . . 75.55 109.708 174.037 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 14.0 tpt . . . . . 0 N--CA 1.484 1.233 0 N-CA-C 109.378 -0.601 . . . . 75.12 109.378 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 17.6 pt20 -63.91 168.01 5.58 Favored 'General case' 0 C--O 1.245 0.847 0 C-N-CA 123.388 0.675 . . . . 74.13 110.657 173.238 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 13.1 t -71.3 145.66 49.37 Favored 'General case' 0 CA--C 1.545 0.772 0 CA-C-N 115.679 -0.691 . . . . 74.24 110.247 176.47 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -84.9 -84.48 0.15 Allowed 'General case' 0 CA--C 1.542 0.665 0 N-CA-C 109.367 -0.605 . . . . 65.42 109.367 175.773 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 172' ' ' LEU . . . . . 0.604 HD23 ' H ' ' A' ' 222' ' ' ALA . 22.3 mt -152.22 161.07 43.16 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 123.888 0.875 . . . . 72.21 110.454 -175.846 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 173' ' ' PHE . . . . . 0.463 ' CD1' HD21 ' A' ' 235' ' ' LEU . 26.2 m-85 -123.99 -62.78 1.26 Allowed 'General case' 0 N--CA 1.475 0.777 0 CA-C-N 115.519 -0.764 . . . . 75.12 110.189 -169.661 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 174' ' ' TYR . . . . . 0.453 ' CD2' ' HB3' ' A' ' 233' ' ' LEU . 1.8 p90 -75.8 -11.38 59.97 Favored 'General case' 0 C--O 1.219 -0.503 0 CA-C-N 114.587 -1.188 . . . . 71.3 112.815 -172.158 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 175' ' ' THR . . . . . 0.599 HG21 HD11 ' A' ' 172' ' ' LEU . 42.9 p -70.61 -2.18 13.47 Favored 'General case' 0 CA--C 1.548 0.9 0 N-CA-C 112.558 0.577 . . . . 73.0 112.558 -176.45 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 176' ' ' MET . . . . . . . . . . . . . 24.9 ptt? -57.1 -41.97 79.89 Favored 'General case' 0 CA--C 1.559 1.299 0 C-N-CA 123.67 0.788 . . . . 75.13 110.261 161.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 14.5 tmtt? 179.51 108.52 0.03 OUTLIER 'General case' 0 CA--C 1.553 1.08 0 C-N-CA 126.18 1.792 . . . . 74.14 106.321 179.463 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 178' ' ' ALA . . . . . 0.495 ' HB2' HD21 ' A' ' 233' ' ' LEU . . . -128.08 -58.77 1.2 Allowed 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 123.081 0.552 . . . . 72.12 112.025 -173.017 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . 0.478 ' HB3' ' HB2' ' A' ' 224' ' ' PRO . . . -71.55 85.22 0.86 Allowed 'General case' 0 CA--C 1.546 0.81 0 CA-C-O 121.57 0.7 . . . . 71.12 109.48 179.463 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 160.7 -32.12 0.38 Allowed Glycine 0 C--N 1.337 0.591 0 CA-C-N 114.298 -1.319 . . . . 75.43 109.889 -172.546 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 20.3 m -80.33 147.68 31.0 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 124.345 1.058 . . . . 73.12 110.886 175.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . 172.21 49.61 0.04 OUTLIER Glycine 0 C--N 1.349 1.257 0 CA-C-N 116.173 -0.467 . . . . 74.22 112.235 -179.527 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -131.49 -101.63 0.87 Allowed Glycine 0 N--CA 1.476 1.334 0 CA-C-O 119.924 -0.376 . . . . 64.55 113.165 -176.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 29.9 t -167.52 156.73 10.06 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 123.443 0.697 . . . . 62.11 110.288 -176.673 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -100.42 -131.64 7.45 Favored Glycine 0 C--N 1.348 1.216 0 N-CA-C 111.535 -0.626 . . . . 64.1 111.535 173.68 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -94.05 -177.35 39.25 Favored Glycine 0 N--CA 1.475 1.279 0 C-N-CA 122.974 0.321 . . . . 75.04 112.528 177.751 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 72.8 m -151.78 -34.34 0.14 Allowed 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 123.533 0.733 . . . . 72.1 111.5 -175.338 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -59.49 -29.33 66.37 Favored Glycine 0 C--N 1.355 1.633 0 N-CA-C 114.402 0.521 . . . . 41.53 114.402 -173.076 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . 0.536 ' HA3' ' HD3' ' A' ' 243' ' ' PRO . . . -105.3 -10.36 31.82 Favored Glycine 0 CA--C 1.533 1.163 0 CA-C-O 119.975 -0.347 . . . . 70.32 113.265 177.007 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 30.5 m 62.43 18.44 10.35 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 124.601 1.16 . . . . 70.03 112.794 179.713 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 191' ' ' GLN . . . . . 0.592 ' HB3' ' HD2' ' A' ' 243' ' ' PRO . 6.8 pt20 -65.19 -28.96 69.75 Favored 'General case' 0 N--CA 1.483 1.178 0 CA-C-O 121.302 0.572 . . . . 72.13 110.768 -178.624 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -76.05 135.61 39.92 Favored 'General case' 0 C--O 1.241 0.624 0 CA-C-N 114.387 -1.279 . . . . 74.43 110.048 -177.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 43.6 mt -117.87 168.26 10.66 Favored 'General case' 0 C--O 1.24 0.589 0 CA-C-N 114.701 -1.136 . . . . 72.53 109.204 177.796 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 31.8 m-85 -138.6 121.86 17.01 Favored 'General case' 0 C--O 1.238 0.466 0 C-N-CA 123.483 0.713 . . . . 74.23 109.656 -179.49 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . 0.468 ' HB1' HD23 ' A' ' 251' ' ' LEU . . . -126.9 133.67 50.62 Favored 'General case' 0 CA--C 1.516 -0.342 0 C-N-CA 123.962 0.905 . . . . 70.04 108.607 177.448 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 2.2 m -81.45 125.59 30.62 Favored 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 108.82 -0.808 . . . . 73.33 108.82 176.234 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . 0.561 HD21 HD13 ' A' ' 251' ' ' LEU . 15.7 tp -109.55 111.39 22.88 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 108.672 -0.862 . . . . 74.14 108.672 -176.624 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -76.19 127.93 33.91 Favored 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 108.55 -0.907 . . . . 73.13 108.55 174.491 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 199' ' ' VAL . . . . . 0.493 ' O ' ' HA ' ' A' ' 255' ' ' ILE . 7.7 p -145.29 133.58 10.74 Favored Pre-proline 0 CA--C 1.544 0.716 0 N-CA-C 108.475 -0.935 . . . . 70.21 108.475 176.112 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 200' ' ' PRO . . . . . 0.455 ' HB2' ' HD2' ' A' ' 202' ' ' PRO . 75.4 Cg_endo -75.74 160.98 37.19 Favored 'Trans proline' 0 C--N 1.361 1.191 0 C-N-CA 121.737 1.625 . . . . 64.33 111.25 167.97 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -55.75 -47.25 99.12 Favored Pre-proline 0 CA--C 1.558 1.282 0 CA-C-O 117.695 -1.145 . . . . 71.35 113.786 -178.323 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 202' ' ' PRO . . . . . 0.455 ' HD2' ' HB2' ' A' ' 200' ' ' PRO . 56.1 Cg_endo -64.47 -37.95 35.95 Favored 'Trans proline' 0 C--N 1.396 3.057 0 C-N-CA 121.691 1.594 . . . . 75.02 112.964 -177.861 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 45.1 mt -67.93 -34.93 70.04 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.062 0 CA-C-O 120.817 0.341 . . . . 75.4 110.436 176.248 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 204' ' ' ALA . . . . . 0.41 ' HA ' HG11 ' A' ' 223' ' ' VAL . . . -67.45 -40.61 85.39 Favored 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 123.048 0.539 . . . . 72.44 112.239 179.382 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 17.1 m -80.27 -45.98 22.0 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.793 0 N-CA-C 112.919 0.711 . . . . 72.51 112.919 -175.543 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 206' ' ' VAL . . . . . 0.422 HG23 ' O ' ' A' ' 202' ' ' PRO . 11.1 m -78.04 -25.57 14.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 C-N-CA 122.213 0.205 . . . . 74.13 111.516 178.477 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 82.24 66.25 1.58 Allowed Glycine 0 C--N 1.344 1.026 0 N-CA-C 111.944 -0.462 . . . . 72.25 111.944 -177.318 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -86.47 -130.93 2.85 Favored Glycine 0 C--N 1.352 1.442 0 C-N-CA 123.262 0.458 . . . . 74.12 112.217 177.494 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 209' ' ' LYS . . . . . 0.43 ' HG2' ' HA ' ' A' ' 222' ' ' ALA . 48.4 mtmt -137.89 155.72 48.64 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 124.063 0.945 . . . . 73.12 111.084 177.001 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 9.5 m -147.51 151.89 13.32 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.793 0 C-N-CA 125.288 1.435 . . . . 74.55 108.682 169.763 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 211' ' ' ARG . . . . . 0.439 ' HD2' ' HB2' ' A' ' 218' ' ' PRO . 54.5 ttp180 -87.55 116.9 25.99 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 123.069 0.548 . . . . 73.31 110.501 179.749 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -100.87 129.01 46.67 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 123.95 0.9 . . . . 74.34 109.769 177.557 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 22.4 mmt -86.29 120.86 28.1 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 108.96 -0.755 . . . . 71.12 108.96 175.49 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 24.0 p -123.41 -174.71 3.02 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 123.928 0.891 . . . . 73.43 109.835 -174.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 77.0 mt -65.77 -29.36 69.85 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 122.752 0.421 . . . . 75.41 110.894 172.259 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 18.6 mm-40 -90.6 6.77 42.4 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 123.859 0.864 . . . . 61.53 110.971 -179.589 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 96.79 -160.34 21.71 Favored Glycine 0 C--N 1.352 1.47 0 CA-C-O 119.581 -0.566 . . . . 74.32 112.636 177.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 218' ' ' PRO . . . . . 0.439 ' HB2' ' HD2' ' A' ' 211' ' ' ARG . 71.8 Cg_endo -75.11 144.25 29.67 Favored 'Trans proline' 0 C--N 1.368 1.565 0 C-N-CA 122.336 2.024 . . . . 74.02 112.471 -179.665 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 7.5 p -146.92 131.27 10.46 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 C-N-CA 123.199 0.599 . . . . 72.01 109.778 177.663 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -69.73 103.09 2.05 Favored 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 108.114 -1.069 . . . . 72.12 108.114 169.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 1.7 p -103.58 120.61 53.88 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.133 0 N-CA-C 108.263 -1.014 . . . . 63.45 108.263 179.74 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . 0.604 ' H ' HD23 ' A' ' 172' ' ' LEU . . . -76.11 109.91 10.15 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 123.382 0.673 . . . . 62.23 111.558 -175.441 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . 0.41 HG11 ' HA ' ' A' ' 204' ' ' ALA . 51.9 t -55.2 138.4 66.52 Favored Pre-proline 0 N--CA 1.48 1.054 0 C-N-CA 125.636 1.574 . . . . 73.31 111.029 -177.087 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 224' ' ' PRO . . . . . 0.478 ' HB2' ' HB3' ' A' ' 179' ' ' ALA . 36.8 Cg_endo -66.42 147.79 83.16 Favored 'Trans proline' 0 C--N 1.377 2.03 0 C-N-CA 121.61 1.54 . . . . 73.0 110.843 170.918 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_exo -69.1 149.33 70.97 Favored 'Trans proline' 0 C--N 1.364 1.378 0 C-N-CA 121.725 1.617 . . . . 75.24 111.672 174.287 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 82.4 mtt180 63.94 39.56 7.99 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 124.79 1.236 . . . . 73.41 111.099 173.09 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 227' ' ' THR . . . . . 0.404 ' OG1' ' HG2' ' A' ' 224' ' ' PRO . 91.3 m -83.08 139.15 33.39 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 115.349 -0.841 . . . . 74.5 109.881 177.436 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 27.3 mp0 -112.36 148.31 34.55 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 124.325 1.05 . . . . 73.22 109.208 176.413 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -59.2 128.65 38.21 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 123.546 0.738 . . . . 65.24 110.854 -179.615 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 105.6 -3.56 39.58 Favored Glycine 0 N--CA 1.471 1.023 0 O-C-N 123.828 0.705 . . . . 72.01 113.18 -177.55 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 231' ' ' ARG . . . . . 0.403 ' HD2' HG23 ' A' ' 227' ' ' THR . 62.8 mtt-85 -71.68 149.96 45.0 Favored 'General case' 0 C--N 1.359 1.006 0 CA-C-N 117.43 0.615 . . . . 73.12 109.839 171.851 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -127.45 103.35 7.31 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 123.263 0.625 . . . . 73.32 109.341 -174.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 233' ' ' LEU . . . . . 0.532 ' HB2' ' HB2' ' A' ' 251' ' ' LEU . 28.9 mt -80.38 149.34 30.25 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 114.16 -1.382 . . . . 75.42 109.121 -177.213 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 56.5 ttt180 -115.39 109.04 17.3 Favored 'General case' 0 N--CA 1.481 1.11 0 O-C-N 121.926 -0.484 . . . . 74.34 111.349 -171.755 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 235' ' ' LEU . . . . . 0.557 ' HB2' ' HB3' ' A' ' 249' ' ' LEU . 19.2 mt -95.68 107.02 19.19 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 123.125 0.57 . . . . 71.35 110.116 176.565 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 21.2 mttt -73.25 137.69 45.08 Favored 'General case' 0 CA--C 1.535 0.393 0 O-C-N 123.214 0.321 . . . . 74.33 110.208 174.114 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 74.01 19.17 79.79 Favored Glycine 0 C--N 1.34 0.78 0 CA-C-N 115.567 -0.742 . . . . 73.31 114.017 179.661 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 34.9 mmtm -121.19 6.93 10.22 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 123.367 0.667 . . . . 60.23 110.616 174.171 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -109.0 -170.5 20.79 Favored Glycine 0 C--N 1.347 1.175 0 N-CA-C 110.534 -1.026 . . . . 72.43 110.534 163.053 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 89.0 m-85 -89.96 147.64 37.77 Favored Pre-proline 0 N--CA 1.478 0.95 0 C-N-CA 123.169 0.588 . . . . 71.52 110.972 -177.66 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 17.6 Cg_exo -68.02 128.2 17.29 Favored 'Trans proline' 0 C--N 1.365 1.404 0 C-N-CA 121.771 1.648 . . . . 75.03 111.137 172.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -158.97 -121.66 0.63 Allowed Glycine 0 C--N 1.347 1.16 0 CA-C-O 118.351 -1.249 . . . . 63.24 112.313 -177.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 243' ' ' PRO . . . . . 0.592 ' HD2' ' HB3' ' A' ' 191' ' ' GLN . 25.2 Cg_endo -55.21 -45.58 39.32 Favored 'Trans proline' 0 C--N 1.38 2.23 0 C-N-CA 124.414 3.409 . . . . 75.14 113.489 -174.599 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -86.64 -13.22 46.21 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 123.156 0.582 . . . . 72.1 111.539 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 92.54 -30.64 6.71 Favored Glycine 0 C--N 1.348 1.21 0 N-CA-C 112.068 -0.413 . . . . 73.24 112.068 -174.402 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 46.0 ttm-85 -128.28 112.47 14.5 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 124.364 1.065 . . . . 70.42 109.114 176.066 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -72.73 154.78 50.43 Favored Glycine 0 C--N 1.347 1.192 0 O-C-N 123.181 0.301 . . . . 71.22 113.584 172.883 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 20.9 m-20 -110.24 165.49 11.72 Favored 'General case' 0 C--O 1.237 0.398 0 C-N-CA 123.996 0.918 . . . . 75.41 110.088 -177.689 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 249' ' ' LEU . . . . . 0.557 ' HB3' ' HB2' ' A' ' 235' ' ' LEU . 34.7 tp -129.47 113.32 14.75 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 123.758 0.823 . . . . 74.52 108.877 176.16 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 250' ' ' TYR . . . . . 0.449 ' HA ' ' O ' ' A' ' 233' ' ' LEU . 7.5 m-85 -91.04 110.55 21.82 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 115.664 -0.698 . . . . 74.54 110.627 -177.452 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 251' ' ' LEU . . . . . 0.561 HD13 HD21 ' A' ' 197' ' ' LEU . 84.6 mt -88.39 105.36 17.54 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 114.139 -1.391 . . . . 75.14 109.143 -178.644 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -80.12 100.83 8.42 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 108.687 -0.857 . . . . 74.14 108.687 175.849 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 12.1 m -63.58 133.97 28.92 Favored 'Isoleucine or valine' 0 C--O 1.246 0.895 0 O-C-N 123.775 0.672 . . . . 64.24 110.094 -179.777 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 20.5 mmm-85 -127.64 94.22 3.91 Favored 'General case' 0 C--O 1.24 0.59 0 N-CA-C 107.815 -1.179 . . . . 75.35 107.815 -177.257 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 255' ' ' ILE . . . . . 0.493 ' HA ' ' O ' ' A' ' 199' ' ' VAL . 22.4 mt -76.76 133.75 30.27 Favored 'Isoleucine or valine' 0 C--O 1.238 0.469 0 O-C-N 124.482 1.114 . . . . 75.24 110.836 -173.909 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 9.7 t . . . . . 0 CA--C 1.569 1.698 0 CA-C-O 117.589 -1.196 . . . . 74.15 108.832 179.824 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 13.5 tpt . . . . . 0 N--CA 1.476 0.869 0 N-CA-C 108.875 -0.787 . . . . 75.23 108.875 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 169' ' ' GLN . . . . . 0.553 ' HG3' ' H ' ' A' ' 170' ' ' THR . 7.5 pt20 -145.79 -74.46 0.22 Allowed 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 123.204 0.602 . . . . 73.23 110.617 -178.931 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 170' ' ' THR . . . . . 0.553 ' H ' ' HG3' ' A' ' 169' ' ' GLN . 14.1 m -164.84 112.56 1.03 Allowed 'General case' 0 CA--C 1.538 0.503 0 N-CA-C 107.062 -1.459 . . . . 75.4 107.062 -162.199 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -124.37 -93.56 0.5 Allowed 'General case' 0 N--CA 1.488 1.431 0 C-N-CA 122.999 0.52 . . . . 72.12 112.053 -168.346 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 172' ' ' LEU . . . . . 0.567 HD22 ' H ' ' A' ' 222' ' ' ALA . 53.3 mt -134.35 145.17 48.74 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 123.591 0.756 . . . . 74.24 110.188 -170.973 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 173' ' ' PHE . . . . . 0.478 ' CD1' HD22 ' A' ' 235' ' ' LEU . 52.3 m-85 -140.66 -58.27 0.52 Allowed 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.829 0.852 . . . . 74.13 109.191 -164.067 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 174' ' ' TYR . . . . . 0.478 ' OH ' ' HB ' ' A' ' 221' ' ' VAL . 7.2 p90 -70.53 -14.96 62.72 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 114.347 -1.297 . . . . 73.12 113.089 -177.806 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -45.73 -29.02 1.16 Allowed 'General case' 0 N--CA 1.49 1.574 0 C-N-CA 126.172 1.789 . . . . 71.22 114.076 -173.157 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 176' ' ' MET . . . . . . . . . . . . . 66.5 mtm -55.7 -38.95 70.38 Favored 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 124.736 1.214 . . . . 75.34 112.934 -178.58 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 14.3 ptmm? -160.42 34.48 0.16 Allowed 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 123.503 0.721 . . . . 75.22 110.848 -170.766 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -64.16 -46.24 84.88 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 124.764 1.226 . . . . 64.12 113.479 -169.705 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . 0.448 ' HB3' ' HB2' ' A' ' 224' ' ' PRO . . . -82.65 65.79 7.95 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-O 122.124 0.964 . . . . 75.55 109.629 -179.71 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -164.61 -169.49 28.27 Favored Glycine 0 C--O 1.243 0.685 0 CA-C-N 114.19 -1.368 . . . . 71.34 110.48 -179.327 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 72.0 m -151.5 90.16 1.55 Allowed 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 124.111 0.964 . . . . 70.03 108.596 176.829 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -79.45 -177.34 50.05 Favored Glycine 0 C--N 1.345 1.047 0 CA-C-N 115.507 -0.77 . . . . 73.42 112.397 177.404 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -82.45 64.36 4.29 Favored Glycine 0 C--N 1.346 1.13 0 CA-C-N 116.891 0.345 . . . . 72.43 112.358 178.38 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 49.6 m -85.04 -11.82 54.5 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 123.829 0.852 . . . . 72.03 111.372 -179.42 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -70.44 117.67 7.34 Favored Glycine 0 C--N 1.349 1.26 0 N-CA-C 111.624 -0.59 . . . . 74.14 111.624 176.693 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -169.98 169.19 41.99 Favored Glycine 0 C--N 1.34 0.781 0 N-CA-C 111.804 -0.518 . . . . 64.44 111.804 -178.573 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 52.6 p -79.39 93.97 5.44 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 123.095 0.558 . . . . 74.52 109.826 177.542 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -66.81 159.36 49.04 Favored Glycine 0 C--N 1.349 1.277 0 CA-C-N 115.656 -0.702 . . . . 44.11 112.376 175.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -104.34 28.17 16.21 Favored Glycine 0 N--CA 1.473 1.109 0 CA-C-O 119.875 -0.403 . . . . 61.44 112.315 179.537 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 19.7 m 70.66 6.01 5.65 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 125.437 1.495 . . . . 75.41 112.263 -173.78 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 191' ' ' GLN . . . . . 0.646 HE22 ' HB3' ' A' ' 244' ' ' ALA . 5.8 pt20 -75.72 -42.06 51.8 Favored 'General case' 0 C--N 1.358 0.954 0 N-CA-C 109.235 -0.654 . . . . 72.11 109.235 175.822 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . 0.504 ' N ' ' HG3' ' A' ' 191' ' ' GLN . 31.3 m-20 -80.27 137.33 36.61 Favored 'General case' 0 C--N 1.354 0.778 0 CA-C-N 115.229 -0.896 . . . . 63.04 109.003 -176.125 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 32.2 mt -113.05 174.83 5.71 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 115.85 -0.614 . . . . 74.12 111.379 -173.438 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 48.5 m-85 -136.93 124.15 21.78 Favored 'General case' 0 C--O 1.238 0.492 0 C-N-CA 124.552 1.141 . . . . 74.0 109.466 -179.771 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . 0.41 ' O ' ' HA ' ' A' ' 251' ' ' LEU . . . -135.42 128.29 31.26 Favored 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 107.269 -1.382 . . . . 73.41 107.269 171.429 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 44.9 m -82.77 125.8 31.68 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 109.188 -0.671 . . . . 74.13 109.188 -179.839 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . 0.5 HD23 HD12 ' A' ' 251' ' ' LEU . 15.9 tp -106.65 110.8 23.09 Favored 'General case' 0 N--CA 1.466 0.333 0 N-CA-C 107.916 -1.142 . . . . 75.24 107.916 -176.743 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -87.69 126.61 35.07 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 123.272 0.629 . . . . 65.52 109.345 -179.336 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 199' ' ' VAL . . . . . 0.479 ' O ' ' HA ' ' A' ' 255' ' ' ILE . 5.5 p -144.83 132.63 10.52 Favored Pre-proline 0 CA--C 1.55 0.969 0 N-CA-C 108.409 -0.96 . . . . 74.42 108.409 -178.792 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -72.74 159.35 48.72 Favored 'Trans proline' 0 C--N 1.368 1.583 0 C-N-CA 121.987 1.792 . . . . 71.44 111.023 171.031 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 201' ' ' ALA . . . . . 0.471 ' O ' HG22 ' A' ' 205' ' ' VAL . . . -50.95 -53.71 45.0 Favored Pre-proline 0 CA--C 1.558 1.264 0 CA-C-O 117.659 -1.162 . . . . 71.32 113.361 -176.466 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -63.95 -35.31 55.73 Favored 'Trans proline' 0 C--N 1.389 2.677 0 C-N-CA 121.598 1.532 . . . . 75.03 113.504 -175.799 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 41.0 mt -68.73 -33.82 61.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 N-CA-C 109.702 -0.481 . . . . 74.41 109.702 176.005 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 204' ' ' ALA . . . . . 0.458 ' HB1' ' HB ' ' A' ' 227' ' ' THR . . . -70.14 -35.66 74.22 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 123.228 0.611 . . . . 73.35 111.305 178.47 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . 0.471 HG22 ' O ' ' A' ' 201' ' ' ALA . 90.2 t -70.94 -56.44 10.65 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 C-N-CA 123.398 0.679 . . . . 73.44 110.522 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 17.3 m -73.32 -27.57 24.11 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.956 0 C-N-CA 122.862 0.465 . . . . 71.32 111.334 -174.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 81.36 69.62 1.39 Allowed Glycine 0 C--N 1.341 0.85 0 CA-C-N 115.839 -0.619 . . . . 74.42 112.262 -175.622 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -87.56 -140.05 6.44 Favored Glycine 0 C--N 1.355 1.618 0 CA-C-O 119.593 -0.56 . . . . 72.53 112.236 177.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 47.8 mtmt -137.35 147.47 45.57 Favored 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 123.66 0.784 . . . . 75.02 110.97 179.662 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 5.6 m -143.39 160.17 17.12 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 C-N-CA 125.271 1.428 . . . . 75.51 109.369 176.804 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 24.3 ttt180 -90.49 114.58 26.8 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 123.929 0.892 . . . . 73.34 110.449 179.587 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -102.18 131.87 48.43 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 124.753 1.221 . . . . 73.12 109.841 174.772 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 37.2 tpp -88.28 130.96 34.97 Favored 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 109.87 -0.418 . . . . 70.13 109.87 176.506 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 63.4 p -120.24 -171.68 2.21 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 124.309 1.043 . . . . 75.1 109.279 177.425 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 89.9 mt -67.93 -22.21 65.07 Favored 'General case' 0 CA--C 1.55 0.971 0 C-N-CA 123.315 0.646 . . . . 73.13 111.789 172.347 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 58.6 mt-10 -90.68 -21.12 21.79 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 123.578 0.751 . . . . 74.41 111.258 -177.685 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 124.48 -156.34 18.52 Favored Glycine 0 C--N 1.34 0.779 0 N-CA-C 111.092 -0.803 . . . . 54.1 111.092 -173.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -76.3 140.16 21.75 Favored 'Trans proline' 0 CA--C 1.551 1.356 0 C-N-CA 122.219 1.946 . . . . 75.23 113.932 -176.821 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 219' ' ' VAL . . . . . 0.412 HG21 HG21 ' A' ' 170' ' ' THR . 2.4 p -131.98 128.98 60.2 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.451 0 C-N-CA 124.678 1.191 . . . . 74.15 108.015 172.109 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -81.75 102.09 10.54 Favored 'General case' 0 C--O 1.236 0.376 0 N-CA-C 108.349 -0.982 . . . . 72.33 108.349 174.011 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 221' ' ' VAL . . . . . 0.478 ' HB ' ' OH ' ' A' ' 174' ' ' TYR . 13.9 m -97.65 138.85 21.33 Favored 'Isoleucine or valine' 0 C--O 1.242 0.679 0 CA-C-N 115.431 -0.804 . . . . 74.33 109.459 179.57 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . 0.567 ' H ' HD22 ' A' ' 172' ' ' LEU . . . -88.85 107.83 19.2 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-N 115.05 -0.977 . . . . 63.41 109.624 -177.355 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 61.2 t -54.09 134.3 59.15 Favored Pre-proline 0 N--CA 1.482 1.137 0 C-N-CA 124.302 1.041 . . . . 65.14 109.532 -179.332 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 224' ' ' PRO . . . . . 0.448 ' HB2' ' HB3' ' A' ' 179' ' ' ALA . 26.1 Cg_endo -60.52 151.23 76.8 Favored 'Trans proline' 0 C--N 1.373 1.858 0 C-N-CA 121.922 1.748 . . . . 72.34 112.647 177.29 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -64.56 133.76 38.37 Favored 'Trans proline' 0 C--N 1.368 1.601 0 C-N-CA 121.485 1.457 . . . . 74.1 110.677 169.505 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 55.3 mtt180 67.03 62.64 0.48 Allowed 'General case' 0 C--O 1.241 0.629 0 C-N-CA 124.797 1.239 . . . . 72.2 109.831 175.668 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 227' ' ' THR . . . . . 0.65 ' HA ' ' HE ' ' A' ' 231' ' ' ARG . 56.1 m -89.87 140.51 29.54 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 113.866 -1.515 . . . . 74.33 109.173 176.582 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -116.64 141.54 48.07 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.736 0.814 . . . . 72.21 108.862 171.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 229' ' ' ALA . . . . . 0.437 ' HB3' ' HB ' ' A' ' 255' ' ' ILE . . . -58.91 116.99 4.15 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 123.651 0.781 . . . . 62.0 110.217 179.911 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 115.16 -2.2 22.51 Favored Glycine 0 CA--C 1.526 0.754 0 CA-C-O 119.123 -0.821 . . . . 73.11 113.542 -173.07 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 231' ' ' ARG . . . . . 0.65 ' HE ' ' HA ' ' A' ' 227' ' ' THR . 77.5 mtt-85 -66.38 145.49 55.64 Favored 'General case' 0 N--CA 1.483 1.203 0 CA-C-N 118.042 0.921 . . . . 62.52 109.183 169.55 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -121.38 98.81 6.15 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 107.899 -1.149 . . . . 74.34 107.899 -174.477 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 233' ' ' LEU . . . . . 0.798 ' HB2' ' HB2' ' A' ' 251' ' ' LEU . 53.7 mt -79.79 152.27 29.86 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 115.36 -0.836 . . . . 73.23 109.371 179.843 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 59.4 ttm-85 -122.29 106.49 11.15 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 122.937 0.495 . . . . 73.23 110.542 -175.464 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 235' ' ' LEU . . . . . 0.594 ' HB2' ' HB3' ' A' ' 249' ' ' LEU . 10.3 mt -91.58 100.17 12.96 Favored 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 109.043 -0.725 . . . . 74.34 109.043 171.376 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 19.4 mttt -67.34 132.91 48.63 Favored 'General case' 0 C--O 1.241 0.61 0 O-C-N 123.365 0.416 . . . . 73.42 111.347 -178.042 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 73.89 18.2 79.55 Favored Glycine 0 C--N 1.347 1.193 0 CA-C-N 115.03 -0.986 . . . . 71.43 115.034 177.248 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 68.9 mmtt -106.4 12.41 29.78 Favored 'General case' 0 N--CA 1.488 1.455 0 CA-C-N 117.405 0.603 . . . . 75.15 110.514 174.749 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -113.9 -165.66 15.73 Favored Glycine 0 CA--C 1.527 0.811 0 CA-C-N 114.822 -1.081 . . . . 71.21 110.732 167.802 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -95.17 168.01 11.84 Favored Pre-proline 0 N--CA 1.479 1.022 0 C-N-CA 124.278 1.031 . . . . 72.44 110.097 -177.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -81.27 149.14 16.97 Favored 'Trans proline' 0 C--N 1.372 1.786 0 C-N-CA 121.599 1.533 . . . . 74.14 112.859 171.63 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 179.52 -119.75 0.66 Allowed Glycine 0 CA--C 1.54 1.598 0 CA-C-O 119.004 -0.887 . . . . 70.22 113.28 176.021 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 243' ' ' PRO . . . . . 0.445 ' HD2' ' HB3' ' A' ' 191' ' ' GLN . 34.1 Cg_endo -55.62 -46.67 30.23 Favored 'Trans proline' 0 C--N 1.382 2.306 1 C-N-CA 125.364 4.043 . . . . 71.0 114.055 -172.241 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 244' ' ' ALA . . . . . 0.646 ' HB3' HE22 ' A' ' 191' ' ' GLN . . . -100.19 -2.21 34.55 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 123.315 0.646 . . . . 74.3 110.952 -179.133 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 87.8 -51.51 4.1 Favored Glycine 0 C--N 1.353 1.489 0 N-CA-C 111.833 -0.507 . . . . 73.02 111.833 -178.461 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 10.2 ttm180 -101.05 109.63 21.55 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 123.947 0.899 . . . . 72.13 109.879 176.679 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -75.98 130.41 10.94 Favored Glycine 0 C--N 1.351 1.373 0 N-CA-C 110.661 -0.976 . . . . 45.53 110.661 169.264 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 67.4 m-20 -112.31 145.65 39.65 Favored 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 109.332 -0.618 . . . . 72.04 109.332 -176.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 249' ' ' LEU . . . . . 0.594 ' HB3' ' HB2' ' A' ' 235' ' ' LEU . 31.4 tp -97.87 118.68 34.99 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 123.677 0.791 . . . . 62.05 109.207 -175.239 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 250' ' ' TYR . . . . . 0.41 ' HA ' ' O ' ' A' ' 233' ' ' LEU . 1.6 m-85 -89.34 108.87 19.88 Favored 'General case' 0 C--O 1.243 0.739 0 N-CA-C 108.727 -0.842 . . . . 75.1 108.727 -177.337 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 251' ' ' LEU . . . . . 0.798 ' HB2' ' HB2' ' A' ' 233' ' ' LEU . 79.7 mt -87.36 104.03 16.04 Favored 'General case' 0 C--O 1.241 0.61 0 N-CA-C 107.94 -1.133 . . . . 74.05 107.94 177.41 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -84.1 100.15 10.93 Favored 'General case' 0 C--O 1.238 0.457 0 CA-C-N 115.063 -0.972 . . . . 72.44 108.918 -177.535 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 11.7 m -72.04 135.59 27.53 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 CA-C-O 121.53 0.681 . . . . 71.43 110.67 -172.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 49.7 mmm-85 -127.42 98.92 5.42 Favored 'General case' 0 C--O 1.237 0.431 0 C-N-CA 124.608 1.163 . . . . 73.44 108.299 -178.594 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 255' ' ' ILE . . . . . 0.479 ' HA ' ' O ' ' A' ' 199' ' ' VAL . 27.2 mt -77.95 128.59 38.14 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 O-C-N 124.169 0.918 . . . . 73.44 109.754 179.735 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 4.2 t . . . . . 0 CA--C 1.559 1.327 0 CA-C-O 117.273 -1.346 . . . . 72.42 107.957 179.486 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 24.7 ptp . . . . . 0 N--CA 1.493 1.695 0 N-CA-C 111.648 0.24 . . . . 74.51 111.648 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -167.16 -157.39 0.24 Allowed 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.539 0.736 . . . . 73.22 109.302 -173.427 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 10.8 t -124.67 172.77 9.01 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 123.483 0.713 . . . . 74.32 109.398 170.425 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 2.7 p-10 -153.64 -63.69 0.14 Allowed 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 123.05 0.54 . . . . 72.23 111.314 -174.415 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 172' ' ' LEU . . . . . 0.426 HD21 ' HB2' ' A' ' 222' ' ' ALA . 43.4 mt -119.56 140.76 50.02 Favored 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 123.102 0.561 . . . . 71.2 112.035 -169.029 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 173' ' ' PHE . . . . . 0.484 ' CD1' HD22 ' A' ' 235' ' ' LEU . 11.9 m-85 -137.65 -44.95 0.54 Allowed 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 124.028 0.931 . . . . 64.25 109.519 -173.042 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 174' ' ' TYR . . . . . 0.504 ' CD2' ' HB3' ' A' ' 233' ' ' LEU . 0.7 OUTLIER -81.97 13.44 3.34 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-N 114.832 -1.076 . . . . 70.32 112.899 -175.689 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 175' ' ' THR . . . . . 0.412 HG21 ' HB3' ' A' ' 172' ' ' LEU . 11.6 p -63.37 -9.12 10.76 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.867 0.867 . . . . 71.24 113.308 -179.857 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 176' ' ' MET . . . . . . . . . . . . . 44.9 mtm -58.41 -63.96 1.09 Allowed 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 123.595 0.758 . . . . 63.53 109.104 166.36 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 44.8 pttt -168.1 119.06 0.81 Allowed 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 125.094 1.358 . . . . 74.42 108.337 -179.053 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 178' ' ' ALA . . . . . 0.571 ' HB2' HD22 ' A' ' 233' ' ' LEU . . . -124.04 -54.5 1.71 Allowed 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 123.916 0.886 . . . . 65.14 109.82 -173.641 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . 0.417 ' HA ' ' HD3' ' A' ' 231' ' ' ARG . . . -79.42 65.13 4.5 Favored 'General case' 0 CA--C 1.543 0.702 0 CA-C-O 121.918 0.866 . . . . 74.11 108.742 169.986 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 140.36 77.59 0.05 OUTLIER Glycine 0 C--N 1.336 0.568 0 N-CA-C 110.148 -1.181 . . . . 42.22 110.148 -171.672 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 24.6 m -81.67 15.05 2.3 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 123.475 0.71 . . . . 74.55 112.406 -176.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -61.41 93.82 0.08 OUTLIER Glycine 0 C--N 1.345 1.065 0 N-CA-C 112.032 -0.427 . . . . 61.45 112.032 172.543 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -163.36 -109.15 0.23 Allowed Glycine 0 C--N 1.335 0.524 0 N-CA-C 111.283 -0.727 . . . . 73.22 111.283 -178.122 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 24.9 p -148.45 166.85 26.92 Favored 'General case' 0 C--O 1.245 0.84 0 C-N-CA 123.34 0.656 . . . . 73.43 111.182 -175.545 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . 0.453 ' HA2' ' NH2' ' A' ' 234' ' ' ARG . . . -114.73 -100.5 2.33 Favored Glycine 0 C--N 1.349 1.292 0 N-CA-C 111.187 -0.765 . . . . 65.42 111.187 176.348 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 149.52 121.91 1.13 Allowed Glycine 0 C--N 1.351 1.368 0 N-CA-C 112.123 -0.391 . . . . 72.12 112.123 -179.619 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 33.1 m -128.34 139.67 52.27 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 123.683 0.793 . . . . 71.21 109.776 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 131.33 17.51 1.41 Allowed Glycine 0 C--N 1.341 0.846 0 CA-C-N 116.083 -0.508 . . . . 63.14 111.885 -176.508 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 153.65 141.09 3.19 Favored Glycine 0 C--N 1.344 1.028 0 N-CA-C 110.551 -1.02 . . . . 74.42 110.551 -178.347 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 68.8 m -73.33 84.14 1.42 Allowed 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 123.396 0.678 . . . . 73.22 110.189 179.658 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 191' ' ' GLN . . . . . 0.431 ' HG3' ' N ' ' A' ' 192' ' ' ASP . 6.5 pt20 -106.14 -42.04 5.19 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 116.162 -0.472 . . . . 73.23 110.278 -179.713 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . 0.431 ' N ' ' HG3' ' A' ' 191' ' ' GLN . 73.5 m-20 -84.94 121.0 27.13 Favored 'General case' 0 C--N 1.347 0.482 0 C-N-CA 123.998 0.919 . . . . 73.24 109.404 -175.722 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . 0.427 HD13 ' HA2' ' A' ' 239' ' ' GLY . 78.5 mt -108.17 177.67 4.73 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 124.351 1.06 . . . . 72.34 110.479 -170.383 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 47.3 m-85 -129.61 123.59 31.65 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 123.426 0.691 . . . . 75.44 110.736 -179.546 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . 0.414 ' HB1' HD11 ' A' ' 249' ' ' LEU . . . -128.29 171.98 11.48 Favored 'General case' 0 C--O 1.238 0.496 0 C-N-CA 125.64 1.576 . . . . 75.25 108.43 173.401 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 48.6 m -119.05 134.03 55.44 Favored 'General case' 0 C--O 1.237 0.446 0 C-N-CA 123.126 0.571 . . . . 71.53 109.675 175.57 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . 0.694 HD22 HD12 ' A' ' 251' ' ' LEU . 17.1 tp -116.37 110.87 19.25 Favored 'General case' 0 C--O 1.234 0.288 0 N-CA-C 108.178 -1.045 . . . . 71.33 108.178 175.477 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -90.14 122.56 33.21 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 108.68 -0.859 . . . . 74.02 108.68 -179.632 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 199' ' ' VAL . . . . . 0.417 ' O ' ' HA ' ' A' ' 255' ' ' ILE . 5.0 p -136.18 132.4 19.08 Favored Pre-proline 0 CA--C 1.549 0.917 0 C-N-CA 124.287 1.035 . . . . 72.21 108.835 -174.795 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 200' ' ' PRO . . . . . 0.403 ' HB2' ' HD2' ' A' ' 202' ' ' PRO . 60.5 Cg_endo -71.73 158.87 52.3 Favored 'Trans proline' 0 C--N 1.367 1.551 0 C-N-CA 122.025 1.817 . . . . 74.21 111.256 171.422 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -53.0 -46.06 97.81 Favored Pre-proline 0 CA--C 1.558 1.257 0 N-CA-C 114.208 1.188 . . . . 73.14 114.208 -179.675 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 202' ' ' PRO . . . . . 0.433 ' O ' HG22 ' A' ' 206' ' ' VAL . 34.3 Cg_endo -62.8 -43.45 20.47 Favored 'Trans proline' 0 C--N 1.385 2.494 0 C-N-CA 121.918 1.745 . . . . 64.43 113.675 177.527 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 43.5 mt -66.01 -30.73 50.89 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.351 0 CA-C-N 118.746 0.703 . . . . 74.4 110.5 177.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -68.74 -49.38 59.26 Favored 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 122.769 0.428 . . . . 73.42 111.587 177.26 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . 0.412 HG23 ' HA ' ' A' ' 202' ' ' PRO . 22.7 m -70.92 -47.83 60.09 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.848 0 C-N-CA 123.542 0.737 . . . . 74.44 112.411 -174.905 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 206' ' ' VAL . . . . . 0.433 HG22 ' O ' ' A' ' 202' ' ' PRO . 11.0 m -76.22 -34.19 25.45 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.235 0 C-N-CA 122.552 0.341 . . . . 61.42 110.979 179.712 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 87.47 61.06 1.57 Allowed Glycine 0 C--N 1.35 1.31 0 CA-C-N 116.251 -0.431 . . . . 70.11 112.135 -175.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -81.59 -133.93 1.64 Allowed Glycine 0 C--N 1.346 1.132 0 N-CA-C 112.511 -0.236 . . . . 74.1 112.511 177.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 209' ' ' LYS . . . . . 0.414 ' HG2' ' HA ' ' A' ' 222' ' ' ALA . 48.0 mtmt -136.21 152.67 51.01 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 123.895 0.878 . . . . 74.35 110.839 178.741 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 4.5 m -144.76 163.52 13.48 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 C-N-CA 125.412 1.485 . . . . 75.32 108.363 172.238 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 42.0 ttp180 -98.94 115.36 28.71 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 123.622 0.769 . . . . 74.14 109.26 179.277 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -101.92 120.81 41.0 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 124.145 0.978 . . . . 73.41 110.429 -179.489 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 74.6 mtp -84.26 137.28 33.56 Favored 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 110.125 -0.324 . . . . 74.24 110.125 175.708 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 38.0 p -130.54 -172.9 2.92 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 124.592 1.157 . . . . 74.02 109.551 -175.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 82.6 mt -58.29 -35.0 71.17 Favored 'General case' 0 N--CA 1.488 1.465 0 CA-C-O 121.152 0.501 . . . . 73.31 110.565 172.723 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -92.29 -8.49 45.05 Favored 'General case' 0 CA--C 1.545 0.754 0 CA-C-N 115.166 -0.925 . . . . 72.01 111.378 -177.8 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 113.61 -159.32 13.75 Favored Glycine 0 C--N 1.348 1.224 0 CA-C-O 119.575 -0.569 . . . . 62.21 113.329 174.111 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -77.86 136.66 15.19 Favored 'Trans proline' 0 C--N 1.368 1.566 0 C-N-CA 123.24 2.627 . . . . 72.44 113.217 -171.584 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 6.2 p -132.8 133.09 59.4 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 C-N-CA 124.403 1.081 . . . . 75.22 109.376 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -76.61 102.06 5.97 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 108.534 -0.913 . . . . 63.04 108.534 176.173 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 6.1 p -110.06 127.25 67.1 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.975 0 N-CA-C 109.242 -0.651 . . . . 70.51 109.242 -174.06 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . 0.426 ' HB2' HD21 ' A' ' 172' ' ' LEU . . . -81.76 108.36 15.24 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 122.991 0.516 . . . . 64.43 110.755 -177.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 65.1 t -54.34 135.25 61.15 Favored Pre-proline 0 N--CA 1.484 1.245 0 C-N-CA 124.671 1.188 . . . . 72.43 110.61 179.8 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -65.41 147.69 87.43 Favored 'Trans proline' 0 C--N 1.378 2.119 0 C-N-CA 122.012 1.808 . . . . 63.13 110.873 174.219 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -60.89 138.0 76.17 Favored 'Trans proline' 0 C--N 1.368 1.592 0 C-N-CA 121.66 1.573 . . . . 73.13 111.058 174.238 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 30.9 mtm105 63.24 51.23 2.76 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 124.597 1.159 . . . . 64.5 110.953 174.632 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 90.4 m -77.7 137.05 38.28 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 115.299 -0.864 . . . . 73.04 109.087 170.457 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 28.1 mp0 -114.65 147.02 40.18 Favored 'General case' 0 N--CA 1.479 0.993 0 N-CA-C 108.939 -0.763 . . . . 64.01 108.939 174.534 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -57.91 124.54 19.58 Favored 'General case' 0 C--O 1.24 0.557 0 O-C-N 123.903 0.752 . . . . 73.11 111.017 -178.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 114.87 -14.53 19.52 Favored Glycine 0 N--CA 1.468 0.816 0 CA-C-O 119.076 -0.847 . . . . 61.13 113.858 -176.776 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 231' ' ' ARG . . . . . 0.417 ' HD3' ' HA ' ' A' ' 179' ' ' ALA . 88.9 mtt-85 -62.95 146.61 52.64 Favored 'General case' 0 N--CA 1.478 0.967 0 CA-C-N 117.759 0.779 . . . . 75.25 111.113 178.12 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 71.7 mmtt -118.84 97.49 5.73 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 123.996 0.918 . . . . 75.22 109.029 -172.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 233' ' ' LEU . . . . . 0.651 ' HB2' ' HB2' ' A' ' 251' ' ' LEU . 21.2 mt -85.52 137.96 32.53 Favored 'General case' 0 CA--C 1.546 0.807 0 N-CA-C 109.126 -0.694 . . . . 73.32 109.126 -175.316 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 234' ' ' ARG . . . . . 0.453 ' NH2' ' HA2' ' A' ' 185' ' ' GLY . 36.3 ttm-85 -110.86 114.31 27.55 Favored 'General case' 0 CA--C 1.558 1.25 0 C-N-CA 123.054 0.542 . . . . 75.44 111.377 -169.027 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 235' ' ' LEU . . . . . 0.538 HD11 HD11 ' A' ' 251' ' ' LEU . 16.5 mt -108.63 113.56 26.65 Favored 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 123.929 0.891 . . . . 74.4 111.641 -176.535 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 34.8 mttp -72.91 148.94 43.86 Favored 'General case' 0 N--CA 1.481 1.114 0 CA-C-O 121.338 0.589 . . . . 73.55 111.76 174.164 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 78.17 0.59 77.6 Favored Glycine 0 C--N 1.344 1.02 0 CA-C-N 114.107 -1.406 . . . . 72.11 113.87 179.775 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 73.4 mmtt -112.85 3.43 16.38 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.177 0.591 . . . . 75.01 111.457 -174.646 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 239' ' ' GLY . . . . . 0.427 ' HA2' HD13 ' A' ' 193' ' ' LEU . . . -113.27 -170.15 17.49 Favored Glycine 0 C--N 1.348 1.241 0 N-CA-C 111.328 -0.709 . . . . 41.1 111.328 166.834 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 79.8 m-85 -88.3 151.71 49.08 Favored Pre-proline 0 N--CA 1.481 1.114 0 C-N-CA 123.084 0.553 . . . . 60.51 110.803 -178.114 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_exo -67.44 168.03 19.06 Favored 'Trans proline' 0 C--N 1.371 1.741 0 C-N-CA 122.361 2.04 . . . . 73.12 112.614 172.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 144.06 -104.78 0.35 Allowed Glycine 0 C--N 1.348 1.212 0 CA-C-O 119.332 -0.704 . . . . 72.21 113.982 172.149 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -64.22 -30.86 64.47 Favored 'Trans proline' 0 C--N 1.375 1.94 0 C-N-CA 124.012 3.141 . . . . 74.21 114.313 -168.0 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -117.15 5.83 12.77 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 122.924 0.489 . . . . 63.15 110.701 173.593 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 87.81 -46.23 3.42 Favored Glycine 0 C--N 1.35 1.353 0 CA-C-N 116.905 -0.134 . . . . 63.33 113.131 178.234 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 31.3 ttm180 -123.99 112.02 16.7 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 124.369 1.068 . . . . 74.5 109.299 177.479 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -73.57 159.56 53.19 Favored Glycine 0 C--N 1.349 1.253 0 O-C-N 123.431 0.457 . . . . 52.12 114.17 176.119 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 248' ' ' ASP . . . . . 0.413 ' HA ' ' O ' ' A' ' 235' ' ' LEU . 12.4 m-20 -111.56 171.52 7.44 Favored 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 124.026 0.93 . . . . 72.23 111.4 -177.838 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 249' ' ' LEU . . . . . 0.414 HD11 ' HB1' ' A' ' 195' ' ' ALA . 25.9 tp -130.6 126.33 36.43 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 115.021 -0.99 . . . . 72.04 109.748 174.107 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 250' ' ' TYR . . . . . . . . . . . . . 2.8 m-30 -89.85 113.0 24.51 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 124.235 1.014 . . . . 73.35 110.516 179.76 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 251' ' ' LEU . . . . . 0.694 HD12 HD22 ' A' ' 197' ' ' LEU . 86.0 mt -87.2 103.34 15.33 Favored 'General case' 0 C--O 1.24 0.578 0 N-CA-C 107.243 -1.391 . . . . 75.2 107.243 176.091 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -80.77 101.54 9.39 Favored 'General case' 0 C--O 1.241 0.625 0 N-CA-C 108.542 -0.91 . . . . 75.1 108.542 177.594 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 17.9 m -73.59 135.56 27.3 Favored 'Isoleucine or valine' 0 C--O 1.244 0.808 0 CA-C-N 115.695 -0.684 . . . . 74.22 110.831 -172.678 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 31.3 mmm180 -125.93 99.23 5.85 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 114.559 -1.2 . . . . 71.1 108.13 -176.734 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 255' ' ' ILE . . . . . 0.417 ' HA ' ' O ' ' A' ' 199' ' ' VAL . 23.5 mt -79.35 123.06 35.77 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 O-C-N 123.565 0.541 . . . . 73.13 110.438 -179.562 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 2.0 t . . . . . 0 CA--C 1.563 1.466 0 N-CA-C 107.673 -1.232 . . . . 71.31 107.673 176.372 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 24.7 ttt . . . . . 0 N--CA 1.479 0.98 0 N-CA-C 109.706 -0.479 . . . . 74.52 109.706 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -82.73 -57.65 3.23 Favored 'General case' 0 CA--C 1.55 0.945 0 N-CA-C 108.665 -0.865 . . . . 74.14 108.665 169.363 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 170' ' ' THR . . . . . 0.483 HG21 HG23 ' A' ' 219' ' ' VAL . 9.0 t 162.25 174.17 0.01 OUTLIER 'General case' 0 CA--C 1.553 1.075 0 C-N-CA 127.041 2.136 . . . . 75.43 107.238 -173.6 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -157.95 -40.34 0.07 Allowed 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 112.501 0.556 . . . . 75.2 112.501 -174.831 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 172' ' ' LEU . . . . . 0.407 HD21 ' O ' ' A' ' 222' ' ' ALA . 26.4 mt -145.32 153.54 41.37 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 112.524 0.565 . . . . 65.44 112.524 -172.686 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 173' ' ' PHE . . . . . 0.494 ' HE1' HG22 ' A' ' 219' ' ' VAL . 38.6 m-85 -150.45 -40.98 0.13 Allowed 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 124.765 1.226 . . . . 74.01 109.411 -171.396 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 174' ' ' TYR . . . . . 0.426 ' CD2' ' HB3' ' A' ' 233' ' ' LEU . 0.7 OUTLIER -96.22 6.69 48.24 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 124.141 0.976 . . . . 74.41 112.785 -172.748 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -50.72 -35.21 30.24 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 125.096 1.358 . . . . 75.13 113.036 -162.446 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 176' ' ' MET . . . . . . . . . . . . . 7.0 ptm -58.39 93.62 0.02 OUTLIER 'General case' 0 CA--C 1.564 1.487 0 C-N-CA 124.638 1.175 . . . . 72.44 112.111 172.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 48.8 mtmt 57.05 42.08 26.5 Favored 'General case' 0 N--CA 1.491 1.61 0 C-N-CA 124.858 1.263 . . . . 72.14 111.873 171.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 178' ' ' ALA . . . . . 0.478 ' HB2' HD23 ' A' ' 233' ' ' LEU . . . -62.19 -42.61 99.45 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.572 1.149 . . . . 74.32 111.56 -179.675 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . 0.482 ' HB2' ' HB2' ' A' ' 224' ' ' PRO . . . -80.68 14.4 2.13 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 123.489 0.716 . . . . 64.43 111.42 176.347 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -100.08 -56.05 0.96 Allowed Glycine 0 C--N 1.342 0.878 0 N-CA-C 109.914 -1.274 . . . . 72.54 109.914 169.496 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 181' ' ' SER . . . . . 0.436 ' HB3' HH11 ' A' ' 231' ' ' ARG . 30.8 t 53.51 20.24 2.0 Allowed 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 124.459 1.104 . . . . 71.04 112.612 174.375 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -85.79 70.05 3.1 Favored Glycine 0 C--N 1.349 1.289 0 C-N-CA 123.096 0.379 . . . . 54.2 112.371 -172.001 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 137.49 149.82 5.63 Favored Glycine 0 C--N 1.34 0.772 0 CA-C-N 115.467 -0.367 . . . . 75.54 112.399 178.501 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 26.2 t -106.41 175.83 5.37 Favored 'General case' 0 C--O 1.245 0.833 0 C-N-CA 124.282 1.033 . . . . 63.15 109.031 176.855 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -158.24 161.12 31.41 Favored Glycine 0 C--N 1.34 0.754 0 N-CA-C 112.435 -0.266 . . . . 70.32 112.435 179.851 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 104.34 123.11 5.2 Favored Glycine 0 C--N 1.346 1.096 0 N-CA-C 111.808 -0.517 . . . . 65.14 111.808 177.198 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 29.8 t -160.15 150.04 18.1 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 123.447 0.699 . . . . 62.42 109.917 -177.508 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 107.9 -32.32 7.19 Favored Glycine 0 C--N 1.351 1.402 0 O-C-N 123.275 0.359 . . . . 54.14 113.318 176.629 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -162.81 153.79 24.5 Favored Glycine 0 C--N 1.34 0.802 0 N-CA-C 111.061 -0.815 . . . . 74.43 111.061 -176.222 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 31.8 m -77.47 69.76 3.77 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 124.062 0.945 . . . . 73.25 110.852 -177.505 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 191' ' ' GLN . . . . . 0.636 ' HB3' ' HD2' ' A' ' 243' ' ' PRO . 8.0 pt20 -91.43 -42.24 10.41 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 123.43 0.692 . . . . 73.45 109.74 179.057 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . 0.413 ' N ' ' HG3' ' A' ' 191' ' ' GLN . 80.9 m-20 -78.77 157.58 28.43 Favored 'General case' 0 C--O 1.239 0.548 0 CA-C-N 115.479 -0.782 . . . . 70.54 110.42 -175.601 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 46.0 mt -127.68 169.35 13.89 Favored 'General case' 0 C--O 1.238 0.493 0 CA-C-N 114.594 -1.185 . . . . 74.33 109.415 -178.297 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 64.5 m-85 -135.23 139.22 44.3 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 124.253 1.021 . . . . 71.25 109.422 179.705 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . 0.424 ' HB2' HD13 ' A' ' 249' ' ' LEU . . . -150.19 171.67 16.55 Favored 'General case' 0 C--O 1.24 0.56 0 C-N-CA 124.861 1.264 . . . . 75.1 108.973 -177.602 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 17.6 m -115.31 137.64 51.82 Favored 'General case' 0 C--O 1.238 0.464 0 C-N-CA 122.966 0.507 . . . . 64.15 109.636 179.013 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . 0.56 HD22 HD12 ' A' ' 251' ' ' LEU . 14.6 tp -115.43 110.64 19.62 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 108.914 -0.773 . . . . 75.12 108.914 177.371 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -79.58 122.79 26.93 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 108.742 -0.836 . . . . 70.5 108.742 174.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 199' ' ' VAL . . . . . 0.47 ' O ' ' HA ' ' A' ' 255' ' ' ILE . 4.1 p -142.58 123.32 8.3 Favored Pre-proline 0 CA--C 1.543 0.694 0 N-CA-C 108.771 -0.826 . . . . 74.32 108.771 178.697 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -67.57 158.48 56.95 Favored 'Trans proline' 0 C--N 1.364 1.365 0 C-N-CA 121.955 1.77 . . . . 74.2 111.049 171.883 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 201' ' ' ALA . . . . . 0.497 ' HA ' HG22 ' A' ' 255' ' ' ILE . . . -47.3 -53.82 25.99 Favored Pre-proline 0 CA--C 1.562 1.42 0 CA-C-O 117.903 -1.046 . . . . 74.22 112.988 -179.093 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -62.45 -39.88 42.9 Favored 'Trans proline' 0 C--N 1.399 3.199 0 C-N-CA 121.997 1.798 . . . . 74.3 113.698 -176.267 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 36.5 mt -66.36 -32.63 58.94 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.252 0 C-N-CA 122.701 0.4 . . . . 75.2 110.091 178.783 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -71.23 -36.02 71.67 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 122.742 0.417 . . . . 74.51 111.63 177.222 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . 0.48 HG23 ' O ' ' A' ' 201' ' ' ALA . 94.9 t -68.58 -57.03 10.22 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.11 0 C-N-CA 123.126 0.57 . . . . 74.31 111.215 -178.979 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 32.8 m -80.05 -27.55 12.16 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 CA-C-N 116.109 -0.496 . . . . 71.3 111.605 -175.373 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 81.96 65.1 1.67 Allowed Glycine 0 C--N 1.342 0.902 0 CA-C-N 116.177 -0.465 . . . . 74.14 111.956 -175.188 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -81.32 -131.99 1.28 Allowed Glycine 0 C--N 1.356 1.655 0 N-CA-C 111.804 -0.519 . . . . 72.32 111.804 177.397 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 21.0 mtmm -137.94 143.37 40.71 Favored 'General case' 0 N--CA 1.481 1.107 0 CA-C-N 117.569 0.685 . . . . 72.04 111.136 177.372 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 11.1 m -135.93 166.37 27.29 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 C-N-CA 125.032 1.333 . . . . 74.43 109.755 176.65 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 58.4 ttp180 -100.25 114.65 28.27 Favored 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 123.545 0.738 . . . . 73.4 110.309 -178.174 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -101.6 139.2 37.57 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 124.035 0.934 . . . . 74.01 110.06 175.402 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 25.2 mmt -96.33 115.17 27.01 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 123.186 0.595 . . . . 64.02 109.68 179.408 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 214' ' ' THR . . . . . 0.429 ' HB ' ' HD2' ' A' ' 238' ' ' LYS . 43.9 p -122.23 -173.47 2.68 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 124.146 0.978 . . . . 73.55 111.038 -175.016 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 82.8 mt -69.25 -22.76 63.82 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 123.475 0.71 . . . . 75.04 111.019 172.771 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 20.4 mm-40 -86.45 -6.07 59.0 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 123.814 0.846 . . . . 74.32 110.663 173.146 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 94.82 -149.9 19.52 Favored Glycine 0 C--N 1.344 1.025 0 CA-C-O 119.331 -0.705 . . . . 63.23 112.303 -177.605 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -73.28 122.05 7.68 Favored 'Trans proline' 0 CA--C 1.555 1.537 0 C-N-CA 122.254 1.969 . . . . 75.24 112.754 -178.559 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 219' ' ' VAL . . . . . 0.494 HG22 ' HE1' ' A' ' 173' ' ' PHE . 2.4 p -116.84 131.15 70.34 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 C-N-CA 124.647 1.179 . . . . 75.14 109.164 173.649 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 -81.12 101.29 9.53 Favored 'General case' 0 C--O 1.24 0.576 0 N-CA-C 107.454 -1.313 . . . . 75.13 107.454 168.688 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 4.6 p -100.63 131.32 48.44 Favored 'Isoleucine or valine' 0 C--O 1.246 0.897 0 N-CA-C 108.872 -0.788 . . . . 72.2 108.872 -176.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . 0.407 ' O ' HD21 ' A' ' 172' ' ' LEU . . . -77.68 106.95 9.81 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 122.759 0.424 . . . . 70.43 110.394 -176.723 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 59.9 t -54.24 135.49 60.08 Favored Pre-proline 0 N--CA 1.48 1.04 0 C-N-CA 124.054 0.942 . . . . 73.42 109.989 178.454 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 224' ' ' PRO . . . . . 0.482 ' HB2' ' HB2' ' A' ' 179' ' ' ALA . 53.8 Cg_endo -67.85 148.76 77.42 Favored 'Trans proline' 0 C--N 1.37 1.672 0 C-N-CA 121.605 1.537 . . . . 74.41 110.688 173.145 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 16.3 Cg_endo -59.78 139.85 90.47 Favored 'Trans proline' 0 C--N 1.366 1.449 0 C-N-CA 121.591 1.528 . . . . 71.03 110.698 172.014 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 69.5 mtm180 66.28 50.52 1.33 Allowed 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 124.194 0.998 . . . . 71.01 111.065 171.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 54.0 m -85.85 136.96 33.09 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.922 0.889 . . . . 65.21 109.415 173.481 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 27.2 mp0 -113.24 144.52 42.56 Favored 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 123.929 0.892 . . . . 62.44 109.634 178.127 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 229' ' ' ALA . . . . . 0.408 ' HB3' ' HB ' ' A' ' 255' ' ' ILE . . . -58.48 120.97 9.77 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 123.92 0.888 . . . . 72.35 110.257 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 113.88 -7.01 23.82 Favored Glycine 0 C--O 1.239 0.44 0 CA-C-O 119.268 -0.74 . . . . 73.31 113.213 -176.013 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 231' ' ' ARG . . . . . 0.436 HH11 ' HB3' ' A' ' 181' ' ' SER . 69.0 mtt-85 -67.27 146.67 53.91 Favored 'General case' 0 C--N 1.355 0.821 0 CA-C-N 117.909 0.854 . . . . 75.04 109.689 172.521 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 232' ' ' LYS . . . . . 0.429 ' HB3' ' HD1' ' A' ' 250' ' ' TYR . 13.1 mtmm -126.28 99.45 5.87 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 123.823 0.849 . . . . 75.51 108.874 -178.803 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 233' ' ' LEU . . . . . 0.478 HD23 ' HB2' ' A' ' 178' ' ' ALA . 21.4 mt -83.56 135.78 34.5 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 113.844 -1.525 . . . . 74.52 109.491 -175.243 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 29.9 ttt85 -104.84 101.01 10.63 Favored 'General case' 0 N--CA 1.476 0.837 0 CA-C-O 121.15 0.5 . . . . 73.31 111.131 -172.815 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 235' ' ' LEU . . . . . 0.51 HD12 HD21 ' A' ' 249' ' ' LEU . 46.7 mt -77.28 100.78 5.99 Favored 'General case' 0 C--O 1.238 0.455 0 C-N-CA 124.512 1.125 . . . . 75.45 110.028 176.079 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 11.7 mtmt -68.11 134.43 50.56 Favored 'General case' 0 C--O 1.241 0.654 0 O-C-N 123.32 0.388 . . . . 72.51 111.535 177.702 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 82.1 18.95 65.98 Favored Glycine 0 C--N 1.35 1.31 0 O-C-N 124.316 1.01 . . . . 72.41 113.612 179.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . 0.429 ' HD2' ' HB ' ' A' ' 214' ' ' THR . 39.4 mmtm -121.38 27.81 8.11 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 123.452 0.701 . . . . 74.54 111.299 -179.002 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -138.4 -171.11 12.05 Favored Glycine 0 CA--C 1.525 0.697 0 N-CA-C 110.272 -1.131 . . . . 61.34 110.272 167.498 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 61.7 m-85 -90.2 155.83 46.61 Favored Pre-proline 0 CA--C 1.545 0.755 0 C-N-CA 123.802 0.841 . . . . 73.22 109.782 -175.711 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -68.28 169.6 16.53 Favored 'Trans proline' 0 C--N 1.365 1.446 0 C-N-CA 121.978 1.786 . . . . 75.05 111.461 169.706 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 163.21 -108.27 0.33 Allowed Glycine 0 CA--C 1.531 1.066 0 CA-C-O 119.043 -0.865 . . . . 60.12 112.533 176.318 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 243' ' ' PRO . . . . . 0.636 ' HD2' ' HB3' ' A' ' 191' ' ' GLN . 84.5 Cg_endo -68.94 -46.92 1.36 Allowed 'Trans proline' 0 C--N 1.372 1.808 0 C-N-CA 123.885 3.056 . . . . 60.31 113.146 -173.656 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -100.67 -0.82 36.71 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 123.658 0.783 . . . . 74.34 111.305 -175.704 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 92.5 -43.79 2.62 Favored Glycine 0 C--N 1.352 1.43 0 O-C-N 123.028 0.205 . . . . 65.22 112.859 -179.665 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 13.3 ttm180 -120.36 112.27 18.8 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 124.153 0.981 . . . . 75.42 110.826 179.24 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -82.84 149.98 27.42 Favored Glycine 0 C--N 1.347 1.169 0 N-CA-C 111.156 -0.778 . . . . 74.35 111.156 167.859 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 38.6 m-20 -135.27 152.38 51.46 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 123.677 0.791 . . . . 72.0 109.675 -172.002 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 249' ' ' LEU . . . . . 0.51 HD21 HD12 ' A' ' 235' ' ' LEU . 61.9 tp -96.88 138.97 33.61 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.158 0.583 . . . . 73.45 110.134 -175.702 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 250' ' ' TYR . . . . . 0.429 ' HD1' ' HB3' ' A' ' 232' ' ' LYS . 7.4 m-85 -99.02 140.2 33.52 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.091 0.556 . . . . 71.23 110.026 173.887 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 251' ' ' LEU . . . . . 0.56 HD12 HD22 ' A' ' 197' ' ' LEU . 76.9 mt -115.67 103.86 11.11 Favored 'General case' 0 C--O 1.236 0.38 0 N-CA-C 108.647 -0.871 . . . . 71.32 108.647 179.763 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -79.54 96.37 6.1 Favored 'General case' 0 C--O 1.242 0.666 0 N-CA-C 108.109 -1.071 . . . . 74.25 108.109 177.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 13.0 m -70.55 136.77 25.28 Favored 'Isoleucine or valine' 0 C--O 1.245 0.848 0 CA-C-O 121.389 0.614 . . . . 64.43 110.59 -173.768 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 11.1 mmt180 -125.78 101.38 6.83 Favored 'General case' 0 C--O 1.241 0.62 0 C-N-CA 124.587 1.155 . . . . 74.22 108.308 -177.652 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 255' ' ' ILE . . . . . 0.497 HG22 ' HA ' ' A' ' 201' ' ' ALA . 22.7 mt -77.43 107.88 9.71 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.745 0 O-C-N 124.027 0.83 . . . . 65.22 109.785 179.341 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 7.2 t . . . . . 0 CA--C 1.567 1.621 0 CA-C-O 117.36 -1.305 . . . . 74.43 108.191 179.122 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 25.0 ttt . . . . . 0 N--CA 1.484 1.248 0 N-CA-C 109.874 -0.417 . . . . 62.22 109.874 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 63.4 tt0 -157.17 -54.21 0.08 Allowed 'General case' 0 C--N 1.35 0.611 0 C-N-CA 123.809 0.844 . . . . 71.1 109.095 -177.808 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 12.5 t -176.09 -176.06 0.77 Allowed 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 123.742 0.817 . . . . 73.32 110.037 -172.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -118.99 -74.88 0.59 Allowed 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 123.875 0.87 . . . . 75.43 110.092 172.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 172' ' ' LEU . . . . . 0.44 HD21 ' HB2' ' A' ' 222' ' ' ALA . 21.1 mt -144.04 156.16 44.27 Favored 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 123.881 0.872 . . . . 74.31 111.317 -167.428 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 173' ' ' PHE . . . . . 0.435 ' CD1' HD23 ' A' ' 235' ' ' LEU . 45.0 m-85 -126.79 -57.83 1.33 Allowed 'General case' 0 N--CA 1.49 1.574 0 CA-C-O 121.679 0.752 . . . . 72.02 110.65 -170.445 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 174' ' ' TYR . . . . . 0.47 ' CD2' ' HB3' ' A' ' 233' ' ' LEU . 4.6 p90 -79.3 4.48 15.02 Favored 'General case' 0 N--CA 1.479 0.994 0 CA-C-N 114.76 -1.109 . . . . 74.25 113.352 -172.776 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 175' ' ' THR . . . . . 0.412 HG22 HD13 ' A' ' 172' ' ' LEU . 15.0 p -69.18 -5.18 20.92 Favored 'General case' 0 N--CA 1.479 0.995 0 N-CA-C 112.681 0.623 . . . . 74.1 112.681 -179.259 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 176' ' ' MET . . . . . . . . . . . . . 24.6 ptt? -61.24 -34.5 75.25 Favored 'General case' 0 CA--C 1.555 1.168 0 C-N-CA 123.632 0.773 . . . . 73.43 110.383 168.029 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 84.6 tttt -165.04 92.77 0.59 Allowed 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 124.869 1.268 . . . . 75.34 108.105 -178.427 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -128.71 142.65 50.94 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 123.877 0.871 . . . . 74.2 110.229 -171.582 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . 0.478 ' HB2' ' HB2' ' A' ' 224' ' ' PRO . . . 59.98 21.56 10.64 Favored 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 124.849 1.26 . . . . 73.11 112.104 -175.961 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -149.99 31.3 1.09 Allowed Glycine 0 C--N 1.34 0.772 0 N-CA-C 110.768 -0.933 . . . . 55.01 110.768 176.288 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 33.3 t -152.17 142.02 22.01 Favored 'General case' 0 C--O 1.246 0.913 0 C-N-CA 124.129 0.971 . . . . 75.03 108.872 -179.385 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 182' ' ' GLY . . . . . 0.519 ' HA2' ' H ' ' A' ' 232' ' ' LYS . . . -153.86 55.0 0.43 Allowed Glycine 0 C--N 1.339 0.7 0 N-CA-C 110.995 -0.842 . . . . 74.43 110.995 179.412 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 129.47 137.42 4.26 Favored Glycine 0 C--N 1.345 1.065 0 N-CA-C 110.46 -1.056 . . . . 62.1 110.46 -176.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 38.4 t -157.17 -54.09 0.08 Allowed 'General case' 0 N--CA 1.479 1.009 0 CA-C-N 117.247 0.523 . . . . 73.35 110.982 -174.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 87.3 145.36 9.63 Favored Glycine 0 CA--C 1.533 1.175 0 CA-C-O 119.473 -0.626 . . . . 72.15 111.66 -174.622 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -61.7 -70.76 0.94 Allowed Glycine 0 C--N 1.349 1.28 0 CA-C-O 119.783 -0.454 . . . . 71.11 113.668 -178.229 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 62.2 p -174.26 -60.41 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 123.883 0.873 . . . . 54.44 110.611 174.88 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 169.93 73.7 0.04 OUTLIER Glycine 0 C--N 1.35 1.346 0 N-CA-C 112.068 -0.413 . . . . 53.24 112.068 -177.863 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 166.02 162.09 16.59 Favored Glycine 0 N--CA 1.474 1.205 0 N-CA-C 110.979 -0.848 . . . . 55.31 110.979 -179.027 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 45.9 m -70.62 86.56 0.65 Allowed 'General case' 0 N--CA 1.478 0.948 0 CA-C-O 121.612 0.72 . . . . 70.51 111.132 -177.577 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 191' ' ' GLN . . . . . 0.529 ' HB2' ' HA2' ' A' ' 247' ' ' GLY . 4.8 pt20 -134.86 -29.88 1.11 Allowed 'General case' 0 N--CA 1.475 0.816 0 CA-C-N 114.83 -1.077 . . . . 73.21 110.99 -176.716 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -75.73 142.35 42.43 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-O 121.41 0.624 . . . . 73.14 111.341 -171.592 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 45.0 mt -130.91 170.96 13.73 Favored 'General case' 0 C--O 1.239 0.501 0 CA-C-N 114.216 -1.356 . . . . 74.3 108.994 174.122 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 26.6 m-85 -143.44 122.27 12.69 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 124.03 0.932 . . . . 75.43 109.503 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . 0.416 ' HB2' HD13 ' A' ' 249' ' ' LEU . . . -124.69 128.89 49.51 Favored 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 107.67 -1.233 . . . . 75.31 107.67 174.154 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 6.1 m -81.47 119.47 23.78 Favored 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 108.203 -1.036 . . . . 63.33 108.203 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . 0.591 HD21 HD11 ' A' ' 251' ' ' LEU . 17.2 tp -104.74 110.55 22.93 Favored 'General case' 0 N--CA 1.466 0.374 0 N-CA-C 108.404 -0.962 . . . . 75.31 108.404 -172.984 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -77.48 125.53 29.48 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 108.482 -0.933 . . . . 73.42 108.482 177.234 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 199' ' ' VAL . . . . . 0.498 ' O ' ' HA ' ' A' ' 255' ' ' ILE . 5.4 p -144.15 129.45 9.62 Favored Pre-proline 0 CA--C 1.545 0.767 0 N-CA-C 108.488 -0.931 . . . . 71.44 108.488 176.465 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -71.86 157.15 55.64 Favored 'Trans proline' 0 C--O 1.248 1.02 0 C-N-CA 121.655 1.57 . . . . 75.41 111.342 170.309 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 201' ' ' ALA . . . . . 0.429 ' O ' HG23 ' A' ' 205' ' ' VAL . . . -51.29 -53.46 49.0 Favored Pre-proline 0 CA--C 1.556 1.2 0 O-C-N 124.32 1.013 . . . . 74.31 113.078 -176.501 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -67.01 -33.5 31.98 Favored 'Trans proline' 0 C--N 1.403 3.438 0 C-N-CA 121.678 1.585 . . . . 73.33 112.854 -175.044 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . 0.462 HG22 ' HA3' ' A' ' 208' ' ' GLY . 27.6 mt -66.03 -35.45 75.09 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.311 0 C-N-CA 122.586 0.354 . . . . 71.22 110.064 176.05 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 204' ' ' ALA . . . . . 0.494 ' HA ' HG13 ' A' ' 223' ' ' VAL . . . -71.01 -31.88 68.51 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 122.656 0.382 . . . . 74.31 111.51 178.617 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . 0.429 HG23 ' O ' ' A' ' 201' ' ' ALA . 92.8 t -73.77 -55.64 11.79 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 C-N-CA 122.896 0.478 . . . . 74.4 111.104 178.43 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 13.7 m -78.86 -26.41 13.44 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.003 0 C-N-CA 122.979 0.512 . . . . 73.24 111.927 -172.248 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 87.9 76.08 1.28 Allowed Glycine 0 CA--C 1.529 0.951 0 N-CA-C 111.972 -0.451 . . . . 73.51 111.972 -175.531 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . 0.462 ' HA3' HG22 ' A' ' 203' ' ' ILE . . . -95.37 -147.13 22.15 Favored Glycine 0 N--CA 1.477 1.369 0 CA-C-O 119.537 -0.591 . . . . 74.13 111.793 175.961 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 49.9 mtmt -132.86 145.63 51.12 Favored 'General case' 0 N--CA 1.482 1.125 0 CA-C-N 117.52 0.66 . . . . 73.21 111.151 176.742 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 12.0 m -139.25 164.91 24.14 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 C-N-CA 125.672 1.589 . . . . 73.11 108.93 175.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 23.9 ttm180 -103.44 117.13 33.75 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 123.386 0.674 . . . . 73.51 109.894 -174.246 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -103.69 123.33 46.82 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 124.729 1.212 . . . . 73.5 109.914 178.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 89.1 mmm -87.49 115.38 24.87 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 123.362 0.665 . . . . 74.45 110.166 -178.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 17.6 p -113.9 -178.71 3.44 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 123.976 0.91 . . . . 71.43 110.607 -175.856 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 81.0 mt -63.27 -23.94 67.64 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 122.842 0.457 . . . . 72.05 111.549 172.713 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -103.54 23.2 13.0 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 124.071 0.948 . . . . 63.43 110.893 179.867 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 87.88 -163.82 33.67 Favored Glycine 0 C--N 1.344 1.005 0 CA-C-N 116.299 -0.409 . . . . 61.21 113.141 175.59 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -72.12 144.73 42.83 Favored 'Trans proline' 0 C--N 1.362 1.244 0 C-N-CA 122.156 1.904 . . . . 73.0 112.804 -178.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 5.4 p -139.67 127.74 26.24 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 N-CA-C 108.083 -1.08 . . . . 73.24 108.083 170.047 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -82.19 103.3 11.69 Favored 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 108.461 -0.94 . . . . 73.34 108.461 176.264 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 2.8 p -100.3 133.62 42.75 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.841 0 O-C-N 124.149 0.906 . . . . 75.01 108.654 -174.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . 0.44 ' HB2' HD21 ' A' ' 172' ' ' LEU . . . -78.91 111.67 15.31 Favored 'General case' 0 C--O 1.24 0.6 0 C-N-CA 122.8 0.44 . . . . 74.21 110.541 -177.874 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . 0.494 HG13 ' HA ' ' A' ' 204' ' ' ALA . 48.9 t -54.61 131.63 64.29 Favored Pre-proline 0 CA--C 1.542 0.643 0 O-C-N 124.509 1.13 . . . . 74.41 109.909 177.496 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 224' ' ' PRO . . . . . 0.478 ' HB2' ' HB2' ' A' ' 179' ' ' ALA . 43.1 Cg_endo -67.3 152.5 79.14 Favored 'Trans proline' 0 CA--C 1.555 1.545 0 C-N-CA 121.657 1.571 . . . . 74.43 111.312 175.546 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -65.6 141.99 69.08 Favored 'Trans proline' 0 C--N 1.371 1.712 0 C-N-CA 121.941 1.761 . . . . 75.23 112.219 179.811 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 96.6 mtt180 65.42 32.15 9.82 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 124.827 1.251 . . . . 71.31 111.834 168.863 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 227' ' ' THR . . . . . 0.451 HG22 ' HD2' ' A' ' 231' ' ' ARG . 98.6 m -72.84 139.02 46.69 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 123.969 0.907 . . . . 74.25 109.89 174.946 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -111.66 155.53 23.28 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 123.113 0.565 . . . . 73.51 109.686 174.595 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 229' ' ' ALA . . . . . 0.573 ' HB3' ' HB ' ' A' ' 255' ' ' ILE . . . -54.99 122.63 11.33 Favored 'General case' 0 CA--C 1.536 0.442 0 O-C-N 124.896 1.372 . . . . 75.51 111.338 -179.302 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 112.57 -10.61 25.91 Favored Glycine 0 C--N 1.341 0.831 0 CA-C-O 119.568 -0.573 . . . . 61.31 113.718 177.029 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 231' ' ' ARG . . . . . 0.451 ' HD2' HG22 ' A' ' 227' ' ' THR . 53.0 mtt-85 -62.1 141.45 58.13 Favored 'General case' 0 N--CA 1.478 0.941 0 CA-C-N 117.246 0.523 . . . . 73.43 111.1 176.418 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 232' ' ' LYS . . . . . 0.519 ' H ' ' HA2' ' A' ' 182' ' ' GLY . 31.5 mmtp -112.47 103.58 11.67 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 108.585 -0.895 . . . . 74.3 108.585 -175.64 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 233' ' ' LEU . . . . . 0.729 ' HB2' ' HB2' ' A' ' 251' ' ' LEU . 41.7 mt -83.08 149.47 26.89 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 115.295 -0.866 . . . . 75.11 108.849 177.181 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 62.0 ttt180 -118.6 102.42 8.86 Favored 'General case' 0 N--CA 1.478 0.926 0 CA-C-N 117.958 0.345 . . . . 74.51 110.482 -173.404 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 235' ' ' LEU . . . . . 0.533 ' HB2' ' HB3' ' A' ' 249' ' ' LEU . 14.8 mt -85.92 94.84 9.29 Favored 'General case' 0 C--O 1.242 0.706 0 C-N-CA 123.197 0.599 . . . . 74.34 109.81 175.507 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 20.2 mttt -69.02 138.12 54.22 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 115.648 -0.706 . . . . 73.44 110.466 175.443 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 85.68 3.03 86.48 Favored Glycine 0 C--N 1.338 0.644 0 O-C-N 123.908 0.755 . . . . 62.11 113.348 -179.355 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 76.0 mmtt -116.78 9.24 13.88 Favored 'General case' 0 N--CA 1.485 1.323 0 CA-C-N 117.414 0.607 . . . . 74.44 111.919 -176.274 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -109.68 -165.65 19.94 Favored Glycine 0 C--N 1.346 1.09 0 N-CA-C 111.139 -0.784 . . . . 65.11 111.139 167.419 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 68.7 m-85 -86.82 158.79 53.13 Favored Pre-proline 0 N--CA 1.484 1.272 0 C-N-CA 123.446 0.698 . . . . 73.4 112.371 -176.291 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_exo -64.21 165.4 19.71 Favored 'Trans proline' 0 C--N 1.371 1.715 0 C-N-CA 122.24 1.96 . . . . 63.3 112.73 166.716 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 157.45 -107.94 0.34 Allowed Glycine 0 C--N 1.34 0.789 0 CA-C-O 118.806 -0.997 . . . . 71.44 111.999 173.431 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -68.65 -57.08 0.15 Allowed 'Trans proline' 0 C--N 1.378 2.09 0 C-N-CA 123.616 2.878 . . . . 72.55 112.666 -170.201 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -80.87 -22.39 39.87 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 123.417 0.687 . . . . 74.32 110.615 175.244 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 96.48 -33.53 5.6 Favored Glycine 0 C--N 1.352 1.437 0 N-CA-C 111.283 -0.727 . . . . 74.23 111.283 -169.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 29.2 ttm180 -106.7 111.89 24.63 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 124.68 1.192 . . . . 74.25 109.981 178.794 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . 0.529 ' HA2' ' HB2' ' A' ' 191' ' ' GLN . . . -79.53 162.97 47.94 Favored Glycine 0 C--O 1.247 0.919 0 O-C-N 123.528 0.518 . . . . 70.14 113.748 169.249 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 17.6 m-20 -128.16 129.23 46.19 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 123.814 0.846 . . . . 74.4 109.173 -169.456 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 249' ' ' LEU . . . . . 0.533 ' HB3' ' HB2' ' A' ' 235' ' ' LEU . 49.3 tp -99.54 113.62 26.13 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 124.005 0.922 . . . . 73.44 109.089 177.715 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 250' ' ' TYR . . . . . 0.416 ' HA ' ' O ' ' A' ' 233' ' ' LEU . 8.8 m-85 -90.28 114.59 26.66 Favored 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 123.593 0.757 . . . . 70.25 110.933 -176.467 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 251' ' ' LEU . . . . . 0.729 ' HB2' ' HB2' ' A' ' 233' ' ' LEU . 89.9 mt -88.05 106.3 18.06 Favored 'General case' 0 C--O 1.241 0.638 0 C-N-CA 124.846 1.258 . . . . 74.22 109.162 -179.013 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -82.3 99.95 9.64 Favored 'General case' 0 C--O 1.242 0.704 0 N-CA-C 108.463 -0.94 . . . . 73.24 108.463 175.386 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 11.5 m -67.23 132.73 32.25 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.853 0 O-C-N 123.782 0.676 . . . . 73.3 109.351 -177.498 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 17.9 mmt85 -123.11 95.21 4.52 Favored 'General case' 0 C--O 1.239 0.502 0 C-N-CA 124.517 1.127 . . . . 75.02 108.216 -177.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 255' ' ' ILE . . . . . 0.573 ' HB ' ' HB3' ' A' ' 229' ' ' ALA . 12.9 mt -76.43 125.25 36.0 Favored 'Isoleucine or valine' 0 C--O 1.233 0.208 0 O-C-N 123.945 0.778 . . . . 63.43 110.21 179.406 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 1.6 t . . . . . 0 CA--C 1.561 1.402 0 CA-C-O 117.546 -1.216 . . . . 71.3 107.768 173.877 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 15.7 tpt . . . . . 0 N--CA 1.479 0.989 0 N-CA-C 109.525 -0.546 . . . . 72.2 109.525 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 9.8 pt20 -137.72 168.31 19.94 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.6 0.76 . . . . 74.2 110.627 -178.756 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 170' ' ' THR . . . . . 0.517 HG21 HG21 ' A' ' 219' ' ' VAL . 6.5 t -80.69 167.59 19.84 Favored 'General case' 0 C--O 1.243 0.739 0 CA-C-N 115.171 -0.922 . . . . 74.05 110.144 173.774 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -117.87 -63.64 1.4 Allowed 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 123.84 0.856 . . . . 62.51 109.965 -177.505 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 172' ' ' LEU . . . . . 0.547 ' HB3' HG21 ' A' ' 175' ' ' THR . 55.7 mt -131.75 154.58 48.9 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 114.555 -1.202 . . . . 65.31 111.27 -164.77 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 173' ' ' PHE . . . . . 0.516 ' CD1' HD21 ' A' ' 235' ' ' LEU . 7.5 m-85 -140.13 -44.1 0.42 Allowed 'General case' 0 N--CA 1.482 1.142 0 CA-C-N 114.966 -1.015 . . . . 74.14 109.118 -171.21 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 174' ' ' TYR . . . . . . . . . . . . . 1.9 p90 -86.18 19.3 2.73 Favored 'General case' 0 CA--C 1.547 0.83 0 CA-C-N 114.502 -1.226 . . . . 72.32 112.394 -176.158 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 175' ' ' THR . . . . . 0.547 HG21 ' HB3' ' A' ' 172' ' ' LEU . 17.6 p -62.87 -21.63 66.11 Favored 'General case' 0 N--CA 1.493 1.692 0 CA-C-N 118.909 0.777 . . . . 73.14 112.853 -179.2 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 176' ' ' MET . . . . . . . . . . . . . 21.4 ptt? -52.4 -42.45 64.04 Favored 'General case' 0 CA--C 1.558 1.287 0 C-N-CA 124.367 1.067 . . . . 75.4 110.95 171.016 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 19.7 tptm -167.42 100.07 0.5 Allowed 'General case' 0 C--N 1.349 0.553 0 C-N-CA 125.532 1.533 . . . . 72.23 107.017 176.844 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -74.65 -74.42 0.2 Allowed 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 115.556 -0.747 . . . . 72.12 112.096 -168.306 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -69.65 95.53 0.87 Allowed 'General case' 0 CA--C 1.541 0.629 0 O-C-N 123.381 0.425 . . . . 74.24 110.19 -177.328 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 80.59 89.2 0.54 Allowed Glycine 0 C--N 1.348 1.243 0 CA-C-N 115.489 -0.778 . . . . 54.21 112.063 -178.328 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 27.8 t -97.88 132.87 43.09 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 123.395 0.678 . . . . 73.01 109.616 178.335 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -86.03 -164.62 39.6 Favored Glycine 0 C--N 1.35 1.307 0 O-C-N 123.618 0.574 . . . . 73.21 114.08 -173.796 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 97.62 14.09 41.95 Favored Glycine 0 C--N 1.35 1.344 0 C-N-CA 123.306 0.479 . . . . 64.13 112.598 -176.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 16.8 m -76.34 142.37 41.24 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 123.892 0.877 . . . . 64.22 111.272 -177.197 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 73.04 35.44 57.72 Favored Glycine 0 C--N 1.345 1.079 0 O-C-N 123.284 0.365 . . . . 63.22 112.566 -179.803 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -152.02 43.51 0.67 Allowed Glycine 0 C--N 1.345 1.041 0 N-CA-C 111.973 -0.451 . . . . 73.43 111.973 -178.604 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 24.3 m -72.57 -61.41 1.81 Allowed 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 123.457 0.703 . . . . 75.0 110.04 175.148 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 79.49 -62.68 4.07 Favored Glycine 0 C--N 1.353 1.486 0 N-CA-C 111.723 -0.551 . . . . 51.41 111.723 -172.631 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -109.37 165.36 12.44 Favored Glycine 0 C--N 1.343 0.926 0 N-CA-C 110.414 -1.074 . . . . 64.11 110.414 167.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 15.7 p -68.83 100.79 1.23 Allowed 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 123.589 0.756 . . . . 64.21 110.526 177.202 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 191' ' ' GLN . . . . . 0.487 ' HG3' ' N ' ' A' ' 192' ' ' ASP . 5.0 pt20 -139.03 -44.24 0.47 Allowed 'General case' 0 CA--C 1.544 0.724 0 CA-C-N 115.676 -0.693 . . . . 74.41 110.758 177.903 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . 0.487 ' N ' ' HG3' ' A' ' 191' ' ' GLN . 24.4 m-20 -77.55 123.87 27.16 Favored 'General case' 0 C--N 1.351 0.643 0 C-N-CA 123.76 0.824 . . . . 73.15 109.096 -177.125 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . 0.501 HD11 ' HA2' ' A' ' 239' ' ' GLY . 41.0 mt -111.71 173.57 6.29 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 124.612 1.165 . . . . 72.43 109.987 -178.186 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 45.8 m-85 -130.15 129.28 43.28 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 123.778 0.831 . . . . 73.4 109.57 176.33 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . 0.42 ' HB1' HD11 ' A' ' 249' ' ' LEU . . . -129.65 167.49 17.91 Favored 'General case' 0 C--O 1.239 0.549 0 C-N-CA 124.989 1.316 . . . . 73.35 107.47 170.237 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 31.4 m -117.27 124.17 48.37 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 108.731 -0.84 . . . . 71.25 108.731 179.335 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . 0.568 HD21 HD13 ' A' ' 251' ' ' LEU . 15.3 tp -107.7 109.81 21.49 Favored 'General case' 0 CA--C 1.53 0.211 0 N-CA-C 107.823 -1.177 . . . . 72.22 107.823 -177.711 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -83.42 128.63 34.66 Favored 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 109.05 -0.722 . . . . 75.01 109.05 178.156 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 199' ' ' VAL . . . . . 0.536 ' O ' ' HA ' ' A' ' 255' ' ' ILE . 4.0 p -143.78 129.57 9.96 Favored Pre-proline 0 CA--C 1.543 0.699 0 N-CA-C 108.201 -1.037 . . . . 75.31 108.201 179.765 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -69.1 157.9 59.91 Favored 'Trans proline' 0 C--N 1.364 1.383 0 C-N-CA 121.905 1.737 . . . . 62.01 111.502 170.038 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 201' ' ' ALA . . . . . 0.465 ' O ' HG23 ' A' ' 205' ' ' VAL . . . -49.74 -53.7 39.17 Favored Pre-proline 0 CA--C 1.561 1.385 0 O-C-N 124.768 1.292 . . . . 74.43 112.792 -178.195 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -61.94 -35.38 77.81 Favored 'Trans proline' 0 C--N 1.401 3.314 0 C-N-CA 121.988 1.792 . . . . 74.1 113.339 -176.388 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 38.1 mt -71.35 -31.94 45.21 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.104 0 C-N-CA 123.068 0.547 . . . . 75.44 110.321 179.145 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -72.95 -34.05 66.27 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 122.463 0.305 . . . . 75.15 111.516 176.18 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . 0.465 HG23 ' O ' ' A' ' 201' ' ' ALA . 90.6 t -67.72 -55.77 15.67 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 C-N-CA 123.836 0.854 . . . . 75.03 110.874 177.936 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 18.4 m -80.87 -27.96 11.2 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.079 0 C-N-CA 122.753 0.421 . . . . 74.22 111.744 -174.469 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 82.02 67.9 1.48 Allowed Glycine 0 C--N 1.347 1.176 0 O-C-N 123.736 0.647 . . . . 52.32 112.113 -173.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -84.35 -131.88 2.25 Favored Glycine 0 C--N 1.352 1.435 0 CA-C-O 119.68 -0.511 . . . . 54.04 111.953 179.436 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 209' ' ' LYS . . . . . 0.44 ' HG2' ' HA ' ' A' ' 222' ' ' ALA . 48.0 mtmt -139.99 150.92 45.05 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 123.908 0.883 . . . . 73.42 111.425 178.258 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 15.2 m -146.04 168.92 6.61 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 C-N-CA 126.005 1.722 . . . . 73.23 108.388 176.584 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 37.0 ptt180 -95.03 128.65 42.02 Favored 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 109.371 -0.603 . . . . 74.02 109.371 172.626 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -102.31 112.36 25.02 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 123.895 0.878 . . . . 64.32 108.631 174.175 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 74.8 mtp -82.98 108.78 16.54 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 109.382 -0.599 . . . . 75.42 109.382 -175.746 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 26.7 p -111.39 -172.47 2.04 Favored 'General case' 0 C--O 1.242 0.686 0 C-N-CA 124.174 0.989 . . . . 74.43 110.224 -173.179 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 84.2 mt -61.97 -28.84 69.84 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 123.439 0.696 . . . . 72.41 111.368 173.386 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -100.22 7.94 44.14 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 123.656 0.783 . . . . 74.35 111.427 179.424 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 100.84 -173.11 24.28 Favored Glycine 0 C--N 1.347 1.16 0 CA-C-O 119.929 -0.373 . . . . 74.03 113.819 175.763 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_endo -71.57 127.59 13.36 Favored 'Trans proline' 0 C--N 1.368 1.579 0 C-N-CA 122.855 2.37 . . . . 74.24 112.351 -176.852 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 219' ' ' VAL . . . . . 0.517 HG21 HG21 ' A' ' 170' ' ' THR . 5.0 p -119.77 130.76 73.75 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 C-N-CA 123.714 0.806 . . . . 65.23 108.846 178.436 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -70.52 101.63 2.04 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 108.751 -0.833 . . . . 75.44 108.751 177.755 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 3.0 p -106.64 134.38 48.45 Favored 'Isoleucine or valine' 0 C--O 1.244 0.774 0 N-CA-C 108.377 -0.971 . . . . 74.04 108.377 -176.304 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . 0.44 ' HA ' ' HG2' ' A' ' 209' ' ' LYS . . . -82.19 108.74 15.89 Favored 'General case' 0 N--CA 1.467 0.414 0 N-CA-C 109.975 -0.38 . . . . 64.32 109.975 -179.358 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 43.0 t -54.54 134.74 63.22 Favored Pre-proline 0 N--CA 1.478 0.945 0 C-N-CA 124.753 1.221 . . . . 74.32 110.436 -178.14 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -58.22 150.46 66.13 Favored 'Trans proline' 0 C--N 1.37 1.699 0 C-N-CA 122.221 1.947 . . . . 64.22 111.942 169.779 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -78.41 148.51 23.67 Favored 'Trans proline' 0 C--N 1.366 1.497 0 C-N-CA 122.065 1.843 . . . . 72.5 110.937 174.136 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 45.8 mtm180 59.56 41.28 19.23 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 124.302 1.041 . . . . 72.43 111.271 174.122 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 227' ' ' THR . . . . . 0.526 HG23 ' HD2' ' A' ' 231' ' ' ARG . 55.5 m -82.29 141.64 32.75 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 114.334 -1.303 . . . . 74.05 109.438 177.097 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 27.7 mp0 -115.96 145.18 43.15 Favored 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 123.764 0.826 . . . . 74.15 109.245 176.381 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 229' ' ' ALA . . . . . 0.43 ' HB3' ' HB ' ' A' ' 255' ' ' ILE . . . -57.04 119.42 6.27 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.986 0.914 . . . . 73.41 111.119 -178.079 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 114.38 -5.33 23.25 Favored Glycine 0 C--N 1.342 0.869 0 O-C-N 123.825 0.703 . . . . 42.41 112.696 -176.768 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 231' ' ' ARG . . . . . 0.526 ' HD2' HG23 ' A' ' 227' ' ' THR . 55.0 mtt-85 -69.67 148.68 48.97 Favored 'General case' 0 C--N 1.363 1.194 0 CA-C-N 117.704 0.752 . . . . 74.32 109.124 169.724 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 36.5 mtmt -130.2 118.26 21.12 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 123.166 0.586 . . . . 73.34 109.56 -174.334 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 233' ' ' LEU . . . . . . . . . . . . . 9.0 mt -101.47 138.94 37.81 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 124.318 1.047 . . . . 65.34 108.487 -172.307 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 234' ' ' ARG . . . . . 0.493 ' HG3' ' HB3' ' A' ' 248' ' ' ASP . 35.8 ttm-85 -102.04 118.45 36.94 Favored 'General case' 0 N--CA 1.479 0.982 0 CA-C-N 118.013 0.37 . . . . 74.51 111.434 -173.83 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 235' ' ' LEU . . . . . 0.516 HD21 ' CD1' ' A' ' 173' ' ' PHE . 13.7 mt -103.87 111.62 24.23 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 123.492 0.717 . . . . 74.45 110.271 179.069 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 65.1 mttt -69.66 144.59 52.86 Favored 'General case' 0 N--CA 1.471 0.578 0 O-C-N 123.205 0.316 . . . . 73.42 111.196 176.178 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 73.88 -5.72 23.25 Favored Glycine 0 N--CA 1.472 1.05 0 O-C-N 124.624 1.203 . . . . 75.32 114.578 179.065 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -101.24 0.89 38.23 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 123.043 0.537 . . . . 74.43 110.896 -176.498 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 239' ' ' GLY . . . . . 0.501 ' HA2' HD11 ' A' ' 193' ' ' LEU . . . -102.9 -168.26 26.18 Favored Glycine 0 C--N 1.347 1.157 0 N-CA-C 110.322 -1.111 . . . . 74.23 110.322 163.184 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 58.0 m-85 -92.78 154.64 42.11 Favored Pre-proline 0 N--CA 1.477 0.918 0 C-N-CA 123.033 0.533 . . . . 74.01 111.028 -176.627 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_exo -72.9 161.92 42.4 Favored 'Trans proline' 0 C--N 1.366 1.498 0 C-N-CA 122.202 1.935 . . . . 64.12 111.865 172.342 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 157.2 -104.25 0.25 Allowed Glycine 0 CA--C 1.527 0.842 0 CA-C-O 119.072 -0.849 . . . . 55.25 112.155 177.8 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 243' ' ' PRO . . . . . 0.421 ' HD2' ' HB3' ' A' ' 191' ' ' GLN . 41.8 Cg_endo -63.67 -52.22 1.97 Allowed 'Trans proline' 0 C--N 1.37 1.663 0 C-N-CA 123.642 2.895 . . . . 65.23 113.241 -169.985 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -93.11 -5.08 51.1 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 123.304 0.642 . . . . 73.02 111.447 179.753 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 92.38 -46.52 2.59 Favored Glycine 0 C--N 1.354 1.572 0 N-CA-C 111.945 -0.462 . . . . 50.13 111.945 -175.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 20.1 ttm180 -116.3 112.4 21.51 Favored 'General case' 0 C--O 1.238 0.486 0 C-N-CA 124.367 1.067 . . . . 70.53 109.127 178.119 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -80.65 168.31 51.16 Favored Glycine 0 C--N 1.348 1.249 0 CA-C-O 121.503 0.502 . . . . 64.21 113.88 172.191 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 248' ' ' ASP . . . . . 0.493 ' HB3' ' HG3' ' A' ' 234' ' ' ARG . 19.4 m-20 -124.65 162.2 24.64 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 114.009 -1.096 . . . . 64.11 110.469 -169.466 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 249' ' ' LEU . . . . . 0.431 ' HB3' ' HB2' ' A' ' 235' ' ' LEU . 41.6 tp -125.9 121.8 34.21 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 123.528 0.731 . . . . 74.42 109.405 178.305 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 250' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -90.47 112.43 24.07 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 123.816 0.846 . . . . 74.3 110.607 -178.733 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 251' ' ' LEU . . . . . 0.568 HD13 HD21 ' A' ' 197' ' ' LEU . 90.7 mt -87.85 104.02 16.19 Favored 'General case' 0 C--O 1.239 0.504 0 N-CA-C 107.889 -1.152 . . . . 74.41 107.889 179.915 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -79.91 98.58 7.19 Favored 'General case' 0 C--O 1.239 0.521 0 N-CA-C 108.145 -1.058 . . . . 72.23 108.145 177.106 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 6.2 m -66.67 125.88 24.94 Favored 'Isoleucine or valine' 0 C--O 1.243 0.759 0 CA-C-O 122.021 0.915 . . . . 63.12 109.362 -178.169 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 17.9 mmm180 -122.2 99.34 6.38 Favored 'General case' 0 C--O 1.239 0.535 0 N-CA-C 107.742 -1.207 . . . . 74.51 107.742 -178.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 255' ' ' ILE . . . . . 0.536 ' HA ' ' O ' ' A' ' 199' ' ' VAL . 55.3 mt -83.29 119.55 32.87 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 CA-C-N 114.103 -1.408 . . . . 73.51 110.267 -175.114 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 CA--C 1.559 1.309 0 C-N-CA 124.6 1.16 . . . . 72.52 108.964 175.547 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.485 1.277 0 N-CA-C 111.902 0.334 . . . . 71.23 111.902 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 9.0 pt20 -142.9 171.8 13.56 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 122.985 0.514 . . . . 71.31 110.01 170.094 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 170' ' ' THR . . . . . 0.445 HG23 HG22 ' A' ' 219' ' ' VAL . 6.6 t -93.61 178.69 5.61 Favored 'General case' 0 CA--C 1.557 1.242 0 C-N-CA 123.813 0.845 . . . . 73.24 110.399 179.198 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -129.01 -82.91 0.57 Allowed 'General case' 0 CA--C 1.555 1.167 0 C-N-CA 122.921 0.488 . . . . 73.41 111.601 -168.71 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 172' ' ' LEU . . . . . 0.411 ' HB3' ' OG1' ' A' ' 175' ' ' THR . 21.0 mt -127.83 160.54 31.47 Favored 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 123.691 0.796 . . . . 64.44 111.71 -173.591 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 173' ' ' PHE . . . . . 0.537 ' CD1' HD22 ' A' ' 235' ' ' LEU . 16.7 m-85 -146.14 -59.28 0.31 Allowed 'General case' 0 N--CA 1.479 1.022 0 CA-C-O 122.123 0.963 . . . . 73.13 108.692 -166.986 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 174' ' ' TYR . . . . . 0.472 ' CD2' ' HB3' ' A' ' 233' ' ' LEU . 0.6 OUTLIER -78.53 14.45 1.27 Allowed 'General case' 0 CA--C 1.547 0.829 0 CA-C-N 113.744 -1.571 . . . . 74.44 112.533 -176.025 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 175' ' ' THR . . . . . 0.411 ' OG1' ' HB3' ' A' ' 172' ' ' LEU . 0.2 OUTLIER -63.95 -19.32 65.05 Favored 'General case' 0 CA--C 1.555 1.152 0 C-N-CA 124.459 1.104 . . . . 72.44 111.432 -173.843 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 176' ' ' MET . . . . . . . . . . . . . 25.1 ptt? -71.45 -40.89 70.04 Favored 'General case' 0 CA--C 1.562 1.409 0 C-N-CA 124.644 1.177 . . . . 74.5 111.72 173.081 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 1.6 ttmp? -164.58 118.45 1.36 Allowed 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 124.644 1.178 . . . . 72.05 109.296 -175.623 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 178' ' ' ALA . . . . . 0.49 ' HB3' HD23 ' A' ' 233' ' ' LEU . . . -152.61 -49.39 0.1 Allowed 'General case' 0 C--O 1.24 0.58 0 C-N-CA 123.309 0.644 . . . . 73.31 110.289 -173.808 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -81.02 37.66 0.44 Allowed 'General case' 0 CA--C 1.554 1.127 0 C-N-CA 123.486 0.715 . . . . 72.21 111.07 178.785 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -137.21 -153.93 6.52 Favored Glycine 0 C--N 1.347 1.154 0 C-N-CA 123.839 0.733 . . . . 71.11 111.76 -177.307 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 21.9 t -130.05 -177.8 4.46 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 123.489 0.716 . . . . 70.22 109.95 -176.611 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . 90.05 -48.65 3.23 Favored Glycine 0 C--N 1.348 1.199 0 N-CA-C 112.411 -0.276 . . . . 75.42 112.411 178.584 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 101.55 -10.64 57.79 Favored Glycine 0 C--N 1.35 1.312 0 CA-C-O 119.451 -0.638 . . . . 73.2 112.797 178.6 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 24.1 t 65.11 15.92 10.27 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 124.681 1.192 . . . . 74.24 112.313 176.499 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -84.39 -90.64 0.78 Allowed Glycine 0 C--N 1.346 1.128 0 CA-C-O 120.121 -0.266 . . . . 74.32 113.139 -175.057 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 61.37 46.3 94.68 Favored Glycine 0 C--N 1.35 1.35 0 O-C-N 124.087 0.522 . . . . 71.11 111.896 -174.541 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 33.5 t -93.41 133.64 36.47 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 123.5 0.72 . . . . 64.54 110.421 -174.381 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -93.85 37.24 3.45 Favored Glycine 0 C--N 1.349 1.277 0 CA-C-N 116.383 -0.372 . . . . 63.13 113.233 178.792 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . 0.472 ' HA3' ' HD3' ' A' ' 243' ' ' PRO . . . -172.41 165.66 38.25 Favored Glycine 0 C--N 1.344 1.013 0 N-CA-C 111.498 -0.641 . . . . 64.21 111.498 179.225 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 37.0 t -86.06 72.16 10.47 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 123.462 0.705 . . . . 72.34 109.165 178.757 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 191' ' ' GLN . . . . . 0.56 ' HB3' ' HD2' ' A' ' 243' ' ' PRO . 3.6 pt20 -108.37 -26.09 10.67 Favored 'General case' 0 N--CA 1.477 0.915 0 CA-C-N 115.402 -0.817 . . . . 74.24 109.858 175.563 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 86.9 m-20 -77.41 153.46 33.63 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 115.39 -0.823 . . . . 64.04 111.504 -174.646 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 26.7 mt -125.74 175.93 7.27 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 124.439 1.096 . . . . 72.52 110.665 -179.226 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 194' ' ' TYR . . . . . 0.456 ' HE2' ' HZ3' ' A' ' 232' ' ' LYS . 32.1 m-85 -140.98 136.67 32.38 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 124.305 1.042 . . . . 75.0 109.905 177.457 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -152.98 131.67 12.33 Favored 'General case' 0 C--O 1.238 0.497 0 C-N-CA 124.651 1.18 . . . . 72.42 108.128 177.064 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 14.9 m -82.61 129.25 34.91 Favored 'General case' 0 CA--C 1.546 0.8 0 CA-C-N 116.267 -0.424 . . . . 72.04 109.974 -176.464 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . 0.556 HD22 HD12 ' A' ' 251' ' ' LEU . 16.0 tp -107.79 111.05 23.02 Favored 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 108.758 -0.83 . . . . 74.02 108.758 -175.878 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -79.63 123.56 27.74 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 123.232 0.613 . . . . 74.2 109.412 176.147 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 199' ' ' VAL . . . . . 0.404 ' O ' ' HA ' ' A' ' 255' ' ' ILE . 6.4 p -142.36 128.95 10.94 Favored Pre-proline 0 CA--C 1.544 0.729 0 N-CA-C 108.675 -0.861 . . . . 73.25 108.675 179.308 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 200' ' ' PRO . . . . . 0.4 ' HB2' ' HD2' ' A' ' 202' ' ' PRO . 66.2 Cg_endo -72.04 159.24 50.62 Favored 'Trans proline' 0 C--N 1.366 1.498 0 C-N-CA 121.825 1.684 . . . . 73.1 111.185 170.711 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 201' ' ' ALA . . . . . 0.414 ' O ' HG21 ' A' ' 205' ' ' VAL . . . -50.61 -50.61 71.56 Favored Pre-proline 0 CA--C 1.556 1.201 0 CA-C-N 114.94 -1.027 . . . . 62.31 113.72 -178.526 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 202' ' ' PRO . . . . . 0.4 ' HD2' ' HB2' ' A' ' 200' ' ' PRO . 52.0 Cg_endo -65.74 -35.82 34.99 Favored 'Trans proline' 0 C--N 1.385 2.469 0 C-N-CA 121.438 1.425 . . . . 72.44 114.697 -178.789 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 50.0 mt -68.88 -29.35 43.13 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.25 0 N-CA-C 110.163 -0.31 . . . . 75.23 110.163 176.812 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -70.96 -41.84 70.52 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 122.62 0.368 . . . . 72.04 111.313 175.448 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . 0.414 HG21 ' O ' ' A' ' 201' ' ' ALA . 85.4 t -64.59 -55.96 18.56 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.283 0 C-N-CA 123.864 0.866 . . . . 72.32 111.644 -179.06 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 25.2 m -76.41 -31.45 20.6 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 CA-C-O 120.635 0.255 . . . . 75.33 111.241 -176.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 82.84 64.17 1.69 Allowed Glycine 0 C--N 1.343 0.928 0 CA-C-N 115.903 -0.59 . . . . 73.32 111.836 -173.394 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -79.98 -134.29 1.22 Allowed Glycine 0 C--N 1.346 1.101 0 CA-C-O 119.752 -0.471 . . . . 72.43 111.96 177.072 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 48.4 mtmt -137.19 148.07 46.3 Favored 'General case' 0 N--CA 1.485 1.296 0 CA-C-N 117.711 0.756 . . . . 72.2 111.061 178.471 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 5.7 m -143.12 158.28 17.65 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 C-N-CA 125.169 1.387 . . . . 74.2 108.436 174.584 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 42.0 ttp-105 -94.9 113.38 25.1 Favored 'General case' 0 CA--C 1.544 0.732 0 CA-C-O 121.167 0.508 . . . . 72.2 110.781 -175.171 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -101.37 113.56 26.76 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 124.283 1.033 . . . . 63.3 109.469 175.786 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 39.9 ttm -88.67 116.88 27.24 Favored 'General case' 0 N--CA 1.477 0.882 0 CA-C-O 121.022 0.439 . . . . 74.35 110.018 -179.161 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 17.5 p -111.55 -171.78 1.91 Allowed 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 124.463 1.105 . . . . 63.44 110.062 -173.216 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 84.0 mt -63.59 -37.58 87.86 Favored 'General case' 0 N--CA 1.489 1.485 0 CA-C-O 121.133 0.492 . . . . 71.22 110.606 171.672 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -80.36 -11.46 59.7 Favored 'General case' 0 N--CA 1.476 0.845 0 CA-C-N 114.797 -1.092 . . . . 72.11 111.087 -174.362 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 123.09 -173.02 16.13 Favored Glycine 0 C--N 1.344 1.01 0 N-CA-C 111.447 -0.661 . . . . 73.31 111.447 -179.614 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -73.1 147.55 43.07 Favored 'Trans proline' 0 CA--C 1.552 1.376 0 C-N-CA 122.384 2.056 . . . . 74.21 111.978 177.527 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 219' ' ' VAL . . . . . 0.445 HG22 HG23 ' A' ' 170' ' ' THR . 3.8 p -139.78 131.36 33.19 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 N-CA-C 108.976 -0.75 . . . . 71.34 108.976 174.346 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -80.86 100.03 8.63 Favored 'General case' 0 C--O 1.239 0.508 0 N-CA-C 107.012 -1.477 . . . . 73.41 107.012 172.258 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 3.8 p -101.67 129.57 52.67 Favored 'Isoleucine or valine' 0 C--O 1.242 0.699 0 N-CA-C 108.602 -0.888 . . . . 73.42 108.602 -172.245 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -76.92 109.39 10.68 Favored 'General case' 0 C--O 1.236 0.386 0 C-N-CA 122.374 0.269 . . . . 75.15 110.523 -177.434 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 58.3 t -52.69 135.04 45.5 Favored Pre-proline 0 CA--C 1.55 0.943 0 O-C-N 124.478 1.111 . . . . 73.23 109.342 178.155 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -61.33 143.5 97.99 Favored 'Trans proline' 0 C--N 1.369 1.642 0 C-N-CA 121.763 1.642 . . . . 72.31 110.495 174.79 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 16.2 Cg_endo -60.35 132.22 42.63 Favored 'Trans proline' 0 C--N 1.37 1.677 0 C-N-CA 121.448 1.432 . . . . 45.42 110.759 175.828 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 65.9 mtm180 65.12 53.05 1.4 Allowed 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.939 1.296 . . . . 72.23 110.834 173.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 26.5 m -75.77 147.48 39.21 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-N 114.886 -1.052 . . . . 75.54 109.651 172.472 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 25.3 mp0 -117.65 145.11 44.6 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 108.301 -1.0 . . . . 64.45 108.301 175.082 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -58.91 134.03 56.57 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 123.684 0.794 . . . . 74.22 111.938 -176.201 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 97.07 -1.33 60.87 Favored Glycine 0 C--N 1.346 1.137 0 CA-C-O 119.079 -0.845 . . . . 63.53 113.934 178.772 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 80.8 mtt-85 -67.28 156.36 36.58 Favored 'General case' 0 N--CA 1.481 1.105 0 CA-C-N 117.862 0.831 . . . . 74.25 111.327 176.781 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 232' ' ' LYS . . . . . 0.456 ' HZ3' ' HE2' ' A' ' 194' ' ' TYR . 70.7 mmtt -119.86 98.93 6.34 Favored 'General case' 0 C--O 1.239 0.548 0 CA-C-N 114.416 -1.265 . . . . 72.2 108.995 -172.641 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 233' ' ' LEU . . . . . 0.639 ' HB2' ' HB2' ' A' ' 251' ' ' LEU . 8.6 mt -86.88 150.28 24.22 Favored 'General case' 0 CA--C 1.542 0.668 0 N-CA-C 107.978 -1.119 . . . . 72.54 107.978 178.105 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 47.2 ttt85 -124.25 108.66 12.49 Favored 'General case' 0 CA--C 1.551 1.017 0 CA-C-N 118.637 0.653 . . . . 73.14 110.736 -176.382 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 235' ' ' LEU . . . . . 0.537 HD22 ' CD1' ' A' ' 173' ' ' PHE . 11.9 mt -86.99 106.5 17.87 Favored 'General case' 0 C--N 1.352 0.702 0 C-N-CA 124.699 1.199 . . . . 75.14 110.524 179.45 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . 0.498 ' H ' ' HB3' ' A' ' 173' ' ' PHE . 12.8 mtmt -74.35 132.37 41.97 Favored 'General case' 0 CA--C 1.539 0.549 0 O-C-N 123.531 0.519 . . . . 75.15 112.229 -178.736 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 81.24 19.57 66.56 Favored Glycine 0 C--N 1.35 1.314 0 CA-C-N 114.711 -1.131 . . . . 55.43 113.818 -178.843 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 75.9 mmtt -122.27 13.21 10.32 Favored 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 122.981 0.512 . . . . 74.5 112.229 -175.124 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -124.32 -172.03 13.54 Favored Glycine 0 C--N 1.344 0.981 0 N-CA-C 111.243 -0.743 . . . . 75.22 111.243 173.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 60.5 m-85 -84.99 160.46 55.19 Favored Pre-proline 0 N--CA 1.485 1.317 0 C-N-CA 123.983 0.913 . . . . 73.42 112.171 -173.538 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 241' ' ' PRO . . . . . 0.441 ' HA ' ' O ' ' A' ' 245' ' ' GLY . 17.2 Cg_exo -68.53 148.64 73.22 Favored 'Trans proline' 0 C--N 1.376 1.983 0 C-N-CA 122.115 1.877 . . . . 74.13 112.395 169.72 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -173.2 -119.91 0.55 Allowed Glycine 0 C--N 1.35 1.335 0 CA-C-O 119.141 -0.811 . . . . 54.23 112.529 177.355 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 243' ' ' PRO . . . . . 0.56 ' HD2' ' HB3' ' A' ' 191' ' ' GLN . 44.8 Cg_endo -59.67 -65.59 0.08 OUTLIER 'Trans proline' 0 C--N 1.378 2.104 0 C-N-CA 124.587 3.525 . . . . 75.4 112.648 -172.651 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -90.7 20.54 4.61 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 123.168 0.587 . . . . 63.5 110.903 175.309 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 245' ' ' GLY . . . . . 0.441 ' O ' ' HA ' ' A' ' 241' ' ' PRO . . . 75.0 -96.92 0.99 Allowed Glycine 0 C--N 1.349 1.29 0 N-CA-C 110.47 -1.052 . . . . 70.43 110.47 -173.033 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 21.5 ttm180 -48.46 108.89 0.19 Allowed 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 124.57 1.148 . . . . 72.32 112.32 -178.238 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -88.52 156.21 26.61 Favored Glycine 0 C--O 1.249 1.091 0 N-CA-C 110.814 -0.915 . . . . 75.11 110.814 167.334 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 40.6 m-20 -130.57 155.2 46.92 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-O 120.912 0.386 . . . . 75.42 110.351 -173.297 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 249' ' ' LEU . . . . . 0.492 ' HB3' ' HB2' ' A' ' 235' ' ' LEU . 47.4 tp -98.01 138.08 35.87 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 123.925 0.89 . . . . 74.44 110.755 -173.165 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 250' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -98.89 113.51 25.69 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 122.808 0.443 . . . . 74.32 110.395 177.384 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 251' ' ' LEU . . . . . 0.639 ' HB2' ' HB2' ' A' ' 233' ' ' LEU . 82.7 mt -88.67 105.18 17.51 Favored 'General case' 0 C--O 1.241 0.646 0 N-CA-C 108.541 -0.911 . . . . 75.41 108.541 174.867 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -88.5 103.86 16.27 Favored 'General case' 0 C--O 1.239 0.528 0 N-CA-C 108.385 -0.969 . . . . 72.15 108.385 177.818 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 19.7 m -72.01 143.1 14.5 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 CA-C-O 121.29 0.567 . . . . 75.51 111.084 -172.18 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 19.0 mmt85 -130.39 101.18 5.63 Favored 'General case' 0 C--O 1.237 0.438 0 C-N-CA 124.228 1.011 . . . . 74.12 108.377 177.452 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 255' ' ' ILE . . . . . 0.404 ' HA ' ' O ' ' A' ' 199' ' ' VAL . 30.9 mt -78.89 124.14 36.84 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 O-C-N 123.893 0.745 . . . . 74.43 110.175 178.81 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 1.4 t . . . . . 0 CA--C 1.558 1.271 0 N-CA-C 107.513 -1.292 . . . . 74.53 107.513 173.797 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 24.7 ptm . . . . . 0 N--CA 1.484 1.226 0 CA-C-O 120.353 0.12 . . . . 75.41 110.681 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 169' ' ' GLN . . . . . 0.54 ' HG2' HG22 ' A' ' 170' ' ' THR . 33.6 tt0 -153.4 -90.03 0.05 OUTLIER 'General case' 0 CA--C 1.546 0.821 0 N-CA-C 108.613 -0.884 . . . . 63.33 108.613 -178.144 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 170' ' ' THR . . . . . 0.54 HG22 ' HG2' ' A' ' 169' ' ' GLN . 10.8 t 172.72 178.61 0.09 Allowed 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 125.371 1.469 . . . . 74.41 109.059 -174.314 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -151.95 -61.37 0.17 Allowed 'General case' 0 N--CA 1.478 0.931 0 CA-C-O 121.001 0.429 . . . . 62.11 110.143 -175.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 172' ' ' LEU . . . . . 0.464 HD21 ' O ' ' A' ' 222' ' ' ALA . 25.0 mt -138.78 154.05 48.47 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 124.07 0.948 . . . . 74.24 112.013 -175.039 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 173' ' ' PHE . . . . . 0.537 ' CD1' HD21 ' A' ' 235' ' ' LEU . 26.4 m-85 -136.78 -48.77 0.63 Allowed 'General case' 0 N--CA 1.477 0.879 0 CA-C-N 114.911 -1.041 . . . . 75.01 109.76 -169.578 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 174' ' ' TYR . . . . . 0.435 ' CD2' ' HB3' ' A' ' 233' ' ' LEU . 7.9 p90 -84.22 13.6 5.09 Favored 'General case' 0 N--CA 1.48 1.07 0 CA-C-N 114.824 -1.08 . . . . 74.02 113.087 -176.928 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 1.8 p -65.06 -10.58 31.29 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 123.107 0.563 . . . . 71.33 112.504 175.189 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 176' ' ' MET . . . . . 0.549 ' HE3' ' HD2' ' A' ' 234' ' ' ARG . 41.8 mtm -53.18 -42.11 65.9 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 124.316 1.047 . . . . 72.24 110.302 169.053 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . 0.538 ' HB2' ' HZ1' ' A' ' 177' ' ' LYS . 2.8 ttmp? -167.41 97.38 0.49 Allowed 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 124.709 1.204 . . . . 65.31 108.301 176.307 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 178' ' ' ALA . . . . . 0.434 ' HB1' ' HB3' ' A' ' 224' ' ' PRO . . . -109.38 146.3 34.65 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 124.149 0.98 . . . . 75.43 110.456 -175.738 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . 0.475 ' HB3' ' HB2' ' A' ' 224' ' ' PRO . . . 59.75 28.86 18.39 Favored 'General case' 0 N--CA 1.492 1.668 0 C-N-CA 124.388 1.075 . . . . 64.33 111.574 -174.362 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -89.9 144.59 17.76 Favored Glycine 0 C--N 1.348 1.25 0 CA-C-N 115.522 -0.763 . . . . 43.21 111.674 -179.578 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 39.2 p -73.22 144.63 46.68 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 123.25 0.62 . . . . 73.32 110.926 176.056 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . 95.04 -134.52 11.98 Favored Glycine 0 C--N 1.346 1.126 0 N-CA-C 111.617 -0.593 . . . . 62.13 111.617 -175.69 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 157.37 58.44 0.01 OUTLIER Glycine 0 C--N 1.338 0.648 0 N-CA-C 110.425 -1.07 . . . . 63.45 110.425 -178.391 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 21.6 m -52.36 113.97 1.21 Allowed 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 124.626 1.17 . . . . 65.55 111.973 -175.661 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 179.23 -78.59 0.06 OUTLIER Glycine 0 C--N 1.344 1.02 0 N-CA-C 110.917 -0.873 . . . . 63.01 110.917 -178.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 68.0 -85.2 0.17 Allowed Glycine 0 C--N 1.355 1.596 0 C-N-CA 123.319 0.485 . . . . 73.54 113.36 174.134 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 36.4 p -130.52 108.05 9.66 Favored 'General case' 0 C--O 1.242 0.691 0 C-N-CA 124.391 1.077 . . . . 74.32 108.764 176.7 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -91.56 -52.34 2.33 Favored Glycine 0 CA--C 1.529 0.925 0 CA-C-N 115.514 -0.766 . . . . 72.14 113.093 -177.307 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 152.83 54.17 0.01 OUTLIER Glycine 0 N--CA 1.477 1.399 0 CA-C-N 117.126 0.463 . . . . 73.23 112.127 179.851 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 46.2 m 63.0 10.53 4.48 Favored 'General case' 0 N--CA 1.49 1.553 0 C-N-CA 124.305 1.042 . . . . 72.35 112.093 -174.831 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 191' ' ' GLN . . . . . 0.682 ' HB2' ' HA2' ' A' ' 247' ' ' GLY . 3.4 pt20 -87.6 -21.97 25.04 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 124.556 1.143 . . . . 70.33 110.296 -177.147 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -76.53 148.28 37.21 Favored 'General case' 0 C--O 1.237 0.403 0 C-N-CA 125.05 1.34 . . . . 73.44 111.255 -162.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . 0.544 HD13 ' HA2' ' A' ' 239' ' ' GLY . 16.3 mt -143.87 170.97 14.89 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 123.607 0.763 . . . . 73.35 110.315 172.11 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 74.6 m-85 -135.74 141.58 44.87 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 124.146 0.978 . . . . 73.12 109.815 179.036 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . 0.462 ' O ' ' HA ' ' A' ' 251' ' ' LEU . . . -154.23 132.77 12.09 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 123.787 0.835 . . . . 64.13 108.758 176.983 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 26.9 m -82.5 127.2 33.08 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.274 -0.639 . . . . 74.43 109.274 178.581 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . 0.68 HD21 HD11 ' A' ' 251' ' ' LEU . 18.1 tp -105.54 107.42 18.4 Favored 'General case' 0 N--CA 1.465 0.306 0 N-CA-C 107.549 -1.278 . . . . 74.11 107.549 -179.469 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -77.81 123.57 26.89 Favored 'General case' 0 C--O 1.237 0.439 0 N-CA-C 107.828 -1.175 . . . . 71.12 107.828 174.072 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 199' ' ' VAL . . . . . 0.533 ' O ' ' HA ' ' A' ' 255' ' ' ILE . 2.8 p -141.62 125.6 10.1 Favored Pre-proline 0 CA--C 1.541 0.625 0 N-CA-C 108.205 -1.035 . . . . 74.21 108.205 -179.652 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -69.98 158.08 57.83 Favored 'Trans proline' 0 C--N 1.365 1.42 0 C-N-CA 122.048 1.832 . . . . 73.42 111.728 171.758 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -49.73 -50.32 67.92 Favored Pre-proline 0 CA--C 1.56 1.329 0 N-CA-C 114.001 1.111 . . . . 73.32 114.001 -178.769 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -63.48 -37.5 48.11 Favored 'Trans proline' 0 C--N 1.393 2.874 0 C-N-CA 122.115 1.877 . . . . 73.24 113.484 -178.507 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 38.3 mt -67.99 -36.11 74.34 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.173 0 CA-C-N 117.995 0.361 . . . . 73.24 110.448 176.102 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 204' ' ' ALA . . . . . 0.448 ' HA ' HG12 ' A' ' 223' ' ' VAL . . . -67.09 -41.78 85.72 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 123.06 0.544 . . . . 74.23 112.231 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 20.9 m -77.81 -51.37 18.14 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.993 0 C-N-CA 123.472 0.709 . . . . 61.2 112.448 -175.592 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 7.9 m -73.4 -30.06 29.32 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.402 0 C-N-CA 122.357 0.263 . . . . 73.33 111.249 -178.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 89.66 63.09 1.29 Allowed Glycine 0 C--N 1.352 1.432 0 CA-C-N 116.216 -0.447 . . . . 44.15 112.373 -175.858 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -86.71 -139.09 5.52 Favored Glycine 0 C--N 1.352 1.429 0 CA-C-O 119.873 -0.404 . . . . 65.33 112.734 -179.833 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 46.4 mtmt -137.89 147.87 44.83 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 123.972 0.909 . . . . 73.3 110.287 178.012 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 5.2 m -140.81 166.34 18.93 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 C-N-CA 124.771 1.229 . . . . 73.2 109.807 174.475 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 29.0 ttp180 -90.06 113.91 25.71 Favored 'General case' 0 CA--C 1.546 0.827 0 C-N-CA 123.63 0.772 . . . . 74.31 109.843 -179.601 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -100.39 117.19 34.07 Favored 'General case' 0 C--O 1.24 0.562 0 N-CA-C 108.586 -0.894 . . . . 75.13 108.586 171.073 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 47.8 tpp -84.0 116.04 22.63 Favored 'General case' 0 C--O 1.241 0.637 0 N-CA-C 109.408 -0.59 . . . . 75.13 109.408 177.58 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 16.6 p -111.47 -173.67 2.3 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 124.59 1.156 . . . . 74.14 109.614 -176.515 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 56.2 mt -61.99 -36.09 80.45 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 122.986 0.514 . . . . 71.14 111.911 175.295 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 27.2 mt-10 -89.81 -8.65 51.59 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.721 0.808 . . . . 62.2 111.435 -172.452 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 124.39 -161.4 18.84 Favored Glycine 0 C--N 1.345 1.058 0 CA-C-O 119.282 -0.732 . . . . 62.45 111.458 -178.08 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -77.71 159.91 31.45 Favored 'Trans proline' 0 CA--C 1.549 1.257 0 C-N-CA 122.525 2.15 . . . . 65.44 112.794 -177.218 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 2.9 p -148.34 129.7 5.65 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 N-CA-C 108.674 -0.862 . . . . 73.32 108.674 171.02 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -76.81 100.29 5.44 Favored 'General case' 0 C--O 1.239 0.544 0 N-CA-C 107.478 -1.305 . . . . 75.22 107.478 169.613 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 9.1 p -100.34 128.36 52.41 Favored 'Isoleucine or valine' 0 C--O 1.245 0.845 0 N-CA-C 108.012 -1.107 . . . . 71.51 108.012 -176.417 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . 0.464 ' O ' HD21 ' A' ' 172' ' ' LEU . . . -77.85 105.19 8.87 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 116.466 -0.334 . . . . 74.3 110.648 -174.696 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . 0.448 HG12 ' HA ' ' A' ' 204' ' ' ALA . 62.6 t -53.8 133.03 56.9 Favored Pre-proline 0 N--CA 1.472 0.662 0 C-N-CA 124.13 0.972 . . . . 63.3 109.54 179.239 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 224' ' ' PRO . . . . . 0.475 ' HB2' ' HB3' ' A' ' 179' ' ' ALA . 30.8 Cg_endo -64.75 150.53 88.02 Favored 'Trans proline' 0 C--N 1.369 1.629 0 C-N-CA 121.327 1.352 . . . . 73.54 110.663 175.561 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -63.48 140.51 76.27 Favored 'Trans proline' 0 C--N 1.366 1.482 0 C-N-CA 121.452 1.435 . . . . 73.11 110.694 176.449 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 56.6 mtm180 64.79 42.44 4.54 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 124.248 1.019 . . . . 75.52 111.074 170.137 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 63.4 m -76.9 143.48 39.56 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-N 115.464 -0.789 . . . . 74.1 109.444 173.537 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 27.8 mp0 -117.22 143.84 45.44 Favored 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 124.144 0.978 . . . . 65.51 109.039 176.475 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -62.35 123.93 19.55 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 123.757 0.823 . . . . 75.22 110.628 -178.282 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 115.15 -6.5 21.52 Favored Glycine 0 C--N 1.338 0.659 0 O-C-N 123.75 0.656 . . . . 75.03 113.178 -175.34 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 95.2 mtt-85 -74.79 157.2 35.58 Favored 'General case' 0 N--CA 1.478 0.954 0 CA-C-N 117.634 0.717 . . . . 75.04 110.055 172.655 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 232' ' ' LYS . . . . . 0.444 ' HA ' ' O ' ' A' ' 251' ' ' LEU . 12.5 mtmm -131.42 120.95 23.76 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.269 0.628 . . . . 75.4 110.53 -179.681 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 233' ' ' LEU . . . . . 0.503 ' HB2' ' HB2' ' A' ' 251' ' ' LEU . 26.7 mt -101.99 154.31 19.08 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 125.138 1.375 . . . . 73.13 109.264 -176.274 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 234' ' ' ARG . . . . . 0.549 ' HD2' ' HE3' ' A' ' 176' ' ' MET . 15.1 ttm180 -111.99 110.87 21.41 Favored 'General case' 0 N--CA 1.48 1.065 0 CA-C-N 118.144 0.429 . . . . 74.14 111.099 -179.736 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 235' ' ' LEU . . . . . 0.576 ' HB2' ' HB3' ' A' ' 249' ' ' LEU . 11.2 mt -88.11 99.56 12.28 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 122.919 0.487 . . . . 61.0 110.023 172.014 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . 0.457 ' H ' ' HB3' ' A' ' 173' ' ' PHE . 11.7 mtmt -72.52 130.47 40.71 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 115.967 -0.56 . . . . 65.14 111.304 -179.789 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 83.69 21.11 58.57 Favored Glycine 0 C--N 1.344 0.995 0 CA-C-N 115.059 -0.973 . . . . 73.15 113.612 -178.182 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt -127.2 17.86 7.11 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 123.012 0.525 . . . . 73.42 111.329 -178.495 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 239' ' ' GLY . . . . . 0.544 ' HA2' HD13 ' A' ' 193' ' ' LEU . . . -118.81 -159.96 11.26 Favored Glycine 0 C--N 1.347 1.146 0 N-CA-C 111.278 -0.729 . . . . 63.03 111.278 170.256 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 60.4 m-85 -92.55 165.37 19.47 Favored Pre-proline 0 CA--C 1.553 1.061 0 C-N-CA 123.713 0.805 . . . . 74.14 110.376 -177.187 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 241' ' ' PRO . . . . . 0.461 ' HA ' ' O ' ' A' ' 245' ' ' GLY . 40.4 Cg_exo -61.17 166.25 11.19 Favored 'Trans proline' 0 C--N 1.374 1.877 0 C-N-CA 121.732 1.621 . . . . 73.52 113.473 170.333 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 167.32 -123.72 1.15 Allowed Glycine 0 CA--C 1.529 0.968 0 CA-C-O 118.874 -0.959 . . . . 70.11 111.862 177.209 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 243' ' ' PRO . . . . . 0.466 ' HD2' ' HB3' ' A' ' 191' ' ' GLN . 30.9 Cg_endo -59.68 -60.78 0.27 Allowed 'Trans proline' 0 C--N 1.379 2.136 0 C-N-CA 123.925 3.083 . . . . 70.02 112.976 -170.001 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -90.93 2.85 55.89 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 123.185 0.594 . . . . 74.53 111.43 177.373 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 245' ' ' GLY . . . . . 0.461 ' O ' ' HA ' ' A' ' 241' ' ' PRO . . . 85.35 -34.57 3.26 Favored Glycine 0 C--N 1.358 1.757 0 N-CA-C 112.319 -0.312 . . . . 54.33 112.319 -173.746 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 10.8 ttm180 -88.66 112.53 23.21 Favored 'General case' 0 CA--C 1.529 0.149 0 C-N-CA 124.79 1.236 . . . . 74.21 111.404 177.557 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . 0.682 ' HA2' ' HB2' ' A' ' 191' ' ' GLN . . . -84.31 163.57 39.37 Favored Glycine 0 C--N 1.345 1.074 0 C-N-CA 121.27 -0.491 . . . . 74.23 114.055 162.855 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 34.6 m-20 -132.65 143.79 49.9 Favored 'General case' 0 C--O 1.241 0.638 0 C-N-CA 123.866 0.866 . . . . 73.24 110.133 -169.063 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 249' ' ' LEU . . . . . 0.576 ' HB3' ' HB2' ' A' ' 235' ' ' LEU . 61.4 tp -106.98 117.86 35.18 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 124.361 1.065 . . . . 74.1 110.087 -177.084 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 250' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 -91.5 110.62 21.93 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 123.245 0.618 . . . . 74.23 110.034 -174.299 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 251' ' ' LEU . . . . . 0.68 HD11 HD21 ' A' ' 197' ' ' LEU . 74.6 mt -86.73 106.35 17.59 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 114.839 -1.073 . . . . 64.45 110.574 -175.037 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -79.63 97.07 6.37 Favored 'General case' 0 C--O 1.241 0.643 0 N-CA-C 108.439 -0.948 . . . . 74.31 108.439 173.746 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 4.6 m -69.42 130.35 34.16 Favored 'Isoleucine or valine' 0 C--O 1.244 0.776 0 CA-C-O 121.762 0.792 . . . . 75.35 110.251 -176.338 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 21.8 mmm180 -126.9 115.13 18.82 Favored 'General case' 0 C--O 1.237 0.44 0 N-CA-C 107.657 -1.238 . . . . 73.05 107.657 178.576 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 255' ' ' ILE . . . . . 0.533 ' HA ' ' O ' ' A' ' 199' ' ' VAL . 49.0 mt -98.82 111.88 29.53 Favored 'Isoleucine or valine' 0 C--O 1.24 0.589 0 O-C-N 123.574 0.546 . . . . 71.54 110.443 -175.09 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 3.1 t . . . . . 0 CA--C 1.56 1.34 0 CA-C-N 115.523 -0.762 . . . . 74.42 108.984 177.276 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 168' ' ' MET . . . . . 0.417 ' N ' ' SD ' ' A' ' 168' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.482 1.13 0 N-CA-C 111.746 0.276 . . . . 75.34 111.746 . . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 17.7 pt20 -138.07 169.1 18.37 Favored 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 123.246 0.618 . . . . 73.25 110.534 176.507 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 10.5 t -95.39 158.5 15.43 Favored 'General case' 0 CA--C 1.551 0.999 0 C-N-CA 123.927 0.891 . . . . 72.43 109.264 174.281 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -115.98 -84.45 0.63 Allowed 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 123.523 0.729 . . . . 73.31 111.53 -173.5 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 172' ' ' LEU . . . . . 0.448 HD22 ' HB3' ' A' ' 222' ' ' ALA . 77.5 mt -126.33 155.9 41.28 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 124.071 0.949 . . . . 74.45 111.654 -163.768 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 173' ' ' PHE . . . . . 0.423 ' CD1' HD22 ' A' ' 235' ' ' LEU . 45.4 m-85 -144.59 -66.95 0.33 Allowed 'General case' 0 N--CA 1.486 1.336 0 N-CA-C 109.391 -0.596 . . . . 75.52 109.391 -166.545 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 174' ' ' TYR . . . . . 0.467 ' CD2' ' HB3' ' A' ' 233' ' ' LEU . 7.7 p90 -64.77 -13.24 54.49 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 123.841 0.857 . . . . 75.34 112.301 177.655 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 175' ' ' THR . . . . . 0.444 HG22 HD12 ' A' ' 172' ' ' LEU . 4.2 m -65.73 0.97 1.45 Allowed 'General case' 0 CA--C 1.565 1.535 0 C-N-CA 125.133 1.373 . . . . 73.52 112.217 -178.154 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 176' ' ' MET . . . . . 0.443 ' HE3' ' HZ2' ' A' ' 236' ' ' LYS . 37.3 mtm -64.85 -59.88 3.7 Favored 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 123.604 0.762 . . . . 75.03 109.148 161.543 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.98 100.32 3.38 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 124.477 1.111 . . . . 71.55 108.651 175.024 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -109.44 -178.38 3.54 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 124.194 0.998 . . . . 73.01 111.612 -170.169 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . 62.14 -91.05 0.03 OUTLIER 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 125.088 1.355 . . . . 72.13 111.044 -177.43 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -136.51 29.9 2.74 Favored Glycine 0 N--CA 1.469 0.877 0 N-CA-C 112.461 -0.256 . . . . 73.54 112.461 -178.225 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 24.5 m -98.43 14.24 28.82 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 123.717 0.807 . . . . 65.44 110.87 178.262 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -170.38 164.61 37.9 Favored Glycine 0 C--N 1.345 1.077 0 CA-C-N 116.089 -0.505 . . . . 43.32 111.86 -178.878 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 175.76 -43.64 0.12 Allowed Glycine 0 C--N 1.345 1.058 0 N-CA-C 112.011 -0.436 . . . . 71.51 112.011 178.871 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 33.3 t -70.08 112.39 6.43 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 123.114 0.566 . . . . 73.53 110.575 -178.858 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . 0.507 ' HA2' HH22 ' A' ' 234' ' ' ARG . . . -76.55 -47.4 10.29 Favored Glycine 0 C--N 1.351 1.365 0 O-C-N 123.438 0.461 . . . . 61.11 113.103 -178.078 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 72.52 43.92 42.9 Favored Glycine 0 C--N 1.35 1.316 0 O-C-N 123.668 0.276 . . . . 61.41 112.592 -176.851 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 48.2 t -109.11 160.93 15.66 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 124.097 0.959 . . . . 54.44 111.594 -175.2 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -146.85 -35.18 0.06 OUTLIER Glycine 0 C--N 1.35 1.339 0 CA-C-N 115.745 -0.661 . . . . 61.0 112.274 179.152 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -87.51 11.1 67.01 Favored Glycine 0 C--N 1.353 1.496 0 CA-C-O 119.338 -0.701 . . . . 55.55 114.056 -177.371 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 50.4 m 60.32 65.39 1.08 Allowed 'General case' 0 C--N 1.358 0.942 0 C-N-CA 124.086 0.954 . . . . 65.54 112.131 178.255 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 191' ' ' GLN . . . . . 0.618 ' HB3' ' HD2' ' A' ' 243' ' ' PRO . 9.9 pt20 -89.81 -22.85 21.9 Favored 'General case' 0 N--CA 1.478 0.962 0 CA-C-N 115.862 -0.608 . . . . 73.41 110.347 174.629 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -77.56 157.58 30.26 Favored 'General case' 0 C--O 1.241 0.617 0 CA-C-N 115.091 -0.959 . . . . 71.22 110.904 -168.539 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 32.7 mt -134.25 171.13 14.68 Favored 'General case' 0 C--O 1.239 0.529 0 CA-C-N 114.284 -1.325 . . . . 70.22 108.69 176.282 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 59.6 m-85 -136.49 126.63 26.24 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 123.768 0.827 . . . . 62.12 110.317 -177.165 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . 0.415 ' O ' ' HA ' ' A' ' 251' ' ' LEU . . . -141.65 130.66 23.21 Favored 'General case' 0 N--CA 1.466 0.344 0 N-CA-C 107.951 -1.129 . . . . 74.13 107.951 175.636 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 30.4 m -83.07 127.78 33.89 Favored 'General case' 0 C--O 1.24 0.559 0 N-CA-C 108.577 -0.897 . . . . 73.21 108.577 176.865 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . 0.679 HD22 HD11 ' A' ' 251' ' ' LEU . 16.7 tp -106.35 110.05 22.17 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 108.331 -0.989 . . . . 74.23 108.331 -178.974 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -80.72 118.42 22.25 Favored 'General case' 0 C--O 1.238 0.475 0 N-CA-C 108.233 -1.025 . . . . 74.3 108.233 -179.817 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 5.1 p -136.89 128.45 16.74 Favored Pre-proline 0 CA--C 1.543 0.691 0 N-CA-C 108.948 -0.76 . . . . 74.44 108.948 -176.28 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 200' ' ' PRO . . . . . 0.436 ' HB2' ' HD2' ' A' ' 202' ' ' PRO . 62.0 Cg_endo -69.69 158.25 57.72 Favored 'Trans proline' 0 C--N 1.365 1.404 0 C-N-CA 121.924 1.749 . . . . 74.32 111.246 172.717 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 201' ' ' ALA . . . . . 0.496 ' HA ' HG22 ' A' ' 255' ' ' ILE . . . -47.34 -54.8 19.16 Favored Pre-proline 0 CA--C 1.562 1.417 0 CA-C-O 117.547 -1.216 . . . . 72.54 113.044 179.88 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 202' ' ' PRO . . . . . 0.436 ' HD2' ' HB2' ' A' ' 200' ' ' PRO . 52.9 Cg_endo -64.74 -37.25 36.85 Favored 'Trans proline' 0 C--N 1.4 3.289 0 C-N-CA 121.9 1.733 . . . . 71.31 113.323 -174.124 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 44.1 mt -65.67 -34.64 71.7 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 C-N-CA 122.54 0.336 . . . . 72.34 110.141 177.604 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -70.53 -39.75 73.86 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 122.518 0.327 . . . . 65.31 111.093 177.277 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . 0.483 HG21 ' O ' ' A' ' 201' ' ' ALA . 83.9 t -67.44 -56.43 13.41 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 C-N-CA 123.565 0.746 . . . . 74.34 111.193 -177.852 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 10.5 m -82.06 -29.49 9.68 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 CA-C-N 116.002 -0.544 . . . . 72.05 111.455 -172.821 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 88.5 65.43 1.31 Allowed Glycine 0 C--N 1.345 1.074 0 CA-C-N 116.093 -0.503 . . . . 73.54 112.129 -174.875 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -87.11 -134.69 4.18 Favored Glycine 0 C--N 1.357 1.726 0 N-CA-C 111.794 -0.523 . . . . 44.54 111.794 177.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 46.6 mtmt -136.61 154.93 50.53 Favored 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 123.524 0.729 . . . . 62.52 110.908 178.602 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 6.3 m -144.94 169.66 7.77 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 C-N-CA 125.597 1.559 . . . . 74.2 108.473 172.319 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 56.0 ttp180 -104.23 119.43 38.94 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 123.573 0.749 . . . . 74.44 109.499 177.487 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -103.57 141.08 36.63 Favored 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 123.894 0.878 . . . . 74.4 109.667 175.402 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 46.9 tpp -100.27 128.32 46.37 Favored 'General case' 0 N--CA 1.475 0.808 0 N-CA-C 109.179 -0.675 . . . . 75.23 109.179 178.389 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 19.6 p -129.27 -171.68 2.55 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 123.818 0.847 . . . . 73.33 110.52 -171.55 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 91.9 mt -62.18 -27.75 69.18 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 123.831 0.853 . . . . 74.02 111.839 173.869 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -99.49 6.48 45.89 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 123.573 0.749 . . . . 70.12 111.52 -179.464 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 94.48 -153.42 20.99 Favored Glycine 0 C--N 1.347 1.146 0 CA-C-O 119.589 -0.562 . . . . 70.51 112.655 -177.807 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_endo -70.35 153.4 66.26 Favored 'Trans proline' 0 C--N 1.37 1.672 0 C-N-CA 122.582 2.188 . . . . 72.11 113.25 -174.489 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 4.6 p -145.52 135.81 18.74 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 C-N-CA 124.368 1.067 . . . . 74.11 109.048 174.245 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -83.6 104.23 13.56 Favored 'General case' 0 C--O 1.239 0.546 0 N-CA-C 107.883 -1.154 . . . . 71.02 107.883 172.659 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 2.9 p -114.39 126.07 71.84 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.018 0 N-CA-C 109.41 -0.589 . . . . 64.35 109.41 -174.476 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . 0.448 ' HB3' HD22 ' A' ' 172' ' ' LEU . . . -78.82 108.43 12.26 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 123.39 0.676 . . . . 55.55 110.69 -179.333 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 84.7 t -55.46 136.17 70.01 Favored Pre-proline 0 N--CA 1.478 0.961 0 C-N-CA 124.754 1.222 . . . . 71.33 109.857 177.12 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -66.31 159.4 50.26 Favored 'Trans proline' 0 C--N 1.373 1.839 0 C-N-CA 121.711 1.607 . . . . 63.51 111.455 174.835 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -69.28 153.13 71.62 Favored 'Trans proline' 0 C--N 1.365 1.428 0 C-N-CA 121.544 1.496 . . . . 73.11 111.08 171.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 39.7 mtm180 60.69 34.41 20.0 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 124.773 1.229 . . . . 71.41 111.578 172.702 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 227' ' ' THR . . . . . 0.478 ' O ' HD13 ' A' ' 255' ' ' ILE . 85.4 m -73.73 120.78 19.8 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 115.049 -0.978 . . . . 71.0 109.547 175.52 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 228' ' ' GLN . . . . . 0.465 ' NE2' HH21 ' A' ' 231' ' ' ARG . 2.2 mp0 -102.59 147.86 26.27 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 124.414 1.086 . . . . 75.42 109.035 177.908 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 229' ' ' ALA . . . . . 0.441 ' HB2' ' HB ' ' A' ' 255' ' ' ILE . . . -59.21 115.03 2.92 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 123.81 0.844 . . . . 71.52 111.274 -177.237 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 113.42 0.2 24.94 Favored Glycine 0 C--N 1.343 0.97 0 O-C-N 123.685 0.616 . . . . 51.24 113.599 -178.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 231' ' ' ARG . . . . . 0.465 HH21 ' NE2' ' A' ' 228' ' ' GLN . 87.5 mtt-85 -65.72 150.77 47.95 Favored 'General case' 0 N--CA 1.486 1.36 0 CA-C-N 117.591 0.696 . . . . 74.44 110.478 173.471 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 71.7 mmtt -118.67 102.22 8.69 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 124.097 0.959 . . . . 74.12 109.488 -171.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 233' ' ' LEU . . . . . 0.764 ' HB2' ' HB2' ' A' ' 251' ' ' LEU . 58.7 mt -88.89 152.21 21.87 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 115.415 -0.812 . . . . 72.5 109.534 178.344 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 234' ' ' ARG . . . . . 0.507 HH22 ' HA2' ' A' ' 185' ' ' GLY . 38.6 ttm-85 -119.32 121.12 38.87 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.512 0.725 . . . . 71.23 110.902 -174.673 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 235' ' ' LEU . . . . . 0.624 ' HB2' ' HB3' ' A' ' 249' ' ' LEU . 16.0 mt -110.43 100.38 9.23 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 122.464 0.306 . . . . 74.44 110.662 176.874 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . 0.543 ' HB3' ' HD2' ' A' ' 246' ' ' ARG . 13.2 mttp -69.13 139.84 54.71 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 110.345 -0.243 . . . . 73.23 110.345 173.323 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 86.85 -3.13 87.22 Favored Glycine 0 N--CA 1.473 1.11 0 CA-C-N 115.757 -0.656 . . . . 72.0 113.193 179.857 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -112.79 5.25 17.45 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 123.573 0.749 . . . . 74.21 111.061 -179.085 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -113.35 -173.82 18.77 Favored Glycine 0 C--N 1.347 1.184 0 N-CA-C 110.997 -0.841 . . . . 72.14 110.997 164.584 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 93.8 m-85 -91.56 160.98 35.51 Favored Pre-proline 0 N--CA 1.483 1.216 0 C-N-CA 123.84 0.856 . . . . 74.12 110.331 -178.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_exo -62.07 158.69 37.81 Favored 'Trans proline' 0 C--N 1.374 1.881 0 C-N-CA 122.136 1.891 . . . . 74.35 112.951 173.724 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 169.19 -128.12 1.62 Allowed Glycine 0 C--N 1.349 1.251 0 CA-C-O 118.766 -1.019 . . . . 65.34 112.307 176.113 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 243' ' ' PRO . . . . . 0.618 ' HD2' ' HB3' ' A' ' 191' ' ' GLN . 18.6 Cg_endo -52.62 -49.66 16.73 Favored 'Trans proline' 0 C--N 1.38 2.199 0 C-N-CA 124.96 3.773 . . . . 73.44 113.826 -173.963 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -95.92 -1.83 48.45 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.295 0.638 . . . . 53.12 111.69 -179.024 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 90.01 -37.76 3.31 Favored Glycine 0 C--N 1.352 1.438 0 CA-C-O 120.955 0.197 . . . . 62.41 113.014 178.1 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 246' ' ' ARG . . . . . 0.543 ' HD2' ' HB3' ' A' ' 236' ' ' LYS . 16.5 ttm180 -120.38 111.73 18.12 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 124.17 0.988 . . . . 72.31 108.593 178.831 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -69.3 155.12 53.44 Favored Glycine 0 C--O 1.25 1.133 0 O-C-N 123.504 0.503 . . . . 74.43 114.255 178.289 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 248' ' ' ASP . . . . . 0.443 ' HB3' ' HG3' ' A' ' 234' ' ' ARG . 40.3 m-20 -112.19 138.87 48.26 Favored 'General case' 0 C--O 1.225 -0.224 0 CA-C-N 114.152 -1.024 . . . . 73.43 109.591 -173.446 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 249' ' ' LEU . . . . . 0.624 ' HB3' ' HB2' ' A' ' 235' ' ' LEU . 44.4 tp -100.12 117.58 34.67 Favored 'General case' 0 C--O 1.238 0.485 0 N-CA-C 108.088 -1.078 . . . . 75.04 108.088 172.051 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 250' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -88.56 108.95 19.69 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 123.651 0.78 . . . . 74.54 108.898 -176.419 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 251' ' ' LEU . . . . . 0.764 ' HB2' ' HB2' ' A' ' 233' ' ' LEU . 85.6 mt -88.38 104.83 17.14 Favored 'General case' 0 C--O 1.24 0.566 0 N-CA-C 108.135 -1.061 . . . . 74.32 108.135 178.281 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -84.36 101.87 12.3 Favored 'General case' 0 C--O 1.241 0.647 0 N-CA-C 107.864 -1.161 . . . . 73.43 107.864 175.222 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 11.2 m -69.45 139.31 20.57 Favored 'Isoleucine or valine' 0 C--O 1.244 0.772 0 O-C-N 123.87 0.731 . . . . 75.31 110.03 -175.774 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 14.4 mmt85 -128.18 105.63 8.5 Favored 'General case' 0 C--O 1.238 0.487 0 C-N-CA 124.073 0.949 . . . . 75.51 108.608 178.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 255' ' ' ILE . . . . . 0.496 HG22 ' HA ' ' A' ' 201' ' ' ALA . 34.0 mt -76.4 123.95 33.7 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 O-C-N 123.932 0.77 . . . . 75.33 109.615 178.582 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 1.8 t . . . . . 0 CA--C 1.554 1.104 0 N-CA-C 107.426 -1.324 . . . . 71.03 107.426 178.773 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 28.1 ttt . . . . . 0 N--CA 1.481 1.093 0 N-CA-C 108.94 -0.763 . . . . 53.42 108.94 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 28.3 pt20 -142.84 167.22 22.58 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 124.013 0.925 . . . . 74.53 110.598 -171.226 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 8.9 t -65.02 160.07 21.71 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 124.095 0.958 . . . . 73.24 111.19 177.534 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 18.9 m-20 -83.92 -89.38 0.09 Allowed 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 123.189 0.595 . . . . 65.01 110.464 -179.273 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 172' ' ' LEU . . . . . 0.677 HD22 ' H ' ' A' ' 222' ' ' ALA . 59.9 mt -146.94 153.95 40.69 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 124.484 1.114 . . . . 75.11 110.449 -167.978 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 173' ' ' PHE . . . . . 0.414 ' CD1' HD22 ' A' ' 235' ' ' LEU . 40.1 m-85 -125.8 -52.26 1.57 Allowed 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 123.927 0.891 . . . . 75.1 108.638 -176.106 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 174' ' ' TYR . . . . . . . . . . . . . 17.3 p90 -68.93 -2.67 10.32 Favored 'General case' 0 C--N 1.345 0.388 0 CA-C-N 113.894 -1.503 . . . . 74.42 114.198 -174.241 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 2.4 p -57.71 -16.06 9.8 Favored 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 123.775 0.83 . . . . 74.53 112.62 173.15 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 176' ' ' MET . . . . . . . . . . . . . 9.4 ptm -52.57 -40.75 62.93 Favored 'General case' 0 CA--C 1.56 1.359 0 C-N-CA 123.988 0.915 . . . . 73.52 111.825 167.519 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 46.5 tptt -153.78 48.28 0.65 Allowed 'General case' 0 N--CA 1.479 1.006 0 CA-C-O 122.019 0.914 . . . . 72.5 109.438 -177.523 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 178' ' ' ALA . . . . . 0.486 ' HB2' ' HB3' ' A' ' 224' ' ' PRO . . . -74.41 131.89 41.48 Favored 'General case' 0 N--CA 1.478 0.958 0 CA-C-N 115.21 -0.904 . . . . 75.34 110.62 -178.271 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . 0.512 ' HB3' ' HB2' ' A' ' 224' ' ' PRO . . . 69.54 14.09 8.3 Favored 'General case' 0 N--CA 1.492 1.639 0 C-N-CA 124.888 1.275 . . . . 74.03 111.448 -171.838 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -94.75 -169.04 36.8 Favored Glycine 0 C--N 1.352 1.452 0 N-CA-C 110.851 -0.9 . . . . 54.45 110.851 171.518 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 33.3 p -91.56 16.11 11.11 Favored 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 123.427 0.691 . . . . 74.4 111.28 176.793 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . 94.87 -60.93 1.68 Allowed Glycine 0 C--N 1.35 1.347 0 C-N-CA 123.182 0.42 . . . . 74.23 112.071 176.766 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 121.38 139.25 5.64 Favored Glycine 0 C--N 1.346 1.086 0 N-CA-C 111.646 -0.582 . . . . 61.3 111.646 179.26 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 15.4 m -59.54 98.06 0.04 OUTLIER 'General case' 0 CA--C 1.55 0.967 0 C-N-CA 124.249 1.02 . . . . 75.45 110.666 -179.001 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -88.9 148.93 20.57 Favored Glycine 0 C--N 1.345 1.041 0 N-CA-C 111.427 -0.669 . . . . 54.5 111.427 176.715 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -142.38 41.02 1.23 Allowed Glycine 0 C--N 1.339 0.7 0 N-CA-C 110.997 -0.841 . . . . 74.2 110.997 179.102 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 29.9 m -64.04 115.09 4.59 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 123.586 0.754 . . . . 74.04 110.307 -177.209 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -59.36 -72.81 0.55 Allowed Glycine 0 C--N 1.36 1.887 0 O-C-N 123.952 0.782 . . . . 75.12 112.807 -177.04 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -68.95 152.71 52.5 Favored Glycine 0 C--N 1.347 1.181 0 N-CA-C 111.18 -0.768 . . . . 70.24 111.18 170.347 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 26.9 t -78.99 77.15 5.46 Favored 'General case' 0 CA--C 1.55 0.953 0 CA-C-O 121.682 0.753 . . . . 62.42 109.861 -179.427 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 191' ' ' GLN . . . . . 0.573 ' HB3' ' HD2' ' A' ' 243' ' ' PRO . 10.5 pt20 -86.14 -20.88 27.99 Favored 'General case' 0 N--CA 1.48 1.031 0 CA-C-N 114.983 -1.008 . . . . 71.1 110.209 175.755 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -76.83 150.16 36.13 Favored 'General case' 0 C--O 1.241 0.657 0 CA-C-N 114.971 -1.013 . . . . 60.13 110.304 -171.031 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 29.5 mt -128.82 168.2 16.25 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 124.549 1.14 . . . . 70.02 109.4 177.872 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 71.6 m-85 -126.17 140.56 52.47 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 123.621 0.768 . . . . 75.33 109.731 179.125 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . 0.472 ' HB3' HD12 ' A' ' 249' ' ' LEU . . . -153.32 129.59 10.5 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 108.09 -1.078 . . . . 70.21 108.09 177.974 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 18.0 m -85.22 125.2 32.67 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 109.237 -0.653 . . . . 75.23 109.237 177.752 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . 0.496 HD22 HD13 ' A' ' 251' ' ' LEU . 20.7 tp -106.54 109.13 20.95 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 108.382 -0.97 . . . . 75.23 108.382 -178.878 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -78.04 127.51 32.43 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 123.388 0.675 . . . . 51.41 109.416 177.285 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 199' ' ' VAL . . . . . 0.486 ' O ' ' HA ' ' A' ' 255' ' ' ILE . 3.3 p -142.75 124.68 8.72 Favored Pre-proline 0 CA--C 1.543 0.693 0 C-N-CA 123.585 0.754 . . . . 73.43 108.971 178.767 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -67.36 153.35 77.17 Favored 'Trans proline' 0 C--N 1.368 1.588 0 C-N-CA 122.146 1.897 . . . . 71.04 111.805 171.545 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 201' ' ' ALA . . . . . 0.417 ' HA ' HG22 ' A' ' 255' ' ' ILE . . . -47.91 -49.53 58.08 Favored Pre-proline 0 CA--C 1.562 1.431 0 N-CA-C 114.433 1.271 . . . . 73.22 114.433 -176.654 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 202' ' ' PRO . . . . . 0.41 ' O ' HG22 ' A' ' 206' ' ' VAL . 54.2 Cg_endo -66.17 -38.71 20.48 Favored 'Trans proline' 0 C--N 1.393 2.908 0 C-N-CA 121.603 1.535 . . . . 75.12 112.701 -179.333 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 29.6 mt -65.06 -32.28 57.59 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.139 0 CA-C-N 118.348 0.522 . . . . 71.41 110.209 177.343 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -68.05 -48.73 64.82 Favored 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 122.994 0.518 . . . . 61.54 111.612 179.004 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 17.6 m -71.82 -50.56 37.55 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.848 0 C-N-CA 123.243 0.617 . . . . 71.22 112.238 -177.67 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 206' ' ' VAL . . . . . 0.41 HG22 ' O ' ' A' ' 202' ' ' PRO . 4.5 m -74.4 -25.96 19.94 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.2 0 C-N-CA 122.746 0.419 . . . . 74.43 111.504 -177.699 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 80.09 70.02 1.36 Allowed Glycine 0 C--N 1.345 1.047 0 O-C-N 123.312 0.382 . . . . 64.45 112.181 -177.59 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -93.44 -131.4 5.91 Favored Glycine 0 C--N 1.35 1.348 0 C-N-CA 123.152 0.406 . . . . 73.23 112.267 179.208 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 209' ' ' LYS . . . . . 0.487 ' HG2' ' HA ' ' A' ' 222' ' ' ALA . 47.4 mtmt -138.26 156.53 47.58 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 123.865 0.866 . . . . 73.41 111.199 177.564 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 9.6 m -147.61 167.18 5.16 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.1 0 C-N-CA 125.519 1.528 . . . . 73.15 108.972 173.332 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 58.6 ttp180 -99.8 119.09 37.62 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 123.096 0.558 . . . . 75.51 110.557 178.918 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -101.58 131.15 47.93 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 124.409 1.084 . . . . 65.43 110.16 176.28 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 50.5 tpp -94.7 129.93 41.41 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 123.22 0.608 . . . . 75.41 109.59 177.389 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 17.3 p -126.48 -172.48 2.64 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 124.199 1.0 . . . . 72.11 109.747 -175.141 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 80.3 mt -61.92 -37.44 84.68 Favored 'General case' 0 N--CA 1.482 1.135 0 CA-C-O 121.133 0.492 . . . . 72.42 110.875 171.063 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -92.05 10.66 28.2 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 124.253 1.021 . . . . 74.22 111.677 -173.163 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 101.67 -158.84 18.53 Favored Glycine 0 C--N 1.351 1.4 0 CA-C-O 119.504 -0.609 . . . . 73.43 112.348 178.403 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -80.46 154.31 21.16 Favored 'Trans proline' 0 C--N 1.368 1.561 0 C-N-CA 122.728 2.285 . . . . 63.13 112.843 -177.584 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 4.2 p -150.8 129.18 2.75 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 N-CA-C 108.328 -0.99 . . . . 74.14 108.328 175.498 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -85.34 103.24 14.08 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 108.982 -0.747 . . . . 73.24 108.982 -178.872 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 15.9 m -97.78 137.91 24.04 Favored 'Isoleucine or valine' 0 C--O 1.241 0.623 0 C-N-CA 123.669 0.787 . . . . 73.04 110.442 -176.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . 0.677 ' H ' HD22 ' A' ' 172' ' ' LEU . . . -84.46 104.79 14.77 Favored 'General case' 0 C--O 1.243 0.722 0 CA-C-N 115.159 -0.928 . . . . 72.53 110.451 -179.016 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 66.5 t -54.7 129.8 64.16 Favored Pre-proline 0 N--CA 1.475 0.792 0 C-N-CA 124.771 1.228 . . . . 70.41 109.669 -179.223 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 224' ' ' PRO . . . . . 0.512 ' HB2' ' HB3' ' A' ' 179' ' ' ALA . 28.6 Cg_endo -62.13 154.79 60.19 Favored 'Trans proline' 0 C--N 1.369 1.656 0 C-N-CA 121.914 1.742 . . . . 71.14 111.514 176.035 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -67.13 143.9 67.03 Favored 'Trans proline' 0 C--N 1.364 1.361 0 C-N-CA 121.152 1.234 . . . . 70.3 111.28 173.453 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 75.3 mtt180 65.61 38.41 5.44 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 124.726 1.21 . . . . 73.2 111.752 172.888 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 55.5 m -74.95 137.95 41.97 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 122.973 0.509 . . . . 75.33 110.45 175.694 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 26.8 mp0 -113.63 146.56 39.57 Favored 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 124.055 0.942 . . . . 74.15 109.994 175.169 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -58.94 119.79 7.88 Favored 'General case' 0 C--N 1.354 0.799 0 C-N-CA 124.276 1.03 . . . . 63.31 111.051 -178.788 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 114.11 -5.06 23.75 Favored Glycine 0 N--CA 1.466 0.689 0 O-C-N 123.834 0.709 . . . . 73.03 112.711 -178.883 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 85.9 mtt-85 -70.36 148.5 48.35 Favored 'General case' 0 C--N 1.358 0.976 0 CA-C-N 117.654 0.727 . . . . 74.5 109.333 172.411 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 41.2 mtmt -125.19 116.1 21.47 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 121.547 0.689 . . . . 73.51 109.599 -175.213 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 233' ' ' LEU . . . . . 0.632 ' HB2' ' HB2' ' A' ' 251' ' ' LEU . 56.7 mt -93.45 141.2 28.73 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 114.211 -1.358 . . . . 74.23 108.575 -177.887 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 14.5 ttp180 -109.26 112.44 24.59 Favored 'General case' 0 N--CA 1.474 0.774 0 O-C-N 122.055 -0.403 . . . . 74.43 111.264 -172.02 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 235' ' ' LEU . . . . . 0.586 ' HB2' ' HB3' ' A' ' 249' ' ' LEU . 12.9 mt -102.07 107.54 18.68 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.542 0.737 . . . . 74.25 110.432 176.228 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . 0.5 ' HB3' ' HD2' ' A' ' 246' ' ' ARG . 40.9 mttm -76.52 151.9 36.22 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-O 120.999 0.428 . . . . 75.44 110.556 172.14 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 77.21 -6.9 40.37 Favored Glycine 0 N--CA 1.476 1.365 0 CA-C-N 115.47 -0.787 . . . . 61.13 113.908 -177.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 72.8 mmtt -104.12 -7.56 20.11 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 123.748 0.819 . . . . 74.53 110.077 -179.695 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -97.14 -167.73 33.03 Favored Glycine 0 C--N 1.358 1.769 0 N-CA-C 111.278 -0.729 . . . . 60.03 111.278 164.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 74.3 m-85 -91.59 157.31 42.16 Favored Pre-proline 0 N--CA 1.481 1.09 0 C-N-CA 123.772 0.829 . . . . 74.33 110.874 179.821 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -70.6 154.77 64.19 Favored 'Trans proline' 0 C--N 1.369 1.63 0 C-N-CA 121.311 1.341 . . . . 74.41 111.059 169.857 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 173.59 -119.63 0.76 Allowed Glycine 0 CA--C 1.527 0.826 0 CA-C-O 118.601 -1.11 . . . . 74.2 111.842 -179.47 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 243' ' ' PRO . . . . . 0.573 ' HD2' ' HB3' ' A' ' 191' ' ' GLN . 40.8 Cg_endo -60.66 -57.24 0.72 Allowed 'Trans proline' 0 C--N 1.38 2.232 0 C-N-CA 123.784 2.989 . . . . 74.01 112.54 -173.117 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -80.24 -12.86 59.58 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 123.167 0.587 . . . . 74.1 111.207 179.845 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 95.78 -34.8 4.67 Favored Glycine 0 C--N 1.353 1.512 0 C-N-CA 122.986 0.327 . . . . 54.31 112.311 179.698 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 246' ' ' ARG . . . . . 0.5 ' HD2' ' HB3' ' A' ' 236' ' ' LYS . 22.3 ttm180 -125.81 111.77 15.25 Favored 'General case' 0 C--O 1.244 0.77 0 C-N-CA 123.727 0.811 . . . . 75.43 108.986 177.751 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -72.12 155.31 51.58 Favored Glycine 0 C--N 1.347 1.182 0 N-CA-C 115.253 0.861 . . . . 73.44 115.253 -177.698 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 38.9 m-20 -100.21 155.43 17.76 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 113.654 -1.273 . . . . 72.34 109.96 -175.515 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 249' ' ' LEU . . . . . 0.586 ' HB3' ' HB2' ' A' ' 235' ' ' LEU . 48.8 tp -129.77 114.87 16.48 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 108.191 -1.04 . . . . 73.53 108.191 173.326 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 250' ' ' TYR . . . . . . . . . . . . . 19.7 m-30 -90.55 109.14 20.3 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 116.191 -0.458 . . . . 72.34 110.191 -174.757 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 251' ' ' LEU . . . . . 0.632 ' HB2' ' HB2' ' A' ' 233' ' ' LEU . 82.4 mt -87.45 102.43 14.55 Favored 'General case' 0 C--O 1.239 0.522 0 N-CA-C 107.923 -1.14 . . . . 75.24 107.923 177.254 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -83.38 99.72 10.24 Favored 'General case' 0 C--O 1.243 0.718 0 N-CA-C 108.257 -1.016 . . . . 73.35 108.257 178.002 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 10.1 m -61.32 132.34 26.83 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.768 0 CA-C-N 115.572 -0.74 . . . . 75.04 110.004 179.63 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 20.3 mmm180 -125.34 105.42 9.08 Favored 'General case' 0 C--O 1.241 0.606 0 N-CA-C 107.273 -1.38 . . . . 73.22 107.273 178.292 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 255' ' ' ILE . . . . . 0.486 ' HA ' ' O ' ' A' ' 199' ' ' VAL . 45.6 mt -77.93 107.54 9.95 Favored 'Isoleucine or valine' 0 C--O 1.239 0.505 0 CA-C-N 115.797 -0.638 . . . . 74.24 109.766 -179.254 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 2.4 t . . . . . 0 CA--C 1.555 1.159 0 CA-C-N 115.035 -0.984 . . . . 74.04 108.462 174.302 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 1.7 pmm? . . . . . 0 N--CA 1.484 1.247 0 N-CA-C 111.994 0.368 . . . . 73.53 111.994 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 10.7 pt20 -94.11 164.54 13.03 Favored 'General case' 0 N--CA 1.482 1.139 0 CA-C-O 121.259 0.552 . . . . 75.14 111.093 -178.268 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 9.0 t -88.44 173.51 8.66 Favored 'General case' 0 CA--C 1.557 1.222 0 CA-C-N 115.169 -0.923 . . . . 71.42 109.455 170.281 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -139.62 -81.37 0.28 Allowed 'General case' 0 N--CA 1.483 1.175 0 C-N-CA 122.726 0.411 . . . . 65.13 111.939 -167.686 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 172' ' ' LEU . . . . . 0.43 HD21 ' HB3' ' A' ' 222' ' ' ALA . 22.7 mt -117.38 143.28 46.14 Favored 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 123.82 0.848 . . . . 75.41 111.759 -174.949 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 173' ' ' PHE . . . . . 0.475 ' CD1' HD23 ' A' ' 235' ' ' LEU . 19.4 m-85 -129.62 -53.8 1.16 Allowed 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 124.124 0.97 . . . . 71.34 109.177 -171.439 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 174' ' ' TYR . . . . . 0.437 ' CD2' ' HB3' ' A' ' 233' ' ' LEU . 0.8 OUTLIER -77.98 14.05 1.24 Allowed 'General case' 0 CA--C 1.547 0.828 0 CA-C-N 114.477 -1.238 . . . . 75.45 113.058 -174.257 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 20.6 p -61.38 -20.26 62.83 Favored 'General case' 0 N--CA 1.484 1.24 0 CA-C-N 118.772 0.715 . . . . 72.32 111.391 173.326 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 176' ' ' MET . . . . . . . . . . . . . 26.5 ptt? -59.03 -37.67 77.52 Favored 'General case' 0 CA--C 1.55 0.969 0 C-N-CA 124.149 0.979 . . . . 71.42 111.494 171.141 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 37.7 ttpt -167.19 87.6 0.29 Allowed 'General case' 0 CA--C 1.55 0.966 0 C-N-CA 124.451 1.1 . . . . 70.23 108.936 179.342 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -106.44 127.39 53.25 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 124.291 1.037 . . . . 74.44 109.246 -178.149 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . 59.93 39.45 20.22 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 124.117 0.967 . . . . 72.52 110.391 -172.773 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -116.28 172.14 14.09 Favored Glycine 0 N--CA 1.472 1.056 0 CA-C-N 115.192 -0.913 . . . . 74.54 113.006 -173.149 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 59.4 p -77.41 135.34 38.3 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.742 0.817 . . . . 63.23 111.082 -175.667 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -71.88 150.08 45.6 Favored Glycine 0 C--N 1.349 1.268 0 O-C-N 123.503 0.502 . . . . 71.25 113.122 -177.291 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -156.56 26.63 0.53 Allowed Glycine 0 C--N 1.346 1.094 0 C-N-CA 122.692 0.187 . . . . 71.22 112.676 -176.013 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 41.5 m -85.33 167.55 15.49 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 123.617 0.767 . . . . 62.03 111.305 -179.365 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 163.53 -177.29 39.49 Favored Glycine 0 C--N 1.34 0.783 0 CA-C-N 115.929 -0.578 . . . . 61.32 111.903 -178.729 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 94.78 -169.6 28.62 Favored Glycine 0 C--N 1.342 0.875 0 N-CA-C 112.287 -0.325 . . . . 54.42 112.287 -179.214 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 17.8 t -148.67 -165.21 2.22 Favored 'General case' 0 CA--C 1.55 0.96 0 N-CA-C 108.709 -0.848 . . . . 75.32 108.709 -176.317 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 120.02 -44.75 1.33 Allowed Glycine 0 N--CA 1.474 1.193 0 N-CA-C 112.102 -0.399 . . . . 73.35 112.102 177.163 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -171.91 151.86 15.96 Favored Glycine 0 C--N 1.335 0.525 0 N-CA-C 110.617 -0.993 . . . . 71.02 110.617 178.758 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 32.6 t -77.06 79.24 3.6 Favored 'General case' 0 CA--C 1.543 0.695 0 CA-C-O 121.663 0.744 . . . . 70.43 109.988 -179.703 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 191' ' ' GLN . . . . . 0.455 ' HB2' ' HA2' ' A' ' 247' ' ' GLY . 7.6 pt20 -76.95 -37.94 54.3 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 114.378 -1.283 . . . . 74.54 110.271 179.771 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -78.03 138.56 38.86 Favored 'General case' 0 C--N 1.351 0.651 0 CA-C-N 115.524 -0.762 . . . . 73.2 109.148 -174.699 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 25.1 mt -120.18 177.18 5.11 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 124.483 1.113 . . . . 75.34 109.158 175.112 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -139.08 121.02 15.55 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 123.413 0.685 . . . . 73.41 110.396 177.185 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -125.13 128.6 48.68 Favored 'General case' 0 C--O 1.241 0.607 0 N-CA-C 106.942 -1.503 . . . . 75.2 106.942 168.566 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 10.6 m -81.26 119.45 23.65 Favored 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 108.363 -0.977 . . . . 74.33 108.363 179.621 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . 0.63 HD21 HD13 ' A' ' 251' ' ' LEU . 20.5 tp -103.96 110.69 22.93 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 108.48 -0.933 . . . . 72.53 108.48 -173.996 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -79.86 127.23 31.99 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 115.219 -0.901 . . . . 74.32 108.92 179.209 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 199' ' ' VAL . . . . . 0.457 ' O ' ' HA ' ' A' ' 255' ' ' ILE . 6.2 p -143.9 128.72 9.51 Favored Pre-proline 0 CA--C 1.547 0.85 0 C-N-CA 123.729 0.812 . . . . 75.31 109.03 178.802 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -69.76 158.47 56.85 Favored 'Trans proline' 0 C--N 1.362 1.285 0 C-N-CA 121.769 1.646 . . . . 72.34 111.595 170.782 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 201' ' ' ALA . . . . . 0.442 ' O ' HG23 ' A' ' 205' ' ' VAL . . . -49.84 -53.99 36.71 Favored Pre-proline 0 CA--C 1.558 1.265 0 CA-C-N 114.744 -1.116 . . . . 72.24 112.863 -176.49 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -65.52 -34.29 43.13 Favored 'Trans proline' 0 C--N 1.399 3.208 0 C-N-CA 121.736 1.624 . . . . 72.12 113.237 -175.527 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 24.7 mt -67.2 -34.05 66.87 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.413 0 N-CA-C 109.975 -0.38 . . . . 71.1 109.975 177.529 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -69.46 -38.09 77.6 Favored 'General case' 0 CA--C 1.549 0.904 0 C-N-CA 122.535 0.334 . . . . 64.33 111.339 177.422 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . 0.442 HG23 ' O ' ' A' ' 201' ' ' ALA . 99.7 t -70.86 -56.55 10.36 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.122 0 C-N-CA 123.168 0.587 . . . . 73.55 111.576 -178.039 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 10.9 m -78.37 -25.42 13.84 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 CA-C-N 116.134 -0.485 . . . . 75.52 110.948 -174.918 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 84.15 60.55 1.92 Allowed Glycine 0 C--N 1.345 1.043 0 CA-C-N 116.04 -0.527 . . . . 61.32 112.615 -179.578 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -78.77 -138.03 1.38 Allowed Glycine 0 N--CA 1.477 1.374 0 CA-C-O 119.696 -0.502 . . . . 60.54 112.168 177.663 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 209' ' ' LYS . . . . . 0.467 ' HG2' ' HA ' ' A' ' 222' ' ' ALA . 29.0 mtmm -134.58 157.3 46.93 Favored 'General case' 0 N--CA 1.481 1.124 0 CA-C-N 117.607 0.704 . . . . 74.12 110.718 176.38 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 7.1 m -142.86 165.75 15.72 Favored 'Isoleucine or valine' 0 C--O 1.241 0.631 0 C-N-CA 126.068 1.747 . . . . 65.1 107.894 173.601 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 31.1 ttm180 -105.07 116.61 32.25 Favored 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 109.396 -0.594 . . . . 74.01 109.396 179.273 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -101.74 113.74 27.18 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.379 1.072 . . . . 73.32 109.563 179.003 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 61.6 tpp -76.22 125.04 28.44 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 108.187 -1.042 . . . . 65.33 108.187 173.702 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 18.4 p -125.24 -175.8 3.41 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.723 0.809 . . . . 72.22 109.721 -175.702 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 71.1 mt -57.01 -40.79 77.28 Favored 'General case' 0 N--CA 1.481 1.079 0 CA-C-O 121.504 0.669 . . . . 75.23 110.415 172.5 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 216' ' ' GLU . . . . . 0.477 ' HB2' ' HZ2' ' A' ' 238' ' ' LYS . 6.0 mm-40 -87.72 15.02 7.43 Favored 'General case' 0 CA--C 1.551 0.994 0 CA-C-N 114.538 -1.21 . . . . 71.11 111.371 -174.751 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 94.73 -171.1 30.02 Favored Glycine 0 C--N 1.35 1.346 0 N-CA-C 112.086 -0.406 . . . . 75.21 112.086 -179.686 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -68.42 149.37 74.89 Favored 'Trans proline' 0 C--N 1.362 1.276 0 C-N-CA 122.205 1.936 . . . . 62.31 111.991 178.129 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 7.1 p -143.27 134.87 23.61 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 N-CA-C 108.543 -0.91 . . . . 72.44 108.543 173.593 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 -86.37 103.27 14.78 Favored 'General case' 0 C--O 1.238 0.475 0 N-CA-C 107.76 -1.2 . . . . 74.52 107.76 179.501 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 2.6 p -108.61 131.35 59.44 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.967 0 C-N-CA 123.615 0.766 . . . . 72.13 109.355 -172.108 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . 0.467 ' HA ' ' HG2' ' A' ' 209' ' ' LYS . . . -83.11 111.25 18.73 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 123.126 0.571 . . . . 74.41 110.62 -176.788 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 58.4 t -54.66 132.65 64.78 Favored Pre-proline 0 N--CA 1.473 0.721 0 O-C-N 124.716 1.26 . . . . 62.43 109.354 177.067 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_endo -63.41 144.95 91.98 Favored 'Trans proline' 0 C--N 1.367 1.541 0 C-N-CA 121.482 1.455 . . . . 62.41 111.266 172.817 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -62.67 139.11 73.55 Favored 'Trans proline' 0 C--N 1.37 1.698 0 C-N-CA 121.572 1.515 . . . . 74.31 110.971 171.816 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 54.2 mtt180 69.64 60.49 0.28 Allowed 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 124.982 1.313 . . . . 73.2 110.74 173.161 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 227' ' ' THR . . . . . 0.561 ' HA ' ' HE ' ' A' ' 231' ' ' ARG . 55.9 m -103.85 142.12 34.94 Favored 'General case' 0 CA--C 1.544 0.74 0 CA-C-N 113.669 -1.605 . . . . 71.21 110.051 -179.857 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -116.66 148.14 41.29 Favored 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 124.074 0.95 . . . . 74.12 109.732 177.527 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 229' ' ' ALA . . . . . 0.491 ' HB1' ' HB ' ' A' ' 255' ' ' ILE . . . -58.77 116.5 3.78 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 123.982 0.913 . . . . 71.43 110.762 -179.84 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 113.21 2.44 24.79 Favored Glycine 0 CA--C 1.524 0.656 0 CA-C-N 115.744 -0.662 . . . . 74.01 112.968 179.238 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 231' ' ' ARG . . . . . 0.561 ' HE ' ' HA ' ' A' ' 227' ' ' THR . 75.0 mtt-85 -66.39 147.44 53.3 Favored 'General case' 0 C--N 1.364 1.206 0 CA-C-N 117.175 0.488 . . . . 74.44 109.757 172.358 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 69.7 mmtt -115.2 98.38 6.74 Favored 'General case' 0 C--O 1.241 0.605 0 CA-C-N 115.139 -0.937 . . . . 73.14 108.757 -174.591 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 233' ' ' LEU . . . . . 0.709 ' HB2' ' HB2' ' A' ' 251' ' ' LEU . 60.1 mt -85.5 151.69 23.76 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 115.3 -0.864 . . . . 73.44 108.883 177.514 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 234' ' ' ARG . . . . . 0.431 HH11 ' HE2' ' A' ' 250' ' ' TYR . 41.0 ttt85 -126.63 109.19 11.83 Favored 'General case' 0 N--CA 1.478 0.963 0 CA-C-O 120.679 0.275 . . . . 72.41 110.63 -172.114 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 235' ' ' LEU . . . . . 0.534 HD13 HD12 ' A' ' 251' ' ' LEU . 23.3 mt -94.98 117.71 30.6 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 123.761 0.824 . . . . 73.12 110.765 -179.571 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 20.9 mttt -69.86 138.51 52.59 Favored 'General case' 0 C--O 1.238 0.468 0 O-C-N 123.415 0.447 . . . . 75.1 111.401 175.74 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 73.94 10.35 80.64 Favored Glycine 0 C--N 1.345 1.029 0 CA-C-N 115.608 -0.723 . . . . 72.23 114.36 175.452 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . 0.477 ' HZ2' ' HB2' ' A' ' 216' ' ' GLU . 72.7 mmtt -112.51 5.28 17.89 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 122.765 0.426 . . . . 74.42 111.062 -179.707 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -107.37 -161.93 21.57 Favored Glycine 0 C--N 1.348 1.216 0 N-CA-C 110.896 -0.881 . . . . 74.05 110.896 168.244 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 40.1 m-85 -94.25 147.25 33.03 Favored Pre-proline 0 N--CA 1.477 0.905 0 C-N-CA 123.045 0.538 . . . . 75.25 110.935 -179.049 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_exo -64.76 167.47 15.45 Favored 'Trans proline' 0 C--N 1.369 1.617 0 C-N-CA 122.333 2.022 . . . . 75.44 112.385 169.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 144.63 -106.02 0.38 Allowed Glycine 0 C--N 1.339 0.75 0 CA-C-O 118.727 -1.041 . . . . 63.32 112.077 175.769 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -61.95 -51.18 4.04 Favored 'Trans proline' 0 C--N 1.38 2.223 0 C-N-CA 123.632 2.888 . . . . 73.33 113.01 -168.855 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -87.13 -10.3 53.13 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 123.06 0.544 . . . . 74.53 111.312 176.466 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 90.76 -44.9 2.88 Favored Glycine 0 C--N 1.352 1.427 0 N-CA-C 111.383 -0.687 . . . . 65.53 111.383 -173.118 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 10.2 ttm180 -115.8 111.94 21.24 Favored 'General case' 0 C--O 1.24 0.59 0 C-N-CA 125.137 1.375 . . . . 64.31 109.281 175.373 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . 0.455 ' HA2' ' HB2' ' A' ' 191' ' ' GLN . . . -80.61 168.43 51.35 Favored Glycine 0 C--N 1.349 1.276 0 CA-C-O 121.766 0.648 . . . . 43.45 113.698 170.987 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -125.38 160.77 28.58 Favored 'General case' 0 N--CA 1.465 0.31 0 C-N-CA 124.19 0.996 . . . . 64.24 110.396 -170.274 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 249' ' ' LEU . . . . . 0.471 ' HB3' ' HB2' ' A' ' 235' ' ' LEU . 41.1 tp -115.84 124.86 51.76 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 123.948 0.899 . . . . 75.11 109.501 177.143 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 250' ' ' TYR . . . . . 0.431 ' HE2' HH11 ' A' ' 234' ' ' ARG . 2.2 m-85 -88.26 109.54 20.02 Favored 'General case' 0 C--O 1.232 0.158 0 N-CA-C 109.268 -0.641 . . . . 74.33 109.268 176.912 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 251' ' ' LEU . . . . . 0.709 ' HB2' ' HB2' ' A' ' 233' ' ' LEU . 86.4 mt -87.2 104.19 16.14 Favored 'General case' 0 C--O 1.241 0.64 0 N-CA-C 106.736 -1.579 . . . . 74.32 106.736 173.945 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -85.05 103.43 14.07 Favored 'General case' 0 C--O 1.24 0.575 0 N-CA-C 107.71 -1.219 . . . . 63.03 107.71 176.037 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 16.7 m -68.43 137.71 23.92 Favored 'Isoleucine or valine' 0 C--O 1.241 0.646 0 O-C-N 124.181 0.926 . . . . 74.32 109.596 -177.193 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 18.1 mmm180 -128.48 106.18 8.81 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 107.774 -1.195 . . . . 75.25 107.774 -179.906 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 255' ' ' ILE . . . . . 0.491 ' HB ' ' HB1' ' A' ' 229' ' ' ALA . 29.6 mt -77.47 123.5 34.23 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.58 0 O-C-N 123.924 0.765 . . . . 73.44 110.086 178.301 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 3.3 t . . . . . 0 CA--C 1.563 1.452 0 C-N-CA 124.143 0.977 . . . . 72.1 109.081 173.729 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 15.0 tpt . . . . . 0 N--CA 1.48 1.042 0 N-CA-C 109.393 -0.595 . . . . 71.45 109.393 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 17.9 pt20 -78.05 166.5 22.73 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.162 0.585 . . . . 73.12 110.093 174.241 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 170' ' ' THR . . . . . 0.424 HG21 HG23 ' A' ' 219' ' ' VAL . 13.5 t -73.77 153.1 40.13 Favored 'General case' 0 CA--C 1.549 0.94 0 CA-C-N 115.515 -0.766 . . . . 75.33 109.871 173.838 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -98.02 -87.47 0.33 Allowed 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 123.263 0.625 . . . . 73.23 111.08 -175.009 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 172' ' ' LEU . . . . . 0.693 HD21 ' H ' ' A' ' 222' ' ' ALA . 78.2 mt -134.9 163.38 29.97 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 123.831 0.852 . . . . 72.53 111.49 -167.151 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 50.1 m-85 -147.62 -68.94 0.24 Allowed 'General case' 0 N--CA 1.479 0.986 0 N-CA-C 108.337 -0.986 . . . . 75.21 108.337 -164.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 174' ' ' TYR . . . . . 0.468 ' OH ' ' HB ' ' A' ' 221' ' ' VAL . 19.9 p90 -62.97 -21.86 66.4 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 113.921 -1.491 . . . . 74.54 112.523 -178.888 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 19.5 m -59.28 -12.59 5.81 Favored 'General case' 0 CA--C 1.56 1.339 0 C-N-CA 125.773 1.629 . . . . 72.35 112.889 -176.277 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 176' ' ' MET . . . . . . . . . . . . . 50.8 mtm -56.36 -50.62 71.02 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 123.773 0.829 . . . . 74.43 110.075 166.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . 0.46 ' HZ3' ' HB2' ' A' ' 177' ' ' LYS . 0.1 OUTLIER -163.84 104.54 0.91 Allowed 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 124.428 1.091 . . . . 72.03 109.475 174.775 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 178' ' ' ALA . . . . . 0.462 ' HB3' HD21 ' A' ' 233' ' ' LEU . . . -125.84 -59.39 1.35 Allowed 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 123.936 0.894 . . . . 70.3 111.224 -171.67 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -72.26 81.8 1.01 Allowed 'General case' 0 CA--C 1.544 0.716 0 CA-C-O 121.86 0.838 . . . . 70.53 109.258 174.765 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 108.57 85.36 1.7 Allowed Glycine 0 C--N 1.337 0.586 0 N-CA-C 109.974 -1.25 . . . . 61.23 109.974 -169.663 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 31.4 m -65.38 91.6 0.12 Allowed 'General case' 0 CA--C 1.553 1.069 0 C-N-CA 123.946 0.898 . . . . 72.54 112.081 -174.123 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -94.3 39.07 2.97 Favored Glycine 0 N--CA 1.468 0.803 0 CA-C-N 115.725 -0.67 . . . . 63.11 112.037 175.626 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -148.41 82.67 0.19 Allowed Glycine 0 C--N 1.347 1.159 0 N-CA-C 111.282 -0.727 . . . . 64.33 111.282 -175.336 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 21.3 m -69.55 122.25 18.68 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 123.436 0.695 . . . . 75.5 110.085 177.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -80.04 -128.75 0.73 Allowed Glycine 0 C--N 1.347 1.148 0 O-C-N 123.419 0.449 . . . . 70.2 113.476 -178.348 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 116.83 -85.96 0.4 Allowed Glycine 0 C--N 1.341 0.817 0 N-CA-C 111.206 -0.758 . . . . 54.34 111.206 -178.897 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 187' ' ' SER . . . . . 0.673 ' HB3' ' HG3' ' A' ' 243' ' ' PRO . 53.6 m 70.86 143.5 0.06 Allowed 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 125.229 1.412 . . . . 75.44 114.245 171.947 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -88.49 75.94 1.95 Allowed Glycine 0 C--N 1.349 1.254 0 CA-C-N 114.957 -1.019 . . . . 73.42 110.848 174.001 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 126.03 131.4 3.57 Favored Glycine 0 C--N 1.341 0.813 0 N-CA-C 110.178 -1.169 . . . . 72.44 110.178 -174.035 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 57.9 m -71.42 85.72 0.83 Allowed 'General case' 0 CA--C 1.545 0.784 0 CA-C-O 121.577 0.703 . . . . 75.03 111.183 -178.031 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 191' ' ' GLN . . . . . 0.699 ' HB2' ' HA2' ' A' ' 247' ' ' GLY . 3.4 pt20 -82.3 -27.85 32.05 Favored 'General case' 0 CA--C 1.545 0.755 0 CA-C-N 114.852 -1.067 . . . . 75.51 110.088 172.474 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . 0.447 ' HA ' ' O ' ' A' ' 248' ' ' ASP . 9.9 m-20 -78.1 152.75 32.71 Favored 'General case' 0 C--N 1.347 0.464 0 CA-C-N 114.438 -1.256 . . . . 71.1 111.797 -167.907 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . 0.431 HD11 ' HA2' ' A' ' 239' ' ' GLY . 22.9 mt -133.86 175.01 9.85 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 124.265 1.026 . . . . 73.3 109.773 177.517 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 77.6 m-85 -136.35 131.43 34.27 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.579 0.752 . . . . 72.44 110.545 179.835 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -144.29 128.99 18.23 Favored 'General case' 0 C--O 1.234 0.28 0 N-CA-C 107.326 -1.361 . . . . 74.4 107.326 176.823 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 3.5 m -81.47 121.35 26.16 Favored 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 109.524 -0.547 . . . . 65.44 109.524 -176.571 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . 0.506 HD22 HD12 ' A' ' 251' ' ' LEU . 20.3 tp -106.35 108.96 20.73 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 107.188 -1.412 . . . . 72.45 107.188 -178.124 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -86.92 132.37 33.83 Favored 'General case' 0 C--O 1.241 0.606 0 N-CA-C 109.223 -0.658 . . . . 65.14 109.223 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 199' ' ' VAL . . . . . 0.425 ' O ' ' HA ' ' A' ' 255' ' ' ILE . 4.0 p -141.92 129.53 11.61 Favored Pre-proline 0 CA--C 1.543 0.694 0 N-CA-C 108.305 -0.998 . . . . 65.43 108.305 -176.626 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -70.23 155.1 65.13 Favored 'Trans proline' 0 C--N 1.364 1.36 0 C-N-CA 121.431 1.421 . . . . 74.34 110.376 170.814 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 201' ' ' ALA . . . . . 0.436 ' HA ' HG22 ' A' ' 255' ' ' ILE . . . -50.64 -49.39 78.98 Favored Pre-proline 0 CA--C 1.556 1.2 0 CA-C-O 117.804 -1.093 . . . . 64.4 112.885 179.871 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -58.74 -39.59 80.71 Favored 'Trans proline' 0 C--N 1.399 3.216 0 C-N-CA 122.312 2.008 . . . . 74.52 113.991 -179.884 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 39.3 mt -68.28 -37.54 78.15 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.395 0 CA-C-N 118.625 0.648 . . . . 75.2 110.475 177.684 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -66.46 -42.8 87.02 Favored 'General case' 0 N--CA 1.479 0.98 0 N-CA-C 112.101 0.408 . . . . 74.14 112.101 179.706 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 26.9 m -77.69 -45.02 28.96 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.917 0 C-N-CA 123.777 0.831 . . . . 74.12 112.722 -172.713 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 5.2 m -81.19 -26.22 10.52 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.325 0 C-N-CA 122.42 0.288 . . . . 75.21 111.338 178.541 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 82.89 77.89 1.07 Allowed Glycine 0 C--N 1.348 1.226 0 N-CA-C 111.858 -0.497 . . . . 74.34 111.858 -176.445 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -102.1 -137.34 9.6 Favored Glycine 0 C--N 1.347 1.186 0 N-CA-C 111.51 -0.636 . . . . 63.42 111.51 177.427 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 48.5 mtmt -136.16 155.46 50.13 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 123.592 0.757 . . . . 74.1 111.088 179.124 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 7.4 m -142.43 168.75 13.81 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.908 0 C-N-CA 125.948 1.699 . . . . 73.55 108.385 172.827 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 44.1 ttm180 -103.25 120.02 39.97 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 122.902 0.481 . . . . 74.1 109.858 177.508 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -102.21 133.55 46.9 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 124.127 0.971 . . . . 75.54 110.213 177.688 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 23.5 mmt -97.24 121.63 39.35 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 123.319 0.648 . . . . 74.14 109.595 178.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 18.2 p -120.17 174.85 6.24 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 124.172 0.989 . . . . 63.13 110.082 -177.095 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 56.5 mt -59.0 -31.48 68.84 Favored 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 123.079 0.551 . . . . 75.32 112.248 179.241 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -87.59 -20.26 26.67 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 123.106 0.563 . . . . 63.32 111.475 -177.4 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 139.33 -161.66 26.06 Favored Glycine 0 C--N 1.35 1.314 0 CA-C-O 119.445 -0.642 . . . . 63.34 111.962 -178.469 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_endo -82.28 155.86 16.87 Favored 'Trans proline' 0 C--N 1.367 1.541 0 C-N-CA 122.53 2.154 . . . . 71.33 112.766 -177.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 219' ' ' VAL . . . . . 0.424 HG23 HG21 ' A' ' 170' ' ' THR . 5.5 p -146.93 134.88 15.0 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.92 0 C-N-CA 123.746 0.819 . . . . 74.55 109.354 177.268 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -83.34 104.16 13.28 Favored 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 108.444 -0.947 . . . . 64.44 108.444 176.243 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 221' ' ' VAL . . . . . 0.468 ' HB ' ' OH ' ' A' ' 174' ' ' TYR . 6.4 m -106.27 132.12 54.21 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 CA-C-O 121.64 0.733 . . . . 74.24 110.578 -178.027 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . 0.693 ' H ' HD21 ' A' ' 172' ' ' LEU . . . -85.74 105.8 16.53 Favored 'General case' 0 C--O 1.238 0.46 0 CA-C-N 114.365 -1.289 . . . . 72.31 110.311 -178.732 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 66.7 t -57.43 128.76 79.56 Favored Pre-proline 0 N--CA 1.478 0.962 0 O-C-N 124.532 1.145 . . . . 64.5 109.124 179.089 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 224' ' ' PRO . . . . . 0.44 ' HD3' ' HE1' ' A' ' 174' ' ' TYR . 24.3 Cg_endo -61.22 146.56 97.3 Favored 'Trans proline' 0 C--N 1.375 1.922 0 C-N-CA 121.892 1.728 . . . . 73.32 110.926 177.559 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_endo -62.36 141.95 89.15 Favored 'Trans proline' 0 C--N 1.37 1.674 0 C-N-CA 121.607 1.538 . . . . 72.34 111.808 175.864 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 77.9 mtt180 64.64 38.96 6.8 Favored 'General case' 0 CA--C 1.554 1.13 0 C-N-CA 125.031 1.333 . . . . 74.13 111.908 172.524 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 227' ' ' THR . . . . . 0.48 HG21 ' HD2' ' A' ' 231' ' ' ARG . 86.7 m -76.17 146.85 38.87 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 123.648 0.779 . . . . 71.43 110.427 176.178 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -111.05 149.41 30.79 Favored 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 123.813 0.845 . . . . 75.13 109.249 174.927 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 229' ' ' ALA . . . . . 0.468 ' HA ' HG21 ' A' ' 253' ' ' VAL . . . -61.19 138.74 58.21 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 124.02 0.928 . . . . 64.14 111.394 -179.325 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 94.11 -3.81 70.3 Favored Glycine 0 C--N 1.339 0.73 0 CA-C-N 115.843 -0.617 . . . . 55.14 112.712 -178.846 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 231' ' ' ARG . . . . . 0.48 ' HD2' HG21 ' A' ' 227' ' ' THR . 57.4 mtt-85 -69.38 143.58 53.65 Favored 'General case' 0 C--N 1.363 1.195 0 N-CA-C 108.924 -0.769 . . . . 75.45 108.924 171.72 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 232' ' ' LYS . . . . . 0.514 ' HG2' ' HB3' ' A' ' 250' ' ' TYR . 13.4 ttmt -126.29 101.36 6.7 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 108.707 -0.849 . . . . 71.34 108.707 -167.309 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 233' ' ' LEU . . . . . 0.68 ' HB2' ' HB2' ' A' ' 251' ' ' LEU . 24.1 mt -76.28 151.72 36.68 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-N 114.011 -1.45 . . . . 71.34 109.172 -176.528 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 47.8 ttt180 -125.14 120.82 32.46 Favored 'General case' 0 N--CA 1.485 1.291 0 CA-C-N 118.998 0.817 . . . . 73.51 110.484 -175.433 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 235' ' ' LEU . . . . . 0.485 HD11 HD11 ' A' ' 251' ' ' LEU . 18.6 mt -108.78 116.45 32.01 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 124.397 1.079 . . . . 74.35 110.768 -175.696 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 31.4 mttp -72.94 141.54 47.82 Favored 'General case' 0 N--CA 1.479 1.004 0 N-CA-C 112.226 0.454 . . . . 72.42 112.226 176.795 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 76.51 10.37 85.75 Favored Glycine 0 C--N 1.349 1.269 0 CA-C-N 115.151 -0.931 . . . . 72.42 114.49 178.582 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt -115.26 10.29 15.92 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 122.736 0.414 . . . . 72.15 111.069 -173.79 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 239' ' ' GLY . . . . . 0.431 ' HA2' HD11 ' A' ' 193' ' ' LEU . . . -119.86 -161.98 11.74 Favored Glycine 0 C--N 1.345 1.06 0 N-CA-C 111.456 -0.657 . . . . 75.21 111.456 172.779 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 37.7 m-85 -93.02 169.3 10.64 Favored Pre-proline 0 N--CA 1.485 1.286 0 C-N-CA 123.79 0.836 . . . . 71.23 111.105 -175.208 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 241' ' ' PRO . . . . . 0.503 ' HA ' ' O ' ' A' ' 245' ' ' GLY . 77.7 Cg_exo -55.01 149.63 42.13 Favored 'Trans proline' 0 C--N 1.376 2.001 0 C-N-CA 121.762 1.641 . . . . 73.1 112.813 165.68 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -174.54 -136.51 2.26 Favored Glycine 0 CA--C 1.526 0.75 0 CA-C-O 119.053 -0.859 . . . . 74.44 111.871 179.085 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 243' ' ' PRO . . . . . 0.673 ' HG3' ' HB3' ' A' ' 187' ' ' SER . 43.1 Cg_endo -60.34 -40.89 54.5 Favored 'Trans proline' 0 C--N 1.371 1.744 0 C-N-CA 124.158 3.238 . . . . 75.41 113.108 -172.53 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -104.12 0.87 30.16 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 124.05 0.94 . . . . 74.43 111.482 179.013 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 245' ' ' GLY . . . . . 0.503 ' O ' ' HA ' ' A' ' 241' ' ' PRO . . . 81.83 -41.22 2.7 Favored Glycine 0 C--N 1.36 1.885 0 N-CA-C 112.386 -0.286 . . . . 75.23 112.386 -175.584 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 9.9 ttm180 -89.02 110.1 20.84 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 124.301 1.04 . . . . 74.24 109.705 175.61 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . 0.699 ' HA2' ' HB2' ' A' ' 191' ' ' GLN . . . -83.11 167.48 45.6 Favored Glycine 0 C--N 1.351 1.417 0 N-CA-C 114.407 0.523 . . . . 73.35 114.407 171.69 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 248' ' ' ASP . . . . . 0.447 ' O ' ' HA ' ' A' ' 192' ' ' ASP . 41.6 m-20 -131.31 135.92 47.69 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 123.482 0.713 . . . . 63.32 111.092 -168.729 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 249' ' ' LEU . . . . . . . . . . . . . 47.5 tp -99.97 129.9 46.09 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 123.497 0.719 . . . . 74.33 110.739 -177.921 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 250' ' ' TYR . . . . . 0.514 ' HB3' ' HG2' ' A' ' 232' ' ' LYS . 2.4 m-85 -95.77 115.49 27.5 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 123.801 0.84 . . . . 70.0 110.522 -178.83 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 251' ' ' LEU . . . . . 0.68 ' HB2' ' HB2' ' A' ' 233' ' ' LEU . 85.8 mt -94.14 105.22 17.22 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 108.711 -0.848 . . . . 74.54 108.711 178.257 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -84.15 104.25 14.04 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 109.743 -0.466 . . . . 72.41 109.743 178.736 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 253' ' ' VAL . . . . . 0.468 HG21 ' HA ' ' A' ' 229' ' ' ALA . 6.1 m -66.1 131.66 31.8 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.937 0 CA-C-O 121.237 0.541 . . . . 75.25 109.687 -179.299 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 10.8 mmm180 -123.96 97.32 5.3 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 108.744 -0.835 . . . . 73.42 108.744 179.057 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 255' ' ' ILE . . . . . 0.436 HG22 ' HA ' ' A' ' 201' ' ' ALA . 32.2 mt -78.46 127.36 38.79 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 O-C-N 124.026 0.829 . . . . 71.31 111.014 -175.172 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 1.9 t . . . . . 0 CA--C 1.561 1.367 0 C-N-CA 124.064 0.946 . . . . 71.43 109.418 175.379 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 25.1 ptt? . . . . . 0 N--CA 1.484 1.259 0 N-CA-C 112.028 0.381 . . . . 75.24 112.028 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 13.0 pt20 -147.05 166.77 25.84 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 122.939 0.496 . . . . 75.34 111.27 178.536 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 14.4 t -72.24 169.46 16.14 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 124.413 1.085 . . . . 73.44 112.275 -174.525 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 27.2 m-20 -94.41 -166.21 1.44 Allowed 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.471 1.108 . . . . 71.32 110.487 178.874 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 172' ' ' LEU . . . . . 0.594 HD22 ' H ' ' A' ' 222' ' ' ALA . 72.8 mt -84.05 145.77 28.3 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 124.231 1.012 . . . . 74.0 110.979 -178.767 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 34.9 m-85 -109.38 -57.93 2.1 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 123.7 0.8 . . . . 74.13 109.805 -174.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 174' ' ' TYR . . . . . 0.415 ' CD2' ' HB3' ' A' ' 233' ' ' LEU . 0.8 OUTLIER -71.17 -6.03 36.34 Favored 'General case' 0 C--N 1.348 0.508 0 CA-C-N 114.724 -1.126 . . . . 72.54 113.446 -173.201 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 175' ' ' THR . . . . . 0.422 HG23 HD12 ' A' ' 172' ' ' LEU . 2.9 p -68.2 -2.12 7.47 Favored 'General case' 0 CA--C 1.549 0.908 0 N-CA-C 114.052 1.131 . . . . 74.34 114.052 -177.328 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 176' ' ' MET . . . . . . . . . . . . . 21.8 ptt? -60.34 -41.93 94.61 Favored 'General case' 0 CA--C 1.559 1.296 0 C-N-CA 123.038 0.535 . . . . 74.22 110.369 163.756 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -178.55 114.03 0.07 Allowed 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 126.425 1.89 . . . . 74.55 106.956 179.337 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 178' ' ' ALA . . . . . 0.402 ' HB1' HD22 ' A' ' 233' ' ' LEU . . . -132.2 -42.04 0.98 Allowed 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 122.799 0.44 . . . . 62.23 111.881 -170.809 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -72.7 81.6 1.13 Allowed 'General case' 0 N--CA 1.472 0.669 0 CA-C-O 121.708 0.766 . . . . 64.42 109.58 179.045 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . 0.432 ' H ' ' HD3' ' A' ' 231' ' ' ARG . . . 161.14 -91.91 0.11 Allowed Glycine 0 C--N 1.332 0.332 0 N-CA-C 108.944 -1.663 . . . . 51.14 108.944 -175.693 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 77.4 p -162.18 159.7 26.2 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 124.524 1.13 . . . . 75.04 109.023 176.409 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 182' ' ' GLY . . . . . 0.438 ' HA3' ' HB2' ' A' ' 234' ' ' ARG . . . -79.57 -31.6 40.41 Favored Glycine 0 C--N 1.349 1.281 0 C-N-CA 123.156 0.408 . . . . 62.52 112.652 179.418 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -163.28 161.06 33.7 Favored Glycine 0 CA--C 1.524 0.608 0 N-CA-C 111.101 -0.8 . . . . 73.22 111.101 176.164 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 77.6 p -66.13 -35.96 81.88 Favored 'General case' 0 N--CA 1.48 1.036 0 CA-C-O 121.154 0.502 . . . . 73.2 109.898 175.65 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 172.36 142.9 3.92 Favored Glycine 0 C--N 1.342 0.916 0 N-CA-C 110.263 -1.135 . . . . 75.24 110.263 174.845 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -154.89 87.6 0.13 Allowed Glycine 0 C--N 1.34 0.792 0 N-CA-C 111.564 -0.614 . . . . 70.25 111.564 -178.69 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 48.9 m -91.15 63.87 5.14 Favored 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 123.576 0.75 . . . . 65.23 109.64 176.2 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -73.05 167.32 54.23 Favored Glycine 0 C--N 1.349 1.275 0 CA-C-N 115.05 -0.977 . . . . 75.15 113.039 -178.897 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -64.51 81.75 0.06 OUTLIER Glycine 0 C--N 1.34 0.772 0 N-CA-C 114.693 0.637 . . . . 70.13 114.693 -176.372 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 20.2 m 58.5 8.34 0.85 Allowed 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 124.987 1.315 . . . . 74.1 114.034 174.465 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 191' ' ' GLN . . . . . 0.526 ' HB3' ' HD2' ' A' ' 243' ' ' PRO . 5.4 pt20 -80.36 -35.27 35.67 Favored 'General case' 0 C--N 1.356 0.855 0 CA-C-O 121.075 0.464 . . . . 73.41 110.763 -173.88 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 21.5 m-20 -77.3 161.33 28.17 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 115.743 -0.662 . . . . 71.2 111.312 -170.536 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 24.2 mt -141.08 166.31 25.13 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 124.375 1.07 . . . . 72.24 110.294 -178.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 61.0 m-85 -136.94 123.02 20.33 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 124.324 1.049 . . . . 74.33 109.771 178.206 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . 0.449 ' O ' ' HA ' ' A' ' 251' ' ' LEU . . . -133.89 132.61 40.51 Favored 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 108.389 -0.967 . . . . 61.35 108.389 176.301 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 41.8 m -86.11 124.06 32.11 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 123.145 0.578 . . . . 73.23 109.87 -179.134 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . 0.591 HD23 HD12 ' A' ' 251' ' ' LEU . 19.7 tp -107.16 109.93 21.88 Favored 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 108.665 -0.865 . . . . 74.2 108.665 -175.367 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -79.75 125.58 29.85 Favored 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 123.441 0.696 . . . . 74.11 109.174 179.219 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 199' ' ' VAL . . . . . 0.454 ' O ' ' HA ' ' A' ' 255' ' ' ILE . 4.4 p -144.02 129.37 9.7 Favored Pre-proline 0 CA--C 1.547 0.829 0 C-N-CA 124.044 0.937 . . . . 74.44 108.93 -178.083 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -67.76 158.55 56.72 Favored 'Trans proline' 0 C--N 1.37 1.682 0 C-N-CA 121.809 1.673 . . . . 75.2 112.264 170.26 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 201' ' ' ALA . . . . . 0.476 ' O ' HG21 ' A' ' 205' ' ' VAL . . . -50.62 -52.91 51.74 Favored Pre-proline 0 CA--C 1.553 1.09 0 N-CA-C 113.692 0.997 . . . . 65.34 113.692 -179.185 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -64.97 -38.6 28.15 Favored 'Trans proline' 0 C--N 1.381 2.258 0 CA-C-N 121.147 1.445 . . . . 75.22 113.835 -177.39 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 31.5 mt -64.04 -30.9 51.27 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 N-CA-C 109.944 -0.391 . . . . 74.43 109.944 175.743 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -72.77 -40.74 65.71 Favored 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 122.578 0.351 . . . . 72.44 111.453 176.765 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . 0.476 HG21 ' O ' ' A' ' 201' ' ' ALA . 91.6 t -70.73 -55.96 12.43 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.239 0 C-N-CA 123.199 0.6 . . . . 71.51 111.035 -176.483 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 14.7 m -81.3 -27.3 10.46 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 CA-C-N 116.532 -0.304 . . . . 73.23 111.188 -176.796 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 85.18 71.56 1.31 Allowed Glycine 0 C--N 1.351 1.393 0 O-C-N 123.439 0.462 . . . . 60.42 113.016 -179.367 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -86.81 -127.8 2.33 Favored Glycine 0 C--N 1.348 1.218 0 CA-C-O 119.736 -0.48 . . . . 64.4 112.808 176.908 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 45.1 mtmt -137.66 152.12 48.98 Favored 'General case' 0 N--CA 1.486 1.336 0 CA-C-N 117.525 0.662 . . . . 73.43 111.128 178.45 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 6.2 m -146.91 159.52 9.67 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 C-N-CA 125.108 1.363 . . . . 72.53 108.536 170.702 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 51.0 ttp180 -97.53 121.18 39.14 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 123.394 0.678 . . . . 75.23 110.675 -179.681 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -102.29 123.18 45.64 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 123.494 0.718 . . . . 72.44 110.192 176.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 49.1 tpp -81.28 126.75 31.93 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 108.893 -0.78 . . . . 73.22 108.893 172.747 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 24.1 p -129.74 -174.31 3.27 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 123.848 0.859 . . . . 75.34 109.673 -173.506 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 67.4 mt -62.29 -27.65 69.18 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 122.809 0.444 . . . . 75.14 111.196 172.781 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 216' ' ' GLU . . . . . 0.403 ' HB2' ' NZ ' ' A' ' 238' ' ' LYS . 34.4 mt-10 -102.87 22.12 14.39 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 123.826 0.851 . . . . 72.43 110.691 -178.84 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 85.85 -156.03 29.62 Favored Glycine 0 C--N 1.354 1.555 0 CA-C-O 119.13 -0.817 . . . . 61.31 113.291 176.628 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -75.71 148.0 32.08 Favored 'Trans proline' 0 C--N 1.369 1.613 0 C-N-CA 122.79 2.327 . . . . 74.03 113.024 -178.151 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 3.8 p -141.5 128.77 21.09 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 N-CA-C 108.735 -0.839 . . . . 54.41 108.735 174.464 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -79.45 102.88 9.0 Favored 'General case' 0 C--O 1.241 0.606 0 N-CA-C 108.453 -0.943 . . . . 74.41 108.453 174.564 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 1.8 p -111.13 115.88 51.03 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.214 0 CA-C-N 115.457 -0.792 . . . . 73.34 108.968 -170.497 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . 0.594 ' H ' HD22 ' A' ' 172' ' ' LEU . . . -67.78 109.17 3.25 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 115.365 -0.834 . . . . 71.11 111.699 179.143 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 57.5 t -55.4 136.86 69.43 Favored Pre-proline 0 CA--C 1.551 1.008 0 C-N-CA 124.975 1.31 . . . . 65.41 110.382 178.29 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -66.42 160.71 44.25 Favored 'Trans proline' 0 C--N 1.371 1.726 0 C-N-CA 122.233 1.956 . . . . 74.21 111.567 173.009 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo -69.92 151.26 68.08 Favored 'Trans proline' 0 C--N 1.363 1.336 0 C-N-CA 121.406 1.404 . . . . 74.21 110.973 171.427 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 49.6 mtt180 61.98 43.76 8.79 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 124.535 1.134 . . . . 74.44 111.054 170.119 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 227' ' ' THR . . . . . 0.428 ' HA ' ' HE ' ' A' ' 231' ' ' ARG . 91.8 m -85.11 124.63 32.01 Favored 'General case' 0 CA--C 1.544 0.739 0 CA-C-N 114.14 -1.391 . . . . 74.4 109.808 178.095 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -104.81 151.62 23.57 Favored 'General case' 0 N--CA 1.492 1.644 0 C-N-CA 123.602 0.761 . . . . 75.15 109.496 176.292 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -58.01 116.25 3.39 Favored 'General case' 0 C--N 1.353 0.75 0 O-C-N 123.915 0.76 . . . . 72.22 110.397 178.895 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 114.21 -2.24 23.9 Favored Glycine 0 C--N 1.338 0.651 0 CA-C-O 119.194 -0.781 . . . . 61.31 113.211 -178.302 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 231' ' ' ARG . . . . . 0.432 ' HD3' ' H ' ' A' ' 180' ' ' GLY . 25.6 mtt-85 -63.41 129.95 42.37 Favored 'General case' 0 C--N 1.361 1.065 0 CA-C-N 117.989 0.894 . . . . 74.33 109.344 171.817 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 77.2 mttt -110.69 96.75 6.37 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 107.83 -1.174 . . . . 75.24 107.83 -175.301 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 233' ' ' LEU . . . . . 0.599 ' HB2' ' HB2' ' A' ' 251' ' ' LEU . 34.0 mt -79.81 151.33 30.34 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 114.137 -1.392 . . . . 73.22 109.42 -174.747 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 234' ' ' ARG . . . . . 0.438 ' HB2' ' HA3' ' A' ' 182' ' ' GLY . 45.8 ttt180 -117.05 103.05 9.85 Favored 'General case' 0 N--CA 1.483 1.21 0 CA-C-N 118.654 0.661 . . . . 72.55 111.579 -170.135 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 235' ' ' LEU . . . . . 0.557 ' HB2' ' HB3' ' A' ' 249' ' ' LEU . 18.7 mt -94.13 101.14 13.14 Favored 'General case' 0 C--O 1.24 0.594 0 C-N-CA 123.239 0.616 . . . . 74.44 109.68 172.442 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 57.5 mttt -72.97 147.84 44.81 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 110.088 -0.338 . . . . 74.32 110.088 173.857 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 79.32 -6.61 56.7 Favored Glycine 0 C--N 1.341 0.834 0 CA-C-N 115.545 -0.752 . . . . 70.2 113.927 -177.367 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . 0.403 ' NZ ' ' HB2' ' A' ' 216' ' ' GLU . 71.8 mmtt -100.4 2.8 42.66 Favored 'General case' 0 C--O 1.239 0.531 0 C-N-CA 123.491 0.716 . . . . 74.5 111.083 179.351 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -103.62 -175.85 25.98 Favored Glycine 0 C--N 1.357 1.74 0 O-C-N 123.528 0.518 . . . . 65.42 112.09 166.477 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 79.9 m-85 -86.89 167.71 20.99 Favored Pre-proline 0 CA--C 1.563 1.462 0 C-N-CA 124.416 1.087 . . . . 74.03 110.812 179.181 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_endo -73.0 168.53 24.5 Favored 'Trans proline' 0 C--N 1.382 2.294 0 C-N-CA 122.187 1.924 . . . . 75.14 113.198 173.747 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 163.03 -120.14 0.93 Allowed Glycine 0 CA--C 1.538 1.529 0 CA-C-O 118.911 -0.938 . . . . 60.03 112.106 176.854 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 243' ' ' PRO . . . . . 0.526 ' HD2' ' HB3' ' A' ' 191' ' ' GLN . 37.1 Cg_endo -59.83 -59.04 0.44 Allowed 'Trans proline' 0 C--N 1.379 2.133 0 C-N-CA 124.563 3.509 . . . . 73.21 112.892 -173.976 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -83.5 -9.28 59.07 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 123.381 0.672 . . . . 73.12 111.066 178.645 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 85.39 -22.82 9.47 Favored Glycine 0 C--N 1.356 1.649 0 C-N-CA 123.175 0.417 . . . . 72.54 113.134 -177.161 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 10.0 ttm180 -125.33 111.56 15.32 Favored 'General case' 0 C--O 1.241 0.649 0 C-N-CA 124.545 1.138 . . . . 73.44 109.21 -179.7 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -76.75 151.46 39.4 Favored Glycine 0 C--N 1.348 1.198 0 O-C-N 123.726 0.641 . . . . 70.52 114.006 178.006 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -103.98 140.95 37.02 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.062 0.945 . . . . 73.34 109.747 -177.727 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 249' ' ' LEU . . . . . 0.557 ' HB3' ' HB2' ' A' ' 235' ' ' LEU . 45.7 tp -109.04 111.9 23.79 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 108.93 -0.767 . . . . 72.01 108.93 176.439 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 250' ' ' TYR . . . . . 0.456 ' HA ' ' O ' ' A' ' 233' ' ' LEU . 4.8 m-85 -89.58 109.28 20.24 Favored 'General case' 0 C--O 1.242 0.703 0 CA-C-O 121.36 0.6 . . . . 74.24 110.163 -179.531 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 251' ' ' LEU . . . . . 0.599 ' HB2' ' HB2' ' A' ' 233' ' ' LEU . 80.1 mt -87.35 104.02 16.03 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-N 114.382 -1.281 . . . . 74.44 108.289 179.865 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 56.3 mt-10 -85.42 94.19 8.92 Favored 'General case' 0 C--O 1.241 0.621 0 N-CA-C 108.572 -0.899 . . . . 73.45 108.572 -178.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 11.4 m -63.36 138.5 22.85 Favored 'Isoleucine or valine' 0 C--N 1.352 0.699 0 O-C-N 123.858 0.724 . . . . 72.21 110.374 -176.403 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 15.4 mmm180 -126.14 108.78 11.66 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 107.272 -1.381 . . . . 74.24 107.272 179.225 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 255' ' ' ILE . . . . . 0.454 ' HA ' ' O ' ' A' ' 199' ' ' VAL . 29.0 mt -78.92 121.15 31.45 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 O-C-N 123.9 0.75 . . . . 62.31 110.116 179.29 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 2.5 t . . . . . 0 C--O 1.254 1.294 0 C-N-CA 123.922 0.889 . . . . 74.32 109.42 174.727 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 26.5 ttt . . . . . 0 N--CA 1.475 0.794 0 N-CA-C 110.167 -0.309 . . . . 74.41 110.167 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 17.0 pt20 -130.57 -176.32 3.94 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 124.67 1.188 . . . . 73.14 109.094 174.656 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 9.9 t -93.0 154.23 18.27 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 123.381 0.673 . . . . 73.05 109.413 169.008 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -96.67 -85.97 0.33 Allowed 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 122.811 0.444 . . . . 73.44 110.175 179.9 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 172' ' ' LEU . . . . . 0.641 HD21 ' H ' ' A' ' 222' ' ' ALA . 41.4 mt -145.74 160.46 41.7 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 123.568 0.747 . . . . 74.41 111.277 -169.164 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 27.5 m-85 -130.94 -47.51 1.02 Allowed 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 114.623 -1.171 . . . . 74.23 109.095 -167.918 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 174' ' ' TYR . . . . . . . . . . . . . 8.2 p90 -84.23 8.07 17.04 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-N 114.36 -1.291 . . . . 75.12 113.324 -173.889 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 14.8 p -60.09 -23.29 63.69 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 123.158 0.583 . . . . 72.15 112.216 177.293 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 176' ' ' MET . . . . . . . . . . . . . 40.1 mtm -54.89 -49.92 70.02 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 124.216 1.006 . . . . 75.3 110.655 173.849 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -169.54 122.28 0.74 Allowed 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 124.834 1.254 . . . . 75.43 108.037 179.295 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 178' ' ' ALA . . . . . 0.613 ' HB1' HD22 ' A' ' 233' ' ' LEU . . . -146.71 -56.94 0.27 Allowed 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 123.209 0.604 . . . . 72.01 110.946 -175.288 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . 0.584 ' HB2' ' HB2' ' A' ' 224' ' ' PRO . . . -75.46 78.55 2.5 Favored 'General case' 0 C--N 1.353 0.754 0 CA-C-O 122.256 1.027 . . . . 74.14 108.832 172.715 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 167.21 -167.03 39.61 Favored Glycine 0 CA--C 1.522 0.487 0 CA-C-N 113.255 -1.793 . . . . 74.32 110.128 -173.759 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 68.0 p -139.71 133.8 31.05 Favored 'General case' 0 N--CA 1.479 0.982 0 CA-C-N 117.397 0.598 . . . . 65.42 110.806 179.741 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . 179.44 150.28 8.93 Favored Glycine 0 C--N 1.349 1.279 0 CA-C-N 115.95 -0.568 . . . . 65.22 112.123 -178.198 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -133.79 -174.38 13.52 Favored Glycine 0 C--N 1.348 1.243 0 N-CA-C 112.003 -0.439 . . . . 72.21 112.003 -179.624 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 17.1 m -135.63 158.98 43.05 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 123.35 0.66 . . . . 72.52 110.709 -178.842 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -110.77 61.06 0.31 Allowed Glycine 0 C--N 1.341 0.807 0 CA-C-N 115.481 -0.781 . . . . 65.11 111.3 179.387 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -86.6 51.89 4.39 Favored Glycine 0 C--N 1.347 1.17 0 N-CA-C 111.82 -0.512 . . . . 52.34 111.82 175.856 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 17.4 m -63.72 -24.11 67.64 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 124.509 1.123 . . . . 74.14 113.044 -171.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -66.77 -12.8 60.23 Favored Glycine 0 C--N 1.35 1.318 0 N-CA-C 115.005 0.762 . . . . 41.53 115.005 -177.101 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -173.18 149.15 10.93 Favored Glycine 0 C--N 1.346 1.128 0 CA-C-N 117.178 0.489 . . . . 74.3 112.553 176.681 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 35.5 m -84.4 69.63 10.54 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 123.482 0.713 . . . . 73.23 111.257 -177.735 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 191' ' ' GLN . . . . . 0.639 ' HB3' ' HD2' ' A' ' 243' ' ' PRO . 9.6 pt20 -79.41 -24.29 42.64 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-N 115.944 -0.571 . . . . 74.32 110.64 175.894 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 17.7 m-20 -74.99 150.62 38.93 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-N 115.367 -0.833 . . . . 72.2 110.704 -174.812 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . 0.617 HD11 ' HA2' ' A' ' 239' ' ' GLY . 32.6 mt -140.79 170.82 15.04 Favored 'General case' 0 C--O 1.241 0.608 0 CA-C-N 114.592 -1.186 . . . . 74.24 109.176 -179.399 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 55.1 m-85 -138.41 122.07 17.47 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 123.491 0.717 . . . . 72.44 109.689 178.846 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . 0.431 ' HB2' HD11 ' A' ' 249' ' ' LEU . . . -126.3 135.98 52.18 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 107.834 -1.172 . . . . 64.01 107.834 174.993 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 9.1 m -83.55 130.63 35.01 Favored 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 109.742 -0.466 . . . . 74.33 109.742 -176.374 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . 0.481 HD23 HD11 ' A' ' 251' ' ' LEU . 15.5 tp -109.35 108.53 19.12 Favored 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 108.663 -0.866 . . . . 74.4 108.663 -179.479 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -81.21 113.23 19.21 Favored 'General case' 0 CA--C 1.542 0.648 0 N-CA-C 108.92 -0.77 . . . . 71.42 108.92 176.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 199' ' ' VAL . . . . . 0.429 ' O ' ' HA ' ' A' ' 255' ' ' ILE . 6.5 p -132.18 128.99 21.53 Favored Pre-proline 0 CA--C 1.55 0.976 0 C-N-CA 124.035 0.934 . . . . 74.12 109.34 -178.706 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -70.58 159.06 54.07 Favored 'Trans proline' 0 C--N 1.37 1.709 0 C-N-CA 122.035 1.823 . . . . 74.05 111.691 170.101 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -51.18 -49.7 79.9 Favored Pre-proline 0 CA--C 1.564 1.497 0 CA-C-O 117.775 -1.107 . . . . 64.51 113.619 -179.56 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 202' ' ' PRO . . . . . 0.434 ' O ' HG22 ' A' ' 206' ' ' VAL . 42.6 Cg_endo -64.24 -43.01 15.79 Favored 'Trans proline' 0 C--N 1.396 3.074 0 C-N-CA 121.861 1.708 . . . . 75.32 113.702 -179.035 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 51.8 mt -63.48 -34.17 65.81 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.386 0 CA-C-N 118.152 0.433 . . . . 73.42 110.351 176.628 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -66.2 -52.68 45.66 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 122.821 0.448 . . . . 73.45 111.622 179.245 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 20.2 m -69.45 -49.67 57.84 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.924 0 C-N-CA 123.618 0.767 . . . . 71.0 112.577 -173.444 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 206' ' ' VAL . . . . . 0.434 HG22 ' O ' ' A' ' 202' ' ' PRO . 6.7 m -76.99 -31.0 18.34 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.181 0 CA-C-O 120.714 0.292 . . . . 71.01 110.909 -179.736 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 85.63 70.26 1.33 Allowed Glycine 0 C--N 1.345 1.066 0 CA-C-N 115.943 -0.571 . . . . 73.21 112.022 -176.826 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -87.51 -126.4 2.29 Favored Glycine 0 C--N 1.352 1.466 0 N-CA-C 111.902 -0.479 . . . . 65.34 111.902 176.403 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 209' ' ' LYS . . . . . 0.405 ' HG2' ' HA ' ' A' ' 222' ' ' ALA . 46.5 mtmt -139.45 151.65 46.39 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 123.695 0.798 . . . . 71.55 111.12 177.234 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 5.8 m -144.81 169.92 7.77 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 C-N-CA 125.335 1.454 . . . . 73.42 109.532 175.664 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 55.4 ttp180 -102.25 117.05 33.93 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 124.1 0.96 . . . . 72.35 110.048 -179.831 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -100.73 128.92 46.6 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 124.104 0.962 . . . . 71.41 110.207 177.439 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 90.8 mmm -92.55 115.57 28.22 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 123.369 0.667 . . . . 73.4 109.413 179.572 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 17.4 p -111.71 -179.39 3.69 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 124.288 1.035 . . . . 73.24 109.907 -176.687 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 89.0 mt -56.77 -29.69 62.88 Favored 'General case' 0 N--CA 1.491 1.583 0 CA-C-O 121.082 0.467 . . . . 74.11 111.216 171.883 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -101.29 23.2 11.29 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 124.476 1.11 . . . . 73.3 111.144 -178.252 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 83.42 -159.42 36.89 Favored Glycine 0 C--N 1.348 1.246 0 CA-C-O 119.508 -0.607 . . . . 55.11 113.303 176.314 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -71.29 157.03 58.0 Favored 'Trans proline' 0 C--N 1.367 1.524 0 C-N-CA 122.665 2.244 . . . . 74.24 113.21 -173.232 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 7.3 p -151.58 136.9 10.96 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 C-N-CA 124.142 0.977 . . . . 72.1 108.869 174.656 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -80.64 103.43 10.48 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 108.832 -0.803 . . . . 74.41 108.832 175.573 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 10.8 m -104.08 133.75 47.25 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 CA-C-O 121.451 0.644 . . . . 72.55 110.057 177.95 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . 0.641 ' H ' HD21 ' A' ' 172' ' ' LEU . . . -86.7 105.66 17.09 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 114.743 -1.117 . . . . 74.42 110.427 -178.731 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 90.6 t -54.49 134.14 62.87 Favored Pre-proline 0 N--CA 1.481 1.112 0 C-N-CA 125.355 1.462 . . . . 74.41 111.179 -176.763 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 224' ' ' PRO . . . . . 0.584 ' HB2' ' HB2' ' A' ' 179' ' ' ALA . 72.4 Cg_endo -70.33 159.84 51.61 Favored 'Trans proline' 0 C--N 1.376 2.022 0 C-N-CA 122.209 1.939 . . . . 72.14 111.924 175.912 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 22.8 Cg_endo -64.6 136.41 49.89 Favored 'Trans proline' 0 C--N 1.38 2.204 0 C-N-CA 121.981 1.788 . . . . 75.43 111.554 176.189 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 44.3 mtm-85 63.72 64.9 0.75 Allowed 'General case' 0 C--O 1.244 0.775 0 C-N-CA 124.7 1.2 . . . . 74.55 110.074 175.672 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 227' ' ' THR . . . . . 0.429 ' HA ' ' HE ' ' A' ' 231' ' ' ARG . 88.5 m -96.68 123.19 40.28 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 108.214 -1.032 . . . . 72.22 108.214 174.458 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -109.7 148.24 31.73 Favored 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 123.49 0.716 . . . . 74.25 109.085 -179.382 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -57.66 114.29 2.2 Favored 'General case' 0 C--N 1.352 0.674 0 O-C-N 124.278 0.986 . . . . 72.41 110.494 -178.685 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 113.76 5.94 21.68 Favored Glycine 0 CA--C 1.528 0.902 0 O-C-N 124.051 0.844 . . . . 75.32 113.402 -175.48 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 231' ' ' ARG . . . . . 0.429 ' HE ' ' HA ' ' A' ' 227' ' ' THR . 40.7 mtt-85 -71.89 149.57 45.02 Favored 'General case' 0 N--CA 1.481 1.095 0 CA-C-N 117.72 0.76 . . . . 72.54 109.074 165.891 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 232' ' ' LYS . . . . . 0.417 ' HA ' ' O ' ' A' ' 251' ' ' LEU . 43.5 mtmt -128.72 99.48 5.36 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 123.513 0.725 . . . . 73.35 109.344 178.404 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 233' ' ' LEU . . . . . 0.613 HD22 ' HB1' ' A' ' 178' ' ' ALA . 24.1 mt -81.65 132.75 35.31 Favored 'General case' 0 CA--C 1.552 1.044 0 C-N-CA 124.088 0.955 . . . . 74.41 110.266 -173.467 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 40.1 ttt180 -89.53 102.97 15.65 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 123.4 0.68 . . . . 63.42 112.35 -169.654 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 235' ' ' LEU . . . . . 0.592 ' HB2' ' HB3' ' A' ' 249' ' ' LEU . 18.0 mt -93.35 97.08 10.35 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 123.057 0.543 . . . . 73.12 110.483 174.679 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 40.8 mtmt -69.49 144.46 53.21 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-O 120.85 0.357 . . . . 74.12 111.192 177.002 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 73.68 1.03 57.48 Favored Glycine 0 N--CA 1.473 1.137 0 CA-C-N 115.237 -0.892 . . . . 72.32 114.949 -177.816 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 76.1 mmtt -106.04 3.87 28.68 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 117.418 0.609 . . . . 72.35 110.525 179.229 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 239' ' ' GLY . . . . . 0.617 ' HA2' HD11 ' A' ' 193' ' ' LEU . . . -101.93 -160.33 26.57 Favored Glycine 0 C--N 1.35 1.318 0 N-CA-C 111.063 -0.815 . . . . 73.44 111.063 164.025 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 71.4 m-85 -95.04 155.03 39.48 Favored Pre-proline 0 N--CA 1.485 1.314 0 C-N-CA 123.826 0.85 . . . . 71.32 110.981 -179.597 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_exo -71.09 130.62 17.98 Favored 'Trans proline' 0 C--N 1.371 1.735 0 C-N-CA 121.764 1.642 . . . . 73.02 111.197 170.933 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -163.54 -121.35 0.56 Allowed Glycine 0 CA--C 1.535 1.325 0 CA-C-O 118.776 -1.013 . . . . 50.42 113.401 -177.829 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 243' ' ' PRO . . . . . 0.639 ' HD2' ' HB3' ' A' ' 191' ' ' GLN . 37.3 Cg_endo -58.96 -42.85 47.99 Favored 'Trans proline' 0 C--N 1.385 2.462 0 C-N-CA 124.379 3.386 . . . . 75.52 112.935 -172.399 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -96.59 -4.88 40.37 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 123.551 0.74 . . . . 65.14 111.044 177.152 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 84.27 -23.39 7.22 Favored Glycine 0 C--N 1.361 1.939 0 C-N-CA 123.142 0.401 . . . . 75.45 113.423 -178.827 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 43.1 ttt85 -128.0 111.58 13.69 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.97 1.308 . . . . 75.34 108.901 -179.649 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -72.48 151.3 46.36 Favored Glycine 0 C--N 1.347 1.145 0 N-CA-C 115.064 0.785 . . . . 61.3 115.064 178.694 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 38.2 m-20 -111.64 127.78 55.86 Favored 'General case' 0 C--O 1.233 0.221 0 C-N-CA 124.295 1.038 . . . . 71.22 109.382 -176.487 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 249' ' ' LEU . . . . . 0.592 ' HB3' ' HB2' ' A' ' 235' ' ' LEU . 58.8 tp -103.76 109.83 21.69 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 108.323 -0.992 . . . . 73.52 108.323 178.526 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 250' ' ' TYR . . . . . . . . . . . . . 4.4 m-85 -88.21 118.65 27.95 Favored 'General case' 0 C--O 1.241 0.646 0 N-CA-C 109.271 -0.64 . . . . 74.23 109.271 -176.267 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 251' ' ' LEU . . . . . 0.481 HD11 HD23 ' A' ' 197' ' ' LEU . 74.3 mt -88.14 103.31 15.64 Favored 'General case' 0 C--N 1.343 0.302 0 N-CA-C 107.935 -1.135 . . . . 65.42 107.935 -177.061 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -83.07 93.11 7.53 Favored 'General case' 0 C--O 1.241 0.638 0 N-CA-C 107.329 -1.36 . . . . 65.01 107.329 -175.53 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 4.9 m -71.94 136.84 24.86 Favored 'Isoleucine or valine' 0 C--N 1.351 0.648 0 CA-C-N 114.959 -1.018 . . . . 73.33 110.819 -170.746 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 24.4 mmm180 -122.05 112.54 18.38 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 106.913 -1.514 . . . . 74.34 106.913 179.737 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 255' ' ' ILE . . . . . 0.429 ' HA ' ' O ' ' A' ' 199' ' ' VAL . 35.2 mt -80.4 115.98 23.8 Favored 'Isoleucine or valine' 0 C--O 1.236 0.382 0 N-CA-C 108.758 -0.83 . . . . 73.24 108.758 173.569 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 9.5 t . . . . . 0 C--O 1.26 1.655 0 N-CA-C 108.349 -0.982 . . . . 74.11 108.349 168.614 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 28.0 ptm . . . . . 0 N--CA 1.481 1.08 0 N-CA-C 111.82 0.304 . . . . 74.32 111.82 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 169' ' ' GLN . . . . . 0.553 ' HG3' HG22 ' A' ' 170' ' ' THR . 12.9 pt20 -112.45 -29.28 7.56 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 123.09 0.556 . . . . 74.32 111.491 -172.743 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 170' ' ' THR . . . . . 0.553 HG22 ' HG3' ' A' ' 169' ' ' GLN . 12.6 t -161.46 144.0 12.11 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 123.466 0.707 . . . . 74.1 111.323 -176.897 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -116.9 -70.74 0.77 Allowed 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 123.184 0.594 . . . . 70.04 110.412 -172.262 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 172' ' ' LEU . . . . . 0.48 HD22 ' H ' ' A' ' 222' ' ' ALA . 63.6 mt -134.3 158.86 42.69 Favored 'General case' 0 N--CA 1.484 1.273 0 CA-C-O 122.039 0.923 . . . . 74.42 112.068 -175.076 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 173' ' ' PHE . . . . . 0.46 ' CD1' HD22 ' A' ' 235' ' ' LEU . 19.8 m-85 -136.71 -51.67 0.69 Allowed 'General case' 0 N--CA 1.477 0.919 0 CA-C-N 114.586 -1.188 . . . . 73.02 108.609 -171.343 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 174' ' ' TYR . . . . . 0.432 ' OH ' ' HB ' ' A' ' 221' ' ' VAL . 2.9 p90 -79.3 17.87 0.76 Allowed 'General case' 0 CA--C 1.552 1.04 0 CA-C-N 113.446 -1.706 . . . . 73.41 112.551 -179.213 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 175' ' ' THR . . . . . 0.412 HG22 HD13 ' A' ' 172' ' ' LEU . 0.2 OUTLIER -66.1 -18.57 65.43 Favored 'General case' 0 CA--C 1.552 1.032 0 C-N-CA 124.1 0.96 . . . . 71.41 111.888 -174.936 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 176' ' ' MET . . . . . 0.51 ' SD ' ' N ' ' A' ' 177' ' ' LYS . 0.0 OUTLIER -70.74 -45.36 64.98 Favored 'General case' 0 CA--C 1.554 1.126 0 C-N-CA 123.978 0.911 . . . . 75.21 111.45 173.509 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . 0.51 ' N ' ' SD ' ' A' ' 176' ' ' MET . 35.7 mttp -162.91 134.15 4.93 Favored 'General case' 0 N--CA 1.491 1.599 0 C-N-CA 125.702 1.601 . . . . 74.44 108.681 175.277 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 178' ' ' ALA . . . . . 0.489 ' HB3' HD23 ' A' ' 233' ' ' LEU . . . -147.99 -53.54 0.2 Allowed 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 123.934 0.893 . . . . 75.03 109.839 -172.859 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -85.48 36.9 0.66 Allowed 'General case' 0 CA--C 1.558 1.259 0 C-N-CA 123.876 0.87 . . . . 75.41 109.957 171.341 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -119.93 -175.67 15.76 Favored Glycine 0 C--N 1.354 1.53 0 N-CA-C 110.638 -0.985 . . . . 72.44 110.638 176.766 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 31.8 t -162.37 170.61 18.54 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 123.645 0.778 . . . . 73.1 109.994 178.898 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . 74.58 85.13 0.3 Allowed Glycine 0 C--N 1.347 1.171 0 N-CA-C 112.165 -0.374 . . . . 73.44 112.165 177.88 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -118.13 134.09 10.79 Favored Glycine 0 C--N 1.348 1.22 0 N-CA-C 111.057 -0.817 . . . . 64.42 111.057 177.574 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 28.9 t -73.08 87.97 1.4 Allowed 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 123.397 0.679 . . . . 70.22 109.902 179.751 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 172.71 -173.53 45.5 Favored Glycine 0 C--N 1.345 1.039 0 N-CA-C 112.074 -0.41 . . . . 42.21 112.074 -179.235 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 137.2 -0.61 2.91 Favored Glycine 0 C--N 1.346 1.097 0 CA-C-O 119.766 -0.463 . . . . 64.33 113.39 177.783 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 38.4 m -79.54 -17.13 54.68 Favored 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 122.944 0.498 . . . . 75.03 110.962 177.338 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 65.7 -128.82 32.7 Favored Glycine 0 C--N 1.349 1.261 0 O-C-N 123.78 0.675 . . . . 60.03 113.397 177.75 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 138.64 34.09 0.18 Allowed Glycine 0 C--N 1.345 1.047 0 CA-C-O 119.604 -0.553 . . . . 64.15 112.124 178.223 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 22.9 t 65.07 19.2 11.76 Favored 'General case' 0 N--CA 1.49 1.555 0 C-N-CA 124.214 1.006 . . . . 63.42 111.976 -179.022 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 191' ' ' GLN . . . . . 0.503 ' HB3' ' HD2' ' A' ' 243' ' ' PRO . 2.3 pt20 -99.45 -13.84 19.36 Favored 'General case' 0 N--CA 1.479 1.008 0 CA-C-O 121.391 0.615 . . . . 71.45 111.092 179.118 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -86.32 144.67 27.26 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 124.35 1.06 . . . . 70.03 110.201 -163.501 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . 0.468 HD12 ' HA2' ' A' ' 239' ' ' GLY . 25.4 mt -138.69 163.63 31.62 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 124.27 1.028 . . . . 73.4 109.391 174.363 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 50.6 m-85 -139.36 122.82 17.24 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 123.779 0.832 . . . . 63.12 109.761 -177.543 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . 0.439 ' HB2' HD11 ' A' ' 249' ' ' LEU . . . -133.02 129.13 37.73 Favored 'General case' 0 N--CA 1.466 0.335 0 O-C-N 124.343 1.027 . . . . 52.22 108.6 175.654 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 33.6 m -76.79 130.82 38.2 Favored 'General case' 0 CA--C 1.541 0.617 0 N-CA-C 109.694 -0.484 . . . . 74.42 109.694 178.157 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . 0.565 HD22 HD11 ' A' ' 251' ' ' LEU . 15.1 tp -112.21 108.79 18.15 Favored 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 107.61 -1.256 . . . . 72.51 107.61 176.645 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -83.76 132.32 34.85 Favored 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 108.841 -0.8 . . . . 74.45 108.841 174.838 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 199' ' ' VAL . . . . . 0.454 ' O ' ' HA ' ' A' ' 255' ' ' ILE . 4.1 p -144.61 129.88 9.44 Favored Pre-proline 0 CA--C 1.549 0.934 0 C-N-CA 123.866 0.866 . . . . 74.41 108.671 -179.983 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -70.35 153.7 65.98 Favored 'Trans proline' 0 C--N 1.367 1.536 0 C-N-CA 122.21 1.94 . . . . 72.31 110.836 168.49 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 201' ' ' ALA . . . . . 0.447 ' O ' HG21 ' A' ' 205' ' ' VAL . . . -49.88 -51.4 61.28 Favored Pre-proline 0 CA--C 1.555 1.153 0 C-N-CA 124.754 1.222 . . . . 71.51 113.361 -177.729 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_endo -60.85 -35.85 86.58 Favored 'Trans proline' 0 C--N 1.397 3.118 0 C-N-CA 121.771 1.647 . . . . 73.11 113.896 -178.487 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 38.1 mt -70.02 -34.14 58.33 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 C-N-CA 122.587 0.355 . . . . 72.32 110.461 177.418 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -67.1 -38.36 85.52 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 122.342 0.257 . . . . 74.33 111.22 175.838 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . 0.447 HG21 ' O ' ' A' ' 201' ' ' ALA . 92.1 t -69.25 -56.49 11.62 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.125 0 C-N-CA 123.963 0.905 . . . . 74.24 111.083 -179.423 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 18.0 m -75.59 -24.07 16.93 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.133 0 CA-C-N 116.09 -0.504 . . . . 62.51 111.574 -174.883 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 76.15 66.21 1.89 Allowed Glycine 0 C--N 1.345 1.042 0 CA-C-N 115.251 -0.886 . . . . 63.24 111.83 -173.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -83.74 -140.46 4.29 Favored Glycine 0 C--N 1.352 1.443 0 N-CA-C 112.161 -0.376 . . . . 41.01 112.161 178.628 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 49.4 mtmt -137.43 137.5 38.83 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.606 0.763 . . . . 74.02 110.414 177.915 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 11.0 m -127.82 165.39 27.03 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 C-N-CA 125.119 1.368 . . . . 72.0 108.742 172.903 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 50.6 ttp180 -101.59 117.47 34.98 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 123.25 0.62 . . . . 74.32 110.323 -178.564 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -101.99 132.59 47.73 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 123.958 0.903 . . . . 73.24 110.239 175.721 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 25.3 mmt -90.91 121.32 32.65 Favored 'General case' 0 N--CA 1.48 1.075 0 N-CA-C 109.343 -0.614 . . . . 74.31 109.343 175.306 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 214' ' ' THR . . . . . 0.416 ' HB ' ' HD2' ' A' ' 238' ' ' LYS . 30.5 p -121.97 -173.54 2.68 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 124.484 1.114 . . . . 74.43 110.371 -174.779 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 83.2 mt -61.65 -30.95 71.05 Favored 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 123.216 0.606 . . . . 74.03 111.097 171.588 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -98.76 21.28 11.65 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 123.498 0.719 . . . . 74.13 111.282 179.791 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 84.49 -159.15 34.76 Favored Glycine 0 C--N 1.356 1.658 0 CA-C-O 119.411 -0.66 . . . . 65.01 113.012 175.359 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -64.76 142.25 75.63 Favored 'Trans proline' 0 C--N 1.369 1.633 0 C-N-CA 122.817 2.345 . . . . 74.01 112.58 178.687 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 4.8 p -140.81 128.53 23.01 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 N-CA-C 108.333 -0.988 . . . . 75.55 108.333 174.323 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 3.8 mp0 -79.28 101.6 8.12 Favored 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 107.28 -1.378 . . . . 72.33 107.28 175.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 221' ' ' VAL . . . . . 0.432 ' HB ' ' OH ' ' A' ' 174' ' ' TYR . 2.8 m -99.39 128.25 51.32 Favored 'Isoleucine or valine' 0 C--O 1.24 0.586 0 CA-C-O 121.602 0.715 . . . . 71.21 109.544 -179.675 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . 0.48 ' H ' HD22 ' A' ' 172' ' ' LEU . . . -80.26 104.81 11.07 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 114.407 -1.27 . . . . 63.12 109.26 179.63 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 61.3 t -53.99 134.9 57.93 Favored Pre-proline 0 CA--C 1.558 1.283 0 O-C-N 124.567 1.167 . . . . 71.0 109.707 178.549 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -63.87 149.85 89.73 Favored 'Trans proline' 0 C--N 1.371 1.722 0 C-N-CA 122.068 1.845 . . . . 73.31 111.452 173.474 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -63.23 134.12 43.99 Favored 'Trans proline' 0 C--N 1.373 1.854 0 C-N-CA 121.907 1.738 . . . . 71.1 110.983 174.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 33.6 mtm-85 63.82 53.39 1.96 Allowed 'General case' 0 CA--C 1.546 0.817 0 O-C-N 124.68 1.237 . . . . 74.13 111.043 175.858 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 30.6 m -78.24 145.17 35.62 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 115.444 -0.798 . . . . 73.41 108.945 170.391 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 27.0 mp0 -116.22 145.54 43.04 Favored 'General case' 0 N--CA 1.48 1.061 0 N-CA-C 108.563 -0.902 . . . . 73.23 108.563 176.916 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 229' ' ' ALA . . . . . 0.532 ' HB3' ' HB ' ' A' ' 255' ' ' ILE . . . -60.2 130.72 48.06 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.543 0.737 . . . . 72.2 109.762 -179.48 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 97.85 12.08 48.0 Favored Glycine 0 CA--C 1.522 0.504 0 O-C-N 123.857 0.723 . . . . 74.31 112.852 -178.248 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 95.1 mtt-85 -84.24 156.14 22.14 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 109.256 -0.646 . . . . 74.4 109.256 165.049 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 232' ' ' LYS . . . . . 0.417 ' HA ' ' O ' ' A' ' 251' ' ' LEU . 42.3 mtmt -130.38 106.84 8.82 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.583 0.753 . . . . 73.44 109.312 -179.735 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 233' ' ' LEU . . . . . 0.523 ' HB2' ' HB2' ' A' ' 251' ' ' LEU . 26.3 mt -80.27 134.04 36.04 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 115.218 -0.901 . . . . 74.45 109.526 -176.677 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 75.3 ttt180 -97.33 109.95 22.6 Favored 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 122.808 0.443 . . . . 73.43 110.93 -170.732 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 235' ' ' LEU . . . . . 0.519 HD13 HD22 ' A' ' 249' ' ' LEU . 15.0 mt -99.77 105.87 17.7 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.265 0.626 . . . . 72.24 111.099 179.522 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 1.9 mtpp -72.09 153.79 41.49 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-O 120.719 0.295 . . . . 72.13 110.563 171.707 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 65.63 13.83 59.4 Favored Glycine 0 N--CA 1.473 1.141 0 O-C-N 124.486 1.116 . . . . 75.43 114.359 -177.198 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . 0.416 ' HD2' ' HB ' ' A' ' 214' ' ' THR . 41.1 mmtm -125.53 4.58 7.59 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 123.782 0.833 . . . . 75.23 111.823 -177.968 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 239' ' ' GLY . . . . . 0.468 ' HA2' HD12 ' A' ' 193' ' ' LEU . . . -107.66 -167.64 21.75 Favored Glycine 0 C--N 1.345 1.028 0 N-CA-C 110.879 -0.888 . . . . 70.44 110.879 165.644 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 66.7 m-85 -92.44 166.55 16.78 Favored Pre-proline 0 CA--C 1.548 0.892 0 C-N-CA 123.794 0.837 . . . . 73.44 110.777 178.807 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -70.88 146.47 53.33 Favored 'Trans proline' 0 C--N 1.374 1.887 0 C-N-CA 121.756 1.637 . . . . 71.13 111.577 168.068 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -169.74 -117.3 0.41 Allowed Glycine 0 CA--C 1.532 1.103 0 CA-C-O 119.039 -0.867 . . . . 52.11 111.587 178.923 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 243' ' ' PRO . . . . . 0.503 ' HD2' ' HB3' ' A' ' 191' ' ' GLN . 65.6 Cg_endo -66.15 -57.36 0.23 Allowed 'Trans proline' 0 C--N 1.375 1.96 0 C-N-CA 124.246 3.298 . . . . 74.33 112.617 -169.574 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -96.39 18.88 12.99 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.899 0.88 . . . . 74.03 110.463 176.415 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 74.66 -103.33 1.52 Allowed Glycine 0 C--N 1.354 1.558 0 N-CA-C 110.322 -1.111 . . . . 71.31 110.322 -170.835 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 31.0 ttm180 -50.42 110.63 0.43 Allowed 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 125.203 1.401 . . . . 74.04 112.559 -176.408 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -89.04 179.46 45.39 Favored Glycine 0 C--N 1.344 0.991 0 CA-C-N 115.898 -0.592 . . . . 72.34 113.478 178.322 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 20.9 m-20 -126.83 152.53 46.86 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 114.598 -0.801 . . . . 71.54 112.504 -168.795 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 249' ' ' LEU . . . . . 0.519 HD22 HD13 ' A' ' 235' ' ' LEU . 55.7 tp -110.17 117.08 32.75 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 114.354 -1.293 . . . . 75.43 108.095 171.117 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 250' ' ' TYR . . . . . . . . . . . . . 3.7 m-85 -90.24 115.16 27.25 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 123.188 0.595 . . . . 75.32 109.404 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 251' ' ' LEU . . . . . 0.565 HD11 HD22 ' A' ' 197' ' ' LEU . 77.2 mt -88.5 105.35 17.56 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-N 114.685 -1.143 . . . . 74.11 108.486 -177.973 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 252' ' ' GLU . . . . . 0.416 ' HG3' ' HD3' ' A' ' 254' ' ' ARG . 12.0 tp10 -79.56 94.06 5.57 Favored 'General case' 0 C--O 1.238 0.486 0 N-CA-C 108.55 -0.907 . . . . 73.12 108.55 -178.746 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 4.4 m -71.67 127.48 33.67 Favored 'Isoleucine or valine' 0 C--N 1.352 0.694 0 CA-C-O 121.619 0.723 . . . . 73.41 109.664 -174.839 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 254' ' ' ARG . . . . . 0.416 ' HD3' ' HG3' ' A' ' 252' ' ' GLU . 22.9 mmm180 -122.87 95.1 4.49 Favored 'General case' 0 C--O 1.239 0.517 0 N-CA-C 107.971 -1.122 . . . . 74.23 107.971 -176.7 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 255' ' ' ILE . . . . . 0.532 ' HB ' ' HB3' ' A' ' 229' ' ' ALA . 40.3 mt -76.6 121.08 28.03 Favored 'Isoleucine or valine' 0 C--O 1.238 0.465 0 CA-C-N 115.589 -0.732 . . . . 74.44 109.669 178.054 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 9.4 t . . . . . 0 C--O 1.254 1.303 0 C-N-CA 123.97 0.908 . . . . 72.44 108.657 175.885 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 23.4 ttt . . . . . 0 N--CA 1.488 1.435 0 CA-C-O 121.228 0.537 . . . . 74.02 110.161 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 13.7 pt20 -147.82 -178.06 6.06 Favored 'General case' 0 C--O 1.241 0.643 0 CA-C-N 115.505 -0.77 . . . . 73.54 110.03 -174.662 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 12.5 t -65.96 157.99 29.33 Favored 'General case' 0 CA--C 1.545 0.788 0 CA-C-N 115.649 -0.705 . . . . 74.43 110.882 173.378 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -99.89 -160.75 0.82 Allowed 'General case' 0 CA--C 1.554 1.123 0 N-CA-C 108.373 -0.973 . . . . 70.43 108.373 179.823 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 172' ' ' LEU . . . . . 0.499 ' HB3' ' OG1' ' A' ' 175' ' ' THR . 26.0 mt -72.5 173.74 8.44 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.935 0.894 . . . . 73.24 112.012 173.511 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 173' ' ' PHE . . . . . 0.525 ' CD1' HD22 ' A' ' 235' ' ' LEU . 20.2 m-85 -141.1 -71.03 0.36 Allowed 'General case' 0 N--CA 1.481 1.099 0 CA-C-O 121.182 0.515 . . . . 75.33 111.297 -163.799 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 174' ' ' TYR . . . . . 0.458 ' CD2' ' HB3' ' A' ' 233' ' ' LEU . 2.1 p90 -83.25 7.2 17.05 Favored 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 124.589 1.156 . . . . 74.34 112.038 -171.364 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 175' ' ' THR . . . . . 0.499 ' OG1' ' HB3' ' A' ' 172' ' ' LEU . 1.5 m -60.23 -36.82 78.59 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 124.365 1.066 . . . . 74.23 113.149 -160.71 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 176' ' ' MET . . . . . . . . . . . . . 3.0 mpp? -68.08 -27.25 66.33 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 123.676 0.79 . . . . 72.14 111.192 -179.774 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 20.8 tptm -122.56 25.92 8.56 Favored 'General case' 0 CA--C 1.556 1.205 0 C-N-CA 124.367 1.067 . . . . 74.44 109.872 -177.459 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 178' ' ' ALA . . . . . 0.609 ' HB1' ' HB3' ' A' ' 224' ' ' PRO . . . -69.46 132.42 46.29 Favored 'General case' 0 N--CA 1.476 0.867 0 CA-C-N 115.865 -0.607 . . . . 74.11 110.053 -179.761 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . 0.538 ' HB2' ' HB2' ' A' ' 224' ' ' PRO . . . 60.89 30.34 19.58 Favored 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 124.315 1.046 . . . . 75.51 110.779 -170.858 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -79.09 166.73 51.91 Favored Glycine 0 C--N 1.345 1.063 0 CA-C-N 115.198 -0.91 . . . . 60.41 112.496 178.711 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 47.1 t -138.95 162.05 35.83 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 123.737 0.815 . . . . 75.42 109.503 178.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . 91.64 169.0 41.37 Favored Glycine 0 CA--C 1.532 1.119 0 CA-C-N 115.768 -0.651 . . . . 74.4 112.308 -176.133 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -73.85 147.35 38.14 Favored Glycine 0 C--N 1.346 1.123 0 CA-C-O 120.202 -0.221 . . . . 74.43 112.805 -179.789 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 29.7 t -103.37 -56.73 2.16 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 124.046 0.938 . . . . 73.21 109.949 179.511 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 126.56 135.84 4.28 Favored Glycine 0 C--N 1.353 1.503 0 N-CA-C 112.076 -0.41 . . . . 63.31 112.076 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 170.96 108.29 0.21 Allowed Glycine 0 C--N 1.34 0.771 0 N-CA-C 111.148 -0.781 . . . . 74.43 111.148 -176.525 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 13.9 t -166.3 37.97 0.05 OUTLIER 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 123.192 0.597 . . . . 75.21 110.066 -179.42 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -142.56 126.66 2.96 Favored Glycine 0 C--N 1.344 1.013 0 CA-C-N 116.209 -0.451 . . . . 63.33 113.443 -174.907 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 66.48 7.2 38.81 Favored Glycine 0 C--N 1.354 1.535 0 N-CA-C 116.509 1.364 . . . . 61.41 116.509 163.654 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 18.3 m 61.37 30.43 18.99 Favored 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 124.102 0.961 . . . . 75.1 111.927 -178.179 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -75.75 -22.92 56.03 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 122.632 0.373 . . . . 65.51 111.278 179.753 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 -75.58 134.98 40.56 Favored 'General case' 0 N--CA 1.47 0.525 0 C-N-CA 123.834 0.854 . . . . 64.33 109.887 -178.294 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 24.2 mt -117.6 162.69 17.6 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 123.568 0.747 . . . . 73.44 110.215 175.46 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 77.0 m-85 -133.17 135.0 44.85 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 123.77 0.828 . . . . 73.41 110.382 -177.751 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . 0.418 ' HB1' HD13 ' A' ' 249' ' ' LEU . . . -147.8 171.16 16.15 Favored 'General case' 0 C--O 1.239 0.53 0 C-N-CA 125.417 1.487 . . . . 73.25 108.494 -179.607 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 34.1 m -129.63 124.42 33.64 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 123.826 0.851 . . . . 71.12 108.717 -178.604 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . 0.6 HD22 HD13 ' A' ' 251' ' ' LEU . 15.7 tp -106.66 110.2 22.32 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 108.681 -0.859 . . . . 74.51 108.681 -173.044 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -82.51 122.77 28.49 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 123.091 0.556 . . . . 73.34 109.774 177.703 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 199' ' ' VAL . . . . . 0.44 ' O ' ' HA ' ' A' ' 255' ' ' ILE . 4.3 p -140.71 128.34 12.32 Favored Pre-proline 0 CA--C 1.545 0.764 0 N-CA-C 108.228 -1.027 . . . . 73.41 108.228 -177.927 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -69.39 156.2 65.0 Favored 'Trans proline' 0 C--N 1.366 1.49 0 C-N-CA 121.917 1.745 . . . . 61.42 111.034 171.15 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 201' ' ' ALA . . . . . 0.492 ' HA ' HG22 ' A' ' 255' ' ' ILE . . . -48.52 -54.2 28.6 Favored Pre-proline 0 CA--C 1.559 1.321 0 CA-C-O 117.754 -1.117 . . . . 75.41 113.122 -177.761 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -60.69 -37.6 77.9 Favored 'Trans proline' 0 C--N 1.391 2.803 0 C-N-CA 121.94 1.76 . . . . 73.22 113.466 -176.376 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 39.7 mt -68.37 -33.94 63.12 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.389 0 C-N-CA 122.51 0.324 . . . . 73.44 110.404 178.056 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -71.66 -33.54 68.96 Favored 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 122.863 0.465 . . . . 63.32 111.47 176.893 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . 0.465 HG23 ' O ' ' A' ' 201' ' ' ALA . 73.5 t -71.8 -52.43 25.51 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 C-N-CA 123.909 0.884 . . . . 74.2 110.951 -179.776 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 16.2 m -82.89 -27.21 8.1 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.096 0 CA-C-N 116.304 -0.407 . . . . 63.43 111.465 -173.493 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 83.74 62.09 1.8 Allowed Glycine 0 C--N 1.343 0.969 0 CA-C-N 116.121 -0.491 . . . . 61.3 112.224 -174.589 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -83.19 -134.38 2.29 Favored Glycine 0 C--N 1.35 1.346 0 CA-C-O 119.9 -0.389 . . . . 62.34 112.462 177.947 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 46.5 mtmt -138.59 153.11 48.65 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 123.917 0.887 . . . . 75.2 110.916 178.037 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 9.7 m -145.37 170.0 6.72 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.092 0 C-N-CA 125.732 1.613 . . . . 74.35 109.096 175.184 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 29.8 ttp180 -97.8 110.57 23.11 Favored 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 123.72 0.808 . . . . 74.32 110.306 -177.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -102.33 112.22 24.83 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 123.485 0.714 . . . . 71.24 109.311 174.121 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 213' ' ' MET . . . . . 0.494 ' HE1' ' HG3' ' A' ' 218' ' ' PRO . 65.5 mtp -86.75 123.47 31.95 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 122.744 0.418 . . . . 63.4 110.071 -178.746 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 31.4 p -127.72 -171.14 2.37 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 124.38 1.072 . . . . 75.15 110.954 -168.4 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 76.9 mt -63.71 -27.91 69.53 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 123.217 0.607 . . . . 74.45 111.236 172.107 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -100.93 21.95 12.92 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.716 0.806 . . . . 75.21 110.615 178.328 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 85.38 -168.56 42.43 Favored Glycine 0 C--N 1.348 1.232 0 CA-C-N 116.008 -0.542 . . . . 60.14 113.702 173.94 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 218' ' ' PRO . . . . . 0.494 ' HG3' ' HE1' ' A' ' 213' ' ' MET . 2.7 Cg_exo -74.19 121.04 6.59 Favored 'Trans proline' 0 C--N 1.366 1.494 0 C-N-CA 122.975 2.45 . . . . 71.52 112.047 -179.625 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 6.7 p -114.4 134.76 56.32 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 C-N-CA 123.799 0.84 . . . . 74.14 109.39 175.488 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -75.56 102.31 5.23 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 107.741 -1.207 . . . . 74.41 107.741 172.382 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 3.8 p -103.91 130.08 55.05 Favored 'Isoleucine or valine' 0 C--O 1.243 0.72 0 N-CA-C 109.149 -0.686 . . . . 73.04 109.149 -175.058 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . 0.485 ' H ' HD22 ' A' ' 172' ' ' LEU . . . -76.03 106.64 7.74 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 123.261 0.624 . . . . 45.42 110.676 -177.427 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 53.5 t -54.71 137.87 62.81 Favored Pre-proline 0 N--CA 1.477 0.888 0 O-C-N 124.522 1.139 . . . . 74.23 109.994 179.626 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 224' ' ' PRO . . . . . 0.609 ' HB3' ' HB1' ' A' ' 178' ' ' ALA . 12.3 Cg_endo -57.77 152.96 46.2 Favored 'Trans proline' 0 C--N 1.369 1.617 0 C-N-CA 122.355 2.037 . . . . 72.33 112.714 171.343 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -76.18 149.54 32.17 Favored 'Trans proline' 0 C--N 1.367 1.527 0 C-N-CA 121.999 1.799 . . . . 63.31 110.741 171.443 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 35.9 mtm105 60.09 36.23 21.26 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 124.305 1.042 . . . . 74.34 111.143 168.563 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 227' ' ' THR . . . . . 0.449 HG22 ' HD2' ' A' ' 231' ' ' ARG . 21.5 m -76.53 150.03 36.62 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 124.587 1.155 . . . . 63.1 110.576 -178.259 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 27.0 mp0 -120.96 143.01 49.23 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 123.606 0.762 . . . . 72.22 109.151 175.066 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 229' ' ' ALA . . . . . 0.442 ' HB1' ' HB ' ' A' ' 255' ' ' ILE . . . -60.02 125.52 23.99 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 123.859 0.864 . . . . 74.31 111.002 -178.528 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 109.25 -2.02 31.19 Favored Glycine 0 CA--C 1.528 0.844 0 O-C-N 123.774 0.671 . . . . 74.03 113.287 -177.776 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 231' ' ' ARG . . . . . 0.449 ' HD2' HG22 ' A' ' 227' ' ' THR . 89.7 mtt-85 -72.35 157.59 37.38 Favored 'General case' 0 N--CA 1.479 0.985 0 CA-C-N 117.701 0.751 . . . . 74.51 109.854 170.484 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 45.7 mtmt -128.97 122.78 30.86 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 123.189 0.596 . . . . 74.14 110.068 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 233' ' ' LEU . . . . . 0.458 ' HB3' ' CD2' ' A' ' 174' ' ' TYR . 19.5 mt -101.77 153.34 19.89 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 124.949 1.3 . . . . 71.01 108.634 -178.043 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 19.5 ttt180 -120.78 103.17 8.89 Favored 'General case' 0 CA--C 1.546 0.801 0 O-C-N 122.188 -0.32 . . . . 74.42 111.486 -171.85 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 235' ' ' LEU . . . . . 0.562 ' HB2' ' HB3' ' A' ' 249' ' ' LEU . 15.6 mt -82.39 102.58 11.36 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 123.585 0.754 . . . . 72.32 110.582 176.966 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . 0.411 ' H ' ' HB3' ' A' ' 173' ' ' PHE . 43.8 mtmt -71.97 144.44 48.87 Favored 'General case' 0 C--O 1.242 0.68 0 CA-C-O 121.529 0.681 . . . . 72.25 112.421 179.967 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 72.14 3.36 56.45 Favored Glycine 0 CA--C 1.531 1.089 0 CA-C-N 114.183 -1.371 . . . . 61.12 114.283 -176.108 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 47.2 mmtm -107.96 13.85 25.8 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 123.538 0.735 . . . . 75.42 111.63 -176.311 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -116.36 -171.0 15.89 Favored Glycine 0 CA--C 1.528 0.877 0 N-CA-C 110.274 -1.13 . . . . 73.42 110.274 166.51 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 68.9 m-85 -87.73 159.13 49.9 Favored Pre-proline 0 N--CA 1.481 1.079 0 C-N-CA 123.264 0.626 . . . . 74.34 112.149 -173.778 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -71.72 164.21 36.43 Favored 'Trans proline' 0 C--N 1.373 1.858 0 C-N-CA 122.04 1.827 . . . . 72.14 112.732 171.595 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 158.35 -109.09 0.39 Allowed Glycine 0 CA--C 1.532 1.123 0 CA-C-O 118.784 -1.009 . . . . 74.13 112.722 174.244 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -65.16 -49.58 2.61 Favored 'Trans proline' 0 C--N 1.381 2.249 0 C-N-CA 123.454 2.769 . . . . 75.15 112.722 -170.385 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -90.61 -8.53 49.85 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 123.976 0.91 . . . . 72.22 111.151 178.349 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 83.68 -42.58 3.06 Favored Glycine 0 C--N 1.359 1.828 0 N-CA-C 111.922 -0.471 . . . . 72.35 111.922 -170.864 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 17.3 ttm180 -103.17 114.82 29.42 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 125.077 1.351 . . . . 73.53 110.639 173.17 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -91.1 158.99 26.13 Favored Glycine 0 C--N 1.341 0.843 0 N-CA-C 110.841 -0.904 . . . . 75.45 110.841 163.664 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 26.9 m-20 -134.52 152.55 51.86 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 122.606 0.363 . . . . 74.54 110.065 -171.531 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 249' ' ' LEU . . . . . 0.562 ' HB3' ' HB2' ' A' ' 235' ' ' LEU . 57.2 tp -99.05 139.97 33.91 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 124.543 1.137 . . . . 73.53 109.844 -176.506 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 250' ' ' TYR . . . . . . . . . . . . . 4.3 m-85 -103.66 123.0 46.19 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 123.856 0.862 . . . . 71.11 110.064 177.837 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 251' ' ' LEU . . . . . 0.6 HD13 HD22 ' A' ' 197' ' ' LEU . 92.1 mt -103.7 103.91 13.88 Favored 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 108.211 -1.033 . . . . 74.41 108.211 179.464 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -81.33 100.99 9.5 Favored 'General case' 0 CA--C 1.543 0.691 0 N-CA-C 108.187 -1.042 . . . . 74.12 108.187 175.371 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 10.2 m -65.68 137.34 25.12 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.788 0 CA-C-O 121.359 0.599 . . . . 73.34 110.801 -175.031 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 24.1 mmt85 -128.79 97.65 4.73 Favored 'General case' 0 C--O 1.238 0.468 0 C-N-CA 124.576 1.151 . . . . 75.12 108.246 179.844 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 255' ' ' ILE . . . . . 0.492 HG22 ' HA ' ' A' ' 201' ' ' ALA . 34.5 mt -77.42 120.79 28.62 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 CA-C-N 115.422 -0.808 . . . . 73.44 109.679 179.376 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 7.1 t . . . . . 0 CA--C 1.562 1.412 0 C-N-CA 123.675 0.79 . . . . 74.34 109.497 -179.43 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 23.9 ptp . . . . . 0 N--CA 1.484 1.265 0 N-CA-C 109.973 -0.381 . . . . 74.31 109.973 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 28.5 pt20 -85.15 166.06 16.92 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 123.289 0.636 . . . . 72.52 110.597 174.872 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 170' ' ' THR . . . . . 0.443 HG21 HG22 ' A' ' 219' ' ' VAL . 8.2 t -67.77 155.16 39.92 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 123.605 0.762 . . . . 65.11 110.234 171.139 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -89.26 -88.51 0.16 Allowed 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 122.42 0.288 . . . . 74.24 111.52 -173.229 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 172' ' ' LEU . . . . . 0.468 HD21 ' HB1' ' A' ' 222' ' ' ALA . 62.9 mt -139.68 160.08 40.7 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.834 0.853 . . . . 74.31 110.802 -165.95 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 173' ' ' PHE . . . . . 0.517 ' CD1' HD22 ' A' ' 235' ' ' LEU . 5.4 m-85 -138.24 -56.24 0.65 Allowed 'General case' 0 N--CA 1.482 1.131 0 CA-C-O 122.023 0.916 . . . . 74.41 108.974 -165.846 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 174' ' ' TYR . . . . . 0.459 ' CD2' ' HB3' ' A' ' 233' ' ' LEU . 1.4 p90 -74.82 4.2 6.8 Favored 'General case' 0 CA--C 1.547 0.865 0 CA-C-N 113.448 -1.705 . . . . 74.33 113.316 -178.79 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 6.2 p -67.29 82.52 0.14 Allowed 'General case' 0 CA--C 1.547 0.853 0 CA-C-O 122.334 1.064 . . . . 62.31 110.705 174.751 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 176' ' ' MET . . . . . 0.449 ' HG3' ' HG2' ' A' ' 177' ' ' LYS . 23.1 ptt? -161.91 -39.61 0.04 OUTLIER 'General case' 0 CA--C 1.541 0.608 0 CA-C-N 113.639 -1.619 . . . . 64.44 108.202 -174.809 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . 0.449 ' HG2' ' HG3' ' A' ' 176' ' ' MET . 18.3 pttp -177.27 34.64 0.0 OUTLIER 'General case' 0 CA--C 1.556 1.179 0 C-N-CA 124.637 1.175 . . . . 72.22 110.052 -178.906 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 178' ' ' ALA . . . . . 0.449 ' HB2' ' HG3' ' A' ' 224' ' ' PRO . . . -59.21 150.44 25.59 Favored 'General case' 0 N--CA 1.487 1.379 0 C-N-CA 124.036 0.935 . . . . 74.01 111.705 178.315 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . 0.412 ' HB1' ' NH1' ' A' ' 231' ' ' ARG . . . 61.75 25.55 15.4 Favored 'General case' 0 N--CA 1.489 1.517 0 C-N-CA 124.169 0.988 . . . . 61.14 110.758 -167.886 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -116.31 90.94 0.53 Allowed Glycine 0 C--N 1.34 0.771 0 CA-C-N 115.43 -0.804 . . . . 73.11 111.128 -176.897 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 15.8 m -69.01 91.73 0.49 Allowed 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 123.672 0.789 . . . . 75.54 109.747 175.764 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -179.69 104.69 0.19 Allowed Glycine 0 C--N 1.345 1.081 0 N-CA-C 111.787 -0.525 . . . . 72.53 111.787 -175.742 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 145.83 166.04 11.73 Favored Glycine 0 C--N 1.346 1.1 0 N-CA-C 112.132 -0.387 . . . . 53.11 112.132 178.076 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 48.8 m -141.32 116.68 10.11 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 124.108 0.963 . . . . 64.02 109.131 -179.205 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -136.0 20.27 3.62 Favored Glycine 0 C--N 1.345 1.036 0 CA-C-O 119.993 -0.337 . . . . 72.42 113.603 -175.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -91.3 8.86 78.74 Favored Glycine 0 N--CA 1.476 1.337 0 C-N-CA 122.759 0.218 . . . . 61.4 113.48 179.668 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 50.4 m -125.35 136.36 53.38 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 124.326 1.051 . . . . 74.11 108.828 175.747 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 108.93 94.06 2.31 Favored Glycine 0 C--N 1.344 1.021 0 N-CA-C 110.701 -0.96 . . . . 75.01 110.701 -173.947 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . 0.438 ' HA3' ' HD3' ' A' ' 243' ' ' PRO . . . 68.14 -150.34 50.97 Favored Glycine 0 C--N 1.352 1.424 0 C-N-CA 123.066 0.365 . . . . 73.42 112.964 -178.657 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 24.3 t -146.68 25.09 1.19 Allowed 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 123.649 0.78 . . . . 73.52 109.041 175.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 191' ' ' GLN . . . . . 0.536 ' HB3' ' HD2' ' A' ' 243' ' ' PRO . 7.5 pt20 -65.68 -25.69 67.45 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-N 115.192 -0.913 . . . . 65.1 111.445 -176.239 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 -75.31 141.61 43.37 Favored 'General case' 0 C--O 1.242 0.691 0 C-N-CA 124.666 1.186 . . . . 73.32 109.827 -176.475 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 23.3 mt -126.62 176.41 7.23 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 123.922 0.889 . . . . 75.2 110.802 -178.009 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 15.6 m-85 -138.23 122.93 18.69 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 124.33 1.052 . . . . 74.45 110.307 179.945 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -139.64 127.5 22.07 Favored 'General case' 0 C--O 1.239 0.509 0 N-CA-C 107.605 -1.257 . . . . 64.33 107.605 170.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 58.6 m -73.66 131.31 41.51 Favored 'General case' 0 C--O 1.241 0.657 0 CA-C-N 115.981 -0.554 . . . . 73.25 109.695 179.475 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . 0.528 HD22 HD11 ' A' ' 251' ' ' LEU . 15.8 tp -106.72 108.88 20.61 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 107.884 -1.154 . . . . 73.24 107.884 -179.588 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -78.4 121.09 24.05 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 108.468 -0.938 . . . . 62.13 108.468 177.114 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 199' ' ' VAL . . . . . 0.46 ' O ' ' HA ' ' A' ' 255' ' ' ILE . 4.1 p -140.98 128.53 12.1 Favored Pre-proline 0 CA--C 1.544 0.736 0 C-N-CA 123.733 0.813 . . . . 74.1 108.968 -177.956 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -70.53 156.78 60.62 Favored 'Trans proline' 0 C--N 1.365 1.402 0 C-N-CA 121.914 1.743 . . . . 72.1 111.006 170.919 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 201' ' ' ALA . . . . . 0.467 ' O ' HG22 ' A' ' 205' ' ' VAL . . . -50.97 -51.84 63.62 Favored Pre-proline 0 CA--C 1.56 1.349 0 CA-C-O 117.719 -1.134 . . . . 73.13 112.688 -179.257 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -61.58 -38.99 58.04 Favored 'Trans proline' 0 C--N 1.394 2.935 0 C-N-CA 121.672 1.581 . . . . 73.42 113.48 -177.535 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 34.4 mt -65.52 -34.01 67.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 CA-C-N 118.082 0.401 . . . . 65.15 110.398 176.382 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -71.34 -35.12 71.08 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 122.372 0.269 . . . . 72.32 111.371 177.428 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . 0.467 HG22 ' O ' ' A' ' 201' ' ' ALA . 96.6 t -71.74 -55.78 12.43 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.153 0 C-N-CA 123.588 0.755 . . . . 74.24 110.984 -179.544 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 18.9 m -79.74 -25.53 12.21 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 C-N-CA 122.863 0.465 . . . . 71.45 111.433 -174.607 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 80.1 72.18 1.22 Allowed Glycine 0 C--N 1.342 0.905 0 N-CA-C 111.647 -0.581 . . . . 74.11 111.647 -173.116 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -93.48 -134.21 6.98 Favored Glycine 0 C--N 1.349 1.298 0 N-CA-C 111.361 -0.695 . . . . 52.35 111.361 178.033 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 46.2 mtmt -138.1 152.78 49.08 Favored 'General case' 0 N--CA 1.486 1.37 0 CA-C-N 117.725 0.763 . . . . 74.22 111.662 179.35 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 15.6 m -147.72 158.67 8.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 C-N-CA 124.881 1.272 . . . . 71.53 109.268 178.403 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 43.5 ttm180 -98.3 114.01 26.16 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 123.089 0.556 . . . . 75.11 111.092 -175.627 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -100.3 124.93 46.37 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 124.509 1.123 . . . . 71.31 110.74 178.559 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 22.2 mmt -85.37 110.74 19.33 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 123.466 0.707 . . . . 61.5 109.49 176.841 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 22.2 p -110.94 -178.63 3.52 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 123.973 0.909 . . . . 64.24 109.73 -176.803 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 82.6 mt -57.67 -36.73 72.3 Favored 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 123.375 0.67 . . . . 62.33 112.709 -179.151 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -96.02 -19.33 19.55 Favored 'General case' 0 N--CA 1.482 1.154 0 N-CA-C 112.63 0.604 . . . . 65.31 112.63 -172.468 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 152.6 -168.33 31.6 Favored Glycine 0 C--N 1.352 1.423 0 CA-C-O 119.956 -0.358 . . . . 70.42 113.009 -178.825 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -85.39 132.24 4.3 Favored 'Trans proline' 0 C--N 1.367 1.543 0 C-N-CA 123.058 2.505 . . . . 75.1 112.566 179.086 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 219' ' ' VAL . . . . . 0.443 HG22 HG21 ' A' ' 170' ' ' THR . 4.1 p -126.44 126.09 68.51 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 N-CA-C 108.563 -0.903 . . . . 72.34 108.563 171.07 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -84.15 102.58 12.68 Favored 'General case' 0 C--O 1.238 0.455 0 N-CA-C 108.212 -1.033 . . . . 74.1 108.212 173.486 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 4.1 p -97.39 139.52 19.63 Favored 'Isoleucine or valine' 0 C--O 1.25 1.093 0 CA-C-N 114.732 -1.122 . . . . 75.32 109.218 -170.723 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . 0.468 ' HB1' HD21 ' A' ' 172' ' ' LEU . . . -78.42 101.27 7.19 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 122.794 0.437 . . . . 75.45 110.684 -177.493 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 47.5 t -53.9 133.08 57.77 Favored Pre-proline 0 N--CA 1.48 1.029 0 C-N-CA 124.28 1.032 . . . . 75.15 109.746 -179.338 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 224' ' ' PRO . . . . . 0.449 ' HG3' ' HB2' ' A' ' 178' ' ' ALA . 35.2 Cg_endo -63.25 147.08 94.15 Favored 'Trans proline' 0 C--N 1.371 1.725 0 C-N-CA 121.574 1.516 . . . . 71.25 110.46 172.029 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -67.33 156.95 64.04 Favored 'Trans proline' 0 C--N 1.361 1.201 0 C-N-CA 121.747 1.631 . . . . 70.42 111.541 177.005 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 40.7 mtt180 64.39 25.61 13.43 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 124.373 1.069 . . . . 72.22 111.634 168.424 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 227' ' ' THR . . . . . 0.593 ' HA ' HH11 ' A' ' 231' ' ' ARG . 94.1 m -75.81 133.99 40.5 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 123.835 0.854 . . . . 74.1 110.628 -179.896 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -99.83 148.71 24.14 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 123.872 0.869 . . . . 75.54 109.746 176.904 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 229' ' ' ALA . . . . . 0.532 ' HB3' ' HB ' ' A' ' 255' ' ' ILE . . . -59.63 128.08 35.23 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 123.989 0.915 . . . . 74.13 111.175 178.028 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 106.1 -5.84 39.43 Favored Glycine 0 N--CA 1.47 0.914 0 O-C-N 123.737 0.648 . . . . 73.53 113.135 -179.8 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 231' ' ' ARG . . . . . 0.593 HH11 ' HA ' ' A' ' 227' ' ' THR . 89.5 mtt180 -72.57 153.99 41.01 Favored 'General case' 0 N--CA 1.479 1.005 0 CA-C-N 117.325 0.563 . . . . 75.2 110.224 173.686 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 232' ' ' LYS . . . . . 0.412 ' HA ' ' O ' ' A' ' 251' ' ' LEU . 53.8 mtmt -130.3 127.32 39.25 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-N 115.99 -0.55 . . . . 75.25 110.044 -178.538 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 233' ' ' LEU . . . . . 0.49 ' HB2' ' HB2' ' A' ' 251' ' ' LEU . 24.1 mt -104.48 150.24 24.75 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 124.852 1.261 . . . . 75.14 108.614 -175.837 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 234' ' ' ARG . . . . . 0.418 ' HG3' ' HB3' ' A' ' 248' ' ' ASP . 56.7 ttm-85 -112.1 120.87 43.3 Favored 'General case' 0 N--CA 1.484 1.254 0 CA-C-N 118.361 0.528 . . . . 72.02 111.404 -170.483 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 235' ' ' LEU . . . . . 0.517 HD22 ' CD1' ' A' ' 173' ' ' PHE . 14.2 mt -110.95 111.73 23.06 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 123.787 0.835 . . . . 74.41 111.621 -176.754 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 31.3 mttp -68.72 141.65 55.22 Favored 'General case' 0 N--CA 1.476 0.875 0 CA-C-O 120.852 0.358 . . . . 64.22 110.914 172.707 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 79.7 -0.58 81.41 Favored Glycine 0 C--N 1.347 1.188 0 CA-C-N 115.18 -0.918 . . . . 72.1 114.658 176.706 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 72.5 mmtt -109.21 1.93 20.59 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 122.788 0.435 . . . . 72.25 110.223 -175.78 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -112.33 -172.78 18.98 Favored Glycine 0 C--N 1.353 1.52 0 N-CA-C 111.289 -0.724 . . . . 74.23 111.289 166.423 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 86.3 m-85 -86.09 157.39 56.87 Favored Pre-proline 0 N--CA 1.491 1.584 0 C-N-CA 123.361 0.664 . . . . 75.14 111.576 -174.424 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -65.95 131.37 26.99 Favored 'Trans proline' 0 C--N 1.376 2.008 0 C-N-CA 121.826 1.684 . . . . 64.32 111.011 170.614 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -160.43 -125.29 0.77 Allowed Glycine 0 C--N 1.34 0.77 0 CA-C-O 118.629 -1.095 . . . . 73.31 112.28 -179.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 243' ' ' PRO . . . . . 0.536 ' HD2' ' HB3' ' A' ' 191' ' ' GLN . 21.4 Cg_endo -54.55 -50.68 12.59 Favored 'Trans proline' 0 C--N 1.377 2.077 0 C-N-CA 124.344 3.363 . . . . 75.44 112.542 -176.589 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -86.59 -11.02 52.67 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 123.254 0.622 . . . . 73.4 111.463 179.938 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 85.43 -21.45 13.39 Favored Glycine 0 C--N 1.357 1.718 0 C-N-CA 122.888 0.28 . . . . 73.45 113.146 -177.941 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 12.7 ttm180 -126.56 113.72 17.14 Favored 'General case' 0 C--O 1.234 0.268 0 C-N-CA 125.038 1.335 . . . . 74.03 107.688 174.219 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -76.79 163.11 52.34 Favored Glycine 0 C--O 1.245 0.794 0 N-CA-C 115.055 0.782 . . . . 45.52 115.055 177.575 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 248' ' ' ASP . . . . . 0.448 ' HA ' ' O ' ' A' ' 235' ' ' LEU . 55.3 m-20 -110.06 159.16 17.56 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 114.101 -1.049 . . . . 75.24 110.354 -176.714 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 249' ' ' LEU . . . . . 0.512 ' HB3' ' HB2' ' A' ' 235' ' ' LEU . 31.3 tp -126.1 126.65 44.53 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 123.457 0.703 . . . . 75.05 109.242 174.452 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 250' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 -90.25 112.19 23.63 Favored 'General case' 0 C--O 1.239 0.532 0 N-CA-C 108.552 -0.907 . . . . 64.45 108.552 -179.628 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 251' ' ' LEU . . . . . 0.528 HD11 HD22 ' A' ' 197' ' ' LEU . 81.2 mt -87.56 101.21 13.41 Favored 'General case' 0 C--O 1.239 0.513 0 N-CA-C 107.072 -1.455 . . . . 73.24 107.072 176.069 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -85.79 91.98 8.48 Favored 'General case' 0 C--O 1.242 0.683 0 N-CA-C 108.013 -1.106 . . . . 75.03 108.013 -176.199 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 4.1 m -61.51 135.76 25.8 Favored 'Isoleucine or valine' 0 C--O 1.243 0.724 0 CA-C-N 115.02 -0.991 . . . . 63.32 109.9 -174.605 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 14.8 mmm180 -131.85 111.22 11.41 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 107.21 -1.404 . . . . 72.23 107.21 178.599 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 255' ' ' ILE . . . . . 0.532 ' HB ' ' HB3' ' A' ' 229' ' ' ALA . 41.8 mt -86.64 116.08 28.69 Favored 'Isoleucine or valine' 0 C--O 1.239 0.531 0 C-N-CA 123.865 0.866 . . . . 73.03 110.086 -176.993 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 2.0 t . . . . . 0 CA--C 1.556 1.201 0 C-N-CA 124.497 1.119 . . . . 73.41 109.577 176.992 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 25.5 ptt? . . . . . 0 N--CA 1.483 1.188 0 CA-C-O 120.392 0.139 . . . . 73.21 111.034 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 4.5 pt20 -103.51 -53.95 2.69 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 123.219 0.608 . . . . 75.11 111.008 -175.445 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 11.0 t -179.77 178.22 0.65 Allowed 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 124.721 1.208 . . . . 70.13 109.408 -177.45 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -132.11 -85.53 0.48 Allowed 'General case' 0 CA--C 1.544 0.734 0 N-CA-C 108.928 -0.768 . . . . 64.04 108.928 173.507 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 31.9 mt -133.25 158.45 42.88 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 123.282 0.633 . . . . 75.1 111.697 -175.664 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 3.9 m-85 -130.06 -56.09 1.11 Allowed 'General case' 0 N--CA 1.475 0.807 0 CA-C-N 114.85 -1.068 . . . . 73.1 109.105 -171.447 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 174' ' ' TYR . . . . . 0.448 ' CD2' ' HB3' ' A' ' 233' ' ' LEU . 0.6 OUTLIER -80.93 3.32 23.24 Favored 'General case' 0 N--CA 1.476 0.83 0 N-CA-C 114.24 1.2 . . . . 75.55 114.24 -167.711 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 24.0 p -53.49 -23.1 9.32 Favored 'General case' 0 N--CA 1.489 1.522 0 C-N-CA 123.955 0.902 . . . . 61.12 113.158 -176.021 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 176' ' ' MET . . . . . . . . . . . . . 13.9 ptm -56.29 85.03 0.01 OUTLIER 'General case' 0 CA--C 1.56 1.351 0 C-N-CA 124.272 1.029 . . . . 72.41 111.119 165.67 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 66.1 mttm 55.73 47.29 20.76 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 125.15 1.38 . . . . 75.53 111.862 178.003 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -63.89 -32.4 73.91 Favored 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 124.891 1.276 . . . . 44.12 111.856 178.108 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -88.52 24.44 1.96 Allowed 'General case' 0 CA--C 1.55 0.966 0 C-N-CA 123.758 0.823 . . . . 64.52 110.816 175.705 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -120.14 -119.88 2.77 Favored Glycine 0 C--N 1.346 1.117 0 N-CA-C 109.455 -1.458 . . . . 73.53 109.455 166.162 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 22.9 t -165.63 112.59 0.93 Allowed 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 109.26 -0.644 . . . . 72.44 109.26 175.247 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -87.64 16.74 48.58 Favored Glycine 0 C--N 1.352 1.451 0 CA-C-O 119.971 -0.35 . . . . 75.33 112.981 175.308 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -68.29 -39.54 87.82 Favored Glycine 0 C--N 1.358 1.792 0 C-N-CA 123.369 0.509 . . . . 74.1 113.349 -178.321 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 17.3 p -73.7 80.14 1.54 Allowed 'General case' 0 C--O 1.24 0.576 0 CA-C-O 121.698 0.761 . . . . 72.34 109.241 175.619 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -143.92 125.85 2.59 Favored Glycine 0 C--N 1.337 0.634 0 CA-C-N 114.583 -1.19 . . . . 63.33 111.434 -173.684 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -158.51 153.72 24.85 Favored Glycine 0 C--N 1.341 0.81 0 N-CA-C 111.171 -0.772 . . . . 64.23 111.171 177.293 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 49.5 m -148.41 -57.54 0.23 Allowed 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 123.598 0.759 . . . . 74.52 110.371 -178.54 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 158.46 59.12 0.01 OUTLIER Glycine 0 C--N 1.352 1.455 0 CA-C-N 116.541 -0.299 . . . . 62.1 112.388 -178.771 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . 0.411 ' HA3' ' HD3' ' A' ' 243' ' ' PRO . . . 156.41 145.85 4.31 Favored Glycine 0 C--N 1.35 1.306 0 N-CA-C 111.901 -0.479 . . . . 73.13 111.901 179.113 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 8.8 t -90.41 63.48 5.63 Favored 'General case' 0 N--CA 1.476 0.854 0 CA-C-O 121.611 0.72 . . . . 73.34 109.969 -179.162 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 191' ' ' GLN . . . . . 0.692 ' HB3' ' HD2' ' A' ' 243' ' ' PRO . 9.6 pt20 -73.93 -30.37 62.53 Favored 'General case' 0 N--CA 1.482 1.153 0 CA-C-N 115.294 -0.866 . . . . 73.15 109.984 175.195 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -79.15 145.95 33.42 Favored 'General case' 0 C--O 1.241 0.618 0 CA-C-N 114.51 -1.223 . . . . 73.42 109.761 -171.435 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 33.5 mt -111.01 173.27 6.41 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 123.925 0.89 . . . . 75.5 110.331 -179.102 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 65.3 m-85 -134.0 121.37 21.51 Favored 'General case' 0 C--O 1.237 0.439 0 C-N-CA 123.596 0.758 . . . . 73.12 110.054 -179.442 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . 0.453 ' O ' ' HA ' ' A' ' 251' ' ' LEU . . . -140.61 146.76 38.4 Favored 'General case' 0 C--O 1.234 0.287 0 N-CA-C 107.538 -1.282 . . . . 63.5 107.538 173.759 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 61.3 m -96.77 140.02 31.96 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 109.918 -0.401 . . . . 74.2 109.918 178.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . 0.61 HD23 HD12 ' A' ' 251' ' ' LEU . 16.5 tp -117.45 108.65 15.79 Favored 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 107.749 -1.204 . . . . 75.3 107.749 177.005 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -82.78 132.01 35.18 Favored 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 109.481 -0.563 . . . . 73.33 109.481 177.513 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 199' ' ' VAL . . . . . 0.539 ' O ' ' HA ' ' A' ' 255' ' ' ILE . 7.5 p -144.07 131.59 10.62 Favored Pre-proline 0 CA--C 1.548 0.894 0 N-CA-C 107.461 -1.311 . . . . 75.33 107.461 179.988 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -72.45 161.17 44.97 Favored 'Trans proline' 0 C--N 1.358 1.03 0 C-N-CA 121.829 1.686 . . . . 75.14 111.346 169.172 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -50.13 -50.12 71.59 Favored Pre-proline 0 CA--C 1.564 1.483 0 N-CA-C 114.021 1.119 . . . . 65.14 114.021 -178.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -64.26 -41.38 21.65 Favored 'Trans proline' 0 C--N 1.396 3.043 0 C-N-CA 121.736 1.624 . . . . 74.32 113.576 -178.779 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 53.2 mt -67.08 -28.25 42.13 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.295 0 CA-C-N 117.898 0.317 . . . . 63.34 110.21 177.296 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -72.83 -50.37 24.5 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 123.209 0.604 . . . . 70.44 111.783 178.534 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 17.1 m -68.62 -43.02 83.67 Favored 'Isoleucine or valine' 0 C--N 1.353 0.729 0 C-N-CA 123.864 0.866 . . . . 73.14 112.574 -173.642 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 14.2 m -80.01 -36.38 16.82 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.226 0 CA-C-O 120.805 0.336 . . . . 74.34 110.746 175.239 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 83.77 80.05 1.04 Allowed Glycine 0 CA--C 1.528 0.885 0 N-CA-C 111.805 -0.518 . . . . 74.13 111.805 -173.064 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -90.78 -128.81 4.04 Favored Glycine 0 C--N 1.354 1.54 0 N-CA-C 111.447 -0.661 . . . . 64.33 111.447 175.789 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 45.3 mtmt -137.87 147.69 44.69 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 123.598 0.759 . . . . 75.5 110.806 174.599 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 3.6 m -139.94 165.18 22.22 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 C-N-CA 125.277 1.431 . . . . 74.11 109.212 175.033 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 45.0 ttp180 -100.97 122.76 44.08 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 123.179 0.591 . . . . 73.5 110.431 -177.807 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -114.68 112.31 22.67 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 124.05 0.94 . . . . 73.31 109.654 177.607 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 213' ' ' MET . . . . . 0.435 ' HA ' ' HA ' ' A' ' 218' ' ' PRO . 55.7 ttm -82.96 123.45 29.44 Favored 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 109.6 -0.518 . . . . 74.35 109.6 176.547 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 23.1 p -115.6 -171.22 1.93 Allowed 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 125.23 1.412 . . . . 74.31 109.568 -174.658 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 94.8 mt -60.75 -32.17 71.47 Favored 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 123.17 0.588 . . . . 71.54 111.016 170.459 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -99.27 19.28 15.71 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 124.107 0.963 . . . . 73.22 111.316 -175.691 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 93.79 -172.51 32.67 Favored Glycine 0 C--N 1.352 1.472 0 CA-C-O 119.683 -0.509 . . . . 75.25 113.175 177.864 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 218' ' ' PRO . . . . . 0.435 ' HA ' ' HA ' ' A' ' 213' ' ' MET . 73.2 Cg_endo -71.59 143.53 42.55 Favored 'Trans proline' 0 C--N 1.363 1.29 0 C-N-CA 122.622 2.214 . . . . 75.13 112.286 179.287 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 5.1 p -131.19 127.87 61.11 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 N-CA-C 108.605 -0.887 . . . . 73.42 108.605 172.943 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -78.28 100.76 6.83 Favored 'General case' 0 C--O 1.242 0.667 0 N-CA-C 106.66 -1.608 . . . . 73.42 106.66 174.79 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 6.2 p -108.35 129.65 62.32 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.844 0 CA-C-N 115.706 -0.679 . . . . 75.13 109.744 -168.745 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -79.66 110.49 15.05 Favored 'General case' 0 C--O 1.239 0.506 0 C-N-CA 123.714 0.805 . . . . 64.11 111.019 -174.903 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 52.7 t -55.12 136.47 67.68 Favored Pre-proline 0 CA--C 1.556 1.211 0 C-N-CA 125.006 1.322 . . . . 74.2 110.247 177.857 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -69.18 159.24 54.61 Favored 'Trans proline' 0 C--N 1.377 2.061 0 C-N-CA 122.293 1.995 . . . . 75.41 111.784 174.021 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -64.29 142.87 81.38 Favored 'Trans proline' 0 C--N 1.37 1.707 0 C-N-CA 121.75 1.633 . . . . 72.25 111.077 169.799 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 43.0 mtm180 62.78 48.21 4.24 Favored 'General case' 0 C--O 1.241 0.645 0 C-N-CA 124.417 1.087 . . . . 72.13 111.443 171.593 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 227' ' ' THR . . . . . 0.45 ' HA ' ' HE ' ' A' ' 231' ' ' ARG . 28.9 m -81.06 121.66 26.35 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 114.945 -1.025 . . . . 61.34 109.507 175.556 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 2.7 mp0 -106.41 148.4 28.15 Favored 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 123.992 0.917 . . . . 64.33 108.909 177.045 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -57.36 125.44 22.84 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 123.474 0.71 . . . . 64.35 111.88 -176.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 104.41 -2.55 43.07 Favored Glycine 0 C--N 1.34 0.786 0 CA-C-N 115.25 -0.886 . . . . 70.13 112.871 -179.619 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 231' ' ' ARG . . . . . 0.45 ' HE ' ' HA ' ' A' ' 227' ' ' THR . 56.4 mtt-85 -59.07 133.61 56.25 Favored 'General case' 0 C--N 1.371 1.505 0 CA-C-N 117.801 0.8 . . . . 73.32 109.695 173.22 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 69.5 mmtt -105.73 97.44 7.26 Favored 'General case' 0 C--O 1.239 0.536 0 CA-C-N 115.072 -0.967 . . . . 74.44 108.476 -172.858 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 233' ' ' LEU . . . . . 0.684 ' HB2' ' HB2' ' A' ' 251' ' ' LEU . 57.5 mt -81.73 142.29 32.79 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 114.713 -1.13 . . . . 75.35 109.046 179.229 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 22.0 ttt180 -122.84 101.28 7.35 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 122.492 0.317 . . . . 75.24 110.547 -171.475 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 235' ' ' LEU . . . . . 0.518 ' HB2' ' HB3' ' A' ' 249' ' ' LEU . 33.3 mt -86.74 105.62 17.1 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 123.57 0.748 . . . . 74.13 110.07 179.132 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 20.8 mttt -67.6 138.43 56.42 Favored 'General case' 0 CA--C 1.541 0.613 0 O-C-N 123.344 0.402 . . . . 75.41 110.921 175.41 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 73.11 16.62 78.51 Favored Glycine 0 C--N 1.348 1.207 0 O-C-N 123.895 0.747 . . . . 74.42 114.577 178.054 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 72.4 mmtt -115.58 7.4 14.83 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 123.211 0.605 . . . . 75.45 111.023 178.639 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -117.81 -167.83 14.31 Favored Glycine 0 C--N 1.348 1.216 0 N-CA-C 111.149 -0.781 . . . . 72.24 111.149 168.727 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 76.0 m-85 -91.34 157.89 41.8 Favored Pre-proline 0 N--CA 1.48 1.031 0 C-N-CA 123.781 0.833 . . . . 72.53 110.797 -175.567 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -64.03 145.38 89.64 Favored 'Trans proline' 0 C--N 1.366 1.487 0 C-N-CA 121.928 1.752 . . . . 74.52 112.833 170.167 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -176.4 -123.78 0.79 Allowed Glycine 0 CA--C 1.536 1.373 0 CA-C-O 118.964 -0.909 . . . . 61.45 112.221 178.161 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 243' ' ' PRO . . . . . 0.692 ' HD2' ' HB3' ' A' ' 191' ' ' GLN . 33.0 Cg_endo -57.75 -46.86 23.9 Favored 'Trans proline' 0 C--N 1.382 2.339 0 C-N-CA 124.889 3.726 . . . . 73.23 113.792 -173.499 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -90.72 -6.09 54.89 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 123.512 0.725 . . . . 72.23 111.153 179.778 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 87.17 -43.73 3.24 Favored Glycine 0 C--N 1.357 1.74 0 N-CA-C 111.966 -0.453 . . . . 74.15 111.966 -176.099 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 26.7 ttm180 -106.37 112.38 25.36 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 125.212 1.405 . . . . 72.12 109.163 175.167 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -74.83 154.27 46.65 Favored Glycine 0 C--N 1.358 1.804 0 N-CA-C 114.388 0.515 . . . . 75.11 114.388 171.282 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -107.43 171.13 7.55 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 124.854 1.262 . . . . 74.14 110.623 -178.52 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 249' ' ' LEU . . . . . 0.518 ' HB3' ' HB2' ' A' ' 235' ' ' LEU . 27.1 tp -128.78 116.76 19.99 Favored 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 108.17 -1.048 . . . . 75.41 108.17 171.009 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 250' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -88.78 108.08 19.31 Favored 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 108.845 -0.798 . . . . 73.42 108.845 -178.31 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 251' ' ' LEU . . . . . 0.684 ' HB2' ' HB2' ' A' ' 233' ' ' LEU . 87.3 mt -90.36 104.83 17.37 Favored 'General case' 0 C--O 1.238 0.453 0 N-CA-C 107.784 -1.191 . . . . 74.21 107.784 174.726 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -82.79 113.06 20.17 Favored 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 108.059 -1.089 . . . . 75.12 108.059 173.685 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 253' ' ' VAL . . . . . 0.44 ' HA ' ' O ' ' A' ' 197' ' ' LEU . 14.0 m -71.67 137.2 24.16 Favored 'Isoleucine or valine' 0 C--O 1.239 0.503 0 N-CA-C 109.677 -0.49 . . . . 74.3 109.677 179.685 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 8.5 mmm180 -123.38 108.54 12.83 Favored 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 108.092 -1.077 . . . . 74.43 108.092 175.902 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 255' ' ' ILE . . . . . 0.539 ' HA ' ' O ' ' A' ' 199' ' ' VAL . 27.3 mt -77.22 127.15 38.2 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 O-C-N 123.566 0.541 . . . . 62.43 109.864 177.792 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 10.7 t . . . . . 0 C--O 1.26 1.608 0 C-N-CA 123.974 0.91 . . . . 75.0 110.073 176.308 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 172' ' ' LEU . . . . . 0.592 HD21 ' H ' ' A' ' 222' ' ' ALA . 25.9 mt . . . . . 0 N--CA 1.479 1.021 0 CA-C-O 120.976 0.417 . . . . 73.230000000000004 110.256 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 173' ' ' PHE . . . . . 0.454 ' CD1' HD22 ' A' ' 235' ' ' LEU . 31.4 m-85 -126.21 -59.14 1.33 Allowed 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 124.135 0.974 . . . . 70.400000000000006 109.828 -170.017 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 174' ' ' TYR . . . . . 0.532 ' CD2' ' HB3' ' A' ' 233' ' ' LEU . 1.7 p90 -82.41 15.51 2.46 Favored 'General case' 0 CA--C 1.548 0.868 0 CA-C-N 114.381 -1.281 . . . . 71.010000000000005 112.898 -171.533 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 4.6 p -62.66 -19.87 64.25 Favored 'General case' 0 CA--C 1.555 1.141 0 C-N-CA 122.805 0.442 . . . . 63.229999999999997 111.354 173.77 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 176' ' ' MET . . . . . . . . . . . . . 22.9 ptt? -65.86 -52.89 46.48 Favored 'General case' 0 CA--C 1.558 1.276 0 C-N-CA 124.214 1.006 . . . . 72.530000000000001 111.361 168.879 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -155.28 119.61 4.67 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 125.016 1.326 . . . . 62.009999999999998 108.223 -173.568 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 178' ' ' ALA . . . . . 0.502 ' HB1' ' HG3' ' A' ' 224' ' ' PRO . . . -154.68 -68.07 0.13 Allowed 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 123.926 0.89 . . . . 74.349999999999994 109.093 -174.524 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -83.37 82.22 8.37 Favored 'General case' 0 C--O 1.24 0.566 0 N-CA-C 107.723 -1.214 . . . . 73.319999999999993 107.723 168.782 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.342 0.892 0 CA-C-N 115.369 -0.832 . . . . 52.229999999999997 111.909 -175.219 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 191' ' ' GLN . . . . . 0.709 ' HB3' ' HD2' ' A' ' 243' ' ' PRO . 8.1 pt20 . . . . . 0 N--CA 1.471 0.609 0 CA-C-O 120.985 0.421 . . . . 74.099999999999994 110.589 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 66.6 m-20 -76.88 162.51 27.56 Favored 'General case' 0 C--O 1.24 0.562 0 CA-C-N 115.111 -0.95 . . . . 72.099999999999994 110.815 -172.996 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 28.8 mt -135.97 176.91 8.26 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 124.509 1.123 . . . . 70.420000000000002 110.014 -175.302 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 60.8 m-85 -134.0 136.9 44.41 Favored 'General case' 0 C--O 1.239 0.527 0 C-N-CA 123.871 0.868 . . . . 71.299999999999997 110.136 177.966 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 195' ' ' ALA . . . . . 0.492 ' HB2' HD11 ' A' ' 249' ' ' LEU . . . -140.04 171.08 14.69 Favored 'General case' 0 C--O 1.236 0.371 0 C-N-CA 124.632 1.173 . . . . 75.209999999999994 108.561 176.069 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 26.1 m -119.02 123.44 44.53 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 108.652 -0.87 . . . . 63.009999999999998 108.652 177.883 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 197' ' ' LEU . . . . . 0.698 HD22 HD13 ' A' ' 251' ' ' LEU . 16.3 tp -107.47 111.08 23.21 Favored 'General case' 0 N--CA 1.467 0.382 0 N-CA-C 108.583 -0.895 . . . . 73.209999999999994 108.583 -179.56 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -84.0 121.48 27.45 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 123.414 0.686 . . . . 73.430000000000007 109.256 179.735 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 199' ' ' VAL . . . . . 0.44 ' O ' ' HA ' ' A' ' 255' ' ' ILE . 4.8 p -142.99 129.85 10.71 Favored Pre-proline 0 CA--C 1.548 0.903 0 C-N-CA 123.707 0.803 . . . . 53.43 109.414 -176.737 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_endo -72.37 162.0 42.76 Favored 'Trans proline' 0 C--N 1.369 1.613 0 C-N-CA 121.801 1.667 . . . . 60.32 111.189 172.341 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 201' ' ' ALA . . . . . 0.477 ' O ' HG23 ' A' ' 205' ' ' VAL . . . -50.6 -55.27 27.69 Favored Pre-proline 0 CA--C 1.562 1.439 0 CA-C-O 117.828 -1.082 . . . . 74.150000000000006 113.109 -177.839 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -68.1 -32.4 27.8 Favored 'Trans proline' 0 C--N 1.396 3.03 0 CA-C-N 121.433 1.548 . . . . 70.109999999999999 113.678 -174.157 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 36.1 mt -67.69 -32.02 54.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 N-CA-C 109.744 -0.465 . . . . 75.439999999999998 109.744 175.219 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -72.28 -40.33 67.68 Favored 'General case' 0 CA--C 1.551 1.011 0 C-N-CA 122.679 0.392 . . . . 73.519999999999996 111.347 176.425 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 205' ' ' VAL . . . . . 0.477 HG23 ' O ' ' A' ' 201' ' ' ALA . 84.7 t -66.66 -53.35 36.04 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.29 0 C-N-CA 123.647 0.779 . . . . 73.409999999999997 111.507 -177.825 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 16.5 m -80.04 -33.39 14.44 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 CA-C-N 116.227 -0.442 . . . . 72.140000000000001 110.986 -177.533 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 85.81 73.93 1.27 Allowed Glycine 0 C--N 1.342 0.901 0 CA-C-N 115.9 -0.591 . . . . 75.109999999999999 111.761 -172.44 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -91.14 -126.86 3.6 Favored Glycine 0 C--N 1.353 1.505 0 CA-C-O 119.43 -0.65 . . . . 45.109999999999999 111.876 177.324 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 209' ' ' LYS . . . . . 0.417 ' HG2' ' HA ' ' A' ' 222' ' ' ALA . 49.3 mtmt -137.81 155.28 49.18 Favored 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 123.604 0.762 . . . . 74.519999999999996 111.609 176.247 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 6.9 m -148.62 170.34 2.65 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.056 0 C-N-CA 125.88 1.672 . . . . 74.400000000000006 108.601 175.738 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 42.0 ttp180 -99.4 119.17 37.54 Favored 'General case' 0 CA--C 1.549 0.904 0 C-N-CA 122.822 0.449 . . . . 74.319999999999993 109.99 177.491 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -100.97 127.4 47.47 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 123.7 0.8 . . . . 52.119999999999997 109.63 175.828 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 88.0 mmm -96.06 122.5 38.96 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 123.336 0.654 . . . . 72.540000000000006 109.85 -177.261 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 21.8 p -129.21 -176.01 3.74 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 124.015 0.926 . . . . 75.329999999999998 110.886 -168.188 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 86.5 mt -65.22 -24.15 67.27 Favored 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 123.178 0.591 . . . . 73.25 112.062 175.67 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -98.99 6.68 46.57 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.454 0.702 . . . . 70.049999999999997 111.093 179.171 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 98.98 -151.44 19.49 Favored Glycine 0 C--N 1.352 1.455 0 CA-C-O 119.317 -0.713 . . . . 45.140000000000001 112.3 -179.667 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -79.85 149.65 20.6 Favored 'Trans proline' 0 C--N 1.365 1.422 0 C-N-CA 122.536 2.157 . . . . 75.299999999999997 113.672 -176.864 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 5.4 p -143.17 130.83 18.72 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 C-N-CA 123.613 0.765 . . . . 72.340000000000003 109.143 175.12 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -75.89 101.89 5.33 Favored 'General case' 0 N--CA 1.476 0.872 0 N-CA-C 108.539 -0.912 . . . . 73.5 108.539 175.149 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 1.4 p -107.06 123.08 61.97 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.047 0 N-CA-C 108.755 -0.832 . . . . 71.409999999999997 108.755 -173.108 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 222' ' ' ALA . . . . . 0.592 ' H ' HD21 ' A' ' 172' ' ' LEU . . . -77.36 109.96 11.7 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 123.194 0.598 . . . . 61.009999999999998 111.075 -178.376 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 63.1 t -54.97 139.47 63.25 Favored Pre-proline 0 N--CA 1.48 1.061 0 C-N-CA 125.43 1.492 . . . . 70.409999999999997 110.445 179.705 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 224' ' ' PRO . . . . . 0.502 ' HG3' ' HB1' ' A' ' 178' ' ' ALA . 72.0 Cg_endo -72.05 159.34 50.35 Favored 'Trans proline' 0 C--N 1.374 1.905 0 C-N-CA 121.939 1.759 . . . . 74.310000000000002 111.566 173.3 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -69.83 147.37 62.28 Favored 'Trans proline' 0 C--N 1.369 1.61 0 C-N-CA 121.507 1.471 . . . . 71.219999999999999 111.194 172.851 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 65.6 mtm180 63.55 47.08 3.93 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 124.578 1.151 . . . . 73.200000000000003 110.868 174.39 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 227' ' ' THR . . . . . 0.47 ' HA ' ' HE ' ' A' ' 231' ' ' ARG . 53.4 m -87.12 125.62 34.26 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 114.84 -1.073 . . . . 54.329999999999998 108.895 174.108 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -115.01 151.86 33.45 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 108.286 -1.005 . . . . 72.439999999999998 108.286 176.037 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -55.73 118.24 4.37 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 124.158 0.983 . . . . 71.129999999999995 111.075 -176.063 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 115.84 -5.06 20.65 Favored Glycine 0 C--N 1.342 0.868 0 CA-C-O 118.773 -1.015 . . . . 64.319999999999993 114.744 -177.399 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 231' ' ' ARG . . . . . 0.47 ' HE ' ' HA ' ' A' ' 227' ' ' THR . 65.2 mtt-85 -62.7 144.23 56.57 Favored 'General case' 0 N--CA 1.484 1.251 0 CA-C-N 118.28 1.04 . . . . 72.120000000000005 110.879 172.844 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 232' ' ' LYS . . . . . 0.427 ' HA ' ' HE3' ' A' ' 232' ' ' LYS . 0.0 OUTLIER -109.08 99.32 8.65 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 114.995 -1.002 . . . . 50.130000000000003 108.804 177.435 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 233' ' ' LEU . . . . . 0.641 ' HB2' ' HB2' ' A' ' 251' ' ' LEU . 39.2 mt -82.78 152.5 25.67 Favored 'General case' 0 CA--C 1.544 0.712 0 N-CA-C 108.589 -0.893 . . . . 62.119999999999997 108.589 175.344 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 22.3 ttt85 -125.61 111.25 14.77 Favored 'General case' 0 N--CA 1.481 1.103 0 CA-C-N 118.117 0.417 . . . . 72.430000000000007 111.043 -171.147 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 235' ' ' LEU . . . . . 0.479 ' HB2' ' HB3' ' A' ' 249' ' ' LEU . 16.2 mt -99.6 111.03 23.43 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 123.402 0.681 . . . . 75.510000000000005 110.683 179.213 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 16.2 mtmt -70.73 139.57 51.15 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 122.938 0.495 . . . . 72.420000000000002 111.695 -179.904 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 77.94 -2.69 63.77 Favored Glycine 0 N--CA 1.477 1.414 0 CA-C-N 115.508 -0.769 . . . . 42.450000000000003 114.292 177.97 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 70.9 mmtt -99.17 3.15 46.38 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 123.394 0.678 . . . . 64.329999999999998 110.717 -177.272 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -108.49 -176.24 21.86 Favored Glycine 0 C--N 1.347 1.183 0 N-CA-C 110.028 -1.229 . . . . 74.340000000000003 110.028 161.71 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 90.6 m-85 -85.46 147.09 45.96 Favored Pre-proline 0 N--CA 1.483 1.204 0 C-N-CA 123.261 0.625 . . . . 61.109999999999999 110.714 -178.095 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -59.78 132.9 47.81 Favored 'Trans proline' 0 C--N 1.37 1.704 0 C-N-CA 122.177 1.918 . . . . 61.409999999999997 112.282 171.572 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -159.27 -124.79 0.77 Allowed Glycine 0 CA--C 1.538 1.528 0 CA-C-O 118.692 -1.06 . . . . 63.130000000000003 112.729 -179.602 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 243' ' ' PRO . . . . . 0.709 ' HD2' ' HB3' ' A' ' 191' ' ' GLN . 35.9 Cg_endo -57.34 -44.13 45.76 Favored 'Trans proline' 0 C--N 1.381 2.286 0 C-N-CA 124.415 3.41 . . . . 64.430000000000007 113.638 -174.319 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -85.81 -14.45 45.06 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 123.389 0.676 . . . . 75.409999999999997 110.745 176.724 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 92.34 -23.34 27.94 Favored Glycine 0 C--N 1.348 1.224 0 CA-C-N 116.126 -0.488 . . . . 75.239999999999995 112.498 -176.104 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 11.4 ttm180 -128.86 111.75 13.41 Favored 'General case' 0 C--O 1.238 0.493 0 C-N-CA 124.575 1.15 . . . . 72.340000000000003 109.18 176.849 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -73.53 155.55 50.11 Favored Glycine 0 C--N 1.351 1.399 0 C-N-CA 121.693 -0.289 . . . . 60.530000000000001 112.769 170.632 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -125.43 145.62 49.99 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 123.376 0.67 . . . . 70.219999999999999 109.871 -173.837 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 249' ' ' LEU . . . . . 0.492 HD11 ' HB2' ' A' ' 195' ' ' ALA . 32.7 tp -100.32 119.25 38.13 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 123.3 0.64 . . . . 73.120000000000005 109.62 -178.563 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 250' ' ' TYR . . . . . . . . . . . . . 2.4 m-30 -89.65 110.09 21.0 Favored 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 108.753 -0.832 . . . . 72.209999999999994 108.753 -178.278 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 251' ' ' LEU . . . . . 0.698 HD13 HD22 ' A' ' 197' ' ' LEU . 85.3 mt -87.6 118.03 26.81 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 123.921 0.889 . . . . 71.400000000000006 109.294 -177.275 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 252' ' ' GLU . . . . . 0.45 ' HG3' ' HD3' ' A' ' 254' ' ' ARG . 10.1 tp10 -83.78 98.62 9.8 Favored 'General case' 0 C--O 1.239 0.506 0 N-CA-C 108.585 -0.895 . . . . 74.25 108.585 175.918 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 6.1 m -71.71 129.64 35.3 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 CA-C-O 121.498 0.666 . . . . 73.340000000000003 110.03 -176.526 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 254' ' ' ARG . . . . . 0.45 ' HD3' ' HG3' ' A' ' 252' ' ' GLU . 15.2 mmm180 -122.43 99.36 6.37 Favored 'General case' 0 C--O 1.238 0.483 0 CA-C-N 115.131 -0.94 . . . . 74.219999999999999 108.993 -173.803 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 255' ' ' ILE . . . . . 0.44 ' HA ' ' O ' ' A' ' 199' ' ' VAL . 15.7 mt -76.61 120.07 26.1 Favored 'Isoleucine or valine' 0 C--O 1.24 0.595 0 CA-C-O 121.443 0.64 . . . . 73.230000000000004 110.231 179.789 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 8.9 t . . . . . 0 CA--C 1.566 1.592 0 C-N-CA 125.198 1.399 . . . . 55.210000000000001 108.06 -178.267 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 172' ' ' LEU . . . . . 0.633 HD21 ' H ' ' A' ' 222' ' ' ALA . 25.8 mt . . . . . 0 N--CA 1.482 1.128 0 CA-C-O 120.998 0.428 . . . . 72.200000000000003 110.345 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 173' ' ' PHE . . . . . 0.486 ' CE2' ' HE3' ' A' ' 238' ' ' LYS . 4.1 m-85 -134.74 -60.85 0.77 Allowed 'General case' 0 N--CA 1.481 1.091 0 CA-C-N 115.367 -0.833 . . . . 64.510000000000005 109.955 -155.767 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 174' ' ' TYR . . . . . 0.476 ' CD2' ' HB3' ' A' ' 233' ' ' LEU . 4.9 p90 -85.68 11.99 9.77 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 114.508 -1.223 . . . . 72.239999999999995 112.18 -175.852 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 175' ' ' THR . . . . . 0.492 ' OG1' ' HB3' ' A' ' 172' ' ' LEU . 0.2 OUTLIER -68.96 -17.5 63.95 Favored 'General case' 0 CA--C 1.551 1.0 0 C-N-CA 123.556 0.742 . . . . 73.319999999999993 112.324 -166.238 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 176' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -73.59 -28.53 61.88 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 123.631 0.773 . . . . 63.340000000000003 111.088 176.038 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 177' ' ' LYS . . . . . 0.446 ' HG2' ' HA3' ' A' ' 180' ' ' GLY . 23.2 ttpp -151.87 62.46 0.85 Allowed 'General case' 0 CA--C 1.551 0.988 0 CA-C-O 122.276 1.036 . . . . 70.340000000000003 108.942 -177.21 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 178' ' ' ALA . . . . . 0.468 ' HB1' ' HB3' ' A' ' 224' ' ' PRO . . . -81.01 126.3 31.23 Favored 'General case' 0 N--CA 1.476 0.864 0 CA-C-N 114.457 -1.247 . . . . 64.319999999999993 110.794 -175.763 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 179' ' ' ALA . . . . . 0.526 ' HB1' HH11 ' A' ' 231' ' ' ARG . . . 66.57 9.92 6.97 Favored 'General case' 0 N--CA 1.497 1.924 0 C-N-CA 124.955 1.302 . . . . 54.030000000000001 111.501 -170.031 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 180' ' ' GLY . . . . . 0.446 ' HA3' ' HG2' ' A' ' 177' ' ' LYS . . . . . . . . 0 N--CA 1.468 0.786 0 CA-C-N 116.267 -0.424 . . . . 71.409999999999997 112.268 -173.411 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 191' ' ' GLN . . . . . 0.625 ' HB3' ' HD2' ' A' ' 243' ' ' PRO . 9.5 pt20 . . . . . 0 N--CA 1.477 0.905 0 CA-C-O 121.438 0.637 . . . . 50.140000000000001 109.915 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 65.7 m-20 -78.32 152.99 32.11 Favored 'General case' 0 C--O 1.239 0.521 0 CA-C-N 114.65 -1.159 . . . . 63.109999999999999 110.955 -173.598 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 193' ' ' LEU . . . . . 0.536 HD12 ' HA2' ' A' ' 239' ' ' GLY . 59.3 mt -128.68 175.76 8.33 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 114.547 -1.206 . . . . 54.329999999999998 110.297 -174.374 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 17.5 m-85 -139.67 122.73 16.78 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 123.915 0.886 . . . . 73.540000000000006 110.046 -177.96 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 195' ' ' ALA . . . . . 0.431 ' HB2' HD11 ' A' ' 249' ' ' LEU . . . -129.4 128.2 42.52 Favored 'General case' 0 C--N 1.341 0.209 0 N-CA-C 108.318 -0.993 . . . . 71.430000000000007 108.318 173.331 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 61.7 m -77.72 123.89 27.26 Favored 'General case' 0 CA--C 1.546 0.799 0 N-CA-C 109.344 -0.613 . . . . 74.209999999999994 109.344 176.888 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 197' ' ' LEU . . . . . 0.718 HD22 HD13 ' A' ' 251' ' ' LEU . 18.9 tp -107.69 110.87 22.83 Favored 'General case' 0 N--CA 1.474 0.775 0 N-CA-C 108.562 -0.903 . . . . 73.140000000000001 108.562 -178.532 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -78.43 132.52 37.34 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 109.321 -0.622 . . . . 71.420000000000002 109.321 173.286 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 199' ' ' VAL . . . . . 0.486 ' O ' ' HA ' ' A' ' 255' ' ' ILE . 4.1 p -144.18 127.3 8.72 Favored Pre-proline 0 CA--C 1.546 0.804 0 N-CA-C 108.453 -0.943 . . . . 74.129999999999995 108.453 177.745 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -69.59 156.09 64.72 Favored 'Trans proline' 0 C--N 1.367 1.517 0 C-N-CA 121.962 1.775 . . . . 72.150000000000006 111.48 170.774 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 201' ' ' ALA . . . . . 0.454 ' O ' HG23 ' A' ' 205' ' ' VAL . . . -51.05 -51.96 62.88 Favored Pre-proline 0 CA--C 1.555 1.166 0 N-CA-C 113.996 1.11 . . . . 55.119999999999997 113.996 -177.354 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -65.39 -32.63 49.79 Favored 'Trans proline' 0 C--N 1.382 2.309 0 CA-C-N 121.181 1.458 . . . . 52.210000000000001 113.253 -176.072 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 27.3 mt -68.48 -34.86 67.88 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.229 0 C-N-CA 122.664 0.386 . . . . 75.340000000000003 110.152 174.307 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -71.54 -33.12 68.88 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 122.295 0.238 . . . . 71.349999999999994 111.369 178.414 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 205' ' ' VAL . . . . . 0.454 HG23 ' O ' ' A' ' 201' ' ' ALA . 80.7 t -71.05 -57.76 6.86 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 C-N-CA 123.349 0.66 . . . . 61.130000000000003 111.041 178.643 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 10.6 m -82.37 -17.26 11.46 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.055 0 CA-C-N 116.272 -0.422 . . . . 74.340000000000003 111.588 -172.798 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 74.86 66.17 1.98 Allowed Glycine 0 C--N 1.342 0.883 0 O-C-N 123.667 0.604 . . . . 52.210000000000001 112.327 -177.422 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -85.57 -130.0 2.33 Favored Glycine 0 C--N 1.346 1.091 0 C-N-CA 122.694 0.188 . . . . 52.240000000000002 112.806 179.522 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 209' ' ' LYS . . . . . 0.416 ' HG2' ' HA ' ' A' ' 222' ' ' ALA . 46.8 mtmt -138.24 155.48 48.6 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.753 0.821 . . . . 71.030000000000001 111.005 176.363 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 11.0 m -144.23 168.93 10.15 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 C-N-CA 125.155 1.382 . . . . 74.319999999999993 108.66 172.406 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 48.9 ttp180 -97.06 114.34 25.97 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 123.227 0.611 . . . . 75.230000000000004 109.939 178.552 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -100.74 139.66 36.1 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 123.667 0.787 . . . . 65.230000000000004 110.208 179.52 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 23.9 mmt -98.46 116.02 29.79 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 123.021 0.528 . . . . 75.400000000000006 109.716 178.707 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 48.9 p -109.46 -175.58 2.79 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 123.928 0.891 . . . . 73.349999999999994 109.182 175.527 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 93.3 mt -63.3 -22.3 66.79 Favored 'General case' 0 CA--C 1.552 1.02 0 C-N-CA 122.71 0.404 . . . . 55.450000000000003 111.356 173.685 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 20.9 mt-10 -81.93 -22.89 36.48 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 123.672 0.789 . . . . 63.210000000000001 110.99 -178.877 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 118.18 -150.06 18.27 Favored Glycine 0 CA--C 1.533 1.16 0 N-CA-C 110.911 -0.876 . . . . 73.010000000000005 110.911 -170.822 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_endo -78.26 144.73 20.94 Favored 'Trans proline' 0 C--N 1.369 1.628 0 C-N-CA 122.463 2.109 . . . . 75.420000000000002 113.19 -176.424 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 219' ' ' VAL . . . . . 0.41 HG21 ' HZ ' ' A' ' 173' ' ' PHE . 7.6 p -144.02 133.03 19.34 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 C-N-CA 123.914 0.886 . . . . 61.420000000000002 109.366 177.363 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 40.0 mm-40 -78.69 104.59 9.41 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 109.658 -0.497 . . . . 72.230000000000004 109.658 177.47 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 4.1 p -107.31 130.19 59.88 Favored 'Isoleucine or valine' 0 C--O 1.244 0.808 0 CA-C-N 115.418 -0.81 . . . . 65.439999999999998 109.224 -174.423 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 222' ' ' ALA . . . . . 0.633 ' H ' HD21 ' A' ' 172' ' ' LEU . . . -81.09 104.64 11.71 Favored 'General case' 0 C--O 1.239 0.536 0 C-N-CA 123.419 0.688 . . . . 73.099999999999994 111.061 -177.16 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 59.9 t -55.6 135.64 71.12 Favored Pre-proline 0 N--CA 1.476 0.865 0 O-C-N 124.423 1.077 . . . . 70.329999999999998 110.056 178.957 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 224' ' ' PRO . . . . . 0.468 ' HB3' ' HB1' ' A' ' 178' ' ' ALA . 17.1 Cg_endo -65.23 148.76 88.98 Favored 'Trans proline' 0 C--N 1.365 1.416 0 C-N-CA 121.747 1.631 . . . . 54.450000000000003 111.801 170.326 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -65.35 150.17 87.46 Favored 'Trans proline' 0 C--N 1.364 1.35 0 C-N-CA 121.499 1.466 . . . . 73.230000000000004 111.612 169.763 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 59.6 mtm180 61.72 35.83 16.68 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 124.654 1.182 . . . . 73.099999999999994 112.484 170.908 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 227' ' ' THR . . . . . 0.425 HG22 HG21 ' A' ' 253' ' ' VAL . 26.6 m -83.04 133.94 35.06 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 115.342 -0.845 . . . . 64.5 109.262 174.365 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 28.3 mp0 -111.2 149.63 30.69 Favored 'General case' 0 N--CA 1.485 1.319 0 N-CA-C 109.398 -0.593 . . . . 55.350000000000001 109.398 175.857 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 229' ' ' ALA . . . . . 0.458 ' HA ' HG23 ' A' ' 253' ' ' VAL . . . -58.47 125.99 25.66 Favored 'General case' 0 N--CA 1.47 0.556 0 O-C-N 124.305 1.003 . . . . 63.130000000000003 111.46 -176.548 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 113.98 -15.46 21.14 Favored Glycine 0 CA--C 1.523 0.551 0 CA-C-N 115.206 -0.907 . . . . 41.5 113.035 -176.58 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 231' ' ' ARG . . . . . 0.526 HH11 ' HB1' ' A' ' 179' ' ' ALA . 75.0 mtt180 -67.66 152.81 45.0 Favored 'General case' 0 C--N 1.363 1.158 0 CA-C-N 117.751 0.775 . . . . 73.319999999999993 109.457 172.547 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 232' ' ' LYS . . . . . 0.48 ' HA ' ' O ' ' A' ' 251' ' ' LEU . 54.0 mtmt -130.05 128.01 41.06 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-O 121.324 0.583 . . . . 71.510000000000005 110.602 179.201 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 233' ' ' LEU . . . . . 0.491 ' HB2' ' HB2' ' A' ' 251' ' ' LEU . 20.1 mt -98.49 148.1 24.08 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 114.354 -1.293 . . . . 75.230000000000004 108.887 -174.993 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 21.2 ttt180 -106.82 110.24 22.35 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 122.851 0.46 . . . . 65.230000000000004 111.263 -170.401 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 235' ' ' LEU . . . . . 0.614 ' HB2' ' HB3' ' A' ' 249' ' ' LEU . 17.1 mt -98.56 103.9 15.89 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 122.641 0.376 . . . . 64.200000000000003 110.092 177.963 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 13.6 mtmt -70.72 134.84 47.82 Favored 'General case' 0 C--O 1.238 0.495 0 CA-C-N 116.231 -0.44 . . . . 70.019999999999996 111.896 -178.154 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 73.72 10.51 80.09 Favored Glycine 0 C--N 1.344 0.996 0 CA-C-N 114.973 -1.012 . . . . 64.109999999999999 114.808 177.975 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 238' ' ' LYS . . . . . 0.486 ' HE3' ' CE2' ' A' ' 173' ' ' PHE . 69.7 mmtt -104.6 5.36 33.69 Favored 'General case' 0 N--CA 1.478 0.957 0 CA-C-N 117.393 0.596 . . . . 62.119999999999997 110.0 179.785 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 239' ' ' GLY . . . . . 0.536 ' HA2' HD12 ' A' ' 193' ' ' LEU . . . -105.7 -168.37 23.5 Favored Glycine 0 C--N 1.35 1.325 0 CA-C-N 115.25 -0.886 . . . . 51.43 111.294 166.733 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -93.73 167.75 13.19 Favored Pre-proline 0 CA--C 1.559 1.319 0 C-N-CA 123.998 0.919 . . . . 73.140000000000001 110.233 178.337 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -71.65 171.51 16.25 Favored 'Trans proline' 0 C--N 1.376 2.001 0 C-N-CA 122.437 2.091 . . . . 63.43 112.926 172.203 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 155.36 -117.25 0.77 Allowed Glycine 0 CA--C 1.537 1.461 0 CA-C-O 119.312 -0.715 . . . . 73.439999999999998 113.219 173.507 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 243' ' ' PRO . . . . . 0.625 ' HD2' ' HB3' ' A' ' 191' ' ' GLN . 60.5 Cg_endo -63.25 -40.65 31.29 Favored 'Trans proline' 0 C--N 1.375 1.966 0 C-N-CA 124.638 3.559 . . . . 72.530000000000001 113.506 -169.348 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 244' ' ' ALA . . . . . 0.429 ' HB3' HE22 ' A' ' 191' ' ' GLN . . . -101.27 -13.99 17.84 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 123.393 0.677 . . . . 72.329999999999998 110.316 177.292 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 96.32 -31.71 7.16 Favored Glycine 0 C--N 1.352 1.464 0 CA-C-N 116.109 -0.496 . . . . 62.130000000000003 112.908 179.66 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 50.5 ttt180 -126.65 110.56 13.31 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 124.17 0.988 . . . . 63.32 109.102 -178.663 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -75.96 151.07 40.22 Favored Glycine 0 C--N 1.347 1.161 0 O-C-N 123.684 0.615 . . . . 62.340000000000003 113.532 179.011 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 18.4 m-20 -118.89 137.65 53.3 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 124.144 0.978 . . . . 70.5 109.67 -175.744 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 249' ' ' LEU . . . . . 0.614 ' HB3' ' HB2' ' A' ' 235' ' ' LEU . 51.6 tp -98.93 118.06 34.84 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 109.049 -0.723 . . . . 75.010000000000005 109.049 179.521 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 250' ' ' TYR . . . . . . . . . . . . . 3.4 m-85 -90.64 112.78 24.64 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 123.62 0.768 . . . . 65.420000000000002 110.331 -175.615 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 251' ' ' LEU . . . . . 0.718 HD13 HD22 ' A' ' 197' ' ' LEU . 83.4 mt -87.57 105.24 17.19 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 124.209 1.004 . . . . 70.310000000000002 109.408 -177.453 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 252' ' ' GLU . . . . . 0.405 ' O ' ' HG2' ' A' ' 254' ' ' ARG . 29.4 mt-10 -78.74 93.94 5.02 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 108.327 -0.99 . . . . 75.420000000000002 108.327 -178.425 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 253' ' ' VAL . . . . . 0.458 HG23 ' HA ' ' A' ' 229' ' ' ALA . 3.9 m -64.19 127.98 25.77 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.871 0 CA-C-O 121.334 0.587 . . . . 62.140000000000001 109.786 -176.701 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 254' ' ' ARG . . . . . 0.405 ' HG2' ' O ' ' A' ' 252' ' ' GLU . 26.6 mmt85 -127.46 98.97 5.43 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 108.713 -0.847 . . . . 72.400000000000006 108.713 -175.194 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 255' ' ' ILE . . . . . 0.486 ' HA ' ' O ' ' A' ' 199' ' ' VAL . 24.8 mt -80.31 110.56 16.02 Favored 'Isoleucine or valine' 0 C--O 1.238 0.473 0 CA-C-N 115.25 -0.886 . . . . 53.399999999999999 110.415 -176.922 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 10.2 t . . . . . 0 C--O 1.257 1.475 0 CA-C-N 115.059 -0.973 . . . . 75.549999999999997 109.708 174.037 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 172' ' ' LEU . . . . . 0.666 HD21 ' H ' ' A' ' 222' ' ' ALA . 22.3 mt . . . . . 0 N--CA 1.483 1.19 0 CA-C-O 120.855 0.359 . . . . 71.140000000000001 110.454 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 173' ' ' PHE . . . . . 0.471 ' CD1' HD22 ' A' ' 235' ' ' LEU . 26.2 m-85 -123.99 -62.78 1.26 Allowed 'General case' 0 N--CA 1.475 0.777 0 CA-C-N 115.519 -0.764 . . . . 75.120000000000005 110.189 -169.661 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 174' ' ' TYR . . . . . 0.464 ' CD2' ' HB3' ' A' ' 233' ' ' LEU . 1.8 p90 -75.8 -11.38 59.97 Favored 'General case' 0 C--O 1.219 -0.503 0 CA-C-N 114.587 -1.188 . . . . 60.420000000000002 112.815 -172.158 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 175' ' ' THR . . . . . 0.662 HG21 HD13 ' A' ' 172' ' ' LEU . 42.9 p -70.61 -2.18 13.47 Favored 'General case' 0 CA--C 1.548 0.9 0 N-CA-C 112.558 0.577 . . . . 73.0 112.558 -176.45 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 176' ' ' MET . . . . . . . . . . . . . 24.9 ptt? -57.1 -41.97 79.89 Favored 'General case' 0 CA--C 1.559 1.299 0 C-N-CA 123.67 0.788 . . . . 72.329999999999998 110.261 161.951 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 14.5 tmtt? 179.51 108.52 0.03 OUTLIER 'General case' 0 CA--C 1.553 1.08 0 C-N-CA 126.18 1.792 . . . . 61.43 106.321 179.463 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 178' ' ' ALA . . . . . 0.523 ' HB1' HD22 ' A' ' 233' ' ' LEU . . . -128.08 -58.77 1.2 Allowed 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 123.081 0.552 . . . . 64.310000000000002 112.025 -173.017 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 179' ' ' ALA . . . . . 0.48 ' HB2' ' HB2' ' A' ' 224' ' ' PRO . . . -71.55 85.22 0.86 Allowed 'General case' 0 CA--C 1.546 0.81 0 CA-C-O 121.57 0.7 . . . . 71.120000000000005 109.48 179.463 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.337 0.591 0 CA-C-N 114.298 -1.319 . . . . 75.430000000000007 109.889 -172.546 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 191' ' ' GLN . . . . . 0.601 ' HB3' ' HD2' ' A' ' 243' ' ' PRO . 6.8 pt20 . . . . . 0 N--CA 1.483 1.178 0 CA-C-O 121.302 0.572 . . . . 64.420000000000002 110.768 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -76.05 135.61 39.92 Favored 'General case' 0 C--O 1.241 0.624 0 CA-C-N 114.387 -1.279 . . . . 74.430000000000007 110.048 -177.969 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 43.6 mt -117.87 168.26 10.66 Favored 'General case' 0 C--O 1.24 0.589 0 CA-C-N 114.701 -1.136 . . . . 72.530000000000001 109.204 177.796 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 31.8 m-85 -138.6 121.86 17.01 Favored 'General case' 0 C--O 1.238 0.466 0 C-N-CA 123.483 0.713 . . . . 72.25 109.656 -179.49 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 195' ' ' ALA . . . . . 0.502 ' HB3' HD23 ' A' ' 251' ' ' LEU . . . -126.9 133.67 50.62 Favored 'General case' 0 CA--C 1.516 -0.342 0 C-N-CA 123.962 0.905 . . . . 70.040000000000006 108.607 177.448 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 2.2 m -81.45 125.59 30.62 Favored 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 108.82 -0.808 . . . . 62.030000000000001 108.82 176.234 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 197' ' ' LEU . . . . . 0.677 HD22 HD13 ' A' ' 251' ' ' LEU . 15.7 tp -109.55 111.39 22.88 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 108.672 -0.862 . . . . 64.209999999999994 108.672 -176.624 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -76.19 127.93 33.91 Favored 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 108.55 -0.907 . . . . 60.420000000000002 108.55 174.491 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 199' ' ' VAL . . . . . 0.494 ' O ' ' HA ' ' A' ' 255' ' ' ILE . 7.7 p -145.29 133.58 10.74 Favored Pre-proline 0 CA--C 1.544 0.716 0 N-CA-C 108.475 -0.935 . . . . 70.209999999999994 108.475 176.112 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 200' ' ' PRO . . . . . 0.444 ' HB2' ' HD2' ' A' ' 202' ' ' PRO . 75.4 Cg_endo -75.74 160.98 37.19 Favored 'Trans proline' 0 C--N 1.361 1.191 0 C-N-CA 121.737 1.625 . . . . 41.310000000000002 111.25 167.97 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -55.75 -47.25 99.12 Favored Pre-proline 0 CA--C 1.558 1.282 0 CA-C-O 117.695 -1.145 . . . . 71.349999999999994 113.786 -178.323 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 202' ' ' PRO . . . . . 0.444 ' HD2' ' HB2' ' A' ' 200' ' ' PRO . 56.1 Cg_endo -64.47 -37.95 35.95 Favored 'Trans proline' 0 C--N 1.396 3.057 0 C-N-CA 121.691 1.594 . . . . 75.019999999999996 112.964 -177.861 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 45.1 mt -67.93 -34.93 70.04 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.062 0 CA-C-O 120.817 0.341 . . . . 74.329999999999998 110.436 176.248 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -67.45 -40.61 85.39 Favored 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 123.048 0.539 . . . . 71.400000000000006 112.239 179.382 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 17.1 m -80.27 -45.98 22.0 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.793 0 N-CA-C 112.919 0.711 . . . . 71.239999999999995 112.919 -175.543 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 206' ' ' VAL . . . . . 0.436 HG22 ' O ' ' A' ' 202' ' ' PRO . 11.1 m -78.04 -25.57 14.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 C-N-CA 122.213 0.205 . . . . 74.129999999999995 111.516 178.477 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 82.24 66.25 1.58 Allowed Glycine 0 C--N 1.344 1.026 0 N-CA-C 111.944 -0.462 . . . . 23.239999999999998 111.944 -177.318 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -86.47 -130.93 2.85 Favored Glycine 0 C--N 1.352 1.442 0 C-N-CA 123.262 0.458 . . . . 54.350000000000001 112.217 177.494 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 209' ' ' LYS . . . . . 0.412 ' HG2' ' HA ' ' A' ' 222' ' ' ALA . 48.4 mtmt -137.89 155.72 48.64 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 124.063 0.945 . . . . 73.120000000000005 111.084 177.001 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 9.5 m -147.51 151.89 13.32 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.793 0 C-N-CA 125.288 1.435 . . . . 74.549999999999997 108.682 169.763 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 211' ' ' ARG . . . . . 0.441 ' HD2' ' HB2' ' A' ' 218' ' ' PRO . 54.5 ttp180 -87.55 116.9 25.99 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 123.069 0.548 . . . . 73.310000000000002 110.501 179.749 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -100.87 129.01 46.67 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 123.95 0.9 . . . . 74.340000000000003 109.769 177.557 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 22.4 mmt -86.29 120.86 28.1 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 108.96 -0.755 . . . . 63.43 108.96 175.49 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 24.0 p -123.41 -174.71 3.02 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 123.928 0.891 . . . . 34.43 109.835 -174.903 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 77.0 mt -65.77 -29.36 69.85 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 122.752 0.421 . . . . 74.310000000000002 110.894 172.259 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 18.6 mm-40 -90.6 6.77 42.4 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 123.859 0.864 . . . . 61.530000000000001 110.971 -179.589 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 96.79 -160.34 21.71 Favored Glycine 0 C--N 1.352 1.47 0 CA-C-O 119.581 -0.566 . . . . 74.319999999999993 112.636 177.915 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 218' ' ' PRO . . . . . 0.441 ' HB2' ' HD2' ' A' ' 211' ' ' ARG . 71.8 Cg_endo -75.11 144.25 29.67 Favored 'Trans proline' 0 C--N 1.368 1.565 0 C-N-CA 122.336 2.024 . . . . 74.019999999999996 112.471 -179.665 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 7.5 p -146.92 131.27 10.46 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 C-N-CA 123.199 0.599 . . . . 71.349999999999994 109.778 177.663 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -69.73 103.09 2.05 Favored 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 108.114 -1.069 . . . . 72.120000000000005 108.114 169.969 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 1.7 p -103.58 120.61 53.88 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.133 0 N-CA-C 108.263 -1.014 . . . . 63.450000000000003 108.263 179.74 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 222' ' ' ALA . . . . . 0.666 ' H ' HD21 ' A' ' 172' ' ' LEU . . . -76.11 109.91 10.15 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 123.382 0.673 . . . . 61.43 111.558 -175.441 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 51.9 t -55.2 138.4 66.52 Favored Pre-proline 0 N--CA 1.48 1.054 0 C-N-CA 125.636 1.574 . . . . 73.310000000000002 111.029 -177.087 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 224' ' ' PRO . . . . . 0.48 ' HB2' ' HB2' ' A' ' 179' ' ' ALA . 36.8 Cg_endo -66.42 147.79 83.16 Favored 'Trans proline' 0 C--N 1.377 2.03 0 C-N-CA 121.61 1.54 . . . . 73.0 110.843 170.918 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_exo -69.1 149.33 70.97 Favored 'Trans proline' 0 C--N 1.364 1.378 0 C-N-CA 121.725 1.617 . . . . 75.239999999999995 111.672 174.287 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 82.4 mtt180 63.94 39.56 7.99 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 124.79 1.236 . . . . 73.409999999999997 111.099 173.09 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 227' ' ' THR . . . . . 0.438 HG23 ' HD2' ' A' ' 231' ' ' ARG . 91.3 m -83.08 139.15 33.39 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 115.349 -0.841 . . . . 71.299999999999997 109.881 177.436 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 27.3 mp0 -112.36 148.31 34.55 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 124.325 1.05 . . . . 70.0 109.208 176.413 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 229' ' ' ALA . . . . . 0.4 ' HA ' HG23 ' A' ' 253' ' ' VAL . . . -59.2 128.65 38.21 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 123.546 0.738 . . . . 65.239999999999995 110.854 -179.615 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 105.6 -3.56 39.58 Favored Glycine 0 N--CA 1.471 1.023 0 O-C-N 123.828 0.705 . . . . 72.010000000000005 113.18 -177.55 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 231' ' ' ARG . . . . . 0.438 ' HD2' HG23 ' A' ' 227' ' ' THR . 62.8 mtt-85 -71.68 149.96 45.0 Favored 'General case' 0 C--N 1.359 1.006 0 CA-C-N 117.43 0.615 . . . . 73.120000000000005 109.839 171.851 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -127.45 103.35 7.31 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 123.263 0.625 . . . . 64.420000000000002 109.341 -174.867 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 233' ' ' LEU . . . . . 0.532 ' HB2' ' HB2' ' A' ' 251' ' ' LEU . 28.9 mt -80.38 149.34 30.25 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 114.16 -1.382 . . . . 72.450000000000003 109.121 -177.213 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 56.5 ttt180 -115.39 109.04 17.3 Favored 'General case' 0 N--CA 1.481 1.11 0 O-C-N 121.926 -0.484 . . . . 74.109999999999999 111.349 -171.755 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 235' ' ' LEU . . . . . 0.564 ' HB2' ' HB3' ' A' ' 249' ' ' LEU . 19.2 mt -95.68 107.02 19.19 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 123.125 0.57 . . . . 71.349999999999994 110.116 176.565 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 21.2 mttt -73.25 137.69 45.08 Favored 'General case' 0 CA--C 1.535 0.393 0 O-C-N 123.214 0.321 . . . . 74.329999999999998 110.208 174.114 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 74.01 19.17 79.79 Favored Glycine 0 C--N 1.34 0.78 0 CA-C-N 115.567 -0.742 . . . . 64.099999999999994 114.017 179.661 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 238' ' ' LYS . . . . . 0.426 ' HZ3' ' HE2' ' A' ' 173' ' ' PHE . 34.9 mmtm -121.19 6.93 10.22 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 123.367 0.667 . . . . 60.229999999999997 110.616 174.171 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -109.0 -170.5 20.79 Favored Glycine 0 C--N 1.347 1.175 0 N-CA-C 110.534 -1.026 . . . . 72.430000000000007 110.534 163.053 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 89.0 m-85 -89.96 147.64 37.77 Favored Pre-proline 0 N--CA 1.478 0.95 0 C-N-CA 123.169 0.588 . . . . 64.329999999999998 110.972 -177.66 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 17.6 Cg_exo -68.02 128.2 17.29 Favored 'Trans proline' 0 C--N 1.365 1.404 0 C-N-CA 121.771 1.648 . . . . 75.030000000000001 111.137 172.977 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -158.97 -121.66 0.63 Allowed Glycine 0 C--N 1.347 1.16 0 CA-C-O 118.351 -1.249 . . . . 63.240000000000002 112.313 -177.949 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 243' ' ' PRO . . . . . 0.601 ' HD2' ' HB3' ' A' ' 191' ' ' GLN . 25.2 Cg_endo -55.21 -45.58 39.32 Favored 'Trans proline' 0 C--N 1.38 2.23 0 C-N-CA 124.414 3.409 . . . . 75.140000000000001 113.489 -174.599 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -86.64 -13.22 46.21 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 123.156 0.582 . . . . 72.099999999999994 111.539 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 92.54 -30.64 6.71 Favored Glycine 0 C--N 1.348 1.21 0 N-CA-C 112.068 -0.413 . . . . 73.239999999999995 112.068 -174.402 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 46.0 ttm-85 -128.28 112.47 14.5 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 124.364 1.065 . . . . 70.420000000000002 109.114 176.066 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -72.73 154.78 50.43 Favored Glycine 0 C--N 1.347 1.192 0 O-C-N 123.181 0.301 . . . . 65.120000000000005 113.584 172.883 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 20.9 m-20 -110.24 165.49 11.72 Favored 'General case' 0 C--O 1.237 0.398 0 C-N-CA 123.996 0.918 . . . . 73.319999999999993 110.088 -177.689 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 249' ' ' LEU . . . . . 0.564 ' HB3' ' HB2' ' A' ' 235' ' ' LEU . 34.7 tp -129.47 113.32 14.75 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 123.758 0.823 . . . . 74.519999999999996 108.877 176.16 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 250' ' ' TYR . . . . . 0.449 ' HA ' ' O ' ' A' ' 233' ' ' LEU . 7.5 m-85 -91.04 110.55 21.82 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 115.664 -0.698 . . . . 74.540000000000006 110.627 -177.452 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 251' ' ' LEU . . . . . 0.677 HD13 HD22 ' A' ' 197' ' ' LEU . 84.6 mt -88.39 105.36 17.54 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 114.139 -1.391 . . . . 72.329999999999998 109.143 -178.644 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -80.12 100.83 8.42 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 108.687 -0.857 . . . . 72.319999999999993 108.687 175.849 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 253' ' ' VAL . . . . . 0.4 HG23 ' HA ' ' A' ' 229' ' ' ALA . 12.1 m -63.58 133.97 28.92 Favored 'Isoleucine or valine' 0 C--O 1.246 0.895 0 O-C-N 123.775 0.672 . . . . 64.239999999999995 110.094 -179.777 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 20.5 mmm-85 -127.64 94.22 3.91 Favored 'General case' 0 C--O 1.24 0.59 0 N-CA-C 107.815 -1.179 . . . . 73.040000000000006 107.815 -177.257 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 255' ' ' ILE . . . . . 0.494 ' HA ' ' O ' ' A' ' 199' ' ' VAL . 22.4 mt -76.76 133.75 30.27 Favored 'Isoleucine or valine' 0 C--O 1.238 0.469 0 O-C-N 124.482 1.114 . . . . 72.049999999999997 110.836 -173.909 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 9.7 t . . . . . 0 CA--C 1.569 1.698 0 CA-C-O 117.589 -1.196 . . . . 63.420000000000002 108.832 179.824 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 172' ' ' LEU . . . . . 0.644 HD21 ' H ' ' A' ' 222' ' ' ALA . 53.3 mt . . . . . 0 N--CA 1.485 1.32 0 CA-C-O 120.985 0.422 . . . . 72.140000000000001 110.188 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 173' ' ' PHE . . . . . 0.486 ' CD1' HD22 ' A' ' 235' ' ' LEU . 52.3 m-85 -140.66 -58.27 0.52 Allowed 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.829 0.852 . . . . 70.400000000000006 109.191 -164.067 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 174' ' ' TYR . . . . . 0.486 ' OH ' ' HB ' ' A' ' 221' ' ' VAL . 7.2 p90 -70.53 -14.96 62.72 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 114.347 -1.297 . . . . 63.340000000000003 113.089 -177.806 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -45.73 -29.02 1.16 Allowed 'General case' 0 N--CA 1.49 1.574 0 C-N-CA 126.172 1.789 . . . . 62.149999999999999 114.076 -173.157 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 176' ' ' MET . . . . . . . . . . . . . 66.5 mtm -55.7 -38.95 70.38 Favored 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 124.736 1.214 . . . . 75.340000000000003 112.934 -178.58 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 14.3 ptmm? -160.42 34.48 0.16 Allowed 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 123.503 0.721 . . . . 55.210000000000001 110.848 -170.766 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -64.16 -46.24 84.88 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 124.764 1.226 . . . . 63.439999999999998 113.479 -169.705 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 179' ' ' ALA . . . . . 0.453 ' HB2' ' HB2' ' A' ' 224' ' ' PRO . . . -82.65 65.79 7.95 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-O 122.124 0.964 . . . . 75.549999999999997 109.629 -179.71 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.243 0.685 0 CA-C-N 114.19 -1.368 . . . . 71.340000000000003 110.48 -179.327 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 191' ' ' GLN . . . . . 0.513 ' HG3' ' N ' ' A' ' 192' ' ' ASP . 2.0 pt20 . . . . . 0 CA--C 1.542 0.665 0 N-CA-C 109.235 -0.654 . . . . 45.210000000000001 109.235 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 192' ' ' ASP . . . . . 0.513 ' N ' ' HG3' ' A' ' 191' ' ' GLN . 31.3 m-20 -80.27 137.33 36.61 Favored 'General case' 0 C--N 1.354 0.778 0 CA-C-N 115.229 -0.896 . . . . 62.25 109.003 -176.125 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 32.2 mt -113.05 174.83 5.71 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 115.85 -0.614 . . . . 64.450000000000003 111.379 -173.438 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 48.5 m-85 -136.93 124.15 21.78 Favored 'General case' 0 C--O 1.238 0.492 0 C-N-CA 124.552 1.141 . . . . 74.0 109.466 -179.771 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 195' ' ' ALA . . . . . 0.4 ' O ' ' HA ' ' A' ' 251' ' ' LEU . . . -135.42 128.29 31.26 Favored 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 107.269 -1.382 . . . . 73.409999999999997 107.269 171.429 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 44.9 m -82.77 125.8 31.68 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 109.188 -0.671 . . . . 74.129999999999995 109.188 -179.839 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 197' ' ' LEU . . . . . 0.52 HD22 HD13 ' A' ' 251' ' ' LEU . 15.9 tp -106.65 110.8 23.09 Favored 'General case' 0 N--CA 1.466 0.333 0 N-CA-C 107.916 -1.142 . . . . 73.239999999999995 107.916 -176.743 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -87.69 126.61 35.07 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 123.272 0.629 . . . . 54.43 109.345 -179.336 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 199' ' ' VAL . . . . . 0.478 ' O ' ' HA ' ' A' ' 255' ' ' ILE . 5.5 p -144.83 132.63 10.52 Favored Pre-proline 0 CA--C 1.55 0.969 0 N-CA-C 108.409 -0.96 . . . . 52.530000000000001 108.409 -178.792 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -72.74 159.35 48.72 Favored 'Trans proline' 0 C--N 1.368 1.583 0 C-N-CA 121.987 1.792 . . . . 55.310000000000002 111.023 171.031 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 201' ' ' ALA . . . . . 0.494 ' O ' HG23 ' A' ' 205' ' ' VAL . . . -50.95 -53.71 45.0 Favored Pre-proline 0 CA--C 1.558 1.264 0 CA-C-O 117.659 -1.162 . . . . 70.340000000000003 113.361 -176.466 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -63.95 -35.31 55.73 Favored 'Trans proline' 0 C--N 1.389 2.677 0 C-N-CA 121.598 1.532 . . . . 75.030000000000001 113.504 -175.799 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 41.0 mt -68.73 -33.82 61.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 N-CA-C 109.702 -0.481 . . . . 74.409999999999997 109.702 176.005 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 204' ' ' ALA . . . . . 0.478 ' HB1' ' HB ' ' A' ' 227' ' ' THR . . . -70.14 -35.66 74.22 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 123.228 0.611 . . . . 55.240000000000002 111.305 178.47 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 205' ' ' VAL . . . . . 0.494 HG23 ' O ' ' A' ' 201' ' ' ALA . 90.2 t -70.94 -56.44 10.65 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 C-N-CA 123.398 0.679 . . . . 73.439999999999998 110.522 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 17.3 m -73.32 -27.57 24.11 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.956 0 C-N-CA 122.862 0.465 . . . . 61.530000000000001 111.334 -174.927 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 81.36 69.62 1.39 Allowed Glycine 0 C--N 1.341 0.85 0 CA-C-N 115.839 -0.619 . . . . 72.540000000000006 112.262 -175.622 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -87.56 -140.05 6.44 Favored Glycine 0 C--N 1.355 1.618 0 CA-C-O 119.593 -0.56 . . . . 72.530000000000001 112.236 177.879 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 47.8 mtmt -137.35 147.47 45.57 Favored 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 123.66 0.784 . . . . 74.120000000000005 110.97 179.662 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 5.6 m -143.39 160.17 17.12 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 C-N-CA 125.271 1.428 . . . . 75.510000000000005 109.369 176.804 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 24.3 ttt180 -90.49 114.58 26.8 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 123.929 0.892 . . . . 70.439999999999998 110.449 179.587 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -102.18 131.87 48.43 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 124.753 1.221 . . . . 60.219999999999999 109.841 174.772 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 37.2 tpp -88.28 130.96 34.97 Favored 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 109.87 -0.418 . . . . 70.129999999999995 109.87 176.506 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 63.4 p -120.24 -171.68 2.21 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 124.309 1.043 . . . . 75.099999999999994 109.279 177.425 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 89.9 mt -67.93 -22.21 65.07 Favored 'General case' 0 CA--C 1.55 0.971 0 C-N-CA 123.315 0.646 . . . . 73.129999999999995 111.789 172.347 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 58.6 mt-10 -90.68 -21.12 21.79 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 123.578 0.751 . . . . 74.409999999999997 111.258 -177.685 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 124.48 -156.34 18.52 Favored Glycine 0 C--N 1.34 0.779 0 N-CA-C 111.092 -0.803 . . . . 42.399999999999999 111.092 -173.977 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -76.3 140.16 21.75 Favored 'Trans proline' 0 CA--C 1.551 1.356 0 C-N-CA 122.219 1.946 . . . . 74.420000000000002 113.932 -176.821 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 2.4 p -131.98 128.98 60.2 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.451 0 C-N-CA 124.678 1.191 . . . . 62.039999999999999 108.015 172.109 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -81.75 102.09 10.54 Favored 'General case' 0 C--O 1.236 0.376 0 N-CA-C 108.349 -0.982 . . . . 72.329999999999998 108.349 174.011 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 221' ' ' VAL . . . . . 0.486 ' HB ' ' OH ' ' A' ' 174' ' ' TYR . 13.9 m -97.65 138.85 21.33 Favored 'Isoleucine or valine' 0 C--O 1.242 0.679 0 CA-C-N 115.431 -0.804 . . . . 64.450000000000003 109.459 179.57 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 222' ' ' ALA . . . . . 0.644 ' H ' HD21 ' A' ' 172' ' ' LEU . . . -88.85 107.83 19.2 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-N 115.05 -0.977 . . . . 63.409999999999997 109.624 -177.355 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 61.2 t -54.09 134.3 59.15 Favored Pre-proline 0 N--CA 1.482 1.137 0 C-N-CA 124.302 1.041 . . . . 65.140000000000001 109.532 -179.332 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 224' ' ' PRO . . . . . 0.453 ' HB2' ' HB2' ' A' ' 179' ' ' ALA . 26.1 Cg_endo -60.52 151.23 76.8 Favored 'Trans proline' 0 C--N 1.373 1.858 0 C-N-CA 121.922 1.748 . . . . 70.129999999999995 112.647 177.29 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -64.56 133.76 38.37 Favored 'Trans proline' 0 C--N 1.368 1.601 0 C-N-CA 121.485 1.457 . . . . 74.099999999999994 110.677 169.505 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 55.3 mtt180 67.03 62.64 0.48 Allowed 'General case' 0 C--O 1.241 0.629 0 C-N-CA 124.797 1.239 . . . . 63.420000000000002 109.831 175.668 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 227' ' ' THR . . . . . 0.677 ' HA ' ' HE ' ' A' ' 231' ' ' ARG . 56.1 m -89.87 140.51 29.54 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 113.866 -1.515 . . . . 74.329999999999998 109.173 176.582 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -116.64 141.54 48.07 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.736 0.814 . . . . 70.219999999999999 108.862 171.884 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 229' ' ' ALA . . . . . 0.441 ' HB2' ' HB ' ' A' ' 255' ' ' ILE . . . -58.91 116.99 4.15 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 123.651 0.781 . . . . 62.0 110.217 179.911 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 115.16 -2.2 22.51 Favored Glycine 0 CA--C 1.526 0.754 0 CA-C-O 119.123 -0.821 . . . . 73.109999999999999 113.542 -173.07 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 231' ' ' ARG . . . . . 0.677 ' HE ' ' HA ' ' A' ' 227' ' ' THR . 77.5 mtt-85 -66.38 145.49 55.64 Favored 'General case' 0 N--CA 1.483 1.203 0 CA-C-N 118.042 0.921 . . . . 52.32 109.183 169.55 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -121.38 98.81 6.15 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 107.899 -1.149 . . . . 74.340000000000003 107.899 -174.477 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 233' ' ' LEU . . . . . 0.807 ' HB2' ' HB2' ' A' ' 251' ' ' LEU . 53.7 mt -79.79 152.27 29.86 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 115.36 -0.836 . . . . 54.229999999999997 109.371 179.843 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 234' ' ' ARG . . . . . 0.459 ' H ' ' HB3' ' A' ' 174' ' ' TYR . 59.4 ttm-85 -122.29 106.49 11.15 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 122.937 0.495 . . . . 72.319999999999993 110.542 -175.464 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 235' ' ' LEU . . . . . 0.603 ' HB2' ' HB3' ' A' ' 249' ' ' LEU . 10.3 mt -91.58 100.17 12.96 Favored 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 109.043 -0.725 . . . . 63.539999999999999 109.043 171.376 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 19.4 mttt -67.34 132.91 48.63 Favored 'General case' 0 C--O 1.241 0.61 0 O-C-N 123.365 0.416 . . . . 73.420000000000002 111.347 -178.042 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 73.89 18.2 79.55 Favored Glycine 0 C--N 1.347 1.193 0 CA-C-N 115.03 -0.986 . . . . 71.430000000000007 115.034 177.248 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 68.9 mmtt -106.4 12.41 29.78 Favored 'General case' 0 N--CA 1.488 1.455 0 CA-C-N 117.405 0.603 . . . . 75.150000000000006 110.514 174.749 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -113.9 -165.66 15.73 Favored Glycine 0 CA--C 1.527 0.811 0 CA-C-N 114.822 -1.081 . . . . 71.209999999999994 110.732 167.802 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -95.17 168.01 11.84 Favored Pre-proline 0 N--CA 1.479 1.022 0 C-N-CA 124.278 1.031 . . . . 62.119999999999997 110.097 -177.949 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -81.27 149.14 16.97 Favored 'Trans proline' 0 C--N 1.372 1.786 0 C-N-CA 121.599 1.533 . . . . 74.140000000000001 112.859 171.63 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 179.52 -119.75 0.66 Allowed Glycine 0 CA--C 1.54 1.598 0 CA-C-O 119.004 -0.887 . . . . 70.219999999999999 113.28 176.021 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 243' ' ' PRO . . . . . 0.445 ' HD2' ' HB3' ' A' ' 191' ' ' GLN . 34.1 Cg_endo -55.62 -46.67 30.23 Favored 'Trans proline' 0 C--N 1.382 2.306 1 C-N-CA 125.364 4.043 . . . . 41.539999999999999 114.055 -172.241 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -100.19 -2.21 34.55 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 123.315 0.646 . . . . 74.299999999999997 110.952 -179.133 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 87.8 -51.51 4.1 Favored Glycine 0 C--N 1.353 1.489 0 N-CA-C 111.833 -0.507 . . . . 71.549999999999997 111.833 -178.461 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 10.2 ttm180 -101.05 109.63 21.55 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 123.947 0.899 . . . . 51.299999999999997 109.879 176.679 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -75.98 130.41 10.94 Favored Glycine 0 C--N 1.351 1.373 0 N-CA-C 110.661 -0.976 . . . . 45.530000000000001 110.661 169.264 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 67.4 m-20 -112.31 145.65 39.65 Favored 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 109.332 -0.618 . . . . 72.040000000000006 109.332 -176.915 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 249' ' ' LEU . . . . . 0.603 ' HB3' ' HB2' ' A' ' 235' ' ' LEU . 31.4 tp -97.87 118.68 34.99 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 123.677 0.791 . . . . 61.119999999999997 109.207 -175.239 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 250' ' ' TYR . . . . . 0.408 ' HA ' ' O ' ' A' ' 233' ' ' LEU . 1.6 m-85 -89.34 108.87 19.88 Favored 'General case' 0 C--O 1.243 0.739 0 N-CA-C 108.727 -0.842 . . . . 75.099999999999994 108.727 -177.337 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 251' ' ' LEU . . . . . 0.807 ' HB2' ' HB2' ' A' ' 233' ' ' LEU . 79.7 mt -87.36 104.03 16.04 Favored 'General case' 0 C--O 1.241 0.61 0 N-CA-C 107.94 -1.133 . . . . 74.049999999999997 107.94 177.41 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -84.1 100.15 10.93 Favored 'General case' 0 C--O 1.238 0.457 0 CA-C-N 115.063 -0.972 . . . . 63.439999999999998 108.918 -177.535 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 11.7 m -72.04 135.59 27.53 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 CA-C-O 121.53 0.681 . . . . 60.25 110.67 -172.978 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 49.7 mmm-85 -127.42 98.92 5.42 Favored 'General case' 0 C--O 1.237 0.431 0 C-N-CA 124.608 1.163 . . . . 71.0 108.299 -178.594 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 255' ' ' ILE . . . . . 0.478 ' HA ' ' O ' ' A' ' 199' ' ' VAL . 27.2 mt -77.95 128.59 38.14 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 O-C-N 124.169 0.918 . . . . 73.120000000000005 109.754 179.735 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 4.2 t . . . . . 0 CA--C 1.559 1.327 0 CA-C-O 117.273 -1.346 . . . . 72.420000000000002 107.957 179.486 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 172' ' ' LEU . . . . . 0.447 HD21 ' HB3' ' A' ' 222' ' ' ALA . 43.4 mt . . . . . 0 N--CA 1.486 1.352 0 CA-C-O 120.97 0.415 . . . . 71.200000000000003 112.035 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 173' ' ' PHE . . . . . 0.501 ' CD1' HD22 ' A' ' 235' ' ' LEU . 11.9 m-85 -137.65 -44.95 0.54 Allowed 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 124.028 0.931 . . . . 64.25 109.519 -173.042 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 174' ' ' TYR . . . . . 0.518 ' CD2' ' HB3' ' A' ' 233' ' ' LEU . 0.7 OUTLIER -81.97 13.44 3.34 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-N 114.832 -1.076 . . . . 70.319999999999993 112.899 -175.689 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 175' ' ' THR . . . . . 0.427 HG23 ' HB3' ' A' ' 172' ' ' LEU . 11.6 p -63.37 -9.12 10.76 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.867 0.867 . . . . 71.239999999999995 113.308 -179.857 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 176' ' ' MET . . . . . . . . . . . . . 44.9 mtm -58.41 -63.96 1.09 Allowed 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 123.595 0.758 . . . . 52.420000000000002 109.104 166.36 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 44.8 pttt -168.1 119.06 0.81 Allowed 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 125.094 1.358 . . . . 74.420000000000002 108.337 -179.053 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 178' ' ' ALA . . . . . 0.583 ' HB1' HD22 ' A' ' 233' ' ' LEU . . . -124.04 -54.5 1.71 Allowed 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 123.916 0.886 . . . . 42.140000000000001 109.82 -173.641 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 179' ' ' ALA . . . . . 0.419 ' HA ' ' HD3' ' A' ' 231' ' ' ARG . . . -79.42 65.13 4.5 Favored 'General case' 0 CA--C 1.543 0.702 0 CA-C-O 121.918 0.866 . . . . 74.109999999999999 108.742 169.986 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.336 0.568 0 N-CA-C 110.148 -1.181 . . . . 35.530000000000001 110.148 -171.672 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 191' ' ' GLN . . . . . 0.435 ' HG3' ' N ' ' A' ' 192' ' ' ASP . 6.5 pt20 . . . . . 0 N--CA 1.47 0.552 0 N-CA-C 110.278 -0.267 . . . . 64.200000000000003 110.278 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 192' ' ' ASP . . . . . 0.435 ' N ' ' HG3' ' A' ' 191' ' ' GLN . 73.5 m-20 -84.94 121.0 27.13 Favored 'General case' 0 C--N 1.347 0.482 0 C-N-CA 123.998 0.919 . . . . 61.240000000000002 109.404 -175.722 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 193' ' ' LEU . . . . . 0.488 HD12 ' HA2' ' A' ' 239' ' ' GLY . 78.5 mt -108.17 177.67 4.73 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 124.351 1.06 . . . . 72.340000000000003 110.479 -170.383 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 47.3 m-85 -129.61 123.59 31.65 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 123.426 0.691 . . . . 71.019999999999996 110.736 -179.546 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 195' ' ' ALA . . . . . 0.435 ' HB2' HD11 ' A' ' 249' ' ' LEU . . . -128.29 171.98 11.48 Favored 'General case' 0 C--O 1.238 0.496 0 C-N-CA 125.64 1.576 . . . . 71.549999999999997 108.43 173.401 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 48.6 m -119.05 134.03 55.44 Favored 'General case' 0 C--O 1.237 0.446 0 C-N-CA 123.126 0.571 . . . . 55.530000000000001 109.675 175.57 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 197' ' ' LEU . . . . . 0.731 HD22 HD13 ' A' ' 251' ' ' LEU . 17.1 tp -116.37 110.87 19.25 Favored 'General case' 0 C--O 1.234 0.288 0 N-CA-C 108.178 -1.045 . . . . 71.329999999999998 108.178 175.477 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -90.14 122.56 33.21 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 108.68 -0.859 . . . . 74.019999999999996 108.68 -179.632 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 199' ' ' VAL . . . . . 0.413 ' O ' ' HA ' ' A' ' 255' ' ' ILE . 5.0 p -136.18 132.4 19.08 Favored Pre-proline 0 CA--C 1.549 0.917 0 C-N-CA 124.287 1.035 . . . . 72.209999999999994 108.835 -174.795 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -71.73 158.87 52.3 Favored 'Trans proline' 0 C--N 1.367 1.551 0 C-N-CA 122.025 1.817 . . . . 74.209999999999994 111.256 171.422 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -53.0 -46.06 97.81 Favored Pre-proline 0 CA--C 1.558 1.257 0 N-CA-C 114.208 1.188 . . . . 73.140000000000001 114.208 -179.675 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 202' ' ' PRO . . . . . 0.465 ' HA ' HG22 ' A' ' 205' ' ' VAL . 34.3 Cg_endo -62.8 -43.45 20.47 Favored 'Trans proline' 0 C--N 1.385 2.494 0 C-N-CA 121.918 1.745 . . . . 64.430000000000007 113.675 177.527 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 43.5 mt -66.01 -30.73 50.89 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.351 0 CA-C-N 118.746 0.703 . . . . 73.129999999999995 110.5 177.979 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -68.74 -49.38 59.26 Favored 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 122.769 0.428 . . . . 64.019999999999996 111.587 177.26 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 205' ' ' VAL . . . . . 0.465 HG22 ' HA ' ' A' ' 202' ' ' PRO . 22.7 m -70.92 -47.83 60.09 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.848 0 C-N-CA 123.542 0.737 . . . . 71.030000000000001 112.411 -174.905 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 206' ' ' VAL . . . . . 0.449 HG22 ' O ' ' A' ' 202' ' ' PRO . 11.0 m -76.22 -34.19 25.45 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.235 0 C-N-CA 122.552 0.341 . . . . 43.119999999999997 110.979 179.712 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 87.47 61.06 1.57 Allowed Glycine 0 C--N 1.35 1.31 0 CA-C-N 116.251 -0.431 . . . . 70.109999999999999 112.135 -175.996 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -81.59 -133.93 1.64 Allowed Glycine 0 C--N 1.346 1.132 0 N-CA-C 112.511 -0.236 . . . . 74.099999999999994 112.511 177.929 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 48.0 mtmt -136.21 152.67 51.01 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 123.895 0.878 . . . . 60.5 110.839 178.741 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 4.5 m -144.76 163.52 13.48 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 C-N-CA 125.412 1.485 . . . . 70.439999999999998 108.363 172.238 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 42.0 ttp180 -98.94 115.36 28.71 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 123.622 0.769 . . . . 74.140000000000001 109.26 179.277 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -101.92 120.81 41.0 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 124.145 0.978 . . . . 71.209999999999994 110.429 -179.489 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 74.6 mtp -84.26 137.28 33.56 Favored 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 110.125 -0.324 . . . . 55.240000000000002 110.125 175.708 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 38.0 p -130.54 -172.9 2.92 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 124.592 1.157 . . . . 74.019999999999996 109.551 -175.889 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 82.6 mt -58.29 -35.0 71.17 Favored 'General case' 0 N--CA 1.488 1.465 0 CA-C-O 121.152 0.501 . . . . 73.310000000000002 110.565 172.723 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -92.29 -8.49 45.05 Favored 'General case' 0 CA--C 1.545 0.754 0 CA-C-N 115.166 -0.925 . . . . 72.010000000000005 111.378 -177.8 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 113.61 -159.32 13.75 Favored Glycine 0 C--N 1.348 1.224 0 CA-C-O 119.575 -0.569 . . . . 62.210000000000001 113.329 174.111 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -77.86 136.66 15.19 Favored 'Trans proline' 0 C--N 1.368 1.566 0 C-N-CA 123.24 2.627 . . . . 72.439999999999998 113.217 -171.584 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 6.2 p -132.8 133.09 59.4 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 C-N-CA 124.403 1.081 . . . . 64.400000000000006 109.376 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -76.61 102.06 5.97 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 108.534 -0.913 . . . . 63.039999999999999 108.534 176.173 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 6.1 p -110.06 127.25 67.1 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.975 0 N-CA-C 109.242 -0.651 . . . . 54.299999999999997 109.242 -174.06 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 222' ' ' ALA . . . . . 0.447 ' HB3' HD21 ' A' ' 172' ' ' LEU . . . -81.76 108.36 15.24 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 122.991 0.516 . . . . 42.109999999999999 110.755 -177.983 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 65.1 t -54.34 135.25 61.15 Favored Pre-proline 0 N--CA 1.484 1.245 0 C-N-CA 124.671 1.188 . . . . 51.299999999999997 110.61 179.8 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -65.41 147.69 87.43 Favored 'Trans proline' 0 C--N 1.378 2.119 0 C-N-CA 122.012 1.808 . . . . 63.130000000000003 110.873 174.219 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -60.89 138.0 76.17 Favored 'Trans proline' 0 C--N 1.368 1.592 0 C-N-CA 121.66 1.573 . . . . 73.129999999999995 111.058 174.238 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 30.9 mtm105 63.24 51.23 2.76 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 124.597 1.159 . . . . 64.5 110.953 174.632 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 227' ' ' THR . . . . . 0.41 HG23 ' HD2' ' A' ' 231' ' ' ARG . 90.4 m -77.7 137.05 38.28 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 115.299 -0.864 . . . . 73.040000000000006 109.087 170.457 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 28.1 mp0 -114.65 147.02 40.18 Favored 'General case' 0 N--CA 1.479 0.993 0 N-CA-C 108.939 -0.763 . . . . 61.229999999999997 108.939 174.534 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -57.91 124.54 19.58 Favored 'General case' 0 C--O 1.24 0.557 0 O-C-N 123.903 0.752 . . . . 73.109999999999999 111.017 -178.951 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 114.87 -14.53 19.52 Favored Glycine 0 N--CA 1.468 0.816 0 CA-C-O 119.076 -0.847 . . . . 43.450000000000003 113.858 -176.776 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 231' ' ' ARG . . . . . 0.419 ' HD3' ' HA ' ' A' ' 179' ' ' ALA . 88.9 mtt-85 -62.95 146.61 52.64 Favored 'General case' 0 N--CA 1.478 0.967 0 CA-C-N 117.759 0.779 . . . . 53.130000000000003 111.113 178.12 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 71.7 mmtt -118.84 97.49 5.73 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 123.996 0.918 . . . . 75.219999999999999 109.029 -172.954 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 233' ' ' LEU . . . . . 0.653 ' HB2' ' HB2' ' A' ' 251' ' ' LEU . 21.2 mt -85.52 137.96 32.53 Favored 'General case' 0 CA--C 1.546 0.807 0 N-CA-C 109.126 -0.694 . . . . 73.319999999999993 109.126 -175.316 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 36.3 ttm-85 -110.86 114.31 27.55 Favored 'General case' 0 CA--C 1.558 1.25 0 C-N-CA 123.054 0.542 . . . . 75.439999999999998 111.377 -169.027 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 235' ' ' LEU . . . . . 0.572 HD11 HD11 ' A' ' 251' ' ' LEU . 16.5 mt -108.63 113.56 26.65 Favored 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 123.929 0.891 . . . . 74.400000000000006 111.641 -176.535 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 34.8 mttp -72.91 148.94 43.86 Favored 'General case' 0 N--CA 1.481 1.114 0 CA-C-O 121.338 0.589 . . . . 73.549999999999997 111.76 174.164 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 78.17 0.59 77.6 Favored Glycine 0 C--N 1.344 1.02 0 CA-C-N 114.107 -1.406 . . . . 72.109999999999999 113.87 179.775 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 73.4 mmtt -112.85 3.43 16.38 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.177 0.591 . . . . 74.049999999999997 111.457 -174.646 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 239' ' ' GLY . . . . . 0.488 ' HA2' HD12 ' A' ' 193' ' ' LEU . . . -113.27 -170.15 17.49 Favored Glycine 0 C--N 1.348 1.241 0 N-CA-C 111.328 -0.709 . . . . 35.0 111.328 166.834 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 79.8 m-85 -88.3 151.71 49.08 Favored Pre-proline 0 N--CA 1.481 1.114 0 C-N-CA 123.084 0.553 . . . . 52.539999999999999 110.803 -178.114 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_exo -67.44 168.03 19.06 Favored 'Trans proline' 0 C--N 1.371 1.741 0 C-N-CA 122.361 2.04 . . . . 73.120000000000005 112.614 172.974 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 144.06 -104.78 0.35 Allowed Glycine 0 C--N 1.348 1.212 0 CA-C-O 119.332 -0.704 . . . . 72.209999999999994 113.982 172.149 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -64.22 -30.86 64.47 Favored 'Trans proline' 0 C--N 1.375 1.94 0 C-N-CA 124.012 3.141 . . . . 72.140000000000001 114.313 -168.0 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -117.15 5.83 12.77 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 122.924 0.489 . . . . 32.409999999999997 110.701 173.593 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 87.81 -46.23 3.42 Favored Glycine 0 C--N 1.35 1.353 0 CA-C-N 116.905 -0.134 . . . . 63.329999999999998 113.131 178.234 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 31.3 ttm180 -123.99 112.02 16.7 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 124.369 1.068 . . . . 72.340000000000003 109.299 177.479 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -73.57 159.56 53.19 Favored Glycine 0 C--N 1.349 1.253 0 O-C-N 123.431 0.457 . . . . 52.119999999999997 114.17 176.119 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 248' ' ' ASP . . . . . 0.418 ' HA ' ' O ' ' A' ' 235' ' ' LEU . 12.4 m-20 -111.56 171.52 7.44 Favored 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 124.026 0.93 . . . . 71.510000000000005 111.4 -177.838 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 249' ' ' LEU . . . . . 0.435 HD11 ' HB2' ' A' ' 195' ' ' ALA . 25.9 tp -130.6 126.33 36.43 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 115.021 -0.99 . . . . 72.040000000000006 109.748 174.107 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 250' ' ' TYR . . . . . . . . . . . . . 2.8 m-30 -89.85 113.0 24.51 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 124.235 1.014 . . . . 72.030000000000001 110.516 179.76 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 251' ' ' LEU . . . . . 0.731 HD13 HD22 ' A' ' 197' ' ' LEU . 86.0 mt -87.2 103.34 15.33 Favored 'General case' 0 C--O 1.24 0.578 0 N-CA-C 107.243 -1.391 . . . . 75.200000000000003 107.243 176.091 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -80.77 101.54 9.39 Favored 'General case' 0 C--O 1.241 0.625 0 N-CA-C 108.542 -0.91 . . . . 75.099999999999994 108.542 177.594 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 17.9 m -73.59 135.56 27.3 Favored 'Isoleucine or valine' 0 C--O 1.244 0.808 0 CA-C-N 115.695 -0.684 . . . . 72.420000000000002 110.831 -172.678 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 31.3 mmm180 -125.93 99.23 5.85 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 114.559 -1.2 . . . . 71.099999999999994 108.13 -176.734 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 255' ' ' ILE . . . . . 0.413 ' HA ' ' O ' ' A' ' 199' ' ' VAL . 23.5 mt -79.35 123.06 35.77 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 O-C-N 123.565 0.541 . . . . 51.399999999999999 110.438 -179.562 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 2.0 t . . . . . 0 CA--C 1.563 1.466 0 N-CA-C 107.673 -1.232 . . . . 71.310000000000002 107.673 176.372 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 172' ' ' LEU . . . . . 0.409 HD21 ' O ' ' A' ' 222' ' ' ALA . 26.4 mt . . . . . 0 N--CA 1.489 1.496 0 N-CA-C 112.524 0.565 . . . . 65.439999999999998 112.524 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 173' ' ' PHE . . . . . 0.512 ' HE1' HG21 ' A' ' 219' ' ' VAL . 38.6 m-85 -150.45 -40.98 0.13 Allowed 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 124.765 1.226 . . . . 74.010000000000005 109.411 -171.396 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 174' ' ' TYR . . . . . 0.434 ' CD2' ' HB3' ' A' ' 233' ' ' LEU . 0.7 OUTLIER -96.22 6.69 48.24 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 124.141 0.976 . . . . 74.409999999999997 112.785 -172.748 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -50.72 -35.21 30.24 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 125.096 1.358 . . . . 65.409999999999997 113.036 -162.446 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 176' ' ' MET . . . . . . . . . . . . . 7.0 ptm -58.39 93.62 0.02 OUTLIER 'General case' 0 CA--C 1.564 1.487 0 C-N-CA 124.638 1.175 . . . . 53.439999999999998 112.111 172.865 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 48.8 mtmt 57.05 42.08 26.5 Favored 'General case' 0 N--CA 1.491 1.61 0 C-N-CA 124.858 1.263 . . . . 70.109999999999999 111.873 171.91 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 178' ' ' ALA . . . . . 0.493 ' HB1' HD22 ' A' ' 233' ' ' LEU . . . -62.19 -42.61 99.45 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.572 1.149 . . . . 74.319999999999993 111.56 -179.675 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 179' ' ' ALA . . . . . 0.48 ' HB2' ' HB2' ' A' ' 224' ' ' PRO . . . -80.68 14.4 2.13 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 123.489 0.716 . . . . 64.310000000000002 111.42 176.347 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.342 0.878 0 N-CA-C 109.914 -1.274 . . . . 45.539999999999999 109.914 169.496 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 191' ' ' GLN . . . . . 0.648 ' HB3' ' HD2' ' A' ' 243' ' ' PRO . 8.0 pt20 . . . . . 0 N--CA 1.469 0.514 0 N-CA-C 109.74 -0.467 . . . . 73.450000000000003 109.74 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 192' ' ' ASP . . . . . 0.42 ' N ' ' HG3' ' A' ' 191' ' ' GLN . 80.9 m-20 -78.77 157.58 28.43 Favored 'General case' 0 C--O 1.239 0.548 0 CA-C-N 115.479 -0.782 . . . . 70.340000000000003 110.42 -175.601 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 46.0 mt -127.68 169.35 13.89 Favored 'General case' 0 C--O 1.238 0.493 0 CA-C-N 114.594 -1.185 . . . . 74.329999999999998 109.415 -178.297 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 64.5 m-85 -135.23 139.22 44.3 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 124.253 1.021 . . . . 71.25 109.422 179.705 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 195' ' ' ALA . . . . . 0.461 ' HB2' HD11 ' A' ' 249' ' ' LEU . . . -150.19 171.67 16.55 Favored 'General case' 0 C--O 1.24 0.56 0 C-N-CA 124.861 1.264 . . . . 75.099999999999994 108.973 -177.602 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 17.6 m -115.31 137.64 51.82 Favored 'General case' 0 C--O 1.238 0.464 0 C-N-CA 122.966 0.507 . . . . 64.150000000000006 109.636 179.013 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 197' ' ' LEU . . . . . 0.674 HD22 HD13 ' A' ' 251' ' ' LEU . 14.6 tp -115.43 110.64 19.62 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 108.914 -0.773 . . . . 74.219999999999999 108.914 177.371 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -79.58 122.79 26.93 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 108.742 -0.836 . . . . 70.5 108.742 174.941 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 199' ' ' VAL . . . . . 0.467 ' O ' ' HA ' ' A' ' 255' ' ' ILE . 4.1 p -142.58 123.32 8.3 Favored Pre-proline 0 CA--C 1.543 0.694 0 N-CA-C 108.771 -0.826 . . . . 72.400000000000006 108.771 178.697 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -67.57 158.48 56.95 Favored 'Trans proline' 0 C--N 1.364 1.365 0 C-N-CA 121.955 1.77 . . . . 74.200000000000003 111.049 171.883 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 201' ' ' ALA . . . . . 0.508 ' O ' HG23 ' A' ' 205' ' ' VAL . . . -47.3 -53.82 25.99 Favored Pre-proline 0 CA--C 1.562 1.42 0 CA-C-O 117.903 -1.046 . . . . 74.219999999999999 112.988 -179.093 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -62.45 -39.88 42.9 Favored 'Trans proline' 0 C--N 1.399 3.199 0 C-N-CA 121.997 1.798 . . . . 74.010000000000005 113.698 -176.267 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 36.5 mt -66.36 -32.63 58.94 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.252 0 C-N-CA 122.701 0.4 . . . . 54.140000000000001 110.091 178.783 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -71.23 -36.02 71.67 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 122.742 0.417 . . . . 74.510000000000005 111.63 177.222 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 205' ' ' VAL . . . . . 0.508 HG23 ' O ' ' A' ' 201' ' ' ALA . 94.9 t -68.58 -57.03 10.22 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.11 0 C-N-CA 123.126 0.57 . . . . 72.129999999999995 111.215 -178.979 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 32.8 m -80.05 -27.55 12.16 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 CA-C-N 116.109 -0.496 . . . . 65.430000000000007 111.605 -175.373 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 81.96 65.1 1.67 Allowed Glycine 0 C--N 1.342 0.902 0 CA-C-N 116.177 -0.465 . . . . 74.140000000000001 111.956 -175.188 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -81.32 -131.99 1.28 Allowed Glycine 0 C--N 1.356 1.655 0 N-CA-C 111.804 -0.519 . . . . 70.25 111.804 177.397 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 21.0 mtmm -137.94 143.37 40.71 Favored 'General case' 0 N--CA 1.481 1.107 0 CA-C-N 117.569 0.685 . . . . 64.040000000000006 111.136 177.372 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 11.1 m -135.93 166.37 27.29 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 C-N-CA 125.032 1.333 . . . . 74.209999999999994 109.755 176.65 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 58.4 ttp180 -100.25 114.65 28.27 Favored 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 123.545 0.738 . . . . 72.25 110.309 -178.174 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -101.6 139.2 37.57 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 124.035 0.934 . . . . 74.010000000000005 110.06 175.402 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 25.2 mmt -96.33 115.17 27.01 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 123.186 0.595 . . . . 63.520000000000003 109.68 179.408 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 214' ' ' THR . . . . . 0.414 ' HB ' ' HD2' ' A' ' 238' ' ' LYS . 43.9 p -122.23 -173.47 2.68 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 124.146 0.978 . . . . 72.409999999999997 111.038 -175.016 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 82.8 mt -69.25 -22.76 63.82 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 123.475 0.71 . . . . 75.040000000000006 111.019 172.771 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 20.4 mm-40 -86.45 -6.07 59.0 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 123.814 0.846 . . . . 74.319999999999993 110.663 173.146 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 94.82 -149.9 19.52 Favored Glycine 0 C--N 1.344 1.025 0 CA-C-O 119.331 -0.705 . . . . 63.229999999999997 112.303 -177.605 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -73.28 122.05 7.68 Favored 'Trans proline' 0 CA--C 1.555 1.537 0 C-N-CA 122.254 1.969 . . . . 75.239999999999995 112.754 -178.559 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 219' ' ' VAL . . . . . 0.512 HG21 ' HE1' ' A' ' 173' ' ' PHE . 2.4 p -116.84 131.15 70.34 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 C-N-CA 124.647 1.179 . . . . 72.430000000000007 109.164 173.649 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 -81.12 101.29 9.53 Favored 'General case' 0 C--O 1.24 0.576 0 N-CA-C 107.454 -1.313 . . . . 73.239999999999995 107.454 168.688 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 4.6 p -100.63 131.32 48.44 Favored 'Isoleucine or valine' 0 C--O 1.246 0.897 0 N-CA-C 108.872 -0.788 . . . . 72.200000000000003 108.872 -176.943 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 222' ' ' ALA . . . . . 0.409 ' O ' HD21 ' A' ' 172' ' ' LEU . . . -77.68 106.95 9.81 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 122.759 0.424 . . . . 70.430000000000007 110.394 -176.723 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 59.9 t -54.24 135.49 60.08 Favored Pre-proline 0 N--CA 1.48 1.04 0 C-N-CA 124.054 0.942 . . . . 53.200000000000003 109.989 178.454 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 224' ' ' PRO . . . . . 0.48 ' HB2' ' HB2' ' A' ' 179' ' ' ALA . 53.8 Cg_endo -67.85 148.76 77.42 Favored 'Trans proline' 0 C--N 1.37 1.672 0 C-N-CA 121.605 1.537 . . . . 74.409999999999997 110.688 173.145 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 16.3 Cg_endo -59.78 139.85 90.47 Favored 'Trans proline' 0 C--N 1.366 1.449 0 C-N-CA 121.591 1.528 . . . . 71.030000000000001 110.698 172.014 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 69.5 mtm180 66.28 50.52 1.33 Allowed 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 124.194 0.998 . . . . 64.150000000000006 111.065 171.981 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 54.0 m -85.85 136.96 33.09 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.922 0.889 . . . . 65.209999999999994 109.415 173.481 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 27.2 mp0 -113.24 144.52 42.56 Favored 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 123.929 0.892 . . . . 62.439999999999998 109.634 178.127 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -58.48 120.97 9.77 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 123.92 0.888 . . . . 72.349999999999994 110.257 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 113.88 -7.01 23.82 Favored Glycine 0 C--O 1.239 0.44 0 CA-C-O 119.268 -0.74 . . . . 73.010000000000005 113.213 -176.013 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 69.0 mtt-85 -67.27 146.67 53.91 Favored 'General case' 0 C--N 1.355 0.821 0 CA-C-N 117.909 0.854 . . . . 75.040000000000006 109.689 172.521 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 232' ' ' LYS . . . . . 0.435 ' HB3' ' HD1' ' A' ' 250' ' ' TYR . 13.1 mtmm -126.28 99.45 5.87 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 123.823 0.849 . . . . 74.349999999999994 108.874 -178.803 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 233' ' ' LEU . . . . . 0.493 HD22 ' HB1' ' A' ' 178' ' ' ALA . 21.4 mt -83.56 135.78 34.5 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 113.844 -1.525 . . . . 74.519999999999996 109.491 -175.243 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 29.9 ttt85 -104.84 101.01 10.63 Favored 'General case' 0 N--CA 1.476 0.837 0 CA-C-O 121.15 0.5 . . . . 71.400000000000006 111.131 -172.815 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 235' ' ' LEU . . . . . 0.531 HD12 HD23 ' A' ' 249' ' ' LEU . 46.7 mt -77.28 100.78 5.99 Favored 'General case' 0 C--O 1.238 0.455 0 C-N-CA 124.512 1.125 . . . . 65.430000000000007 110.028 176.079 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 11.7 mtmt -68.11 134.43 50.56 Favored 'General case' 0 C--O 1.241 0.654 0 O-C-N 123.32 0.388 . . . . 71.400000000000006 111.535 177.702 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 82.1 18.95 65.98 Favored Glycine 0 C--N 1.35 1.31 0 O-C-N 124.316 1.01 . . . . 72.409999999999997 113.612 179.907 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 238' ' ' LYS . . . . . 0.414 ' HD2' ' HB ' ' A' ' 214' ' ' THR . 39.4 mmtm -121.38 27.81 8.11 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 123.452 0.701 . . . . 72.030000000000001 111.299 -179.002 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -138.4 -171.11 12.05 Favored Glycine 0 CA--C 1.525 0.697 0 N-CA-C 110.272 -1.131 . . . . 54.329999999999998 110.272 167.498 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 61.7 m-85 -90.2 155.83 46.61 Favored Pre-proline 0 CA--C 1.545 0.755 0 C-N-CA 123.802 0.841 . . . . 73.219999999999999 109.782 -175.711 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -68.28 169.6 16.53 Favored 'Trans proline' 0 C--N 1.365 1.446 0 C-N-CA 121.978 1.786 . . . . 75.049999999999997 111.461 169.706 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 163.21 -108.27 0.33 Allowed Glycine 0 CA--C 1.531 1.066 0 CA-C-O 119.043 -0.865 . . . . 60.119999999999997 112.533 176.318 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 243' ' ' PRO . . . . . 0.648 ' HD2' ' HB3' ' A' ' 191' ' ' GLN . 84.5 Cg_endo -68.94 -46.92 1.36 Allowed 'Trans proline' 0 C--N 1.372 1.808 0 C-N-CA 123.885 3.056 . . . . 33.299999999999997 113.146 -173.656 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -100.67 -0.82 36.71 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 123.658 0.783 . . . . 74.340000000000003 111.305 -175.704 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 92.5 -43.79 2.62 Favored Glycine 0 C--N 1.352 1.43 0 O-C-N 123.028 0.205 . . . . 61.43 112.859 -179.665 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 13.3 ttm180 -120.36 112.27 18.8 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 124.153 0.981 . . . . 75.420000000000002 110.826 179.24 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -82.84 149.98 27.42 Favored Glycine 0 C--N 1.347 1.169 0 N-CA-C 111.156 -0.778 . . . . 53.43 111.156 167.859 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 38.6 m-20 -135.27 152.38 51.46 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 123.677 0.791 . . . . 72.0 109.675 -172.002 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 249' ' ' LEU . . . . . 0.531 HD23 HD12 ' A' ' 235' ' ' LEU . 61.9 tp -96.88 138.97 33.61 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.158 0.583 . . . . 42.149999999999999 110.134 -175.702 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 250' ' ' TYR . . . . . 0.435 ' HD1' ' HB3' ' A' ' 232' ' ' LYS . 7.4 m-85 -99.02 140.2 33.52 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.091 0.556 . . . . 62.399999999999999 110.026 173.887 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 251' ' ' LEU . . . . . 0.674 HD13 HD22 ' A' ' 197' ' ' LEU . 76.9 mt -115.67 103.86 11.11 Favored 'General case' 0 C--O 1.236 0.38 0 N-CA-C 108.647 -0.871 . . . . 70.409999999999997 108.647 179.763 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -79.54 96.37 6.1 Favored 'General case' 0 C--O 1.242 0.666 0 N-CA-C 108.109 -1.071 . . . . 74.25 108.109 177.917 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 13.0 m -70.55 136.77 25.28 Favored 'Isoleucine or valine' 0 C--O 1.245 0.848 0 CA-C-O 121.389 0.614 . . . . 54.009999999999998 110.59 -173.768 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 11.1 mmt180 -125.78 101.38 6.83 Favored 'General case' 0 C--O 1.241 0.62 0 C-N-CA 124.587 1.155 . . . . 74.219999999999999 108.308 -177.652 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 255' ' ' ILE . . . . . 0.47 HG23 ' HA ' ' A' ' 201' ' ' ALA . 22.7 mt -77.43 107.88 9.71 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.745 0 O-C-N 124.027 0.83 . . . . 62.109999999999999 109.785 179.341 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 7.2 t . . . . . 0 CA--C 1.567 1.621 0 CA-C-O 117.36 -1.305 . . . . 52.530000000000001 108.191 179.122 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 172' ' ' LEU . . . . . 0.49 HD21 ' HB3' ' A' ' 222' ' ' ALA . 21.1 mt . . . . . 0 N--CA 1.488 1.427 0 CA-C-O 120.735 0.302 . . . . 74.310000000000002 111.317 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 173' ' ' PHE . . . . . 0.451 ' CD1' HD22 ' A' ' 235' ' ' LEU . 45.0 m-85 -126.79 -57.83 1.33 Allowed 'General case' 0 N--CA 1.49 1.574 0 CA-C-O 121.679 0.752 . . . . 64.209999999999994 110.65 -170.445 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 174' ' ' TYR . . . . . 0.479 ' CD2' ' HB3' ' A' ' 233' ' ' LEU . 4.6 p90 -79.3 4.48 15.02 Favored 'General case' 0 N--CA 1.479 0.994 0 CA-C-N 114.76 -1.109 . . . . 74.25 113.352 -172.776 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 175' ' ' THR . . . . . 0.432 HG21 HD13 ' A' ' 172' ' ' LEU . 15.0 p -69.18 -5.18 20.92 Favored 'General case' 0 N--CA 1.479 0.995 0 N-CA-C 112.681 0.623 . . . . 54.109999999999999 112.681 -179.259 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 176' ' ' MET . . . . . . . . . . . . . 24.6 ptt? -61.24 -34.5 75.25 Favored 'General case' 0 CA--C 1.555 1.168 0 C-N-CA 123.632 0.773 . . . . 73.430000000000007 110.383 168.029 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 84.6 tttt -165.04 92.77 0.59 Allowed 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 124.869 1.268 . . . . 65.109999999999999 108.105 -178.427 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -128.71 142.65 50.94 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 123.877 0.871 . . . . 74.200000000000003 110.229 -171.582 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 179' ' ' ALA . . . . . 0.42 ' HB2' ' HB2' ' A' ' 224' ' ' PRO . . . 59.98 21.56 10.64 Favored 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 124.849 1.26 . . . . 73.109999999999999 112.104 -175.961 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.34 0.772 0 N-CA-C 110.768 -0.933 . . . . 55.009999999999998 110.768 176.288 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 191' ' ' GLN . . . . . 0.52 ' HB2' ' HA2' ' A' ' 247' ' ' GLY . 29.0 pt20 . . . . . 0 N--CA 1.475 0.816 0 CA-C-O 120.415 0.15 . . . . 73.209999999999994 110.99 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -75.73 142.35 42.43 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-O 121.41 0.624 . . . . 73.140000000000001 111.341 -171.592 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 45.0 mt -130.91 170.96 13.73 Favored 'General case' 0 C--O 1.239 0.501 0 CA-C-N 114.216 -1.356 . . . . 73.120000000000005 108.994 174.122 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 26.6 m-85 -143.44 122.27 12.69 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 124.03 0.932 . . . . 75.430000000000007 109.503 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 195' ' ' ALA . . . . . 0.439 ' HB2' HD11 ' A' ' 249' ' ' LEU . . . -124.69 128.89 49.51 Favored 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 107.67 -1.233 . . . . 55.439999999999998 107.67 174.154 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 6.1 m -81.47 119.47 23.78 Favored 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 108.203 -1.036 . . . . 63.329999999999998 108.203 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 197' ' ' LEU . . . . . 0.717 HD22 HD13 ' A' ' 251' ' ' LEU . 17.2 tp -104.74 110.55 22.93 Favored 'General case' 0 N--CA 1.466 0.374 0 N-CA-C 108.404 -0.962 . . . . 75.310000000000002 108.404 -172.984 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -77.48 125.53 29.48 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 108.482 -0.933 . . . . 73.420000000000002 108.482 177.234 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 199' ' ' VAL . . . . . 0.491 ' O ' ' HA ' ' A' ' 255' ' ' ILE . 5.4 p -144.15 129.45 9.62 Favored Pre-proline 0 CA--C 1.545 0.767 0 N-CA-C 108.488 -0.931 . . . . 71.219999999999999 108.488 176.465 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -71.86 157.15 55.64 Favored 'Trans proline' 0 C--O 1.248 1.02 0 C-N-CA 121.655 1.57 . . . . 72.430000000000007 111.342 170.309 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 201' ' ' ALA . . . . . 0.448 ' O ' HG23 ' A' ' 205' ' ' VAL . . . -51.29 -53.46 49.0 Favored Pre-proline 0 CA--C 1.556 1.2 0 O-C-N 124.32 1.013 . . . . 74.310000000000002 113.078 -176.501 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -67.01 -33.5 31.98 Favored 'Trans proline' 0 C--N 1.403 3.438 0 C-N-CA 121.678 1.585 . . . . 71.409999999999997 112.854 -175.044 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 203' ' ' ILE . . . . . 0.438 HG23 ' HA3' ' A' ' 208' ' ' GLY . 27.6 mt -66.03 -35.45 75.09 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.311 0 C-N-CA 122.586 0.354 . . . . 62.310000000000002 110.064 176.05 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 204' ' ' ALA . . . . . 0.485 ' HA ' HG11 ' A' ' 223' ' ' VAL . . . -71.01 -31.88 68.51 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 122.656 0.382 . . . . 74.310000000000002 111.51 178.617 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 205' ' ' VAL . . . . . 0.448 HG23 ' O ' ' A' ' 201' ' ' ALA . 92.8 t -73.77 -55.64 11.79 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 C-N-CA 122.896 0.478 . . . . 73.530000000000001 111.104 178.43 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 13.7 m -78.86 -26.41 13.44 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.003 0 C-N-CA 122.979 0.512 . . . . 71.310000000000002 111.927 -172.248 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 87.9 76.08 1.28 Allowed Glycine 0 CA--C 1.529 0.951 0 N-CA-C 111.972 -0.451 . . . . 73.510000000000005 111.972 -175.531 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 208' ' ' GLY . . . . . 0.438 ' HA3' HG23 ' A' ' 203' ' ' ILE . . . -95.37 -147.13 22.15 Favored Glycine 0 N--CA 1.477 1.369 0 CA-C-O 119.537 -0.591 . . . . 74.129999999999995 111.793 175.961 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 49.9 mtmt -132.86 145.63 51.12 Favored 'General case' 0 N--CA 1.482 1.125 0 CA-C-N 117.52 0.66 . . . . 73.209999999999994 111.151 176.742 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 12.0 m -139.25 164.91 24.14 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 C-N-CA 125.672 1.589 . . . . 73.109999999999999 108.93 175.932 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 23.9 ttm180 -103.44 117.13 33.75 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 123.386 0.674 . . . . 72.540000000000006 109.894 -174.246 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -103.69 123.33 46.82 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 124.729 1.212 . . . . 62.229999999999997 109.914 178.934 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 89.1 mmm -87.49 115.38 24.87 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 123.362 0.665 . . . . 74.450000000000003 110.166 -178.988 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 17.6 p -113.9 -178.71 3.44 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 123.976 0.91 . . . . 45.310000000000002 110.607 -175.856 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 81.0 mt -63.27 -23.94 67.64 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 122.842 0.457 . . . . 63.020000000000003 111.549 172.713 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -103.54 23.2 13.0 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 124.071 0.948 . . . . 63.43 110.893 179.867 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 87.88 -163.82 33.67 Favored Glycine 0 C--N 1.344 1.005 0 CA-C-N 116.299 -0.409 . . . . 45.310000000000002 113.141 175.59 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -72.12 144.73 42.83 Favored 'Trans proline' 0 C--N 1.362 1.244 0 C-N-CA 122.156 1.904 . . . . 73.0 112.804 -178.935 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 5.4 p -139.67 127.74 26.24 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 N-CA-C 108.083 -1.08 . . . . 73.230000000000004 108.083 170.047 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -82.19 103.3 11.69 Favored 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 108.461 -0.94 . . . . 72.439999999999998 108.461 176.264 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 2.8 p -100.3 133.62 42.75 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.841 0 O-C-N 124.149 0.906 . . . . 75.010000000000005 108.654 -174.931 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 222' ' ' ALA . . . . . 0.49 ' HB3' HD21 ' A' ' 172' ' ' LEU . . . -78.91 111.67 15.31 Favored 'General case' 0 C--O 1.24 0.6 0 C-N-CA 122.8 0.44 . . . . 74.209999999999994 110.541 -177.874 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 223' ' ' VAL . . . . . 0.485 HG11 ' HA ' ' A' ' 204' ' ' ALA . 48.9 t -54.61 131.63 64.29 Favored Pre-proline 0 CA--C 1.542 0.643 0 O-C-N 124.509 1.13 . . . . 74.409999999999997 109.909 177.496 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 224' ' ' PRO . . . . . 0.425 ' HD3' ' CE1' ' A' ' 174' ' ' TYR . 43.1 Cg_endo -67.3 152.5 79.14 Favored 'Trans proline' 0 CA--C 1.555 1.545 0 C-N-CA 121.657 1.571 . . . . 44.399999999999999 111.312 175.546 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -65.6 141.99 69.08 Favored 'Trans proline' 0 C--N 1.371 1.712 0 C-N-CA 121.941 1.761 . . . . 75.230000000000004 112.219 179.811 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 96.6 mtt180 65.42 32.15 9.82 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 124.827 1.251 . . . . 71.310000000000002 111.834 168.863 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 227' ' ' THR . . . . . 0.471 HG23 ' HD2' ' A' ' 231' ' ' ARG . 98.6 m -72.84 139.02 46.69 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 123.969 0.907 . . . . 74.25 109.89 174.946 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -111.66 155.53 23.28 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 123.113 0.565 . . . . 73.510000000000005 109.686 174.595 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 229' ' ' ALA . . . . . 0.601 ' HB2' ' HB ' ' A' ' 255' ' ' ILE . . . -54.99 122.63 11.33 Favored 'General case' 0 CA--C 1.536 0.442 0 O-C-N 124.896 1.372 . . . . 74.230000000000004 111.338 -179.302 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 112.57 -10.61 25.91 Favored Glycine 0 C--N 1.341 0.831 0 CA-C-O 119.568 -0.573 . . . . 35.210000000000001 113.718 177.029 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 231' ' ' ARG . . . . . 0.471 ' HD2' HG23 ' A' ' 227' ' ' THR . 53.0 mtt-85 -62.1 141.45 58.13 Favored 'General case' 0 N--CA 1.478 0.941 0 CA-C-N 117.246 0.523 . . . . 73.25 111.1 176.418 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 31.5 mmtp -112.47 103.58 11.67 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 108.585 -0.895 . . . . 52.100000000000001 108.585 -175.64 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 233' ' ' LEU . . . . . 0.736 ' HB2' ' HB2' ' A' ' 251' ' ' LEU . 41.7 mt -83.08 149.47 26.89 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 115.295 -0.866 . . . . 71.299999999999997 108.849 177.181 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 62.0 ttt180 -118.6 102.42 8.86 Favored 'General case' 0 N--CA 1.478 0.926 0 CA-C-N 117.958 0.345 . . . . 74.510000000000005 110.482 -173.404 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 235' ' ' LEU . . . . . 0.544 ' HB2' ' HB3' ' A' ' 249' ' ' LEU . 14.8 mt -85.92 94.84 9.29 Favored 'General case' 0 C--O 1.242 0.706 0 C-N-CA 123.197 0.599 . . . . 73.200000000000003 109.81 175.507 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 20.2 mttt -69.02 138.12 54.22 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 115.648 -0.706 . . . . 73.439999999999998 110.466 175.443 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 85.68 3.03 86.48 Favored Glycine 0 C--N 1.338 0.644 0 O-C-N 123.908 0.755 . . . . 33.399999999999999 113.348 -179.355 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 76.0 mmtt -116.78 9.24 13.88 Favored 'General case' 0 N--CA 1.485 1.323 0 CA-C-N 117.414 0.607 . . . . 73.25 111.919 -176.274 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -109.68 -165.65 19.94 Favored Glycine 0 C--N 1.346 1.09 0 N-CA-C 111.139 -0.784 . . . . 65.109999999999999 111.139 167.419 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 68.7 m-85 -86.82 158.79 53.13 Favored Pre-proline 0 N--CA 1.484 1.272 0 C-N-CA 123.446 0.698 . . . . 72.150000000000006 112.371 -176.291 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_exo -64.21 165.4 19.71 Favored 'Trans proline' 0 C--N 1.371 1.715 0 C-N-CA 122.24 1.96 . . . . 63.299999999999997 112.73 166.716 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 157.45 -107.94 0.34 Allowed Glycine 0 C--N 1.34 0.789 0 CA-C-O 118.806 -0.997 . . . . 71.439999999999998 111.999 173.431 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -68.65 -57.08 0.15 Allowed 'Trans proline' 0 C--N 1.378 2.09 0 C-N-CA 123.616 2.878 . . . . 72.549999999999997 112.666 -170.201 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -80.87 -22.39 39.87 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 123.417 0.687 . . . . 74.319999999999993 110.615 175.244 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 96.48 -33.53 5.6 Favored Glycine 0 C--N 1.352 1.437 0 N-CA-C 111.283 -0.727 . . . . 73.129999999999995 111.283 -169.894 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 29.2 ttm180 -106.7 111.89 24.63 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 124.68 1.192 . . . . 71.239999999999995 109.981 178.794 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 247' ' ' GLY . . . . . 0.52 ' HA2' ' HB2' ' A' ' 191' ' ' GLN . . . -79.53 162.97 47.94 Favored Glycine 0 C--O 1.247 0.919 0 O-C-N 123.528 0.518 . . . . 70.140000000000001 113.748 169.249 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 17.6 m-20 -128.16 129.23 46.19 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 123.814 0.846 . . . . 74.400000000000006 109.173 -169.456 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 249' ' ' LEU . . . . . 0.544 ' HB3' ' HB2' ' A' ' 235' ' ' LEU . 49.3 tp -99.54 113.62 26.13 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 124.005 0.922 . . . . 60.030000000000001 109.089 177.715 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 250' ' ' TYR . . . . . 0.421 ' HA ' ' O ' ' A' ' 233' ' ' LEU . 8.8 m-85 -90.28 114.59 26.66 Favored 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 123.593 0.757 . . . . 70.25 110.933 -176.467 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 251' ' ' LEU . . . . . 0.736 ' HB2' ' HB2' ' A' ' 233' ' ' LEU . 89.9 mt -88.05 106.3 18.06 Favored 'General case' 0 C--O 1.241 0.638 0 C-N-CA 124.846 1.258 . . . . 74.219999999999999 109.162 -179.013 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -82.3 99.95 9.64 Favored 'General case' 0 C--O 1.242 0.704 0 N-CA-C 108.463 -0.94 . . . . 73.239999999999995 108.463 175.386 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 11.5 m -67.23 132.73 32.25 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.853 0 O-C-N 123.782 0.676 . . . . 60.030000000000001 109.351 -177.498 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 17.9 mmt85 -123.11 95.21 4.52 Favored 'General case' 0 C--O 1.239 0.502 0 C-N-CA 124.517 1.127 . . . . 75.019999999999996 108.216 -177.996 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 255' ' ' ILE . . . . . 0.601 ' HB ' ' HB2' ' A' ' 229' ' ' ALA . 12.9 mt -76.43 125.25 36.0 Favored 'Isoleucine or valine' 0 C--O 1.233 0.208 0 O-C-N 123.945 0.778 . . . . 62.43 110.21 179.406 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 1.6 t . . . . . 0 CA--C 1.561 1.402 0 CA-C-O 117.546 -1.216 . . . . 37.960000000000001 107.768 173.877 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 172' ' ' LEU . . . . . 0.569 ' HB3' HG23 ' A' ' 175' ' ' THR . 55.7 mt . . . . . 0 N--CA 1.467 0.419 0 CA-C-O 121.134 0.493 . . . . 61.439999999999998 111.27 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 173' ' ' PHE . . . . . 0.552 ' CD1' HD22 ' A' ' 235' ' ' LEU . 7.5 m-85 -140.13 -44.1 0.42 Allowed 'General case' 0 N--CA 1.482 1.142 0 CA-C-N 114.966 -1.015 . . . . 73.519999999999996 109.118 -171.21 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 174' ' ' TYR . . . . . . . . . . . . . 1.9 p90 -86.18 19.3 2.73 Favored 'General case' 0 CA--C 1.547 0.83 0 CA-C-N 114.502 -1.226 . . . . 61.229999999999997 112.394 -176.158 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 175' ' ' THR . . . . . 0.569 HG23 ' HB3' ' A' ' 172' ' ' LEU . 17.6 p -62.87 -21.63 66.11 Favored 'General case' 0 N--CA 1.493 1.692 0 CA-C-N 118.909 0.777 . . . . 70.530000000000001 112.853 -179.2 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 176' ' ' MET . . . . . . . . . . . . . 21.4 ptt? -52.4 -42.45 64.04 Favored 'General case' 0 CA--C 1.558 1.287 0 C-N-CA 124.367 1.067 . . . . 52.43 110.95 171.016 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 19.7 tptm -167.42 100.07 0.5 Allowed 'General case' 0 C--N 1.349 0.553 0 C-N-CA 125.532 1.533 . . . . 64.329999999999998 107.017 176.844 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 178' ' ' ALA . . . . . 0.434 ' HB1' ' HB3' ' A' ' 224' ' ' PRO . . . -74.65 -74.42 0.2 Allowed 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 115.556 -0.747 . . . . 72.120000000000005 112.096 -168.306 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -69.65 95.53 0.87 Allowed 'General case' 0 CA--C 1.541 0.629 0 O-C-N 123.381 0.425 . . . . 74.239999999999995 110.19 -177.328 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.348 1.243 0 CA-C-N 115.489 -0.778 . . . . 41.119999999999997 112.063 -178.328 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 191' ' ' GLN . . . . . 0.492 ' HG3' ' N ' ' A' ' 192' ' ' ASP . 5.0 pt20 . . . . . 0 CA--C 1.544 0.724 0 CA-C-O 120.617 0.246 . . . . 55.130000000000003 110.758 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 192' ' ' ASP . . . . . 0.492 ' N ' ' HG3' ' A' ' 191' ' ' GLN . 24.4 m-20 -77.55 123.87 27.16 Favored 'General case' 0 C--N 1.351 0.643 0 C-N-CA 123.76 0.824 . . . . 73.150000000000006 109.096 -177.125 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 193' ' ' LEU . . . . . 0.544 HD12 ' HA2' ' A' ' 239' ' ' GLY . 41.0 mt -111.71 173.57 6.29 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 124.612 1.165 . . . . 72.420000000000002 109.987 -178.186 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 45.8 m-85 -130.15 129.28 43.28 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 123.778 0.831 . . . . 65.219999999999999 109.57 176.33 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 195' ' ' ALA . . . . . 0.451 ' HB2' HD11 ' A' ' 249' ' ' LEU . . . -129.65 167.49 17.91 Favored 'General case' 0 C--O 1.239 0.549 0 C-N-CA 124.989 1.316 . . . . 33.399999999999999 107.47 170.237 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 31.4 m -117.27 124.17 48.37 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 108.731 -0.84 . . . . 71.25 108.731 179.335 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 197' ' ' LEU . . . . . 0.653 HD22 HD13 ' A' ' 251' ' ' LEU . 15.3 tp -107.7 109.81 21.49 Favored 'General case' 0 CA--C 1.53 0.211 0 N-CA-C 107.823 -1.177 . . . . 72.219999999999999 107.823 -177.711 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -83.42 128.63 34.66 Favored 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 109.05 -0.722 . . . . 73.340000000000003 109.05 178.156 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 199' ' ' VAL . . . . . 0.543 ' O ' ' HA ' ' A' ' 255' ' ' ILE . 4.0 p -143.78 129.57 9.96 Favored Pre-proline 0 CA--C 1.543 0.699 0 N-CA-C 108.201 -1.037 . . . . 75.310000000000002 108.201 179.765 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -69.1 157.9 59.91 Favored 'Trans proline' 0 C--N 1.364 1.383 0 C-N-CA 121.905 1.737 . . . . 54.240000000000002 111.502 170.038 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 201' ' ' ALA . . . . . 0.486 ' O ' HG23 ' A' ' 205' ' ' VAL . . . -49.74 -53.7 39.17 Favored Pre-proline 0 CA--C 1.561 1.385 0 O-C-N 124.768 1.292 . . . . 74.430000000000007 112.792 -178.195 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -61.94 -35.38 77.81 Favored 'Trans proline' 0 C--N 1.401 3.314 0 C-N-CA 121.988 1.792 . . . . 71.099999999999994 113.339 -176.388 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 38.1 mt -71.35 -31.94 45.21 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.104 0 C-N-CA 123.068 0.547 . . . . 75.439999999999998 110.321 179.145 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -72.95 -34.05 66.27 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 122.463 0.305 . . . . 63.109999999999999 111.516 176.18 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 205' ' ' VAL . . . . . 0.486 HG23 ' O ' ' A' ' 201' ' ' ALA . 90.6 t -67.72 -55.77 15.67 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 C-N-CA 123.836 0.854 . . . . 72.409999999999997 110.874 177.936 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 18.4 m -80.87 -27.96 11.2 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.079 0 C-N-CA 122.753 0.421 . . . . 54.130000000000003 111.744 -174.469 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 82.02 67.9 1.48 Allowed Glycine 0 C--N 1.347 1.176 0 O-C-N 123.736 0.647 . . . . 52.32 112.113 -173.988 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -84.35 -131.88 2.25 Favored Glycine 0 C--N 1.352 1.435 0 CA-C-O 119.68 -0.511 . . . . 54.039999999999999 111.953 179.436 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 209' ' ' LYS . . . . . 0.431 ' HG2' ' HA ' ' A' ' 222' ' ' ALA . 48.0 mtmt -139.99 150.92 45.05 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 123.908 0.883 . . . . 64.230000000000004 111.425 178.258 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 15.2 m -146.04 168.92 6.61 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 C-N-CA 126.005 1.722 . . . . 73.230000000000004 108.388 176.584 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 37.0 ptt180 -95.03 128.65 42.02 Favored 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 109.371 -0.603 . . . . 74.019999999999996 109.371 172.626 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -102.31 112.36 25.02 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 123.895 0.878 . . . . 64.319999999999993 108.631 174.175 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 74.8 mtp -82.98 108.78 16.54 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 109.382 -0.599 . . . . 75.420000000000002 109.382 -175.746 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 26.7 p -111.39 -172.47 2.04 Favored 'General case' 0 C--O 1.242 0.686 0 C-N-CA 124.174 0.989 . . . . 73.040000000000006 110.224 -173.179 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 84.2 mt -61.97 -28.84 69.84 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 123.439 0.696 . . . . 72.409999999999997 111.368 173.386 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -100.22 7.94 44.14 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 123.656 0.783 . . . . 74.349999999999994 111.427 179.424 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 100.84 -173.11 24.28 Favored Glycine 0 C--N 1.347 1.16 0 CA-C-O 119.929 -0.373 . . . . 74.030000000000001 113.819 175.763 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_endo -71.57 127.59 13.36 Favored 'Trans proline' 0 C--N 1.368 1.579 0 C-N-CA 122.855 2.37 . . . . 74.239999999999995 112.351 -176.852 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 5.0 p -119.77 130.76 73.75 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 C-N-CA 123.714 0.806 . . . . 65.230000000000004 108.846 178.436 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -70.52 101.63 2.04 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 108.751 -0.833 . . . . 75.439999999999998 108.751 177.755 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 3.0 p -106.64 134.38 48.45 Favored 'Isoleucine or valine' 0 C--O 1.244 0.774 0 N-CA-C 108.377 -0.971 . . . . 52.119999999999997 108.377 -176.304 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 222' ' ' ALA . . . . . 0.445 ' HB3' HD21 ' A' ' 172' ' ' LEU . . . -82.19 108.74 15.89 Favored 'General case' 0 N--CA 1.467 0.414 0 N-CA-C 109.975 -0.38 . . . . 54.299999999999997 109.975 -179.358 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 43.0 t -54.54 134.74 63.22 Favored Pre-proline 0 N--CA 1.478 0.945 0 C-N-CA 124.753 1.221 . . . . 62.009999999999998 110.436 -178.14 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 224' ' ' PRO . . . . . 0.434 ' HB3' ' HB1' ' A' ' 178' ' ' ALA . 12.2 Cg_endo -58.22 150.46 66.13 Favored 'Trans proline' 0 C--N 1.37 1.699 0 C-N-CA 122.221 1.947 . . . . 64.219999999999999 111.942 169.779 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -78.41 148.51 23.67 Favored 'Trans proline' 0 C--N 1.366 1.497 0 C-N-CA 122.065 1.843 . . . . 65.400000000000006 110.937 174.136 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 45.8 mtm180 59.56 41.28 19.23 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 124.302 1.041 . . . . 72.420000000000002 111.271 174.122 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 227' ' ' THR . . . . . 0.545 HG23 ' HD2' ' A' ' 231' ' ' ARG . 55.5 m -82.29 141.64 32.75 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 114.334 -1.303 . . . . 72.129999999999995 109.438 177.097 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 27.7 mp0 -115.96 145.18 43.15 Favored 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 123.764 0.826 . . . . 52.140000000000001 109.245 176.381 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 229' ' ' ALA . . . . . 0.413 ' HB2' ' HB ' ' A' ' 255' ' ' ILE . . . -57.04 119.42 6.27 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.986 0.914 . . . . 40.140000000000001 111.119 -178.079 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 114.38 -5.33 23.25 Favored Glycine 0 C--N 1.342 0.869 0 O-C-N 123.825 0.703 . . . . 42.409999999999997 112.696 -176.768 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 231' ' ' ARG . . . . . 0.545 ' HD2' HG23 ' A' ' 227' ' ' THR . 55.0 mtt-85 -69.67 148.68 48.97 Favored 'General case' 0 C--N 1.363 1.194 0 CA-C-N 117.704 0.752 . . . . 74.319999999999993 109.124 169.724 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 36.5 mtmt -130.2 118.26 21.12 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 123.166 0.586 . . . . 64.439999999999998 109.56 -174.334 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 233' ' ' LEU . . . . . . . . . . . . . 9.0 mt -101.47 138.94 37.81 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 124.318 1.047 . . . . 65.340000000000003 108.487 -172.307 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 234' ' ' ARG . . . . . 0.505 ' HG3' ' HB3' ' A' ' 248' ' ' ASP . 35.8 ttm-85 -102.04 118.45 36.94 Favored 'General case' 0 N--CA 1.479 0.982 0 CA-C-N 118.013 0.37 . . . . 73.329999999999998 111.434 -173.83 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 235' ' ' LEU . . . . . 0.552 HD22 ' CD1' ' A' ' 173' ' ' PHE . 13.7 mt -103.87 111.62 24.23 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 123.492 0.717 . . . . 64.310000000000002 110.271 179.069 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 65.1 mttt -69.66 144.59 52.86 Favored 'General case' 0 N--CA 1.471 0.578 0 O-C-N 123.205 0.316 . . . . 61.340000000000003 111.196 176.178 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 73.88 -5.72 23.25 Favored Glycine 0 N--CA 1.472 1.05 0 O-C-N 124.624 1.203 . . . . 75.319999999999993 114.578 179.065 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -101.24 0.89 38.23 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 123.043 0.537 . . . . 73.329999999999998 110.896 -176.498 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 239' ' ' GLY . . . . . 0.544 ' HA2' HD12 ' A' ' 193' ' ' LEU . . . -102.9 -168.26 26.18 Favored Glycine 0 C--N 1.347 1.157 0 N-CA-C 110.322 -1.111 . . . . 71.340000000000003 110.322 163.184 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 58.0 m-85 -92.78 154.64 42.11 Favored Pre-proline 0 N--CA 1.477 0.918 0 C-N-CA 123.033 0.533 . . . . 74.010000000000005 111.028 -176.627 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_exo -72.9 161.92 42.4 Favored 'Trans proline' 0 C--N 1.366 1.498 0 C-N-CA 122.202 1.935 . . . . 63.299999999999997 111.865 172.342 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 157.2 -104.25 0.25 Allowed Glycine 0 CA--C 1.527 0.842 0 CA-C-O 119.072 -0.849 . . . . 53.5 112.155 177.8 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 243' ' ' PRO . . . . . 0.429 ' HD2' ' HB3' ' A' ' 191' ' ' GLN . 41.8 Cg_endo -63.67 -52.22 1.97 Allowed 'Trans proline' 0 C--N 1.37 1.663 0 C-N-CA 123.642 2.895 . . . . 33.32 113.241 -169.985 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -93.11 -5.08 51.1 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 123.304 0.642 . . . . 73.019999999999996 111.447 179.753 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 92.38 -46.52 2.59 Favored Glycine 0 C--N 1.354 1.572 0 N-CA-C 111.945 -0.462 . . . . 50.130000000000003 111.945 -175.971 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 20.1 ttm180 -116.3 112.4 21.51 Favored 'General case' 0 C--O 1.238 0.486 0 C-N-CA 124.367 1.067 . . . . 64.120000000000005 109.127 178.119 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -80.65 168.31 51.16 Favored Glycine 0 C--N 1.348 1.249 0 CA-C-O 121.503 0.502 . . . . 52.310000000000002 113.88 172.191 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 248' ' ' ASP . . . . . 0.505 ' HB3' ' HG3' ' A' ' 234' ' ' ARG . 19.4 m-20 -124.65 162.2 24.64 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 114.009 -1.096 . . . . 64.109999999999999 110.469 -169.466 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 249' ' ' LEU . . . . . 0.451 HD11 ' HB2' ' A' ' 195' ' ' ALA . 41.6 tp -125.9 121.8 34.21 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 123.528 0.731 . . . . 74.420000000000002 109.405 178.305 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 250' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -90.47 112.43 24.07 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 123.816 0.846 . . . . 65.219999999999999 110.607 -178.733 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 251' ' ' LEU . . . . . 0.653 HD13 HD22 ' A' ' 197' ' ' LEU . 90.7 mt -87.85 104.02 16.19 Favored 'General case' 0 C--O 1.239 0.504 0 N-CA-C 107.889 -1.152 . . . . 73.25 107.889 179.915 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -79.91 98.58 7.19 Favored 'General case' 0 C--O 1.239 0.521 0 N-CA-C 108.145 -1.058 . . . . 62.520000000000003 108.145 177.106 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 253' ' ' VAL . . . . . 0.406 HG21 HG22 ' A' ' 227' ' ' THR . 6.2 m -66.67 125.88 24.94 Favored 'Isoleucine or valine' 0 C--O 1.243 0.759 0 CA-C-O 122.021 0.915 . . . . 54.539999999999999 109.362 -178.169 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 17.9 mmm180 -122.2 99.34 6.38 Favored 'General case' 0 C--O 1.239 0.535 0 N-CA-C 107.742 -1.207 . . . . 72.030000000000001 107.742 -178.996 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 255' ' ' ILE . . . . . 0.543 ' HA ' ' O ' ' A' ' 199' ' ' VAL . 55.3 mt -83.29 119.55 32.87 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 CA-C-N 114.103 -1.408 . . . . 73.510000000000005 110.267 -175.114 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 CA--C 1.559 1.309 0 C-N-CA 124.6 1.16 . . . . 72.519999999999996 108.964 175.547 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 172' ' ' LEU . . . . . 0.419 ' HB3' ' OG1' ' A' ' 175' ' ' THR . 21.0 mt . . . . . 0 N--CA 1.485 1.323 0 CA-C-O 121.219 0.533 . . . . 62.130000000000003 111.71 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 173' ' ' PHE . . . . . 0.549 ' CD1' HD22 ' A' ' 235' ' ' LEU . 16.7 m-85 -146.14 -59.28 0.31 Allowed 'General case' 0 N--CA 1.479 1.022 0 CA-C-O 122.123 0.963 . . . . 70.209999999999994 108.692 -166.986 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 174' ' ' TYR . . . . . 0.483 ' CD2' ' HB3' ' A' ' 233' ' ' LEU . 0.6 OUTLIER -78.53 14.45 1.27 Allowed 'General case' 0 CA--C 1.547 0.829 0 CA-C-N 113.744 -1.571 . . . . 74.439999999999998 112.533 -176.025 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 175' ' ' THR . . . . . 0.419 ' OG1' ' HB3' ' A' ' 172' ' ' LEU . 0.2 OUTLIER -63.95 -19.32 65.05 Favored 'General case' 0 CA--C 1.555 1.152 0 C-N-CA 124.459 1.104 . . . . 72.439999999999998 111.432 -173.843 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 176' ' ' MET . . . . . . . . . . . . . 25.1 ptt? -71.45 -40.89 70.04 Favored 'General case' 0 CA--C 1.562 1.409 0 C-N-CA 124.644 1.177 . . . . 74.150000000000006 111.72 173.081 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 1.6 ttmp? -164.58 118.45 1.36 Allowed 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 124.644 1.178 . . . . 54.039999999999999 109.296 -175.623 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 178' ' ' ALA . . . . . 0.5 ' HB1' HD22 ' A' ' 233' ' ' LEU . . . -152.61 -49.39 0.1 Allowed 'General case' 0 C--O 1.24 0.58 0 C-N-CA 123.309 0.644 . . . . 73.310000000000002 110.289 -173.808 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 179' ' ' ALA . . . . . 0.401 ' HB2' ' HB2' ' A' ' 224' ' ' PRO . . . -81.02 37.66 0.44 Allowed 'General case' 0 CA--C 1.554 1.127 0 C-N-CA 123.486 0.715 . . . . 51.399999999999999 111.07 178.785 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.347 1.154 0 C-N-CA 123.839 0.733 . . . . 63.240000000000002 111.76 -177.307 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 191' ' ' GLN . . . . . 0.559 ' HB3' ' HD2' ' A' ' 243' ' ' PRO . 3.6 pt20 . . . . . 0 N--CA 1.477 0.915 0 CA-C-O 121.143 0.497 . . . . 73.219999999999999 109.858 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 86.9 m-20 -77.41 153.46 33.63 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 115.39 -0.823 . . . . 64.040000000000006 111.504 -174.646 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 26.7 mt -125.74 175.93 7.27 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 124.439 1.096 . . . . 64.25 110.665 -179.226 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 32.1 m-85 -140.98 136.67 32.38 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 124.305 1.042 . . . . 71.109999999999999 109.905 177.457 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -152.98 131.67 12.33 Favored 'General case' 0 C--O 1.238 0.497 0 C-N-CA 124.651 1.18 . . . . 65.349999999999994 108.128 177.064 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 14.9 m -82.61 129.25 34.91 Favored 'General case' 0 CA--C 1.546 0.8 0 CA-C-N 116.267 -0.424 . . . . 70.519999999999996 109.974 -176.464 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 197' ' ' LEU . . . . . 0.733 HD22 HD13 ' A' ' 251' ' ' LEU . 16.0 tp -107.79 111.05 23.02 Favored 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 108.758 -0.83 . . . . 71.040000000000006 108.758 -175.878 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -79.63 123.56 27.74 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 123.232 0.613 . . . . 74.200000000000003 109.412 176.147 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 6.4 p -142.36 128.95 10.94 Favored Pre-proline 0 CA--C 1.544 0.729 0 N-CA-C 108.675 -0.861 . . . . 73.25 108.675 179.308 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -72.04 159.24 50.62 Favored 'Trans proline' 0 C--N 1.366 1.498 0 C-N-CA 121.825 1.684 . . . . 73.099999999999994 111.185 170.711 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 201' ' ' ALA . . . . . 0.437 ' O ' HG23 ' A' ' 205' ' ' VAL . . . -50.61 -50.61 71.56 Favored Pre-proline 0 CA--C 1.556 1.201 0 CA-C-N 114.94 -1.027 . . . . 40.100000000000001 113.72 -178.526 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_endo -65.74 -35.82 34.99 Favored 'Trans proline' 0 C--N 1.385 2.469 0 C-N-CA 121.438 1.425 . . . . 71.450000000000003 114.697 -178.789 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 50.0 mt -68.88 -29.35 43.13 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.25 0 N-CA-C 110.163 -0.31 . . . . 75.230000000000004 110.163 176.812 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -70.96 -41.84 70.52 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 122.62 0.368 . . . . 63.200000000000003 111.313 175.448 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 205' ' ' VAL . . . . . 0.437 HG23 ' O ' ' A' ' 201' ' ' ALA . 85.4 t -64.59 -55.96 18.56 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.283 0 C-N-CA 123.864 0.866 . . . . 72.319999999999993 111.644 -179.06 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 25.2 m -76.41 -31.45 20.6 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 CA-C-O 120.635 0.255 . . . . 75.329999999999998 111.241 -176.966 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 82.84 64.17 1.69 Allowed Glycine 0 C--N 1.343 0.928 0 CA-C-N 115.903 -0.59 . . . . 44.009999999999998 111.836 -173.394 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -79.98 -134.29 1.22 Allowed Glycine 0 C--N 1.346 1.101 0 CA-C-O 119.752 -0.471 . . . . 72.430000000000007 111.96 177.072 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 48.4 mtmt -137.19 148.07 46.3 Favored 'General case' 0 N--CA 1.485 1.296 0 CA-C-N 117.711 0.756 . . . . 64.400000000000006 111.061 178.471 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 5.7 m -143.12 158.28 17.65 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 C-N-CA 125.169 1.387 . . . . 74.200000000000003 108.436 174.584 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 42.0 ttp-105 -94.9 113.38 25.1 Favored 'General case' 0 CA--C 1.544 0.732 0 CA-C-O 121.167 0.508 . . . . 65.549999999999997 110.781 -175.171 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -101.37 113.56 26.76 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 124.283 1.033 . . . . 63.299999999999997 109.469 175.786 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 39.9 ttm -88.67 116.88 27.24 Favored 'General case' 0 N--CA 1.477 0.882 0 CA-C-O 121.022 0.439 . . . . 74.349999999999994 110.018 -179.161 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 17.5 p -111.55 -171.78 1.91 Allowed 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 124.463 1.105 . . . . 53.439999999999998 110.062 -173.216 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 84.0 mt -63.59 -37.58 87.86 Favored 'General case' 0 N--CA 1.489 1.485 0 CA-C-O 121.133 0.492 . . . . 71.219999999999999 110.606 171.672 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -80.36 -11.46 59.7 Favored 'General case' 0 N--CA 1.476 0.845 0 CA-C-N 114.797 -1.092 . . . . 72.109999999999999 111.087 -174.362 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 123.09 -173.02 16.13 Favored Glycine 0 C--N 1.344 1.01 0 N-CA-C 111.447 -0.661 . . . . 62.149999999999999 111.447 -179.614 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -73.1 147.55 43.07 Favored 'Trans proline' 0 CA--C 1.552 1.376 0 C-N-CA 122.384 2.056 . . . . 74.209999999999994 111.978 177.527 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 3.8 p -139.78 131.36 33.19 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 N-CA-C 108.976 -0.75 . . . . 62.219999999999999 108.976 174.346 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -80.86 100.03 8.63 Favored 'General case' 0 C--O 1.239 0.508 0 N-CA-C 107.012 -1.477 . . . . 73.409999999999997 107.012 172.258 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 3.8 p -101.67 129.57 52.67 Favored 'Isoleucine or valine' 0 C--O 1.242 0.699 0 N-CA-C 108.602 -0.888 . . . . 73.420000000000002 108.602 -172.245 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -76.92 109.39 10.68 Favored 'General case' 0 C--O 1.236 0.386 0 C-N-CA 122.374 0.269 . . . . 75.150000000000006 110.523 -177.434 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 58.3 t -52.69 135.04 45.5 Favored Pre-proline 0 CA--C 1.55 0.943 0 O-C-N 124.478 1.111 . . . . 53.43 109.342 178.155 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 224' ' ' PRO . . . . . 0.401 ' HB2' ' HB2' ' A' ' 179' ' ' ALA . 29.4 Cg_endo -61.33 143.5 97.99 Favored 'Trans proline' 0 C--N 1.369 1.642 0 C-N-CA 121.763 1.642 . . . . 72.310000000000002 110.495 174.79 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 16.2 Cg_endo -60.35 132.22 42.63 Favored 'Trans proline' 0 C--N 1.37 1.677 0 C-N-CA 121.448 1.432 . . . . 43.229999999999997 110.759 175.828 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 65.9 mtm180 65.12 53.05 1.4 Allowed 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.939 1.296 . . . . 62.119999999999997 110.834 173.949 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 26.5 m -75.77 147.48 39.21 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-N 114.886 -1.052 . . . . 75.540000000000006 109.651 172.472 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 25.3 mp0 -117.65 145.11 44.6 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 108.301 -1.0 . . . . 62.329999999999998 108.301 175.082 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -58.91 134.03 56.57 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 123.684 0.794 . . . . 71.310000000000002 111.938 -176.201 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 97.07 -1.33 60.87 Favored Glycine 0 C--N 1.346 1.137 0 CA-C-O 119.079 -0.845 . . . . 63.530000000000001 113.934 178.772 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 80.8 mtt-85 -67.28 156.36 36.58 Favored 'General case' 0 N--CA 1.481 1.105 0 CA-C-N 117.862 0.831 . . . . 63.109999999999999 111.327 176.781 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 70.7 mmtt -119.86 98.93 6.34 Favored 'General case' 0 C--O 1.239 0.548 0 CA-C-N 114.416 -1.265 . . . . 72.200000000000003 108.995 -172.641 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 233' ' ' LEU . . . . . 0.633 ' HB2' ' HB2' ' A' ' 251' ' ' LEU . 8.6 mt -86.88 150.28 24.22 Favored 'General case' 0 CA--C 1.542 0.668 0 N-CA-C 107.978 -1.119 . . . . 54.030000000000001 107.978 178.105 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 47.2 ttt85 -124.25 108.66 12.49 Favored 'General case' 0 CA--C 1.551 1.017 0 CA-C-N 118.637 0.653 . . . . 55.439999999999998 110.736 -176.382 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 235' ' ' LEU . . . . . 0.549 HD22 ' CD1' ' A' ' 173' ' ' PHE . 11.9 mt -86.99 106.5 17.87 Favored 'General case' 0 C--N 1.352 0.702 0 C-N-CA 124.699 1.199 . . . . 74.329999999999998 110.524 179.45 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 236' ' ' LYS . . . . . 0.527 ' H ' ' HB3' ' A' ' 173' ' ' PHE . 12.8 mtmt -74.35 132.37 41.97 Favored 'General case' 0 CA--C 1.539 0.549 0 O-C-N 123.531 0.519 . . . . 61.409999999999997 112.229 -178.736 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 81.24 19.57 66.56 Favored Glycine 0 C--N 1.35 1.314 0 CA-C-N 114.711 -1.131 . . . . 55.43 113.818 -178.843 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 75.9 mmtt -122.27 13.21 10.32 Favored 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 122.981 0.512 . . . . 72.409999999999997 112.229 -175.124 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -124.32 -172.03 13.54 Favored Glycine 0 C--N 1.344 0.981 0 N-CA-C 111.243 -0.743 . . . . 75.219999999999999 111.243 173.9 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 60.5 m-85 -84.99 160.46 55.19 Favored Pre-proline 0 N--CA 1.485 1.317 0 C-N-CA 123.983 0.913 . . . . 73.420000000000002 112.171 -173.538 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 241' ' ' PRO . . . . . 0.485 ' HA ' ' O ' ' A' ' 245' ' ' GLY . 17.2 Cg_exo -68.53 148.64 73.22 Favored 'Trans proline' 0 C--N 1.376 1.983 0 C-N-CA 122.115 1.877 . . . . 74.129999999999995 112.395 169.72 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -173.2 -119.91 0.55 Allowed Glycine 0 C--N 1.35 1.335 0 CA-C-O 119.141 -0.811 . . . . 54.229999999999997 112.529 177.355 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 243' ' ' PRO . . . . . 0.559 ' HD2' ' HB3' ' A' ' 191' ' ' GLN . 44.8 Cg_endo -59.67 -65.59 0.08 OUTLIER 'Trans proline' 0 C--N 1.378 2.104 0 C-N-CA 124.587 3.525 . . . . 72.0 112.648 -172.651 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -90.7 20.54 4.61 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 123.168 0.587 . . . . 63.350000000000001 110.903 175.309 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 245' ' ' GLY . . . . . 0.485 ' O ' ' HA ' ' A' ' 241' ' ' PRO . . . 75.0 -96.92 0.99 Allowed Glycine 0 C--N 1.349 1.29 0 N-CA-C 110.47 -1.052 . . . . 53.350000000000001 110.47 -173.033 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 21.5 ttm180 -48.46 108.89 0.19 Allowed 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 124.57 1.148 . . . . 72.319999999999993 112.32 -178.238 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -88.52 156.21 26.61 Favored Glycine 0 C--O 1.249 1.091 0 N-CA-C 110.814 -0.915 . . . . 54.210000000000001 110.814 167.334 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 40.6 m-20 -130.57 155.2 46.92 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-O 120.912 0.386 . . . . 75.420000000000002 110.351 -173.297 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 249' ' ' LEU . . . . . 0.496 ' HB3' ' HB2' ' A' ' 235' ' ' LEU . 47.4 tp -98.01 138.08 35.87 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 123.925 0.89 . . . . 53.329999999999998 110.755 -173.165 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 250' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -98.89 113.51 25.69 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 122.808 0.443 . . . . 74.319999999999993 110.395 177.384 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 251' ' ' LEU . . . . . 0.733 HD13 HD22 ' A' ' 197' ' ' LEU . 82.7 mt -88.67 105.18 17.51 Favored 'General case' 0 C--O 1.241 0.646 0 N-CA-C 108.541 -0.911 . . . . 72.310000000000002 108.541 174.867 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -88.5 103.86 16.27 Favored 'General case' 0 C--O 1.239 0.528 0 N-CA-C 108.385 -0.969 . . . . 65.230000000000004 108.385 177.818 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 19.7 m -72.01 143.1 14.5 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 CA-C-O 121.29 0.567 . . . . 63.329999999999998 111.084 -172.18 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 19.0 mmt85 -130.39 101.18 5.63 Favored 'General case' 0 C--O 1.237 0.438 0 C-N-CA 124.228 1.011 . . . . 61.32 108.377 177.452 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 30.9 mt -78.89 124.14 36.84 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 O-C-N 123.893 0.745 . . . . 74.019999999999996 110.175 178.81 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 1.4 t . . . . . 0 CA--C 1.558 1.271 0 N-CA-C 107.513 -1.292 . . . . 71.340000000000003 107.513 173.797 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 172' ' ' LEU . . . . . 0.479 HD21 ' O ' ' A' ' 222' ' ' ALA . 25.0 mt . . . . . 0 N--CA 1.482 1.142 0 CA-C-O 121.523 0.678 . . . . 74.239999999999995 112.013 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 173' ' ' PHE . . . . . 0.557 ' CD1' HD22 ' A' ' 235' ' ' LEU . 26.4 m-85 -136.78 -48.77 0.63 Allowed 'General case' 0 N--CA 1.477 0.879 0 CA-C-N 114.911 -1.041 . . . . 75.010000000000005 109.76 -169.578 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 174' ' ' TYR . . . . . 0.444 ' CD2' ' HB3' ' A' ' 233' ' ' LEU . 7.9 p90 -84.22 13.6 5.09 Favored 'General case' 0 N--CA 1.48 1.07 0 CA-C-N 114.824 -1.08 . . . . 74.019999999999996 113.087 -176.928 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 1.8 p -65.06 -10.58 31.29 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 123.107 0.563 . . . . 70.230000000000004 112.504 175.189 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 176' ' ' MET . . . . . . . . . . . . . 41.8 mtm -53.18 -42.11 65.9 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 124.316 1.047 . . . . 72.239999999999995 110.302 169.053 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 177' ' ' LYS . . . . . 0.443 ' NZ ' ' HB2' ' A' ' 177' ' ' LYS . 2.8 ttmp? -167.41 97.38 0.49 Allowed 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 124.709 1.204 . . . . 65.310000000000002 108.301 176.307 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 178' ' ' ALA . . . . . 0.472 ' HB1' ' HB3' ' A' ' 224' ' ' PRO . . . -109.38 146.3 34.65 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 124.149 0.98 . . . . 75.430000000000007 110.456 -175.738 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 179' ' ' ALA . . . . . 0.448 ' HB2' ' HB2' ' A' ' 224' ' ' PRO . . . 59.75 28.86 18.39 Favored 'General case' 0 N--CA 1.492 1.668 0 C-N-CA 124.388 1.075 . . . . 64.329999999999998 111.574 -174.362 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.348 1.25 0 CA-C-N 115.522 -0.763 . . . . 43.210000000000001 111.674 -179.578 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 191' ' ' GLN . . . . . 0.688 ' HB2' ' HA2' ' A' ' 247' ' ' GLY . 26.9 pt20 . . . . . 0 CA--C 1.547 0.829 0 CA-C-O 121.735 0.779 . . . . 70.329999999999998 110.296 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -76.53 148.28 37.21 Favored 'General case' 0 C--O 1.237 0.403 0 C-N-CA 125.05 1.34 . . . . 61.140000000000001 111.255 -162.939 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 193' ' ' LEU . . . . . 0.584 HD12 ' HA2' ' A' ' 239' ' ' GLY . 16.3 mt -143.87 170.97 14.89 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 123.607 0.763 . . . . 73.349999999999994 110.315 172.11 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 74.6 m-85 -135.74 141.58 44.87 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 124.146 0.978 . . . . 73.120000000000005 109.815 179.036 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 195' ' ' ALA . . . . . 0.473 ' HB2' HD11 ' A' ' 249' ' ' LEU . . . -154.23 132.77 12.09 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 123.787 0.835 . . . . 64.129999999999995 108.758 176.983 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 26.9 m -82.5 127.2 33.08 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.274 -0.639 . . . . 63.520000000000003 109.274 178.581 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 197' ' ' LEU . . . . . 0.744 HD22 HD13 ' A' ' 251' ' ' LEU . 18.1 tp -105.54 107.42 18.4 Favored 'General case' 0 N--CA 1.465 0.306 0 N-CA-C 107.549 -1.278 . . . . 74.109999999999999 107.549 -179.469 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -77.81 123.57 26.89 Favored 'General case' 0 C--O 1.237 0.439 0 N-CA-C 107.828 -1.175 . . . . 71.120000000000005 107.828 174.072 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 199' ' ' VAL . . . . . 0.533 ' O ' ' HA ' ' A' ' 255' ' ' ILE . 2.8 p -141.62 125.6 10.1 Favored Pre-proline 0 CA--C 1.541 0.625 0 N-CA-C 108.205 -1.035 . . . . 73.209999999999994 108.205 -179.652 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -69.98 158.08 57.83 Favored 'Trans proline' 0 C--N 1.365 1.42 0 C-N-CA 122.048 1.832 . . . . 73.420000000000002 111.728 171.758 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -49.73 -50.32 67.92 Favored Pre-proline 0 CA--C 1.56 1.329 0 N-CA-C 114.001 1.111 . . . . 73.319999999999993 114.001 -178.769 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 202' ' ' PRO . . . . . 0.406 ' HA ' HG22 ' A' ' 205' ' ' VAL . 44.2 Cg_endo -63.48 -37.5 48.11 Favored 'Trans proline' 0 C--N 1.393 2.874 0 C-N-CA 122.115 1.877 . . . . 73.239999999999995 113.484 -178.507 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 38.3 mt -67.99 -36.11 74.34 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.173 0 CA-C-N 117.995 0.361 . . . . 71.299999999999997 110.448 176.102 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 204' ' ' ALA . . . . . 0.434 ' HA ' HG11 ' A' ' 223' ' ' VAL . . . -67.09 -41.78 85.72 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 123.06 0.544 . . . . 74.230000000000004 112.231 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 205' ' ' VAL . . . . . 0.406 HG22 ' HA ' ' A' ' 202' ' ' PRO . 20.9 m -77.81 -51.37 18.14 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.993 0 C-N-CA 123.472 0.709 . . . . 61.200000000000003 112.448 -175.592 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 206' ' ' VAL . . . . . 0.404 HG22 ' O ' ' A' ' 202' ' ' PRO . 7.9 m -73.4 -30.06 29.32 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.402 0 C-N-CA 122.357 0.263 . . . . 72.120000000000005 111.249 -178.961 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 89.66 63.09 1.29 Allowed Glycine 0 C--N 1.352 1.432 0 CA-C-N 116.216 -0.447 . . . . 44.149999999999999 112.373 -175.858 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -86.71 -139.09 5.52 Favored Glycine 0 C--N 1.352 1.429 0 CA-C-O 119.873 -0.404 . . . . 63.420000000000002 112.734 -179.833 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 46.4 mtmt -137.89 147.87 44.83 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 123.972 0.909 . . . . 73.299999999999997 110.287 178.012 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 5.2 m -140.81 166.34 18.93 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 C-N-CA 124.771 1.229 . . . . 73.200000000000003 109.807 174.475 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 29.0 ttp180 -90.06 113.91 25.71 Favored 'General case' 0 CA--C 1.546 0.827 0 C-N-CA 123.63 0.772 . . . . 74.310000000000002 109.843 -179.601 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -100.39 117.19 34.07 Favored 'General case' 0 C--O 1.24 0.562 0 N-CA-C 108.586 -0.894 . . . . 75.129999999999995 108.586 171.073 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 47.8 tpp -84.0 116.04 22.63 Favored 'General case' 0 C--O 1.241 0.637 0 N-CA-C 109.408 -0.59 . . . . 71.510000000000005 109.408 177.58 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 16.6 p -111.47 -173.67 2.3 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 124.59 1.156 . . . . 74.140000000000001 109.614 -176.515 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 56.2 mt -61.99 -36.09 80.45 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 122.986 0.514 . . . . 71.140000000000001 111.911 175.295 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 27.2 mt-10 -89.81 -8.65 51.59 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.721 0.808 . . . . 62.140000000000001 111.435 -172.452 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 124.39 -161.4 18.84 Favored Glycine 0 C--N 1.345 1.058 0 CA-C-O 119.282 -0.732 . . . . 62.450000000000003 111.458 -178.08 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -77.71 159.91 31.45 Favored 'Trans proline' 0 CA--C 1.549 1.257 0 C-N-CA 122.525 2.15 . . . . 65.439999999999998 112.794 -177.218 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 2.9 p -148.34 129.7 5.65 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 N-CA-C 108.674 -0.862 . . . . 73.319999999999993 108.674 171.02 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -76.81 100.29 5.44 Favored 'General case' 0 C--O 1.239 0.544 0 N-CA-C 107.478 -1.305 . . . . 75.219999999999999 107.478 169.613 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 9.1 p -100.34 128.36 52.41 Favored 'Isoleucine or valine' 0 C--O 1.245 0.845 0 N-CA-C 108.012 -1.107 . . . . 71.239999999999995 108.012 -176.417 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 222' ' ' ALA . . . . . 0.479 ' O ' HD21 ' A' ' 172' ' ' LEU . . . -77.85 105.19 8.87 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 116.466 -0.334 . . . . 74.299999999999997 110.648 -174.696 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 223' ' ' VAL . . . . . 0.434 HG11 ' HA ' ' A' ' 204' ' ' ALA . 62.6 t -53.8 133.03 56.9 Favored Pre-proline 0 N--CA 1.472 0.662 0 C-N-CA 124.13 0.972 . . . . 32.520000000000003 109.54 179.239 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 224' ' ' PRO . . . . . 0.472 ' HB3' ' HB1' ' A' ' 178' ' ' ALA . 30.8 Cg_endo -64.75 150.53 88.02 Favored 'Trans proline' 0 C--N 1.369 1.629 0 C-N-CA 121.327 1.352 . . . . 73.540000000000006 110.663 175.561 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -63.48 140.51 76.27 Favored 'Trans proline' 0 C--N 1.366 1.482 0 C-N-CA 121.452 1.435 . . . . 73.109999999999999 110.694 176.449 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 56.6 mtm180 64.79 42.44 4.54 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 124.248 1.019 . . . . 73.109999999999999 111.074 170.137 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 63.4 m -76.9 143.48 39.56 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-N 115.464 -0.789 . . . . 74.099999999999994 109.444 173.537 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 27.8 mp0 -117.22 143.84 45.44 Favored 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 124.144 0.978 . . . . 44.520000000000003 109.039 176.475 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -62.35 123.93 19.55 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 123.757 0.823 . . . . 73.099999999999994 110.628 -178.282 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 115.15 -6.5 21.52 Favored Glycine 0 C--N 1.338 0.659 0 O-C-N 123.75 0.656 . . . . 75.030000000000001 113.178 -175.34 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 95.2 mtt-85 -74.79 157.2 35.58 Favored 'General case' 0 N--CA 1.478 0.954 0 CA-C-N 117.634 0.717 . . . . 74.049999999999997 110.055 172.655 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 232' ' ' LYS . . . . . 0.451 ' HA ' ' O ' ' A' ' 251' ' ' LEU . 12.5 mtmm -131.42 120.95 23.76 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.269 0.628 . . . . 75.400000000000006 110.53 -179.681 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 233' ' ' LEU . . . . . 0.502 ' HB2' ' HB2' ' A' ' 251' ' ' LEU . 26.7 mt -101.99 154.31 19.08 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 125.138 1.375 . . . . 64.129999999999995 109.264 -176.274 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 15.1 ttm180 -111.99 110.87 21.41 Favored 'General case' 0 N--CA 1.48 1.065 0 CA-C-N 118.144 0.429 . . . . 64.519999999999996 111.099 -179.736 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 235' ' ' LEU . . . . . 0.59 ' HB2' ' HB3' ' A' ' 249' ' ' LEU . 11.2 mt -88.11 99.56 12.28 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 122.919 0.487 . . . . 61.0 110.023 172.014 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 236' ' ' LYS . . . . . 0.492 ' H ' ' HB3' ' A' ' 173' ' ' PHE . 11.7 mtmt -72.52 130.47 40.71 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 115.967 -0.56 . . . . 61.009999999999998 111.304 -179.789 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 83.69 21.11 58.57 Favored Glycine 0 C--N 1.344 0.995 0 CA-C-N 115.059 -0.973 . . . . 73.150000000000006 113.612 -178.182 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt -127.2 17.86 7.11 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 123.012 0.525 . . . . 61.219999999999999 111.329 -178.495 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 239' ' ' GLY . . . . . 0.584 ' HA2' HD12 ' A' ' 193' ' ' LEU . . . -118.81 -159.96 11.26 Favored Glycine 0 C--N 1.347 1.146 0 N-CA-C 111.278 -0.729 . . . . 55.420000000000002 111.278 170.256 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 60.4 m-85 -92.55 165.37 19.47 Favored Pre-proline 0 CA--C 1.553 1.061 0 C-N-CA 123.713 0.805 . . . . 71.349999999999994 110.376 -177.187 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 241' ' ' PRO . . . . . 0.437 ' HA ' ' O ' ' A' ' 245' ' ' GLY . 40.4 Cg_exo -61.17 166.25 11.19 Favored 'Trans proline' 0 C--N 1.374 1.877 0 C-N-CA 121.732 1.621 . . . . 54.32 113.473 170.333 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 167.32 -123.72 1.15 Allowed Glycine 0 CA--C 1.529 0.968 0 CA-C-O 118.874 -0.959 . . . . 70.109999999999999 111.862 177.209 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 243' ' ' PRO . . . . . 0.477 ' HD2' ' HB3' ' A' ' 191' ' ' GLN . 30.9 Cg_endo -59.68 -60.78 0.27 Allowed 'Trans proline' 0 C--N 1.379 2.136 0 C-N-CA 123.925 3.083 . . . . 70.019999999999996 112.976 -170.001 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -90.93 2.85 55.89 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 123.185 0.594 . . . . 74.409999999999997 111.43 177.373 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 245' ' ' GLY . . . . . 0.437 ' O ' ' HA ' ' A' ' 241' ' ' PRO . . . 85.35 -34.57 3.26 Favored Glycine 0 C--N 1.358 1.757 0 N-CA-C 112.319 -0.312 . . . . 51.450000000000003 112.319 -173.746 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 10.8 ttm180 -88.66 112.53 23.21 Favored 'General case' 0 CA--C 1.529 0.149 0 C-N-CA 124.79 1.236 . . . . 74.209999999999994 111.404 177.557 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 247' ' ' GLY . . . . . 0.688 ' HA2' ' HB2' ' A' ' 191' ' ' GLN . . . -84.31 163.57 39.37 Favored Glycine 0 C--N 1.345 1.074 0 C-N-CA 121.27 -0.491 . . . . 63.340000000000003 114.055 162.855 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 34.6 m-20 -132.65 143.79 49.9 Favored 'General case' 0 C--O 1.241 0.638 0 C-N-CA 123.866 0.866 . . . . 73.129999999999995 110.133 -169.063 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 249' ' ' LEU . . . . . 0.59 ' HB3' ' HB2' ' A' ' 235' ' ' LEU . 61.4 tp -106.98 117.86 35.18 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 124.361 1.065 . . . . 64.299999999999997 110.087 -177.084 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 250' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 -91.5 110.62 21.93 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 123.245 0.618 . . . . 74.230000000000004 110.034 -174.299 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 251' ' ' LEU . . . . . 0.744 HD13 HD22 ' A' ' 197' ' ' LEU . 74.6 mt -86.73 106.35 17.59 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 114.839 -1.073 . . . . 64.450000000000003 110.574 -175.037 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -79.63 97.07 6.37 Favored 'General case' 0 C--O 1.241 0.643 0 N-CA-C 108.439 -0.948 . . . . 62.020000000000003 108.439 173.746 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 4.6 m -69.42 130.35 34.16 Favored 'Isoleucine or valine' 0 C--O 1.244 0.776 0 CA-C-O 121.762 0.792 . . . . 72.040000000000006 110.251 -176.338 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 21.8 mmm180 -126.9 115.13 18.82 Favored 'General case' 0 C--O 1.237 0.44 0 N-CA-C 107.657 -1.238 . . . . 73.049999999999997 107.657 178.576 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 255' ' ' ILE . . . . . 0.533 ' HA ' ' O ' ' A' ' 199' ' ' VAL . 49.0 mt -98.82 111.88 29.53 Favored 'Isoleucine or valine' 0 C--O 1.24 0.589 0 O-C-N 123.574 0.546 . . . . 71.200000000000003 110.443 -175.09 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 3.1 t . . . . . 0 CA--C 1.56 1.34 0 CA-C-N 115.523 -0.762 . . . . 74.420000000000002 108.984 177.276 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 172' ' ' LEU . . . . . 0.485 HD21 ' HB3' ' A' ' 222' ' ' ALA . 77.5 mt . . . . . 0 N--CA 1.48 1.059 0 CA-C-O 120.73 0.3 . . . . 74.450000000000003 111.654 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 173' ' ' PHE . . . . . 0.435 ' CD1' HD22 ' A' ' 235' ' ' LEU . 45.4 m-85 -144.59 -66.95 0.33 Allowed 'General case' 0 N--CA 1.486 1.336 0 N-CA-C 109.391 -0.596 . . . . 75.519999999999996 109.391 -166.545 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 174' ' ' TYR . . . . . 0.478 ' CD2' ' HB3' ' A' ' 233' ' ' LEU . 7.7 p90 -64.77 -13.24 54.49 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 123.841 0.857 . . . . 75.340000000000003 112.301 177.655 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 175' ' ' THR . . . . . 0.456 HG21 HD13 ' A' ' 172' ' ' LEU . 4.2 m -65.73 0.97 1.45 Allowed 'General case' 0 CA--C 1.565 1.535 0 C-N-CA 125.133 1.373 . . . . 73.519999999999996 112.217 -178.154 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 176' ' ' MET . . . . . . . . . . . . . 37.3 mtm -64.85 -59.88 3.7 Favored 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 123.604 0.762 . . . . 75.030000000000001 109.148 161.543 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.98 100.32 3.38 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 124.477 1.111 . . . . 63.310000000000002 108.651 175.024 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -109.44 -178.38 3.54 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 124.194 0.998 . . . . 61.229999999999997 111.612 -170.169 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . 62.14 -91.05 0.03 OUTLIER 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 125.088 1.355 . . . . 72.129999999999995 111.044 -177.43 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.877 0 N-CA-C 112.461 -0.256 . . . . 73.540000000000006 112.461 -178.225 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 191' ' ' GLN . . . . . 0.621 ' HB3' ' HD2' ' A' ' 243' ' ' PRO . 9.9 pt20 . . . . . 0 N--CA 1.478 0.962 0 CA-C-O 120.949 0.404 . . . . 73.409999999999997 110.347 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -77.56 157.58 30.26 Favored 'General case' 0 C--O 1.241 0.617 0 CA-C-N 115.091 -0.959 . . . . 71.219999999999999 110.904 -168.539 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 32.7 mt -134.25 171.13 14.68 Favored 'General case' 0 C--O 1.239 0.529 0 CA-C-N 114.284 -1.325 . . . . 70.219999999999999 108.69 176.282 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 59.6 m-85 -136.49 126.63 26.24 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 123.768 0.827 . . . . 53.43 110.317 -177.165 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 195' ' ' ALA . . . . . 0.414 ' O ' ' HA ' ' A' ' 251' ' ' LEU . . . -141.65 130.66 23.21 Favored 'General case' 0 N--CA 1.466 0.344 0 N-CA-C 107.951 -1.129 . . . . 74.129999999999995 107.951 175.636 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 30.4 m -83.07 127.78 33.89 Favored 'General case' 0 C--O 1.24 0.559 0 N-CA-C 108.577 -0.897 . . . . 73.209999999999994 108.577 176.865 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 197' ' ' LEU . . . . . 0.724 HD22 HD13 ' A' ' 251' ' ' LEU . 16.7 tp -106.35 110.05 22.17 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 108.331 -0.989 . . . . 72.540000000000006 108.331 -178.974 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -80.72 118.42 22.25 Favored 'General case' 0 C--O 1.238 0.475 0 N-CA-C 108.233 -1.025 . . . . 74.299999999999997 108.233 -179.817 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 5.1 p -136.89 128.45 16.74 Favored Pre-proline 0 CA--C 1.543 0.691 0 N-CA-C 108.948 -0.76 . . . . 74.439999999999998 108.948 -176.28 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 200' ' ' PRO . . . . . 0.432 ' HB2' ' HD2' ' A' ' 202' ' ' PRO . 62.0 Cg_endo -69.69 158.25 57.72 Favored 'Trans proline' 0 C--N 1.365 1.404 0 C-N-CA 121.924 1.749 . . . . 74.319999999999993 111.246 172.717 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 201' ' ' ALA . . . . . 0.51 ' O ' HG23 ' A' ' 205' ' ' VAL . . . -47.34 -54.8 19.16 Favored Pre-proline 0 CA--C 1.562 1.417 0 CA-C-O 117.547 -1.216 . . . . 72.540000000000006 113.044 179.88 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 202' ' ' PRO . . . . . 0.432 ' HD2' ' HB2' ' A' ' 200' ' ' PRO . 52.9 Cg_endo -64.74 -37.25 36.85 Favored 'Trans proline' 0 C--N 1.4 3.289 0 C-N-CA 121.9 1.733 . . . . 71.310000000000002 113.323 -174.124 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 44.1 mt -65.67 -34.64 71.7 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 C-N-CA 122.54 0.336 . . . . 72.340000000000003 110.141 177.604 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -70.53 -39.75 73.86 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 122.518 0.327 . . . . 65.310000000000002 111.093 177.277 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 205' ' ' VAL . . . . . 0.51 HG23 ' O ' ' A' ' 201' ' ' ALA . 83.9 t -67.44 -56.43 13.41 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 C-N-CA 123.565 0.746 . . . . 74.340000000000003 111.193 -177.852 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 10.5 m -82.06 -29.49 9.68 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 CA-C-N 116.002 -0.544 . . . . 70.25 111.455 -172.821 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 88.5 65.43 1.31 Allowed Glycine 0 C--N 1.345 1.074 0 CA-C-N 116.093 -0.503 . . . . 73.209999999999994 112.129 -174.875 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -87.11 -134.69 4.18 Favored Glycine 0 C--N 1.357 1.726 0 N-CA-C 111.794 -0.523 . . . . 44.539999999999999 111.794 177.957 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 46.6 mtmt -136.61 154.93 50.53 Favored 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 123.524 0.729 . . . . 61.340000000000003 110.908 178.602 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 6.3 m -144.94 169.66 7.77 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 C-N-CA 125.597 1.559 . . . . 72.510000000000005 108.473 172.319 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 56.0 ttp180 -104.23 119.43 38.94 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 123.573 0.749 . . . . 65.430000000000007 109.499 177.487 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -103.57 141.08 36.63 Favored 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 123.894 0.878 . . . . 74.400000000000006 109.667 175.402 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 46.9 tpp -100.27 128.32 46.37 Favored 'General case' 0 N--CA 1.475 0.808 0 N-CA-C 109.179 -0.675 . . . . 75.230000000000004 109.179 178.389 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 19.6 p -129.27 -171.68 2.55 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 123.818 0.847 . . . . 51.009999999999998 110.52 -171.55 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 91.9 mt -62.18 -27.75 69.18 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 123.831 0.853 . . . . 44.420000000000002 111.839 173.869 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -99.49 6.48 45.89 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 123.573 0.749 . . . . 70.120000000000005 111.52 -179.464 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 94.48 -153.42 20.99 Favored Glycine 0 C--N 1.347 1.146 0 CA-C-O 119.589 -0.562 . . . . 61.119999999999997 112.655 -177.807 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_endo -70.35 153.4 66.26 Favored 'Trans proline' 0 C--N 1.37 1.672 0 C-N-CA 122.582 2.188 . . . . 72.109999999999999 113.25 -174.489 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 4.6 p -145.52 135.81 18.74 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 C-N-CA 124.368 1.067 . . . . 74.109999999999999 109.048 174.245 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -83.6 104.23 13.56 Favored 'General case' 0 C--O 1.239 0.546 0 N-CA-C 107.883 -1.154 . . . . 71.019999999999996 107.883 172.659 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 2.9 p -114.39 126.07 71.84 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.018 0 N-CA-C 109.41 -0.589 . . . . 62.43 109.41 -174.476 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 222' ' ' ALA . . . . . 0.485 ' HB3' HD21 ' A' ' 172' ' ' LEU . . . -78.82 108.43 12.26 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 123.39 0.676 . . . . 55.549999999999997 110.69 -179.333 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 84.7 t -55.46 136.17 70.01 Favored Pre-proline 0 N--CA 1.478 0.961 0 C-N-CA 124.754 1.222 . . . . 71.329999999999998 109.857 177.12 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -66.31 159.4 50.26 Favored 'Trans proline' 0 C--N 1.373 1.839 0 C-N-CA 121.711 1.607 . . . . 63.509999999999998 111.455 174.835 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -69.28 153.13 71.62 Favored 'Trans proline' 0 C--N 1.365 1.428 0 C-N-CA 121.544 1.496 . . . . 73.109999999999999 111.08 171.917 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 39.7 mtm180 60.69 34.41 20.0 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 124.773 1.229 . . . . 65.340000000000003 111.578 172.702 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 227' ' ' THR . . . . . 0.518 ' O ' HD11 ' A' ' 255' ' ' ILE . 85.4 m -73.73 120.78 19.8 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 115.049 -0.978 . . . . 62.350000000000001 109.547 175.52 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 228' ' ' GLN . . . . . 0.436 ' H ' ' NE ' ' A' ' 231' ' ' ARG . 1.2 mp0 -102.59 147.86 26.27 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 124.414 1.086 . . . . 72.140000000000001 109.035 177.908 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 229' ' ' ALA . . . . . 0.445 ' HB2' ' HB ' ' A' ' 255' ' ' ILE . . . -59.21 115.03 2.92 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 123.81 0.844 . . . . 71.519999999999996 111.274 -177.237 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 113.42 0.2 24.94 Favored Glycine 0 C--N 1.343 0.97 0 O-C-N 123.685 0.616 . . . . 43.43 113.599 -178.97 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 231' ' ' ARG . . . . . 0.436 ' NE ' ' H ' ' A' ' 228' ' ' GLN . 87.5 mtt-85 -65.72 150.77 47.95 Favored 'General case' 0 N--CA 1.486 1.36 0 CA-C-N 117.591 0.696 . . . . 63.420000000000002 110.478 173.471 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 71.7 mmtt -118.67 102.22 8.69 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 124.097 0.959 . . . . 74.120000000000005 109.488 -171.936 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 233' ' ' LEU . . . . . 0.776 ' HB2' ' HB2' ' A' ' 251' ' ' LEU . 58.7 mt -88.89 152.21 21.87 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 115.415 -0.812 . . . . 71.310000000000002 109.534 178.344 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 234' ' ' ARG . . . . . 0.453 ' HG3' ' HB3' ' A' ' 248' ' ' ASP . 38.6 ttm-85 -119.32 121.12 38.87 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.512 0.725 . . . . 62.439999999999998 110.902 -174.673 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 235' ' ' LEU . . . . . 0.64 ' HB2' ' HB3' ' A' ' 249' ' ' LEU . 16.0 mt -110.43 100.38 9.23 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 122.464 0.306 . . . . 71.140000000000001 110.662 176.874 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 236' ' ' LYS . . . . . 0.563 ' HB3' ' HD2' ' A' ' 246' ' ' ARG . 13.2 mttp -69.13 139.84 54.71 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 110.345 -0.243 . . . . 63.229999999999997 110.345 173.323 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 86.85 -3.13 87.22 Favored Glycine 0 N--CA 1.473 1.11 0 CA-C-N 115.757 -0.656 . . . . 72.0 113.193 179.857 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -112.79 5.25 17.45 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 123.573 0.749 . . . . 70.530000000000001 111.061 -179.085 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -113.35 -173.82 18.77 Favored Glycine 0 C--N 1.347 1.184 0 N-CA-C 110.997 -0.841 . . . . 52.039999999999999 110.997 164.584 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 93.8 m-85 -91.56 160.98 35.51 Favored Pre-proline 0 N--CA 1.483 1.216 0 C-N-CA 123.84 0.856 . . . . 70.150000000000006 110.331 -178.988 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_exo -62.07 158.69 37.81 Favored 'Trans proline' 0 C--N 1.374 1.881 0 C-N-CA 122.136 1.891 . . . . 73.519999999999996 112.951 173.724 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 169.19 -128.12 1.62 Allowed Glycine 0 C--N 1.349 1.251 0 CA-C-O 118.766 -1.019 . . . . 65.340000000000003 112.307 176.113 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 243' ' ' PRO . . . . . 0.621 ' HD2' ' HB3' ' A' ' 191' ' ' GLN . 18.6 Cg_endo -52.62 -49.66 16.73 Favored 'Trans proline' 0 C--N 1.38 2.199 0 C-N-CA 124.96 3.773 . . . . 60.509999999999998 113.826 -173.963 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -95.92 -1.83 48.45 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.295 0.638 . . . . 53.119999999999997 111.69 -179.024 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 90.01 -37.76 3.31 Favored Glycine 0 C--N 1.352 1.438 0 CA-C-O 120.955 0.197 . . . . 62.409999999999997 113.014 178.1 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 246' ' ' ARG . . . . . 0.563 ' HD2' ' HB3' ' A' ' 236' ' ' LYS . 16.5 ttm180 -120.38 111.73 18.12 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 124.17 0.988 . . . . 72.310000000000002 108.593 178.831 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -69.3 155.12 53.44 Favored Glycine 0 C--O 1.25 1.133 0 O-C-N 123.504 0.503 . . . . 74.430000000000007 114.255 178.289 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 248' ' ' ASP . . . . . 0.453 ' HB3' ' HG3' ' A' ' 234' ' ' ARG . 40.3 m-20 -112.19 138.87 48.26 Favored 'General case' 0 C--O 1.225 -0.224 0 CA-C-N 114.152 -1.024 . . . . 73.430000000000007 109.591 -173.446 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 249' ' ' LEU . . . . . 0.64 ' HB3' ' HB2' ' A' ' 235' ' ' LEU . 44.4 tp -100.12 117.58 34.67 Favored 'General case' 0 C--O 1.238 0.485 0 N-CA-C 108.088 -1.078 . . . . 75.040000000000006 108.088 172.051 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 250' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -88.56 108.95 19.69 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 123.651 0.78 . . . . 74.540000000000006 108.898 -176.419 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 251' ' ' LEU . . . . . 0.776 ' HB2' ' HB2' ' A' ' 233' ' ' LEU . 85.6 mt -88.38 104.83 17.14 Favored 'General case' 0 C--O 1.24 0.566 0 N-CA-C 108.135 -1.061 . . . . 73.310000000000002 108.135 178.281 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -84.36 101.87 12.3 Favored 'General case' 0 C--O 1.241 0.647 0 N-CA-C 107.864 -1.161 . . . . 72.340000000000003 107.864 175.222 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 11.2 m -69.45 139.31 20.57 Favored 'Isoleucine or valine' 0 C--O 1.244 0.772 0 O-C-N 123.87 0.731 . . . . 75.310000000000002 110.03 -175.774 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 14.4 mmt85 -128.18 105.63 8.5 Favored 'General case' 0 C--O 1.238 0.487 0 C-N-CA 124.073 0.949 . . . . 70.340000000000003 108.608 178.977 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 255' ' ' ILE . . . . . 0.518 HD11 ' O ' ' A' ' 227' ' ' THR . 34.0 mt -76.4 123.95 33.7 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 O-C-N 123.932 0.77 . . . . 74.099999999999994 109.615 178.582 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 1.8 t . . . . . 0 CA--C 1.554 1.104 0 N-CA-C 107.426 -1.324 . . . . 71.030000000000001 107.426 178.773 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 172' ' ' LEU . . . . . 0.756 HD21 ' H ' ' A' ' 222' ' ' ALA . 59.9 mt . . . . . 0 N--CA 1.48 1.055 0 N-CA-C 110.449 -0.204 . . . . 71.120000000000005 110.449 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 173' ' ' PHE . . . . . 0.422 ' CD1' HD22 ' A' ' 235' ' ' LEU . 40.1 m-85 -125.8 -52.26 1.57 Allowed 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 123.927 0.891 . . . . 75.099999999999994 108.638 -176.106 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 174' ' ' TYR . . . . . . . . . . . . . 17.3 p90 -68.93 -2.67 10.32 Favored 'General case' 0 C--N 1.345 0.388 0 CA-C-N 113.894 -1.503 . . . . 72.310000000000002 114.198 -174.241 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 2.4 p -57.71 -16.06 9.8 Favored 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 123.775 0.83 . . . . 74.530000000000001 112.62 173.15 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 176' ' ' MET . . . . . . . . . . . . . 9.4 ptm -52.57 -40.75 62.93 Favored 'General case' 0 CA--C 1.56 1.359 0 C-N-CA 123.988 0.915 . . . . 72.109999999999999 111.825 167.519 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 46.5 tptt -153.78 48.28 0.65 Allowed 'General case' 0 N--CA 1.479 1.006 0 CA-C-O 122.019 0.914 . . . . 72.5 109.438 -177.523 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 178' ' ' ALA . . . . . 0.524 ' HB1' ' HB3' ' A' ' 224' ' ' PRO . . . -74.41 131.89 41.48 Favored 'General case' 0 N--CA 1.478 0.958 0 CA-C-N 115.21 -0.904 . . . . 75.340000000000003 110.62 -178.271 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 179' ' ' ALA . . . . . 0.477 ' HB2' ' HB2' ' A' ' 224' ' ' PRO . . . 69.54 14.09 8.3 Favored 'General case' 0 N--CA 1.492 1.639 0 C-N-CA 124.888 1.275 . . . . 74.030000000000001 111.448 -171.838 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.352 1.452 0 N-CA-C 110.851 -0.9 . . . . 54.450000000000003 110.851 171.518 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 191' ' ' GLN . . . . . 0.582 ' HB3' ' HD2' ' A' ' 243' ' ' PRO . 10.5 pt20 . . . . . 0 N--CA 1.48 1.031 0 CA-C-O 121.084 0.469 . . . . 65.109999999999999 110.209 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -76.83 150.16 36.13 Favored 'General case' 0 C--O 1.241 0.657 0 CA-C-N 114.971 -1.013 . . . . 55.109999999999999 110.304 -171.031 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 193' ' ' LEU . . . . . 0.41 HD12 ' HA2' ' A' ' 239' ' ' GLY . 29.5 mt -128.82 168.2 16.25 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 124.549 1.14 . . . . 64.430000000000007 109.4 177.872 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 71.6 m-85 -126.17 140.56 52.47 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 123.621 0.768 . . . . 75.329999999999998 109.731 179.125 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 195' ' ' ALA . . . . . 0.493 ' HB2' HD11 ' A' ' 249' ' ' LEU . . . -153.32 129.59 10.5 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 108.09 -1.078 . . . . 65.409999999999997 108.09 177.974 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 18.0 m -85.22 125.2 32.67 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 109.237 -0.653 . . . . 75.230000000000004 109.237 177.752 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 197' ' ' LEU . . . . . 0.511 HD22 HD13 ' A' ' 251' ' ' LEU . 20.7 tp -106.54 109.13 20.95 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 108.382 -0.97 . . . . 63.43 108.382 -178.878 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -78.04 127.51 32.43 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 123.388 0.675 . . . . 51.409999999999997 109.416 177.285 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 199' ' ' VAL . . . . . 0.479 ' O ' ' HA ' ' A' ' 255' ' ' ILE . 3.3 p -142.75 124.68 8.72 Favored Pre-proline 0 CA--C 1.543 0.693 0 C-N-CA 123.585 0.754 . . . . 53.140000000000001 108.971 178.767 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -67.36 153.35 77.17 Favored 'Trans proline' 0 C--N 1.368 1.588 0 C-N-CA 122.146 1.897 . . . . 55.140000000000001 111.805 171.545 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -47.91 -49.53 58.08 Favored Pre-proline 0 CA--C 1.562 1.431 0 N-CA-C 114.433 1.271 . . . . 73.219999999999999 114.433 -176.654 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 202' ' ' PRO . . . . . 0.429 ' O ' HG22 ' A' ' 206' ' ' VAL . 54.2 Cg_endo -66.17 -38.71 20.48 Favored 'Trans proline' 0 C--N 1.393 2.908 0 C-N-CA 121.603 1.535 . . . . 73.329999999999998 112.701 -179.333 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 29.6 mt -65.06 -32.28 57.59 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.139 0 CA-C-N 118.348 0.522 . . . . 52.240000000000002 110.209 177.343 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -68.05 -48.73 64.82 Favored 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 122.994 0.518 . . . . 61.030000000000001 111.612 179.004 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 205' ' ' VAL . . . . . 0.42 HG22 ' HA ' ' A' ' 202' ' ' PRO . 17.6 m -71.82 -50.56 37.55 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.848 0 C-N-CA 123.243 0.617 . . . . 71.219999999999999 112.238 -177.67 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 206' ' ' VAL . . . . . 0.429 HG22 ' O ' ' A' ' 202' ' ' PRO . 4.5 m -74.4 -25.96 19.94 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.2 0 C-N-CA 122.746 0.419 . . . . 74.430000000000007 111.504 -177.699 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 80.09 70.02 1.36 Allowed Glycine 0 C--N 1.345 1.047 0 O-C-N 123.312 0.382 . . . . 64.450000000000003 112.181 -177.59 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -93.44 -131.4 5.91 Favored Glycine 0 C--N 1.35 1.348 0 C-N-CA 123.152 0.406 . . . . 73.230000000000004 112.267 179.208 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 209' ' ' LYS . . . . . 0.49 ' HG2' ' HA ' ' A' ' 222' ' ' ALA . 47.4 mtmt -138.26 156.53 47.58 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 123.865 0.866 . . . . 73.409999999999997 111.199 177.564 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 9.6 m -147.61 167.18 5.16 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.1 0 C-N-CA 125.519 1.528 . . . . 73.150000000000006 108.972 173.332 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 58.6 ttp180 -99.8 119.09 37.62 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 123.096 0.558 . . . . 75.510000000000005 110.557 178.918 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -101.58 131.15 47.93 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 124.409 1.084 . . . . 54.420000000000002 110.16 176.28 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 50.5 tpp -94.7 129.93 41.41 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 123.22 0.608 . . . . 75.409999999999997 109.59 177.389 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 17.3 p -126.48 -172.48 2.64 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 124.199 1.0 . . . . 63.329999999999998 109.747 -175.141 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 80.3 mt -61.92 -37.44 84.68 Favored 'General case' 0 N--CA 1.482 1.135 0 CA-C-O 121.133 0.492 . . . . 72.040000000000006 110.875 171.063 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -92.05 10.66 28.2 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 124.253 1.021 . . . . 74.219999999999999 111.677 -173.163 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 101.67 -158.84 18.53 Favored Glycine 0 C--N 1.351 1.4 0 CA-C-O 119.504 -0.609 . . . . 61.32 112.348 178.403 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -80.46 154.31 21.16 Favored 'Trans proline' 0 C--N 1.368 1.561 0 C-N-CA 122.728 2.285 . . . . 63.130000000000003 112.843 -177.584 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 4.2 p -150.8 129.18 2.75 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 N-CA-C 108.328 -0.99 . . . . 74.140000000000001 108.328 175.498 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -85.34 103.24 14.08 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 108.982 -0.747 . . . . 70.209999999999994 108.982 -178.872 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 15.9 m -97.78 137.91 24.04 Favored 'Isoleucine or valine' 0 C--O 1.241 0.623 0 C-N-CA 123.669 0.787 . . . . 54.509999999999998 110.442 -176.929 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 222' ' ' ALA . . . . . 0.756 ' H ' HD21 ' A' ' 172' ' ' LEU . . . -84.46 104.79 14.77 Favored 'General case' 0 C--O 1.243 0.722 0 CA-C-N 115.159 -0.928 . . . . 72.530000000000001 110.451 -179.016 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 66.5 t -54.7 129.8 64.16 Favored Pre-proline 0 N--CA 1.475 0.792 0 C-N-CA 124.771 1.228 . . . . 70.409999999999997 109.669 -179.223 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 224' ' ' PRO . . . . . 0.524 ' HB3' ' HB1' ' A' ' 178' ' ' ALA . 28.6 Cg_endo -62.13 154.79 60.19 Favored 'Trans proline' 0 C--N 1.369 1.656 0 C-N-CA 121.914 1.742 . . . . 71.140000000000001 111.514 176.035 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -67.13 143.9 67.03 Favored 'Trans proline' 0 C--N 1.364 1.361 0 C-N-CA 121.152 1.234 . . . . 70.299999999999997 111.28 173.453 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 75.3 mtt180 65.61 38.41 5.44 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 124.726 1.21 . . . . 64.209999999999994 111.752 172.888 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 55.5 m -74.95 137.95 41.97 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 122.973 0.509 . . . . 75.329999999999998 110.45 175.694 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 26.8 mp0 -113.63 146.56 39.57 Favored 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 124.055 0.942 . . . . 74.150000000000006 109.994 175.169 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -58.94 119.79 7.88 Favored 'General case' 0 C--N 1.354 0.799 0 C-N-CA 124.276 1.03 . . . . 62.100000000000001 111.051 -178.788 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 114.11 -5.06 23.75 Favored Glycine 0 N--CA 1.466 0.689 0 O-C-N 123.834 0.709 . . . . 73.030000000000001 112.711 -178.883 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 85.9 mtt-85 -70.36 148.5 48.35 Favored 'General case' 0 C--N 1.358 0.976 0 CA-C-N 117.654 0.727 . . . . 72.349999999999994 109.333 172.411 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 41.2 mtmt -125.19 116.1 21.47 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 121.547 0.689 . . . . 73.510000000000005 109.599 -175.213 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 233' ' ' LEU . . . . . 0.639 ' HB2' ' HB2' ' A' ' 251' ' ' LEU . 56.7 mt -93.45 141.2 28.73 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 114.211 -1.358 . . . . 54.25 108.575 -177.887 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 14.5 ttp180 -109.26 112.44 24.59 Favored 'General case' 0 N--CA 1.474 0.774 0 O-C-N 122.055 -0.403 . . . . 72.430000000000007 111.264 -172.02 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 235' ' ' LEU . . . . . 0.593 ' HB2' ' HB3' ' A' ' 249' ' ' LEU . 12.9 mt -102.07 107.54 18.68 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.542 0.737 . . . . 73.450000000000003 110.432 176.228 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 236' ' ' LYS . . . . . 0.521 ' HB3' ' HD2' ' A' ' 246' ' ' ARG . 40.9 mttm -76.52 151.9 36.22 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-O 120.999 0.428 . . . . 75.439999999999998 110.556 172.14 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 77.21 -6.9 40.37 Favored Glycine 0 N--CA 1.476 1.365 0 CA-C-N 115.47 -0.787 . . . . 55.130000000000003 113.908 -177.98 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 72.8 mmtt -104.12 -7.56 20.11 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 123.748 0.819 . . . . 74.530000000000001 110.077 -179.695 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 239' ' ' GLY . . . . . 0.41 ' HA2' HD12 ' A' ' 193' ' ' LEU . . . -97.14 -167.73 33.03 Favored Glycine 0 C--N 1.358 1.769 0 N-CA-C 111.278 -0.729 . . . . 60.030000000000001 111.278 164.983 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 74.3 m-85 -91.59 157.31 42.16 Favored Pre-proline 0 N--CA 1.481 1.09 0 C-N-CA 123.772 0.829 . . . . 74.040000000000006 110.874 179.821 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -70.6 154.77 64.19 Favored 'Trans proline' 0 C--N 1.369 1.63 0 C-N-CA 121.311 1.341 . . . . 64.420000000000002 111.059 169.857 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 173.59 -119.63 0.76 Allowed Glycine 0 CA--C 1.527 0.826 0 CA-C-O 118.601 -1.11 . . . . 74.200000000000003 111.842 -179.47 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 243' ' ' PRO . . . . . 0.582 ' HD2' ' HB3' ' A' ' 191' ' ' GLN . 40.8 Cg_endo -60.66 -57.24 0.72 Allowed 'Trans proline' 0 C--N 1.38 2.232 0 C-N-CA 123.784 2.989 . . . . 74.010000000000005 112.54 -173.117 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -80.24 -12.86 59.58 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 123.167 0.587 . . . . 55.229999999999997 111.207 179.845 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 95.78 -34.8 4.67 Favored Glycine 0 C--N 1.353 1.512 0 C-N-CA 122.986 0.327 . . . . 54.310000000000002 112.311 179.698 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 246' ' ' ARG . . . . . 0.521 ' HD2' ' HB3' ' A' ' 236' ' ' LYS . 22.3 ttm180 -125.81 111.77 15.25 Favored 'General case' 0 C--O 1.244 0.77 0 C-N-CA 123.727 0.811 . . . . 75.430000000000007 108.986 177.751 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -72.12 155.31 51.58 Favored Glycine 0 C--N 1.347 1.182 0 N-CA-C 115.253 0.861 . . . . 73.329999999999998 115.253 -177.698 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 38.9 m-20 -100.21 155.43 17.76 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 113.654 -1.273 . . . . 72.340000000000003 109.96 -175.515 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 249' ' ' LEU . . . . . 0.593 ' HB3' ' HB2' ' A' ' 235' ' ' LEU . 48.8 tp -129.77 114.87 16.48 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 108.191 -1.04 . . . . 63.450000000000003 108.191 173.326 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 250' ' ' TYR . . . . . . . . . . . . . 19.7 m-30 -90.55 109.14 20.3 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 116.191 -0.458 . . . . 72.340000000000003 110.191 -174.757 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 251' ' ' LEU . . . . . 0.639 ' HB2' ' HB2' ' A' ' 233' ' ' LEU . 82.4 mt -87.45 102.43 14.55 Favored 'General case' 0 C--O 1.239 0.522 0 N-CA-C 107.923 -1.14 . . . . 72.25 107.923 177.254 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -83.38 99.72 10.24 Favored 'General case' 0 C--O 1.243 0.718 0 N-CA-C 108.257 -1.016 . . . . 73.349999999999994 108.257 178.002 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 10.1 m -61.32 132.34 26.83 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.768 0 CA-C-N 115.572 -0.74 . . . . 75.040000000000006 110.004 179.63 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 20.3 mmm180 -125.34 105.42 9.08 Favored 'General case' 0 C--O 1.241 0.606 0 N-CA-C 107.273 -1.38 . . . . 64.219999999999999 107.273 178.292 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 255' ' ' ILE . . . . . 0.479 ' HA ' ' O ' ' A' ' 199' ' ' VAL . 45.6 mt -77.93 107.54 9.95 Favored 'Isoleucine or valine' 0 C--O 1.239 0.505 0 CA-C-N 115.797 -0.638 . . . . 62.420000000000002 109.766 -179.254 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 2.4 t . . . . . 0 CA--C 1.555 1.159 0 CA-C-N 115.035 -0.984 . . . . 74.040000000000006 108.462 174.302 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 172' ' ' LEU . . . . . 0.45 HD21 ' HB3' ' A' ' 222' ' ' ALA . 22.7 mt . . . . . 0 N--CA 1.491 1.589 0 CA-C-O 120.799 0.333 . . . . 75.150000000000006 111.759 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 173' ' ' PHE . . . . . 0.499 ' CD1' HD22 ' A' ' 235' ' ' LEU . 19.4 m-85 -129.62 -53.8 1.16 Allowed 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 124.124 0.97 . . . . 71.340000000000003 109.177 -171.439 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 174' ' ' TYR . . . . . 0.444 ' CD2' ' HB3' ' A' ' 233' ' ' LEU . 0.8 OUTLIER -77.98 14.05 1.24 Allowed 'General case' 0 CA--C 1.547 0.828 0 CA-C-N 114.477 -1.238 . . . . 75.450000000000003 113.058 -174.257 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 20.6 p -61.38 -20.26 62.83 Favored 'General case' 0 N--CA 1.484 1.24 0 CA-C-N 118.772 0.715 . . . . 72.319999999999993 111.391 173.326 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 176' ' ' MET . . . . . . . . . . . . . 26.5 ptt? -59.03 -37.67 77.52 Favored 'General case' 0 CA--C 1.55 0.969 0 C-N-CA 124.149 0.979 . . . . 71.420000000000002 111.494 171.141 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 37.7 ttpt -167.19 87.6 0.29 Allowed 'General case' 0 CA--C 1.55 0.966 0 C-N-CA 124.451 1.1 . . . . 64.239999999999995 108.936 179.342 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -106.44 127.39 53.25 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 124.291 1.037 . . . . 60.119999999999997 109.246 -178.149 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 179' ' ' ALA . . . . . 0.428 ' HA ' ' HD3' ' A' ' 231' ' ' ARG . . . 59.93 39.45 20.22 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 124.117 0.967 . . . . 53.219999999999999 110.391 -172.773 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.056 0 CA-C-N 115.192 -0.913 . . . . 74.540000000000006 113.006 -173.149 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 191' ' ' GLN . . . . . 0.444 ' HB2' ' HA2' ' A' ' 247' ' ' GLY . 7.6 pt20 . . . . . 0 N--CA 1.471 0.602 0 CA-C-O 120.938 0.399 . . . . 74.540000000000006 110.271 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -78.03 138.56 38.86 Favored 'General case' 0 C--N 1.351 0.651 0 CA-C-N 115.524 -0.762 . . . . 73.200000000000003 109.148 -174.699 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 193' ' ' LEU . . . . . 0.406 HD12 ' HA2' ' A' ' 239' ' ' GLY . 25.1 mt -120.18 177.18 5.11 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 124.483 1.113 . . . . 74.329999999999998 109.158 175.112 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -139.08 121.02 15.55 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 123.413 0.685 . . . . 64.010000000000005 110.396 177.185 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -125.13 128.6 48.68 Favored 'General case' 0 C--O 1.241 0.607 0 N-CA-C 106.942 -1.503 . . . . 54.32 106.942 168.566 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 10.6 m -81.26 119.45 23.65 Favored 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 108.363 -0.977 . . . . 74.329999999999998 108.363 179.621 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 197' ' ' LEU . . . . . 0.722 HD22 HD13 ' A' ' 251' ' ' LEU . 20.5 tp -103.96 110.69 22.93 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 108.48 -0.933 . . . . 53.229999999999997 108.48 -173.996 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -79.86 127.23 31.99 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 115.219 -0.901 . . . . 74.319999999999993 108.92 179.209 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 199' ' ' VAL . . . . . 0.452 ' O ' ' HA ' ' A' ' 255' ' ' ILE . 6.2 p -143.9 128.72 9.51 Favored Pre-proline 0 CA--C 1.547 0.85 0 C-N-CA 123.729 0.812 . . . . 75.310000000000002 109.03 178.802 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -69.76 158.47 56.85 Favored 'Trans proline' 0 C--N 1.362 1.285 0 C-N-CA 121.769 1.646 . . . . 53.340000000000003 111.595 170.782 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 201' ' ' ALA . . . . . 0.46 ' O ' HG23 ' A' ' 205' ' ' VAL . . . -49.84 -53.99 36.71 Favored Pre-proline 0 CA--C 1.558 1.265 0 CA-C-N 114.744 -1.116 . . . . 72.239999999999995 112.863 -176.49 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -65.52 -34.29 43.13 Favored 'Trans proline' 0 C--N 1.399 3.208 0 C-N-CA 121.736 1.624 . . . . 72.120000000000005 113.237 -175.527 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 24.7 mt -67.2 -34.05 66.87 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.413 0 N-CA-C 109.975 -0.38 . . . . 63.039999999999999 109.975 177.529 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -69.46 -38.09 77.6 Favored 'General case' 0 CA--C 1.549 0.904 0 C-N-CA 122.535 0.334 . . . . 63.43 111.339 177.422 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 205' ' ' VAL . . . . . 0.46 HG23 ' O ' ' A' ' 201' ' ' ALA . 99.7 t -70.86 -56.55 10.36 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.122 0 C-N-CA 123.168 0.587 . . . . 62.32 111.576 -178.039 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 10.9 m -78.37 -25.42 13.84 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 CA-C-N 116.134 -0.485 . . . . 74.329999999999998 110.948 -174.918 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 84.15 60.55 1.92 Allowed Glycine 0 C--N 1.345 1.043 0 CA-C-N 116.04 -0.527 . . . . 61.32 112.615 -179.578 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -78.77 -138.03 1.38 Allowed Glycine 0 N--CA 1.477 1.374 0 CA-C-O 119.696 -0.502 . . . . 60.539999999999999 112.168 177.663 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 209' ' ' LYS . . . . . 0.479 ' HG2' ' HA ' ' A' ' 222' ' ' ALA . 29.0 mtmm -134.58 157.3 46.93 Favored 'General case' 0 N--CA 1.481 1.124 0 CA-C-N 117.607 0.704 . . . . 65.420000000000002 110.718 176.38 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 7.1 m -142.86 165.75 15.72 Favored 'Isoleucine or valine' 0 C--O 1.241 0.631 0 C-N-CA 126.068 1.747 . . . . 61.140000000000001 107.894 173.601 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 31.1 ttm180 -105.07 116.61 32.25 Favored 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 109.396 -0.594 . . . . 74.010000000000005 109.396 179.273 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -101.74 113.74 27.18 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.379 1.072 . . . . 63.210000000000001 109.563 179.003 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 61.6 tpp -76.22 125.04 28.44 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 108.187 -1.042 . . . . 65.329999999999998 108.187 173.702 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 18.4 p -125.24 -175.8 3.41 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.723 0.809 . . . . 65.310000000000002 109.721 -175.702 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 71.1 mt -57.01 -40.79 77.28 Favored 'General case' 0 N--CA 1.481 1.079 0 CA-C-O 121.504 0.669 . . . . 65.310000000000002 110.415 172.5 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 216' ' ' GLU . . . . . 0.472 ' HB2' ' NZ ' ' A' ' 238' ' ' LYS . 6.0 mm-40 -87.72 15.02 7.43 Favored 'General case' 0 CA--C 1.551 0.994 0 CA-C-N 114.538 -1.21 . . . . 62.450000000000003 111.371 -174.751 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 94.73 -171.1 30.02 Favored Glycine 0 C--N 1.35 1.346 0 N-CA-C 112.086 -0.406 . . . . 72.230000000000004 112.086 -179.686 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -68.42 149.37 74.89 Favored 'Trans proline' 0 C--N 1.362 1.276 0 C-N-CA 122.205 1.936 . . . . 62.310000000000002 111.991 178.129 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 7.1 p -143.27 134.87 23.61 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 N-CA-C 108.543 -0.91 . . . . 72.439999999999998 108.543 173.593 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 -86.37 103.27 14.78 Favored 'General case' 0 C--O 1.238 0.475 0 N-CA-C 107.76 -1.2 . . . . 65.019999999999996 107.76 179.501 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 2.6 p -108.61 131.35 59.44 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.967 0 C-N-CA 123.615 0.766 . . . . 64.439999999999998 109.355 -172.108 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 222' ' ' ALA . . . . . 0.479 ' HA ' ' HG2' ' A' ' 209' ' ' LYS . . . -83.11 111.25 18.73 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 123.126 0.571 . . . . 65.219999999999999 110.62 -176.788 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 58.4 t -54.66 132.65 64.78 Favored Pre-proline 0 N--CA 1.473 0.721 0 O-C-N 124.716 1.26 . . . . 62.43 109.354 177.067 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_endo -63.41 144.95 91.98 Favored 'Trans proline' 0 C--N 1.367 1.541 0 C-N-CA 121.482 1.455 . . . . 55.119999999999997 111.266 172.817 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -62.67 139.11 73.55 Favored 'Trans proline' 0 C--N 1.37 1.698 0 C-N-CA 121.572 1.515 . . . . 42.310000000000002 110.971 171.816 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 54.2 mtt180 69.64 60.49 0.28 Allowed 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 124.982 1.313 . . . . 73.200000000000003 110.74 173.161 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 227' ' ' THR . . . . . 0.593 ' HA ' ' HE ' ' A' ' 231' ' ' ARG . 55.9 m -103.85 142.12 34.94 Favored 'General case' 0 CA--C 1.544 0.74 0 CA-C-N 113.669 -1.605 . . . . 65.010000000000005 110.051 -179.857 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -116.66 148.14 41.29 Favored 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 124.074 0.95 . . . . 61.310000000000002 109.732 177.527 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 229' ' ' ALA . . . . . 0.487 ' HB2' ' HB ' ' A' ' 255' ' ' ILE . . . -58.77 116.5 3.78 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 123.982 0.913 . . . . 71.430000000000007 110.762 -179.84 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 113.21 2.44 24.79 Favored Glycine 0 CA--C 1.524 0.656 0 CA-C-N 115.744 -0.662 . . . . 74.010000000000005 112.968 179.238 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 231' ' ' ARG . . . . . 0.593 ' HE ' ' HA ' ' A' ' 227' ' ' THR . 75.0 mtt-85 -66.39 147.44 53.3 Favored 'General case' 0 C--N 1.364 1.206 0 CA-C-N 117.175 0.488 . . . . 74.439999999999998 109.757 172.358 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 69.7 mmtt -115.2 98.38 6.74 Favored 'General case' 0 C--O 1.241 0.605 0 CA-C-N 115.139 -0.937 . . . . 73.140000000000001 108.757 -174.591 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 233' ' ' LEU . . . . . 0.714 ' HB2' ' HB2' ' A' ' 251' ' ' LEU . 60.1 mt -85.5 151.69 23.76 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 115.3 -0.864 . . . . 73.319999999999993 108.883 177.514 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 234' ' ' ARG . . . . . 0.441 HH11 ' HE2' ' A' ' 250' ' ' TYR . 41.0 ttt85 -126.63 109.19 11.83 Favored 'General case' 0 N--CA 1.478 0.963 0 CA-C-O 120.679 0.275 . . . . 72.409999999999997 110.63 -172.114 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 235' ' ' LEU . . . . . 0.556 HD11 HD11 ' A' ' 251' ' ' LEU . 23.3 mt -94.98 117.71 30.6 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 123.761 0.824 . . . . 51.340000000000003 110.765 -179.571 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 20.9 mttt -69.86 138.51 52.59 Favored 'General case' 0 C--O 1.238 0.468 0 O-C-N 123.415 0.447 . . . . 75.099999999999994 111.401 175.74 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 73.94 10.35 80.64 Favored Glycine 0 C--N 1.345 1.029 0 CA-C-N 115.608 -0.723 . . . . 70.310000000000002 114.36 175.452 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 238' ' ' LYS . . . . . 0.472 ' NZ ' ' HB2' ' A' ' 216' ' ' GLU . 72.7 mmtt -112.51 5.28 17.89 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 122.765 0.426 . . . . 74.420000000000002 111.062 -179.707 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 239' ' ' GLY . . . . . 0.406 ' HA2' HD12 ' A' ' 193' ' ' LEU . . . -107.37 -161.93 21.57 Favored Glycine 0 C--N 1.348 1.216 0 N-CA-C 110.896 -0.881 . . . . 74.049999999999997 110.896 168.244 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 40.1 m-85 -94.25 147.25 33.03 Favored Pre-proline 0 N--CA 1.477 0.905 0 C-N-CA 123.045 0.538 . . . . 73.439999999999998 110.935 -179.049 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_exo -64.76 167.47 15.45 Favored 'Trans proline' 0 C--N 1.369 1.617 0 C-N-CA 122.333 2.022 . . . . 72.230000000000004 112.385 169.911 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 144.63 -106.02 0.38 Allowed Glycine 0 C--N 1.339 0.75 0 CA-C-O 118.727 -1.041 . . . . 63.32 112.077 175.769 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -61.95 -51.18 4.04 Favored 'Trans proline' 0 C--N 1.38 2.223 0 C-N-CA 123.632 2.888 . . . . 64.310000000000002 113.01 -168.855 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -87.13 -10.3 53.13 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 123.06 0.544 . . . . 71.329999999999998 111.312 176.466 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 90.76 -44.9 2.88 Favored Glycine 0 C--N 1.352 1.427 0 N-CA-C 111.383 -0.687 . . . . 64.209999999999994 111.383 -173.118 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 10.2 ttm180 -115.8 111.94 21.24 Favored 'General case' 0 C--O 1.24 0.59 0 C-N-CA 125.137 1.375 . . . . 63.530000000000001 109.281 175.373 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 247' ' ' GLY . . . . . 0.444 ' HA2' ' HB2' ' A' ' 191' ' ' GLN . . . -80.61 168.43 51.35 Favored Glycine 0 C--N 1.349 1.276 0 CA-C-O 121.766 0.648 . . . . 43.450000000000003 113.698 170.987 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -125.38 160.77 28.58 Favored 'General case' 0 N--CA 1.465 0.31 0 C-N-CA 124.19 0.996 . . . . 64.239999999999995 110.396 -170.274 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 249' ' ' LEU . . . . . 0.477 ' HB3' ' HB2' ' A' ' 235' ' ' LEU . 41.1 tp -115.84 124.86 51.76 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 123.948 0.899 . . . . 75.109999999999999 109.501 177.143 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 250' ' ' TYR . . . . . 0.441 ' HE2' HH11 ' A' ' 234' ' ' ARG . 2.2 m-85 -88.26 109.54 20.02 Favored 'General case' 0 C--O 1.232 0.158 0 N-CA-C 109.268 -0.641 . . . . 73.25 109.268 176.912 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 251' ' ' LEU . . . . . 0.722 HD13 HD22 ' A' ' 197' ' ' LEU . 86.4 mt -87.2 104.19 16.14 Favored 'General case' 0 C--O 1.241 0.64 0 N-CA-C 106.736 -1.579 . . . . 74.209999999999994 106.736 173.945 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -85.05 103.43 14.07 Favored 'General case' 0 C--O 1.24 0.575 0 N-CA-C 107.71 -1.219 . . . . 63.030000000000001 107.71 176.037 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 16.7 m -68.43 137.71 23.92 Favored 'Isoleucine or valine' 0 C--O 1.241 0.646 0 O-C-N 124.181 0.926 . . . . 74.129999999999995 109.596 -177.193 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 18.1 mmm180 -128.48 106.18 8.81 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 107.774 -1.195 . . . . 75.25 107.774 -179.906 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 255' ' ' ILE . . . . . 0.487 ' HB ' ' HB2' ' A' ' 229' ' ' ALA . 29.6 mt -77.47 123.5 34.23 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.58 0 O-C-N 123.924 0.765 . . . . 64.0 110.086 178.301 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 3.3 t . . . . . 0 CA--C 1.563 1.452 0 C-N-CA 124.143 0.977 . . . . 72.099999999999994 109.081 173.729 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 172' ' ' LEU . . . . . 0.755 HD21 ' H ' ' A' ' 222' ' ' ALA . 78.2 mt . . . . . 0 N--CA 1.479 0.992 0 CA-C-O 121.16 0.505 . . . . 72.530000000000001 111.49 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 173' ' ' PHE . . . . . 0.403 ' CD1' HD22 ' A' ' 235' ' ' LEU . 50.1 m-85 -147.62 -68.94 0.24 Allowed 'General case' 0 N--CA 1.479 0.986 0 N-CA-C 108.337 -0.986 . . . . 75.209999999999994 108.337 -164.952 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 174' ' ' TYR . . . . . 0.475 ' OH ' ' HB ' ' A' ' 221' ' ' VAL . 19.9 p90 -62.97 -21.86 66.4 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 113.921 -1.491 . . . . 72.420000000000002 112.523 -178.888 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 19.5 m -59.28 -12.59 5.81 Favored 'General case' 0 CA--C 1.56 1.339 0 C-N-CA 125.773 1.629 . . . . 72.349999999999994 112.889 -176.277 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 176' ' ' MET . . . . . . . . . . . . . 50.8 mtm -56.36 -50.62 71.02 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 123.773 0.829 . . . . 65.430000000000007 110.075 166.989 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -163.84 104.54 0.91 Allowed 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 124.428 1.091 . . . . 71.200000000000003 109.475 174.775 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 178' ' ' ALA . . . . . 0.457 ' HB1' HD22 ' A' ' 233' ' ' LEU . . . -125.84 -59.39 1.35 Allowed 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 123.936 0.894 . . . . 61.310000000000002 111.224 -171.67 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -72.26 81.8 1.01 Allowed 'General case' 0 CA--C 1.544 0.716 0 CA-C-O 121.86 0.838 . . . . 51.32 109.258 174.765 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.337 0.586 0 N-CA-C 109.974 -1.25 . . . . 61.229999999999997 109.974 -169.663 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 191' ' ' GLN . . . . . 0.699 ' HB2' ' HA2' ' A' ' 247' ' ' GLY . 25.1 pt20 . . . . . 0 CA--C 1.545 0.755 0 CA-C-O 121.41 0.624 . . . . 75.510000000000005 110.088 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 192' ' ' ASP . . . . . 0.454 ' HA ' ' O ' ' A' ' 248' ' ' ASP . 9.9 m-20 -78.1 152.75 32.71 Favored 'General case' 0 C--N 1.347 0.464 0 CA-C-N 114.438 -1.256 . . . . 71.099999999999994 111.797 -167.907 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 193' ' ' LEU . . . . . 0.475 HD12 ' HA2' ' A' ' 239' ' ' GLY . 22.9 mt -133.86 175.01 9.85 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 124.265 1.026 . . . . 73.299999999999997 109.773 177.517 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 77.6 m-85 -136.35 131.43 34.27 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.579 0.752 . . . . 71.120000000000005 110.545 179.835 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -144.29 128.99 18.23 Favored 'General case' 0 C--O 1.234 0.28 0 N-CA-C 107.326 -1.361 . . . . 74.400000000000006 107.326 176.823 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 3.5 m -81.47 121.35 26.16 Favored 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 109.524 -0.547 . . . . 65.439999999999998 109.524 -176.571 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 197' ' ' LEU . . . . . 0.544 HD22 HD13 ' A' ' 251' ' ' LEU . 20.3 tp -106.35 108.96 20.73 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 107.188 -1.412 . . . . 72.450000000000003 107.188 -178.124 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -86.92 132.37 33.83 Favored 'General case' 0 C--O 1.241 0.606 0 N-CA-C 109.223 -0.658 . . . . 65.140000000000001 109.223 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 199' ' ' VAL . . . . . 0.432 ' O ' ' HA ' ' A' ' 255' ' ' ILE . 4.0 p -141.92 129.53 11.61 Favored Pre-proline 0 CA--C 1.543 0.694 0 N-CA-C 108.305 -0.998 . . . . 44.020000000000003 108.305 -176.626 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -70.23 155.1 65.13 Favored 'Trans proline' 0 C--N 1.364 1.36 0 C-N-CA 121.431 1.421 . . . . 74.340000000000003 110.376 170.814 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 201' ' ' ALA . . . . . 0.414 ' HA ' HG23 ' A' ' 255' ' ' ILE . . . -50.64 -49.39 78.98 Favored Pre-proline 0 CA--C 1.556 1.2 0 CA-C-O 117.804 -1.093 . . . . 64.400000000000006 112.885 179.871 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 202' ' ' PRO . . . . . 0.436 ' HA ' HG22 ' A' ' 205' ' ' VAL . 29.7 Cg_endo -58.74 -39.59 80.71 Favored 'Trans proline' 0 C--N 1.399 3.216 0 C-N-CA 122.312 2.008 . . . . 65.310000000000002 113.991 -179.884 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 39.3 mt -68.28 -37.54 78.15 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.395 0 CA-C-N 118.625 0.648 . . . . 75.200000000000003 110.475 177.684 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -66.46 -42.8 87.02 Favored 'General case' 0 N--CA 1.479 0.98 0 N-CA-C 112.101 0.408 . . . . 74.140000000000001 112.101 179.706 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 205' ' ' VAL . . . . . 0.436 HG22 ' HA ' ' A' ' 202' ' ' PRO . 26.9 m -77.69 -45.02 28.96 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.917 0 C-N-CA 123.777 0.831 . . . . 74.120000000000005 112.722 -172.713 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 206' ' ' VAL . . . . . 0.402 HG22 ' O ' ' A' ' 202' ' ' PRO . 5.2 m -81.19 -26.22 10.52 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.325 0 C-N-CA 122.42 0.288 . . . . 71.150000000000006 111.338 178.541 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 82.89 77.89 1.07 Allowed Glycine 0 C--N 1.348 1.226 0 N-CA-C 111.858 -0.497 . . . . 62.350000000000001 111.858 -176.445 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -102.1 -137.34 9.6 Favored Glycine 0 C--N 1.347 1.186 0 N-CA-C 111.51 -0.636 . . . . 63.420000000000002 111.51 177.427 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 48.5 mtmt -136.16 155.46 50.13 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 123.592 0.757 . . . . 74.099999999999994 111.088 179.124 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 7.4 m -142.43 168.75 13.81 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.908 0 C-N-CA 125.948 1.699 . . . . 62.43 108.385 172.827 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 44.1 ttm180 -103.25 120.02 39.97 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 122.902 0.481 . . . . 53.329999999999998 109.858 177.508 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -102.21 133.55 46.9 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 124.127 0.971 . . . . 75.540000000000006 110.213 177.688 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 23.5 mmt -97.24 121.63 39.35 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 123.319 0.648 . . . . 73.310000000000002 109.595 178.97 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 18.2 p -120.17 174.85 6.24 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 124.172 0.989 . . . . 60.329999999999998 110.082 -177.095 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 56.5 mt -59.0 -31.48 68.84 Favored 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 123.079 0.551 . . . . 75.319999999999993 112.248 179.241 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -87.59 -20.26 26.67 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 123.106 0.563 . . . . 61.439999999999998 111.475 -177.4 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 139.33 -161.66 26.06 Favored Glycine 0 C--N 1.35 1.314 0 CA-C-O 119.445 -0.642 . . . . 63.329999999999998 111.962 -178.469 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_endo -82.28 155.86 16.87 Favored 'Trans proline' 0 C--N 1.367 1.541 0 C-N-CA 122.53 2.154 . . . . 63.009999999999998 112.766 -177.967 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 5.5 p -146.93 134.88 15.0 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.92 0 C-N-CA 123.746 0.819 . . . . 63.420000000000002 109.354 177.268 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -83.34 104.16 13.28 Favored 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 108.444 -0.947 . . . . 61.119999999999997 108.444 176.243 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 221' ' ' VAL . . . . . 0.475 ' HB ' ' OH ' ' A' ' 174' ' ' TYR . 6.4 m -106.27 132.12 54.21 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 CA-C-O 121.64 0.733 . . . . 73.409999999999997 110.578 -178.027 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 222' ' ' ALA . . . . . 0.755 ' H ' HD21 ' A' ' 172' ' ' LEU . . . -85.74 105.8 16.53 Favored 'General case' 0 C--O 1.238 0.46 0 CA-C-N 114.365 -1.289 . . . . 72.310000000000002 110.311 -178.732 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 66.7 t -57.43 128.76 79.56 Favored Pre-proline 0 N--CA 1.478 0.962 0 O-C-N 124.532 1.145 . . . . 52.340000000000003 109.124 179.089 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 224' ' ' PRO . . . . . 0.444 ' HD3' ' HE1' ' A' ' 174' ' ' TYR . 24.3 Cg_endo -61.22 146.56 97.3 Favored 'Trans proline' 0 C--N 1.375 1.922 0 C-N-CA 121.892 1.728 . . . . 73.319999999999993 110.926 177.559 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_endo -62.36 141.95 89.15 Favored 'Trans proline' 0 C--N 1.37 1.674 0 C-N-CA 121.607 1.538 . . . . 64.239999999999995 111.808 175.864 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 77.9 mtt180 64.64 38.96 6.8 Favored 'General case' 0 CA--C 1.554 1.13 0 C-N-CA 125.031 1.333 . . . . 74.129999999999995 111.908 172.524 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 227' ' ' THR . . . . . 0.511 HG23 ' HD2' ' A' ' 231' ' ' ARG . 86.7 m -76.17 146.85 38.87 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 123.648 0.779 . . . . 62.149999999999999 110.427 176.178 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -111.05 149.41 30.79 Favored 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 123.813 0.845 . . . . 53.310000000000002 109.249 174.927 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 229' ' ' ALA . . . . . 0.488 ' HA ' HG23 ' A' ' 253' ' ' VAL . . . -61.19 138.74 58.21 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 124.02 0.928 . . . . 64.140000000000001 111.394 -179.325 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 94.11 -3.81 70.3 Favored Glycine 0 C--N 1.339 0.73 0 CA-C-N 115.843 -0.617 . . . . 44.229999999999997 112.712 -178.846 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 231' ' ' ARG . . . . . 0.511 ' HD2' HG23 ' A' ' 227' ' ' THR . 57.4 mtt-85 -69.38 143.58 53.65 Favored 'General case' 0 C--N 1.363 1.195 0 N-CA-C 108.924 -0.769 . . . . 75.450000000000003 108.924 171.72 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 232' ' ' LYS . . . . . 0.518 ' HG2' ' HB3' ' A' ' 250' ' ' TYR . 13.4 ttmt -126.29 101.36 6.7 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 108.707 -0.849 . . . . 52.25 108.707 -167.309 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 233' ' ' LEU . . . . . 0.682 ' HB2' ' HB2' ' A' ' 251' ' ' LEU . 24.1 mt -76.28 151.72 36.68 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-N 114.011 -1.45 . . . . 71.340000000000003 109.172 -176.528 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 47.8 ttt180 -125.14 120.82 32.46 Favored 'General case' 0 N--CA 1.485 1.291 0 CA-C-N 118.998 0.817 . . . . 73.510000000000005 110.484 -175.433 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 235' ' ' LEU . . . . . 0.483 HD11 HD11 ' A' ' 251' ' ' LEU . 18.6 mt -108.78 116.45 32.01 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 124.397 1.079 . . . . 74.349999999999994 110.768 -175.696 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 31.4 mttp -72.94 141.54 47.82 Favored 'General case' 0 N--CA 1.479 1.004 0 N-CA-C 112.226 0.454 . . . . 72.420000000000002 112.226 176.795 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 76.51 10.37 85.75 Favored Glycine 0 C--N 1.349 1.269 0 CA-C-N 115.151 -0.931 . . . . 72.420000000000002 114.49 178.582 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt -115.26 10.29 15.92 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 122.736 0.414 . . . . 72.150000000000006 111.069 -173.79 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 239' ' ' GLY . . . . . 0.475 ' HA2' HD12 ' A' ' 193' ' ' LEU . . . -119.86 -161.98 11.74 Favored Glycine 0 C--N 1.345 1.06 0 N-CA-C 111.456 -0.657 . . . . 75.209999999999994 111.456 172.779 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 37.7 m-85 -93.02 169.3 10.64 Favored Pre-proline 0 N--CA 1.485 1.286 0 C-N-CA 123.79 0.836 . . . . 70.530000000000001 111.105 -175.208 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 241' ' ' PRO . . . . . 0.5 ' HA ' ' O ' ' A' ' 245' ' ' GLY . 77.7 Cg_exo -55.01 149.63 42.13 Favored 'Trans proline' 0 C--N 1.376 2.001 0 C-N-CA 121.762 1.641 . . . . 55.32 112.813 165.68 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -174.54 -136.51 2.26 Favored Glycine 0 CA--C 1.526 0.75 0 CA-C-O 119.053 -0.859 . . . . 73.510000000000005 111.871 179.085 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 243' ' ' PRO . . . . . 0.683 ' HD2' ' HB3' ' A' ' 191' ' ' GLN . 43.1 Cg_endo -60.34 -40.89 54.5 Favored 'Trans proline' 0 C--N 1.371 1.744 0 C-N-CA 124.158 3.238 . . . . 75.140000000000001 113.108 -172.53 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -104.12 0.87 30.16 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 124.05 0.94 . . . . 74.430000000000007 111.482 179.013 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 245' ' ' GLY . . . . . 0.5 ' O ' ' HA ' ' A' ' 241' ' ' PRO . . . 81.83 -41.22 2.7 Favored Glycine 0 C--N 1.36 1.885 0 N-CA-C 112.386 -0.286 . . . . 75.230000000000004 112.386 -175.584 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 9.9 ttm180 -89.02 110.1 20.84 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 124.301 1.04 . . . . 74.239999999999995 109.705 175.61 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 247' ' ' GLY . . . . . 0.699 ' HA2' ' HB2' ' A' ' 191' ' ' GLN . . . -83.11 167.48 45.6 Favored Glycine 0 C--N 1.351 1.417 0 N-CA-C 114.407 0.523 . . . . 73.349999999999994 114.407 171.69 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 248' ' ' ASP . . . . . 0.454 ' O ' ' HA ' ' A' ' 192' ' ' ASP . 41.6 m-20 -131.31 135.92 47.69 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 123.482 0.713 . . . . 63.32 111.092 -168.729 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 249' ' ' LEU . . . . . . . . . . . . . 47.5 tp -99.97 129.9 46.09 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 123.497 0.719 . . . . 74.329999999999998 110.739 -177.921 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 250' ' ' TYR . . . . . 0.519 ' HA ' ' O ' ' A' ' 233' ' ' LEU . 2.4 m-85 -95.77 115.49 27.5 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 123.801 0.84 . . . . 70.0 110.522 -178.83 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 251' ' ' LEU . . . . . 0.682 ' HB2' ' HB2' ' A' ' 233' ' ' LEU . 85.8 mt -94.14 105.22 17.22 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 108.711 -0.848 . . . . 74.540000000000006 108.711 178.257 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -84.15 104.25 14.04 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 109.743 -0.466 . . . . 72.409999999999997 109.743 178.736 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 253' ' ' VAL . . . . . 0.488 HG23 ' HA ' ' A' ' 229' ' ' ALA . 6.1 m -66.1 131.66 31.8 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.937 0 CA-C-O 121.237 0.541 . . . . 45.409999999999997 109.687 -179.299 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 10.8 mmm180 -123.96 97.32 5.3 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 108.744 -0.835 . . . . 71.329999999999998 108.744 179.057 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 255' ' ' ILE . . . . . 0.432 ' HA ' ' O ' ' A' ' 199' ' ' VAL . 32.2 mt -78.46 127.36 38.79 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 O-C-N 124.026 0.829 . . . . 65.209999999999994 111.014 -175.172 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 1.9 t . . . . . 0 CA--C 1.561 1.367 0 C-N-CA 124.064 0.946 . . . . 71.430000000000007 109.418 175.379 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 172' ' ' LEU . . . . . 0.682 HD21 ' H ' ' A' ' 222' ' ' ALA . 72.8 mt . . . . . 0 CA--C 1.54 0.584 0 CA-C-O 120.622 0.249 . . . . 73.150000000000006 110.979 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 34.9 m-85 -109.38 -57.93 2.1 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 123.7 0.8 . . . . 74.129999999999995 109.805 -174.937 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 174' ' ' TYR . . . . . 0.424 ' CD2' ' HB3' ' A' ' 233' ' ' LEU . 0.8 OUTLIER -71.17 -6.03 36.34 Favored 'General case' 0 C--N 1.348 0.508 0 CA-C-N 114.724 -1.126 . . . . 71.040000000000006 113.446 -173.201 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 175' ' ' THR . . . . . 0.485 HG21 HD13 ' A' ' 172' ' ' LEU . 2.9 p -68.2 -2.12 7.47 Favored 'General case' 0 CA--C 1.549 0.908 0 N-CA-C 114.052 1.131 . . . . 42.310000000000002 114.052 -177.328 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 176' ' ' MET . . . . . . . . . . . . . 21.8 ptt? -60.34 -41.93 94.61 Favored 'General case' 0 CA--C 1.559 1.296 0 C-N-CA 123.038 0.535 . . . . 70.209999999999994 110.369 163.756 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -178.55 114.03 0.07 Allowed 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 126.425 1.89 . . . . 74.549999999999997 106.956 179.337 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 178' ' ' ALA . . . . . 0.413 ' HB1' HD22 ' A' ' 233' ' ' LEU . . . -132.2 -42.04 0.98 Allowed 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 122.799 0.44 . . . . 54.299999999999997 111.881 -170.809 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -72.7 81.6 1.13 Allowed 'General case' 0 N--CA 1.472 0.669 0 CA-C-O 121.708 0.766 . . . . 64.420000000000002 109.58 179.045 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 180' ' ' GLY . . . . . 0.473 ' H ' ' HD3' ' A' ' 231' ' ' ARG . . . . . . . . 0 C--N 1.332 0.332 0 N-CA-C 108.944 -1.663 . . . . 51.140000000000001 108.944 -175.693 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 191' ' ' GLN . . . . . 0.525 ' HB3' ' HD2' ' A' ' 243' ' ' PRO . 5.4 pt20 . . . . . 0 N--CA 1.474 0.738 0 CA-C-O 121.075 0.464 . . . . 72.129999999999995 110.763 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 21.5 m-20 -77.3 161.33 28.17 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 115.743 -0.662 . . . . 71.200000000000003 111.312 -170.536 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 24.2 mt -141.08 166.31 25.13 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 124.375 1.07 . . . . 63.299999999999997 110.294 -178.953 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 61.0 m-85 -136.94 123.02 20.33 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 124.324 1.049 . . . . 73.219999999999999 109.771 178.206 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 195' ' ' ALA . . . . . 0.454 ' O ' ' HA ' ' A' ' 251' ' ' LEU . . . -133.89 132.61 40.51 Favored 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 108.389 -0.967 . . . . 53.229999999999997 108.389 176.301 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 41.8 m -86.11 124.06 32.11 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 123.145 0.578 . . . . 73.230000000000004 109.87 -179.134 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 197' ' ' LEU . . . . . 0.645 HD22 HD13 ' A' ' 251' ' ' LEU . 19.7 tp -107.16 109.93 21.88 Favored 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 108.665 -0.865 . . . . 62.130000000000003 108.665 -175.367 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -79.75 125.58 29.85 Favored 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 123.441 0.696 . . . . 74.109999999999999 109.174 179.219 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 199' ' ' VAL . . . . . 0.456 ' O ' ' HA ' ' A' ' 255' ' ' ILE . 4.4 p -144.02 129.37 9.7 Favored Pre-proline 0 CA--C 1.547 0.829 0 C-N-CA 124.044 0.937 . . . . 74.439999999999998 108.93 -178.083 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -67.76 158.55 56.72 Favored 'Trans proline' 0 C--N 1.37 1.682 0 C-N-CA 121.809 1.673 . . . . 75.200000000000003 112.264 170.26 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 201' ' ' ALA . . . . . 0.499 ' O ' HG23 ' A' ' 205' ' ' VAL . . . -50.62 -52.91 51.74 Favored Pre-proline 0 CA--C 1.553 1.09 0 N-CA-C 113.692 0.997 . . . . 65.340000000000003 113.692 -179.185 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 202' ' ' PRO . . . . . 0.406 ' O ' HG22 ' A' ' 206' ' ' VAL . 49.8 Cg_endo -64.97 -38.6 28.15 Favored 'Trans proline' 0 C--N 1.381 2.258 0 CA-C-N 121.147 1.445 . . . . 75.219999999999999 113.835 -177.39 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 31.5 mt -64.04 -30.9 51.27 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 N-CA-C 109.944 -0.391 . . . . 62.25 109.944 175.743 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -72.77 -40.74 65.71 Favored 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 122.578 0.351 . . . . 71.450000000000003 111.453 176.765 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 205' ' ' VAL . . . . . 0.499 HG23 ' O ' ' A' ' 201' ' ' ALA . 91.6 t -70.73 -55.96 12.43 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.239 0 C-N-CA 123.199 0.6 . . . . 51.25 111.035 -176.483 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 206' ' ' VAL . . . . . 0.406 HG22 ' O ' ' A' ' 202' ' ' PRO . 14.7 m -81.3 -27.3 10.46 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 CA-C-N 116.532 -0.304 . . . . 73.230000000000004 111.188 -176.796 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 85.18 71.56 1.31 Allowed Glycine 0 C--N 1.351 1.393 0 O-C-N 123.439 0.462 . . . . 60.420000000000002 113.016 -179.367 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -86.81 -127.8 2.33 Favored Glycine 0 C--N 1.348 1.218 0 CA-C-O 119.736 -0.48 . . . . 64.400000000000006 112.808 176.908 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 45.1 mtmt -137.66 152.12 48.98 Favored 'General case' 0 N--CA 1.486 1.336 0 CA-C-N 117.525 0.662 . . . . 73.349999999999994 111.128 178.45 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 6.2 m -146.91 159.52 9.67 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 C-N-CA 125.108 1.363 . . . . 70.400000000000006 108.536 170.702 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 51.0 ttp180 -97.53 121.18 39.14 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 123.394 0.678 . . . . 74.430000000000007 110.675 -179.681 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -102.29 123.18 45.64 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 123.494 0.718 . . . . 63.32 110.192 176.99 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 49.1 tpp -81.28 126.75 31.93 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 108.893 -0.78 . . . . 65.299999999999997 108.893 172.747 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 24.1 p -129.74 -174.31 3.27 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 123.848 0.859 . . . . 64.540000000000006 109.673 -173.506 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 67.4 mt -62.29 -27.65 69.18 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 122.809 0.444 . . . . 54.039999999999999 111.196 172.781 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 216' ' ' GLU . . . . . 0.403 ' HB2' ' NZ ' ' A' ' 238' ' ' LYS . 34.4 mt-10 -102.87 22.12 14.39 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 123.826 0.851 . . . . 72.430000000000007 110.691 -178.84 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 85.85 -156.03 29.62 Favored Glycine 0 C--N 1.354 1.555 0 CA-C-O 119.13 -0.817 . . . . 52.240000000000002 113.291 176.628 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -75.71 148.0 32.08 Favored 'Trans proline' 0 C--N 1.369 1.613 0 C-N-CA 122.79 2.327 . . . . 63.240000000000002 113.024 -178.151 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 3.8 p -141.5 128.77 21.09 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 N-CA-C 108.735 -0.839 . . . . 54.409999999999997 108.735 174.464 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -79.45 102.88 9.0 Favored 'General case' 0 C--O 1.241 0.606 0 N-CA-C 108.453 -0.943 . . . . 64.140000000000001 108.453 174.564 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 1.8 p -111.13 115.88 51.03 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.214 0 CA-C-N 115.457 -0.792 . . . . 73.340000000000003 108.968 -170.497 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 222' ' ' ALA . . . . . 0.682 ' H ' HD21 ' A' ' 172' ' ' LEU . . . -67.78 109.17 3.25 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 115.365 -0.834 . . . . 71.109999999999999 111.699 179.143 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 57.5 t -55.4 136.86 69.43 Favored Pre-proline 0 CA--C 1.551 1.008 0 C-N-CA 124.975 1.31 . . . . 40.329999999999998 110.382 178.29 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -66.42 160.71 44.25 Favored 'Trans proline' 0 C--N 1.371 1.726 0 C-N-CA 122.233 1.956 . . . . 74.209999999999994 111.567 173.009 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo -69.92 151.26 68.08 Favored 'Trans proline' 0 C--N 1.363 1.336 0 C-N-CA 121.406 1.404 . . . . 73.329999999999998 110.973 171.427 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 49.6 mtt180 61.98 43.76 8.79 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 124.535 1.134 . . . . 70.219999999999999 111.054 170.119 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 227' ' ' THR . . . . . 0.44 ' HA ' ' HE ' ' A' ' 231' ' ' ARG . 91.8 m -85.11 124.63 32.01 Favored 'General case' 0 CA--C 1.544 0.739 0 CA-C-N 114.14 -1.391 . . . . 72.340000000000003 109.808 178.095 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -104.81 151.62 23.57 Favored 'General case' 0 N--CA 1.492 1.644 0 C-N-CA 123.602 0.761 . . . . 75.150000000000006 109.496 176.292 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -58.01 116.25 3.39 Favored 'General case' 0 C--N 1.353 0.75 0 O-C-N 123.915 0.76 . . . . 61.039999999999999 110.397 178.895 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 114.21 -2.24 23.9 Favored Glycine 0 C--N 1.338 0.651 0 CA-C-O 119.194 -0.781 . . . . 61.310000000000002 113.211 -178.302 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 231' ' ' ARG . . . . . 0.473 ' HD3' ' H ' ' A' ' 180' ' ' GLY . 25.6 mtt-85 -63.41 129.95 42.37 Favored 'General case' 0 C--N 1.361 1.065 0 CA-C-N 117.989 0.894 . . . . 63.130000000000003 109.344 171.817 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 77.2 mttt -110.69 96.75 6.37 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 107.83 -1.174 . . . . 75.239999999999995 107.83 -175.301 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 233' ' ' LEU . . . . . 0.604 ' HB2' ' HB2' ' A' ' 251' ' ' LEU . 34.0 mt -79.81 151.33 30.34 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 114.137 -1.392 . . . . 73.200000000000003 109.42 -174.747 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 45.8 ttt180 -117.05 103.05 9.85 Favored 'General case' 0 N--CA 1.483 1.21 0 CA-C-N 118.654 0.661 . . . . 51.109999999999999 111.579 -170.135 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 235' ' ' LEU . . . . . 0.566 ' HB2' ' HB3' ' A' ' 249' ' ' LEU . 18.7 mt -94.13 101.14 13.14 Favored 'General case' 0 C--O 1.24 0.594 0 C-N-CA 123.239 0.616 . . . . 74.140000000000001 109.68 172.442 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 57.5 mttt -72.97 147.84 44.81 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 110.088 -0.338 . . . . 71.430000000000007 110.088 173.857 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 79.32 -6.61 56.7 Favored Glycine 0 C--N 1.341 0.834 0 CA-C-N 115.545 -0.752 . . . . 60.520000000000003 113.927 -177.367 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 238' ' ' LYS . . . . . 0.403 ' NZ ' ' HB2' ' A' ' 216' ' ' GLU . 71.8 mmtt -100.4 2.8 42.66 Favored 'General case' 0 C--O 1.239 0.531 0 C-N-CA 123.491 0.716 . . . . 74.5 111.083 179.351 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -103.62 -175.85 25.98 Favored Glycine 0 C--N 1.357 1.74 0 O-C-N 123.528 0.518 . . . . 65.420000000000002 112.09 166.477 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 79.9 m-85 -86.89 167.71 20.99 Favored Pre-proline 0 CA--C 1.563 1.462 0 C-N-CA 124.416 1.087 . . . . 73.040000000000006 110.812 179.181 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_endo -73.0 168.53 24.5 Favored 'Trans proline' 0 C--N 1.382 2.294 0 C-N-CA 122.187 1.924 . . . . 53.229999999999997 113.198 173.747 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 163.03 -120.14 0.93 Allowed Glycine 0 CA--C 1.538 1.529 0 CA-C-O 118.911 -0.938 . . . . 43.299999999999997 112.106 176.854 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 243' ' ' PRO . . . . . 0.525 ' HD2' ' HB3' ' A' ' 191' ' ' GLN . 37.1 Cg_endo -59.83 -59.04 0.44 Allowed 'Trans proline' 0 C--N 1.379 2.133 0 C-N-CA 124.563 3.509 . . . . 73.209999999999994 112.892 -173.976 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -83.5 -9.28 59.07 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 123.381 0.672 . . . . 73.120000000000005 111.066 178.645 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 85.39 -22.82 9.47 Favored Glycine 0 C--N 1.356 1.649 0 C-N-CA 123.175 0.417 . . . . 53.409999999999997 113.134 -177.161 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 10.0 ttm180 -125.33 111.56 15.32 Favored 'General case' 0 C--O 1.241 0.649 0 C-N-CA 124.545 1.138 . . . . 72.329999999999998 109.21 -179.7 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -76.75 151.46 39.4 Favored Glycine 0 C--N 1.348 1.198 0 O-C-N 123.726 0.641 . . . . 65.099999999999994 114.006 178.006 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -103.98 140.95 37.02 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.062 0.945 . . . . 73.340000000000003 109.747 -177.727 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 249' ' ' LEU . . . . . 0.566 ' HB3' ' HB2' ' A' ' 235' ' ' LEU . 45.7 tp -109.04 111.9 23.79 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 108.93 -0.767 . . . . 72.010000000000005 108.93 176.439 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 250' ' ' TYR . . . . . 0.461 ' HA ' ' O ' ' A' ' 233' ' ' LEU . 4.8 m-85 -89.58 109.28 20.24 Favored 'General case' 0 C--O 1.242 0.703 0 CA-C-O 121.36 0.6 . . . . 71.430000000000007 110.163 -179.531 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 251' ' ' LEU . . . . . 0.645 HD13 HD22 ' A' ' 197' ' ' LEU . 80.1 mt -87.35 104.02 16.03 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-N 114.382 -1.281 . . . . 73.510000000000005 108.289 179.865 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 56.3 mt-10 -85.42 94.19 8.92 Favored 'General case' 0 C--O 1.241 0.621 0 N-CA-C 108.572 -0.899 . . . . 73.450000000000003 108.572 -178.964 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 11.4 m -63.36 138.5 22.85 Favored 'Isoleucine or valine' 0 C--N 1.352 0.699 0 O-C-N 123.858 0.724 . . . . 72.209999999999994 110.374 -176.403 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 15.4 mmm180 -126.14 108.78 11.66 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 107.272 -1.381 . . . . 74.239999999999995 107.272 179.225 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 255' ' ' ILE . . . . . 0.456 ' HA ' ' O ' ' A' ' 199' ' ' VAL . 29.0 mt -78.92 121.15 31.45 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 O-C-N 123.9 0.75 . . . . 62.310000000000002 110.116 179.29 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 2.5 t . . . . . 0 C--O 1.254 1.294 0 C-N-CA 123.922 0.889 . . . . 71.349999999999994 109.42 174.727 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 172' ' ' LEU . . . . . 0.71 HD21 ' H ' ' A' ' 222' ' ' ALA . 41.4 mt . . . . . 0 N--CA 1.481 1.114 0 CA-C-O 121.418 0.627 . . . . 70.230000000000004 111.277 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 173' ' ' PHE . . . . . 0.401 ' CD1' HD22 ' A' ' 235' ' ' LEU . 27.5 m-85 -130.94 -47.51 1.02 Allowed 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 114.623 -1.171 . . . . 65.420000000000002 109.095 -167.918 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 174' ' ' TYR . . . . . 0.435 ' HB2' ' HB2' ' A' ' 178' ' ' ALA . 8.2 p90 -84.23 8.07 17.04 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-N 114.36 -1.291 . . . . 75.120000000000005 113.324 -173.889 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 14.8 p -60.09 -23.29 63.69 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 123.158 0.583 . . . . 72.150000000000006 112.216 177.293 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 176' ' ' MET . . . . . . . . . . . . . 40.1 mtm -54.89 -49.92 70.02 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 124.216 1.006 . . . . 70.140000000000001 110.655 173.849 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -169.54 122.28 0.74 Allowed 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 124.834 1.254 . . . . 61.32 108.037 179.295 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 178' ' ' ALA . . . . . 0.634 ' HB1' HD22 ' A' ' 233' ' ' LEU . . . -146.71 -56.94 0.27 Allowed 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 123.209 0.604 . . . . 72.010000000000005 110.946 -175.288 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 179' ' ' ALA . . . . . 0.603 ' HB2' ' HB2' ' A' ' 224' ' ' PRO . . . -75.46 78.55 2.5 Favored 'General case' 0 C--N 1.353 0.754 0 CA-C-O 122.256 1.027 . . . . 74.140000000000001 108.832 172.715 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.487 0 CA-C-N 113.255 -1.793 . . . . 74.129999999999995 110.128 -173.759 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 191' ' ' GLN . . . . . 0.651 ' HB3' ' HD2' ' A' ' 243' ' ' PRO . 9.6 pt20 . . . . . 0 N--CA 1.473 0.719 0 CA-C-O 120.849 0.357 . . . . 62.109999999999999 110.64 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 17.7 m-20 -74.99 150.62 38.93 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-N 115.367 -0.833 . . . . 72.200000000000003 110.704 -174.812 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 193' ' ' LEU . . . . . 0.662 HD12 ' HA2' ' A' ' 239' ' ' GLY . 32.6 mt -140.79 170.82 15.04 Favored 'General case' 0 C--O 1.241 0.608 0 CA-C-N 114.592 -1.186 . . . . 61.520000000000003 109.176 -179.399 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 55.1 m-85 -138.41 122.07 17.47 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 123.491 0.717 . . . . 62.549999999999997 109.689 178.846 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 195' ' ' ALA . . . . . 0.463 ' HB2' HD11 ' A' ' 249' ' ' LEU . . . -126.3 135.98 52.18 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 107.834 -1.172 . . . . 64.010000000000005 107.834 174.993 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 9.1 m -83.55 130.63 35.01 Favored 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 109.742 -0.466 . . . . 72.200000000000003 109.742 -176.374 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 197' ' ' LEU . . . . . 0.502 HD22 HD13 ' A' ' 251' ' ' LEU . 15.5 tp -109.35 108.53 19.12 Favored 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 108.663 -0.866 . . . . 74.400000000000006 108.663 -179.479 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -81.21 113.23 19.21 Favored 'General case' 0 CA--C 1.542 0.648 0 N-CA-C 108.92 -0.77 . . . . 71.420000000000002 108.92 176.966 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 199' ' ' VAL . . . . . 0.413 ' O ' ' HA ' ' A' ' 255' ' ' ILE . 6.5 p -132.18 128.99 21.53 Favored Pre-proline 0 CA--C 1.55 0.976 0 C-N-CA 124.035 0.934 . . . . 71.140000000000001 109.34 -178.706 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -70.58 159.06 54.07 Favored 'Trans proline' 0 C--N 1.37 1.709 0 C-N-CA 122.035 1.823 . . . . 74.049999999999997 111.691 170.101 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -51.18 -49.7 79.9 Favored Pre-proline 0 CA--C 1.564 1.497 0 CA-C-O 117.775 -1.107 . . . . 30.140000000000001 113.619 -179.56 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 202' ' ' PRO . . . . . 0.458 ' O ' HG22 ' A' ' 206' ' ' VAL . 42.6 Cg_endo -64.24 -43.01 15.79 Favored 'Trans proline' 0 C--N 1.396 3.074 0 C-N-CA 121.861 1.708 . . . . 61.200000000000003 113.702 -179.035 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 51.8 mt -63.48 -34.17 65.81 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.386 0 CA-C-N 118.152 0.433 . . . . 73.109999999999999 110.351 176.628 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -66.2 -52.68 45.66 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 122.821 0.448 . . . . 62.219999999999999 111.622 179.245 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 20.2 m -69.45 -49.67 57.84 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.924 0 C-N-CA 123.618 0.767 . . . . 64.549999999999997 112.577 -173.444 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 206' ' ' VAL . . . . . 0.458 HG22 ' O ' ' A' ' 202' ' ' PRO . 6.7 m -76.99 -31.0 18.34 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.181 0 CA-C-O 120.714 0.292 . . . . 71.010000000000005 110.909 -179.736 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 85.63 70.26 1.33 Allowed Glycine 0 C--N 1.345 1.066 0 CA-C-N 115.943 -0.571 . . . . 73.209999999999994 112.022 -176.826 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -87.51 -126.4 2.29 Favored Glycine 0 C--N 1.352 1.466 0 N-CA-C 111.902 -0.479 . . . . 51.130000000000003 111.902 176.403 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 46.5 mtmt -139.45 151.65 46.39 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 123.695 0.798 . . . . 65.530000000000001 111.12 177.234 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 5.8 m -144.81 169.92 7.77 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 C-N-CA 125.335 1.454 . . . . 64.349999999999994 109.532 175.664 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 55.4 ttp180 -102.25 117.05 33.93 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 124.1 0.96 . . . . 72.349999999999994 110.048 -179.831 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -100.73 128.92 46.6 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 124.104 0.962 . . . . 71.409999999999997 110.207 177.439 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 90.8 mmm -92.55 115.57 28.22 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 123.369 0.667 . . . . 73.400000000000006 109.413 179.572 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 17.4 p -111.71 -179.39 3.69 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 124.288 1.035 . . . . 73.239999999999995 109.907 -176.687 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 89.0 mt -56.77 -29.69 62.88 Favored 'General case' 0 N--CA 1.491 1.583 0 CA-C-O 121.082 0.467 . . . . 73.140000000000001 111.216 171.883 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -101.29 23.2 11.29 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 124.476 1.11 . . . . 73.299999999999997 111.144 -178.252 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 83.42 -159.42 36.89 Favored Glycine 0 C--N 1.348 1.246 0 CA-C-O 119.508 -0.607 . . . . 54.130000000000003 113.303 176.314 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -71.29 157.03 58.0 Favored 'Trans proline' 0 C--N 1.367 1.524 0 C-N-CA 122.665 2.244 . . . . 74.239999999999995 113.21 -173.232 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 7.3 p -151.58 136.9 10.96 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 C-N-CA 124.142 0.977 . . . . 72.099999999999994 108.869 174.656 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -80.64 103.43 10.48 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 108.832 -0.803 . . . . 74.409999999999997 108.832 175.573 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 10.8 m -104.08 133.75 47.25 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 CA-C-O 121.451 0.644 . . . . 72.549999999999997 110.057 177.95 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 222' ' ' ALA . . . . . 0.71 ' H ' HD21 ' A' ' 172' ' ' LEU . . . -86.7 105.66 17.09 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 114.743 -1.117 . . . . 74.25 110.427 -178.731 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 90.6 t -54.49 134.14 62.87 Favored Pre-proline 0 N--CA 1.481 1.112 0 C-N-CA 125.355 1.462 . . . . 70.409999999999997 111.179 -176.763 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 224' ' ' PRO . . . . . 0.603 ' HB2' ' HB2' ' A' ' 179' ' ' ALA . 72.4 Cg_endo -70.33 159.84 51.61 Favored 'Trans proline' 0 C--N 1.376 2.022 0 C-N-CA 122.209 1.939 . . . . 64.140000000000001 111.924 175.912 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 22.8 Cg_endo -64.6 136.41 49.89 Favored 'Trans proline' 0 C--N 1.38 2.204 0 C-N-CA 121.981 1.788 . . . . 75.430000000000007 111.554 176.189 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 44.3 mtm-85 63.72 64.9 0.75 Allowed 'General case' 0 C--O 1.244 0.775 0 C-N-CA 124.7 1.2 . . . . 73.420000000000002 110.074 175.672 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 227' ' ' THR . . . . . 0.446 ' HA ' ' HE ' ' A' ' 231' ' ' ARG . 88.5 m -96.68 123.19 40.28 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 108.214 -1.032 . . . . 72.219999999999999 108.214 174.458 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 27.6 mp0 -109.7 148.24 31.73 Favored 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 123.49 0.716 . . . . 74.25 109.085 -179.382 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -57.66 114.29 2.2 Favored 'General case' 0 C--N 1.352 0.674 0 O-C-N 124.278 0.986 . . . . 60.439999999999998 110.494 -178.685 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 113.76 5.94 21.68 Favored Glycine 0 CA--C 1.528 0.902 0 O-C-N 124.051 0.844 . . . . 70.019999999999996 113.402 -175.48 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 231' ' ' ARG . . . . . 0.446 ' HE ' ' HA ' ' A' ' 227' ' ' THR . 40.7 mtt-85 -71.89 149.57 45.02 Favored 'General case' 0 N--CA 1.481 1.095 0 CA-C-N 117.72 0.76 . . . . 72.540000000000006 109.074 165.891 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 232' ' ' LYS . . . . . 0.407 ' HA ' ' O ' ' A' ' 251' ' ' LEU . 43.5 mtmt -128.72 99.48 5.36 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 123.513 0.725 . . . . 73.349999999999994 109.344 178.404 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 233' ' ' LEU . . . . . 0.634 HD22 ' HB1' ' A' ' 178' ' ' ALA . 24.1 mt -81.65 132.75 35.31 Favored 'General case' 0 CA--C 1.552 1.044 0 C-N-CA 124.088 0.955 . . . . 74.409999999999997 110.266 -173.467 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 40.1 ttt180 -89.53 102.97 15.65 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 123.4 0.68 . . . . 63.420000000000002 112.35 -169.654 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 235' ' ' LEU . . . . . 0.604 ' HB2' ' HB3' ' A' ' 249' ' ' LEU . 18.0 mt -93.35 97.08 10.35 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 123.057 0.543 . . . . 73.120000000000005 110.483 174.679 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 40.8 mtmt -69.49 144.46 53.21 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-O 120.85 0.357 . . . . 74.120000000000005 111.192 177.002 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 73.68 1.03 57.48 Favored Glycine 0 N--CA 1.473 1.137 0 CA-C-N 115.237 -0.892 . . . . 72.319999999999993 114.949 -177.816 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 76.1 mmtt -106.04 3.87 28.68 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 117.418 0.609 . . . . 70.439999999999998 110.525 179.229 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 239' ' ' GLY . . . . . 0.662 ' HA2' HD12 ' A' ' 193' ' ' LEU . . . -101.93 -160.33 26.57 Favored Glycine 0 C--N 1.35 1.318 0 N-CA-C 111.063 -0.815 . . . . 73.439999999999998 111.063 164.025 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 71.4 m-85 -95.04 155.03 39.48 Favored Pre-proline 0 N--CA 1.485 1.314 0 C-N-CA 123.826 0.85 . . . . 71.319999999999993 110.981 -179.597 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_exo -71.09 130.62 17.98 Favored 'Trans proline' 0 C--N 1.371 1.735 0 C-N-CA 121.764 1.642 . . . . 71.319999999999993 111.197 170.933 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -163.54 -121.35 0.56 Allowed Glycine 0 CA--C 1.535 1.325 0 CA-C-O 118.776 -1.013 . . . . 50.420000000000002 113.401 -177.829 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 243' ' ' PRO . . . . . 0.651 ' HD2' ' HB3' ' A' ' 191' ' ' GLN . 37.3 Cg_endo -58.96 -42.85 47.99 Favored 'Trans proline' 0 C--N 1.385 2.462 0 C-N-CA 124.379 3.386 . . . . 75.519999999999996 112.935 -172.399 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -96.59 -4.88 40.37 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 123.551 0.74 . . . . 65.140000000000001 111.044 177.152 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 84.27 -23.39 7.22 Favored Glycine 0 C--N 1.361 1.939 0 C-N-CA 123.142 0.401 . . . . 75.450000000000003 113.423 -178.827 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 43.1 ttt85 -128.0 111.58 13.69 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.97 1.308 . . . . 75.340000000000003 108.901 -179.649 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -72.48 151.3 46.36 Favored Glycine 0 C--N 1.347 1.145 0 N-CA-C 115.064 0.785 . . . . 61.299999999999997 115.064 178.694 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 38.2 m-20 -111.64 127.78 55.86 Favored 'General case' 0 C--O 1.233 0.221 0 C-N-CA 124.295 1.038 . . . . 71.219999999999999 109.382 -176.487 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 249' ' ' LEU . . . . . 0.604 ' HB3' ' HB2' ' A' ' 235' ' ' LEU . 58.8 tp -103.76 109.83 21.69 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 108.323 -0.992 . . . . 73.519999999999996 108.323 178.526 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 250' ' ' TYR . . . . . . . . . . . . . 4.4 m-85 -88.21 118.65 27.95 Favored 'General case' 0 C--O 1.241 0.646 0 N-CA-C 109.271 -0.64 . . . . 73.430000000000007 109.271 -176.267 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 251' ' ' LEU . . . . . 0.502 HD13 HD22 ' A' ' 197' ' ' LEU . 74.3 mt -88.14 103.31 15.64 Favored 'General case' 0 C--N 1.343 0.302 0 N-CA-C 107.935 -1.135 . . . . 62.409999999999997 107.935 -177.061 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -83.07 93.11 7.53 Favored 'General case' 0 C--O 1.241 0.638 0 N-CA-C 107.329 -1.36 . . . . 63.130000000000003 107.329 -175.53 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 4.9 m -71.94 136.84 24.86 Favored 'Isoleucine or valine' 0 C--N 1.351 0.648 0 CA-C-N 114.959 -1.018 . . . . 73.329999999999998 110.819 -170.746 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 24.4 mmm180 -122.05 112.54 18.38 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 106.913 -1.514 . . . . 74.340000000000003 106.913 179.737 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 255' ' ' ILE . . . . . 0.413 ' HA ' ' O ' ' A' ' 199' ' ' VAL . 35.2 mt -80.4 115.98 23.8 Favored 'Isoleucine or valine' 0 C--O 1.236 0.382 0 N-CA-C 108.758 -0.83 . . . . 65.140000000000001 108.758 173.569 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 9.5 t . . . . . 0 C--O 1.26 1.655 0 N-CA-C 108.349 -0.982 . . . . 74.109999999999999 108.349 168.614 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 172' ' ' LEU . . . . . 0.539 HD21 ' H ' ' A' ' 222' ' ' ALA . 63.6 mt . . . . . 0 N--CA 1.484 1.273 0 CA-C-O 122.039 0.923 . . . . 74.420000000000002 112.068 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 173' ' ' PHE . . . . . 0.485 ' CD1' HD22 ' A' ' 235' ' ' LEU . 19.8 m-85 -136.71 -51.67 0.69 Allowed 'General case' 0 N--CA 1.477 0.919 0 CA-C-N 114.586 -1.188 . . . . 72.340000000000003 108.609 -171.343 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 174' ' ' TYR . . . . . 0.44 ' OH ' ' HB ' ' A' ' 221' ' ' VAL . 2.9 p90 -79.3 17.87 0.76 Allowed 'General case' 0 CA--C 1.552 1.04 0 CA-C-N 113.446 -1.706 . . . . 73.150000000000006 112.551 -179.213 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 175' ' ' THR . . . . . 0.45 HG23 HD13 ' A' ' 172' ' ' LEU . 0.2 OUTLIER -66.1 -18.57 65.43 Favored 'General case' 0 CA--C 1.552 1.032 0 C-N-CA 124.1 0.96 . . . . 71.409999999999997 111.888 -174.936 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 176' ' ' MET . . . . . 0.51 ' SD ' ' N ' ' A' ' 177' ' ' LYS . 0.0 OUTLIER -70.74 -45.36 64.98 Favored 'General case' 0 CA--C 1.554 1.126 0 C-N-CA 123.978 0.911 . . . . 75.209999999999994 111.45 173.509 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 177' ' ' LYS . . . . . 0.51 ' N ' ' SD ' ' A' ' 176' ' ' MET . 35.7 mttp -162.91 134.15 4.93 Favored 'General case' 0 N--CA 1.491 1.599 0 C-N-CA 125.702 1.601 . . . . 54.149999999999999 108.681 175.277 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 178' ' ' ALA . . . . . 0.495 ' HB1' HD22 ' A' ' 233' ' ' LEU . . . -147.99 -53.54 0.2 Allowed 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 123.934 0.893 . . . . 75.030000000000001 109.839 -172.859 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -85.48 36.9 0.66 Allowed 'General case' 0 CA--C 1.558 1.259 0 C-N-CA 123.876 0.87 . . . . 74.349999999999994 109.957 171.341 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.354 1.53 0 N-CA-C 110.638 -0.985 . . . . 72.439999999999998 110.638 176.766 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 191' ' ' GLN . . . . . 0.509 ' HB3' ' HD2' ' A' ' 243' ' ' PRO . 2.3 pt20 . . . . . 0 N--CA 1.479 1.008 0 CA-C-O 121.391 0.615 . . . . 71.450000000000003 111.092 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -86.32 144.67 27.26 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 124.35 1.06 . . . . 70.030000000000001 110.201 -163.501 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 193' ' ' LEU . . . . . 0.5 HD12 ' HA2' ' A' ' 239' ' ' GLY . 25.4 mt -138.69 163.63 31.62 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 124.27 1.028 . . . . 72.340000000000003 109.391 174.363 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 50.6 m-85 -139.36 122.82 17.24 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 123.779 0.832 . . . . 55.210000000000001 109.761 -177.543 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 195' ' ' ALA . . . . . 0.44 ' HB2' HD11 ' A' ' 249' ' ' LEU . . . -133.02 129.13 37.73 Favored 'General case' 0 N--CA 1.466 0.335 0 O-C-N 124.343 1.027 . . . . 31.329999999999998 108.6 175.654 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 33.6 m -76.79 130.82 38.2 Favored 'General case' 0 CA--C 1.541 0.617 0 N-CA-C 109.694 -0.484 . . . . 74.420000000000002 109.694 178.157 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 197' ' ' LEU . . . . . 0.598 HD22 HD13 ' A' ' 251' ' ' LEU . 15.1 tp -112.21 108.79 18.15 Favored 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 107.61 -1.256 . . . . 72.400000000000006 107.61 176.645 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -83.76 132.32 34.85 Favored 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 108.841 -0.8 . . . . 74.450000000000003 108.841 174.838 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 199' ' ' VAL . . . . . 0.45 ' O ' ' HA ' ' A' ' 255' ' ' ILE . 4.1 p -144.61 129.88 9.44 Favored Pre-proline 0 CA--C 1.549 0.934 0 C-N-CA 123.866 0.866 . . . . 74.409999999999997 108.671 -179.983 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -70.35 153.7 65.98 Favored 'Trans proline' 0 C--N 1.367 1.536 0 C-N-CA 122.21 1.94 . . . . 72.310000000000002 110.836 168.49 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 201' ' ' ALA . . . . . 0.465 ' O ' HG23 ' A' ' 205' ' ' VAL . . . -49.88 -51.4 61.28 Favored Pre-proline 0 CA--C 1.555 1.153 0 C-N-CA 124.754 1.222 . . . . 63.020000000000003 113.361 -177.729 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_endo -60.85 -35.85 86.58 Favored 'Trans proline' 0 C--N 1.397 3.118 0 C-N-CA 121.771 1.647 . . . . 73.109999999999999 113.896 -178.487 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 38.1 mt -70.02 -34.14 58.33 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 C-N-CA 122.587 0.355 . . . . 71.409999999999997 110.461 177.418 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -67.1 -38.36 85.52 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 122.342 0.257 . . . . 74.329999999999998 111.22 175.838 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 205' ' ' VAL . . . . . 0.465 HG23 ' O ' ' A' ' 201' ' ' ALA . 92.1 t -69.25 -56.49 11.62 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.125 0 C-N-CA 123.963 0.905 . . . . 55.119999999999997 111.083 -179.423 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 18.0 m -75.59 -24.07 16.93 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.133 0 CA-C-N 116.09 -0.504 . . . . 62.509999999999998 111.574 -174.883 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 76.15 66.21 1.89 Allowed Glycine 0 C--N 1.345 1.042 0 CA-C-N 115.251 -0.886 . . . . 63.240000000000002 111.83 -173.987 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -83.74 -140.46 4.29 Favored Glycine 0 C--N 1.352 1.443 0 N-CA-C 112.161 -0.376 . . . . 41.009999999999998 112.161 178.628 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 49.4 mtmt -137.43 137.5 38.83 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.606 0.763 . . . . 63.439999999999998 110.414 177.915 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 11.0 m -127.82 165.39 27.03 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 C-N-CA 125.119 1.368 . . . . 71.120000000000005 108.742 172.903 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 50.6 ttp180 -101.59 117.47 34.98 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 123.25 0.62 . . . . 71.239999999999995 110.323 -178.564 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -101.99 132.59 47.73 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 123.958 0.903 . . . . 73.239999999999995 110.239 175.721 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 25.3 mmt -90.91 121.32 32.65 Favored 'General case' 0 N--CA 1.48 1.075 0 N-CA-C 109.343 -0.614 . . . . 74.310000000000002 109.343 175.306 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 30.5 p -121.97 -173.54 2.68 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 124.484 1.114 . . . . 62.200000000000003 110.371 -174.779 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 83.2 mt -61.65 -30.95 71.05 Favored 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 123.216 0.606 . . . . 70.200000000000003 111.097 171.588 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -98.76 21.28 11.65 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 123.498 0.719 . . . . 74.129999999999995 111.282 179.791 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 84.49 -159.15 34.76 Favored Glycine 0 C--N 1.356 1.658 0 CA-C-O 119.411 -0.66 . . . . 61.409999999999997 113.012 175.359 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -64.76 142.25 75.63 Favored 'Trans proline' 0 C--N 1.369 1.633 0 C-N-CA 122.817 2.345 . . . . 73.200000000000003 112.58 178.687 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 4.8 p -140.81 128.53 23.01 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 N-CA-C 108.333 -0.988 . . . . 43.210000000000001 108.333 174.323 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 3.8 mp0 -79.28 101.6 8.12 Favored 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 107.28 -1.378 . . . . 72.329999999999998 107.28 175.949 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 221' ' ' VAL . . . . . 0.44 ' HB ' ' OH ' ' A' ' 174' ' ' TYR . 2.8 m -99.39 128.25 51.32 Favored 'Isoleucine or valine' 0 C--O 1.24 0.586 0 CA-C-O 121.602 0.715 . . . . 71.209999999999994 109.544 -179.675 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 222' ' ' ALA . . . . . 0.539 ' H ' HD21 ' A' ' 172' ' ' LEU . . . -80.26 104.81 11.07 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 114.407 -1.27 . . . . 52.420000000000002 109.26 179.63 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 61.3 t -53.99 134.9 57.93 Favored Pre-proline 0 CA--C 1.558 1.283 0 O-C-N 124.567 1.167 . . . . 54.240000000000002 109.707 178.549 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -63.87 149.85 89.73 Favored 'Trans proline' 0 C--N 1.371 1.722 0 C-N-CA 122.068 1.845 . . . . 55.32 111.452 173.474 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -63.23 134.12 43.99 Favored 'Trans proline' 0 C--N 1.373 1.854 0 C-N-CA 121.907 1.738 . . . . 71.010000000000005 110.983 174.952 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 33.6 mtm-85 63.82 53.39 1.96 Allowed 'General case' 0 CA--C 1.546 0.817 0 O-C-N 124.68 1.237 . . . . 74.129999999999995 111.043 175.858 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 227' ' ' THR . . . . . 0.424 HG23 ' HD2' ' A' ' 231' ' ' ARG . 30.6 m -78.24 145.17 35.62 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 115.444 -0.798 . . . . 72.409999999999997 108.945 170.391 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 27.0 mp0 -116.22 145.54 43.04 Favored 'General case' 0 N--CA 1.48 1.061 0 N-CA-C 108.563 -0.902 . . . . 70.510000000000005 108.563 176.916 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 229' ' ' ALA . . . . . 0.523 ' HB2' ' HB ' ' A' ' 255' ' ' ILE . . . -60.2 130.72 48.06 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.543 0.737 . . . . 72.200000000000003 109.762 -179.48 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 97.85 12.08 48.0 Favored Glycine 0 CA--C 1.522 0.504 0 O-C-N 123.857 0.723 . . . . 74.310000000000002 112.852 -178.248 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 231' ' ' ARG . . . . . 0.424 ' HD2' HG23 ' A' ' 227' ' ' THR . 95.1 mtt-85 -84.24 156.14 22.14 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 109.256 -0.646 . . . . 74.400000000000006 109.256 165.049 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 232' ' ' LYS . . . . . 0.421 ' HA ' ' O ' ' A' ' 251' ' ' LEU . 42.3 mtmt -130.38 106.84 8.82 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.583 0.753 . . . . 73.439999999999998 109.312 -179.735 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 233' ' ' LEU . . . . . 0.526 ' HB2' ' HB2' ' A' ' 251' ' ' LEU . 26.3 mt -80.27 134.04 36.04 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 115.218 -0.901 . . . . 74.450000000000003 109.526 -176.677 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 75.3 ttt180 -97.33 109.95 22.6 Favored 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 122.808 0.443 . . . . 73.430000000000007 110.93 -170.732 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 235' ' ' LEU . . . . . 0.543 HD12 HD23 ' A' ' 249' ' ' LEU . 15.0 mt -99.77 105.87 17.7 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.265 0.626 . . . . 72.239999999999995 111.099 179.522 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 1.9 mtpp -72.09 153.79 41.49 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-O 120.719 0.295 . . . . 70.519999999999996 110.563 171.707 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 65.63 13.83 59.4 Favored Glycine 0 N--CA 1.473 1.141 0 O-C-N 124.486 1.116 . . . . 75.430000000000007 114.359 -177.198 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 41.1 mmtm -125.53 4.58 7.59 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 123.782 0.833 . . . . 72.230000000000004 111.823 -177.968 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 239' ' ' GLY . . . . . 0.5 ' HA2' HD12 ' A' ' 193' ' ' LEU . . . -107.66 -167.64 21.75 Favored Glycine 0 C--N 1.345 1.028 0 N-CA-C 110.879 -0.888 . . . . 70.030000000000001 110.879 165.644 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 66.7 m-85 -92.44 166.55 16.78 Favored Pre-proline 0 CA--C 1.548 0.892 0 C-N-CA 123.794 0.837 . . . . 73.439999999999998 110.777 178.807 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 241' ' ' PRO . . . . . 0.414 ' HA ' ' O ' ' A' ' 245' ' ' GLY . 55.2 Cg_endo -70.88 146.47 53.33 Favored 'Trans proline' 0 C--N 1.374 1.887 0 C-N-CA 121.756 1.637 . . . . 65.420000000000002 111.577 168.068 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -169.74 -117.3 0.41 Allowed Glycine 0 CA--C 1.532 1.103 0 CA-C-O 119.039 -0.867 . . . . 52.109999999999999 111.587 178.923 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 243' ' ' PRO . . . . . 0.509 ' HD2' ' HB3' ' A' ' 191' ' ' GLN . 65.6 Cg_endo -66.15 -57.36 0.23 Allowed 'Trans proline' 0 C--N 1.375 1.96 0 C-N-CA 124.246 3.298 . . . . 70.450000000000003 112.617 -169.574 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -96.39 18.88 12.99 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.899 0.88 . . . . 74.030000000000001 110.463 176.415 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 245' ' ' GLY . . . . . 0.414 ' O ' ' HA ' ' A' ' 241' ' ' PRO . . . 74.66 -103.33 1.52 Allowed Glycine 0 C--N 1.354 1.558 0 N-CA-C 110.322 -1.111 . . . . 71.310000000000002 110.322 -170.835 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 31.0 ttm180 -50.42 110.63 0.43 Allowed 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 125.203 1.401 . . . . 74.040000000000006 112.559 -176.408 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -89.04 179.46 45.39 Favored Glycine 0 C--N 1.344 0.991 0 CA-C-N 115.898 -0.592 . . . . 65.420000000000002 113.478 178.322 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 20.9 m-20 -126.83 152.53 46.86 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 114.598 -0.801 . . . . 71.540000000000006 112.504 -168.795 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 249' ' ' LEU . . . . . 0.543 HD23 HD12 ' A' ' 235' ' ' LEU . 55.7 tp -110.17 117.08 32.75 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 114.354 -1.293 . . . . 75.430000000000007 108.095 171.117 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 250' ' ' TYR . . . . . . . . . . . . . 3.7 m-85 -90.24 115.16 27.25 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 123.188 0.595 . . . . 53.32 109.404 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 251' ' ' LEU . . . . . 0.598 HD13 HD22 ' A' ' 197' ' ' LEU . 77.2 mt -88.5 105.35 17.56 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-N 114.685 -1.143 . . . . 74.109999999999999 108.486 -177.973 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 252' ' ' GLU . . . . . 0.451 ' HG3' ' HD3' ' A' ' 254' ' ' ARG . 12.0 tp10 -79.56 94.06 5.57 Favored 'General case' 0 C--O 1.238 0.486 0 N-CA-C 108.55 -0.907 . . . . 63.32 108.55 -178.746 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 4.4 m -71.67 127.48 33.67 Favored 'Isoleucine or valine' 0 C--N 1.352 0.694 0 CA-C-O 121.619 0.723 . . . . 71.209999999999994 109.664 -174.839 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 254' ' ' ARG . . . . . 0.451 ' HD3' ' HG3' ' A' ' 252' ' ' GLU . 22.9 mmm180 -122.87 95.1 4.49 Favored 'General case' 0 C--O 1.239 0.517 0 N-CA-C 107.971 -1.122 . . . . 65.319999999999993 107.971 -176.7 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 255' ' ' ILE . . . . . 0.523 ' HB ' ' HB2' ' A' ' 229' ' ' ALA . 40.3 mt -76.6 121.08 28.03 Favored 'Isoleucine or valine' 0 C--O 1.238 0.465 0 CA-C-N 115.589 -0.732 . . . . 72.019999999999996 109.669 178.054 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 9.4 t . . . . . 0 C--O 1.254 1.303 0 C-N-CA 123.97 0.908 . . . . 72.329999999999998 108.657 175.885 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 172' ' ' LEU . . . . . 0.55 HD21 ' H ' ' A' ' 222' ' ' ALA . 26.0 mt . . . . . 0 N--CA 1.478 0.963 0 CA-C-O 121.147 0.498 . . . . 62.450000000000003 112.012 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 173' ' ' PHE . . . . . 0.534 ' CD1' HD22 ' A' ' 235' ' ' LEU . 20.2 m-85 -141.1 -71.03 0.36 Allowed 'General case' 0 N--CA 1.481 1.099 0 CA-C-O 121.182 0.515 . . . . 75.319999999999993 111.297 -163.799 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 174' ' ' TYR . . . . . 0.468 ' CD2' ' HB3' ' A' ' 233' ' ' LEU . 2.1 p90 -83.25 7.2 17.05 Favored 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 124.589 1.156 . . . . 74.219999999999999 112.038 -171.364 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 175' ' ' THR . . . . . 0.503 ' OG1' ' HB3' ' A' ' 172' ' ' LEU . 1.5 m -60.23 -36.82 78.59 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 124.365 1.066 . . . . 74.230000000000004 113.149 -160.71 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 176' ' ' MET . . . . . . . . . . . . . 3.0 mpp? -68.08 -27.25 66.33 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 123.676 0.79 . . . . 72.140000000000001 111.192 -179.774 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 20.8 tptm -122.56 25.92 8.56 Favored 'General case' 0 CA--C 1.556 1.205 0 C-N-CA 124.367 1.067 . . . . 74.439999999999998 109.872 -177.459 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 178' ' ' ALA . . . . . 0.616 ' HB1' ' HB3' ' A' ' 224' ' ' PRO . . . -69.46 132.42 46.29 Favored 'General case' 0 N--CA 1.476 0.867 0 CA-C-N 115.865 -0.607 . . . . 74.109999999999999 110.053 -179.761 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 179' ' ' ALA . . . . . 0.533 ' HB2' ' HB2' ' A' ' 224' ' ' PRO . . . 60.89 30.34 19.58 Favored 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 124.315 1.046 . . . . 63.420000000000002 110.779 -170.858 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.345 1.063 0 CA-C-N 115.198 -0.91 . . . . 60.409999999999997 112.496 178.711 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 7.2 pt20 . . . . . 0 N--CA 1.479 1.016 0 CA-C-O 120.594 0.235 . . . . 64.310000000000002 111.278 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 -75.58 134.98 40.56 Favored 'General case' 0 N--CA 1.47 0.525 0 C-N-CA 123.834 0.854 . . . . 64.329999999999998 109.887 -178.294 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 24.2 mt -117.6 162.69 17.6 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 123.568 0.747 . . . . 72.409999999999997 110.215 175.46 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 77.0 m-85 -133.17 135.0 44.85 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 123.77 0.828 . . . . 73.409999999999997 110.382 -177.751 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 195' ' ' ALA . . . . . 0.438 ' HB2' HD11 ' A' ' 249' ' ' LEU . . . -147.8 171.16 16.15 Favored 'General case' 0 C--O 1.239 0.53 0 C-N-CA 125.417 1.487 . . . . 73.25 108.494 -179.607 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 34.1 m -129.63 124.42 33.64 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 123.826 0.851 . . . . 71.120000000000005 108.717 -178.604 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 197' ' ' LEU . . . . . 0.763 HD22 HD13 ' A' ' 251' ' ' LEU . 15.7 tp -106.66 110.2 22.32 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 108.681 -0.859 . . . . 74.510000000000005 108.681 -173.044 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -82.51 122.77 28.49 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 123.091 0.556 . . . . 73.340000000000003 109.774 177.703 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 199' ' ' VAL . . . . . 0.443 ' O ' ' HA ' ' A' ' 255' ' ' ILE . 4.3 p -140.71 128.34 12.32 Favored Pre-proline 0 CA--C 1.545 0.764 0 N-CA-C 108.228 -1.027 . . . . 53.25 108.228 -177.927 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -69.39 156.2 65.0 Favored 'Trans proline' 0 C--N 1.366 1.49 0 C-N-CA 121.917 1.745 . . . . 52.530000000000001 111.034 171.15 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 201' ' ' ALA . . . . . 0.507 ' O ' HG23 ' A' ' 205' ' ' VAL . . . -48.52 -54.2 28.6 Favored Pre-proline 0 CA--C 1.559 1.321 0 CA-C-O 117.754 -1.117 . . . . 75.409999999999997 113.122 -177.761 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -60.69 -37.6 77.9 Favored 'Trans proline' 0 C--N 1.391 2.803 0 C-N-CA 121.94 1.76 . . . . 53.229999999999997 113.466 -176.376 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 39.7 mt -68.37 -33.94 63.12 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.389 0 C-N-CA 122.51 0.324 . . . . 73.400000000000006 110.404 178.056 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -71.66 -33.54 68.96 Favored 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 122.863 0.465 . . . . 63.32 111.47 176.893 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 205' ' ' VAL . . . . . 0.507 HG23 ' O ' ' A' ' 201' ' ' ALA . 73.5 t -71.8 -52.43 25.51 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 C-N-CA 123.909 0.884 . . . . 74.200000000000003 110.951 -179.776 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 16.2 m -82.89 -27.21 8.1 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.096 0 CA-C-N 116.304 -0.407 . . . . 63.43 111.465 -173.493 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 83.74 62.09 1.8 Allowed Glycine 0 C--N 1.343 0.969 0 CA-C-N 116.121 -0.491 . . . . 61.299999999999997 112.224 -174.589 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -83.19 -134.38 2.29 Favored Glycine 0 C--N 1.35 1.346 0 CA-C-O 119.9 -0.389 . . . . 60.520000000000003 112.462 177.947 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 46.5 mtmt -138.59 153.11 48.65 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 123.917 0.887 . . . . 72.019999999999996 110.916 178.037 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 9.7 m -145.37 170.0 6.72 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.092 0 C-N-CA 125.732 1.613 . . . . 73.329999999999998 109.096 175.184 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 29.8 ttp180 -97.8 110.57 23.11 Favored 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 123.72 0.808 . . . . 64.450000000000003 110.306 -177.938 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -102.33 112.22 24.83 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 123.485 0.714 . . . . 63.43 109.311 174.121 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 65.5 mtp -86.75 123.47 31.95 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 122.744 0.418 . . . . 61.210000000000001 110.071 -178.746 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 31.4 p -127.72 -171.14 2.37 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 124.38 1.072 . . . . 75.150000000000006 110.954 -168.4 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 76.9 mt -63.71 -27.91 69.53 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 123.217 0.607 . . . . 74.450000000000003 111.236 172.107 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -100.93 21.95 12.92 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.716 0.806 . . . . 75.209999999999994 110.615 178.328 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 85.38 -168.56 42.43 Favored Glycine 0 C--N 1.348 1.232 0 CA-C-N 116.008 -0.542 . . . . 52.43 113.702 173.94 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -74.19 121.04 6.59 Favored 'Trans proline' 0 C--N 1.366 1.494 0 C-N-CA 122.975 2.45 . . . . 44.200000000000003 112.047 -179.625 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 6.7 p -114.4 134.76 56.32 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 C-N-CA 123.799 0.84 . . . . 60.340000000000003 109.39 175.488 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -75.56 102.31 5.23 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 107.741 -1.207 . . . . 74.219999999999999 107.741 172.382 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 3.8 p -103.91 130.08 55.05 Favored 'Isoleucine or valine' 0 C--O 1.243 0.72 0 N-CA-C 109.149 -0.686 . . . . 73.040000000000006 109.149 -175.058 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 222' ' ' ALA . . . . . 0.55 ' H ' HD21 ' A' ' 172' ' ' LEU . . . -76.03 106.64 7.74 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 123.261 0.624 . . . . 24.350000000000001 110.676 -177.427 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 53.5 t -54.71 137.87 62.81 Favored Pre-proline 0 N--CA 1.477 0.888 0 O-C-N 124.522 1.139 . . . . 71.239999999999995 109.994 179.626 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 224' ' ' PRO . . . . . 0.616 ' HB3' ' HB1' ' A' ' 178' ' ' ALA . 12.3 Cg_endo -57.77 152.96 46.2 Favored 'Trans proline' 0 C--N 1.369 1.617 0 C-N-CA 122.355 2.037 . . . . 72.129999999999995 112.714 171.343 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -76.18 149.54 32.17 Favored 'Trans proline' 0 C--N 1.367 1.527 0 C-N-CA 121.999 1.799 . . . . 52.229999999999997 110.741 171.443 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 35.9 mtm105 60.09 36.23 21.26 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 124.305 1.042 . . . . 73.230000000000004 111.143 168.563 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 227' ' ' THR . . . . . 0.457 HG23 ' HD2' ' A' ' 231' ' ' ARG . 21.5 m -76.53 150.03 36.62 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 124.587 1.155 . . . . 62.210000000000001 110.576 -178.259 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 27.0 mp0 -120.96 143.01 49.23 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 123.606 0.762 . . . . 72.219999999999999 109.151 175.066 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 229' ' ' ALA . . . . . 0.44 ' HB2' ' HB ' ' A' ' 255' ' ' ILE . . . -60.02 125.52 23.99 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 123.859 0.864 . . . . 63.399999999999999 111.002 -178.528 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 109.25 -2.02 31.19 Favored Glycine 0 CA--C 1.528 0.844 0 O-C-N 123.774 0.671 . . . . 42.530000000000001 113.287 -177.776 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 231' ' ' ARG . . . . . 0.457 ' HD2' HG23 ' A' ' 227' ' ' THR . 89.7 mtt-85 -72.35 157.59 37.38 Favored 'General case' 0 N--CA 1.479 0.985 0 CA-C-N 117.701 0.751 . . . . 74.510000000000005 109.854 170.484 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 45.7 mtmt -128.97 122.78 30.86 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 123.189 0.596 . . . . 71.310000000000002 110.068 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 233' ' ' LEU . . . . . 0.468 ' HB3' ' CD2' ' A' ' 174' ' ' TYR . 19.5 mt -101.77 153.34 19.89 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 124.949 1.3 . . . . 71.010000000000005 108.634 -178.043 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 19.5 ttt180 -120.78 103.17 8.89 Favored 'General case' 0 CA--C 1.546 0.801 0 O-C-N 122.188 -0.32 . . . . 74.420000000000002 111.486 -171.85 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 235' ' ' LEU . . . . . 0.569 ' HB2' ' HB3' ' A' ' 249' ' ' LEU . 15.6 mt -82.39 102.58 11.36 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 123.585 0.754 . . . . 72.319999999999993 110.582 176.966 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 236' ' ' LYS . . . . . 0.426 ' H ' ' HB3' ' A' ' 173' ' ' PHE . 43.8 mtmt -71.97 144.44 48.87 Favored 'General case' 0 C--O 1.242 0.68 0 CA-C-O 121.529 0.681 . . . . 72.25 112.421 179.967 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 72.14 3.36 56.45 Favored Glycine 0 CA--C 1.531 1.089 0 CA-C-N 114.183 -1.371 . . . . 61.119999999999997 114.283 -176.108 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 47.2 mmtm -107.96 13.85 25.8 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 123.538 0.735 . . . . 74.549999999999997 111.63 -176.311 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -116.36 -171.0 15.89 Favored Glycine 0 CA--C 1.528 0.877 0 N-CA-C 110.274 -1.13 . . . . 73.420000000000002 110.274 166.51 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 68.9 m-85 -87.73 159.13 49.9 Favored Pre-proline 0 N--CA 1.481 1.079 0 C-N-CA 123.264 0.626 . . . . 61.409999999999997 112.149 -173.778 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -71.72 164.21 36.43 Favored 'Trans proline' 0 C--N 1.373 1.858 0 C-N-CA 122.04 1.827 . . . . 64.219999999999999 112.732 171.595 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 158.35 -109.09 0.39 Allowed Glycine 0 CA--C 1.532 1.123 0 CA-C-O 118.784 -1.009 . . . . 63.009999999999998 112.722 174.244 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -65.16 -49.58 2.61 Favored 'Trans proline' 0 C--N 1.381 2.249 0 C-N-CA 123.454 2.769 . . . . 75.150000000000006 112.722 -170.385 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -90.61 -8.53 49.85 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 123.976 0.91 . . . . 72.219999999999999 111.151 178.349 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 83.68 -42.58 3.06 Favored Glycine 0 C--N 1.359 1.828 0 N-CA-C 111.922 -0.471 . . . . 72.349999999999994 111.922 -170.864 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 17.3 ttm180 -103.17 114.82 29.42 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 125.077 1.351 . . . . 73.530000000000001 110.639 173.17 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -91.1 158.99 26.13 Favored Glycine 0 C--N 1.341 0.843 0 N-CA-C 110.841 -0.904 . . . . 75.450000000000003 110.841 163.664 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 26.9 m-20 -134.52 152.55 51.86 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 122.606 0.363 . . . . 74.540000000000006 110.065 -171.531 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 249' ' ' LEU . . . . . 0.569 ' HB3' ' HB2' ' A' ' 235' ' ' LEU . 57.2 tp -99.05 139.97 33.91 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 124.543 1.137 . . . . 73.530000000000001 109.844 -176.506 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 250' ' ' TYR . . . . . . . . . . . . . 4.3 m-85 -103.66 123.0 46.19 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 123.856 0.862 . . . . 71.109999999999999 110.064 177.837 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 251' ' ' LEU . . . . . 0.763 HD13 HD22 ' A' ' 197' ' ' LEU . 92.1 mt -103.7 103.91 13.88 Favored 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 108.211 -1.033 . . . . 74.409999999999997 108.211 179.464 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -81.33 100.99 9.5 Favored 'General case' 0 CA--C 1.543 0.691 0 N-CA-C 108.187 -1.042 . . . . 74.120000000000005 108.187 175.371 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 10.2 m -65.68 137.34 25.12 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.788 0 CA-C-O 121.359 0.599 . . . . 73.340000000000003 110.801 -175.031 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 24.1 mmt85 -128.79 97.65 4.73 Favored 'General case' 0 C--O 1.238 0.468 0 C-N-CA 124.576 1.151 . . . . 75.120000000000005 108.246 179.844 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 255' ' ' ILE . . . . . 0.454 HG23 ' HA ' ' A' ' 201' ' ' ALA . 34.5 mt -77.42 120.79 28.62 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 CA-C-N 115.422 -0.808 . . . . 52.119999999999997 109.679 179.376 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 7.1 t . . . . . 0 CA--C 1.562 1.412 0 C-N-CA 123.675 0.79 . . . . 62.329999999999998 109.497 -179.43 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 172' ' ' LEU . . . . . 0.531 HD21 ' HB3' ' A' ' 222' ' ' ALA . 62.9 mt . . . . . 0 N--CA 1.478 0.97 0 CA-C-O 120.948 0.404 . . . . 70.439999999999998 110.802 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 173' ' ' PHE . . . . . 0.538 ' CD1' HD22 ' A' ' 235' ' ' LEU . 5.4 m-85 -138.24 -56.24 0.65 Allowed 'General case' 0 N--CA 1.482 1.131 0 CA-C-O 122.023 0.916 . . . . 74.409999999999997 108.974 -165.846 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 174' ' ' TYR . . . . . 0.464 ' CD2' ' HB3' ' A' ' 233' ' ' LEU . 1.4 p90 -74.82 4.2 6.8 Favored 'General case' 0 CA--C 1.547 0.865 0 CA-C-N 113.448 -1.705 . . . . 74.329999999999998 113.316 -178.79 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 6.2 p -67.29 82.52 0.14 Allowed 'General case' 0 CA--C 1.547 0.853 0 CA-C-O 122.334 1.064 . . . . 62.310000000000002 110.705 174.751 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 176' ' ' MET . . . . . 0.456 ' HG3' ' HG2' ' A' ' 177' ' ' LYS . 23.1 ptt? -161.91 -39.61 0.04 OUTLIER 'General case' 0 CA--C 1.541 0.608 0 CA-C-N 113.639 -1.619 . . . . 64.439999999999998 108.202 -174.809 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 177' ' ' LYS . . . . . 0.456 ' HG2' ' HG3' ' A' ' 176' ' ' MET . 18.3 pttp -177.27 34.64 0.0 OUTLIER 'General case' 0 CA--C 1.556 1.179 0 C-N-CA 124.637 1.175 . . . . 71.230000000000004 110.052 -178.906 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 178' ' ' ALA . . . . . 0.471 ' HB1' ' HG3' ' A' ' 224' ' ' PRO . . . -59.21 150.44 25.59 Favored 'General case' 0 N--CA 1.487 1.379 0 C-N-CA 124.036 0.935 . . . . 74.010000000000005 111.705 178.315 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 179' ' ' ALA . . . . . 0.411 ' HB1' ' NH1' ' A' ' 231' ' ' ARG . . . 61.75 25.55 15.4 Favored 'General case' 0 N--CA 1.489 1.517 0 C-N-CA 124.169 0.988 . . . . 53.509999999999998 110.758 -167.886 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.34 0.771 0 CA-C-N 115.43 -0.804 . . . . 73.109999999999999 111.128 -176.897 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 191' ' ' GLN . . . . . 0.528 ' HB3' ' HD2' ' A' ' 243' ' ' PRO . 7.5 pt20 . . . . . 0 N--CA 1.476 0.829 0 CA-C-O 120.952 0.406 . . . . 63.200000000000003 111.445 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 -75.31 141.61 43.37 Favored 'General case' 0 C--O 1.242 0.691 0 C-N-CA 124.666 1.186 . . . . 73.319999999999993 109.827 -176.475 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 193' ' ' LEU . . . . . 0.413 HD12 ' HA2' ' A' ' 239' ' ' GLY . 23.3 mt -126.62 176.41 7.23 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 123.922 0.889 . . . . 74.120000000000005 110.802 -178.009 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 15.6 m-85 -138.23 122.93 18.69 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 124.33 1.052 . . . . 73.319999999999993 110.307 179.945 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -139.64 127.5 22.07 Favored 'General case' 0 C--O 1.239 0.509 0 N-CA-C 107.605 -1.257 . . . . 63.130000000000003 107.605 170.966 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 58.6 m -73.66 131.31 41.51 Favored 'General case' 0 C--O 1.241 0.657 0 CA-C-N 115.981 -0.554 . . . . 73.25 109.695 179.475 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 197' ' ' LEU . . . . . 0.647 HD22 HD13 ' A' ' 251' ' ' LEU . 15.8 tp -106.72 108.88 20.61 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 107.884 -1.154 . . . . 72.040000000000006 107.884 -179.588 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -78.4 121.09 24.05 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 108.468 -0.938 . . . . 62.130000000000003 108.468 177.114 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 199' ' ' VAL . . . . . 0.461 ' O ' ' HA ' ' A' ' 255' ' ' ILE . 4.1 p -140.98 128.53 12.1 Favored Pre-proline 0 CA--C 1.544 0.736 0 C-N-CA 123.733 0.813 . . . . 74.099999999999994 108.968 -177.956 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -70.53 156.78 60.62 Favored 'Trans proline' 0 C--N 1.365 1.402 0 C-N-CA 121.914 1.743 . . . . 60.299999999999997 111.006 170.919 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 201' ' ' ALA . . . . . 0.488 ' O ' HG23 ' A' ' 205' ' ' VAL . . . -50.97 -51.84 63.62 Favored Pre-proline 0 CA--C 1.56 1.349 0 CA-C-O 117.719 -1.134 . . . . 65.230000000000004 112.688 -179.257 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -61.58 -38.99 58.04 Favored 'Trans proline' 0 C--N 1.394 2.935 0 C-N-CA 121.672 1.581 . . . . 54.420000000000002 113.48 -177.535 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 34.4 mt -65.52 -34.01 67.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 CA-C-N 118.082 0.401 . . . . 62.420000000000002 110.398 176.382 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -71.34 -35.12 71.08 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 122.372 0.269 . . . . 72.319999999999993 111.371 177.428 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 205' ' ' VAL . . . . . 0.488 HG23 ' O ' ' A' ' 201' ' ' ALA . 96.6 t -71.74 -55.78 12.43 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.153 0 C-N-CA 123.588 0.755 . . . . 63.409999999999997 110.984 -179.544 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 18.9 m -79.74 -25.53 12.21 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 C-N-CA 122.863 0.465 . . . . 55.409999999999997 111.433 -174.607 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 80.1 72.18 1.22 Allowed Glycine 0 C--N 1.342 0.905 0 N-CA-C 111.647 -0.581 . . . . 53.32 111.647 -173.116 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -93.48 -134.21 6.98 Favored Glycine 0 C--N 1.349 1.298 0 N-CA-C 111.361 -0.695 . . . . 52.350000000000001 111.361 178.033 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 46.2 mtmt -138.1 152.78 49.08 Favored 'General case' 0 N--CA 1.486 1.37 0 CA-C-N 117.725 0.763 . . . . 74.219999999999999 111.662 179.35 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 15.6 m -147.72 158.67 8.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 C-N-CA 124.881 1.272 . . . . 64.219999999999999 109.268 178.403 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 43.5 ttm180 -98.3 114.01 26.16 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 123.089 0.556 . . . . 75.109999999999999 111.092 -175.627 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -100.3 124.93 46.37 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 124.509 1.123 . . . . 55.340000000000003 110.74 178.559 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 22.2 mmt -85.37 110.74 19.33 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 123.466 0.707 . . . . 61.5 109.49 176.841 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 22.2 p -110.94 -178.63 3.52 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 123.973 0.909 . . . . 64.239999999999995 109.73 -176.803 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 82.6 mt -57.67 -36.73 72.3 Favored 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 123.375 0.67 . . . . 40.219999999999999 112.709 -179.151 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -96.02 -19.33 19.55 Favored 'General case' 0 N--CA 1.482 1.154 0 N-CA-C 112.63 0.604 . . . . 65.310000000000002 112.63 -172.468 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 152.6 -168.33 31.6 Favored Glycine 0 C--N 1.352 1.423 0 CA-C-O 119.956 -0.358 . . . . 53.350000000000001 113.009 -178.825 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -85.39 132.24 4.3 Favored 'Trans proline' 0 C--N 1.367 1.543 0 C-N-CA 123.058 2.505 . . . . 75.099999999999994 112.566 179.086 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 4.1 p -126.44 126.09 68.51 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 N-CA-C 108.563 -0.903 . . . . 72.340000000000003 108.563 171.07 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -84.15 102.58 12.68 Favored 'General case' 0 C--O 1.238 0.455 0 N-CA-C 108.212 -1.033 . . . . 74.099999999999994 108.212 173.486 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 4.1 p -97.39 139.52 19.63 Favored 'Isoleucine or valine' 0 C--O 1.25 1.093 0 CA-C-N 114.732 -1.122 . . . . 61.030000000000001 109.218 -170.723 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 222' ' ' ALA . . . . . 0.531 ' HB3' HD21 ' A' ' 172' ' ' LEU . . . -78.42 101.27 7.19 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 122.794 0.437 . . . . 75.450000000000003 110.684 -177.493 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 47.5 t -53.9 133.08 57.77 Favored Pre-proline 0 N--CA 1.48 1.029 0 C-N-CA 124.28 1.032 . . . . 61.140000000000001 109.746 -179.338 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 224' ' ' PRO . . . . . 0.471 ' HG3' ' HB1' ' A' ' 178' ' ' ALA . 35.2 Cg_endo -63.25 147.08 94.15 Favored 'Trans proline' 0 C--N 1.371 1.725 0 C-N-CA 121.574 1.516 . . . . 52.039999999999999 110.46 172.029 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -67.33 156.95 64.04 Favored 'Trans proline' 0 C--N 1.361 1.201 0 C-N-CA 121.747 1.631 . . . . 70.420000000000002 111.541 177.005 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 40.7 mtt180 64.39 25.61 13.43 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 124.373 1.069 . . . . 72.219999999999999 111.634 168.424 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 227' ' ' THR . . . . . 0.59 ' HA ' HH11 ' A' ' 231' ' ' ARG . 94.1 m -75.81 133.99 40.5 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 123.835 0.854 . . . . 72.439999999999998 110.628 -179.896 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -99.83 148.71 24.14 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 123.872 0.869 . . . . 75.510000000000005 109.746 176.904 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 229' ' ' ALA . . . . . 0.538 ' HB2' ' HB ' ' A' ' 255' ' ' ILE . . . -59.63 128.08 35.23 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 123.989 0.915 . . . . 74.129999999999995 111.175 178.028 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 106.1 -5.84 39.43 Favored Glycine 0 N--CA 1.47 0.914 0 O-C-N 123.737 0.648 . . . . 41.25 113.135 -179.8 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 231' ' ' ARG . . . . . 0.59 HH11 ' HA ' ' A' ' 227' ' ' THR . 89.5 mtt180 -72.57 153.99 41.01 Favored 'General case' 0 N--CA 1.479 1.005 0 CA-C-N 117.325 0.563 . . . . 75.200000000000003 110.224 173.686 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 232' ' ' LYS . . . . . 0.413 ' HA ' ' O ' ' A' ' 251' ' ' LEU . 53.8 mtmt -130.3 127.32 39.25 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-N 115.99 -0.55 . . . . 64.040000000000006 110.044 -178.538 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 233' ' ' LEU . . . . . 0.488 ' HB2' ' HB2' ' A' ' 251' ' ' LEU . 24.1 mt -104.48 150.24 24.75 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 124.852 1.261 . . . . 74.150000000000006 108.614 -175.837 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 234' ' ' ARG . . . . . 0.426 ' HG3' ' HB3' ' A' ' 248' ' ' ASP . 56.7 ttm-85 -112.1 120.87 43.3 Favored 'General case' 0 N--CA 1.484 1.254 0 CA-C-N 118.361 0.528 . . . . 70.230000000000004 111.404 -170.483 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 235' ' ' LEU . . . . . 0.538 HD22 ' CD1' ' A' ' 173' ' ' PHE . 14.2 mt -110.95 111.73 23.06 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 123.787 0.835 . . . . 64.319999999999993 111.621 -176.754 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 31.3 mttp -68.72 141.65 55.22 Favored 'General case' 0 N--CA 1.476 0.875 0 CA-C-O 120.852 0.358 . . . . 64.219999999999999 110.914 172.707 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 79.7 -0.58 81.41 Favored Glycine 0 C--N 1.347 1.188 0 CA-C-N 115.18 -0.918 . . . . 50.130000000000003 114.658 176.706 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 72.5 mmtt -109.21 1.93 20.59 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 122.788 0.435 . . . . 72.25 110.223 -175.78 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 239' ' ' GLY . . . . . 0.413 ' HA2' HD12 ' A' ' 193' ' ' LEU . . . -112.33 -172.78 18.98 Favored Glycine 0 C--N 1.353 1.52 0 N-CA-C 111.289 -0.724 . . . . 74.230000000000004 111.289 166.423 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 86.3 m-85 -86.09 157.39 56.87 Favored Pre-proline 0 N--CA 1.491 1.584 0 C-N-CA 123.361 0.664 . . . . 75.140000000000001 111.576 -174.424 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -65.95 131.37 26.99 Favored 'Trans proline' 0 C--N 1.376 2.008 0 C-N-CA 121.826 1.684 . . . . 64.319999999999993 111.011 170.614 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -160.43 -125.29 0.77 Allowed Glycine 0 C--N 1.34 0.77 0 CA-C-O 118.629 -1.095 . . . . 73.310000000000002 112.28 -179.95 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 243' ' ' PRO . . . . . 0.528 ' HD2' ' HB3' ' A' ' 191' ' ' GLN . 21.4 Cg_endo -54.55 -50.68 12.59 Favored 'Trans proline' 0 C--N 1.377 2.077 0 C-N-CA 124.344 3.363 . . . . 55.43 112.542 -176.589 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -86.59 -11.02 52.67 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 123.254 0.622 . . . . 73.200000000000003 111.463 179.938 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 85.43 -21.45 13.39 Favored Glycine 0 C--N 1.357 1.718 0 C-N-CA 122.888 0.28 . . . . 44.219999999999999 113.146 -177.941 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 12.7 ttm180 -126.56 113.72 17.14 Favored 'General case' 0 C--O 1.234 0.268 0 C-N-CA 125.038 1.335 . . . . 74.030000000000001 107.688 174.219 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -76.79 163.11 52.34 Favored Glycine 0 C--O 1.245 0.794 0 N-CA-C 115.055 0.782 . . . . 45.520000000000003 115.055 177.575 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 248' ' ' ASP . . . . . 0.455 ' HA ' ' O ' ' A' ' 235' ' ' LEU . 55.3 m-20 -110.06 159.16 17.56 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 114.101 -1.049 . . . . 75.239999999999995 110.354 -176.714 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 249' ' ' LEU . . . . . 0.511 ' HB3' ' HB2' ' A' ' 235' ' ' LEU . 31.3 tp -126.1 126.65 44.53 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 123.457 0.703 . . . . 65.420000000000002 109.242 174.452 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 250' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 -90.25 112.19 23.63 Favored 'General case' 0 C--O 1.239 0.532 0 N-CA-C 108.552 -0.907 . . . . 64.450000000000003 108.552 -179.628 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 251' ' ' LEU . . . . . 0.647 HD13 HD22 ' A' ' 197' ' ' LEU . 81.2 mt -87.56 101.21 13.41 Favored 'General case' 0 C--O 1.239 0.513 0 N-CA-C 107.072 -1.455 . . . . 73.239999999999995 107.072 176.069 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -85.79 91.98 8.48 Favored 'General case' 0 C--O 1.242 0.683 0 N-CA-C 108.013 -1.106 . . . . 72.420000000000002 108.013 -176.199 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 4.1 m -61.51 135.76 25.8 Favored 'Isoleucine or valine' 0 C--O 1.243 0.724 0 CA-C-N 115.02 -0.991 . . . . 63.32 109.9 -174.605 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 14.8 mmm180 -131.85 111.22 11.41 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 107.21 -1.404 . . . . 71.129999999999995 107.21 178.599 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 255' ' ' ILE . . . . . 0.538 ' HB ' ' HB2' ' A' ' 229' ' ' ALA . 41.8 mt -86.64 116.08 28.69 Favored 'Isoleucine or valine' 0 C--O 1.239 0.531 0 C-N-CA 123.865 0.866 . . . . 65.109999999999999 110.086 -176.993 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 2.0 t . . . . . 0 CA--C 1.556 1.201 0 C-N-CA 124.497 1.119 . . . . 73.409999999999997 109.577 176.992 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 31.9 mt . . . . . 0 N--CA 1.481 1.116 0 CA-C-O 121.356 0.598 . . . . 54.409999999999997 111.697 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 3.9 m-85 -130.06 -56.09 1.11 Allowed 'General case' 0 N--CA 1.475 0.807 0 CA-C-N 114.85 -1.068 . . . . 72.129999999999995 109.105 -171.447 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 174' ' ' TYR . . . . . 0.463 ' CE2' HD13 ' A' ' 233' ' ' LEU . 0.6 OUTLIER -80.93 3.32 23.24 Favored 'General case' 0 N--CA 1.476 0.83 0 N-CA-C 114.24 1.2 . . . . 71.140000000000001 114.24 -167.711 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 24.0 p -53.49 -23.1 9.32 Favored 'General case' 0 N--CA 1.489 1.522 0 C-N-CA 123.955 0.902 . . . . 61.119999999999997 113.158 -176.021 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 176' ' ' MET . . . . . . . . . . . . . 13.9 ptm -56.29 85.03 0.01 OUTLIER 'General case' 0 CA--C 1.56 1.351 0 C-N-CA 124.272 1.029 . . . . 72.409999999999997 111.119 165.67 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 66.1 mttm 55.73 47.29 20.76 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 125.15 1.38 . . . . 75.109999999999999 111.862 178.003 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -63.89 -32.4 73.91 Favored 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 124.891 1.276 . . . . 35.329999999999998 111.856 178.108 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -88.52 24.44 1.96 Allowed 'General case' 0 CA--C 1.55 0.966 0 C-N-CA 123.758 0.823 . . . . 64.519999999999996 110.816 175.705 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.346 1.117 0 N-CA-C 109.455 -1.458 . . . . 73.530000000000001 109.455 166.162 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 191' ' ' GLN . . . . . 0.688 ' HB3' ' HD2' ' A' ' 243' ' ' PRO . 9.6 pt20 . . . . . 0 N--CA 1.482 1.153 0 CA-C-O 121.588 0.709 . . . . 73.150000000000006 109.984 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -79.15 145.95 33.42 Favored 'General case' 0 C--O 1.241 0.618 0 CA-C-N 114.51 -1.223 . . . . 73.420000000000002 109.761 -171.435 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 33.5 mt -111.01 173.27 6.41 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 123.925 0.89 . . . . 63.009999999999998 110.331 -179.102 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 65.3 m-85 -134.0 121.37 21.51 Favored 'General case' 0 C--O 1.237 0.439 0 C-N-CA 123.596 0.758 . . . . 73.120000000000005 110.054 -179.442 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 195' ' ' ALA . . . . . 0.448 ' O ' ' HA ' ' A' ' 251' ' ' LEU . . . -140.61 146.76 38.4 Favored 'General case' 0 C--O 1.234 0.287 0 N-CA-C 107.538 -1.282 . . . . 63.109999999999999 107.538 173.759 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 61.3 m -96.77 140.02 31.96 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 109.918 -0.401 . . . . 50.240000000000002 109.918 178.973 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 197' ' ' LEU . . . . . 0.672 HD22 HD13 ' A' ' 251' ' ' LEU . 16.5 tp -117.45 108.65 15.79 Favored 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 107.749 -1.204 . . . . 75.299999999999997 107.749 177.005 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -82.78 132.01 35.18 Favored 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 109.481 -0.563 . . . . 73.329999999999998 109.481 177.513 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 199' ' ' VAL . . . . . 0.533 ' O ' ' HA ' ' A' ' 255' ' ' ILE . 7.5 p -144.07 131.59 10.62 Favored Pre-proline 0 CA--C 1.548 0.894 0 N-CA-C 107.461 -1.311 . . . . 75.329999999999998 107.461 179.988 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -72.45 161.17 44.97 Favored 'Trans proline' 0 C--N 1.358 1.03 0 C-N-CA 121.829 1.686 . . . . 75.140000000000001 111.346 169.172 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -50.13 -50.12 71.59 Favored Pre-proline 0 CA--C 1.564 1.483 0 N-CA-C 114.021 1.119 . . . . 61.25 114.021 -178.999 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 202' ' ' PRO . . . . . 0.424 ' HA ' HG22 ' A' ' 205' ' ' VAL . 43.2 Cg_endo -64.26 -41.38 21.65 Favored 'Trans proline' 0 C--N 1.396 3.043 0 C-N-CA 121.736 1.624 . . . . 73.239999999999995 113.576 -178.779 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 53.2 mt -67.08 -28.25 42.13 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.295 0 CA-C-N 117.898 0.317 . . . . 63.340000000000003 110.21 177.296 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -72.83 -50.37 24.5 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 123.209 0.604 . . . . 52.130000000000003 111.783 178.534 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 205' ' ' VAL . . . . . 0.424 HG22 ' HA ' ' A' ' 202' ' ' PRO . 17.1 m -68.62 -43.02 83.67 Favored 'Isoleucine or valine' 0 C--N 1.353 0.729 0 C-N-CA 123.864 0.866 . . . . 72.319999999999993 112.574 -173.642 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 206' ' ' VAL . . . . . 0.414 HG22 ' O ' ' A' ' 202' ' ' PRO . 14.2 m -80.01 -36.38 16.82 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.226 0 CA-C-O 120.805 0.336 . . . . 54.450000000000003 110.746 175.239 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 83.77 80.05 1.04 Allowed Glycine 0 CA--C 1.528 0.885 0 N-CA-C 111.805 -0.518 . . . . 74.129999999999995 111.805 -173.064 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -90.78 -128.81 4.04 Favored Glycine 0 C--N 1.354 1.54 0 N-CA-C 111.447 -0.661 . . . . 64.329999999999998 111.447 175.789 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 45.3 mtmt -137.87 147.69 44.69 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 123.598 0.759 . . . . 74.400000000000006 110.806 174.599 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 3.6 m -139.94 165.18 22.22 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 C-N-CA 125.277 1.431 . . . . 72.519999999999996 109.212 175.033 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 45.0 ttp180 -100.97 122.76 44.08 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 123.179 0.591 . . . . 73.5 110.431 -177.807 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -114.68 112.31 22.67 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 124.05 0.94 . . . . 73.310000000000002 109.654 177.607 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 213' ' ' MET . . . . . 0.401 ' HA ' ' HA ' ' A' ' 218' ' ' PRO . 55.7 ttm -82.96 123.45 29.44 Favored 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 109.6 -0.518 . . . . 74.349999999999994 109.6 176.547 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 23.1 p -115.6 -171.22 1.93 Allowed 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 125.23 1.412 . . . . 71.239999999999995 109.568 -174.658 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 94.8 mt -60.75 -32.17 71.47 Favored 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 123.17 0.588 . . . . 71.340000000000003 111.016 170.459 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -99.27 19.28 15.71 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 124.107 0.963 . . . . 72.340000000000003 111.316 -175.691 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 93.79 -172.51 32.67 Favored Glycine 0 C--N 1.352 1.472 0 CA-C-O 119.683 -0.509 . . . . 75.25 113.175 177.864 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 218' ' ' PRO . . . . . 0.401 ' HA ' ' HA ' ' A' ' 213' ' ' MET . 73.2 Cg_endo -71.59 143.53 42.55 Favored 'Trans proline' 0 C--N 1.363 1.29 0 C-N-CA 122.622 2.214 . . . . 64.209999999999994 112.286 179.287 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 5.1 p -131.19 127.87 61.11 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 N-CA-C 108.605 -0.887 . . . . 52.229999999999997 108.605 172.943 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -78.28 100.76 6.83 Favored 'General case' 0 C--O 1.242 0.667 0 N-CA-C 106.66 -1.608 . . . . 73.310000000000002 106.66 174.79 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 6.2 p -108.35 129.65 62.32 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.844 0 CA-C-N 115.706 -0.679 . . . . 75.129999999999995 109.744 -168.745 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -79.66 110.49 15.05 Favored 'General case' 0 C--O 1.239 0.506 0 C-N-CA 123.714 0.805 . . . . 64.030000000000001 111.019 -174.903 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 52.7 t -55.12 136.47 67.68 Favored Pre-proline 0 CA--C 1.556 1.211 0 C-N-CA 125.006 1.322 . . . . 74.200000000000003 110.247 177.857 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -69.18 159.24 54.61 Favored 'Trans proline' 0 C--N 1.377 2.061 0 C-N-CA 122.293 1.995 . . . . 75.409999999999997 111.784 174.021 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -64.29 142.87 81.38 Favored 'Trans proline' 0 C--N 1.37 1.707 0 C-N-CA 121.75 1.633 . . . . 72.25 111.077 169.799 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 43.0 mtm180 62.78 48.21 4.24 Favored 'General case' 0 C--O 1.241 0.645 0 C-N-CA 124.417 1.087 . . . . 64.319999999999993 111.443 171.593 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 227' ' ' THR . . . . . 0.459 ' HA ' ' HE ' ' A' ' 231' ' ' ARG . 28.9 m -81.06 121.66 26.35 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 114.945 -1.025 . . . . 50.030000000000001 109.507 175.556 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 2.7 mp0 -106.41 148.4 28.15 Favored 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 123.992 0.917 . . . . 53.100000000000001 108.909 177.045 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -57.36 125.44 22.84 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 123.474 0.71 . . . . 64.349999999999994 111.88 -176.962 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 104.41 -2.55 43.07 Favored Glycine 0 C--N 1.34 0.786 0 CA-C-N 115.25 -0.886 . . . . 64.420000000000002 112.871 -179.619 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 231' ' ' ARG . . . . . 0.459 ' HE ' ' HA ' ' A' ' 227' ' ' THR . 56.4 mtt-85 -59.07 133.61 56.25 Favored 'General case' 0 C--N 1.371 1.505 0 CA-C-N 117.801 0.8 . . . . 65.420000000000002 109.695 173.22 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 69.5 mmtt -105.73 97.44 7.26 Favored 'General case' 0 C--O 1.239 0.536 0 CA-C-N 115.072 -0.967 . . . . 72.120000000000005 108.476 -172.858 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 233' ' ' LEU . . . . . 0.695 ' HB2' ' HB2' ' A' ' 251' ' ' LEU . 57.5 mt -81.73 142.29 32.79 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 114.713 -1.13 . . . . 63.119999999999997 109.046 179.229 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 22.0 ttt180 -122.84 101.28 7.35 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 122.492 0.317 . . . . 75.239999999999995 110.547 -171.475 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 235' ' ' LEU . . . . . 0.523 ' HB2' ' HB3' ' A' ' 249' ' ' LEU . 33.3 mt -86.74 105.62 17.1 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 123.57 0.748 . . . . 70.310000000000002 110.07 179.132 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 20.8 mttt -67.6 138.43 56.42 Favored 'General case' 0 CA--C 1.541 0.613 0 O-C-N 123.344 0.402 . . . . 71.209999999999994 110.921 175.41 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 73.11 16.62 78.51 Favored Glycine 0 C--N 1.348 1.207 0 O-C-N 123.895 0.747 . . . . 74.420000000000002 114.577 178.054 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 72.4 mmtt -115.58 7.4 14.83 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 123.211 0.605 . . . . 75.450000000000003 111.023 178.639 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -117.81 -167.83 14.31 Favored Glycine 0 C--N 1.348 1.216 0 N-CA-C 111.149 -0.781 . . . . 72.239999999999995 111.149 168.727 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 76.0 m-85 -91.34 157.89 41.8 Favored Pre-proline 0 N--CA 1.48 1.031 0 C-N-CA 123.781 0.833 . . . . 72.099999999999994 110.797 -175.567 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -64.03 145.38 89.64 Favored 'Trans proline' 0 C--N 1.366 1.487 0 C-N-CA 121.928 1.752 . . . . 74.519999999999996 112.833 170.167 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -176.4 -123.78 0.79 Allowed Glycine 0 CA--C 1.536 1.373 0 CA-C-O 118.964 -0.909 . . . . 44.100000000000001 112.221 178.161 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 243' ' ' PRO . . . . . 0.688 ' HD2' ' HB3' ' A' ' 191' ' ' GLN . 33.0 Cg_endo -57.75 -46.86 23.9 Favored 'Trans proline' 0 C--N 1.382 2.339 0 C-N-CA 124.889 3.726 . . . . 73.230000000000004 113.792 -173.499 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -90.72 -6.09 54.89 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 123.512 0.725 . . . . 72.230000000000004 111.153 179.778 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 87.17 -43.73 3.24 Favored Glycine 0 C--N 1.357 1.74 0 N-CA-C 111.966 -0.453 . . . . 72.140000000000001 111.966 -176.099 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 26.7 ttm180 -106.37 112.38 25.36 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 125.212 1.405 . . . . 72.120000000000005 109.163 175.167 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -74.83 154.27 46.65 Favored Glycine 0 C--N 1.358 1.804 0 N-CA-C 114.388 0.515 . . . . 75.109999999999999 114.388 171.282 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -107.43 171.13 7.55 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 124.854 1.262 . . . . 74.140000000000001 110.623 -178.52 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 249' ' ' LEU . . . . . 0.523 ' HB3' ' HB2' ' A' ' 235' ' ' LEU . 27.1 tp -128.78 116.76 19.99 Favored 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 108.17 -1.048 . . . . 75.409999999999997 108.17 171.009 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 250' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -88.78 108.08 19.31 Favored 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 108.845 -0.798 . . . . 73.420000000000002 108.845 -178.31 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 251' ' ' LEU . . . . . 0.695 ' HB2' ' HB2' ' A' ' 233' ' ' LEU . 87.3 mt -90.36 104.83 17.37 Favored 'General case' 0 C--O 1.238 0.453 0 N-CA-C 107.784 -1.191 . . . . 65.200000000000003 107.784 174.726 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -82.79 113.06 20.17 Favored 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 108.059 -1.089 . . . . 75.120000000000005 108.059 173.685 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 253' ' ' VAL . . . . . 0.428 ' HA ' ' O ' ' A' ' 197' ' ' LEU . 14.0 m -71.67 137.2 24.16 Favored 'Isoleucine or valine' 0 C--O 1.239 0.503 0 N-CA-C 109.677 -0.49 . . . . 65.209999999999994 109.677 179.685 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 8.5 mmm180 -123.38 108.54 12.83 Favored 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 108.092 -1.077 . . . . 74.430000000000007 108.092 175.902 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 255' ' ' ILE . . . . . 0.533 ' HA ' ' O ' ' A' ' 199' ' ' VAL . 27.3 mt -77.22 127.15 38.2 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 O-C-N 123.566 0.541 . . . . 61.399999999999999 109.864 177.792 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 10.7 t . . . . . 0 C--O 1.26 1.608 0 C-N-CA 123.974 0.91 . . . . 73.129999999999995 110.073 176.308 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 16.8 ptm . . . . . 0 N--CA 1.486 1.335 0 N-CA-C 110.15 -0.315 . . . . 73.329999999999998 110.15 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 169' ' ' GLN . . . . . 0.53 ' HG3' HG22 ' A' ' 170' ' ' THR . 23.0 pt20 -57.04 -32.66 66.42 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 113.966 1.099 . . . . 74.319999999999993 113.966 -167.611 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 170' ' ' THR . . . . . 0.53 HG22 ' HG3' ' A' ' 169' ' ' GLN . 15.1 t -167.41 -176.72 3.33 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 122.963 0.505 . . . . 75.209999999999994 111.0 -174.84 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -121.93 -75.7 0.59 Allowed 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 124.772 1.229 . . . . 62.130000000000003 108.421 173.295 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 172' ' ' LEU . . . . . 0.592 HD21 ' H ' ' A' ' 222' ' ' ALA . 25.9 mt -150.16 162.58 40.18 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 124.357 1.063 . . . . 73.230000000000004 110.256 -178.773 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 173' ' ' PHE . . . . . 0.454 ' CD1' HD22 ' A' ' 235' ' ' LEU . 31.4 m-85 -126.21 -59.14 1.33 Allowed 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 124.135 0.974 . . . . 70.400000000000006 109.828 -170.017 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 174' ' ' TYR . . . . . 0.532 ' CD2' ' HB3' ' A' ' 233' ' ' LEU . 1.7 p90 -82.41 15.51 2.46 Favored 'General case' 0 CA--C 1.548 0.868 0 CA-C-N 114.381 -1.281 . . . . 71.010000000000005 112.898 -171.533 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 4.6 p -62.66 -19.87 64.25 Favored 'General case' 0 CA--C 1.555 1.141 0 C-N-CA 122.805 0.442 . . . . 63.229999999999997 111.354 173.77 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 176' ' ' MET . . . . . . . . . . . . . 22.9 ptt? -65.86 -52.89 46.48 Favored 'General case' 0 CA--C 1.558 1.276 0 C-N-CA 124.214 1.006 . . . . 72.530000000000001 111.361 168.879 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 177' ' ' LYS . . . . . 0.642 ' HB3' ' HA ' ' A' ' 181' ' ' SER . 96.2 mttt -155.28 119.61 4.67 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 125.016 1.326 . . . . 62.009999999999998 108.223 -173.568 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 178' ' ' ALA . . . . . 0.502 ' HB1' ' HG3' ' A' ' 224' ' ' PRO . . . -154.68 -68.07 0.13 Allowed 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 123.926 0.89 . . . . 74.349999999999994 109.093 -174.524 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -83.37 82.22 8.37 Favored 'General case' 0 C--O 1.24 0.566 0 N-CA-C 107.723 -1.214 . . . . 73.319999999999993 107.723 168.782 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 103.09 58.62 0.74 Allowed Glycine 0 C--N 1.342 0.892 0 CA-C-N 115.369 -0.832 . . . . 52.229999999999997 111.909 -175.219 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 181' ' ' SER . . . . . 0.642 ' HA ' ' HB3' ' A' ' 177' ' ' LYS . 38.5 m -73.34 -38.42 65.77 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 123.514 0.726 . . . . 61.450000000000003 111.8 178.952 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . 81.31 -69.89 3.19 Favored Glycine 0 C--N 1.345 1.05 0 CA-C-N 116.199 -0.455 . . . . 64.430000000000007 112.056 -177.697 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 150.88 139.16 2.96 Favored Glycine 0 C--N 1.342 0.875 0 N-CA-C 111.163 -0.775 . . . . 74.219999999999999 111.163 177.995 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 25.1 t -149.04 141.13 23.89 Favored 'General case' 0 C--O 1.241 0.629 0 C-N-CA 123.485 0.714 . . . . 71.200000000000003 109.104 177.236 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 88.99 -135.12 12.81 Favored Glycine 0 C--N 1.344 0.993 0 O-C-N 123.494 0.496 . . . . 73.400000000000006 112.247 -178.891 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 84.23 12.19 76.75 Favored Glycine 0 CA--C 1.531 1.041 0 CA-C-O 119.736 -0.48 . . . . 62.240000000000002 113.268 -176.782 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 56.6 p -158.43 172.75 17.76 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 123.366 0.666 . . . . 73.209999999999994 110.988 -179.626 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 85.12 -149.32 23.87 Favored Glycine 0 C--N 1.349 1.293 0 N-CA-C 111.564 -0.614 . . . . 71.420000000000002 111.564 -171.834 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -75.13 159.01 51.48 Favored Glycine 0 C--N 1.349 1.266 0 CA-C-N 117.453 0.626 . . . . 72.209999999999994 111.82 172.743 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 38.4 m -81.49 63.52 5.83 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 123.602 0.761 . . . . 62.219999999999999 110.969 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 191' ' ' GLN . . . . . 0.709 ' HB3' ' HD2' ' A' ' 243' ' ' PRO . 8.1 pt20 -74.03 -36.4 64.41 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 115.471 -0.786 . . . . 74.099999999999994 110.589 -179.002 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 66.6 m-20 -76.88 162.51 27.56 Favored 'General case' 0 C--O 1.24 0.562 0 CA-C-N 115.111 -0.95 . . . . 72.099999999999994 110.815 -172.996 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 28.8 mt -135.97 176.91 8.26 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 124.509 1.123 . . . . 70.420000000000002 110.014 -175.302 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 60.8 m-85 -134.0 136.9 44.41 Favored 'General case' 0 C--O 1.239 0.527 0 C-N-CA 123.871 0.868 . . . . 71.299999999999997 110.136 177.966 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 195' ' ' ALA . . . . . 0.492 ' HB2' HD11 ' A' ' 249' ' ' LEU . . . -140.04 171.08 14.69 Favored 'General case' 0 C--O 1.236 0.371 0 C-N-CA 124.632 1.173 . . . . 75.209999999999994 108.561 176.069 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 26.1 m -119.02 123.44 44.53 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 108.652 -0.87 . . . . 63.009999999999998 108.652 177.883 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 0.698 HD22 HD13 ' A' ' 251' ' ' LEU . 16.3 tp -107.47 111.08 23.21 Favored 'General case' 0 N--CA 1.467 0.382 0 N-CA-C 108.583 -0.895 . . . . 73.209999999999994 108.583 -179.56 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -84.0 121.48 27.45 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 123.414 0.686 . . . . 73.430000000000007 109.256 179.735 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 199' ' ' VAL . . . . . 0.44 ' O ' ' HA ' ' A' ' 255' ' ' ILE . 4.8 p -142.99 129.85 10.71 Favored Pre-proline 0 CA--C 1.548 0.903 0 C-N-CA 123.707 0.803 . . . . 53.43 109.414 -176.737 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_endo -72.37 162.0 42.76 Favored 'Trans proline' 0 C--N 1.369 1.613 0 C-N-CA 121.801 1.667 . . . . 60.32 111.189 172.341 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 201' ' ' ALA . . . . . 0.477 ' O ' HG23 ' A' ' 205' ' ' VAL . . . -50.6 -55.27 27.69 Favored Pre-proline 0 CA--C 1.562 1.439 0 CA-C-O 117.828 -1.082 . . . . 74.150000000000006 113.109 -177.839 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -68.1 -32.4 27.8 Favored 'Trans proline' 0 C--N 1.396 3.03 0 CA-C-N 121.433 1.548 . . . . 70.109999999999999 113.678 -174.157 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 36.1 mt -67.69 -32.02 54.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 N-CA-C 109.744 -0.465 . . . . 75.439999999999998 109.744 175.219 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -72.28 -40.33 67.68 Favored 'General case' 0 CA--C 1.551 1.011 0 C-N-CA 122.679 0.392 . . . . 73.519999999999996 111.347 176.425 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 205' ' ' VAL . . . . . 0.477 HG23 ' O ' ' A' ' 201' ' ' ALA . 84.7 t -66.66 -53.35 36.04 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.29 0 C-N-CA 123.647 0.779 . . . . 73.409999999999997 111.507 -177.825 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 16.5 m -80.04 -33.39 14.44 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 CA-C-N 116.227 -0.442 . . . . 72.140000000000001 110.986 -177.533 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 85.81 73.93 1.27 Allowed Glycine 0 C--N 1.342 0.901 0 CA-C-N 115.9 -0.591 . . . . 75.109999999999999 111.761 -172.44 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -91.14 -126.86 3.6 Favored Glycine 0 C--N 1.353 1.505 0 CA-C-O 119.43 -0.65 . . . . 45.109999999999999 111.876 177.324 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 209' ' ' LYS . . . . . 0.417 ' HG2' ' HA ' ' A' ' 222' ' ' ALA . 49.3 mtmt -137.81 155.28 49.18 Favored 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 123.604 0.762 . . . . 74.519999999999996 111.609 176.247 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 6.9 m -148.62 170.34 2.65 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.056 0 C-N-CA 125.88 1.672 . . . . 74.400000000000006 108.601 175.738 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 42.0 ttp180 -99.4 119.17 37.54 Favored 'General case' 0 CA--C 1.549 0.904 0 C-N-CA 122.822 0.449 . . . . 74.319999999999993 109.99 177.491 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -100.97 127.4 47.47 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 123.7 0.8 . . . . 52.119999999999997 109.63 175.828 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 88.0 mmm -96.06 122.5 38.96 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 123.336 0.654 . . . . 72.540000000000006 109.85 -177.261 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 21.8 p -129.21 -176.01 3.74 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 124.015 0.926 . . . . 75.329999999999998 110.886 -168.188 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 86.5 mt -65.22 -24.15 67.27 Favored 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 123.178 0.591 . . . . 73.25 112.062 175.67 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -98.99 6.68 46.57 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.454 0.702 . . . . 70.049999999999997 111.093 179.171 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 98.98 -151.44 19.49 Favored Glycine 0 C--N 1.352 1.455 0 CA-C-O 119.317 -0.713 . . . . 45.140000000000001 112.3 -179.667 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -79.85 149.65 20.6 Favored 'Trans proline' 0 C--N 1.365 1.422 0 C-N-CA 122.536 2.157 . . . . 75.299999999999997 113.672 -176.864 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 5.4 p -143.17 130.83 18.72 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 C-N-CA 123.613 0.765 . . . . 72.340000000000003 109.143 175.12 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -75.89 101.89 5.33 Favored 'General case' 0 N--CA 1.476 0.872 0 N-CA-C 108.539 -0.912 . . . . 73.5 108.539 175.149 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 1.4 p -107.06 123.08 61.97 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.047 0 N-CA-C 108.755 -0.832 . . . . 71.409999999999997 108.755 -173.108 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 222' ' ' ALA . . . . . 0.592 ' H ' HD21 ' A' ' 172' ' ' LEU . . . -77.36 109.96 11.7 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 123.194 0.598 . . . . 61.009999999999998 111.075 -178.376 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 63.1 t -54.97 139.47 63.25 Favored Pre-proline 0 N--CA 1.48 1.061 0 C-N-CA 125.43 1.492 . . . . 70.409999999999997 110.445 179.705 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 224' ' ' PRO . . . . . 0.502 ' HG3' ' HB1' ' A' ' 178' ' ' ALA . 72.0 Cg_endo -72.05 159.34 50.35 Favored 'Trans proline' 0 C--N 1.374 1.905 0 C-N-CA 121.939 1.759 . . . . 74.310000000000002 111.566 173.3 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -69.83 147.37 62.28 Favored 'Trans proline' 0 C--N 1.369 1.61 0 C-N-CA 121.507 1.471 . . . . 71.219999999999999 111.194 172.851 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 65.6 mtm180 63.55 47.08 3.93 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 124.578 1.151 . . . . 73.200000000000003 110.868 174.39 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 227' ' ' THR . . . . . 0.47 ' HA ' ' HE ' ' A' ' 231' ' ' ARG . 53.4 m -87.12 125.62 34.26 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 114.84 -1.073 . . . . 54.329999999999998 108.895 174.108 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -115.01 151.86 33.45 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 108.286 -1.005 . . . . 72.439999999999998 108.286 176.037 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -55.73 118.24 4.37 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 124.158 0.983 . . . . 71.129999999999995 111.075 -176.063 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 115.84 -5.06 20.65 Favored Glycine 0 C--N 1.342 0.868 0 CA-C-O 118.773 -1.015 . . . . 64.319999999999993 114.744 -177.399 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 231' ' ' ARG . . . . . 0.47 ' HE ' ' HA ' ' A' ' 227' ' ' THR . 65.2 mtt-85 -62.7 144.23 56.57 Favored 'General case' 0 N--CA 1.484 1.251 0 CA-C-N 118.28 1.04 . . . . 72.120000000000005 110.879 172.844 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 232' ' ' LYS . . . . . 0.427 ' HE3' ' HA ' ' A' ' 232' ' ' LYS . 0.0 OUTLIER -109.08 99.32 8.65 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 114.995 -1.002 . . . . 50.130000000000003 108.804 177.435 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 233' ' ' LEU . . . . . 0.641 ' HB2' ' HB2' ' A' ' 251' ' ' LEU . 39.2 mt -82.78 152.5 25.67 Favored 'General case' 0 CA--C 1.544 0.712 0 N-CA-C 108.589 -0.893 . . . . 62.119999999999997 108.589 175.344 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 22.3 ttt85 -125.61 111.25 14.77 Favored 'General case' 0 N--CA 1.481 1.103 0 CA-C-N 118.117 0.417 . . . . 72.430000000000007 111.043 -171.147 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 235' ' ' LEU . . . . . 0.479 ' HB2' ' HB3' ' A' ' 249' ' ' LEU . 16.2 mt -99.6 111.03 23.43 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 123.402 0.681 . . . . 75.510000000000005 110.683 179.213 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 16.2 mtmt -70.73 139.57 51.15 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 122.938 0.495 . . . . 72.420000000000002 111.695 -179.904 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 77.94 -2.69 63.77 Favored Glycine 0 N--CA 1.477 1.414 0 CA-C-N 115.508 -0.769 . . . . 42.450000000000003 114.292 177.97 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 70.9 mmtt -99.17 3.15 46.38 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 123.394 0.678 . . . . 64.329999999999998 110.717 -177.272 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -108.49 -176.24 21.86 Favored Glycine 0 C--N 1.347 1.183 0 N-CA-C 110.028 -1.229 . . . . 74.340000000000003 110.028 161.71 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 90.6 m-85 -85.46 147.09 45.96 Favored Pre-proline 0 N--CA 1.483 1.204 0 C-N-CA 123.261 0.625 . . . . 61.109999999999999 110.714 -178.095 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -59.78 132.9 47.81 Favored 'Trans proline' 0 C--N 1.37 1.704 0 C-N-CA 122.177 1.918 . . . . 61.409999999999997 112.282 171.572 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -159.27 -124.79 0.77 Allowed Glycine 0 CA--C 1.538 1.528 0 CA-C-O 118.692 -1.06 . . . . 63.130000000000003 112.729 -179.602 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 243' ' ' PRO . . . . . 0.709 ' HD2' ' HB3' ' A' ' 191' ' ' GLN . 35.9 Cg_endo -57.34 -44.13 45.76 Favored 'Trans proline' 0 C--N 1.381 2.286 0 C-N-CA 124.415 3.41 . . . . 64.430000000000007 113.638 -174.319 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -85.81 -14.45 45.06 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 123.389 0.676 . . . . 75.409999999999997 110.745 176.724 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 92.34 -23.34 27.94 Favored Glycine 0 C--N 1.348 1.224 0 CA-C-N 116.126 -0.488 . . . . 75.239999999999995 112.498 -176.104 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 11.4 ttm180 -128.86 111.75 13.41 Favored 'General case' 0 C--O 1.238 0.493 0 C-N-CA 124.575 1.15 . . . . 72.340000000000003 109.18 176.849 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -73.53 155.55 50.11 Favored Glycine 0 C--N 1.351 1.399 0 C-N-CA 121.693 -0.289 . . . . 60.530000000000001 112.769 170.632 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -125.43 145.62 49.99 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 123.376 0.67 . . . . 70.219999999999999 109.871 -173.837 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 249' ' ' LEU . . . . . 0.492 HD11 ' HB2' ' A' ' 195' ' ' ALA . 32.7 tp -100.32 119.25 38.13 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 123.3 0.64 . . . . 73.120000000000005 109.62 -178.563 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 250' ' ' TYR . . . . . . . . . . . . . 2.4 m-30 -89.65 110.09 21.0 Favored 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 108.753 -0.832 . . . . 72.209999999999994 108.753 -178.278 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 251' ' ' LEU . . . . . 0.698 HD13 HD22 ' A' ' 197' ' ' LEU . 85.3 mt -87.6 118.03 26.81 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 123.921 0.889 . . . . 71.400000000000006 109.294 -177.275 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 252' ' ' GLU . . . . . 0.45 ' HG3' ' HD3' ' A' ' 254' ' ' ARG . 10.1 tp10 -83.78 98.62 9.8 Favored 'General case' 0 C--O 1.239 0.506 0 N-CA-C 108.585 -0.895 . . . . 74.25 108.585 175.918 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 6.1 m -71.71 129.64 35.3 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 CA-C-O 121.498 0.666 . . . . 73.340000000000003 110.03 -176.526 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 254' ' ' ARG . . . . . 0.45 ' HD3' ' HG3' ' A' ' 252' ' ' GLU . 15.2 mmm180 -122.43 99.36 6.37 Favored 'General case' 0 C--O 1.238 0.483 0 CA-C-N 115.131 -0.94 . . . . 74.219999999999999 108.993 -173.803 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 255' ' ' ILE . . . . . 0.44 ' HA ' ' O ' ' A' ' 199' ' ' VAL . 15.7 mt -76.61 120.07 26.1 Favored 'Isoleucine or valine' 0 C--O 1.24 0.595 0 CA-C-O 121.443 0.64 . . . . 73.230000000000004 110.231 179.789 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 8.9 t . . . . . 0 CA--C 1.566 1.592 0 C-N-CA 125.198 1.399 . . . . 55.210000000000001 108.06 -178.267 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 23.9 ptt? . . . . . 0 N--CA 1.49 1.564 0 N-CA-C 111.684 0.253 . . . . 72.510000000000005 111.684 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -112.44 -172.47 2.05 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 123.631 0.773 . . . . 75.010000000000005 110.293 179.377 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 4.5 t -83.67 163.66 20.15 Favored 'General case' 0 CA--C 1.557 1.231 0 C-N-CA 123.438 0.695 . . . . 73.019999999999996 110.178 177.311 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -129.97 -82.89 0.55 Allowed 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 123.19 0.596 . . . . 63.439999999999998 111.244 -169.385 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 172' ' ' LEU . . . . . 0.633 HD21 ' H ' ' A' ' 222' ' ' ALA . 25.8 mt -139.1 151.88 47.06 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 123.516 0.726 . . . . 72.200000000000003 110.345 -174.469 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 173' ' ' PHE . . . . . 0.486 ' CE2' ' HE3' ' A' ' 238' ' ' LYS . 4.1 m-85 -134.74 -60.85 0.77 Allowed 'General case' 0 N--CA 1.481 1.091 0 CA-C-N 115.367 -0.833 . . . . 64.510000000000005 109.955 -155.767 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 174' ' ' TYR . . . . . 0.476 ' CD2' ' HB3' ' A' ' 233' ' ' LEU . 4.9 p90 -85.68 11.99 9.77 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 114.508 -1.223 . . . . 72.239999999999995 112.18 -175.852 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 175' ' ' THR . . . . . 0.492 ' OG1' ' HB3' ' A' ' 172' ' ' LEU . 0.2 OUTLIER -68.96 -17.5 63.95 Favored 'General case' 0 CA--C 1.551 1.0 0 C-N-CA 123.556 0.742 . . . . 73.319999999999993 112.324 -166.238 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 176' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -73.59 -28.53 61.88 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 123.631 0.773 . . . . 63.340000000000003 111.088 176.038 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 177' ' ' LYS . . . . . 0.446 ' HG2' ' HA3' ' A' ' 180' ' ' GLY . 23.2 ttpp -151.87 62.46 0.85 Allowed 'General case' 0 CA--C 1.551 0.988 0 CA-C-O 122.276 1.036 . . . . 70.340000000000003 108.942 -177.21 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 178' ' ' ALA . . . . . 0.468 ' HB1' ' HB3' ' A' ' 224' ' ' PRO . . . -81.01 126.3 31.23 Favored 'General case' 0 N--CA 1.476 0.864 0 CA-C-N 114.457 -1.247 . . . . 64.319999999999993 110.794 -175.763 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 179' ' ' ALA . . . . . 0.526 ' HB1' HH11 ' A' ' 231' ' ' ARG . . . 66.57 9.92 6.97 Favored 'General case' 0 N--CA 1.497 1.924 0 C-N-CA 124.955 1.302 . . . . 54.030000000000001 111.501 -170.031 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 180' ' ' GLY . . . . . 0.446 ' HA3' ' HG2' ' A' ' 177' ' ' LYS . . . -89.6 55.02 3.82 Favored Glycine 0 N--CA 1.468 0.786 0 CA-C-N 116.267 -0.424 . . . . 71.409999999999997 112.268 -173.411 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 16.4 m -77.78 93.78 4.37 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 123.865 0.866 . . . . 72.219999999999999 109.657 -179.289 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -112.54 -63.58 0.46 Allowed Glycine 0 C--N 1.343 0.932 0 CA-C-N 115.416 -0.811 . . . . 71.319999999999993 112.521 -173.622 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -170.7 83.63 0.08 OUTLIER Glycine 0 C--N 1.347 1.158 0 N-CA-C 112.384 -0.286 . . . . 50.340000000000003 112.384 -177.609 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 19.4 m -97.71 97.59 9.14 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 123.312 0.645 . . . . 72.5 110.412 -178.259 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -81.13 108.33 2.82 Favored Glycine 0 C--N 1.344 0.977 0 CA-C-N 116.21 -0.45 . . . . 72.129999999999995 112.977 179.587 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -66.24 133.69 33.6 Favored Glycine 0 CA--C 1.533 1.175 0 N-CA-C 111.327 -0.709 . . . . 72.430000000000007 111.327 170.222 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 187' ' ' SER . . . . . 0.571 ' HB2' ' HB2' ' A' ' 243' ' ' PRO . 15.1 m -92.96 44.99 1.16 Allowed 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 123.857 0.863 . . . . 41.43 112.998 -167.358 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 88.12 -66.25 3.32 Favored Glycine 0 N--CA 1.472 1.087 0 CA-C-N 116.34 -0.391 . . . . 31.120000000000001 113.49 174.791 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -63.99 136.72 40.8 Favored Glycine 0 C--N 1.349 1.26 0 N-CA-C 111.905 -0.478 . . . . 43.130000000000003 111.905 177.502 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 25.1 t -87.53 58.79 5.12 Favored 'General case' 0 CA--C 1.551 0.999 0 CA-C-O 121.35 0.595 . . . . 73.310000000000002 110.889 -175.592 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 191' ' ' GLN . . . . . 0.625 ' HB3' ' HD2' ' A' ' 243' ' ' PRO . 9.5 pt20 -69.07 -32.5 72.01 Favored 'General case' 0 N--CA 1.477 0.905 0 CA-C-N 115.653 -0.703 . . . . 50.140000000000001 109.915 171.377 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 65.7 m-20 -78.32 152.99 32.11 Favored 'General case' 0 C--O 1.239 0.521 0 CA-C-N 114.65 -1.159 . . . . 63.109999999999999 110.955 -173.598 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 193' ' ' LEU . . . . . 0.536 HD12 ' HA2' ' A' ' 239' ' ' GLY . 59.3 mt -128.68 175.76 8.33 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 114.547 -1.206 . . . . 54.329999999999998 110.297 -174.374 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 17.5 m-85 -139.67 122.73 16.78 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 123.915 0.886 . . . . 73.540000000000006 110.046 -177.96 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 195' ' ' ALA . . . . . 0.431 ' HB2' HD11 ' A' ' 249' ' ' LEU . . . -129.4 128.2 42.52 Favored 'General case' 0 C--N 1.341 0.209 0 N-CA-C 108.318 -0.993 . . . . 71.430000000000007 108.318 173.331 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 61.7 m -77.72 123.89 27.26 Favored 'General case' 0 CA--C 1.546 0.799 0 N-CA-C 109.344 -0.613 . . . . 74.209999999999994 109.344 176.888 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 0.718 HD22 HD13 ' A' ' 251' ' ' LEU . 18.9 tp -107.69 110.87 22.83 Favored 'General case' 0 N--CA 1.474 0.775 0 N-CA-C 108.562 -0.903 . . . . 73.140000000000001 108.562 -178.532 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -78.43 132.52 37.34 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 109.321 -0.622 . . . . 71.420000000000002 109.321 173.286 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 199' ' ' VAL . . . . . 0.486 ' O ' ' HA ' ' A' ' 255' ' ' ILE . 4.1 p -144.18 127.3 8.72 Favored Pre-proline 0 CA--C 1.546 0.804 0 N-CA-C 108.453 -0.943 . . . . 74.129999999999995 108.453 177.745 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -69.59 156.09 64.72 Favored 'Trans proline' 0 C--N 1.367 1.517 0 C-N-CA 121.962 1.775 . . . . 72.150000000000006 111.48 170.774 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 201' ' ' ALA . . . . . 0.454 ' O ' HG23 ' A' ' 205' ' ' VAL . . . -51.05 -51.96 62.88 Favored Pre-proline 0 CA--C 1.555 1.166 0 N-CA-C 113.996 1.11 . . . . 55.119999999999997 113.996 -177.354 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -65.39 -32.63 49.79 Favored 'Trans proline' 0 C--N 1.382 2.309 0 CA-C-N 121.181 1.458 . . . . 52.210000000000001 113.253 -176.072 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 27.3 mt -68.48 -34.86 67.88 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.229 0 C-N-CA 122.664 0.386 . . . . 75.340000000000003 110.152 174.307 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -71.54 -33.12 68.88 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 122.295 0.238 . . . . 71.349999999999994 111.369 178.414 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 205' ' ' VAL . . . . . 0.454 HG23 ' O ' ' A' ' 201' ' ' ALA . 80.7 t -71.05 -57.76 6.86 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 C-N-CA 123.349 0.66 . . . . 61.130000000000003 111.041 178.643 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 10.6 m -82.37 -17.26 11.46 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.055 0 CA-C-N 116.272 -0.422 . . . . 74.340000000000003 111.588 -172.798 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 74.86 66.17 1.98 Allowed Glycine 0 C--N 1.342 0.883 0 O-C-N 123.667 0.604 . . . . 52.210000000000001 112.327 -177.422 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -85.57 -130.0 2.33 Favored Glycine 0 C--N 1.346 1.091 0 C-N-CA 122.694 0.188 . . . . 52.240000000000002 112.806 179.522 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 209' ' ' LYS . . . . . 0.416 ' HG2' ' HA ' ' A' ' 222' ' ' ALA . 46.8 mtmt -138.24 155.48 48.6 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.753 0.821 . . . . 71.030000000000001 111.005 176.363 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 11.0 m -144.23 168.93 10.15 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 C-N-CA 125.155 1.382 . . . . 74.319999999999993 108.66 172.406 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 48.9 ttp180 -97.06 114.34 25.97 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 123.227 0.611 . . . . 75.230000000000004 109.939 178.552 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -100.74 139.66 36.1 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 123.667 0.787 . . . . 65.230000000000004 110.208 179.52 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 23.9 mmt -98.46 116.02 29.79 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 123.021 0.528 . . . . 75.400000000000006 109.716 178.707 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 48.9 p -109.46 -175.58 2.79 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 123.928 0.891 . . . . 73.349999999999994 109.182 175.527 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 93.3 mt -63.3 -22.3 66.79 Favored 'General case' 0 CA--C 1.552 1.02 0 C-N-CA 122.71 0.404 . . . . 55.450000000000003 111.356 173.685 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 20.9 mt-10 -81.93 -22.89 36.48 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 123.672 0.789 . . . . 63.210000000000001 110.99 -178.877 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 118.18 -150.06 18.27 Favored Glycine 0 CA--C 1.533 1.16 0 N-CA-C 110.911 -0.876 . . . . 73.010000000000005 110.911 -170.822 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_endo -78.26 144.73 20.94 Favored 'Trans proline' 0 C--N 1.369 1.628 0 C-N-CA 122.463 2.109 . . . . 75.420000000000002 113.19 -176.424 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 219' ' ' VAL . . . . . 0.41 HG21 ' HZ ' ' A' ' 173' ' ' PHE . 7.6 p -144.02 133.03 19.34 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 C-N-CA 123.914 0.886 . . . . 61.420000000000002 109.366 177.363 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 40.0 mm-40 -78.69 104.59 9.41 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 109.658 -0.497 . . . . 72.230000000000004 109.658 177.47 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 4.1 p -107.31 130.19 59.88 Favored 'Isoleucine or valine' 0 C--O 1.244 0.808 0 CA-C-N 115.418 -0.81 . . . . 65.439999999999998 109.224 -174.423 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 222' ' ' ALA . . . . . 0.633 ' H ' HD21 ' A' ' 172' ' ' LEU . . . -81.09 104.64 11.71 Favored 'General case' 0 C--O 1.239 0.536 0 C-N-CA 123.419 0.688 . . . . 73.099999999999994 111.061 -177.16 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 59.9 t -55.6 135.64 71.12 Favored Pre-proline 0 N--CA 1.476 0.865 0 O-C-N 124.423 1.077 . . . . 70.329999999999998 110.056 178.957 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 224' ' ' PRO . . . . . 0.468 ' HB3' ' HB1' ' A' ' 178' ' ' ALA . 17.1 Cg_endo -65.23 148.76 88.98 Favored 'Trans proline' 0 C--N 1.365 1.416 0 C-N-CA 121.747 1.631 . . . . 54.450000000000003 111.801 170.326 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -65.35 150.17 87.46 Favored 'Trans proline' 0 C--N 1.364 1.35 0 C-N-CA 121.499 1.466 . . . . 73.230000000000004 111.612 169.763 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 59.6 mtm180 61.72 35.83 16.68 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 124.654 1.182 . . . . 73.099999999999994 112.484 170.908 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 227' ' ' THR . . . . . 0.425 HG22 HG21 ' A' ' 253' ' ' VAL . 26.6 m -83.04 133.94 35.06 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 115.342 -0.845 . . . . 64.5 109.262 174.365 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 28.3 mp0 -111.2 149.63 30.69 Favored 'General case' 0 N--CA 1.485 1.319 0 N-CA-C 109.398 -0.593 . . . . 55.350000000000001 109.398 175.857 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 229' ' ' ALA . . . . . 0.458 ' HA ' HG23 ' A' ' 253' ' ' VAL . . . -58.47 125.99 25.66 Favored 'General case' 0 N--CA 1.47 0.556 0 O-C-N 124.305 1.003 . . . . 63.130000000000003 111.46 -176.548 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 113.98 -15.46 21.14 Favored Glycine 0 CA--C 1.523 0.551 0 CA-C-N 115.206 -0.907 . . . . 41.5 113.035 -176.58 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 231' ' ' ARG . . . . . 0.526 HH11 ' HB1' ' A' ' 179' ' ' ALA . 75.0 mtt180 -67.66 152.81 45.0 Favored 'General case' 0 C--N 1.363 1.158 0 CA-C-N 117.751 0.775 . . . . 73.319999999999993 109.457 172.547 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 232' ' ' LYS . . . . . 0.48 ' HA ' ' O ' ' A' ' 251' ' ' LEU . 54.0 mtmt -130.05 128.01 41.06 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-O 121.324 0.583 . . . . 71.510000000000005 110.602 179.201 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 233' ' ' LEU . . . . . 0.491 ' HB2' ' HB2' ' A' ' 251' ' ' LEU . 20.1 mt -98.49 148.1 24.08 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 114.354 -1.293 . . . . 75.230000000000004 108.887 -174.993 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 21.2 ttt180 -106.82 110.24 22.35 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 122.851 0.46 . . . . 65.230000000000004 111.263 -170.401 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 235' ' ' LEU . . . . . 0.614 ' HB2' ' HB3' ' A' ' 249' ' ' LEU . 17.1 mt -98.56 103.9 15.89 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 122.641 0.376 . . . . 64.200000000000003 110.092 177.963 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 13.6 mtmt -70.72 134.84 47.82 Favored 'General case' 0 C--O 1.238 0.495 0 CA-C-N 116.231 -0.44 . . . . 70.019999999999996 111.896 -178.154 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 73.72 10.51 80.09 Favored Glycine 0 C--N 1.344 0.996 0 CA-C-N 114.973 -1.012 . . . . 64.109999999999999 114.808 177.975 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 238' ' ' LYS . . . . . 0.486 ' HE3' ' CE2' ' A' ' 173' ' ' PHE . 69.7 mmtt -104.6 5.36 33.69 Favored 'General case' 0 N--CA 1.478 0.957 0 CA-C-N 117.393 0.596 . . . . 62.119999999999997 110.0 179.785 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 239' ' ' GLY . . . . . 0.536 ' HA2' HD12 ' A' ' 193' ' ' LEU . . . -105.7 -168.37 23.5 Favored Glycine 0 C--N 1.35 1.325 0 CA-C-N 115.25 -0.886 . . . . 51.43 111.294 166.733 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -93.73 167.75 13.19 Favored Pre-proline 0 CA--C 1.559 1.319 0 C-N-CA 123.998 0.919 . . . . 73.140000000000001 110.233 178.337 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -71.65 171.51 16.25 Favored 'Trans proline' 0 C--N 1.376 2.001 0 C-N-CA 122.437 2.091 . . . . 63.43 112.926 172.203 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 155.36 -117.25 0.77 Allowed Glycine 0 CA--C 1.537 1.461 0 CA-C-O 119.312 -0.715 . . . . 73.439999999999998 113.219 173.507 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 243' ' ' PRO . . . . . 0.625 ' HD2' ' HB3' ' A' ' 191' ' ' GLN . 60.5 Cg_endo -63.25 -40.65 31.29 Favored 'Trans proline' 0 C--N 1.375 1.966 0 C-N-CA 124.638 3.559 . . . . 72.530000000000001 113.506 -169.348 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 244' ' ' ALA . . . . . 0.429 ' HB3' HE22 ' A' ' 191' ' ' GLN . . . -101.27 -13.99 17.84 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 123.393 0.677 . . . . 72.329999999999998 110.316 177.292 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 96.32 -31.71 7.16 Favored Glycine 0 C--N 1.352 1.464 0 CA-C-N 116.109 -0.496 . . . . 62.130000000000003 112.908 179.66 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 50.5 ttt180 -126.65 110.56 13.31 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 124.17 0.988 . . . . 63.32 109.102 -178.663 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -75.96 151.07 40.22 Favored Glycine 0 C--N 1.347 1.161 0 O-C-N 123.684 0.615 . . . . 62.340000000000003 113.532 179.011 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 18.4 m-20 -118.89 137.65 53.3 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 124.144 0.978 . . . . 70.5 109.67 -175.744 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 249' ' ' LEU . . . . . 0.614 ' HB3' ' HB2' ' A' ' 235' ' ' LEU . 51.6 tp -98.93 118.06 34.84 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 109.049 -0.723 . . . . 75.010000000000005 109.049 179.521 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 250' ' ' TYR . . . . . . . . . . . . . 3.4 m-85 -90.64 112.78 24.64 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 123.62 0.768 . . . . 65.420000000000002 110.331 -175.615 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 251' ' ' LEU . . . . . 0.718 HD13 HD22 ' A' ' 197' ' ' LEU . 83.4 mt -87.57 105.24 17.19 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 124.209 1.004 . . . . 70.310000000000002 109.408 -177.453 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 252' ' ' GLU . . . . . 0.405 ' O ' ' HG2' ' A' ' 254' ' ' ARG . 29.4 mt-10 -78.74 93.94 5.02 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 108.327 -0.99 . . . . 75.420000000000002 108.327 -178.425 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 253' ' ' VAL . . . . . 0.458 HG23 ' HA ' ' A' ' 229' ' ' ALA . 3.9 m -64.19 127.98 25.77 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.871 0 CA-C-O 121.334 0.587 . . . . 62.140000000000001 109.786 -176.701 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 254' ' ' ARG . . . . . 0.405 ' HG2' ' O ' ' A' ' 252' ' ' GLU . 26.6 mmt85 -127.46 98.97 5.43 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 108.713 -0.847 . . . . 72.400000000000006 108.713 -175.194 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 255' ' ' ILE . . . . . 0.486 ' HA ' ' O ' ' A' ' 199' ' ' VAL . 24.8 mt -80.31 110.56 16.02 Favored 'Isoleucine or valine' 0 C--O 1.238 0.473 0 CA-C-N 115.25 -0.886 . . . . 53.399999999999999 110.415 -176.922 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 10.2 t . . . . . 0 C--O 1.257 1.475 0 CA-C-N 115.059 -0.973 . . . . 75.549999999999997 109.708 174.037 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 14.0 tpt . . . . . 0 N--CA 1.484 1.233 0 N-CA-C 109.378 -0.601 . . . . 64.329999999999998 109.378 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 17.6 pt20 -63.91 168.01 5.58 Favored 'General case' 0 C--O 1.245 0.847 0 C-N-CA 123.388 0.675 . . . . 74.129999999999995 110.657 173.238 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 13.1 t -71.3 145.66 49.37 Favored 'General case' 0 CA--C 1.545 0.772 0 CA-C-N 115.679 -0.691 . . . . 74.239999999999995 110.247 176.47 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -84.9 -84.48 0.15 Allowed 'General case' 0 CA--C 1.542 0.665 0 N-CA-C 109.367 -0.605 . . . . 61.109999999999999 109.367 175.773 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 172' ' ' LEU . . . . . 0.666 HD21 ' H ' ' A' ' 222' ' ' ALA . 22.3 mt -152.22 161.07 43.16 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 123.888 0.875 . . . . 71.140000000000001 110.454 -175.846 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 173' ' ' PHE . . . . . 0.471 ' CD1' HD22 ' A' ' 235' ' ' LEU . 26.2 m-85 -123.99 -62.78 1.26 Allowed 'General case' 0 N--CA 1.475 0.777 0 CA-C-N 115.519 -0.764 . . . . 75.120000000000005 110.189 -169.661 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 174' ' ' TYR . . . . . 0.464 ' CD2' ' HB3' ' A' ' 233' ' ' LEU . 1.8 p90 -75.8 -11.38 59.97 Favored 'General case' 0 C--O 1.219 -0.503 0 CA-C-N 114.587 -1.188 . . . . 60.420000000000002 112.815 -172.158 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 175' ' ' THR . . . . . 0.662 HG21 HD13 ' A' ' 172' ' ' LEU . 42.9 p -70.61 -2.18 13.47 Favored 'General case' 0 CA--C 1.548 0.9 0 N-CA-C 112.558 0.577 . . . . 73.0 112.558 -176.45 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 176' ' ' MET . . . . . . . . . . . . . 24.9 ptt? -57.1 -41.97 79.89 Favored 'General case' 0 CA--C 1.559 1.299 0 C-N-CA 123.67 0.788 . . . . 72.329999999999998 110.261 161.951 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 14.5 tmtt? 179.51 108.52 0.03 OUTLIER 'General case' 0 CA--C 1.553 1.08 0 C-N-CA 126.18 1.792 . . . . 61.43 106.321 179.463 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 178' ' ' ALA . . . . . 0.523 ' HB1' HD22 ' A' ' 233' ' ' LEU . . . -128.08 -58.77 1.2 Allowed 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 123.081 0.552 . . . . 64.310000000000002 112.025 -173.017 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 179' ' ' ALA . . . . . 0.48 ' HB2' ' HB2' ' A' ' 224' ' ' PRO . . . -71.55 85.22 0.86 Allowed 'General case' 0 CA--C 1.546 0.81 0 CA-C-O 121.57 0.7 . . . . 71.120000000000005 109.48 179.463 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 160.7 -32.12 0.38 Allowed Glycine 0 C--N 1.337 0.591 0 CA-C-N 114.298 -1.319 . . . . 75.430000000000007 109.889 -172.546 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 20.3 m -80.33 147.68 31.0 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 124.345 1.058 . . . . 73.120000000000005 110.886 175.982 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . 172.21 49.61 0.04 OUTLIER Glycine 0 C--N 1.349 1.257 0 CA-C-N 116.173 -0.467 . . . . 74.219999999999999 112.235 -179.527 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -131.49 -101.63 0.87 Allowed Glycine 0 N--CA 1.476 1.334 0 CA-C-O 119.924 -0.376 . . . . 64.549999999999997 113.165 -176.0 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 29.9 t -167.52 156.73 10.06 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 123.443 0.697 . . . . 62.030000000000001 110.288 -176.673 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -100.42 -131.64 7.45 Favored Glycine 0 C--N 1.348 1.216 0 N-CA-C 111.535 -0.626 . . . . 64.099999999999994 111.535 173.68 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -94.05 -177.35 39.25 Favored Glycine 0 N--CA 1.475 1.279 0 C-N-CA 122.974 0.321 . . . . 75.040000000000006 112.528 177.751 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 72.8 m -151.78 -34.34 0.14 Allowed 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 123.533 0.733 . . . . 72.099999999999994 111.5 -175.338 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -59.49 -29.33 66.37 Favored Glycine 0 C--N 1.355 1.633 0 N-CA-C 114.402 0.521 . . . . 41.530000000000001 114.402 -173.076 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 189' ' ' GLY . . . . . 0.56 ' HA3' ' HD3' ' A' ' 243' ' ' PRO . . . -105.3 -10.36 31.82 Favored Glycine 0 CA--C 1.533 1.163 0 CA-C-O 119.975 -0.347 . . . . 63.240000000000002 113.265 177.007 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 30.5 m 62.43 18.44 10.35 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 124.601 1.16 . . . . 70.030000000000001 112.794 179.713 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 191' ' ' GLN . . . . . 0.601 ' HB3' ' HD2' ' A' ' 243' ' ' PRO . 6.8 pt20 -65.19 -28.96 69.75 Favored 'General case' 0 N--CA 1.483 1.178 0 CA-C-O 121.302 0.572 . . . . 64.420000000000002 110.768 -178.624 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -76.05 135.61 39.92 Favored 'General case' 0 C--O 1.241 0.624 0 CA-C-N 114.387 -1.279 . . . . 74.430000000000007 110.048 -177.969 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 43.6 mt -117.87 168.26 10.66 Favored 'General case' 0 C--O 1.24 0.589 0 CA-C-N 114.701 -1.136 . . . . 72.530000000000001 109.204 177.796 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 31.8 m-85 -138.6 121.86 17.01 Favored 'General case' 0 C--O 1.238 0.466 0 C-N-CA 123.483 0.713 . . . . 72.25 109.656 -179.49 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 195' ' ' ALA . . . . . 0.502 ' HB3' HD23 ' A' ' 251' ' ' LEU . . . -126.9 133.67 50.62 Favored 'General case' 0 CA--C 1.516 -0.342 0 C-N-CA 123.962 0.905 . . . . 70.040000000000006 108.607 177.448 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 2.2 m -81.45 125.59 30.62 Favored 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 108.82 -0.808 . . . . 62.030000000000001 108.82 176.234 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 0.677 HD22 HD13 ' A' ' 251' ' ' LEU . 15.7 tp -109.55 111.39 22.88 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 108.672 -0.862 . . . . 64.209999999999994 108.672 -176.624 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -76.19 127.93 33.91 Favored 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 108.55 -0.907 . . . . 60.420000000000002 108.55 174.491 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 199' ' ' VAL . . . . . 0.494 ' O ' ' HA ' ' A' ' 255' ' ' ILE . 7.7 p -145.29 133.58 10.74 Favored Pre-proline 0 CA--C 1.544 0.716 0 N-CA-C 108.475 -0.935 . . . . 70.209999999999994 108.475 176.112 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 200' ' ' PRO . . . . . 0.444 ' HB2' ' HD2' ' A' ' 202' ' ' PRO . 75.4 Cg_endo -75.74 160.98 37.19 Favored 'Trans proline' 0 C--N 1.361 1.191 0 C-N-CA 121.737 1.625 . . . . 41.310000000000002 111.25 167.97 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -55.75 -47.25 99.12 Favored Pre-proline 0 CA--C 1.558 1.282 0 CA-C-O 117.695 -1.145 . . . . 71.349999999999994 113.786 -178.323 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 202' ' ' PRO . . . . . 0.444 ' HD2' ' HB2' ' A' ' 200' ' ' PRO . 56.1 Cg_endo -64.47 -37.95 35.95 Favored 'Trans proline' 0 C--N 1.396 3.057 0 C-N-CA 121.691 1.594 . . . . 75.019999999999996 112.964 -177.861 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 45.1 mt -67.93 -34.93 70.04 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.062 0 CA-C-O 120.817 0.341 . . . . 74.329999999999998 110.436 176.248 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -67.45 -40.61 85.39 Favored 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 123.048 0.539 . . . . 71.400000000000006 112.239 179.382 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 17.1 m -80.27 -45.98 22.0 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.793 0 N-CA-C 112.919 0.711 . . . . 71.239999999999995 112.919 -175.543 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 206' ' ' VAL . . . . . 0.436 HG22 ' O ' ' A' ' 202' ' ' PRO . 11.1 m -78.04 -25.57 14.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 C-N-CA 122.213 0.205 . . . . 74.129999999999995 111.516 178.477 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 82.24 66.25 1.58 Allowed Glycine 0 C--N 1.344 1.026 0 N-CA-C 111.944 -0.462 . . . . 23.239999999999998 111.944 -177.318 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -86.47 -130.93 2.85 Favored Glycine 0 C--N 1.352 1.442 0 C-N-CA 123.262 0.458 . . . . 54.350000000000001 112.217 177.494 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 209' ' ' LYS . . . . . 0.412 ' HG2' ' HA ' ' A' ' 222' ' ' ALA . 48.4 mtmt -137.89 155.72 48.64 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 124.063 0.945 . . . . 73.120000000000005 111.084 177.001 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 9.5 m -147.51 151.89 13.32 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.793 0 C-N-CA 125.288 1.435 . . . . 74.549999999999997 108.682 169.763 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 211' ' ' ARG . . . . . 0.441 ' HD2' ' HB2' ' A' ' 218' ' ' PRO . 54.5 ttp180 -87.55 116.9 25.99 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 123.069 0.548 . . . . 73.310000000000002 110.501 179.749 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -100.87 129.01 46.67 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 123.95 0.9 . . . . 74.340000000000003 109.769 177.557 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 22.4 mmt -86.29 120.86 28.1 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 108.96 -0.755 . . . . 63.43 108.96 175.49 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 24.0 p -123.41 -174.71 3.02 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 123.928 0.891 . . . . 34.43 109.835 -174.903 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 77.0 mt -65.77 -29.36 69.85 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 122.752 0.421 . . . . 74.310000000000002 110.894 172.259 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 18.6 mm-40 -90.6 6.77 42.4 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 123.859 0.864 . . . . 61.530000000000001 110.971 -179.589 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 96.79 -160.34 21.71 Favored Glycine 0 C--N 1.352 1.47 0 CA-C-O 119.581 -0.566 . . . . 74.319999999999993 112.636 177.915 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 218' ' ' PRO . . . . . 0.441 ' HB2' ' HD2' ' A' ' 211' ' ' ARG . 71.8 Cg_endo -75.11 144.25 29.67 Favored 'Trans proline' 0 C--N 1.368 1.565 0 C-N-CA 122.336 2.024 . . . . 74.019999999999996 112.471 -179.665 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 7.5 p -146.92 131.27 10.46 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 C-N-CA 123.199 0.599 . . . . 71.349999999999994 109.778 177.663 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -69.73 103.09 2.05 Favored 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 108.114 -1.069 . . . . 72.120000000000005 108.114 169.969 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 1.7 p -103.58 120.61 53.88 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.133 0 N-CA-C 108.263 -1.014 . . . . 63.450000000000003 108.263 179.74 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 222' ' ' ALA . . . . . 0.666 ' H ' HD21 ' A' ' 172' ' ' LEU . . . -76.11 109.91 10.15 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 123.382 0.673 . . . . 61.43 111.558 -175.441 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 51.9 t -55.2 138.4 66.52 Favored Pre-proline 0 N--CA 1.48 1.054 0 C-N-CA 125.636 1.574 . . . . 73.310000000000002 111.029 -177.087 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 224' ' ' PRO . . . . . 0.48 ' HB2' ' HB2' ' A' ' 179' ' ' ALA . 36.8 Cg_endo -66.42 147.79 83.16 Favored 'Trans proline' 0 C--N 1.377 2.03 0 C-N-CA 121.61 1.54 . . . . 73.0 110.843 170.918 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_exo -69.1 149.33 70.97 Favored 'Trans proline' 0 C--N 1.364 1.378 0 C-N-CA 121.725 1.617 . . . . 75.239999999999995 111.672 174.287 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 82.4 mtt180 63.94 39.56 7.99 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 124.79 1.236 . . . . 73.409999999999997 111.099 173.09 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 227' ' ' THR . . . . . 0.438 HG23 ' HD2' ' A' ' 231' ' ' ARG . 91.3 m -83.08 139.15 33.39 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 115.349 -0.841 . . . . 71.299999999999997 109.881 177.436 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 27.3 mp0 -112.36 148.31 34.55 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 124.325 1.05 . . . . 70.0 109.208 176.413 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 229' ' ' ALA . . . . . 0.4 ' HA ' HG23 ' A' ' 253' ' ' VAL . . . -59.2 128.65 38.21 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 123.546 0.738 . . . . 65.239999999999995 110.854 -179.615 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 105.6 -3.56 39.58 Favored Glycine 0 N--CA 1.471 1.023 0 O-C-N 123.828 0.705 . . . . 72.010000000000005 113.18 -177.55 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 231' ' ' ARG . . . . . 0.438 ' HD2' HG23 ' A' ' 227' ' ' THR . 62.8 mtt-85 -71.68 149.96 45.0 Favored 'General case' 0 C--N 1.359 1.006 0 CA-C-N 117.43 0.615 . . . . 73.120000000000005 109.839 171.851 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -127.45 103.35 7.31 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 123.263 0.625 . . . . 64.420000000000002 109.341 -174.867 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 233' ' ' LEU . . . . . 0.532 ' HB2' ' HB2' ' A' ' 251' ' ' LEU . 28.9 mt -80.38 149.34 30.25 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 114.16 -1.382 . . . . 72.450000000000003 109.121 -177.213 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 56.5 ttt180 -115.39 109.04 17.3 Favored 'General case' 0 N--CA 1.481 1.11 0 O-C-N 121.926 -0.484 . . . . 74.109999999999999 111.349 -171.755 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 235' ' ' LEU . . . . . 0.564 ' HB2' ' HB3' ' A' ' 249' ' ' LEU . 19.2 mt -95.68 107.02 19.19 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 123.125 0.57 . . . . 71.349999999999994 110.116 176.565 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 21.2 mttt -73.25 137.69 45.08 Favored 'General case' 0 CA--C 1.535 0.393 0 O-C-N 123.214 0.321 . . . . 74.329999999999998 110.208 174.114 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 74.01 19.17 79.79 Favored Glycine 0 C--N 1.34 0.78 0 CA-C-N 115.567 -0.742 . . . . 64.099999999999994 114.017 179.661 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 238' ' ' LYS . . . . . 0.426 ' HZ3' ' HE2' ' A' ' 173' ' ' PHE . 34.9 mmtm -121.19 6.93 10.22 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 123.367 0.667 . . . . 60.229999999999997 110.616 174.171 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -109.0 -170.5 20.79 Favored Glycine 0 C--N 1.347 1.175 0 N-CA-C 110.534 -1.026 . . . . 72.430000000000007 110.534 163.053 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 89.0 m-85 -89.96 147.64 37.77 Favored Pre-proline 0 N--CA 1.478 0.95 0 C-N-CA 123.169 0.588 . . . . 64.329999999999998 110.972 -177.66 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 17.6 Cg_exo -68.02 128.2 17.29 Favored 'Trans proline' 0 C--N 1.365 1.404 0 C-N-CA 121.771 1.648 . . . . 75.030000000000001 111.137 172.977 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -158.97 -121.66 0.63 Allowed Glycine 0 C--N 1.347 1.16 0 CA-C-O 118.351 -1.249 . . . . 63.240000000000002 112.313 -177.949 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 243' ' ' PRO . . . . . 0.601 ' HD2' ' HB3' ' A' ' 191' ' ' GLN . 25.2 Cg_endo -55.21 -45.58 39.32 Favored 'Trans proline' 0 C--N 1.38 2.23 0 C-N-CA 124.414 3.409 . . . . 75.140000000000001 113.489 -174.599 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -86.64 -13.22 46.21 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 123.156 0.582 . . . . 72.099999999999994 111.539 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 92.54 -30.64 6.71 Favored Glycine 0 C--N 1.348 1.21 0 N-CA-C 112.068 -0.413 . . . . 73.239999999999995 112.068 -174.402 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 46.0 ttm-85 -128.28 112.47 14.5 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 124.364 1.065 . . . . 70.420000000000002 109.114 176.066 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -72.73 154.78 50.43 Favored Glycine 0 C--N 1.347 1.192 0 O-C-N 123.181 0.301 . . . . 65.120000000000005 113.584 172.883 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 20.9 m-20 -110.24 165.49 11.72 Favored 'General case' 0 C--O 1.237 0.398 0 C-N-CA 123.996 0.918 . . . . 73.319999999999993 110.088 -177.689 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 249' ' ' LEU . . . . . 0.564 ' HB3' ' HB2' ' A' ' 235' ' ' LEU . 34.7 tp -129.47 113.32 14.75 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 123.758 0.823 . . . . 74.519999999999996 108.877 176.16 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 250' ' ' TYR . . . . . 0.449 ' HA ' ' O ' ' A' ' 233' ' ' LEU . 7.5 m-85 -91.04 110.55 21.82 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 115.664 -0.698 . . . . 74.540000000000006 110.627 -177.452 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 251' ' ' LEU . . . . . 0.677 HD13 HD22 ' A' ' 197' ' ' LEU . 84.6 mt -88.39 105.36 17.54 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 114.139 -1.391 . . . . 72.329999999999998 109.143 -178.644 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -80.12 100.83 8.42 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 108.687 -0.857 . . . . 72.319999999999993 108.687 175.849 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 253' ' ' VAL . . . . . 0.4 HG23 ' HA ' ' A' ' 229' ' ' ALA . 12.1 m -63.58 133.97 28.92 Favored 'Isoleucine or valine' 0 C--O 1.246 0.895 0 O-C-N 123.775 0.672 . . . . 64.239999999999995 110.094 -179.777 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 20.5 mmm-85 -127.64 94.22 3.91 Favored 'General case' 0 C--O 1.24 0.59 0 N-CA-C 107.815 -1.179 . . . . 73.040000000000006 107.815 -177.257 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 255' ' ' ILE . . . . . 0.494 ' HA ' ' O ' ' A' ' 199' ' ' VAL . 22.4 mt -76.76 133.75 30.27 Favored 'Isoleucine or valine' 0 C--O 1.238 0.469 0 O-C-N 124.482 1.114 . . . . 72.049999999999997 110.836 -173.909 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 9.7 t . . . . . 0 CA--C 1.569 1.698 0 CA-C-O 117.589 -1.196 . . . . 63.420000000000002 108.832 179.824 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 13.5 tpt . . . . . 0 N--CA 1.476 0.869 0 N-CA-C 108.875 -0.787 . . . . 75.230000000000004 108.875 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 169' ' ' GLN . . . . . 0.589 ' HG3' ' H ' ' A' ' 170' ' ' THR . 7.5 pt20 -145.79 -74.46 0.22 Allowed 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 123.204 0.602 . . . . 73.230000000000004 110.617 -178.931 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 170' ' ' THR . . . . . 0.589 ' H ' ' HG3' ' A' ' 169' ' ' GLN . 14.1 m -164.84 112.56 1.03 Allowed 'General case' 0 CA--C 1.538 0.503 0 N-CA-C 107.062 -1.459 . . . . 63.399999999999999 107.062 -162.199 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -124.37 -93.56 0.5 Allowed 'General case' 0 N--CA 1.488 1.431 0 C-N-CA 122.999 0.52 . . . . 71.239999999999995 112.053 -168.346 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 172' ' ' LEU . . . . . 0.644 HD21 ' H ' ' A' ' 222' ' ' ALA . 53.3 mt -134.35 145.17 48.74 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 123.591 0.756 . . . . 72.140000000000001 110.188 -170.973 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 173' ' ' PHE . . . . . 0.486 ' CD1' HD22 ' A' ' 235' ' ' LEU . 52.3 m-85 -140.66 -58.27 0.52 Allowed 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.829 0.852 . . . . 70.400000000000006 109.191 -164.067 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 174' ' ' TYR . . . . . 0.486 ' OH ' ' HB ' ' A' ' 221' ' ' VAL . 7.2 p90 -70.53 -14.96 62.72 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 114.347 -1.297 . . . . 63.340000000000003 113.089 -177.806 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -45.73 -29.02 1.16 Allowed 'General case' 0 N--CA 1.49 1.574 0 C-N-CA 126.172 1.789 . . . . 62.149999999999999 114.076 -173.157 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 176' ' ' MET . . . . . . . . . . . . . 66.5 mtm -55.7 -38.95 70.38 Favored 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 124.736 1.214 . . . . 75.340000000000003 112.934 -178.58 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 14.3 ptmm? -160.42 34.48 0.16 Allowed 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 123.503 0.721 . . . . 55.210000000000001 110.848 -170.766 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -64.16 -46.24 84.88 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 124.764 1.226 . . . . 63.439999999999998 113.479 -169.705 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 179' ' ' ALA . . . . . 0.453 ' HB2' ' HB2' ' A' ' 224' ' ' PRO . . . -82.65 65.79 7.95 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-O 122.124 0.964 . . . . 75.549999999999997 109.629 -179.71 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -164.61 -169.49 28.27 Favored Glycine 0 C--O 1.243 0.685 0 CA-C-N 114.19 -1.368 . . . . 71.340000000000003 110.48 -179.327 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 72.0 m -151.5 90.16 1.55 Allowed 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 124.111 0.964 . . . . 70.030000000000001 108.596 176.829 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -79.45 -177.34 50.05 Favored Glycine 0 C--N 1.345 1.047 0 CA-C-N 115.507 -0.77 . . . . 73.420000000000002 112.397 177.404 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -82.45 64.36 4.29 Favored Glycine 0 C--N 1.346 1.13 0 CA-C-N 116.891 0.345 . . . . 72.430000000000007 112.358 178.38 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 49.6 m -85.04 -11.82 54.5 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 123.829 0.852 . . . . 72.030000000000001 111.372 -179.42 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -70.44 117.67 7.34 Favored Glycine 0 C--N 1.349 1.26 0 N-CA-C 111.624 -0.59 . . . . 53.039999999999999 111.624 176.693 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -169.98 169.19 41.99 Favored Glycine 0 C--N 1.34 0.781 0 N-CA-C 111.804 -0.518 . . . . 35.530000000000001 111.804 -178.573 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 52.6 p -79.39 93.97 5.44 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 123.095 0.558 . . . . 63.340000000000003 109.826 177.542 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -66.81 159.36 49.04 Favored Glycine 0 C--N 1.349 1.277 0 CA-C-N 115.656 -0.702 . . . . 24.440000000000001 112.376 175.956 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -104.34 28.17 16.21 Favored Glycine 0 N--CA 1.473 1.109 0 CA-C-O 119.875 -0.403 . . . . 61.439999999999998 112.315 179.537 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 19.7 m 70.66 6.01 5.65 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 125.437 1.495 . . . . 75.409999999999997 112.263 -173.78 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 191' ' ' GLN . . . . . 0.513 ' HG3' ' N ' ' A' ' 192' ' ' ASP . 2.0 pt20 -75.72 -42.06 51.8 Favored 'General case' 0 C--N 1.358 0.954 0 N-CA-C 109.235 -0.654 . . . . 45.210000000000001 109.235 175.822 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 192' ' ' ASP . . . . . 0.513 ' N ' ' HG3' ' A' ' 191' ' ' GLN . 31.3 m-20 -80.27 137.33 36.61 Favored 'General case' 0 C--N 1.354 0.778 0 CA-C-N 115.229 -0.896 . . . . 62.25 109.003 -176.125 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 32.2 mt -113.05 174.83 5.71 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 115.85 -0.614 . . . . 64.450000000000003 111.379 -173.438 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 48.5 m-85 -136.93 124.15 21.78 Favored 'General case' 0 C--O 1.238 0.492 0 C-N-CA 124.552 1.141 . . . . 74.0 109.466 -179.771 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 195' ' ' ALA . . . . . 0.4 ' O ' ' HA ' ' A' ' 251' ' ' LEU . . . -135.42 128.29 31.26 Favored 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 107.269 -1.382 . . . . 73.409999999999997 107.269 171.429 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 44.9 m -82.77 125.8 31.68 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 109.188 -0.671 . . . . 74.129999999999995 109.188 -179.839 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 0.52 HD22 HD13 ' A' ' 251' ' ' LEU . 15.9 tp -106.65 110.8 23.09 Favored 'General case' 0 N--CA 1.466 0.333 0 N-CA-C 107.916 -1.142 . . . . 73.239999999999995 107.916 -176.743 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -87.69 126.61 35.07 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 123.272 0.629 . . . . 54.43 109.345 -179.336 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 199' ' ' VAL . . . . . 0.478 ' O ' ' HA ' ' A' ' 255' ' ' ILE . 5.5 p -144.83 132.63 10.52 Favored Pre-proline 0 CA--C 1.55 0.969 0 N-CA-C 108.409 -0.96 . . . . 52.530000000000001 108.409 -178.792 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -72.74 159.35 48.72 Favored 'Trans proline' 0 C--N 1.368 1.583 0 C-N-CA 121.987 1.792 . . . . 55.310000000000002 111.023 171.031 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 201' ' ' ALA . . . . . 0.494 ' O ' HG23 ' A' ' 205' ' ' VAL . . . -50.95 -53.71 45.0 Favored Pre-proline 0 CA--C 1.558 1.264 0 CA-C-O 117.659 -1.162 . . . . 70.340000000000003 113.361 -176.466 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -63.95 -35.31 55.73 Favored 'Trans proline' 0 C--N 1.389 2.677 0 C-N-CA 121.598 1.532 . . . . 75.030000000000001 113.504 -175.799 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 41.0 mt -68.73 -33.82 61.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 N-CA-C 109.702 -0.481 . . . . 74.409999999999997 109.702 176.005 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 204' ' ' ALA . . . . . 0.478 ' HB1' ' HB ' ' A' ' 227' ' ' THR . . . -70.14 -35.66 74.22 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 123.228 0.611 . . . . 55.240000000000002 111.305 178.47 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 205' ' ' VAL . . . . . 0.494 HG23 ' O ' ' A' ' 201' ' ' ALA . 90.2 t -70.94 -56.44 10.65 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 C-N-CA 123.398 0.679 . . . . 73.439999999999998 110.522 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 17.3 m -73.32 -27.57 24.11 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.956 0 C-N-CA 122.862 0.465 . . . . 61.530000000000001 111.334 -174.927 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 81.36 69.62 1.39 Allowed Glycine 0 C--N 1.341 0.85 0 CA-C-N 115.839 -0.619 . . . . 72.540000000000006 112.262 -175.622 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -87.56 -140.05 6.44 Favored Glycine 0 C--N 1.355 1.618 0 CA-C-O 119.593 -0.56 . . . . 72.530000000000001 112.236 177.879 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 47.8 mtmt -137.35 147.47 45.57 Favored 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 123.66 0.784 . . . . 74.120000000000005 110.97 179.662 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 5.6 m -143.39 160.17 17.12 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 C-N-CA 125.271 1.428 . . . . 75.510000000000005 109.369 176.804 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 24.3 ttt180 -90.49 114.58 26.8 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 123.929 0.892 . . . . 70.439999999999998 110.449 179.587 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -102.18 131.87 48.43 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 124.753 1.221 . . . . 60.219999999999999 109.841 174.772 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 37.2 tpp -88.28 130.96 34.97 Favored 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 109.87 -0.418 . . . . 70.129999999999995 109.87 176.506 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 63.4 p -120.24 -171.68 2.21 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 124.309 1.043 . . . . 75.099999999999994 109.279 177.425 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 89.9 mt -67.93 -22.21 65.07 Favored 'General case' 0 CA--C 1.55 0.971 0 C-N-CA 123.315 0.646 . . . . 73.129999999999995 111.789 172.347 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 58.6 mt-10 -90.68 -21.12 21.79 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 123.578 0.751 . . . . 74.409999999999997 111.258 -177.685 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 124.48 -156.34 18.52 Favored Glycine 0 C--N 1.34 0.779 0 N-CA-C 111.092 -0.803 . . . . 42.399999999999999 111.092 -173.977 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -76.3 140.16 21.75 Favored 'Trans proline' 0 CA--C 1.551 1.356 0 C-N-CA 122.219 1.946 . . . . 74.420000000000002 113.932 -176.821 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 2.4 p -131.98 128.98 60.2 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.451 0 C-N-CA 124.678 1.191 . . . . 62.039999999999999 108.015 172.109 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -81.75 102.09 10.54 Favored 'General case' 0 C--O 1.236 0.376 0 N-CA-C 108.349 -0.982 . . . . 72.329999999999998 108.349 174.011 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 221' ' ' VAL . . . . . 0.486 ' HB ' ' OH ' ' A' ' 174' ' ' TYR . 13.9 m -97.65 138.85 21.33 Favored 'Isoleucine or valine' 0 C--O 1.242 0.679 0 CA-C-N 115.431 -0.804 . . . . 64.450000000000003 109.459 179.57 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 222' ' ' ALA . . . . . 0.644 ' H ' HD21 ' A' ' 172' ' ' LEU . . . -88.85 107.83 19.2 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-N 115.05 -0.977 . . . . 63.409999999999997 109.624 -177.355 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 61.2 t -54.09 134.3 59.15 Favored Pre-proline 0 N--CA 1.482 1.137 0 C-N-CA 124.302 1.041 . . . . 65.140000000000001 109.532 -179.332 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 224' ' ' PRO . . . . . 0.453 ' HB2' ' HB2' ' A' ' 179' ' ' ALA . 26.1 Cg_endo -60.52 151.23 76.8 Favored 'Trans proline' 0 C--N 1.373 1.858 0 C-N-CA 121.922 1.748 . . . . 70.129999999999995 112.647 177.29 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -64.56 133.76 38.37 Favored 'Trans proline' 0 C--N 1.368 1.601 0 C-N-CA 121.485 1.457 . . . . 74.099999999999994 110.677 169.505 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 55.3 mtt180 67.03 62.64 0.48 Allowed 'General case' 0 C--O 1.241 0.629 0 C-N-CA 124.797 1.239 . . . . 63.420000000000002 109.831 175.668 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 227' ' ' THR . . . . . 0.677 ' HA ' ' HE ' ' A' ' 231' ' ' ARG . 56.1 m -89.87 140.51 29.54 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 113.866 -1.515 . . . . 74.329999999999998 109.173 176.582 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -116.64 141.54 48.07 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.736 0.814 . . . . 70.219999999999999 108.862 171.884 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 229' ' ' ALA . . . . . 0.441 ' HB2' ' HB ' ' A' ' 255' ' ' ILE . . . -58.91 116.99 4.15 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 123.651 0.781 . . . . 62.0 110.217 179.911 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 115.16 -2.2 22.51 Favored Glycine 0 CA--C 1.526 0.754 0 CA-C-O 119.123 -0.821 . . . . 73.109999999999999 113.542 -173.07 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 231' ' ' ARG . . . . . 0.677 ' HE ' ' HA ' ' A' ' 227' ' ' THR . 77.5 mtt-85 -66.38 145.49 55.64 Favored 'General case' 0 N--CA 1.483 1.203 0 CA-C-N 118.042 0.921 . . . . 52.32 109.183 169.55 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -121.38 98.81 6.15 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 107.899 -1.149 . . . . 74.340000000000003 107.899 -174.477 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 233' ' ' LEU . . . . . 0.807 ' HB2' ' HB2' ' A' ' 251' ' ' LEU . 53.7 mt -79.79 152.27 29.86 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 115.36 -0.836 . . . . 54.229999999999997 109.371 179.843 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 234' ' ' ARG . . . . . 0.459 ' H ' ' HB3' ' A' ' 174' ' ' TYR . 59.4 ttm-85 -122.29 106.49 11.15 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 122.937 0.495 . . . . 72.319999999999993 110.542 -175.464 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 235' ' ' LEU . . . . . 0.603 ' HB2' ' HB3' ' A' ' 249' ' ' LEU . 10.3 mt -91.58 100.17 12.96 Favored 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 109.043 -0.725 . . . . 63.539999999999999 109.043 171.376 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 19.4 mttt -67.34 132.91 48.63 Favored 'General case' 0 C--O 1.241 0.61 0 O-C-N 123.365 0.416 . . . . 73.420000000000002 111.347 -178.042 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 73.89 18.2 79.55 Favored Glycine 0 C--N 1.347 1.193 0 CA-C-N 115.03 -0.986 . . . . 71.430000000000007 115.034 177.248 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 68.9 mmtt -106.4 12.41 29.78 Favored 'General case' 0 N--CA 1.488 1.455 0 CA-C-N 117.405 0.603 . . . . 75.150000000000006 110.514 174.749 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -113.9 -165.66 15.73 Favored Glycine 0 CA--C 1.527 0.811 0 CA-C-N 114.822 -1.081 . . . . 71.209999999999994 110.732 167.802 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -95.17 168.01 11.84 Favored Pre-proline 0 N--CA 1.479 1.022 0 C-N-CA 124.278 1.031 . . . . 62.119999999999997 110.097 -177.949 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -81.27 149.14 16.97 Favored 'Trans proline' 0 C--N 1.372 1.786 0 C-N-CA 121.599 1.533 . . . . 74.140000000000001 112.859 171.63 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 179.52 -119.75 0.66 Allowed Glycine 0 CA--C 1.54 1.598 0 CA-C-O 119.004 -0.887 . . . . 70.219999999999999 113.28 176.021 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 243' ' ' PRO . . . . . 0.445 ' HD2' ' HB3' ' A' ' 191' ' ' GLN . 34.1 Cg_endo -55.62 -46.67 30.23 Favored 'Trans proline' 0 C--N 1.382 2.306 1 C-N-CA 125.364 4.043 . . . . 41.539999999999999 114.055 -172.241 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -100.19 -2.21 34.55 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 123.315 0.646 . . . . 74.299999999999997 110.952 -179.133 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 87.8 -51.51 4.1 Favored Glycine 0 C--N 1.353 1.489 0 N-CA-C 111.833 -0.507 . . . . 71.549999999999997 111.833 -178.461 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 10.2 ttm180 -101.05 109.63 21.55 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 123.947 0.899 . . . . 51.299999999999997 109.879 176.679 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -75.98 130.41 10.94 Favored Glycine 0 C--N 1.351 1.373 0 N-CA-C 110.661 -0.976 . . . . 45.530000000000001 110.661 169.264 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 67.4 m-20 -112.31 145.65 39.65 Favored 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 109.332 -0.618 . . . . 72.040000000000006 109.332 -176.915 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 249' ' ' LEU . . . . . 0.603 ' HB3' ' HB2' ' A' ' 235' ' ' LEU . 31.4 tp -97.87 118.68 34.99 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 123.677 0.791 . . . . 61.119999999999997 109.207 -175.239 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 250' ' ' TYR . . . . . 0.408 ' HA ' ' O ' ' A' ' 233' ' ' LEU . 1.6 m-85 -89.34 108.87 19.88 Favored 'General case' 0 C--O 1.243 0.739 0 N-CA-C 108.727 -0.842 . . . . 75.099999999999994 108.727 -177.337 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 251' ' ' LEU . . . . . 0.807 ' HB2' ' HB2' ' A' ' 233' ' ' LEU . 79.7 mt -87.36 104.03 16.04 Favored 'General case' 0 C--O 1.241 0.61 0 N-CA-C 107.94 -1.133 . . . . 74.049999999999997 107.94 177.41 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -84.1 100.15 10.93 Favored 'General case' 0 C--O 1.238 0.457 0 CA-C-N 115.063 -0.972 . . . . 63.439999999999998 108.918 -177.535 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 11.7 m -72.04 135.59 27.53 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 CA-C-O 121.53 0.681 . . . . 60.25 110.67 -172.978 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 49.7 mmm-85 -127.42 98.92 5.42 Favored 'General case' 0 C--O 1.237 0.431 0 C-N-CA 124.608 1.163 . . . . 71.0 108.299 -178.594 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 255' ' ' ILE . . . . . 0.478 ' HA ' ' O ' ' A' ' 199' ' ' VAL . 27.2 mt -77.95 128.59 38.14 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 O-C-N 124.169 0.918 . . . . 73.120000000000005 109.754 179.735 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 4.2 t . . . . . 0 CA--C 1.559 1.327 0 CA-C-O 117.273 -1.346 . . . . 72.420000000000002 107.957 179.486 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 24.7 ptp . . . . . 0 N--CA 1.493 1.695 0 N-CA-C 111.648 0.24 . . . . 74.510000000000005 111.648 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -167.16 -157.39 0.24 Allowed 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.539 0.736 . . . . 72.420000000000002 109.302 -173.427 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 10.8 t -124.67 172.77 9.01 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 123.483 0.713 . . . . 74.319999999999993 109.398 170.425 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 171' ' ' ASP . . . . . 0.405 ' O ' HG23 ' A' ' 221' ' ' VAL . 2.7 p-10 -153.64 -63.69 0.14 Allowed 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 123.05 0.54 . . . . 72.230000000000004 111.314 -174.415 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 172' ' ' LEU . . . . . 0.447 HD21 ' HB3' ' A' ' 222' ' ' ALA . 43.4 mt -119.56 140.76 50.02 Favored 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 123.102 0.561 . . . . 71.200000000000003 112.035 -169.029 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 173' ' ' PHE . . . . . 0.501 ' CD1' HD22 ' A' ' 235' ' ' LEU . 11.9 m-85 -137.65 -44.95 0.54 Allowed 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 124.028 0.931 . . . . 64.25 109.519 -173.042 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 174' ' ' TYR . . . . . 0.518 ' CD2' ' HB3' ' A' ' 233' ' ' LEU . 0.7 OUTLIER -81.97 13.44 3.34 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-N 114.832 -1.076 . . . . 70.319999999999993 112.899 -175.689 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 175' ' ' THR . . . . . 0.427 HG23 ' HB3' ' A' ' 172' ' ' LEU . 11.6 p -63.37 -9.12 10.76 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.867 0.867 . . . . 71.239999999999995 113.308 -179.857 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 176' ' ' MET . . . . . . . . . . . . . 44.9 mtm -58.41 -63.96 1.09 Allowed 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 123.595 0.758 . . . . 52.420000000000002 109.104 166.36 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 44.8 pttt -168.1 119.06 0.81 Allowed 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 125.094 1.358 . . . . 74.420000000000002 108.337 -179.053 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 178' ' ' ALA . . . . . 0.583 ' HB1' HD22 ' A' ' 233' ' ' LEU . . . -124.04 -54.5 1.71 Allowed 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 123.916 0.886 . . . . 42.140000000000001 109.82 -173.641 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 179' ' ' ALA . . . . . 0.419 ' HA ' ' HD3' ' A' ' 231' ' ' ARG . . . -79.42 65.13 4.5 Favored 'General case' 0 CA--C 1.543 0.702 0 CA-C-O 121.918 0.866 . . . . 74.109999999999999 108.742 169.986 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 140.36 77.59 0.05 OUTLIER Glycine 0 C--N 1.336 0.568 0 N-CA-C 110.148 -1.181 . . . . 35.530000000000001 110.148 -171.672 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 24.6 m -81.67 15.05 2.3 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 123.475 0.71 . . . . 74.549999999999997 112.406 -176.922 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -61.41 93.82 0.08 OUTLIER Glycine 0 C--N 1.345 1.065 0 N-CA-C 112.032 -0.427 . . . . 61.450000000000003 112.032 172.543 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -163.36 -109.15 0.23 Allowed Glycine 0 C--N 1.335 0.524 0 N-CA-C 111.283 -0.727 . . . . 71.319999999999993 111.283 -178.122 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 24.9 p -148.45 166.85 26.92 Favored 'General case' 0 C--O 1.245 0.84 0 C-N-CA 123.34 0.656 . . . . 72.510000000000005 111.182 -175.545 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 185' ' ' GLY . . . . . 0.451 ' HA2' ' NH2' ' A' ' 234' ' ' ARG . . . -114.73 -100.5 2.33 Favored Glycine 0 C--N 1.349 1.292 0 N-CA-C 111.187 -0.765 . . . . 53.439999999999998 111.187 176.348 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 149.52 121.91 1.13 Allowed Glycine 0 C--N 1.351 1.368 0 N-CA-C 112.123 -0.391 . . . . 72.120000000000005 112.123 -179.619 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 33.1 m -128.34 139.67 52.27 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 123.683 0.793 . . . . 71.209999999999994 109.776 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 131.33 17.51 1.41 Allowed Glycine 0 C--N 1.341 0.846 0 CA-C-N 116.083 -0.508 . . . . 63.140000000000001 111.885 -176.508 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 153.65 141.09 3.19 Favored Glycine 0 C--N 1.344 1.028 0 N-CA-C 110.551 -1.02 . . . . 74.420000000000002 110.551 -178.347 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 68.8 m -73.33 84.14 1.42 Allowed 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 123.396 0.678 . . . . 73.219999999999999 110.189 179.658 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 191' ' ' GLN . . . . . 0.435 ' HG3' ' N ' ' A' ' 192' ' ' ASP . 6.5 pt20 -106.14 -42.04 5.19 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 116.162 -0.472 . . . . 64.200000000000003 110.278 -179.713 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 192' ' ' ASP . . . . . 0.435 ' N ' ' HG3' ' A' ' 191' ' ' GLN . 73.5 m-20 -84.94 121.0 27.13 Favored 'General case' 0 C--N 1.347 0.482 0 C-N-CA 123.998 0.919 . . . . 61.240000000000002 109.404 -175.722 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 193' ' ' LEU . . . . . 0.488 HD12 ' HA2' ' A' ' 239' ' ' GLY . 78.5 mt -108.17 177.67 4.73 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 124.351 1.06 . . . . 72.340000000000003 110.479 -170.383 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 47.3 m-85 -129.61 123.59 31.65 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 123.426 0.691 . . . . 71.019999999999996 110.736 -179.546 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 195' ' ' ALA . . . . . 0.435 ' HB2' HD11 ' A' ' 249' ' ' LEU . . . -128.29 171.98 11.48 Favored 'General case' 0 C--O 1.238 0.496 0 C-N-CA 125.64 1.576 . . . . 71.549999999999997 108.43 173.401 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 48.6 m -119.05 134.03 55.44 Favored 'General case' 0 C--O 1.237 0.446 0 C-N-CA 123.126 0.571 . . . . 55.530000000000001 109.675 175.57 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 0.731 HD22 HD13 ' A' ' 251' ' ' LEU . 17.1 tp -116.37 110.87 19.25 Favored 'General case' 0 C--O 1.234 0.288 0 N-CA-C 108.178 -1.045 . . . . 71.329999999999998 108.178 175.477 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -90.14 122.56 33.21 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 108.68 -0.859 . . . . 74.019999999999996 108.68 -179.632 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 199' ' ' VAL . . . . . 0.413 ' O ' ' HA ' ' A' ' 255' ' ' ILE . 5.0 p -136.18 132.4 19.08 Favored Pre-proline 0 CA--C 1.549 0.917 0 C-N-CA 124.287 1.035 . . . . 72.209999999999994 108.835 -174.795 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -71.73 158.87 52.3 Favored 'Trans proline' 0 C--N 1.367 1.551 0 C-N-CA 122.025 1.817 . . . . 74.209999999999994 111.256 171.422 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -53.0 -46.06 97.81 Favored Pre-proline 0 CA--C 1.558 1.257 0 N-CA-C 114.208 1.188 . . . . 73.140000000000001 114.208 -179.675 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 202' ' ' PRO . . . . . 0.465 ' HA ' HG22 ' A' ' 205' ' ' VAL . 34.3 Cg_endo -62.8 -43.45 20.47 Favored 'Trans proline' 0 C--N 1.385 2.494 0 C-N-CA 121.918 1.745 . . . . 64.430000000000007 113.675 177.527 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 43.5 mt -66.01 -30.73 50.89 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.351 0 CA-C-N 118.746 0.703 . . . . 73.129999999999995 110.5 177.979 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -68.74 -49.38 59.26 Favored 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 122.769 0.428 . . . . 64.019999999999996 111.587 177.26 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 205' ' ' VAL . . . . . 0.465 HG22 ' HA ' ' A' ' 202' ' ' PRO . 22.7 m -70.92 -47.83 60.09 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.848 0 C-N-CA 123.542 0.737 . . . . 71.030000000000001 112.411 -174.905 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 206' ' ' VAL . . . . . 0.449 HG22 ' O ' ' A' ' 202' ' ' PRO . 11.0 m -76.22 -34.19 25.45 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.235 0 C-N-CA 122.552 0.341 . . . . 43.119999999999997 110.979 179.712 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 87.47 61.06 1.57 Allowed Glycine 0 C--N 1.35 1.31 0 CA-C-N 116.251 -0.431 . . . . 70.109999999999999 112.135 -175.996 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -81.59 -133.93 1.64 Allowed Glycine 0 C--N 1.346 1.132 0 N-CA-C 112.511 -0.236 . . . . 74.099999999999994 112.511 177.929 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 48.0 mtmt -136.21 152.67 51.01 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 123.895 0.878 . . . . 60.5 110.839 178.741 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 4.5 m -144.76 163.52 13.48 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 C-N-CA 125.412 1.485 . . . . 70.439999999999998 108.363 172.238 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 42.0 ttp180 -98.94 115.36 28.71 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 123.622 0.769 . . . . 74.140000000000001 109.26 179.277 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -101.92 120.81 41.0 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 124.145 0.978 . . . . 71.209999999999994 110.429 -179.489 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 74.6 mtp -84.26 137.28 33.56 Favored 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 110.125 -0.324 . . . . 55.240000000000002 110.125 175.708 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 38.0 p -130.54 -172.9 2.92 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 124.592 1.157 . . . . 74.019999999999996 109.551 -175.889 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 82.6 mt -58.29 -35.0 71.17 Favored 'General case' 0 N--CA 1.488 1.465 0 CA-C-O 121.152 0.501 . . . . 73.310000000000002 110.565 172.723 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -92.29 -8.49 45.05 Favored 'General case' 0 CA--C 1.545 0.754 0 CA-C-N 115.166 -0.925 . . . . 72.010000000000005 111.378 -177.8 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 113.61 -159.32 13.75 Favored Glycine 0 C--N 1.348 1.224 0 CA-C-O 119.575 -0.569 . . . . 62.210000000000001 113.329 174.111 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -77.86 136.66 15.19 Favored 'Trans proline' 0 C--N 1.368 1.566 0 C-N-CA 123.24 2.627 . . . . 72.439999999999998 113.217 -171.584 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 6.2 p -132.8 133.09 59.4 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 C-N-CA 124.403 1.081 . . . . 64.400000000000006 109.376 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -76.61 102.06 5.97 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 108.534 -0.913 . . . . 63.039999999999999 108.534 176.173 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 221' ' ' VAL . . . . . 0.405 HG23 ' O ' ' A' ' 171' ' ' ASP . 6.1 p -110.06 127.25 67.1 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.975 0 N-CA-C 109.242 -0.651 . . . . 54.299999999999997 109.242 -174.06 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 222' ' ' ALA . . . . . 0.447 ' HB3' HD21 ' A' ' 172' ' ' LEU . . . -81.76 108.36 15.24 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 122.991 0.516 . . . . 42.109999999999999 110.755 -177.983 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 65.1 t -54.34 135.25 61.15 Favored Pre-proline 0 N--CA 1.484 1.245 0 C-N-CA 124.671 1.188 . . . . 51.299999999999997 110.61 179.8 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -65.41 147.69 87.43 Favored 'Trans proline' 0 C--N 1.378 2.119 0 C-N-CA 122.012 1.808 . . . . 63.130000000000003 110.873 174.219 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -60.89 138.0 76.17 Favored 'Trans proline' 0 C--N 1.368 1.592 0 C-N-CA 121.66 1.573 . . . . 73.129999999999995 111.058 174.238 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 30.9 mtm105 63.24 51.23 2.76 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 124.597 1.159 . . . . 64.5 110.953 174.632 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 227' ' ' THR . . . . . 0.41 HG23 ' HD2' ' A' ' 231' ' ' ARG . 90.4 m -77.7 137.05 38.28 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 115.299 -0.864 . . . . 73.040000000000006 109.087 170.457 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 28.1 mp0 -114.65 147.02 40.18 Favored 'General case' 0 N--CA 1.479 0.993 0 N-CA-C 108.939 -0.763 . . . . 61.229999999999997 108.939 174.534 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -57.91 124.54 19.58 Favored 'General case' 0 C--O 1.24 0.557 0 O-C-N 123.903 0.752 . . . . 73.109999999999999 111.017 -178.951 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 114.87 -14.53 19.52 Favored Glycine 0 N--CA 1.468 0.816 0 CA-C-O 119.076 -0.847 . . . . 43.450000000000003 113.858 -176.776 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 231' ' ' ARG . . . . . 0.419 ' HD3' ' HA ' ' A' ' 179' ' ' ALA . 88.9 mtt-85 -62.95 146.61 52.64 Favored 'General case' 0 N--CA 1.478 0.967 0 CA-C-N 117.759 0.779 . . . . 53.130000000000003 111.113 178.12 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 71.7 mmtt -118.84 97.49 5.73 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 123.996 0.918 . . . . 75.219999999999999 109.029 -172.954 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 233' ' ' LEU . . . . . 0.653 ' HB2' ' HB2' ' A' ' 251' ' ' LEU . 21.2 mt -85.52 137.96 32.53 Favored 'General case' 0 CA--C 1.546 0.807 0 N-CA-C 109.126 -0.694 . . . . 73.319999999999993 109.126 -175.316 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 234' ' ' ARG . . . . . 0.451 ' NH2' ' HA2' ' A' ' 185' ' ' GLY . 36.3 ttm-85 -110.86 114.31 27.55 Favored 'General case' 0 CA--C 1.558 1.25 0 C-N-CA 123.054 0.542 . . . . 75.439999999999998 111.377 -169.027 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 235' ' ' LEU . . . . . 0.572 HD11 HD11 ' A' ' 251' ' ' LEU . 16.5 mt -108.63 113.56 26.65 Favored 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 123.929 0.891 . . . . 74.400000000000006 111.641 -176.535 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 34.8 mttp -72.91 148.94 43.86 Favored 'General case' 0 N--CA 1.481 1.114 0 CA-C-O 121.338 0.589 . . . . 73.549999999999997 111.76 174.164 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 78.17 0.59 77.6 Favored Glycine 0 C--N 1.344 1.02 0 CA-C-N 114.107 -1.406 . . . . 72.109999999999999 113.87 179.775 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 73.4 mmtt -112.85 3.43 16.38 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.177 0.591 . . . . 74.049999999999997 111.457 -174.646 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 239' ' ' GLY . . . . . 0.488 ' HA2' HD12 ' A' ' 193' ' ' LEU . . . -113.27 -170.15 17.49 Favored Glycine 0 C--N 1.348 1.241 0 N-CA-C 111.328 -0.709 . . . . 35.0 111.328 166.834 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 79.8 m-85 -88.3 151.71 49.08 Favored Pre-proline 0 N--CA 1.481 1.114 0 C-N-CA 123.084 0.553 . . . . 52.539999999999999 110.803 -178.114 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_exo -67.44 168.03 19.06 Favored 'Trans proline' 0 C--N 1.371 1.741 0 C-N-CA 122.361 2.04 . . . . 73.120000000000005 112.614 172.974 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 144.06 -104.78 0.35 Allowed Glycine 0 C--N 1.348 1.212 0 CA-C-O 119.332 -0.704 . . . . 72.209999999999994 113.982 172.149 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -64.22 -30.86 64.47 Favored 'Trans proline' 0 C--N 1.375 1.94 0 C-N-CA 124.012 3.141 . . . . 72.140000000000001 114.313 -168.0 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -117.15 5.83 12.77 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 122.924 0.489 . . . . 32.409999999999997 110.701 173.593 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 87.81 -46.23 3.42 Favored Glycine 0 C--N 1.35 1.353 0 CA-C-N 116.905 -0.134 . . . . 63.329999999999998 113.131 178.234 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 31.3 ttm180 -123.99 112.02 16.7 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 124.369 1.068 . . . . 72.340000000000003 109.299 177.479 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -73.57 159.56 53.19 Favored Glycine 0 C--N 1.349 1.253 0 O-C-N 123.431 0.457 . . . . 52.119999999999997 114.17 176.119 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 248' ' ' ASP . . . . . 0.418 ' HA ' ' O ' ' A' ' 235' ' ' LEU . 12.4 m-20 -111.56 171.52 7.44 Favored 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 124.026 0.93 . . . . 71.510000000000005 111.4 -177.838 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 249' ' ' LEU . . . . . 0.435 HD11 ' HB2' ' A' ' 195' ' ' ALA . 25.9 tp -130.6 126.33 36.43 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 115.021 -0.99 . . . . 72.040000000000006 109.748 174.107 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 250' ' ' TYR . . . . . . . . . . . . . 2.8 m-30 -89.85 113.0 24.51 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 124.235 1.014 . . . . 72.030000000000001 110.516 179.76 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 251' ' ' LEU . . . . . 0.731 HD13 HD22 ' A' ' 197' ' ' LEU . 86.0 mt -87.2 103.34 15.33 Favored 'General case' 0 C--O 1.24 0.578 0 N-CA-C 107.243 -1.391 . . . . 75.200000000000003 107.243 176.091 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -80.77 101.54 9.39 Favored 'General case' 0 C--O 1.241 0.625 0 N-CA-C 108.542 -0.91 . . . . 75.099999999999994 108.542 177.594 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 17.9 m -73.59 135.56 27.3 Favored 'Isoleucine or valine' 0 C--O 1.244 0.808 0 CA-C-N 115.695 -0.684 . . . . 72.420000000000002 110.831 -172.678 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 31.3 mmm180 -125.93 99.23 5.85 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 114.559 -1.2 . . . . 71.099999999999994 108.13 -176.734 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 255' ' ' ILE . . . . . 0.413 ' HA ' ' O ' ' A' ' 199' ' ' VAL . 23.5 mt -79.35 123.06 35.77 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 O-C-N 123.565 0.541 . . . . 51.399999999999999 110.438 -179.562 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 2.0 t . . . . . 0 CA--C 1.563 1.466 0 N-CA-C 107.673 -1.232 . . . . 71.310000000000002 107.673 176.372 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 24.7 ttt . . . . . 0 N--CA 1.479 0.98 0 N-CA-C 109.706 -0.479 . . . . 74.519999999999996 109.706 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -82.73 -57.65 3.23 Favored 'General case' 0 CA--C 1.55 0.945 0 N-CA-C 108.665 -0.865 . . . . 63.25 108.665 169.363 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 170' ' ' THR . . . . . 0.545 HG23 HG23 ' A' ' 219' ' ' VAL . 9.0 t 162.25 174.17 0.01 OUTLIER 'General case' 0 CA--C 1.553 1.075 0 C-N-CA 127.041 2.136 . . . . 75.430000000000007 107.238 -173.6 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -157.95 -40.34 0.07 Allowed 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 112.501 0.556 . . . . 74.310000000000002 112.501 -174.831 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 172' ' ' LEU . . . . . 0.409 HD21 ' O ' ' A' ' 222' ' ' ALA . 26.4 mt -145.32 153.54 41.37 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 112.524 0.565 . . . . 65.439999999999998 112.524 -172.686 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 173' ' ' PHE . . . . . 0.512 ' HE1' HG21 ' A' ' 219' ' ' VAL . 38.6 m-85 -150.45 -40.98 0.13 Allowed 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 124.765 1.226 . . . . 74.010000000000005 109.411 -171.396 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 174' ' ' TYR . . . . . 0.434 ' CD2' ' HB3' ' A' ' 233' ' ' LEU . 0.7 OUTLIER -96.22 6.69 48.24 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 124.141 0.976 . . . . 74.409999999999997 112.785 -172.748 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -50.72 -35.21 30.24 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 125.096 1.358 . . . . 65.409999999999997 113.036 -162.446 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 176' ' ' MET . . . . . . . . . . . . . 7.0 ptm -58.39 93.62 0.02 OUTLIER 'General case' 0 CA--C 1.564 1.487 0 C-N-CA 124.638 1.175 . . . . 53.439999999999998 112.111 172.865 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 48.8 mtmt 57.05 42.08 26.5 Favored 'General case' 0 N--CA 1.491 1.61 0 C-N-CA 124.858 1.263 . . . . 70.109999999999999 111.873 171.91 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 178' ' ' ALA . . . . . 0.493 ' HB1' HD22 ' A' ' 233' ' ' LEU . . . -62.19 -42.61 99.45 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.572 1.149 . . . . 74.319999999999993 111.56 -179.675 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 179' ' ' ALA . . . . . 0.48 ' HB2' ' HB2' ' A' ' 224' ' ' PRO . . . -80.68 14.4 2.13 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 123.489 0.716 . . . . 64.310000000000002 111.42 176.347 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -100.08 -56.05 0.96 Allowed Glycine 0 C--N 1.342 0.878 0 N-CA-C 109.914 -1.274 . . . . 45.539999999999999 109.914 169.496 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 181' ' ' SER . . . . . 0.46 ' HB3' HH11 ' A' ' 231' ' ' ARG . 30.8 t 53.51 20.24 2.0 Allowed 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 124.459 1.104 . . . . 55.109999999999999 112.612 174.375 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -85.79 70.05 3.1 Favored Glycine 0 C--N 1.349 1.289 0 C-N-CA 123.096 0.379 . . . . 53.509999999999998 112.371 -172.001 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 137.49 149.82 5.63 Favored Glycine 0 C--N 1.34 0.772 0 CA-C-N 115.467 -0.367 . . . . 62.329999999999998 112.399 178.501 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 26.2 t -106.41 175.83 5.37 Favored 'General case' 0 C--O 1.245 0.833 0 C-N-CA 124.282 1.033 . . . . 63.149999999999999 109.031 176.855 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -158.24 161.12 31.41 Favored Glycine 0 C--N 1.34 0.754 0 N-CA-C 112.435 -0.266 . . . . 63.009999999999998 112.435 179.851 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 104.34 123.11 5.2 Favored Glycine 0 C--N 1.346 1.096 0 N-CA-C 111.808 -0.517 . . . . 65.120000000000005 111.808 177.198 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 29.8 t -160.15 150.04 18.1 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 123.447 0.699 . . . . 62.420000000000002 109.917 -177.508 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 107.9 -32.32 7.19 Favored Glycine 0 C--N 1.351 1.402 0 O-C-N 123.275 0.359 . . . . 54.140000000000001 113.318 176.629 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -162.81 153.79 24.5 Favored Glycine 0 C--N 1.34 0.802 0 N-CA-C 111.061 -0.815 . . . . 74.430000000000007 111.061 -176.222 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 31.8 m -77.47 69.76 3.77 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 124.062 0.945 . . . . 73.25 110.852 -177.505 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 191' ' ' GLN . . . . . 0.648 ' HB3' ' HD2' ' A' ' 243' ' ' PRO . 8.0 pt20 -91.43 -42.24 10.41 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 123.43 0.692 . . . . 73.450000000000003 109.74 179.057 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 192' ' ' ASP . . . . . 0.42 ' N ' ' HG3' ' A' ' 191' ' ' GLN . 80.9 m-20 -78.77 157.58 28.43 Favored 'General case' 0 C--O 1.239 0.548 0 CA-C-N 115.479 -0.782 . . . . 70.340000000000003 110.42 -175.601 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 46.0 mt -127.68 169.35 13.89 Favored 'General case' 0 C--O 1.238 0.493 0 CA-C-N 114.594 -1.185 . . . . 74.329999999999998 109.415 -178.297 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 64.5 m-85 -135.23 139.22 44.3 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 124.253 1.021 . . . . 71.25 109.422 179.705 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 195' ' ' ALA . . . . . 0.461 ' HB2' HD11 ' A' ' 249' ' ' LEU . . . -150.19 171.67 16.55 Favored 'General case' 0 C--O 1.24 0.56 0 C-N-CA 124.861 1.264 . . . . 75.099999999999994 108.973 -177.602 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 17.6 m -115.31 137.64 51.82 Favored 'General case' 0 C--O 1.238 0.464 0 C-N-CA 122.966 0.507 . . . . 64.150000000000006 109.636 179.013 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 0.674 HD22 HD13 ' A' ' 251' ' ' LEU . 14.6 tp -115.43 110.64 19.62 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 108.914 -0.773 . . . . 74.219999999999999 108.914 177.371 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -79.58 122.79 26.93 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 108.742 -0.836 . . . . 70.5 108.742 174.941 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 199' ' ' VAL . . . . . 0.467 ' O ' ' HA ' ' A' ' 255' ' ' ILE . 4.1 p -142.58 123.32 8.3 Favored Pre-proline 0 CA--C 1.543 0.694 0 N-CA-C 108.771 -0.826 . . . . 72.400000000000006 108.771 178.697 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -67.57 158.48 56.95 Favored 'Trans proline' 0 C--N 1.364 1.365 0 C-N-CA 121.955 1.77 . . . . 74.200000000000003 111.049 171.883 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 201' ' ' ALA . . . . . 0.508 ' O ' HG23 ' A' ' 205' ' ' VAL . . . -47.3 -53.82 25.99 Favored Pre-proline 0 CA--C 1.562 1.42 0 CA-C-O 117.903 -1.046 . . . . 74.219999999999999 112.988 -179.093 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -62.45 -39.88 42.9 Favored 'Trans proline' 0 C--N 1.399 3.199 0 C-N-CA 121.997 1.798 . . . . 74.010000000000005 113.698 -176.267 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 36.5 mt -66.36 -32.63 58.94 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.252 0 C-N-CA 122.701 0.4 . . . . 54.140000000000001 110.091 178.783 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -71.23 -36.02 71.67 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 122.742 0.417 . . . . 74.510000000000005 111.63 177.222 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 205' ' ' VAL . . . . . 0.508 HG23 ' O ' ' A' ' 201' ' ' ALA . 94.9 t -68.58 -57.03 10.22 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.11 0 C-N-CA 123.126 0.57 . . . . 72.129999999999995 111.215 -178.979 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 32.8 m -80.05 -27.55 12.16 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 CA-C-N 116.109 -0.496 . . . . 65.430000000000007 111.605 -175.373 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 81.96 65.1 1.67 Allowed Glycine 0 C--N 1.342 0.902 0 CA-C-N 116.177 -0.465 . . . . 74.140000000000001 111.956 -175.188 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -81.32 -131.99 1.28 Allowed Glycine 0 C--N 1.356 1.655 0 N-CA-C 111.804 -0.519 . . . . 70.25 111.804 177.397 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 21.0 mtmm -137.94 143.37 40.71 Favored 'General case' 0 N--CA 1.481 1.107 0 CA-C-N 117.569 0.685 . . . . 64.040000000000006 111.136 177.372 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 11.1 m -135.93 166.37 27.29 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 C-N-CA 125.032 1.333 . . . . 74.209999999999994 109.755 176.65 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 58.4 ttp180 -100.25 114.65 28.27 Favored 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 123.545 0.738 . . . . 72.25 110.309 -178.174 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -101.6 139.2 37.57 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 124.035 0.934 . . . . 74.010000000000005 110.06 175.402 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 25.2 mmt -96.33 115.17 27.01 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 123.186 0.595 . . . . 63.520000000000003 109.68 179.408 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 214' ' ' THR . . . . . 0.414 ' HB ' ' HD2' ' A' ' 238' ' ' LYS . 43.9 p -122.23 -173.47 2.68 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 124.146 0.978 . . . . 72.409999999999997 111.038 -175.016 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 82.8 mt -69.25 -22.76 63.82 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 123.475 0.71 . . . . 75.040000000000006 111.019 172.771 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 20.4 mm-40 -86.45 -6.07 59.0 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 123.814 0.846 . . . . 74.319999999999993 110.663 173.146 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 94.82 -149.9 19.52 Favored Glycine 0 C--N 1.344 1.025 0 CA-C-O 119.331 -0.705 . . . . 63.229999999999997 112.303 -177.605 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -73.28 122.05 7.68 Favored 'Trans proline' 0 CA--C 1.555 1.537 0 C-N-CA 122.254 1.969 . . . . 75.239999999999995 112.754 -178.559 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 219' ' ' VAL . . . . . 0.545 HG23 HG23 ' A' ' 170' ' ' THR . 2.4 p -116.84 131.15 70.34 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 C-N-CA 124.647 1.179 . . . . 72.430000000000007 109.164 173.649 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 -81.12 101.29 9.53 Favored 'General case' 0 C--O 1.24 0.576 0 N-CA-C 107.454 -1.313 . . . . 73.239999999999995 107.454 168.688 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 4.6 p -100.63 131.32 48.44 Favored 'Isoleucine or valine' 0 C--O 1.246 0.897 0 N-CA-C 108.872 -0.788 . . . . 72.200000000000003 108.872 -176.943 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 222' ' ' ALA . . . . . 0.409 ' O ' HD21 ' A' ' 172' ' ' LEU . . . -77.68 106.95 9.81 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 122.759 0.424 . . . . 70.430000000000007 110.394 -176.723 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 59.9 t -54.24 135.49 60.08 Favored Pre-proline 0 N--CA 1.48 1.04 0 C-N-CA 124.054 0.942 . . . . 53.200000000000003 109.989 178.454 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 224' ' ' PRO . . . . . 0.48 ' HB2' ' HB2' ' A' ' 179' ' ' ALA . 53.8 Cg_endo -67.85 148.76 77.42 Favored 'Trans proline' 0 C--N 1.37 1.672 0 C-N-CA 121.605 1.537 . . . . 74.409999999999997 110.688 173.145 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 16.3 Cg_endo -59.78 139.85 90.47 Favored 'Trans proline' 0 C--N 1.366 1.449 0 C-N-CA 121.591 1.528 . . . . 71.030000000000001 110.698 172.014 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 69.5 mtm180 66.28 50.52 1.33 Allowed 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 124.194 0.998 . . . . 64.150000000000006 111.065 171.981 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 54.0 m -85.85 136.96 33.09 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.922 0.889 . . . . 65.209999999999994 109.415 173.481 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 27.2 mp0 -113.24 144.52 42.56 Favored 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 123.929 0.892 . . . . 62.439999999999998 109.634 178.127 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -58.48 120.97 9.77 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 123.92 0.888 . . . . 72.349999999999994 110.257 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 113.88 -7.01 23.82 Favored Glycine 0 C--O 1.239 0.44 0 CA-C-O 119.268 -0.74 . . . . 73.010000000000005 113.213 -176.013 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 231' ' ' ARG . . . . . 0.46 HH11 ' HB3' ' A' ' 181' ' ' SER . 69.0 mtt-85 -67.27 146.67 53.91 Favored 'General case' 0 C--N 1.355 0.821 0 CA-C-N 117.909 0.854 . . . . 75.040000000000006 109.689 172.521 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 232' ' ' LYS . . . . . 0.435 ' HB3' ' HD1' ' A' ' 250' ' ' TYR . 13.1 mtmm -126.28 99.45 5.87 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 123.823 0.849 . . . . 74.349999999999994 108.874 -178.803 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 233' ' ' LEU . . . . . 0.493 HD22 ' HB1' ' A' ' 178' ' ' ALA . 21.4 mt -83.56 135.78 34.5 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 113.844 -1.525 . . . . 74.519999999999996 109.491 -175.243 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 29.9 ttt85 -104.84 101.01 10.63 Favored 'General case' 0 N--CA 1.476 0.837 0 CA-C-O 121.15 0.5 . . . . 71.400000000000006 111.131 -172.815 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 235' ' ' LEU . . . . . 0.531 HD12 HD23 ' A' ' 249' ' ' LEU . 46.7 mt -77.28 100.78 5.99 Favored 'General case' 0 C--O 1.238 0.455 0 C-N-CA 124.512 1.125 . . . . 65.430000000000007 110.028 176.079 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 11.7 mtmt -68.11 134.43 50.56 Favored 'General case' 0 C--O 1.241 0.654 0 O-C-N 123.32 0.388 . . . . 71.400000000000006 111.535 177.702 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 82.1 18.95 65.98 Favored Glycine 0 C--N 1.35 1.31 0 O-C-N 124.316 1.01 . . . . 72.409999999999997 113.612 179.907 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 238' ' ' LYS . . . . . 0.414 ' HD2' ' HB ' ' A' ' 214' ' ' THR . 39.4 mmtm -121.38 27.81 8.11 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 123.452 0.701 . . . . 72.030000000000001 111.299 -179.002 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -138.4 -171.11 12.05 Favored Glycine 0 CA--C 1.525 0.697 0 N-CA-C 110.272 -1.131 . . . . 54.329999999999998 110.272 167.498 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 61.7 m-85 -90.2 155.83 46.61 Favored Pre-proline 0 CA--C 1.545 0.755 0 C-N-CA 123.802 0.841 . . . . 73.219999999999999 109.782 -175.711 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -68.28 169.6 16.53 Favored 'Trans proline' 0 C--N 1.365 1.446 0 C-N-CA 121.978 1.786 . . . . 75.049999999999997 111.461 169.706 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 163.21 -108.27 0.33 Allowed Glycine 0 CA--C 1.531 1.066 0 CA-C-O 119.043 -0.865 . . . . 60.119999999999997 112.533 176.318 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 243' ' ' PRO . . . . . 0.648 ' HD2' ' HB3' ' A' ' 191' ' ' GLN . 84.5 Cg_endo -68.94 -46.92 1.36 Allowed 'Trans proline' 0 C--N 1.372 1.808 0 C-N-CA 123.885 3.056 . . . . 33.299999999999997 113.146 -173.656 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -100.67 -0.82 36.71 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 123.658 0.783 . . . . 74.340000000000003 111.305 -175.704 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 92.5 -43.79 2.62 Favored Glycine 0 C--N 1.352 1.43 0 O-C-N 123.028 0.205 . . . . 61.43 112.859 -179.665 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 13.3 ttm180 -120.36 112.27 18.8 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 124.153 0.981 . . . . 75.420000000000002 110.826 179.24 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -82.84 149.98 27.42 Favored Glycine 0 C--N 1.347 1.169 0 N-CA-C 111.156 -0.778 . . . . 53.43 111.156 167.859 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 38.6 m-20 -135.27 152.38 51.46 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 123.677 0.791 . . . . 72.0 109.675 -172.002 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 249' ' ' LEU . . . . . 0.531 HD23 HD12 ' A' ' 235' ' ' LEU . 61.9 tp -96.88 138.97 33.61 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.158 0.583 . . . . 42.149999999999999 110.134 -175.702 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 250' ' ' TYR . . . . . 0.435 ' HD1' ' HB3' ' A' ' 232' ' ' LYS . 7.4 m-85 -99.02 140.2 33.52 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.091 0.556 . . . . 62.399999999999999 110.026 173.887 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 251' ' ' LEU . . . . . 0.674 HD13 HD22 ' A' ' 197' ' ' LEU . 76.9 mt -115.67 103.86 11.11 Favored 'General case' 0 C--O 1.236 0.38 0 N-CA-C 108.647 -0.871 . . . . 70.409999999999997 108.647 179.763 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -79.54 96.37 6.1 Favored 'General case' 0 C--O 1.242 0.666 0 N-CA-C 108.109 -1.071 . . . . 74.25 108.109 177.917 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 13.0 m -70.55 136.77 25.28 Favored 'Isoleucine or valine' 0 C--O 1.245 0.848 0 CA-C-O 121.389 0.614 . . . . 54.009999999999998 110.59 -173.768 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 11.1 mmt180 -125.78 101.38 6.83 Favored 'General case' 0 C--O 1.241 0.62 0 C-N-CA 124.587 1.155 . . . . 74.219999999999999 108.308 -177.652 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 255' ' ' ILE . . . . . 0.47 HG23 ' HA ' ' A' ' 201' ' ' ALA . 22.7 mt -77.43 107.88 9.71 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.745 0 O-C-N 124.027 0.83 . . . . 62.109999999999999 109.785 179.341 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 7.2 t . . . . . 0 CA--C 1.567 1.621 0 CA-C-O 117.36 -1.305 . . . . 52.530000000000001 108.191 179.122 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 25.0 ttt . . . . . 0 N--CA 1.484 1.248 0 N-CA-C 109.874 -0.417 . . . . 53.240000000000002 109.874 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 63.4 tt0 -157.17 -54.21 0.08 Allowed 'General case' 0 C--N 1.35 0.611 0 C-N-CA 123.809 0.844 . . . . 71.099999999999994 109.095 -177.808 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 170' ' ' THR . . . . . 0.455 HG21 ' CZ ' ' A' ' 173' ' ' PHE . 12.5 t -176.09 -176.06 0.77 Allowed 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 123.742 0.817 . . . . 71.329999999999998 110.037 -172.928 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -118.99 -74.88 0.59 Allowed 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 123.875 0.87 . . . . 74.239999999999995 110.092 172.899 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 172' ' ' LEU . . . . . 0.49 HD21 ' HB3' ' A' ' 222' ' ' ALA . 21.1 mt -144.04 156.16 44.27 Favored 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 123.881 0.872 . . . . 74.310000000000002 111.317 -167.428 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 173' ' ' PHE . . . . . 0.455 ' CZ ' HG21 ' A' ' 170' ' ' THR . 45.0 m-85 -126.79 -57.83 1.33 Allowed 'General case' 0 N--CA 1.49 1.574 0 CA-C-O 121.679 0.752 . . . . 64.209999999999994 110.65 -170.445 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 174' ' ' TYR . . . . . 0.479 ' CD2' ' HB3' ' A' ' 233' ' ' LEU . 4.6 p90 -79.3 4.48 15.02 Favored 'General case' 0 N--CA 1.479 0.994 0 CA-C-N 114.76 -1.109 . . . . 74.25 113.352 -172.776 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 175' ' ' THR . . . . . 0.432 HG21 HD13 ' A' ' 172' ' ' LEU . 15.0 p -69.18 -5.18 20.92 Favored 'General case' 0 N--CA 1.479 0.995 0 N-CA-C 112.681 0.623 . . . . 54.109999999999999 112.681 -179.259 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 176' ' ' MET . . . . . . . . . . . . . 24.6 ptt? -61.24 -34.5 75.25 Favored 'General case' 0 CA--C 1.555 1.168 0 C-N-CA 123.632 0.773 . . . . 73.430000000000007 110.383 168.029 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 84.6 tttt -165.04 92.77 0.59 Allowed 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 124.869 1.268 . . . . 65.109999999999999 108.105 -178.427 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -128.71 142.65 50.94 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 123.877 0.871 . . . . 74.200000000000003 110.229 -171.582 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 179' ' ' ALA . . . . . 0.42 ' HB2' ' HB2' ' A' ' 224' ' ' PRO . . . 59.98 21.56 10.64 Favored 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 124.849 1.26 . . . . 73.109999999999999 112.104 -175.961 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -149.99 31.3 1.09 Allowed Glycine 0 C--N 1.34 0.772 0 N-CA-C 110.768 -0.933 . . . . 55.009999999999998 110.768 176.288 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 33.3 t -152.17 142.02 22.01 Favored 'General case' 0 C--O 1.246 0.913 0 C-N-CA 124.129 0.971 . . . . 74.209999999999994 108.872 -179.385 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 182' ' ' GLY . . . . . 0.587 ' HA2' ' H ' ' A' ' 232' ' ' LYS . . . -153.86 55.0 0.43 Allowed Glycine 0 C--N 1.339 0.7 0 N-CA-C 110.995 -0.842 . . . . 73.019999999999996 110.995 179.412 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 129.47 137.42 4.26 Favored Glycine 0 C--N 1.345 1.065 0 N-CA-C 110.46 -1.056 . . . . 62.100000000000001 110.46 -176.988 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 38.4 t -157.17 -54.09 0.08 Allowed 'General case' 0 N--CA 1.479 1.009 0 CA-C-N 117.247 0.523 . . . . 73.349999999999994 110.982 -174.968 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 87.3 145.36 9.63 Favored Glycine 0 CA--C 1.533 1.175 0 CA-C-O 119.473 -0.626 . . . . 72.150000000000006 111.66 -174.622 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -61.7 -70.76 0.94 Allowed Glycine 0 C--N 1.349 1.28 0 CA-C-O 119.783 -0.454 . . . . 52.229999999999997 113.668 -178.229 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 62.2 p -174.26 -60.41 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 123.883 0.873 . . . . 52.130000000000003 110.611 174.88 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 169.93 73.7 0.04 OUTLIER Glycine 0 C--N 1.35 1.346 0 N-CA-C 112.068 -0.413 . . . . 40.130000000000003 112.068 -177.863 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 166.02 162.09 16.59 Favored Glycine 0 N--CA 1.474 1.205 0 N-CA-C 110.979 -0.848 . . . . 55.310000000000002 110.979 -179.027 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 45.9 m -70.62 86.56 0.65 Allowed 'General case' 0 N--CA 1.478 0.948 0 CA-C-O 121.612 0.72 . . . . 70.510000000000005 111.132 -177.577 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 191' ' ' GLN . . . . . 0.52 ' HB2' ' HA2' ' A' ' 247' ' ' GLY . 4.8 pt20 -134.86 -29.88 1.11 Allowed 'General case' 0 N--CA 1.475 0.816 0 CA-C-N 114.83 -1.077 . . . . 73.209999999999994 110.99 -176.716 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -75.73 142.35 42.43 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-O 121.41 0.624 . . . . 73.140000000000001 111.341 -171.592 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 45.0 mt -130.91 170.96 13.73 Favored 'General case' 0 C--O 1.239 0.501 0 CA-C-N 114.216 -1.356 . . . . 73.120000000000005 108.994 174.122 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 26.6 m-85 -143.44 122.27 12.69 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 124.03 0.932 . . . . 75.430000000000007 109.503 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 195' ' ' ALA . . . . . 0.439 ' HB2' HD11 ' A' ' 249' ' ' LEU . . . -124.69 128.89 49.51 Favored 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 107.67 -1.233 . . . . 55.439999999999998 107.67 174.154 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 6.1 m -81.47 119.47 23.78 Favored 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 108.203 -1.036 . . . . 63.329999999999998 108.203 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 0.717 HD22 HD13 ' A' ' 251' ' ' LEU . 17.2 tp -104.74 110.55 22.93 Favored 'General case' 0 N--CA 1.466 0.374 0 N-CA-C 108.404 -0.962 . . . . 75.310000000000002 108.404 -172.984 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -77.48 125.53 29.48 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 108.482 -0.933 . . . . 73.420000000000002 108.482 177.234 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 199' ' ' VAL . . . . . 0.491 ' O ' ' HA ' ' A' ' 255' ' ' ILE . 5.4 p -144.15 129.45 9.62 Favored Pre-proline 0 CA--C 1.545 0.767 0 N-CA-C 108.488 -0.931 . . . . 71.219999999999999 108.488 176.465 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -71.86 157.15 55.64 Favored 'Trans proline' 0 C--O 1.248 1.02 0 C-N-CA 121.655 1.57 . . . . 72.430000000000007 111.342 170.309 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 201' ' ' ALA . . . . . 0.448 ' O ' HG23 ' A' ' 205' ' ' VAL . . . -51.29 -53.46 49.0 Favored Pre-proline 0 CA--C 1.556 1.2 0 O-C-N 124.32 1.013 . . . . 74.310000000000002 113.078 -176.501 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -67.01 -33.5 31.98 Favored 'Trans proline' 0 C--N 1.403 3.438 0 C-N-CA 121.678 1.585 . . . . 71.409999999999997 112.854 -175.044 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 203' ' ' ILE . . . . . 0.438 HG23 ' HA3' ' A' ' 208' ' ' GLY . 27.6 mt -66.03 -35.45 75.09 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.311 0 C-N-CA 122.586 0.354 . . . . 62.310000000000002 110.064 176.05 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 204' ' ' ALA . . . . . 0.485 ' HA ' HG11 ' A' ' 223' ' ' VAL . . . -71.01 -31.88 68.51 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 122.656 0.382 . . . . 74.310000000000002 111.51 178.617 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 205' ' ' VAL . . . . . 0.448 HG23 ' O ' ' A' ' 201' ' ' ALA . 92.8 t -73.77 -55.64 11.79 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 C-N-CA 122.896 0.478 . . . . 73.530000000000001 111.104 178.43 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 13.7 m -78.86 -26.41 13.44 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.003 0 C-N-CA 122.979 0.512 . . . . 71.310000000000002 111.927 -172.248 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 87.9 76.08 1.28 Allowed Glycine 0 CA--C 1.529 0.951 0 N-CA-C 111.972 -0.451 . . . . 73.510000000000005 111.972 -175.531 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 208' ' ' GLY . . . . . 0.438 ' HA3' HG23 ' A' ' 203' ' ' ILE . . . -95.37 -147.13 22.15 Favored Glycine 0 N--CA 1.477 1.369 0 CA-C-O 119.537 -0.591 . . . . 74.129999999999995 111.793 175.961 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 49.9 mtmt -132.86 145.63 51.12 Favored 'General case' 0 N--CA 1.482 1.125 0 CA-C-N 117.52 0.66 . . . . 73.209999999999994 111.151 176.742 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 12.0 m -139.25 164.91 24.14 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 C-N-CA 125.672 1.589 . . . . 73.109999999999999 108.93 175.932 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 23.9 ttm180 -103.44 117.13 33.75 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 123.386 0.674 . . . . 72.540000000000006 109.894 -174.246 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -103.69 123.33 46.82 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 124.729 1.212 . . . . 62.229999999999997 109.914 178.934 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 89.1 mmm -87.49 115.38 24.87 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 123.362 0.665 . . . . 74.450000000000003 110.166 -178.988 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 17.6 p -113.9 -178.71 3.44 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 123.976 0.91 . . . . 45.310000000000002 110.607 -175.856 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 81.0 mt -63.27 -23.94 67.64 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 122.842 0.457 . . . . 63.020000000000003 111.549 172.713 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -103.54 23.2 13.0 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 124.071 0.948 . . . . 63.43 110.893 179.867 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 87.88 -163.82 33.67 Favored Glycine 0 C--N 1.344 1.005 0 CA-C-N 116.299 -0.409 . . . . 45.310000000000002 113.141 175.59 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -72.12 144.73 42.83 Favored 'Trans proline' 0 C--N 1.362 1.244 0 C-N-CA 122.156 1.904 . . . . 73.0 112.804 -178.935 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 5.4 p -139.67 127.74 26.24 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 N-CA-C 108.083 -1.08 . . . . 73.230000000000004 108.083 170.047 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -82.19 103.3 11.69 Favored 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 108.461 -0.94 . . . . 72.439999999999998 108.461 176.264 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 2.8 p -100.3 133.62 42.75 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.841 0 O-C-N 124.149 0.906 . . . . 75.010000000000005 108.654 -174.931 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 222' ' ' ALA . . . . . 0.49 ' HB3' HD21 ' A' ' 172' ' ' LEU . . . -78.91 111.67 15.31 Favored 'General case' 0 C--O 1.24 0.6 0 C-N-CA 122.8 0.44 . . . . 74.209999999999994 110.541 -177.874 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 223' ' ' VAL . . . . . 0.485 HG11 ' HA ' ' A' ' 204' ' ' ALA . 48.9 t -54.61 131.63 64.29 Favored Pre-proline 0 CA--C 1.542 0.643 0 O-C-N 124.509 1.13 . . . . 74.409999999999997 109.909 177.496 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 224' ' ' PRO . . . . . 0.425 ' HD3' ' CE1' ' A' ' 174' ' ' TYR . 43.1 Cg_endo -67.3 152.5 79.14 Favored 'Trans proline' 0 CA--C 1.555 1.545 0 C-N-CA 121.657 1.571 . . . . 44.399999999999999 111.312 175.546 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -65.6 141.99 69.08 Favored 'Trans proline' 0 C--N 1.371 1.712 0 C-N-CA 121.941 1.761 . . . . 75.230000000000004 112.219 179.811 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 96.6 mtt180 65.42 32.15 9.82 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 124.827 1.251 . . . . 71.310000000000002 111.834 168.863 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 227' ' ' THR . . . . . 0.471 HG23 ' HD2' ' A' ' 231' ' ' ARG . 98.6 m -72.84 139.02 46.69 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 123.969 0.907 . . . . 74.25 109.89 174.946 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -111.66 155.53 23.28 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 123.113 0.565 . . . . 73.510000000000005 109.686 174.595 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 229' ' ' ALA . . . . . 0.601 ' HB2' ' HB ' ' A' ' 255' ' ' ILE . . . -54.99 122.63 11.33 Favored 'General case' 0 CA--C 1.536 0.442 0 O-C-N 124.896 1.372 . . . . 74.230000000000004 111.338 -179.302 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 112.57 -10.61 25.91 Favored Glycine 0 C--N 1.341 0.831 0 CA-C-O 119.568 -0.573 . . . . 35.210000000000001 113.718 177.029 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 231' ' ' ARG . . . . . 0.471 ' HD2' HG23 ' A' ' 227' ' ' THR . 53.0 mtt-85 -62.1 141.45 58.13 Favored 'General case' 0 N--CA 1.478 0.941 0 CA-C-N 117.246 0.523 . . . . 73.25 111.1 176.418 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 232' ' ' LYS . . . . . 0.587 ' H ' ' HA2' ' A' ' 182' ' ' GLY . 31.5 mmtp -112.47 103.58 11.67 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 108.585 -0.895 . . . . 52.100000000000001 108.585 -175.64 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 233' ' ' LEU . . . . . 0.736 ' HB2' ' HB2' ' A' ' 251' ' ' LEU . 41.7 mt -83.08 149.47 26.89 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 115.295 -0.866 . . . . 71.299999999999997 108.849 177.181 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 62.0 ttt180 -118.6 102.42 8.86 Favored 'General case' 0 N--CA 1.478 0.926 0 CA-C-N 117.958 0.345 . . . . 74.510000000000005 110.482 -173.404 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 235' ' ' LEU . . . . . 0.544 ' HB2' ' HB3' ' A' ' 249' ' ' LEU . 14.8 mt -85.92 94.84 9.29 Favored 'General case' 0 C--O 1.242 0.706 0 C-N-CA 123.197 0.599 . . . . 73.200000000000003 109.81 175.507 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 20.2 mttt -69.02 138.12 54.22 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 115.648 -0.706 . . . . 73.439999999999998 110.466 175.443 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 85.68 3.03 86.48 Favored Glycine 0 C--N 1.338 0.644 0 O-C-N 123.908 0.755 . . . . 33.399999999999999 113.348 -179.355 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 76.0 mmtt -116.78 9.24 13.88 Favored 'General case' 0 N--CA 1.485 1.323 0 CA-C-N 117.414 0.607 . . . . 73.25 111.919 -176.274 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -109.68 -165.65 19.94 Favored Glycine 0 C--N 1.346 1.09 0 N-CA-C 111.139 -0.784 . . . . 65.109999999999999 111.139 167.419 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 68.7 m-85 -86.82 158.79 53.13 Favored Pre-proline 0 N--CA 1.484 1.272 0 C-N-CA 123.446 0.698 . . . . 72.150000000000006 112.371 -176.291 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_exo -64.21 165.4 19.71 Favored 'Trans proline' 0 C--N 1.371 1.715 0 C-N-CA 122.24 1.96 . . . . 63.299999999999997 112.73 166.716 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 157.45 -107.94 0.34 Allowed Glycine 0 C--N 1.34 0.789 0 CA-C-O 118.806 -0.997 . . . . 71.439999999999998 111.999 173.431 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -68.65 -57.08 0.15 Allowed 'Trans proline' 0 C--N 1.378 2.09 0 C-N-CA 123.616 2.878 . . . . 72.549999999999997 112.666 -170.201 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -80.87 -22.39 39.87 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 123.417 0.687 . . . . 74.319999999999993 110.615 175.244 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 96.48 -33.53 5.6 Favored Glycine 0 C--N 1.352 1.437 0 N-CA-C 111.283 -0.727 . . . . 73.129999999999995 111.283 -169.894 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 29.2 ttm180 -106.7 111.89 24.63 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 124.68 1.192 . . . . 71.239999999999995 109.981 178.794 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 247' ' ' GLY . . . . . 0.52 ' HA2' ' HB2' ' A' ' 191' ' ' GLN . . . -79.53 162.97 47.94 Favored Glycine 0 C--O 1.247 0.919 0 O-C-N 123.528 0.518 . . . . 70.140000000000001 113.748 169.249 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 17.6 m-20 -128.16 129.23 46.19 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 123.814 0.846 . . . . 74.400000000000006 109.173 -169.456 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 249' ' ' LEU . . . . . 0.544 ' HB3' ' HB2' ' A' ' 235' ' ' LEU . 49.3 tp -99.54 113.62 26.13 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 124.005 0.922 . . . . 60.030000000000001 109.089 177.715 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 250' ' ' TYR . . . . . 0.421 ' HA ' ' O ' ' A' ' 233' ' ' LEU . 8.8 m-85 -90.28 114.59 26.66 Favored 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 123.593 0.757 . . . . 70.25 110.933 -176.467 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 251' ' ' LEU . . . . . 0.736 ' HB2' ' HB2' ' A' ' 233' ' ' LEU . 89.9 mt -88.05 106.3 18.06 Favored 'General case' 0 C--O 1.241 0.638 0 C-N-CA 124.846 1.258 . . . . 74.219999999999999 109.162 -179.013 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -82.3 99.95 9.64 Favored 'General case' 0 C--O 1.242 0.704 0 N-CA-C 108.463 -0.94 . . . . 73.239999999999995 108.463 175.386 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 11.5 m -67.23 132.73 32.25 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.853 0 O-C-N 123.782 0.676 . . . . 60.030000000000001 109.351 -177.498 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 17.9 mmt85 -123.11 95.21 4.52 Favored 'General case' 0 C--O 1.239 0.502 0 C-N-CA 124.517 1.127 . . . . 75.019999999999996 108.216 -177.996 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 255' ' ' ILE . . . . . 0.601 ' HB ' ' HB2' ' A' ' 229' ' ' ALA . 12.9 mt -76.43 125.25 36.0 Favored 'Isoleucine or valine' 0 C--O 1.233 0.208 0 O-C-N 123.945 0.778 . . . . 62.43 110.21 179.406 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 1.6 t . . . . . 0 CA--C 1.561 1.402 0 CA-C-O 117.546 -1.216 . . . . 37.960000000000001 107.768 173.877 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 15.7 tpt . . . . . 0 N--CA 1.479 0.989 0 N-CA-C 109.525 -0.546 . . . . 52.219999999999999 109.525 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 9.8 pt20 -137.72 168.31 19.94 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.6 0.76 . . . . 74.200000000000003 110.627 -178.756 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 170' ' ' THR . . . . . 0.521 HG23 HG21 ' A' ' 219' ' ' VAL . 6.5 t -80.69 167.59 19.84 Favored 'General case' 0 C--O 1.243 0.739 0 CA-C-N 115.171 -0.922 . . . . 73.109999999999999 110.144 173.774 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -117.87 -63.64 1.4 Allowed 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 123.84 0.856 . . . . 62.509999999999998 109.965 -177.505 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 172' ' ' LEU . . . . . 0.569 ' HB3' HG23 ' A' ' 175' ' ' THR . 55.7 mt -131.75 154.58 48.9 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 114.555 -1.202 . . . . 61.439999999999998 111.27 -164.77 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 173' ' ' PHE . . . . . 0.552 ' CD1' HD22 ' A' ' 235' ' ' LEU . 7.5 m-85 -140.13 -44.1 0.42 Allowed 'General case' 0 N--CA 1.482 1.142 0 CA-C-N 114.966 -1.015 . . . . 73.519999999999996 109.118 -171.21 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 174' ' ' TYR . . . . . . . . . . . . . 1.9 p90 -86.18 19.3 2.73 Favored 'General case' 0 CA--C 1.547 0.83 0 CA-C-N 114.502 -1.226 . . . . 61.229999999999997 112.394 -176.158 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 175' ' ' THR . . . . . 0.569 HG23 ' HB3' ' A' ' 172' ' ' LEU . 17.6 p -62.87 -21.63 66.11 Favored 'General case' 0 N--CA 1.493 1.692 0 CA-C-N 118.909 0.777 . . . . 70.530000000000001 112.853 -179.2 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 176' ' ' MET . . . . . . . . . . . . . 21.4 ptt? -52.4 -42.45 64.04 Favored 'General case' 0 CA--C 1.558 1.287 0 C-N-CA 124.367 1.067 . . . . 52.43 110.95 171.016 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 19.7 tptm -167.42 100.07 0.5 Allowed 'General case' 0 C--N 1.349 0.553 0 C-N-CA 125.532 1.533 . . . . 64.329999999999998 107.017 176.844 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 178' ' ' ALA . . . . . 0.434 ' HB1' ' HB3' ' A' ' 224' ' ' PRO . . . -74.65 -74.42 0.2 Allowed 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 115.556 -0.747 . . . . 72.120000000000005 112.096 -168.306 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -69.65 95.53 0.87 Allowed 'General case' 0 CA--C 1.541 0.629 0 O-C-N 123.381 0.425 . . . . 74.239999999999995 110.19 -177.328 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 80.59 89.2 0.54 Allowed Glycine 0 C--N 1.348 1.243 0 CA-C-N 115.489 -0.778 . . . . 41.119999999999997 112.063 -178.328 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 27.8 t -97.88 132.87 43.09 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 123.395 0.678 . . . . 42.409999999999997 109.616 178.335 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -86.03 -164.62 39.6 Favored Glycine 0 C--N 1.35 1.307 0 O-C-N 123.618 0.574 . . . . 73.209999999999994 114.08 -173.796 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 97.62 14.09 41.95 Favored Glycine 0 C--N 1.35 1.344 0 C-N-CA 123.306 0.479 . . . . 55.310000000000002 112.598 -176.936 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 16.8 m -76.34 142.37 41.24 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 123.892 0.877 . . . . 31.43 111.272 -177.197 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 73.04 35.44 57.72 Favored Glycine 0 C--N 1.345 1.079 0 O-C-N 123.284 0.365 . . . . 63.219999999999999 112.566 -179.803 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -152.02 43.51 0.67 Allowed Glycine 0 C--N 1.345 1.041 0 N-CA-C 111.973 -0.451 . . . . 73.430000000000007 111.973 -178.604 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 24.3 m -72.57 -61.41 1.81 Allowed 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 123.457 0.703 . . . . 75.0 110.04 175.148 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 79.49 -62.68 4.07 Favored Glycine 0 C--N 1.353 1.486 0 N-CA-C 111.723 -0.551 . . . . 4.1299999999999999 111.723 -172.631 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -109.37 165.36 12.44 Favored Glycine 0 C--N 1.343 0.926 0 N-CA-C 110.414 -1.074 . . . . 64.109999999999999 110.414 167.998 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 15.7 p -68.83 100.79 1.23 Allowed 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 123.589 0.756 . . . . 64.209999999999994 110.526 177.202 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 191' ' ' GLN . . . . . 0.492 ' HG3' ' N ' ' A' ' 192' ' ' ASP . 5.0 pt20 -139.03 -44.24 0.47 Allowed 'General case' 0 CA--C 1.544 0.724 0 CA-C-N 115.676 -0.693 . . . . 55.130000000000003 110.758 177.903 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 192' ' ' ASP . . . . . 0.492 ' N ' ' HG3' ' A' ' 191' ' ' GLN . 24.4 m-20 -77.55 123.87 27.16 Favored 'General case' 0 C--N 1.351 0.643 0 C-N-CA 123.76 0.824 . . . . 73.150000000000006 109.096 -177.125 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 193' ' ' LEU . . . . . 0.544 HD12 ' HA2' ' A' ' 239' ' ' GLY . 41.0 mt -111.71 173.57 6.29 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 124.612 1.165 . . . . 72.420000000000002 109.987 -178.186 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 45.8 m-85 -130.15 129.28 43.28 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 123.778 0.831 . . . . 65.219999999999999 109.57 176.33 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 195' ' ' ALA . . . . . 0.451 ' HB2' HD11 ' A' ' 249' ' ' LEU . . . -129.65 167.49 17.91 Favored 'General case' 0 C--O 1.239 0.549 0 C-N-CA 124.989 1.316 . . . . 33.399999999999999 107.47 170.237 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 31.4 m -117.27 124.17 48.37 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 108.731 -0.84 . . . . 71.25 108.731 179.335 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 0.653 HD22 HD13 ' A' ' 251' ' ' LEU . 15.3 tp -107.7 109.81 21.49 Favored 'General case' 0 CA--C 1.53 0.211 0 N-CA-C 107.823 -1.177 . . . . 72.219999999999999 107.823 -177.711 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -83.42 128.63 34.66 Favored 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 109.05 -0.722 . . . . 73.340000000000003 109.05 178.156 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 199' ' ' VAL . . . . . 0.543 ' O ' ' HA ' ' A' ' 255' ' ' ILE . 4.0 p -143.78 129.57 9.96 Favored Pre-proline 0 CA--C 1.543 0.699 0 N-CA-C 108.201 -1.037 . . . . 75.310000000000002 108.201 179.765 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -69.1 157.9 59.91 Favored 'Trans proline' 0 C--N 1.364 1.383 0 C-N-CA 121.905 1.737 . . . . 54.240000000000002 111.502 170.038 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 201' ' ' ALA . . . . . 0.486 ' O ' HG23 ' A' ' 205' ' ' VAL . . . -49.74 -53.7 39.17 Favored Pre-proline 0 CA--C 1.561 1.385 0 O-C-N 124.768 1.292 . . . . 74.430000000000007 112.792 -178.195 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -61.94 -35.38 77.81 Favored 'Trans proline' 0 C--N 1.401 3.314 0 C-N-CA 121.988 1.792 . . . . 71.099999999999994 113.339 -176.388 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 38.1 mt -71.35 -31.94 45.21 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.104 0 C-N-CA 123.068 0.547 . . . . 75.439999999999998 110.321 179.145 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -72.95 -34.05 66.27 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 122.463 0.305 . . . . 63.109999999999999 111.516 176.18 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 205' ' ' VAL . . . . . 0.486 HG23 ' O ' ' A' ' 201' ' ' ALA . 90.6 t -67.72 -55.77 15.67 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 C-N-CA 123.836 0.854 . . . . 72.409999999999997 110.874 177.936 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 18.4 m -80.87 -27.96 11.2 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.079 0 C-N-CA 122.753 0.421 . . . . 54.130000000000003 111.744 -174.469 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 82.02 67.9 1.48 Allowed Glycine 0 C--N 1.347 1.176 0 O-C-N 123.736 0.647 . . . . 52.32 112.113 -173.988 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -84.35 -131.88 2.25 Favored Glycine 0 C--N 1.352 1.435 0 CA-C-O 119.68 -0.511 . . . . 54.039999999999999 111.953 179.436 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 209' ' ' LYS . . . . . 0.431 ' HG2' ' HA ' ' A' ' 222' ' ' ALA . 48.0 mtmt -139.99 150.92 45.05 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 123.908 0.883 . . . . 64.230000000000004 111.425 178.258 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 15.2 m -146.04 168.92 6.61 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 C-N-CA 126.005 1.722 . . . . 73.230000000000004 108.388 176.584 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 37.0 ptt180 -95.03 128.65 42.02 Favored 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 109.371 -0.603 . . . . 74.019999999999996 109.371 172.626 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -102.31 112.36 25.02 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 123.895 0.878 . . . . 64.319999999999993 108.631 174.175 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 74.8 mtp -82.98 108.78 16.54 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 109.382 -0.599 . . . . 75.420000000000002 109.382 -175.746 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 26.7 p -111.39 -172.47 2.04 Favored 'General case' 0 C--O 1.242 0.686 0 C-N-CA 124.174 0.989 . . . . 73.040000000000006 110.224 -173.179 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 84.2 mt -61.97 -28.84 69.84 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 123.439 0.696 . . . . 72.409999999999997 111.368 173.386 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -100.22 7.94 44.14 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 123.656 0.783 . . . . 74.349999999999994 111.427 179.424 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 100.84 -173.11 24.28 Favored Glycine 0 C--N 1.347 1.16 0 CA-C-O 119.929 -0.373 . . . . 74.030000000000001 113.819 175.763 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_endo -71.57 127.59 13.36 Favored 'Trans proline' 0 C--N 1.368 1.579 0 C-N-CA 122.855 2.37 . . . . 74.239999999999995 112.351 -176.852 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 219' ' ' VAL . . . . . 0.521 HG21 HG23 ' A' ' 170' ' ' THR . 5.0 p -119.77 130.76 73.75 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 C-N-CA 123.714 0.806 . . . . 65.230000000000004 108.846 178.436 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -70.52 101.63 2.04 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 108.751 -0.833 . . . . 75.439999999999998 108.751 177.755 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 3.0 p -106.64 134.38 48.45 Favored 'Isoleucine or valine' 0 C--O 1.244 0.774 0 N-CA-C 108.377 -0.971 . . . . 52.119999999999997 108.377 -176.304 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 222' ' ' ALA . . . . . 0.445 ' HB3' HD21 ' A' ' 172' ' ' LEU . . . -82.19 108.74 15.89 Favored 'General case' 0 N--CA 1.467 0.414 0 N-CA-C 109.975 -0.38 . . . . 54.299999999999997 109.975 -179.358 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 43.0 t -54.54 134.74 63.22 Favored Pre-proline 0 N--CA 1.478 0.945 0 C-N-CA 124.753 1.221 . . . . 62.009999999999998 110.436 -178.14 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 224' ' ' PRO . . . . . 0.434 ' HB3' ' HB1' ' A' ' 178' ' ' ALA . 12.2 Cg_endo -58.22 150.46 66.13 Favored 'Trans proline' 0 C--N 1.37 1.699 0 C-N-CA 122.221 1.947 . . . . 64.219999999999999 111.942 169.779 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -78.41 148.51 23.67 Favored 'Trans proline' 0 C--N 1.366 1.497 0 C-N-CA 122.065 1.843 . . . . 65.400000000000006 110.937 174.136 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 45.8 mtm180 59.56 41.28 19.23 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 124.302 1.041 . . . . 72.420000000000002 111.271 174.122 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 227' ' ' THR . . . . . 0.545 HG23 ' HD2' ' A' ' 231' ' ' ARG . 55.5 m -82.29 141.64 32.75 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 114.334 -1.303 . . . . 72.129999999999995 109.438 177.097 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 27.7 mp0 -115.96 145.18 43.15 Favored 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 123.764 0.826 . . . . 52.140000000000001 109.245 176.381 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 229' ' ' ALA . . . . . 0.413 ' HB2' ' HB ' ' A' ' 255' ' ' ILE . . . -57.04 119.42 6.27 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.986 0.914 . . . . 40.140000000000001 111.119 -178.079 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 114.38 -5.33 23.25 Favored Glycine 0 C--N 1.342 0.869 0 O-C-N 123.825 0.703 . . . . 42.409999999999997 112.696 -176.768 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 231' ' ' ARG . . . . . 0.545 ' HD2' HG23 ' A' ' 227' ' ' THR . 55.0 mtt-85 -69.67 148.68 48.97 Favored 'General case' 0 C--N 1.363 1.194 0 CA-C-N 117.704 0.752 . . . . 74.319999999999993 109.124 169.724 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 36.5 mtmt -130.2 118.26 21.12 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 123.166 0.586 . . . . 64.439999999999998 109.56 -174.334 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 233' ' ' LEU . . . . . . . . . . . . . 9.0 mt -101.47 138.94 37.81 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 124.318 1.047 . . . . 65.340000000000003 108.487 -172.307 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 234' ' ' ARG . . . . . 0.505 ' HG3' ' HB3' ' A' ' 248' ' ' ASP . 35.8 ttm-85 -102.04 118.45 36.94 Favored 'General case' 0 N--CA 1.479 0.982 0 CA-C-N 118.013 0.37 . . . . 73.329999999999998 111.434 -173.83 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 235' ' ' LEU . . . . . 0.552 HD22 ' CD1' ' A' ' 173' ' ' PHE . 13.7 mt -103.87 111.62 24.23 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 123.492 0.717 . . . . 64.310000000000002 110.271 179.069 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 65.1 mttt -69.66 144.59 52.86 Favored 'General case' 0 N--CA 1.471 0.578 0 O-C-N 123.205 0.316 . . . . 61.340000000000003 111.196 176.178 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 73.88 -5.72 23.25 Favored Glycine 0 N--CA 1.472 1.05 0 O-C-N 124.624 1.203 . . . . 75.319999999999993 114.578 179.065 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -101.24 0.89 38.23 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 123.043 0.537 . . . . 73.329999999999998 110.896 -176.498 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 239' ' ' GLY . . . . . 0.544 ' HA2' HD12 ' A' ' 193' ' ' LEU . . . -102.9 -168.26 26.18 Favored Glycine 0 C--N 1.347 1.157 0 N-CA-C 110.322 -1.111 . . . . 71.340000000000003 110.322 163.184 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 58.0 m-85 -92.78 154.64 42.11 Favored Pre-proline 0 N--CA 1.477 0.918 0 C-N-CA 123.033 0.533 . . . . 74.010000000000005 111.028 -176.627 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_exo -72.9 161.92 42.4 Favored 'Trans proline' 0 C--N 1.366 1.498 0 C-N-CA 122.202 1.935 . . . . 63.299999999999997 111.865 172.342 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 157.2 -104.25 0.25 Allowed Glycine 0 CA--C 1.527 0.842 0 CA-C-O 119.072 -0.849 . . . . 53.5 112.155 177.8 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 243' ' ' PRO . . . . . 0.429 ' HD2' ' HB3' ' A' ' 191' ' ' GLN . 41.8 Cg_endo -63.67 -52.22 1.97 Allowed 'Trans proline' 0 C--N 1.37 1.663 0 C-N-CA 123.642 2.895 . . . . 33.32 113.241 -169.985 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -93.11 -5.08 51.1 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 123.304 0.642 . . . . 73.019999999999996 111.447 179.753 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 92.38 -46.52 2.59 Favored Glycine 0 C--N 1.354 1.572 0 N-CA-C 111.945 -0.462 . . . . 50.130000000000003 111.945 -175.971 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 20.1 ttm180 -116.3 112.4 21.51 Favored 'General case' 0 C--O 1.238 0.486 0 C-N-CA 124.367 1.067 . . . . 64.120000000000005 109.127 178.119 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -80.65 168.31 51.16 Favored Glycine 0 C--N 1.348 1.249 0 CA-C-O 121.503 0.502 . . . . 52.310000000000002 113.88 172.191 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 248' ' ' ASP . . . . . 0.505 ' HB3' ' HG3' ' A' ' 234' ' ' ARG . 19.4 m-20 -124.65 162.2 24.64 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 114.009 -1.096 . . . . 64.109999999999999 110.469 -169.466 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 249' ' ' LEU . . . . . 0.451 HD11 ' HB2' ' A' ' 195' ' ' ALA . 41.6 tp -125.9 121.8 34.21 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 123.528 0.731 . . . . 74.420000000000002 109.405 178.305 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 250' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -90.47 112.43 24.07 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 123.816 0.846 . . . . 65.219999999999999 110.607 -178.733 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 251' ' ' LEU . . . . . 0.653 HD13 HD22 ' A' ' 197' ' ' LEU . 90.7 mt -87.85 104.02 16.19 Favored 'General case' 0 C--O 1.239 0.504 0 N-CA-C 107.889 -1.152 . . . . 73.25 107.889 179.915 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -79.91 98.58 7.19 Favored 'General case' 0 C--O 1.239 0.521 0 N-CA-C 108.145 -1.058 . . . . 62.520000000000003 108.145 177.106 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 253' ' ' VAL . . . . . 0.406 HG21 HG22 ' A' ' 227' ' ' THR . 6.2 m -66.67 125.88 24.94 Favored 'Isoleucine or valine' 0 C--O 1.243 0.759 0 CA-C-O 122.021 0.915 . . . . 54.539999999999999 109.362 -178.169 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 17.9 mmm180 -122.2 99.34 6.38 Favored 'General case' 0 C--O 1.239 0.535 0 N-CA-C 107.742 -1.207 . . . . 72.030000000000001 107.742 -178.996 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 255' ' ' ILE . . . . . 0.543 ' HA ' ' O ' ' A' ' 199' ' ' VAL . 55.3 mt -83.29 119.55 32.87 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 CA-C-N 114.103 -1.408 . . . . 73.510000000000005 110.267 -175.114 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 CA--C 1.559 1.309 0 C-N-CA 124.6 1.16 . . . . 72.519999999999996 108.964 175.547 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.485 1.277 0 N-CA-C 111.902 0.334 . . . . 64.299999999999997 111.902 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 9.0 pt20 -142.9 171.8 13.56 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 122.985 0.514 . . . . 71.310000000000002 110.01 170.094 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 6.6 t -93.61 178.69 5.61 Favored 'General case' 0 CA--C 1.557 1.242 0 C-N-CA 123.813 0.845 . . . . 52.140000000000001 110.399 179.198 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -129.01 -82.91 0.57 Allowed 'General case' 0 CA--C 1.555 1.167 0 C-N-CA 122.921 0.488 . . . . 61.409999999999997 111.601 -168.71 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 172' ' ' LEU . . . . . 0.419 ' HB3' ' OG1' ' A' ' 175' ' ' THR . 21.0 mt -127.83 160.54 31.47 Favored 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 123.691 0.796 . . . . 62.130000000000003 111.71 -173.591 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 173' ' ' PHE . . . . . 0.549 ' CD1' HD22 ' A' ' 235' ' ' LEU . 16.7 m-85 -146.14 -59.28 0.31 Allowed 'General case' 0 N--CA 1.479 1.022 0 CA-C-O 122.123 0.963 . . . . 70.209999999999994 108.692 -166.986 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 174' ' ' TYR . . . . . 0.483 ' CD2' ' HB3' ' A' ' 233' ' ' LEU . 0.6 OUTLIER -78.53 14.45 1.27 Allowed 'General case' 0 CA--C 1.547 0.829 0 CA-C-N 113.744 -1.571 . . . . 74.439999999999998 112.533 -176.025 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 175' ' ' THR . . . . . 0.419 ' OG1' ' HB3' ' A' ' 172' ' ' LEU . 0.2 OUTLIER -63.95 -19.32 65.05 Favored 'General case' 0 CA--C 1.555 1.152 0 C-N-CA 124.459 1.104 . . . . 72.439999999999998 111.432 -173.843 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 176' ' ' MET . . . . . . . . . . . . . 25.1 ptt? -71.45 -40.89 70.04 Favored 'General case' 0 CA--C 1.562 1.409 0 C-N-CA 124.644 1.177 . . . . 74.150000000000006 111.72 173.081 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 1.6 ttmp? -164.58 118.45 1.36 Allowed 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 124.644 1.178 . . . . 54.039999999999999 109.296 -175.623 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 178' ' ' ALA . . . . . 0.5 ' HB1' HD22 ' A' ' 233' ' ' LEU . . . -152.61 -49.39 0.1 Allowed 'General case' 0 C--O 1.24 0.58 0 C-N-CA 123.309 0.644 . . . . 73.310000000000002 110.289 -173.808 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 179' ' ' ALA . . . . . 0.401 ' HB2' ' HB2' ' A' ' 224' ' ' PRO . . . -81.02 37.66 0.44 Allowed 'General case' 0 CA--C 1.554 1.127 0 C-N-CA 123.486 0.715 . . . . 51.399999999999999 111.07 178.785 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -137.21 -153.93 6.52 Favored Glycine 0 C--N 1.347 1.154 0 C-N-CA 123.839 0.733 . . . . 63.240000000000002 111.76 -177.307 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 21.9 t -130.05 -177.8 4.46 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 123.489 0.716 . . . . 64.420000000000002 109.95 -176.611 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . 90.05 -48.65 3.23 Favored Glycine 0 C--N 1.348 1.199 0 N-CA-C 112.411 -0.276 . . . . 75.420000000000002 112.411 178.584 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 101.55 -10.64 57.79 Favored Glycine 0 C--N 1.35 1.312 0 CA-C-O 119.451 -0.638 . . . . 33.229999999999997 112.797 178.6 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 24.1 t 65.11 15.92 10.27 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 124.681 1.192 . . . . 74.239999999999995 112.313 176.499 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -84.39 -90.64 0.78 Allowed Glycine 0 C--N 1.346 1.128 0 CA-C-O 120.121 -0.266 . . . . 74.319999999999993 113.139 -175.057 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 61.37 46.3 94.68 Favored Glycine 0 C--N 1.35 1.35 0 O-C-N 124.087 0.522 . . . . 53.32 111.896 -174.541 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 33.5 t -93.41 133.64 36.47 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 123.5 0.72 . . . . 64.540000000000006 110.421 -174.381 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -93.85 37.24 3.45 Favored Glycine 0 C--N 1.349 1.277 0 CA-C-N 116.383 -0.372 . . . . 63.130000000000003 113.233 178.792 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 189' ' ' GLY . . . . . 0.453 ' HA3' ' HD3' ' A' ' 243' ' ' PRO . . . -172.41 165.66 38.25 Favored Glycine 0 C--N 1.344 1.013 0 N-CA-C 111.498 -0.641 . . . . 62.32 111.498 179.225 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 37.0 t -86.06 72.16 10.47 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 123.462 0.705 . . . . 72.340000000000003 109.165 178.757 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 191' ' ' GLN . . . . . 0.559 ' HB3' ' HD2' ' A' ' 243' ' ' PRO . 3.6 pt20 -108.37 -26.09 10.67 Favored 'General case' 0 N--CA 1.477 0.915 0 CA-C-N 115.402 -0.817 . . . . 73.219999999999999 109.858 175.563 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 86.9 m-20 -77.41 153.46 33.63 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 115.39 -0.823 . . . . 64.040000000000006 111.504 -174.646 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 26.7 mt -125.74 175.93 7.27 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 124.439 1.096 . . . . 64.25 110.665 -179.226 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 32.1 m-85 -140.98 136.67 32.38 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 124.305 1.042 . . . . 71.109999999999999 109.905 177.457 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -152.98 131.67 12.33 Favored 'General case' 0 C--O 1.238 0.497 0 C-N-CA 124.651 1.18 . . . . 65.349999999999994 108.128 177.064 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 14.9 m -82.61 129.25 34.91 Favored 'General case' 0 CA--C 1.546 0.8 0 CA-C-N 116.267 -0.424 . . . . 70.519999999999996 109.974 -176.464 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 0.733 HD22 HD13 ' A' ' 251' ' ' LEU . 16.0 tp -107.79 111.05 23.02 Favored 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 108.758 -0.83 . . . . 71.040000000000006 108.758 -175.878 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -79.63 123.56 27.74 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 123.232 0.613 . . . . 74.200000000000003 109.412 176.147 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 6.4 p -142.36 128.95 10.94 Favored Pre-proline 0 CA--C 1.544 0.729 0 N-CA-C 108.675 -0.861 . . . . 73.25 108.675 179.308 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -72.04 159.24 50.62 Favored 'Trans proline' 0 C--N 1.366 1.498 0 C-N-CA 121.825 1.684 . . . . 73.099999999999994 111.185 170.711 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 201' ' ' ALA . . . . . 0.437 ' O ' HG23 ' A' ' 205' ' ' VAL . . . -50.61 -50.61 71.56 Favored Pre-proline 0 CA--C 1.556 1.201 0 CA-C-N 114.94 -1.027 . . . . 40.100000000000001 113.72 -178.526 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_endo -65.74 -35.82 34.99 Favored 'Trans proline' 0 C--N 1.385 2.469 0 C-N-CA 121.438 1.425 . . . . 71.450000000000003 114.697 -178.789 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 50.0 mt -68.88 -29.35 43.13 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.25 0 N-CA-C 110.163 -0.31 . . . . 75.230000000000004 110.163 176.812 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -70.96 -41.84 70.52 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 122.62 0.368 . . . . 63.200000000000003 111.313 175.448 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 205' ' ' VAL . . . . . 0.437 HG23 ' O ' ' A' ' 201' ' ' ALA . 85.4 t -64.59 -55.96 18.56 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.283 0 C-N-CA 123.864 0.866 . . . . 72.319999999999993 111.644 -179.06 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 25.2 m -76.41 -31.45 20.6 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 CA-C-O 120.635 0.255 . . . . 75.329999999999998 111.241 -176.966 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 82.84 64.17 1.69 Allowed Glycine 0 C--N 1.343 0.928 0 CA-C-N 115.903 -0.59 . . . . 44.009999999999998 111.836 -173.394 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -79.98 -134.29 1.22 Allowed Glycine 0 C--N 1.346 1.101 0 CA-C-O 119.752 -0.471 . . . . 72.430000000000007 111.96 177.072 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 48.4 mtmt -137.19 148.07 46.3 Favored 'General case' 0 N--CA 1.485 1.296 0 CA-C-N 117.711 0.756 . . . . 64.400000000000006 111.061 178.471 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 5.7 m -143.12 158.28 17.65 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 C-N-CA 125.169 1.387 . . . . 74.200000000000003 108.436 174.584 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 42.0 ttp-105 -94.9 113.38 25.1 Favored 'General case' 0 CA--C 1.544 0.732 0 CA-C-O 121.167 0.508 . . . . 65.549999999999997 110.781 -175.171 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -101.37 113.56 26.76 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 124.283 1.033 . . . . 63.299999999999997 109.469 175.786 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 39.9 ttm -88.67 116.88 27.24 Favored 'General case' 0 N--CA 1.477 0.882 0 CA-C-O 121.022 0.439 . . . . 74.349999999999994 110.018 -179.161 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 17.5 p -111.55 -171.78 1.91 Allowed 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 124.463 1.105 . . . . 53.439999999999998 110.062 -173.216 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 84.0 mt -63.59 -37.58 87.86 Favored 'General case' 0 N--CA 1.489 1.485 0 CA-C-O 121.133 0.492 . . . . 71.219999999999999 110.606 171.672 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -80.36 -11.46 59.7 Favored 'General case' 0 N--CA 1.476 0.845 0 CA-C-N 114.797 -1.092 . . . . 72.109999999999999 111.087 -174.362 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 123.09 -173.02 16.13 Favored Glycine 0 C--N 1.344 1.01 0 N-CA-C 111.447 -0.661 . . . . 62.149999999999999 111.447 -179.614 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -73.1 147.55 43.07 Favored 'Trans proline' 0 CA--C 1.552 1.376 0 C-N-CA 122.384 2.056 . . . . 74.209999999999994 111.978 177.527 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 3.8 p -139.78 131.36 33.19 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 N-CA-C 108.976 -0.75 . . . . 62.219999999999999 108.976 174.346 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -80.86 100.03 8.63 Favored 'General case' 0 C--O 1.239 0.508 0 N-CA-C 107.012 -1.477 . . . . 73.409999999999997 107.012 172.258 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 3.8 p -101.67 129.57 52.67 Favored 'Isoleucine or valine' 0 C--O 1.242 0.699 0 N-CA-C 108.602 -0.888 . . . . 73.420000000000002 108.602 -172.245 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -76.92 109.39 10.68 Favored 'General case' 0 C--O 1.236 0.386 0 C-N-CA 122.374 0.269 . . . . 75.150000000000006 110.523 -177.434 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 58.3 t -52.69 135.04 45.5 Favored Pre-proline 0 CA--C 1.55 0.943 0 O-C-N 124.478 1.111 . . . . 53.43 109.342 178.155 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 224' ' ' PRO . . . . . 0.401 ' HB2' ' HB2' ' A' ' 179' ' ' ALA . 29.4 Cg_endo -61.33 143.5 97.99 Favored 'Trans proline' 0 C--N 1.369 1.642 0 C-N-CA 121.763 1.642 . . . . 72.310000000000002 110.495 174.79 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 16.2 Cg_endo -60.35 132.22 42.63 Favored 'Trans proline' 0 C--N 1.37 1.677 0 C-N-CA 121.448 1.432 . . . . 43.229999999999997 110.759 175.828 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 65.9 mtm180 65.12 53.05 1.4 Allowed 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.939 1.296 . . . . 62.119999999999997 110.834 173.949 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 26.5 m -75.77 147.48 39.21 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-N 114.886 -1.052 . . . . 75.540000000000006 109.651 172.472 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 25.3 mp0 -117.65 145.11 44.6 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 108.301 -1.0 . . . . 62.329999999999998 108.301 175.082 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -58.91 134.03 56.57 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 123.684 0.794 . . . . 71.310000000000002 111.938 -176.201 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 97.07 -1.33 60.87 Favored Glycine 0 C--N 1.346 1.137 0 CA-C-O 119.079 -0.845 . . . . 63.530000000000001 113.934 178.772 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 80.8 mtt-85 -67.28 156.36 36.58 Favored 'General case' 0 N--CA 1.481 1.105 0 CA-C-N 117.862 0.831 . . . . 63.109999999999999 111.327 176.781 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 70.7 mmtt -119.86 98.93 6.34 Favored 'General case' 0 C--O 1.239 0.548 0 CA-C-N 114.416 -1.265 . . . . 72.200000000000003 108.995 -172.641 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 233' ' ' LEU . . . . . 0.633 ' HB2' ' HB2' ' A' ' 251' ' ' LEU . 8.6 mt -86.88 150.28 24.22 Favored 'General case' 0 CA--C 1.542 0.668 0 N-CA-C 107.978 -1.119 . . . . 54.030000000000001 107.978 178.105 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 47.2 ttt85 -124.25 108.66 12.49 Favored 'General case' 0 CA--C 1.551 1.017 0 CA-C-N 118.637 0.653 . . . . 55.439999999999998 110.736 -176.382 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 235' ' ' LEU . . . . . 0.549 HD22 ' CD1' ' A' ' 173' ' ' PHE . 11.9 mt -86.99 106.5 17.87 Favored 'General case' 0 C--N 1.352 0.702 0 C-N-CA 124.699 1.199 . . . . 74.329999999999998 110.524 179.45 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 236' ' ' LYS . . . . . 0.527 ' H ' ' HB3' ' A' ' 173' ' ' PHE . 12.8 mtmt -74.35 132.37 41.97 Favored 'General case' 0 CA--C 1.539 0.549 0 O-C-N 123.531 0.519 . . . . 61.409999999999997 112.229 -178.736 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 81.24 19.57 66.56 Favored Glycine 0 C--N 1.35 1.314 0 CA-C-N 114.711 -1.131 . . . . 55.43 113.818 -178.843 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 75.9 mmtt -122.27 13.21 10.32 Favored 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 122.981 0.512 . . . . 72.409999999999997 112.229 -175.124 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -124.32 -172.03 13.54 Favored Glycine 0 C--N 1.344 0.981 0 N-CA-C 111.243 -0.743 . . . . 75.219999999999999 111.243 173.9 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 60.5 m-85 -84.99 160.46 55.19 Favored Pre-proline 0 N--CA 1.485 1.317 0 C-N-CA 123.983 0.913 . . . . 73.420000000000002 112.171 -173.538 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 241' ' ' PRO . . . . . 0.485 ' HA ' ' O ' ' A' ' 245' ' ' GLY . 17.2 Cg_exo -68.53 148.64 73.22 Favored 'Trans proline' 0 C--N 1.376 1.983 0 C-N-CA 122.115 1.877 . . . . 74.129999999999995 112.395 169.72 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -173.2 -119.91 0.55 Allowed Glycine 0 C--N 1.35 1.335 0 CA-C-O 119.141 -0.811 . . . . 54.229999999999997 112.529 177.355 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 243' ' ' PRO . . . . . 0.559 ' HD2' ' HB3' ' A' ' 191' ' ' GLN . 44.8 Cg_endo -59.67 -65.59 0.08 OUTLIER 'Trans proline' 0 C--N 1.378 2.104 0 C-N-CA 124.587 3.525 . . . . 72.0 112.648 -172.651 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -90.7 20.54 4.61 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 123.168 0.587 . . . . 63.350000000000001 110.903 175.309 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 245' ' ' GLY . . . . . 0.485 ' O ' ' HA ' ' A' ' 241' ' ' PRO . . . 75.0 -96.92 0.99 Allowed Glycine 0 C--N 1.349 1.29 0 N-CA-C 110.47 -1.052 . . . . 53.350000000000001 110.47 -173.033 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 21.5 ttm180 -48.46 108.89 0.19 Allowed 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 124.57 1.148 . . . . 72.319999999999993 112.32 -178.238 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -88.52 156.21 26.61 Favored Glycine 0 C--O 1.249 1.091 0 N-CA-C 110.814 -0.915 . . . . 54.210000000000001 110.814 167.334 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 40.6 m-20 -130.57 155.2 46.92 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-O 120.912 0.386 . . . . 75.420000000000002 110.351 -173.297 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 249' ' ' LEU . . . . . 0.496 ' HB3' ' HB2' ' A' ' 235' ' ' LEU . 47.4 tp -98.01 138.08 35.87 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 123.925 0.89 . . . . 53.329999999999998 110.755 -173.165 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 250' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -98.89 113.51 25.69 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 122.808 0.443 . . . . 74.319999999999993 110.395 177.384 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 251' ' ' LEU . . . . . 0.733 HD13 HD22 ' A' ' 197' ' ' LEU . 82.7 mt -88.67 105.18 17.51 Favored 'General case' 0 C--O 1.241 0.646 0 N-CA-C 108.541 -0.911 . . . . 72.310000000000002 108.541 174.867 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -88.5 103.86 16.27 Favored 'General case' 0 C--O 1.239 0.528 0 N-CA-C 108.385 -0.969 . . . . 65.230000000000004 108.385 177.818 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 19.7 m -72.01 143.1 14.5 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 CA-C-O 121.29 0.567 . . . . 63.329999999999998 111.084 -172.18 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 19.0 mmt85 -130.39 101.18 5.63 Favored 'General case' 0 C--O 1.237 0.438 0 C-N-CA 124.228 1.011 . . . . 61.32 108.377 177.452 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 30.9 mt -78.89 124.14 36.84 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 O-C-N 123.893 0.745 . . . . 74.019999999999996 110.175 178.81 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 1.4 t . . . . . 0 CA--C 1.558 1.271 0 N-CA-C 107.513 -1.292 . . . . 71.340000000000003 107.513 173.797 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 24.7 ptm . . . . . 0 N--CA 1.484 1.226 0 CA-C-O 120.353 0.12 . . . . 72.129999999999995 110.681 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 169' ' ' GLN . . . . . 0.554 ' HG2' HG22 ' A' ' 170' ' ' THR . 33.6 tt0 -153.4 -90.03 0.05 OUTLIER 'General case' 0 CA--C 1.546 0.821 0 N-CA-C 108.613 -0.884 . . . . 61.329999999999998 108.613 -178.144 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 170' ' ' THR . . . . . 0.554 HG22 ' HG2' ' A' ' 169' ' ' GLN . 10.8 t 172.72 178.61 0.09 Allowed 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 125.371 1.469 . . . . 62.520000000000003 109.059 -174.314 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -151.95 -61.37 0.17 Allowed 'General case' 0 N--CA 1.478 0.931 0 CA-C-O 121.001 0.429 . . . . 61.009999999999998 110.143 -175.978 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 172' ' ' LEU . . . . . 0.479 HD21 ' O ' ' A' ' 222' ' ' ALA . 25.0 mt -138.78 154.05 48.47 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 124.07 0.948 . . . . 74.239999999999995 112.013 -175.039 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 173' ' ' PHE . . . . . 0.557 ' CD1' HD22 ' A' ' 235' ' ' LEU . 26.4 m-85 -136.78 -48.77 0.63 Allowed 'General case' 0 N--CA 1.477 0.879 0 CA-C-N 114.911 -1.041 . . . . 75.010000000000005 109.76 -169.578 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 174' ' ' TYR . . . . . 0.444 ' CD2' ' HB3' ' A' ' 233' ' ' LEU . 7.9 p90 -84.22 13.6 5.09 Favored 'General case' 0 N--CA 1.48 1.07 0 CA-C-N 114.824 -1.08 . . . . 74.019999999999996 113.087 -176.928 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 1.8 p -65.06 -10.58 31.29 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 123.107 0.563 . . . . 70.230000000000004 112.504 175.189 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 176' ' ' MET . . . . . . . . . . . . . 41.8 mtm -53.18 -42.11 65.9 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 124.316 1.047 . . . . 72.239999999999995 110.302 169.053 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 177' ' ' LYS . . . . . 0.443 ' NZ ' ' HB2' ' A' ' 177' ' ' LYS . 2.8 ttmp? -167.41 97.38 0.49 Allowed 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 124.709 1.204 . . . . 65.310000000000002 108.301 176.307 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 178' ' ' ALA . . . . . 0.472 ' HB1' ' HB3' ' A' ' 224' ' ' PRO . . . -109.38 146.3 34.65 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 124.149 0.98 . . . . 75.430000000000007 110.456 -175.738 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 179' ' ' ALA . . . . . 0.448 ' HB2' ' HB2' ' A' ' 224' ' ' PRO . . . 59.75 28.86 18.39 Favored 'General case' 0 N--CA 1.492 1.668 0 C-N-CA 124.388 1.075 . . . . 64.329999999999998 111.574 -174.362 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -89.9 144.59 17.76 Favored Glycine 0 C--N 1.348 1.25 0 CA-C-N 115.522 -0.763 . . . . 43.210000000000001 111.674 -179.578 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 39.2 p -73.22 144.63 46.68 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 123.25 0.62 . . . . 53.100000000000001 110.926 176.056 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . 95.04 -134.52 11.98 Favored Glycine 0 C--N 1.346 1.126 0 N-CA-C 111.617 -0.593 . . . . 62.130000000000003 111.617 -175.69 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 157.37 58.44 0.01 OUTLIER Glycine 0 C--N 1.338 0.648 0 N-CA-C 110.425 -1.07 . . . . 63.450000000000003 110.425 -178.391 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 21.6 m -52.36 113.97 1.21 Allowed 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 124.626 1.17 . . . . 65.549999999999997 111.973 -175.661 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 179.23 -78.59 0.06 OUTLIER Glycine 0 C--N 1.344 1.02 0 N-CA-C 110.917 -0.873 . . . . 51.520000000000003 110.917 -178.86 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 68.0 -85.2 0.17 Allowed Glycine 0 C--N 1.355 1.596 0 C-N-CA 123.319 0.485 . . . . 73.540000000000006 113.36 174.134 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 36.4 p -130.52 108.05 9.66 Favored 'General case' 0 C--O 1.242 0.691 0 C-N-CA 124.391 1.077 . . . . 44.539999999999999 108.764 176.7 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -91.56 -52.34 2.33 Favored Glycine 0 CA--C 1.529 0.925 0 CA-C-N 115.514 -0.766 . . . . 51.439999999999998 113.093 -177.307 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 152.83 54.17 0.01 OUTLIER Glycine 0 N--CA 1.477 1.399 0 CA-C-N 117.126 0.463 . . . . 73.230000000000004 112.127 179.851 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 46.2 m 63.0 10.53 4.48 Favored 'General case' 0 N--CA 1.49 1.553 0 C-N-CA 124.305 1.042 . . . . 65.530000000000001 112.093 -174.831 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 191' ' ' GLN . . . . . 0.688 ' HB2' ' HA2' ' A' ' 247' ' ' GLY . 3.4 pt20 -87.6 -21.97 25.04 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 124.556 1.143 . . . . 70.329999999999998 110.296 -177.147 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -76.53 148.28 37.21 Favored 'General case' 0 C--O 1.237 0.403 0 C-N-CA 125.05 1.34 . . . . 61.140000000000001 111.255 -162.939 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 193' ' ' LEU . . . . . 0.584 HD12 ' HA2' ' A' ' 239' ' ' GLY . 16.3 mt -143.87 170.97 14.89 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 123.607 0.763 . . . . 73.349999999999994 110.315 172.11 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 74.6 m-85 -135.74 141.58 44.87 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 124.146 0.978 . . . . 73.120000000000005 109.815 179.036 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 195' ' ' ALA . . . . . 0.473 ' HB2' HD11 ' A' ' 249' ' ' LEU . . . -154.23 132.77 12.09 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 123.787 0.835 . . . . 64.129999999999995 108.758 176.983 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 26.9 m -82.5 127.2 33.08 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.274 -0.639 . . . . 63.520000000000003 109.274 178.581 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 0.744 HD22 HD13 ' A' ' 251' ' ' LEU . 18.1 tp -105.54 107.42 18.4 Favored 'General case' 0 N--CA 1.465 0.306 0 N-CA-C 107.549 -1.278 . . . . 74.109999999999999 107.549 -179.469 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -77.81 123.57 26.89 Favored 'General case' 0 C--O 1.237 0.439 0 N-CA-C 107.828 -1.175 . . . . 71.120000000000005 107.828 174.072 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 199' ' ' VAL . . . . . 0.533 ' O ' ' HA ' ' A' ' 255' ' ' ILE . 2.8 p -141.62 125.6 10.1 Favored Pre-proline 0 CA--C 1.541 0.625 0 N-CA-C 108.205 -1.035 . . . . 73.209999999999994 108.205 -179.652 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -69.98 158.08 57.83 Favored 'Trans proline' 0 C--N 1.365 1.42 0 C-N-CA 122.048 1.832 . . . . 73.420000000000002 111.728 171.758 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -49.73 -50.32 67.92 Favored Pre-proline 0 CA--C 1.56 1.329 0 N-CA-C 114.001 1.111 . . . . 73.319999999999993 114.001 -178.769 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 202' ' ' PRO . . . . . 0.406 ' HA ' HG22 ' A' ' 205' ' ' VAL . 44.2 Cg_endo -63.48 -37.5 48.11 Favored 'Trans proline' 0 C--N 1.393 2.874 0 C-N-CA 122.115 1.877 . . . . 73.239999999999995 113.484 -178.507 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 38.3 mt -67.99 -36.11 74.34 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.173 0 CA-C-N 117.995 0.361 . . . . 71.299999999999997 110.448 176.102 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 204' ' ' ALA . . . . . 0.434 ' HA ' HG11 ' A' ' 223' ' ' VAL . . . -67.09 -41.78 85.72 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 123.06 0.544 . . . . 74.230000000000004 112.231 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 205' ' ' VAL . . . . . 0.406 HG22 ' HA ' ' A' ' 202' ' ' PRO . 20.9 m -77.81 -51.37 18.14 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.993 0 C-N-CA 123.472 0.709 . . . . 61.200000000000003 112.448 -175.592 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 206' ' ' VAL . . . . . 0.404 HG22 ' O ' ' A' ' 202' ' ' PRO . 7.9 m -73.4 -30.06 29.32 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.402 0 C-N-CA 122.357 0.263 . . . . 72.120000000000005 111.249 -178.961 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 89.66 63.09 1.29 Allowed Glycine 0 C--N 1.352 1.432 0 CA-C-N 116.216 -0.447 . . . . 44.149999999999999 112.373 -175.858 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -86.71 -139.09 5.52 Favored Glycine 0 C--N 1.352 1.429 0 CA-C-O 119.873 -0.404 . . . . 63.420000000000002 112.734 -179.833 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 46.4 mtmt -137.89 147.87 44.83 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 123.972 0.909 . . . . 73.299999999999997 110.287 178.012 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 5.2 m -140.81 166.34 18.93 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 C-N-CA 124.771 1.229 . . . . 73.200000000000003 109.807 174.475 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 29.0 ttp180 -90.06 113.91 25.71 Favored 'General case' 0 CA--C 1.546 0.827 0 C-N-CA 123.63 0.772 . . . . 74.310000000000002 109.843 -179.601 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -100.39 117.19 34.07 Favored 'General case' 0 C--O 1.24 0.562 0 N-CA-C 108.586 -0.894 . . . . 75.129999999999995 108.586 171.073 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 47.8 tpp -84.0 116.04 22.63 Favored 'General case' 0 C--O 1.241 0.637 0 N-CA-C 109.408 -0.59 . . . . 71.510000000000005 109.408 177.58 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 16.6 p -111.47 -173.67 2.3 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 124.59 1.156 . . . . 74.140000000000001 109.614 -176.515 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 56.2 mt -61.99 -36.09 80.45 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 122.986 0.514 . . . . 71.140000000000001 111.911 175.295 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 27.2 mt-10 -89.81 -8.65 51.59 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.721 0.808 . . . . 62.140000000000001 111.435 -172.452 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 124.39 -161.4 18.84 Favored Glycine 0 C--N 1.345 1.058 0 CA-C-O 119.282 -0.732 . . . . 62.450000000000003 111.458 -178.08 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -77.71 159.91 31.45 Favored 'Trans proline' 0 CA--C 1.549 1.257 0 C-N-CA 122.525 2.15 . . . . 65.439999999999998 112.794 -177.218 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 2.9 p -148.34 129.7 5.65 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 N-CA-C 108.674 -0.862 . . . . 73.319999999999993 108.674 171.02 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -76.81 100.29 5.44 Favored 'General case' 0 C--O 1.239 0.544 0 N-CA-C 107.478 -1.305 . . . . 75.219999999999999 107.478 169.613 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 9.1 p -100.34 128.36 52.41 Favored 'Isoleucine or valine' 0 C--O 1.245 0.845 0 N-CA-C 108.012 -1.107 . . . . 71.239999999999995 108.012 -176.417 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 222' ' ' ALA . . . . . 0.479 ' O ' HD21 ' A' ' 172' ' ' LEU . . . -77.85 105.19 8.87 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 116.466 -0.334 . . . . 74.299999999999997 110.648 -174.696 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 223' ' ' VAL . . . . . 0.434 HG11 ' HA ' ' A' ' 204' ' ' ALA . 62.6 t -53.8 133.03 56.9 Favored Pre-proline 0 N--CA 1.472 0.662 0 C-N-CA 124.13 0.972 . . . . 32.520000000000003 109.54 179.239 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 224' ' ' PRO . . . . . 0.472 ' HB3' ' HB1' ' A' ' 178' ' ' ALA . 30.8 Cg_endo -64.75 150.53 88.02 Favored 'Trans proline' 0 C--N 1.369 1.629 0 C-N-CA 121.327 1.352 . . . . 73.540000000000006 110.663 175.561 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -63.48 140.51 76.27 Favored 'Trans proline' 0 C--N 1.366 1.482 0 C-N-CA 121.452 1.435 . . . . 73.109999999999999 110.694 176.449 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 56.6 mtm180 64.79 42.44 4.54 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 124.248 1.019 . . . . 73.109999999999999 111.074 170.137 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 63.4 m -76.9 143.48 39.56 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-N 115.464 -0.789 . . . . 74.099999999999994 109.444 173.537 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 27.8 mp0 -117.22 143.84 45.44 Favored 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 124.144 0.978 . . . . 44.520000000000003 109.039 176.475 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -62.35 123.93 19.55 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 123.757 0.823 . . . . 73.099999999999994 110.628 -178.282 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 115.15 -6.5 21.52 Favored Glycine 0 C--N 1.338 0.659 0 O-C-N 123.75 0.656 . . . . 75.030000000000001 113.178 -175.34 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 95.2 mtt-85 -74.79 157.2 35.58 Favored 'General case' 0 N--CA 1.478 0.954 0 CA-C-N 117.634 0.717 . . . . 74.049999999999997 110.055 172.655 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 232' ' ' LYS . . . . . 0.451 ' HA ' ' O ' ' A' ' 251' ' ' LEU . 12.5 mtmm -131.42 120.95 23.76 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.269 0.628 . . . . 75.400000000000006 110.53 -179.681 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 233' ' ' LEU . . . . . 0.502 ' HB2' ' HB2' ' A' ' 251' ' ' LEU . 26.7 mt -101.99 154.31 19.08 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 125.138 1.375 . . . . 64.129999999999995 109.264 -176.274 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 15.1 ttm180 -111.99 110.87 21.41 Favored 'General case' 0 N--CA 1.48 1.065 0 CA-C-N 118.144 0.429 . . . . 64.519999999999996 111.099 -179.736 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 235' ' ' LEU . . . . . 0.59 ' HB2' ' HB3' ' A' ' 249' ' ' LEU . 11.2 mt -88.11 99.56 12.28 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 122.919 0.487 . . . . 61.0 110.023 172.014 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 236' ' ' LYS . . . . . 0.492 ' H ' ' HB3' ' A' ' 173' ' ' PHE . 11.7 mtmt -72.52 130.47 40.71 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 115.967 -0.56 . . . . 61.009999999999998 111.304 -179.789 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 83.69 21.11 58.57 Favored Glycine 0 C--N 1.344 0.995 0 CA-C-N 115.059 -0.973 . . . . 73.150000000000006 113.612 -178.182 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt -127.2 17.86 7.11 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 123.012 0.525 . . . . 61.219999999999999 111.329 -178.495 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 239' ' ' GLY . . . . . 0.584 ' HA2' HD12 ' A' ' 193' ' ' LEU . . . -118.81 -159.96 11.26 Favored Glycine 0 C--N 1.347 1.146 0 N-CA-C 111.278 -0.729 . . . . 55.420000000000002 111.278 170.256 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 60.4 m-85 -92.55 165.37 19.47 Favored Pre-proline 0 CA--C 1.553 1.061 0 C-N-CA 123.713 0.805 . . . . 71.349999999999994 110.376 -177.187 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 241' ' ' PRO . . . . . 0.437 ' HA ' ' O ' ' A' ' 245' ' ' GLY . 40.4 Cg_exo -61.17 166.25 11.19 Favored 'Trans proline' 0 C--N 1.374 1.877 0 C-N-CA 121.732 1.621 . . . . 54.32 113.473 170.333 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 167.32 -123.72 1.15 Allowed Glycine 0 CA--C 1.529 0.968 0 CA-C-O 118.874 -0.959 . . . . 70.109999999999999 111.862 177.209 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 243' ' ' PRO . . . . . 0.477 ' HD2' ' HB3' ' A' ' 191' ' ' GLN . 30.9 Cg_endo -59.68 -60.78 0.27 Allowed 'Trans proline' 0 C--N 1.379 2.136 0 C-N-CA 123.925 3.083 . . . . 70.019999999999996 112.976 -170.001 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -90.93 2.85 55.89 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 123.185 0.594 . . . . 74.409999999999997 111.43 177.373 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 245' ' ' GLY . . . . . 0.437 ' O ' ' HA ' ' A' ' 241' ' ' PRO . . . 85.35 -34.57 3.26 Favored Glycine 0 C--N 1.358 1.757 0 N-CA-C 112.319 -0.312 . . . . 51.450000000000003 112.319 -173.746 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 10.8 ttm180 -88.66 112.53 23.21 Favored 'General case' 0 CA--C 1.529 0.149 0 C-N-CA 124.79 1.236 . . . . 74.209999999999994 111.404 177.557 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 247' ' ' GLY . . . . . 0.688 ' HA2' ' HB2' ' A' ' 191' ' ' GLN . . . -84.31 163.57 39.37 Favored Glycine 0 C--N 1.345 1.074 0 C-N-CA 121.27 -0.491 . . . . 63.340000000000003 114.055 162.855 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 34.6 m-20 -132.65 143.79 49.9 Favored 'General case' 0 C--O 1.241 0.638 0 C-N-CA 123.866 0.866 . . . . 73.129999999999995 110.133 -169.063 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 249' ' ' LEU . . . . . 0.59 ' HB3' ' HB2' ' A' ' 235' ' ' LEU . 61.4 tp -106.98 117.86 35.18 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 124.361 1.065 . . . . 64.299999999999997 110.087 -177.084 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 250' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 -91.5 110.62 21.93 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 123.245 0.618 . . . . 74.230000000000004 110.034 -174.299 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 251' ' ' LEU . . . . . 0.744 HD13 HD22 ' A' ' 197' ' ' LEU . 74.6 mt -86.73 106.35 17.59 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 114.839 -1.073 . . . . 64.450000000000003 110.574 -175.037 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -79.63 97.07 6.37 Favored 'General case' 0 C--O 1.241 0.643 0 N-CA-C 108.439 -0.948 . . . . 62.020000000000003 108.439 173.746 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 4.6 m -69.42 130.35 34.16 Favored 'Isoleucine or valine' 0 C--O 1.244 0.776 0 CA-C-O 121.762 0.792 . . . . 72.040000000000006 110.251 -176.338 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 21.8 mmm180 -126.9 115.13 18.82 Favored 'General case' 0 C--O 1.237 0.44 0 N-CA-C 107.657 -1.238 . . . . 73.049999999999997 107.657 178.576 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 255' ' ' ILE . . . . . 0.533 ' HA ' ' O ' ' A' ' 199' ' ' VAL . 49.0 mt -98.82 111.88 29.53 Favored 'Isoleucine or valine' 0 C--O 1.24 0.589 0 O-C-N 123.574 0.546 . . . . 71.200000000000003 110.443 -175.09 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 3.1 t . . . . . 0 CA--C 1.56 1.34 0 CA-C-N 115.523 -0.762 . . . . 74.420000000000002 108.984 177.276 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 168' ' ' MET . . . . . 0.417 ' N ' ' SD ' ' A' ' 168' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.482 1.13 0 N-CA-C 111.746 0.276 . . . . 75.239999999999995 111.746 . . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 10.2 pt20 -138.07 169.1 18.37 Favored 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 123.246 0.618 . . . . 73.25 110.534 176.507 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 10.5 t -95.39 158.5 15.43 Favored 'General case' 0 CA--C 1.551 0.999 0 C-N-CA 123.927 0.891 . . . . 71.030000000000001 109.264 174.281 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -115.98 -84.45 0.63 Allowed 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 123.523 0.729 . . . . 71.530000000000001 111.53 -173.5 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 172' ' ' LEU . . . . . 0.485 HD21 ' HB3' ' A' ' 222' ' ' ALA . 77.5 mt -126.33 155.9 41.28 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 124.071 0.949 . . . . 74.450000000000003 111.654 -163.768 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 173' ' ' PHE . . . . . 0.435 ' CD1' HD22 ' A' ' 235' ' ' LEU . 45.4 m-85 -144.59 -66.95 0.33 Allowed 'General case' 0 N--CA 1.486 1.336 0 N-CA-C 109.391 -0.596 . . . . 75.519999999999996 109.391 -166.545 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 174' ' ' TYR . . . . . 0.478 ' CD2' ' HB3' ' A' ' 233' ' ' LEU . 7.7 p90 -64.77 -13.24 54.49 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 123.841 0.857 . . . . 75.340000000000003 112.301 177.655 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 175' ' ' THR . . . . . 0.456 HG21 HD13 ' A' ' 172' ' ' LEU . 4.2 m -65.73 0.97 1.45 Allowed 'General case' 0 CA--C 1.565 1.535 0 C-N-CA 125.133 1.373 . . . . 73.519999999999996 112.217 -178.154 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 176' ' ' MET . . . . . . . . . . . . . 37.3 mtm -64.85 -59.88 3.7 Favored 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 123.604 0.762 . . . . 75.030000000000001 109.148 161.543 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.98 100.32 3.38 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 124.477 1.111 . . . . 63.310000000000002 108.651 175.024 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -109.44 -178.38 3.54 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 124.194 0.998 . . . . 61.229999999999997 111.612 -170.169 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . 62.14 -91.05 0.03 OUTLIER 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 125.088 1.355 . . . . 72.129999999999995 111.044 -177.43 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -136.51 29.9 2.74 Favored Glycine 0 N--CA 1.469 0.877 0 N-CA-C 112.461 -0.256 . . . . 73.540000000000006 112.461 -178.225 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 24.5 m -98.43 14.24 28.82 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 123.717 0.807 . . . . 65.439999999999998 110.87 178.262 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -170.38 164.61 37.9 Favored Glycine 0 C--N 1.345 1.077 0 CA-C-N 116.089 -0.505 . . . . 43.32 111.86 -178.878 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 175.76 -43.64 0.12 Allowed Glycine 0 C--N 1.345 1.058 0 N-CA-C 112.011 -0.436 . . . . 71.510000000000005 112.011 178.871 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 33.3 t -70.08 112.39 6.43 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 123.114 0.566 . . . . 61.009999999999998 110.575 -178.858 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 185' ' ' GLY . . . . . 0.534 ' HA2' HH22 ' A' ' 234' ' ' ARG . . . -76.55 -47.4 10.29 Favored Glycine 0 C--N 1.351 1.365 0 O-C-N 123.438 0.461 . . . . 42.399999999999999 113.103 -178.078 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 72.52 43.92 42.9 Favored Glycine 0 C--N 1.35 1.316 0 O-C-N 123.668 0.276 . . . . 61.409999999999997 112.592 -176.851 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 48.2 t -109.11 160.93 15.66 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 124.097 0.959 . . . . 54.439999999999998 111.594 -175.2 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -146.85 -35.18 0.06 OUTLIER Glycine 0 C--N 1.35 1.339 0 CA-C-N 115.745 -0.661 . . . . 32.229999999999997 112.274 179.152 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -87.51 11.1 67.01 Favored Glycine 0 C--N 1.353 1.496 0 CA-C-O 119.338 -0.701 . . . . 55.549999999999997 114.056 -177.371 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 50.4 m 60.32 65.39 1.08 Allowed 'General case' 0 C--N 1.358 0.942 0 C-N-CA 124.086 0.954 . . . . 65.450000000000003 112.131 178.255 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 191' ' ' GLN . . . . . 0.621 ' HB3' ' HD2' ' A' ' 243' ' ' PRO . 9.9 pt20 -89.81 -22.85 21.9 Favored 'General case' 0 N--CA 1.478 0.962 0 CA-C-N 115.862 -0.608 . . . . 73.409999999999997 110.347 174.629 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -77.56 157.58 30.26 Favored 'General case' 0 C--O 1.241 0.617 0 CA-C-N 115.091 -0.959 . . . . 71.219999999999999 110.904 -168.539 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 32.7 mt -134.25 171.13 14.68 Favored 'General case' 0 C--O 1.239 0.529 0 CA-C-N 114.284 -1.325 . . . . 70.219999999999999 108.69 176.282 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 59.6 m-85 -136.49 126.63 26.24 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 123.768 0.827 . . . . 53.43 110.317 -177.165 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 195' ' ' ALA . . . . . 0.414 ' O ' ' HA ' ' A' ' 251' ' ' LEU . . . -141.65 130.66 23.21 Favored 'General case' 0 N--CA 1.466 0.344 0 N-CA-C 107.951 -1.129 . . . . 74.129999999999995 107.951 175.636 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 30.4 m -83.07 127.78 33.89 Favored 'General case' 0 C--O 1.24 0.559 0 N-CA-C 108.577 -0.897 . . . . 73.209999999999994 108.577 176.865 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 0.724 HD22 HD13 ' A' ' 251' ' ' LEU . 16.7 tp -106.35 110.05 22.17 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 108.331 -0.989 . . . . 72.540000000000006 108.331 -178.974 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -80.72 118.42 22.25 Favored 'General case' 0 C--O 1.238 0.475 0 N-CA-C 108.233 -1.025 . . . . 74.299999999999997 108.233 -179.817 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 5.1 p -136.89 128.45 16.74 Favored Pre-proline 0 CA--C 1.543 0.691 0 N-CA-C 108.948 -0.76 . . . . 74.439999999999998 108.948 -176.28 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 200' ' ' PRO . . . . . 0.432 ' HB2' ' HD2' ' A' ' 202' ' ' PRO . 62.0 Cg_endo -69.69 158.25 57.72 Favored 'Trans proline' 0 C--N 1.365 1.404 0 C-N-CA 121.924 1.749 . . . . 74.319999999999993 111.246 172.717 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 201' ' ' ALA . . . . . 0.51 ' O ' HG23 ' A' ' 205' ' ' VAL . . . -47.34 -54.8 19.16 Favored Pre-proline 0 CA--C 1.562 1.417 0 CA-C-O 117.547 -1.216 . . . . 72.540000000000006 113.044 179.88 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 202' ' ' PRO . . . . . 0.432 ' HD2' ' HB2' ' A' ' 200' ' ' PRO . 52.9 Cg_endo -64.74 -37.25 36.85 Favored 'Trans proline' 0 C--N 1.4 3.289 0 C-N-CA 121.9 1.733 . . . . 71.310000000000002 113.323 -174.124 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 44.1 mt -65.67 -34.64 71.7 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 C-N-CA 122.54 0.336 . . . . 72.340000000000003 110.141 177.604 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -70.53 -39.75 73.86 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 122.518 0.327 . . . . 65.310000000000002 111.093 177.277 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 205' ' ' VAL . . . . . 0.51 HG23 ' O ' ' A' ' 201' ' ' ALA . 83.9 t -67.44 -56.43 13.41 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 C-N-CA 123.565 0.746 . . . . 74.340000000000003 111.193 -177.852 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 10.5 m -82.06 -29.49 9.68 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 CA-C-N 116.002 -0.544 . . . . 70.25 111.455 -172.821 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 88.5 65.43 1.31 Allowed Glycine 0 C--N 1.345 1.074 0 CA-C-N 116.093 -0.503 . . . . 73.209999999999994 112.129 -174.875 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -87.11 -134.69 4.18 Favored Glycine 0 C--N 1.357 1.726 0 N-CA-C 111.794 -0.523 . . . . 44.539999999999999 111.794 177.957 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 46.6 mtmt -136.61 154.93 50.53 Favored 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 123.524 0.729 . . . . 61.340000000000003 110.908 178.602 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 6.3 m -144.94 169.66 7.77 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 C-N-CA 125.597 1.559 . . . . 72.510000000000005 108.473 172.319 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 56.0 ttp180 -104.23 119.43 38.94 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 123.573 0.749 . . . . 65.430000000000007 109.499 177.487 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -103.57 141.08 36.63 Favored 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 123.894 0.878 . . . . 74.400000000000006 109.667 175.402 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 46.9 tpp -100.27 128.32 46.37 Favored 'General case' 0 N--CA 1.475 0.808 0 N-CA-C 109.179 -0.675 . . . . 75.230000000000004 109.179 178.389 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 19.6 p -129.27 -171.68 2.55 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 123.818 0.847 . . . . 51.009999999999998 110.52 -171.55 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 91.9 mt -62.18 -27.75 69.18 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 123.831 0.853 . . . . 44.420000000000002 111.839 173.869 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -99.49 6.48 45.89 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 123.573 0.749 . . . . 70.120000000000005 111.52 -179.464 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 94.48 -153.42 20.99 Favored Glycine 0 C--N 1.347 1.146 0 CA-C-O 119.589 -0.562 . . . . 61.119999999999997 112.655 -177.807 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_endo -70.35 153.4 66.26 Favored 'Trans proline' 0 C--N 1.37 1.672 0 C-N-CA 122.582 2.188 . . . . 72.109999999999999 113.25 -174.489 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 4.6 p -145.52 135.81 18.74 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 C-N-CA 124.368 1.067 . . . . 74.109999999999999 109.048 174.245 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -83.6 104.23 13.56 Favored 'General case' 0 C--O 1.239 0.546 0 N-CA-C 107.883 -1.154 . . . . 71.019999999999996 107.883 172.659 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 2.9 p -114.39 126.07 71.84 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.018 0 N-CA-C 109.41 -0.589 . . . . 62.43 109.41 -174.476 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 222' ' ' ALA . . . . . 0.485 ' HB3' HD21 ' A' ' 172' ' ' LEU . . . -78.82 108.43 12.26 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 123.39 0.676 . . . . 55.549999999999997 110.69 -179.333 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 84.7 t -55.46 136.17 70.01 Favored Pre-proline 0 N--CA 1.478 0.961 0 C-N-CA 124.754 1.222 . . . . 71.329999999999998 109.857 177.12 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -66.31 159.4 50.26 Favored 'Trans proline' 0 C--N 1.373 1.839 0 C-N-CA 121.711 1.607 . . . . 63.509999999999998 111.455 174.835 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -69.28 153.13 71.62 Favored 'Trans proline' 0 C--N 1.365 1.428 0 C-N-CA 121.544 1.496 . . . . 73.109999999999999 111.08 171.917 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 39.7 mtm180 60.69 34.41 20.0 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 124.773 1.229 . . . . 65.340000000000003 111.578 172.702 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 227' ' ' THR . . . . . 0.518 ' O ' HD11 ' A' ' 255' ' ' ILE . 85.4 m -73.73 120.78 19.8 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 115.049 -0.978 . . . . 62.350000000000001 109.547 175.52 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 228' ' ' GLN . . . . . 0.436 ' H ' ' NE ' ' A' ' 231' ' ' ARG . 1.2 mp0 -102.59 147.86 26.27 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 124.414 1.086 . . . . 72.140000000000001 109.035 177.908 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 229' ' ' ALA . . . . . 0.445 ' HB2' ' HB ' ' A' ' 255' ' ' ILE . . . -59.21 115.03 2.92 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 123.81 0.844 . . . . 71.519999999999996 111.274 -177.237 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 113.42 0.2 24.94 Favored Glycine 0 C--N 1.343 0.97 0 O-C-N 123.685 0.616 . . . . 43.43 113.599 -178.97 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 231' ' ' ARG . . . . . 0.436 ' NE ' ' H ' ' A' ' 228' ' ' GLN . 87.5 mtt-85 -65.72 150.77 47.95 Favored 'General case' 0 N--CA 1.486 1.36 0 CA-C-N 117.591 0.696 . . . . 63.420000000000002 110.478 173.471 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 71.7 mmtt -118.67 102.22 8.69 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 124.097 0.959 . . . . 74.120000000000005 109.488 -171.936 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 233' ' ' LEU . . . . . 0.776 ' HB2' ' HB2' ' A' ' 251' ' ' LEU . 58.7 mt -88.89 152.21 21.87 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 115.415 -0.812 . . . . 71.310000000000002 109.534 178.344 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 234' ' ' ARG . . . . . 0.534 HH22 ' HA2' ' A' ' 185' ' ' GLY . 38.6 ttm-85 -119.32 121.12 38.87 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.512 0.725 . . . . 62.439999999999998 110.902 -174.673 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 235' ' ' LEU . . . . . 0.64 ' HB2' ' HB3' ' A' ' 249' ' ' LEU . 16.0 mt -110.43 100.38 9.23 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 122.464 0.306 . . . . 71.140000000000001 110.662 176.874 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 236' ' ' LYS . . . . . 0.563 ' HB3' ' HD2' ' A' ' 246' ' ' ARG . 13.2 mttp -69.13 139.84 54.71 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 110.345 -0.243 . . . . 63.229999999999997 110.345 173.323 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 86.85 -3.13 87.22 Favored Glycine 0 N--CA 1.473 1.11 0 CA-C-N 115.757 -0.656 . . . . 72.0 113.193 179.857 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -112.79 5.25 17.45 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 123.573 0.749 . . . . 70.530000000000001 111.061 -179.085 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -113.35 -173.82 18.77 Favored Glycine 0 C--N 1.347 1.184 0 N-CA-C 110.997 -0.841 . . . . 52.039999999999999 110.997 164.584 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 93.8 m-85 -91.56 160.98 35.51 Favored Pre-proline 0 N--CA 1.483 1.216 0 C-N-CA 123.84 0.856 . . . . 70.150000000000006 110.331 -178.988 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_exo -62.07 158.69 37.81 Favored 'Trans proline' 0 C--N 1.374 1.881 0 C-N-CA 122.136 1.891 . . . . 73.519999999999996 112.951 173.724 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 169.19 -128.12 1.62 Allowed Glycine 0 C--N 1.349 1.251 0 CA-C-O 118.766 -1.019 . . . . 65.340000000000003 112.307 176.113 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 243' ' ' PRO . . . . . 0.621 ' HD2' ' HB3' ' A' ' 191' ' ' GLN . 18.6 Cg_endo -52.62 -49.66 16.73 Favored 'Trans proline' 0 C--N 1.38 2.199 0 C-N-CA 124.96 3.773 . . . . 60.509999999999998 113.826 -173.963 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -95.92 -1.83 48.45 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.295 0.638 . . . . 53.119999999999997 111.69 -179.024 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 90.01 -37.76 3.31 Favored Glycine 0 C--N 1.352 1.438 0 CA-C-O 120.955 0.197 . . . . 62.409999999999997 113.014 178.1 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 246' ' ' ARG . . . . . 0.563 ' HD2' ' HB3' ' A' ' 236' ' ' LYS . 16.5 ttm180 -120.38 111.73 18.12 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 124.17 0.988 . . . . 72.310000000000002 108.593 178.831 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -69.3 155.12 53.44 Favored Glycine 0 C--O 1.25 1.133 0 O-C-N 123.504 0.503 . . . . 74.430000000000007 114.255 178.289 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 248' ' ' ASP . . . . . 0.453 ' HB3' ' HG3' ' A' ' 234' ' ' ARG . 40.3 m-20 -112.19 138.87 48.26 Favored 'General case' 0 C--O 1.225 -0.224 0 CA-C-N 114.152 -1.024 . . . . 73.430000000000007 109.591 -173.446 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 249' ' ' LEU . . . . . 0.64 ' HB3' ' HB2' ' A' ' 235' ' ' LEU . 44.4 tp -100.12 117.58 34.67 Favored 'General case' 0 C--O 1.238 0.485 0 N-CA-C 108.088 -1.078 . . . . 75.040000000000006 108.088 172.051 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 250' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -88.56 108.95 19.69 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 123.651 0.78 . . . . 74.540000000000006 108.898 -176.419 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 251' ' ' LEU . . . . . 0.776 ' HB2' ' HB2' ' A' ' 233' ' ' LEU . 85.6 mt -88.38 104.83 17.14 Favored 'General case' 0 C--O 1.24 0.566 0 N-CA-C 108.135 -1.061 . . . . 73.310000000000002 108.135 178.281 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -84.36 101.87 12.3 Favored 'General case' 0 C--O 1.241 0.647 0 N-CA-C 107.864 -1.161 . . . . 72.340000000000003 107.864 175.222 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 11.2 m -69.45 139.31 20.57 Favored 'Isoleucine or valine' 0 C--O 1.244 0.772 0 O-C-N 123.87 0.731 . . . . 75.310000000000002 110.03 -175.774 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 14.4 mmt85 -128.18 105.63 8.5 Favored 'General case' 0 C--O 1.238 0.487 0 C-N-CA 124.073 0.949 . . . . 70.340000000000003 108.608 178.977 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 255' ' ' ILE . . . . . 0.518 HD11 ' O ' ' A' ' 227' ' ' THR . 34.0 mt -76.4 123.95 33.7 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 O-C-N 123.932 0.77 . . . . 74.099999999999994 109.615 178.582 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 1.8 t . . . . . 0 CA--C 1.554 1.104 0 N-CA-C 107.426 -1.324 . . . . 71.030000000000001 107.426 178.773 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 28.1 ttt . . . . . 0 N--CA 1.481 1.093 0 N-CA-C 108.94 -0.763 . . . . 34.509999999999998 108.94 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 28.3 pt20 -142.84 167.22 22.58 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 124.013 0.925 . . . . 74.120000000000005 110.598 -171.226 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 8.9 t -65.02 160.07 21.71 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 124.095 0.958 . . . . 71.430000000000007 111.19 177.534 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 18.9 m-20 -83.92 -89.38 0.09 Allowed 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 123.189 0.595 . . . . 65.010000000000005 110.464 -179.273 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 172' ' ' LEU . . . . . 0.756 HD21 ' H ' ' A' ' 222' ' ' ALA . 59.9 mt -146.94 153.95 40.69 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 124.484 1.114 . . . . 71.120000000000005 110.449 -167.978 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 173' ' ' PHE . . . . . 0.422 ' CD1' HD22 ' A' ' 235' ' ' LEU . 40.1 m-85 -125.8 -52.26 1.57 Allowed 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 123.927 0.891 . . . . 75.099999999999994 108.638 -176.106 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 174' ' ' TYR . . . . . . . . . . . . . 17.3 p90 -68.93 -2.67 10.32 Favored 'General case' 0 C--N 1.345 0.388 0 CA-C-N 113.894 -1.503 . . . . 72.310000000000002 114.198 -174.241 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 2.4 p -57.71 -16.06 9.8 Favored 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 123.775 0.83 . . . . 74.530000000000001 112.62 173.15 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 176' ' ' MET . . . . . . . . . . . . . 9.4 ptm -52.57 -40.75 62.93 Favored 'General case' 0 CA--C 1.56 1.359 0 C-N-CA 123.988 0.915 . . . . 72.109999999999999 111.825 167.519 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 46.5 tptt -153.78 48.28 0.65 Allowed 'General case' 0 N--CA 1.479 1.006 0 CA-C-O 122.019 0.914 . . . . 72.5 109.438 -177.523 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 178' ' ' ALA . . . . . 0.524 ' HB1' ' HB3' ' A' ' 224' ' ' PRO . . . -74.41 131.89 41.48 Favored 'General case' 0 N--CA 1.478 0.958 0 CA-C-N 115.21 -0.904 . . . . 75.340000000000003 110.62 -178.271 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 179' ' ' ALA . . . . . 0.477 ' HB2' ' HB2' ' A' ' 224' ' ' PRO . . . 69.54 14.09 8.3 Favored 'General case' 0 N--CA 1.492 1.639 0 C-N-CA 124.888 1.275 . . . . 74.030000000000001 111.448 -171.838 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -94.75 -169.04 36.8 Favored Glycine 0 C--N 1.352 1.452 0 N-CA-C 110.851 -0.9 . . . . 54.450000000000003 110.851 171.518 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 33.3 p -91.56 16.11 11.11 Favored 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 123.427 0.691 . . . . 74.400000000000006 111.28 176.793 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . 94.87 -60.93 1.68 Allowed Glycine 0 C--N 1.35 1.347 0 C-N-CA 123.182 0.42 . . . . 74.230000000000004 112.071 176.766 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 121.38 139.25 5.64 Favored Glycine 0 C--N 1.346 1.086 0 N-CA-C 111.646 -0.582 . . . . 61.299999999999997 111.646 179.26 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 15.4 m -59.54 98.06 0.04 OUTLIER 'General case' 0 CA--C 1.55 0.967 0 C-N-CA 124.249 1.02 . . . . 75.450000000000003 110.666 -179.001 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -88.9 148.93 20.57 Favored Glycine 0 C--N 1.345 1.041 0 N-CA-C 111.427 -0.669 . . . . 54.5 111.427 176.715 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -142.38 41.02 1.23 Allowed Glycine 0 C--N 1.339 0.7 0 N-CA-C 110.997 -0.841 . . . . 74.200000000000003 110.997 179.102 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 29.9 m -64.04 115.09 4.59 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 123.586 0.754 . . . . 72.109999999999999 110.307 -177.209 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -59.36 -72.81 0.55 Allowed Glycine 0 C--N 1.36 1.887 0 O-C-N 123.952 0.782 . . . . 74.349999999999994 112.807 -177.04 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -68.95 152.71 52.5 Favored Glycine 0 C--N 1.347 1.181 0 N-CA-C 111.18 -0.768 . . . . 41.420000000000002 111.18 170.347 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 26.9 t -78.99 77.15 5.46 Favored 'General case' 0 CA--C 1.55 0.953 0 CA-C-O 121.682 0.753 . . . . 54.020000000000003 109.861 -179.427 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 191' ' ' GLN . . . . . 0.582 ' HB3' ' HD2' ' A' ' 243' ' ' PRO . 10.5 pt20 -86.14 -20.88 27.99 Favored 'General case' 0 N--CA 1.48 1.031 0 CA-C-N 114.983 -1.008 . . . . 65.109999999999999 110.209 175.755 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -76.83 150.16 36.13 Favored 'General case' 0 C--O 1.241 0.657 0 CA-C-N 114.971 -1.013 . . . . 55.109999999999999 110.304 -171.031 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 193' ' ' LEU . . . . . 0.41 HD12 ' HA2' ' A' ' 239' ' ' GLY . 29.5 mt -128.82 168.2 16.25 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 124.549 1.14 . . . . 64.430000000000007 109.4 177.872 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 71.6 m-85 -126.17 140.56 52.47 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 123.621 0.768 . . . . 75.329999999999998 109.731 179.125 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 195' ' ' ALA . . . . . 0.493 ' HB2' HD11 ' A' ' 249' ' ' LEU . . . -153.32 129.59 10.5 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 108.09 -1.078 . . . . 65.409999999999997 108.09 177.974 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 18.0 m -85.22 125.2 32.67 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 109.237 -0.653 . . . . 75.230000000000004 109.237 177.752 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 0.511 HD22 HD13 ' A' ' 251' ' ' LEU . 20.7 tp -106.54 109.13 20.95 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 108.382 -0.97 . . . . 63.43 108.382 -178.878 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -78.04 127.51 32.43 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 123.388 0.675 . . . . 51.409999999999997 109.416 177.285 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 199' ' ' VAL . . . . . 0.479 ' O ' ' HA ' ' A' ' 255' ' ' ILE . 3.3 p -142.75 124.68 8.72 Favored Pre-proline 0 CA--C 1.543 0.693 0 C-N-CA 123.585 0.754 . . . . 53.140000000000001 108.971 178.767 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -67.36 153.35 77.17 Favored 'Trans proline' 0 C--N 1.368 1.588 0 C-N-CA 122.146 1.897 . . . . 55.140000000000001 111.805 171.545 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -47.91 -49.53 58.08 Favored Pre-proline 0 CA--C 1.562 1.431 0 N-CA-C 114.433 1.271 . . . . 73.219999999999999 114.433 -176.654 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 202' ' ' PRO . . . . . 0.429 ' O ' HG22 ' A' ' 206' ' ' VAL . 54.2 Cg_endo -66.17 -38.71 20.48 Favored 'Trans proline' 0 C--N 1.393 2.908 0 C-N-CA 121.603 1.535 . . . . 73.329999999999998 112.701 -179.333 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 29.6 mt -65.06 -32.28 57.59 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.139 0 CA-C-N 118.348 0.522 . . . . 52.240000000000002 110.209 177.343 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -68.05 -48.73 64.82 Favored 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 122.994 0.518 . . . . 61.030000000000001 111.612 179.004 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 205' ' ' VAL . . . . . 0.42 HG22 ' HA ' ' A' ' 202' ' ' PRO . 17.6 m -71.82 -50.56 37.55 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.848 0 C-N-CA 123.243 0.617 . . . . 71.219999999999999 112.238 -177.67 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 206' ' ' VAL . . . . . 0.429 HG22 ' O ' ' A' ' 202' ' ' PRO . 4.5 m -74.4 -25.96 19.94 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.2 0 C-N-CA 122.746 0.419 . . . . 74.430000000000007 111.504 -177.699 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 80.09 70.02 1.36 Allowed Glycine 0 C--N 1.345 1.047 0 O-C-N 123.312 0.382 . . . . 64.450000000000003 112.181 -177.59 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -93.44 -131.4 5.91 Favored Glycine 0 C--N 1.35 1.348 0 C-N-CA 123.152 0.406 . . . . 73.230000000000004 112.267 179.208 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 209' ' ' LYS . . . . . 0.49 ' HG2' ' HA ' ' A' ' 222' ' ' ALA . 47.4 mtmt -138.26 156.53 47.58 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 123.865 0.866 . . . . 73.409999999999997 111.199 177.564 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 9.6 m -147.61 167.18 5.16 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.1 0 C-N-CA 125.519 1.528 . . . . 73.150000000000006 108.972 173.332 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 58.6 ttp180 -99.8 119.09 37.62 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 123.096 0.558 . . . . 75.510000000000005 110.557 178.918 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -101.58 131.15 47.93 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 124.409 1.084 . . . . 54.420000000000002 110.16 176.28 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 50.5 tpp -94.7 129.93 41.41 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 123.22 0.608 . . . . 75.409999999999997 109.59 177.389 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 17.3 p -126.48 -172.48 2.64 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 124.199 1.0 . . . . 63.329999999999998 109.747 -175.141 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 80.3 mt -61.92 -37.44 84.68 Favored 'General case' 0 N--CA 1.482 1.135 0 CA-C-O 121.133 0.492 . . . . 72.040000000000006 110.875 171.063 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -92.05 10.66 28.2 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 124.253 1.021 . . . . 74.219999999999999 111.677 -173.163 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 101.67 -158.84 18.53 Favored Glycine 0 C--N 1.351 1.4 0 CA-C-O 119.504 -0.609 . . . . 61.32 112.348 178.403 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -80.46 154.31 21.16 Favored 'Trans proline' 0 C--N 1.368 1.561 0 C-N-CA 122.728 2.285 . . . . 63.130000000000003 112.843 -177.584 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 4.2 p -150.8 129.18 2.75 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 N-CA-C 108.328 -0.99 . . . . 74.140000000000001 108.328 175.498 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -85.34 103.24 14.08 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 108.982 -0.747 . . . . 70.209999999999994 108.982 -178.872 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 15.9 m -97.78 137.91 24.04 Favored 'Isoleucine or valine' 0 C--O 1.241 0.623 0 C-N-CA 123.669 0.787 . . . . 54.509999999999998 110.442 -176.929 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 222' ' ' ALA . . . . . 0.756 ' H ' HD21 ' A' ' 172' ' ' LEU . . . -84.46 104.79 14.77 Favored 'General case' 0 C--O 1.243 0.722 0 CA-C-N 115.159 -0.928 . . . . 72.530000000000001 110.451 -179.016 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 66.5 t -54.7 129.8 64.16 Favored Pre-proline 0 N--CA 1.475 0.792 0 C-N-CA 124.771 1.228 . . . . 70.409999999999997 109.669 -179.223 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 224' ' ' PRO . . . . . 0.524 ' HB3' ' HB1' ' A' ' 178' ' ' ALA . 28.6 Cg_endo -62.13 154.79 60.19 Favored 'Trans proline' 0 C--N 1.369 1.656 0 C-N-CA 121.914 1.742 . . . . 71.140000000000001 111.514 176.035 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -67.13 143.9 67.03 Favored 'Trans proline' 0 C--N 1.364 1.361 0 C-N-CA 121.152 1.234 . . . . 70.299999999999997 111.28 173.453 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 75.3 mtt180 65.61 38.41 5.44 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 124.726 1.21 . . . . 64.209999999999994 111.752 172.888 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 55.5 m -74.95 137.95 41.97 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 122.973 0.509 . . . . 75.329999999999998 110.45 175.694 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 26.8 mp0 -113.63 146.56 39.57 Favored 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 124.055 0.942 . . . . 74.150000000000006 109.994 175.169 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -58.94 119.79 7.88 Favored 'General case' 0 C--N 1.354 0.799 0 C-N-CA 124.276 1.03 . . . . 62.100000000000001 111.051 -178.788 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 114.11 -5.06 23.75 Favored Glycine 0 N--CA 1.466 0.689 0 O-C-N 123.834 0.709 . . . . 73.030000000000001 112.711 -178.883 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 85.9 mtt-85 -70.36 148.5 48.35 Favored 'General case' 0 C--N 1.358 0.976 0 CA-C-N 117.654 0.727 . . . . 72.349999999999994 109.333 172.411 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 41.2 mtmt -125.19 116.1 21.47 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 121.547 0.689 . . . . 73.510000000000005 109.599 -175.213 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 233' ' ' LEU . . . . . 0.639 ' HB2' ' HB2' ' A' ' 251' ' ' LEU . 56.7 mt -93.45 141.2 28.73 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 114.211 -1.358 . . . . 54.25 108.575 -177.887 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 14.5 ttp180 -109.26 112.44 24.59 Favored 'General case' 0 N--CA 1.474 0.774 0 O-C-N 122.055 -0.403 . . . . 72.430000000000007 111.264 -172.02 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 235' ' ' LEU . . . . . 0.593 ' HB2' ' HB3' ' A' ' 249' ' ' LEU . 12.9 mt -102.07 107.54 18.68 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.542 0.737 . . . . 73.450000000000003 110.432 176.228 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 236' ' ' LYS . . . . . 0.521 ' HB3' ' HD2' ' A' ' 246' ' ' ARG . 40.9 mttm -76.52 151.9 36.22 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-O 120.999 0.428 . . . . 75.439999999999998 110.556 172.14 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 77.21 -6.9 40.37 Favored Glycine 0 N--CA 1.476 1.365 0 CA-C-N 115.47 -0.787 . . . . 55.130000000000003 113.908 -177.98 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 72.8 mmtt -104.12 -7.56 20.11 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 123.748 0.819 . . . . 74.530000000000001 110.077 -179.695 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 239' ' ' GLY . . . . . 0.41 ' HA2' HD12 ' A' ' 193' ' ' LEU . . . -97.14 -167.73 33.03 Favored Glycine 0 C--N 1.358 1.769 0 N-CA-C 111.278 -0.729 . . . . 60.030000000000001 111.278 164.983 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 74.3 m-85 -91.59 157.31 42.16 Favored Pre-proline 0 N--CA 1.481 1.09 0 C-N-CA 123.772 0.829 . . . . 74.040000000000006 110.874 179.821 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -70.6 154.77 64.19 Favored 'Trans proline' 0 C--N 1.369 1.63 0 C-N-CA 121.311 1.341 . . . . 64.420000000000002 111.059 169.857 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 173.59 -119.63 0.76 Allowed Glycine 0 CA--C 1.527 0.826 0 CA-C-O 118.601 -1.11 . . . . 74.200000000000003 111.842 -179.47 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 243' ' ' PRO . . . . . 0.582 ' HD2' ' HB3' ' A' ' 191' ' ' GLN . 40.8 Cg_endo -60.66 -57.24 0.72 Allowed 'Trans proline' 0 C--N 1.38 2.232 0 C-N-CA 123.784 2.989 . . . . 74.010000000000005 112.54 -173.117 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -80.24 -12.86 59.58 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 123.167 0.587 . . . . 55.229999999999997 111.207 179.845 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 95.78 -34.8 4.67 Favored Glycine 0 C--N 1.353 1.512 0 C-N-CA 122.986 0.327 . . . . 54.310000000000002 112.311 179.698 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 246' ' ' ARG . . . . . 0.521 ' HD2' ' HB3' ' A' ' 236' ' ' LYS . 22.3 ttm180 -125.81 111.77 15.25 Favored 'General case' 0 C--O 1.244 0.77 0 C-N-CA 123.727 0.811 . . . . 75.430000000000007 108.986 177.751 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -72.12 155.31 51.58 Favored Glycine 0 C--N 1.347 1.182 0 N-CA-C 115.253 0.861 . . . . 73.329999999999998 115.253 -177.698 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 38.9 m-20 -100.21 155.43 17.76 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 113.654 -1.273 . . . . 72.340000000000003 109.96 -175.515 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 249' ' ' LEU . . . . . 0.593 ' HB3' ' HB2' ' A' ' 235' ' ' LEU . 48.8 tp -129.77 114.87 16.48 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 108.191 -1.04 . . . . 63.450000000000003 108.191 173.326 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 250' ' ' TYR . . . . . . . . . . . . . 19.7 m-30 -90.55 109.14 20.3 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 116.191 -0.458 . . . . 72.340000000000003 110.191 -174.757 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 251' ' ' LEU . . . . . 0.639 ' HB2' ' HB2' ' A' ' 233' ' ' LEU . 82.4 mt -87.45 102.43 14.55 Favored 'General case' 0 C--O 1.239 0.522 0 N-CA-C 107.923 -1.14 . . . . 72.25 107.923 177.254 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -83.38 99.72 10.24 Favored 'General case' 0 C--O 1.243 0.718 0 N-CA-C 108.257 -1.016 . . . . 73.349999999999994 108.257 178.002 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 10.1 m -61.32 132.34 26.83 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.768 0 CA-C-N 115.572 -0.74 . . . . 75.040000000000006 110.004 179.63 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 20.3 mmm180 -125.34 105.42 9.08 Favored 'General case' 0 C--O 1.241 0.606 0 N-CA-C 107.273 -1.38 . . . . 64.219999999999999 107.273 178.292 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 255' ' ' ILE . . . . . 0.479 ' HA ' ' O ' ' A' ' 199' ' ' VAL . 45.6 mt -77.93 107.54 9.95 Favored 'Isoleucine or valine' 0 C--O 1.239 0.505 0 CA-C-N 115.797 -0.638 . . . . 62.420000000000002 109.766 -179.254 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 2.4 t . . . . . 0 CA--C 1.555 1.159 0 CA-C-N 115.035 -0.984 . . . . 74.040000000000006 108.462 174.302 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 1.7 pmm? . . . . . 0 N--CA 1.484 1.247 0 N-CA-C 111.994 0.368 . . . . 73.530000000000001 111.994 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 10.7 pt20 -94.11 164.54 13.03 Favored 'General case' 0 N--CA 1.482 1.139 0 CA-C-O 121.259 0.552 . . . . 75.140000000000001 111.093 -178.268 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 9.0 t -88.44 173.51 8.66 Favored 'General case' 0 CA--C 1.557 1.222 0 CA-C-N 115.169 -0.923 . . . . 71.420000000000002 109.455 170.281 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -139.62 -81.37 0.28 Allowed 'General case' 0 N--CA 1.483 1.175 0 C-N-CA 122.726 0.411 . . . . 60.140000000000001 111.939 -167.686 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 172' ' ' LEU . . . . . 0.45 HD21 ' HB3' ' A' ' 222' ' ' ALA . 22.7 mt -117.38 143.28 46.14 Favored 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 123.82 0.848 . . . . 75.150000000000006 111.759 -174.949 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 173' ' ' PHE . . . . . 0.499 ' CD1' HD22 ' A' ' 235' ' ' LEU . 19.4 m-85 -129.62 -53.8 1.16 Allowed 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 124.124 0.97 . . . . 71.340000000000003 109.177 -171.439 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 174' ' ' TYR . . . . . 0.444 ' CD2' ' HB3' ' A' ' 233' ' ' LEU . 0.8 OUTLIER -77.98 14.05 1.24 Allowed 'General case' 0 CA--C 1.547 0.828 0 CA-C-N 114.477 -1.238 . . . . 75.450000000000003 113.058 -174.257 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 20.6 p -61.38 -20.26 62.83 Favored 'General case' 0 N--CA 1.484 1.24 0 CA-C-N 118.772 0.715 . . . . 72.319999999999993 111.391 173.326 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 176' ' ' MET . . . . . . . . . . . . . 26.5 ptt? -59.03 -37.67 77.52 Favored 'General case' 0 CA--C 1.55 0.969 0 C-N-CA 124.149 0.979 . . . . 71.420000000000002 111.494 171.141 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 37.7 ttpt -167.19 87.6 0.29 Allowed 'General case' 0 CA--C 1.55 0.966 0 C-N-CA 124.451 1.1 . . . . 64.239999999999995 108.936 179.342 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -106.44 127.39 53.25 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 124.291 1.037 . . . . 60.119999999999997 109.246 -178.149 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 179' ' ' ALA . . . . . 0.428 ' HA ' ' HD3' ' A' ' 231' ' ' ARG . . . 59.93 39.45 20.22 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 124.117 0.967 . . . . 53.219999999999999 110.391 -172.773 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -116.28 172.14 14.09 Favored Glycine 0 N--CA 1.472 1.056 0 CA-C-N 115.192 -0.913 . . . . 74.540000000000006 113.006 -173.149 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 59.4 p -77.41 135.34 38.3 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.742 0.817 . . . . 63.229999999999997 111.082 -175.667 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -71.88 150.08 45.6 Favored Glycine 0 C--N 1.349 1.268 0 O-C-N 123.503 0.502 . . . . 71.25 113.122 -177.291 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -156.56 26.63 0.53 Allowed Glycine 0 C--N 1.346 1.094 0 C-N-CA 122.692 0.187 . . . . 71.219999999999999 112.676 -176.013 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 41.5 m -85.33 167.55 15.49 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 123.617 0.767 . . . . 62.030000000000001 111.305 -179.365 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 163.53 -177.29 39.49 Favored Glycine 0 C--N 1.34 0.783 0 CA-C-N 115.929 -0.578 . . . . 61.32 111.903 -178.729 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 94.78 -169.6 28.62 Favored Glycine 0 C--N 1.342 0.875 0 N-CA-C 112.287 -0.325 . . . . 54.420000000000002 112.287 -179.214 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 17.8 t -148.67 -165.21 2.22 Favored 'General case' 0 CA--C 1.55 0.96 0 N-CA-C 108.709 -0.848 . . . . 73.329999999999998 108.709 -176.317 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 120.02 -44.75 1.33 Allowed Glycine 0 N--CA 1.474 1.193 0 N-CA-C 112.102 -0.399 . . . . 73.349999999999994 112.102 177.163 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -171.91 151.86 15.96 Favored Glycine 0 C--N 1.335 0.525 0 N-CA-C 110.617 -0.993 . . . . 54.039999999999999 110.617 178.758 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 32.6 t -77.06 79.24 3.6 Favored 'General case' 0 CA--C 1.543 0.695 0 CA-C-O 121.663 0.744 . . . . 64.200000000000003 109.988 -179.703 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 191' ' ' GLN . . . . . 0.444 ' HB2' ' HA2' ' A' ' 247' ' ' GLY . 7.6 pt20 -76.95 -37.94 54.3 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 114.378 -1.283 . . . . 74.540000000000006 110.271 179.771 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -78.03 138.56 38.86 Favored 'General case' 0 C--N 1.351 0.651 0 CA-C-N 115.524 -0.762 . . . . 73.200000000000003 109.148 -174.699 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 193' ' ' LEU . . . . . 0.406 HD12 ' HA2' ' A' ' 239' ' ' GLY . 25.1 mt -120.18 177.18 5.11 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 124.483 1.113 . . . . 74.329999999999998 109.158 175.112 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -139.08 121.02 15.55 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 123.413 0.685 . . . . 64.010000000000005 110.396 177.185 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -125.13 128.6 48.68 Favored 'General case' 0 C--O 1.241 0.607 0 N-CA-C 106.942 -1.503 . . . . 54.32 106.942 168.566 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 10.6 m -81.26 119.45 23.65 Favored 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 108.363 -0.977 . . . . 74.329999999999998 108.363 179.621 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 0.722 HD22 HD13 ' A' ' 251' ' ' LEU . 20.5 tp -103.96 110.69 22.93 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 108.48 -0.933 . . . . 53.229999999999997 108.48 -173.996 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -79.86 127.23 31.99 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 115.219 -0.901 . . . . 74.319999999999993 108.92 179.209 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 199' ' ' VAL . . . . . 0.452 ' O ' ' HA ' ' A' ' 255' ' ' ILE . 6.2 p -143.9 128.72 9.51 Favored Pre-proline 0 CA--C 1.547 0.85 0 C-N-CA 123.729 0.812 . . . . 75.310000000000002 109.03 178.802 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -69.76 158.47 56.85 Favored 'Trans proline' 0 C--N 1.362 1.285 0 C-N-CA 121.769 1.646 . . . . 53.340000000000003 111.595 170.782 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 201' ' ' ALA . . . . . 0.46 ' O ' HG23 ' A' ' 205' ' ' VAL . . . -49.84 -53.99 36.71 Favored Pre-proline 0 CA--C 1.558 1.265 0 CA-C-N 114.744 -1.116 . . . . 72.239999999999995 112.863 -176.49 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -65.52 -34.29 43.13 Favored 'Trans proline' 0 C--N 1.399 3.208 0 C-N-CA 121.736 1.624 . . . . 72.120000000000005 113.237 -175.527 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 24.7 mt -67.2 -34.05 66.87 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.413 0 N-CA-C 109.975 -0.38 . . . . 63.039999999999999 109.975 177.529 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -69.46 -38.09 77.6 Favored 'General case' 0 CA--C 1.549 0.904 0 C-N-CA 122.535 0.334 . . . . 63.43 111.339 177.422 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 205' ' ' VAL . . . . . 0.46 HG23 ' O ' ' A' ' 201' ' ' ALA . 99.7 t -70.86 -56.55 10.36 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.122 0 C-N-CA 123.168 0.587 . . . . 62.32 111.576 -178.039 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 10.9 m -78.37 -25.42 13.84 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 CA-C-N 116.134 -0.485 . . . . 74.329999999999998 110.948 -174.918 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 84.15 60.55 1.92 Allowed Glycine 0 C--N 1.345 1.043 0 CA-C-N 116.04 -0.527 . . . . 61.32 112.615 -179.578 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -78.77 -138.03 1.38 Allowed Glycine 0 N--CA 1.477 1.374 0 CA-C-O 119.696 -0.502 . . . . 60.539999999999999 112.168 177.663 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 209' ' ' LYS . . . . . 0.479 ' HG2' ' HA ' ' A' ' 222' ' ' ALA . 29.0 mtmm -134.58 157.3 46.93 Favored 'General case' 0 N--CA 1.481 1.124 0 CA-C-N 117.607 0.704 . . . . 65.420000000000002 110.718 176.38 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 7.1 m -142.86 165.75 15.72 Favored 'Isoleucine or valine' 0 C--O 1.241 0.631 0 C-N-CA 126.068 1.747 . . . . 61.140000000000001 107.894 173.601 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 31.1 ttm180 -105.07 116.61 32.25 Favored 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 109.396 -0.594 . . . . 74.010000000000005 109.396 179.273 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -101.74 113.74 27.18 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.379 1.072 . . . . 63.210000000000001 109.563 179.003 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 61.6 tpp -76.22 125.04 28.44 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 108.187 -1.042 . . . . 65.329999999999998 108.187 173.702 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 18.4 p -125.24 -175.8 3.41 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.723 0.809 . . . . 65.310000000000002 109.721 -175.702 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 71.1 mt -57.01 -40.79 77.28 Favored 'General case' 0 N--CA 1.481 1.079 0 CA-C-O 121.504 0.669 . . . . 65.310000000000002 110.415 172.5 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 216' ' ' GLU . . . . . 0.474 ' HB2' ' HZ2' ' A' ' 238' ' ' LYS . 6.0 mm-40 -87.72 15.02 7.43 Favored 'General case' 0 CA--C 1.551 0.994 0 CA-C-N 114.538 -1.21 . . . . 62.450000000000003 111.371 -174.751 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 94.73 -171.1 30.02 Favored Glycine 0 C--N 1.35 1.346 0 N-CA-C 112.086 -0.406 . . . . 72.230000000000004 112.086 -179.686 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -68.42 149.37 74.89 Favored 'Trans proline' 0 C--N 1.362 1.276 0 C-N-CA 122.205 1.936 . . . . 62.310000000000002 111.991 178.129 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 7.1 p -143.27 134.87 23.61 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 N-CA-C 108.543 -0.91 . . . . 72.439999999999998 108.543 173.593 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 -86.37 103.27 14.78 Favored 'General case' 0 C--O 1.238 0.475 0 N-CA-C 107.76 -1.2 . . . . 65.019999999999996 107.76 179.501 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 2.6 p -108.61 131.35 59.44 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.967 0 C-N-CA 123.615 0.766 . . . . 64.439999999999998 109.355 -172.108 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 222' ' ' ALA . . . . . 0.479 ' HA ' ' HG2' ' A' ' 209' ' ' LYS . . . -83.11 111.25 18.73 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 123.126 0.571 . . . . 65.219999999999999 110.62 -176.788 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 58.4 t -54.66 132.65 64.78 Favored Pre-proline 0 N--CA 1.473 0.721 0 O-C-N 124.716 1.26 . . . . 62.43 109.354 177.067 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_endo -63.41 144.95 91.98 Favored 'Trans proline' 0 C--N 1.367 1.541 0 C-N-CA 121.482 1.455 . . . . 55.119999999999997 111.266 172.817 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -62.67 139.11 73.55 Favored 'Trans proline' 0 C--N 1.37 1.698 0 C-N-CA 121.572 1.515 . . . . 42.310000000000002 110.971 171.816 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 54.2 mtt180 69.64 60.49 0.28 Allowed 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 124.982 1.313 . . . . 73.200000000000003 110.74 173.161 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 227' ' ' THR . . . . . 0.593 ' HA ' ' HE ' ' A' ' 231' ' ' ARG . 55.9 m -103.85 142.12 34.94 Favored 'General case' 0 CA--C 1.544 0.74 0 CA-C-N 113.669 -1.605 . . . . 65.010000000000005 110.051 -179.857 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -116.66 148.14 41.29 Favored 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 124.074 0.95 . . . . 61.310000000000002 109.732 177.527 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 229' ' ' ALA . . . . . 0.487 ' HB2' ' HB ' ' A' ' 255' ' ' ILE . . . -58.77 116.5 3.78 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 123.982 0.913 . . . . 71.430000000000007 110.762 -179.84 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 113.21 2.44 24.79 Favored Glycine 0 CA--C 1.524 0.656 0 CA-C-N 115.744 -0.662 . . . . 74.010000000000005 112.968 179.238 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 231' ' ' ARG . . . . . 0.593 ' HE ' ' HA ' ' A' ' 227' ' ' THR . 75.0 mtt-85 -66.39 147.44 53.3 Favored 'General case' 0 C--N 1.364 1.206 0 CA-C-N 117.175 0.488 . . . . 74.439999999999998 109.757 172.358 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 69.7 mmtt -115.2 98.38 6.74 Favored 'General case' 0 C--O 1.241 0.605 0 CA-C-N 115.139 -0.937 . . . . 73.140000000000001 108.757 -174.591 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 233' ' ' LEU . . . . . 0.714 ' HB2' ' HB2' ' A' ' 251' ' ' LEU . 60.1 mt -85.5 151.69 23.76 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 115.3 -0.864 . . . . 73.319999999999993 108.883 177.514 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 234' ' ' ARG . . . . . 0.441 HH11 ' HE2' ' A' ' 250' ' ' TYR . 41.0 ttt85 -126.63 109.19 11.83 Favored 'General case' 0 N--CA 1.478 0.963 0 CA-C-O 120.679 0.275 . . . . 72.409999999999997 110.63 -172.114 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 235' ' ' LEU . . . . . 0.556 HD11 HD11 ' A' ' 251' ' ' LEU . 23.3 mt -94.98 117.71 30.6 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 123.761 0.824 . . . . 51.340000000000003 110.765 -179.571 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 20.9 mttt -69.86 138.51 52.59 Favored 'General case' 0 C--O 1.238 0.468 0 O-C-N 123.415 0.447 . . . . 75.099999999999994 111.401 175.74 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 73.94 10.35 80.64 Favored Glycine 0 C--N 1.345 1.029 0 CA-C-N 115.608 -0.723 . . . . 70.310000000000002 114.36 175.452 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 238' ' ' LYS . . . . . 0.474 ' HZ2' ' HB2' ' A' ' 216' ' ' GLU . 72.7 mmtt -112.51 5.28 17.89 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 122.765 0.426 . . . . 74.420000000000002 111.062 -179.707 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 239' ' ' GLY . . . . . 0.406 ' HA2' HD12 ' A' ' 193' ' ' LEU . . . -107.37 -161.93 21.57 Favored Glycine 0 C--N 1.348 1.216 0 N-CA-C 110.896 -0.881 . . . . 74.049999999999997 110.896 168.244 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 40.1 m-85 -94.25 147.25 33.03 Favored Pre-proline 0 N--CA 1.477 0.905 0 C-N-CA 123.045 0.538 . . . . 73.439999999999998 110.935 -179.049 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_exo -64.76 167.47 15.45 Favored 'Trans proline' 0 C--N 1.369 1.617 0 C-N-CA 122.333 2.022 . . . . 72.230000000000004 112.385 169.911 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 144.63 -106.02 0.38 Allowed Glycine 0 C--N 1.339 0.75 0 CA-C-O 118.727 -1.041 . . . . 63.32 112.077 175.769 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -61.95 -51.18 4.04 Favored 'Trans proline' 0 C--N 1.38 2.223 0 C-N-CA 123.632 2.888 . . . . 64.310000000000002 113.01 -168.855 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -87.13 -10.3 53.13 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 123.06 0.544 . . . . 71.329999999999998 111.312 176.466 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 90.76 -44.9 2.88 Favored Glycine 0 C--N 1.352 1.427 0 N-CA-C 111.383 -0.687 . . . . 64.209999999999994 111.383 -173.118 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 10.2 ttm180 -115.8 111.94 21.24 Favored 'General case' 0 C--O 1.24 0.59 0 C-N-CA 125.137 1.375 . . . . 63.530000000000001 109.281 175.373 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 247' ' ' GLY . . . . . 0.444 ' HA2' ' HB2' ' A' ' 191' ' ' GLN . . . -80.61 168.43 51.35 Favored Glycine 0 C--N 1.349 1.276 0 CA-C-O 121.766 0.648 . . . . 43.450000000000003 113.698 170.987 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -125.38 160.77 28.58 Favored 'General case' 0 N--CA 1.465 0.31 0 C-N-CA 124.19 0.996 . . . . 64.239999999999995 110.396 -170.274 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 249' ' ' LEU . . . . . 0.477 ' HB3' ' HB2' ' A' ' 235' ' ' LEU . 41.1 tp -115.84 124.86 51.76 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 123.948 0.899 . . . . 75.109999999999999 109.501 177.143 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 250' ' ' TYR . . . . . 0.441 ' HE2' HH11 ' A' ' 234' ' ' ARG . 2.2 m-85 -88.26 109.54 20.02 Favored 'General case' 0 C--O 1.232 0.158 0 N-CA-C 109.268 -0.641 . . . . 73.25 109.268 176.912 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 251' ' ' LEU . . . . . 0.722 HD13 HD22 ' A' ' 197' ' ' LEU . 86.4 mt -87.2 104.19 16.14 Favored 'General case' 0 C--O 1.241 0.64 0 N-CA-C 106.736 -1.579 . . . . 74.209999999999994 106.736 173.945 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -85.05 103.43 14.07 Favored 'General case' 0 C--O 1.24 0.575 0 N-CA-C 107.71 -1.219 . . . . 63.030000000000001 107.71 176.037 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 16.7 m -68.43 137.71 23.92 Favored 'Isoleucine or valine' 0 C--O 1.241 0.646 0 O-C-N 124.181 0.926 . . . . 74.129999999999995 109.596 -177.193 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 18.1 mmm180 -128.48 106.18 8.81 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 107.774 -1.195 . . . . 75.25 107.774 -179.906 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 255' ' ' ILE . . . . . 0.487 ' HB ' ' HB2' ' A' ' 229' ' ' ALA . 29.6 mt -77.47 123.5 34.23 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.58 0 O-C-N 123.924 0.765 . . . . 64.0 110.086 178.301 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 3.3 t . . . . . 0 CA--C 1.563 1.452 0 C-N-CA 124.143 0.977 . . . . 72.099999999999994 109.081 173.729 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 15.0 tpt . . . . . 0 N--CA 1.48 1.042 0 N-CA-C 109.393 -0.595 . . . . 71.400000000000006 109.393 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 17.9 pt20 -78.05 166.5 22.73 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.162 0.585 . . . . 72.120000000000005 110.093 174.241 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 13.5 t -73.77 153.1 40.13 Favored 'General case' 0 CA--C 1.549 0.94 0 CA-C-N 115.515 -0.766 . . . . 75.329999999999998 109.871 173.838 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -98.02 -87.47 0.33 Allowed 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 123.263 0.625 . . . . 72.209999999999994 111.08 -175.009 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 172' ' ' LEU . . . . . 0.755 HD21 ' H ' ' A' ' 222' ' ' ALA . 78.2 mt -134.9 163.38 29.97 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 123.831 0.852 . . . . 72.530000000000001 111.49 -167.151 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 173' ' ' PHE . . . . . 0.403 ' CD1' HD22 ' A' ' 235' ' ' LEU . 50.1 m-85 -147.62 -68.94 0.24 Allowed 'General case' 0 N--CA 1.479 0.986 0 N-CA-C 108.337 -0.986 . . . . 75.209999999999994 108.337 -164.952 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 174' ' ' TYR . . . . . 0.475 ' OH ' ' HB ' ' A' ' 221' ' ' VAL . 19.9 p90 -62.97 -21.86 66.4 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 113.921 -1.491 . . . . 72.420000000000002 112.523 -178.888 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 19.5 m -59.28 -12.59 5.81 Favored 'General case' 0 CA--C 1.56 1.339 0 C-N-CA 125.773 1.629 . . . . 72.349999999999994 112.889 -176.277 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 176' ' ' MET . . . . . . . . . . . . . 50.8 mtm -56.36 -50.62 71.02 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 123.773 0.829 . . . . 65.430000000000007 110.075 166.989 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -163.84 104.54 0.91 Allowed 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 124.428 1.091 . . . . 71.200000000000003 109.475 174.775 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 178' ' ' ALA . . . . . 0.457 ' HB1' HD22 ' A' ' 233' ' ' LEU . . . -125.84 -59.39 1.35 Allowed 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 123.936 0.894 . . . . 61.310000000000002 111.224 -171.67 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -72.26 81.8 1.01 Allowed 'General case' 0 CA--C 1.544 0.716 0 CA-C-O 121.86 0.838 . . . . 51.32 109.258 174.765 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 108.57 85.36 1.7 Allowed Glycine 0 C--N 1.337 0.586 0 N-CA-C 109.974 -1.25 . . . . 61.229999999999997 109.974 -169.663 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 31.4 m -65.38 91.6 0.12 Allowed 'General case' 0 CA--C 1.553 1.069 0 C-N-CA 123.946 0.898 . . . . 72.540000000000006 112.081 -174.123 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -94.3 39.07 2.97 Favored Glycine 0 N--CA 1.468 0.803 0 CA-C-N 115.725 -0.67 . . . . 54.130000000000003 112.037 175.626 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -148.41 82.67 0.19 Allowed Glycine 0 C--N 1.347 1.159 0 N-CA-C 111.282 -0.727 . . . . 64.329999999999998 111.282 -175.336 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 21.3 m -69.55 122.25 18.68 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 123.436 0.695 . . . . 75.5 110.085 177.936 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -80.04 -128.75 0.73 Allowed Glycine 0 C--N 1.347 1.148 0 O-C-N 123.419 0.449 . . . . 70.200000000000003 113.476 -178.348 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 116.83 -85.96 0.4 Allowed Glycine 0 C--N 1.341 0.817 0 N-CA-C 111.206 -0.758 . . . . 52.100000000000001 111.206 -178.897 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 187' ' ' SER . . . . . 0.674 ' HB3' ' HG3' ' A' ' 243' ' ' PRO . 53.6 m 70.86 143.5 0.06 Allowed 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 125.229 1.412 . . . . 61.340000000000003 114.245 171.947 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -88.49 75.94 1.95 Allowed Glycine 0 C--N 1.349 1.254 0 CA-C-N 114.957 -1.019 . . . . 73.420000000000002 110.848 174.001 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 126.03 131.4 3.57 Favored Glycine 0 C--N 1.341 0.813 0 N-CA-C 110.178 -1.169 . . . . 72.439999999999998 110.178 -174.035 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 57.9 m -71.42 85.72 0.83 Allowed 'General case' 0 CA--C 1.545 0.784 0 CA-C-O 121.577 0.703 . . . . 75.030000000000001 111.183 -178.031 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 191' ' ' GLN . . . . . 0.699 ' HB2' ' HA2' ' A' ' 247' ' ' GLY . 25.1 pt20 -82.3 -27.85 32.05 Favored 'General case' 0 CA--C 1.545 0.755 0 CA-C-N 114.852 -1.067 . . . . 75.510000000000005 110.088 172.474 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 192' ' ' ASP . . . . . 0.454 ' HA ' ' O ' ' A' ' 248' ' ' ASP . 9.9 m-20 -78.1 152.75 32.71 Favored 'General case' 0 C--N 1.347 0.464 0 CA-C-N 114.438 -1.256 . . . . 71.099999999999994 111.797 -167.907 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 193' ' ' LEU . . . . . 0.475 HD12 ' HA2' ' A' ' 239' ' ' GLY . 22.9 mt -133.86 175.01 9.85 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 124.265 1.026 . . . . 73.299999999999997 109.773 177.517 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 77.6 m-85 -136.35 131.43 34.27 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.579 0.752 . . . . 71.120000000000005 110.545 179.835 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -144.29 128.99 18.23 Favored 'General case' 0 C--O 1.234 0.28 0 N-CA-C 107.326 -1.361 . . . . 74.400000000000006 107.326 176.823 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 3.5 m -81.47 121.35 26.16 Favored 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 109.524 -0.547 . . . . 65.439999999999998 109.524 -176.571 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 0.544 HD22 HD13 ' A' ' 251' ' ' LEU . 20.3 tp -106.35 108.96 20.73 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 107.188 -1.412 . . . . 72.450000000000003 107.188 -178.124 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -86.92 132.37 33.83 Favored 'General case' 0 C--O 1.241 0.606 0 N-CA-C 109.223 -0.658 . . . . 65.140000000000001 109.223 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 199' ' ' VAL . . . . . 0.432 ' O ' ' HA ' ' A' ' 255' ' ' ILE . 4.0 p -141.92 129.53 11.61 Favored Pre-proline 0 CA--C 1.543 0.694 0 N-CA-C 108.305 -0.998 . . . . 44.020000000000003 108.305 -176.626 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -70.23 155.1 65.13 Favored 'Trans proline' 0 C--N 1.364 1.36 0 C-N-CA 121.431 1.421 . . . . 74.340000000000003 110.376 170.814 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 201' ' ' ALA . . . . . 0.414 ' HA ' HG23 ' A' ' 255' ' ' ILE . . . -50.64 -49.39 78.98 Favored Pre-proline 0 CA--C 1.556 1.2 0 CA-C-O 117.804 -1.093 . . . . 64.400000000000006 112.885 179.871 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 202' ' ' PRO . . . . . 0.436 ' HA ' HG22 ' A' ' 205' ' ' VAL . 29.7 Cg_endo -58.74 -39.59 80.71 Favored 'Trans proline' 0 C--N 1.399 3.216 0 C-N-CA 122.312 2.008 . . . . 65.310000000000002 113.991 -179.884 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 39.3 mt -68.28 -37.54 78.15 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.395 0 CA-C-N 118.625 0.648 . . . . 75.200000000000003 110.475 177.684 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -66.46 -42.8 87.02 Favored 'General case' 0 N--CA 1.479 0.98 0 N-CA-C 112.101 0.408 . . . . 74.140000000000001 112.101 179.706 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 205' ' ' VAL . . . . . 0.436 HG22 ' HA ' ' A' ' 202' ' ' PRO . 26.9 m -77.69 -45.02 28.96 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.917 0 C-N-CA 123.777 0.831 . . . . 74.120000000000005 112.722 -172.713 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 206' ' ' VAL . . . . . 0.402 HG22 ' O ' ' A' ' 202' ' ' PRO . 5.2 m -81.19 -26.22 10.52 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.325 0 C-N-CA 122.42 0.288 . . . . 71.150000000000006 111.338 178.541 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 82.89 77.89 1.07 Allowed Glycine 0 C--N 1.348 1.226 0 N-CA-C 111.858 -0.497 . . . . 62.350000000000001 111.858 -176.445 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -102.1 -137.34 9.6 Favored Glycine 0 C--N 1.347 1.186 0 N-CA-C 111.51 -0.636 . . . . 63.420000000000002 111.51 177.427 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 48.5 mtmt -136.16 155.46 50.13 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 123.592 0.757 . . . . 74.099999999999994 111.088 179.124 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 7.4 m -142.43 168.75 13.81 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.908 0 C-N-CA 125.948 1.699 . . . . 62.43 108.385 172.827 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 44.1 ttm180 -103.25 120.02 39.97 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 122.902 0.481 . . . . 53.329999999999998 109.858 177.508 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -102.21 133.55 46.9 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 124.127 0.971 . . . . 75.540000000000006 110.213 177.688 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 23.5 mmt -97.24 121.63 39.35 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 123.319 0.648 . . . . 73.310000000000002 109.595 178.97 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 18.2 p -120.17 174.85 6.24 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 124.172 0.989 . . . . 60.329999999999998 110.082 -177.095 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 56.5 mt -59.0 -31.48 68.84 Favored 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 123.079 0.551 . . . . 75.319999999999993 112.248 179.241 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -87.59 -20.26 26.67 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 123.106 0.563 . . . . 61.439999999999998 111.475 -177.4 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 139.33 -161.66 26.06 Favored Glycine 0 C--N 1.35 1.314 0 CA-C-O 119.445 -0.642 . . . . 63.329999999999998 111.962 -178.469 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_endo -82.28 155.86 16.87 Favored 'Trans proline' 0 C--N 1.367 1.541 0 C-N-CA 122.53 2.154 . . . . 63.009999999999998 112.766 -177.967 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 5.5 p -146.93 134.88 15.0 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.92 0 C-N-CA 123.746 0.819 . . . . 63.420000000000002 109.354 177.268 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -83.34 104.16 13.28 Favored 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 108.444 -0.947 . . . . 61.119999999999997 108.444 176.243 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 221' ' ' VAL . . . . . 0.475 ' HB ' ' OH ' ' A' ' 174' ' ' TYR . 6.4 m -106.27 132.12 54.21 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 CA-C-O 121.64 0.733 . . . . 73.409999999999997 110.578 -178.027 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 222' ' ' ALA . . . . . 0.755 ' H ' HD21 ' A' ' 172' ' ' LEU . . . -85.74 105.8 16.53 Favored 'General case' 0 C--O 1.238 0.46 0 CA-C-N 114.365 -1.289 . . . . 72.310000000000002 110.311 -178.732 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 66.7 t -57.43 128.76 79.56 Favored Pre-proline 0 N--CA 1.478 0.962 0 O-C-N 124.532 1.145 . . . . 52.340000000000003 109.124 179.089 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 224' ' ' PRO . . . . . 0.444 ' HD3' ' HE1' ' A' ' 174' ' ' TYR . 24.3 Cg_endo -61.22 146.56 97.3 Favored 'Trans proline' 0 C--N 1.375 1.922 0 C-N-CA 121.892 1.728 . . . . 73.319999999999993 110.926 177.559 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_endo -62.36 141.95 89.15 Favored 'Trans proline' 0 C--N 1.37 1.674 0 C-N-CA 121.607 1.538 . . . . 64.239999999999995 111.808 175.864 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 77.9 mtt180 64.64 38.96 6.8 Favored 'General case' 0 CA--C 1.554 1.13 0 C-N-CA 125.031 1.333 . . . . 74.129999999999995 111.908 172.524 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 227' ' ' THR . . . . . 0.511 HG23 ' HD2' ' A' ' 231' ' ' ARG . 86.7 m -76.17 146.85 38.87 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 123.648 0.779 . . . . 62.149999999999999 110.427 176.178 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -111.05 149.41 30.79 Favored 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 123.813 0.845 . . . . 53.310000000000002 109.249 174.927 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 229' ' ' ALA . . . . . 0.488 ' HA ' HG23 ' A' ' 253' ' ' VAL . . . -61.19 138.74 58.21 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 124.02 0.928 . . . . 64.140000000000001 111.394 -179.325 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 94.11 -3.81 70.3 Favored Glycine 0 C--N 1.339 0.73 0 CA-C-N 115.843 -0.617 . . . . 44.229999999999997 112.712 -178.846 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 231' ' ' ARG . . . . . 0.511 ' HD2' HG23 ' A' ' 227' ' ' THR . 57.4 mtt-85 -69.38 143.58 53.65 Favored 'General case' 0 C--N 1.363 1.195 0 N-CA-C 108.924 -0.769 . . . . 75.450000000000003 108.924 171.72 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 232' ' ' LYS . . . . . 0.518 ' HG2' ' HB3' ' A' ' 250' ' ' TYR . 13.4 ttmt -126.29 101.36 6.7 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 108.707 -0.849 . . . . 52.25 108.707 -167.309 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 233' ' ' LEU . . . . . 0.682 ' HB2' ' HB2' ' A' ' 251' ' ' LEU . 24.1 mt -76.28 151.72 36.68 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-N 114.011 -1.45 . . . . 71.340000000000003 109.172 -176.528 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 47.8 ttt180 -125.14 120.82 32.46 Favored 'General case' 0 N--CA 1.485 1.291 0 CA-C-N 118.998 0.817 . . . . 73.510000000000005 110.484 -175.433 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 235' ' ' LEU . . . . . 0.483 HD11 HD11 ' A' ' 251' ' ' LEU . 18.6 mt -108.78 116.45 32.01 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 124.397 1.079 . . . . 74.349999999999994 110.768 -175.696 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 31.4 mttp -72.94 141.54 47.82 Favored 'General case' 0 N--CA 1.479 1.004 0 N-CA-C 112.226 0.454 . . . . 72.420000000000002 112.226 176.795 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 76.51 10.37 85.75 Favored Glycine 0 C--N 1.349 1.269 0 CA-C-N 115.151 -0.931 . . . . 72.420000000000002 114.49 178.582 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt -115.26 10.29 15.92 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 122.736 0.414 . . . . 72.150000000000006 111.069 -173.79 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 239' ' ' GLY . . . . . 0.475 ' HA2' HD12 ' A' ' 193' ' ' LEU . . . -119.86 -161.98 11.74 Favored Glycine 0 C--N 1.345 1.06 0 N-CA-C 111.456 -0.657 . . . . 75.209999999999994 111.456 172.779 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 37.7 m-85 -93.02 169.3 10.64 Favored Pre-proline 0 N--CA 1.485 1.286 0 C-N-CA 123.79 0.836 . . . . 70.530000000000001 111.105 -175.208 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 241' ' ' PRO . . . . . 0.5 ' HA ' ' O ' ' A' ' 245' ' ' GLY . 77.7 Cg_exo -55.01 149.63 42.13 Favored 'Trans proline' 0 C--N 1.376 2.001 0 C-N-CA 121.762 1.641 . . . . 55.32 112.813 165.68 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -174.54 -136.51 2.26 Favored Glycine 0 CA--C 1.526 0.75 0 CA-C-O 119.053 -0.859 . . . . 73.510000000000005 111.871 179.085 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 243' ' ' PRO . . . . . 0.683 ' HD2' ' HB3' ' A' ' 191' ' ' GLN . 43.1 Cg_endo -60.34 -40.89 54.5 Favored 'Trans proline' 0 C--N 1.371 1.744 0 C-N-CA 124.158 3.238 . . . . 75.140000000000001 113.108 -172.53 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -104.12 0.87 30.16 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 124.05 0.94 . . . . 74.430000000000007 111.482 179.013 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 245' ' ' GLY . . . . . 0.5 ' O ' ' HA ' ' A' ' 241' ' ' PRO . . . 81.83 -41.22 2.7 Favored Glycine 0 C--N 1.36 1.885 0 N-CA-C 112.386 -0.286 . . . . 75.230000000000004 112.386 -175.584 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 9.9 ttm180 -89.02 110.1 20.84 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 124.301 1.04 . . . . 74.239999999999995 109.705 175.61 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 247' ' ' GLY . . . . . 0.699 ' HA2' ' HB2' ' A' ' 191' ' ' GLN . . . -83.11 167.48 45.6 Favored Glycine 0 C--N 1.351 1.417 0 N-CA-C 114.407 0.523 . . . . 73.349999999999994 114.407 171.69 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 248' ' ' ASP . . . . . 0.454 ' O ' ' HA ' ' A' ' 192' ' ' ASP . 41.6 m-20 -131.31 135.92 47.69 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 123.482 0.713 . . . . 63.32 111.092 -168.729 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 249' ' ' LEU . . . . . . . . . . . . . 47.5 tp -99.97 129.9 46.09 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 123.497 0.719 . . . . 74.329999999999998 110.739 -177.921 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 250' ' ' TYR . . . . . 0.519 ' HA ' ' O ' ' A' ' 233' ' ' LEU . 2.4 m-85 -95.77 115.49 27.5 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 123.801 0.84 . . . . 70.0 110.522 -178.83 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 251' ' ' LEU . . . . . 0.682 ' HB2' ' HB2' ' A' ' 233' ' ' LEU . 85.8 mt -94.14 105.22 17.22 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 108.711 -0.848 . . . . 74.540000000000006 108.711 178.257 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -84.15 104.25 14.04 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 109.743 -0.466 . . . . 72.409999999999997 109.743 178.736 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 253' ' ' VAL . . . . . 0.488 HG23 ' HA ' ' A' ' 229' ' ' ALA . 6.1 m -66.1 131.66 31.8 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.937 0 CA-C-O 121.237 0.541 . . . . 45.409999999999997 109.687 -179.299 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 10.8 mmm180 -123.96 97.32 5.3 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 108.744 -0.835 . . . . 71.329999999999998 108.744 179.057 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 255' ' ' ILE . . . . . 0.432 ' HA ' ' O ' ' A' ' 199' ' ' VAL . 32.2 mt -78.46 127.36 38.79 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 O-C-N 124.026 0.829 . . . . 65.209999999999994 111.014 -175.172 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 1.9 t . . . . . 0 CA--C 1.561 1.367 0 C-N-CA 124.064 0.946 . . . . 71.430000000000007 109.418 175.379 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 25.1 ptt? . . . . . 0 N--CA 1.484 1.259 0 N-CA-C 112.028 0.381 . . . . 72.530000000000001 112.028 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 13.0 pt20 -147.05 166.77 25.84 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 122.939 0.496 . . . . 74.310000000000002 111.27 178.536 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 14.4 t -72.24 169.46 16.14 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 124.413 1.085 . . . . 73.439999999999998 112.275 -174.525 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 27.2 m-20 -94.41 -166.21 1.44 Allowed 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.471 1.108 . . . . 71.319999999999993 110.487 178.874 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 172' ' ' LEU . . . . . 0.682 HD21 ' H ' ' A' ' 222' ' ' ALA . 72.8 mt -84.05 145.77 28.3 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 124.231 1.012 . . . . 73.150000000000006 110.979 -178.767 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 34.9 m-85 -109.38 -57.93 2.1 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 123.7 0.8 . . . . 74.129999999999995 109.805 -174.937 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 174' ' ' TYR . . . . . 0.424 ' CD2' ' HB3' ' A' ' 233' ' ' LEU . 0.8 OUTLIER -71.17 -6.03 36.34 Favored 'General case' 0 C--N 1.348 0.508 0 CA-C-N 114.724 -1.126 . . . . 71.040000000000006 113.446 -173.201 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 175' ' ' THR . . . . . 0.485 HG21 HD13 ' A' ' 172' ' ' LEU . 2.9 p -68.2 -2.12 7.47 Favored 'General case' 0 CA--C 1.549 0.908 0 N-CA-C 114.052 1.131 . . . . 42.310000000000002 114.052 -177.328 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 176' ' ' MET . . . . . . . . . . . . . 21.8 ptt? -60.34 -41.93 94.61 Favored 'General case' 0 CA--C 1.559 1.296 0 C-N-CA 123.038 0.535 . . . . 70.209999999999994 110.369 163.756 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -178.55 114.03 0.07 Allowed 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 126.425 1.89 . . . . 74.549999999999997 106.956 179.337 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 178' ' ' ALA . . . . . 0.413 ' HB1' HD22 ' A' ' 233' ' ' LEU . . . -132.2 -42.04 0.98 Allowed 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 122.799 0.44 . . . . 54.299999999999997 111.881 -170.809 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -72.7 81.6 1.13 Allowed 'General case' 0 N--CA 1.472 0.669 0 CA-C-O 121.708 0.766 . . . . 64.420000000000002 109.58 179.045 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 180' ' ' GLY . . . . . 0.473 ' H ' ' HD3' ' A' ' 231' ' ' ARG . . . 161.14 -91.91 0.11 Allowed Glycine 0 C--N 1.332 0.332 0 N-CA-C 108.944 -1.663 . . . . 51.140000000000001 108.944 -175.693 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 77.4 p -162.18 159.7 26.2 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 124.524 1.13 . . . . 74.0 109.023 176.409 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 182' ' ' GLY . . . . . 0.477 ' HA3' ' HB2' ' A' ' 234' ' ' ARG . . . -79.57 -31.6 40.41 Favored Glycine 0 C--N 1.349 1.281 0 C-N-CA 123.156 0.408 . . . . 60.140000000000001 112.652 179.418 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -163.28 161.06 33.7 Favored Glycine 0 CA--C 1.524 0.608 0 N-CA-C 111.101 -0.8 . . . . 73.219999999999999 111.101 176.164 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 77.6 p -66.13 -35.96 81.88 Favored 'General case' 0 N--CA 1.48 1.036 0 CA-C-O 121.154 0.502 . . . . 73.200000000000003 109.898 175.65 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 172.36 142.9 3.92 Favored Glycine 0 C--N 1.342 0.916 0 N-CA-C 110.263 -1.135 . . . . 45.520000000000003 110.263 174.845 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -154.89 87.6 0.13 Allowed Glycine 0 C--N 1.34 0.792 0 N-CA-C 111.564 -0.614 . . . . 70.25 111.564 -178.69 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 48.9 m -91.15 63.87 5.14 Favored 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 123.576 0.75 . . . . 60.020000000000003 109.64 176.2 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -73.05 167.32 54.23 Favored Glycine 0 C--N 1.349 1.275 0 CA-C-N 115.05 -0.977 . . . . 75.150000000000006 113.039 -178.897 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -64.51 81.75 0.06 OUTLIER Glycine 0 C--N 1.34 0.772 0 N-CA-C 114.693 0.637 . . . . 63.5 114.693 -176.372 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 20.2 m 58.5 8.34 0.85 Allowed 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 124.987 1.315 . . . . 71.230000000000004 114.034 174.465 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 191' ' ' GLN . . . . . 0.525 ' HB3' ' HD2' ' A' ' 243' ' ' PRO . 5.4 pt20 -80.36 -35.27 35.67 Favored 'General case' 0 C--N 1.356 0.855 0 CA-C-O 121.075 0.464 . . . . 72.129999999999995 110.763 -173.88 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 21.5 m-20 -77.3 161.33 28.17 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 115.743 -0.662 . . . . 71.200000000000003 111.312 -170.536 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 24.2 mt -141.08 166.31 25.13 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 124.375 1.07 . . . . 63.299999999999997 110.294 -178.953 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 61.0 m-85 -136.94 123.02 20.33 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 124.324 1.049 . . . . 73.219999999999999 109.771 178.206 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 195' ' ' ALA . . . . . 0.454 ' O ' ' HA ' ' A' ' 251' ' ' LEU . . . -133.89 132.61 40.51 Favored 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 108.389 -0.967 . . . . 53.229999999999997 108.389 176.301 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 41.8 m -86.11 124.06 32.11 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 123.145 0.578 . . . . 73.230000000000004 109.87 -179.134 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 0.645 HD22 HD13 ' A' ' 251' ' ' LEU . 19.7 tp -107.16 109.93 21.88 Favored 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 108.665 -0.865 . . . . 62.130000000000003 108.665 -175.367 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -79.75 125.58 29.85 Favored 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 123.441 0.696 . . . . 74.109999999999999 109.174 179.219 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 199' ' ' VAL . . . . . 0.456 ' O ' ' HA ' ' A' ' 255' ' ' ILE . 4.4 p -144.02 129.37 9.7 Favored Pre-proline 0 CA--C 1.547 0.829 0 C-N-CA 124.044 0.937 . . . . 74.439999999999998 108.93 -178.083 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -67.76 158.55 56.72 Favored 'Trans proline' 0 C--N 1.37 1.682 0 C-N-CA 121.809 1.673 . . . . 75.200000000000003 112.264 170.26 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 201' ' ' ALA . . . . . 0.499 ' O ' HG23 ' A' ' 205' ' ' VAL . . . -50.62 -52.91 51.74 Favored Pre-proline 0 CA--C 1.553 1.09 0 N-CA-C 113.692 0.997 . . . . 65.340000000000003 113.692 -179.185 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 202' ' ' PRO . . . . . 0.406 ' O ' HG22 ' A' ' 206' ' ' VAL . 49.8 Cg_endo -64.97 -38.6 28.15 Favored 'Trans proline' 0 C--N 1.381 2.258 0 CA-C-N 121.147 1.445 . . . . 75.219999999999999 113.835 -177.39 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 31.5 mt -64.04 -30.9 51.27 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 N-CA-C 109.944 -0.391 . . . . 62.25 109.944 175.743 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -72.77 -40.74 65.71 Favored 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 122.578 0.351 . . . . 71.450000000000003 111.453 176.765 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 205' ' ' VAL . . . . . 0.499 HG23 ' O ' ' A' ' 201' ' ' ALA . 91.6 t -70.73 -55.96 12.43 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.239 0 C-N-CA 123.199 0.6 . . . . 51.25 111.035 -176.483 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 206' ' ' VAL . . . . . 0.406 HG22 ' O ' ' A' ' 202' ' ' PRO . 14.7 m -81.3 -27.3 10.46 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 CA-C-N 116.532 -0.304 . . . . 73.230000000000004 111.188 -176.796 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 85.18 71.56 1.31 Allowed Glycine 0 C--N 1.351 1.393 0 O-C-N 123.439 0.462 . . . . 60.420000000000002 113.016 -179.367 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -86.81 -127.8 2.33 Favored Glycine 0 C--N 1.348 1.218 0 CA-C-O 119.736 -0.48 . . . . 64.400000000000006 112.808 176.908 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 45.1 mtmt -137.66 152.12 48.98 Favored 'General case' 0 N--CA 1.486 1.336 0 CA-C-N 117.525 0.662 . . . . 73.349999999999994 111.128 178.45 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 6.2 m -146.91 159.52 9.67 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 C-N-CA 125.108 1.363 . . . . 70.400000000000006 108.536 170.702 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 51.0 ttp180 -97.53 121.18 39.14 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 123.394 0.678 . . . . 74.430000000000007 110.675 -179.681 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -102.29 123.18 45.64 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 123.494 0.718 . . . . 63.32 110.192 176.99 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 49.1 tpp -81.28 126.75 31.93 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 108.893 -0.78 . . . . 65.299999999999997 108.893 172.747 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 24.1 p -129.74 -174.31 3.27 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 123.848 0.859 . . . . 64.540000000000006 109.673 -173.506 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 67.4 mt -62.29 -27.65 69.18 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 122.809 0.444 . . . . 54.039999999999999 111.196 172.781 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 216' ' ' GLU . . . . . 0.403 ' HB2' ' NZ ' ' A' ' 238' ' ' LYS . 34.4 mt-10 -102.87 22.12 14.39 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 123.826 0.851 . . . . 72.430000000000007 110.691 -178.84 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 85.85 -156.03 29.62 Favored Glycine 0 C--N 1.354 1.555 0 CA-C-O 119.13 -0.817 . . . . 52.240000000000002 113.291 176.628 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -75.71 148.0 32.08 Favored 'Trans proline' 0 C--N 1.369 1.613 0 C-N-CA 122.79 2.327 . . . . 63.240000000000002 113.024 -178.151 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 3.8 p -141.5 128.77 21.09 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 N-CA-C 108.735 -0.839 . . . . 54.409999999999997 108.735 174.464 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -79.45 102.88 9.0 Favored 'General case' 0 C--O 1.241 0.606 0 N-CA-C 108.453 -0.943 . . . . 64.140000000000001 108.453 174.564 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 1.8 p -111.13 115.88 51.03 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.214 0 CA-C-N 115.457 -0.792 . . . . 73.340000000000003 108.968 -170.497 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 222' ' ' ALA . . . . . 0.682 ' H ' HD21 ' A' ' 172' ' ' LEU . . . -67.78 109.17 3.25 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 115.365 -0.834 . . . . 71.109999999999999 111.699 179.143 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 57.5 t -55.4 136.86 69.43 Favored Pre-proline 0 CA--C 1.551 1.008 0 C-N-CA 124.975 1.31 . . . . 40.329999999999998 110.382 178.29 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -66.42 160.71 44.25 Favored 'Trans proline' 0 C--N 1.371 1.726 0 C-N-CA 122.233 1.956 . . . . 74.209999999999994 111.567 173.009 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo -69.92 151.26 68.08 Favored 'Trans proline' 0 C--N 1.363 1.336 0 C-N-CA 121.406 1.404 . . . . 73.329999999999998 110.973 171.427 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 49.6 mtt180 61.98 43.76 8.79 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 124.535 1.134 . . . . 70.219999999999999 111.054 170.119 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 227' ' ' THR . . . . . 0.44 ' HA ' ' HE ' ' A' ' 231' ' ' ARG . 91.8 m -85.11 124.63 32.01 Favored 'General case' 0 CA--C 1.544 0.739 0 CA-C-N 114.14 -1.391 . . . . 72.340000000000003 109.808 178.095 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -104.81 151.62 23.57 Favored 'General case' 0 N--CA 1.492 1.644 0 C-N-CA 123.602 0.761 . . . . 75.150000000000006 109.496 176.292 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -58.01 116.25 3.39 Favored 'General case' 0 C--N 1.353 0.75 0 O-C-N 123.915 0.76 . . . . 61.039999999999999 110.397 178.895 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 114.21 -2.24 23.9 Favored Glycine 0 C--N 1.338 0.651 0 CA-C-O 119.194 -0.781 . . . . 61.310000000000002 113.211 -178.302 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 231' ' ' ARG . . . . . 0.473 ' HD3' ' H ' ' A' ' 180' ' ' GLY . 25.6 mtt-85 -63.41 129.95 42.37 Favored 'General case' 0 C--N 1.361 1.065 0 CA-C-N 117.989 0.894 . . . . 63.130000000000003 109.344 171.817 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 77.2 mttt -110.69 96.75 6.37 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 107.83 -1.174 . . . . 75.239999999999995 107.83 -175.301 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 233' ' ' LEU . . . . . 0.604 ' HB2' ' HB2' ' A' ' 251' ' ' LEU . 34.0 mt -79.81 151.33 30.34 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 114.137 -1.392 . . . . 73.200000000000003 109.42 -174.747 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 234' ' ' ARG . . . . . 0.477 ' HB2' ' HA3' ' A' ' 182' ' ' GLY . 45.8 ttt180 -117.05 103.05 9.85 Favored 'General case' 0 N--CA 1.483 1.21 0 CA-C-N 118.654 0.661 . . . . 51.109999999999999 111.579 -170.135 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 235' ' ' LEU . . . . . 0.566 ' HB2' ' HB3' ' A' ' 249' ' ' LEU . 18.7 mt -94.13 101.14 13.14 Favored 'General case' 0 C--O 1.24 0.594 0 C-N-CA 123.239 0.616 . . . . 74.140000000000001 109.68 172.442 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 57.5 mttt -72.97 147.84 44.81 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 110.088 -0.338 . . . . 71.430000000000007 110.088 173.857 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 79.32 -6.61 56.7 Favored Glycine 0 C--N 1.341 0.834 0 CA-C-N 115.545 -0.752 . . . . 60.520000000000003 113.927 -177.367 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 238' ' ' LYS . . . . . 0.403 ' NZ ' ' HB2' ' A' ' 216' ' ' GLU . 71.8 mmtt -100.4 2.8 42.66 Favored 'General case' 0 C--O 1.239 0.531 0 C-N-CA 123.491 0.716 . . . . 74.5 111.083 179.351 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -103.62 -175.85 25.98 Favored Glycine 0 C--N 1.357 1.74 0 O-C-N 123.528 0.518 . . . . 65.420000000000002 112.09 166.477 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 79.9 m-85 -86.89 167.71 20.99 Favored Pre-proline 0 CA--C 1.563 1.462 0 C-N-CA 124.416 1.087 . . . . 73.040000000000006 110.812 179.181 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_endo -73.0 168.53 24.5 Favored 'Trans proline' 0 C--N 1.382 2.294 0 C-N-CA 122.187 1.924 . . . . 53.229999999999997 113.198 173.747 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 163.03 -120.14 0.93 Allowed Glycine 0 CA--C 1.538 1.529 0 CA-C-O 118.911 -0.938 . . . . 43.299999999999997 112.106 176.854 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 243' ' ' PRO . . . . . 0.525 ' HD2' ' HB3' ' A' ' 191' ' ' GLN . 37.1 Cg_endo -59.83 -59.04 0.44 Allowed 'Trans proline' 0 C--N 1.379 2.133 0 C-N-CA 124.563 3.509 . . . . 73.209999999999994 112.892 -173.976 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -83.5 -9.28 59.07 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 123.381 0.672 . . . . 73.120000000000005 111.066 178.645 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 85.39 -22.82 9.47 Favored Glycine 0 C--N 1.356 1.649 0 C-N-CA 123.175 0.417 . . . . 53.409999999999997 113.134 -177.161 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 10.0 ttm180 -125.33 111.56 15.32 Favored 'General case' 0 C--O 1.241 0.649 0 C-N-CA 124.545 1.138 . . . . 72.329999999999998 109.21 -179.7 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -76.75 151.46 39.4 Favored Glycine 0 C--N 1.348 1.198 0 O-C-N 123.726 0.641 . . . . 65.099999999999994 114.006 178.006 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -103.98 140.95 37.02 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.062 0.945 . . . . 73.340000000000003 109.747 -177.727 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 249' ' ' LEU . . . . . 0.566 ' HB3' ' HB2' ' A' ' 235' ' ' LEU . 45.7 tp -109.04 111.9 23.79 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 108.93 -0.767 . . . . 72.010000000000005 108.93 176.439 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 250' ' ' TYR . . . . . 0.461 ' HA ' ' O ' ' A' ' 233' ' ' LEU . 4.8 m-85 -89.58 109.28 20.24 Favored 'General case' 0 C--O 1.242 0.703 0 CA-C-O 121.36 0.6 . . . . 71.430000000000007 110.163 -179.531 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 251' ' ' LEU . . . . . 0.645 HD13 HD22 ' A' ' 197' ' ' LEU . 80.1 mt -87.35 104.02 16.03 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-N 114.382 -1.281 . . . . 73.510000000000005 108.289 179.865 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 56.3 mt-10 -85.42 94.19 8.92 Favored 'General case' 0 C--O 1.241 0.621 0 N-CA-C 108.572 -0.899 . . . . 73.450000000000003 108.572 -178.964 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 11.4 m -63.36 138.5 22.85 Favored 'Isoleucine or valine' 0 C--N 1.352 0.699 0 O-C-N 123.858 0.724 . . . . 72.209999999999994 110.374 -176.403 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 15.4 mmm180 -126.14 108.78 11.66 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 107.272 -1.381 . . . . 74.239999999999995 107.272 179.225 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 255' ' ' ILE . . . . . 0.456 ' HA ' ' O ' ' A' ' 199' ' ' VAL . 29.0 mt -78.92 121.15 31.45 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 O-C-N 123.9 0.75 . . . . 62.310000000000002 110.116 179.29 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 2.5 t . . . . . 0 C--O 1.254 1.294 0 C-N-CA 123.922 0.889 . . . . 71.349999999999994 109.42 174.727 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 26.5 ttt . . . . . 0 N--CA 1.475 0.794 0 N-CA-C 110.167 -0.309 . . . . 74.010000000000005 110.167 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 17.0 pt20 -130.57 -176.32 3.94 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 124.67 1.188 . . . . 61.420000000000002 109.094 174.656 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 9.9 t -93.0 154.23 18.27 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 123.381 0.673 . . . . 73.049999999999997 109.413 169.008 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -96.67 -85.97 0.33 Allowed 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 122.811 0.444 . . . . 73.439999999999998 110.175 179.9 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 172' ' ' LEU . . . . . 0.71 HD21 ' H ' ' A' ' 222' ' ' ALA . 41.4 mt -145.74 160.46 41.7 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 123.568 0.747 . . . . 70.230000000000004 111.277 -169.164 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 173' ' ' PHE . . . . . 0.401 ' CD1' HD22 ' A' ' 235' ' ' LEU . 27.5 m-85 -130.94 -47.51 1.02 Allowed 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 114.623 -1.171 . . . . 65.420000000000002 109.095 -167.918 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 174' ' ' TYR . . . . . 0.435 ' HB2' ' HB2' ' A' ' 178' ' ' ALA . 8.2 p90 -84.23 8.07 17.04 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-N 114.36 -1.291 . . . . 75.120000000000005 113.324 -173.889 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 14.8 p -60.09 -23.29 63.69 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 123.158 0.583 . . . . 72.150000000000006 112.216 177.293 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 176' ' ' MET . . . . . . . . . . . . . 40.1 mtm -54.89 -49.92 70.02 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 124.216 1.006 . . . . 70.140000000000001 110.655 173.849 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -169.54 122.28 0.74 Allowed 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 124.834 1.254 . . . . 61.32 108.037 179.295 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 178' ' ' ALA . . . . . 0.634 ' HB1' HD22 ' A' ' 233' ' ' LEU . . . -146.71 -56.94 0.27 Allowed 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 123.209 0.604 . . . . 72.010000000000005 110.946 -175.288 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 179' ' ' ALA . . . . . 0.603 ' HB2' ' HB2' ' A' ' 224' ' ' PRO . . . -75.46 78.55 2.5 Favored 'General case' 0 C--N 1.353 0.754 0 CA-C-O 122.256 1.027 . . . . 74.140000000000001 108.832 172.715 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 167.21 -167.03 39.61 Favored Glycine 0 CA--C 1.522 0.487 0 CA-C-N 113.255 -1.793 . . . . 74.129999999999995 110.128 -173.759 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 68.0 p -139.71 133.8 31.05 Favored 'General case' 0 N--CA 1.479 0.982 0 CA-C-N 117.397 0.598 . . . . 64.430000000000007 110.806 179.741 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . 179.44 150.28 8.93 Favored Glycine 0 C--N 1.349 1.279 0 CA-C-N 115.95 -0.568 . . . . 65.219999999999999 112.123 -178.198 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -133.79 -174.38 13.52 Favored Glycine 0 C--N 1.348 1.243 0 N-CA-C 112.003 -0.439 . . . . 34.420000000000002 112.003 -179.624 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 17.1 m -135.63 158.98 43.05 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 123.35 0.66 . . . . 72.239999999999995 110.709 -178.842 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -110.77 61.06 0.31 Allowed Glycine 0 C--N 1.341 0.807 0 CA-C-N 115.481 -0.781 . . . . 33.119999999999997 111.3 179.387 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -86.6 51.89 4.39 Favored Glycine 0 C--N 1.347 1.17 0 N-CA-C 111.82 -0.512 . . . . 52.340000000000003 111.82 175.856 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 17.4 m -63.72 -24.11 67.64 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 124.509 1.123 . . . . 74.140000000000001 113.044 -171.99 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -66.77 -12.8 60.23 Favored Glycine 0 C--N 1.35 1.318 0 N-CA-C 115.005 0.762 . . . . 20.140000000000001 115.005 -177.101 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -173.18 149.15 10.93 Favored Glycine 0 C--N 1.346 1.128 0 CA-C-N 117.178 0.489 . . . . 74.299999999999997 112.553 176.681 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 35.5 m -84.4 69.63 10.54 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 123.482 0.713 . . . . 63.340000000000003 111.257 -177.735 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 191' ' ' GLN . . . . . 0.651 ' HB3' ' HD2' ' A' ' 243' ' ' PRO . 9.6 pt20 -79.41 -24.29 42.64 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-N 115.944 -0.571 . . . . 62.109999999999999 110.64 175.894 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 17.7 m-20 -74.99 150.62 38.93 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-N 115.367 -0.833 . . . . 72.200000000000003 110.704 -174.812 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 193' ' ' LEU . . . . . 0.662 HD12 ' HA2' ' A' ' 239' ' ' GLY . 32.6 mt -140.79 170.82 15.04 Favored 'General case' 0 C--O 1.241 0.608 0 CA-C-N 114.592 -1.186 . . . . 61.520000000000003 109.176 -179.399 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 55.1 m-85 -138.41 122.07 17.47 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 123.491 0.717 . . . . 62.549999999999997 109.689 178.846 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 195' ' ' ALA . . . . . 0.463 ' HB2' HD11 ' A' ' 249' ' ' LEU . . . -126.3 135.98 52.18 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 107.834 -1.172 . . . . 64.010000000000005 107.834 174.993 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 9.1 m -83.55 130.63 35.01 Favored 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 109.742 -0.466 . . . . 72.200000000000003 109.742 -176.374 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 0.502 HD22 HD13 ' A' ' 251' ' ' LEU . 15.5 tp -109.35 108.53 19.12 Favored 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 108.663 -0.866 . . . . 74.400000000000006 108.663 -179.479 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -81.21 113.23 19.21 Favored 'General case' 0 CA--C 1.542 0.648 0 N-CA-C 108.92 -0.77 . . . . 71.420000000000002 108.92 176.966 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 199' ' ' VAL . . . . . 0.413 ' O ' ' HA ' ' A' ' 255' ' ' ILE . 6.5 p -132.18 128.99 21.53 Favored Pre-proline 0 CA--C 1.55 0.976 0 C-N-CA 124.035 0.934 . . . . 71.140000000000001 109.34 -178.706 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -70.58 159.06 54.07 Favored 'Trans proline' 0 C--N 1.37 1.709 0 C-N-CA 122.035 1.823 . . . . 74.049999999999997 111.691 170.101 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -51.18 -49.7 79.9 Favored Pre-proline 0 CA--C 1.564 1.497 0 CA-C-O 117.775 -1.107 . . . . 30.140000000000001 113.619 -179.56 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 202' ' ' PRO . . . . . 0.458 ' O ' HG22 ' A' ' 206' ' ' VAL . 42.6 Cg_endo -64.24 -43.01 15.79 Favored 'Trans proline' 0 C--N 1.396 3.074 0 C-N-CA 121.861 1.708 . . . . 61.200000000000003 113.702 -179.035 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 51.8 mt -63.48 -34.17 65.81 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.386 0 CA-C-N 118.152 0.433 . . . . 73.109999999999999 110.351 176.628 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -66.2 -52.68 45.66 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 122.821 0.448 . . . . 62.219999999999999 111.622 179.245 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 20.2 m -69.45 -49.67 57.84 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.924 0 C-N-CA 123.618 0.767 . . . . 64.549999999999997 112.577 -173.444 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 206' ' ' VAL . . . . . 0.458 HG22 ' O ' ' A' ' 202' ' ' PRO . 6.7 m -76.99 -31.0 18.34 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.181 0 CA-C-O 120.714 0.292 . . . . 71.010000000000005 110.909 -179.736 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 85.63 70.26 1.33 Allowed Glycine 0 C--N 1.345 1.066 0 CA-C-N 115.943 -0.571 . . . . 73.209999999999994 112.022 -176.826 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -87.51 -126.4 2.29 Favored Glycine 0 C--N 1.352 1.466 0 N-CA-C 111.902 -0.479 . . . . 51.130000000000003 111.902 176.403 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 46.5 mtmt -139.45 151.65 46.39 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 123.695 0.798 . . . . 65.530000000000001 111.12 177.234 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 5.8 m -144.81 169.92 7.77 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 C-N-CA 125.335 1.454 . . . . 64.349999999999994 109.532 175.664 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 55.4 ttp180 -102.25 117.05 33.93 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 124.1 0.96 . . . . 72.349999999999994 110.048 -179.831 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -100.73 128.92 46.6 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 124.104 0.962 . . . . 71.409999999999997 110.207 177.439 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 90.8 mmm -92.55 115.57 28.22 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 123.369 0.667 . . . . 73.400000000000006 109.413 179.572 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 17.4 p -111.71 -179.39 3.69 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 124.288 1.035 . . . . 73.239999999999995 109.907 -176.687 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 89.0 mt -56.77 -29.69 62.88 Favored 'General case' 0 N--CA 1.491 1.583 0 CA-C-O 121.082 0.467 . . . . 73.140000000000001 111.216 171.883 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -101.29 23.2 11.29 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 124.476 1.11 . . . . 73.299999999999997 111.144 -178.252 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 83.42 -159.42 36.89 Favored Glycine 0 C--N 1.348 1.246 0 CA-C-O 119.508 -0.607 . . . . 54.130000000000003 113.303 176.314 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -71.29 157.03 58.0 Favored 'Trans proline' 0 C--N 1.367 1.524 0 C-N-CA 122.665 2.244 . . . . 74.239999999999995 113.21 -173.232 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 7.3 p -151.58 136.9 10.96 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 C-N-CA 124.142 0.977 . . . . 72.099999999999994 108.869 174.656 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -80.64 103.43 10.48 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 108.832 -0.803 . . . . 74.409999999999997 108.832 175.573 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 10.8 m -104.08 133.75 47.25 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 CA-C-O 121.451 0.644 . . . . 72.549999999999997 110.057 177.95 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 222' ' ' ALA . . . . . 0.71 ' H ' HD21 ' A' ' 172' ' ' LEU . . . -86.7 105.66 17.09 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 114.743 -1.117 . . . . 74.25 110.427 -178.731 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 90.6 t -54.49 134.14 62.87 Favored Pre-proline 0 N--CA 1.481 1.112 0 C-N-CA 125.355 1.462 . . . . 70.409999999999997 111.179 -176.763 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 224' ' ' PRO . . . . . 0.603 ' HB2' ' HB2' ' A' ' 179' ' ' ALA . 72.4 Cg_endo -70.33 159.84 51.61 Favored 'Trans proline' 0 C--N 1.376 2.022 0 C-N-CA 122.209 1.939 . . . . 64.140000000000001 111.924 175.912 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 22.8 Cg_endo -64.6 136.41 49.89 Favored 'Trans proline' 0 C--N 1.38 2.204 0 C-N-CA 121.981 1.788 . . . . 75.430000000000007 111.554 176.189 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 44.3 mtm-85 63.72 64.9 0.75 Allowed 'General case' 0 C--O 1.244 0.775 0 C-N-CA 124.7 1.2 . . . . 73.420000000000002 110.074 175.672 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 227' ' ' THR . . . . . 0.446 ' HA ' ' HE ' ' A' ' 231' ' ' ARG . 88.5 m -96.68 123.19 40.28 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 108.214 -1.032 . . . . 72.219999999999999 108.214 174.458 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 27.6 mp0 -109.7 148.24 31.73 Favored 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 123.49 0.716 . . . . 74.25 109.085 -179.382 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -57.66 114.29 2.2 Favored 'General case' 0 C--N 1.352 0.674 0 O-C-N 124.278 0.986 . . . . 60.439999999999998 110.494 -178.685 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 113.76 5.94 21.68 Favored Glycine 0 CA--C 1.528 0.902 0 O-C-N 124.051 0.844 . . . . 70.019999999999996 113.402 -175.48 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 231' ' ' ARG . . . . . 0.446 ' HE ' ' HA ' ' A' ' 227' ' ' THR . 40.7 mtt-85 -71.89 149.57 45.02 Favored 'General case' 0 N--CA 1.481 1.095 0 CA-C-N 117.72 0.76 . . . . 72.540000000000006 109.074 165.891 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 232' ' ' LYS . . . . . 0.407 ' HA ' ' O ' ' A' ' 251' ' ' LEU . 43.5 mtmt -128.72 99.48 5.36 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 123.513 0.725 . . . . 73.349999999999994 109.344 178.404 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 233' ' ' LEU . . . . . 0.634 HD22 ' HB1' ' A' ' 178' ' ' ALA . 24.1 mt -81.65 132.75 35.31 Favored 'General case' 0 CA--C 1.552 1.044 0 C-N-CA 124.088 0.955 . . . . 74.409999999999997 110.266 -173.467 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 40.1 ttt180 -89.53 102.97 15.65 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 123.4 0.68 . . . . 63.420000000000002 112.35 -169.654 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 235' ' ' LEU . . . . . 0.604 ' HB2' ' HB3' ' A' ' 249' ' ' LEU . 18.0 mt -93.35 97.08 10.35 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 123.057 0.543 . . . . 73.120000000000005 110.483 174.679 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 40.8 mtmt -69.49 144.46 53.21 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-O 120.85 0.357 . . . . 74.120000000000005 111.192 177.002 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 73.68 1.03 57.48 Favored Glycine 0 N--CA 1.473 1.137 0 CA-C-N 115.237 -0.892 . . . . 72.319999999999993 114.949 -177.816 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 76.1 mmtt -106.04 3.87 28.68 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 117.418 0.609 . . . . 70.439999999999998 110.525 179.229 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 239' ' ' GLY . . . . . 0.662 ' HA2' HD12 ' A' ' 193' ' ' LEU . . . -101.93 -160.33 26.57 Favored Glycine 0 C--N 1.35 1.318 0 N-CA-C 111.063 -0.815 . . . . 73.439999999999998 111.063 164.025 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 71.4 m-85 -95.04 155.03 39.48 Favored Pre-proline 0 N--CA 1.485 1.314 0 C-N-CA 123.826 0.85 . . . . 71.319999999999993 110.981 -179.597 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_exo -71.09 130.62 17.98 Favored 'Trans proline' 0 C--N 1.371 1.735 0 C-N-CA 121.764 1.642 . . . . 71.319999999999993 111.197 170.933 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -163.54 -121.35 0.56 Allowed Glycine 0 CA--C 1.535 1.325 0 CA-C-O 118.776 -1.013 . . . . 50.420000000000002 113.401 -177.829 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 243' ' ' PRO . . . . . 0.651 ' HD2' ' HB3' ' A' ' 191' ' ' GLN . 37.3 Cg_endo -58.96 -42.85 47.99 Favored 'Trans proline' 0 C--N 1.385 2.462 0 C-N-CA 124.379 3.386 . . . . 75.519999999999996 112.935 -172.399 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -96.59 -4.88 40.37 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 123.551 0.74 . . . . 65.140000000000001 111.044 177.152 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 84.27 -23.39 7.22 Favored Glycine 0 C--N 1.361 1.939 0 C-N-CA 123.142 0.401 . . . . 75.450000000000003 113.423 -178.827 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 43.1 ttt85 -128.0 111.58 13.69 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.97 1.308 . . . . 75.340000000000003 108.901 -179.649 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -72.48 151.3 46.36 Favored Glycine 0 C--N 1.347 1.145 0 N-CA-C 115.064 0.785 . . . . 61.299999999999997 115.064 178.694 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 38.2 m-20 -111.64 127.78 55.86 Favored 'General case' 0 C--O 1.233 0.221 0 C-N-CA 124.295 1.038 . . . . 71.219999999999999 109.382 -176.487 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 249' ' ' LEU . . . . . 0.604 ' HB3' ' HB2' ' A' ' 235' ' ' LEU . 58.8 tp -103.76 109.83 21.69 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 108.323 -0.992 . . . . 73.519999999999996 108.323 178.526 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 250' ' ' TYR . . . . . . . . . . . . . 4.4 m-85 -88.21 118.65 27.95 Favored 'General case' 0 C--O 1.241 0.646 0 N-CA-C 109.271 -0.64 . . . . 73.430000000000007 109.271 -176.267 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 251' ' ' LEU . . . . . 0.502 HD13 HD22 ' A' ' 197' ' ' LEU . 74.3 mt -88.14 103.31 15.64 Favored 'General case' 0 C--N 1.343 0.302 0 N-CA-C 107.935 -1.135 . . . . 62.409999999999997 107.935 -177.061 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -83.07 93.11 7.53 Favored 'General case' 0 C--O 1.241 0.638 0 N-CA-C 107.329 -1.36 . . . . 63.130000000000003 107.329 -175.53 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 4.9 m -71.94 136.84 24.86 Favored 'Isoleucine or valine' 0 C--N 1.351 0.648 0 CA-C-N 114.959 -1.018 . . . . 73.329999999999998 110.819 -170.746 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 24.4 mmm180 -122.05 112.54 18.38 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 106.913 -1.514 . . . . 74.340000000000003 106.913 179.737 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 255' ' ' ILE . . . . . 0.413 ' HA ' ' O ' ' A' ' 199' ' ' VAL . 35.2 mt -80.4 115.98 23.8 Favored 'Isoleucine or valine' 0 C--O 1.236 0.382 0 N-CA-C 108.758 -0.83 . . . . 65.140000000000001 108.758 173.569 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 9.5 t . . . . . 0 C--O 1.26 1.655 0 N-CA-C 108.349 -0.982 . . . . 74.109999999999999 108.349 168.614 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 28.0 ptm . . . . . 0 N--CA 1.481 1.08 0 N-CA-C 111.82 0.304 . . . . 74.319999999999993 111.82 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 169' ' ' GLN . . . . . 0.582 ' HG3' HG22 ' A' ' 170' ' ' THR . 12.9 pt20 -112.45 -29.28 7.56 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 123.09 0.556 . . . . 74.319999999999993 111.491 -172.743 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 170' ' ' THR . . . . . 0.582 HG22 ' HG3' ' A' ' 169' ' ' GLN . 12.6 t -161.46 144.0 12.11 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 123.466 0.707 . . . . 74.099999999999994 111.323 -176.897 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -116.9 -70.74 0.77 Allowed 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 123.184 0.594 . . . . 63.109999999999999 110.412 -172.262 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 172' ' ' LEU . . . . . 0.539 HD21 ' H ' ' A' ' 222' ' ' ALA . 63.6 mt -134.3 158.86 42.69 Favored 'General case' 0 N--CA 1.484 1.273 0 CA-C-O 122.039 0.923 . . . . 74.420000000000002 112.068 -175.076 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 173' ' ' PHE . . . . . 0.485 ' CD1' HD22 ' A' ' 235' ' ' LEU . 19.8 m-85 -136.71 -51.67 0.69 Allowed 'General case' 0 N--CA 1.477 0.919 0 CA-C-N 114.586 -1.188 . . . . 72.340000000000003 108.609 -171.343 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 174' ' ' TYR . . . . . 0.44 ' OH ' ' HB ' ' A' ' 221' ' ' VAL . 2.9 p90 -79.3 17.87 0.76 Allowed 'General case' 0 CA--C 1.552 1.04 0 CA-C-N 113.446 -1.706 . . . . 73.150000000000006 112.551 -179.213 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 175' ' ' THR . . . . . 0.45 HG23 HD13 ' A' ' 172' ' ' LEU . 0.2 OUTLIER -66.1 -18.57 65.43 Favored 'General case' 0 CA--C 1.552 1.032 0 C-N-CA 124.1 0.96 . . . . 71.409999999999997 111.888 -174.936 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 176' ' ' MET . . . . . 0.51 ' SD ' ' N ' ' A' ' 177' ' ' LYS . 0.0 OUTLIER -70.74 -45.36 64.98 Favored 'General case' 0 CA--C 1.554 1.126 0 C-N-CA 123.978 0.911 . . . . 75.209999999999994 111.45 173.509 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 177' ' ' LYS . . . . . 0.51 ' N ' ' SD ' ' A' ' 176' ' ' MET . 35.7 mttp -162.91 134.15 4.93 Favored 'General case' 0 N--CA 1.491 1.599 0 C-N-CA 125.702 1.601 . . . . 54.149999999999999 108.681 175.277 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 178' ' ' ALA . . . . . 0.495 ' HB1' HD22 ' A' ' 233' ' ' LEU . . . -147.99 -53.54 0.2 Allowed 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 123.934 0.893 . . . . 75.030000000000001 109.839 -172.859 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -85.48 36.9 0.66 Allowed 'General case' 0 CA--C 1.558 1.259 0 C-N-CA 123.876 0.87 . . . . 74.349999999999994 109.957 171.341 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -119.93 -175.67 15.76 Favored Glycine 0 C--N 1.354 1.53 0 N-CA-C 110.638 -0.985 . . . . 72.439999999999998 110.638 176.766 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 31.8 t -162.37 170.61 18.54 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 123.645 0.778 . . . . 71.099999999999994 109.994 178.898 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . 74.58 85.13 0.3 Allowed Glycine 0 C--N 1.347 1.171 0 N-CA-C 112.165 -0.374 . . . . 61.439999999999998 112.165 177.88 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -118.13 134.09 10.79 Favored Glycine 0 C--N 1.348 1.22 0 N-CA-C 111.057 -0.817 . . . . 64.420000000000002 111.057 177.574 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 28.9 t -73.08 87.97 1.4 Allowed 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 123.397 0.679 . . . . 64.340000000000003 109.902 179.751 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 172.71 -173.53 45.5 Favored Glycine 0 C--N 1.345 1.039 0 N-CA-C 112.074 -0.41 . . . . 42.210000000000001 112.074 -179.235 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 137.2 -0.61 2.91 Favored Glycine 0 C--N 1.346 1.097 0 CA-C-O 119.766 -0.463 . . . . 54.140000000000001 113.39 177.783 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 38.4 m -79.54 -17.13 54.68 Favored 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 122.944 0.498 . . . . 75.030000000000001 110.962 177.338 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 65.7 -128.82 32.7 Favored Glycine 0 C--N 1.349 1.261 0 O-C-N 123.78 0.675 . . . . 60.030000000000001 113.397 177.75 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 138.64 34.09 0.18 Allowed Glycine 0 C--N 1.345 1.047 0 CA-C-O 119.604 -0.553 . . . . 64.150000000000006 112.124 178.223 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 22.9 t 65.07 19.2 11.76 Favored 'General case' 0 N--CA 1.49 1.555 0 C-N-CA 124.214 1.006 . . . . 63.420000000000002 111.976 -179.022 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 191' ' ' GLN . . . . . 0.509 ' HB3' ' HD2' ' A' ' 243' ' ' PRO . 2.3 pt20 -99.45 -13.84 19.36 Favored 'General case' 0 N--CA 1.479 1.008 0 CA-C-O 121.391 0.615 . . . . 71.450000000000003 111.092 179.118 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -86.32 144.67 27.26 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 124.35 1.06 . . . . 70.030000000000001 110.201 -163.501 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 193' ' ' LEU . . . . . 0.5 HD12 ' HA2' ' A' ' 239' ' ' GLY . 25.4 mt -138.69 163.63 31.62 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 124.27 1.028 . . . . 72.340000000000003 109.391 174.363 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 50.6 m-85 -139.36 122.82 17.24 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 123.779 0.832 . . . . 55.210000000000001 109.761 -177.543 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 195' ' ' ALA . . . . . 0.44 ' HB2' HD11 ' A' ' 249' ' ' LEU . . . -133.02 129.13 37.73 Favored 'General case' 0 N--CA 1.466 0.335 0 O-C-N 124.343 1.027 . . . . 31.329999999999998 108.6 175.654 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 33.6 m -76.79 130.82 38.2 Favored 'General case' 0 CA--C 1.541 0.617 0 N-CA-C 109.694 -0.484 . . . . 74.420000000000002 109.694 178.157 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 0.598 HD22 HD13 ' A' ' 251' ' ' LEU . 15.1 tp -112.21 108.79 18.15 Favored 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 107.61 -1.256 . . . . 72.400000000000006 107.61 176.645 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -83.76 132.32 34.85 Favored 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 108.841 -0.8 . . . . 74.450000000000003 108.841 174.838 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 199' ' ' VAL . . . . . 0.45 ' O ' ' HA ' ' A' ' 255' ' ' ILE . 4.1 p -144.61 129.88 9.44 Favored Pre-proline 0 CA--C 1.549 0.934 0 C-N-CA 123.866 0.866 . . . . 74.409999999999997 108.671 -179.983 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -70.35 153.7 65.98 Favored 'Trans proline' 0 C--N 1.367 1.536 0 C-N-CA 122.21 1.94 . . . . 72.310000000000002 110.836 168.49 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 201' ' ' ALA . . . . . 0.465 ' O ' HG23 ' A' ' 205' ' ' VAL . . . -49.88 -51.4 61.28 Favored Pre-proline 0 CA--C 1.555 1.153 0 C-N-CA 124.754 1.222 . . . . 63.020000000000003 113.361 -177.729 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_endo -60.85 -35.85 86.58 Favored 'Trans proline' 0 C--N 1.397 3.118 0 C-N-CA 121.771 1.647 . . . . 73.109999999999999 113.896 -178.487 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 38.1 mt -70.02 -34.14 58.33 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 C-N-CA 122.587 0.355 . . . . 71.409999999999997 110.461 177.418 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -67.1 -38.36 85.52 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 122.342 0.257 . . . . 74.329999999999998 111.22 175.838 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 205' ' ' VAL . . . . . 0.465 HG23 ' O ' ' A' ' 201' ' ' ALA . 92.1 t -69.25 -56.49 11.62 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.125 0 C-N-CA 123.963 0.905 . . . . 55.119999999999997 111.083 -179.423 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 18.0 m -75.59 -24.07 16.93 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.133 0 CA-C-N 116.09 -0.504 . . . . 62.509999999999998 111.574 -174.883 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 76.15 66.21 1.89 Allowed Glycine 0 C--N 1.345 1.042 0 CA-C-N 115.251 -0.886 . . . . 63.240000000000002 111.83 -173.987 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -83.74 -140.46 4.29 Favored Glycine 0 C--N 1.352 1.443 0 N-CA-C 112.161 -0.376 . . . . 41.009999999999998 112.161 178.628 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 49.4 mtmt -137.43 137.5 38.83 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.606 0.763 . . . . 63.439999999999998 110.414 177.915 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 11.0 m -127.82 165.39 27.03 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 C-N-CA 125.119 1.368 . . . . 71.120000000000005 108.742 172.903 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 50.6 ttp180 -101.59 117.47 34.98 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 123.25 0.62 . . . . 71.239999999999995 110.323 -178.564 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -101.99 132.59 47.73 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 123.958 0.903 . . . . 73.239999999999995 110.239 175.721 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 25.3 mmt -90.91 121.32 32.65 Favored 'General case' 0 N--CA 1.48 1.075 0 N-CA-C 109.343 -0.614 . . . . 74.310000000000002 109.343 175.306 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 30.5 p -121.97 -173.54 2.68 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 124.484 1.114 . . . . 62.200000000000003 110.371 -174.779 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 83.2 mt -61.65 -30.95 71.05 Favored 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 123.216 0.606 . . . . 70.200000000000003 111.097 171.588 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -98.76 21.28 11.65 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 123.498 0.719 . . . . 74.129999999999995 111.282 179.791 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 84.49 -159.15 34.76 Favored Glycine 0 C--N 1.356 1.658 0 CA-C-O 119.411 -0.66 . . . . 61.409999999999997 113.012 175.359 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -64.76 142.25 75.63 Favored 'Trans proline' 0 C--N 1.369 1.633 0 C-N-CA 122.817 2.345 . . . . 73.200000000000003 112.58 178.687 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 4.8 p -140.81 128.53 23.01 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 N-CA-C 108.333 -0.988 . . . . 43.210000000000001 108.333 174.323 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 3.8 mp0 -79.28 101.6 8.12 Favored 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 107.28 -1.378 . . . . 72.329999999999998 107.28 175.949 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 221' ' ' VAL . . . . . 0.44 ' HB ' ' OH ' ' A' ' 174' ' ' TYR . 2.8 m -99.39 128.25 51.32 Favored 'Isoleucine or valine' 0 C--O 1.24 0.586 0 CA-C-O 121.602 0.715 . . . . 71.209999999999994 109.544 -179.675 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 222' ' ' ALA . . . . . 0.539 ' H ' HD21 ' A' ' 172' ' ' LEU . . . -80.26 104.81 11.07 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 114.407 -1.27 . . . . 52.420000000000002 109.26 179.63 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 61.3 t -53.99 134.9 57.93 Favored Pre-proline 0 CA--C 1.558 1.283 0 O-C-N 124.567 1.167 . . . . 54.240000000000002 109.707 178.549 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -63.87 149.85 89.73 Favored 'Trans proline' 0 C--N 1.371 1.722 0 C-N-CA 122.068 1.845 . . . . 55.32 111.452 173.474 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -63.23 134.12 43.99 Favored 'Trans proline' 0 C--N 1.373 1.854 0 C-N-CA 121.907 1.738 . . . . 71.010000000000005 110.983 174.952 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 33.6 mtm-85 63.82 53.39 1.96 Allowed 'General case' 0 CA--C 1.546 0.817 0 O-C-N 124.68 1.237 . . . . 74.129999999999995 111.043 175.858 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 227' ' ' THR . . . . . 0.424 HG23 ' HD2' ' A' ' 231' ' ' ARG . 30.6 m -78.24 145.17 35.62 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 115.444 -0.798 . . . . 72.409999999999997 108.945 170.391 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 27.0 mp0 -116.22 145.54 43.04 Favored 'General case' 0 N--CA 1.48 1.061 0 N-CA-C 108.563 -0.902 . . . . 70.510000000000005 108.563 176.916 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 229' ' ' ALA . . . . . 0.523 ' HB2' ' HB ' ' A' ' 255' ' ' ILE . . . -60.2 130.72 48.06 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.543 0.737 . . . . 72.200000000000003 109.762 -179.48 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 97.85 12.08 48.0 Favored Glycine 0 CA--C 1.522 0.504 0 O-C-N 123.857 0.723 . . . . 74.310000000000002 112.852 -178.248 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 231' ' ' ARG . . . . . 0.424 ' HD2' HG23 ' A' ' 227' ' ' THR . 95.1 mtt-85 -84.24 156.14 22.14 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 109.256 -0.646 . . . . 74.400000000000006 109.256 165.049 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 232' ' ' LYS . . . . . 0.421 ' HA ' ' O ' ' A' ' 251' ' ' LEU . 42.3 mtmt -130.38 106.84 8.82 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.583 0.753 . . . . 73.439999999999998 109.312 -179.735 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 233' ' ' LEU . . . . . 0.526 ' HB2' ' HB2' ' A' ' 251' ' ' LEU . 26.3 mt -80.27 134.04 36.04 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 115.218 -0.901 . . . . 74.450000000000003 109.526 -176.677 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 75.3 ttt180 -97.33 109.95 22.6 Favored 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 122.808 0.443 . . . . 73.430000000000007 110.93 -170.732 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 235' ' ' LEU . . . . . 0.543 HD12 HD23 ' A' ' 249' ' ' LEU . 15.0 mt -99.77 105.87 17.7 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.265 0.626 . . . . 72.239999999999995 111.099 179.522 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 1.9 mtpp -72.09 153.79 41.49 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-O 120.719 0.295 . . . . 70.519999999999996 110.563 171.707 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 65.63 13.83 59.4 Favored Glycine 0 N--CA 1.473 1.141 0 O-C-N 124.486 1.116 . . . . 75.430000000000007 114.359 -177.198 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 41.1 mmtm -125.53 4.58 7.59 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 123.782 0.833 . . . . 72.230000000000004 111.823 -177.968 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 239' ' ' GLY . . . . . 0.5 ' HA2' HD12 ' A' ' 193' ' ' LEU . . . -107.66 -167.64 21.75 Favored Glycine 0 C--N 1.345 1.028 0 N-CA-C 110.879 -0.888 . . . . 70.030000000000001 110.879 165.644 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 66.7 m-85 -92.44 166.55 16.78 Favored Pre-proline 0 CA--C 1.548 0.892 0 C-N-CA 123.794 0.837 . . . . 73.439999999999998 110.777 178.807 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 241' ' ' PRO . . . . . 0.414 ' HA ' ' O ' ' A' ' 245' ' ' GLY . 55.2 Cg_endo -70.88 146.47 53.33 Favored 'Trans proline' 0 C--N 1.374 1.887 0 C-N-CA 121.756 1.637 . . . . 65.420000000000002 111.577 168.068 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -169.74 -117.3 0.41 Allowed Glycine 0 CA--C 1.532 1.103 0 CA-C-O 119.039 -0.867 . . . . 52.109999999999999 111.587 178.923 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 243' ' ' PRO . . . . . 0.509 ' HD2' ' HB3' ' A' ' 191' ' ' GLN . 65.6 Cg_endo -66.15 -57.36 0.23 Allowed 'Trans proline' 0 C--N 1.375 1.96 0 C-N-CA 124.246 3.298 . . . . 70.450000000000003 112.617 -169.574 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -96.39 18.88 12.99 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.899 0.88 . . . . 74.030000000000001 110.463 176.415 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 245' ' ' GLY . . . . . 0.414 ' O ' ' HA ' ' A' ' 241' ' ' PRO . . . 74.66 -103.33 1.52 Allowed Glycine 0 C--N 1.354 1.558 0 N-CA-C 110.322 -1.111 . . . . 71.310000000000002 110.322 -170.835 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 31.0 ttm180 -50.42 110.63 0.43 Allowed 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 125.203 1.401 . . . . 74.040000000000006 112.559 -176.408 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -89.04 179.46 45.39 Favored Glycine 0 C--N 1.344 0.991 0 CA-C-N 115.898 -0.592 . . . . 65.420000000000002 113.478 178.322 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 20.9 m-20 -126.83 152.53 46.86 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 114.598 -0.801 . . . . 71.540000000000006 112.504 -168.795 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 249' ' ' LEU . . . . . 0.543 HD23 HD12 ' A' ' 235' ' ' LEU . 55.7 tp -110.17 117.08 32.75 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 114.354 -1.293 . . . . 75.430000000000007 108.095 171.117 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 250' ' ' TYR . . . . . . . . . . . . . 3.7 m-85 -90.24 115.16 27.25 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 123.188 0.595 . . . . 53.32 109.404 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 251' ' ' LEU . . . . . 0.598 HD13 HD22 ' A' ' 197' ' ' LEU . 77.2 mt -88.5 105.35 17.56 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-N 114.685 -1.143 . . . . 74.109999999999999 108.486 -177.973 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 252' ' ' GLU . . . . . 0.451 ' HG3' ' HD3' ' A' ' 254' ' ' ARG . 12.0 tp10 -79.56 94.06 5.57 Favored 'General case' 0 C--O 1.238 0.486 0 N-CA-C 108.55 -0.907 . . . . 63.32 108.55 -178.746 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 4.4 m -71.67 127.48 33.67 Favored 'Isoleucine or valine' 0 C--N 1.352 0.694 0 CA-C-O 121.619 0.723 . . . . 71.209999999999994 109.664 -174.839 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 254' ' ' ARG . . . . . 0.451 ' HD3' ' HG3' ' A' ' 252' ' ' GLU . 22.9 mmm180 -122.87 95.1 4.49 Favored 'General case' 0 C--O 1.239 0.517 0 N-CA-C 107.971 -1.122 . . . . 65.319999999999993 107.971 -176.7 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 255' ' ' ILE . . . . . 0.523 ' HB ' ' HB2' ' A' ' 229' ' ' ALA . 40.3 mt -76.6 121.08 28.03 Favored 'Isoleucine or valine' 0 C--O 1.238 0.465 0 CA-C-N 115.589 -0.732 . . . . 72.019999999999996 109.669 178.054 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 9.4 t . . . . . 0 C--O 1.254 1.303 0 C-N-CA 123.97 0.908 . . . . 72.329999999999998 108.657 175.885 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 23.4 ttt . . . . . 0 N--CA 1.488 1.435 0 CA-C-O 121.228 0.537 . . . . 74.019999999999996 110.161 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 13.7 pt20 -147.82 -178.06 6.06 Favored 'General case' 0 C--O 1.241 0.643 0 CA-C-N 115.505 -0.77 . . . . 73.540000000000006 110.03 -174.662 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 12.5 t -65.96 157.99 29.33 Favored 'General case' 0 CA--C 1.545 0.788 0 CA-C-N 115.649 -0.705 . . . . 72.420000000000002 110.882 173.378 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -99.89 -160.75 0.82 Allowed 'General case' 0 CA--C 1.554 1.123 0 N-CA-C 108.373 -0.973 . . . . 54.149999999999999 108.373 179.823 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 172' ' ' LEU . . . . . 0.55 HD21 ' H ' ' A' ' 222' ' ' ALA . 26.0 mt -72.5 173.74 8.44 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.935 0.894 . . . . 62.450000000000003 112.012 173.511 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 173' ' ' PHE . . . . . 0.534 ' CD1' HD22 ' A' ' 235' ' ' LEU . 20.2 m-85 -141.1 -71.03 0.36 Allowed 'General case' 0 N--CA 1.481 1.099 0 CA-C-O 121.182 0.515 . . . . 75.319999999999993 111.297 -163.799 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 174' ' ' TYR . . . . . 0.468 ' CD2' ' HB3' ' A' ' 233' ' ' LEU . 2.1 p90 -83.25 7.2 17.05 Favored 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 124.589 1.156 . . . . 74.219999999999999 112.038 -171.364 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 175' ' ' THR . . . . . 0.503 ' OG1' ' HB3' ' A' ' 172' ' ' LEU . 1.5 m -60.23 -36.82 78.59 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 124.365 1.066 . . . . 74.230000000000004 113.149 -160.71 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 176' ' ' MET . . . . . . . . . . . . . 3.0 mpp? -68.08 -27.25 66.33 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 123.676 0.79 . . . . 72.140000000000001 111.192 -179.774 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 20.8 tptm -122.56 25.92 8.56 Favored 'General case' 0 CA--C 1.556 1.205 0 C-N-CA 124.367 1.067 . . . . 74.439999999999998 109.872 -177.459 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 178' ' ' ALA . . . . . 0.616 ' HB1' ' HB3' ' A' ' 224' ' ' PRO . . . -69.46 132.42 46.29 Favored 'General case' 0 N--CA 1.476 0.867 0 CA-C-N 115.865 -0.607 . . . . 74.109999999999999 110.053 -179.761 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 179' ' ' ALA . . . . . 0.533 ' HB2' ' HB2' ' A' ' 224' ' ' PRO . . . 60.89 30.34 19.58 Favored 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 124.315 1.046 . . . . 63.420000000000002 110.779 -170.858 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -79.09 166.73 51.91 Favored Glycine 0 C--N 1.345 1.063 0 CA-C-N 115.198 -0.91 . . . . 60.409999999999997 112.496 178.711 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 47.1 t -138.95 162.05 35.83 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 123.737 0.815 . . . . 75.420000000000002 109.503 178.99 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . 91.64 169.0 41.37 Favored Glycine 0 CA--C 1.532 1.119 0 CA-C-N 115.768 -0.651 . . . . 60.039999999999999 112.308 -176.133 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -73.85 147.35 38.14 Favored Glycine 0 C--N 1.346 1.123 0 CA-C-O 120.202 -0.221 . . . . 74.430000000000007 112.805 -179.789 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 29.7 t -103.37 -56.73 2.16 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 124.046 0.938 . . . . 65.530000000000001 109.949 179.511 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 126.56 135.84 4.28 Favored Glycine 0 C--N 1.353 1.503 0 N-CA-C 112.076 -0.41 . . . . 63.310000000000002 112.076 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 170.96 108.29 0.21 Allowed Glycine 0 C--N 1.34 0.771 0 N-CA-C 111.148 -0.781 . . . . 61.140000000000001 111.148 -176.525 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 13.9 t -166.3 37.97 0.05 OUTLIER 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 123.192 0.597 . . . . 75.209999999999994 110.066 -179.42 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -142.56 126.66 2.96 Favored Glycine 0 C--N 1.344 1.013 0 CA-C-N 116.209 -0.451 . . . . 62.439999999999998 113.443 -174.907 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 66.48 7.2 38.81 Favored Glycine 0 C--N 1.354 1.535 0 N-CA-C 116.509 1.364 . . . . 52.439999999999998 116.509 163.654 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 18.3 m 61.37 30.43 18.99 Favored 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 124.102 0.961 . . . . 52.299999999999997 111.927 -178.179 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 7.2 pt20 -75.75 -22.92 56.03 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 122.632 0.373 . . . . 64.310000000000002 111.278 179.753 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 -75.58 134.98 40.56 Favored 'General case' 0 N--CA 1.47 0.525 0 C-N-CA 123.834 0.854 . . . . 64.329999999999998 109.887 -178.294 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 24.2 mt -117.6 162.69 17.6 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 123.568 0.747 . . . . 72.409999999999997 110.215 175.46 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 77.0 m-85 -133.17 135.0 44.85 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 123.77 0.828 . . . . 73.409999999999997 110.382 -177.751 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 195' ' ' ALA . . . . . 0.438 ' HB2' HD11 ' A' ' 249' ' ' LEU . . . -147.8 171.16 16.15 Favored 'General case' 0 C--O 1.239 0.53 0 C-N-CA 125.417 1.487 . . . . 73.25 108.494 -179.607 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 34.1 m -129.63 124.42 33.64 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 123.826 0.851 . . . . 71.120000000000005 108.717 -178.604 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 0.763 HD22 HD13 ' A' ' 251' ' ' LEU . 15.7 tp -106.66 110.2 22.32 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 108.681 -0.859 . . . . 74.510000000000005 108.681 -173.044 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -82.51 122.77 28.49 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 123.091 0.556 . . . . 73.340000000000003 109.774 177.703 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 199' ' ' VAL . . . . . 0.443 ' O ' ' HA ' ' A' ' 255' ' ' ILE . 4.3 p -140.71 128.34 12.32 Favored Pre-proline 0 CA--C 1.545 0.764 0 N-CA-C 108.228 -1.027 . . . . 53.25 108.228 -177.927 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -69.39 156.2 65.0 Favored 'Trans proline' 0 C--N 1.366 1.49 0 C-N-CA 121.917 1.745 . . . . 52.530000000000001 111.034 171.15 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 201' ' ' ALA . . . . . 0.507 ' O ' HG23 ' A' ' 205' ' ' VAL . . . -48.52 -54.2 28.6 Favored Pre-proline 0 CA--C 1.559 1.321 0 CA-C-O 117.754 -1.117 . . . . 75.409999999999997 113.122 -177.761 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -60.69 -37.6 77.9 Favored 'Trans proline' 0 C--N 1.391 2.803 0 C-N-CA 121.94 1.76 . . . . 53.229999999999997 113.466 -176.376 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 39.7 mt -68.37 -33.94 63.12 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.389 0 C-N-CA 122.51 0.324 . . . . 73.400000000000006 110.404 178.056 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -71.66 -33.54 68.96 Favored 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 122.863 0.465 . . . . 63.32 111.47 176.893 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 205' ' ' VAL . . . . . 0.507 HG23 ' O ' ' A' ' 201' ' ' ALA . 73.5 t -71.8 -52.43 25.51 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 C-N-CA 123.909 0.884 . . . . 74.200000000000003 110.951 -179.776 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 16.2 m -82.89 -27.21 8.1 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.096 0 CA-C-N 116.304 -0.407 . . . . 63.43 111.465 -173.493 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 83.74 62.09 1.8 Allowed Glycine 0 C--N 1.343 0.969 0 CA-C-N 116.121 -0.491 . . . . 61.299999999999997 112.224 -174.589 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -83.19 -134.38 2.29 Favored Glycine 0 C--N 1.35 1.346 0 CA-C-O 119.9 -0.389 . . . . 60.520000000000003 112.462 177.947 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 46.5 mtmt -138.59 153.11 48.65 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 123.917 0.887 . . . . 72.019999999999996 110.916 178.037 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 9.7 m -145.37 170.0 6.72 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.092 0 C-N-CA 125.732 1.613 . . . . 73.329999999999998 109.096 175.184 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 29.8 ttp180 -97.8 110.57 23.11 Favored 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 123.72 0.808 . . . . 64.450000000000003 110.306 -177.938 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -102.33 112.22 24.83 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 123.485 0.714 . . . . 63.43 109.311 174.121 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 65.5 mtp -86.75 123.47 31.95 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 122.744 0.418 . . . . 61.210000000000001 110.071 -178.746 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 31.4 p -127.72 -171.14 2.37 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 124.38 1.072 . . . . 75.150000000000006 110.954 -168.4 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 76.9 mt -63.71 -27.91 69.53 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 123.217 0.607 . . . . 74.450000000000003 111.236 172.107 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -100.93 21.95 12.92 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.716 0.806 . . . . 75.209999999999994 110.615 178.328 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 85.38 -168.56 42.43 Favored Glycine 0 C--N 1.348 1.232 0 CA-C-N 116.008 -0.542 . . . . 52.43 113.702 173.94 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -74.19 121.04 6.59 Favored 'Trans proline' 0 C--N 1.366 1.494 0 C-N-CA 122.975 2.45 . . . . 44.200000000000003 112.047 -179.625 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 6.7 p -114.4 134.76 56.32 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 C-N-CA 123.799 0.84 . . . . 60.340000000000003 109.39 175.488 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -75.56 102.31 5.23 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 107.741 -1.207 . . . . 74.219999999999999 107.741 172.382 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 3.8 p -103.91 130.08 55.05 Favored 'Isoleucine or valine' 0 C--O 1.243 0.72 0 N-CA-C 109.149 -0.686 . . . . 73.040000000000006 109.149 -175.058 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 222' ' ' ALA . . . . . 0.55 ' H ' HD21 ' A' ' 172' ' ' LEU . . . -76.03 106.64 7.74 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 123.261 0.624 . . . . 24.350000000000001 110.676 -177.427 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 53.5 t -54.71 137.87 62.81 Favored Pre-proline 0 N--CA 1.477 0.888 0 O-C-N 124.522 1.139 . . . . 71.239999999999995 109.994 179.626 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 224' ' ' PRO . . . . . 0.616 ' HB3' ' HB1' ' A' ' 178' ' ' ALA . 12.3 Cg_endo -57.77 152.96 46.2 Favored 'Trans proline' 0 C--N 1.369 1.617 0 C-N-CA 122.355 2.037 . . . . 72.129999999999995 112.714 171.343 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -76.18 149.54 32.17 Favored 'Trans proline' 0 C--N 1.367 1.527 0 C-N-CA 121.999 1.799 . . . . 52.229999999999997 110.741 171.443 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 35.9 mtm105 60.09 36.23 21.26 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 124.305 1.042 . . . . 73.230000000000004 111.143 168.563 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 227' ' ' THR . . . . . 0.457 HG23 ' HD2' ' A' ' 231' ' ' ARG . 21.5 m -76.53 150.03 36.62 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 124.587 1.155 . . . . 62.210000000000001 110.576 -178.259 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 27.0 mp0 -120.96 143.01 49.23 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 123.606 0.762 . . . . 72.219999999999999 109.151 175.066 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 229' ' ' ALA . . . . . 0.44 ' HB2' ' HB ' ' A' ' 255' ' ' ILE . . . -60.02 125.52 23.99 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 123.859 0.864 . . . . 63.399999999999999 111.002 -178.528 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 109.25 -2.02 31.19 Favored Glycine 0 CA--C 1.528 0.844 0 O-C-N 123.774 0.671 . . . . 42.530000000000001 113.287 -177.776 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 231' ' ' ARG . . . . . 0.457 ' HD2' HG23 ' A' ' 227' ' ' THR . 89.7 mtt-85 -72.35 157.59 37.38 Favored 'General case' 0 N--CA 1.479 0.985 0 CA-C-N 117.701 0.751 . . . . 74.510000000000005 109.854 170.484 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 45.7 mtmt -128.97 122.78 30.86 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 123.189 0.596 . . . . 71.310000000000002 110.068 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 233' ' ' LEU . . . . . 0.468 ' HB3' ' CD2' ' A' ' 174' ' ' TYR . 19.5 mt -101.77 153.34 19.89 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 124.949 1.3 . . . . 71.010000000000005 108.634 -178.043 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 19.5 ttt180 -120.78 103.17 8.89 Favored 'General case' 0 CA--C 1.546 0.801 0 O-C-N 122.188 -0.32 . . . . 74.420000000000002 111.486 -171.85 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 235' ' ' LEU . . . . . 0.569 ' HB2' ' HB3' ' A' ' 249' ' ' LEU . 15.6 mt -82.39 102.58 11.36 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 123.585 0.754 . . . . 72.319999999999993 110.582 176.966 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 236' ' ' LYS . . . . . 0.426 ' H ' ' HB3' ' A' ' 173' ' ' PHE . 43.8 mtmt -71.97 144.44 48.87 Favored 'General case' 0 C--O 1.242 0.68 0 CA-C-O 121.529 0.681 . . . . 72.25 112.421 179.967 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 72.14 3.36 56.45 Favored Glycine 0 CA--C 1.531 1.089 0 CA-C-N 114.183 -1.371 . . . . 61.119999999999997 114.283 -176.108 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 47.2 mmtm -107.96 13.85 25.8 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 123.538 0.735 . . . . 74.549999999999997 111.63 -176.311 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -116.36 -171.0 15.89 Favored Glycine 0 CA--C 1.528 0.877 0 N-CA-C 110.274 -1.13 . . . . 73.420000000000002 110.274 166.51 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 68.9 m-85 -87.73 159.13 49.9 Favored Pre-proline 0 N--CA 1.481 1.079 0 C-N-CA 123.264 0.626 . . . . 61.409999999999997 112.149 -173.778 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -71.72 164.21 36.43 Favored 'Trans proline' 0 C--N 1.373 1.858 0 C-N-CA 122.04 1.827 . . . . 64.219999999999999 112.732 171.595 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 158.35 -109.09 0.39 Allowed Glycine 0 CA--C 1.532 1.123 0 CA-C-O 118.784 -1.009 . . . . 63.009999999999998 112.722 174.244 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -65.16 -49.58 2.61 Favored 'Trans proline' 0 C--N 1.381 2.249 0 C-N-CA 123.454 2.769 . . . . 75.150000000000006 112.722 -170.385 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -90.61 -8.53 49.85 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 123.976 0.91 . . . . 72.219999999999999 111.151 178.349 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 83.68 -42.58 3.06 Favored Glycine 0 C--N 1.359 1.828 0 N-CA-C 111.922 -0.471 . . . . 72.349999999999994 111.922 -170.864 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 17.3 ttm180 -103.17 114.82 29.42 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 125.077 1.351 . . . . 73.530000000000001 110.639 173.17 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -91.1 158.99 26.13 Favored Glycine 0 C--N 1.341 0.843 0 N-CA-C 110.841 -0.904 . . . . 75.450000000000003 110.841 163.664 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 26.9 m-20 -134.52 152.55 51.86 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 122.606 0.363 . . . . 74.540000000000006 110.065 -171.531 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 249' ' ' LEU . . . . . 0.569 ' HB3' ' HB2' ' A' ' 235' ' ' LEU . 57.2 tp -99.05 139.97 33.91 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 124.543 1.137 . . . . 73.530000000000001 109.844 -176.506 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 250' ' ' TYR . . . . . . . . . . . . . 4.3 m-85 -103.66 123.0 46.19 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 123.856 0.862 . . . . 71.109999999999999 110.064 177.837 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 251' ' ' LEU . . . . . 0.763 HD13 HD22 ' A' ' 197' ' ' LEU . 92.1 mt -103.7 103.91 13.88 Favored 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 108.211 -1.033 . . . . 74.409999999999997 108.211 179.464 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -81.33 100.99 9.5 Favored 'General case' 0 CA--C 1.543 0.691 0 N-CA-C 108.187 -1.042 . . . . 74.120000000000005 108.187 175.371 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 10.2 m -65.68 137.34 25.12 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.788 0 CA-C-O 121.359 0.599 . . . . 73.340000000000003 110.801 -175.031 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 24.1 mmt85 -128.79 97.65 4.73 Favored 'General case' 0 C--O 1.238 0.468 0 C-N-CA 124.576 1.151 . . . . 75.120000000000005 108.246 179.844 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 255' ' ' ILE . . . . . 0.454 HG23 ' HA ' ' A' ' 201' ' ' ALA . 34.5 mt -77.42 120.79 28.62 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 CA-C-N 115.422 -0.808 . . . . 52.119999999999997 109.679 179.376 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 7.1 t . . . . . 0 CA--C 1.562 1.412 0 C-N-CA 123.675 0.79 . . . . 62.329999999999998 109.497 -179.43 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 23.9 ptp . . . . . 0 N--CA 1.484 1.265 0 N-CA-C 109.973 -0.381 . . . . 72.430000000000007 109.973 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 28.5 pt20 -85.15 166.06 16.92 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 123.289 0.636 . . . . 65.319999999999993 110.597 174.872 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 8.2 t -67.77 155.16 39.92 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 123.605 0.762 . . . . 62.530000000000001 110.234 171.139 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -89.26 -88.51 0.16 Allowed 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 122.42 0.288 . . . . 74.239999999999995 111.52 -173.229 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 172' ' ' LEU . . . . . 0.531 HD21 ' HB3' ' A' ' 222' ' ' ALA . 62.9 mt -139.68 160.08 40.7 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.834 0.853 . . . . 70.439999999999998 110.802 -165.95 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 173' ' ' PHE . . . . . 0.538 ' CD1' HD22 ' A' ' 235' ' ' LEU . 5.4 m-85 -138.24 -56.24 0.65 Allowed 'General case' 0 N--CA 1.482 1.131 0 CA-C-O 122.023 0.916 . . . . 74.409999999999997 108.974 -165.846 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 174' ' ' TYR . . . . . 0.464 ' CD2' ' HB3' ' A' ' 233' ' ' LEU . 1.4 p90 -74.82 4.2 6.8 Favored 'General case' 0 CA--C 1.547 0.865 0 CA-C-N 113.448 -1.705 . . . . 74.329999999999998 113.316 -178.79 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 6.2 p -67.29 82.52 0.14 Allowed 'General case' 0 CA--C 1.547 0.853 0 CA-C-O 122.334 1.064 . . . . 62.310000000000002 110.705 174.751 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 176' ' ' MET . . . . . 0.456 ' HG3' ' HG2' ' A' ' 177' ' ' LYS . 23.1 ptt? -161.91 -39.61 0.04 OUTLIER 'General case' 0 CA--C 1.541 0.608 0 CA-C-N 113.639 -1.619 . . . . 64.439999999999998 108.202 -174.809 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 177' ' ' LYS . . . . . 0.456 ' HG2' ' HG3' ' A' ' 176' ' ' MET . 18.3 pttp -177.27 34.64 0.0 OUTLIER 'General case' 0 CA--C 1.556 1.179 0 C-N-CA 124.637 1.175 . . . . 71.230000000000004 110.052 -178.906 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 178' ' ' ALA . . . . . 0.471 ' HB1' ' HG3' ' A' ' 224' ' ' PRO . . . -59.21 150.44 25.59 Favored 'General case' 0 N--CA 1.487 1.379 0 C-N-CA 124.036 0.935 . . . . 74.010000000000005 111.705 178.315 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 179' ' ' ALA . . . . . 0.411 ' HB1' ' NH1' ' A' ' 231' ' ' ARG . . . 61.75 25.55 15.4 Favored 'General case' 0 N--CA 1.489 1.517 0 C-N-CA 124.169 0.988 . . . . 53.509999999999998 110.758 -167.886 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -116.31 90.94 0.53 Allowed Glycine 0 C--N 1.34 0.771 0 CA-C-N 115.43 -0.804 . . . . 73.109999999999999 111.128 -176.897 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 15.8 m -69.01 91.73 0.49 Allowed 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 123.672 0.789 . . . . 65.450000000000003 109.747 175.764 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -179.69 104.69 0.19 Allowed Glycine 0 C--N 1.345 1.081 0 N-CA-C 111.787 -0.525 . . . . 72.530000000000001 111.787 -175.742 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 145.83 166.04 11.73 Favored Glycine 0 C--N 1.346 1.1 0 N-CA-C 112.132 -0.387 . . . . 53.109999999999999 112.132 178.076 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 48.8 m -141.32 116.68 10.11 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 124.108 0.963 . . . . 64.019999999999996 109.131 -179.205 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -136.0 20.27 3.62 Favored Glycine 0 C--N 1.345 1.036 0 CA-C-O 119.993 -0.337 . . . . 72.420000000000002 113.603 -175.959 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -91.3 8.86 78.74 Favored Glycine 0 N--CA 1.476 1.337 0 C-N-CA 122.759 0.218 . . . . 61.399999999999999 113.48 179.668 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 50.4 m -125.35 136.36 53.38 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 124.326 1.051 . . . . 74.109999999999999 108.828 175.747 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 108.93 94.06 2.31 Favored Glycine 0 C--N 1.344 1.021 0 N-CA-C 110.701 -0.96 . . . . 75.010000000000005 110.701 -173.947 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 189' ' ' GLY . . . . . 0.445 ' HA3' ' HD3' ' A' ' 243' ' ' PRO . . . 68.14 -150.34 50.97 Favored Glycine 0 C--N 1.352 1.424 0 C-N-CA 123.066 0.365 . . . . 73.420000000000002 112.964 -178.657 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 24.3 t -146.68 25.09 1.19 Allowed 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 123.649 0.78 . . . . 65.540000000000006 109.041 175.993 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 191' ' ' GLN . . . . . 0.528 ' HB3' ' HD2' ' A' ' 243' ' ' PRO . 7.5 pt20 -65.68 -25.69 67.45 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-N 115.192 -0.913 . . . . 63.200000000000003 111.445 -176.239 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 -75.31 141.61 43.37 Favored 'General case' 0 C--O 1.242 0.691 0 C-N-CA 124.666 1.186 . . . . 73.319999999999993 109.827 -176.475 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 193' ' ' LEU . . . . . 0.413 HD12 ' HA2' ' A' ' 239' ' ' GLY . 23.3 mt -126.62 176.41 7.23 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 123.922 0.889 . . . . 74.120000000000005 110.802 -178.009 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 15.6 m-85 -138.23 122.93 18.69 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 124.33 1.052 . . . . 73.319999999999993 110.307 179.945 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -139.64 127.5 22.07 Favored 'General case' 0 C--O 1.239 0.509 0 N-CA-C 107.605 -1.257 . . . . 63.130000000000003 107.605 170.966 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 58.6 m -73.66 131.31 41.51 Favored 'General case' 0 C--O 1.241 0.657 0 CA-C-N 115.981 -0.554 . . . . 73.25 109.695 179.475 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 0.647 HD22 HD13 ' A' ' 251' ' ' LEU . 15.8 tp -106.72 108.88 20.61 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 107.884 -1.154 . . . . 72.040000000000006 107.884 -179.588 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -78.4 121.09 24.05 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 108.468 -0.938 . . . . 62.130000000000003 108.468 177.114 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 199' ' ' VAL . . . . . 0.461 ' O ' ' HA ' ' A' ' 255' ' ' ILE . 4.1 p -140.98 128.53 12.1 Favored Pre-proline 0 CA--C 1.544 0.736 0 C-N-CA 123.733 0.813 . . . . 74.099999999999994 108.968 -177.956 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -70.53 156.78 60.62 Favored 'Trans proline' 0 C--N 1.365 1.402 0 C-N-CA 121.914 1.743 . . . . 60.299999999999997 111.006 170.919 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 201' ' ' ALA . . . . . 0.488 ' O ' HG23 ' A' ' 205' ' ' VAL . . . -50.97 -51.84 63.62 Favored Pre-proline 0 CA--C 1.56 1.349 0 CA-C-O 117.719 -1.134 . . . . 65.230000000000004 112.688 -179.257 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -61.58 -38.99 58.04 Favored 'Trans proline' 0 C--N 1.394 2.935 0 C-N-CA 121.672 1.581 . . . . 54.420000000000002 113.48 -177.535 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 34.4 mt -65.52 -34.01 67.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 CA-C-N 118.082 0.401 . . . . 62.420000000000002 110.398 176.382 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -71.34 -35.12 71.08 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 122.372 0.269 . . . . 72.319999999999993 111.371 177.428 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 205' ' ' VAL . . . . . 0.488 HG23 ' O ' ' A' ' 201' ' ' ALA . 96.6 t -71.74 -55.78 12.43 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.153 0 C-N-CA 123.588 0.755 . . . . 63.409999999999997 110.984 -179.544 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 18.9 m -79.74 -25.53 12.21 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 C-N-CA 122.863 0.465 . . . . 55.409999999999997 111.433 -174.607 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 80.1 72.18 1.22 Allowed Glycine 0 C--N 1.342 0.905 0 N-CA-C 111.647 -0.581 . . . . 53.32 111.647 -173.116 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -93.48 -134.21 6.98 Favored Glycine 0 C--N 1.349 1.298 0 N-CA-C 111.361 -0.695 . . . . 52.350000000000001 111.361 178.033 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 46.2 mtmt -138.1 152.78 49.08 Favored 'General case' 0 N--CA 1.486 1.37 0 CA-C-N 117.725 0.763 . . . . 74.219999999999999 111.662 179.35 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 15.6 m -147.72 158.67 8.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 C-N-CA 124.881 1.272 . . . . 64.219999999999999 109.268 178.403 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 43.5 ttm180 -98.3 114.01 26.16 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 123.089 0.556 . . . . 75.109999999999999 111.092 -175.627 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -100.3 124.93 46.37 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 124.509 1.123 . . . . 55.340000000000003 110.74 178.559 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 22.2 mmt -85.37 110.74 19.33 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 123.466 0.707 . . . . 61.5 109.49 176.841 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 22.2 p -110.94 -178.63 3.52 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 123.973 0.909 . . . . 64.239999999999995 109.73 -176.803 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 82.6 mt -57.67 -36.73 72.3 Favored 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 123.375 0.67 . . . . 40.219999999999999 112.709 -179.151 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -96.02 -19.33 19.55 Favored 'General case' 0 N--CA 1.482 1.154 0 N-CA-C 112.63 0.604 . . . . 65.310000000000002 112.63 -172.468 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 152.6 -168.33 31.6 Favored Glycine 0 C--N 1.352 1.423 0 CA-C-O 119.956 -0.358 . . . . 53.350000000000001 113.009 -178.825 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -85.39 132.24 4.3 Favored 'Trans proline' 0 C--N 1.367 1.543 0 C-N-CA 123.058 2.505 . . . . 75.099999999999994 112.566 179.086 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 4.1 p -126.44 126.09 68.51 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 N-CA-C 108.563 -0.903 . . . . 72.340000000000003 108.563 171.07 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -84.15 102.58 12.68 Favored 'General case' 0 C--O 1.238 0.455 0 N-CA-C 108.212 -1.033 . . . . 74.099999999999994 108.212 173.486 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 4.1 p -97.39 139.52 19.63 Favored 'Isoleucine or valine' 0 C--O 1.25 1.093 0 CA-C-N 114.732 -1.122 . . . . 61.030000000000001 109.218 -170.723 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 222' ' ' ALA . . . . . 0.531 ' HB3' HD21 ' A' ' 172' ' ' LEU . . . -78.42 101.27 7.19 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 122.794 0.437 . . . . 75.450000000000003 110.684 -177.493 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 47.5 t -53.9 133.08 57.77 Favored Pre-proline 0 N--CA 1.48 1.029 0 C-N-CA 124.28 1.032 . . . . 61.140000000000001 109.746 -179.338 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 224' ' ' PRO . . . . . 0.471 ' HG3' ' HB1' ' A' ' 178' ' ' ALA . 35.2 Cg_endo -63.25 147.08 94.15 Favored 'Trans proline' 0 C--N 1.371 1.725 0 C-N-CA 121.574 1.516 . . . . 52.039999999999999 110.46 172.029 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -67.33 156.95 64.04 Favored 'Trans proline' 0 C--N 1.361 1.201 0 C-N-CA 121.747 1.631 . . . . 70.420000000000002 111.541 177.005 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 40.7 mtt180 64.39 25.61 13.43 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 124.373 1.069 . . . . 72.219999999999999 111.634 168.424 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 227' ' ' THR . . . . . 0.59 ' HA ' HH11 ' A' ' 231' ' ' ARG . 94.1 m -75.81 133.99 40.5 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 123.835 0.854 . . . . 72.439999999999998 110.628 -179.896 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -99.83 148.71 24.14 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 123.872 0.869 . . . . 75.510000000000005 109.746 176.904 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 229' ' ' ALA . . . . . 0.538 ' HB2' ' HB ' ' A' ' 255' ' ' ILE . . . -59.63 128.08 35.23 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 123.989 0.915 . . . . 74.129999999999995 111.175 178.028 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 106.1 -5.84 39.43 Favored Glycine 0 N--CA 1.47 0.914 0 O-C-N 123.737 0.648 . . . . 41.25 113.135 -179.8 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 231' ' ' ARG . . . . . 0.59 HH11 ' HA ' ' A' ' 227' ' ' THR . 89.5 mtt180 -72.57 153.99 41.01 Favored 'General case' 0 N--CA 1.479 1.005 0 CA-C-N 117.325 0.563 . . . . 75.200000000000003 110.224 173.686 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 232' ' ' LYS . . . . . 0.413 ' HA ' ' O ' ' A' ' 251' ' ' LEU . 53.8 mtmt -130.3 127.32 39.25 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-N 115.99 -0.55 . . . . 64.040000000000006 110.044 -178.538 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 233' ' ' LEU . . . . . 0.488 ' HB2' ' HB2' ' A' ' 251' ' ' LEU . 24.1 mt -104.48 150.24 24.75 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 124.852 1.261 . . . . 74.150000000000006 108.614 -175.837 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 234' ' ' ARG . . . . . 0.426 ' HG3' ' HB3' ' A' ' 248' ' ' ASP . 56.7 ttm-85 -112.1 120.87 43.3 Favored 'General case' 0 N--CA 1.484 1.254 0 CA-C-N 118.361 0.528 . . . . 70.230000000000004 111.404 -170.483 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 235' ' ' LEU . . . . . 0.538 HD22 ' CD1' ' A' ' 173' ' ' PHE . 14.2 mt -110.95 111.73 23.06 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 123.787 0.835 . . . . 64.319999999999993 111.621 -176.754 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 31.3 mttp -68.72 141.65 55.22 Favored 'General case' 0 N--CA 1.476 0.875 0 CA-C-O 120.852 0.358 . . . . 64.219999999999999 110.914 172.707 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 79.7 -0.58 81.41 Favored Glycine 0 C--N 1.347 1.188 0 CA-C-N 115.18 -0.918 . . . . 50.130000000000003 114.658 176.706 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 72.5 mmtt -109.21 1.93 20.59 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 122.788 0.435 . . . . 72.25 110.223 -175.78 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 239' ' ' GLY . . . . . 0.413 ' HA2' HD12 ' A' ' 193' ' ' LEU . . . -112.33 -172.78 18.98 Favored Glycine 0 C--N 1.353 1.52 0 N-CA-C 111.289 -0.724 . . . . 74.230000000000004 111.289 166.423 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 86.3 m-85 -86.09 157.39 56.87 Favored Pre-proline 0 N--CA 1.491 1.584 0 C-N-CA 123.361 0.664 . . . . 75.140000000000001 111.576 -174.424 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -65.95 131.37 26.99 Favored 'Trans proline' 0 C--N 1.376 2.008 0 C-N-CA 121.826 1.684 . . . . 64.319999999999993 111.011 170.614 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -160.43 -125.29 0.77 Allowed Glycine 0 C--N 1.34 0.77 0 CA-C-O 118.629 -1.095 . . . . 73.310000000000002 112.28 -179.95 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 243' ' ' PRO . . . . . 0.528 ' HD2' ' HB3' ' A' ' 191' ' ' GLN . 21.4 Cg_endo -54.55 -50.68 12.59 Favored 'Trans proline' 0 C--N 1.377 2.077 0 C-N-CA 124.344 3.363 . . . . 55.43 112.542 -176.589 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -86.59 -11.02 52.67 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 123.254 0.622 . . . . 73.200000000000003 111.463 179.938 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 85.43 -21.45 13.39 Favored Glycine 0 C--N 1.357 1.718 0 C-N-CA 122.888 0.28 . . . . 44.219999999999999 113.146 -177.941 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 12.7 ttm180 -126.56 113.72 17.14 Favored 'General case' 0 C--O 1.234 0.268 0 C-N-CA 125.038 1.335 . . . . 74.030000000000001 107.688 174.219 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -76.79 163.11 52.34 Favored Glycine 0 C--O 1.245 0.794 0 N-CA-C 115.055 0.782 . . . . 45.520000000000003 115.055 177.575 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 248' ' ' ASP . . . . . 0.455 ' HA ' ' O ' ' A' ' 235' ' ' LEU . 55.3 m-20 -110.06 159.16 17.56 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 114.101 -1.049 . . . . 75.239999999999995 110.354 -176.714 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 249' ' ' LEU . . . . . 0.511 ' HB3' ' HB2' ' A' ' 235' ' ' LEU . 31.3 tp -126.1 126.65 44.53 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 123.457 0.703 . . . . 65.420000000000002 109.242 174.452 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 250' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 -90.25 112.19 23.63 Favored 'General case' 0 C--O 1.239 0.532 0 N-CA-C 108.552 -0.907 . . . . 64.450000000000003 108.552 -179.628 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 251' ' ' LEU . . . . . 0.647 HD13 HD22 ' A' ' 197' ' ' LEU . 81.2 mt -87.56 101.21 13.41 Favored 'General case' 0 C--O 1.239 0.513 0 N-CA-C 107.072 -1.455 . . . . 73.239999999999995 107.072 176.069 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -85.79 91.98 8.48 Favored 'General case' 0 C--O 1.242 0.683 0 N-CA-C 108.013 -1.106 . . . . 72.420000000000002 108.013 -176.199 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 4.1 m -61.51 135.76 25.8 Favored 'Isoleucine or valine' 0 C--O 1.243 0.724 0 CA-C-N 115.02 -0.991 . . . . 63.32 109.9 -174.605 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 14.8 mmm180 -131.85 111.22 11.41 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 107.21 -1.404 . . . . 71.129999999999995 107.21 178.599 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 255' ' ' ILE . . . . . 0.538 ' HB ' ' HB2' ' A' ' 229' ' ' ALA . 41.8 mt -86.64 116.08 28.69 Favored 'Isoleucine or valine' 0 C--O 1.239 0.531 0 C-N-CA 123.865 0.866 . . . . 65.109999999999999 110.086 -176.993 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 2.0 t . . . . . 0 CA--C 1.556 1.201 0 C-N-CA 124.497 1.119 . . . . 73.409999999999997 109.577 176.992 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 25.5 ptt? . . . . . 0 N--CA 1.483 1.188 0 CA-C-O 120.392 0.139 . . . . 73.120000000000005 111.034 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 4.5 pt20 -103.51 -53.95 2.69 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 123.219 0.608 . . . . 63.43 111.008 -175.445 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 11.0 t -179.77 178.22 0.65 Allowed 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 124.721 1.208 . . . . 70.099999999999994 109.408 -177.45 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -132.11 -85.53 0.48 Allowed 'General case' 0 CA--C 1.544 0.734 0 N-CA-C 108.928 -0.768 . . . . 64.040000000000006 108.928 173.507 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 31.9 mt -133.25 158.45 42.88 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 123.282 0.633 . . . . 54.409999999999997 111.697 -175.664 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 3.9 m-85 -130.06 -56.09 1.11 Allowed 'General case' 0 N--CA 1.475 0.807 0 CA-C-N 114.85 -1.068 . . . . 72.129999999999995 109.105 -171.447 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 174' ' ' TYR . . . . . 0.463 ' CE2' HD13 ' A' ' 233' ' ' LEU . 0.6 OUTLIER -80.93 3.32 23.24 Favored 'General case' 0 N--CA 1.476 0.83 0 N-CA-C 114.24 1.2 . . . . 71.140000000000001 114.24 -167.711 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 24.0 p -53.49 -23.1 9.32 Favored 'General case' 0 N--CA 1.489 1.522 0 C-N-CA 123.955 0.902 . . . . 61.119999999999997 113.158 -176.021 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 176' ' ' MET . . . . . . . . . . . . . 13.9 ptm -56.29 85.03 0.01 OUTLIER 'General case' 0 CA--C 1.56 1.351 0 C-N-CA 124.272 1.029 . . . . 72.409999999999997 111.119 165.67 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 66.1 mttm 55.73 47.29 20.76 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 125.15 1.38 . . . . 75.109999999999999 111.862 178.003 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -63.89 -32.4 73.91 Favored 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 124.891 1.276 . . . . 35.329999999999998 111.856 178.108 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -88.52 24.44 1.96 Allowed 'General case' 0 CA--C 1.55 0.966 0 C-N-CA 123.758 0.823 . . . . 64.519999999999996 110.816 175.705 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -120.14 -119.88 2.77 Favored Glycine 0 C--N 1.346 1.117 0 N-CA-C 109.455 -1.458 . . . . 73.530000000000001 109.455 166.162 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 22.9 t -165.63 112.59 0.93 Allowed 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 109.26 -0.644 . . . . 62.329999999999998 109.26 175.247 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -87.64 16.74 48.58 Favored Glycine 0 C--N 1.352 1.451 0 CA-C-O 119.971 -0.35 . . . . 72.310000000000002 112.981 175.308 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -68.29 -39.54 87.82 Favored Glycine 0 C--N 1.358 1.792 0 C-N-CA 123.369 0.509 . . . . 65.129999999999995 113.349 -178.321 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 17.3 p -73.7 80.14 1.54 Allowed 'General case' 0 C--O 1.24 0.576 0 CA-C-O 121.698 0.761 . . . . 72.340000000000003 109.241 175.619 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -143.92 125.85 2.59 Favored Glycine 0 C--N 1.337 0.634 0 CA-C-N 114.583 -1.19 . . . . 52.210000000000001 111.434 -173.684 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -158.51 153.72 24.85 Favored Glycine 0 C--N 1.341 0.81 0 N-CA-C 111.171 -0.772 . . . . 54.43 111.171 177.293 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 49.5 m -148.41 -57.54 0.23 Allowed 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 123.598 0.759 . . . . 72.409999999999997 110.371 -178.54 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 158.46 59.12 0.01 OUTLIER Glycine 0 C--N 1.352 1.455 0 CA-C-N 116.541 -0.299 . . . . 62.100000000000001 112.388 -178.771 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 156.41 145.85 4.31 Favored Glycine 0 C--N 1.35 1.306 0 N-CA-C 111.901 -0.479 . . . . 53.439999999999998 111.901 179.113 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 8.8 t -90.41 63.48 5.63 Favored 'General case' 0 N--CA 1.476 0.854 0 CA-C-O 121.611 0.72 . . . . 62.219999999999999 109.969 -179.162 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 191' ' ' GLN . . . . . 0.688 ' HB3' ' HD2' ' A' ' 243' ' ' PRO . 9.6 pt20 -73.93 -30.37 62.53 Favored 'General case' 0 N--CA 1.482 1.153 0 CA-C-N 115.294 -0.866 . . . . 73.150000000000006 109.984 175.195 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -79.15 145.95 33.42 Favored 'General case' 0 C--O 1.241 0.618 0 CA-C-N 114.51 -1.223 . . . . 73.420000000000002 109.761 -171.435 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 33.5 mt -111.01 173.27 6.41 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 123.925 0.89 . . . . 63.009999999999998 110.331 -179.102 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 65.3 m-85 -134.0 121.37 21.51 Favored 'General case' 0 C--O 1.237 0.439 0 C-N-CA 123.596 0.758 . . . . 73.120000000000005 110.054 -179.442 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 195' ' ' ALA . . . . . 0.448 ' O ' ' HA ' ' A' ' 251' ' ' LEU . . . -140.61 146.76 38.4 Favored 'General case' 0 C--O 1.234 0.287 0 N-CA-C 107.538 -1.282 . . . . 63.109999999999999 107.538 173.759 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 61.3 m -96.77 140.02 31.96 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 109.918 -0.401 . . . . 50.240000000000002 109.918 178.973 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 0.672 HD22 HD13 ' A' ' 251' ' ' LEU . 16.5 tp -117.45 108.65 15.79 Favored 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 107.749 -1.204 . . . . 75.299999999999997 107.749 177.005 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -82.78 132.01 35.18 Favored 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 109.481 -0.563 . . . . 73.329999999999998 109.481 177.513 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 199' ' ' VAL . . . . . 0.533 ' O ' ' HA ' ' A' ' 255' ' ' ILE . 7.5 p -144.07 131.59 10.62 Favored Pre-proline 0 CA--C 1.548 0.894 0 N-CA-C 107.461 -1.311 . . . . 75.329999999999998 107.461 179.988 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -72.45 161.17 44.97 Favored 'Trans proline' 0 C--N 1.358 1.03 0 C-N-CA 121.829 1.686 . . . . 75.140000000000001 111.346 169.172 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -50.13 -50.12 71.59 Favored Pre-proline 0 CA--C 1.564 1.483 0 N-CA-C 114.021 1.119 . . . . 61.25 114.021 -178.999 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 202' ' ' PRO . . . . . 0.424 ' HA ' HG22 ' A' ' 205' ' ' VAL . 43.2 Cg_endo -64.26 -41.38 21.65 Favored 'Trans proline' 0 C--N 1.396 3.043 0 C-N-CA 121.736 1.624 . . . . 73.239999999999995 113.576 -178.779 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 53.2 mt -67.08 -28.25 42.13 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.295 0 CA-C-N 117.898 0.317 . . . . 63.340000000000003 110.21 177.296 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -72.83 -50.37 24.5 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 123.209 0.604 . . . . 52.130000000000003 111.783 178.534 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 205' ' ' VAL . . . . . 0.424 HG22 ' HA ' ' A' ' 202' ' ' PRO . 17.1 m -68.62 -43.02 83.67 Favored 'Isoleucine or valine' 0 C--N 1.353 0.729 0 C-N-CA 123.864 0.866 . . . . 72.319999999999993 112.574 -173.642 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 206' ' ' VAL . . . . . 0.414 HG22 ' O ' ' A' ' 202' ' ' PRO . 14.2 m -80.01 -36.38 16.82 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.226 0 CA-C-O 120.805 0.336 . . . . 54.450000000000003 110.746 175.239 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 83.77 80.05 1.04 Allowed Glycine 0 CA--C 1.528 0.885 0 N-CA-C 111.805 -0.518 . . . . 74.129999999999995 111.805 -173.064 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -90.78 -128.81 4.04 Favored Glycine 0 C--N 1.354 1.54 0 N-CA-C 111.447 -0.661 . . . . 64.329999999999998 111.447 175.789 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 45.3 mtmt -137.87 147.69 44.69 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 123.598 0.759 . . . . 74.400000000000006 110.806 174.599 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 3.6 m -139.94 165.18 22.22 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 C-N-CA 125.277 1.431 . . . . 72.519999999999996 109.212 175.033 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 45.0 ttp180 -100.97 122.76 44.08 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 123.179 0.591 . . . . 73.5 110.431 -177.807 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -114.68 112.31 22.67 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 124.05 0.94 . . . . 73.310000000000002 109.654 177.607 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 213' ' ' MET . . . . . 0.401 ' HA ' ' HA ' ' A' ' 218' ' ' PRO . 55.7 ttm -82.96 123.45 29.44 Favored 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 109.6 -0.518 . . . . 74.349999999999994 109.6 176.547 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 23.1 p -115.6 -171.22 1.93 Allowed 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 125.23 1.412 . . . . 71.239999999999995 109.568 -174.658 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 94.8 mt -60.75 -32.17 71.47 Favored 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 123.17 0.588 . . . . 71.340000000000003 111.016 170.459 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -99.27 19.28 15.71 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 124.107 0.963 . . . . 72.340000000000003 111.316 -175.691 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 93.79 -172.51 32.67 Favored Glycine 0 C--N 1.352 1.472 0 CA-C-O 119.683 -0.509 . . . . 75.25 113.175 177.864 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 218' ' ' PRO . . . . . 0.401 ' HA ' ' HA ' ' A' ' 213' ' ' MET . 73.2 Cg_endo -71.59 143.53 42.55 Favored 'Trans proline' 0 C--N 1.363 1.29 0 C-N-CA 122.622 2.214 . . . . 64.209999999999994 112.286 179.287 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 5.1 p -131.19 127.87 61.11 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 N-CA-C 108.605 -0.887 . . . . 52.229999999999997 108.605 172.943 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -78.28 100.76 6.83 Favored 'General case' 0 C--O 1.242 0.667 0 N-CA-C 106.66 -1.608 . . . . 73.310000000000002 106.66 174.79 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 6.2 p -108.35 129.65 62.32 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.844 0 CA-C-N 115.706 -0.679 . . . . 75.129999999999995 109.744 -168.745 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -79.66 110.49 15.05 Favored 'General case' 0 C--O 1.239 0.506 0 C-N-CA 123.714 0.805 . . . . 64.030000000000001 111.019 -174.903 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 52.7 t -55.12 136.47 67.68 Favored Pre-proline 0 CA--C 1.556 1.211 0 C-N-CA 125.006 1.322 . . . . 74.200000000000003 110.247 177.857 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -69.18 159.24 54.61 Favored 'Trans proline' 0 C--N 1.377 2.061 0 C-N-CA 122.293 1.995 . . . . 75.409999999999997 111.784 174.021 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -64.29 142.87 81.38 Favored 'Trans proline' 0 C--N 1.37 1.707 0 C-N-CA 121.75 1.633 . . . . 72.25 111.077 169.799 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 43.0 mtm180 62.78 48.21 4.24 Favored 'General case' 0 C--O 1.241 0.645 0 C-N-CA 124.417 1.087 . . . . 64.319999999999993 111.443 171.593 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 227' ' ' THR . . . . . 0.459 ' HA ' ' HE ' ' A' ' 231' ' ' ARG . 28.9 m -81.06 121.66 26.35 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 114.945 -1.025 . . . . 50.030000000000001 109.507 175.556 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 2.7 mp0 -106.41 148.4 28.15 Favored 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 123.992 0.917 . . . . 53.100000000000001 108.909 177.045 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -57.36 125.44 22.84 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 123.474 0.71 . . . . 64.349999999999994 111.88 -176.962 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 104.41 -2.55 43.07 Favored Glycine 0 C--N 1.34 0.786 0 CA-C-N 115.25 -0.886 . . . . 64.420000000000002 112.871 -179.619 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 231' ' ' ARG . . . . . 0.459 ' HE ' ' HA ' ' A' ' 227' ' ' THR . 56.4 mtt-85 -59.07 133.61 56.25 Favored 'General case' 0 C--N 1.371 1.505 0 CA-C-N 117.801 0.8 . . . . 65.420000000000002 109.695 173.22 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 69.5 mmtt -105.73 97.44 7.26 Favored 'General case' 0 C--O 1.239 0.536 0 CA-C-N 115.072 -0.967 . . . . 72.120000000000005 108.476 -172.858 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 233' ' ' LEU . . . . . 0.695 ' HB2' ' HB2' ' A' ' 251' ' ' LEU . 57.5 mt -81.73 142.29 32.79 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 114.713 -1.13 . . . . 63.119999999999997 109.046 179.229 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 22.0 ttt180 -122.84 101.28 7.35 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 122.492 0.317 . . . . 75.239999999999995 110.547 -171.475 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 235' ' ' LEU . . . . . 0.523 ' HB2' ' HB3' ' A' ' 249' ' ' LEU . 33.3 mt -86.74 105.62 17.1 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 123.57 0.748 . . . . 70.310000000000002 110.07 179.132 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 20.8 mttt -67.6 138.43 56.42 Favored 'General case' 0 CA--C 1.541 0.613 0 O-C-N 123.344 0.402 . . . . 71.209999999999994 110.921 175.41 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 73.11 16.62 78.51 Favored Glycine 0 C--N 1.348 1.207 0 O-C-N 123.895 0.747 . . . . 74.420000000000002 114.577 178.054 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 72.4 mmtt -115.58 7.4 14.83 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 123.211 0.605 . . . . 75.450000000000003 111.023 178.639 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -117.81 -167.83 14.31 Favored Glycine 0 C--N 1.348 1.216 0 N-CA-C 111.149 -0.781 . . . . 72.239999999999995 111.149 168.727 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 76.0 m-85 -91.34 157.89 41.8 Favored Pre-proline 0 N--CA 1.48 1.031 0 C-N-CA 123.781 0.833 . . . . 72.099999999999994 110.797 -175.567 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -64.03 145.38 89.64 Favored 'Trans proline' 0 C--N 1.366 1.487 0 C-N-CA 121.928 1.752 . . . . 74.519999999999996 112.833 170.167 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -176.4 -123.78 0.79 Allowed Glycine 0 CA--C 1.536 1.373 0 CA-C-O 118.964 -0.909 . . . . 44.100000000000001 112.221 178.161 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 243' ' ' PRO . . . . . 0.688 ' HD2' ' HB3' ' A' ' 191' ' ' GLN . 33.0 Cg_endo -57.75 -46.86 23.9 Favored 'Trans proline' 0 C--N 1.382 2.339 0 C-N-CA 124.889 3.726 . . . . 73.230000000000004 113.792 -173.499 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -90.72 -6.09 54.89 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 123.512 0.725 . . . . 72.230000000000004 111.153 179.778 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 87.17 -43.73 3.24 Favored Glycine 0 C--N 1.357 1.74 0 N-CA-C 111.966 -0.453 . . . . 72.140000000000001 111.966 -176.099 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 26.7 ttm180 -106.37 112.38 25.36 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 125.212 1.405 . . . . 72.120000000000005 109.163 175.167 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -74.83 154.27 46.65 Favored Glycine 0 C--N 1.358 1.804 0 N-CA-C 114.388 0.515 . . . . 75.109999999999999 114.388 171.282 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -107.43 171.13 7.55 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 124.854 1.262 . . . . 74.140000000000001 110.623 -178.52 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 249' ' ' LEU . . . . . 0.523 ' HB3' ' HB2' ' A' ' 235' ' ' LEU . 27.1 tp -128.78 116.76 19.99 Favored 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 108.17 -1.048 . . . . 75.409999999999997 108.17 171.009 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 250' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -88.78 108.08 19.31 Favored 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 108.845 -0.798 . . . . 73.420000000000002 108.845 -178.31 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 251' ' ' LEU . . . . . 0.695 ' HB2' ' HB2' ' A' ' 233' ' ' LEU . 87.3 mt -90.36 104.83 17.37 Favored 'General case' 0 C--O 1.238 0.453 0 N-CA-C 107.784 -1.191 . . . . 65.200000000000003 107.784 174.726 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -82.79 113.06 20.17 Favored 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 108.059 -1.089 . . . . 75.120000000000005 108.059 173.685 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 253' ' ' VAL . . . . . 0.428 ' HA ' ' O ' ' A' ' 197' ' ' LEU . 14.0 m -71.67 137.2 24.16 Favored 'Isoleucine or valine' 0 C--O 1.239 0.503 0 N-CA-C 109.677 -0.49 . . . . 65.209999999999994 109.677 179.685 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 8.5 mmm180 -123.38 108.54 12.83 Favored 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 108.092 -1.077 . . . . 74.430000000000007 108.092 175.902 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 255' ' ' ILE . . . . . 0.533 ' HA ' ' O ' ' A' ' 199' ' ' VAL . 27.3 mt -77.22 127.15 38.2 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 O-C-N 123.566 0.541 . . . . 61.399999999999999 109.864 177.792 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 10.7 t . . . . . 0 C--O 1.26 1.608 0 C-N-CA 123.974 0.91 . . . . 73.129999999999995 110.073 176.308 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 172' ' ' LEU . . . . . 0.592 HD21 ' H ' ' A' ' 222' ' ' ALA . 25.9 mt . . . . . 0 N--CA 1.479 1.021 0 CA-C-O 120.976 0.417 . . . . 73.23 110.256 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 173' ' ' PHE . . . . . 0.454 ' CD1' HD22 ' A' ' 235' ' ' LEU . 31.4 m-85 -126.21 -59.14 1.33 Allowed 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 124.135 0.974 . . . . 70.4 109.828 -170.017 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 174' ' ' TYR . . . . . 0.532 ' CD2' ' HB3' ' A' ' 233' ' ' LEU . 1.7 p90 -82.41 15.51 2.46 Favored 'General case' 0 CA--C 1.548 0.868 0 CA-C-N 114.381 -1.281 . . . . 71.01 112.898 -171.533 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 4.6 p -62.66 -19.87 64.25 Favored 'General case' 0 CA--C 1.555 1.141 0 C-N-CA 122.805 0.442 . . . . 63.23 111.354 173.77 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 176' ' ' MET . . . . . . . . . . . . . 22.9 ptt? -65.86 -52.89 46.48 Favored 'General case' 0 CA--C 1.558 1.276 0 C-N-CA 124.214 1.006 . . . . 72.53 111.361 168.879 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -155.28 119.61 4.67 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 125.016 1.326 . . . . 62.01 108.223 -173.568 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 178' ' ' ALA . . . . . 0.502 ' HB1' ' HG3' ' A' ' 224' ' ' PRO . . . -154.68 -68.07 0.13 Allowed 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 123.926 0.89 . . . . 74.35 109.093 -174.524 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -83.37 82.22 8.37 Favored 'General case' 0 C--O 1.24 0.566 0 N-CA-C 107.723 -1.214 . . . . 73.32 107.723 168.782 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.342 0.892 0 CA-C-N 115.369 -0.832 . . . . 52.23 111.909 -175.219 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 191' ' ' GLN . . . . . 0.709 ' HB3' ' HD2' ' A' ' 243' ' ' PRO . 8.1 pt20 . . . . . 0 N--CA 1.471 0.609 0 CA-C-O 120.985 0.421 . . . . 74.1 110.589 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 66.6 m-20 -76.88 162.51 27.56 Favored 'General case' 0 C--O 1.24 0.562 0 CA-C-N 115.111 -0.95 . . . . 72.1 110.815 -172.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 28.8 mt -135.97 176.91 8.26 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 124.509 1.123 . . . . 70.42 110.014 -175.302 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 60.8 m-85 -134.0 136.9 44.41 Favored 'General case' 0 C--O 1.239 0.527 0 C-N-CA 123.871 0.868 . . . . 71.3 110.136 177.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . 0.492 ' HB2' HD11 ' A' ' 249' ' ' LEU . . . -140.04 171.08 14.69 Favored 'General case' 0 C--O 1.236 0.371 0 C-N-CA 124.632 1.173 . . . . 75.21 108.561 176.069 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 26.1 m -119.02 123.44 44.53 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 108.652 -0.87 . . . . 63.01 108.652 177.883 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . 0.698 HD22 HD13 ' A' ' 251' ' ' LEU . 16.3 tp -107.47 111.08 23.21 Favored 'General case' 0 N--CA 1.467 0.382 0 N-CA-C 108.583 -0.895 . . . . 73.21 108.583 -179.56 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -84.0 121.48 27.45 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 123.414 0.686 . . . . 73.43 109.256 179.735 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 199' ' ' VAL . . . . . 0.44 ' O ' ' HA ' ' A' ' 255' ' ' ILE . 4.8 p -142.99 129.85 10.71 Favored Pre-proline 0 CA--C 1.548 0.903 0 C-N-CA 123.707 0.803 . . . . 53.43 109.414 -176.737 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_endo -72.37 162.0 42.76 Favored 'Trans proline' 0 C--N 1.369 1.613 0 C-N-CA 121.801 1.667 . . . . 60.32 111.189 172.341 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 201' ' ' ALA . . . . . 0.477 ' O ' HG23 ' A' ' 205' ' ' VAL . . . -50.6 -55.27 27.69 Favored Pre-proline 0 CA--C 1.562 1.439 0 CA-C-O 117.828 -1.082 . . . . 74.15 113.109 -177.839 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -68.1 -32.4 27.8 Favored 'Trans proline' 0 C--N 1.396 3.03 0 CA-C-N 121.433 1.548 . . . . 70.11 113.678 -174.157 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 36.1 mt -67.69 -32.02 54.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 N-CA-C 109.744 -0.465 . . . . 75.44 109.744 175.219 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -72.28 -40.33 67.68 Favored 'General case' 0 CA--C 1.551 1.011 0 C-N-CA 122.679 0.392 . . . . 73.52 111.347 176.425 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 205' ' ' VAL . . . . . 0.477 HG23 ' O ' ' A' ' 201' ' ' ALA . 84.7 t -66.66 -53.35 36.04 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.29 0 C-N-CA 123.647 0.779 . . . . 73.41 111.507 -177.825 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 16.5 m -80.04 -33.39 14.44 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 CA-C-N 116.227 -0.442 . . . . 72.14 110.986 -177.533 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 85.81 73.93 1.27 Allowed Glycine 0 C--N 1.342 0.901 0 CA-C-N 115.9 -0.591 . . . . 75.11 111.761 -172.44 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -91.14 -126.86 3.6 Favored Glycine 0 C--N 1.353 1.505 0 CA-C-O 119.43 -0.65 . . . . 45.11 111.876 177.324 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 209' ' ' LYS . . . . . 0.417 ' HG2' ' HA ' ' A' ' 222' ' ' ALA . 49.3 mtmt -137.81 155.28 49.18 Favored 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 123.604 0.762 . . . . 74.52 111.609 176.247 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 6.9 m -148.62 170.34 2.65 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.056 0 C-N-CA 125.88 1.672 . . . . 74.4 108.601 175.738 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 42.0 ttp180 -99.4 119.17 37.54 Favored 'General case' 0 CA--C 1.549 0.904 0 C-N-CA 122.822 0.449 . . . . 74.32 109.99 177.491 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -100.97 127.4 47.47 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 123.7 0.8 . . . . 52.12 109.63 175.828 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 88.0 mmm -96.06 122.5 38.96 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 123.336 0.654 . . . . 72.54 109.85 -177.261 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 21.8 p -129.21 -176.01 3.74 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 124.015 0.926 . . . . 75.33 110.886 -168.188 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 86.5 mt -65.22 -24.15 67.27 Favored 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 123.178 0.591 . . . . 73.25 112.062 175.67 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -98.99 6.68 46.57 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.454 0.702 . . . . 70.05 111.093 179.171 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 98.98 -151.44 19.49 Favored Glycine 0 C--N 1.352 1.455 0 CA-C-O 119.317 -0.713 . . . . 45.14 112.3 -179.667 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -79.85 149.65 20.6 Favored 'Trans proline' 0 C--N 1.365 1.422 0 C-N-CA 122.536 2.157 . . . . 75.3 113.672 -176.864 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 5.4 p -143.17 130.83 18.72 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 C-N-CA 123.613 0.765 . . . . 72.34 109.143 175.12 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -75.89 101.89 5.33 Favored 'General case' 0 N--CA 1.476 0.872 0 N-CA-C 108.539 -0.912 . . . . 73.5 108.539 175.149 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 1.4 p -107.06 123.08 61.97 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.047 0 N-CA-C 108.755 -0.832 . . . . 71.41 108.755 -173.108 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 222' ' ' ALA . . . . . 0.592 ' H ' HD21 ' A' ' 172' ' ' LEU . . . -77.36 109.96 11.7 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 123.194 0.598 . . . . 61.01 111.075 -178.376 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 63.1 t -54.97 139.47 63.25 Favored Pre-proline 0 N--CA 1.48 1.061 0 C-N-CA 125.43 1.492 . . . . 70.41 110.445 179.705 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 224' ' ' PRO . . . . . 0.502 ' HG3' ' HB1' ' A' ' 178' ' ' ALA . 72.0 Cg_endo -72.05 159.34 50.35 Favored 'Trans proline' 0 C--N 1.374 1.905 0 C-N-CA 121.939 1.759 . . . . 74.31 111.566 173.3 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -69.83 147.37 62.28 Favored 'Trans proline' 0 C--N 1.369 1.61 0 C-N-CA 121.507 1.471 . . . . 71.22 111.194 172.851 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 65.6 mtm180 63.55 47.08 3.93 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 124.578 1.151 . . . . 73.2 110.868 174.39 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 227' ' ' THR . . . . . 0.47 ' HA ' ' HE ' ' A' ' 231' ' ' ARG . 53.4 m -87.12 125.62 34.26 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 114.84 -1.073 . . . . 54.33 108.895 174.108 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -115.01 151.86 33.45 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 108.286 -1.005 . . . . 72.44 108.286 176.037 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -55.73 118.24 4.37 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 124.158 0.983 . . . . 71.13 111.075 -176.063 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 115.84 -5.06 20.65 Favored Glycine 0 C--N 1.342 0.868 0 CA-C-O 118.773 -1.015 . . . . 64.32 114.744 -177.399 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 231' ' ' ARG . . . . . 0.47 ' HE ' ' HA ' ' A' ' 227' ' ' THR . 65.2 mtt-85 -62.7 144.23 56.57 Favored 'General case' 0 N--CA 1.484 1.251 0 CA-C-N 118.28 1.04 . . . . 72.12 110.879 172.844 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 232' ' ' LYS . . . . . 0.427 ' HE3' ' HA ' ' A' ' 232' ' ' LYS . 0.0 OUTLIER -109.08 99.32 8.65 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 114.995 -1.002 . . . . 50.13 108.804 177.435 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 233' ' ' LEU . . . . . 0.641 ' HB2' ' HB2' ' A' ' 251' ' ' LEU . 39.2 mt -82.78 152.5 25.67 Favored 'General case' 0 CA--C 1.544 0.712 0 N-CA-C 108.589 -0.893 . . . . 62.12 108.589 175.344 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 22.3 ttt85 -125.61 111.25 14.77 Favored 'General case' 0 N--CA 1.481 1.103 0 CA-C-N 118.117 0.417 . . . . 72.43 111.043 -171.147 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 235' ' ' LEU . . . . . 0.479 ' HB2' ' HB3' ' A' ' 249' ' ' LEU . 16.2 mt -99.6 111.03 23.43 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 123.402 0.681 . . . . 75.51 110.683 179.213 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 16.2 mtmt -70.73 139.57 51.15 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 122.938 0.495 . . . . 72.42 111.695 -179.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 77.94 -2.69 63.77 Favored Glycine 0 N--CA 1.477 1.414 0 CA-C-N 115.508 -0.769 . . . . 42.45 114.292 177.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 70.9 mmtt -99.17 3.15 46.38 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 123.394 0.678 . . . . 64.33 110.717 -177.272 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -108.49 -176.24 21.86 Favored Glycine 0 C--N 1.347 1.183 0 N-CA-C 110.028 -1.229 . . . . 74.34 110.028 161.71 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 90.6 m-85 -85.46 147.09 45.96 Favored Pre-proline 0 N--CA 1.483 1.204 0 C-N-CA 123.261 0.625 . . . . 61.11 110.714 -178.095 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -59.78 132.9 47.81 Favored 'Trans proline' 0 C--N 1.37 1.704 0 C-N-CA 122.177 1.918 . . . . 61.41 112.282 171.572 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -159.27 -124.79 0.77 Allowed Glycine 0 CA--C 1.538 1.528 0 CA-C-O 118.692 -1.06 . . . . 63.13 112.729 -179.602 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 243' ' ' PRO . . . . . 0.709 ' HD2' ' HB3' ' A' ' 191' ' ' GLN . 35.9 Cg_endo -57.34 -44.13 45.76 Favored 'Trans proline' 0 C--N 1.381 2.286 0 C-N-CA 124.415 3.41 . . . . 64.43 113.638 -174.319 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -85.81 -14.45 45.06 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 123.389 0.676 . . . . 75.41 110.745 176.724 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 92.34 -23.34 27.94 Favored Glycine 0 C--N 1.348 1.224 0 CA-C-N 116.126 -0.488 . . . . 75.24 112.498 -176.104 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 11.4 ttm180 -128.86 111.75 13.41 Favored 'General case' 0 C--O 1.238 0.493 0 C-N-CA 124.575 1.15 . . . . 72.34 109.18 176.849 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -73.53 155.55 50.11 Favored Glycine 0 C--N 1.351 1.399 0 C-N-CA 121.693 -0.289 . . . . 60.53 112.769 170.632 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -125.43 145.62 49.99 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 123.376 0.67 . . . . 70.22 109.871 -173.837 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 249' ' ' LEU . . . . . 0.492 HD11 ' HB2' ' A' ' 195' ' ' ALA . 32.7 tp -100.32 119.25 38.13 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 123.3 0.64 . . . . 73.12 109.62 -178.563 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 250' ' ' TYR . . . . . . . . . . . . . 2.4 m-30 -89.65 110.09 21.0 Favored 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 108.753 -0.832 . . . . 72.21 108.753 -178.278 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 251' ' ' LEU . . . . . 0.698 HD13 HD22 ' A' ' 197' ' ' LEU . 85.3 mt -87.6 118.03 26.81 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 123.921 0.889 . . . . 71.4 109.294 -177.275 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 252' ' ' GLU . . . . . 0.45 ' HG3' ' HD3' ' A' ' 254' ' ' ARG . 10.1 tp10 -83.78 98.62 9.8 Favored 'General case' 0 C--O 1.239 0.506 0 N-CA-C 108.585 -0.895 . . . . 74.25 108.585 175.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 6.1 m -71.71 129.64 35.3 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 CA-C-O 121.498 0.666 . . . . 73.34 110.03 -176.526 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 254' ' ' ARG . . . . . 0.45 ' HD3' ' HG3' ' A' ' 252' ' ' GLU . 15.2 mmm180 -122.43 99.36 6.37 Favored 'General case' 0 C--O 1.238 0.483 0 CA-C-N 115.131 -0.94 . . . . 74.22 108.993 -173.803 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 255' ' ' ILE . . . . . 0.44 ' HA ' ' O ' ' A' ' 199' ' ' VAL . 15.7 mt -76.61 120.07 26.1 Favored 'Isoleucine or valine' 0 C--O 1.24 0.595 0 CA-C-O 121.443 0.64 . . . . 73.23 110.231 179.789 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 8.9 t . . . . . 0 CA--C 1.566 1.592 0 C-N-CA 125.198 1.399 . . . . 55.21 108.06 -178.267 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 172' ' ' LEU . . . . . 0.633 HD21 ' H ' ' A' ' 222' ' ' ALA . 25.8 mt . . . . . 0 N--CA 1.482 1.128 0 CA-C-O 120.998 0.428 . . . . 72.2 110.345 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 173' ' ' PHE . . . . . 0.486 ' CE2' ' HE3' ' A' ' 238' ' ' LYS . 4.1 m-85 -134.74 -60.85 0.77 Allowed 'General case' 0 N--CA 1.481 1.091 0 CA-C-N 115.367 -0.833 . . . . 64.51 109.955 -155.767 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 174' ' ' TYR . . . . . 0.476 ' CD2' ' HB3' ' A' ' 233' ' ' LEU . 4.9 p90 -85.68 11.99 9.77 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 114.508 -1.223 . . . . 72.24 112.18 -175.852 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 175' ' ' THR . . . . . 0.492 ' OG1' ' HB3' ' A' ' 172' ' ' LEU . 0.2 OUTLIER -68.96 -17.5 63.95 Favored 'General case' 0 CA--C 1.551 1.0 0 C-N-CA 123.556 0.742 . . . . 73.32 112.324 -166.238 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 176' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -73.59 -28.53 61.88 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 123.631 0.773 . . . . 63.34 111.088 176.038 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . 0.446 ' HG2' ' HA3' ' A' ' 180' ' ' GLY . 23.2 ttpp -151.87 62.46 0.85 Allowed 'General case' 0 CA--C 1.551 0.988 0 CA-C-O 122.276 1.036 . . . . 70.34 108.942 -177.21 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 178' ' ' ALA . . . . . 0.468 ' HB1' ' HB3' ' A' ' 224' ' ' PRO . . . -81.01 126.3 31.23 Favored 'General case' 0 N--CA 1.476 0.864 0 CA-C-N 114.457 -1.247 . . . . 64.32 110.794 -175.763 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . 0.526 ' HB1' HH11 ' A' ' 231' ' ' ARG . . . 66.57 9.92 6.97 Favored 'General case' 0 N--CA 1.497 1.924 0 C-N-CA 124.955 1.302 . . . . 54.03 111.501 -170.031 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . 0.446 ' HA3' ' HG2' ' A' ' 177' ' ' LYS . . . . . . . . 0 N--CA 1.468 0.786 0 CA-C-N 116.267 -0.424 . . . . 71.41 112.268 -173.411 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 191' ' ' GLN . . . . . 0.625 ' HB3' ' HD2' ' A' ' 243' ' ' PRO . 9.5 pt20 . . . . . 0 N--CA 1.477 0.905 0 CA-C-O 121.438 0.637 . . . . 50.14 109.915 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 65.7 m-20 -78.32 152.99 32.11 Favored 'General case' 0 C--O 1.239 0.521 0 CA-C-N 114.65 -1.159 . . . . 63.11 110.955 -173.598 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . 0.536 HD12 ' HA2' ' A' ' 239' ' ' GLY . 59.3 mt -128.68 175.76 8.33 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 114.547 -1.206 . . . . 54.33 110.297 -174.374 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 17.5 m-85 -139.67 122.73 16.78 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 123.915 0.886 . . . . 73.54 110.046 -177.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . 0.431 ' HB2' HD11 ' A' ' 249' ' ' LEU . . . -129.4 128.2 42.52 Favored 'General case' 0 C--N 1.341 0.209 0 N-CA-C 108.318 -0.993 . . . . 71.43 108.318 173.331 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 61.7 m -77.72 123.89 27.26 Favored 'General case' 0 CA--C 1.546 0.799 0 N-CA-C 109.344 -0.613 . . . . 74.21 109.344 176.888 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . 0.718 HD22 HD13 ' A' ' 251' ' ' LEU . 18.9 tp -107.69 110.87 22.83 Favored 'General case' 0 N--CA 1.474 0.775 0 N-CA-C 108.562 -0.903 . . . . 73.14 108.562 -178.532 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -78.43 132.52 37.34 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 109.321 -0.622 . . . . 71.42 109.321 173.286 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 199' ' ' VAL . . . . . 0.486 ' O ' ' HA ' ' A' ' 255' ' ' ILE . 4.1 p -144.18 127.3 8.72 Favored Pre-proline 0 CA--C 1.546 0.804 0 N-CA-C 108.453 -0.943 . . . . 74.13 108.453 177.745 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -69.59 156.09 64.72 Favored 'Trans proline' 0 C--N 1.367 1.517 0 C-N-CA 121.962 1.775 . . . . 72.15 111.48 170.774 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 201' ' ' ALA . . . . . 0.454 ' O ' HG23 ' A' ' 205' ' ' VAL . . . -51.05 -51.96 62.88 Favored Pre-proline 0 CA--C 1.555 1.166 0 N-CA-C 113.996 1.11 . . . . 55.12 113.996 -177.354 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -65.39 -32.63 49.79 Favored 'Trans proline' 0 C--N 1.382 2.309 0 CA-C-N 121.181 1.458 . . . . 52.21 113.253 -176.072 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 27.3 mt -68.48 -34.86 67.88 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.229 0 C-N-CA 122.664 0.386 . . . . 75.34 110.152 174.307 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -71.54 -33.12 68.88 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 122.295 0.238 . . . . 71.35 111.369 178.414 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 205' ' ' VAL . . . . . 0.454 HG23 ' O ' ' A' ' 201' ' ' ALA . 80.7 t -71.05 -57.76 6.86 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 C-N-CA 123.349 0.66 . . . . 61.13 111.041 178.643 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 10.6 m -82.37 -17.26 11.46 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.055 0 CA-C-N 116.272 -0.422 . . . . 74.34 111.588 -172.798 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 74.86 66.17 1.98 Allowed Glycine 0 C--N 1.342 0.883 0 O-C-N 123.667 0.604 . . . . 52.21 112.327 -177.422 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -85.57 -130.0 2.33 Favored Glycine 0 C--N 1.346 1.091 0 C-N-CA 122.694 0.188 . . . . 52.24 112.806 179.522 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 209' ' ' LYS . . . . . 0.416 ' HG2' ' HA ' ' A' ' 222' ' ' ALA . 46.8 mtmt -138.24 155.48 48.6 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.753 0.821 . . . . 71.03 111.005 176.363 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 11.0 m -144.23 168.93 10.15 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 C-N-CA 125.155 1.382 . . . . 74.32 108.66 172.406 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 48.9 ttp180 -97.06 114.34 25.97 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 123.227 0.611 . . . . 75.23 109.939 178.552 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -100.74 139.66 36.1 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 123.667 0.787 . . . . 65.23 110.208 179.52 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 23.9 mmt -98.46 116.02 29.79 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 123.021 0.528 . . . . 75.4 109.716 178.707 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 48.9 p -109.46 -175.58 2.79 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 123.928 0.891 . . . . 73.35 109.182 175.527 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 93.3 mt -63.3 -22.3 66.79 Favored 'General case' 0 CA--C 1.552 1.02 0 C-N-CA 122.71 0.404 . . . . 55.45 111.356 173.685 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 20.9 mt-10 -81.93 -22.89 36.48 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 123.672 0.789 . . . . 63.21 110.99 -178.877 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 118.18 -150.06 18.27 Favored Glycine 0 CA--C 1.533 1.16 0 N-CA-C 110.911 -0.876 . . . . 73.01 110.911 -170.822 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_endo -78.26 144.73 20.94 Favored 'Trans proline' 0 C--N 1.369 1.628 0 C-N-CA 122.463 2.109 . . . . 75.42 113.19 -176.424 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 219' ' ' VAL . . . . . 0.41 HG21 ' HZ ' ' A' ' 173' ' ' PHE . 7.6 p -144.02 133.03 19.34 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 C-N-CA 123.914 0.886 . . . . 61.42 109.366 177.363 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 40.0 mm-40 -78.69 104.59 9.41 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 109.658 -0.497 . . . . 72.23 109.658 177.47 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 4.1 p -107.31 130.19 59.88 Favored 'Isoleucine or valine' 0 C--O 1.244 0.808 0 CA-C-N 115.418 -0.81 . . . . 65.44 109.224 -174.423 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 222' ' ' ALA . . . . . 0.633 ' H ' HD21 ' A' ' 172' ' ' LEU . . . -81.09 104.64 11.71 Favored 'General case' 0 C--O 1.239 0.536 0 C-N-CA 123.419 0.688 . . . . 73.1 111.061 -177.16 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 59.9 t -55.6 135.64 71.12 Favored Pre-proline 0 N--CA 1.476 0.865 0 O-C-N 124.423 1.077 . . . . 70.33 110.056 178.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 224' ' ' PRO . . . . . 0.468 ' HB3' ' HB1' ' A' ' 178' ' ' ALA . 17.1 Cg_endo -65.23 148.76 88.98 Favored 'Trans proline' 0 C--N 1.365 1.416 0 C-N-CA 121.747 1.631 . . . . 54.45 111.801 170.326 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -65.35 150.17 87.46 Favored 'Trans proline' 0 C--N 1.364 1.35 0 C-N-CA 121.499 1.466 . . . . 73.23 111.612 169.763 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 59.6 mtm180 61.72 35.83 16.68 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 124.654 1.182 . . . . 73.1 112.484 170.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 227' ' ' THR . . . . . 0.425 HG22 HG21 ' A' ' 253' ' ' VAL . 26.6 m -83.04 133.94 35.06 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 115.342 -0.845 . . . . 64.5 109.262 174.365 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 28.3 mp0 -111.2 149.63 30.69 Favored 'General case' 0 N--CA 1.485 1.319 0 N-CA-C 109.398 -0.593 . . . . 55.35 109.398 175.857 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 229' ' ' ALA . . . . . 0.458 ' HA ' HG23 ' A' ' 253' ' ' VAL . . . -58.47 125.99 25.66 Favored 'General case' 0 N--CA 1.47 0.556 0 O-C-N 124.305 1.003 . . . . 63.13 111.46 -176.548 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 113.98 -15.46 21.14 Favored Glycine 0 CA--C 1.523 0.551 0 CA-C-N 115.206 -0.907 . . . . 41.5 113.035 -176.58 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 231' ' ' ARG . . . . . 0.526 HH11 ' HB1' ' A' ' 179' ' ' ALA . 75.0 mtt180 -67.66 152.81 45.0 Favored 'General case' 0 C--N 1.363 1.158 0 CA-C-N 117.751 0.775 . . . . 73.32 109.457 172.547 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 232' ' ' LYS . . . . . 0.48 ' HA ' ' O ' ' A' ' 251' ' ' LEU . 54.0 mtmt -130.05 128.01 41.06 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-O 121.324 0.583 . . . . 71.51 110.602 179.201 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 233' ' ' LEU . . . . . 0.491 ' HB2' ' HB2' ' A' ' 251' ' ' LEU . 20.1 mt -98.49 148.1 24.08 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 114.354 -1.293 . . . . 75.23 108.887 -174.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 21.2 ttt180 -106.82 110.24 22.35 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 122.851 0.46 . . . . 65.23 111.263 -170.401 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 235' ' ' LEU . . . . . 0.614 ' HB2' ' HB3' ' A' ' 249' ' ' LEU . 17.1 mt -98.56 103.9 15.89 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 122.641 0.376 . . . . 64.2 110.092 177.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 13.6 mtmt -70.72 134.84 47.82 Favored 'General case' 0 C--O 1.238 0.495 0 CA-C-N 116.231 -0.44 . . . . 70.02 111.896 -178.154 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 73.72 10.51 80.09 Favored Glycine 0 C--N 1.344 0.996 0 CA-C-N 114.973 -1.012 . . . . 64.11 114.808 177.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . 0.486 ' HE3' ' CE2' ' A' ' 173' ' ' PHE . 69.7 mmtt -104.6 5.36 33.69 Favored 'General case' 0 N--CA 1.478 0.957 0 CA-C-N 117.393 0.596 . . . . 62.12 110.0 179.785 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 239' ' ' GLY . . . . . 0.536 ' HA2' HD12 ' A' ' 193' ' ' LEU . . . -105.7 -168.37 23.5 Favored Glycine 0 C--N 1.35 1.325 0 CA-C-N 115.25 -0.886 . . . . 51.43 111.294 166.733 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -93.73 167.75 13.19 Favored Pre-proline 0 CA--C 1.559 1.319 0 C-N-CA 123.998 0.919 . . . . 73.14 110.233 178.337 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -71.65 171.51 16.25 Favored 'Trans proline' 0 C--N 1.376 2.001 0 C-N-CA 122.437 2.091 . . . . 63.43 112.926 172.203 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 155.36 -117.25 0.77 Allowed Glycine 0 CA--C 1.537 1.461 0 CA-C-O 119.312 -0.715 . . . . 73.44 113.219 173.507 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 243' ' ' PRO . . . . . 0.625 ' HD2' ' HB3' ' A' ' 191' ' ' GLN . 60.5 Cg_endo -63.25 -40.65 31.29 Favored 'Trans proline' 0 C--N 1.375 1.966 0 C-N-CA 124.638 3.559 . . . . 72.53 113.506 -169.348 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 244' ' ' ALA . . . . . 0.429 ' HB3' HE22 ' A' ' 191' ' ' GLN . . . -101.27 -13.99 17.84 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 123.393 0.677 . . . . 72.33 110.316 177.292 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 96.32 -31.71 7.16 Favored Glycine 0 C--N 1.352 1.464 0 CA-C-N 116.109 -0.496 . . . . 62.13 112.908 179.66 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 50.5 ttt180 -126.65 110.56 13.31 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 124.17 0.988 . . . . 63.32 109.102 -178.663 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -75.96 151.07 40.22 Favored Glycine 0 C--N 1.347 1.161 0 O-C-N 123.684 0.615 . . . . 62.34 113.532 179.011 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 18.4 m-20 -118.89 137.65 53.3 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 124.144 0.978 . . . . 70.5 109.67 -175.744 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 249' ' ' LEU . . . . . 0.614 ' HB3' ' HB2' ' A' ' 235' ' ' LEU . 51.6 tp -98.93 118.06 34.84 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 109.049 -0.723 . . . . 75.01 109.049 179.521 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 250' ' ' TYR . . . . . . . . . . . . . 3.4 m-85 -90.64 112.78 24.64 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 123.62 0.768 . . . . 65.42 110.331 -175.615 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 251' ' ' LEU . . . . . 0.718 HD13 HD22 ' A' ' 197' ' ' LEU . 83.4 mt -87.57 105.24 17.19 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 124.209 1.004 . . . . 70.31 109.408 -177.453 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 252' ' ' GLU . . . . . 0.405 ' O ' ' HG2' ' A' ' 254' ' ' ARG . 29.4 mt-10 -78.74 93.94 5.02 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 108.327 -0.99 . . . . 75.42 108.327 -178.425 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 253' ' ' VAL . . . . . 0.458 HG23 ' HA ' ' A' ' 229' ' ' ALA . 3.9 m -64.19 127.98 25.77 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.871 0 CA-C-O 121.334 0.587 . . . . 62.14 109.786 -176.701 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 254' ' ' ARG . . . . . 0.405 ' HG2' ' O ' ' A' ' 252' ' ' GLU . 26.6 mmt85 -127.46 98.97 5.43 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 108.713 -0.847 . . . . 72.4 108.713 -175.194 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 255' ' ' ILE . . . . . 0.486 ' HA ' ' O ' ' A' ' 199' ' ' VAL . 24.8 mt -80.31 110.56 16.02 Favored 'Isoleucine or valine' 0 C--O 1.238 0.473 0 CA-C-N 115.25 -0.886 . . . . 53.4 110.415 -176.922 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 10.2 t . . . . . 0 C--O 1.257 1.475 0 CA-C-N 115.059 -0.973 . . . . 75.55 109.708 174.037 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 172' ' ' LEU . . . . . 0.666 HD21 ' H ' ' A' ' 222' ' ' ALA . 22.3 mt . . . . . 0 N--CA 1.483 1.19 0 CA-C-O 120.855 0.359 . . . . 71.14 110.454 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 173' ' ' PHE . . . . . 0.471 ' CD1' HD22 ' A' ' 235' ' ' LEU . 26.2 m-85 -123.99 -62.78 1.26 Allowed 'General case' 0 N--CA 1.475 0.777 0 CA-C-N 115.519 -0.764 . . . . 75.12 110.189 -169.661 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 174' ' ' TYR . . . . . 0.464 ' CD2' ' HB3' ' A' ' 233' ' ' LEU . 1.8 p90 -75.8 -11.38 59.97 Favored 'General case' 0 C--O 1.219 -0.503 0 CA-C-N 114.587 -1.188 . . . . 60.42 112.815 -172.158 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 175' ' ' THR . . . . . 0.662 HG21 HD13 ' A' ' 172' ' ' LEU . 42.9 p -70.61 -2.18 13.47 Favored 'General case' 0 CA--C 1.548 0.9 0 N-CA-C 112.558 0.577 . . . . 73.0 112.558 -176.45 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 176' ' ' MET . . . . . . . . . . . . . 24.9 ptt? -57.1 -41.97 79.89 Favored 'General case' 0 CA--C 1.559 1.299 0 C-N-CA 123.67 0.788 . . . . 72.33 110.261 161.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 14.5 tmtt? 179.51 108.52 0.03 OUTLIER 'General case' 0 CA--C 1.553 1.08 0 C-N-CA 126.18 1.792 . . . . 61.43 106.321 179.463 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 178' ' ' ALA . . . . . 0.523 ' HB1' HD22 ' A' ' 233' ' ' LEU . . . -128.08 -58.77 1.2 Allowed 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 123.081 0.552 . . . . 64.31 112.025 -173.017 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . 0.48 ' HB2' ' HB2' ' A' ' 224' ' ' PRO . . . -71.55 85.22 0.86 Allowed 'General case' 0 CA--C 1.546 0.81 0 CA-C-O 121.57 0.7 . . . . 71.12 109.48 179.463 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.337 0.591 0 CA-C-N 114.298 -1.319 . . . . 75.43 109.889 -172.546 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 191' ' ' GLN . . . . . 0.601 ' HB3' ' HD2' ' A' ' 243' ' ' PRO . 6.8 pt20 . . . . . 0 N--CA 1.483 1.178 0 CA-C-O 121.302 0.572 . . . . 64.42 110.768 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -76.05 135.61 39.92 Favored 'General case' 0 C--O 1.241 0.624 0 CA-C-N 114.387 -1.279 . . . . 74.43 110.048 -177.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 43.6 mt -117.87 168.26 10.66 Favored 'General case' 0 C--O 1.24 0.589 0 CA-C-N 114.701 -1.136 . . . . 72.53 109.204 177.796 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 31.8 m-85 -138.6 121.86 17.01 Favored 'General case' 0 C--O 1.238 0.466 0 C-N-CA 123.483 0.713 . . . . 72.25 109.656 -179.49 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . 0.502 ' HB3' HD23 ' A' ' 251' ' ' LEU . . . -126.9 133.67 50.62 Favored 'General case' 0 CA--C 1.516 -0.342 0 C-N-CA 123.962 0.905 . . . . 70.04 108.607 177.448 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 2.2 m -81.45 125.59 30.62 Favored 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 108.82 -0.808 . . . . 62.03 108.82 176.234 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . 0.677 HD22 HD13 ' A' ' 251' ' ' LEU . 15.7 tp -109.55 111.39 22.88 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 108.672 -0.862 . . . . 64.21 108.672 -176.624 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -76.19 127.93 33.91 Favored 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 108.55 -0.907 . . . . 60.42 108.55 174.491 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 199' ' ' VAL . . . . . 0.494 ' O ' ' HA ' ' A' ' 255' ' ' ILE . 7.7 p -145.29 133.58 10.74 Favored Pre-proline 0 CA--C 1.544 0.716 0 N-CA-C 108.475 -0.935 . . . . 70.21 108.475 176.112 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 200' ' ' PRO . . . . . 0.444 ' HB2' ' HD2' ' A' ' 202' ' ' PRO . 75.4 Cg_endo -75.74 160.98 37.19 Favored 'Trans proline' 0 C--N 1.361 1.191 0 C-N-CA 121.737 1.625 . . . . 41.31 111.25 167.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -55.75 -47.25 99.12 Favored Pre-proline 0 CA--C 1.558 1.282 0 CA-C-O 117.695 -1.145 . . . . 71.35 113.786 -178.323 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 202' ' ' PRO . . . . . 0.444 ' HD2' ' HB2' ' A' ' 200' ' ' PRO . 56.1 Cg_endo -64.47 -37.95 35.95 Favored 'Trans proline' 0 C--N 1.396 3.057 0 C-N-CA 121.691 1.594 . . . . 75.02 112.964 -177.861 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 45.1 mt -67.93 -34.93 70.04 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.062 0 CA-C-O 120.817 0.341 . . . . 74.33 110.436 176.248 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -67.45 -40.61 85.39 Favored 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 123.048 0.539 . . . . 71.4 112.239 179.382 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 17.1 m -80.27 -45.98 22.0 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.793 0 N-CA-C 112.919 0.711 . . . . 71.24 112.919 -175.543 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 206' ' ' VAL . . . . . 0.436 HG22 ' O ' ' A' ' 202' ' ' PRO . 11.1 m -78.04 -25.57 14.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 C-N-CA 122.213 0.205 . . . . 74.13 111.516 178.477 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 82.24 66.25 1.58 Allowed Glycine 0 C--N 1.344 1.026 0 N-CA-C 111.944 -0.462 . . . . 23.24 111.944 -177.318 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -86.47 -130.93 2.85 Favored Glycine 0 C--N 1.352 1.442 0 C-N-CA 123.262 0.458 . . . . 54.35 112.217 177.494 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 209' ' ' LYS . . . . . 0.412 ' HG2' ' HA ' ' A' ' 222' ' ' ALA . 48.4 mtmt -137.89 155.72 48.64 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 124.063 0.945 . . . . 73.12 111.084 177.001 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 9.5 m -147.51 151.89 13.32 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.793 0 C-N-CA 125.288 1.435 . . . . 74.55 108.682 169.763 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 211' ' ' ARG . . . . . 0.441 ' HD2' ' HB2' ' A' ' 218' ' ' PRO . 54.5 ttp180 -87.55 116.9 25.99 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 123.069 0.548 . . . . 73.31 110.501 179.749 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -100.87 129.01 46.67 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 123.95 0.9 . . . . 74.34 109.769 177.557 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 22.4 mmt -86.29 120.86 28.1 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 108.96 -0.755 . . . . 63.43 108.96 175.49 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 24.0 p -123.41 -174.71 3.02 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 123.928 0.891 . . . . 34.43 109.835 -174.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 77.0 mt -65.77 -29.36 69.85 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 122.752 0.421 . . . . 74.31 110.894 172.259 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 18.6 mm-40 -90.6 6.77 42.4 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 123.859 0.864 . . . . 61.53 110.971 -179.589 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 96.79 -160.34 21.71 Favored Glycine 0 C--N 1.352 1.47 0 CA-C-O 119.581 -0.566 . . . . 74.32 112.636 177.915 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 218' ' ' PRO . . . . . 0.441 ' HB2' ' HD2' ' A' ' 211' ' ' ARG . 71.8 Cg_endo -75.11 144.25 29.67 Favored 'Trans proline' 0 C--N 1.368 1.565 0 C-N-CA 122.336 2.024 . . . . 74.02 112.471 -179.665 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 7.5 p -146.92 131.27 10.46 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 C-N-CA 123.199 0.599 . . . . 71.35 109.778 177.663 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -69.73 103.09 2.05 Favored 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 108.114 -1.069 . . . . 72.12 108.114 169.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 1.7 p -103.58 120.61 53.88 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.133 0 N-CA-C 108.263 -1.014 . . . . 63.45 108.263 179.74 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 222' ' ' ALA . . . . . 0.666 ' H ' HD21 ' A' ' 172' ' ' LEU . . . -76.11 109.91 10.15 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 123.382 0.673 . . . . 61.43 111.558 -175.441 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 51.9 t -55.2 138.4 66.52 Favored Pre-proline 0 N--CA 1.48 1.054 0 C-N-CA 125.636 1.574 . . . . 73.31 111.029 -177.087 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 224' ' ' PRO . . . . . 0.48 ' HB2' ' HB2' ' A' ' 179' ' ' ALA . 36.8 Cg_endo -66.42 147.79 83.16 Favored 'Trans proline' 0 C--N 1.377 2.03 0 C-N-CA 121.61 1.54 . . . . 73.0 110.843 170.918 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_exo -69.1 149.33 70.97 Favored 'Trans proline' 0 C--N 1.364 1.378 0 C-N-CA 121.725 1.617 . . . . 75.24 111.672 174.287 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 82.4 mtt180 63.94 39.56 7.99 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 124.79 1.236 . . . . 73.41 111.099 173.09 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 227' ' ' THR . . . . . 0.438 HG23 ' HD2' ' A' ' 231' ' ' ARG . 91.3 m -83.08 139.15 33.39 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 115.349 -0.841 . . . . 71.3 109.881 177.436 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 27.3 mp0 -112.36 148.31 34.55 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 124.325 1.05 . . . . 70.0 109.208 176.413 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 229' ' ' ALA . . . . . 0.4 ' HA ' HG23 ' A' ' 253' ' ' VAL . . . -59.2 128.65 38.21 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 123.546 0.738 . . . . 65.24 110.854 -179.615 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 105.6 -3.56 39.58 Favored Glycine 0 N--CA 1.471 1.023 0 O-C-N 123.828 0.705 . . . . 72.01 113.18 -177.55 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 231' ' ' ARG . . . . . 0.438 ' HD2' HG23 ' A' ' 227' ' ' THR . 62.8 mtt-85 -71.68 149.96 45.0 Favored 'General case' 0 C--N 1.359 1.006 0 CA-C-N 117.43 0.615 . . . . 73.12 109.839 171.851 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -127.45 103.35 7.31 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 123.263 0.625 . . . . 64.42 109.341 -174.867 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 233' ' ' LEU . . . . . 0.532 ' HB2' ' HB2' ' A' ' 251' ' ' LEU . 28.9 mt -80.38 149.34 30.25 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 114.16 -1.382 . . . . 72.45 109.121 -177.213 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 56.5 ttt180 -115.39 109.04 17.3 Favored 'General case' 0 N--CA 1.481 1.11 0 O-C-N 121.926 -0.484 . . . . 74.11 111.349 -171.755 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 235' ' ' LEU . . . . . 0.564 ' HB2' ' HB3' ' A' ' 249' ' ' LEU . 19.2 mt -95.68 107.02 19.19 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 123.125 0.57 . . . . 71.35 110.116 176.565 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 21.2 mttt -73.25 137.69 45.08 Favored 'General case' 0 CA--C 1.535 0.393 0 O-C-N 123.214 0.321 . . . . 74.33 110.208 174.114 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 74.01 19.17 79.79 Favored Glycine 0 C--N 1.34 0.78 0 CA-C-N 115.567 -0.742 . . . . 64.1 114.017 179.661 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . 0.426 ' HZ3' ' HE2' ' A' ' 173' ' ' PHE . 34.9 mmtm -121.19 6.93 10.22 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 123.367 0.667 . . . . 60.23 110.616 174.171 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -109.0 -170.5 20.79 Favored Glycine 0 C--N 1.347 1.175 0 N-CA-C 110.534 -1.026 . . . . 72.43 110.534 163.053 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 89.0 m-85 -89.96 147.64 37.77 Favored Pre-proline 0 N--CA 1.478 0.95 0 C-N-CA 123.169 0.588 . . . . 64.33 110.972 -177.66 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 17.6 Cg_exo -68.02 128.2 17.29 Favored 'Trans proline' 0 C--N 1.365 1.404 0 C-N-CA 121.771 1.648 . . . . 75.03 111.137 172.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -158.97 -121.66 0.63 Allowed Glycine 0 C--N 1.347 1.16 0 CA-C-O 118.351 -1.249 . . . . 63.24 112.313 -177.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 243' ' ' PRO . . . . . 0.601 ' HD2' ' HB3' ' A' ' 191' ' ' GLN . 25.2 Cg_endo -55.21 -45.58 39.32 Favored 'Trans proline' 0 C--N 1.38 2.23 0 C-N-CA 124.414 3.409 . . . . 75.14 113.489 -174.599 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -86.64 -13.22 46.21 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 123.156 0.582 . . . . 72.1 111.539 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 92.54 -30.64 6.71 Favored Glycine 0 C--N 1.348 1.21 0 N-CA-C 112.068 -0.413 . . . . 73.24 112.068 -174.402 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 46.0 ttm-85 -128.28 112.47 14.5 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 124.364 1.065 . . . . 70.42 109.114 176.066 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -72.73 154.78 50.43 Favored Glycine 0 C--N 1.347 1.192 0 O-C-N 123.181 0.301 . . . . 65.12 113.584 172.883 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 20.9 m-20 -110.24 165.49 11.72 Favored 'General case' 0 C--O 1.237 0.398 0 C-N-CA 123.996 0.918 . . . . 73.32 110.088 -177.689 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 249' ' ' LEU . . . . . 0.564 ' HB3' ' HB2' ' A' ' 235' ' ' LEU . 34.7 tp -129.47 113.32 14.75 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 123.758 0.823 . . . . 74.52 108.877 176.16 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 250' ' ' TYR . . . . . 0.449 ' HA ' ' O ' ' A' ' 233' ' ' LEU . 7.5 m-85 -91.04 110.55 21.82 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 115.664 -0.698 . . . . 74.54 110.627 -177.452 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 251' ' ' LEU . . . . . 0.677 HD13 HD22 ' A' ' 197' ' ' LEU . 84.6 mt -88.39 105.36 17.54 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 114.139 -1.391 . . . . 72.33 109.143 -178.644 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -80.12 100.83 8.42 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 108.687 -0.857 . . . . 72.32 108.687 175.849 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 253' ' ' VAL . . . . . 0.4 HG23 ' HA ' ' A' ' 229' ' ' ALA . 12.1 m -63.58 133.97 28.92 Favored 'Isoleucine or valine' 0 C--O 1.246 0.895 0 O-C-N 123.775 0.672 . . . . 64.24 110.094 -179.777 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 20.5 mmm-85 -127.64 94.22 3.91 Favored 'General case' 0 C--O 1.24 0.59 0 N-CA-C 107.815 -1.179 . . . . 73.04 107.815 -177.257 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 255' ' ' ILE . . . . . 0.494 ' HA ' ' O ' ' A' ' 199' ' ' VAL . 22.4 mt -76.76 133.75 30.27 Favored 'Isoleucine or valine' 0 C--O 1.238 0.469 0 O-C-N 124.482 1.114 . . . . 72.05 110.836 -173.909 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 9.7 t . . . . . 0 CA--C 1.569 1.698 0 CA-C-O 117.589 -1.196 . . . . 63.42 108.832 179.824 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 172' ' ' LEU . . . . . 0.644 HD21 ' H ' ' A' ' 222' ' ' ALA . 53.3 mt . . . . . 0 N--CA 1.485 1.32 0 CA-C-O 120.985 0.422 . . . . 72.14 110.188 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 173' ' ' PHE . . . . . 0.486 ' CD1' HD22 ' A' ' 235' ' ' LEU . 52.3 m-85 -140.66 -58.27 0.52 Allowed 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.829 0.852 . . . . 70.4 109.191 -164.067 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 174' ' ' TYR . . . . . 0.486 ' OH ' ' HB ' ' A' ' 221' ' ' VAL . 7.2 p90 -70.53 -14.96 62.72 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 114.347 -1.297 . . . . 63.34 113.089 -177.806 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -45.73 -29.02 1.16 Allowed 'General case' 0 N--CA 1.49 1.574 0 C-N-CA 126.172 1.789 . . . . 62.15 114.076 -173.157 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 176' ' ' MET . . . . . . . . . . . . . 66.5 mtm -55.7 -38.95 70.38 Favored 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 124.736 1.214 . . . . 75.34 112.934 -178.58 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 14.3 ptmm? -160.42 34.48 0.16 Allowed 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 123.503 0.721 . . . . 55.21 110.848 -170.766 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -64.16 -46.24 84.88 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 124.764 1.226 . . . . 63.44 113.479 -169.705 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . 0.453 ' HB2' ' HB2' ' A' ' 224' ' ' PRO . . . -82.65 65.79 7.95 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-O 122.124 0.964 . . . . 75.55 109.629 -179.71 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.243 0.685 0 CA-C-N 114.19 -1.368 . . . . 71.34 110.48 -179.327 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 191' ' ' GLN . . . . . 0.718 HE22 ' HB3' ' A' ' 244' ' ' ALA . 5.8 pt20 . . . . . 0 CA--C 1.542 0.665 0 N-CA-C 109.235 -0.654 . . . . 45.21 109.235 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 192' ' ' ASP . . . . . 0.513 ' N ' ' HG3' ' A' ' 191' ' ' GLN . 31.3 m-20 -80.27 137.33 36.61 Favored 'General case' 0 C--N 1.354 0.778 0 CA-C-N 115.229 -0.896 . . . . 62.25 109.003 -176.125 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 32.2 mt -113.05 174.83 5.71 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 115.85 -0.614 . . . . 64.45 111.379 -173.438 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 48.5 m-85 -136.93 124.15 21.78 Favored 'General case' 0 C--O 1.238 0.492 0 C-N-CA 124.552 1.141 . . . . 74.0 109.466 -179.771 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . 0.4 ' O ' ' HA ' ' A' ' 251' ' ' LEU . . . -135.42 128.29 31.26 Favored 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 107.269 -1.382 . . . . 73.41 107.269 171.429 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 44.9 m -82.77 125.8 31.68 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 109.188 -0.671 . . . . 74.13 109.188 -179.839 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . 0.52 HD22 HD13 ' A' ' 251' ' ' LEU . 15.9 tp -106.65 110.8 23.09 Favored 'General case' 0 N--CA 1.466 0.333 0 N-CA-C 107.916 -1.142 . . . . 73.24 107.916 -176.743 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -87.69 126.61 35.07 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 123.272 0.629 . . . . 54.43 109.345 -179.336 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 199' ' ' VAL . . . . . 0.478 ' O ' ' HA ' ' A' ' 255' ' ' ILE . 5.5 p -144.83 132.63 10.52 Favored Pre-proline 0 CA--C 1.55 0.969 0 N-CA-C 108.409 -0.96 . . . . 52.53 108.409 -178.792 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -72.74 159.35 48.72 Favored 'Trans proline' 0 C--N 1.368 1.583 0 C-N-CA 121.987 1.792 . . . . 55.31 111.023 171.031 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 201' ' ' ALA . . . . . 0.494 ' O ' HG23 ' A' ' 205' ' ' VAL . . . -50.95 -53.71 45.0 Favored Pre-proline 0 CA--C 1.558 1.264 0 CA-C-O 117.659 -1.162 . . . . 70.34 113.361 -176.466 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -63.95 -35.31 55.73 Favored 'Trans proline' 0 C--N 1.389 2.677 0 C-N-CA 121.598 1.532 . . . . 75.03 113.504 -175.799 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 41.0 mt -68.73 -33.82 61.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 N-CA-C 109.702 -0.481 . . . . 74.41 109.702 176.005 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 204' ' ' ALA . . . . . 0.478 ' HB1' ' HB ' ' A' ' 227' ' ' THR . . . -70.14 -35.66 74.22 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 123.228 0.611 . . . . 55.24 111.305 178.47 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 205' ' ' VAL . . . . . 0.494 HG23 ' O ' ' A' ' 201' ' ' ALA . 90.2 t -70.94 -56.44 10.65 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 C-N-CA 123.398 0.679 . . . . 73.44 110.522 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 17.3 m -73.32 -27.57 24.11 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.956 0 C-N-CA 122.862 0.465 . . . . 61.53 111.334 -174.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 81.36 69.62 1.39 Allowed Glycine 0 C--N 1.341 0.85 0 CA-C-N 115.839 -0.619 . . . . 72.54 112.262 -175.622 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -87.56 -140.05 6.44 Favored Glycine 0 C--N 1.355 1.618 0 CA-C-O 119.593 -0.56 . . . . 72.53 112.236 177.879 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 47.8 mtmt -137.35 147.47 45.57 Favored 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 123.66 0.784 . . . . 74.12 110.97 179.662 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 5.6 m -143.39 160.17 17.12 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 C-N-CA 125.271 1.428 . . . . 75.51 109.369 176.804 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 24.3 ttt180 -90.49 114.58 26.8 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 123.929 0.892 . . . . 70.44 110.449 179.587 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -102.18 131.87 48.43 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 124.753 1.221 . . . . 60.22 109.841 174.772 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 37.2 tpp -88.28 130.96 34.97 Favored 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 109.87 -0.418 . . . . 70.13 109.87 176.506 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 63.4 p -120.24 -171.68 2.21 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 124.309 1.043 . . . . 75.1 109.279 177.425 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 89.9 mt -67.93 -22.21 65.07 Favored 'General case' 0 CA--C 1.55 0.971 0 C-N-CA 123.315 0.646 . . . . 73.13 111.789 172.347 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 58.6 mt-10 -90.68 -21.12 21.79 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 123.578 0.751 . . . . 74.41 111.258 -177.685 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 124.48 -156.34 18.52 Favored Glycine 0 C--N 1.34 0.779 0 N-CA-C 111.092 -0.803 . . . . 42.4 111.092 -173.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -76.3 140.16 21.75 Favored 'Trans proline' 0 CA--C 1.551 1.356 0 C-N-CA 122.219 1.946 . . . . 74.42 113.932 -176.821 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 2.4 p -131.98 128.98 60.2 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.451 0 C-N-CA 124.678 1.191 . . . . 62.04 108.015 172.109 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -81.75 102.09 10.54 Favored 'General case' 0 C--O 1.236 0.376 0 N-CA-C 108.349 -0.982 . . . . 72.33 108.349 174.011 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 221' ' ' VAL . . . . . 0.486 ' HB ' ' OH ' ' A' ' 174' ' ' TYR . 13.9 m -97.65 138.85 21.33 Favored 'Isoleucine or valine' 0 C--O 1.242 0.679 0 CA-C-N 115.431 -0.804 . . . . 64.45 109.459 179.57 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 222' ' ' ALA . . . . . 0.644 ' H ' HD21 ' A' ' 172' ' ' LEU . . . -88.85 107.83 19.2 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-N 115.05 -0.977 . . . . 63.41 109.624 -177.355 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 61.2 t -54.09 134.3 59.15 Favored Pre-proline 0 N--CA 1.482 1.137 0 C-N-CA 124.302 1.041 . . . . 65.14 109.532 -179.332 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 224' ' ' PRO . . . . . 0.453 ' HB2' ' HB2' ' A' ' 179' ' ' ALA . 26.1 Cg_endo -60.52 151.23 76.8 Favored 'Trans proline' 0 C--N 1.373 1.858 0 C-N-CA 121.922 1.748 . . . . 70.13 112.647 177.29 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -64.56 133.76 38.37 Favored 'Trans proline' 0 C--N 1.368 1.601 0 C-N-CA 121.485 1.457 . . . . 74.1 110.677 169.505 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 55.3 mtt180 67.03 62.64 0.48 Allowed 'General case' 0 C--O 1.241 0.629 0 C-N-CA 124.797 1.239 . . . . 63.42 109.831 175.668 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 227' ' ' THR . . . . . 0.677 ' HA ' ' HE ' ' A' ' 231' ' ' ARG . 56.1 m -89.87 140.51 29.54 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 113.866 -1.515 . . . . 74.33 109.173 176.582 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -116.64 141.54 48.07 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.736 0.814 . . . . 70.22 108.862 171.884 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 229' ' ' ALA . . . . . 0.441 ' HB2' ' HB ' ' A' ' 255' ' ' ILE . . . -58.91 116.99 4.15 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 123.651 0.781 . . . . 62.0 110.217 179.911 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 115.16 -2.2 22.51 Favored Glycine 0 CA--C 1.526 0.754 0 CA-C-O 119.123 -0.821 . . . . 73.11 113.542 -173.07 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 231' ' ' ARG . . . . . 0.677 ' HE ' ' HA ' ' A' ' 227' ' ' THR . 77.5 mtt-85 -66.38 145.49 55.64 Favored 'General case' 0 N--CA 1.483 1.203 0 CA-C-N 118.042 0.921 . . . . 52.32 109.183 169.55 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -121.38 98.81 6.15 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 107.899 -1.149 . . . . 74.34 107.899 -174.477 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 233' ' ' LEU . . . . . 0.807 ' HB2' ' HB2' ' A' ' 251' ' ' LEU . 53.7 mt -79.79 152.27 29.86 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 115.36 -0.836 . . . . 54.23 109.371 179.843 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 234' ' ' ARG . . . . . 0.459 ' H ' ' HB3' ' A' ' 174' ' ' TYR . 59.4 ttm-85 -122.29 106.49 11.15 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 122.937 0.495 . . . . 72.32 110.542 -175.464 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 235' ' ' LEU . . . . . 0.603 ' HB2' ' HB3' ' A' ' 249' ' ' LEU . 10.3 mt -91.58 100.17 12.96 Favored 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 109.043 -0.725 . . . . 63.54 109.043 171.376 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 19.4 mttt -67.34 132.91 48.63 Favored 'General case' 0 C--O 1.241 0.61 0 O-C-N 123.365 0.416 . . . . 73.42 111.347 -178.042 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 73.89 18.2 79.55 Favored Glycine 0 C--N 1.347 1.193 0 CA-C-N 115.03 -0.986 . . . . 71.43 115.034 177.248 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 68.9 mmtt -106.4 12.41 29.78 Favored 'General case' 0 N--CA 1.488 1.455 0 CA-C-N 117.405 0.603 . . . . 75.15 110.514 174.749 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -113.9 -165.66 15.73 Favored Glycine 0 CA--C 1.527 0.811 0 CA-C-N 114.822 -1.081 . . . . 71.21 110.732 167.802 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -95.17 168.01 11.84 Favored Pre-proline 0 N--CA 1.479 1.022 0 C-N-CA 124.278 1.031 . . . . 62.12 110.097 -177.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -81.27 149.14 16.97 Favored 'Trans proline' 0 C--N 1.372 1.786 0 C-N-CA 121.599 1.533 . . . . 74.14 112.859 171.63 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 179.52 -119.75 0.66 Allowed Glycine 0 CA--C 1.54 1.598 0 CA-C-O 119.004 -0.887 . . . . 70.22 113.28 176.021 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 243' ' ' PRO . . . . . 0.445 ' HD2' ' HB3' ' A' ' 191' ' ' GLN . 34.1 Cg_endo -55.62 -46.67 30.23 Favored 'Trans proline' 0 C--N 1.382 2.306 1 C-N-CA 125.364 4.043 . . . . 41.54 114.055 -172.241 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 244' ' ' ALA . . . . . 0.718 ' HB3' HE22 ' A' ' 191' ' ' GLN . . . -100.19 -2.21 34.55 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 123.315 0.646 . . . . 74.3 110.952 -179.133 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 87.8 -51.51 4.1 Favored Glycine 0 C--N 1.353 1.489 0 N-CA-C 111.833 -0.507 . . . . 71.55 111.833 -178.461 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 10.2 ttm180 -101.05 109.63 21.55 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 123.947 0.899 . . . . 51.3 109.879 176.679 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -75.98 130.41 10.94 Favored Glycine 0 C--N 1.351 1.373 0 N-CA-C 110.661 -0.976 . . . . 45.53 110.661 169.264 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 67.4 m-20 -112.31 145.65 39.65 Favored 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 109.332 -0.618 . . . . 72.04 109.332 -176.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 249' ' ' LEU . . . . . 0.603 ' HB3' ' HB2' ' A' ' 235' ' ' LEU . 31.4 tp -97.87 118.68 34.99 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 123.677 0.791 . . . . 61.12 109.207 -175.239 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 250' ' ' TYR . . . . . 0.408 ' HA ' ' O ' ' A' ' 233' ' ' LEU . 1.6 m-85 -89.34 108.87 19.88 Favored 'General case' 0 C--O 1.243 0.739 0 N-CA-C 108.727 -0.842 . . . . 75.1 108.727 -177.337 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 251' ' ' LEU . . . . . 0.807 ' HB2' ' HB2' ' A' ' 233' ' ' LEU . 79.7 mt -87.36 104.03 16.04 Favored 'General case' 0 C--O 1.241 0.61 0 N-CA-C 107.94 -1.133 . . . . 74.05 107.94 177.41 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -84.1 100.15 10.93 Favored 'General case' 0 C--O 1.238 0.457 0 CA-C-N 115.063 -0.972 . . . . 63.44 108.918 -177.535 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 11.7 m -72.04 135.59 27.53 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 CA-C-O 121.53 0.681 . . . . 60.25 110.67 -172.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 49.7 mmm-85 -127.42 98.92 5.42 Favored 'General case' 0 C--O 1.237 0.431 0 C-N-CA 124.608 1.163 . . . . 71.0 108.299 -178.594 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 255' ' ' ILE . . . . . 0.478 ' HA ' ' O ' ' A' ' 199' ' ' VAL . 27.2 mt -77.95 128.59 38.14 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 O-C-N 124.169 0.918 . . . . 73.12 109.754 179.735 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 4.2 t . . . . . 0 CA--C 1.559 1.327 0 CA-C-O 117.273 -1.346 . . . . 72.42 107.957 179.486 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 172' ' ' LEU . . . . . 0.447 HD21 ' HB3' ' A' ' 222' ' ' ALA . 43.4 mt . . . . . 0 N--CA 1.486 1.352 0 CA-C-O 120.97 0.415 . . . . 71.2 112.035 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 173' ' ' PHE . . . . . 0.501 ' CD1' HD22 ' A' ' 235' ' ' LEU . 11.9 m-85 -137.65 -44.95 0.54 Allowed 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 124.028 0.931 . . . . 64.25 109.519 -173.042 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 174' ' ' TYR . . . . . 0.518 ' CD2' ' HB3' ' A' ' 233' ' ' LEU . 0.7 OUTLIER -81.97 13.44 3.34 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-N 114.832 -1.076 . . . . 70.32 112.899 -175.689 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 175' ' ' THR . . . . . 0.427 HG23 ' HB3' ' A' ' 172' ' ' LEU . 11.6 p -63.37 -9.12 10.76 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.867 0.867 . . . . 71.24 113.308 -179.857 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 176' ' ' MET . . . . . . . . . . . . . 44.9 mtm -58.41 -63.96 1.09 Allowed 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 123.595 0.758 . . . . 52.42 109.104 166.36 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 44.8 pttt -168.1 119.06 0.81 Allowed 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 125.094 1.358 . . . . 74.42 108.337 -179.053 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 178' ' ' ALA . . . . . 0.583 ' HB1' HD22 ' A' ' 233' ' ' LEU . . . -124.04 -54.5 1.71 Allowed 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 123.916 0.886 . . . . 42.14 109.82 -173.641 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . 0.419 ' HA ' ' HD3' ' A' ' 231' ' ' ARG . . . -79.42 65.13 4.5 Favored 'General case' 0 CA--C 1.543 0.702 0 CA-C-O 121.918 0.866 . . . . 74.11 108.742 169.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.336 0.568 0 N-CA-C 110.148 -1.181 . . . . 35.53 110.148 -171.672 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 191' ' ' GLN . . . . . 0.435 ' HG3' ' N ' ' A' ' 192' ' ' ASP . 6.5 pt20 . . . . . 0 N--CA 1.47 0.552 0 N-CA-C 110.278 -0.267 . . . . 64.2 110.278 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 192' ' ' ASP . . . . . 0.435 ' N ' ' HG3' ' A' ' 191' ' ' GLN . 73.5 m-20 -84.94 121.0 27.13 Favored 'General case' 0 C--N 1.347 0.482 0 C-N-CA 123.998 0.919 . . . . 61.24 109.404 -175.722 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . 0.488 HD12 ' HA2' ' A' ' 239' ' ' GLY . 78.5 mt -108.17 177.67 4.73 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 124.351 1.06 . . . . 72.34 110.479 -170.383 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 47.3 m-85 -129.61 123.59 31.65 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 123.426 0.691 . . . . 71.02 110.736 -179.546 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . 0.435 ' HB2' HD11 ' A' ' 249' ' ' LEU . . . -128.29 171.98 11.48 Favored 'General case' 0 C--O 1.238 0.496 0 C-N-CA 125.64 1.576 . . . . 71.55 108.43 173.401 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 48.6 m -119.05 134.03 55.44 Favored 'General case' 0 C--O 1.237 0.446 0 C-N-CA 123.126 0.571 . . . . 55.53 109.675 175.57 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . 0.731 HD22 HD13 ' A' ' 251' ' ' LEU . 17.1 tp -116.37 110.87 19.25 Favored 'General case' 0 C--O 1.234 0.288 0 N-CA-C 108.178 -1.045 . . . . 71.33 108.178 175.477 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -90.14 122.56 33.21 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 108.68 -0.859 . . . . 74.02 108.68 -179.632 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 199' ' ' VAL . . . . . 0.413 ' O ' ' HA ' ' A' ' 255' ' ' ILE . 5.0 p -136.18 132.4 19.08 Favored Pre-proline 0 CA--C 1.549 0.917 0 C-N-CA 124.287 1.035 . . . . 72.21 108.835 -174.795 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -71.73 158.87 52.3 Favored 'Trans proline' 0 C--N 1.367 1.551 0 C-N-CA 122.025 1.817 . . . . 74.21 111.256 171.422 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -53.0 -46.06 97.81 Favored Pre-proline 0 CA--C 1.558 1.257 0 N-CA-C 114.208 1.188 . . . . 73.14 114.208 -179.675 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 202' ' ' PRO . . . . . 0.465 ' HA ' HG22 ' A' ' 205' ' ' VAL . 34.3 Cg_endo -62.8 -43.45 20.47 Favored 'Trans proline' 0 C--N 1.385 2.494 0 C-N-CA 121.918 1.745 . . . . 64.43 113.675 177.527 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 43.5 mt -66.01 -30.73 50.89 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.351 0 CA-C-N 118.746 0.703 . . . . 73.13 110.5 177.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -68.74 -49.38 59.26 Favored 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 122.769 0.428 . . . . 64.02 111.587 177.26 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 205' ' ' VAL . . . . . 0.465 HG22 ' HA ' ' A' ' 202' ' ' PRO . 22.7 m -70.92 -47.83 60.09 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.848 0 C-N-CA 123.542 0.737 . . . . 71.03 112.411 -174.905 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 206' ' ' VAL . . . . . 0.449 HG22 ' O ' ' A' ' 202' ' ' PRO . 11.0 m -76.22 -34.19 25.45 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.235 0 C-N-CA 122.552 0.341 . . . . 43.12 110.979 179.712 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 87.47 61.06 1.57 Allowed Glycine 0 C--N 1.35 1.31 0 CA-C-N 116.251 -0.431 . . . . 70.11 112.135 -175.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -81.59 -133.93 1.64 Allowed Glycine 0 C--N 1.346 1.132 0 N-CA-C 112.511 -0.236 . . . . 74.1 112.511 177.929 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 48.0 mtmt -136.21 152.67 51.01 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 123.895 0.878 . . . . 60.5 110.839 178.741 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 4.5 m -144.76 163.52 13.48 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 C-N-CA 125.412 1.485 . . . . 70.44 108.363 172.238 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 42.0 ttp180 -98.94 115.36 28.71 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 123.622 0.769 . . . . 74.14 109.26 179.277 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -101.92 120.81 41.0 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 124.145 0.978 . . . . 71.21 110.429 -179.489 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 74.6 mtp -84.26 137.28 33.56 Favored 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 110.125 -0.324 . . . . 55.24 110.125 175.708 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 38.0 p -130.54 -172.9 2.92 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 124.592 1.157 . . . . 74.02 109.551 -175.889 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 82.6 mt -58.29 -35.0 71.17 Favored 'General case' 0 N--CA 1.488 1.465 0 CA-C-O 121.152 0.501 . . . . 73.31 110.565 172.723 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -92.29 -8.49 45.05 Favored 'General case' 0 CA--C 1.545 0.754 0 CA-C-N 115.166 -0.925 . . . . 72.01 111.378 -177.8 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 113.61 -159.32 13.75 Favored Glycine 0 C--N 1.348 1.224 0 CA-C-O 119.575 -0.569 . . . . 62.21 113.329 174.111 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -77.86 136.66 15.19 Favored 'Trans proline' 0 C--N 1.368 1.566 0 C-N-CA 123.24 2.627 . . . . 72.44 113.217 -171.584 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 6.2 p -132.8 133.09 59.4 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 C-N-CA 124.403 1.081 . . . . 64.4 109.376 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -76.61 102.06 5.97 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 108.534 -0.913 . . . . 63.04 108.534 176.173 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 6.1 p -110.06 127.25 67.1 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.975 0 N-CA-C 109.242 -0.651 . . . . 54.3 109.242 -174.06 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 222' ' ' ALA . . . . . 0.447 ' HB3' HD21 ' A' ' 172' ' ' LEU . . . -81.76 108.36 15.24 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 122.991 0.516 . . . . 42.11 110.755 -177.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 65.1 t -54.34 135.25 61.15 Favored Pre-proline 0 N--CA 1.484 1.245 0 C-N-CA 124.671 1.188 . . . . 51.3 110.61 179.8 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -65.41 147.69 87.43 Favored 'Trans proline' 0 C--N 1.378 2.119 0 C-N-CA 122.012 1.808 . . . . 63.13 110.873 174.219 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -60.89 138.0 76.17 Favored 'Trans proline' 0 C--N 1.368 1.592 0 C-N-CA 121.66 1.573 . . . . 73.13 111.058 174.238 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 30.9 mtm105 63.24 51.23 2.76 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 124.597 1.159 . . . . 64.5 110.953 174.632 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 227' ' ' THR . . . . . 0.41 HG23 ' HD2' ' A' ' 231' ' ' ARG . 90.4 m -77.7 137.05 38.28 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 115.299 -0.864 . . . . 73.04 109.087 170.457 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 28.1 mp0 -114.65 147.02 40.18 Favored 'General case' 0 N--CA 1.479 0.993 0 N-CA-C 108.939 -0.763 . . . . 61.23 108.939 174.534 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -57.91 124.54 19.58 Favored 'General case' 0 C--O 1.24 0.557 0 O-C-N 123.903 0.752 . . . . 73.11 111.017 -178.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 114.87 -14.53 19.52 Favored Glycine 0 N--CA 1.468 0.816 0 CA-C-O 119.076 -0.847 . . . . 43.45 113.858 -176.776 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 231' ' ' ARG . . . . . 0.419 ' HD3' ' HA ' ' A' ' 179' ' ' ALA . 88.9 mtt-85 -62.95 146.61 52.64 Favored 'General case' 0 N--CA 1.478 0.967 0 CA-C-N 117.759 0.779 . . . . 53.13 111.113 178.12 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 71.7 mmtt -118.84 97.49 5.73 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 123.996 0.918 . . . . 75.22 109.029 -172.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 233' ' ' LEU . . . . . 0.653 ' HB2' ' HB2' ' A' ' 251' ' ' LEU . 21.2 mt -85.52 137.96 32.53 Favored 'General case' 0 CA--C 1.546 0.807 0 N-CA-C 109.126 -0.694 . . . . 73.32 109.126 -175.316 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 36.3 ttm-85 -110.86 114.31 27.55 Favored 'General case' 0 CA--C 1.558 1.25 0 C-N-CA 123.054 0.542 . . . . 75.44 111.377 -169.027 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 235' ' ' LEU . . . . . 0.572 HD11 HD11 ' A' ' 251' ' ' LEU . 16.5 mt -108.63 113.56 26.65 Favored 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 123.929 0.891 . . . . 74.4 111.641 -176.535 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 34.8 mttp -72.91 148.94 43.86 Favored 'General case' 0 N--CA 1.481 1.114 0 CA-C-O 121.338 0.589 . . . . 73.55 111.76 174.164 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 78.17 0.59 77.6 Favored Glycine 0 C--N 1.344 1.02 0 CA-C-N 114.107 -1.406 . . . . 72.11 113.87 179.775 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 73.4 mmtt -112.85 3.43 16.38 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.177 0.591 . . . . 74.05 111.457 -174.646 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 239' ' ' GLY . . . . . 0.488 ' HA2' HD12 ' A' ' 193' ' ' LEU . . . -113.27 -170.15 17.49 Favored Glycine 0 C--N 1.348 1.241 0 N-CA-C 111.328 -0.709 . . . . 35.0 111.328 166.834 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 79.8 m-85 -88.3 151.71 49.08 Favored Pre-proline 0 N--CA 1.481 1.114 0 C-N-CA 123.084 0.553 . . . . 52.54 110.803 -178.114 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_exo -67.44 168.03 19.06 Favored 'Trans proline' 0 C--N 1.371 1.741 0 C-N-CA 122.361 2.04 . . . . 73.12 112.614 172.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 144.06 -104.78 0.35 Allowed Glycine 0 C--N 1.348 1.212 0 CA-C-O 119.332 -0.704 . . . . 72.21 113.982 172.149 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -64.22 -30.86 64.47 Favored 'Trans proline' 0 C--N 1.375 1.94 0 C-N-CA 124.012 3.141 . . . . 72.14 114.313 -168.0 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -117.15 5.83 12.77 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 122.924 0.489 . . . . 32.41 110.701 173.593 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 87.81 -46.23 3.42 Favored Glycine 0 C--N 1.35 1.353 0 CA-C-N 116.905 -0.134 . . . . 63.33 113.131 178.234 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 31.3 ttm180 -123.99 112.02 16.7 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 124.369 1.068 . . . . 72.34 109.299 177.479 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -73.57 159.56 53.19 Favored Glycine 0 C--N 1.349 1.253 0 O-C-N 123.431 0.457 . . . . 52.12 114.17 176.119 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 248' ' ' ASP . . . . . 0.418 ' HA ' ' O ' ' A' ' 235' ' ' LEU . 12.4 m-20 -111.56 171.52 7.44 Favored 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 124.026 0.93 . . . . 71.51 111.4 -177.838 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 249' ' ' LEU . . . . . 0.435 HD11 ' HB2' ' A' ' 195' ' ' ALA . 25.9 tp -130.6 126.33 36.43 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 115.021 -0.99 . . . . 72.04 109.748 174.107 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 250' ' ' TYR . . . . . . . . . . . . . 2.8 m-30 -89.85 113.0 24.51 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 124.235 1.014 . . . . 72.03 110.516 179.76 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 251' ' ' LEU . . . . . 0.731 HD13 HD22 ' A' ' 197' ' ' LEU . 86.0 mt -87.2 103.34 15.33 Favored 'General case' 0 C--O 1.24 0.578 0 N-CA-C 107.243 -1.391 . . . . 75.2 107.243 176.091 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -80.77 101.54 9.39 Favored 'General case' 0 C--O 1.241 0.625 0 N-CA-C 108.542 -0.91 . . . . 75.1 108.542 177.594 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 17.9 m -73.59 135.56 27.3 Favored 'Isoleucine or valine' 0 C--O 1.244 0.808 0 CA-C-N 115.695 -0.684 . . . . 72.42 110.831 -172.678 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 31.3 mmm180 -125.93 99.23 5.85 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 114.559 -1.2 . . . . 71.1 108.13 -176.734 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 255' ' ' ILE . . . . . 0.413 ' HA ' ' O ' ' A' ' 199' ' ' VAL . 23.5 mt -79.35 123.06 35.77 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 O-C-N 123.565 0.541 . . . . 51.4 110.438 -179.562 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 2.0 t . . . . . 0 CA--C 1.563 1.466 0 N-CA-C 107.673 -1.232 . . . . 71.31 107.673 176.372 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 172' ' ' LEU . . . . . 0.409 HD21 ' O ' ' A' ' 222' ' ' ALA . 26.4 mt . . . . . 0 N--CA 1.489 1.496 0 N-CA-C 112.524 0.565 . . . . 65.44 112.524 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 173' ' ' PHE . . . . . 0.512 ' HE1' HG21 ' A' ' 219' ' ' VAL . 38.6 m-85 -150.45 -40.98 0.13 Allowed 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 124.765 1.226 . . . . 74.01 109.411 -171.396 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 174' ' ' TYR . . . . . 0.434 ' CD2' ' HB3' ' A' ' 233' ' ' LEU . 0.7 OUTLIER -96.22 6.69 48.24 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 124.141 0.976 . . . . 74.41 112.785 -172.748 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -50.72 -35.21 30.24 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 125.096 1.358 . . . . 65.41 113.036 -162.446 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 176' ' ' MET . . . . . . . . . . . . . 7.0 ptm -58.39 93.62 0.02 OUTLIER 'General case' 0 CA--C 1.564 1.487 0 C-N-CA 124.638 1.175 . . . . 53.44 112.111 172.865 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 48.8 mtmt 57.05 42.08 26.5 Favored 'General case' 0 N--CA 1.491 1.61 0 C-N-CA 124.858 1.263 . . . . 70.11 111.873 171.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 178' ' ' ALA . . . . . 0.493 ' HB1' HD22 ' A' ' 233' ' ' LEU . . . -62.19 -42.61 99.45 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.572 1.149 . . . . 74.32 111.56 -179.675 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . 0.48 ' HB2' ' HB2' ' A' ' 224' ' ' PRO . . . -80.68 14.4 2.13 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 123.489 0.716 . . . . 64.31 111.42 176.347 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.342 0.878 0 N-CA-C 109.914 -1.274 . . . . 45.54 109.914 169.496 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 191' ' ' GLN . . . . . 0.648 ' HB3' ' HD2' ' A' ' 243' ' ' PRO . 8.0 pt20 . . . . . 0 N--CA 1.469 0.514 0 N-CA-C 109.74 -0.467 . . . . 73.45 109.74 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 192' ' ' ASP . . . . . 0.42 ' N ' ' HG3' ' A' ' 191' ' ' GLN . 80.9 m-20 -78.77 157.58 28.43 Favored 'General case' 0 C--O 1.239 0.548 0 CA-C-N 115.479 -0.782 . . . . 70.34 110.42 -175.601 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 46.0 mt -127.68 169.35 13.89 Favored 'General case' 0 C--O 1.238 0.493 0 CA-C-N 114.594 -1.185 . . . . 74.33 109.415 -178.297 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 64.5 m-85 -135.23 139.22 44.3 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 124.253 1.021 . . . . 71.25 109.422 179.705 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . 0.461 ' HB2' HD11 ' A' ' 249' ' ' LEU . . . -150.19 171.67 16.55 Favored 'General case' 0 C--O 1.24 0.56 0 C-N-CA 124.861 1.264 . . . . 75.1 108.973 -177.602 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 17.6 m -115.31 137.64 51.82 Favored 'General case' 0 C--O 1.238 0.464 0 C-N-CA 122.966 0.507 . . . . 64.15 109.636 179.013 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . 0.674 HD22 HD13 ' A' ' 251' ' ' LEU . 14.6 tp -115.43 110.64 19.62 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 108.914 -0.773 . . . . 74.22 108.914 177.371 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -79.58 122.79 26.93 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 108.742 -0.836 . . . . 70.5 108.742 174.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 199' ' ' VAL . . . . . 0.467 ' O ' ' HA ' ' A' ' 255' ' ' ILE . 4.1 p -142.58 123.32 8.3 Favored Pre-proline 0 CA--C 1.543 0.694 0 N-CA-C 108.771 -0.826 . . . . 72.4 108.771 178.697 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -67.57 158.48 56.95 Favored 'Trans proline' 0 C--N 1.364 1.365 0 C-N-CA 121.955 1.77 . . . . 74.2 111.049 171.883 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 201' ' ' ALA . . . . . 0.508 ' O ' HG23 ' A' ' 205' ' ' VAL . . . -47.3 -53.82 25.99 Favored Pre-proline 0 CA--C 1.562 1.42 0 CA-C-O 117.903 -1.046 . . . . 74.22 112.988 -179.093 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -62.45 -39.88 42.9 Favored 'Trans proline' 0 C--N 1.399 3.199 0 C-N-CA 121.997 1.798 . . . . 74.01 113.698 -176.267 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 36.5 mt -66.36 -32.63 58.94 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.252 0 C-N-CA 122.701 0.4 . . . . 54.14 110.091 178.783 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -71.23 -36.02 71.67 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 122.742 0.417 . . . . 74.51 111.63 177.222 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 205' ' ' VAL . . . . . 0.508 HG23 ' O ' ' A' ' 201' ' ' ALA . 94.9 t -68.58 -57.03 10.22 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.11 0 C-N-CA 123.126 0.57 . . . . 72.13 111.215 -178.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 32.8 m -80.05 -27.55 12.16 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 CA-C-N 116.109 -0.496 . . . . 65.43 111.605 -175.373 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 81.96 65.1 1.67 Allowed Glycine 0 C--N 1.342 0.902 0 CA-C-N 116.177 -0.465 . . . . 74.14 111.956 -175.188 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -81.32 -131.99 1.28 Allowed Glycine 0 C--N 1.356 1.655 0 N-CA-C 111.804 -0.519 . . . . 70.25 111.804 177.397 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 21.0 mtmm -137.94 143.37 40.71 Favored 'General case' 0 N--CA 1.481 1.107 0 CA-C-N 117.569 0.685 . . . . 64.04 111.136 177.372 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 11.1 m -135.93 166.37 27.29 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 C-N-CA 125.032 1.333 . . . . 74.21 109.755 176.65 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 58.4 ttp180 -100.25 114.65 28.27 Favored 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 123.545 0.738 . . . . 72.25 110.309 -178.174 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -101.6 139.2 37.57 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 124.035 0.934 . . . . 74.01 110.06 175.402 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 25.2 mmt -96.33 115.17 27.01 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 123.186 0.595 . . . . 63.52 109.68 179.408 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 214' ' ' THR . . . . . 0.414 ' HB ' ' HD2' ' A' ' 238' ' ' LYS . 43.9 p -122.23 -173.47 2.68 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 124.146 0.978 . . . . 72.41 111.038 -175.016 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 82.8 mt -69.25 -22.76 63.82 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 123.475 0.71 . . . . 75.04 111.019 172.771 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 20.4 mm-40 -86.45 -6.07 59.0 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 123.814 0.846 . . . . 74.32 110.663 173.146 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 94.82 -149.9 19.52 Favored Glycine 0 C--N 1.344 1.025 0 CA-C-O 119.331 -0.705 . . . . 63.23 112.303 -177.605 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -73.28 122.05 7.68 Favored 'Trans proline' 0 CA--C 1.555 1.537 0 C-N-CA 122.254 1.969 . . . . 75.24 112.754 -178.559 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 219' ' ' VAL . . . . . 0.512 HG21 ' HE1' ' A' ' 173' ' ' PHE . 2.4 p -116.84 131.15 70.34 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 C-N-CA 124.647 1.179 . . . . 72.43 109.164 173.649 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 -81.12 101.29 9.53 Favored 'General case' 0 C--O 1.24 0.576 0 N-CA-C 107.454 -1.313 . . . . 73.24 107.454 168.688 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 4.6 p -100.63 131.32 48.44 Favored 'Isoleucine or valine' 0 C--O 1.246 0.897 0 N-CA-C 108.872 -0.788 . . . . 72.2 108.872 -176.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 222' ' ' ALA . . . . . 0.409 ' O ' HD21 ' A' ' 172' ' ' LEU . . . -77.68 106.95 9.81 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 122.759 0.424 . . . . 70.43 110.394 -176.723 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 59.9 t -54.24 135.49 60.08 Favored Pre-proline 0 N--CA 1.48 1.04 0 C-N-CA 124.054 0.942 . . . . 53.2 109.989 178.454 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 224' ' ' PRO . . . . . 0.48 ' HB2' ' HB2' ' A' ' 179' ' ' ALA . 53.8 Cg_endo -67.85 148.76 77.42 Favored 'Trans proline' 0 C--N 1.37 1.672 0 C-N-CA 121.605 1.537 . . . . 74.41 110.688 173.145 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 16.3 Cg_endo -59.78 139.85 90.47 Favored 'Trans proline' 0 C--N 1.366 1.449 0 C-N-CA 121.591 1.528 . . . . 71.03 110.698 172.014 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 69.5 mtm180 66.28 50.52 1.33 Allowed 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 124.194 0.998 . . . . 64.15 111.065 171.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 54.0 m -85.85 136.96 33.09 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.922 0.889 . . . . 65.21 109.415 173.481 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 27.2 mp0 -113.24 144.52 42.56 Favored 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 123.929 0.892 . . . . 62.44 109.634 178.127 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -58.48 120.97 9.77 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 123.92 0.888 . . . . 72.35 110.257 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 113.88 -7.01 23.82 Favored Glycine 0 C--O 1.239 0.44 0 CA-C-O 119.268 -0.74 . . . . 73.01 113.213 -176.013 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 69.0 mtt-85 -67.27 146.67 53.91 Favored 'General case' 0 C--N 1.355 0.821 0 CA-C-N 117.909 0.854 . . . . 75.04 109.689 172.521 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 232' ' ' LYS . . . . . 0.435 ' HB3' ' HD1' ' A' ' 250' ' ' TYR . 13.1 mtmm -126.28 99.45 5.87 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 123.823 0.849 . . . . 74.35 108.874 -178.803 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 233' ' ' LEU . . . . . 0.493 HD22 ' HB1' ' A' ' 178' ' ' ALA . 21.4 mt -83.56 135.78 34.5 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 113.844 -1.525 . . . . 74.52 109.491 -175.243 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 29.9 ttt85 -104.84 101.01 10.63 Favored 'General case' 0 N--CA 1.476 0.837 0 CA-C-O 121.15 0.5 . . . . 71.4 111.131 -172.815 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 235' ' ' LEU . . . . . 0.531 HD12 HD23 ' A' ' 249' ' ' LEU . 46.7 mt -77.28 100.78 5.99 Favored 'General case' 0 C--O 1.238 0.455 0 C-N-CA 124.512 1.125 . . . . 65.43 110.028 176.079 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 11.7 mtmt -68.11 134.43 50.56 Favored 'General case' 0 C--O 1.241 0.654 0 O-C-N 123.32 0.388 . . . . 71.4 111.535 177.702 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 82.1 18.95 65.98 Favored Glycine 0 C--N 1.35 1.31 0 O-C-N 124.316 1.01 . . . . 72.41 113.612 179.907 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . 0.414 ' HD2' ' HB ' ' A' ' 214' ' ' THR . 39.4 mmtm -121.38 27.81 8.11 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 123.452 0.701 . . . . 72.03 111.299 -179.002 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -138.4 -171.11 12.05 Favored Glycine 0 CA--C 1.525 0.697 0 N-CA-C 110.272 -1.131 . . . . 54.33 110.272 167.498 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 61.7 m-85 -90.2 155.83 46.61 Favored Pre-proline 0 CA--C 1.545 0.755 0 C-N-CA 123.802 0.841 . . . . 73.22 109.782 -175.711 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -68.28 169.6 16.53 Favored 'Trans proline' 0 C--N 1.365 1.446 0 C-N-CA 121.978 1.786 . . . . 75.05 111.461 169.706 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 163.21 -108.27 0.33 Allowed Glycine 0 CA--C 1.531 1.066 0 CA-C-O 119.043 -0.865 . . . . 60.12 112.533 176.318 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 243' ' ' PRO . . . . . 0.648 ' HD2' ' HB3' ' A' ' 191' ' ' GLN . 84.5 Cg_endo -68.94 -46.92 1.36 Allowed 'Trans proline' 0 C--N 1.372 1.808 0 C-N-CA 123.885 3.056 . . . . 33.3 113.146 -173.656 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -100.67 -0.82 36.71 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 123.658 0.783 . . . . 74.34 111.305 -175.704 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 92.5 -43.79 2.62 Favored Glycine 0 C--N 1.352 1.43 0 O-C-N 123.028 0.205 . . . . 61.43 112.859 -179.665 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 13.3 ttm180 -120.36 112.27 18.8 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 124.153 0.981 . . . . 75.42 110.826 179.24 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -82.84 149.98 27.42 Favored Glycine 0 C--N 1.347 1.169 0 N-CA-C 111.156 -0.778 . . . . 53.43 111.156 167.859 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 38.6 m-20 -135.27 152.38 51.46 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 123.677 0.791 . . . . 72.0 109.675 -172.002 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 249' ' ' LEU . . . . . 0.531 HD23 HD12 ' A' ' 235' ' ' LEU . 61.9 tp -96.88 138.97 33.61 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.158 0.583 . . . . 42.15 110.134 -175.702 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 250' ' ' TYR . . . . . 0.435 ' HD1' ' HB3' ' A' ' 232' ' ' LYS . 7.4 m-85 -99.02 140.2 33.52 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.091 0.556 . . . . 62.4 110.026 173.887 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 251' ' ' LEU . . . . . 0.674 HD13 HD22 ' A' ' 197' ' ' LEU . 76.9 mt -115.67 103.86 11.11 Favored 'General case' 0 C--O 1.236 0.38 0 N-CA-C 108.647 -0.871 . . . . 70.41 108.647 179.763 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -79.54 96.37 6.1 Favored 'General case' 0 C--O 1.242 0.666 0 N-CA-C 108.109 -1.071 . . . . 74.25 108.109 177.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 13.0 m -70.55 136.77 25.28 Favored 'Isoleucine or valine' 0 C--O 1.245 0.848 0 CA-C-O 121.389 0.614 . . . . 54.01 110.59 -173.768 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 11.1 mmt180 -125.78 101.38 6.83 Favored 'General case' 0 C--O 1.241 0.62 0 C-N-CA 124.587 1.155 . . . . 74.22 108.308 -177.652 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 255' ' ' ILE . . . . . 0.47 HG23 ' HA ' ' A' ' 201' ' ' ALA . 22.7 mt -77.43 107.88 9.71 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.745 0 O-C-N 124.027 0.83 . . . . 62.11 109.785 179.341 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 7.2 t . . . . . 0 CA--C 1.567 1.621 0 CA-C-O 117.36 -1.305 . . . . 52.53 108.191 179.122 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 172' ' ' LEU . . . . . 0.49 HD21 ' HB3' ' A' ' 222' ' ' ALA . 21.1 mt . . . . . 0 N--CA 1.488 1.427 0 CA-C-O 120.735 0.302 . . . . 74.31 111.317 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 173' ' ' PHE . . . . . 0.451 ' CD1' HD22 ' A' ' 235' ' ' LEU . 45.0 m-85 -126.79 -57.83 1.33 Allowed 'General case' 0 N--CA 1.49 1.574 0 CA-C-O 121.679 0.752 . . . . 64.21 110.65 -170.445 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 174' ' ' TYR . . . . . 0.479 ' CD2' ' HB3' ' A' ' 233' ' ' LEU . 4.6 p90 -79.3 4.48 15.02 Favored 'General case' 0 N--CA 1.479 0.994 0 CA-C-N 114.76 -1.109 . . . . 74.25 113.352 -172.776 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 175' ' ' THR . . . . . 0.432 HG21 HD13 ' A' ' 172' ' ' LEU . 15.0 p -69.18 -5.18 20.92 Favored 'General case' 0 N--CA 1.479 0.995 0 N-CA-C 112.681 0.623 . . . . 54.11 112.681 -179.259 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 176' ' ' MET . . . . . . . . . . . . . 24.6 ptt? -61.24 -34.5 75.25 Favored 'General case' 0 CA--C 1.555 1.168 0 C-N-CA 123.632 0.773 . . . . 73.43 110.383 168.029 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 84.6 tttt -165.04 92.77 0.59 Allowed 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 124.869 1.268 . . . . 65.11 108.105 -178.427 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -128.71 142.65 50.94 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 123.877 0.871 . . . . 74.2 110.229 -171.582 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . 0.42 ' HB2' ' HB2' ' A' ' 224' ' ' PRO . . . 59.98 21.56 10.64 Favored 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 124.849 1.26 . . . . 73.11 112.104 -175.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.34 0.772 0 N-CA-C 110.768 -0.933 . . . . 55.01 110.768 176.288 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 191' ' ' GLN . . . . . 0.52 ' HB2' ' HA2' ' A' ' 247' ' ' GLY . 4.8 pt20 . . . . . 0 N--CA 1.475 0.816 0 CA-C-O 120.415 0.15 . . . . 73.21 110.99 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -75.73 142.35 42.43 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-O 121.41 0.624 . . . . 73.14 111.341 -171.592 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 45.0 mt -130.91 170.96 13.73 Favored 'General case' 0 C--O 1.239 0.501 0 CA-C-N 114.216 -1.356 . . . . 73.12 108.994 174.122 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 26.6 m-85 -143.44 122.27 12.69 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 124.03 0.932 . . . . 75.43 109.503 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . 0.439 ' HB2' HD11 ' A' ' 249' ' ' LEU . . . -124.69 128.89 49.51 Favored 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 107.67 -1.233 . . . . 55.44 107.67 174.154 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 6.1 m -81.47 119.47 23.78 Favored 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 108.203 -1.036 . . . . 63.33 108.203 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . 0.717 HD22 HD13 ' A' ' 251' ' ' LEU . 17.2 tp -104.74 110.55 22.93 Favored 'General case' 0 N--CA 1.466 0.374 0 N-CA-C 108.404 -0.962 . . . . 75.31 108.404 -172.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -77.48 125.53 29.48 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 108.482 -0.933 . . . . 73.42 108.482 177.234 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 199' ' ' VAL . . . . . 0.491 ' O ' ' HA ' ' A' ' 255' ' ' ILE . 5.4 p -144.15 129.45 9.62 Favored Pre-proline 0 CA--C 1.545 0.767 0 N-CA-C 108.488 -0.931 . . . . 71.22 108.488 176.465 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -71.86 157.15 55.64 Favored 'Trans proline' 0 C--O 1.248 1.02 0 C-N-CA 121.655 1.57 . . . . 72.43 111.342 170.309 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 201' ' ' ALA . . . . . 0.448 ' O ' HG23 ' A' ' 205' ' ' VAL . . . -51.29 -53.46 49.0 Favored Pre-proline 0 CA--C 1.556 1.2 0 O-C-N 124.32 1.013 . . . . 74.31 113.078 -176.501 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -67.01 -33.5 31.98 Favored 'Trans proline' 0 C--N 1.403 3.438 0 C-N-CA 121.678 1.585 . . . . 71.41 112.854 -175.044 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 203' ' ' ILE . . . . . 0.438 HG23 ' HA3' ' A' ' 208' ' ' GLY . 27.6 mt -66.03 -35.45 75.09 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.311 0 C-N-CA 122.586 0.354 . . . . 62.31 110.064 176.05 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 204' ' ' ALA . . . . . 0.485 ' HA ' HG11 ' A' ' 223' ' ' VAL . . . -71.01 -31.88 68.51 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 122.656 0.382 . . . . 74.31 111.51 178.617 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 205' ' ' VAL . . . . . 0.448 HG23 ' O ' ' A' ' 201' ' ' ALA . 92.8 t -73.77 -55.64 11.79 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 C-N-CA 122.896 0.478 . . . . 73.53 111.104 178.43 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 13.7 m -78.86 -26.41 13.44 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.003 0 C-N-CA 122.979 0.512 . . . . 71.31 111.927 -172.248 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 87.9 76.08 1.28 Allowed Glycine 0 CA--C 1.529 0.951 0 N-CA-C 111.972 -0.451 . . . . 73.51 111.972 -175.531 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 208' ' ' GLY . . . . . 0.438 ' HA3' HG23 ' A' ' 203' ' ' ILE . . . -95.37 -147.13 22.15 Favored Glycine 0 N--CA 1.477 1.369 0 CA-C-O 119.537 -0.591 . . . . 74.13 111.793 175.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 49.9 mtmt -132.86 145.63 51.12 Favored 'General case' 0 N--CA 1.482 1.125 0 CA-C-N 117.52 0.66 . . . . 73.21 111.151 176.742 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 12.0 m -139.25 164.91 24.14 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 C-N-CA 125.672 1.589 . . . . 73.11 108.93 175.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 23.9 ttm180 -103.44 117.13 33.75 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 123.386 0.674 . . . . 72.54 109.894 -174.246 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -103.69 123.33 46.82 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 124.729 1.212 . . . . 62.23 109.914 178.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 89.1 mmm -87.49 115.38 24.87 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 123.362 0.665 . . . . 74.45 110.166 -178.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 17.6 p -113.9 -178.71 3.44 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 123.976 0.91 . . . . 45.31 110.607 -175.856 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 81.0 mt -63.27 -23.94 67.64 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 122.842 0.457 . . . . 63.02 111.549 172.713 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -103.54 23.2 13.0 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 124.071 0.948 . . . . 63.43 110.893 179.867 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 87.88 -163.82 33.67 Favored Glycine 0 C--N 1.344 1.005 0 CA-C-N 116.299 -0.409 . . . . 45.31 113.141 175.59 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -72.12 144.73 42.83 Favored 'Trans proline' 0 C--N 1.362 1.244 0 C-N-CA 122.156 1.904 . . . . 73.0 112.804 -178.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 5.4 p -139.67 127.74 26.24 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 N-CA-C 108.083 -1.08 . . . . 73.23 108.083 170.047 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -82.19 103.3 11.69 Favored 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 108.461 -0.94 . . . . 72.44 108.461 176.264 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 2.8 p -100.3 133.62 42.75 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.841 0 O-C-N 124.149 0.906 . . . . 75.01 108.654 -174.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 222' ' ' ALA . . . . . 0.49 ' HB3' HD21 ' A' ' 172' ' ' LEU . . . -78.91 111.67 15.31 Favored 'General case' 0 C--O 1.24 0.6 0 C-N-CA 122.8 0.44 . . . . 74.21 110.541 -177.874 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 223' ' ' VAL . . . . . 0.485 HG11 ' HA ' ' A' ' 204' ' ' ALA . 48.9 t -54.61 131.63 64.29 Favored Pre-proline 0 CA--C 1.542 0.643 0 O-C-N 124.509 1.13 . . . . 74.41 109.909 177.496 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 224' ' ' PRO . . . . . 0.425 ' HD3' ' CE1' ' A' ' 174' ' ' TYR . 43.1 Cg_endo -67.3 152.5 79.14 Favored 'Trans proline' 0 CA--C 1.555 1.545 0 C-N-CA 121.657 1.571 . . . . 44.4 111.312 175.546 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -65.6 141.99 69.08 Favored 'Trans proline' 0 C--N 1.371 1.712 0 C-N-CA 121.941 1.761 . . . . 75.23 112.219 179.811 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 96.6 mtt180 65.42 32.15 9.82 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 124.827 1.251 . . . . 71.31 111.834 168.863 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 227' ' ' THR . . . . . 0.471 HG23 ' HD2' ' A' ' 231' ' ' ARG . 98.6 m -72.84 139.02 46.69 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 123.969 0.907 . . . . 74.25 109.89 174.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -111.66 155.53 23.28 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 123.113 0.565 . . . . 73.51 109.686 174.595 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 229' ' ' ALA . . . . . 0.601 ' HB2' ' HB ' ' A' ' 255' ' ' ILE . . . -54.99 122.63 11.33 Favored 'General case' 0 CA--C 1.536 0.442 0 O-C-N 124.896 1.372 . . . . 74.23 111.338 -179.302 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 112.57 -10.61 25.91 Favored Glycine 0 C--N 1.341 0.831 0 CA-C-O 119.568 -0.573 . . . . 35.21 113.718 177.029 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 231' ' ' ARG . . . . . 0.471 ' HD2' HG23 ' A' ' 227' ' ' THR . 53.0 mtt-85 -62.1 141.45 58.13 Favored 'General case' 0 N--CA 1.478 0.941 0 CA-C-N 117.246 0.523 . . . . 73.25 111.1 176.418 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 31.5 mmtp -112.47 103.58 11.67 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 108.585 -0.895 . . . . 52.1 108.585 -175.64 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 233' ' ' LEU . . . . . 0.736 ' HB2' ' HB2' ' A' ' 251' ' ' LEU . 41.7 mt -83.08 149.47 26.89 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 115.295 -0.866 . . . . 71.3 108.849 177.181 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 62.0 ttt180 -118.6 102.42 8.86 Favored 'General case' 0 N--CA 1.478 0.926 0 CA-C-N 117.958 0.345 . . . . 74.51 110.482 -173.404 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 235' ' ' LEU . . . . . 0.544 ' HB2' ' HB3' ' A' ' 249' ' ' LEU . 14.8 mt -85.92 94.84 9.29 Favored 'General case' 0 C--O 1.242 0.706 0 C-N-CA 123.197 0.599 . . . . 73.2 109.81 175.507 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 20.2 mttt -69.02 138.12 54.22 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 115.648 -0.706 . . . . 73.44 110.466 175.443 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 85.68 3.03 86.48 Favored Glycine 0 C--N 1.338 0.644 0 O-C-N 123.908 0.755 . . . . 33.4 113.348 -179.355 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 76.0 mmtt -116.78 9.24 13.88 Favored 'General case' 0 N--CA 1.485 1.323 0 CA-C-N 117.414 0.607 . . . . 73.25 111.919 -176.274 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -109.68 -165.65 19.94 Favored Glycine 0 C--N 1.346 1.09 0 N-CA-C 111.139 -0.784 . . . . 65.11 111.139 167.419 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 68.7 m-85 -86.82 158.79 53.13 Favored Pre-proline 0 N--CA 1.484 1.272 0 C-N-CA 123.446 0.698 . . . . 72.15 112.371 -176.291 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_exo -64.21 165.4 19.71 Favored 'Trans proline' 0 C--N 1.371 1.715 0 C-N-CA 122.24 1.96 . . . . 63.3 112.73 166.716 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 157.45 -107.94 0.34 Allowed Glycine 0 C--N 1.34 0.789 0 CA-C-O 118.806 -0.997 . . . . 71.44 111.999 173.431 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -68.65 -57.08 0.15 Allowed 'Trans proline' 0 C--N 1.378 2.09 0 C-N-CA 123.616 2.878 . . . . 72.55 112.666 -170.201 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -80.87 -22.39 39.87 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 123.417 0.687 . . . . 74.32 110.615 175.244 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 96.48 -33.53 5.6 Favored Glycine 0 C--N 1.352 1.437 0 N-CA-C 111.283 -0.727 . . . . 73.13 111.283 -169.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 29.2 ttm180 -106.7 111.89 24.63 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 124.68 1.192 . . . . 71.24 109.981 178.794 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 247' ' ' GLY . . . . . 0.52 ' HA2' ' HB2' ' A' ' 191' ' ' GLN . . . -79.53 162.97 47.94 Favored Glycine 0 C--O 1.247 0.919 0 O-C-N 123.528 0.518 . . . . 70.14 113.748 169.249 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 17.6 m-20 -128.16 129.23 46.19 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 123.814 0.846 . . . . 74.4 109.173 -169.456 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 249' ' ' LEU . . . . . 0.544 ' HB3' ' HB2' ' A' ' 235' ' ' LEU . 49.3 tp -99.54 113.62 26.13 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 124.005 0.922 . . . . 60.03 109.089 177.715 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 250' ' ' TYR . . . . . 0.421 ' HA ' ' O ' ' A' ' 233' ' ' LEU . 8.8 m-85 -90.28 114.59 26.66 Favored 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 123.593 0.757 . . . . 70.25 110.933 -176.467 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 251' ' ' LEU . . . . . 0.736 ' HB2' ' HB2' ' A' ' 233' ' ' LEU . 89.9 mt -88.05 106.3 18.06 Favored 'General case' 0 C--O 1.241 0.638 0 C-N-CA 124.846 1.258 . . . . 74.22 109.162 -179.013 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -82.3 99.95 9.64 Favored 'General case' 0 C--O 1.242 0.704 0 N-CA-C 108.463 -0.94 . . . . 73.24 108.463 175.386 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 11.5 m -67.23 132.73 32.25 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.853 0 O-C-N 123.782 0.676 . . . . 60.03 109.351 -177.498 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 17.9 mmt85 -123.11 95.21 4.52 Favored 'General case' 0 C--O 1.239 0.502 0 C-N-CA 124.517 1.127 . . . . 75.02 108.216 -177.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 255' ' ' ILE . . . . . 0.601 ' HB ' ' HB2' ' A' ' 229' ' ' ALA . 12.9 mt -76.43 125.25 36.0 Favored 'Isoleucine or valine' 0 C--O 1.233 0.208 0 O-C-N 123.945 0.778 . . . . 62.43 110.21 179.406 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 1.6 t . . . . . 0 CA--C 1.561 1.402 0 CA-C-O 117.546 -1.216 . . . . 37.96 107.768 173.877 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 172' ' ' LEU . . . . . 0.569 ' HB3' HG23 ' A' ' 175' ' ' THR . 55.7 mt . . . . . 0 N--CA 1.467 0.419 0 CA-C-O 121.134 0.493 . . . . 61.44 111.27 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 173' ' ' PHE . . . . . 0.552 ' CD1' HD22 ' A' ' 235' ' ' LEU . 7.5 m-85 -140.13 -44.1 0.42 Allowed 'General case' 0 N--CA 1.482 1.142 0 CA-C-N 114.966 -1.015 . . . . 73.52 109.118 -171.21 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 174' ' ' TYR . . . . . . . . . . . . . 1.9 p90 -86.18 19.3 2.73 Favored 'General case' 0 CA--C 1.547 0.83 0 CA-C-N 114.502 -1.226 . . . . 61.23 112.394 -176.158 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 175' ' ' THR . . . . . 0.569 HG23 ' HB3' ' A' ' 172' ' ' LEU . 17.6 p -62.87 -21.63 66.11 Favored 'General case' 0 N--CA 1.493 1.692 0 CA-C-N 118.909 0.777 . . . . 70.53 112.853 -179.2 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 176' ' ' MET . . . . . . . . . . . . . 21.4 ptt? -52.4 -42.45 64.04 Favored 'General case' 0 CA--C 1.558 1.287 0 C-N-CA 124.367 1.067 . . . . 52.43 110.95 171.016 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 19.7 tptm -167.42 100.07 0.5 Allowed 'General case' 0 C--N 1.349 0.553 0 C-N-CA 125.532 1.533 . . . . 64.33 107.017 176.844 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 178' ' ' ALA . . . . . 0.434 ' HB1' ' HB3' ' A' ' 224' ' ' PRO . . . -74.65 -74.42 0.2 Allowed 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 115.556 -0.747 . . . . 72.12 112.096 -168.306 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -69.65 95.53 0.87 Allowed 'General case' 0 CA--C 1.541 0.629 0 O-C-N 123.381 0.425 . . . . 74.24 110.19 -177.328 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.348 1.243 0 CA-C-N 115.489 -0.778 . . . . 41.12 112.063 -178.328 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 191' ' ' GLN . . . . . 0.492 ' HG3' ' N ' ' A' ' 192' ' ' ASP . 5.0 pt20 . . . . . 0 CA--C 1.544 0.724 0 CA-C-O 120.617 0.246 . . . . 55.13 110.758 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 192' ' ' ASP . . . . . 0.492 ' N ' ' HG3' ' A' ' 191' ' ' GLN . 24.4 m-20 -77.55 123.87 27.16 Favored 'General case' 0 C--N 1.351 0.643 0 C-N-CA 123.76 0.824 . . . . 73.15 109.096 -177.125 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . 0.544 HD12 ' HA2' ' A' ' 239' ' ' GLY . 41.0 mt -111.71 173.57 6.29 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 124.612 1.165 . . . . 72.42 109.987 -178.186 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 45.8 m-85 -130.15 129.28 43.28 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 123.778 0.831 . . . . 65.22 109.57 176.33 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . 0.451 ' HB2' HD11 ' A' ' 249' ' ' LEU . . . -129.65 167.49 17.91 Favored 'General case' 0 C--O 1.239 0.549 0 C-N-CA 124.989 1.316 . . . . 33.4 107.47 170.237 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 31.4 m -117.27 124.17 48.37 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 108.731 -0.84 . . . . 71.25 108.731 179.335 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . 0.653 HD22 HD13 ' A' ' 251' ' ' LEU . 15.3 tp -107.7 109.81 21.49 Favored 'General case' 0 CA--C 1.53 0.211 0 N-CA-C 107.823 -1.177 . . . . 72.22 107.823 -177.711 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -83.42 128.63 34.66 Favored 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 109.05 -0.722 . . . . 73.34 109.05 178.156 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 199' ' ' VAL . . . . . 0.543 ' O ' ' HA ' ' A' ' 255' ' ' ILE . 4.0 p -143.78 129.57 9.96 Favored Pre-proline 0 CA--C 1.543 0.699 0 N-CA-C 108.201 -1.037 . . . . 75.31 108.201 179.765 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -69.1 157.9 59.91 Favored 'Trans proline' 0 C--N 1.364 1.383 0 C-N-CA 121.905 1.737 . . . . 54.24 111.502 170.038 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 201' ' ' ALA . . . . . 0.486 ' O ' HG23 ' A' ' 205' ' ' VAL . . . -49.74 -53.7 39.17 Favored Pre-proline 0 CA--C 1.561 1.385 0 O-C-N 124.768 1.292 . . . . 74.43 112.792 -178.195 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -61.94 -35.38 77.81 Favored 'Trans proline' 0 C--N 1.401 3.314 0 C-N-CA 121.988 1.792 . . . . 71.1 113.339 -176.388 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 38.1 mt -71.35 -31.94 45.21 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.104 0 C-N-CA 123.068 0.547 . . . . 75.44 110.321 179.145 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -72.95 -34.05 66.27 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 122.463 0.305 . . . . 63.11 111.516 176.18 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 205' ' ' VAL . . . . . 0.486 HG23 ' O ' ' A' ' 201' ' ' ALA . 90.6 t -67.72 -55.77 15.67 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 C-N-CA 123.836 0.854 . . . . 72.41 110.874 177.936 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 18.4 m -80.87 -27.96 11.2 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.079 0 C-N-CA 122.753 0.421 . . . . 54.13 111.744 -174.469 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 82.02 67.9 1.48 Allowed Glycine 0 C--N 1.347 1.176 0 O-C-N 123.736 0.647 . . . . 52.32 112.113 -173.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -84.35 -131.88 2.25 Favored Glycine 0 C--N 1.352 1.435 0 CA-C-O 119.68 -0.511 . . . . 54.04 111.953 179.436 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 209' ' ' LYS . . . . . 0.431 ' HG2' ' HA ' ' A' ' 222' ' ' ALA . 48.0 mtmt -139.99 150.92 45.05 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 123.908 0.883 . . . . 64.23 111.425 178.258 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 15.2 m -146.04 168.92 6.61 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 C-N-CA 126.005 1.722 . . . . 73.23 108.388 176.584 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 37.0 ptt180 -95.03 128.65 42.02 Favored 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 109.371 -0.603 . . . . 74.02 109.371 172.626 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -102.31 112.36 25.02 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 123.895 0.878 . . . . 64.32 108.631 174.175 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 74.8 mtp -82.98 108.78 16.54 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 109.382 -0.599 . . . . 75.42 109.382 -175.746 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 26.7 p -111.39 -172.47 2.04 Favored 'General case' 0 C--O 1.242 0.686 0 C-N-CA 124.174 0.989 . . . . 73.04 110.224 -173.179 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 84.2 mt -61.97 -28.84 69.84 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 123.439 0.696 . . . . 72.41 111.368 173.386 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -100.22 7.94 44.14 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 123.656 0.783 . . . . 74.35 111.427 179.424 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 100.84 -173.11 24.28 Favored Glycine 0 C--N 1.347 1.16 0 CA-C-O 119.929 -0.373 . . . . 74.03 113.819 175.763 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_endo -71.57 127.59 13.36 Favored 'Trans proline' 0 C--N 1.368 1.579 0 C-N-CA 122.855 2.37 . . . . 74.24 112.351 -176.852 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 5.0 p -119.77 130.76 73.75 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 C-N-CA 123.714 0.806 . . . . 65.23 108.846 178.436 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -70.52 101.63 2.04 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 108.751 -0.833 . . . . 75.44 108.751 177.755 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 3.0 p -106.64 134.38 48.45 Favored 'Isoleucine or valine' 0 C--O 1.244 0.774 0 N-CA-C 108.377 -0.971 . . . . 52.12 108.377 -176.304 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 222' ' ' ALA . . . . . 0.445 ' HB3' HD21 ' A' ' 172' ' ' LEU . . . -82.19 108.74 15.89 Favored 'General case' 0 N--CA 1.467 0.414 0 N-CA-C 109.975 -0.38 . . . . 54.3 109.975 -179.358 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 43.0 t -54.54 134.74 63.22 Favored Pre-proline 0 N--CA 1.478 0.945 0 C-N-CA 124.753 1.221 . . . . 62.01 110.436 -178.14 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 224' ' ' PRO . . . . . 0.434 ' HB3' ' HB1' ' A' ' 178' ' ' ALA . 12.2 Cg_endo -58.22 150.46 66.13 Favored 'Trans proline' 0 C--N 1.37 1.699 0 C-N-CA 122.221 1.947 . . . . 64.22 111.942 169.779 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -78.41 148.51 23.67 Favored 'Trans proline' 0 C--N 1.366 1.497 0 C-N-CA 122.065 1.843 . . . . 65.4 110.937 174.136 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 45.8 mtm180 59.56 41.28 19.23 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 124.302 1.041 . . . . 72.42 111.271 174.122 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 227' ' ' THR . . . . . 0.545 HG23 ' HD2' ' A' ' 231' ' ' ARG . 55.5 m -82.29 141.64 32.75 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 114.334 -1.303 . . . . 72.13 109.438 177.097 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 27.7 mp0 -115.96 145.18 43.15 Favored 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 123.764 0.826 . . . . 52.14 109.245 176.381 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 229' ' ' ALA . . . . . 0.413 ' HB2' ' HB ' ' A' ' 255' ' ' ILE . . . -57.04 119.42 6.27 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.986 0.914 . . . . 40.14 111.119 -178.079 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 114.38 -5.33 23.25 Favored Glycine 0 C--N 1.342 0.869 0 O-C-N 123.825 0.703 . . . . 42.41 112.696 -176.768 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 231' ' ' ARG . . . . . 0.545 ' HD2' HG23 ' A' ' 227' ' ' THR . 55.0 mtt-85 -69.67 148.68 48.97 Favored 'General case' 0 C--N 1.363 1.194 0 CA-C-N 117.704 0.752 . . . . 74.32 109.124 169.724 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 36.5 mtmt -130.2 118.26 21.12 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 123.166 0.586 . . . . 64.44 109.56 -174.334 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 233' ' ' LEU . . . . . . . . . . . . . 9.0 mt -101.47 138.94 37.81 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 124.318 1.047 . . . . 65.34 108.487 -172.307 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 234' ' ' ARG . . . . . 0.505 ' HG3' ' HB3' ' A' ' 248' ' ' ASP . 35.8 ttm-85 -102.04 118.45 36.94 Favored 'General case' 0 N--CA 1.479 0.982 0 CA-C-N 118.013 0.37 . . . . 73.33 111.434 -173.83 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 235' ' ' LEU . . . . . 0.552 HD22 ' CD1' ' A' ' 173' ' ' PHE . 13.7 mt -103.87 111.62 24.23 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 123.492 0.717 . . . . 64.31 110.271 179.069 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 65.1 mttt -69.66 144.59 52.86 Favored 'General case' 0 N--CA 1.471 0.578 0 O-C-N 123.205 0.316 . . . . 61.34 111.196 176.178 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 73.88 -5.72 23.25 Favored Glycine 0 N--CA 1.472 1.05 0 O-C-N 124.624 1.203 . . . . 75.32 114.578 179.065 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -101.24 0.89 38.23 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 123.043 0.537 . . . . 73.33 110.896 -176.498 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 239' ' ' GLY . . . . . 0.544 ' HA2' HD12 ' A' ' 193' ' ' LEU . . . -102.9 -168.26 26.18 Favored Glycine 0 C--N 1.347 1.157 0 N-CA-C 110.322 -1.111 . . . . 71.34 110.322 163.184 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 58.0 m-85 -92.78 154.64 42.11 Favored Pre-proline 0 N--CA 1.477 0.918 0 C-N-CA 123.033 0.533 . . . . 74.01 111.028 -176.627 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_exo -72.9 161.92 42.4 Favored 'Trans proline' 0 C--N 1.366 1.498 0 C-N-CA 122.202 1.935 . . . . 63.3 111.865 172.342 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 157.2 -104.25 0.25 Allowed Glycine 0 CA--C 1.527 0.842 0 CA-C-O 119.072 -0.849 . . . . 53.5 112.155 177.8 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 243' ' ' PRO . . . . . 0.429 ' HD2' ' HB3' ' A' ' 191' ' ' GLN . 41.8 Cg_endo -63.67 -52.22 1.97 Allowed 'Trans proline' 0 C--N 1.37 1.663 0 C-N-CA 123.642 2.895 . . . . 33.32 113.241 -169.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -93.11 -5.08 51.1 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 123.304 0.642 . . . . 73.02 111.447 179.753 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 92.38 -46.52 2.59 Favored Glycine 0 C--N 1.354 1.572 0 N-CA-C 111.945 -0.462 . . . . 50.13 111.945 -175.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 20.1 ttm180 -116.3 112.4 21.51 Favored 'General case' 0 C--O 1.238 0.486 0 C-N-CA 124.367 1.067 . . . . 64.12 109.127 178.119 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -80.65 168.31 51.16 Favored Glycine 0 C--N 1.348 1.249 0 CA-C-O 121.503 0.502 . . . . 52.31 113.88 172.191 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 248' ' ' ASP . . . . . 0.505 ' HB3' ' HG3' ' A' ' 234' ' ' ARG . 19.4 m-20 -124.65 162.2 24.64 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 114.009 -1.096 . . . . 64.11 110.469 -169.466 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 249' ' ' LEU . . . . . 0.451 HD11 ' HB2' ' A' ' 195' ' ' ALA . 41.6 tp -125.9 121.8 34.21 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 123.528 0.731 . . . . 74.42 109.405 178.305 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 250' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -90.47 112.43 24.07 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 123.816 0.846 . . . . 65.22 110.607 -178.733 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 251' ' ' LEU . . . . . 0.653 HD13 HD22 ' A' ' 197' ' ' LEU . 90.7 mt -87.85 104.02 16.19 Favored 'General case' 0 C--O 1.239 0.504 0 N-CA-C 107.889 -1.152 . . . . 73.25 107.889 179.915 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -79.91 98.58 7.19 Favored 'General case' 0 C--O 1.239 0.521 0 N-CA-C 108.145 -1.058 . . . . 62.52 108.145 177.106 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 253' ' ' VAL . . . . . 0.406 HG21 HG22 ' A' ' 227' ' ' THR . 6.2 m -66.67 125.88 24.94 Favored 'Isoleucine or valine' 0 C--O 1.243 0.759 0 CA-C-O 122.021 0.915 . . . . 54.54 109.362 -178.169 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 17.9 mmm180 -122.2 99.34 6.38 Favored 'General case' 0 C--O 1.239 0.535 0 N-CA-C 107.742 -1.207 . . . . 72.03 107.742 -178.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 255' ' ' ILE . . . . . 0.543 ' HA ' ' O ' ' A' ' 199' ' ' VAL . 55.3 mt -83.29 119.55 32.87 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 CA-C-N 114.103 -1.408 . . . . 73.51 110.267 -175.114 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 CA--C 1.559 1.309 0 C-N-CA 124.6 1.16 . . . . 72.52 108.964 175.547 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 172' ' ' LEU . . . . . 0.419 ' HB3' ' OG1' ' A' ' 175' ' ' THR . 21.0 mt . . . . . 0 N--CA 1.485 1.323 0 CA-C-O 121.219 0.533 . . . . 62.13 111.71 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 173' ' ' PHE . . . . . 0.549 ' CD1' HD22 ' A' ' 235' ' ' LEU . 16.7 m-85 -146.14 -59.28 0.31 Allowed 'General case' 0 N--CA 1.479 1.022 0 CA-C-O 122.123 0.963 . . . . 70.21 108.692 -166.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 174' ' ' TYR . . . . . 0.483 ' CD2' ' HB3' ' A' ' 233' ' ' LEU . 0.6 OUTLIER -78.53 14.45 1.27 Allowed 'General case' 0 CA--C 1.547 0.829 0 CA-C-N 113.744 -1.571 . . . . 74.44 112.533 -176.025 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 175' ' ' THR . . . . . 0.419 ' OG1' ' HB3' ' A' ' 172' ' ' LEU . 0.2 OUTLIER -63.95 -19.32 65.05 Favored 'General case' 0 CA--C 1.555 1.152 0 C-N-CA 124.459 1.104 . . . . 72.44 111.432 -173.843 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 176' ' ' MET . . . . . . . . . . . . . 25.1 ptt? -71.45 -40.89 70.04 Favored 'General case' 0 CA--C 1.562 1.409 0 C-N-CA 124.644 1.177 . . . . 74.15 111.72 173.081 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 1.6 ttmp? -164.58 118.45 1.36 Allowed 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 124.644 1.178 . . . . 54.04 109.296 -175.623 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 178' ' ' ALA . . . . . 0.5 ' HB1' HD22 ' A' ' 233' ' ' LEU . . . -152.61 -49.39 0.1 Allowed 'General case' 0 C--O 1.24 0.58 0 C-N-CA 123.309 0.644 . . . . 73.31 110.289 -173.808 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . 0.401 ' HB2' ' HB2' ' A' ' 224' ' ' PRO . . . -81.02 37.66 0.44 Allowed 'General case' 0 CA--C 1.554 1.127 0 C-N-CA 123.486 0.715 . . . . 51.4 111.07 178.785 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.347 1.154 0 C-N-CA 123.839 0.733 . . . . 63.24 111.76 -177.307 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 191' ' ' GLN . . . . . 0.559 ' HB3' ' HD2' ' A' ' 243' ' ' PRO . 3.6 pt20 . . . . . 0 N--CA 1.477 0.915 0 CA-C-O 121.143 0.497 . . . . 73.22 109.858 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 86.9 m-20 -77.41 153.46 33.63 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 115.39 -0.823 . . . . 64.04 111.504 -174.646 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 26.7 mt -125.74 175.93 7.27 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 124.439 1.096 . . . . 64.25 110.665 -179.226 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 32.1 m-85 -140.98 136.67 32.38 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 124.305 1.042 . . . . 71.11 109.905 177.457 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -152.98 131.67 12.33 Favored 'General case' 0 C--O 1.238 0.497 0 C-N-CA 124.651 1.18 . . . . 65.35 108.128 177.064 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 14.9 m -82.61 129.25 34.91 Favored 'General case' 0 CA--C 1.546 0.8 0 CA-C-N 116.267 -0.424 . . . . 70.52 109.974 -176.464 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . 0.733 HD22 HD13 ' A' ' 251' ' ' LEU . 16.0 tp -107.79 111.05 23.02 Favored 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 108.758 -0.83 . . . . 71.04 108.758 -175.878 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -79.63 123.56 27.74 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 123.232 0.613 . . . . 74.2 109.412 176.147 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 6.4 p -142.36 128.95 10.94 Favored Pre-proline 0 CA--C 1.544 0.729 0 N-CA-C 108.675 -0.861 . . . . 73.25 108.675 179.308 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -72.04 159.24 50.62 Favored 'Trans proline' 0 C--N 1.366 1.498 0 C-N-CA 121.825 1.684 . . . . 73.1 111.185 170.711 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 201' ' ' ALA . . . . . 0.437 ' O ' HG23 ' A' ' 205' ' ' VAL . . . -50.61 -50.61 71.56 Favored Pre-proline 0 CA--C 1.556 1.201 0 CA-C-N 114.94 -1.027 . . . . 40.1 113.72 -178.526 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_endo -65.74 -35.82 34.99 Favored 'Trans proline' 0 C--N 1.385 2.469 0 C-N-CA 121.438 1.425 . . . . 71.45 114.697 -178.789 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 50.0 mt -68.88 -29.35 43.13 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.25 0 N-CA-C 110.163 -0.31 . . . . 75.23 110.163 176.812 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -70.96 -41.84 70.52 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 122.62 0.368 . . . . 63.2 111.313 175.448 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 205' ' ' VAL . . . . . 0.437 HG23 ' O ' ' A' ' 201' ' ' ALA . 85.4 t -64.59 -55.96 18.56 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.283 0 C-N-CA 123.864 0.866 . . . . 72.32 111.644 -179.06 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 25.2 m -76.41 -31.45 20.6 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 CA-C-O 120.635 0.255 . . . . 75.33 111.241 -176.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 82.84 64.17 1.69 Allowed Glycine 0 C--N 1.343 0.928 0 CA-C-N 115.903 -0.59 . . . . 44.01 111.836 -173.394 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -79.98 -134.29 1.22 Allowed Glycine 0 C--N 1.346 1.101 0 CA-C-O 119.752 -0.471 . . . . 72.43 111.96 177.072 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 48.4 mtmt -137.19 148.07 46.3 Favored 'General case' 0 N--CA 1.485 1.296 0 CA-C-N 117.711 0.756 . . . . 64.4 111.061 178.471 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 5.7 m -143.12 158.28 17.65 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 C-N-CA 125.169 1.387 . . . . 74.2 108.436 174.584 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 42.0 ttp-105 -94.9 113.38 25.1 Favored 'General case' 0 CA--C 1.544 0.732 0 CA-C-O 121.167 0.508 . . . . 65.55 110.781 -175.171 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -101.37 113.56 26.76 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 124.283 1.033 . . . . 63.3 109.469 175.786 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 39.9 ttm -88.67 116.88 27.24 Favored 'General case' 0 N--CA 1.477 0.882 0 CA-C-O 121.022 0.439 . . . . 74.35 110.018 -179.161 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 17.5 p -111.55 -171.78 1.91 Allowed 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 124.463 1.105 . . . . 53.44 110.062 -173.216 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 84.0 mt -63.59 -37.58 87.86 Favored 'General case' 0 N--CA 1.489 1.485 0 CA-C-O 121.133 0.492 . . . . 71.22 110.606 171.672 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -80.36 -11.46 59.7 Favored 'General case' 0 N--CA 1.476 0.845 0 CA-C-N 114.797 -1.092 . . . . 72.11 111.087 -174.362 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 123.09 -173.02 16.13 Favored Glycine 0 C--N 1.344 1.01 0 N-CA-C 111.447 -0.661 . . . . 62.15 111.447 -179.614 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -73.1 147.55 43.07 Favored 'Trans proline' 0 CA--C 1.552 1.376 0 C-N-CA 122.384 2.056 . . . . 74.21 111.978 177.527 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 3.8 p -139.78 131.36 33.19 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 N-CA-C 108.976 -0.75 . . . . 62.22 108.976 174.346 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -80.86 100.03 8.63 Favored 'General case' 0 C--O 1.239 0.508 0 N-CA-C 107.012 -1.477 . . . . 73.41 107.012 172.258 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 3.8 p -101.67 129.57 52.67 Favored 'Isoleucine or valine' 0 C--O 1.242 0.699 0 N-CA-C 108.602 -0.888 . . . . 73.42 108.602 -172.245 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -76.92 109.39 10.68 Favored 'General case' 0 C--O 1.236 0.386 0 C-N-CA 122.374 0.269 . . . . 75.15 110.523 -177.434 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 58.3 t -52.69 135.04 45.5 Favored Pre-proline 0 CA--C 1.55 0.943 0 O-C-N 124.478 1.111 . . . . 53.43 109.342 178.155 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 224' ' ' PRO . . . . . 0.401 ' HB2' ' HB2' ' A' ' 179' ' ' ALA . 29.4 Cg_endo -61.33 143.5 97.99 Favored 'Trans proline' 0 C--N 1.369 1.642 0 C-N-CA 121.763 1.642 . . . . 72.31 110.495 174.79 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 16.2 Cg_endo -60.35 132.22 42.63 Favored 'Trans proline' 0 C--N 1.37 1.677 0 C-N-CA 121.448 1.432 . . . . 43.23 110.759 175.828 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 65.9 mtm180 65.12 53.05 1.4 Allowed 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.939 1.296 . . . . 62.12 110.834 173.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 26.5 m -75.77 147.48 39.21 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-N 114.886 -1.052 . . . . 75.54 109.651 172.472 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 25.3 mp0 -117.65 145.11 44.6 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 108.301 -1.0 . . . . 62.33 108.301 175.082 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -58.91 134.03 56.57 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 123.684 0.794 . . . . 71.31 111.938 -176.201 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 97.07 -1.33 60.87 Favored Glycine 0 C--N 1.346 1.137 0 CA-C-O 119.079 -0.845 . . . . 63.53 113.934 178.772 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 80.8 mtt-85 -67.28 156.36 36.58 Favored 'General case' 0 N--CA 1.481 1.105 0 CA-C-N 117.862 0.831 . . . . 63.11 111.327 176.781 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 70.7 mmtt -119.86 98.93 6.34 Favored 'General case' 0 C--O 1.239 0.548 0 CA-C-N 114.416 -1.265 . . . . 72.2 108.995 -172.641 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 233' ' ' LEU . . . . . 0.633 ' HB2' ' HB2' ' A' ' 251' ' ' LEU . 8.6 mt -86.88 150.28 24.22 Favored 'General case' 0 CA--C 1.542 0.668 0 N-CA-C 107.978 -1.119 . . . . 54.03 107.978 178.105 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 47.2 ttt85 -124.25 108.66 12.49 Favored 'General case' 0 CA--C 1.551 1.017 0 CA-C-N 118.637 0.653 . . . . 55.44 110.736 -176.382 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 235' ' ' LEU . . . . . 0.549 HD22 ' CD1' ' A' ' 173' ' ' PHE . 11.9 mt -86.99 106.5 17.87 Favored 'General case' 0 C--N 1.352 0.702 0 C-N-CA 124.699 1.199 . . . . 74.33 110.524 179.45 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 236' ' ' LYS . . . . . 0.527 ' H ' ' HB3' ' A' ' 173' ' ' PHE . 12.8 mtmt -74.35 132.37 41.97 Favored 'General case' 0 CA--C 1.539 0.549 0 O-C-N 123.531 0.519 . . . . 61.41 112.229 -178.736 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 81.24 19.57 66.56 Favored Glycine 0 C--N 1.35 1.314 0 CA-C-N 114.711 -1.131 . . . . 55.43 113.818 -178.843 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 75.9 mmtt -122.27 13.21 10.32 Favored 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 122.981 0.512 . . . . 72.41 112.229 -175.124 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -124.32 -172.03 13.54 Favored Glycine 0 C--N 1.344 0.981 0 N-CA-C 111.243 -0.743 . . . . 75.22 111.243 173.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 60.5 m-85 -84.99 160.46 55.19 Favored Pre-proline 0 N--CA 1.485 1.317 0 C-N-CA 123.983 0.913 . . . . 73.42 112.171 -173.538 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 241' ' ' PRO . . . . . 0.485 ' HA ' ' O ' ' A' ' 245' ' ' GLY . 17.2 Cg_exo -68.53 148.64 73.22 Favored 'Trans proline' 0 C--N 1.376 1.983 0 C-N-CA 122.115 1.877 . . . . 74.13 112.395 169.72 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -173.2 -119.91 0.55 Allowed Glycine 0 C--N 1.35 1.335 0 CA-C-O 119.141 -0.811 . . . . 54.23 112.529 177.355 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 243' ' ' PRO . . . . . 0.559 ' HD2' ' HB3' ' A' ' 191' ' ' GLN . 44.8 Cg_endo -59.67 -65.59 0.08 OUTLIER 'Trans proline' 0 C--N 1.378 2.104 0 C-N-CA 124.587 3.525 . . . . 72.0 112.648 -172.651 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -90.7 20.54 4.61 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 123.168 0.587 . . . . 63.35 110.903 175.309 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 245' ' ' GLY . . . . . 0.485 ' O ' ' HA ' ' A' ' 241' ' ' PRO . . . 75.0 -96.92 0.99 Allowed Glycine 0 C--N 1.349 1.29 0 N-CA-C 110.47 -1.052 . . . . 53.35 110.47 -173.033 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 21.5 ttm180 -48.46 108.89 0.19 Allowed 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 124.57 1.148 . . . . 72.32 112.32 -178.238 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -88.52 156.21 26.61 Favored Glycine 0 C--O 1.249 1.091 0 N-CA-C 110.814 -0.915 . . . . 54.21 110.814 167.334 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 40.6 m-20 -130.57 155.2 46.92 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-O 120.912 0.386 . . . . 75.42 110.351 -173.297 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 249' ' ' LEU . . . . . 0.496 ' HB3' ' HB2' ' A' ' 235' ' ' LEU . 47.4 tp -98.01 138.08 35.87 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 123.925 0.89 . . . . 53.33 110.755 -173.165 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 250' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -98.89 113.51 25.69 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 122.808 0.443 . . . . 74.32 110.395 177.384 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 251' ' ' LEU . . . . . 0.733 HD13 HD22 ' A' ' 197' ' ' LEU . 82.7 mt -88.67 105.18 17.51 Favored 'General case' 0 C--O 1.241 0.646 0 N-CA-C 108.541 -0.911 . . . . 72.31 108.541 174.867 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -88.5 103.86 16.27 Favored 'General case' 0 C--O 1.239 0.528 0 N-CA-C 108.385 -0.969 . . . . 65.23 108.385 177.818 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 19.7 m -72.01 143.1 14.5 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 CA-C-O 121.29 0.567 . . . . 63.33 111.084 -172.18 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 19.0 mmt85 -130.39 101.18 5.63 Favored 'General case' 0 C--O 1.237 0.438 0 C-N-CA 124.228 1.011 . . . . 61.32 108.377 177.452 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 30.9 mt -78.89 124.14 36.84 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 O-C-N 123.893 0.745 . . . . 74.02 110.175 178.81 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 1.4 t . . . . . 0 CA--C 1.558 1.271 0 N-CA-C 107.513 -1.292 . . . . 71.34 107.513 173.797 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 172' ' ' LEU . . . . . 0.479 HD21 ' O ' ' A' ' 222' ' ' ALA . 25.0 mt . . . . . 0 N--CA 1.482 1.142 0 CA-C-O 121.523 0.678 . . . . 74.24 112.013 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 173' ' ' PHE . . . . . 0.557 ' CD1' HD22 ' A' ' 235' ' ' LEU . 26.4 m-85 -136.78 -48.77 0.63 Allowed 'General case' 0 N--CA 1.477 0.879 0 CA-C-N 114.911 -1.041 . . . . 75.01 109.76 -169.578 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 174' ' ' TYR . . . . . 0.444 ' CD2' ' HB3' ' A' ' 233' ' ' LEU . 7.9 p90 -84.22 13.6 5.09 Favored 'General case' 0 N--CA 1.48 1.07 0 CA-C-N 114.824 -1.08 . . . . 74.02 113.087 -176.928 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 1.8 p -65.06 -10.58 31.29 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 123.107 0.563 . . . . 70.23 112.504 175.189 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 176' ' ' MET . . . . . . . . . . . . . 41.8 mtm -53.18 -42.11 65.9 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 124.316 1.047 . . . . 72.24 110.302 169.053 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . 0.443 ' NZ ' ' HB2' ' A' ' 177' ' ' LYS . 2.8 ttmp? -167.41 97.38 0.49 Allowed 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 124.709 1.204 . . . . 65.31 108.301 176.307 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 178' ' ' ALA . . . . . 0.472 ' HB1' ' HB3' ' A' ' 224' ' ' PRO . . . -109.38 146.3 34.65 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 124.149 0.98 . . . . 75.43 110.456 -175.738 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . 0.448 ' HB2' ' HB2' ' A' ' 224' ' ' PRO . . . 59.75 28.86 18.39 Favored 'General case' 0 N--CA 1.492 1.668 0 C-N-CA 124.388 1.075 . . . . 64.33 111.574 -174.362 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.348 1.25 0 CA-C-N 115.522 -0.763 . . . . 43.21 111.674 -179.578 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 191' ' ' GLN . . . . . 0.688 ' HB2' ' HA2' ' A' ' 247' ' ' GLY . 3.4 pt20 . . . . . 0 CA--C 1.547 0.829 0 CA-C-O 121.735 0.779 . . . . 70.33 110.296 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -76.53 148.28 37.21 Favored 'General case' 0 C--O 1.237 0.403 0 C-N-CA 125.05 1.34 . . . . 61.14 111.255 -162.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . 0.584 HD12 ' HA2' ' A' ' 239' ' ' GLY . 16.3 mt -143.87 170.97 14.89 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 123.607 0.763 . . . . 73.35 110.315 172.11 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 74.6 m-85 -135.74 141.58 44.87 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 124.146 0.978 . . . . 73.12 109.815 179.036 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . 0.473 ' HB2' HD11 ' A' ' 249' ' ' LEU . . . -154.23 132.77 12.09 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 123.787 0.835 . . . . 64.13 108.758 176.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 26.9 m -82.5 127.2 33.08 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.274 -0.639 . . . . 63.52 109.274 178.581 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . 0.744 HD22 HD13 ' A' ' 251' ' ' LEU . 18.1 tp -105.54 107.42 18.4 Favored 'General case' 0 N--CA 1.465 0.306 0 N-CA-C 107.549 -1.278 . . . . 74.11 107.549 -179.469 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -77.81 123.57 26.89 Favored 'General case' 0 C--O 1.237 0.439 0 N-CA-C 107.828 -1.175 . . . . 71.12 107.828 174.072 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 199' ' ' VAL . . . . . 0.533 ' O ' ' HA ' ' A' ' 255' ' ' ILE . 2.8 p -141.62 125.6 10.1 Favored Pre-proline 0 CA--C 1.541 0.625 0 N-CA-C 108.205 -1.035 . . . . 73.21 108.205 -179.652 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -69.98 158.08 57.83 Favored 'Trans proline' 0 C--N 1.365 1.42 0 C-N-CA 122.048 1.832 . . . . 73.42 111.728 171.758 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -49.73 -50.32 67.92 Favored Pre-proline 0 CA--C 1.56 1.329 0 N-CA-C 114.001 1.111 . . . . 73.32 114.001 -178.769 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 202' ' ' PRO . . . . . 0.406 ' HA ' HG22 ' A' ' 205' ' ' VAL . 44.2 Cg_endo -63.48 -37.5 48.11 Favored 'Trans proline' 0 C--N 1.393 2.874 0 C-N-CA 122.115 1.877 . . . . 73.24 113.484 -178.507 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 38.3 mt -67.99 -36.11 74.34 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.173 0 CA-C-N 117.995 0.361 . . . . 71.3 110.448 176.102 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 204' ' ' ALA . . . . . 0.434 ' HA ' HG11 ' A' ' 223' ' ' VAL . . . -67.09 -41.78 85.72 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 123.06 0.544 . . . . 74.23 112.231 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 205' ' ' VAL . . . . . 0.406 HG22 ' HA ' ' A' ' 202' ' ' PRO . 20.9 m -77.81 -51.37 18.14 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.993 0 C-N-CA 123.472 0.709 . . . . 61.2 112.448 -175.592 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 206' ' ' VAL . . . . . 0.404 HG22 ' O ' ' A' ' 202' ' ' PRO . 7.9 m -73.4 -30.06 29.32 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.402 0 C-N-CA 122.357 0.263 . . . . 72.12 111.249 -178.961 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 89.66 63.09 1.29 Allowed Glycine 0 C--N 1.352 1.432 0 CA-C-N 116.216 -0.447 . . . . 44.15 112.373 -175.858 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -86.71 -139.09 5.52 Favored Glycine 0 C--N 1.352 1.429 0 CA-C-O 119.873 -0.404 . . . . 63.42 112.734 -179.833 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 46.4 mtmt -137.89 147.87 44.83 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 123.972 0.909 . . . . 73.3 110.287 178.012 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 5.2 m -140.81 166.34 18.93 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 C-N-CA 124.771 1.229 . . . . 73.2 109.807 174.475 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 29.0 ttp180 -90.06 113.91 25.71 Favored 'General case' 0 CA--C 1.546 0.827 0 C-N-CA 123.63 0.772 . . . . 74.31 109.843 -179.601 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -100.39 117.19 34.07 Favored 'General case' 0 C--O 1.24 0.562 0 N-CA-C 108.586 -0.894 . . . . 75.13 108.586 171.073 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 47.8 tpp -84.0 116.04 22.63 Favored 'General case' 0 C--O 1.241 0.637 0 N-CA-C 109.408 -0.59 . . . . 71.51 109.408 177.58 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 16.6 p -111.47 -173.67 2.3 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 124.59 1.156 . . . . 74.14 109.614 -176.515 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 56.2 mt -61.99 -36.09 80.45 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 122.986 0.514 . . . . 71.14 111.911 175.295 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 27.2 mt-10 -89.81 -8.65 51.59 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.721 0.808 . . . . 62.14 111.435 -172.452 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 124.39 -161.4 18.84 Favored Glycine 0 C--N 1.345 1.058 0 CA-C-O 119.282 -0.732 . . . . 62.45 111.458 -178.08 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -77.71 159.91 31.45 Favored 'Trans proline' 0 CA--C 1.549 1.257 0 C-N-CA 122.525 2.15 . . . . 65.44 112.794 -177.218 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 2.9 p -148.34 129.7 5.65 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 N-CA-C 108.674 -0.862 . . . . 73.32 108.674 171.02 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -76.81 100.29 5.44 Favored 'General case' 0 C--O 1.239 0.544 0 N-CA-C 107.478 -1.305 . . . . 75.22 107.478 169.613 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 9.1 p -100.34 128.36 52.41 Favored 'Isoleucine or valine' 0 C--O 1.245 0.845 0 N-CA-C 108.012 -1.107 . . . . 71.24 108.012 -176.417 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 222' ' ' ALA . . . . . 0.479 ' O ' HD21 ' A' ' 172' ' ' LEU . . . -77.85 105.19 8.87 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 116.466 -0.334 . . . . 74.3 110.648 -174.696 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 223' ' ' VAL . . . . . 0.434 HG11 ' HA ' ' A' ' 204' ' ' ALA . 62.6 t -53.8 133.03 56.9 Favored Pre-proline 0 N--CA 1.472 0.662 0 C-N-CA 124.13 0.972 . . . . 32.52 109.54 179.239 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 224' ' ' PRO . . . . . 0.472 ' HB3' ' HB1' ' A' ' 178' ' ' ALA . 30.8 Cg_endo -64.75 150.53 88.02 Favored 'Trans proline' 0 C--N 1.369 1.629 0 C-N-CA 121.327 1.352 . . . . 73.54 110.663 175.561 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -63.48 140.51 76.27 Favored 'Trans proline' 0 C--N 1.366 1.482 0 C-N-CA 121.452 1.435 . . . . 73.11 110.694 176.449 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 56.6 mtm180 64.79 42.44 4.54 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 124.248 1.019 . . . . 73.11 111.074 170.137 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 63.4 m -76.9 143.48 39.56 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-N 115.464 -0.789 . . . . 74.1 109.444 173.537 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 27.8 mp0 -117.22 143.84 45.44 Favored 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 124.144 0.978 . . . . 44.52 109.039 176.475 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -62.35 123.93 19.55 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 123.757 0.823 . . . . 73.1 110.628 -178.282 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 115.15 -6.5 21.52 Favored Glycine 0 C--N 1.338 0.659 0 O-C-N 123.75 0.656 . . . . 75.03 113.178 -175.34 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 95.2 mtt-85 -74.79 157.2 35.58 Favored 'General case' 0 N--CA 1.478 0.954 0 CA-C-N 117.634 0.717 . . . . 74.05 110.055 172.655 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 232' ' ' LYS . . . . . 0.451 ' HA ' ' O ' ' A' ' 251' ' ' LEU . 12.5 mtmm -131.42 120.95 23.76 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.269 0.628 . . . . 75.4 110.53 -179.681 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 233' ' ' LEU . . . . . 0.502 ' HB2' ' HB2' ' A' ' 251' ' ' LEU . 26.7 mt -101.99 154.31 19.08 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 125.138 1.375 . . . . 64.13 109.264 -176.274 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 15.1 ttm180 -111.99 110.87 21.41 Favored 'General case' 0 N--CA 1.48 1.065 0 CA-C-N 118.144 0.429 . . . . 64.52 111.099 -179.736 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 235' ' ' LEU . . . . . 0.59 ' HB2' ' HB3' ' A' ' 249' ' ' LEU . 11.2 mt -88.11 99.56 12.28 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 122.919 0.487 . . . . 61.0 110.023 172.014 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 236' ' ' LYS . . . . . 0.492 ' H ' ' HB3' ' A' ' 173' ' ' PHE . 11.7 mtmt -72.52 130.47 40.71 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 115.967 -0.56 . . . . 61.01 111.304 -179.789 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 83.69 21.11 58.57 Favored Glycine 0 C--N 1.344 0.995 0 CA-C-N 115.059 -0.973 . . . . 73.15 113.612 -178.182 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt -127.2 17.86 7.11 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 123.012 0.525 . . . . 61.22 111.329 -178.495 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 239' ' ' GLY . . . . . 0.584 ' HA2' HD12 ' A' ' 193' ' ' LEU . . . -118.81 -159.96 11.26 Favored Glycine 0 C--N 1.347 1.146 0 N-CA-C 111.278 -0.729 . . . . 55.42 111.278 170.256 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 60.4 m-85 -92.55 165.37 19.47 Favored Pre-proline 0 CA--C 1.553 1.061 0 C-N-CA 123.713 0.805 . . . . 71.35 110.376 -177.187 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 241' ' ' PRO . . . . . 0.437 ' HA ' ' O ' ' A' ' 245' ' ' GLY . 40.4 Cg_exo -61.17 166.25 11.19 Favored 'Trans proline' 0 C--N 1.374 1.877 0 C-N-CA 121.732 1.621 . . . . 54.32 113.473 170.333 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 167.32 -123.72 1.15 Allowed Glycine 0 CA--C 1.529 0.968 0 CA-C-O 118.874 -0.959 . . . . 70.11 111.862 177.209 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 243' ' ' PRO . . . . . 0.477 ' HD2' ' HB3' ' A' ' 191' ' ' GLN . 30.9 Cg_endo -59.68 -60.78 0.27 Allowed 'Trans proline' 0 C--N 1.379 2.136 0 C-N-CA 123.925 3.083 . . . . 70.02 112.976 -170.001 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -90.93 2.85 55.89 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 123.185 0.594 . . . . 74.41 111.43 177.373 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 245' ' ' GLY . . . . . 0.437 ' O ' ' HA ' ' A' ' 241' ' ' PRO . . . 85.35 -34.57 3.26 Favored Glycine 0 C--N 1.358 1.757 0 N-CA-C 112.319 -0.312 . . . . 51.45 112.319 -173.746 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 10.8 ttm180 -88.66 112.53 23.21 Favored 'General case' 0 CA--C 1.529 0.149 0 C-N-CA 124.79 1.236 . . . . 74.21 111.404 177.557 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 247' ' ' GLY . . . . . 0.688 ' HA2' ' HB2' ' A' ' 191' ' ' GLN . . . -84.31 163.57 39.37 Favored Glycine 0 C--N 1.345 1.074 0 C-N-CA 121.27 -0.491 . . . . 63.34 114.055 162.855 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 34.6 m-20 -132.65 143.79 49.9 Favored 'General case' 0 C--O 1.241 0.638 0 C-N-CA 123.866 0.866 . . . . 73.13 110.133 -169.063 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 249' ' ' LEU . . . . . 0.59 ' HB3' ' HB2' ' A' ' 235' ' ' LEU . 61.4 tp -106.98 117.86 35.18 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 124.361 1.065 . . . . 64.3 110.087 -177.084 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 250' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 -91.5 110.62 21.93 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 123.245 0.618 . . . . 74.23 110.034 -174.299 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 251' ' ' LEU . . . . . 0.744 HD13 HD22 ' A' ' 197' ' ' LEU . 74.6 mt -86.73 106.35 17.59 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 114.839 -1.073 . . . . 64.45 110.574 -175.037 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -79.63 97.07 6.37 Favored 'General case' 0 C--O 1.241 0.643 0 N-CA-C 108.439 -0.948 . . . . 62.02 108.439 173.746 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 4.6 m -69.42 130.35 34.16 Favored 'Isoleucine or valine' 0 C--O 1.244 0.776 0 CA-C-O 121.762 0.792 . . . . 72.04 110.251 -176.338 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 21.8 mmm180 -126.9 115.13 18.82 Favored 'General case' 0 C--O 1.237 0.44 0 N-CA-C 107.657 -1.238 . . . . 73.05 107.657 178.576 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 255' ' ' ILE . . . . . 0.533 ' HA ' ' O ' ' A' ' 199' ' ' VAL . 49.0 mt -98.82 111.88 29.53 Favored 'Isoleucine or valine' 0 C--O 1.24 0.589 0 O-C-N 123.574 0.546 . . . . 71.2 110.443 -175.09 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 3.1 t . . . . . 0 CA--C 1.56 1.34 0 CA-C-N 115.523 -0.762 . . . . 74.42 108.984 177.276 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 172' ' ' LEU . . . . . 0.485 HD21 ' HB3' ' A' ' 222' ' ' ALA . 77.5 mt . . . . . 0 N--CA 1.48 1.059 0 CA-C-O 120.73 0.3 . . . . 74.45 111.654 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 173' ' ' PHE . . . . . 0.435 ' CD1' HD22 ' A' ' 235' ' ' LEU . 45.4 m-85 -144.59 -66.95 0.33 Allowed 'General case' 0 N--CA 1.486 1.336 0 N-CA-C 109.391 -0.596 . . . . 75.52 109.391 -166.545 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 174' ' ' TYR . . . . . 0.478 ' CD2' ' HB3' ' A' ' 233' ' ' LEU . 7.7 p90 -64.77 -13.24 54.49 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 123.841 0.857 . . . . 75.34 112.301 177.655 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 175' ' ' THR . . . . . 0.456 HG21 HD13 ' A' ' 172' ' ' LEU . 4.2 m -65.73 0.97 1.45 Allowed 'General case' 0 CA--C 1.565 1.535 0 C-N-CA 125.133 1.373 . . . . 73.52 112.217 -178.154 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 176' ' ' MET . . . . . . . . . . . . . 37.3 mtm -64.85 -59.88 3.7 Favored 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 123.604 0.762 . . . . 75.03 109.148 161.543 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.98 100.32 3.38 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 124.477 1.111 . . . . 63.31 108.651 175.024 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -109.44 -178.38 3.54 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 124.194 0.998 . . . . 61.23 111.612 -170.169 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . 62.14 -91.05 0.03 OUTLIER 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 125.088 1.355 . . . . 72.13 111.044 -177.43 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.877 0 N-CA-C 112.461 -0.256 . . . . 73.54 112.461 -178.225 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 191' ' ' GLN . . . . . 0.621 ' HB3' ' HD2' ' A' ' 243' ' ' PRO . 9.9 pt20 . . . . . 0 N--CA 1.478 0.962 0 CA-C-O 120.949 0.404 . . . . 73.41 110.347 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -77.56 157.58 30.26 Favored 'General case' 0 C--O 1.241 0.617 0 CA-C-N 115.091 -0.959 . . . . 71.22 110.904 -168.539 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 32.7 mt -134.25 171.13 14.68 Favored 'General case' 0 C--O 1.239 0.529 0 CA-C-N 114.284 -1.325 . . . . 70.22 108.69 176.282 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 59.6 m-85 -136.49 126.63 26.24 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 123.768 0.827 . . . . 53.43 110.317 -177.165 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . 0.414 ' O ' ' HA ' ' A' ' 251' ' ' LEU . . . -141.65 130.66 23.21 Favored 'General case' 0 N--CA 1.466 0.344 0 N-CA-C 107.951 -1.129 . . . . 74.13 107.951 175.636 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 30.4 m -83.07 127.78 33.89 Favored 'General case' 0 C--O 1.24 0.559 0 N-CA-C 108.577 -0.897 . . . . 73.21 108.577 176.865 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . 0.724 HD22 HD13 ' A' ' 251' ' ' LEU . 16.7 tp -106.35 110.05 22.17 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 108.331 -0.989 . . . . 72.54 108.331 -178.974 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -80.72 118.42 22.25 Favored 'General case' 0 C--O 1.238 0.475 0 N-CA-C 108.233 -1.025 . . . . 74.3 108.233 -179.817 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 5.1 p -136.89 128.45 16.74 Favored Pre-proline 0 CA--C 1.543 0.691 0 N-CA-C 108.948 -0.76 . . . . 74.44 108.948 -176.28 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 200' ' ' PRO . . . . . 0.432 ' HB2' ' HD2' ' A' ' 202' ' ' PRO . 62.0 Cg_endo -69.69 158.25 57.72 Favored 'Trans proline' 0 C--N 1.365 1.404 0 C-N-CA 121.924 1.749 . . . . 74.32 111.246 172.717 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 201' ' ' ALA . . . . . 0.51 ' O ' HG23 ' A' ' 205' ' ' VAL . . . -47.34 -54.8 19.16 Favored Pre-proline 0 CA--C 1.562 1.417 0 CA-C-O 117.547 -1.216 . . . . 72.54 113.044 179.88 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 202' ' ' PRO . . . . . 0.432 ' HD2' ' HB2' ' A' ' 200' ' ' PRO . 52.9 Cg_endo -64.74 -37.25 36.85 Favored 'Trans proline' 0 C--N 1.4 3.289 0 C-N-CA 121.9 1.733 . . . . 71.31 113.323 -174.124 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 44.1 mt -65.67 -34.64 71.7 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 C-N-CA 122.54 0.336 . . . . 72.34 110.141 177.604 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -70.53 -39.75 73.86 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 122.518 0.327 . . . . 65.31 111.093 177.277 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 205' ' ' VAL . . . . . 0.51 HG23 ' O ' ' A' ' 201' ' ' ALA . 83.9 t -67.44 -56.43 13.41 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 C-N-CA 123.565 0.746 . . . . 74.34 111.193 -177.852 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 10.5 m -82.06 -29.49 9.68 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 CA-C-N 116.002 -0.544 . . . . 70.25 111.455 -172.821 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 88.5 65.43 1.31 Allowed Glycine 0 C--N 1.345 1.074 0 CA-C-N 116.093 -0.503 . . . . 73.21 112.129 -174.875 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -87.11 -134.69 4.18 Favored Glycine 0 C--N 1.357 1.726 0 N-CA-C 111.794 -0.523 . . . . 44.54 111.794 177.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 46.6 mtmt -136.61 154.93 50.53 Favored 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 123.524 0.729 . . . . 61.34 110.908 178.602 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 6.3 m -144.94 169.66 7.77 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 C-N-CA 125.597 1.559 . . . . 72.51 108.473 172.319 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 56.0 ttp180 -104.23 119.43 38.94 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 123.573 0.749 . . . . 65.43 109.499 177.487 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -103.57 141.08 36.63 Favored 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 123.894 0.878 . . . . 74.4 109.667 175.402 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 46.9 tpp -100.27 128.32 46.37 Favored 'General case' 0 N--CA 1.475 0.808 0 N-CA-C 109.179 -0.675 . . . . 75.23 109.179 178.389 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 19.6 p -129.27 -171.68 2.55 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 123.818 0.847 . . . . 51.01 110.52 -171.55 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 91.9 mt -62.18 -27.75 69.18 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 123.831 0.853 . . . . 44.42 111.839 173.869 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -99.49 6.48 45.89 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 123.573 0.749 . . . . 70.12 111.52 -179.464 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 94.48 -153.42 20.99 Favored Glycine 0 C--N 1.347 1.146 0 CA-C-O 119.589 -0.562 . . . . 61.12 112.655 -177.807 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_endo -70.35 153.4 66.26 Favored 'Trans proline' 0 C--N 1.37 1.672 0 C-N-CA 122.582 2.188 . . . . 72.11 113.25 -174.489 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 4.6 p -145.52 135.81 18.74 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 C-N-CA 124.368 1.067 . . . . 74.11 109.048 174.245 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -83.6 104.23 13.56 Favored 'General case' 0 C--O 1.239 0.546 0 N-CA-C 107.883 -1.154 . . . . 71.02 107.883 172.659 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 2.9 p -114.39 126.07 71.84 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.018 0 N-CA-C 109.41 -0.589 . . . . 62.43 109.41 -174.476 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 222' ' ' ALA . . . . . 0.485 ' HB3' HD21 ' A' ' 172' ' ' LEU . . . -78.82 108.43 12.26 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 123.39 0.676 . . . . 55.55 110.69 -179.333 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 84.7 t -55.46 136.17 70.01 Favored Pre-proline 0 N--CA 1.478 0.961 0 C-N-CA 124.754 1.222 . . . . 71.33 109.857 177.12 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -66.31 159.4 50.26 Favored 'Trans proline' 0 C--N 1.373 1.839 0 C-N-CA 121.711 1.607 . . . . 63.51 111.455 174.835 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -69.28 153.13 71.62 Favored 'Trans proline' 0 C--N 1.365 1.428 0 C-N-CA 121.544 1.496 . . . . 73.11 111.08 171.917 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 39.7 mtm180 60.69 34.41 20.0 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 124.773 1.229 . . . . 65.34 111.578 172.702 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 227' ' ' THR . . . . . 0.518 ' O ' HD11 ' A' ' 255' ' ' ILE . 85.4 m -73.73 120.78 19.8 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 115.049 -0.978 . . . . 62.35 109.547 175.52 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 228' ' ' GLN . . . . . 0.475 ' NE2' HH21 ' A' ' 231' ' ' ARG . 2.2 mp0 -102.59 147.86 26.27 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 124.414 1.086 . . . . 72.14 109.035 177.908 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 229' ' ' ALA . . . . . 0.445 ' HB2' ' HB ' ' A' ' 255' ' ' ILE . . . -59.21 115.03 2.92 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 123.81 0.844 . . . . 71.52 111.274 -177.237 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 113.42 0.2 24.94 Favored Glycine 0 C--N 1.343 0.97 0 O-C-N 123.685 0.616 . . . . 43.43 113.599 -178.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 231' ' ' ARG . . . . . 0.475 HH21 ' NE2' ' A' ' 228' ' ' GLN . 87.5 mtt-85 -65.72 150.77 47.95 Favored 'General case' 0 N--CA 1.486 1.36 0 CA-C-N 117.591 0.696 . . . . 63.42 110.478 173.471 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 71.7 mmtt -118.67 102.22 8.69 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 124.097 0.959 . . . . 74.12 109.488 -171.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 233' ' ' LEU . . . . . 0.776 ' HB2' ' HB2' ' A' ' 251' ' ' LEU . 58.7 mt -88.89 152.21 21.87 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 115.415 -0.812 . . . . 71.31 109.534 178.344 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 234' ' ' ARG . . . . . 0.453 ' HG3' ' HB3' ' A' ' 248' ' ' ASP . 38.6 ttm-85 -119.32 121.12 38.87 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.512 0.725 . . . . 62.44 110.902 -174.673 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 235' ' ' LEU . . . . . 0.64 ' HB2' ' HB3' ' A' ' 249' ' ' LEU . 16.0 mt -110.43 100.38 9.23 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 122.464 0.306 . . . . 71.14 110.662 176.874 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 236' ' ' LYS . . . . . 0.563 ' HB3' ' HD2' ' A' ' 246' ' ' ARG . 13.2 mttp -69.13 139.84 54.71 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 110.345 -0.243 . . . . 63.23 110.345 173.323 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 86.85 -3.13 87.22 Favored Glycine 0 N--CA 1.473 1.11 0 CA-C-N 115.757 -0.656 . . . . 72.0 113.193 179.857 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -112.79 5.25 17.45 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 123.573 0.749 . . . . 70.53 111.061 -179.085 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -113.35 -173.82 18.77 Favored Glycine 0 C--N 1.347 1.184 0 N-CA-C 110.997 -0.841 . . . . 52.04 110.997 164.584 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 93.8 m-85 -91.56 160.98 35.51 Favored Pre-proline 0 N--CA 1.483 1.216 0 C-N-CA 123.84 0.856 . . . . 70.15 110.331 -178.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_exo -62.07 158.69 37.81 Favored 'Trans proline' 0 C--N 1.374 1.881 0 C-N-CA 122.136 1.891 . . . . 73.52 112.951 173.724 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 169.19 -128.12 1.62 Allowed Glycine 0 C--N 1.349 1.251 0 CA-C-O 118.766 -1.019 . . . . 65.34 112.307 176.113 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 243' ' ' PRO . . . . . 0.621 ' HD2' ' HB3' ' A' ' 191' ' ' GLN . 18.6 Cg_endo -52.62 -49.66 16.73 Favored 'Trans proline' 0 C--N 1.38 2.199 0 C-N-CA 124.96 3.773 . . . . 60.51 113.826 -173.963 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -95.92 -1.83 48.45 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.295 0.638 . . . . 53.12 111.69 -179.024 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 90.01 -37.76 3.31 Favored Glycine 0 C--N 1.352 1.438 0 CA-C-O 120.955 0.197 . . . . 62.41 113.014 178.1 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 246' ' ' ARG . . . . . 0.563 ' HD2' ' HB3' ' A' ' 236' ' ' LYS . 16.5 ttm180 -120.38 111.73 18.12 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 124.17 0.988 . . . . 72.31 108.593 178.831 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -69.3 155.12 53.44 Favored Glycine 0 C--O 1.25 1.133 0 O-C-N 123.504 0.503 . . . . 74.43 114.255 178.289 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 248' ' ' ASP . . . . . 0.453 ' HB3' ' HG3' ' A' ' 234' ' ' ARG . 40.3 m-20 -112.19 138.87 48.26 Favored 'General case' 0 C--O 1.225 -0.224 0 CA-C-N 114.152 -1.024 . . . . 73.43 109.591 -173.446 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 249' ' ' LEU . . . . . 0.64 ' HB3' ' HB2' ' A' ' 235' ' ' LEU . 44.4 tp -100.12 117.58 34.67 Favored 'General case' 0 C--O 1.238 0.485 0 N-CA-C 108.088 -1.078 . . . . 75.04 108.088 172.051 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 250' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -88.56 108.95 19.69 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 123.651 0.78 . . . . 74.54 108.898 -176.419 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 251' ' ' LEU . . . . . 0.776 ' HB2' ' HB2' ' A' ' 233' ' ' LEU . 85.6 mt -88.38 104.83 17.14 Favored 'General case' 0 C--O 1.24 0.566 0 N-CA-C 108.135 -1.061 . . . . 73.31 108.135 178.281 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -84.36 101.87 12.3 Favored 'General case' 0 C--O 1.241 0.647 0 N-CA-C 107.864 -1.161 . . . . 72.34 107.864 175.222 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 11.2 m -69.45 139.31 20.57 Favored 'Isoleucine or valine' 0 C--O 1.244 0.772 0 O-C-N 123.87 0.731 . . . . 75.31 110.03 -175.774 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 14.4 mmt85 -128.18 105.63 8.5 Favored 'General case' 0 C--O 1.238 0.487 0 C-N-CA 124.073 0.949 . . . . 70.34 108.608 178.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 255' ' ' ILE . . . . . 0.518 HD11 ' O ' ' A' ' 227' ' ' THR . 34.0 mt -76.4 123.95 33.7 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 O-C-N 123.932 0.77 . . . . 74.1 109.615 178.582 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 1.8 t . . . . . 0 CA--C 1.554 1.104 0 N-CA-C 107.426 -1.324 . . . . 71.03 107.426 178.773 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 172' ' ' LEU . . . . . 0.756 HD21 ' H ' ' A' ' 222' ' ' ALA . 59.9 mt . . . . . 0 N--CA 1.48 1.055 0 N-CA-C 110.449 -0.204 . . . . 71.12 110.449 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 173' ' ' PHE . . . . . 0.422 ' CD1' HD22 ' A' ' 235' ' ' LEU . 40.1 m-85 -125.8 -52.26 1.57 Allowed 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 123.927 0.891 . . . . 75.1 108.638 -176.106 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 174' ' ' TYR . . . . . . . . . . . . . 17.3 p90 -68.93 -2.67 10.32 Favored 'General case' 0 C--N 1.345 0.388 0 CA-C-N 113.894 -1.503 . . . . 72.31 114.198 -174.241 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 2.4 p -57.71 -16.06 9.8 Favored 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 123.775 0.83 . . . . 74.53 112.62 173.15 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 176' ' ' MET . . . . . . . . . . . . . 9.4 ptm -52.57 -40.75 62.93 Favored 'General case' 0 CA--C 1.56 1.359 0 C-N-CA 123.988 0.915 . . . . 72.11 111.825 167.519 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 46.5 tptt -153.78 48.28 0.65 Allowed 'General case' 0 N--CA 1.479 1.006 0 CA-C-O 122.019 0.914 . . . . 72.5 109.438 -177.523 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 178' ' ' ALA . . . . . 0.524 ' HB1' ' HB3' ' A' ' 224' ' ' PRO . . . -74.41 131.89 41.48 Favored 'General case' 0 N--CA 1.478 0.958 0 CA-C-N 115.21 -0.904 . . . . 75.34 110.62 -178.271 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . 0.477 ' HB2' ' HB2' ' A' ' 224' ' ' PRO . . . 69.54 14.09 8.3 Favored 'General case' 0 N--CA 1.492 1.639 0 C-N-CA 124.888 1.275 . . . . 74.03 111.448 -171.838 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.352 1.452 0 N-CA-C 110.851 -0.9 . . . . 54.45 110.851 171.518 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 191' ' ' GLN . . . . . 0.582 ' HB3' ' HD2' ' A' ' 243' ' ' PRO . 10.5 pt20 . . . . . 0 N--CA 1.48 1.031 0 CA-C-O 121.084 0.469 . . . . 65.11 110.209 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -76.83 150.16 36.13 Favored 'General case' 0 C--O 1.241 0.657 0 CA-C-N 114.971 -1.013 . . . . 55.11 110.304 -171.031 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . 0.41 HD12 ' HA2' ' A' ' 239' ' ' GLY . 29.5 mt -128.82 168.2 16.25 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 124.549 1.14 . . . . 64.43 109.4 177.872 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 71.6 m-85 -126.17 140.56 52.47 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 123.621 0.768 . . . . 75.33 109.731 179.125 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . 0.493 ' HB2' HD11 ' A' ' 249' ' ' LEU . . . -153.32 129.59 10.5 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 108.09 -1.078 . . . . 65.41 108.09 177.974 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 18.0 m -85.22 125.2 32.67 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 109.237 -0.653 . . . . 75.23 109.237 177.752 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . 0.511 HD22 HD13 ' A' ' 251' ' ' LEU . 20.7 tp -106.54 109.13 20.95 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 108.382 -0.97 . . . . 63.43 108.382 -178.878 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -78.04 127.51 32.43 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 123.388 0.675 . . . . 51.41 109.416 177.285 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 199' ' ' VAL . . . . . 0.479 ' O ' ' HA ' ' A' ' 255' ' ' ILE . 3.3 p -142.75 124.68 8.72 Favored Pre-proline 0 CA--C 1.543 0.693 0 C-N-CA 123.585 0.754 . . . . 53.14 108.971 178.767 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -67.36 153.35 77.17 Favored 'Trans proline' 0 C--N 1.368 1.588 0 C-N-CA 122.146 1.897 . . . . 55.14 111.805 171.545 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -47.91 -49.53 58.08 Favored Pre-proline 0 CA--C 1.562 1.431 0 N-CA-C 114.433 1.271 . . . . 73.22 114.433 -176.654 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 202' ' ' PRO . . . . . 0.429 ' O ' HG22 ' A' ' 206' ' ' VAL . 54.2 Cg_endo -66.17 -38.71 20.48 Favored 'Trans proline' 0 C--N 1.393 2.908 0 C-N-CA 121.603 1.535 . . . . 73.33 112.701 -179.333 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 29.6 mt -65.06 -32.28 57.59 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.139 0 CA-C-N 118.348 0.522 . . . . 52.24 110.209 177.343 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -68.05 -48.73 64.82 Favored 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 122.994 0.518 . . . . 61.03 111.612 179.004 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 205' ' ' VAL . . . . . 0.42 HG22 ' HA ' ' A' ' 202' ' ' PRO . 17.6 m -71.82 -50.56 37.55 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.848 0 C-N-CA 123.243 0.617 . . . . 71.22 112.238 -177.67 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 206' ' ' VAL . . . . . 0.429 HG22 ' O ' ' A' ' 202' ' ' PRO . 4.5 m -74.4 -25.96 19.94 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.2 0 C-N-CA 122.746 0.419 . . . . 74.43 111.504 -177.699 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 80.09 70.02 1.36 Allowed Glycine 0 C--N 1.345 1.047 0 O-C-N 123.312 0.382 . . . . 64.45 112.181 -177.59 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -93.44 -131.4 5.91 Favored Glycine 0 C--N 1.35 1.348 0 C-N-CA 123.152 0.406 . . . . 73.23 112.267 179.208 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 209' ' ' LYS . . . . . 0.49 ' HG2' ' HA ' ' A' ' 222' ' ' ALA . 47.4 mtmt -138.26 156.53 47.58 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 123.865 0.866 . . . . 73.41 111.199 177.564 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 9.6 m -147.61 167.18 5.16 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.1 0 C-N-CA 125.519 1.528 . . . . 73.15 108.972 173.332 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 58.6 ttp180 -99.8 119.09 37.62 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 123.096 0.558 . . . . 75.51 110.557 178.918 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -101.58 131.15 47.93 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 124.409 1.084 . . . . 54.42 110.16 176.28 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 50.5 tpp -94.7 129.93 41.41 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 123.22 0.608 . . . . 75.41 109.59 177.389 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 17.3 p -126.48 -172.48 2.64 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 124.199 1.0 . . . . 63.33 109.747 -175.141 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 80.3 mt -61.92 -37.44 84.68 Favored 'General case' 0 N--CA 1.482 1.135 0 CA-C-O 121.133 0.492 . . . . 72.04 110.875 171.063 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -92.05 10.66 28.2 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 124.253 1.021 . . . . 74.22 111.677 -173.163 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 101.67 -158.84 18.53 Favored Glycine 0 C--N 1.351 1.4 0 CA-C-O 119.504 -0.609 . . . . 61.32 112.348 178.403 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -80.46 154.31 21.16 Favored 'Trans proline' 0 C--N 1.368 1.561 0 C-N-CA 122.728 2.285 . . . . 63.13 112.843 -177.584 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 4.2 p -150.8 129.18 2.75 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 N-CA-C 108.328 -0.99 . . . . 74.14 108.328 175.498 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -85.34 103.24 14.08 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 108.982 -0.747 . . . . 70.21 108.982 -178.872 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 15.9 m -97.78 137.91 24.04 Favored 'Isoleucine or valine' 0 C--O 1.241 0.623 0 C-N-CA 123.669 0.787 . . . . 54.51 110.442 -176.929 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 222' ' ' ALA . . . . . 0.756 ' H ' HD21 ' A' ' 172' ' ' LEU . . . -84.46 104.79 14.77 Favored 'General case' 0 C--O 1.243 0.722 0 CA-C-N 115.159 -0.928 . . . . 72.53 110.451 -179.016 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 66.5 t -54.7 129.8 64.16 Favored Pre-proline 0 N--CA 1.475 0.792 0 C-N-CA 124.771 1.228 . . . . 70.41 109.669 -179.223 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 224' ' ' PRO . . . . . 0.524 ' HB3' ' HB1' ' A' ' 178' ' ' ALA . 28.6 Cg_endo -62.13 154.79 60.19 Favored 'Trans proline' 0 C--N 1.369 1.656 0 C-N-CA 121.914 1.742 . . . . 71.14 111.514 176.035 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -67.13 143.9 67.03 Favored 'Trans proline' 0 C--N 1.364 1.361 0 C-N-CA 121.152 1.234 . . . . 70.3 111.28 173.453 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 75.3 mtt180 65.61 38.41 5.44 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 124.726 1.21 . . . . 64.21 111.752 172.888 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 55.5 m -74.95 137.95 41.97 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 122.973 0.509 . . . . 75.33 110.45 175.694 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 26.8 mp0 -113.63 146.56 39.57 Favored 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 124.055 0.942 . . . . 74.15 109.994 175.169 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -58.94 119.79 7.88 Favored 'General case' 0 C--N 1.354 0.799 0 C-N-CA 124.276 1.03 . . . . 62.1 111.051 -178.788 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 114.11 -5.06 23.75 Favored Glycine 0 N--CA 1.466 0.689 0 O-C-N 123.834 0.709 . . . . 73.03 112.711 -178.883 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 85.9 mtt-85 -70.36 148.5 48.35 Favored 'General case' 0 C--N 1.358 0.976 0 CA-C-N 117.654 0.727 . . . . 72.35 109.333 172.411 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 41.2 mtmt -125.19 116.1 21.47 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 121.547 0.689 . . . . 73.51 109.599 -175.213 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 233' ' ' LEU . . . . . 0.639 ' HB2' ' HB2' ' A' ' 251' ' ' LEU . 56.7 mt -93.45 141.2 28.73 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 114.211 -1.358 . . . . 54.25 108.575 -177.887 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 14.5 ttp180 -109.26 112.44 24.59 Favored 'General case' 0 N--CA 1.474 0.774 0 O-C-N 122.055 -0.403 . . . . 72.43 111.264 -172.02 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 235' ' ' LEU . . . . . 0.593 ' HB2' ' HB3' ' A' ' 249' ' ' LEU . 12.9 mt -102.07 107.54 18.68 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.542 0.737 . . . . 73.45 110.432 176.228 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 236' ' ' LYS . . . . . 0.521 ' HB3' ' HD2' ' A' ' 246' ' ' ARG . 40.9 mttm -76.52 151.9 36.22 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-O 120.999 0.428 . . . . 75.44 110.556 172.14 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 77.21 -6.9 40.37 Favored Glycine 0 N--CA 1.476 1.365 0 CA-C-N 115.47 -0.787 . . . . 55.13 113.908 -177.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 72.8 mmtt -104.12 -7.56 20.11 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 123.748 0.819 . . . . 74.53 110.077 -179.695 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 239' ' ' GLY . . . . . 0.41 ' HA2' HD12 ' A' ' 193' ' ' LEU . . . -97.14 -167.73 33.03 Favored Glycine 0 C--N 1.358 1.769 0 N-CA-C 111.278 -0.729 . . . . 60.03 111.278 164.983 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 74.3 m-85 -91.59 157.31 42.16 Favored Pre-proline 0 N--CA 1.481 1.09 0 C-N-CA 123.772 0.829 . . . . 74.04 110.874 179.821 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -70.6 154.77 64.19 Favored 'Trans proline' 0 C--N 1.369 1.63 0 C-N-CA 121.311 1.341 . . . . 64.42 111.059 169.857 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 173.59 -119.63 0.76 Allowed Glycine 0 CA--C 1.527 0.826 0 CA-C-O 118.601 -1.11 . . . . 74.2 111.842 -179.47 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 243' ' ' PRO . . . . . 0.582 ' HD2' ' HB3' ' A' ' 191' ' ' GLN . 40.8 Cg_endo -60.66 -57.24 0.72 Allowed 'Trans proline' 0 C--N 1.38 2.232 0 C-N-CA 123.784 2.989 . . . . 74.01 112.54 -173.117 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -80.24 -12.86 59.58 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 123.167 0.587 . . . . 55.23 111.207 179.845 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 95.78 -34.8 4.67 Favored Glycine 0 C--N 1.353 1.512 0 C-N-CA 122.986 0.327 . . . . 54.31 112.311 179.698 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 246' ' ' ARG . . . . . 0.521 ' HD2' ' HB3' ' A' ' 236' ' ' LYS . 22.3 ttm180 -125.81 111.77 15.25 Favored 'General case' 0 C--O 1.244 0.77 0 C-N-CA 123.727 0.811 . . . . 75.43 108.986 177.751 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -72.12 155.31 51.58 Favored Glycine 0 C--N 1.347 1.182 0 N-CA-C 115.253 0.861 . . . . 73.33 115.253 -177.698 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 38.9 m-20 -100.21 155.43 17.76 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 113.654 -1.273 . . . . 72.34 109.96 -175.515 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 249' ' ' LEU . . . . . 0.593 ' HB3' ' HB2' ' A' ' 235' ' ' LEU . 48.8 tp -129.77 114.87 16.48 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 108.191 -1.04 . . . . 63.45 108.191 173.326 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 250' ' ' TYR . . . . . . . . . . . . . 19.7 m-30 -90.55 109.14 20.3 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 116.191 -0.458 . . . . 72.34 110.191 -174.757 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 251' ' ' LEU . . . . . 0.639 ' HB2' ' HB2' ' A' ' 233' ' ' LEU . 82.4 mt -87.45 102.43 14.55 Favored 'General case' 0 C--O 1.239 0.522 0 N-CA-C 107.923 -1.14 . . . . 72.25 107.923 177.254 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -83.38 99.72 10.24 Favored 'General case' 0 C--O 1.243 0.718 0 N-CA-C 108.257 -1.016 . . . . 73.35 108.257 178.002 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 10.1 m -61.32 132.34 26.83 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.768 0 CA-C-N 115.572 -0.74 . . . . 75.04 110.004 179.63 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 20.3 mmm180 -125.34 105.42 9.08 Favored 'General case' 0 C--O 1.241 0.606 0 N-CA-C 107.273 -1.38 . . . . 64.22 107.273 178.292 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 255' ' ' ILE . . . . . 0.479 ' HA ' ' O ' ' A' ' 199' ' ' VAL . 45.6 mt -77.93 107.54 9.95 Favored 'Isoleucine or valine' 0 C--O 1.239 0.505 0 CA-C-N 115.797 -0.638 . . . . 62.42 109.766 -179.254 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 2.4 t . . . . . 0 CA--C 1.555 1.159 0 CA-C-N 115.035 -0.984 . . . . 74.04 108.462 174.302 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 172' ' ' LEU . . . . . 0.45 HD21 ' HB3' ' A' ' 222' ' ' ALA . 22.7 mt . . . . . 0 N--CA 1.491 1.589 0 CA-C-O 120.799 0.333 . . . . 75.15 111.759 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 173' ' ' PHE . . . . . 0.499 ' CD1' HD22 ' A' ' 235' ' ' LEU . 19.4 m-85 -129.62 -53.8 1.16 Allowed 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 124.124 0.97 . . . . 71.34 109.177 -171.439 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 174' ' ' TYR . . . . . 0.444 ' CD2' ' HB3' ' A' ' 233' ' ' LEU . 0.8 OUTLIER -77.98 14.05 1.24 Allowed 'General case' 0 CA--C 1.547 0.828 0 CA-C-N 114.477 -1.238 . . . . 75.45 113.058 -174.257 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 20.6 p -61.38 -20.26 62.83 Favored 'General case' 0 N--CA 1.484 1.24 0 CA-C-N 118.772 0.715 . . . . 72.32 111.391 173.326 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 176' ' ' MET . . . . . . . . . . . . . 26.5 ptt? -59.03 -37.67 77.52 Favored 'General case' 0 CA--C 1.55 0.969 0 C-N-CA 124.149 0.979 . . . . 71.42 111.494 171.141 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 37.7 ttpt -167.19 87.6 0.29 Allowed 'General case' 0 CA--C 1.55 0.966 0 C-N-CA 124.451 1.1 . . . . 64.24 108.936 179.342 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -106.44 127.39 53.25 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 124.291 1.037 . . . . 60.12 109.246 -178.149 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . 0.428 ' HA ' ' HD3' ' A' ' 231' ' ' ARG . . . 59.93 39.45 20.22 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 124.117 0.967 . . . . 53.22 110.391 -172.773 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.056 0 CA-C-N 115.192 -0.913 . . . . 74.54 113.006 -173.149 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 191' ' ' GLN . . . . . 0.444 ' HB2' ' HA2' ' A' ' 247' ' ' GLY . 7.6 pt20 . . . . . 0 N--CA 1.471 0.602 0 CA-C-O 120.938 0.399 . . . . 74.54 110.271 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -78.03 138.56 38.86 Favored 'General case' 0 C--N 1.351 0.651 0 CA-C-N 115.524 -0.762 . . . . 73.2 109.148 -174.699 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . 0.406 HD12 ' HA2' ' A' ' 239' ' ' GLY . 25.1 mt -120.18 177.18 5.11 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 124.483 1.113 . . . . 74.33 109.158 175.112 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -139.08 121.02 15.55 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 123.413 0.685 . . . . 64.01 110.396 177.185 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -125.13 128.6 48.68 Favored 'General case' 0 C--O 1.241 0.607 0 N-CA-C 106.942 -1.503 . . . . 54.32 106.942 168.566 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 10.6 m -81.26 119.45 23.65 Favored 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 108.363 -0.977 . . . . 74.33 108.363 179.621 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . 0.722 HD22 HD13 ' A' ' 251' ' ' LEU . 20.5 tp -103.96 110.69 22.93 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 108.48 -0.933 . . . . 53.23 108.48 -173.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -79.86 127.23 31.99 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 115.219 -0.901 . . . . 74.32 108.92 179.209 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 199' ' ' VAL . . . . . 0.452 ' O ' ' HA ' ' A' ' 255' ' ' ILE . 6.2 p -143.9 128.72 9.51 Favored Pre-proline 0 CA--C 1.547 0.85 0 C-N-CA 123.729 0.812 . . . . 75.31 109.03 178.802 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -69.76 158.47 56.85 Favored 'Trans proline' 0 C--N 1.362 1.285 0 C-N-CA 121.769 1.646 . . . . 53.34 111.595 170.782 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 201' ' ' ALA . . . . . 0.46 ' O ' HG23 ' A' ' 205' ' ' VAL . . . -49.84 -53.99 36.71 Favored Pre-proline 0 CA--C 1.558 1.265 0 CA-C-N 114.744 -1.116 . . . . 72.24 112.863 -176.49 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -65.52 -34.29 43.13 Favored 'Trans proline' 0 C--N 1.399 3.208 0 C-N-CA 121.736 1.624 . . . . 72.12 113.237 -175.527 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 24.7 mt -67.2 -34.05 66.87 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.413 0 N-CA-C 109.975 -0.38 . . . . 63.04 109.975 177.529 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -69.46 -38.09 77.6 Favored 'General case' 0 CA--C 1.549 0.904 0 C-N-CA 122.535 0.334 . . . . 63.43 111.339 177.422 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 205' ' ' VAL . . . . . 0.46 HG23 ' O ' ' A' ' 201' ' ' ALA . 99.7 t -70.86 -56.55 10.36 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.122 0 C-N-CA 123.168 0.587 . . . . 62.32 111.576 -178.039 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 10.9 m -78.37 -25.42 13.84 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 CA-C-N 116.134 -0.485 . . . . 74.33 110.948 -174.918 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 84.15 60.55 1.92 Allowed Glycine 0 C--N 1.345 1.043 0 CA-C-N 116.04 -0.527 . . . . 61.32 112.615 -179.578 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -78.77 -138.03 1.38 Allowed Glycine 0 N--CA 1.477 1.374 0 CA-C-O 119.696 -0.502 . . . . 60.54 112.168 177.663 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 209' ' ' LYS . . . . . 0.479 ' HG2' ' HA ' ' A' ' 222' ' ' ALA . 29.0 mtmm -134.58 157.3 46.93 Favored 'General case' 0 N--CA 1.481 1.124 0 CA-C-N 117.607 0.704 . . . . 65.42 110.718 176.38 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 7.1 m -142.86 165.75 15.72 Favored 'Isoleucine or valine' 0 C--O 1.241 0.631 0 C-N-CA 126.068 1.747 . . . . 61.14 107.894 173.601 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 31.1 ttm180 -105.07 116.61 32.25 Favored 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 109.396 -0.594 . . . . 74.01 109.396 179.273 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -101.74 113.74 27.18 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.379 1.072 . . . . 63.21 109.563 179.003 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 61.6 tpp -76.22 125.04 28.44 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 108.187 -1.042 . . . . 65.33 108.187 173.702 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 18.4 p -125.24 -175.8 3.41 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.723 0.809 . . . . 65.31 109.721 -175.702 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 71.1 mt -57.01 -40.79 77.28 Favored 'General case' 0 N--CA 1.481 1.079 0 CA-C-O 121.504 0.669 . . . . 65.31 110.415 172.5 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 216' ' ' GLU . . . . . 0.472 ' HB2' ' NZ ' ' A' ' 238' ' ' LYS . 6.0 mm-40 -87.72 15.02 7.43 Favored 'General case' 0 CA--C 1.551 0.994 0 CA-C-N 114.538 -1.21 . . . . 62.45 111.371 -174.751 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 94.73 -171.1 30.02 Favored Glycine 0 C--N 1.35 1.346 0 N-CA-C 112.086 -0.406 . . . . 72.23 112.086 -179.686 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -68.42 149.37 74.89 Favored 'Trans proline' 0 C--N 1.362 1.276 0 C-N-CA 122.205 1.936 . . . . 62.31 111.991 178.129 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 7.1 p -143.27 134.87 23.61 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 N-CA-C 108.543 -0.91 . . . . 72.44 108.543 173.593 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 -86.37 103.27 14.78 Favored 'General case' 0 C--O 1.238 0.475 0 N-CA-C 107.76 -1.2 . . . . 65.02 107.76 179.501 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 2.6 p -108.61 131.35 59.44 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.967 0 C-N-CA 123.615 0.766 . . . . 64.44 109.355 -172.108 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 222' ' ' ALA . . . . . 0.479 ' HA ' ' HG2' ' A' ' 209' ' ' LYS . . . -83.11 111.25 18.73 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 123.126 0.571 . . . . 65.22 110.62 -176.788 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 58.4 t -54.66 132.65 64.78 Favored Pre-proline 0 N--CA 1.473 0.721 0 O-C-N 124.716 1.26 . . . . 62.43 109.354 177.067 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_endo -63.41 144.95 91.98 Favored 'Trans proline' 0 C--N 1.367 1.541 0 C-N-CA 121.482 1.455 . . . . 55.12 111.266 172.817 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -62.67 139.11 73.55 Favored 'Trans proline' 0 C--N 1.37 1.698 0 C-N-CA 121.572 1.515 . . . . 42.31 110.971 171.816 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 54.2 mtt180 69.64 60.49 0.28 Allowed 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 124.982 1.313 . . . . 73.2 110.74 173.161 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 227' ' ' THR . . . . . 0.593 ' HA ' ' HE ' ' A' ' 231' ' ' ARG . 55.9 m -103.85 142.12 34.94 Favored 'General case' 0 CA--C 1.544 0.74 0 CA-C-N 113.669 -1.605 . . . . 65.01 110.051 -179.857 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -116.66 148.14 41.29 Favored 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 124.074 0.95 . . . . 61.31 109.732 177.527 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 229' ' ' ALA . . . . . 0.487 ' HB2' ' HB ' ' A' ' 255' ' ' ILE . . . -58.77 116.5 3.78 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 123.982 0.913 . . . . 71.43 110.762 -179.84 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 113.21 2.44 24.79 Favored Glycine 0 CA--C 1.524 0.656 0 CA-C-N 115.744 -0.662 . . . . 74.01 112.968 179.238 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 231' ' ' ARG . . . . . 0.593 ' HE ' ' HA ' ' A' ' 227' ' ' THR . 75.0 mtt-85 -66.39 147.44 53.3 Favored 'General case' 0 C--N 1.364 1.206 0 CA-C-N 117.175 0.488 . . . . 74.44 109.757 172.358 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 69.7 mmtt -115.2 98.38 6.74 Favored 'General case' 0 C--O 1.241 0.605 0 CA-C-N 115.139 -0.937 . . . . 73.14 108.757 -174.591 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 233' ' ' LEU . . . . . 0.714 ' HB2' ' HB2' ' A' ' 251' ' ' LEU . 60.1 mt -85.5 151.69 23.76 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 115.3 -0.864 . . . . 73.32 108.883 177.514 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 234' ' ' ARG . . . . . 0.441 HH11 ' HE2' ' A' ' 250' ' ' TYR . 41.0 ttt85 -126.63 109.19 11.83 Favored 'General case' 0 N--CA 1.478 0.963 0 CA-C-O 120.679 0.275 . . . . 72.41 110.63 -172.114 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 235' ' ' LEU . . . . . 0.556 HD11 HD11 ' A' ' 251' ' ' LEU . 23.3 mt -94.98 117.71 30.6 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 123.761 0.824 . . . . 51.34 110.765 -179.571 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 20.9 mttt -69.86 138.51 52.59 Favored 'General case' 0 C--O 1.238 0.468 0 O-C-N 123.415 0.447 . . . . 75.1 111.401 175.74 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 73.94 10.35 80.64 Favored Glycine 0 C--N 1.345 1.029 0 CA-C-N 115.608 -0.723 . . . . 70.31 114.36 175.452 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . 0.472 ' NZ ' ' HB2' ' A' ' 216' ' ' GLU . 72.7 mmtt -112.51 5.28 17.89 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 122.765 0.426 . . . . 74.42 111.062 -179.707 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 239' ' ' GLY . . . . . 0.406 ' HA2' HD12 ' A' ' 193' ' ' LEU . . . -107.37 -161.93 21.57 Favored Glycine 0 C--N 1.348 1.216 0 N-CA-C 110.896 -0.881 . . . . 74.05 110.896 168.244 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 40.1 m-85 -94.25 147.25 33.03 Favored Pre-proline 0 N--CA 1.477 0.905 0 C-N-CA 123.045 0.538 . . . . 73.44 110.935 -179.049 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_exo -64.76 167.47 15.45 Favored 'Trans proline' 0 C--N 1.369 1.617 0 C-N-CA 122.333 2.022 . . . . 72.23 112.385 169.911 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 144.63 -106.02 0.38 Allowed Glycine 0 C--N 1.339 0.75 0 CA-C-O 118.727 -1.041 . . . . 63.32 112.077 175.769 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -61.95 -51.18 4.04 Favored 'Trans proline' 0 C--N 1.38 2.223 0 C-N-CA 123.632 2.888 . . . . 64.31 113.01 -168.855 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -87.13 -10.3 53.13 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 123.06 0.544 . . . . 71.33 111.312 176.466 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 90.76 -44.9 2.88 Favored Glycine 0 C--N 1.352 1.427 0 N-CA-C 111.383 -0.687 . . . . 64.21 111.383 -173.118 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 10.2 ttm180 -115.8 111.94 21.24 Favored 'General case' 0 C--O 1.24 0.59 0 C-N-CA 125.137 1.375 . . . . 63.53 109.281 175.373 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 247' ' ' GLY . . . . . 0.444 ' HA2' ' HB2' ' A' ' 191' ' ' GLN . . . -80.61 168.43 51.35 Favored Glycine 0 C--N 1.349 1.276 0 CA-C-O 121.766 0.648 . . . . 43.45 113.698 170.987 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -125.38 160.77 28.58 Favored 'General case' 0 N--CA 1.465 0.31 0 C-N-CA 124.19 0.996 . . . . 64.24 110.396 -170.274 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 249' ' ' LEU . . . . . 0.477 ' HB3' ' HB2' ' A' ' 235' ' ' LEU . 41.1 tp -115.84 124.86 51.76 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 123.948 0.899 . . . . 75.11 109.501 177.143 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 250' ' ' TYR . . . . . 0.441 ' HE2' HH11 ' A' ' 234' ' ' ARG . 2.2 m-85 -88.26 109.54 20.02 Favored 'General case' 0 C--O 1.232 0.158 0 N-CA-C 109.268 -0.641 . . . . 73.25 109.268 176.912 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 251' ' ' LEU . . . . . 0.722 HD13 HD22 ' A' ' 197' ' ' LEU . 86.4 mt -87.2 104.19 16.14 Favored 'General case' 0 C--O 1.241 0.64 0 N-CA-C 106.736 -1.579 . . . . 74.21 106.736 173.945 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -85.05 103.43 14.07 Favored 'General case' 0 C--O 1.24 0.575 0 N-CA-C 107.71 -1.219 . . . . 63.03 107.71 176.037 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 16.7 m -68.43 137.71 23.92 Favored 'Isoleucine or valine' 0 C--O 1.241 0.646 0 O-C-N 124.181 0.926 . . . . 74.13 109.596 -177.193 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 18.1 mmm180 -128.48 106.18 8.81 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 107.774 -1.195 . . . . 75.25 107.774 -179.906 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 255' ' ' ILE . . . . . 0.487 ' HB ' ' HB2' ' A' ' 229' ' ' ALA . 29.6 mt -77.47 123.5 34.23 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.58 0 O-C-N 123.924 0.765 . . . . 64.0 110.086 178.301 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 3.3 t . . . . . 0 CA--C 1.563 1.452 0 C-N-CA 124.143 0.977 . . . . 72.1 109.081 173.729 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 172' ' ' LEU . . . . . 0.755 HD21 ' H ' ' A' ' 222' ' ' ALA . 78.2 mt . . . . . 0 N--CA 1.479 0.992 0 CA-C-O 121.16 0.505 . . . . 72.53 111.49 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 173' ' ' PHE . . . . . 0.403 ' CD1' HD22 ' A' ' 235' ' ' LEU . 50.1 m-85 -147.62 -68.94 0.24 Allowed 'General case' 0 N--CA 1.479 0.986 0 N-CA-C 108.337 -0.986 . . . . 75.21 108.337 -164.952 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 174' ' ' TYR . . . . . 0.475 ' OH ' ' HB ' ' A' ' 221' ' ' VAL . 19.9 p90 -62.97 -21.86 66.4 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 113.921 -1.491 . . . . 72.42 112.523 -178.888 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 19.5 m -59.28 -12.59 5.81 Favored 'General case' 0 CA--C 1.56 1.339 0 C-N-CA 125.773 1.629 . . . . 72.35 112.889 -176.277 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 176' ' ' MET . . . . . . . . . . . . . 50.8 mtm -56.36 -50.62 71.02 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 123.773 0.829 . . . . 65.43 110.075 166.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -163.84 104.54 0.91 Allowed 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 124.428 1.091 . . . . 71.2 109.475 174.775 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 178' ' ' ALA . . . . . 0.457 ' HB1' HD22 ' A' ' 233' ' ' LEU . . . -125.84 -59.39 1.35 Allowed 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 123.936 0.894 . . . . 61.31 111.224 -171.67 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -72.26 81.8 1.01 Allowed 'General case' 0 CA--C 1.544 0.716 0 CA-C-O 121.86 0.838 . . . . 51.32 109.258 174.765 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.337 0.586 0 N-CA-C 109.974 -1.25 . . . . 61.23 109.974 -169.663 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 191' ' ' GLN . . . . . 0.699 ' HB2' ' HA2' ' A' ' 247' ' ' GLY . 3.4 pt20 . . . . . 0 CA--C 1.545 0.755 0 CA-C-O 121.41 0.624 . . . . 75.51 110.088 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 192' ' ' ASP . . . . . 0.454 ' HA ' ' O ' ' A' ' 248' ' ' ASP . 9.9 m-20 -78.1 152.75 32.71 Favored 'General case' 0 C--N 1.347 0.464 0 CA-C-N 114.438 -1.256 . . . . 71.1 111.797 -167.907 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . 0.475 HD12 ' HA2' ' A' ' 239' ' ' GLY . 22.9 mt -133.86 175.01 9.85 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 124.265 1.026 . . . . 73.3 109.773 177.517 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 77.6 m-85 -136.35 131.43 34.27 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.579 0.752 . . . . 71.12 110.545 179.835 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -144.29 128.99 18.23 Favored 'General case' 0 C--O 1.234 0.28 0 N-CA-C 107.326 -1.361 . . . . 74.4 107.326 176.823 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 3.5 m -81.47 121.35 26.16 Favored 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 109.524 -0.547 . . . . 65.44 109.524 -176.571 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . 0.544 HD22 HD13 ' A' ' 251' ' ' LEU . 20.3 tp -106.35 108.96 20.73 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 107.188 -1.412 . . . . 72.45 107.188 -178.124 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -86.92 132.37 33.83 Favored 'General case' 0 C--O 1.241 0.606 0 N-CA-C 109.223 -0.658 . . . . 65.14 109.223 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 199' ' ' VAL . . . . . 0.432 ' O ' ' HA ' ' A' ' 255' ' ' ILE . 4.0 p -141.92 129.53 11.61 Favored Pre-proline 0 CA--C 1.543 0.694 0 N-CA-C 108.305 -0.998 . . . . 44.02 108.305 -176.626 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -70.23 155.1 65.13 Favored 'Trans proline' 0 C--N 1.364 1.36 0 C-N-CA 121.431 1.421 . . . . 74.34 110.376 170.814 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 201' ' ' ALA . . . . . 0.414 ' HA ' HG23 ' A' ' 255' ' ' ILE . . . -50.64 -49.39 78.98 Favored Pre-proline 0 CA--C 1.556 1.2 0 CA-C-O 117.804 -1.093 . . . . 64.4 112.885 179.871 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 202' ' ' PRO . . . . . 0.436 ' HA ' HG22 ' A' ' 205' ' ' VAL . 29.7 Cg_endo -58.74 -39.59 80.71 Favored 'Trans proline' 0 C--N 1.399 3.216 0 C-N-CA 122.312 2.008 . . . . 65.31 113.991 -179.884 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 39.3 mt -68.28 -37.54 78.15 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.395 0 CA-C-N 118.625 0.648 . . . . 75.2 110.475 177.684 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -66.46 -42.8 87.02 Favored 'General case' 0 N--CA 1.479 0.98 0 N-CA-C 112.101 0.408 . . . . 74.14 112.101 179.706 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 205' ' ' VAL . . . . . 0.436 HG22 ' HA ' ' A' ' 202' ' ' PRO . 26.9 m -77.69 -45.02 28.96 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.917 0 C-N-CA 123.777 0.831 . . . . 74.12 112.722 -172.713 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 206' ' ' VAL . . . . . 0.402 HG22 ' O ' ' A' ' 202' ' ' PRO . 5.2 m -81.19 -26.22 10.52 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.325 0 C-N-CA 122.42 0.288 . . . . 71.15 111.338 178.541 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 82.89 77.89 1.07 Allowed Glycine 0 C--N 1.348 1.226 0 N-CA-C 111.858 -0.497 . . . . 62.35 111.858 -176.445 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -102.1 -137.34 9.6 Favored Glycine 0 C--N 1.347 1.186 0 N-CA-C 111.51 -0.636 . . . . 63.42 111.51 177.427 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 48.5 mtmt -136.16 155.46 50.13 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 123.592 0.757 . . . . 74.1 111.088 179.124 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 7.4 m -142.43 168.75 13.81 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.908 0 C-N-CA 125.948 1.699 . . . . 62.43 108.385 172.827 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 44.1 ttm180 -103.25 120.02 39.97 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 122.902 0.481 . . . . 53.33 109.858 177.508 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -102.21 133.55 46.9 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 124.127 0.971 . . . . 75.54 110.213 177.688 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 23.5 mmt -97.24 121.63 39.35 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 123.319 0.648 . . . . 73.31 109.595 178.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 18.2 p -120.17 174.85 6.24 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 124.172 0.989 . . . . 60.33 110.082 -177.095 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 56.5 mt -59.0 -31.48 68.84 Favored 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 123.079 0.551 . . . . 75.32 112.248 179.241 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -87.59 -20.26 26.67 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 123.106 0.563 . . . . 61.44 111.475 -177.4 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 139.33 -161.66 26.06 Favored Glycine 0 C--N 1.35 1.314 0 CA-C-O 119.445 -0.642 . . . . 63.33 111.962 -178.469 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_endo -82.28 155.86 16.87 Favored 'Trans proline' 0 C--N 1.367 1.541 0 C-N-CA 122.53 2.154 . . . . 63.01 112.766 -177.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 5.5 p -146.93 134.88 15.0 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.92 0 C-N-CA 123.746 0.819 . . . . 63.42 109.354 177.268 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -83.34 104.16 13.28 Favored 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 108.444 -0.947 . . . . 61.12 108.444 176.243 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 221' ' ' VAL . . . . . 0.475 ' HB ' ' OH ' ' A' ' 174' ' ' TYR . 6.4 m -106.27 132.12 54.21 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 CA-C-O 121.64 0.733 . . . . 73.41 110.578 -178.027 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 222' ' ' ALA . . . . . 0.755 ' H ' HD21 ' A' ' 172' ' ' LEU . . . -85.74 105.8 16.53 Favored 'General case' 0 C--O 1.238 0.46 0 CA-C-N 114.365 -1.289 . . . . 72.31 110.311 -178.732 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 66.7 t -57.43 128.76 79.56 Favored Pre-proline 0 N--CA 1.478 0.962 0 O-C-N 124.532 1.145 . . . . 52.34 109.124 179.089 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 224' ' ' PRO . . . . . 0.444 ' HD3' ' HE1' ' A' ' 174' ' ' TYR . 24.3 Cg_endo -61.22 146.56 97.3 Favored 'Trans proline' 0 C--N 1.375 1.922 0 C-N-CA 121.892 1.728 . . . . 73.32 110.926 177.559 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_endo -62.36 141.95 89.15 Favored 'Trans proline' 0 C--N 1.37 1.674 0 C-N-CA 121.607 1.538 . . . . 64.24 111.808 175.864 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 77.9 mtt180 64.64 38.96 6.8 Favored 'General case' 0 CA--C 1.554 1.13 0 C-N-CA 125.031 1.333 . . . . 74.13 111.908 172.524 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 227' ' ' THR . . . . . 0.511 HG23 ' HD2' ' A' ' 231' ' ' ARG . 86.7 m -76.17 146.85 38.87 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 123.648 0.779 . . . . 62.15 110.427 176.178 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -111.05 149.41 30.79 Favored 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 123.813 0.845 . . . . 53.31 109.249 174.927 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 229' ' ' ALA . . . . . 0.488 ' HA ' HG23 ' A' ' 253' ' ' VAL . . . -61.19 138.74 58.21 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 124.02 0.928 . . . . 64.14 111.394 -179.325 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 94.11 -3.81 70.3 Favored Glycine 0 C--N 1.339 0.73 0 CA-C-N 115.843 -0.617 . . . . 44.23 112.712 -178.846 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 231' ' ' ARG . . . . . 0.511 ' HD2' HG23 ' A' ' 227' ' ' THR . 57.4 mtt-85 -69.38 143.58 53.65 Favored 'General case' 0 C--N 1.363 1.195 0 N-CA-C 108.924 -0.769 . . . . 75.45 108.924 171.72 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 232' ' ' LYS . . . . . 0.518 ' HG2' ' HB3' ' A' ' 250' ' ' TYR . 13.4 ttmt -126.29 101.36 6.7 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 108.707 -0.849 . . . . 52.25 108.707 -167.309 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 233' ' ' LEU . . . . . 0.682 ' HB2' ' HB2' ' A' ' 251' ' ' LEU . 24.1 mt -76.28 151.72 36.68 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-N 114.011 -1.45 . . . . 71.34 109.172 -176.528 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 47.8 ttt180 -125.14 120.82 32.46 Favored 'General case' 0 N--CA 1.485 1.291 0 CA-C-N 118.998 0.817 . . . . 73.51 110.484 -175.433 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 235' ' ' LEU . . . . . 0.483 HD11 HD11 ' A' ' 251' ' ' LEU . 18.6 mt -108.78 116.45 32.01 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 124.397 1.079 . . . . 74.35 110.768 -175.696 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 31.4 mttp -72.94 141.54 47.82 Favored 'General case' 0 N--CA 1.479 1.004 0 N-CA-C 112.226 0.454 . . . . 72.42 112.226 176.795 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 76.51 10.37 85.75 Favored Glycine 0 C--N 1.349 1.269 0 CA-C-N 115.151 -0.931 . . . . 72.42 114.49 178.582 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt -115.26 10.29 15.92 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 122.736 0.414 . . . . 72.15 111.069 -173.79 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 239' ' ' GLY . . . . . 0.475 ' HA2' HD12 ' A' ' 193' ' ' LEU . . . -119.86 -161.98 11.74 Favored Glycine 0 C--N 1.345 1.06 0 N-CA-C 111.456 -0.657 . . . . 75.21 111.456 172.779 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 37.7 m-85 -93.02 169.3 10.64 Favored Pre-proline 0 N--CA 1.485 1.286 0 C-N-CA 123.79 0.836 . . . . 70.53 111.105 -175.208 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 241' ' ' PRO . . . . . 0.5 ' HA ' ' O ' ' A' ' 245' ' ' GLY . 77.7 Cg_exo -55.01 149.63 42.13 Favored 'Trans proline' 0 C--N 1.376 2.001 0 C-N-CA 121.762 1.641 . . . . 55.32 112.813 165.68 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -174.54 -136.51 2.26 Favored Glycine 0 CA--C 1.526 0.75 0 CA-C-O 119.053 -0.859 . . . . 73.51 111.871 179.085 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 243' ' ' PRO . . . . . 0.683 ' HD2' ' HB3' ' A' ' 191' ' ' GLN . 43.1 Cg_endo -60.34 -40.89 54.5 Favored 'Trans proline' 0 C--N 1.371 1.744 0 C-N-CA 124.158 3.238 . . . . 75.14 113.108 -172.53 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -104.12 0.87 30.16 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 124.05 0.94 . . . . 74.43 111.482 179.013 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 245' ' ' GLY . . . . . 0.5 ' O ' ' HA ' ' A' ' 241' ' ' PRO . . . 81.83 -41.22 2.7 Favored Glycine 0 C--N 1.36 1.885 0 N-CA-C 112.386 -0.286 . . . . 75.23 112.386 -175.584 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 9.9 ttm180 -89.02 110.1 20.84 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 124.301 1.04 . . . . 74.24 109.705 175.61 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 247' ' ' GLY . . . . . 0.699 ' HA2' ' HB2' ' A' ' 191' ' ' GLN . . . -83.11 167.48 45.6 Favored Glycine 0 C--N 1.351 1.417 0 N-CA-C 114.407 0.523 . . . . 73.35 114.407 171.69 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 248' ' ' ASP . . . . . 0.454 ' O ' ' HA ' ' A' ' 192' ' ' ASP . 41.6 m-20 -131.31 135.92 47.69 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 123.482 0.713 . . . . 63.32 111.092 -168.729 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 249' ' ' LEU . . . . . . . . . . . . . 47.5 tp -99.97 129.9 46.09 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 123.497 0.719 . . . . 74.33 110.739 -177.921 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 250' ' ' TYR . . . . . 0.519 ' HA ' ' O ' ' A' ' 233' ' ' LEU . 2.4 m-85 -95.77 115.49 27.5 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 123.801 0.84 . . . . 70.0 110.522 -178.83 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 251' ' ' LEU . . . . . 0.682 ' HB2' ' HB2' ' A' ' 233' ' ' LEU . 85.8 mt -94.14 105.22 17.22 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 108.711 -0.848 . . . . 74.54 108.711 178.257 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -84.15 104.25 14.04 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 109.743 -0.466 . . . . 72.41 109.743 178.736 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 253' ' ' VAL . . . . . 0.488 HG23 ' HA ' ' A' ' 229' ' ' ALA . 6.1 m -66.1 131.66 31.8 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.937 0 CA-C-O 121.237 0.541 . . . . 45.41 109.687 -179.299 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 10.8 mmm180 -123.96 97.32 5.3 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 108.744 -0.835 . . . . 71.33 108.744 179.057 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 255' ' ' ILE . . . . . 0.432 ' HA ' ' O ' ' A' ' 199' ' ' VAL . 32.2 mt -78.46 127.36 38.79 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 O-C-N 124.026 0.829 . . . . 65.21 111.014 -175.172 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 1.9 t . . . . . 0 CA--C 1.561 1.367 0 C-N-CA 124.064 0.946 . . . . 71.43 109.418 175.379 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 172' ' ' LEU . . . . . 0.682 HD21 ' H ' ' A' ' 222' ' ' ALA . 72.8 mt . . . . . 0 CA--C 1.54 0.584 0 CA-C-O 120.622 0.249 . . . . 73.15 110.979 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 34.9 m-85 -109.38 -57.93 2.1 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 123.7 0.8 . . . . 74.13 109.805 -174.937 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 174' ' ' TYR . . . . . 0.424 ' CD2' ' HB3' ' A' ' 233' ' ' LEU . 0.8 OUTLIER -71.17 -6.03 36.34 Favored 'General case' 0 C--N 1.348 0.508 0 CA-C-N 114.724 -1.126 . . . . 71.04 113.446 -173.201 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 175' ' ' THR . . . . . 0.485 HG21 HD13 ' A' ' 172' ' ' LEU . 2.9 p -68.2 -2.12 7.47 Favored 'General case' 0 CA--C 1.549 0.908 0 N-CA-C 114.052 1.131 . . . . 42.31 114.052 -177.328 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 176' ' ' MET . . . . . . . . . . . . . 21.8 ptt? -60.34 -41.93 94.61 Favored 'General case' 0 CA--C 1.559 1.296 0 C-N-CA 123.038 0.535 . . . . 70.21 110.369 163.756 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -178.55 114.03 0.07 Allowed 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 126.425 1.89 . . . . 74.55 106.956 179.337 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 178' ' ' ALA . . . . . 0.413 ' HB1' HD22 ' A' ' 233' ' ' LEU . . . -132.2 -42.04 0.98 Allowed 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 122.799 0.44 . . . . 54.3 111.881 -170.809 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -72.7 81.6 1.13 Allowed 'General case' 0 N--CA 1.472 0.669 0 CA-C-O 121.708 0.766 . . . . 64.42 109.58 179.045 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . 0.473 ' H ' ' HD3' ' A' ' 231' ' ' ARG . . . . . . . . 0 C--N 1.332 0.332 0 N-CA-C 108.944 -1.663 . . . . 51.14 108.944 -175.693 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 191' ' ' GLN . . . . . 0.525 ' HB3' ' HD2' ' A' ' 243' ' ' PRO . 5.4 pt20 . . . . . 0 N--CA 1.474 0.738 0 CA-C-O 121.075 0.464 . . . . 72.13 110.763 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 21.5 m-20 -77.3 161.33 28.17 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 115.743 -0.662 . . . . 71.2 111.312 -170.536 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 24.2 mt -141.08 166.31 25.13 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 124.375 1.07 . . . . 63.3 110.294 -178.953 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 61.0 m-85 -136.94 123.02 20.33 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 124.324 1.049 . . . . 73.22 109.771 178.206 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . 0.454 ' O ' ' HA ' ' A' ' 251' ' ' LEU . . . -133.89 132.61 40.51 Favored 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 108.389 -0.967 . . . . 53.23 108.389 176.301 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 41.8 m -86.11 124.06 32.11 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 123.145 0.578 . . . . 73.23 109.87 -179.134 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . 0.645 HD22 HD13 ' A' ' 251' ' ' LEU . 19.7 tp -107.16 109.93 21.88 Favored 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 108.665 -0.865 . . . . 62.13 108.665 -175.367 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -79.75 125.58 29.85 Favored 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 123.441 0.696 . . . . 74.11 109.174 179.219 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 199' ' ' VAL . . . . . 0.456 ' O ' ' HA ' ' A' ' 255' ' ' ILE . 4.4 p -144.02 129.37 9.7 Favored Pre-proline 0 CA--C 1.547 0.829 0 C-N-CA 124.044 0.937 . . . . 74.44 108.93 -178.083 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -67.76 158.55 56.72 Favored 'Trans proline' 0 C--N 1.37 1.682 0 C-N-CA 121.809 1.673 . . . . 75.2 112.264 170.26 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 201' ' ' ALA . . . . . 0.499 ' O ' HG23 ' A' ' 205' ' ' VAL . . . -50.62 -52.91 51.74 Favored Pre-proline 0 CA--C 1.553 1.09 0 N-CA-C 113.692 0.997 . . . . 65.34 113.692 -179.185 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 202' ' ' PRO . . . . . 0.406 ' O ' HG22 ' A' ' 206' ' ' VAL . 49.8 Cg_endo -64.97 -38.6 28.15 Favored 'Trans proline' 0 C--N 1.381 2.258 0 CA-C-N 121.147 1.445 . . . . 75.22 113.835 -177.39 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 31.5 mt -64.04 -30.9 51.27 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 N-CA-C 109.944 -0.391 . . . . 62.25 109.944 175.743 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -72.77 -40.74 65.71 Favored 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 122.578 0.351 . . . . 71.45 111.453 176.765 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 205' ' ' VAL . . . . . 0.499 HG23 ' O ' ' A' ' 201' ' ' ALA . 91.6 t -70.73 -55.96 12.43 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.239 0 C-N-CA 123.199 0.6 . . . . 51.25 111.035 -176.483 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 206' ' ' VAL . . . . . 0.406 HG22 ' O ' ' A' ' 202' ' ' PRO . 14.7 m -81.3 -27.3 10.46 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 CA-C-N 116.532 -0.304 . . . . 73.23 111.188 -176.796 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 85.18 71.56 1.31 Allowed Glycine 0 C--N 1.351 1.393 0 O-C-N 123.439 0.462 . . . . 60.42 113.016 -179.367 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -86.81 -127.8 2.33 Favored Glycine 0 C--N 1.348 1.218 0 CA-C-O 119.736 -0.48 . . . . 64.4 112.808 176.908 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 45.1 mtmt -137.66 152.12 48.98 Favored 'General case' 0 N--CA 1.486 1.336 0 CA-C-N 117.525 0.662 . . . . 73.35 111.128 178.45 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 6.2 m -146.91 159.52 9.67 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 C-N-CA 125.108 1.363 . . . . 70.4 108.536 170.702 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 51.0 ttp180 -97.53 121.18 39.14 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 123.394 0.678 . . . . 74.43 110.675 -179.681 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -102.29 123.18 45.64 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 123.494 0.718 . . . . 63.32 110.192 176.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 49.1 tpp -81.28 126.75 31.93 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 108.893 -0.78 . . . . 65.3 108.893 172.747 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 24.1 p -129.74 -174.31 3.27 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 123.848 0.859 . . . . 64.54 109.673 -173.506 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 67.4 mt -62.29 -27.65 69.18 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 122.809 0.444 . . . . 54.04 111.196 172.781 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 216' ' ' GLU . . . . . 0.403 ' HB2' ' NZ ' ' A' ' 238' ' ' LYS . 34.4 mt-10 -102.87 22.12 14.39 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 123.826 0.851 . . . . 72.43 110.691 -178.84 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 85.85 -156.03 29.62 Favored Glycine 0 C--N 1.354 1.555 0 CA-C-O 119.13 -0.817 . . . . 52.24 113.291 176.628 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -75.71 148.0 32.08 Favored 'Trans proline' 0 C--N 1.369 1.613 0 C-N-CA 122.79 2.327 . . . . 63.24 113.024 -178.151 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 3.8 p -141.5 128.77 21.09 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 N-CA-C 108.735 -0.839 . . . . 54.41 108.735 174.464 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -79.45 102.88 9.0 Favored 'General case' 0 C--O 1.241 0.606 0 N-CA-C 108.453 -0.943 . . . . 64.14 108.453 174.564 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 1.8 p -111.13 115.88 51.03 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.214 0 CA-C-N 115.457 -0.792 . . . . 73.34 108.968 -170.497 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 222' ' ' ALA . . . . . 0.682 ' H ' HD21 ' A' ' 172' ' ' LEU . . . -67.78 109.17 3.25 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 115.365 -0.834 . . . . 71.11 111.699 179.143 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 57.5 t -55.4 136.86 69.43 Favored Pre-proline 0 CA--C 1.551 1.008 0 C-N-CA 124.975 1.31 . . . . 40.33 110.382 178.29 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -66.42 160.71 44.25 Favored 'Trans proline' 0 C--N 1.371 1.726 0 C-N-CA 122.233 1.956 . . . . 74.21 111.567 173.009 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo -69.92 151.26 68.08 Favored 'Trans proline' 0 C--N 1.363 1.336 0 C-N-CA 121.406 1.404 . . . . 73.33 110.973 171.427 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 49.6 mtt180 61.98 43.76 8.79 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 124.535 1.134 . . . . 70.22 111.054 170.119 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 227' ' ' THR . . . . . 0.44 ' HA ' ' HE ' ' A' ' 231' ' ' ARG . 91.8 m -85.11 124.63 32.01 Favored 'General case' 0 CA--C 1.544 0.739 0 CA-C-N 114.14 -1.391 . . . . 72.34 109.808 178.095 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -104.81 151.62 23.57 Favored 'General case' 0 N--CA 1.492 1.644 0 C-N-CA 123.602 0.761 . . . . 75.15 109.496 176.292 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -58.01 116.25 3.39 Favored 'General case' 0 C--N 1.353 0.75 0 O-C-N 123.915 0.76 . . . . 61.04 110.397 178.895 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 114.21 -2.24 23.9 Favored Glycine 0 C--N 1.338 0.651 0 CA-C-O 119.194 -0.781 . . . . 61.31 113.211 -178.302 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 231' ' ' ARG . . . . . 0.473 ' HD3' ' H ' ' A' ' 180' ' ' GLY . 25.6 mtt-85 -63.41 129.95 42.37 Favored 'General case' 0 C--N 1.361 1.065 0 CA-C-N 117.989 0.894 . . . . 63.13 109.344 171.817 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 77.2 mttt -110.69 96.75 6.37 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 107.83 -1.174 . . . . 75.24 107.83 -175.301 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 233' ' ' LEU . . . . . 0.604 ' HB2' ' HB2' ' A' ' 251' ' ' LEU . 34.0 mt -79.81 151.33 30.34 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 114.137 -1.392 . . . . 73.2 109.42 -174.747 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 45.8 ttt180 -117.05 103.05 9.85 Favored 'General case' 0 N--CA 1.483 1.21 0 CA-C-N 118.654 0.661 . . . . 51.11 111.579 -170.135 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 235' ' ' LEU . . . . . 0.566 ' HB2' ' HB3' ' A' ' 249' ' ' LEU . 18.7 mt -94.13 101.14 13.14 Favored 'General case' 0 C--O 1.24 0.594 0 C-N-CA 123.239 0.616 . . . . 74.14 109.68 172.442 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 57.5 mttt -72.97 147.84 44.81 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 110.088 -0.338 . . . . 71.43 110.088 173.857 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 79.32 -6.61 56.7 Favored Glycine 0 C--N 1.341 0.834 0 CA-C-N 115.545 -0.752 . . . . 60.52 113.927 -177.367 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . 0.403 ' NZ ' ' HB2' ' A' ' 216' ' ' GLU . 71.8 mmtt -100.4 2.8 42.66 Favored 'General case' 0 C--O 1.239 0.531 0 C-N-CA 123.491 0.716 . . . . 74.5 111.083 179.351 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -103.62 -175.85 25.98 Favored Glycine 0 C--N 1.357 1.74 0 O-C-N 123.528 0.518 . . . . 65.42 112.09 166.477 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 79.9 m-85 -86.89 167.71 20.99 Favored Pre-proline 0 CA--C 1.563 1.462 0 C-N-CA 124.416 1.087 . . . . 73.04 110.812 179.181 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_endo -73.0 168.53 24.5 Favored 'Trans proline' 0 C--N 1.382 2.294 0 C-N-CA 122.187 1.924 . . . . 53.23 113.198 173.747 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 163.03 -120.14 0.93 Allowed Glycine 0 CA--C 1.538 1.529 0 CA-C-O 118.911 -0.938 . . . . 43.3 112.106 176.854 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 243' ' ' PRO . . . . . 0.525 ' HD2' ' HB3' ' A' ' 191' ' ' GLN . 37.1 Cg_endo -59.83 -59.04 0.44 Allowed 'Trans proline' 0 C--N 1.379 2.133 0 C-N-CA 124.563 3.509 . . . . 73.21 112.892 -173.976 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -83.5 -9.28 59.07 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 123.381 0.672 . . . . 73.12 111.066 178.645 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 85.39 -22.82 9.47 Favored Glycine 0 C--N 1.356 1.649 0 C-N-CA 123.175 0.417 . . . . 53.41 113.134 -177.161 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 10.0 ttm180 -125.33 111.56 15.32 Favored 'General case' 0 C--O 1.241 0.649 0 C-N-CA 124.545 1.138 . . . . 72.33 109.21 -179.7 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -76.75 151.46 39.4 Favored Glycine 0 C--N 1.348 1.198 0 O-C-N 123.726 0.641 . . . . 65.1 114.006 178.006 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -103.98 140.95 37.02 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.062 0.945 . . . . 73.34 109.747 -177.727 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 249' ' ' LEU . . . . . 0.566 ' HB3' ' HB2' ' A' ' 235' ' ' LEU . 45.7 tp -109.04 111.9 23.79 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 108.93 -0.767 . . . . 72.01 108.93 176.439 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 250' ' ' TYR . . . . . 0.461 ' HA ' ' O ' ' A' ' 233' ' ' LEU . 4.8 m-85 -89.58 109.28 20.24 Favored 'General case' 0 C--O 1.242 0.703 0 CA-C-O 121.36 0.6 . . . . 71.43 110.163 -179.531 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 251' ' ' LEU . . . . . 0.645 HD13 HD22 ' A' ' 197' ' ' LEU . 80.1 mt -87.35 104.02 16.03 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-N 114.382 -1.281 . . . . 73.51 108.289 179.865 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 56.3 mt-10 -85.42 94.19 8.92 Favored 'General case' 0 C--O 1.241 0.621 0 N-CA-C 108.572 -0.899 . . . . 73.45 108.572 -178.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 11.4 m -63.36 138.5 22.85 Favored 'Isoleucine or valine' 0 C--N 1.352 0.699 0 O-C-N 123.858 0.724 . . . . 72.21 110.374 -176.403 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 15.4 mmm180 -126.14 108.78 11.66 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 107.272 -1.381 . . . . 74.24 107.272 179.225 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 255' ' ' ILE . . . . . 0.456 ' HA ' ' O ' ' A' ' 199' ' ' VAL . 29.0 mt -78.92 121.15 31.45 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 O-C-N 123.9 0.75 . . . . 62.31 110.116 179.29 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 2.5 t . . . . . 0 C--O 1.254 1.294 0 C-N-CA 123.922 0.889 . . . . 71.35 109.42 174.727 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 172' ' ' LEU . . . . . 0.71 HD21 ' H ' ' A' ' 222' ' ' ALA . 41.4 mt . . . . . 0 N--CA 1.481 1.114 0 CA-C-O 121.418 0.627 . . . . 70.23 111.277 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 173' ' ' PHE . . . . . 0.401 ' CD1' HD22 ' A' ' 235' ' ' LEU . 27.5 m-85 -130.94 -47.51 1.02 Allowed 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 114.623 -1.171 . . . . 65.42 109.095 -167.918 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 174' ' ' TYR . . . . . 0.435 ' HB2' ' HB2' ' A' ' 178' ' ' ALA . 8.2 p90 -84.23 8.07 17.04 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-N 114.36 -1.291 . . . . 75.12 113.324 -173.889 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 14.8 p -60.09 -23.29 63.69 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 123.158 0.583 . . . . 72.15 112.216 177.293 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 176' ' ' MET . . . . . . . . . . . . . 40.1 mtm -54.89 -49.92 70.02 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 124.216 1.006 . . . . 70.14 110.655 173.849 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -169.54 122.28 0.74 Allowed 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 124.834 1.254 . . . . 61.32 108.037 179.295 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 178' ' ' ALA . . . . . 0.634 ' HB1' HD22 ' A' ' 233' ' ' LEU . . . -146.71 -56.94 0.27 Allowed 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 123.209 0.604 . . . . 72.01 110.946 -175.288 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . 0.603 ' HB2' ' HB2' ' A' ' 224' ' ' PRO . . . -75.46 78.55 2.5 Favored 'General case' 0 C--N 1.353 0.754 0 CA-C-O 122.256 1.027 . . . . 74.14 108.832 172.715 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.487 0 CA-C-N 113.255 -1.793 . . . . 74.13 110.128 -173.759 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 191' ' ' GLN . . . . . 0.651 ' HB3' ' HD2' ' A' ' 243' ' ' PRO . 9.6 pt20 . . . . . 0 N--CA 1.473 0.719 0 CA-C-O 120.849 0.357 . . . . 62.11 110.64 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 17.7 m-20 -74.99 150.62 38.93 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-N 115.367 -0.833 . . . . 72.2 110.704 -174.812 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . 0.662 HD12 ' HA2' ' A' ' 239' ' ' GLY . 32.6 mt -140.79 170.82 15.04 Favored 'General case' 0 C--O 1.241 0.608 0 CA-C-N 114.592 -1.186 . . . . 61.52 109.176 -179.399 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 55.1 m-85 -138.41 122.07 17.47 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 123.491 0.717 . . . . 62.55 109.689 178.846 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . 0.463 ' HB2' HD11 ' A' ' 249' ' ' LEU . . . -126.3 135.98 52.18 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 107.834 -1.172 . . . . 64.01 107.834 174.993 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 9.1 m -83.55 130.63 35.01 Favored 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 109.742 -0.466 . . . . 72.2 109.742 -176.374 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . 0.502 HD22 HD13 ' A' ' 251' ' ' LEU . 15.5 tp -109.35 108.53 19.12 Favored 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 108.663 -0.866 . . . . 74.4 108.663 -179.479 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -81.21 113.23 19.21 Favored 'General case' 0 CA--C 1.542 0.648 0 N-CA-C 108.92 -0.77 . . . . 71.42 108.92 176.966 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 199' ' ' VAL . . . . . 0.413 ' O ' ' HA ' ' A' ' 255' ' ' ILE . 6.5 p -132.18 128.99 21.53 Favored Pre-proline 0 CA--C 1.55 0.976 0 C-N-CA 124.035 0.934 . . . . 71.14 109.34 -178.706 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -70.58 159.06 54.07 Favored 'Trans proline' 0 C--N 1.37 1.709 0 C-N-CA 122.035 1.823 . . . . 74.05 111.691 170.101 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -51.18 -49.7 79.9 Favored Pre-proline 0 CA--C 1.564 1.497 0 CA-C-O 117.775 -1.107 . . . . 30.14 113.619 -179.56 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 202' ' ' PRO . . . . . 0.458 ' O ' HG22 ' A' ' 206' ' ' VAL . 42.6 Cg_endo -64.24 -43.01 15.79 Favored 'Trans proline' 0 C--N 1.396 3.074 0 C-N-CA 121.861 1.708 . . . . 61.2 113.702 -179.035 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 51.8 mt -63.48 -34.17 65.81 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.386 0 CA-C-N 118.152 0.433 . . . . 73.11 110.351 176.628 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -66.2 -52.68 45.66 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 122.821 0.448 . . . . 62.22 111.622 179.245 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 20.2 m -69.45 -49.67 57.84 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.924 0 C-N-CA 123.618 0.767 . . . . 64.55 112.577 -173.444 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 206' ' ' VAL . . . . . 0.458 HG22 ' O ' ' A' ' 202' ' ' PRO . 6.7 m -76.99 -31.0 18.34 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.181 0 CA-C-O 120.714 0.292 . . . . 71.01 110.909 -179.736 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 85.63 70.26 1.33 Allowed Glycine 0 C--N 1.345 1.066 0 CA-C-N 115.943 -0.571 . . . . 73.21 112.022 -176.826 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -87.51 -126.4 2.29 Favored Glycine 0 C--N 1.352 1.466 0 N-CA-C 111.902 -0.479 . . . . 51.13 111.902 176.403 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 46.5 mtmt -139.45 151.65 46.39 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 123.695 0.798 . . . . 65.53 111.12 177.234 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 5.8 m -144.81 169.92 7.77 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 C-N-CA 125.335 1.454 . . . . 64.35 109.532 175.664 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 55.4 ttp180 -102.25 117.05 33.93 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 124.1 0.96 . . . . 72.35 110.048 -179.831 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -100.73 128.92 46.6 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 124.104 0.962 . . . . 71.41 110.207 177.439 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 90.8 mmm -92.55 115.57 28.22 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 123.369 0.667 . . . . 73.4 109.413 179.572 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 17.4 p -111.71 -179.39 3.69 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 124.288 1.035 . . . . 73.24 109.907 -176.687 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 89.0 mt -56.77 -29.69 62.88 Favored 'General case' 0 N--CA 1.491 1.583 0 CA-C-O 121.082 0.467 . . . . 73.14 111.216 171.883 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -101.29 23.2 11.29 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 124.476 1.11 . . . . 73.3 111.144 -178.252 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 83.42 -159.42 36.89 Favored Glycine 0 C--N 1.348 1.246 0 CA-C-O 119.508 -0.607 . . . . 54.13 113.303 176.314 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -71.29 157.03 58.0 Favored 'Trans proline' 0 C--N 1.367 1.524 0 C-N-CA 122.665 2.244 . . . . 74.24 113.21 -173.232 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 7.3 p -151.58 136.9 10.96 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 C-N-CA 124.142 0.977 . . . . 72.1 108.869 174.656 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -80.64 103.43 10.48 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 108.832 -0.803 . . . . 74.41 108.832 175.573 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 10.8 m -104.08 133.75 47.25 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 CA-C-O 121.451 0.644 . . . . 72.55 110.057 177.95 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 222' ' ' ALA . . . . . 0.71 ' H ' HD21 ' A' ' 172' ' ' LEU . . . -86.7 105.66 17.09 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 114.743 -1.117 . . . . 74.25 110.427 -178.731 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 90.6 t -54.49 134.14 62.87 Favored Pre-proline 0 N--CA 1.481 1.112 0 C-N-CA 125.355 1.462 . . . . 70.41 111.179 -176.763 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 224' ' ' PRO . . . . . 0.603 ' HB2' ' HB2' ' A' ' 179' ' ' ALA . 72.4 Cg_endo -70.33 159.84 51.61 Favored 'Trans proline' 0 C--N 1.376 2.022 0 C-N-CA 122.209 1.939 . . . . 64.14 111.924 175.912 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 22.8 Cg_endo -64.6 136.41 49.89 Favored 'Trans proline' 0 C--N 1.38 2.204 0 C-N-CA 121.981 1.788 . . . . 75.43 111.554 176.189 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 44.3 mtm-85 63.72 64.9 0.75 Allowed 'General case' 0 C--O 1.244 0.775 0 C-N-CA 124.7 1.2 . . . . 73.42 110.074 175.672 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 227' ' ' THR . . . . . 0.446 ' HA ' ' HE ' ' A' ' 231' ' ' ARG . 88.5 m -96.68 123.19 40.28 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 108.214 -1.032 . . . . 72.22 108.214 174.458 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -109.7 148.24 31.73 Favored 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 123.49 0.716 . . . . 74.25 109.085 -179.382 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -57.66 114.29 2.2 Favored 'General case' 0 C--N 1.352 0.674 0 O-C-N 124.278 0.986 . . . . 60.44 110.494 -178.685 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 113.76 5.94 21.68 Favored Glycine 0 CA--C 1.528 0.902 0 O-C-N 124.051 0.844 . . . . 70.02 113.402 -175.48 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 231' ' ' ARG . . . . . 0.446 ' HE ' ' HA ' ' A' ' 227' ' ' THR . 40.7 mtt-85 -71.89 149.57 45.02 Favored 'General case' 0 N--CA 1.481 1.095 0 CA-C-N 117.72 0.76 . . . . 72.54 109.074 165.891 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 232' ' ' LYS . . . . . 0.407 ' HA ' ' O ' ' A' ' 251' ' ' LEU . 43.5 mtmt -128.72 99.48 5.36 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 123.513 0.725 . . . . 73.35 109.344 178.404 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 233' ' ' LEU . . . . . 0.634 HD22 ' HB1' ' A' ' 178' ' ' ALA . 24.1 mt -81.65 132.75 35.31 Favored 'General case' 0 CA--C 1.552 1.044 0 C-N-CA 124.088 0.955 . . . . 74.41 110.266 -173.467 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 40.1 ttt180 -89.53 102.97 15.65 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 123.4 0.68 . . . . 63.42 112.35 -169.654 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 235' ' ' LEU . . . . . 0.604 ' HB2' ' HB3' ' A' ' 249' ' ' LEU . 18.0 mt -93.35 97.08 10.35 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 123.057 0.543 . . . . 73.12 110.483 174.679 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 40.8 mtmt -69.49 144.46 53.21 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-O 120.85 0.357 . . . . 74.12 111.192 177.002 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 73.68 1.03 57.48 Favored Glycine 0 N--CA 1.473 1.137 0 CA-C-N 115.237 -0.892 . . . . 72.32 114.949 -177.816 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 76.1 mmtt -106.04 3.87 28.68 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 117.418 0.609 . . . . 70.44 110.525 179.229 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 239' ' ' GLY . . . . . 0.662 ' HA2' HD12 ' A' ' 193' ' ' LEU . . . -101.93 -160.33 26.57 Favored Glycine 0 C--N 1.35 1.318 0 N-CA-C 111.063 -0.815 . . . . 73.44 111.063 164.025 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 71.4 m-85 -95.04 155.03 39.48 Favored Pre-proline 0 N--CA 1.485 1.314 0 C-N-CA 123.826 0.85 . . . . 71.32 110.981 -179.597 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_exo -71.09 130.62 17.98 Favored 'Trans proline' 0 C--N 1.371 1.735 0 C-N-CA 121.764 1.642 . . . . 71.32 111.197 170.933 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -163.54 -121.35 0.56 Allowed Glycine 0 CA--C 1.535 1.325 0 CA-C-O 118.776 -1.013 . . . . 50.42 113.401 -177.829 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 243' ' ' PRO . . . . . 0.651 ' HD2' ' HB3' ' A' ' 191' ' ' GLN . 37.3 Cg_endo -58.96 -42.85 47.99 Favored 'Trans proline' 0 C--N 1.385 2.462 0 C-N-CA 124.379 3.386 . . . . 75.52 112.935 -172.399 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -96.59 -4.88 40.37 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 123.551 0.74 . . . . 65.14 111.044 177.152 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 84.27 -23.39 7.22 Favored Glycine 0 C--N 1.361 1.939 0 C-N-CA 123.142 0.401 . . . . 75.45 113.423 -178.827 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 43.1 ttt85 -128.0 111.58 13.69 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.97 1.308 . . . . 75.34 108.901 -179.649 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -72.48 151.3 46.36 Favored Glycine 0 C--N 1.347 1.145 0 N-CA-C 115.064 0.785 . . . . 61.3 115.064 178.694 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 38.2 m-20 -111.64 127.78 55.86 Favored 'General case' 0 C--O 1.233 0.221 0 C-N-CA 124.295 1.038 . . . . 71.22 109.382 -176.487 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 249' ' ' LEU . . . . . 0.604 ' HB3' ' HB2' ' A' ' 235' ' ' LEU . 58.8 tp -103.76 109.83 21.69 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 108.323 -0.992 . . . . 73.52 108.323 178.526 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 250' ' ' TYR . . . . . . . . . . . . . 4.4 m-85 -88.21 118.65 27.95 Favored 'General case' 0 C--O 1.241 0.646 0 N-CA-C 109.271 -0.64 . . . . 73.43 109.271 -176.267 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 251' ' ' LEU . . . . . 0.502 HD13 HD22 ' A' ' 197' ' ' LEU . 74.3 mt -88.14 103.31 15.64 Favored 'General case' 0 C--N 1.343 0.302 0 N-CA-C 107.935 -1.135 . . . . 62.41 107.935 -177.061 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -83.07 93.11 7.53 Favored 'General case' 0 C--O 1.241 0.638 0 N-CA-C 107.329 -1.36 . . . . 63.13 107.329 -175.53 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 4.9 m -71.94 136.84 24.86 Favored 'Isoleucine or valine' 0 C--N 1.351 0.648 0 CA-C-N 114.959 -1.018 . . . . 73.33 110.819 -170.746 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 24.4 mmm180 -122.05 112.54 18.38 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 106.913 -1.514 . . . . 74.34 106.913 179.737 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 255' ' ' ILE . . . . . 0.413 ' HA ' ' O ' ' A' ' 199' ' ' VAL . 35.2 mt -80.4 115.98 23.8 Favored 'Isoleucine or valine' 0 C--O 1.236 0.382 0 N-CA-C 108.758 -0.83 . . . . 65.14 108.758 173.569 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 9.5 t . . . . . 0 C--O 1.26 1.655 0 N-CA-C 108.349 -0.982 . . . . 74.11 108.349 168.614 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 172' ' ' LEU . . . . . 0.539 HD21 ' H ' ' A' ' 222' ' ' ALA . 63.6 mt . . . . . 0 N--CA 1.484 1.273 0 CA-C-O 122.039 0.923 . . . . 74.42 112.068 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 173' ' ' PHE . . . . . 0.485 ' CD1' HD22 ' A' ' 235' ' ' LEU . 19.8 m-85 -136.71 -51.67 0.69 Allowed 'General case' 0 N--CA 1.477 0.919 0 CA-C-N 114.586 -1.188 . . . . 72.34 108.609 -171.343 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 174' ' ' TYR . . . . . 0.44 ' OH ' ' HB ' ' A' ' 221' ' ' VAL . 2.9 p90 -79.3 17.87 0.76 Allowed 'General case' 0 CA--C 1.552 1.04 0 CA-C-N 113.446 -1.706 . . . . 73.15 112.551 -179.213 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 175' ' ' THR . . . . . 0.45 HG23 HD13 ' A' ' 172' ' ' LEU . 0.2 OUTLIER -66.1 -18.57 65.43 Favored 'General case' 0 CA--C 1.552 1.032 0 C-N-CA 124.1 0.96 . . . . 71.41 111.888 -174.936 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 176' ' ' MET . . . . . 0.51 ' SD ' ' N ' ' A' ' 177' ' ' LYS . 0.0 OUTLIER -70.74 -45.36 64.98 Favored 'General case' 0 CA--C 1.554 1.126 0 C-N-CA 123.978 0.911 . . . . 75.21 111.45 173.509 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . 0.51 ' N ' ' SD ' ' A' ' 176' ' ' MET . 35.7 mttp -162.91 134.15 4.93 Favored 'General case' 0 N--CA 1.491 1.599 0 C-N-CA 125.702 1.601 . . . . 54.15 108.681 175.277 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 178' ' ' ALA . . . . . 0.495 ' HB1' HD22 ' A' ' 233' ' ' LEU . . . -147.99 -53.54 0.2 Allowed 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 123.934 0.893 . . . . 75.03 109.839 -172.859 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -85.48 36.9 0.66 Allowed 'General case' 0 CA--C 1.558 1.259 0 C-N-CA 123.876 0.87 . . . . 74.35 109.957 171.341 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.354 1.53 0 N-CA-C 110.638 -0.985 . . . . 72.44 110.638 176.766 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 191' ' ' GLN . . . . . 0.509 ' HB3' ' HD2' ' A' ' 243' ' ' PRO . 2.3 pt20 . . . . . 0 N--CA 1.479 1.008 0 CA-C-O 121.391 0.615 . . . . 71.45 111.092 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -86.32 144.67 27.26 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 124.35 1.06 . . . . 70.03 110.201 -163.501 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . 0.5 HD12 ' HA2' ' A' ' 239' ' ' GLY . 25.4 mt -138.69 163.63 31.62 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 124.27 1.028 . . . . 72.34 109.391 174.363 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 50.6 m-85 -139.36 122.82 17.24 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 123.779 0.832 . . . . 55.21 109.761 -177.543 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . 0.44 ' HB2' HD11 ' A' ' 249' ' ' LEU . . . -133.02 129.13 37.73 Favored 'General case' 0 N--CA 1.466 0.335 0 O-C-N 124.343 1.027 . . . . 31.33 108.6 175.654 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 33.6 m -76.79 130.82 38.2 Favored 'General case' 0 CA--C 1.541 0.617 0 N-CA-C 109.694 -0.484 . . . . 74.42 109.694 178.157 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . 0.598 HD22 HD13 ' A' ' 251' ' ' LEU . 15.1 tp -112.21 108.79 18.15 Favored 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 107.61 -1.256 . . . . 72.4 107.61 176.645 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -83.76 132.32 34.85 Favored 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 108.841 -0.8 . . . . 74.45 108.841 174.838 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 199' ' ' VAL . . . . . 0.45 ' O ' ' HA ' ' A' ' 255' ' ' ILE . 4.1 p -144.61 129.88 9.44 Favored Pre-proline 0 CA--C 1.549 0.934 0 C-N-CA 123.866 0.866 . . . . 74.41 108.671 -179.983 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -70.35 153.7 65.98 Favored 'Trans proline' 0 C--N 1.367 1.536 0 C-N-CA 122.21 1.94 . . . . 72.31 110.836 168.49 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 201' ' ' ALA . . . . . 0.465 ' O ' HG23 ' A' ' 205' ' ' VAL . . . -49.88 -51.4 61.28 Favored Pre-proline 0 CA--C 1.555 1.153 0 C-N-CA 124.754 1.222 . . . . 63.02 113.361 -177.729 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_endo -60.85 -35.85 86.58 Favored 'Trans proline' 0 C--N 1.397 3.118 0 C-N-CA 121.771 1.647 . . . . 73.11 113.896 -178.487 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 38.1 mt -70.02 -34.14 58.33 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 C-N-CA 122.587 0.355 . . . . 71.41 110.461 177.418 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -67.1 -38.36 85.52 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 122.342 0.257 . . . . 74.33 111.22 175.838 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 205' ' ' VAL . . . . . 0.465 HG23 ' O ' ' A' ' 201' ' ' ALA . 92.1 t -69.25 -56.49 11.62 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.125 0 C-N-CA 123.963 0.905 . . . . 55.12 111.083 -179.423 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 18.0 m -75.59 -24.07 16.93 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.133 0 CA-C-N 116.09 -0.504 . . . . 62.51 111.574 -174.883 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 76.15 66.21 1.89 Allowed Glycine 0 C--N 1.345 1.042 0 CA-C-N 115.251 -0.886 . . . . 63.24 111.83 -173.987 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -83.74 -140.46 4.29 Favored Glycine 0 C--N 1.352 1.443 0 N-CA-C 112.161 -0.376 . . . . 41.01 112.161 178.628 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 49.4 mtmt -137.43 137.5 38.83 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.606 0.763 . . . . 63.44 110.414 177.915 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 11.0 m -127.82 165.39 27.03 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 C-N-CA 125.119 1.368 . . . . 71.12 108.742 172.903 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 50.6 ttp180 -101.59 117.47 34.98 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 123.25 0.62 . . . . 71.24 110.323 -178.564 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -101.99 132.59 47.73 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 123.958 0.903 . . . . 73.24 110.239 175.721 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 25.3 mmt -90.91 121.32 32.65 Favored 'General case' 0 N--CA 1.48 1.075 0 N-CA-C 109.343 -0.614 . . . . 74.31 109.343 175.306 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 30.5 p -121.97 -173.54 2.68 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 124.484 1.114 . . . . 62.2 110.371 -174.779 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 83.2 mt -61.65 -30.95 71.05 Favored 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 123.216 0.606 . . . . 70.2 111.097 171.588 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -98.76 21.28 11.65 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 123.498 0.719 . . . . 74.13 111.282 179.791 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 84.49 -159.15 34.76 Favored Glycine 0 C--N 1.356 1.658 0 CA-C-O 119.411 -0.66 . . . . 61.41 113.012 175.359 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -64.76 142.25 75.63 Favored 'Trans proline' 0 C--N 1.369 1.633 0 C-N-CA 122.817 2.345 . . . . 73.2 112.58 178.687 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 4.8 p -140.81 128.53 23.01 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 N-CA-C 108.333 -0.988 . . . . 43.21 108.333 174.323 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 3.8 mp0 -79.28 101.6 8.12 Favored 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 107.28 -1.378 . . . . 72.33 107.28 175.949 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 221' ' ' VAL . . . . . 0.44 ' HB ' ' OH ' ' A' ' 174' ' ' TYR . 2.8 m -99.39 128.25 51.32 Favored 'Isoleucine or valine' 0 C--O 1.24 0.586 0 CA-C-O 121.602 0.715 . . . . 71.21 109.544 -179.675 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 222' ' ' ALA . . . . . 0.539 ' H ' HD21 ' A' ' 172' ' ' LEU . . . -80.26 104.81 11.07 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 114.407 -1.27 . . . . 52.42 109.26 179.63 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 61.3 t -53.99 134.9 57.93 Favored Pre-proline 0 CA--C 1.558 1.283 0 O-C-N 124.567 1.167 . . . . 54.24 109.707 178.549 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -63.87 149.85 89.73 Favored 'Trans proline' 0 C--N 1.371 1.722 0 C-N-CA 122.068 1.845 . . . . 55.32 111.452 173.474 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -63.23 134.12 43.99 Favored 'Trans proline' 0 C--N 1.373 1.854 0 C-N-CA 121.907 1.738 . . . . 71.01 110.983 174.952 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 33.6 mtm-85 63.82 53.39 1.96 Allowed 'General case' 0 CA--C 1.546 0.817 0 O-C-N 124.68 1.237 . . . . 74.13 111.043 175.858 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 227' ' ' THR . . . . . 0.424 HG23 ' HD2' ' A' ' 231' ' ' ARG . 30.6 m -78.24 145.17 35.62 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 115.444 -0.798 . . . . 72.41 108.945 170.391 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 27.0 mp0 -116.22 145.54 43.04 Favored 'General case' 0 N--CA 1.48 1.061 0 N-CA-C 108.563 -0.902 . . . . 70.51 108.563 176.916 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 229' ' ' ALA . . . . . 0.523 ' HB2' ' HB ' ' A' ' 255' ' ' ILE . . . -60.2 130.72 48.06 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.543 0.737 . . . . 72.2 109.762 -179.48 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 97.85 12.08 48.0 Favored Glycine 0 CA--C 1.522 0.504 0 O-C-N 123.857 0.723 . . . . 74.31 112.852 -178.248 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 231' ' ' ARG . . . . . 0.424 ' HD2' HG23 ' A' ' 227' ' ' THR . 95.1 mtt-85 -84.24 156.14 22.14 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 109.256 -0.646 . . . . 74.4 109.256 165.049 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 232' ' ' LYS . . . . . 0.421 ' HA ' ' O ' ' A' ' 251' ' ' LEU . 42.3 mtmt -130.38 106.84 8.82 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.583 0.753 . . . . 73.44 109.312 -179.735 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 233' ' ' LEU . . . . . 0.526 ' HB2' ' HB2' ' A' ' 251' ' ' LEU . 26.3 mt -80.27 134.04 36.04 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 115.218 -0.901 . . . . 74.45 109.526 -176.677 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 75.3 ttt180 -97.33 109.95 22.6 Favored 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 122.808 0.443 . . . . 73.43 110.93 -170.732 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 235' ' ' LEU . . . . . 0.543 HD12 HD23 ' A' ' 249' ' ' LEU . 15.0 mt -99.77 105.87 17.7 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.265 0.626 . . . . 72.24 111.099 179.522 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 1.9 mtpp -72.09 153.79 41.49 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-O 120.719 0.295 . . . . 70.52 110.563 171.707 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 65.63 13.83 59.4 Favored Glycine 0 N--CA 1.473 1.141 0 O-C-N 124.486 1.116 . . . . 75.43 114.359 -177.198 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 41.1 mmtm -125.53 4.58 7.59 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 123.782 0.833 . . . . 72.23 111.823 -177.968 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 239' ' ' GLY . . . . . 0.5 ' HA2' HD12 ' A' ' 193' ' ' LEU . . . -107.66 -167.64 21.75 Favored Glycine 0 C--N 1.345 1.028 0 N-CA-C 110.879 -0.888 . . . . 70.03 110.879 165.644 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 66.7 m-85 -92.44 166.55 16.78 Favored Pre-proline 0 CA--C 1.548 0.892 0 C-N-CA 123.794 0.837 . . . . 73.44 110.777 178.807 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 241' ' ' PRO . . . . . 0.414 ' HA ' ' O ' ' A' ' 245' ' ' GLY . 55.2 Cg_endo -70.88 146.47 53.33 Favored 'Trans proline' 0 C--N 1.374 1.887 0 C-N-CA 121.756 1.637 . . . . 65.42 111.577 168.068 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -169.74 -117.3 0.41 Allowed Glycine 0 CA--C 1.532 1.103 0 CA-C-O 119.039 -0.867 . . . . 52.11 111.587 178.923 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 243' ' ' PRO . . . . . 0.509 ' HD2' ' HB3' ' A' ' 191' ' ' GLN . 65.6 Cg_endo -66.15 -57.36 0.23 Allowed 'Trans proline' 0 C--N 1.375 1.96 0 C-N-CA 124.246 3.298 . . . . 70.45 112.617 -169.574 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -96.39 18.88 12.99 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.899 0.88 . . . . 74.03 110.463 176.415 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 245' ' ' GLY . . . . . 0.414 ' O ' ' HA ' ' A' ' 241' ' ' PRO . . . 74.66 -103.33 1.52 Allowed Glycine 0 C--N 1.354 1.558 0 N-CA-C 110.322 -1.111 . . . . 71.31 110.322 -170.835 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 31.0 ttm180 -50.42 110.63 0.43 Allowed 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 125.203 1.401 . . . . 74.04 112.559 -176.408 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -89.04 179.46 45.39 Favored Glycine 0 C--N 1.344 0.991 0 CA-C-N 115.898 -0.592 . . . . 65.42 113.478 178.322 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 20.9 m-20 -126.83 152.53 46.86 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 114.598 -0.801 . . . . 71.54 112.504 -168.795 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 249' ' ' LEU . . . . . 0.543 HD23 HD12 ' A' ' 235' ' ' LEU . 55.7 tp -110.17 117.08 32.75 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 114.354 -1.293 . . . . 75.43 108.095 171.117 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 250' ' ' TYR . . . . . . . . . . . . . 3.7 m-85 -90.24 115.16 27.25 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 123.188 0.595 . . . . 53.32 109.404 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 251' ' ' LEU . . . . . 0.598 HD13 HD22 ' A' ' 197' ' ' LEU . 77.2 mt -88.5 105.35 17.56 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-N 114.685 -1.143 . . . . 74.11 108.486 -177.973 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 252' ' ' GLU . . . . . 0.451 ' HG3' ' HD3' ' A' ' 254' ' ' ARG . 12.0 tp10 -79.56 94.06 5.57 Favored 'General case' 0 C--O 1.238 0.486 0 N-CA-C 108.55 -0.907 . . . . 63.32 108.55 -178.746 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 4.4 m -71.67 127.48 33.67 Favored 'Isoleucine or valine' 0 C--N 1.352 0.694 0 CA-C-O 121.619 0.723 . . . . 71.21 109.664 -174.839 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 254' ' ' ARG . . . . . 0.451 ' HD3' ' HG3' ' A' ' 252' ' ' GLU . 22.9 mmm180 -122.87 95.1 4.49 Favored 'General case' 0 C--O 1.239 0.517 0 N-CA-C 107.971 -1.122 . . . . 65.32 107.971 -176.7 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 255' ' ' ILE . . . . . 0.523 ' HB ' ' HB2' ' A' ' 229' ' ' ALA . 40.3 mt -76.6 121.08 28.03 Favored 'Isoleucine or valine' 0 C--O 1.238 0.465 0 CA-C-N 115.589 -0.732 . . . . 72.02 109.669 178.054 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 9.4 t . . . . . 0 C--O 1.254 1.303 0 C-N-CA 123.97 0.908 . . . . 72.33 108.657 175.885 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 172' ' ' LEU . . . . . 0.55 HD21 ' H ' ' A' ' 222' ' ' ALA . 26.0 mt . . . . . 0 N--CA 1.478 0.963 0 CA-C-O 121.147 0.498 . . . . 62.45 112.012 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 173' ' ' PHE . . . . . 0.534 ' CD1' HD22 ' A' ' 235' ' ' LEU . 20.2 m-85 -141.1 -71.03 0.36 Allowed 'General case' 0 N--CA 1.481 1.099 0 CA-C-O 121.182 0.515 . . . . 75.32 111.297 -163.799 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 174' ' ' TYR . . . . . 0.468 ' CD2' ' HB3' ' A' ' 233' ' ' LEU . 2.1 p90 -83.25 7.2 17.05 Favored 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 124.589 1.156 . . . . 74.22 112.038 -171.364 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 175' ' ' THR . . . . . 0.503 ' OG1' ' HB3' ' A' ' 172' ' ' LEU . 1.5 m -60.23 -36.82 78.59 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 124.365 1.066 . . . . 74.23 113.149 -160.71 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 176' ' ' MET . . . . . . . . . . . . . 3.0 mpp? -68.08 -27.25 66.33 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 123.676 0.79 . . . . 72.14 111.192 -179.774 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 20.8 tptm -122.56 25.92 8.56 Favored 'General case' 0 CA--C 1.556 1.205 0 C-N-CA 124.367 1.067 . . . . 74.44 109.872 -177.459 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 178' ' ' ALA . . . . . 0.616 ' HB1' ' HB3' ' A' ' 224' ' ' PRO . . . -69.46 132.42 46.29 Favored 'General case' 0 N--CA 1.476 0.867 0 CA-C-N 115.865 -0.607 . . . . 74.11 110.053 -179.761 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . 0.533 ' HB2' ' HB2' ' A' ' 224' ' ' PRO . . . 60.89 30.34 19.58 Favored 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 124.315 1.046 . . . . 63.42 110.779 -170.858 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.345 1.063 0 CA-C-N 115.198 -0.91 . . . . 60.41 112.496 178.711 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 191' ' ' GLN . . . . . 0.419 HE22 ' HB3' ' A' ' 244' ' ' ALA . 2.9 pt20 . . . . . 0 N--CA 1.479 1.016 0 CA-C-O 120.594 0.235 . . . . 64.31 111.278 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 -75.58 134.98 40.56 Favored 'General case' 0 N--CA 1.47 0.525 0 C-N-CA 123.834 0.854 . . . . 64.33 109.887 -178.294 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 24.2 mt -117.6 162.69 17.6 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 123.568 0.747 . . . . 72.41 110.215 175.46 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 77.0 m-85 -133.17 135.0 44.85 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 123.77 0.828 . . . . 73.41 110.382 -177.751 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . 0.438 ' HB2' HD11 ' A' ' 249' ' ' LEU . . . -147.8 171.16 16.15 Favored 'General case' 0 C--O 1.239 0.53 0 C-N-CA 125.417 1.487 . . . . 73.25 108.494 -179.607 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 34.1 m -129.63 124.42 33.64 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 123.826 0.851 . . . . 71.12 108.717 -178.604 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . 0.763 HD22 HD13 ' A' ' 251' ' ' LEU . 15.7 tp -106.66 110.2 22.32 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 108.681 -0.859 . . . . 74.51 108.681 -173.044 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -82.51 122.77 28.49 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 123.091 0.556 . . . . 73.34 109.774 177.703 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 199' ' ' VAL . . . . . 0.443 ' O ' ' HA ' ' A' ' 255' ' ' ILE . 4.3 p -140.71 128.34 12.32 Favored Pre-proline 0 CA--C 1.545 0.764 0 N-CA-C 108.228 -1.027 . . . . 53.25 108.228 -177.927 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -69.39 156.2 65.0 Favored 'Trans proline' 0 C--N 1.366 1.49 0 C-N-CA 121.917 1.745 . . . . 52.53 111.034 171.15 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 201' ' ' ALA . . . . . 0.507 ' O ' HG23 ' A' ' 205' ' ' VAL . . . -48.52 -54.2 28.6 Favored Pre-proline 0 CA--C 1.559 1.321 0 CA-C-O 117.754 -1.117 . . . . 75.41 113.122 -177.761 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -60.69 -37.6 77.9 Favored 'Trans proline' 0 C--N 1.391 2.803 0 C-N-CA 121.94 1.76 . . . . 53.23 113.466 -176.376 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 39.7 mt -68.37 -33.94 63.12 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.389 0 C-N-CA 122.51 0.324 . . . . 73.4 110.404 178.056 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -71.66 -33.54 68.96 Favored 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 122.863 0.465 . . . . 63.32 111.47 176.893 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 205' ' ' VAL . . . . . 0.507 HG23 ' O ' ' A' ' 201' ' ' ALA . 73.5 t -71.8 -52.43 25.51 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 C-N-CA 123.909 0.884 . . . . 74.2 110.951 -179.776 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 16.2 m -82.89 -27.21 8.1 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.096 0 CA-C-N 116.304 -0.407 . . . . 63.43 111.465 -173.493 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 83.74 62.09 1.8 Allowed Glycine 0 C--N 1.343 0.969 0 CA-C-N 116.121 -0.491 . . . . 61.3 112.224 -174.589 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -83.19 -134.38 2.29 Favored Glycine 0 C--N 1.35 1.346 0 CA-C-O 119.9 -0.389 . . . . 60.52 112.462 177.947 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 46.5 mtmt -138.59 153.11 48.65 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 123.917 0.887 . . . . 72.02 110.916 178.037 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 9.7 m -145.37 170.0 6.72 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.092 0 C-N-CA 125.732 1.613 . . . . 73.33 109.096 175.184 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 29.8 ttp180 -97.8 110.57 23.11 Favored 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 123.72 0.808 . . . . 64.45 110.306 -177.938 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -102.33 112.22 24.83 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 123.485 0.714 . . . . 63.43 109.311 174.121 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 65.5 mtp -86.75 123.47 31.95 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 122.744 0.418 . . . . 61.21 110.071 -178.746 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 31.4 p -127.72 -171.14 2.37 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 124.38 1.072 . . . . 75.15 110.954 -168.4 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 76.9 mt -63.71 -27.91 69.53 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 123.217 0.607 . . . . 74.45 111.236 172.107 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -100.93 21.95 12.92 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.716 0.806 . . . . 75.21 110.615 178.328 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 85.38 -168.56 42.43 Favored Glycine 0 C--N 1.348 1.232 0 CA-C-N 116.008 -0.542 . . . . 52.43 113.702 173.94 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -74.19 121.04 6.59 Favored 'Trans proline' 0 C--N 1.366 1.494 0 C-N-CA 122.975 2.45 . . . . 44.2 112.047 -179.625 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 6.7 p -114.4 134.76 56.32 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 C-N-CA 123.799 0.84 . . . . 60.34 109.39 175.488 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -75.56 102.31 5.23 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 107.741 -1.207 . . . . 74.22 107.741 172.382 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 3.8 p -103.91 130.08 55.05 Favored 'Isoleucine or valine' 0 C--O 1.243 0.72 0 N-CA-C 109.149 -0.686 . . . . 73.04 109.149 -175.058 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 222' ' ' ALA . . . . . 0.55 ' H ' HD21 ' A' ' 172' ' ' LEU . . . -76.03 106.64 7.74 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 123.261 0.624 . . . . 24.35 110.676 -177.427 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 53.5 t -54.71 137.87 62.81 Favored Pre-proline 0 N--CA 1.477 0.888 0 O-C-N 124.522 1.139 . . . . 71.24 109.994 179.626 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 224' ' ' PRO . . . . . 0.616 ' HB3' ' HB1' ' A' ' 178' ' ' ALA . 12.3 Cg_endo -57.77 152.96 46.2 Favored 'Trans proline' 0 C--N 1.369 1.617 0 C-N-CA 122.355 2.037 . . . . 72.13 112.714 171.343 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -76.18 149.54 32.17 Favored 'Trans proline' 0 C--N 1.367 1.527 0 C-N-CA 121.999 1.799 . . . . 52.23 110.741 171.443 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 35.9 mtm105 60.09 36.23 21.26 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 124.305 1.042 . . . . 73.23 111.143 168.563 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 227' ' ' THR . . . . . 0.457 HG23 ' HD2' ' A' ' 231' ' ' ARG . 21.5 m -76.53 150.03 36.62 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 124.587 1.155 . . . . 62.21 110.576 -178.259 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 27.0 mp0 -120.96 143.01 49.23 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 123.606 0.762 . . . . 72.22 109.151 175.066 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 229' ' ' ALA . . . . . 0.44 ' HB2' ' HB ' ' A' ' 255' ' ' ILE . . . -60.02 125.52 23.99 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 123.859 0.864 . . . . 63.4 111.002 -178.528 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 109.25 -2.02 31.19 Favored Glycine 0 CA--C 1.528 0.844 0 O-C-N 123.774 0.671 . . . . 42.53 113.287 -177.776 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 231' ' ' ARG . . . . . 0.457 ' HD2' HG23 ' A' ' 227' ' ' THR . 89.7 mtt-85 -72.35 157.59 37.38 Favored 'General case' 0 N--CA 1.479 0.985 0 CA-C-N 117.701 0.751 . . . . 74.51 109.854 170.484 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 45.7 mtmt -128.97 122.78 30.86 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 123.189 0.596 . . . . 71.31 110.068 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 233' ' ' LEU . . . . . 0.468 ' HB3' ' CD2' ' A' ' 174' ' ' TYR . 19.5 mt -101.77 153.34 19.89 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 124.949 1.3 . . . . 71.01 108.634 -178.043 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 19.5 ttt180 -120.78 103.17 8.89 Favored 'General case' 0 CA--C 1.546 0.801 0 O-C-N 122.188 -0.32 . . . . 74.42 111.486 -171.85 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 235' ' ' LEU . . . . . 0.569 ' HB2' ' HB3' ' A' ' 249' ' ' LEU . 15.6 mt -82.39 102.58 11.36 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 123.585 0.754 . . . . 72.32 110.582 176.966 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 236' ' ' LYS . . . . . 0.426 ' H ' ' HB3' ' A' ' 173' ' ' PHE . 43.8 mtmt -71.97 144.44 48.87 Favored 'General case' 0 C--O 1.242 0.68 0 CA-C-O 121.529 0.681 . . . . 72.25 112.421 179.967 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 72.14 3.36 56.45 Favored Glycine 0 CA--C 1.531 1.089 0 CA-C-N 114.183 -1.371 . . . . 61.12 114.283 -176.108 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 47.2 mmtm -107.96 13.85 25.8 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 123.538 0.735 . . . . 74.55 111.63 -176.311 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -116.36 -171.0 15.89 Favored Glycine 0 CA--C 1.528 0.877 0 N-CA-C 110.274 -1.13 . . . . 73.42 110.274 166.51 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 68.9 m-85 -87.73 159.13 49.9 Favored Pre-proline 0 N--CA 1.481 1.079 0 C-N-CA 123.264 0.626 . . . . 61.41 112.149 -173.778 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -71.72 164.21 36.43 Favored 'Trans proline' 0 C--N 1.373 1.858 0 C-N-CA 122.04 1.827 . . . . 64.22 112.732 171.595 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 158.35 -109.09 0.39 Allowed Glycine 0 CA--C 1.532 1.123 0 CA-C-O 118.784 -1.009 . . . . 63.01 112.722 174.244 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -65.16 -49.58 2.61 Favored 'Trans proline' 0 C--N 1.381 2.249 0 C-N-CA 123.454 2.769 . . . . 75.15 112.722 -170.385 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 244' ' ' ALA . . . . . 0.419 ' HB3' HE22 ' A' ' 191' ' ' GLN . . . -90.61 -8.53 49.85 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 123.976 0.91 . . . . 72.22 111.151 178.349 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 83.68 -42.58 3.06 Favored Glycine 0 C--N 1.359 1.828 0 N-CA-C 111.922 -0.471 . . . . 72.35 111.922 -170.864 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 17.3 ttm180 -103.17 114.82 29.42 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 125.077 1.351 . . . . 73.53 110.639 173.17 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -91.1 158.99 26.13 Favored Glycine 0 C--N 1.341 0.843 0 N-CA-C 110.841 -0.904 . . . . 75.45 110.841 163.664 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 26.9 m-20 -134.52 152.55 51.86 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 122.606 0.363 . . . . 74.54 110.065 -171.531 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 249' ' ' LEU . . . . . 0.569 ' HB3' ' HB2' ' A' ' 235' ' ' LEU . 57.2 tp -99.05 139.97 33.91 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 124.543 1.137 . . . . 73.53 109.844 -176.506 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 250' ' ' TYR . . . . . . . . . . . . . 4.3 m-85 -103.66 123.0 46.19 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 123.856 0.862 . . . . 71.11 110.064 177.837 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 251' ' ' LEU . . . . . 0.763 HD13 HD22 ' A' ' 197' ' ' LEU . 92.1 mt -103.7 103.91 13.88 Favored 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 108.211 -1.033 . . . . 74.41 108.211 179.464 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -81.33 100.99 9.5 Favored 'General case' 0 CA--C 1.543 0.691 0 N-CA-C 108.187 -1.042 . . . . 74.12 108.187 175.371 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 10.2 m -65.68 137.34 25.12 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.788 0 CA-C-O 121.359 0.599 . . . . 73.34 110.801 -175.031 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 24.1 mmt85 -128.79 97.65 4.73 Favored 'General case' 0 C--O 1.238 0.468 0 C-N-CA 124.576 1.151 . . . . 75.12 108.246 179.844 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 255' ' ' ILE . . . . . 0.454 HG23 ' HA ' ' A' ' 201' ' ' ALA . 34.5 mt -77.42 120.79 28.62 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 CA-C-N 115.422 -0.808 . . . . 52.12 109.679 179.376 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 7.1 t . . . . . 0 CA--C 1.562 1.412 0 C-N-CA 123.675 0.79 . . . . 62.33 109.497 -179.43 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 172' ' ' LEU . . . . . 0.531 HD21 ' HB3' ' A' ' 222' ' ' ALA . 62.9 mt . . . . . 0 N--CA 1.478 0.97 0 CA-C-O 120.948 0.404 . . . . 70.44 110.802 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 173' ' ' PHE . . . . . 0.538 ' CD1' HD22 ' A' ' 235' ' ' LEU . 5.4 m-85 -138.24 -56.24 0.65 Allowed 'General case' 0 N--CA 1.482 1.131 0 CA-C-O 122.023 0.916 . . . . 74.41 108.974 -165.846 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 174' ' ' TYR . . . . . 0.464 ' CD2' ' HB3' ' A' ' 233' ' ' LEU . 1.4 p90 -74.82 4.2 6.8 Favored 'General case' 0 CA--C 1.547 0.865 0 CA-C-N 113.448 -1.705 . . . . 74.33 113.316 -178.79 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 6.2 p -67.29 82.52 0.14 Allowed 'General case' 0 CA--C 1.547 0.853 0 CA-C-O 122.334 1.064 . . . . 62.31 110.705 174.751 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 176' ' ' MET . . . . . 0.456 ' HG3' ' HG2' ' A' ' 177' ' ' LYS . 23.1 ptt? -161.91 -39.61 0.04 OUTLIER 'General case' 0 CA--C 1.541 0.608 0 CA-C-N 113.639 -1.619 . . . . 64.44 108.202 -174.809 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . 0.456 ' HG2' ' HG3' ' A' ' 176' ' ' MET . 18.3 pttp -177.27 34.64 0.0 OUTLIER 'General case' 0 CA--C 1.556 1.179 0 C-N-CA 124.637 1.175 . . . . 71.23 110.052 -178.906 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 178' ' ' ALA . . . . . 0.471 ' HB1' ' HG3' ' A' ' 224' ' ' PRO . . . -59.21 150.44 25.59 Favored 'General case' 0 N--CA 1.487 1.379 0 C-N-CA 124.036 0.935 . . . . 74.01 111.705 178.315 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . 0.411 ' HB1' ' NH1' ' A' ' 231' ' ' ARG . . . 61.75 25.55 15.4 Favored 'General case' 0 N--CA 1.489 1.517 0 C-N-CA 124.169 0.988 . . . . 53.51 110.758 -167.886 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.34 0.771 0 CA-C-N 115.43 -0.804 . . . . 73.11 111.128 -176.897 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 191' ' ' GLN . . . . . 0.528 ' HB3' ' HD2' ' A' ' 243' ' ' PRO . 7.5 pt20 . . . . . 0 N--CA 1.476 0.829 0 CA-C-O 120.952 0.406 . . . . 63.2 111.445 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 -75.31 141.61 43.37 Favored 'General case' 0 C--O 1.242 0.691 0 C-N-CA 124.666 1.186 . . . . 73.32 109.827 -176.475 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . 0.413 HD12 ' HA2' ' A' ' 239' ' ' GLY . 23.3 mt -126.62 176.41 7.23 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 123.922 0.889 . . . . 74.12 110.802 -178.009 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 15.6 m-85 -138.23 122.93 18.69 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 124.33 1.052 . . . . 73.32 110.307 179.945 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -139.64 127.5 22.07 Favored 'General case' 0 C--O 1.239 0.509 0 N-CA-C 107.605 -1.257 . . . . 63.13 107.605 170.966 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 58.6 m -73.66 131.31 41.51 Favored 'General case' 0 C--O 1.241 0.657 0 CA-C-N 115.981 -0.554 . . . . 73.25 109.695 179.475 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . 0.647 HD22 HD13 ' A' ' 251' ' ' LEU . 15.8 tp -106.72 108.88 20.61 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 107.884 -1.154 . . . . 72.04 107.884 -179.588 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -78.4 121.09 24.05 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 108.468 -0.938 . . . . 62.13 108.468 177.114 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 199' ' ' VAL . . . . . 0.461 ' O ' ' HA ' ' A' ' 255' ' ' ILE . 4.1 p -140.98 128.53 12.1 Favored Pre-proline 0 CA--C 1.544 0.736 0 C-N-CA 123.733 0.813 . . . . 74.1 108.968 -177.956 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -70.53 156.78 60.62 Favored 'Trans proline' 0 C--N 1.365 1.402 0 C-N-CA 121.914 1.743 . . . . 60.3 111.006 170.919 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 201' ' ' ALA . . . . . 0.488 ' O ' HG23 ' A' ' 205' ' ' VAL . . . -50.97 -51.84 63.62 Favored Pre-proline 0 CA--C 1.56 1.349 0 CA-C-O 117.719 -1.134 . . . . 65.23 112.688 -179.257 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -61.58 -38.99 58.04 Favored 'Trans proline' 0 C--N 1.394 2.935 0 C-N-CA 121.672 1.581 . . . . 54.42 113.48 -177.535 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 34.4 mt -65.52 -34.01 67.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 CA-C-N 118.082 0.401 . . . . 62.42 110.398 176.382 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -71.34 -35.12 71.08 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 122.372 0.269 . . . . 72.32 111.371 177.428 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 205' ' ' VAL . . . . . 0.488 HG23 ' O ' ' A' ' 201' ' ' ALA . 96.6 t -71.74 -55.78 12.43 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.153 0 C-N-CA 123.588 0.755 . . . . 63.41 110.984 -179.544 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 18.9 m -79.74 -25.53 12.21 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 C-N-CA 122.863 0.465 . . . . 55.41 111.433 -174.607 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 80.1 72.18 1.22 Allowed Glycine 0 C--N 1.342 0.905 0 N-CA-C 111.647 -0.581 . . . . 53.32 111.647 -173.116 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -93.48 -134.21 6.98 Favored Glycine 0 C--N 1.349 1.298 0 N-CA-C 111.361 -0.695 . . . . 52.35 111.361 178.033 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 46.2 mtmt -138.1 152.78 49.08 Favored 'General case' 0 N--CA 1.486 1.37 0 CA-C-N 117.725 0.763 . . . . 74.22 111.662 179.35 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 15.6 m -147.72 158.67 8.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 C-N-CA 124.881 1.272 . . . . 64.22 109.268 178.403 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 43.5 ttm180 -98.3 114.01 26.16 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 123.089 0.556 . . . . 75.11 111.092 -175.627 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -100.3 124.93 46.37 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 124.509 1.123 . . . . 55.34 110.74 178.559 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 22.2 mmt -85.37 110.74 19.33 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 123.466 0.707 . . . . 61.5 109.49 176.841 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 22.2 p -110.94 -178.63 3.52 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 123.973 0.909 . . . . 64.24 109.73 -176.803 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 82.6 mt -57.67 -36.73 72.3 Favored 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 123.375 0.67 . . . . 40.22 112.709 -179.151 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -96.02 -19.33 19.55 Favored 'General case' 0 N--CA 1.482 1.154 0 N-CA-C 112.63 0.604 . . . . 65.31 112.63 -172.468 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 152.6 -168.33 31.6 Favored Glycine 0 C--N 1.352 1.423 0 CA-C-O 119.956 -0.358 . . . . 53.35 113.009 -178.825 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -85.39 132.24 4.3 Favored 'Trans proline' 0 C--N 1.367 1.543 0 C-N-CA 123.058 2.505 . . . . 75.1 112.566 179.086 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 4.1 p -126.44 126.09 68.51 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 N-CA-C 108.563 -0.903 . . . . 72.34 108.563 171.07 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -84.15 102.58 12.68 Favored 'General case' 0 C--O 1.238 0.455 0 N-CA-C 108.212 -1.033 . . . . 74.1 108.212 173.486 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 4.1 p -97.39 139.52 19.63 Favored 'Isoleucine or valine' 0 C--O 1.25 1.093 0 CA-C-N 114.732 -1.122 . . . . 61.03 109.218 -170.723 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 222' ' ' ALA . . . . . 0.531 ' HB3' HD21 ' A' ' 172' ' ' LEU . . . -78.42 101.27 7.19 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 122.794 0.437 . . . . 75.45 110.684 -177.493 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 47.5 t -53.9 133.08 57.77 Favored Pre-proline 0 N--CA 1.48 1.029 0 C-N-CA 124.28 1.032 . . . . 61.14 109.746 -179.338 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 224' ' ' PRO . . . . . 0.471 ' HG3' ' HB1' ' A' ' 178' ' ' ALA . 35.2 Cg_endo -63.25 147.08 94.15 Favored 'Trans proline' 0 C--N 1.371 1.725 0 C-N-CA 121.574 1.516 . . . . 52.04 110.46 172.029 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -67.33 156.95 64.04 Favored 'Trans proline' 0 C--N 1.361 1.201 0 C-N-CA 121.747 1.631 . . . . 70.42 111.541 177.005 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 40.7 mtt180 64.39 25.61 13.43 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 124.373 1.069 . . . . 72.22 111.634 168.424 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 227' ' ' THR . . . . . 0.59 ' HA ' HH11 ' A' ' 231' ' ' ARG . 94.1 m -75.81 133.99 40.5 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 123.835 0.854 . . . . 72.44 110.628 -179.896 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -99.83 148.71 24.14 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 123.872 0.869 . . . . 75.51 109.746 176.904 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 229' ' ' ALA . . . . . 0.538 ' HB2' ' HB ' ' A' ' 255' ' ' ILE . . . -59.63 128.08 35.23 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 123.989 0.915 . . . . 74.13 111.175 178.028 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 106.1 -5.84 39.43 Favored Glycine 0 N--CA 1.47 0.914 0 O-C-N 123.737 0.648 . . . . 41.25 113.135 -179.8 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 231' ' ' ARG . . . . . 0.59 HH11 ' HA ' ' A' ' 227' ' ' THR . 89.5 mtt180 -72.57 153.99 41.01 Favored 'General case' 0 N--CA 1.479 1.005 0 CA-C-N 117.325 0.563 . . . . 75.2 110.224 173.686 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 232' ' ' LYS . . . . . 0.413 ' HA ' ' O ' ' A' ' 251' ' ' LEU . 53.8 mtmt -130.3 127.32 39.25 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-N 115.99 -0.55 . . . . 64.04 110.044 -178.538 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 233' ' ' LEU . . . . . 0.488 ' HB2' ' HB2' ' A' ' 251' ' ' LEU . 24.1 mt -104.48 150.24 24.75 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 124.852 1.261 . . . . 74.15 108.614 -175.837 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 234' ' ' ARG . . . . . 0.426 ' HG3' ' HB3' ' A' ' 248' ' ' ASP . 56.7 ttm-85 -112.1 120.87 43.3 Favored 'General case' 0 N--CA 1.484 1.254 0 CA-C-N 118.361 0.528 . . . . 70.23 111.404 -170.483 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 235' ' ' LEU . . . . . 0.538 HD22 ' CD1' ' A' ' 173' ' ' PHE . 14.2 mt -110.95 111.73 23.06 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 123.787 0.835 . . . . 64.32 111.621 -176.754 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 31.3 mttp -68.72 141.65 55.22 Favored 'General case' 0 N--CA 1.476 0.875 0 CA-C-O 120.852 0.358 . . . . 64.22 110.914 172.707 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 79.7 -0.58 81.41 Favored Glycine 0 C--N 1.347 1.188 0 CA-C-N 115.18 -0.918 . . . . 50.13 114.658 176.706 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 72.5 mmtt -109.21 1.93 20.59 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 122.788 0.435 . . . . 72.25 110.223 -175.78 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 239' ' ' GLY . . . . . 0.413 ' HA2' HD12 ' A' ' 193' ' ' LEU . . . -112.33 -172.78 18.98 Favored Glycine 0 C--N 1.353 1.52 0 N-CA-C 111.289 -0.724 . . . . 74.23 111.289 166.423 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 86.3 m-85 -86.09 157.39 56.87 Favored Pre-proline 0 N--CA 1.491 1.584 0 C-N-CA 123.361 0.664 . . . . 75.14 111.576 -174.424 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -65.95 131.37 26.99 Favored 'Trans proline' 0 C--N 1.376 2.008 0 C-N-CA 121.826 1.684 . . . . 64.32 111.011 170.614 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -160.43 -125.29 0.77 Allowed Glycine 0 C--N 1.34 0.77 0 CA-C-O 118.629 -1.095 . . . . 73.31 112.28 -179.95 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 243' ' ' PRO . . . . . 0.528 ' HD2' ' HB3' ' A' ' 191' ' ' GLN . 21.4 Cg_endo -54.55 -50.68 12.59 Favored 'Trans proline' 0 C--N 1.377 2.077 0 C-N-CA 124.344 3.363 . . . . 55.43 112.542 -176.589 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -86.59 -11.02 52.67 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 123.254 0.622 . . . . 73.2 111.463 179.938 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 85.43 -21.45 13.39 Favored Glycine 0 C--N 1.357 1.718 0 C-N-CA 122.888 0.28 . . . . 44.22 113.146 -177.941 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 12.7 ttm180 -126.56 113.72 17.14 Favored 'General case' 0 C--O 1.234 0.268 0 C-N-CA 125.038 1.335 . . . . 74.03 107.688 174.219 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -76.79 163.11 52.34 Favored Glycine 0 C--O 1.245 0.794 0 N-CA-C 115.055 0.782 . . . . 45.52 115.055 177.575 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 248' ' ' ASP . . . . . 0.455 ' HA ' ' O ' ' A' ' 235' ' ' LEU . 55.3 m-20 -110.06 159.16 17.56 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 114.101 -1.049 . . . . 75.24 110.354 -176.714 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 249' ' ' LEU . . . . . 0.511 ' HB3' ' HB2' ' A' ' 235' ' ' LEU . 31.3 tp -126.1 126.65 44.53 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 123.457 0.703 . . . . 65.42 109.242 174.452 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 250' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 -90.25 112.19 23.63 Favored 'General case' 0 C--O 1.239 0.532 0 N-CA-C 108.552 -0.907 . . . . 64.45 108.552 -179.628 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 251' ' ' LEU . . . . . 0.647 HD13 HD22 ' A' ' 197' ' ' LEU . 81.2 mt -87.56 101.21 13.41 Favored 'General case' 0 C--O 1.239 0.513 0 N-CA-C 107.072 -1.455 . . . . 73.24 107.072 176.069 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -85.79 91.98 8.48 Favored 'General case' 0 C--O 1.242 0.683 0 N-CA-C 108.013 -1.106 . . . . 72.42 108.013 -176.199 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 4.1 m -61.51 135.76 25.8 Favored 'Isoleucine or valine' 0 C--O 1.243 0.724 0 CA-C-N 115.02 -0.991 . . . . 63.32 109.9 -174.605 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 14.8 mmm180 -131.85 111.22 11.41 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 107.21 -1.404 . . . . 71.13 107.21 178.599 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 255' ' ' ILE . . . . . 0.538 ' HB ' ' HB2' ' A' ' 229' ' ' ALA . 41.8 mt -86.64 116.08 28.69 Favored 'Isoleucine or valine' 0 C--O 1.239 0.531 0 C-N-CA 123.865 0.866 . . . . 65.11 110.086 -176.993 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 2.0 t . . . . . 0 CA--C 1.556 1.201 0 C-N-CA 124.497 1.119 . . . . 73.41 109.577 176.992 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 31.9 mt . . . . . 0 N--CA 1.481 1.116 0 CA-C-O 121.356 0.598 . . . . 54.41 111.697 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 3.9 m-85 -130.06 -56.09 1.11 Allowed 'General case' 0 N--CA 1.475 0.807 0 CA-C-N 114.85 -1.068 . . . . 72.13 109.105 -171.447 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 174' ' ' TYR . . . . . 0.463 ' CE2' HD13 ' A' ' 233' ' ' LEU . 0.6 OUTLIER -80.93 3.32 23.24 Favored 'General case' 0 N--CA 1.476 0.83 0 N-CA-C 114.24 1.2 . . . . 71.14 114.24 -167.711 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 24.0 p -53.49 -23.1 9.32 Favored 'General case' 0 N--CA 1.489 1.522 0 C-N-CA 123.955 0.902 . . . . 61.12 113.158 -176.021 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 176' ' ' MET . . . . . . . . . . . . . 13.9 ptm -56.29 85.03 0.01 OUTLIER 'General case' 0 CA--C 1.56 1.351 0 C-N-CA 124.272 1.029 . . . . 72.41 111.119 165.67 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 66.1 mttm 55.73 47.29 20.76 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 125.15 1.38 . . . . 75.11 111.862 178.003 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -63.89 -32.4 73.91 Favored 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 124.891 1.276 . . . . 35.33 111.856 178.108 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -88.52 24.44 1.96 Allowed 'General case' 0 CA--C 1.55 0.966 0 C-N-CA 123.758 0.823 . . . . 64.52 110.816 175.705 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.346 1.117 0 N-CA-C 109.455 -1.458 . . . . 73.53 109.455 166.162 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 191' ' ' GLN . . . . . 0.688 ' HB3' ' HD2' ' A' ' 243' ' ' PRO . 9.6 pt20 . . . . . 0 N--CA 1.482 1.153 0 CA-C-O 121.588 0.709 . . . . 73.15 109.984 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -79.15 145.95 33.42 Favored 'General case' 0 C--O 1.241 0.618 0 CA-C-N 114.51 -1.223 . . . . 73.42 109.761 -171.435 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 33.5 mt -111.01 173.27 6.41 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 123.925 0.89 . . . . 63.01 110.331 -179.102 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 65.3 m-85 -134.0 121.37 21.51 Favored 'General case' 0 C--O 1.237 0.439 0 C-N-CA 123.596 0.758 . . . . 73.12 110.054 -179.442 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . 0.448 ' O ' ' HA ' ' A' ' 251' ' ' LEU . . . -140.61 146.76 38.4 Favored 'General case' 0 C--O 1.234 0.287 0 N-CA-C 107.538 -1.282 . . . . 63.11 107.538 173.759 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 61.3 m -96.77 140.02 31.96 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 109.918 -0.401 . . . . 50.24 109.918 178.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . 0.672 HD22 HD13 ' A' ' 251' ' ' LEU . 16.5 tp -117.45 108.65 15.79 Favored 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 107.749 -1.204 . . . . 75.3 107.749 177.005 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -82.78 132.01 35.18 Favored 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 109.481 -0.563 . . . . 73.33 109.481 177.513 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 199' ' ' VAL . . . . . 0.533 ' O ' ' HA ' ' A' ' 255' ' ' ILE . 7.5 p -144.07 131.59 10.62 Favored Pre-proline 0 CA--C 1.548 0.894 0 N-CA-C 107.461 -1.311 . . . . 75.33 107.461 179.988 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -72.45 161.17 44.97 Favored 'Trans proline' 0 C--N 1.358 1.03 0 C-N-CA 121.829 1.686 . . . . 75.14 111.346 169.172 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -50.13 -50.12 71.59 Favored Pre-proline 0 CA--C 1.564 1.483 0 N-CA-C 114.021 1.119 . . . . 61.25 114.021 -178.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 202' ' ' PRO . . . . . 0.424 ' HA ' HG22 ' A' ' 205' ' ' VAL . 43.2 Cg_endo -64.26 -41.38 21.65 Favored 'Trans proline' 0 C--N 1.396 3.043 0 C-N-CA 121.736 1.624 . . . . 73.24 113.576 -178.779 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 53.2 mt -67.08 -28.25 42.13 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.295 0 CA-C-N 117.898 0.317 . . . . 63.34 110.21 177.296 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -72.83 -50.37 24.5 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 123.209 0.604 . . . . 52.13 111.783 178.534 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 205' ' ' VAL . . . . . 0.424 HG22 ' HA ' ' A' ' 202' ' ' PRO . 17.1 m -68.62 -43.02 83.67 Favored 'Isoleucine or valine' 0 C--N 1.353 0.729 0 C-N-CA 123.864 0.866 . . . . 72.32 112.574 -173.642 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 206' ' ' VAL . . . . . 0.414 HG22 ' O ' ' A' ' 202' ' ' PRO . 14.2 m -80.01 -36.38 16.82 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.226 0 CA-C-O 120.805 0.336 . . . . 54.45 110.746 175.239 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 83.77 80.05 1.04 Allowed Glycine 0 CA--C 1.528 0.885 0 N-CA-C 111.805 -0.518 . . . . 74.13 111.805 -173.064 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -90.78 -128.81 4.04 Favored Glycine 0 C--N 1.354 1.54 0 N-CA-C 111.447 -0.661 . . . . 64.33 111.447 175.789 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 45.3 mtmt -137.87 147.69 44.69 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 123.598 0.759 . . . . 74.4 110.806 174.599 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 3.6 m -139.94 165.18 22.22 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 C-N-CA 125.277 1.431 . . . . 72.52 109.212 175.033 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 45.0 ttp180 -100.97 122.76 44.08 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 123.179 0.591 . . . . 73.5 110.431 -177.807 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -114.68 112.31 22.67 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 124.05 0.94 . . . . 73.31 109.654 177.607 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 213' ' ' MET . . . . . 0.401 ' HA ' ' HA ' ' A' ' 218' ' ' PRO . 55.7 ttm -82.96 123.45 29.44 Favored 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 109.6 -0.518 . . . . 74.35 109.6 176.547 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 23.1 p -115.6 -171.22 1.93 Allowed 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 125.23 1.412 . . . . 71.24 109.568 -174.658 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 94.8 mt -60.75 -32.17 71.47 Favored 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 123.17 0.588 . . . . 71.34 111.016 170.459 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -99.27 19.28 15.71 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 124.107 0.963 . . . . 72.34 111.316 -175.691 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 93.79 -172.51 32.67 Favored Glycine 0 C--N 1.352 1.472 0 CA-C-O 119.683 -0.509 . . . . 75.25 113.175 177.864 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 218' ' ' PRO . . . . . 0.401 ' HA ' ' HA ' ' A' ' 213' ' ' MET . 73.2 Cg_endo -71.59 143.53 42.55 Favored 'Trans proline' 0 C--N 1.363 1.29 0 C-N-CA 122.622 2.214 . . . . 64.21 112.286 179.287 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 5.1 p -131.19 127.87 61.11 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 N-CA-C 108.605 -0.887 . . . . 52.23 108.605 172.943 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -78.28 100.76 6.83 Favored 'General case' 0 C--O 1.242 0.667 0 N-CA-C 106.66 -1.608 . . . . 73.31 106.66 174.79 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 6.2 p -108.35 129.65 62.32 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.844 0 CA-C-N 115.706 -0.679 . . . . 75.13 109.744 -168.745 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -79.66 110.49 15.05 Favored 'General case' 0 C--O 1.239 0.506 0 C-N-CA 123.714 0.805 . . . . 64.03 111.019 -174.903 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 52.7 t -55.12 136.47 67.68 Favored Pre-proline 0 CA--C 1.556 1.211 0 C-N-CA 125.006 1.322 . . . . 74.2 110.247 177.857 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -69.18 159.24 54.61 Favored 'Trans proline' 0 C--N 1.377 2.061 0 C-N-CA 122.293 1.995 . . . . 75.41 111.784 174.021 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -64.29 142.87 81.38 Favored 'Trans proline' 0 C--N 1.37 1.707 0 C-N-CA 121.75 1.633 . . . . 72.25 111.077 169.799 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 43.0 mtm180 62.78 48.21 4.24 Favored 'General case' 0 C--O 1.241 0.645 0 C-N-CA 124.417 1.087 . . . . 64.32 111.443 171.593 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 227' ' ' THR . . . . . 0.459 ' HA ' ' HE ' ' A' ' 231' ' ' ARG . 28.9 m -81.06 121.66 26.35 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 114.945 -1.025 . . . . 50.03 109.507 175.556 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 2.7 mp0 -106.41 148.4 28.15 Favored 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 123.992 0.917 . . . . 53.1 108.909 177.045 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -57.36 125.44 22.84 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 123.474 0.71 . . . . 64.35 111.88 -176.962 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 104.41 -2.55 43.07 Favored Glycine 0 C--N 1.34 0.786 0 CA-C-N 115.25 -0.886 . . . . 64.42 112.871 -179.619 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 231' ' ' ARG . . . . . 0.459 ' HE ' ' HA ' ' A' ' 227' ' ' THR . 56.4 mtt-85 -59.07 133.61 56.25 Favored 'General case' 0 C--N 1.371 1.505 0 CA-C-N 117.801 0.8 . . . . 65.42 109.695 173.22 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 69.5 mmtt -105.73 97.44 7.26 Favored 'General case' 0 C--O 1.239 0.536 0 CA-C-N 115.072 -0.967 . . . . 72.12 108.476 -172.858 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 233' ' ' LEU . . . . . 0.695 ' HB2' ' HB2' ' A' ' 251' ' ' LEU . 57.5 mt -81.73 142.29 32.79 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 114.713 -1.13 . . . . 63.12 109.046 179.229 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 22.0 ttt180 -122.84 101.28 7.35 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 122.492 0.317 . . . . 75.24 110.547 -171.475 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 235' ' ' LEU . . . . . 0.523 ' HB2' ' HB3' ' A' ' 249' ' ' LEU . 33.3 mt -86.74 105.62 17.1 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 123.57 0.748 . . . . 70.31 110.07 179.132 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 20.8 mttt -67.6 138.43 56.42 Favored 'General case' 0 CA--C 1.541 0.613 0 O-C-N 123.344 0.402 . . . . 71.21 110.921 175.41 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 73.11 16.62 78.51 Favored Glycine 0 C--N 1.348 1.207 0 O-C-N 123.895 0.747 . . . . 74.42 114.577 178.054 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 72.4 mmtt -115.58 7.4 14.83 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 123.211 0.605 . . . . 75.45 111.023 178.639 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -117.81 -167.83 14.31 Favored Glycine 0 C--N 1.348 1.216 0 N-CA-C 111.149 -0.781 . . . . 72.24 111.149 168.727 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 76.0 m-85 -91.34 157.89 41.8 Favored Pre-proline 0 N--CA 1.48 1.031 0 C-N-CA 123.781 0.833 . . . . 72.1 110.797 -175.567 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -64.03 145.38 89.64 Favored 'Trans proline' 0 C--N 1.366 1.487 0 C-N-CA 121.928 1.752 . . . . 74.52 112.833 170.167 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -176.4 -123.78 0.79 Allowed Glycine 0 CA--C 1.536 1.373 0 CA-C-O 118.964 -0.909 . . . . 44.1 112.221 178.161 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 243' ' ' PRO . . . . . 0.688 ' HD2' ' HB3' ' A' ' 191' ' ' GLN . 33.0 Cg_endo -57.75 -46.86 23.9 Favored 'Trans proline' 0 C--N 1.382 2.339 0 C-N-CA 124.889 3.726 . . . . 73.23 113.792 -173.499 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -90.72 -6.09 54.89 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 123.512 0.725 . . . . 72.23 111.153 179.778 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 87.17 -43.73 3.24 Favored Glycine 0 C--N 1.357 1.74 0 N-CA-C 111.966 -0.453 . . . . 72.14 111.966 -176.099 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 26.7 ttm180 -106.37 112.38 25.36 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 125.212 1.405 . . . . 72.12 109.163 175.167 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -74.83 154.27 46.65 Favored Glycine 0 C--N 1.358 1.804 0 N-CA-C 114.388 0.515 . . . . 75.11 114.388 171.282 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -107.43 171.13 7.55 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 124.854 1.262 . . . . 74.14 110.623 -178.52 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 249' ' ' LEU . . . . . 0.523 ' HB3' ' HB2' ' A' ' 235' ' ' LEU . 27.1 tp -128.78 116.76 19.99 Favored 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 108.17 -1.048 . . . . 75.41 108.17 171.009 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 250' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -88.78 108.08 19.31 Favored 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 108.845 -0.798 . . . . 73.42 108.845 -178.31 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 251' ' ' LEU . . . . . 0.695 ' HB2' ' HB2' ' A' ' 233' ' ' LEU . 87.3 mt -90.36 104.83 17.37 Favored 'General case' 0 C--O 1.238 0.453 0 N-CA-C 107.784 -1.191 . . . . 65.2 107.784 174.726 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -82.79 113.06 20.17 Favored 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 108.059 -1.089 . . . . 75.12 108.059 173.685 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 253' ' ' VAL . . . . . 0.428 ' HA ' ' O ' ' A' ' 197' ' ' LEU . 14.0 m -71.67 137.2 24.16 Favored 'Isoleucine or valine' 0 C--O 1.239 0.503 0 N-CA-C 109.677 -0.49 . . . . 65.21 109.677 179.685 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 8.5 mmm180 -123.38 108.54 12.83 Favored 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 108.092 -1.077 . . . . 74.43 108.092 175.902 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 255' ' ' ILE . . . . . 0.533 ' HA ' ' O ' ' A' ' 199' ' ' VAL . 27.3 mt -77.22 127.15 38.2 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 O-C-N 123.566 0.541 . . . . 61.4 109.864 177.792 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 10.7 t . . . . . 0 C--O 1.26 1.608 0 C-N-CA 123.974 0.91 . . . . 73.13 110.073 176.308 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 16.8 ptm . . . . . 0 N--CA 1.486 1.335 0 N-CA-C 110.15 -0.315 . . . . 73.33 110.15 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' GLN . . . . . 0.53 ' HG3' HG22 ' A' ' 170' ' ' THR . 23.0 pt20 -57.04 -32.66 66.42 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 113.966 1.099 . . . . 74.32 113.966 -167.611 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . 0.53 HG22 ' HG3' ' A' ' 169' ' ' GLN . 15.1 t -167.41 -176.72 3.33 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 122.963 0.505 . . . . 75.21 111.0 -174.84 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -121.93 -75.7 0.59 Allowed 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 124.772 1.229 . . . . 62.13 108.421 173.295 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 172' ' ' LEU . . . . . 0.592 HD21 ' H ' ' A' ' 222' ' ' ALA . 25.9 mt -150.16 162.58 40.18 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 124.357 1.063 . . . . 73.23 110.256 -178.773 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 173' ' ' PHE . . . . . 0.454 ' CD1' HD22 ' A' ' 235' ' ' LEU . 31.4 m-85 -126.21 -59.14 1.33 Allowed 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 124.135 0.974 . . . . 70.4 109.828 -170.017 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 174' ' ' TYR . . . . . 0.532 ' CD2' ' HB3' ' A' ' 233' ' ' LEU . 1.7 p90 -82.41 15.51 2.46 Favored 'General case' 0 CA--C 1.548 0.868 0 CA-C-N 114.381 -1.281 . . . . 71.01 112.898 -171.533 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 4.6 p -62.66 -19.87 64.25 Favored 'General case' 0 CA--C 1.555 1.141 0 C-N-CA 122.805 0.442 . . . . 63.23 111.354 173.77 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 176' ' ' MET . . . . . . . . . . . . . 22.9 ptt? -65.86 -52.89 46.48 Favored 'General case' 0 CA--C 1.558 1.276 0 C-N-CA 124.214 1.006 . . . . 72.53 111.361 168.879 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . 0.642 ' HB3' ' HA ' ' A' ' 181' ' ' SER . 96.2 mttt -155.28 119.61 4.67 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 125.016 1.326 . . . . 62.01 108.223 -173.568 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 178' ' ' ALA . . . . . 0.502 ' HB1' ' HG3' ' A' ' 224' ' ' PRO . . . -154.68 -68.07 0.13 Allowed 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 123.926 0.89 . . . . 74.35 109.093 -174.524 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -83.37 82.22 8.37 Favored 'General case' 0 C--O 1.24 0.566 0 N-CA-C 107.723 -1.214 . . . . 73.32 107.723 168.782 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 103.09 58.62 0.74 Allowed Glycine 0 C--N 1.342 0.892 0 CA-C-N 115.369 -0.832 . . . . 52.23 111.909 -175.219 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 181' ' ' SER . . . . . 0.642 ' HA ' ' HB3' ' A' ' 177' ' ' LYS . 38.5 m -73.34 -38.42 65.77 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 123.514 0.726 . . . . 61.45 111.8 178.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . 81.31 -69.89 3.19 Favored Glycine 0 C--N 1.345 1.05 0 CA-C-N 116.199 -0.455 . . . . 64.43 112.056 -177.697 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 150.88 139.16 2.96 Favored Glycine 0 C--N 1.342 0.875 0 N-CA-C 111.163 -0.775 . . . . 74.22 111.163 177.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 25.1 t -149.04 141.13 23.89 Favored 'General case' 0 C--O 1.241 0.629 0 C-N-CA 123.485 0.714 . . . . 71.2 109.104 177.236 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 88.99 -135.12 12.81 Favored Glycine 0 C--N 1.344 0.993 0 O-C-N 123.494 0.496 . . . . 73.4 112.247 -178.891 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 84.23 12.19 76.75 Favored Glycine 0 CA--C 1.531 1.041 0 CA-C-O 119.736 -0.48 . . . . 62.24 113.268 -176.782 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 56.6 p -158.43 172.75 17.76 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 123.366 0.666 . . . . 73.21 110.988 -179.626 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 85.12 -149.32 23.87 Favored Glycine 0 C--N 1.349 1.293 0 N-CA-C 111.564 -0.614 . . . . 71.42 111.564 -171.834 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -75.13 159.01 51.48 Favored Glycine 0 C--N 1.349 1.266 0 CA-C-N 117.453 0.626 . . . . 72.21 111.82 172.743 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 38.4 m -81.49 63.52 5.83 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 123.602 0.761 . . . . 62.22 110.969 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 191' ' ' GLN . . . . . 0.709 ' HB3' ' HD2' ' A' ' 243' ' ' PRO . 8.1 pt20 -74.03 -36.4 64.41 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 115.471 -0.786 . . . . 74.1 110.589 -179.002 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 66.6 m-20 -76.88 162.51 27.56 Favored 'General case' 0 C--O 1.24 0.562 0 CA-C-N 115.111 -0.95 . . . . 72.1 110.815 -172.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 28.8 mt -135.97 176.91 8.26 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 124.509 1.123 . . . . 70.42 110.014 -175.302 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 60.8 m-85 -134.0 136.9 44.41 Favored 'General case' 0 C--O 1.239 0.527 0 C-N-CA 123.871 0.868 . . . . 71.3 110.136 177.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . 0.492 ' HB2' HD11 ' A' ' 249' ' ' LEU . . . -140.04 171.08 14.69 Favored 'General case' 0 C--O 1.236 0.371 0 C-N-CA 124.632 1.173 . . . . 75.21 108.561 176.069 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 26.1 m -119.02 123.44 44.53 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 108.652 -0.87 . . . . 63.01 108.652 177.883 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 0.698 HD22 HD13 ' A' ' 251' ' ' LEU . 16.3 tp -107.47 111.08 23.21 Favored 'General case' 0 N--CA 1.467 0.382 0 N-CA-C 108.583 -0.895 . . . . 73.21 108.583 -179.56 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -84.0 121.48 27.45 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 123.414 0.686 . . . . 73.43 109.256 179.735 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 199' ' ' VAL . . . . . 0.44 ' O ' ' HA ' ' A' ' 255' ' ' ILE . 4.8 p -142.99 129.85 10.71 Favored Pre-proline 0 CA--C 1.548 0.903 0 C-N-CA 123.707 0.803 . . . . 53.43 109.414 -176.737 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_endo -72.37 162.0 42.76 Favored 'Trans proline' 0 C--N 1.369 1.613 0 C-N-CA 121.801 1.667 . . . . 60.32 111.189 172.341 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 201' ' ' ALA . . . . . 0.477 ' O ' HG23 ' A' ' 205' ' ' VAL . . . -50.6 -55.27 27.69 Favored Pre-proline 0 CA--C 1.562 1.439 0 CA-C-O 117.828 -1.082 . . . . 74.15 113.109 -177.839 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -68.1 -32.4 27.8 Favored 'Trans proline' 0 C--N 1.396 3.03 0 CA-C-N 121.433 1.548 . . . . 70.11 113.678 -174.157 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 36.1 mt -67.69 -32.02 54.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 N-CA-C 109.744 -0.465 . . . . 75.44 109.744 175.219 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -72.28 -40.33 67.68 Favored 'General case' 0 CA--C 1.551 1.011 0 C-N-CA 122.679 0.392 . . . . 73.52 111.347 176.425 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . 0.477 HG23 ' O ' ' A' ' 201' ' ' ALA . 84.7 t -66.66 -53.35 36.04 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.29 0 C-N-CA 123.647 0.779 . . . . 73.41 111.507 -177.825 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 16.5 m -80.04 -33.39 14.44 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 CA-C-N 116.227 -0.442 . . . . 72.14 110.986 -177.533 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 85.81 73.93 1.27 Allowed Glycine 0 C--N 1.342 0.901 0 CA-C-N 115.9 -0.591 . . . . 75.11 111.761 -172.44 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -91.14 -126.86 3.6 Favored Glycine 0 C--N 1.353 1.505 0 CA-C-O 119.43 -0.65 . . . . 45.11 111.876 177.324 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 209' ' ' LYS . . . . . 0.417 ' HG2' ' HA ' ' A' ' 222' ' ' ALA . 49.3 mtmt -137.81 155.28 49.18 Favored 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 123.604 0.762 . . . . 74.52 111.609 176.247 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 6.9 m -148.62 170.34 2.65 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.056 0 C-N-CA 125.88 1.672 . . . . 74.4 108.601 175.738 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 42.0 ttp180 -99.4 119.17 37.54 Favored 'General case' 0 CA--C 1.549 0.904 0 C-N-CA 122.822 0.449 . . . . 74.32 109.99 177.491 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -100.97 127.4 47.47 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 123.7 0.8 . . . . 52.12 109.63 175.828 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 88.0 mmm -96.06 122.5 38.96 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 123.336 0.654 . . . . 72.54 109.85 -177.261 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 21.8 p -129.21 -176.01 3.74 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 124.015 0.926 . . . . 75.33 110.886 -168.188 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 86.5 mt -65.22 -24.15 67.27 Favored 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 123.178 0.591 . . . . 73.25 112.062 175.67 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -98.99 6.68 46.57 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.454 0.702 . . . . 70.05 111.093 179.171 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 98.98 -151.44 19.49 Favored Glycine 0 C--N 1.352 1.455 0 CA-C-O 119.317 -0.713 . . . . 45.14 112.3 -179.667 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -79.85 149.65 20.6 Favored 'Trans proline' 0 C--N 1.365 1.422 0 C-N-CA 122.536 2.157 . . . . 75.3 113.672 -176.864 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 5.4 p -143.17 130.83 18.72 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 C-N-CA 123.613 0.765 . . . . 72.34 109.143 175.12 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -75.89 101.89 5.33 Favored 'General case' 0 N--CA 1.476 0.872 0 N-CA-C 108.539 -0.912 . . . . 73.5 108.539 175.149 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 1.4 p -107.06 123.08 61.97 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.047 0 N-CA-C 108.755 -0.832 . . . . 71.41 108.755 -173.108 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . 0.592 ' H ' HD21 ' A' ' 172' ' ' LEU . . . -77.36 109.96 11.7 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 123.194 0.598 . . . . 61.01 111.075 -178.376 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 63.1 t -54.97 139.47 63.25 Favored Pre-proline 0 N--CA 1.48 1.061 0 C-N-CA 125.43 1.492 . . . . 70.41 110.445 179.705 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 224' ' ' PRO . . . . . 0.502 ' HG3' ' HB1' ' A' ' 178' ' ' ALA . 72.0 Cg_endo -72.05 159.34 50.35 Favored 'Trans proline' 0 C--N 1.374 1.905 0 C-N-CA 121.939 1.759 . . . . 74.31 111.566 173.3 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -69.83 147.37 62.28 Favored 'Trans proline' 0 C--N 1.369 1.61 0 C-N-CA 121.507 1.471 . . . . 71.22 111.194 172.851 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 65.6 mtm180 63.55 47.08 3.93 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 124.578 1.151 . . . . 73.2 110.868 174.39 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 227' ' ' THR . . . . . 0.47 ' HA ' ' HE ' ' A' ' 231' ' ' ARG . 53.4 m -87.12 125.62 34.26 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 114.84 -1.073 . . . . 54.33 108.895 174.108 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -115.01 151.86 33.45 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 108.286 -1.005 . . . . 72.44 108.286 176.037 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -55.73 118.24 4.37 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 124.158 0.983 . . . . 71.13 111.075 -176.063 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 115.84 -5.06 20.65 Favored Glycine 0 C--N 1.342 0.868 0 CA-C-O 118.773 -1.015 . . . . 64.32 114.744 -177.399 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 231' ' ' ARG . . . . . 0.47 ' HE ' ' HA ' ' A' ' 227' ' ' THR . 65.2 mtt-85 -62.7 144.23 56.57 Favored 'General case' 0 N--CA 1.484 1.251 0 CA-C-N 118.28 1.04 . . . . 72.12 110.879 172.844 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 232' ' ' LYS . . . . . 0.427 ' HA ' ' HE3' ' A' ' 232' ' ' LYS . 0.0 OUTLIER -109.08 99.32 8.65 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 114.995 -1.002 . . . . 50.13 108.804 177.435 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 233' ' ' LEU . . . . . 0.641 ' HB2' ' HB2' ' A' ' 251' ' ' LEU . 39.2 mt -82.78 152.5 25.67 Favored 'General case' 0 CA--C 1.544 0.712 0 N-CA-C 108.589 -0.893 . . . . 62.12 108.589 175.344 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 22.3 ttt85 -125.61 111.25 14.77 Favored 'General case' 0 N--CA 1.481 1.103 0 CA-C-N 118.117 0.417 . . . . 72.43 111.043 -171.147 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 235' ' ' LEU . . . . . 0.479 ' HB2' ' HB3' ' A' ' 249' ' ' LEU . 16.2 mt -99.6 111.03 23.43 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 123.402 0.681 . . . . 75.51 110.683 179.213 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 16.2 mtmt -70.73 139.57 51.15 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 122.938 0.495 . . . . 72.42 111.695 -179.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 77.94 -2.69 63.77 Favored Glycine 0 N--CA 1.477 1.414 0 CA-C-N 115.508 -0.769 . . . . 42.45 114.292 177.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 70.9 mmtt -99.17 3.15 46.38 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 123.394 0.678 . . . . 64.33 110.717 -177.272 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -108.49 -176.24 21.86 Favored Glycine 0 C--N 1.347 1.183 0 N-CA-C 110.028 -1.229 . . . . 74.34 110.028 161.71 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 90.6 m-85 -85.46 147.09 45.96 Favored Pre-proline 0 N--CA 1.483 1.204 0 C-N-CA 123.261 0.625 . . . . 61.11 110.714 -178.095 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -59.78 132.9 47.81 Favored 'Trans proline' 0 C--N 1.37 1.704 0 C-N-CA 122.177 1.918 . . . . 61.41 112.282 171.572 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -159.27 -124.79 0.77 Allowed Glycine 0 CA--C 1.538 1.528 0 CA-C-O 118.692 -1.06 . . . . 63.13 112.729 -179.602 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 243' ' ' PRO . . . . . 0.709 ' HD2' ' HB3' ' A' ' 191' ' ' GLN . 35.9 Cg_endo -57.34 -44.13 45.76 Favored 'Trans proline' 0 C--N 1.381 2.286 0 C-N-CA 124.415 3.41 . . . . 64.43 113.638 -174.319 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -85.81 -14.45 45.06 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 123.389 0.676 . . . . 75.41 110.745 176.724 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 92.34 -23.34 27.94 Favored Glycine 0 C--N 1.348 1.224 0 CA-C-N 116.126 -0.488 . . . . 75.24 112.498 -176.104 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 11.4 ttm180 -128.86 111.75 13.41 Favored 'General case' 0 C--O 1.238 0.493 0 C-N-CA 124.575 1.15 . . . . 72.34 109.18 176.849 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -73.53 155.55 50.11 Favored Glycine 0 C--N 1.351 1.399 0 C-N-CA 121.693 -0.289 . . . . 60.53 112.769 170.632 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -125.43 145.62 49.99 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 123.376 0.67 . . . . 70.22 109.871 -173.837 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 249' ' ' LEU . . . . . 0.492 HD11 ' HB2' ' A' ' 195' ' ' ALA . 32.7 tp -100.32 119.25 38.13 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 123.3 0.64 . . . . 73.12 109.62 -178.563 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 250' ' ' TYR . . . . . . . . . . . . . 2.4 m-30 -89.65 110.09 21.0 Favored 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 108.753 -0.832 . . . . 72.21 108.753 -178.278 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 251' ' ' LEU . . . . . 0.698 HD13 HD22 ' A' ' 197' ' ' LEU . 85.3 mt -87.6 118.03 26.81 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 123.921 0.889 . . . . 71.4 109.294 -177.275 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 252' ' ' GLU . . . . . 0.45 ' HG3' ' HD3' ' A' ' 254' ' ' ARG . 10.1 tp10 -83.78 98.62 9.8 Favored 'General case' 0 C--O 1.239 0.506 0 N-CA-C 108.585 -0.895 . . . . 74.25 108.585 175.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 6.1 m -71.71 129.64 35.3 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 CA-C-O 121.498 0.666 . . . . 73.34 110.03 -176.526 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 254' ' ' ARG . . . . . 0.45 ' HD3' ' HG3' ' A' ' 252' ' ' GLU . 15.2 mmm180 -122.43 99.36 6.37 Favored 'General case' 0 C--O 1.238 0.483 0 CA-C-N 115.131 -0.94 . . . . 74.22 108.993 -173.803 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 255' ' ' ILE . . . . . 0.44 ' HA ' ' O ' ' A' ' 199' ' ' VAL . 15.7 mt -76.61 120.07 26.1 Favored 'Isoleucine or valine' 0 C--O 1.24 0.595 0 CA-C-O 121.443 0.64 . . . . 73.23 110.231 179.789 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 8.9 t . . . . . 0 CA--C 1.566 1.592 0 C-N-CA 125.198 1.399 . . . . 55.21 108.06 -178.267 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 23.9 ptt? . . . . . 0 N--CA 1.49 1.564 0 N-CA-C 111.684 0.253 . . . . 72.51 111.684 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -112.44 -172.47 2.05 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 123.631 0.773 . . . . 75.01 110.293 179.377 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 4.5 t -83.67 163.66 20.15 Favored 'General case' 0 CA--C 1.557 1.231 0 C-N-CA 123.438 0.695 . . . . 73.02 110.178 177.311 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -129.97 -82.89 0.55 Allowed 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 123.19 0.596 . . . . 63.44 111.244 -169.385 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 172' ' ' LEU . . . . . 0.633 HD21 ' H ' ' A' ' 222' ' ' ALA . 25.8 mt -139.1 151.88 47.06 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 123.516 0.726 . . . . 72.2 110.345 -174.469 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 173' ' ' PHE . . . . . 0.486 ' CE2' ' HE3' ' A' ' 238' ' ' LYS . 4.1 m-85 -134.74 -60.85 0.77 Allowed 'General case' 0 N--CA 1.481 1.091 0 CA-C-N 115.367 -0.833 . . . . 64.51 109.955 -155.767 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 174' ' ' TYR . . . . . 0.476 ' CD2' ' HB3' ' A' ' 233' ' ' LEU . 4.9 p90 -85.68 11.99 9.77 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 114.508 -1.223 . . . . 72.24 112.18 -175.852 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 175' ' ' THR . . . . . 0.492 ' OG1' ' HB3' ' A' ' 172' ' ' LEU . 0.2 OUTLIER -68.96 -17.5 63.95 Favored 'General case' 0 CA--C 1.551 1.0 0 C-N-CA 123.556 0.742 . . . . 73.32 112.324 -166.238 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 176' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -73.59 -28.53 61.88 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 123.631 0.773 . . . . 63.34 111.088 176.038 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . 0.446 ' HG2' ' HA3' ' A' ' 180' ' ' GLY . 23.2 ttpp -151.87 62.46 0.85 Allowed 'General case' 0 CA--C 1.551 0.988 0 CA-C-O 122.276 1.036 . . . . 70.34 108.942 -177.21 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 178' ' ' ALA . . . . . 0.468 ' HB1' ' HB3' ' A' ' 224' ' ' PRO . . . -81.01 126.3 31.23 Favored 'General case' 0 N--CA 1.476 0.864 0 CA-C-N 114.457 -1.247 . . . . 64.32 110.794 -175.763 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . 0.526 ' HB1' HH11 ' A' ' 231' ' ' ARG . . . 66.57 9.92 6.97 Favored 'General case' 0 N--CA 1.497 1.924 0 C-N-CA 124.955 1.302 . . . . 54.03 111.501 -170.031 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . 0.446 ' HA3' ' HG2' ' A' ' 177' ' ' LYS . . . -89.6 55.02 3.82 Favored Glycine 0 N--CA 1.468 0.786 0 CA-C-N 116.267 -0.424 . . . . 71.41 112.268 -173.411 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 16.4 m -77.78 93.78 4.37 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 123.865 0.866 . . . . 72.22 109.657 -179.289 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -112.54 -63.58 0.46 Allowed Glycine 0 C--N 1.343 0.932 0 CA-C-N 115.416 -0.811 . . . . 71.32 112.521 -173.622 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -170.7 83.63 0.08 OUTLIER Glycine 0 C--N 1.347 1.158 0 N-CA-C 112.384 -0.286 . . . . 50.34 112.384 -177.609 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 19.4 m -97.71 97.59 9.14 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 123.312 0.645 . . . . 72.5 110.412 -178.259 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -81.13 108.33 2.82 Favored Glycine 0 C--N 1.344 0.977 0 CA-C-N 116.21 -0.45 . . . . 72.13 112.977 179.587 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -66.24 133.69 33.6 Favored Glycine 0 CA--C 1.533 1.175 0 N-CA-C 111.327 -0.709 . . . . 72.43 111.327 170.222 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . 0.571 ' HB2' ' HB2' ' A' ' 243' ' ' PRO . 15.1 m -92.96 44.99 1.16 Allowed 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 123.857 0.863 . . . . 41.43 112.998 -167.358 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 88.12 -66.25 3.32 Favored Glycine 0 N--CA 1.472 1.087 0 CA-C-N 116.34 -0.391 . . . . 31.12 113.49 174.791 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -63.99 136.72 40.8 Favored Glycine 0 C--N 1.349 1.26 0 N-CA-C 111.905 -0.478 . . . . 43.13 111.905 177.502 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 25.1 t -87.53 58.79 5.12 Favored 'General case' 0 CA--C 1.551 0.999 0 CA-C-O 121.35 0.595 . . . . 73.31 110.889 -175.592 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 191' ' ' GLN . . . . . 0.625 ' HB3' ' HD2' ' A' ' 243' ' ' PRO . 9.5 pt20 -69.07 -32.5 72.01 Favored 'General case' 0 N--CA 1.477 0.905 0 CA-C-N 115.653 -0.703 . . . . 50.14 109.915 171.377 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 65.7 m-20 -78.32 152.99 32.11 Favored 'General case' 0 C--O 1.239 0.521 0 CA-C-N 114.65 -1.159 . . . . 63.11 110.955 -173.598 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . 0.536 HD12 ' HA2' ' A' ' 239' ' ' GLY . 59.3 mt -128.68 175.76 8.33 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 114.547 -1.206 . . . . 54.33 110.297 -174.374 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 17.5 m-85 -139.67 122.73 16.78 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 123.915 0.886 . . . . 73.54 110.046 -177.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . 0.431 ' HB2' HD11 ' A' ' 249' ' ' LEU . . . -129.4 128.2 42.52 Favored 'General case' 0 C--N 1.341 0.209 0 N-CA-C 108.318 -0.993 . . . . 71.43 108.318 173.331 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 61.7 m -77.72 123.89 27.26 Favored 'General case' 0 CA--C 1.546 0.799 0 N-CA-C 109.344 -0.613 . . . . 74.21 109.344 176.888 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 0.718 HD22 HD13 ' A' ' 251' ' ' LEU . 18.9 tp -107.69 110.87 22.83 Favored 'General case' 0 N--CA 1.474 0.775 0 N-CA-C 108.562 -0.903 . . . . 73.14 108.562 -178.532 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -78.43 132.52 37.34 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 109.321 -0.622 . . . . 71.42 109.321 173.286 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 199' ' ' VAL . . . . . 0.486 ' O ' ' HA ' ' A' ' 255' ' ' ILE . 4.1 p -144.18 127.3 8.72 Favored Pre-proline 0 CA--C 1.546 0.804 0 N-CA-C 108.453 -0.943 . . . . 74.13 108.453 177.745 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -69.59 156.09 64.72 Favored 'Trans proline' 0 C--N 1.367 1.517 0 C-N-CA 121.962 1.775 . . . . 72.15 111.48 170.774 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 201' ' ' ALA . . . . . 0.454 ' O ' HG23 ' A' ' 205' ' ' VAL . . . -51.05 -51.96 62.88 Favored Pre-proline 0 CA--C 1.555 1.166 0 N-CA-C 113.996 1.11 . . . . 55.12 113.996 -177.354 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -65.39 -32.63 49.79 Favored 'Trans proline' 0 C--N 1.382 2.309 0 CA-C-N 121.181 1.458 . . . . 52.21 113.253 -176.072 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 27.3 mt -68.48 -34.86 67.88 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.229 0 C-N-CA 122.664 0.386 . . . . 75.34 110.152 174.307 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -71.54 -33.12 68.88 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 122.295 0.238 . . . . 71.35 111.369 178.414 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . 0.454 HG23 ' O ' ' A' ' 201' ' ' ALA . 80.7 t -71.05 -57.76 6.86 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 C-N-CA 123.349 0.66 . . . . 61.13 111.041 178.643 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 10.6 m -82.37 -17.26 11.46 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.055 0 CA-C-N 116.272 -0.422 . . . . 74.34 111.588 -172.798 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 74.86 66.17 1.98 Allowed Glycine 0 C--N 1.342 0.883 0 O-C-N 123.667 0.604 . . . . 52.21 112.327 -177.422 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -85.57 -130.0 2.33 Favored Glycine 0 C--N 1.346 1.091 0 C-N-CA 122.694 0.188 . . . . 52.24 112.806 179.522 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 209' ' ' LYS . . . . . 0.416 ' HG2' ' HA ' ' A' ' 222' ' ' ALA . 46.8 mtmt -138.24 155.48 48.6 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.753 0.821 . . . . 71.03 111.005 176.363 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 11.0 m -144.23 168.93 10.15 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 C-N-CA 125.155 1.382 . . . . 74.32 108.66 172.406 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 48.9 ttp180 -97.06 114.34 25.97 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 123.227 0.611 . . . . 75.23 109.939 178.552 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -100.74 139.66 36.1 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 123.667 0.787 . . . . 65.23 110.208 179.52 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 23.9 mmt -98.46 116.02 29.79 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 123.021 0.528 . . . . 75.4 109.716 178.707 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 48.9 p -109.46 -175.58 2.79 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 123.928 0.891 . . . . 73.35 109.182 175.527 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 93.3 mt -63.3 -22.3 66.79 Favored 'General case' 0 CA--C 1.552 1.02 0 C-N-CA 122.71 0.404 . . . . 55.45 111.356 173.685 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 20.9 mt-10 -81.93 -22.89 36.48 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 123.672 0.789 . . . . 63.21 110.99 -178.877 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 118.18 -150.06 18.27 Favored Glycine 0 CA--C 1.533 1.16 0 N-CA-C 110.911 -0.876 . . . . 73.01 110.911 -170.822 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_endo -78.26 144.73 20.94 Favored 'Trans proline' 0 C--N 1.369 1.628 0 C-N-CA 122.463 2.109 . . . . 75.42 113.19 -176.424 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 219' ' ' VAL . . . . . 0.41 HG21 ' HZ ' ' A' ' 173' ' ' PHE . 7.6 p -144.02 133.03 19.34 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 C-N-CA 123.914 0.886 . . . . 61.42 109.366 177.363 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 40.0 mm-40 -78.69 104.59 9.41 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 109.658 -0.497 . . . . 72.23 109.658 177.47 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 4.1 p -107.31 130.19 59.88 Favored 'Isoleucine or valine' 0 C--O 1.244 0.808 0 CA-C-N 115.418 -0.81 . . . . 65.44 109.224 -174.423 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . 0.633 ' H ' HD21 ' A' ' 172' ' ' LEU . . . -81.09 104.64 11.71 Favored 'General case' 0 C--O 1.239 0.536 0 C-N-CA 123.419 0.688 . . . . 73.1 111.061 -177.16 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 59.9 t -55.6 135.64 71.12 Favored Pre-proline 0 N--CA 1.476 0.865 0 O-C-N 124.423 1.077 . . . . 70.33 110.056 178.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 224' ' ' PRO . . . . . 0.468 ' HB3' ' HB1' ' A' ' 178' ' ' ALA . 17.1 Cg_endo -65.23 148.76 88.98 Favored 'Trans proline' 0 C--N 1.365 1.416 0 C-N-CA 121.747 1.631 . . . . 54.45 111.801 170.326 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -65.35 150.17 87.46 Favored 'Trans proline' 0 C--N 1.364 1.35 0 C-N-CA 121.499 1.466 . . . . 73.23 111.612 169.763 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 59.6 mtm180 61.72 35.83 16.68 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 124.654 1.182 . . . . 73.1 112.484 170.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 227' ' ' THR . . . . . 0.425 HG22 HG21 ' A' ' 253' ' ' VAL . 26.6 m -83.04 133.94 35.06 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 115.342 -0.845 . . . . 64.5 109.262 174.365 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 28.3 mp0 -111.2 149.63 30.69 Favored 'General case' 0 N--CA 1.485 1.319 0 N-CA-C 109.398 -0.593 . . . . 55.35 109.398 175.857 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 229' ' ' ALA . . . . . 0.458 ' HA ' HG23 ' A' ' 253' ' ' VAL . . . -58.47 125.99 25.66 Favored 'General case' 0 N--CA 1.47 0.556 0 O-C-N 124.305 1.003 . . . . 63.13 111.46 -176.548 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 113.98 -15.46 21.14 Favored Glycine 0 CA--C 1.523 0.551 0 CA-C-N 115.206 -0.907 . . . . 41.5 113.035 -176.58 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 231' ' ' ARG . . . . . 0.526 HH11 ' HB1' ' A' ' 179' ' ' ALA . 75.0 mtt180 -67.66 152.81 45.0 Favored 'General case' 0 C--N 1.363 1.158 0 CA-C-N 117.751 0.775 . . . . 73.32 109.457 172.547 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 232' ' ' LYS . . . . . 0.48 ' HA ' ' O ' ' A' ' 251' ' ' LEU . 54.0 mtmt -130.05 128.01 41.06 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-O 121.324 0.583 . . . . 71.51 110.602 179.201 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 233' ' ' LEU . . . . . 0.491 ' HB2' ' HB2' ' A' ' 251' ' ' LEU . 20.1 mt -98.49 148.1 24.08 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 114.354 -1.293 . . . . 75.23 108.887 -174.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 21.2 ttt180 -106.82 110.24 22.35 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 122.851 0.46 . . . . 65.23 111.263 -170.401 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 235' ' ' LEU . . . . . 0.614 ' HB2' ' HB3' ' A' ' 249' ' ' LEU . 17.1 mt -98.56 103.9 15.89 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 122.641 0.376 . . . . 64.2 110.092 177.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 13.6 mtmt -70.72 134.84 47.82 Favored 'General case' 0 C--O 1.238 0.495 0 CA-C-N 116.231 -0.44 . . . . 70.02 111.896 -178.154 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 73.72 10.51 80.09 Favored Glycine 0 C--N 1.344 0.996 0 CA-C-N 114.973 -1.012 . . . . 64.11 114.808 177.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . 0.486 ' HE3' ' CE2' ' A' ' 173' ' ' PHE . 69.7 mmtt -104.6 5.36 33.69 Favored 'General case' 0 N--CA 1.478 0.957 0 CA-C-N 117.393 0.596 . . . . 62.12 110.0 179.785 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 239' ' ' GLY . . . . . 0.536 ' HA2' HD12 ' A' ' 193' ' ' LEU . . . -105.7 -168.37 23.5 Favored Glycine 0 C--N 1.35 1.325 0 CA-C-N 115.25 -0.886 . . . . 51.43 111.294 166.733 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -93.73 167.75 13.19 Favored Pre-proline 0 CA--C 1.559 1.319 0 C-N-CA 123.998 0.919 . . . . 73.14 110.233 178.337 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -71.65 171.51 16.25 Favored 'Trans proline' 0 C--N 1.376 2.001 0 C-N-CA 122.437 2.091 . . . . 63.43 112.926 172.203 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 155.36 -117.25 0.77 Allowed Glycine 0 CA--C 1.537 1.461 0 CA-C-O 119.312 -0.715 . . . . 73.44 113.219 173.507 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 243' ' ' PRO . . . . . 0.625 ' HD2' ' HB3' ' A' ' 191' ' ' GLN . 60.5 Cg_endo -63.25 -40.65 31.29 Favored 'Trans proline' 0 C--N 1.375 1.966 0 C-N-CA 124.638 3.559 . . . . 72.53 113.506 -169.348 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 244' ' ' ALA . . . . . 0.429 ' HB3' HE22 ' A' ' 191' ' ' GLN . . . -101.27 -13.99 17.84 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 123.393 0.677 . . . . 72.33 110.316 177.292 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 96.32 -31.71 7.16 Favored Glycine 0 C--N 1.352 1.464 0 CA-C-N 116.109 -0.496 . . . . 62.13 112.908 179.66 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 50.5 ttt180 -126.65 110.56 13.31 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 124.17 0.988 . . . . 63.32 109.102 -178.663 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -75.96 151.07 40.22 Favored Glycine 0 C--N 1.347 1.161 0 O-C-N 123.684 0.615 . . . . 62.34 113.532 179.011 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 18.4 m-20 -118.89 137.65 53.3 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 124.144 0.978 . . . . 70.5 109.67 -175.744 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 249' ' ' LEU . . . . . 0.614 ' HB3' ' HB2' ' A' ' 235' ' ' LEU . 51.6 tp -98.93 118.06 34.84 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 109.049 -0.723 . . . . 75.01 109.049 179.521 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 250' ' ' TYR . . . . . . . . . . . . . 3.4 m-85 -90.64 112.78 24.64 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 123.62 0.768 . . . . 65.42 110.331 -175.615 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 251' ' ' LEU . . . . . 0.718 HD13 HD22 ' A' ' 197' ' ' LEU . 83.4 mt -87.57 105.24 17.19 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 124.209 1.004 . . . . 70.31 109.408 -177.453 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 252' ' ' GLU . . . . . 0.405 ' O ' ' HG2' ' A' ' 254' ' ' ARG . 29.4 mt-10 -78.74 93.94 5.02 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 108.327 -0.99 . . . . 75.42 108.327 -178.425 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 253' ' ' VAL . . . . . 0.458 HG23 ' HA ' ' A' ' 229' ' ' ALA . 3.9 m -64.19 127.98 25.77 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.871 0 CA-C-O 121.334 0.587 . . . . 62.14 109.786 -176.701 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 254' ' ' ARG . . . . . 0.405 ' HG2' ' O ' ' A' ' 252' ' ' GLU . 26.6 mmt85 -127.46 98.97 5.43 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 108.713 -0.847 . . . . 72.4 108.713 -175.194 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 255' ' ' ILE . . . . . 0.486 ' HA ' ' O ' ' A' ' 199' ' ' VAL . 24.8 mt -80.31 110.56 16.02 Favored 'Isoleucine or valine' 0 C--O 1.238 0.473 0 CA-C-N 115.25 -0.886 . . . . 53.4 110.415 -176.922 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 10.2 t . . . . . 0 C--O 1.257 1.475 0 CA-C-N 115.059 -0.973 . . . . 75.55 109.708 174.037 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 14.0 tpt . . . . . 0 N--CA 1.484 1.233 0 N-CA-C 109.378 -0.601 . . . . 64.33 109.378 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 17.6 pt20 -63.91 168.01 5.58 Favored 'General case' 0 C--O 1.245 0.847 0 C-N-CA 123.388 0.675 . . . . 74.13 110.657 173.238 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 13.1 t -71.3 145.66 49.37 Favored 'General case' 0 CA--C 1.545 0.772 0 CA-C-N 115.679 -0.691 . . . . 74.24 110.247 176.47 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -84.9 -84.48 0.15 Allowed 'General case' 0 CA--C 1.542 0.665 0 N-CA-C 109.367 -0.605 . . . . 61.11 109.367 175.773 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 172' ' ' LEU . . . . . 0.666 HD21 ' H ' ' A' ' 222' ' ' ALA . 22.3 mt -152.22 161.07 43.16 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 123.888 0.875 . . . . 71.14 110.454 -175.846 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 173' ' ' PHE . . . . . 0.471 ' CD1' HD22 ' A' ' 235' ' ' LEU . 26.2 m-85 -123.99 -62.78 1.26 Allowed 'General case' 0 N--CA 1.475 0.777 0 CA-C-N 115.519 -0.764 . . . . 75.12 110.189 -169.661 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 174' ' ' TYR . . . . . 0.464 ' CD2' ' HB3' ' A' ' 233' ' ' LEU . 1.8 p90 -75.8 -11.38 59.97 Favored 'General case' 0 C--O 1.219 -0.503 0 CA-C-N 114.587 -1.188 . . . . 60.42 112.815 -172.158 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 175' ' ' THR . . . . . 0.662 HG21 HD13 ' A' ' 172' ' ' LEU . 42.9 p -70.61 -2.18 13.47 Favored 'General case' 0 CA--C 1.548 0.9 0 N-CA-C 112.558 0.577 . . . . 73.0 112.558 -176.45 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 176' ' ' MET . . . . . . . . . . . . . 24.9 ptt? -57.1 -41.97 79.89 Favored 'General case' 0 CA--C 1.559 1.299 0 C-N-CA 123.67 0.788 . . . . 72.33 110.261 161.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 14.5 tmtt? 179.51 108.52 0.03 OUTLIER 'General case' 0 CA--C 1.553 1.08 0 C-N-CA 126.18 1.792 . . . . 61.43 106.321 179.463 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 178' ' ' ALA . . . . . 0.523 ' HB1' HD22 ' A' ' 233' ' ' LEU . . . -128.08 -58.77 1.2 Allowed 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 123.081 0.552 . . . . 64.31 112.025 -173.017 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . 0.48 ' HB2' ' HB2' ' A' ' 224' ' ' PRO . . . -71.55 85.22 0.86 Allowed 'General case' 0 CA--C 1.546 0.81 0 CA-C-O 121.57 0.7 . . . . 71.12 109.48 179.463 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 160.7 -32.12 0.38 Allowed Glycine 0 C--N 1.337 0.591 0 CA-C-N 114.298 -1.319 . . . . 75.43 109.889 -172.546 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 20.3 m -80.33 147.68 31.0 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 124.345 1.058 . . . . 73.12 110.886 175.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . 172.21 49.61 0.04 OUTLIER Glycine 0 C--N 1.349 1.257 0 CA-C-N 116.173 -0.467 . . . . 74.22 112.235 -179.527 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -131.49 -101.63 0.87 Allowed Glycine 0 N--CA 1.476 1.334 0 CA-C-O 119.924 -0.376 . . . . 64.55 113.165 -176.0 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 29.9 t -167.52 156.73 10.06 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 123.443 0.697 . . . . 62.03 110.288 -176.673 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -100.42 -131.64 7.45 Favored Glycine 0 C--N 1.348 1.216 0 N-CA-C 111.535 -0.626 . . . . 64.1 111.535 173.68 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -94.05 -177.35 39.25 Favored Glycine 0 N--CA 1.475 1.279 0 C-N-CA 122.974 0.321 . . . . 75.04 112.528 177.751 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 72.8 m -151.78 -34.34 0.14 Allowed 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 123.533 0.733 . . . . 72.1 111.5 -175.338 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -59.49 -29.33 66.37 Favored Glycine 0 C--N 1.355 1.633 0 N-CA-C 114.402 0.521 . . . . 41.53 114.402 -173.076 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . 0.56 ' HA3' ' HD3' ' A' ' 243' ' ' PRO . . . -105.3 -10.36 31.82 Favored Glycine 0 CA--C 1.533 1.163 0 CA-C-O 119.975 -0.347 . . . . 63.24 113.265 177.007 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 30.5 m 62.43 18.44 10.35 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 124.601 1.16 . . . . 70.03 112.794 179.713 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 191' ' ' GLN . . . . . 0.601 ' HB3' ' HD2' ' A' ' 243' ' ' PRO . 6.8 pt20 -65.19 -28.96 69.75 Favored 'General case' 0 N--CA 1.483 1.178 0 CA-C-O 121.302 0.572 . . . . 64.42 110.768 -178.624 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -76.05 135.61 39.92 Favored 'General case' 0 C--O 1.241 0.624 0 CA-C-N 114.387 -1.279 . . . . 74.43 110.048 -177.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 43.6 mt -117.87 168.26 10.66 Favored 'General case' 0 C--O 1.24 0.589 0 CA-C-N 114.701 -1.136 . . . . 72.53 109.204 177.796 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 31.8 m-85 -138.6 121.86 17.01 Favored 'General case' 0 C--O 1.238 0.466 0 C-N-CA 123.483 0.713 . . . . 72.25 109.656 -179.49 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . 0.502 ' HB3' HD23 ' A' ' 251' ' ' LEU . . . -126.9 133.67 50.62 Favored 'General case' 0 CA--C 1.516 -0.342 0 C-N-CA 123.962 0.905 . . . . 70.04 108.607 177.448 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 2.2 m -81.45 125.59 30.62 Favored 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 108.82 -0.808 . . . . 62.03 108.82 176.234 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 0.677 HD22 HD13 ' A' ' 251' ' ' LEU . 15.7 tp -109.55 111.39 22.88 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 108.672 -0.862 . . . . 64.21 108.672 -176.624 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -76.19 127.93 33.91 Favored 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 108.55 -0.907 . . . . 60.42 108.55 174.491 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 199' ' ' VAL . . . . . 0.494 ' O ' ' HA ' ' A' ' 255' ' ' ILE . 7.7 p -145.29 133.58 10.74 Favored Pre-proline 0 CA--C 1.544 0.716 0 N-CA-C 108.475 -0.935 . . . . 70.21 108.475 176.112 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 200' ' ' PRO . . . . . 0.444 ' HB2' ' HD2' ' A' ' 202' ' ' PRO . 75.4 Cg_endo -75.74 160.98 37.19 Favored 'Trans proline' 0 C--N 1.361 1.191 0 C-N-CA 121.737 1.625 . . . . 41.31 111.25 167.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -55.75 -47.25 99.12 Favored Pre-proline 0 CA--C 1.558 1.282 0 CA-C-O 117.695 -1.145 . . . . 71.35 113.786 -178.323 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 202' ' ' PRO . . . . . 0.444 ' HD2' ' HB2' ' A' ' 200' ' ' PRO . 56.1 Cg_endo -64.47 -37.95 35.95 Favored 'Trans proline' 0 C--N 1.396 3.057 0 C-N-CA 121.691 1.594 . . . . 75.02 112.964 -177.861 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 45.1 mt -67.93 -34.93 70.04 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.062 0 CA-C-O 120.817 0.341 . . . . 74.33 110.436 176.248 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -67.45 -40.61 85.39 Favored 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 123.048 0.539 . . . . 71.4 112.239 179.382 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 17.1 m -80.27 -45.98 22.0 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.793 0 N-CA-C 112.919 0.711 . . . . 71.24 112.919 -175.543 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 206' ' ' VAL . . . . . 0.436 HG22 ' O ' ' A' ' 202' ' ' PRO . 11.1 m -78.04 -25.57 14.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 C-N-CA 122.213 0.205 . . . . 74.13 111.516 178.477 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 82.24 66.25 1.58 Allowed Glycine 0 C--N 1.344 1.026 0 N-CA-C 111.944 -0.462 . . . . 23.24 111.944 -177.318 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -86.47 -130.93 2.85 Favored Glycine 0 C--N 1.352 1.442 0 C-N-CA 123.262 0.458 . . . . 54.35 112.217 177.494 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 209' ' ' LYS . . . . . 0.412 ' HG2' ' HA ' ' A' ' 222' ' ' ALA . 48.4 mtmt -137.89 155.72 48.64 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 124.063 0.945 . . . . 73.12 111.084 177.001 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 9.5 m -147.51 151.89 13.32 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.793 0 C-N-CA 125.288 1.435 . . . . 74.55 108.682 169.763 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 211' ' ' ARG . . . . . 0.441 ' HD2' ' HB2' ' A' ' 218' ' ' PRO . 54.5 ttp180 -87.55 116.9 25.99 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 123.069 0.548 . . . . 73.31 110.501 179.749 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -100.87 129.01 46.67 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 123.95 0.9 . . . . 74.34 109.769 177.557 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 22.4 mmt -86.29 120.86 28.1 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 108.96 -0.755 . . . . 63.43 108.96 175.49 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 24.0 p -123.41 -174.71 3.02 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 123.928 0.891 . . . . 34.43 109.835 -174.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 77.0 mt -65.77 -29.36 69.85 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 122.752 0.421 . . . . 74.31 110.894 172.259 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 18.6 mm-40 -90.6 6.77 42.4 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 123.859 0.864 . . . . 61.53 110.971 -179.589 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 96.79 -160.34 21.71 Favored Glycine 0 C--N 1.352 1.47 0 CA-C-O 119.581 -0.566 . . . . 74.32 112.636 177.915 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 218' ' ' PRO . . . . . 0.441 ' HB2' ' HD2' ' A' ' 211' ' ' ARG . 71.8 Cg_endo -75.11 144.25 29.67 Favored 'Trans proline' 0 C--N 1.368 1.565 0 C-N-CA 122.336 2.024 . . . . 74.02 112.471 -179.665 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 7.5 p -146.92 131.27 10.46 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 C-N-CA 123.199 0.599 . . . . 71.35 109.778 177.663 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -69.73 103.09 2.05 Favored 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 108.114 -1.069 . . . . 72.12 108.114 169.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 1.7 p -103.58 120.61 53.88 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.133 0 N-CA-C 108.263 -1.014 . . . . 63.45 108.263 179.74 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . 0.666 ' H ' HD21 ' A' ' 172' ' ' LEU . . . -76.11 109.91 10.15 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 123.382 0.673 . . . . 61.43 111.558 -175.441 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 51.9 t -55.2 138.4 66.52 Favored Pre-proline 0 N--CA 1.48 1.054 0 C-N-CA 125.636 1.574 . . . . 73.31 111.029 -177.087 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 224' ' ' PRO . . . . . 0.48 ' HB2' ' HB2' ' A' ' 179' ' ' ALA . 36.8 Cg_endo -66.42 147.79 83.16 Favored 'Trans proline' 0 C--N 1.377 2.03 0 C-N-CA 121.61 1.54 . . . . 73.0 110.843 170.918 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_exo -69.1 149.33 70.97 Favored 'Trans proline' 0 C--N 1.364 1.378 0 C-N-CA 121.725 1.617 . . . . 75.24 111.672 174.287 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 82.4 mtt180 63.94 39.56 7.99 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 124.79 1.236 . . . . 73.41 111.099 173.09 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 227' ' ' THR . . . . . 0.438 HG23 ' HD2' ' A' ' 231' ' ' ARG . 91.3 m -83.08 139.15 33.39 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 115.349 -0.841 . . . . 71.3 109.881 177.436 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 27.3 mp0 -112.36 148.31 34.55 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 124.325 1.05 . . . . 70.0 109.208 176.413 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 229' ' ' ALA . . . . . 0.4 ' HA ' HG23 ' A' ' 253' ' ' VAL . . . -59.2 128.65 38.21 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 123.546 0.738 . . . . 65.24 110.854 -179.615 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 105.6 -3.56 39.58 Favored Glycine 0 N--CA 1.471 1.023 0 O-C-N 123.828 0.705 . . . . 72.01 113.18 -177.55 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 231' ' ' ARG . . . . . 0.438 ' HD2' HG23 ' A' ' 227' ' ' THR . 62.8 mtt-85 -71.68 149.96 45.0 Favored 'General case' 0 C--N 1.359 1.006 0 CA-C-N 117.43 0.615 . . . . 73.12 109.839 171.851 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -127.45 103.35 7.31 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 123.263 0.625 . . . . 64.42 109.341 -174.867 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 233' ' ' LEU . . . . . 0.532 ' HB2' ' HB2' ' A' ' 251' ' ' LEU . 28.9 mt -80.38 149.34 30.25 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 114.16 -1.382 . . . . 72.45 109.121 -177.213 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 56.5 ttt180 -115.39 109.04 17.3 Favored 'General case' 0 N--CA 1.481 1.11 0 O-C-N 121.926 -0.484 . . . . 74.11 111.349 -171.755 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 235' ' ' LEU . . . . . 0.564 ' HB2' ' HB3' ' A' ' 249' ' ' LEU . 19.2 mt -95.68 107.02 19.19 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 123.125 0.57 . . . . 71.35 110.116 176.565 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 21.2 mttt -73.25 137.69 45.08 Favored 'General case' 0 CA--C 1.535 0.393 0 O-C-N 123.214 0.321 . . . . 74.33 110.208 174.114 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 74.01 19.17 79.79 Favored Glycine 0 C--N 1.34 0.78 0 CA-C-N 115.567 -0.742 . . . . 64.1 114.017 179.661 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . 0.426 ' HZ3' ' HE2' ' A' ' 173' ' ' PHE . 34.9 mmtm -121.19 6.93 10.22 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 123.367 0.667 . . . . 60.23 110.616 174.171 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -109.0 -170.5 20.79 Favored Glycine 0 C--N 1.347 1.175 0 N-CA-C 110.534 -1.026 . . . . 72.43 110.534 163.053 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 89.0 m-85 -89.96 147.64 37.77 Favored Pre-proline 0 N--CA 1.478 0.95 0 C-N-CA 123.169 0.588 . . . . 64.33 110.972 -177.66 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 17.6 Cg_exo -68.02 128.2 17.29 Favored 'Trans proline' 0 C--N 1.365 1.404 0 C-N-CA 121.771 1.648 . . . . 75.03 111.137 172.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -158.97 -121.66 0.63 Allowed Glycine 0 C--N 1.347 1.16 0 CA-C-O 118.351 -1.249 . . . . 63.24 112.313 -177.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 243' ' ' PRO . . . . . 0.601 ' HD2' ' HB3' ' A' ' 191' ' ' GLN . 25.2 Cg_endo -55.21 -45.58 39.32 Favored 'Trans proline' 0 C--N 1.38 2.23 0 C-N-CA 124.414 3.409 . . . . 75.14 113.489 -174.599 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -86.64 -13.22 46.21 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 123.156 0.582 . . . . 72.1 111.539 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 92.54 -30.64 6.71 Favored Glycine 0 C--N 1.348 1.21 0 N-CA-C 112.068 -0.413 . . . . 73.24 112.068 -174.402 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 46.0 ttm-85 -128.28 112.47 14.5 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 124.364 1.065 . . . . 70.42 109.114 176.066 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -72.73 154.78 50.43 Favored Glycine 0 C--N 1.347 1.192 0 O-C-N 123.181 0.301 . . . . 65.12 113.584 172.883 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 20.9 m-20 -110.24 165.49 11.72 Favored 'General case' 0 C--O 1.237 0.398 0 C-N-CA 123.996 0.918 . . . . 73.32 110.088 -177.689 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 249' ' ' LEU . . . . . 0.564 ' HB3' ' HB2' ' A' ' 235' ' ' LEU . 34.7 tp -129.47 113.32 14.75 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 123.758 0.823 . . . . 74.52 108.877 176.16 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 250' ' ' TYR . . . . . 0.449 ' HA ' ' O ' ' A' ' 233' ' ' LEU . 7.5 m-85 -91.04 110.55 21.82 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 115.664 -0.698 . . . . 74.54 110.627 -177.452 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 251' ' ' LEU . . . . . 0.677 HD13 HD22 ' A' ' 197' ' ' LEU . 84.6 mt -88.39 105.36 17.54 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 114.139 -1.391 . . . . 72.33 109.143 -178.644 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -80.12 100.83 8.42 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 108.687 -0.857 . . . . 72.32 108.687 175.849 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 253' ' ' VAL . . . . . 0.4 HG23 ' HA ' ' A' ' 229' ' ' ALA . 12.1 m -63.58 133.97 28.92 Favored 'Isoleucine or valine' 0 C--O 1.246 0.895 0 O-C-N 123.775 0.672 . . . . 64.24 110.094 -179.777 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 20.5 mmm-85 -127.64 94.22 3.91 Favored 'General case' 0 C--O 1.24 0.59 0 N-CA-C 107.815 -1.179 . . . . 73.04 107.815 -177.257 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 255' ' ' ILE . . . . . 0.494 ' HA ' ' O ' ' A' ' 199' ' ' VAL . 22.4 mt -76.76 133.75 30.27 Favored 'Isoleucine or valine' 0 C--O 1.238 0.469 0 O-C-N 124.482 1.114 . . . . 72.05 110.836 -173.909 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 9.7 t . . . . . 0 CA--C 1.569 1.698 0 CA-C-O 117.589 -1.196 . . . . 63.42 108.832 179.824 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 13.5 tpt . . . . . 0 N--CA 1.476 0.869 0 N-CA-C 108.875 -0.787 . . . . 75.23 108.875 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 169' ' ' GLN . . . . . 0.589 ' HG3' ' H ' ' A' ' 170' ' ' THR . 7.5 pt20 -145.79 -74.46 0.22 Allowed 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 123.204 0.602 . . . . 73.23 110.617 -178.931 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . 0.589 ' H ' ' HG3' ' A' ' 169' ' ' GLN . 14.1 m -164.84 112.56 1.03 Allowed 'General case' 0 CA--C 1.538 0.503 0 N-CA-C 107.062 -1.459 . . . . 63.4 107.062 -162.199 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -124.37 -93.56 0.5 Allowed 'General case' 0 N--CA 1.488 1.431 0 C-N-CA 122.999 0.52 . . . . 71.24 112.053 -168.346 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 172' ' ' LEU . . . . . 0.644 HD21 ' H ' ' A' ' 222' ' ' ALA . 53.3 mt -134.35 145.17 48.74 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 123.591 0.756 . . . . 72.14 110.188 -170.973 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 173' ' ' PHE . . . . . 0.486 ' CD1' HD22 ' A' ' 235' ' ' LEU . 52.3 m-85 -140.66 -58.27 0.52 Allowed 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.829 0.852 . . . . 70.4 109.191 -164.067 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 174' ' ' TYR . . . . . 0.486 ' OH ' ' HB ' ' A' ' 221' ' ' VAL . 7.2 p90 -70.53 -14.96 62.72 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 114.347 -1.297 . . . . 63.34 113.089 -177.806 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -45.73 -29.02 1.16 Allowed 'General case' 0 N--CA 1.49 1.574 0 C-N-CA 126.172 1.789 . . . . 62.15 114.076 -173.157 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 176' ' ' MET . . . . . . . . . . . . . 66.5 mtm -55.7 -38.95 70.38 Favored 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 124.736 1.214 . . . . 75.34 112.934 -178.58 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 14.3 ptmm? -160.42 34.48 0.16 Allowed 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 123.503 0.721 . . . . 55.21 110.848 -170.766 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -64.16 -46.24 84.88 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 124.764 1.226 . . . . 63.44 113.479 -169.705 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . 0.453 ' HB2' ' HB2' ' A' ' 224' ' ' PRO . . . -82.65 65.79 7.95 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-O 122.124 0.964 . . . . 75.55 109.629 -179.71 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -164.61 -169.49 28.27 Favored Glycine 0 C--O 1.243 0.685 0 CA-C-N 114.19 -1.368 . . . . 71.34 110.48 -179.327 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 72.0 m -151.5 90.16 1.55 Allowed 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 124.111 0.964 . . . . 70.03 108.596 176.829 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -79.45 -177.34 50.05 Favored Glycine 0 C--N 1.345 1.047 0 CA-C-N 115.507 -0.77 . . . . 73.42 112.397 177.404 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -82.45 64.36 4.29 Favored Glycine 0 C--N 1.346 1.13 0 CA-C-N 116.891 0.345 . . . . 72.43 112.358 178.38 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 49.6 m -85.04 -11.82 54.5 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 123.829 0.852 . . . . 72.03 111.372 -179.42 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -70.44 117.67 7.34 Favored Glycine 0 C--N 1.349 1.26 0 N-CA-C 111.624 -0.59 . . . . 53.04 111.624 176.693 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -169.98 169.19 41.99 Favored Glycine 0 C--N 1.34 0.781 0 N-CA-C 111.804 -0.518 . . . . 35.53 111.804 -178.573 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 52.6 p -79.39 93.97 5.44 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 123.095 0.558 . . . . 63.34 109.826 177.542 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -66.81 159.36 49.04 Favored Glycine 0 C--N 1.349 1.277 0 CA-C-N 115.656 -0.702 . . . . 24.44 112.376 175.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -104.34 28.17 16.21 Favored Glycine 0 N--CA 1.473 1.109 0 CA-C-O 119.875 -0.403 . . . . 61.44 112.315 179.537 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 19.7 m 70.66 6.01 5.65 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 125.437 1.495 . . . . 75.41 112.263 -173.78 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 191' ' ' GLN . . . . . 0.718 HE22 ' HB3' ' A' ' 244' ' ' ALA . 5.8 pt20 -75.72 -42.06 51.8 Favored 'General case' 0 C--N 1.358 0.954 0 N-CA-C 109.235 -0.654 . . . . 45.21 109.235 175.822 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . 0.513 ' N ' ' HG3' ' A' ' 191' ' ' GLN . 31.3 m-20 -80.27 137.33 36.61 Favored 'General case' 0 C--N 1.354 0.778 0 CA-C-N 115.229 -0.896 . . . . 62.25 109.003 -176.125 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 32.2 mt -113.05 174.83 5.71 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 115.85 -0.614 . . . . 64.45 111.379 -173.438 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 48.5 m-85 -136.93 124.15 21.78 Favored 'General case' 0 C--O 1.238 0.492 0 C-N-CA 124.552 1.141 . . . . 74.0 109.466 -179.771 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . 0.4 ' O ' ' HA ' ' A' ' 251' ' ' LEU . . . -135.42 128.29 31.26 Favored 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 107.269 -1.382 . . . . 73.41 107.269 171.429 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 44.9 m -82.77 125.8 31.68 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 109.188 -0.671 . . . . 74.13 109.188 -179.839 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 0.52 HD22 HD13 ' A' ' 251' ' ' LEU . 15.9 tp -106.65 110.8 23.09 Favored 'General case' 0 N--CA 1.466 0.333 0 N-CA-C 107.916 -1.142 . . . . 73.24 107.916 -176.743 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -87.69 126.61 35.07 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 123.272 0.629 . . . . 54.43 109.345 -179.336 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 199' ' ' VAL . . . . . 0.478 ' O ' ' HA ' ' A' ' 255' ' ' ILE . 5.5 p -144.83 132.63 10.52 Favored Pre-proline 0 CA--C 1.55 0.969 0 N-CA-C 108.409 -0.96 . . . . 52.53 108.409 -178.792 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -72.74 159.35 48.72 Favored 'Trans proline' 0 C--N 1.368 1.583 0 C-N-CA 121.987 1.792 . . . . 55.31 111.023 171.031 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 201' ' ' ALA . . . . . 0.494 ' O ' HG23 ' A' ' 205' ' ' VAL . . . -50.95 -53.71 45.0 Favored Pre-proline 0 CA--C 1.558 1.264 0 CA-C-O 117.659 -1.162 . . . . 70.34 113.361 -176.466 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -63.95 -35.31 55.73 Favored 'Trans proline' 0 C--N 1.389 2.677 0 C-N-CA 121.598 1.532 . . . . 75.03 113.504 -175.799 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 41.0 mt -68.73 -33.82 61.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 N-CA-C 109.702 -0.481 . . . . 74.41 109.702 176.005 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 204' ' ' ALA . . . . . 0.478 ' HB1' ' HB ' ' A' ' 227' ' ' THR . . . -70.14 -35.66 74.22 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 123.228 0.611 . . . . 55.24 111.305 178.47 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . 0.494 HG23 ' O ' ' A' ' 201' ' ' ALA . 90.2 t -70.94 -56.44 10.65 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 C-N-CA 123.398 0.679 . . . . 73.44 110.522 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 17.3 m -73.32 -27.57 24.11 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.956 0 C-N-CA 122.862 0.465 . . . . 61.53 111.334 -174.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 81.36 69.62 1.39 Allowed Glycine 0 C--N 1.341 0.85 0 CA-C-N 115.839 -0.619 . . . . 72.54 112.262 -175.622 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -87.56 -140.05 6.44 Favored Glycine 0 C--N 1.355 1.618 0 CA-C-O 119.593 -0.56 . . . . 72.53 112.236 177.879 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 47.8 mtmt -137.35 147.47 45.57 Favored 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 123.66 0.784 . . . . 74.12 110.97 179.662 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 5.6 m -143.39 160.17 17.12 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 C-N-CA 125.271 1.428 . . . . 75.51 109.369 176.804 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 24.3 ttt180 -90.49 114.58 26.8 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 123.929 0.892 . . . . 70.44 110.449 179.587 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -102.18 131.87 48.43 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 124.753 1.221 . . . . 60.22 109.841 174.772 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 37.2 tpp -88.28 130.96 34.97 Favored 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 109.87 -0.418 . . . . 70.13 109.87 176.506 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 63.4 p -120.24 -171.68 2.21 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 124.309 1.043 . . . . 75.1 109.279 177.425 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 89.9 mt -67.93 -22.21 65.07 Favored 'General case' 0 CA--C 1.55 0.971 0 C-N-CA 123.315 0.646 . . . . 73.13 111.789 172.347 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 58.6 mt-10 -90.68 -21.12 21.79 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 123.578 0.751 . . . . 74.41 111.258 -177.685 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 124.48 -156.34 18.52 Favored Glycine 0 C--N 1.34 0.779 0 N-CA-C 111.092 -0.803 . . . . 42.4 111.092 -173.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -76.3 140.16 21.75 Favored 'Trans proline' 0 CA--C 1.551 1.356 0 C-N-CA 122.219 1.946 . . . . 74.42 113.932 -176.821 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 2.4 p -131.98 128.98 60.2 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.451 0 C-N-CA 124.678 1.191 . . . . 62.04 108.015 172.109 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -81.75 102.09 10.54 Favored 'General case' 0 C--O 1.236 0.376 0 N-CA-C 108.349 -0.982 . . . . 72.33 108.349 174.011 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 221' ' ' VAL . . . . . 0.486 ' HB ' ' OH ' ' A' ' 174' ' ' TYR . 13.9 m -97.65 138.85 21.33 Favored 'Isoleucine or valine' 0 C--O 1.242 0.679 0 CA-C-N 115.431 -0.804 . . . . 64.45 109.459 179.57 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . 0.644 ' H ' HD21 ' A' ' 172' ' ' LEU . . . -88.85 107.83 19.2 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-N 115.05 -0.977 . . . . 63.41 109.624 -177.355 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 61.2 t -54.09 134.3 59.15 Favored Pre-proline 0 N--CA 1.482 1.137 0 C-N-CA 124.302 1.041 . . . . 65.14 109.532 -179.332 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 224' ' ' PRO . . . . . 0.453 ' HB2' ' HB2' ' A' ' 179' ' ' ALA . 26.1 Cg_endo -60.52 151.23 76.8 Favored 'Trans proline' 0 C--N 1.373 1.858 0 C-N-CA 121.922 1.748 . . . . 70.13 112.647 177.29 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -64.56 133.76 38.37 Favored 'Trans proline' 0 C--N 1.368 1.601 0 C-N-CA 121.485 1.457 . . . . 74.1 110.677 169.505 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 55.3 mtt180 67.03 62.64 0.48 Allowed 'General case' 0 C--O 1.241 0.629 0 C-N-CA 124.797 1.239 . . . . 63.42 109.831 175.668 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 227' ' ' THR . . . . . 0.677 ' HA ' ' HE ' ' A' ' 231' ' ' ARG . 56.1 m -89.87 140.51 29.54 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 113.866 -1.515 . . . . 74.33 109.173 176.582 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -116.64 141.54 48.07 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.736 0.814 . . . . 70.22 108.862 171.884 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 229' ' ' ALA . . . . . 0.441 ' HB2' ' HB ' ' A' ' 255' ' ' ILE . . . -58.91 116.99 4.15 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 123.651 0.781 . . . . 62.0 110.217 179.911 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 115.16 -2.2 22.51 Favored Glycine 0 CA--C 1.526 0.754 0 CA-C-O 119.123 -0.821 . . . . 73.11 113.542 -173.07 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 231' ' ' ARG . . . . . 0.677 ' HE ' ' HA ' ' A' ' 227' ' ' THR . 77.5 mtt-85 -66.38 145.49 55.64 Favored 'General case' 0 N--CA 1.483 1.203 0 CA-C-N 118.042 0.921 . . . . 52.32 109.183 169.55 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -121.38 98.81 6.15 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 107.899 -1.149 . . . . 74.34 107.899 -174.477 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 233' ' ' LEU . . . . . 0.807 ' HB2' ' HB2' ' A' ' 251' ' ' LEU . 53.7 mt -79.79 152.27 29.86 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 115.36 -0.836 . . . . 54.23 109.371 179.843 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 234' ' ' ARG . . . . . 0.459 ' H ' ' HB3' ' A' ' 174' ' ' TYR . 59.4 ttm-85 -122.29 106.49 11.15 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 122.937 0.495 . . . . 72.32 110.542 -175.464 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 235' ' ' LEU . . . . . 0.603 ' HB2' ' HB3' ' A' ' 249' ' ' LEU . 10.3 mt -91.58 100.17 12.96 Favored 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 109.043 -0.725 . . . . 63.54 109.043 171.376 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 19.4 mttt -67.34 132.91 48.63 Favored 'General case' 0 C--O 1.241 0.61 0 O-C-N 123.365 0.416 . . . . 73.42 111.347 -178.042 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 73.89 18.2 79.55 Favored Glycine 0 C--N 1.347 1.193 0 CA-C-N 115.03 -0.986 . . . . 71.43 115.034 177.248 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 68.9 mmtt -106.4 12.41 29.78 Favored 'General case' 0 N--CA 1.488 1.455 0 CA-C-N 117.405 0.603 . . . . 75.15 110.514 174.749 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -113.9 -165.66 15.73 Favored Glycine 0 CA--C 1.527 0.811 0 CA-C-N 114.822 -1.081 . . . . 71.21 110.732 167.802 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -95.17 168.01 11.84 Favored Pre-proline 0 N--CA 1.479 1.022 0 C-N-CA 124.278 1.031 . . . . 62.12 110.097 -177.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -81.27 149.14 16.97 Favored 'Trans proline' 0 C--N 1.372 1.786 0 C-N-CA 121.599 1.533 . . . . 74.14 112.859 171.63 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 179.52 -119.75 0.66 Allowed Glycine 0 CA--C 1.54 1.598 0 CA-C-O 119.004 -0.887 . . . . 70.22 113.28 176.021 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 243' ' ' PRO . . . . . 0.445 ' HD2' ' HB3' ' A' ' 191' ' ' GLN . 34.1 Cg_endo -55.62 -46.67 30.23 Favored 'Trans proline' 0 C--N 1.382 2.306 1 C-N-CA 125.364 4.043 . . . . 41.54 114.055 -172.241 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 244' ' ' ALA . . . . . 0.718 ' HB3' HE22 ' A' ' 191' ' ' GLN . . . -100.19 -2.21 34.55 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 123.315 0.646 . . . . 74.3 110.952 -179.133 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 87.8 -51.51 4.1 Favored Glycine 0 C--N 1.353 1.489 0 N-CA-C 111.833 -0.507 . . . . 71.55 111.833 -178.461 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 10.2 ttm180 -101.05 109.63 21.55 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 123.947 0.899 . . . . 51.3 109.879 176.679 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -75.98 130.41 10.94 Favored Glycine 0 C--N 1.351 1.373 0 N-CA-C 110.661 -0.976 . . . . 45.53 110.661 169.264 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 67.4 m-20 -112.31 145.65 39.65 Favored 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 109.332 -0.618 . . . . 72.04 109.332 -176.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 249' ' ' LEU . . . . . 0.603 ' HB3' ' HB2' ' A' ' 235' ' ' LEU . 31.4 tp -97.87 118.68 34.99 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 123.677 0.791 . . . . 61.12 109.207 -175.239 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 250' ' ' TYR . . . . . 0.408 ' HA ' ' O ' ' A' ' 233' ' ' LEU . 1.6 m-85 -89.34 108.87 19.88 Favored 'General case' 0 C--O 1.243 0.739 0 N-CA-C 108.727 -0.842 . . . . 75.1 108.727 -177.337 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 251' ' ' LEU . . . . . 0.807 ' HB2' ' HB2' ' A' ' 233' ' ' LEU . 79.7 mt -87.36 104.03 16.04 Favored 'General case' 0 C--O 1.241 0.61 0 N-CA-C 107.94 -1.133 . . . . 74.05 107.94 177.41 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -84.1 100.15 10.93 Favored 'General case' 0 C--O 1.238 0.457 0 CA-C-N 115.063 -0.972 . . . . 63.44 108.918 -177.535 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 11.7 m -72.04 135.59 27.53 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 CA-C-O 121.53 0.681 . . . . 60.25 110.67 -172.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 49.7 mmm-85 -127.42 98.92 5.42 Favored 'General case' 0 C--O 1.237 0.431 0 C-N-CA 124.608 1.163 . . . . 71.0 108.299 -178.594 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 255' ' ' ILE . . . . . 0.478 ' HA ' ' O ' ' A' ' 199' ' ' VAL . 27.2 mt -77.95 128.59 38.14 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 O-C-N 124.169 0.918 . . . . 73.12 109.754 179.735 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 4.2 t . . . . . 0 CA--C 1.559 1.327 0 CA-C-O 117.273 -1.346 . . . . 72.42 107.957 179.486 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 24.7 ptp . . . . . 0 N--CA 1.493 1.695 0 N-CA-C 111.648 0.24 . . . . 74.51 111.648 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -167.16 -157.39 0.24 Allowed 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.539 0.736 . . . . 72.42 109.302 -173.427 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 10.8 t -124.67 172.77 9.01 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 123.483 0.713 . . . . 74.32 109.398 170.425 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . 0.405 ' O ' HG23 ' A' ' 221' ' ' VAL . 2.7 p-10 -153.64 -63.69 0.14 Allowed 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 123.05 0.54 . . . . 72.23 111.314 -174.415 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 172' ' ' LEU . . . . . 0.447 HD21 ' HB3' ' A' ' 222' ' ' ALA . 43.4 mt -119.56 140.76 50.02 Favored 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 123.102 0.561 . . . . 71.2 112.035 -169.029 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 173' ' ' PHE . . . . . 0.501 ' CD1' HD22 ' A' ' 235' ' ' LEU . 11.9 m-85 -137.65 -44.95 0.54 Allowed 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 124.028 0.931 . . . . 64.25 109.519 -173.042 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 174' ' ' TYR . . . . . 0.518 ' CD2' ' HB3' ' A' ' 233' ' ' LEU . 0.7 OUTLIER -81.97 13.44 3.34 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-N 114.832 -1.076 . . . . 70.32 112.899 -175.689 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 175' ' ' THR . . . . . 0.427 HG23 ' HB3' ' A' ' 172' ' ' LEU . 11.6 p -63.37 -9.12 10.76 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.867 0.867 . . . . 71.24 113.308 -179.857 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 176' ' ' MET . . . . . . . . . . . . . 44.9 mtm -58.41 -63.96 1.09 Allowed 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 123.595 0.758 . . . . 52.42 109.104 166.36 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 44.8 pttt -168.1 119.06 0.81 Allowed 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 125.094 1.358 . . . . 74.42 108.337 -179.053 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 178' ' ' ALA . . . . . 0.583 ' HB1' HD22 ' A' ' 233' ' ' LEU . . . -124.04 -54.5 1.71 Allowed 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 123.916 0.886 . . . . 42.14 109.82 -173.641 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . 0.419 ' HA ' ' HD3' ' A' ' 231' ' ' ARG . . . -79.42 65.13 4.5 Favored 'General case' 0 CA--C 1.543 0.702 0 CA-C-O 121.918 0.866 . . . . 74.11 108.742 169.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 140.36 77.59 0.05 OUTLIER Glycine 0 C--N 1.336 0.568 0 N-CA-C 110.148 -1.181 . . . . 35.53 110.148 -171.672 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 24.6 m -81.67 15.05 2.3 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 123.475 0.71 . . . . 74.55 112.406 -176.922 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -61.41 93.82 0.08 OUTLIER Glycine 0 C--N 1.345 1.065 0 N-CA-C 112.032 -0.427 . . . . 61.45 112.032 172.543 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -163.36 -109.15 0.23 Allowed Glycine 0 C--N 1.335 0.524 0 N-CA-C 111.283 -0.727 . . . . 71.32 111.283 -178.122 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 24.9 p -148.45 166.85 26.92 Favored 'General case' 0 C--O 1.245 0.84 0 C-N-CA 123.34 0.656 . . . . 72.51 111.182 -175.545 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . 0.451 ' HA2' ' NH2' ' A' ' 234' ' ' ARG . . . -114.73 -100.5 2.33 Favored Glycine 0 C--N 1.349 1.292 0 N-CA-C 111.187 -0.765 . . . . 53.44 111.187 176.348 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 149.52 121.91 1.13 Allowed Glycine 0 C--N 1.351 1.368 0 N-CA-C 112.123 -0.391 . . . . 72.12 112.123 -179.619 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 33.1 m -128.34 139.67 52.27 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 123.683 0.793 . . . . 71.21 109.776 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 131.33 17.51 1.41 Allowed Glycine 0 C--N 1.341 0.846 0 CA-C-N 116.083 -0.508 . . . . 63.14 111.885 -176.508 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 153.65 141.09 3.19 Favored Glycine 0 C--N 1.344 1.028 0 N-CA-C 110.551 -1.02 . . . . 74.42 110.551 -178.347 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 68.8 m -73.33 84.14 1.42 Allowed 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 123.396 0.678 . . . . 73.22 110.189 179.658 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 191' ' ' GLN . . . . . 0.435 ' HG3' ' N ' ' A' ' 192' ' ' ASP . 6.5 pt20 -106.14 -42.04 5.19 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 116.162 -0.472 . . . . 64.2 110.278 -179.713 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . 0.435 ' N ' ' HG3' ' A' ' 191' ' ' GLN . 73.5 m-20 -84.94 121.0 27.13 Favored 'General case' 0 C--N 1.347 0.482 0 C-N-CA 123.998 0.919 . . . . 61.24 109.404 -175.722 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . 0.488 HD12 ' HA2' ' A' ' 239' ' ' GLY . 78.5 mt -108.17 177.67 4.73 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 124.351 1.06 . . . . 72.34 110.479 -170.383 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 47.3 m-85 -129.61 123.59 31.65 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 123.426 0.691 . . . . 71.02 110.736 -179.546 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . 0.435 ' HB2' HD11 ' A' ' 249' ' ' LEU . . . -128.29 171.98 11.48 Favored 'General case' 0 C--O 1.238 0.496 0 C-N-CA 125.64 1.576 . . . . 71.55 108.43 173.401 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 48.6 m -119.05 134.03 55.44 Favored 'General case' 0 C--O 1.237 0.446 0 C-N-CA 123.126 0.571 . . . . 55.53 109.675 175.57 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 0.731 HD22 HD13 ' A' ' 251' ' ' LEU . 17.1 tp -116.37 110.87 19.25 Favored 'General case' 0 C--O 1.234 0.288 0 N-CA-C 108.178 -1.045 . . . . 71.33 108.178 175.477 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -90.14 122.56 33.21 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 108.68 -0.859 . . . . 74.02 108.68 -179.632 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 199' ' ' VAL . . . . . 0.413 ' O ' ' HA ' ' A' ' 255' ' ' ILE . 5.0 p -136.18 132.4 19.08 Favored Pre-proline 0 CA--C 1.549 0.917 0 C-N-CA 124.287 1.035 . . . . 72.21 108.835 -174.795 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -71.73 158.87 52.3 Favored 'Trans proline' 0 C--N 1.367 1.551 0 C-N-CA 122.025 1.817 . . . . 74.21 111.256 171.422 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -53.0 -46.06 97.81 Favored Pre-proline 0 CA--C 1.558 1.257 0 N-CA-C 114.208 1.188 . . . . 73.14 114.208 -179.675 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 202' ' ' PRO . . . . . 0.465 ' HA ' HG22 ' A' ' 205' ' ' VAL . 34.3 Cg_endo -62.8 -43.45 20.47 Favored 'Trans proline' 0 C--N 1.385 2.494 0 C-N-CA 121.918 1.745 . . . . 64.43 113.675 177.527 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 43.5 mt -66.01 -30.73 50.89 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.351 0 CA-C-N 118.746 0.703 . . . . 73.13 110.5 177.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -68.74 -49.38 59.26 Favored 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 122.769 0.428 . . . . 64.02 111.587 177.26 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . 0.465 HG22 ' HA ' ' A' ' 202' ' ' PRO . 22.7 m -70.92 -47.83 60.09 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.848 0 C-N-CA 123.542 0.737 . . . . 71.03 112.411 -174.905 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 206' ' ' VAL . . . . . 0.449 HG22 ' O ' ' A' ' 202' ' ' PRO . 11.0 m -76.22 -34.19 25.45 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.235 0 C-N-CA 122.552 0.341 . . . . 43.12 110.979 179.712 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 87.47 61.06 1.57 Allowed Glycine 0 C--N 1.35 1.31 0 CA-C-N 116.251 -0.431 . . . . 70.11 112.135 -175.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -81.59 -133.93 1.64 Allowed Glycine 0 C--N 1.346 1.132 0 N-CA-C 112.511 -0.236 . . . . 74.1 112.511 177.929 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 48.0 mtmt -136.21 152.67 51.01 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 123.895 0.878 . . . . 60.5 110.839 178.741 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 4.5 m -144.76 163.52 13.48 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 C-N-CA 125.412 1.485 . . . . 70.44 108.363 172.238 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 42.0 ttp180 -98.94 115.36 28.71 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 123.622 0.769 . . . . 74.14 109.26 179.277 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -101.92 120.81 41.0 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 124.145 0.978 . . . . 71.21 110.429 -179.489 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 74.6 mtp -84.26 137.28 33.56 Favored 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 110.125 -0.324 . . . . 55.24 110.125 175.708 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 38.0 p -130.54 -172.9 2.92 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 124.592 1.157 . . . . 74.02 109.551 -175.889 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 82.6 mt -58.29 -35.0 71.17 Favored 'General case' 0 N--CA 1.488 1.465 0 CA-C-O 121.152 0.501 . . . . 73.31 110.565 172.723 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -92.29 -8.49 45.05 Favored 'General case' 0 CA--C 1.545 0.754 0 CA-C-N 115.166 -0.925 . . . . 72.01 111.378 -177.8 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 113.61 -159.32 13.75 Favored Glycine 0 C--N 1.348 1.224 0 CA-C-O 119.575 -0.569 . . . . 62.21 113.329 174.111 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -77.86 136.66 15.19 Favored 'Trans proline' 0 C--N 1.368 1.566 0 C-N-CA 123.24 2.627 . . . . 72.44 113.217 -171.584 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 6.2 p -132.8 133.09 59.4 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 C-N-CA 124.403 1.081 . . . . 64.4 109.376 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -76.61 102.06 5.97 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 108.534 -0.913 . . . . 63.04 108.534 176.173 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 221' ' ' VAL . . . . . 0.405 HG23 ' O ' ' A' ' 171' ' ' ASP . 6.1 p -110.06 127.25 67.1 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.975 0 N-CA-C 109.242 -0.651 . . . . 54.3 109.242 -174.06 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . 0.447 ' HB3' HD21 ' A' ' 172' ' ' LEU . . . -81.76 108.36 15.24 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 122.991 0.516 . . . . 42.11 110.755 -177.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 65.1 t -54.34 135.25 61.15 Favored Pre-proline 0 N--CA 1.484 1.245 0 C-N-CA 124.671 1.188 . . . . 51.3 110.61 179.8 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -65.41 147.69 87.43 Favored 'Trans proline' 0 C--N 1.378 2.119 0 C-N-CA 122.012 1.808 . . . . 63.13 110.873 174.219 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -60.89 138.0 76.17 Favored 'Trans proline' 0 C--N 1.368 1.592 0 C-N-CA 121.66 1.573 . . . . 73.13 111.058 174.238 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 30.9 mtm105 63.24 51.23 2.76 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 124.597 1.159 . . . . 64.5 110.953 174.632 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 227' ' ' THR . . . . . 0.41 HG23 ' HD2' ' A' ' 231' ' ' ARG . 90.4 m -77.7 137.05 38.28 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 115.299 -0.864 . . . . 73.04 109.087 170.457 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 28.1 mp0 -114.65 147.02 40.18 Favored 'General case' 0 N--CA 1.479 0.993 0 N-CA-C 108.939 -0.763 . . . . 61.23 108.939 174.534 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -57.91 124.54 19.58 Favored 'General case' 0 C--O 1.24 0.557 0 O-C-N 123.903 0.752 . . . . 73.11 111.017 -178.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 114.87 -14.53 19.52 Favored Glycine 0 N--CA 1.468 0.816 0 CA-C-O 119.076 -0.847 . . . . 43.45 113.858 -176.776 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 231' ' ' ARG . . . . . 0.419 ' HD3' ' HA ' ' A' ' 179' ' ' ALA . 88.9 mtt-85 -62.95 146.61 52.64 Favored 'General case' 0 N--CA 1.478 0.967 0 CA-C-N 117.759 0.779 . . . . 53.13 111.113 178.12 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 71.7 mmtt -118.84 97.49 5.73 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 123.996 0.918 . . . . 75.22 109.029 -172.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 233' ' ' LEU . . . . . 0.653 ' HB2' ' HB2' ' A' ' 251' ' ' LEU . 21.2 mt -85.52 137.96 32.53 Favored 'General case' 0 CA--C 1.546 0.807 0 N-CA-C 109.126 -0.694 . . . . 73.32 109.126 -175.316 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 234' ' ' ARG . . . . . 0.451 ' NH2' ' HA2' ' A' ' 185' ' ' GLY . 36.3 ttm-85 -110.86 114.31 27.55 Favored 'General case' 0 CA--C 1.558 1.25 0 C-N-CA 123.054 0.542 . . . . 75.44 111.377 -169.027 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 235' ' ' LEU . . . . . 0.572 HD11 HD11 ' A' ' 251' ' ' LEU . 16.5 mt -108.63 113.56 26.65 Favored 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 123.929 0.891 . . . . 74.4 111.641 -176.535 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 34.8 mttp -72.91 148.94 43.86 Favored 'General case' 0 N--CA 1.481 1.114 0 CA-C-O 121.338 0.589 . . . . 73.55 111.76 174.164 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 78.17 0.59 77.6 Favored Glycine 0 C--N 1.344 1.02 0 CA-C-N 114.107 -1.406 . . . . 72.11 113.87 179.775 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 73.4 mmtt -112.85 3.43 16.38 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.177 0.591 . . . . 74.05 111.457 -174.646 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 239' ' ' GLY . . . . . 0.488 ' HA2' HD12 ' A' ' 193' ' ' LEU . . . -113.27 -170.15 17.49 Favored Glycine 0 C--N 1.348 1.241 0 N-CA-C 111.328 -0.709 . . . . 35.0 111.328 166.834 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 79.8 m-85 -88.3 151.71 49.08 Favored Pre-proline 0 N--CA 1.481 1.114 0 C-N-CA 123.084 0.553 . . . . 52.54 110.803 -178.114 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_exo -67.44 168.03 19.06 Favored 'Trans proline' 0 C--N 1.371 1.741 0 C-N-CA 122.361 2.04 . . . . 73.12 112.614 172.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 144.06 -104.78 0.35 Allowed Glycine 0 C--N 1.348 1.212 0 CA-C-O 119.332 -0.704 . . . . 72.21 113.982 172.149 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -64.22 -30.86 64.47 Favored 'Trans proline' 0 C--N 1.375 1.94 0 C-N-CA 124.012 3.141 . . . . 72.14 114.313 -168.0 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -117.15 5.83 12.77 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 122.924 0.489 . . . . 32.41 110.701 173.593 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 87.81 -46.23 3.42 Favored Glycine 0 C--N 1.35 1.353 0 CA-C-N 116.905 -0.134 . . . . 63.33 113.131 178.234 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 31.3 ttm180 -123.99 112.02 16.7 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 124.369 1.068 . . . . 72.34 109.299 177.479 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -73.57 159.56 53.19 Favored Glycine 0 C--N 1.349 1.253 0 O-C-N 123.431 0.457 . . . . 52.12 114.17 176.119 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 248' ' ' ASP . . . . . 0.418 ' HA ' ' O ' ' A' ' 235' ' ' LEU . 12.4 m-20 -111.56 171.52 7.44 Favored 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 124.026 0.93 . . . . 71.51 111.4 -177.838 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 249' ' ' LEU . . . . . 0.435 HD11 ' HB2' ' A' ' 195' ' ' ALA . 25.9 tp -130.6 126.33 36.43 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 115.021 -0.99 . . . . 72.04 109.748 174.107 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 250' ' ' TYR . . . . . . . . . . . . . 2.8 m-30 -89.85 113.0 24.51 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 124.235 1.014 . . . . 72.03 110.516 179.76 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 251' ' ' LEU . . . . . 0.731 HD13 HD22 ' A' ' 197' ' ' LEU . 86.0 mt -87.2 103.34 15.33 Favored 'General case' 0 C--O 1.24 0.578 0 N-CA-C 107.243 -1.391 . . . . 75.2 107.243 176.091 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -80.77 101.54 9.39 Favored 'General case' 0 C--O 1.241 0.625 0 N-CA-C 108.542 -0.91 . . . . 75.1 108.542 177.594 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 17.9 m -73.59 135.56 27.3 Favored 'Isoleucine or valine' 0 C--O 1.244 0.808 0 CA-C-N 115.695 -0.684 . . . . 72.42 110.831 -172.678 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 31.3 mmm180 -125.93 99.23 5.85 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 114.559 -1.2 . . . . 71.1 108.13 -176.734 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 255' ' ' ILE . . . . . 0.413 ' HA ' ' O ' ' A' ' 199' ' ' VAL . 23.5 mt -79.35 123.06 35.77 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 O-C-N 123.565 0.541 . . . . 51.4 110.438 -179.562 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 2.0 t . . . . . 0 CA--C 1.563 1.466 0 N-CA-C 107.673 -1.232 . . . . 71.31 107.673 176.372 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 24.7 ttt . . . . . 0 N--CA 1.479 0.98 0 N-CA-C 109.706 -0.479 . . . . 74.52 109.706 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -82.73 -57.65 3.23 Favored 'General case' 0 CA--C 1.55 0.945 0 N-CA-C 108.665 -0.865 . . . . 63.25 108.665 169.363 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . 0.545 HG23 HG23 ' A' ' 219' ' ' VAL . 9.0 t 162.25 174.17 0.01 OUTLIER 'General case' 0 CA--C 1.553 1.075 0 C-N-CA 127.041 2.136 . . . . 75.43 107.238 -173.6 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -157.95 -40.34 0.07 Allowed 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 112.501 0.556 . . . . 74.31 112.501 -174.831 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 172' ' ' LEU . . . . . 0.409 HD21 ' O ' ' A' ' 222' ' ' ALA . 26.4 mt -145.32 153.54 41.37 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 112.524 0.565 . . . . 65.44 112.524 -172.686 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 173' ' ' PHE . . . . . 0.512 ' HE1' HG21 ' A' ' 219' ' ' VAL . 38.6 m-85 -150.45 -40.98 0.13 Allowed 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 124.765 1.226 . . . . 74.01 109.411 -171.396 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 174' ' ' TYR . . . . . 0.434 ' CD2' ' HB3' ' A' ' 233' ' ' LEU . 0.7 OUTLIER -96.22 6.69 48.24 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 124.141 0.976 . . . . 74.41 112.785 -172.748 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -50.72 -35.21 30.24 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 125.096 1.358 . . . . 65.41 113.036 -162.446 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 176' ' ' MET . . . . . . . . . . . . . 7.0 ptm -58.39 93.62 0.02 OUTLIER 'General case' 0 CA--C 1.564 1.487 0 C-N-CA 124.638 1.175 . . . . 53.44 112.111 172.865 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 48.8 mtmt 57.05 42.08 26.5 Favored 'General case' 0 N--CA 1.491 1.61 0 C-N-CA 124.858 1.263 . . . . 70.11 111.873 171.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 178' ' ' ALA . . . . . 0.493 ' HB1' HD22 ' A' ' 233' ' ' LEU . . . -62.19 -42.61 99.45 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.572 1.149 . . . . 74.32 111.56 -179.675 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . 0.48 ' HB2' ' HB2' ' A' ' 224' ' ' PRO . . . -80.68 14.4 2.13 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 123.489 0.716 . . . . 64.31 111.42 176.347 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -100.08 -56.05 0.96 Allowed Glycine 0 C--N 1.342 0.878 0 N-CA-C 109.914 -1.274 . . . . 45.54 109.914 169.496 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 181' ' ' SER . . . . . 0.46 ' HB3' HH11 ' A' ' 231' ' ' ARG . 30.8 t 53.51 20.24 2.0 Allowed 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 124.459 1.104 . . . . 55.11 112.612 174.375 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -85.79 70.05 3.1 Favored Glycine 0 C--N 1.349 1.289 0 C-N-CA 123.096 0.379 . . . . 53.51 112.371 -172.001 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 137.49 149.82 5.63 Favored Glycine 0 C--N 1.34 0.772 0 CA-C-N 115.467 -0.367 . . . . 62.33 112.399 178.501 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 26.2 t -106.41 175.83 5.37 Favored 'General case' 0 C--O 1.245 0.833 0 C-N-CA 124.282 1.033 . . . . 63.15 109.031 176.855 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -158.24 161.12 31.41 Favored Glycine 0 C--N 1.34 0.754 0 N-CA-C 112.435 -0.266 . . . . 63.01 112.435 179.851 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 104.34 123.11 5.2 Favored Glycine 0 C--N 1.346 1.096 0 N-CA-C 111.808 -0.517 . . . . 65.12 111.808 177.198 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 29.8 t -160.15 150.04 18.1 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 123.447 0.699 . . . . 62.42 109.917 -177.508 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 107.9 -32.32 7.19 Favored Glycine 0 C--N 1.351 1.402 0 O-C-N 123.275 0.359 . . . . 54.14 113.318 176.629 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -162.81 153.79 24.5 Favored Glycine 0 C--N 1.34 0.802 0 N-CA-C 111.061 -0.815 . . . . 74.43 111.061 -176.222 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 31.8 m -77.47 69.76 3.77 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 124.062 0.945 . . . . 73.25 110.852 -177.505 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 191' ' ' GLN . . . . . 0.648 ' HB3' ' HD2' ' A' ' 243' ' ' PRO . 8.0 pt20 -91.43 -42.24 10.41 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 123.43 0.692 . . . . 73.45 109.74 179.057 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . 0.42 ' N ' ' HG3' ' A' ' 191' ' ' GLN . 80.9 m-20 -78.77 157.58 28.43 Favored 'General case' 0 C--O 1.239 0.548 0 CA-C-N 115.479 -0.782 . . . . 70.34 110.42 -175.601 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 46.0 mt -127.68 169.35 13.89 Favored 'General case' 0 C--O 1.238 0.493 0 CA-C-N 114.594 -1.185 . . . . 74.33 109.415 -178.297 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 64.5 m-85 -135.23 139.22 44.3 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 124.253 1.021 . . . . 71.25 109.422 179.705 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . 0.461 ' HB2' HD11 ' A' ' 249' ' ' LEU . . . -150.19 171.67 16.55 Favored 'General case' 0 C--O 1.24 0.56 0 C-N-CA 124.861 1.264 . . . . 75.1 108.973 -177.602 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 17.6 m -115.31 137.64 51.82 Favored 'General case' 0 C--O 1.238 0.464 0 C-N-CA 122.966 0.507 . . . . 64.15 109.636 179.013 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 0.674 HD22 HD13 ' A' ' 251' ' ' LEU . 14.6 tp -115.43 110.64 19.62 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 108.914 -0.773 . . . . 74.22 108.914 177.371 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -79.58 122.79 26.93 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 108.742 -0.836 . . . . 70.5 108.742 174.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 199' ' ' VAL . . . . . 0.467 ' O ' ' HA ' ' A' ' 255' ' ' ILE . 4.1 p -142.58 123.32 8.3 Favored Pre-proline 0 CA--C 1.543 0.694 0 N-CA-C 108.771 -0.826 . . . . 72.4 108.771 178.697 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -67.57 158.48 56.95 Favored 'Trans proline' 0 C--N 1.364 1.365 0 C-N-CA 121.955 1.77 . . . . 74.2 111.049 171.883 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 201' ' ' ALA . . . . . 0.508 ' O ' HG23 ' A' ' 205' ' ' VAL . . . -47.3 -53.82 25.99 Favored Pre-proline 0 CA--C 1.562 1.42 0 CA-C-O 117.903 -1.046 . . . . 74.22 112.988 -179.093 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -62.45 -39.88 42.9 Favored 'Trans proline' 0 C--N 1.399 3.199 0 C-N-CA 121.997 1.798 . . . . 74.01 113.698 -176.267 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 36.5 mt -66.36 -32.63 58.94 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.252 0 C-N-CA 122.701 0.4 . . . . 54.14 110.091 178.783 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -71.23 -36.02 71.67 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 122.742 0.417 . . . . 74.51 111.63 177.222 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . 0.508 HG23 ' O ' ' A' ' 201' ' ' ALA . 94.9 t -68.58 -57.03 10.22 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.11 0 C-N-CA 123.126 0.57 . . . . 72.13 111.215 -178.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 32.8 m -80.05 -27.55 12.16 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 CA-C-N 116.109 -0.496 . . . . 65.43 111.605 -175.373 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 81.96 65.1 1.67 Allowed Glycine 0 C--N 1.342 0.902 0 CA-C-N 116.177 -0.465 . . . . 74.14 111.956 -175.188 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -81.32 -131.99 1.28 Allowed Glycine 0 C--N 1.356 1.655 0 N-CA-C 111.804 -0.519 . . . . 70.25 111.804 177.397 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 21.0 mtmm -137.94 143.37 40.71 Favored 'General case' 0 N--CA 1.481 1.107 0 CA-C-N 117.569 0.685 . . . . 64.04 111.136 177.372 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 11.1 m -135.93 166.37 27.29 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 C-N-CA 125.032 1.333 . . . . 74.21 109.755 176.65 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 58.4 ttp180 -100.25 114.65 28.27 Favored 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 123.545 0.738 . . . . 72.25 110.309 -178.174 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -101.6 139.2 37.57 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 124.035 0.934 . . . . 74.01 110.06 175.402 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 25.2 mmt -96.33 115.17 27.01 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 123.186 0.595 . . . . 63.52 109.68 179.408 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 214' ' ' THR . . . . . 0.414 ' HB ' ' HD2' ' A' ' 238' ' ' LYS . 43.9 p -122.23 -173.47 2.68 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 124.146 0.978 . . . . 72.41 111.038 -175.016 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 82.8 mt -69.25 -22.76 63.82 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 123.475 0.71 . . . . 75.04 111.019 172.771 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 20.4 mm-40 -86.45 -6.07 59.0 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 123.814 0.846 . . . . 74.32 110.663 173.146 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 94.82 -149.9 19.52 Favored Glycine 0 C--N 1.344 1.025 0 CA-C-O 119.331 -0.705 . . . . 63.23 112.303 -177.605 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -73.28 122.05 7.68 Favored 'Trans proline' 0 CA--C 1.555 1.537 0 C-N-CA 122.254 1.969 . . . . 75.24 112.754 -178.559 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 219' ' ' VAL . . . . . 0.545 HG23 HG23 ' A' ' 170' ' ' THR . 2.4 p -116.84 131.15 70.34 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 C-N-CA 124.647 1.179 . . . . 72.43 109.164 173.649 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 -81.12 101.29 9.53 Favored 'General case' 0 C--O 1.24 0.576 0 N-CA-C 107.454 -1.313 . . . . 73.24 107.454 168.688 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 4.6 p -100.63 131.32 48.44 Favored 'Isoleucine or valine' 0 C--O 1.246 0.897 0 N-CA-C 108.872 -0.788 . . . . 72.2 108.872 -176.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . 0.409 ' O ' HD21 ' A' ' 172' ' ' LEU . . . -77.68 106.95 9.81 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 122.759 0.424 . . . . 70.43 110.394 -176.723 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 59.9 t -54.24 135.49 60.08 Favored Pre-proline 0 N--CA 1.48 1.04 0 C-N-CA 124.054 0.942 . . . . 53.2 109.989 178.454 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 224' ' ' PRO . . . . . 0.48 ' HB2' ' HB2' ' A' ' 179' ' ' ALA . 53.8 Cg_endo -67.85 148.76 77.42 Favored 'Trans proline' 0 C--N 1.37 1.672 0 C-N-CA 121.605 1.537 . . . . 74.41 110.688 173.145 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 16.3 Cg_endo -59.78 139.85 90.47 Favored 'Trans proline' 0 C--N 1.366 1.449 0 C-N-CA 121.591 1.528 . . . . 71.03 110.698 172.014 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 69.5 mtm180 66.28 50.52 1.33 Allowed 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 124.194 0.998 . . . . 64.15 111.065 171.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 54.0 m -85.85 136.96 33.09 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.922 0.889 . . . . 65.21 109.415 173.481 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 27.2 mp0 -113.24 144.52 42.56 Favored 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 123.929 0.892 . . . . 62.44 109.634 178.127 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -58.48 120.97 9.77 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 123.92 0.888 . . . . 72.35 110.257 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 113.88 -7.01 23.82 Favored Glycine 0 C--O 1.239 0.44 0 CA-C-O 119.268 -0.74 . . . . 73.01 113.213 -176.013 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 231' ' ' ARG . . . . . 0.46 HH11 ' HB3' ' A' ' 181' ' ' SER . 69.0 mtt-85 -67.27 146.67 53.91 Favored 'General case' 0 C--N 1.355 0.821 0 CA-C-N 117.909 0.854 . . . . 75.04 109.689 172.521 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 232' ' ' LYS . . . . . 0.435 ' HB3' ' HD1' ' A' ' 250' ' ' TYR . 13.1 mtmm -126.28 99.45 5.87 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 123.823 0.849 . . . . 74.35 108.874 -178.803 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 233' ' ' LEU . . . . . 0.493 HD22 ' HB1' ' A' ' 178' ' ' ALA . 21.4 mt -83.56 135.78 34.5 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 113.844 -1.525 . . . . 74.52 109.491 -175.243 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 29.9 ttt85 -104.84 101.01 10.63 Favored 'General case' 0 N--CA 1.476 0.837 0 CA-C-O 121.15 0.5 . . . . 71.4 111.131 -172.815 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 235' ' ' LEU . . . . . 0.531 HD12 HD23 ' A' ' 249' ' ' LEU . 46.7 mt -77.28 100.78 5.99 Favored 'General case' 0 C--O 1.238 0.455 0 C-N-CA 124.512 1.125 . . . . 65.43 110.028 176.079 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 11.7 mtmt -68.11 134.43 50.56 Favored 'General case' 0 C--O 1.241 0.654 0 O-C-N 123.32 0.388 . . . . 71.4 111.535 177.702 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 82.1 18.95 65.98 Favored Glycine 0 C--N 1.35 1.31 0 O-C-N 124.316 1.01 . . . . 72.41 113.612 179.907 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . 0.414 ' HD2' ' HB ' ' A' ' 214' ' ' THR . 39.4 mmtm -121.38 27.81 8.11 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 123.452 0.701 . . . . 72.03 111.299 -179.002 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -138.4 -171.11 12.05 Favored Glycine 0 CA--C 1.525 0.697 0 N-CA-C 110.272 -1.131 . . . . 54.33 110.272 167.498 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 61.7 m-85 -90.2 155.83 46.61 Favored Pre-proline 0 CA--C 1.545 0.755 0 C-N-CA 123.802 0.841 . . . . 73.22 109.782 -175.711 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -68.28 169.6 16.53 Favored 'Trans proline' 0 C--N 1.365 1.446 0 C-N-CA 121.978 1.786 . . . . 75.05 111.461 169.706 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 163.21 -108.27 0.33 Allowed Glycine 0 CA--C 1.531 1.066 0 CA-C-O 119.043 -0.865 . . . . 60.12 112.533 176.318 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 243' ' ' PRO . . . . . 0.648 ' HD2' ' HB3' ' A' ' 191' ' ' GLN . 84.5 Cg_endo -68.94 -46.92 1.36 Allowed 'Trans proline' 0 C--N 1.372 1.808 0 C-N-CA 123.885 3.056 . . . . 33.3 113.146 -173.656 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -100.67 -0.82 36.71 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 123.658 0.783 . . . . 74.34 111.305 -175.704 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 92.5 -43.79 2.62 Favored Glycine 0 C--N 1.352 1.43 0 O-C-N 123.028 0.205 . . . . 61.43 112.859 -179.665 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 13.3 ttm180 -120.36 112.27 18.8 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 124.153 0.981 . . . . 75.42 110.826 179.24 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -82.84 149.98 27.42 Favored Glycine 0 C--N 1.347 1.169 0 N-CA-C 111.156 -0.778 . . . . 53.43 111.156 167.859 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 38.6 m-20 -135.27 152.38 51.46 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 123.677 0.791 . . . . 72.0 109.675 -172.002 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 249' ' ' LEU . . . . . 0.531 HD23 HD12 ' A' ' 235' ' ' LEU . 61.9 tp -96.88 138.97 33.61 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.158 0.583 . . . . 42.15 110.134 -175.702 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 250' ' ' TYR . . . . . 0.435 ' HD1' ' HB3' ' A' ' 232' ' ' LYS . 7.4 m-85 -99.02 140.2 33.52 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.091 0.556 . . . . 62.4 110.026 173.887 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 251' ' ' LEU . . . . . 0.674 HD13 HD22 ' A' ' 197' ' ' LEU . 76.9 mt -115.67 103.86 11.11 Favored 'General case' 0 C--O 1.236 0.38 0 N-CA-C 108.647 -0.871 . . . . 70.41 108.647 179.763 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -79.54 96.37 6.1 Favored 'General case' 0 C--O 1.242 0.666 0 N-CA-C 108.109 -1.071 . . . . 74.25 108.109 177.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 13.0 m -70.55 136.77 25.28 Favored 'Isoleucine or valine' 0 C--O 1.245 0.848 0 CA-C-O 121.389 0.614 . . . . 54.01 110.59 -173.768 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 11.1 mmt180 -125.78 101.38 6.83 Favored 'General case' 0 C--O 1.241 0.62 0 C-N-CA 124.587 1.155 . . . . 74.22 108.308 -177.652 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 255' ' ' ILE . . . . . 0.47 HG23 ' HA ' ' A' ' 201' ' ' ALA . 22.7 mt -77.43 107.88 9.71 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.745 0 O-C-N 124.027 0.83 . . . . 62.11 109.785 179.341 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 7.2 t . . . . . 0 CA--C 1.567 1.621 0 CA-C-O 117.36 -1.305 . . . . 52.53 108.191 179.122 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 25.0 ttt . . . . . 0 N--CA 1.484 1.248 0 N-CA-C 109.874 -0.417 . . . . 53.24 109.874 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 63.4 tt0 -157.17 -54.21 0.08 Allowed 'General case' 0 C--N 1.35 0.611 0 C-N-CA 123.809 0.844 . . . . 71.1 109.095 -177.808 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . 0.455 HG21 ' CZ ' ' A' ' 173' ' ' PHE . 12.5 t -176.09 -176.06 0.77 Allowed 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 123.742 0.817 . . . . 71.33 110.037 -172.928 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -118.99 -74.88 0.59 Allowed 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 123.875 0.87 . . . . 74.24 110.092 172.899 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 172' ' ' LEU . . . . . 0.49 HD21 ' HB3' ' A' ' 222' ' ' ALA . 21.1 mt -144.04 156.16 44.27 Favored 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 123.881 0.872 . . . . 74.31 111.317 -167.428 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 173' ' ' PHE . . . . . 0.455 ' CZ ' HG21 ' A' ' 170' ' ' THR . 45.0 m-85 -126.79 -57.83 1.33 Allowed 'General case' 0 N--CA 1.49 1.574 0 CA-C-O 121.679 0.752 . . . . 64.21 110.65 -170.445 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 174' ' ' TYR . . . . . 0.479 ' CD2' ' HB3' ' A' ' 233' ' ' LEU . 4.6 p90 -79.3 4.48 15.02 Favored 'General case' 0 N--CA 1.479 0.994 0 CA-C-N 114.76 -1.109 . . . . 74.25 113.352 -172.776 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 175' ' ' THR . . . . . 0.432 HG21 HD13 ' A' ' 172' ' ' LEU . 15.0 p -69.18 -5.18 20.92 Favored 'General case' 0 N--CA 1.479 0.995 0 N-CA-C 112.681 0.623 . . . . 54.11 112.681 -179.259 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 176' ' ' MET . . . . . . . . . . . . . 24.6 ptt? -61.24 -34.5 75.25 Favored 'General case' 0 CA--C 1.555 1.168 0 C-N-CA 123.632 0.773 . . . . 73.43 110.383 168.029 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 84.6 tttt -165.04 92.77 0.59 Allowed 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 124.869 1.268 . . . . 65.11 108.105 -178.427 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -128.71 142.65 50.94 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 123.877 0.871 . . . . 74.2 110.229 -171.582 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . 0.42 ' HB2' ' HB2' ' A' ' 224' ' ' PRO . . . 59.98 21.56 10.64 Favored 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 124.849 1.26 . . . . 73.11 112.104 -175.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -149.99 31.3 1.09 Allowed Glycine 0 C--N 1.34 0.772 0 N-CA-C 110.768 -0.933 . . . . 55.01 110.768 176.288 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 33.3 t -152.17 142.02 22.01 Favored 'General case' 0 C--O 1.246 0.913 0 C-N-CA 124.129 0.971 . . . . 74.21 108.872 -179.385 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 182' ' ' GLY . . . . . 0.587 ' HA2' ' H ' ' A' ' 232' ' ' LYS . . . -153.86 55.0 0.43 Allowed Glycine 0 C--N 1.339 0.7 0 N-CA-C 110.995 -0.842 . . . . 73.02 110.995 179.412 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 129.47 137.42 4.26 Favored Glycine 0 C--N 1.345 1.065 0 N-CA-C 110.46 -1.056 . . . . 62.1 110.46 -176.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 38.4 t -157.17 -54.09 0.08 Allowed 'General case' 0 N--CA 1.479 1.009 0 CA-C-N 117.247 0.523 . . . . 73.35 110.982 -174.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 87.3 145.36 9.63 Favored Glycine 0 CA--C 1.533 1.175 0 CA-C-O 119.473 -0.626 . . . . 72.15 111.66 -174.622 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -61.7 -70.76 0.94 Allowed Glycine 0 C--N 1.349 1.28 0 CA-C-O 119.783 -0.454 . . . . 52.23 113.668 -178.229 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 62.2 p -174.26 -60.41 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 123.883 0.873 . . . . 52.13 110.611 174.88 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 169.93 73.7 0.04 OUTLIER Glycine 0 C--N 1.35 1.346 0 N-CA-C 112.068 -0.413 . . . . 40.13 112.068 -177.863 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 166.02 162.09 16.59 Favored Glycine 0 N--CA 1.474 1.205 0 N-CA-C 110.979 -0.848 . . . . 55.31 110.979 -179.027 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 45.9 m -70.62 86.56 0.65 Allowed 'General case' 0 N--CA 1.478 0.948 0 CA-C-O 121.612 0.72 . . . . 70.51 111.132 -177.577 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 191' ' ' GLN . . . . . 0.52 ' HB2' ' HA2' ' A' ' 247' ' ' GLY . 4.8 pt20 -134.86 -29.88 1.11 Allowed 'General case' 0 N--CA 1.475 0.816 0 CA-C-N 114.83 -1.077 . . . . 73.21 110.99 -176.716 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -75.73 142.35 42.43 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-O 121.41 0.624 . . . . 73.14 111.341 -171.592 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 45.0 mt -130.91 170.96 13.73 Favored 'General case' 0 C--O 1.239 0.501 0 CA-C-N 114.216 -1.356 . . . . 73.12 108.994 174.122 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 26.6 m-85 -143.44 122.27 12.69 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 124.03 0.932 . . . . 75.43 109.503 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . 0.439 ' HB2' HD11 ' A' ' 249' ' ' LEU . . . -124.69 128.89 49.51 Favored 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 107.67 -1.233 . . . . 55.44 107.67 174.154 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 6.1 m -81.47 119.47 23.78 Favored 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 108.203 -1.036 . . . . 63.33 108.203 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 0.717 HD22 HD13 ' A' ' 251' ' ' LEU . 17.2 tp -104.74 110.55 22.93 Favored 'General case' 0 N--CA 1.466 0.374 0 N-CA-C 108.404 -0.962 . . . . 75.31 108.404 -172.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -77.48 125.53 29.48 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 108.482 -0.933 . . . . 73.42 108.482 177.234 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 199' ' ' VAL . . . . . 0.491 ' O ' ' HA ' ' A' ' 255' ' ' ILE . 5.4 p -144.15 129.45 9.62 Favored Pre-proline 0 CA--C 1.545 0.767 0 N-CA-C 108.488 -0.931 . . . . 71.22 108.488 176.465 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -71.86 157.15 55.64 Favored 'Trans proline' 0 C--O 1.248 1.02 0 C-N-CA 121.655 1.57 . . . . 72.43 111.342 170.309 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 201' ' ' ALA . . . . . 0.448 ' O ' HG23 ' A' ' 205' ' ' VAL . . . -51.29 -53.46 49.0 Favored Pre-proline 0 CA--C 1.556 1.2 0 O-C-N 124.32 1.013 . . . . 74.31 113.078 -176.501 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -67.01 -33.5 31.98 Favored 'Trans proline' 0 C--N 1.403 3.438 0 C-N-CA 121.678 1.585 . . . . 71.41 112.854 -175.044 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . 0.438 HG23 ' HA3' ' A' ' 208' ' ' GLY . 27.6 mt -66.03 -35.45 75.09 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.311 0 C-N-CA 122.586 0.354 . . . . 62.31 110.064 176.05 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 204' ' ' ALA . . . . . 0.485 ' HA ' HG11 ' A' ' 223' ' ' VAL . . . -71.01 -31.88 68.51 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 122.656 0.382 . . . . 74.31 111.51 178.617 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . 0.448 HG23 ' O ' ' A' ' 201' ' ' ALA . 92.8 t -73.77 -55.64 11.79 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 C-N-CA 122.896 0.478 . . . . 73.53 111.104 178.43 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 13.7 m -78.86 -26.41 13.44 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.003 0 C-N-CA 122.979 0.512 . . . . 71.31 111.927 -172.248 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 87.9 76.08 1.28 Allowed Glycine 0 CA--C 1.529 0.951 0 N-CA-C 111.972 -0.451 . . . . 73.51 111.972 -175.531 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . 0.438 ' HA3' HG23 ' A' ' 203' ' ' ILE . . . -95.37 -147.13 22.15 Favored Glycine 0 N--CA 1.477 1.369 0 CA-C-O 119.537 -0.591 . . . . 74.13 111.793 175.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 49.9 mtmt -132.86 145.63 51.12 Favored 'General case' 0 N--CA 1.482 1.125 0 CA-C-N 117.52 0.66 . . . . 73.21 111.151 176.742 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 12.0 m -139.25 164.91 24.14 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 C-N-CA 125.672 1.589 . . . . 73.11 108.93 175.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 23.9 ttm180 -103.44 117.13 33.75 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 123.386 0.674 . . . . 72.54 109.894 -174.246 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -103.69 123.33 46.82 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 124.729 1.212 . . . . 62.23 109.914 178.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 89.1 mmm -87.49 115.38 24.87 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 123.362 0.665 . . . . 74.45 110.166 -178.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 17.6 p -113.9 -178.71 3.44 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 123.976 0.91 . . . . 45.31 110.607 -175.856 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 81.0 mt -63.27 -23.94 67.64 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 122.842 0.457 . . . . 63.02 111.549 172.713 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -103.54 23.2 13.0 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 124.071 0.948 . . . . 63.43 110.893 179.867 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 87.88 -163.82 33.67 Favored Glycine 0 C--N 1.344 1.005 0 CA-C-N 116.299 -0.409 . . . . 45.31 113.141 175.59 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -72.12 144.73 42.83 Favored 'Trans proline' 0 C--N 1.362 1.244 0 C-N-CA 122.156 1.904 . . . . 73.0 112.804 -178.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 5.4 p -139.67 127.74 26.24 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 N-CA-C 108.083 -1.08 . . . . 73.23 108.083 170.047 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -82.19 103.3 11.69 Favored 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 108.461 -0.94 . . . . 72.44 108.461 176.264 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 2.8 p -100.3 133.62 42.75 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.841 0 O-C-N 124.149 0.906 . . . . 75.01 108.654 -174.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . 0.49 ' HB3' HD21 ' A' ' 172' ' ' LEU . . . -78.91 111.67 15.31 Favored 'General case' 0 C--O 1.24 0.6 0 C-N-CA 122.8 0.44 . . . . 74.21 110.541 -177.874 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . 0.485 HG11 ' HA ' ' A' ' 204' ' ' ALA . 48.9 t -54.61 131.63 64.29 Favored Pre-proline 0 CA--C 1.542 0.643 0 O-C-N 124.509 1.13 . . . . 74.41 109.909 177.496 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 224' ' ' PRO . . . . . 0.425 ' HD3' ' CE1' ' A' ' 174' ' ' TYR . 43.1 Cg_endo -67.3 152.5 79.14 Favored 'Trans proline' 0 CA--C 1.555 1.545 0 C-N-CA 121.657 1.571 . . . . 44.4 111.312 175.546 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -65.6 141.99 69.08 Favored 'Trans proline' 0 C--N 1.371 1.712 0 C-N-CA 121.941 1.761 . . . . 75.23 112.219 179.811 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 96.6 mtt180 65.42 32.15 9.82 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 124.827 1.251 . . . . 71.31 111.834 168.863 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 227' ' ' THR . . . . . 0.471 HG23 ' HD2' ' A' ' 231' ' ' ARG . 98.6 m -72.84 139.02 46.69 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 123.969 0.907 . . . . 74.25 109.89 174.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -111.66 155.53 23.28 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 123.113 0.565 . . . . 73.51 109.686 174.595 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 229' ' ' ALA . . . . . 0.601 ' HB2' ' HB ' ' A' ' 255' ' ' ILE . . . -54.99 122.63 11.33 Favored 'General case' 0 CA--C 1.536 0.442 0 O-C-N 124.896 1.372 . . . . 74.23 111.338 -179.302 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 112.57 -10.61 25.91 Favored Glycine 0 C--N 1.341 0.831 0 CA-C-O 119.568 -0.573 . . . . 35.21 113.718 177.029 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 231' ' ' ARG . . . . . 0.471 ' HD2' HG23 ' A' ' 227' ' ' THR . 53.0 mtt-85 -62.1 141.45 58.13 Favored 'General case' 0 N--CA 1.478 0.941 0 CA-C-N 117.246 0.523 . . . . 73.25 111.1 176.418 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 232' ' ' LYS . . . . . 0.587 ' H ' ' HA2' ' A' ' 182' ' ' GLY . 31.5 mmtp -112.47 103.58 11.67 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 108.585 -0.895 . . . . 52.1 108.585 -175.64 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 233' ' ' LEU . . . . . 0.736 ' HB2' ' HB2' ' A' ' 251' ' ' LEU . 41.7 mt -83.08 149.47 26.89 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 115.295 -0.866 . . . . 71.3 108.849 177.181 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 62.0 ttt180 -118.6 102.42 8.86 Favored 'General case' 0 N--CA 1.478 0.926 0 CA-C-N 117.958 0.345 . . . . 74.51 110.482 -173.404 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 235' ' ' LEU . . . . . 0.544 ' HB2' ' HB3' ' A' ' 249' ' ' LEU . 14.8 mt -85.92 94.84 9.29 Favored 'General case' 0 C--O 1.242 0.706 0 C-N-CA 123.197 0.599 . . . . 73.2 109.81 175.507 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 20.2 mttt -69.02 138.12 54.22 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 115.648 -0.706 . . . . 73.44 110.466 175.443 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 85.68 3.03 86.48 Favored Glycine 0 C--N 1.338 0.644 0 O-C-N 123.908 0.755 . . . . 33.4 113.348 -179.355 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 76.0 mmtt -116.78 9.24 13.88 Favored 'General case' 0 N--CA 1.485 1.323 0 CA-C-N 117.414 0.607 . . . . 73.25 111.919 -176.274 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -109.68 -165.65 19.94 Favored Glycine 0 C--N 1.346 1.09 0 N-CA-C 111.139 -0.784 . . . . 65.11 111.139 167.419 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 68.7 m-85 -86.82 158.79 53.13 Favored Pre-proline 0 N--CA 1.484 1.272 0 C-N-CA 123.446 0.698 . . . . 72.15 112.371 -176.291 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_exo -64.21 165.4 19.71 Favored 'Trans proline' 0 C--N 1.371 1.715 0 C-N-CA 122.24 1.96 . . . . 63.3 112.73 166.716 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 157.45 -107.94 0.34 Allowed Glycine 0 C--N 1.34 0.789 0 CA-C-O 118.806 -0.997 . . . . 71.44 111.999 173.431 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -68.65 -57.08 0.15 Allowed 'Trans proline' 0 C--N 1.378 2.09 0 C-N-CA 123.616 2.878 . . . . 72.55 112.666 -170.201 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -80.87 -22.39 39.87 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 123.417 0.687 . . . . 74.32 110.615 175.244 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 96.48 -33.53 5.6 Favored Glycine 0 C--N 1.352 1.437 0 N-CA-C 111.283 -0.727 . . . . 73.13 111.283 -169.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 29.2 ttm180 -106.7 111.89 24.63 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 124.68 1.192 . . . . 71.24 109.981 178.794 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . 0.52 ' HA2' ' HB2' ' A' ' 191' ' ' GLN . . . -79.53 162.97 47.94 Favored Glycine 0 C--O 1.247 0.919 0 O-C-N 123.528 0.518 . . . . 70.14 113.748 169.249 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 17.6 m-20 -128.16 129.23 46.19 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 123.814 0.846 . . . . 74.4 109.173 -169.456 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 249' ' ' LEU . . . . . 0.544 ' HB3' ' HB2' ' A' ' 235' ' ' LEU . 49.3 tp -99.54 113.62 26.13 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 124.005 0.922 . . . . 60.03 109.089 177.715 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 250' ' ' TYR . . . . . 0.421 ' HA ' ' O ' ' A' ' 233' ' ' LEU . 8.8 m-85 -90.28 114.59 26.66 Favored 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 123.593 0.757 . . . . 70.25 110.933 -176.467 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 251' ' ' LEU . . . . . 0.736 ' HB2' ' HB2' ' A' ' 233' ' ' LEU . 89.9 mt -88.05 106.3 18.06 Favored 'General case' 0 C--O 1.241 0.638 0 C-N-CA 124.846 1.258 . . . . 74.22 109.162 -179.013 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -82.3 99.95 9.64 Favored 'General case' 0 C--O 1.242 0.704 0 N-CA-C 108.463 -0.94 . . . . 73.24 108.463 175.386 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 11.5 m -67.23 132.73 32.25 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.853 0 O-C-N 123.782 0.676 . . . . 60.03 109.351 -177.498 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 17.9 mmt85 -123.11 95.21 4.52 Favored 'General case' 0 C--O 1.239 0.502 0 C-N-CA 124.517 1.127 . . . . 75.02 108.216 -177.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 255' ' ' ILE . . . . . 0.601 ' HB ' ' HB2' ' A' ' 229' ' ' ALA . 12.9 mt -76.43 125.25 36.0 Favored 'Isoleucine or valine' 0 C--O 1.233 0.208 0 O-C-N 123.945 0.778 . . . . 62.43 110.21 179.406 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 1.6 t . . . . . 0 CA--C 1.561 1.402 0 CA-C-O 117.546 -1.216 . . . . 37.96 107.768 173.877 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 15.7 tpt . . . . . 0 N--CA 1.479 0.989 0 N-CA-C 109.525 -0.546 . . . . 52.22 109.525 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 9.8 pt20 -137.72 168.31 19.94 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.6 0.76 . . . . 74.2 110.627 -178.756 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . 0.521 HG23 HG21 ' A' ' 219' ' ' VAL . 6.5 t -80.69 167.59 19.84 Favored 'General case' 0 C--O 1.243 0.739 0 CA-C-N 115.171 -0.922 . . . . 73.11 110.144 173.774 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -117.87 -63.64 1.4 Allowed 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 123.84 0.856 . . . . 62.51 109.965 -177.505 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 172' ' ' LEU . . . . . 0.569 ' HB3' HG23 ' A' ' 175' ' ' THR . 55.7 mt -131.75 154.58 48.9 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 114.555 -1.202 . . . . 61.44 111.27 -164.77 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 173' ' ' PHE . . . . . 0.552 ' CD1' HD22 ' A' ' 235' ' ' LEU . 7.5 m-85 -140.13 -44.1 0.42 Allowed 'General case' 0 N--CA 1.482 1.142 0 CA-C-N 114.966 -1.015 . . . . 73.52 109.118 -171.21 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 174' ' ' TYR . . . . . . . . . . . . . 1.9 p90 -86.18 19.3 2.73 Favored 'General case' 0 CA--C 1.547 0.83 0 CA-C-N 114.502 -1.226 . . . . 61.23 112.394 -176.158 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 175' ' ' THR . . . . . 0.569 HG23 ' HB3' ' A' ' 172' ' ' LEU . 17.6 p -62.87 -21.63 66.11 Favored 'General case' 0 N--CA 1.493 1.692 0 CA-C-N 118.909 0.777 . . . . 70.53 112.853 -179.2 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 176' ' ' MET . . . . . . . . . . . . . 21.4 ptt? -52.4 -42.45 64.04 Favored 'General case' 0 CA--C 1.558 1.287 0 C-N-CA 124.367 1.067 . . . . 52.43 110.95 171.016 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 19.7 tptm -167.42 100.07 0.5 Allowed 'General case' 0 C--N 1.349 0.553 0 C-N-CA 125.532 1.533 . . . . 64.33 107.017 176.844 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 178' ' ' ALA . . . . . 0.434 ' HB1' ' HB3' ' A' ' 224' ' ' PRO . . . -74.65 -74.42 0.2 Allowed 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 115.556 -0.747 . . . . 72.12 112.096 -168.306 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -69.65 95.53 0.87 Allowed 'General case' 0 CA--C 1.541 0.629 0 O-C-N 123.381 0.425 . . . . 74.24 110.19 -177.328 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 80.59 89.2 0.54 Allowed Glycine 0 C--N 1.348 1.243 0 CA-C-N 115.489 -0.778 . . . . 41.12 112.063 -178.328 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 27.8 t -97.88 132.87 43.09 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 123.395 0.678 . . . . 42.41 109.616 178.335 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -86.03 -164.62 39.6 Favored Glycine 0 C--N 1.35 1.307 0 O-C-N 123.618 0.574 . . . . 73.21 114.08 -173.796 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 97.62 14.09 41.95 Favored Glycine 0 C--N 1.35 1.344 0 C-N-CA 123.306 0.479 . . . . 55.31 112.598 -176.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 16.8 m -76.34 142.37 41.24 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 123.892 0.877 . . . . 31.43 111.272 -177.197 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 73.04 35.44 57.72 Favored Glycine 0 C--N 1.345 1.079 0 O-C-N 123.284 0.365 . . . . 63.22 112.566 -179.803 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -152.02 43.51 0.67 Allowed Glycine 0 C--N 1.345 1.041 0 N-CA-C 111.973 -0.451 . . . . 73.43 111.973 -178.604 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 24.3 m -72.57 -61.41 1.81 Allowed 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 123.457 0.703 . . . . 75.0 110.04 175.148 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 79.49 -62.68 4.07 Favored Glycine 0 C--N 1.353 1.486 0 N-CA-C 111.723 -0.551 . . . . 4.13 111.723 -172.631 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -109.37 165.36 12.44 Favored Glycine 0 C--N 1.343 0.926 0 N-CA-C 110.414 -1.074 . . . . 64.11 110.414 167.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 15.7 p -68.83 100.79 1.23 Allowed 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 123.589 0.756 . . . . 64.21 110.526 177.202 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 191' ' ' GLN . . . . . 0.492 ' HG3' ' N ' ' A' ' 192' ' ' ASP . 5.0 pt20 -139.03 -44.24 0.47 Allowed 'General case' 0 CA--C 1.544 0.724 0 CA-C-N 115.676 -0.693 . . . . 55.13 110.758 177.903 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . 0.492 ' N ' ' HG3' ' A' ' 191' ' ' GLN . 24.4 m-20 -77.55 123.87 27.16 Favored 'General case' 0 C--N 1.351 0.643 0 C-N-CA 123.76 0.824 . . . . 73.15 109.096 -177.125 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . 0.544 HD12 ' HA2' ' A' ' 239' ' ' GLY . 41.0 mt -111.71 173.57 6.29 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 124.612 1.165 . . . . 72.42 109.987 -178.186 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 45.8 m-85 -130.15 129.28 43.28 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 123.778 0.831 . . . . 65.22 109.57 176.33 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . 0.451 ' HB2' HD11 ' A' ' 249' ' ' LEU . . . -129.65 167.49 17.91 Favored 'General case' 0 C--O 1.239 0.549 0 C-N-CA 124.989 1.316 . . . . 33.4 107.47 170.237 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 31.4 m -117.27 124.17 48.37 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 108.731 -0.84 . . . . 71.25 108.731 179.335 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 0.653 HD22 HD13 ' A' ' 251' ' ' LEU . 15.3 tp -107.7 109.81 21.49 Favored 'General case' 0 CA--C 1.53 0.211 0 N-CA-C 107.823 -1.177 . . . . 72.22 107.823 -177.711 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -83.42 128.63 34.66 Favored 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 109.05 -0.722 . . . . 73.34 109.05 178.156 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 199' ' ' VAL . . . . . 0.543 ' O ' ' HA ' ' A' ' 255' ' ' ILE . 4.0 p -143.78 129.57 9.96 Favored Pre-proline 0 CA--C 1.543 0.699 0 N-CA-C 108.201 -1.037 . . . . 75.31 108.201 179.765 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -69.1 157.9 59.91 Favored 'Trans proline' 0 C--N 1.364 1.383 0 C-N-CA 121.905 1.737 . . . . 54.24 111.502 170.038 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 201' ' ' ALA . . . . . 0.486 ' O ' HG23 ' A' ' 205' ' ' VAL . . . -49.74 -53.7 39.17 Favored Pre-proline 0 CA--C 1.561 1.385 0 O-C-N 124.768 1.292 . . . . 74.43 112.792 -178.195 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -61.94 -35.38 77.81 Favored 'Trans proline' 0 C--N 1.401 3.314 0 C-N-CA 121.988 1.792 . . . . 71.1 113.339 -176.388 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 38.1 mt -71.35 -31.94 45.21 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.104 0 C-N-CA 123.068 0.547 . . . . 75.44 110.321 179.145 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -72.95 -34.05 66.27 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 122.463 0.305 . . . . 63.11 111.516 176.18 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . 0.486 HG23 ' O ' ' A' ' 201' ' ' ALA . 90.6 t -67.72 -55.77 15.67 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 C-N-CA 123.836 0.854 . . . . 72.41 110.874 177.936 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 18.4 m -80.87 -27.96 11.2 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.079 0 C-N-CA 122.753 0.421 . . . . 54.13 111.744 -174.469 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 82.02 67.9 1.48 Allowed Glycine 0 C--N 1.347 1.176 0 O-C-N 123.736 0.647 . . . . 52.32 112.113 -173.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -84.35 -131.88 2.25 Favored Glycine 0 C--N 1.352 1.435 0 CA-C-O 119.68 -0.511 . . . . 54.04 111.953 179.436 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 209' ' ' LYS . . . . . 0.431 ' HG2' ' HA ' ' A' ' 222' ' ' ALA . 48.0 mtmt -139.99 150.92 45.05 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 123.908 0.883 . . . . 64.23 111.425 178.258 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 15.2 m -146.04 168.92 6.61 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 C-N-CA 126.005 1.722 . . . . 73.23 108.388 176.584 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 37.0 ptt180 -95.03 128.65 42.02 Favored 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 109.371 -0.603 . . . . 74.02 109.371 172.626 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -102.31 112.36 25.02 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 123.895 0.878 . . . . 64.32 108.631 174.175 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 74.8 mtp -82.98 108.78 16.54 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 109.382 -0.599 . . . . 75.42 109.382 -175.746 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 26.7 p -111.39 -172.47 2.04 Favored 'General case' 0 C--O 1.242 0.686 0 C-N-CA 124.174 0.989 . . . . 73.04 110.224 -173.179 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 84.2 mt -61.97 -28.84 69.84 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 123.439 0.696 . . . . 72.41 111.368 173.386 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -100.22 7.94 44.14 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 123.656 0.783 . . . . 74.35 111.427 179.424 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 100.84 -173.11 24.28 Favored Glycine 0 C--N 1.347 1.16 0 CA-C-O 119.929 -0.373 . . . . 74.03 113.819 175.763 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_endo -71.57 127.59 13.36 Favored 'Trans proline' 0 C--N 1.368 1.579 0 C-N-CA 122.855 2.37 . . . . 74.24 112.351 -176.852 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 219' ' ' VAL . . . . . 0.521 HG21 HG23 ' A' ' 170' ' ' THR . 5.0 p -119.77 130.76 73.75 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 C-N-CA 123.714 0.806 . . . . 65.23 108.846 178.436 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -70.52 101.63 2.04 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 108.751 -0.833 . . . . 75.44 108.751 177.755 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 3.0 p -106.64 134.38 48.45 Favored 'Isoleucine or valine' 0 C--O 1.244 0.774 0 N-CA-C 108.377 -0.971 . . . . 52.12 108.377 -176.304 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . 0.445 ' HB3' HD21 ' A' ' 172' ' ' LEU . . . -82.19 108.74 15.89 Favored 'General case' 0 N--CA 1.467 0.414 0 N-CA-C 109.975 -0.38 . . . . 54.3 109.975 -179.358 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 43.0 t -54.54 134.74 63.22 Favored Pre-proline 0 N--CA 1.478 0.945 0 C-N-CA 124.753 1.221 . . . . 62.01 110.436 -178.14 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 224' ' ' PRO . . . . . 0.434 ' HB3' ' HB1' ' A' ' 178' ' ' ALA . 12.2 Cg_endo -58.22 150.46 66.13 Favored 'Trans proline' 0 C--N 1.37 1.699 0 C-N-CA 122.221 1.947 . . . . 64.22 111.942 169.779 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -78.41 148.51 23.67 Favored 'Trans proline' 0 C--N 1.366 1.497 0 C-N-CA 122.065 1.843 . . . . 65.4 110.937 174.136 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 45.8 mtm180 59.56 41.28 19.23 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 124.302 1.041 . . . . 72.42 111.271 174.122 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 227' ' ' THR . . . . . 0.545 HG23 ' HD2' ' A' ' 231' ' ' ARG . 55.5 m -82.29 141.64 32.75 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 114.334 -1.303 . . . . 72.13 109.438 177.097 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 27.7 mp0 -115.96 145.18 43.15 Favored 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 123.764 0.826 . . . . 52.14 109.245 176.381 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 229' ' ' ALA . . . . . 0.413 ' HB2' ' HB ' ' A' ' 255' ' ' ILE . . . -57.04 119.42 6.27 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.986 0.914 . . . . 40.14 111.119 -178.079 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 114.38 -5.33 23.25 Favored Glycine 0 C--N 1.342 0.869 0 O-C-N 123.825 0.703 . . . . 42.41 112.696 -176.768 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 231' ' ' ARG . . . . . 0.545 ' HD2' HG23 ' A' ' 227' ' ' THR . 55.0 mtt-85 -69.67 148.68 48.97 Favored 'General case' 0 C--N 1.363 1.194 0 CA-C-N 117.704 0.752 . . . . 74.32 109.124 169.724 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 36.5 mtmt -130.2 118.26 21.12 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 123.166 0.586 . . . . 64.44 109.56 -174.334 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 233' ' ' LEU . . . . . . . . . . . . . 9.0 mt -101.47 138.94 37.81 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 124.318 1.047 . . . . 65.34 108.487 -172.307 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 234' ' ' ARG . . . . . 0.505 ' HG3' ' HB3' ' A' ' 248' ' ' ASP . 35.8 ttm-85 -102.04 118.45 36.94 Favored 'General case' 0 N--CA 1.479 0.982 0 CA-C-N 118.013 0.37 . . . . 73.33 111.434 -173.83 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 235' ' ' LEU . . . . . 0.552 HD22 ' CD1' ' A' ' 173' ' ' PHE . 13.7 mt -103.87 111.62 24.23 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 123.492 0.717 . . . . 64.31 110.271 179.069 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 65.1 mttt -69.66 144.59 52.86 Favored 'General case' 0 N--CA 1.471 0.578 0 O-C-N 123.205 0.316 . . . . 61.34 111.196 176.178 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 73.88 -5.72 23.25 Favored Glycine 0 N--CA 1.472 1.05 0 O-C-N 124.624 1.203 . . . . 75.32 114.578 179.065 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -101.24 0.89 38.23 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 123.043 0.537 . . . . 73.33 110.896 -176.498 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 239' ' ' GLY . . . . . 0.544 ' HA2' HD12 ' A' ' 193' ' ' LEU . . . -102.9 -168.26 26.18 Favored Glycine 0 C--N 1.347 1.157 0 N-CA-C 110.322 -1.111 . . . . 71.34 110.322 163.184 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 58.0 m-85 -92.78 154.64 42.11 Favored Pre-proline 0 N--CA 1.477 0.918 0 C-N-CA 123.033 0.533 . . . . 74.01 111.028 -176.627 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_exo -72.9 161.92 42.4 Favored 'Trans proline' 0 C--N 1.366 1.498 0 C-N-CA 122.202 1.935 . . . . 63.3 111.865 172.342 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 157.2 -104.25 0.25 Allowed Glycine 0 CA--C 1.527 0.842 0 CA-C-O 119.072 -0.849 . . . . 53.5 112.155 177.8 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 243' ' ' PRO . . . . . 0.429 ' HD2' ' HB3' ' A' ' 191' ' ' GLN . 41.8 Cg_endo -63.67 -52.22 1.97 Allowed 'Trans proline' 0 C--N 1.37 1.663 0 C-N-CA 123.642 2.895 . . . . 33.32 113.241 -169.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -93.11 -5.08 51.1 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 123.304 0.642 . . . . 73.02 111.447 179.753 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 92.38 -46.52 2.59 Favored Glycine 0 C--N 1.354 1.572 0 N-CA-C 111.945 -0.462 . . . . 50.13 111.945 -175.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 20.1 ttm180 -116.3 112.4 21.51 Favored 'General case' 0 C--O 1.238 0.486 0 C-N-CA 124.367 1.067 . . . . 64.12 109.127 178.119 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -80.65 168.31 51.16 Favored Glycine 0 C--N 1.348 1.249 0 CA-C-O 121.503 0.502 . . . . 52.31 113.88 172.191 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 248' ' ' ASP . . . . . 0.505 ' HB3' ' HG3' ' A' ' 234' ' ' ARG . 19.4 m-20 -124.65 162.2 24.64 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 114.009 -1.096 . . . . 64.11 110.469 -169.466 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 249' ' ' LEU . . . . . 0.451 HD11 ' HB2' ' A' ' 195' ' ' ALA . 41.6 tp -125.9 121.8 34.21 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 123.528 0.731 . . . . 74.42 109.405 178.305 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 250' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -90.47 112.43 24.07 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 123.816 0.846 . . . . 65.22 110.607 -178.733 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 251' ' ' LEU . . . . . 0.653 HD13 HD22 ' A' ' 197' ' ' LEU . 90.7 mt -87.85 104.02 16.19 Favored 'General case' 0 C--O 1.239 0.504 0 N-CA-C 107.889 -1.152 . . . . 73.25 107.889 179.915 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -79.91 98.58 7.19 Favored 'General case' 0 C--O 1.239 0.521 0 N-CA-C 108.145 -1.058 . . . . 62.52 108.145 177.106 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 253' ' ' VAL . . . . . 0.406 HG21 HG22 ' A' ' 227' ' ' THR . 6.2 m -66.67 125.88 24.94 Favored 'Isoleucine or valine' 0 C--O 1.243 0.759 0 CA-C-O 122.021 0.915 . . . . 54.54 109.362 -178.169 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 17.9 mmm180 -122.2 99.34 6.38 Favored 'General case' 0 C--O 1.239 0.535 0 N-CA-C 107.742 -1.207 . . . . 72.03 107.742 -178.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 255' ' ' ILE . . . . . 0.543 ' HA ' ' O ' ' A' ' 199' ' ' VAL . 55.3 mt -83.29 119.55 32.87 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 CA-C-N 114.103 -1.408 . . . . 73.51 110.267 -175.114 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 CA--C 1.559 1.309 0 C-N-CA 124.6 1.16 . . . . 72.52 108.964 175.547 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.485 1.277 0 N-CA-C 111.902 0.334 . . . . 64.3 111.902 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 9.0 pt20 -142.9 171.8 13.56 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 122.985 0.514 . . . . 71.31 110.01 170.094 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 6.6 t -93.61 178.69 5.61 Favored 'General case' 0 CA--C 1.557 1.242 0 C-N-CA 123.813 0.845 . . . . 52.14 110.399 179.198 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -129.01 -82.91 0.57 Allowed 'General case' 0 CA--C 1.555 1.167 0 C-N-CA 122.921 0.488 . . . . 61.41 111.601 -168.71 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 172' ' ' LEU . . . . . 0.419 ' HB3' ' OG1' ' A' ' 175' ' ' THR . 21.0 mt -127.83 160.54 31.47 Favored 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 123.691 0.796 . . . . 62.13 111.71 -173.591 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 173' ' ' PHE . . . . . 0.549 ' CD1' HD22 ' A' ' 235' ' ' LEU . 16.7 m-85 -146.14 -59.28 0.31 Allowed 'General case' 0 N--CA 1.479 1.022 0 CA-C-O 122.123 0.963 . . . . 70.21 108.692 -166.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 174' ' ' TYR . . . . . 0.483 ' CD2' ' HB3' ' A' ' 233' ' ' LEU . 0.6 OUTLIER -78.53 14.45 1.27 Allowed 'General case' 0 CA--C 1.547 0.829 0 CA-C-N 113.744 -1.571 . . . . 74.44 112.533 -176.025 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 175' ' ' THR . . . . . 0.419 ' OG1' ' HB3' ' A' ' 172' ' ' LEU . 0.2 OUTLIER -63.95 -19.32 65.05 Favored 'General case' 0 CA--C 1.555 1.152 0 C-N-CA 124.459 1.104 . . . . 72.44 111.432 -173.843 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 176' ' ' MET . . . . . . . . . . . . . 25.1 ptt? -71.45 -40.89 70.04 Favored 'General case' 0 CA--C 1.562 1.409 0 C-N-CA 124.644 1.177 . . . . 74.15 111.72 173.081 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 1.6 ttmp? -164.58 118.45 1.36 Allowed 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 124.644 1.178 . . . . 54.04 109.296 -175.623 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 178' ' ' ALA . . . . . 0.5 ' HB1' HD22 ' A' ' 233' ' ' LEU . . . -152.61 -49.39 0.1 Allowed 'General case' 0 C--O 1.24 0.58 0 C-N-CA 123.309 0.644 . . . . 73.31 110.289 -173.808 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . 0.401 ' HB2' ' HB2' ' A' ' 224' ' ' PRO . . . -81.02 37.66 0.44 Allowed 'General case' 0 CA--C 1.554 1.127 0 C-N-CA 123.486 0.715 . . . . 51.4 111.07 178.785 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -137.21 -153.93 6.52 Favored Glycine 0 C--N 1.347 1.154 0 C-N-CA 123.839 0.733 . . . . 63.24 111.76 -177.307 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 21.9 t -130.05 -177.8 4.46 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 123.489 0.716 . . . . 64.42 109.95 -176.611 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . 90.05 -48.65 3.23 Favored Glycine 0 C--N 1.348 1.199 0 N-CA-C 112.411 -0.276 . . . . 75.42 112.411 178.584 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 101.55 -10.64 57.79 Favored Glycine 0 C--N 1.35 1.312 0 CA-C-O 119.451 -0.638 . . . . 33.23 112.797 178.6 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 24.1 t 65.11 15.92 10.27 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 124.681 1.192 . . . . 74.24 112.313 176.499 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -84.39 -90.64 0.78 Allowed Glycine 0 C--N 1.346 1.128 0 CA-C-O 120.121 -0.266 . . . . 74.32 113.139 -175.057 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 61.37 46.3 94.68 Favored Glycine 0 C--N 1.35 1.35 0 O-C-N 124.087 0.522 . . . . 53.32 111.896 -174.541 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 33.5 t -93.41 133.64 36.47 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 123.5 0.72 . . . . 64.54 110.421 -174.381 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -93.85 37.24 3.45 Favored Glycine 0 C--N 1.349 1.277 0 CA-C-N 116.383 -0.372 . . . . 63.13 113.233 178.792 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . 0.453 ' HA3' ' HD3' ' A' ' 243' ' ' PRO . . . -172.41 165.66 38.25 Favored Glycine 0 C--N 1.344 1.013 0 N-CA-C 111.498 -0.641 . . . . 62.32 111.498 179.225 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 37.0 t -86.06 72.16 10.47 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 123.462 0.705 . . . . 72.34 109.165 178.757 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 191' ' ' GLN . . . . . 0.559 ' HB3' ' HD2' ' A' ' 243' ' ' PRO . 3.6 pt20 -108.37 -26.09 10.67 Favored 'General case' 0 N--CA 1.477 0.915 0 CA-C-N 115.402 -0.817 . . . . 73.22 109.858 175.563 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 86.9 m-20 -77.41 153.46 33.63 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 115.39 -0.823 . . . . 64.04 111.504 -174.646 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 26.7 mt -125.74 175.93 7.27 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 124.439 1.096 . . . . 64.25 110.665 -179.226 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 32.1 m-85 -140.98 136.67 32.38 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 124.305 1.042 . . . . 71.11 109.905 177.457 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -152.98 131.67 12.33 Favored 'General case' 0 C--O 1.238 0.497 0 C-N-CA 124.651 1.18 . . . . 65.35 108.128 177.064 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 14.9 m -82.61 129.25 34.91 Favored 'General case' 0 CA--C 1.546 0.8 0 CA-C-N 116.267 -0.424 . . . . 70.52 109.974 -176.464 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 0.733 HD22 HD13 ' A' ' 251' ' ' LEU . 16.0 tp -107.79 111.05 23.02 Favored 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 108.758 -0.83 . . . . 71.04 108.758 -175.878 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -79.63 123.56 27.74 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 123.232 0.613 . . . . 74.2 109.412 176.147 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 6.4 p -142.36 128.95 10.94 Favored Pre-proline 0 CA--C 1.544 0.729 0 N-CA-C 108.675 -0.861 . . . . 73.25 108.675 179.308 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -72.04 159.24 50.62 Favored 'Trans proline' 0 C--N 1.366 1.498 0 C-N-CA 121.825 1.684 . . . . 73.1 111.185 170.711 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 201' ' ' ALA . . . . . 0.437 ' O ' HG23 ' A' ' 205' ' ' VAL . . . -50.61 -50.61 71.56 Favored Pre-proline 0 CA--C 1.556 1.201 0 CA-C-N 114.94 -1.027 . . . . 40.1 113.72 -178.526 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_endo -65.74 -35.82 34.99 Favored 'Trans proline' 0 C--N 1.385 2.469 0 C-N-CA 121.438 1.425 . . . . 71.45 114.697 -178.789 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 50.0 mt -68.88 -29.35 43.13 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.25 0 N-CA-C 110.163 -0.31 . . . . 75.23 110.163 176.812 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -70.96 -41.84 70.52 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 122.62 0.368 . . . . 63.2 111.313 175.448 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . 0.437 HG23 ' O ' ' A' ' 201' ' ' ALA . 85.4 t -64.59 -55.96 18.56 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.283 0 C-N-CA 123.864 0.866 . . . . 72.32 111.644 -179.06 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 25.2 m -76.41 -31.45 20.6 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 CA-C-O 120.635 0.255 . . . . 75.33 111.241 -176.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 82.84 64.17 1.69 Allowed Glycine 0 C--N 1.343 0.928 0 CA-C-N 115.903 -0.59 . . . . 44.01 111.836 -173.394 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -79.98 -134.29 1.22 Allowed Glycine 0 C--N 1.346 1.101 0 CA-C-O 119.752 -0.471 . . . . 72.43 111.96 177.072 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 48.4 mtmt -137.19 148.07 46.3 Favored 'General case' 0 N--CA 1.485 1.296 0 CA-C-N 117.711 0.756 . . . . 64.4 111.061 178.471 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 5.7 m -143.12 158.28 17.65 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 C-N-CA 125.169 1.387 . . . . 74.2 108.436 174.584 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 42.0 ttp-105 -94.9 113.38 25.1 Favored 'General case' 0 CA--C 1.544 0.732 0 CA-C-O 121.167 0.508 . . . . 65.55 110.781 -175.171 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -101.37 113.56 26.76 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 124.283 1.033 . . . . 63.3 109.469 175.786 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 39.9 ttm -88.67 116.88 27.24 Favored 'General case' 0 N--CA 1.477 0.882 0 CA-C-O 121.022 0.439 . . . . 74.35 110.018 -179.161 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 17.5 p -111.55 -171.78 1.91 Allowed 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 124.463 1.105 . . . . 53.44 110.062 -173.216 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 84.0 mt -63.59 -37.58 87.86 Favored 'General case' 0 N--CA 1.489 1.485 0 CA-C-O 121.133 0.492 . . . . 71.22 110.606 171.672 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -80.36 -11.46 59.7 Favored 'General case' 0 N--CA 1.476 0.845 0 CA-C-N 114.797 -1.092 . . . . 72.11 111.087 -174.362 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 123.09 -173.02 16.13 Favored Glycine 0 C--N 1.344 1.01 0 N-CA-C 111.447 -0.661 . . . . 62.15 111.447 -179.614 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -73.1 147.55 43.07 Favored 'Trans proline' 0 CA--C 1.552 1.376 0 C-N-CA 122.384 2.056 . . . . 74.21 111.978 177.527 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 3.8 p -139.78 131.36 33.19 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 N-CA-C 108.976 -0.75 . . . . 62.22 108.976 174.346 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -80.86 100.03 8.63 Favored 'General case' 0 C--O 1.239 0.508 0 N-CA-C 107.012 -1.477 . . . . 73.41 107.012 172.258 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 3.8 p -101.67 129.57 52.67 Favored 'Isoleucine or valine' 0 C--O 1.242 0.699 0 N-CA-C 108.602 -0.888 . . . . 73.42 108.602 -172.245 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -76.92 109.39 10.68 Favored 'General case' 0 C--O 1.236 0.386 0 C-N-CA 122.374 0.269 . . . . 75.15 110.523 -177.434 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 58.3 t -52.69 135.04 45.5 Favored Pre-proline 0 CA--C 1.55 0.943 0 O-C-N 124.478 1.111 . . . . 53.43 109.342 178.155 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 224' ' ' PRO . . . . . 0.401 ' HB2' ' HB2' ' A' ' 179' ' ' ALA . 29.4 Cg_endo -61.33 143.5 97.99 Favored 'Trans proline' 0 C--N 1.369 1.642 0 C-N-CA 121.763 1.642 . . . . 72.31 110.495 174.79 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 16.2 Cg_endo -60.35 132.22 42.63 Favored 'Trans proline' 0 C--N 1.37 1.677 0 C-N-CA 121.448 1.432 . . . . 43.23 110.759 175.828 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 65.9 mtm180 65.12 53.05 1.4 Allowed 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.939 1.296 . . . . 62.12 110.834 173.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 26.5 m -75.77 147.48 39.21 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-N 114.886 -1.052 . . . . 75.54 109.651 172.472 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 25.3 mp0 -117.65 145.11 44.6 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 108.301 -1.0 . . . . 62.33 108.301 175.082 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -58.91 134.03 56.57 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 123.684 0.794 . . . . 71.31 111.938 -176.201 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 97.07 -1.33 60.87 Favored Glycine 0 C--N 1.346 1.137 0 CA-C-O 119.079 -0.845 . . . . 63.53 113.934 178.772 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 80.8 mtt-85 -67.28 156.36 36.58 Favored 'General case' 0 N--CA 1.481 1.105 0 CA-C-N 117.862 0.831 . . . . 63.11 111.327 176.781 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 70.7 mmtt -119.86 98.93 6.34 Favored 'General case' 0 C--O 1.239 0.548 0 CA-C-N 114.416 -1.265 . . . . 72.2 108.995 -172.641 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 233' ' ' LEU . . . . . 0.633 ' HB2' ' HB2' ' A' ' 251' ' ' LEU . 8.6 mt -86.88 150.28 24.22 Favored 'General case' 0 CA--C 1.542 0.668 0 N-CA-C 107.978 -1.119 . . . . 54.03 107.978 178.105 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 47.2 ttt85 -124.25 108.66 12.49 Favored 'General case' 0 CA--C 1.551 1.017 0 CA-C-N 118.637 0.653 . . . . 55.44 110.736 -176.382 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 235' ' ' LEU . . . . . 0.549 HD22 ' CD1' ' A' ' 173' ' ' PHE . 11.9 mt -86.99 106.5 17.87 Favored 'General case' 0 C--N 1.352 0.702 0 C-N-CA 124.699 1.199 . . . . 74.33 110.524 179.45 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . 0.527 ' H ' ' HB3' ' A' ' 173' ' ' PHE . 12.8 mtmt -74.35 132.37 41.97 Favored 'General case' 0 CA--C 1.539 0.549 0 O-C-N 123.531 0.519 . . . . 61.41 112.229 -178.736 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 81.24 19.57 66.56 Favored Glycine 0 C--N 1.35 1.314 0 CA-C-N 114.711 -1.131 . . . . 55.43 113.818 -178.843 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 75.9 mmtt -122.27 13.21 10.32 Favored 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 122.981 0.512 . . . . 72.41 112.229 -175.124 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -124.32 -172.03 13.54 Favored Glycine 0 C--N 1.344 0.981 0 N-CA-C 111.243 -0.743 . . . . 75.22 111.243 173.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 60.5 m-85 -84.99 160.46 55.19 Favored Pre-proline 0 N--CA 1.485 1.317 0 C-N-CA 123.983 0.913 . . . . 73.42 112.171 -173.538 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 241' ' ' PRO . . . . . 0.485 ' HA ' ' O ' ' A' ' 245' ' ' GLY . 17.2 Cg_exo -68.53 148.64 73.22 Favored 'Trans proline' 0 C--N 1.376 1.983 0 C-N-CA 122.115 1.877 . . . . 74.13 112.395 169.72 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -173.2 -119.91 0.55 Allowed Glycine 0 C--N 1.35 1.335 0 CA-C-O 119.141 -0.811 . . . . 54.23 112.529 177.355 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 243' ' ' PRO . . . . . 0.559 ' HD2' ' HB3' ' A' ' 191' ' ' GLN . 44.8 Cg_endo -59.67 -65.59 0.08 OUTLIER 'Trans proline' 0 C--N 1.378 2.104 0 C-N-CA 124.587 3.525 . . . . 72.0 112.648 -172.651 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -90.7 20.54 4.61 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 123.168 0.587 . . . . 63.35 110.903 175.309 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 245' ' ' GLY . . . . . 0.485 ' O ' ' HA ' ' A' ' 241' ' ' PRO . . . 75.0 -96.92 0.99 Allowed Glycine 0 C--N 1.349 1.29 0 N-CA-C 110.47 -1.052 . . . . 53.35 110.47 -173.033 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 21.5 ttm180 -48.46 108.89 0.19 Allowed 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 124.57 1.148 . . . . 72.32 112.32 -178.238 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -88.52 156.21 26.61 Favored Glycine 0 C--O 1.249 1.091 0 N-CA-C 110.814 -0.915 . . . . 54.21 110.814 167.334 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 40.6 m-20 -130.57 155.2 46.92 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-O 120.912 0.386 . . . . 75.42 110.351 -173.297 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 249' ' ' LEU . . . . . 0.496 ' HB3' ' HB2' ' A' ' 235' ' ' LEU . 47.4 tp -98.01 138.08 35.87 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 123.925 0.89 . . . . 53.33 110.755 -173.165 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 250' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -98.89 113.51 25.69 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 122.808 0.443 . . . . 74.32 110.395 177.384 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 251' ' ' LEU . . . . . 0.733 HD13 HD22 ' A' ' 197' ' ' LEU . 82.7 mt -88.67 105.18 17.51 Favored 'General case' 0 C--O 1.241 0.646 0 N-CA-C 108.541 -0.911 . . . . 72.31 108.541 174.867 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -88.5 103.86 16.27 Favored 'General case' 0 C--O 1.239 0.528 0 N-CA-C 108.385 -0.969 . . . . 65.23 108.385 177.818 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 19.7 m -72.01 143.1 14.5 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 CA-C-O 121.29 0.567 . . . . 63.33 111.084 -172.18 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 19.0 mmt85 -130.39 101.18 5.63 Favored 'General case' 0 C--O 1.237 0.438 0 C-N-CA 124.228 1.011 . . . . 61.32 108.377 177.452 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 30.9 mt -78.89 124.14 36.84 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 O-C-N 123.893 0.745 . . . . 74.02 110.175 178.81 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 1.4 t . . . . . 0 CA--C 1.558 1.271 0 N-CA-C 107.513 -1.292 . . . . 71.34 107.513 173.797 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 24.7 ptm . . . . . 0 N--CA 1.484 1.226 0 CA-C-O 120.353 0.12 . . . . 72.13 110.681 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 169' ' ' GLN . . . . . 0.554 ' HG2' HG22 ' A' ' 170' ' ' THR . 33.6 tt0 -153.4 -90.03 0.05 OUTLIER 'General case' 0 CA--C 1.546 0.821 0 N-CA-C 108.613 -0.884 . . . . 61.33 108.613 -178.144 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . 0.554 HG22 ' HG2' ' A' ' 169' ' ' GLN . 10.8 t 172.72 178.61 0.09 Allowed 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 125.371 1.469 . . . . 62.52 109.059 -174.314 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -151.95 -61.37 0.17 Allowed 'General case' 0 N--CA 1.478 0.931 0 CA-C-O 121.001 0.429 . . . . 61.01 110.143 -175.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 172' ' ' LEU . . . . . 0.479 HD21 ' O ' ' A' ' 222' ' ' ALA . 25.0 mt -138.78 154.05 48.47 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 124.07 0.948 . . . . 74.24 112.013 -175.039 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 173' ' ' PHE . . . . . 0.557 ' CD1' HD22 ' A' ' 235' ' ' LEU . 26.4 m-85 -136.78 -48.77 0.63 Allowed 'General case' 0 N--CA 1.477 0.879 0 CA-C-N 114.911 -1.041 . . . . 75.01 109.76 -169.578 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 174' ' ' TYR . . . . . 0.444 ' CD2' ' HB3' ' A' ' 233' ' ' LEU . 7.9 p90 -84.22 13.6 5.09 Favored 'General case' 0 N--CA 1.48 1.07 0 CA-C-N 114.824 -1.08 . . . . 74.02 113.087 -176.928 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 1.8 p -65.06 -10.58 31.29 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 123.107 0.563 . . . . 70.23 112.504 175.189 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 176' ' ' MET . . . . . . . . . . . . . 41.8 mtm -53.18 -42.11 65.9 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 124.316 1.047 . . . . 72.24 110.302 169.053 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . 0.443 ' NZ ' ' HB2' ' A' ' 177' ' ' LYS . 2.8 ttmp? -167.41 97.38 0.49 Allowed 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 124.709 1.204 . . . . 65.31 108.301 176.307 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 178' ' ' ALA . . . . . 0.472 ' HB1' ' HB3' ' A' ' 224' ' ' PRO . . . -109.38 146.3 34.65 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 124.149 0.98 . . . . 75.43 110.456 -175.738 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . 0.448 ' HB2' ' HB2' ' A' ' 224' ' ' PRO . . . 59.75 28.86 18.39 Favored 'General case' 0 N--CA 1.492 1.668 0 C-N-CA 124.388 1.075 . . . . 64.33 111.574 -174.362 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -89.9 144.59 17.76 Favored Glycine 0 C--N 1.348 1.25 0 CA-C-N 115.522 -0.763 . . . . 43.21 111.674 -179.578 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 39.2 p -73.22 144.63 46.68 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 123.25 0.62 . . . . 53.1 110.926 176.056 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . 95.04 -134.52 11.98 Favored Glycine 0 C--N 1.346 1.126 0 N-CA-C 111.617 -0.593 . . . . 62.13 111.617 -175.69 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 157.37 58.44 0.01 OUTLIER Glycine 0 C--N 1.338 0.648 0 N-CA-C 110.425 -1.07 . . . . 63.45 110.425 -178.391 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 21.6 m -52.36 113.97 1.21 Allowed 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 124.626 1.17 . . . . 65.55 111.973 -175.661 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 179.23 -78.59 0.06 OUTLIER Glycine 0 C--N 1.344 1.02 0 N-CA-C 110.917 -0.873 . . . . 51.52 110.917 -178.86 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 68.0 -85.2 0.17 Allowed Glycine 0 C--N 1.355 1.596 0 C-N-CA 123.319 0.485 . . . . 73.54 113.36 174.134 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 36.4 p -130.52 108.05 9.66 Favored 'General case' 0 C--O 1.242 0.691 0 C-N-CA 124.391 1.077 . . . . 44.54 108.764 176.7 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -91.56 -52.34 2.33 Favored Glycine 0 CA--C 1.529 0.925 0 CA-C-N 115.514 -0.766 . . . . 51.44 113.093 -177.307 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 152.83 54.17 0.01 OUTLIER Glycine 0 N--CA 1.477 1.399 0 CA-C-N 117.126 0.463 . . . . 73.23 112.127 179.851 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 46.2 m 63.0 10.53 4.48 Favored 'General case' 0 N--CA 1.49 1.553 0 C-N-CA 124.305 1.042 . . . . 65.53 112.093 -174.831 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 191' ' ' GLN . . . . . 0.688 ' HB2' ' HA2' ' A' ' 247' ' ' GLY . 3.4 pt20 -87.6 -21.97 25.04 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 124.556 1.143 . . . . 70.33 110.296 -177.147 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -76.53 148.28 37.21 Favored 'General case' 0 C--O 1.237 0.403 0 C-N-CA 125.05 1.34 . . . . 61.14 111.255 -162.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . 0.584 HD12 ' HA2' ' A' ' 239' ' ' GLY . 16.3 mt -143.87 170.97 14.89 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 123.607 0.763 . . . . 73.35 110.315 172.11 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 74.6 m-85 -135.74 141.58 44.87 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 124.146 0.978 . . . . 73.12 109.815 179.036 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . 0.473 ' HB2' HD11 ' A' ' 249' ' ' LEU . . . -154.23 132.77 12.09 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 123.787 0.835 . . . . 64.13 108.758 176.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 26.9 m -82.5 127.2 33.08 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.274 -0.639 . . . . 63.52 109.274 178.581 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 0.744 HD22 HD13 ' A' ' 251' ' ' LEU . 18.1 tp -105.54 107.42 18.4 Favored 'General case' 0 N--CA 1.465 0.306 0 N-CA-C 107.549 -1.278 . . . . 74.11 107.549 -179.469 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -77.81 123.57 26.89 Favored 'General case' 0 C--O 1.237 0.439 0 N-CA-C 107.828 -1.175 . . . . 71.12 107.828 174.072 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 199' ' ' VAL . . . . . 0.533 ' O ' ' HA ' ' A' ' 255' ' ' ILE . 2.8 p -141.62 125.6 10.1 Favored Pre-proline 0 CA--C 1.541 0.625 0 N-CA-C 108.205 -1.035 . . . . 73.21 108.205 -179.652 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -69.98 158.08 57.83 Favored 'Trans proline' 0 C--N 1.365 1.42 0 C-N-CA 122.048 1.832 . . . . 73.42 111.728 171.758 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -49.73 -50.32 67.92 Favored Pre-proline 0 CA--C 1.56 1.329 0 N-CA-C 114.001 1.111 . . . . 73.32 114.001 -178.769 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 202' ' ' PRO . . . . . 0.406 ' HA ' HG22 ' A' ' 205' ' ' VAL . 44.2 Cg_endo -63.48 -37.5 48.11 Favored 'Trans proline' 0 C--N 1.393 2.874 0 C-N-CA 122.115 1.877 . . . . 73.24 113.484 -178.507 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 38.3 mt -67.99 -36.11 74.34 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.173 0 CA-C-N 117.995 0.361 . . . . 71.3 110.448 176.102 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 204' ' ' ALA . . . . . 0.434 ' HA ' HG11 ' A' ' 223' ' ' VAL . . . -67.09 -41.78 85.72 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 123.06 0.544 . . . . 74.23 112.231 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . 0.406 HG22 ' HA ' ' A' ' 202' ' ' PRO . 20.9 m -77.81 -51.37 18.14 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.993 0 C-N-CA 123.472 0.709 . . . . 61.2 112.448 -175.592 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 206' ' ' VAL . . . . . 0.404 HG22 ' O ' ' A' ' 202' ' ' PRO . 7.9 m -73.4 -30.06 29.32 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.402 0 C-N-CA 122.357 0.263 . . . . 72.12 111.249 -178.961 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 89.66 63.09 1.29 Allowed Glycine 0 C--N 1.352 1.432 0 CA-C-N 116.216 -0.447 . . . . 44.15 112.373 -175.858 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -86.71 -139.09 5.52 Favored Glycine 0 C--N 1.352 1.429 0 CA-C-O 119.873 -0.404 . . . . 63.42 112.734 -179.833 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 46.4 mtmt -137.89 147.87 44.83 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 123.972 0.909 . . . . 73.3 110.287 178.012 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 5.2 m -140.81 166.34 18.93 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 C-N-CA 124.771 1.229 . . . . 73.2 109.807 174.475 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 29.0 ttp180 -90.06 113.91 25.71 Favored 'General case' 0 CA--C 1.546 0.827 0 C-N-CA 123.63 0.772 . . . . 74.31 109.843 -179.601 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -100.39 117.19 34.07 Favored 'General case' 0 C--O 1.24 0.562 0 N-CA-C 108.586 -0.894 . . . . 75.13 108.586 171.073 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 47.8 tpp -84.0 116.04 22.63 Favored 'General case' 0 C--O 1.241 0.637 0 N-CA-C 109.408 -0.59 . . . . 71.51 109.408 177.58 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 16.6 p -111.47 -173.67 2.3 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 124.59 1.156 . . . . 74.14 109.614 -176.515 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 56.2 mt -61.99 -36.09 80.45 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 122.986 0.514 . . . . 71.14 111.911 175.295 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 27.2 mt-10 -89.81 -8.65 51.59 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.721 0.808 . . . . 62.14 111.435 -172.452 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 124.39 -161.4 18.84 Favored Glycine 0 C--N 1.345 1.058 0 CA-C-O 119.282 -0.732 . . . . 62.45 111.458 -178.08 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -77.71 159.91 31.45 Favored 'Trans proline' 0 CA--C 1.549 1.257 0 C-N-CA 122.525 2.15 . . . . 65.44 112.794 -177.218 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 2.9 p -148.34 129.7 5.65 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 N-CA-C 108.674 -0.862 . . . . 73.32 108.674 171.02 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -76.81 100.29 5.44 Favored 'General case' 0 C--O 1.239 0.544 0 N-CA-C 107.478 -1.305 . . . . 75.22 107.478 169.613 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 9.1 p -100.34 128.36 52.41 Favored 'Isoleucine or valine' 0 C--O 1.245 0.845 0 N-CA-C 108.012 -1.107 . . . . 71.24 108.012 -176.417 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . 0.479 ' O ' HD21 ' A' ' 172' ' ' LEU . . . -77.85 105.19 8.87 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 116.466 -0.334 . . . . 74.3 110.648 -174.696 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . 0.434 HG11 ' HA ' ' A' ' 204' ' ' ALA . 62.6 t -53.8 133.03 56.9 Favored Pre-proline 0 N--CA 1.472 0.662 0 C-N-CA 124.13 0.972 . . . . 32.52 109.54 179.239 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 224' ' ' PRO . . . . . 0.472 ' HB3' ' HB1' ' A' ' 178' ' ' ALA . 30.8 Cg_endo -64.75 150.53 88.02 Favored 'Trans proline' 0 C--N 1.369 1.629 0 C-N-CA 121.327 1.352 . . . . 73.54 110.663 175.561 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -63.48 140.51 76.27 Favored 'Trans proline' 0 C--N 1.366 1.482 0 C-N-CA 121.452 1.435 . . . . 73.11 110.694 176.449 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 56.6 mtm180 64.79 42.44 4.54 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 124.248 1.019 . . . . 73.11 111.074 170.137 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 63.4 m -76.9 143.48 39.56 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-N 115.464 -0.789 . . . . 74.1 109.444 173.537 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 27.8 mp0 -117.22 143.84 45.44 Favored 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 124.144 0.978 . . . . 44.52 109.039 176.475 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -62.35 123.93 19.55 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 123.757 0.823 . . . . 73.1 110.628 -178.282 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 115.15 -6.5 21.52 Favored Glycine 0 C--N 1.338 0.659 0 O-C-N 123.75 0.656 . . . . 75.03 113.178 -175.34 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 95.2 mtt-85 -74.79 157.2 35.58 Favored 'General case' 0 N--CA 1.478 0.954 0 CA-C-N 117.634 0.717 . . . . 74.05 110.055 172.655 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 232' ' ' LYS . . . . . 0.451 ' HA ' ' O ' ' A' ' 251' ' ' LEU . 12.5 mtmm -131.42 120.95 23.76 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.269 0.628 . . . . 75.4 110.53 -179.681 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 233' ' ' LEU . . . . . 0.502 ' HB2' ' HB2' ' A' ' 251' ' ' LEU . 26.7 mt -101.99 154.31 19.08 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 125.138 1.375 . . . . 64.13 109.264 -176.274 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 15.1 ttm180 -111.99 110.87 21.41 Favored 'General case' 0 N--CA 1.48 1.065 0 CA-C-N 118.144 0.429 . . . . 64.52 111.099 -179.736 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 235' ' ' LEU . . . . . 0.59 ' HB2' ' HB3' ' A' ' 249' ' ' LEU . 11.2 mt -88.11 99.56 12.28 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 122.919 0.487 . . . . 61.0 110.023 172.014 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . 0.492 ' H ' ' HB3' ' A' ' 173' ' ' PHE . 11.7 mtmt -72.52 130.47 40.71 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 115.967 -0.56 . . . . 61.01 111.304 -179.789 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 83.69 21.11 58.57 Favored Glycine 0 C--N 1.344 0.995 0 CA-C-N 115.059 -0.973 . . . . 73.15 113.612 -178.182 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt -127.2 17.86 7.11 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 123.012 0.525 . . . . 61.22 111.329 -178.495 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 239' ' ' GLY . . . . . 0.584 ' HA2' HD12 ' A' ' 193' ' ' LEU . . . -118.81 -159.96 11.26 Favored Glycine 0 C--N 1.347 1.146 0 N-CA-C 111.278 -0.729 . . . . 55.42 111.278 170.256 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 60.4 m-85 -92.55 165.37 19.47 Favored Pre-proline 0 CA--C 1.553 1.061 0 C-N-CA 123.713 0.805 . . . . 71.35 110.376 -177.187 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 241' ' ' PRO . . . . . 0.437 ' HA ' ' O ' ' A' ' 245' ' ' GLY . 40.4 Cg_exo -61.17 166.25 11.19 Favored 'Trans proline' 0 C--N 1.374 1.877 0 C-N-CA 121.732 1.621 . . . . 54.32 113.473 170.333 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 167.32 -123.72 1.15 Allowed Glycine 0 CA--C 1.529 0.968 0 CA-C-O 118.874 -0.959 . . . . 70.11 111.862 177.209 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 243' ' ' PRO . . . . . 0.477 ' HD2' ' HB3' ' A' ' 191' ' ' GLN . 30.9 Cg_endo -59.68 -60.78 0.27 Allowed 'Trans proline' 0 C--N 1.379 2.136 0 C-N-CA 123.925 3.083 . . . . 70.02 112.976 -170.001 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -90.93 2.85 55.89 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 123.185 0.594 . . . . 74.41 111.43 177.373 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 245' ' ' GLY . . . . . 0.437 ' O ' ' HA ' ' A' ' 241' ' ' PRO . . . 85.35 -34.57 3.26 Favored Glycine 0 C--N 1.358 1.757 0 N-CA-C 112.319 -0.312 . . . . 51.45 112.319 -173.746 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 10.8 ttm180 -88.66 112.53 23.21 Favored 'General case' 0 CA--C 1.529 0.149 0 C-N-CA 124.79 1.236 . . . . 74.21 111.404 177.557 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . 0.688 ' HA2' ' HB2' ' A' ' 191' ' ' GLN . . . -84.31 163.57 39.37 Favored Glycine 0 C--N 1.345 1.074 0 C-N-CA 121.27 -0.491 . . . . 63.34 114.055 162.855 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 34.6 m-20 -132.65 143.79 49.9 Favored 'General case' 0 C--O 1.241 0.638 0 C-N-CA 123.866 0.866 . . . . 73.13 110.133 -169.063 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 249' ' ' LEU . . . . . 0.59 ' HB3' ' HB2' ' A' ' 235' ' ' LEU . 61.4 tp -106.98 117.86 35.18 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 124.361 1.065 . . . . 64.3 110.087 -177.084 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 250' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 -91.5 110.62 21.93 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 123.245 0.618 . . . . 74.23 110.034 -174.299 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 251' ' ' LEU . . . . . 0.744 HD13 HD22 ' A' ' 197' ' ' LEU . 74.6 mt -86.73 106.35 17.59 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 114.839 -1.073 . . . . 64.45 110.574 -175.037 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -79.63 97.07 6.37 Favored 'General case' 0 C--O 1.241 0.643 0 N-CA-C 108.439 -0.948 . . . . 62.02 108.439 173.746 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 4.6 m -69.42 130.35 34.16 Favored 'Isoleucine or valine' 0 C--O 1.244 0.776 0 CA-C-O 121.762 0.792 . . . . 72.04 110.251 -176.338 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 21.8 mmm180 -126.9 115.13 18.82 Favored 'General case' 0 C--O 1.237 0.44 0 N-CA-C 107.657 -1.238 . . . . 73.05 107.657 178.576 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 255' ' ' ILE . . . . . 0.533 ' HA ' ' O ' ' A' ' 199' ' ' VAL . 49.0 mt -98.82 111.88 29.53 Favored 'Isoleucine or valine' 0 C--O 1.24 0.589 0 O-C-N 123.574 0.546 . . . . 71.2 110.443 -175.09 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 3.1 t . . . . . 0 CA--C 1.56 1.34 0 CA-C-N 115.523 -0.762 . . . . 74.42 108.984 177.276 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 168' ' ' MET . . . . . 0.417 ' N ' ' SD ' ' A' ' 168' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.482 1.13 0 N-CA-C 111.746 0.276 . . . . 75.24 111.746 . . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 17.7 pt20 -138.07 169.1 18.37 Favored 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 123.246 0.618 . . . . 73.25 110.534 176.507 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 10.5 t -95.39 158.5 15.43 Favored 'General case' 0 CA--C 1.551 0.999 0 C-N-CA 123.927 0.891 . . . . 71.03 109.264 174.281 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -115.98 -84.45 0.63 Allowed 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 123.523 0.729 . . . . 71.53 111.53 -173.5 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 172' ' ' LEU . . . . . 0.485 HD21 ' HB3' ' A' ' 222' ' ' ALA . 77.5 mt -126.33 155.9 41.28 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 124.071 0.949 . . . . 74.45 111.654 -163.768 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 173' ' ' PHE . . . . . 0.435 ' CD1' HD22 ' A' ' 235' ' ' LEU . 45.4 m-85 -144.59 -66.95 0.33 Allowed 'General case' 0 N--CA 1.486 1.336 0 N-CA-C 109.391 -0.596 . . . . 75.52 109.391 -166.545 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 174' ' ' TYR . . . . . 0.478 ' CD2' ' HB3' ' A' ' 233' ' ' LEU . 7.7 p90 -64.77 -13.24 54.49 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 123.841 0.857 . . . . 75.34 112.301 177.655 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 175' ' ' THR . . . . . 0.456 HG21 HD13 ' A' ' 172' ' ' LEU . 4.2 m -65.73 0.97 1.45 Allowed 'General case' 0 CA--C 1.565 1.535 0 C-N-CA 125.133 1.373 . . . . 73.52 112.217 -178.154 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 176' ' ' MET . . . . . . . . . . . . . 37.3 mtm -64.85 -59.88 3.7 Favored 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 123.604 0.762 . . . . 75.03 109.148 161.543 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.98 100.32 3.38 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 124.477 1.111 . . . . 63.31 108.651 175.024 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -109.44 -178.38 3.54 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 124.194 0.998 . . . . 61.23 111.612 -170.169 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . 62.14 -91.05 0.03 OUTLIER 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 125.088 1.355 . . . . 72.13 111.044 -177.43 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -136.51 29.9 2.74 Favored Glycine 0 N--CA 1.469 0.877 0 N-CA-C 112.461 -0.256 . . . . 73.54 112.461 -178.225 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 24.5 m -98.43 14.24 28.82 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 123.717 0.807 . . . . 65.44 110.87 178.262 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -170.38 164.61 37.9 Favored Glycine 0 C--N 1.345 1.077 0 CA-C-N 116.089 -0.505 . . . . 43.32 111.86 -178.878 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 175.76 -43.64 0.12 Allowed Glycine 0 C--N 1.345 1.058 0 N-CA-C 112.011 -0.436 . . . . 71.51 112.011 178.871 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 33.3 t -70.08 112.39 6.43 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 123.114 0.566 . . . . 61.01 110.575 -178.858 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . 0.534 ' HA2' HH22 ' A' ' 234' ' ' ARG . . . -76.55 -47.4 10.29 Favored Glycine 0 C--N 1.351 1.365 0 O-C-N 123.438 0.461 . . . . 42.4 113.103 -178.078 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 72.52 43.92 42.9 Favored Glycine 0 C--N 1.35 1.316 0 O-C-N 123.668 0.276 . . . . 61.41 112.592 -176.851 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 48.2 t -109.11 160.93 15.66 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 124.097 0.959 . . . . 54.44 111.594 -175.2 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -146.85 -35.18 0.06 OUTLIER Glycine 0 C--N 1.35 1.339 0 CA-C-N 115.745 -0.661 . . . . 32.23 112.274 179.152 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -87.51 11.1 67.01 Favored Glycine 0 C--N 1.353 1.496 0 CA-C-O 119.338 -0.701 . . . . 55.55 114.056 -177.371 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 50.4 m 60.32 65.39 1.08 Allowed 'General case' 0 C--N 1.358 0.942 0 C-N-CA 124.086 0.954 . . . . 65.45 112.131 178.255 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 191' ' ' GLN . . . . . 0.621 ' HB3' ' HD2' ' A' ' 243' ' ' PRO . 9.9 pt20 -89.81 -22.85 21.9 Favored 'General case' 0 N--CA 1.478 0.962 0 CA-C-N 115.862 -0.608 . . . . 73.41 110.347 174.629 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -77.56 157.58 30.26 Favored 'General case' 0 C--O 1.241 0.617 0 CA-C-N 115.091 -0.959 . . . . 71.22 110.904 -168.539 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 32.7 mt -134.25 171.13 14.68 Favored 'General case' 0 C--O 1.239 0.529 0 CA-C-N 114.284 -1.325 . . . . 70.22 108.69 176.282 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 59.6 m-85 -136.49 126.63 26.24 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 123.768 0.827 . . . . 53.43 110.317 -177.165 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . 0.414 ' O ' ' HA ' ' A' ' 251' ' ' LEU . . . -141.65 130.66 23.21 Favored 'General case' 0 N--CA 1.466 0.344 0 N-CA-C 107.951 -1.129 . . . . 74.13 107.951 175.636 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 30.4 m -83.07 127.78 33.89 Favored 'General case' 0 C--O 1.24 0.559 0 N-CA-C 108.577 -0.897 . . . . 73.21 108.577 176.865 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 0.724 HD22 HD13 ' A' ' 251' ' ' LEU . 16.7 tp -106.35 110.05 22.17 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 108.331 -0.989 . . . . 72.54 108.331 -178.974 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -80.72 118.42 22.25 Favored 'General case' 0 C--O 1.238 0.475 0 N-CA-C 108.233 -1.025 . . . . 74.3 108.233 -179.817 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 5.1 p -136.89 128.45 16.74 Favored Pre-proline 0 CA--C 1.543 0.691 0 N-CA-C 108.948 -0.76 . . . . 74.44 108.948 -176.28 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 200' ' ' PRO . . . . . 0.432 ' HB2' ' HD2' ' A' ' 202' ' ' PRO . 62.0 Cg_endo -69.69 158.25 57.72 Favored 'Trans proline' 0 C--N 1.365 1.404 0 C-N-CA 121.924 1.749 . . . . 74.32 111.246 172.717 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 201' ' ' ALA . . . . . 0.51 ' O ' HG23 ' A' ' 205' ' ' VAL . . . -47.34 -54.8 19.16 Favored Pre-proline 0 CA--C 1.562 1.417 0 CA-C-O 117.547 -1.216 . . . . 72.54 113.044 179.88 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 202' ' ' PRO . . . . . 0.432 ' HD2' ' HB2' ' A' ' 200' ' ' PRO . 52.9 Cg_endo -64.74 -37.25 36.85 Favored 'Trans proline' 0 C--N 1.4 3.289 0 C-N-CA 121.9 1.733 . . . . 71.31 113.323 -174.124 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 44.1 mt -65.67 -34.64 71.7 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 C-N-CA 122.54 0.336 . . . . 72.34 110.141 177.604 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -70.53 -39.75 73.86 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 122.518 0.327 . . . . 65.31 111.093 177.277 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . 0.51 HG23 ' O ' ' A' ' 201' ' ' ALA . 83.9 t -67.44 -56.43 13.41 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 C-N-CA 123.565 0.746 . . . . 74.34 111.193 -177.852 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 10.5 m -82.06 -29.49 9.68 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 CA-C-N 116.002 -0.544 . . . . 70.25 111.455 -172.821 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 88.5 65.43 1.31 Allowed Glycine 0 C--N 1.345 1.074 0 CA-C-N 116.093 -0.503 . . . . 73.21 112.129 -174.875 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -87.11 -134.69 4.18 Favored Glycine 0 C--N 1.357 1.726 0 N-CA-C 111.794 -0.523 . . . . 44.54 111.794 177.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 46.6 mtmt -136.61 154.93 50.53 Favored 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 123.524 0.729 . . . . 61.34 110.908 178.602 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 6.3 m -144.94 169.66 7.77 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 C-N-CA 125.597 1.559 . . . . 72.51 108.473 172.319 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 56.0 ttp180 -104.23 119.43 38.94 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 123.573 0.749 . . . . 65.43 109.499 177.487 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -103.57 141.08 36.63 Favored 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 123.894 0.878 . . . . 74.4 109.667 175.402 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 46.9 tpp -100.27 128.32 46.37 Favored 'General case' 0 N--CA 1.475 0.808 0 N-CA-C 109.179 -0.675 . . . . 75.23 109.179 178.389 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 19.6 p -129.27 -171.68 2.55 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 123.818 0.847 . . . . 51.01 110.52 -171.55 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 91.9 mt -62.18 -27.75 69.18 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 123.831 0.853 . . . . 44.42 111.839 173.869 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -99.49 6.48 45.89 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 123.573 0.749 . . . . 70.12 111.52 -179.464 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 94.48 -153.42 20.99 Favored Glycine 0 C--N 1.347 1.146 0 CA-C-O 119.589 -0.562 . . . . 61.12 112.655 -177.807 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_endo -70.35 153.4 66.26 Favored 'Trans proline' 0 C--N 1.37 1.672 0 C-N-CA 122.582 2.188 . . . . 72.11 113.25 -174.489 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 4.6 p -145.52 135.81 18.74 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 C-N-CA 124.368 1.067 . . . . 74.11 109.048 174.245 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -83.6 104.23 13.56 Favored 'General case' 0 C--O 1.239 0.546 0 N-CA-C 107.883 -1.154 . . . . 71.02 107.883 172.659 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 2.9 p -114.39 126.07 71.84 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.018 0 N-CA-C 109.41 -0.589 . . . . 62.43 109.41 -174.476 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . 0.485 ' HB3' HD21 ' A' ' 172' ' ' LEU . . . -78.82 108.43 12.26 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 123.39 0.676 . . . . 55.55 110.69 -179.333 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 84.7 t -55.46 136.17 70.01 Favored Pre-proline 0 N--CA 1.478 0.961 0 C-N-CA 124.754 1.222 . . . . 71.33 109.857 177.12 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -66.31 159.4 50.26 Favored 'Trans proline' 0 C--N 1.373 1.839 0 C-N-CA 121.711 1.607 . . . . 63.51 111.455 174.835 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -69.28 153.13 71.62 Favored 'Trans proline' 0 C--N 1.365 1.428 0 C-N-CA 121.544 1.496 . . . . 73.11 111.08 171.917 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 39.7 mtm180 60.69 34.41 20.0 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 124.773 1.229 . . . . 65.34 111.578 172.702 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 227' ' ' THR . . . . . 0.518 ' O ' HD11 ' A' ' 255' ' ' ILE . 85.4 m -73.73 120.78 19.8 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 115.049 -0.978 . . . . 62.35 109.547 175.52 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 228' ' ' GLN . . . . . 0.475 ' NE2' HH21 ' A' ' 231' ' ' ARG . 2.2 mp0 -102.59 147.86 26.27 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 124.414 1.086 . . . . 72.14 109.035 177.908 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 229' ' ' ALA . . . . . 0.445 ' HB2' ' HB ' ' A' ' 255' ' ' ILE . . . -59.21 115.03 2.92 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 123.81 0.844 . . . . 71.52 111.274 -177.237 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 113.42 0.2 24.94 Favored Glycine 0 C--N 1.343 0.97 0 O-C-N 123.685 0.616 . . . . 43.43 113.599 -178.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 231' ' ' ARG . . . . . 0.475 HH21 ' NE2' ' A' ' 228' ' ' GLN . 87.5 mtt-85 -65.72 150.77 47.95 Favored 'General case' 0 N--CA 1.486 1.36 0 CA-C-N 117.591 0.696 . . . . 63.42 110.478 173.471 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 71.7 mmtt -118.67 102.22 8.69 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 124.097 0.959 . . . . 74.12 109.488 -171.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 233' ' ' LEU . . . . . 0.776 ' HB2' ' HB2' ' A' ' 251' ' ' LEU . 58.7 mt -88.89 152.21 21.87 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 115.415 -0.812 . . . . 71.31 109.534 178.344 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 234' ' ' ARG . . . . . 0.534 HH22 ' HA2' ' A' ' 185' ' ' GLY . 38.6 ttm-85 -119.32 121.12 38.87 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.512 0.725 . . . . 62.44 110.902 -174.673 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 235' ' ' LEU . . . . . 0.64 ' HB2' ' HB3' ' A' ' 249' ' ' LEU . 16.0 mt -110.43 100.38 9.23 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 122.464 0.306 . . . . 71.14 110.662 176.874 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . 0.563 ' HB3' ' HD2' ' A' ' 246' ' ' ARG . 13.2 mttp -69.13 139.84 54.71 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 110.345 -0.243 . . . . 63.23 110.345 173.323 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 86.85 -3.13 87.22 Favored Glycine 0 N--CA 1.473 1.11 0 CA-C-N 115.757 -0.656 . . . . 72.0 113.193 179.857 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -112.79 5.25 17.45 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 123.573 0.749 . . . . 70.53 111.061 -179.085 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -113.35 -173.82 18.77 Favored Glycine 0 C--N 1.347 1.184 0 N-CA-C 110.997 -0.841 . . . . 52.04 110.997 164.584 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 93.8 m-85 -91.56 160.98 35.51 Favored Pre-proline 0 N--CA 1.483 1.216 0 C-N-CA 123.84 0.856 . . . . 70.15 110.331 -178.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_exo -62.07 158.69 37.81 Favored 'Trans proline' 0 C--N 1.374 1.881 0 C-N-CA 122.136 1.891 . . . . 73.52 112.951 173.724 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 169.19 -128.12 1.62 Allowed Glycine 0 C--N 1.349 1.251 0 CA-C-O 118.766 -1.019 . . . . 65.34 112.307 176.113 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 243' ' ' PRO . . . . . 0.621 ' HD2' ' HB3' ' A' ' 191' ' ' GLN . 18.6 Cg_endo -52.62 -49.66 16.73 Favored 'Trans proline' 0 C--N 1.38 2.199 0 C-N-CA 124.96 3.773 . . . . 60.51 113.826 -173.963 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -95.92 -1.83 48.45 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.295 0.638 . . . . 53.12 111.69 -179.024 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 90.01 -37.76 3.31 Favored Glycine 0 C--N 1.352 1.438 0 CA-C-O 120.955 0.197 . . . . 62.41 113.014 178.1 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 246' ' ' ARG . . . . . 0.563 ' HD2' ' HB3' ' A' ' 236' ' ' LYS . 16.5 ttm180 -120.38 111.73 18.12 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 124.17 0.988 . . . . 72.31 108.593 178.831 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -69.3 155.12 53.44 Favored Glycine 0 C--O 1.25 1.133 0 O-C-N 123.504 0.503 . . . . 74.43 114.255 178.289 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 248' ' ' ASP . . . . . 0.453 ' HB3' ' HG3' ' A' ' 234' ' ' ARG . 40.3 m-20 -112.19 138.87 48.26 Favored 'General case' 0 C--O 1.225 -0.224 0 CA-C-N 114.152 -1.024 . . . . 73.43 109.591 -173.446 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 249' ' ' LEU . . . . . 0.64 ' HB3' ' HB2' ' A' ' 235' ' ' LEU . 44.4 tp -100.12 117.58 34.67 Favored 'General case' 0 C--O 1.238 0.485 0 N-CA-C 108.088 -1.078 . . . . 75.04 108.088 172.051 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 250' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -88.56 108.95 19.69 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 123.651 0.78 . . . . 74.54 108.898 -176.419 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 251' ' ' LEU . . . . . 0.776 ' HB2' ' HB2' ' A' ' 233' ' ' LEU . 85.6 mt -88.38 104.83 17.14 Favored 'General case' 0 C--O 1.24 0.566 0 N-CA-C 108.135 -1.061 . . . . 73.31 108.135 178.281 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -84.36 101.87 12.3 Favored 'General case' 0 C--O 1.241 0.647 0 N-CA-C 107.864 -1.161 . . . . 72.34 107.864 175.222 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 11.2 m -69.45 139.31 20.57 Favored 'Isoleucine or valine' 0 C--O 1.244 0.772 0 O-C-N 123.87 0.731 . . . . 75.31 110.03 -175.774 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 14.4 mmt85 -128.18 105.63 8.5 Favored 'General case' 0 C--O 1.238 0.487 0 C-N-CA 124.073 0.949 . . . . 70.34 108.608 178.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 255' ' ' ILE . . . . . 0.518 HD11 ' O ' ' A' ' 227' ' ' THR . 34.0 mt -76.4 123.95 33.7 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 O-C-N 123.932 0.77 . . . . 74.1 109.615 178.582 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 1.8 t . . . . . 0 CA--C 1.554 1.104 0 N-CA-C 107.426 -1.324 . . . . 71.03 107.426 178.773 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 28.1 ttt . . . . . 0 N--CA 1.481 1.093 0 N-CA-C 108.94 -0.763 . . . . 34.51 108.94 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 28.3 pt20 -142.84 167.22 22.58 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 124.013 0.925 . . . . 74.12 110.598 -171.226 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 8.9 t -65.02 160.07 21.71 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 124.095 0.958 . . . . 71.43 111.19 177.534 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 18.9 m-20 -83.92 -89.38 0.09 Allowed 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 123.189 0.595 . . . . 65.01 110.464 -179.273 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 172' ' ' LEU . . . . . 0.756 HD21 ' H ' ' A' ' 222' ' ' ALA . 59.9 mt -146.94 153.95 40.69 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 124.484 1.114 . . . . 71.12 110.449 -167.978 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 173' ' ' PHE . . . . . 0.422 ' CD1' HD22 ' A' ' 235' ' ' LEU . 40.1 m-85 -125.8 -52.26 1.57 Allowed 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 123.927 0.891 . . . . 75.1 108.638 -176.106 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 174' ' ' TYR . . . . . . . . . . . . . 17.3 p90 -68.93 -2.67 10.32 Favored 'General case' 0 C--N 1.345 0.388 0 CA-C-N 113.894 -1.503 . . . . 72.31 114.198 -174.241 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 2.4 p -57.71 -16.06 9.8 Favored 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 123.775 0.83 . . . . 74.53 112.62 173.15 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 176' ' ' MET . . . . . . . . . . . . . 9.4 ptm -52.57 -40.75 62.93 Favored 'General case' 0 CA--C 1.56 1.359 0 C-N-CA 123.988 0.915 . . . . 72.11 111.825 167.519 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 46.5 tptt -153.78 48.28 0.65 Allowed 'General case' 0 N--CA 1.479 1.006 0 CA-C-O 122.019 0.914 . . . . 72.5 109.438 -177.523 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 178' ' ' ALA . . . . . 0.524 ' HB1' ' HB3' ' A' ' 224' ' ' PRO . . . -74.41 131.89 41.48 Favored 'General case' 0 N--CA 1.478 0.958 0 CA-C-N 115.21 -0.904 . . . . 75.34 110.62 -178.271 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . 0.477 ' HB2' ' HB2' ' A' ' 224' ' ' PRO . . . 69.54 14.09 8.3 Favored 'General case' 0 N--CA 1.492 1.639 0 C-N-CA 124.888 1.275 . . . . 74.03 111.448 -171.838 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -94.75 -169.04 36.8 Favored Glycine 0 C--N 1.352 1.452 0 N-CA-C 110.851 -0.9 . . . . 54.45 110.851 171.518 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 33.3 p -91.56 16.11 11.11 Favored 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 123.427 0.691 . . . . 74.4 111.28 176.793 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . 94.87 -60.93 1.68 Allowed Glycine 0 C--N 1.35 1.347 0 C-N-CA 123.182 0.42 . . . . 74.23 112.071 176.766 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 121.38 139.25 5.64 Favored Glycine 0 C--N 1.346 1.086 0 N-CA-C 111.646 -0.582 . . . . 61.3 111.646 179.26 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 15.4 m -59.54 98.06 0.04 OUTLIER 'General case' 0 CA--C 1.55 0.967 0 C-N-CA 124.249 1.02 . . . . 75.45 110.666 -179.001 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -88.9 148.93 20.57 Favored Glycine 0 C--N 1.345 1.041 0 N-CA-C 111.427 -0.669 . . . . 54.5 111.427 176.715 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -142.38 41.02 1.23 Allowed Glycine 0 C--N 1.339 0.7 0 N-CA-C 110.997 -0.841 . . . . 74.2 110.997 179.102 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 29.9 m -64.04 115.09 4.59 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 123.586 0.754 . . . . 72.11 110.307 -177.209 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -59.36 -72.81 0.55 Allowed Glycine 0 C--N 1.36 1.887 0 O-C-N 123.952 0.782 . . . . 74.35 112.807 -177.04 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -68.95 152.71 52.5 Favored Glycine 0 C--N 1.347 1.181 0 N-CA-C 111.18 -0.768 . . . . 41.42 111.18 170.347 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 26.9 t -78.99 77.15 5.46 Favored 'General case' 0 CA--C 1.55 0.953 0 CA-C-O 121.682 0.753 . . . . 54.02 109.861 -179.427 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 191' ' ' GLN . . . . . 0.582 ' HB3' ' HD2' ' A' ' 243' ' ' PRO . 10.5 pt20 -86.14 -20.88 27.99 Favored 'General case' 0 N--CA 1.48 1.031 0 CA-C-N 114.983 -1.008 . . . . 65.11 110.209 175.755 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -76.83 150.16 36.13 Favored 'General case' 0 C--O 1.241 0.657 0 CA-C-N 114.971 -1.013 . . . . 55.11 110.304 -171.031 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . 0.41 HD12 ' HA2' ' A' ' 239' ' ' GLY . 29.5 mt -128.82 168.2 16.25 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 124.549 1.14 . . . . 64.43 109.4 177.872 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 71.6 m-85 -126.17 140.56 52.47 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 123.621 0.768 . . . . 75.33 109.731 179.125 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . 0.493 ' HB2' HD11 ' A' ' 249' ' ' LEU . . . -153.32 129.59 10.5 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 108.09 -1.078 . . . . 65.41 108.09 177.974 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 18.0 m -85.22 125.2 32.67 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 109.237 -0.653 . . . . 75.23 109.237 177.752 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 0.511 HD22 HD13 ' A' ' 251' ' ' LEU . 20.7 tp -106.54 109.13 20.95 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 108.382 -0.97 . . . . 63.43 108.382 -178.878 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -78.04 127.51 32.43 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 123.388 0.675 . . . . 51.41 109.416 177.285 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 199' ' ' VAL . . . . . 0.479 ' O ' ' HA ' ' A' ' 255' ' ' ILE . 3.3 p -142.75 124.68 8.72 Favored Pre-proline 0 CA--C 1.543 0.693 0 C-N-CA 123.585 0.754 . . . . 53.14 108.971 178.767 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -67.36 153.35 77.17 Favored 'Trans proline' 0 C--N 1.368 1.588 0 C-N-CA 122.146 1.897 . . . . 55.14 111.805 171.545 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -47.91 -49.53 58.08 Favored Pre-proline 0 CA--C 1.562 1.431 0 N-CA-C 114.433 1.271 . . . . 73.22 114.433 -176.654 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 202' ' ' PRO . . . . . 0.429 ' O ' HG22 ' A' ' 206' ' ' VAL . 54.2 Cg_endo -66.17 -38.71 20.48 Favored 'Trans proline' 0 C--N 1.393 2.908 0 C-N-CA 121.603 1.535 . . . . 73.33 112.701 -179.333 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 29.6 mt -65.06 -32.28 57.59 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.139 0 CA-C-N 118.348 0.522 . . . . 52.24 110.209 177.343 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -68.05 -48.73 64.82 Favored 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 122.994 0.518 . . . . 61.03 111.612 179.004 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . 0.42 HG22 ' HA ' ' A' ' 202' ' ' PRO . 17.6 m -71.82 -50.56 37.55 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.848 0 C-N-CA 123.243 0.617 . . . . 71.22 112.238 -177.67 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 206' ' ' VAL . . . . . 0.429 HG22 ' O ' ' A' ' 202' ' ' PRO . 4.5 m -74.4 -25.96 19.94 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.2 0 C-N-CA 122.746 0.419 . . . . 74.43 111.504 -177.699 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 80.09 70.02 1.36 Allowed Glycine 0 C--N 1.345 1.047 0 O-C-N 123.312 0.382 . . . . 64.45 112.181 -177.59 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -93.44 -131.4 5.91 Favored Glycine 0 C--N 1.35 1.348 0 C-N-CA 123.152 0.406 . . . . 73.23 112.267 179.208 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 209' ' ' LYS . . . . . 0.49 ' HG2' ' HA ' ' A' ' 222' ' ' ALA . 47.4 mtmt -138.26 156.53 47.58 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 123.865 0.866 . . . . 73.41 111.199 177.564 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 9.6 m -147.61 167.18 5.16 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.1 0 C-N-CA 125.519 1.528 . . . . 73.15 108.972 173.332 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 58.6 ttp180 -99.8 119.09 37.62 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 123.096 0.558 . . . . 75.51 110.557 178.918 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -101.58 131.15 47.93 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 124.409 1.084 . . . . 54.42 110.16 176.28 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 50.5 tpp -94.7 129.93 41.41 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 123.22 0.608 . . . . 75.41 109.59 177.389 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 17.3 p -126.48 -172.48 2.64 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 124.199 1.0 . . . . 63.33 109.747 -175.141 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 80.3 mt -61.92 -37.44 84.68 Favored 'General case' 0 N--CA 1.482 1.135 0 CA-C-O 121.133 0.492 . . . . 72.04 110.875 171.063 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -92.05 10.66 28.2 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 124.253 1.021 . . . . 74.22 111.677 -173.163 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 101.67 -158.84 18.53 Favored Glycine 0 C--N 1.351 1.4 0 CA-C-O 119.504 -0.609 . . . . 61.32 112.348 178.403 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -80.46 154.31 21.16 Favored 'Trans proline' 0 C--N 1.368 1.561 0 C-N-CA 122.728 2.285 . . . . 63.13 112.843 -177.584 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 4.2 p -150.8 129.18 2.75 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 N-CA-C 108.328 -0.99 . . . . 74.14 108.328 175.498 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -85.34 103.24 14.08 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 108.982 -0.747 . . . . 70.21 108.982 -178.872 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 15.9 m -97.78 137.91 24.04 Favored 'Isoleucine or valine' 0 C--O 1.241 0.623 0 C-N-CA 123.669 0.787 . . . . 54.51 110.442 -176.929 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . 0.756 ' H ' HD21 ' A' ' 172' ' ' LEU . . . -84.46 104.79 14.77 Favored 'General case' 0 C--O 1.243 0.722 0 CA-C-N 115.159 -0.928 . . . . 72.53 110.451 -179.016 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 66.5 t -54.7 129.8 64.16 Favored Pre-proline 0 N--CA 1.475 0.792 0 C-N-CA 124.771 1.228 . . . . 70.41 109.669 -179.223 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 224' ' ' PRO . . . . . 0.524 ' HB3' ' HB1' ' A' ' 178' ' ' ALA . 28.6 Cg_endo -62.13 154.79 60.19 Favored 'Trans proline' 0 C--N 1.369 1.656 0 C-N-CA 121.914 1.742 . . . . 71.14 111.514 176.035 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -67.13 143.9 67.03 Favored 'Trans proline' 0 C--N 1.364 1.361 0 C-N-CA 121.152 1.234 . . . . 70.3 111.28 173.453 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 75.3 mtt180 65.61 38.41 5.44 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 124.726 1.21 . . . . 64.21 111.752 172.888 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 55.5 m -74.95 137.95 41.97 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 122.973 0.509 . . . . 75.33 110.45 175.694 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 26.8 mp0 -113.63 146.56 39.57 Favored 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 124.055 0.942 . . . . 74.15 109.994 175.169 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -58.94 119.79 7.88 Favored 'General case' 0 C--N 1.354 0.799 0 C-N-CA 124.276 1.03 . . . . 62.1 111.051 -178.788 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 114.11 -5.06 23.75 Favored Glycine 0 N--CA 1.466 0.689 0 O-C-N 123.834 0.709 . . . . 73.03 112.711 -178.883 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 85.9 mtt-85 -70.36 148.5 48.35 Favored 'General case' 0 C--N 1.358 0.976 0 CA-C-N 117.654 0.727 . . . . 72.35 109.333 172.411 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 41.2 mtmt -125.19 116.1 21.47 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 121.547 0.689 . . . . 73.51 109.599 -175.213 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 233' ' ' LEU . . . . . 0.639 ' HB2' ' HB2' ' A' ' 251' ' ' LEU . 56.7 mt -93.45 141.2 28.73 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 114.211 -1.358 . . . . 54.25 108.575 -177.887 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 14.5 ttp180 -109.26 112.44 24.59 Favored 'General case' 0 N--CA 1.474 0.774 0 O-C-N 122.055 -0.403 . . . . 72.43 111.264 -172.02 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 235' ' ' LEU . . . . . 0.593 ' HB2' ' HB3' ' A' ' 249' ' ' LEU . 12.9 mt -102.07 107.54 18.68 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.542 0.737 . . . . 73.45 110.432 176.228 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . 0.521 ' HB3' ' HD2' ' A' ' 246' ' ' ARG . 40.9 mttm -76.52 151.9 36.22 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-O 120.999 0.428 . . . . 75.44 110.556 172.14 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 77.21 -6.9 40.37 Favored Glycine 0 N--CA 1.476 1.365 0 CA-C-N 115.47 -0.787 . . . . 55.13 113.908 -177.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 72.8 mmtt -104.12 -7.56 20.11 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 123.748 0.819 . . . . 74.53 110.077 -179.695 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 239' ' ' GLY . . . . . 0.41 ' HA2' HD12 ' A' ' 193' ' ' LEU . . . -97.14 -167.73 33.03 Favored Glycine 0 C--N 1.358 1.769 0 N-CA-C 111.278 -0.729 . . . . 60.03 111.278 164.983 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 74.3 m-85 -91.59 157.31 42.16 Favored Pre-proline 0 N--CA 1.481 1.09 0 C-N-CA 123.772 0.829 . . . . 74.04 110.874 179.821 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -70.6 154.77 64.19 Favored 'Trans proline' 0 C--N 1.369 1.63 0 C-N-CA 121.311 1.341 . . . . 64.42 111.059 169.857 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 173.59 -119.63 0.76 Allowed Glycine 0 CA--C 1.527 0.826 0 CA-C-O 118.601 -1.11 . . . . 74.2 111.842 -179.47 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 243' ' ' PRO . . . . . 0.582 ' HD2' ' HB3' ' A' ' 191' ' ' GLN . 40.8 Cg_endo -60.66 -57.24 0.72 Allowed 'Trans proline' 0 C--N 1.38 2.232 0 C-N-CA 123.784 2.989 . . . . 74.01 112.54 -173.117 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -80.24 -12.86 59.58 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 123.167 0.587 . . . . 55.23 111.207 179.845 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 95.78 -34.8 4.67 Favored Glycine 0 C--N 1.353 1.512 0 C-N-CA 122.986 0.327 . . . . 54.31 112.311 179.698 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 246' ' ' ARG . . . . . 0.521 ' HD2' ' HB3' ' A' ' 236' ' ' LYS . 22.3 ttm180 -125.81 111.77 15.25 Favored 'General case' 0 C--O 1.244 0.77 0 C-N-CA 123.727 0.811 . . . . 75.43 108.986 177.751 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -72.12 155.31 51.58 Favored Glycine 0 C--N 1.347 1.182 0 N-CA-C 115.253 0.861 . . . . 73.33 115.253 -177.698 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 38.9 m-20 -100.21 155.43 17.76 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 113.654 -1.273 . . . . 72.34 109.96 -175.515 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 249' ' ' LEU . . . . . 0.593 ' HB3' ' HB2' ' A' ' 235' ' ' LEU . 48.8 tp -129.77 114.87 16.48 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 108.191 -1.04 . . . . 63.45 108.191 173.326 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 250' ' ' TYR . . . . . . . . . . . . . 19.7 m-30 -90.55 109.14 20.3 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 116.191 -0.458 . . . . 72.34 110.191 -174.757 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 251' ' ' LEU . . . . . 0.639 ' HB2' ' HB2' ' A' ' 233' ' ' LEU . 82.4 mt -87.45 102.43 14.55 Favored 'General case' 0 C--O 1.239 0.522 0 N-CA-C 107.923 -1.14 . . . . 72.25 107.923 177.254 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -83.38 99.72 10.24 Favored 'General case' 0 C--O 1.243 0.718 0 N-CA-C 108.257 -1.016 . . . . 73.35 108.257 178.002 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 10.1 m -61.32 132.34 26.83 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.768 0 CA-C-N 115.572 -0.74 . . . . 75.04 110.004 179.63 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 20.3 mmm180 -125.34 105.42 9.08 Favored 'General case' 0 C--O 1.241 0.606 0 N-CA-C 107.273 -1.38 . . . . 64.22 107.273 178.292 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 255' ' ' ILE . . . . . 0.479 ' HA ' ' O ' ' A' ' 199' ' ' VAL . 45.6 mt -77.93 107.54 9.95 Favored 'Isoleucine or valine' 0 C--O 1.239 0.505 0 CA-C-N 115.797 -0.638 . . . . 62.42 109.766 -179.254 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 2.4 t . . . . . 0 CA--C 1.555 1.159 0 CA-C-N 115.035 -0.984 . . . . 74.04 108.462 174.302 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 1.7 pmm? . . . . . 0 N--CA 1.484 1.247 0 N-CA-C 111.994 0.368 . . . . 73.53 111.994 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 10.7 pt20 -94.11 164.54 13.03 Favored 'General case' 0 N--CA 1.482 1.139 0 CA-C-O 121.259 0.552 . . . . 75.14 111.093 -178.268 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 9.0 t -88.44 173.51 8.66 Favored 'General case' 0 CA--C 1.557 1.222 0 CA-C-N 115.169 -0.923 . . . . 71.42 109.455 170.281 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -139.62 -81.37 0.28 Allowed 'General case' 0 N--CA 1.483 1.175 0 C-N-CA 122.726 0.411 . . . . 60.14 111.939 -167.686 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 172' ' ' LEU . . . . . 0.45 HD21 ' HB3' ' A' ' 222' ' ' ALA . 22.7 mt -117.38 143.28 46.14 Favored 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 123.82 0.848 . . . . 75.15 111.759 -174.949 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 173' ' ' PHE . . . . . 0.499 ' CD1' HD22 ' A' ' 235' ' ' LEU . 19.4 m-85 -129.62 -53.8 1.16 Allowed 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 124.124 0.97 . . . . 71.34 109.177 -171.439 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 174' ' ' TYR . . . . . 0.444 ' CD2' ' HB3' ' A' ' 233' ' ' LEU . 0.8 OUTLIER -77.98 14.05 1.24 Allowed 'General case' 0 CA--C 1.547 0.828 0 CA-C-N 114.477 -1.238 . . . . 75.45 113.058 -174.257 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 20.6 p -61.38 -20.26 62.83 Favored 'General case' 0 N--CA 1.484 1.24 0 CA-C-N 118.772 0.715 . . . . 72.32 111.391 173.326 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 176' ' ' MET . . . . . . . . . . . . . 26.5 ptt? -59.03 -37.67 77.52 Favored 'General case' 0 CA--C 1.55 0.969 0 C-N-CA 124.149 0.979 . . . . 71.42 111.494 171.141 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 37.7 ttpt -167.19 87.6 0.29 Allowed 'General case' 0 CA--C 1.55 0.966 0 C-N-CA 124.451 1.1 . . . . 64.24 108.936 179.342 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -106.44 127.39 53.25 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 124.291 1.037 . . . . 60.12 109.246 -178.149 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . 0.428 ' HA ' ' HD3' ' A' ' 231' ' ' ARG . . . 59.93 39.45 20.22 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 124.117 0.967 . . . . 53.22 110.391 -172.773 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -116.28 172.14 14.09 Favored Glycine 0 N--CA 1.472 1.056 0 CA-C-N 115.192 -0.913 . . . . 74.54 113.006 -173.149 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 59.4 p -77.41 135.34 38.3 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.742 0.817 . . . . 63.23 111.082 -175.667 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -71.88 150.08 45.6 Favored Glycine 0 C--N 1.349 1.268 0 O-C-N 123.503 0.502 . . . . 71.25 113.122 -177.291 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -156.56 26.63 0.53 Allowed Glycine 0 C--N 1.346 1.094 0 C-N-CA 122.692 0.187 . . . . 71.22 112.676 -176.013 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 41.5 m -85.33 167.55 15.49 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 123.617 0.767 . . . . 62.03 111.305 -179.365 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 163.53 -177.29 39.49 Favored Glycine 0 C--N 1.34 0.783 0 CA-C-N 115.929 -0.578 . . . . 61.32 111.903 -178.729 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 94.78 -169.6 28.62 Favored Glycine 0 C--N 1.342 0.875 0 N-CA-C 112.287 -0.325 . . . . 54.42 112.287 -179.214 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 17.8 t -148.67 -165.21 2.22 Favored 'General case' 0 CA--C 1.55 0.96 0 N-CA-C 108.709 -0.848 . . . . 73.33 108.709 -176.317 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 120.02 -44.75 1.33 Allowed Glycine 0 N--CA 1.474 1.193 0 N-CA-C 112.102 -0.399 . . . . 73.35 112.102 177.163 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -171.91 151.86 15.96 Favored Glycine 0 C--N 1.335 0.525 0 N-CA-C 110.617 -0.993 . . . . 54.04 110.617 178.758 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 32.6 t -77.06 79.24 3.6 Favored 'General case' 0 CA--C 1.543 0.695 0 CA-C-O 121.663 0.744 . . . . 64.2 109.988 -179.703 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 191' ' ' GLN . . . . . 0.444 ' HB2' ' HA2' ' A' ' 247' ' ' GLY . 7.6 pt20 -76.95 -37.94 54.3 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 114.378 -1.283 . . . . 74.54 110.271 179.771 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -78.03 138.56 38.86 Favored 'General case' 0 C--N 1.351 0.651 0 CA-C-N 115.524 -0.762 . . . . 73.2 109.148 -174.699 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . 0.406 HD12 ' HA2' ' A' ' 239' ' ' GLY . 25.1 mt -120.18 177.18 5.11 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 124.483 1.113 . . . . 74.33 109.158 175.112 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -139.08 121.02 15.55 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 123.413 0.685 . . . . 64.01 110.396 177.185 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -125.13 128.6 48.68 Favored 'General case' 0 C--O 1.241 0.607 0 N-CA-C 106.942 -1.503 . . . . 54.32 106.942 168.566 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 10.6 m -81.26 119.45 23.65 Favored 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 108.363 -0.977 . . . . 74.33 108.363 179.621 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 0.722 HD22 HD13 ' A' ' 251' ' ' LEU . 20.5 tp -103.96 110.69 22.93 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 108.48 -0.933 . . . . 53.23 108.48 -173.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -79.86 127.23 31.99 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 115.219 -0.901 . . . . 74.32 108.92 179.209 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 199' ' ' VAL . . . . . 0.452 ' O ' ' HA ' ' A' ' 255' ' ' ILE . 6.2 p -143.9 128.72 9.51 Favored Pre-proline 0 CA--C 1.547 0.85 0 C-N-CA 123.729 0.812 . . . . 75.31 109.03 178.802 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -69.76 158.47 56.85 Favored 'Trans proline' 0 C--N 1.362 1.285 0 C-N-CA 121.769 1.646 . . . . 53.34 111.595 170.782 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 201' ' ' ALA . . . . . 0.46 ' O ' HG23 ' A' ' 205' ' ' VAL . . . -49.84 -53.99 36.71 Favored Pre-proline 0 CA--C 1.558 1.265 0 CA-C-N 114.744 -1.116 . . . . 72.24 112.863 -176.49 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -65.52 -34.29 43.13 Favored 'Trans proline' 0 C--N 1.399 3.208 0 C-N-CA 121.736 1.624 . . . . 72.12 113.237 -175.527 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 24.7 mt -67.2 -34.05 66.87 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.413 0 N-CA-C 109.975 -0.38 . . . . 63.04 109.975 177.529 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -69.46 -38.09 77.6 Favored 'General case' 0 CA--C 1.549 0.904 0 C-N-CA 122.535 0.334 . . . . 63.43 111.339 177.422 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . 0.46 HG23 ' O ' ' A' ' 201' ' ' ALA . 99.7 t -70.86 -56.55 10.36 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.122 0 C-N-CA 123.168 0.587 . . . . 62.32 111.576 -178.039 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 10.9 m -78.37 -25.42 13.84 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 CA-C-N 116.134 -0.485 . . . . 74.33 110.948 -174.918 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 84.15 60.55 1.92 Allowed Glycine 0 C--N 1.345 1.043 0 CA-C-N 116.04 -0.527 . . . . 61.32 112.615 -179.578 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -78.77 -138.03 1.38 Allowed Glycine 0 N--CA 1.477 1.374 0 CA-C-O 119.696 -0.502 . . . . 60.54 112.168 177.663 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 209' ' ' LYS . . . . . 0.479 ' HG2' ' HA ' ' A' ' 222' ' ' ALA . 29.0 mtmm -134.58 157.3 46.93 Favored 'General case' 0 N--CA 1.481 1.124 0 CA-C-N 117.607 0.704 . . . . 65.42 110.718 176.38 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 7.1 m -142.86 165.75 15.72 Favored 'Isoleucine or valine' 0 C--O 1.241 0.631 0 C-N-CA 126.068 1.747 . . . . 61.14 107.894 173.601 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 31.1 ttm180 -105.07 116.61 32.25 Favored 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 109.396 -0.594 . . . . 74.01 109.396 179.273 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -101.74 113.74 27.18 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.379 1.072 . . . . 63.21 109.563 179.003 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 61.6 tpp -76.22 125.04 28.44 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 108.187 -1.042 . . . . 65.33 108.187 173.702 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 18.4 p -125.24 -175.8 3.41 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.723 0.809 . . . . 65.31 109.721 -175.702 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 71.1 mt -57.01 -40.79 77.28 Favored 'General case' 0 N--CA 1.481 1.079 0 CA-C-O 121.504 0.669 . . . . 65.31 110.415 172.5 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 216' ' ' GLU . . . . . 0.474 ' HB2' ' HZ2' ' A' ' 238' ' ' LYS . 6.0 mm-40 -87.72 15.02 7.43 Favored 'General case' 0 CA--C 1.551 0.994 0 CA-C-N 114.538 -1.21 . . . . 62.45 111.371 -174.751 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 94.73 -171.1 30.02 Favored Glycine 0 C--N 1.35 1.346 0 N-CA-C 112.086 -0.406 . . . . 72.23 112.086 -179.686 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -68.42 149.37 74.89 Favored 'Trans proline' 0 C--N 1.362 1.276 0 C-N-CA 122.205 1.936 . . . . 62.31 111.991 178.129 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 7.1 p -143.27 134.87 23.61 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 N-CA-C 108.543 -0.91 . . . . 72.44 108.543 173.593 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 -86.37 103.27 14.78 Favored 'General case' 0 C--O 1.238 0.475 0 N-CA-C 107.76 -1.2 . . . . 65.02 107.76 179.501 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 2.6 p -108.61 131.35 59.44 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.967 0 C-N-CA 123.615 0.766 . . . . 64.44 109.355 -172.108 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . 0.479 ' HA ' ' HG2' ' A' ' 209' ' ' LYS . . . -83.11 111.25 18.73 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 123.126 0.571 . . . . 65.22 110.62 -176.788 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 58.4 t -54.66 132.65 64.78 Favored Pre-proline 0 N--CA 1.473 0.721 0 O-C-N 124.716 1.26 . . . . 62.43 109.354 177.067 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_endo -63.41 144.95 91.98 Favored 'Trans proline' 0 C--N 1.367 1.541 0 C-N-CA 121.482 1.455 . . . . 55.12 111.266 172.817 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -62.67 139.11 73.55 Favored 'Trans proline' 0 C--N 1.37 1.698 0 C-N-CA 121.572 1.515 . . . . 42.31 110.971 171.816 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 54.2 mtt180 69.64 60.49 0.28 Allowed 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 124.982 1.313 . . . . 73.2 110.74 173.161 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 227' ' ' THR . . . . . 0.593 ' HA ' ' HE ' ' A' ' 231' ' ' ARG . 55.9 m -103.85 142.12 34.94 Favored 'General case' 0 CA--C 1.544 0.74 0 CA-C-N 113.669 -1.605 . . . . 65.01 110.051 -179.857 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -116.66 148.14 41.29 Favored 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 124.074 0.95 . . . . 61.31 109.732 177.527 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 229' ' ' ALA . . . . . 0.487 ' HB2' ' HB ' ' A' ' 255' ' ' ILE . . . -58.77 116.5 3.78 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 123.982 0.913 . . . . 71.43 110.762 -179.84 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 113.21 2.44 24.79 Favored Glycine 0 CA--C 1.524 0.656 0 CA-C-N 115.744 -0.662 . . . . 74.01 112.968 179.238 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 231' ' ' ARG . . . . . 0.593 ' HE ' ' HA ' ' A' ' 227' ' ' THR . 75.0 mtt-85 -66.39 147.44 53.3 Favored 'General case' 0 C--N 1.364 1.206 0 CA-C-N 117.175 0.488 . . . . 74.44 109.757 172.358 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 69.7 mmtt -115.2 98.38 6.74 Favored 'General case' 0 C--O 1.241 0.605 0 CA-C-N 115.139 -0.937 . . . . 73.14 108.757 -174.591 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 233' ' ' LEU . . . . . 0.714 ' HB2' ' HB2' ' A' ' 251' ' ' LEU . 60.1 mt -85.5 151.69 23.76 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 115.3 -0.864 . . . . 73.32 108.883 177.514 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 234' ' ' ARG . . . . . 0.441 HH11 ' HE2' ' A' ' 250' ' ' TYR . 41.0 ttt85 -126.63 109.19 11.83 Favored 'General case' 0 N--CA 1.478 0.963 0 CA-C-O 120.679 0.275 . . . . 72.41 110.63 -172.114 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 235' ' ' LEU . . . . . 0.556 HD11 HD11 ' A' ' 251' ' ' LEU . 23.3 mt -94.98 117.71 30.6 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 123.761 0.824 . . . . 51.34 110.765 -179.571 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 20.9 mttt -69.86 138.51 52.59 Favored 'General case' 0 C--O 1.238 0.468 0 O-C-N 123.415 0.447 . . . . 75.1 111.401 175.74 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 73.94 10.35 80.64 Favored Glycine 0 C--N 1.345 1.029 0 CA-C-N 115.608 -0.723 . . . . 70.31 114.36 175.452 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . 0.474 ' HZ2' ' HB2' ' A' ' 216' ' ' GLU . 72.7 mmtt -112.51 5.28 17.89 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 122.765 0.426 . . . . 74.42 111.062 -179.707 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 239' ' ' GLY . . . . . 0.406 ' HA2' HD12 ' A' ' 193' ' ' LEU . . . -107.37 -161.93 21.57 Favored Glycine 0 C--N 1.348 1.216 0 N-CA-C 110.896 -0.881 . . . . 74.05 110.896 168.244 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 40.1 m-85 -94.25 147.25 33.03 Favored Pre-proline 0 N--CA 1.477 0.905 0 C-N-CA 123.045 0.538 . . . . 73.44 110.935 -179.049 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_exo -64.76 167.47 15.45 Favored 'Trans proline' 0 C--N 1.369 1.617 0 C-N-CA 122.333 2.022 . . . . 72.23 112.385 169.911 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 144.63 -106.02 0.38 Allowed Glycine 0 C--N 1.339 0.75 0 CA-C-O 118.727 -1.041 . . . . 63.32 112.077 175.769 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -61.95 -51.18 4.04 Favored 'Trans proline' 0 C--N 1.38 2.223 0 C-N-CA 123.632 2.888 . . . . 64.31 113.01 -168.855 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -87.13 -10.3 53.13 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 123.06 0.544 . . . . 71.33 111.312 176.466 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 90.76 -44.9 2.88 Favored Glycine 0 C--N 1.352 1.427 0 N-CA-C 111.383 -0.687 . . . . 64.21 111.383 -173.118 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 10.2 ttm180 -115.8 111.94 21.24 Favored 'General case' 0 C--O 1.24 0.59 0 C-N-CA 125.137 1.375 . . . . 63.53 109.281 175.373 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . 0.444 ' HA2' ' HB2' ' A' ' 191' ' ' GLN . . . -80.61 168.43 51.35 Favored Glycine 0 C--N 1.349 1.276 0 CA-C-O 121.766 0.648 . . . . 43.45 113.698 170.987 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -125.38 160.77 28.58 Favored 'General case' 0 N--CA 1.465 0.31 0 C-N-CA 124.19 0.996 . . . . 64.24 110.396 -170.274 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 249' ' ' LEU . . . . . 0.477 ' HB3' ' HB2' ' A' ' 235' ' ' LEU . 41.1 tp -115.84 124.86 51.76 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 123.948 0.899 . . . . 75.11 109.501 177.143 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 250' ' ' TYR . . . . . 0.441 ' HE2' HH11 ' A' ' 234' ' ' ARG . 2.2 m-85 -88.26 109.54 20.02 Favored 'General case' 0 C--O 1.232 0.158 0 N-CA-C 109.268 -0.641 . . . . 73.25 109.268 176.912 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 251' ' ' LEU . . . . . 0.722 HD13 HD22 ' A' ' 197' ' ' LEU . 86.4 mt -87.2 104.19 16.14 Favored 'General case' 0 C--O 1.241 0.64 0 N-CA-C 106.736 -1.579 . . . . 74.21 106.736 173.945 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -85.05 103.43 14.07 Favored 'General case' 0 C--O 1.24 0.575 0 N-CA-C 107.71 -1.219 . . . . 63.03 107.71 176.037 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 16.7 m -68.43 137.71 23.92 Favored 'Isoleucine or valine' 0 C--O 1.241 0.646 0 O-C-N 124.181 0.926 . . . . 74.13 109.596 -177.193 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 18.1 mmm180 -128.48 106.18 8.81 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 107.774 -1.195 . . . . 75.25 107.774 -179.906 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 255' ' ' ILE . . . . . 0.487 ' HB ' ' HB2' ' A' ' 229' ' ' ALA . 29.6 mt -77.47 123.5 34.23 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.58 0 O-C-N 123.924 0.765 . . . . 64.0 110.086 178.301 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 3.3 t . . . . . 0 CA--C 1.563 1.452 0 C-N-CA 124.143 0.977 . . . . 72.1 109.081 173.729 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 15.0 tpt . . . . . 0 N--CA 1.48 1.042 0 N-CA-C 109.393 -0.595 . . . . 71.4 109.393 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 17.9 pt20 -78.05 166.5 22.73 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.162 0.585 . . . . 72.12 110.093 174.241 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 13.5 t -73.77 153.1 40.13 Favored 'General case' 0 CA--C 1.549 0.94 0 CA-C-N 115.515 -0.766 . . . . 75.33 109.871 173.838 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -98.02 -87.47 0.33 Allowed 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 123.263 0.625 . . . . 72.21 111.08 -175.009 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 172' ' ' LEU . . . . . 0.755 HD21 ' H ' ' A' ' 222' ' ' ALA . 78.2 mt -134.9 163.38 29.97 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 123.831 0.852 . . . . 72.53 111.49 -167.151 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 173' ' ' PHE . . . . . 0.403 ' CD1' HD22 ' A' ' 235' ' ' LEU . 50.1 m-85 -147.62 -68.94 0.24 Allowed 'General case' 0 N--CA 1.479 0.986 0 N-CA-C 108.337 -0.986 . . . . 75.21 108.337 -164.952 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 174' ' ' TYR . . . . . 0.475 ' OH ' ' HB ' ' A' ' 221' ' ' VAL . 19.9 p90 -62.97 -21.86 66.4 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 113.921 -1.491 . . . . 72.42 112.523 -178.888 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 19.5 m -59.28 -12.59 5.81 Favored 'General case' 0 CA--C 1.56 1.339 0 C-N-CA 125.773 1.629 . . . . 72.35 112.889 -176.277 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 176' ' ' MET . . . . . . . . . . . . . 50.8 mtm -56.36 -50.62 71.02 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 123.773 0.829 . . . . 65.43 110.075 166.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -163.84 104.54 0.91 Allowed 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 124.428 1.091 . . . . 71.2 109.475 174.775 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 178' ' ' ALA . . . . . 0.457 ' HB1' HD22 ' A' ' 233' ' ' LEU . . . -125.84 -59.39 1.35 Allowed 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 123.936 0.894 . . . . 61.31 111.224 -171.67 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -72.26 81.8 1.01 Allowed 'General case' 0 CA--C 1.544 0.716 0 CA-C-O 121.86 0.838 . . . . 51.32 109.258 174.765 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 108.57 85.36 1.7 Allowed Glycine 0 C--N 1.337 0.586 0 N-CA-C 109.974 -1.25 . . . . 61.23 109.974 -169.663 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 31.4 m -65.38 91.6 0.12 Allowed 'General case' 0 CA--C 1.553 1.069 0 C-N-CA 123.946 0.898 . . . . 72.54 112.081 -174.123 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -94.3 39.07 2.97 Favored Glycine 0 N--CA 1.468 0.803 0 CA-C-N 115.725 -0.67 . . . . 54.13 112.037 175.626 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -148.41 82.67 0.19 Allowed Glycine 0 C--N 1.347 1.159 0 N-CA-C 111.282 -0.727 . . . . 64.33 111.282 -175.336 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 21.3 m -69.55 122.25 18.68 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 123.436 0.695 . . . . 75.5 110.085 177.936 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -80.04 -128.75 0.73 Allowed Glycine 0 C--N 1.347 1.148 0 O-C-N 123.419 0.449 . . . . 70.2 113.476 -178.348 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 116.83 -85.96 0.4 Allowed Glycine 0 C--N 1.341 0.817 0 N-CA-C 111.206 -0.758 . . . . 52.1 111.206 -178.897 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . 0.674 ' HB3' ' HG3' ' A' ' 243' ' ' PRO . 53.6 m 70.86 143.5 0.06 Allowed 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 125.229 1.412 . . . . 61.34 114.245 171.947 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -88.49 75.94 1.95 Allowed Glycine 0 C--N 1.349 1.254 0 CA-C-N 114.957 -1.019 . . . . 73.42 110.848 174.001 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 126.03 131.4 3.57 Favored Glycine 0 C--N 1.341 0.813 0 N-CA-C 110.178 -1.169 . . . . 72.44 110.178 -174.035 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 57.9 m -71.42 85.72 0.83 Allowed 'General case' 0 CA--C 1.545 0.784 0 CA-C-O 121.577 0.703 . . . . 75.03 111.183 -178.031 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 191' ' ' GLN . . . . . 0.699 ' HB2' ' HA2' ' A' ' 247' ' ' GLY . 3.4 pt20 -82.3 -27.85 32.05 Favored 'General case' 0 CA--C 1.545 0.755 0 CA-C-N 114.852 -1.067 . . . . 75.51 110.088 172.474 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . 0.454 ' HA ' ' O ' ' A' ' 248' ' ' ASP . 9.9 m-20 -78.1 152.75 32.71 Favored 'General case' 0 C--N 1.347 0.464 0 CA-C-N 114.438 -1.256 . . . . 71.1 111.797 -167.907 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . 0.475 HD12 ' HA2' ' A' ' 239' ' ' GLY . 22.9 mt -133.86 175.01 9.85 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 124.265 1.026 . . . . 73.3 109.773 177.517 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 77.6 m-85 -136.35 131.43 34.27 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.579 0.752 . . . . 71.12 110.545 179.835 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -144.29 128.99 18.23 Favored 'General case' 0 C--O 1.234 0.28 0 N-CA-C 107.326 -1.361 . . . . 74.4 107.326 176.823 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 3.5 m -81.47 121.35 26.16 Favored 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 109.524 -0.547 . . . . 65.44 109.524 -176.571 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 0.544 HD22 HD13 ' A' ' 251' ' ' LEU . 20.3 tp -106.35 108.96 20.73 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 107.188 -1.412 . . . . 72.45 107.188 -178.124 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -86.92 132.37 33.83 Favored 'General case' 0 C--O 1.241 0.606 0 N-CA-C 109.223 -0.658 . . . . 65.14 109.223 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 199' ' ' VAL . . . . . 0.432 ' O ' ' HA ' ' A' ' 255' ' ' ILE . 4.0 p -141.92 129.53 11.61 Favored Pre-proline 0 CA--C 1.543 0.694 0 N-CA-C 108.305 -0.998 . . . . 44.02 108.305 -176.626 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -70.23 155.1 65.13 Favored 'Trans proline' 0 C--N 1.364 1.36 0 C-N-CA 121.431 1.421 . . . . 74.34 110.376 170.814 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 201' ' ' ALA . . . . . 0.414 ' HA ' HG23 ' A' ' 255' ' ' ILE . . . -50.64 -49.39 78.98 Favored Pre-proline 0 CA--C 1.556 1.2 0 CA-C-O 117.804 -1.093 . . . . 64.4 112.885 179.871 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 202' ' ' PRO . . . . . 0.436 ' HA ' HG22 ' A' ' 205' ' ' VAL . 29.7 Cg_endo -58.74 -39.59 80.71 Favored 'Trans proline' 0 C--N 1.399 3.216 0 C-N-CA 122.312 2.008 . . . . 65.31 113.991 -179.884 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 39.3 mt -68.28 -37.54 78.15 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.395 0 CA-C-N 118.625 0.648 . . . . 75.2 110.475 177.684 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -66.46 -42.8 87.02 Favored 'General case' 0 N--CA 1.479 0.98 0 N-CA-C 112.101 0.408 . . . . 74.14 112.101 179.706 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . 0.436 HG22 ' HA ' ' A' ' 202' ' ' PRO . 26.9 m -77.69 -45.02 28.96 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.917 0 C-N-CA 123.777 0.831 . . . . 74.12 112.722 -172.713 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 206' ' ' VAL . . . . . 0.402 HG22 ' O ' ' A' ' 202' ' ' PRO . 5.2 m -81.19 -26.22 10.52 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.325 0 C-N-CA 122.42 0.288 . . . . 71.15 111.338 178.541 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 82.89 77.89 1.07 Allowed Glycine 0 C--N 1.348 1.226 0 N-CA-C 111.858 -0.497 . . . . 62.35 111.858 -176.445 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -102.1 -137.34 9.6 Favored Glycine 0 C--N 1.347 1.186 0 N-CA-C 111.51 -0.636 . . . . 63.42 111.51 177.427 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 48.5 mtmt -136.16 155.46 50.13 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 123.592 0.757 . . . . 74.1 111.088 179.124 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 7.4 m -142.43 168.75 13.81 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.908 0 C-N-CA 125.948 1.699 . . . . 62.43 108.385 172.827 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 44.1 ttm180 -103.25 120.02 39.97 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 122.902 0.481 . . . . 53.33 109.858 177.508 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -102.21 133.55 46.9 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 124.127 0.971 . . . . 75.54 110.213 177.688 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 23.5 mmt -97.24 121.63 39.35 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 123.319 0.648 . . . . 73.31 109.595 178.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 18.2 p -120.17 174.85 6.24 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 124.172 0.989 . . . . 60.33 110.082 -177.095 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 56.5 mt -59.0 -31.48 68.84 Favored 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 123.079 0.551 . . . . 75.32 112.248 179.241 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -87.59 -20.26 26.67 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 123.106 0.563 . . . . 61.44 111.475 -177.4 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 139.33 -161.66 26.06 Favored Glycine 0 C--N 1.35 1.314 0 CA-C-O 119.445 -0.642 . . . . 63.33 111.962 -178.469 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_endo -82.28 155.86 16.87 Favored 'Trans proline' 0 C--N 1.367 1.541 0 C-N-CA 122.53 2.154 . . . . 63.01 112.766 -177.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 5.5 p -146.93 134.88 15.0 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.92 0 C-N-CA 123.746 0.819 . . . . 63.42 109.354 177.268 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -83.34 104.16 13.28 Favored 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 108.444 -0.947 . . . . 61.12 108.444 176.243 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 221' ' ' VAL . . . . . 0.475 ' HB ' ' OH ' ' A' ' 174' ' ' TYR . 6.4 m -106.27 132.12 54.21 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 CA-C-O 121.64 0.733 . . . . 73.41 110.578 -178.027 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . 0.755 ' H ' HD21 ' A' ' 172' ' ' LEU . . . -85.74 105.8 16.53 Favored 'General case' 0 C--O 1.238 0.46 0 CA-C-N 114.365 -1.289 . . . . 72.31 110.311 -178.732 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 66.7 t -57.43 128.76 79.56 Favored Pre-proline 0 N--CA 1.478 0.962 0 O-C-N 124.532 1.145 . . . . 52.34 109.124 179.089 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 224' ' ' PRO . . . . . 0.444 ' HD3' ' HE1' ' A' ' 174' ' ' TYR . 24.3 Cg_endo -61.22 146.56 97.3 Favored 'Trans proline' 0 C--N 1.375 1.922 0 C-N-CA 121.892 1.728 . . . . 73.32 110.926 177.559 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_endo -62.36 141.95 89.15 Favored 'Trans proline' 0 C--N 1.37 1.674 0 C-N-CA 121.607 1.538 . . . . 64.24 111.808 175.864 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 77.9 mtt180 64.64 38.96 6.8 Favored 'General case' 0 CA--C 1.554 1.13 0 C-N-CA 125.031 1.333 . . . . 74.13 111.908 172.524 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 227' ' ' THR . . . . . 0.511 HG23 ' HD2' ' A' ' 231' ' ' ARG . 86.7 m -76.17 146.85 38.87 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 123.648 0.779 . . . . 62.15 110.427 176.178 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -111.05 149.41 30.79 Favored 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 123.813 0.845 . . . . 53.31 109.249 174.927 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 229' ' ' ALA . . . . . 0.488 ' HA ' HG23 ' A' ' 253' ' ' VAL . . . -61.19 138.74 58.21 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 124.02 0.928 . . . . 64.14 111.394 -179.325 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 94.11 -3.81 70.3 Favored Glycine 0 C--N 1.339 0.73 0 CA-C-N 115.843 -0.617 . . . . 44.23 112.712 -178.846 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 231' ' ' ARG . . . . . 0.511 ' HD2' HG23 ' A' ' 227' ' ' THR . 57.4 mtt-85 -69.38 143.58 53.65 Favored 'General case' 0 C--N 1.363 1.195 0 N-CA-C 108.924 -0.769 . . . . 75.45 108.924 171.72 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 232' ' ' LYS . . . . . 0.518 ' HG2' ' HB3' ' A' ' 250' ' ' TYR . 13.4 ttmt -126.29 101.36 6.7 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 108.707 -0.849 . . . . 52.25 108.707 -167.309 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 233' ' ' LEU . . . . . 0.682 ' HB2' ' HB2' ' A' ' 251' ' ' LEU . 24.1 mt -76.28 151.72 36.68 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-N 114.011 -1.45 . . . . 71.34 109.172 -176.528 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 47.8 ttt180 -125.14 120.82 32.46 Favored 'General case' 0 N--CA 1.485 1.291 0 CA-C-N 118.998 0.817 . . . . 73.51 110.484 -175.433 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 235' ' ' LEU . . . . . 0.483 HD11 HD11 ' A' ' 251' ' ' LEU . 18.6 mt -108.78 116.45 32.01 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 124.397 1.079 . . . . 74.35 110.768 -175.696 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 31.4 mttp -72.94 141.54 47.82 Favored 'General case' 0 N--CA 1.479 1.004 0 N-CA-C 112.226 0.454 . . . . 72.42 112.226 176.795 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 76.51 10.37 85.75 Favored Glycine 0 C--N 1.349 1.269 0 CA-C-N 115.151 -0.931 . . . . 72.42 114.49 178.582 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt -115.26 10.29 15.92 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 122.736 0.414 . . . . 72.15 111.069 -173.79 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 239' ' ' GLY . . . . . 0.475 ' HA2' HD12 ' A' ' 193' ' ' LEU . . . -119.86 -161.98 11.74 Favored Glycine 0 C--N 1.345 1.06 0 N-CA-C 111.456 -0.657 . . . . 75.21 111.456 172.779 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 37.7 m-85 -93.02 169.3 10.64 Favored Pre-proline 0 N--CA 1.485 1.286 0 C-N-CA 123.79 0.836 . . . . 70.53 111.105 -175.208 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 241' ' ' PRO . . . . . 0.5 ' HA ' ' O ' ' A' ' 245' ' ' GLY . 77.7 Cg_exo -55.01 149.63 42.13 Favored 'Trans proline' 0 C--N 1.376 2.001 0 C-N-CA 121.762 1.641 . . . . 55.32 112.813 165.68 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -174.54 -136.51 2.26 Favored Glycine 0 CA--C 1.526 0.75 0 CA-C-O 119.053 -0.859 . . . . 73.51 111.871 179.085 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 243' ' ' PRO . . . . . 0.683 ' HD2' ' HB3' ' A' ' 191' ' ' GLN . 43.1 Cg_endo -60.34 -40.89 54.5 Favored 'Trans proline' 0 C--N 1.371 1.744 0 C-N-CA 124.158 3.238 . . . . 75.14 113.108 -172.53 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -104.12 0.87 30.16 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 124.05 0.94 . . . . 74.43 111.482 179.013 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 245' ' ' GLY . . . . . 0.5 ' O ' ' HA ' ' A' ' 241' ' ' PRO . . . 81.83 -41.22 2.7 Favored Glycine 0 C--N 1.36 1.885 0 N-CA-C 112.386 -0.286 . . . . 75.23 112.386 -175.584 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 9.9 ttm180 -89.02 110.1 20.84 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 124.301 1.04 . . . . 74.24 109.705 175.61 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . 0.699 ' HA2' ' HB2' ' A' ' 191' ' ' GLN . . . -83.11 167.48 45.6 Favored Glycine 0 C--N 1.351 1.417 0 N-CA-C 114.407 0.523 . . . . 73.35 114.407 171.69 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 248' ' ' ASP . . . . . 0.454 ' O ' ' HA ' ' A' ' 192' ' ' ASP . 41.6 m-20 -131.31 135.92 47.69 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 123.482 0.713 . . . . 63.32 111.092 -168.729 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 249' ' ' LEU . . . . . . . . . . . . . 47.5 tp -99.97 129.9 46.09 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 123.497 0.719 . . . . 74.33 110.739 -177.921 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 250' ' ' TYR . . . . . 0.519 ' HA ' ' O ' ' A' ' 233' ' ' LEU . 2.4 m-85 -95.77 115.49 27.5 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 123.801 0.84 . . . . 70.0 110.522 -178.83 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 251' ' ' LEU . . . . . 0.682 ' HB2' ' HB2' ' A' ' 233' ' ' LEU . 85.8 mt -94.14 105.22 17.22 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 108.711 -0.848 . . . . 74.54 108.711 178.257 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -84.15 104.25 14.04 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 109.743 -0.466 . . . . 72.41 109.743 178.736 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 253' ' ' VAL . . . . . 0.488 HG23 ' HA ' ' A' ' 229' ' ' ALA . 6.1 m -66.1 131.66 31.8 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.937 0 CA-C-O 121.237 0.541 . . . . 45.41 109.687 -179.299 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 10.8 mmm180 -123.96 97.32 5.3 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 108.744 -0.835 . . . . 71.33 108.744 179.057 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 255' ' ' ILE . . . . . 0.432 ' HA ' ' O ' ' A' ' 199' ' ' VAL . 32.2 mt -78.46 127.36 38.79 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 O-C-N 124.026 0.829 . . . . 65.21 111.014 -175.172 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 1.9 t . . . . . 0 CA--C 1.561 1.367 0 C-N-CA 124.064 0.946 . . . . 71.43 109.418 175.379 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 25.1 ptt? . . . . . 0 N--CA 1.484 1.259 0 N-CA-C 112.028 0.381 . . . . 72.53 112.028 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 13.0 pt20 -147.05 166.77 25.84 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 122.939 0.496 . . . . 74.31 111.27 178.536 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 14.4 t -72.24 169.46 16.14 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 124.413 1.085 . . . . 73.44 112.275 -174.525 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 27.2 m-20 -94.41 -166.21 1.44 Allowed 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.471 1.108 . . . . 71.32 110.487 178.874 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 172' ' ' LEU . . . . . 0.682 HD21 ' H ' ' A' ' 222' ' ' ALA . 72.8 mt -84.05 145.77 28.3 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 124.231 1.012 . . . . 73.15 110.979 -178.767 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 34.9 m-85 -109.38 -57.93 2.1 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 123.7 0.8 . . . . 74.13 109.805 -174.937 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 174' ' ' TYR . . . . . 0.424 ' CD2' ' HB3' ' A' ' 233' ' ' LEU . 0.8 OUTLIER -71.17 -6.03 36.34 Favored 'General case' 0 C--N 1.348 0.508 0 CA-C-N 114.724 -1.126 . . . . 71.04 113.446 -173.201 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 175' ' ' THR . . . . . 0.485 HG21 HD13 ' A' ' 172' ' ' LEU . 2.9 p -68.2 -2.12 7.47 Favored 'General case' 0 CA--C 1.549 0.908 0 N-CA-C 114.052 1.131 . . . . 42.31 114.052 -177.328 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 176' ' ' MET . . . . . . . . . . . . . 21.8 ptt? -60.34 -41.93 94.61 Favored 'General case' 0 CA--C 1.559 1.296 0 C-N-CA 123.038 0.535 . . . . 70.21 110.369 163.756 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -178.55 114.03 0.07 Allowed 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 126.425 1.89 . . . . 74.55 106.956 179.337 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 178' ' ' ALA . . . . . 0.413 ' HB1' HD22 ' A' ' 233' ' ' LEU . . . -132.2 -42.04 0.98 Allowed 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 122.799 0.44 . . . . 54.3 111.881 -170.809 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -72.7 81.6 1.13 Allowed 'General case' 0 N--CA 1.472 0.669 0 CA-C-O 121.708 0.766 . . . . 64.42 109.58 179.045 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . 0.473 ' H ' ' HD3' ' A' ' 231' ' ' ARG . . . 161.14 -91.91 0.11 Allowed Glycine 0 C--N 1.332 0.332 0 N-CA-C 108.944 -1.663 . . . . 51.14 108.944 -175.693 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 77.4 p -162.18 159.7 26.2 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 124.524 1.13 . . . . 74.0 109.023 176.409 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 182' ' ' GLY . . . . . 0.477 ' HA3' ' HB2' ' A' ' 234' ' ' ARG . . . -79.57 -31.6 40.41 Favored Glycine 0 C--N 1.349 1.281 0 C-N-CA 123.156 0.408 . . . . 60.14 112.652 179.418 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -163.28 161.06 33.7 Favored Glycine 0 CA--C 1.524 0.608 0 N-CA-C 111.101 -0.8 . . . . 73.22 111.101 176.164 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 77.6 p -66.13 -35.96 81.88 Favored 'General case' 0 N--CA 1.48 1.036 0 CA-C-O 121.154 0.502 . . . . 73.2 109.898 175.65 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 172.36 142.9 3.92 Favored Glycine 0 C--N 1.342 0.916 0 N-CA-C 110.263 -1.135 . . . . 45.52 110.263 174.845 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -154.89 87.6 0.13 Allowed Glycine 0 C--N 1.34 0.792 0 N-CA-C 111.564 -0.614 . . . . 70.25 111.564 -178.69 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 48.9 m -91.15 63.87 5.14 Favored 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 123.576 0.75 . . . . 60.02 109.64 176.2 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -73.05 167.32 54.23 Favored Glycine 0 C--N 1.349 1.275 0 CA-C-N 115.05 -0.977 . . . . 75.15 113.039 -178.897 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -64.51 81.75 0.06 OUTLIER Glycine 0 C--N 1.34 0.772 0 N-CA-C 114.693 0.637 . . . . 63.5 114.693 -176.372 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 20.2 m 58.5 8.34 0.85 Allowed 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 124.987 1.315 . . . . 71.23 114.034 174.465 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 191' ' ' GLN . . . . . 0.525 ' HB3' ' HD2' ' A' ' 243' ' ' PRO . 5.4 pt20 -80.36 -35.27 35.67 Favored 'General case' 0 C--N 1.356 0.855 0 CA-C-O 121.075 0.464 . . . . 72.13 110.763 -173.88 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 21.5 m-20 -77.3 161.33 28.17 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 115.743 -0.662 . . . . 71.2 111.312 -170.536 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 24.2 mt -141.08 166.31 25.13 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 124.375 1.07 . . . . 63.3 110.294 -178.953 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 61.0 m-85 -136.94 123.02 20.33 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 124.324 1.049 . . . . 73.22 109.771 178.206 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . 0.454 ' O ' ' HA ' ' A' ' 251' ' ' LEU . . . -133.89 132.61 40.51 Favored 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 108.389 -0.967 . . . . 53.23 108.389 176.301 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 41.8 m -86.11 124.06 32.11 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 123.145 0.578 . . . . 73.23 109.87 -179.134 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 0.645 HD22 HD13 ' A' ' 251' ' ' LEU . 19.7 tp -107.16 109.93 21.88 Favored 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 108.665 -0.865 . . . . 62.13 108.665 -175.367 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -79.75 125.58 29.85 Favored 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 123.441 0.696 . . . . 74.11 109.174 179.219 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 199' ' ' VAL . . . . . 0.456 ' O ' ' HA ' ' A' ' 255' ' ' ILE . 4.4 p -144.02 129.37 9.7 Favored Pre-proline 0 CA--C 1.547 0.829 0 C-N-CA 124.044 0.937 . . . . 74.44 108.93 -178.083 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -67.76 158.55 56.72 Favored 'Trans proline' 0 C--N 1.37 1.682 0 C-N-CA 121.809 1.673 . . . . 75.2 112.264 170.26 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 201' ' ' ALA . . . . . 0.499 ' O ' HG23 ' A' ' 205' ' ' VAL . . . -50.62 -52.91 51.74 Favored Pre-proline 0 CA--C 1.553 1.09 0 N-CA-C 113.692 0.997 . . . . 65.34 113.692 -179.185 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 202' ' ' PRO . . . . . 0.406 ' O ' HG22 ' A' ' 206' ' ' VAL . 49.8 Cg_endo -64.97 -38.6 28.15 Favored 'Trans proline' 0 C--N 1.381 2.258 0 CA-C-N 121.147 1.445 . . . . 75.22 113.835 -177.39 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 31.5 mt -64.04 -30.9 51.27 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 N-CA-C 109.944 -0.391 . . . . 62.25 109.944 175.743 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -72.77 -40.74 65.71 Favored 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 122.578 0.351 . . . . 71.45 111.453 176.765 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . 0.499 HG23 ' O ' ' A' ' 201' ' ' ALA . 91.6 t -70.73 -55.96 12.43 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.239 0 C-N-CA 123.199 0.6 . . . . 51.25 111.035 -176.483 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 206' ' ' VAL . . . . . 0.406 HG22 ' O ' ' A' ' 202' ' ' PRO . 14.7 m -81.3 -27.3 10.46 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 CA-C-N 116.532 -0.304 . . . . 73.23 111.188 -176.796 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 85.18 71.56 1.31 Allowed Glycine 0 C--N 1.351 1.393 0 O-C-N 123.439 0.462 . . . . 60.42 113.016 -179.367 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -86.81 -127.8 2.33 Favored Glycine 0 C--N 1.348 1.218 0 CA-C-O 119.736 -0.48 . . . . 64.4 112.808 176.908 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 45.1 mtmt -137.66 152.12 48.98 Favored 'General case' 0 N--CA 1.486 1.336 0 CA-C-N 117.525 0.662 . . . . 73.35 111.128 178.45 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 6.2 m -146.91 159.52 9.67 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 C-N-CA 125.108 1.363 . . . . 70.4 108.536 170.702 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 51.0 ttp180 -97.53 121.18 39.14 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 123.394 0.678 . . . . 74.43 110.675 -179.681 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -102.29 123.18 45.64 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 123.494 0.718 . . . . 63.32 110.192 176.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 49.1 tpp -81.28 126.75 31.93 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 108.893 -0.78 . . . . 65.3 108.893 172.747 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 24.1 p -129.74 -174.31 3.27 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 123.848 0.859 . . . . 64.54 109.673 -173.506 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 67.4 mt -62.29 -27.65 69.18 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 122.809 0.444 . . . . 54.04 111.196 172.781 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 216' ' ' GLU . . . . . 0.403 ' HB2' ' NZ ' ' A' ' 238' ' ' LYS . 34.4 mt-10 -102.87 22.12 14.39 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 123.826 0.851 . . . . 72.43 110.691 -178.84 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 85.85 -156.03 29.62 Favored Glycine 0 C--N 1.354 1.555 0 CA-C-O 119.13 -0.817 . . . . 52.24 113.291 176.628 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -75.71 148.0 32.08 Favored 'Trans proline' 0 C--N 1.369 1.613 0 C-N-CA 122.79 2.327 . . . . 63.24 113.024 -178.151 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 3.8 p -141.5 128.77 21.09 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 N-CA-C 108.735 -0.839 . . . . 54.41 108.735 174.464 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -79.45 102.88 9.0 Favored 'General case' 0 C--O 1.241 0.606 0 N-CA-C 108.453 -0.943 . . . . 64.14 108.453 174.564 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 1.8 p -111.13 115.88 51.03 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.214 0 CA-C-N 115.457 -0.792 . . . . 73.34 108.968 -170.497 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . 0.682 ' H ' HD21 ' A' ' 172' ' ' LEU . . . -67.78 109.17 3.25 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 115.365 -0.834 . . . . 71.11 111.699 179.143 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 57.5 t -55.4 136.86 69.43 Favored Pre-proline 0 CA--C 1.551 1.008 0 C-N-CA 124.975 1.31 . . . . 40.33 110.382 178.29 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -66.42 160.71 44.25 Favored 'Trans proline' 0 C--N 1.371 1.726 0 C-N-CA 122.233 1.956 . . . . 74.21 111.567 173.009 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo -69.92 151.26 68.08 Favored 'Trans proline' 0 C--N 1.363 1.336 0 C-N-CA 121.406 1.404 . . . . 73.33 110.973 171.427 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 49.6 mtt180 61.98 43.76 8.79 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 124.535 1.134 . . . . 70.22 111.054 170.119 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 227' ' ' THR . . . . . 0.44 ' HA ' ' HE ' ' A' ' 231' ' ' ARG . 91.8 m -85.11 124.63 32.01 Favored 'General case' 0 CA--C 1.544 0.739 0 CA-C-N 114.14 -1.391 . . . . 72.34 109.808 178.095 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -104.81 151.62 23.57 Favored 'General case' 0 N--CA 1.492 1.644 0 C-N-CA 123.602 0.761 . . . . 75.15 109.496 176.292 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -58.01 116.25 3.39 Favored 'General case' 0 C--N 1.353 0.75 0 O-C-N 123.915 0.76 . . . . 61.04 110.397 178.895 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 114.21 -2.24 23.9 Favored Glycine 0 C--N 1.338 0.651 0 CA-C-O 119.194 -0.781 . . . . 61.31 113.211 -178.302 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 231' ' ' ARG . . . . . 0.473 ' HD3' ' H ' ' A' ' 180' ' ' GLY . 25.6 mtt-85 -63.41 129.95 42.37 Favored 'General case' 0 C--N 1.361 1.065 0 CA-C-N 117.989 0.894 . . . . 63.13 109.344 171.817 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 77.2 mttt -110.69 96.75 6.37 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 107.83 -1.174 . . . . 75.24 107.83 -175.301 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 233' ' ' LEU . . . . . 0.604 ' HB2' ' HB2' ' A' ' 251' ' ' LEU . 34.0 mt -79.81 151.33 30.34 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 114.137 -1.392 . . . . 73.2 109.42 -174.747 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 234' ' ' ARG . . . . . 0.477 ' HB2' ' HA3' ' A' ' 182' ' ' GLY . 45.8 ttt180 -117.05 103.05 9.85 Favored 'General case' 0 N--CA 1.483 1.21 0 CA-C-N 118.654 0.661 . . . . 51.11 111.579 -170.135 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 235' ' ' LEU . . . . . 0.566 ' HB2' ' HB3' ' A' ' 249' ' ' LEU . 18.7 mt -94.13 101.14 13.14 Favored 'General case' 0 C--O 1.24 0.594 0 C-N-CA 123.239 0.616 . . . . 74.14 109.68 172.442 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 57.5 mttt -72.97 147.84 44.81 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 110.088 -0.338 . . . . 71.43 110.088 173.857 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 79.32 -6.61 56.7 Favored Glycine 0 C--N 1.341 0.834 0 CA-C-N 115.545 -0.752 . . . . 60.52 113.927 -177.367 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . 0.403 ' NZ ' ' HB2' ' A' ' 216' ' ' GLU . 71.8 mmtt -100.4 2.8 42.66 Favored 'General case' 0 C--O 1.239 0.531 0 C-N-CA 123.491 0.716 . . . . 74.5 111.083 179.351 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -103.62 -175.85 25.98 Favored Glycine 0 C--N 1.357 1.74 0 O-C-N 123.528 0.518 . . . . 65.42 112.09 166.477 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 79.9 m-85 -86.89 167.71 20.99 Favored Pre-proline 0 CA--C 1.563 1.462 0 C-N-CA 124.416 1.087 . . . . 73.04 110.812 179.181 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_endo -73.0 168.53 24.5 Favored 'Trans proline' 0 C--N 1.382 2.294 0 C-N-CA 122.187 1.924 . . . . 53.23 113.198 173.747 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 163.03 -120.14 0.93 Allowed Glycine 0 CA--C 1.538 1.529 0 CA-C-O 118.911 -0.938 . . . . 43.3 112.106 176.854 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 243' ' ' PRO . . . . . 0.525 ' HD2' ' HB3' ' A' ' 191' ' ' GLN . 37.1 Cg_endo -59.83 -59.04 0.44 Allowed 'Trans proline' 0 C--N 1.379 2.133 0 C-N-CA 124.563 3.509 . . . . 73.21 112.892 -173.976 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -83.5 -9.28 59.07 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 123.381 0.672 . . . . 73.12 111.066 178.645 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 85.39 -22.82 9.47 Favored Glycine 0 C--N 1.356 1.649 0 C-N-CA 123.175 0.417 . . . . 53.41 113.134 -177.161 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 10.0 ttm180 -125.33 111.56 15.32 Favored 'General case' 0 C--O 1.241 0.649 0 C-N-CA 124.545 1.138 . . . . 72.33 109.21 -179.7 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -76.75 151.46 39.4 Favored Glycine 0 C--N 1.348 1.198 0 O-C-N 123.726 0.641 . . . . 65.1 114.006 178.006 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -103.98 140.95 37.02 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.062 0.945 . . . . 73.34 109.747 -177.727 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 249' ' ' LEU . . . . . 0.566 ' HB3' ' HB2' ' A' ' 235' ' ' LEU . 45.7 tp -109.04 111.9 23.79 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 108.93 -0.767 . . . . 72.01 108.93 176.439 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 250' ' ' TYR . . . . . 0.461 ' HA ' ' O ' ' A' ' 233' ' ' LEU . 4.8 m-85 -89.58 109.28 20.24 Favored 'General case' 0 C--O 1.242 0.703 0 CA-C-O 121.36 0.6 . . . . 71.43 110.163 -179.531 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 251' ' ' LEU . . . . . 0.645 HD13 HD22 ' A' ' 197' ' ' LEU . 80.1 mt -87.35 104.02 16.03 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-N 114.382 -1.281 . . . . 73.51 108.289 179.865 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 56.3 mt-10 -85.42 94.19 8.92 Favored 'General case' 0 C--O 1.241 0.621 0 N-CA-C 108.572 -0.899 . . . . 73.45 108.572 -178.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 11.4 m -63.36 138.5 22.85 Favored 'Isoleucine or valine' 0 C--N 1.352 0.699 0 O-C-N 123.858 0.724 . . . . 72.21 110.374 -176.403 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 15.4 mmm180 -126.14 108.78 11.66 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 107.272 -1.381 . . . . 74.24 107.272 179.225 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 255' ' ' ILE . . . . . 0.456 ' HA ' ' O ' ' A' ' 199' ' ' VAL . 29.0 mt -78.92 121.15 31.45 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 O-C-N 123.9 0.75 . . . . 62.31 110.116 179.29 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 2.5 t . . . . . 0 C--O 1.254 1.294 0 C-N-CA 123.922 0.889 . . . . 71.35 109.42 174.727 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 26.5 ttt . . . . . 0 N--CA 1.475 0.794 0 N-CA-C 110.167 -0.309 . . . . 74.01 110.167 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 17.0 pt20 -130.57 -176.32 3.94 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 124.67 1.188 . . . . 61.42 109.094 174.656 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 9.9 t -93.0 154.23 18.27 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 123.381 0.673 . . . . 73.05 109.413 169.008 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -96.67 -85.97 0.33 Allowed 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 122.811 0.444 . . . . 73.44 110.175 179.9 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 172' ' ' LEU . . . . . 0.71 HD21 ' H ' ' A' ' 222' ' ' ALA . 41.4 mt -145.74 160.46 41.7 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 123.568 0.747 . . . . 70.23 111.277 -169.164 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 173' ' ' PHE . . . . . 0.401 ' CD1' HD22 ' A' ' 235' ' ' LEU . 27.5 m-85 -130.94 -47.51 1.02 Allowed 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 114.623 -1.171 . . . . 65.42 109.095 -167.918 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 174' ' ' TYR . . . . . 0.435 ' HB2' ' HB2' ' A' ' 178' ' ' ALA . 8.2 p90 -84.23 8.07 17.04 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-N 114.36 -1.291 . . . . 75.12 113.324 -173.889 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 14.8 p -60.09 -23.29 63.69 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 123.158 0.583 . . . . 72.15 112.216 177.293 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 176' ' ' MET . . . . . . . . . . . . . 40.1 mtm -54.89 -49.92 70.02 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 124.216 1.006 . . . . 70.14 110.655 173.849 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -169.54 122.28 0.74 Allowed 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 124.834 1.254 . . . . 61.32 108.037 179.295 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 178' ' ' ALA . . . . . 0.634 ' HB1' HD22 ' A' ' 233' ' ' LEU . . . -146.71 -56.94 0.27 Allowed 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 123.209 0.604 . . . . 72.01 110.946 -175.288 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . 0.603 ' HB2' ' HB2' ' A' ' 224' ' ' PRO . . . -75.46 78.55 2.5 Favored 'General case' 0 C--N 1.353 0.754 0 CA-C-O 122.256 1.027 . . . . 74.14 108.832 172.715 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 167.21 -167.03 39.61 Favored Glycine 0 CA--C 1.522 0.487 0 CA-C-N 113.255 -1.793 . . . . 74.13 110.128 -173.759 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 68.0 p -139.71 133.8 31.05 Favored 'General case' 0 N--CA 1.479 0.982 0 CA-C-N 117.397 0.598 . . . . 64.43 110.806 179.741 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . 179.44 150.28 8.93 Favored Glycine 0 C--N 1.349 1.279 0 CA-C-N 115.95 -0.568 . . . . 65.22 112.123 -178.198 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -133.79 -174.38 13.52 Favored Glycine 0 C--N 1.348 1.243 0 N-CA-C 112.003 -0.439 . . . . 34.42 112.003 -179.624 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 17.1 m -135.63 158.98 43.05 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 123.35 0.66 . . . . 72.24 110.709 -178.842 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -110.77 61.06 0.31 Allowed Glycine 0 C--N 1.341 0.807 0 CA-C-N 115.481 -0.781 . . . . 33.12 111.3 179.387 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -86.6 51.89 4.39 Favored Glycine 0 C--N 1.347 1.17 0 N-CA-C 111.82 -0.512 . . . . 52.34 111.82 175.856 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 17.4 m -63.72 -24.11 67.64 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 124.509 1.123 . . . . 74.14 113.044 -171.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -66.77 -12.8 60.23 Favored Glycine 0 C--N 1.35 1.318 0 N-CA-C 115.005 0.762 . . . . 20.14 115.005 -177.101 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -173.18 149.15 10.93 Favored Glycine 0 C--N 1.346 1.128 0 CA-C-N 117.178 0.489 . . . . 74.3 112.553 176.681 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 35.5 m -84.4 69.63 10.54 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 123.482 0.713 . . . . 63.34 111.257 -177.735 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 191' ' ' GLN . . . . . 0.651 ' HB3' ' HD2' ' A' ' 243' ' ' PRO . 9.6 pt20 -79.41 -24.29 42.64 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-N 115.944 -0.571 . . . . 62.11 110.64 175.894 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 17.7 m-20 -74.99 150.62 38.93 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-N 115.367 -0.833 . . . . 72.2 110.704 -174.812 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . 0.662 HD12 ' HA2' ' A' ' 239' ' ' GLY . 32.6 mt -140.79 170.82 15.04 Favored 'General case' 0 C--O 1.241 0.608 0 CA-C-N 114.592 -1.186 . . . . 61.52 109.176 -179.399 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 55.1 m-85 -138.41 122.07 17.47 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 123.491 0.717 . . . . 62.55 109.689 178.846 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . 0.463 ' HB2' HD11 ' A' ' 249' ' ' LEU . . . -126.3 135.98 52.18 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 107.834 -1.172 . . . . 64.01 107.834 174.993 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 9.1 m -83.55 130.63 35.01 Favored 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 109.742 -0.466 . . . . 72.2 109.742 -176.374 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 0.502 HD22 HD13 ' A' ' 251' ' ' LEU . 15.5 tp -109.35 108.53 19.12 Favored 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 108.663 -0.866 . . . . 74.4 108.663 -179.479 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -81.21 113.23 19.21 Favored 'General case' 0 CA--C 1.542 0.648 0 N-CA-C 108.92 -0.77 . . . . 71.42 108.92 176.966 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 199' ' ' VAL . . . . . 0.413 ' O ' ' HA ' ' A' ' 255' ' ' ILE . 6.5 p -132.18 128.99 21.53 Favored Pre-proline 0 CA--C 1.55 0.976 0 C-N-CA 124.035 0.934 . . . . 71.14 109.34 -178.706 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -70.58 159.06 54.07 Favored 'Trans proline' 0 C--N 1.37 1.709 0 C-N-CA 122.035 1.823 . . . . 74.05 111.691 170.101 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -51.18 -49.7 79.9 Favored Pre-proline 0 CA--C 1.564 1.497 0 CA-C-O 117.775 -1.107 . . . . 30.14 113.619 -179.56 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 202' ' ' PRO . . . . . 0.458 ' O ' HG22 ' A' ' 206' ' ' VAL . 42.6 Cg_endo -64.24 -43.01 15.79 Favored 'Trans proline' 0 C--N 1.396 3.074 0 C-N-CA 121.861 1.708 . . . . 61.2 113.702 -179.035 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 51.8 mt -63.48 -34.17 65.81 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.386 0 CA-C-N 118.152 0.433 . . . . 73.11 110.351 176.628 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -66.2 -52.68 45.66 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 122.821 0.448 . . . . 62.22 111.622 179.245 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 20.2 m -69.45 -49.67 57.84 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.924 0 C-N-CA 123.618 0.767 . . . . 64.55 112.577 -173.444 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 206' ' ' VAL . . . . . 0.458 HG22 ' O ' ' A' ' 202' ' ' PRO . 6.7 m -76.99 -31.0 18.34 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.181 0 CA-C-O 120.714 0.292 . . . . 71.01 110.909 -179.736 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 85.63 70.26 1.33 Allowed Glycine 0 C--N 1.345 1.066 0 CA-C-N 115.943 -0.571 . . . . 73.21 112.022 -176.826 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -87.51 -126.4 2.29 Favored Glycine 0 C--N 1.352 1.466 0 N-CA-C 111.902 -0.479 . . . . 51.13 111.902 176.403 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 46.5 mtmt -139.45 151.65 46.39 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 123.695 0.798 . . . . 65.53 111.12 177.234 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 5.8 m -144.81 169.92 7.77 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 C-N-CA 125.335 1.454 . . . . 64.35 109.532 175.664 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 55.4 ttp180 -102.25 117.05 33.93 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 124.1 0.96 . . . . 72.35 110.048 -179.831 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -100.73 128.92 46.6 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 124.104 0.962 . . . . 71.41 110.207 177.439 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 90.8 mmm -92.55 115.57 28.22 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 123.369 0.667 . . . . 73.4 109.413 179.572 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 17.4 p -111.71 -179.39 3.69 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 124.288 1.035 . . . . 73.24 109.907 -176.687 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 89.0 mt -56.77 -29.69 62.88 Favored 'General case' 0 N--CA 1.491 1.583 0 CA-C-O 121.082 0.467 . . . . 73.14 111.216 171.883 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -101.29 23.2 11.29 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 124.476 1.11 . . . . 73.3 111.144 -178.252 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 83.42 -159.42 36.89 Favored Glycine 0 C--N 1.348 1.246 0 CA-C-O 119.508 -0.607 . . . . 54.13 113.303 176.314 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -71.29 157.03 58.0 Favored 'Trans proline' 0 C--N 1.367 1.524 0 C-N-CA 122.665 2.244 . . . . 74.24 113.21 -173.232 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 7.3 p -151.58 136.9 10.96 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 C-N-CA 124.142 0.977 . . . . 72.1 108.869 174.656 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -80.64 103.43 10.48 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 108.832 -0.803 . . . . 74.41 108.832 175.573 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 10.8 m -104.08 133.75 47.25 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 CA-C-O 121.451 0.644 . . . . 72.55 110.057 177.95 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . 0.71 ' H ' HD21 ' A' ' 172' ' ' LEU . . . -86.7 105.66 17.09 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 114.743 -1.117 . . . . 74.25 110.427 -178.731 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 90.6 t -54.49 134.14 62.87 Favored Pre-proline 0 N--CA 1.481 1.112 0 C-N-CA 125.355 1.462 . . . . 70.41 111.179 -176.763 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 224' ' ' PRO . . . . . 0.603 ' HB2' ' HB2' ' A' ' 179' ' ' ALA . 72.4 Cg_endo -70.33 159.84 51.61 Favored 'Trans proline' 0 C--N 1.376 2.022 0 C-N-CA 122.209 1.939 . . . . 64.14 111.924 175.912 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 22.8 Cg_endo -64.6 136.41 49.89 Favored 'Trans proline' 0 C--N 1.38 2.204 0 C-N-CA 121.981 1.788 . . . . 75.43 111.554 176.189 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 44.3 mtm-85 63.72 64.9 0.75 Allowed 'General case' 0 C--O 1.244 0.775 0 C-N-CA 124.7 1.2 . . . . 73.42 110.074 175.672 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 227' ' ' THR . . . . . 0.446 ' HA ' ' HE ' ' A' ' 231' ' ' ARG . 88.5 m -96.68 123.19 40.28 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 108.214 -1.032 . . . . 72.22 108.214 174.458 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -109.7 148.24 31.73 Favored 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 123.49 0.716 . . . . 74.25 109.085 -179.382 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -57.66 114.29 2.2 Favored 'General case' 0 C--N 1.352 0.674 0 O-C-N 124.278 0.986 . . . . 60.44 110.494 -178.685 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 113.76 5.94 21.68 Favored Glycine 0 CA--C 1.528 0.902 0 O-C-N 124.051 0.844 . . . . 70.02 113.402 -175.48 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 231' ' ' ARG . . . . . 0.446 ' HE ' ' HA ' ' A' ' 227' ' ' THR . 40.7 mtt-85 -71.89 149.57 45.02 Favored 'General case' 0 N--CA 1.481 1.095 0 CA-C-N 117.72 0.76 . . . . 72.54 109.074 165.891 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 232' ' ' LYS . . . . . 0.407 ' HA ' ' O ' ' A' ' 251' ' ' LEU . 43.5 mtmt -128.72 99.48 5.36 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 123.513 0.725 . . . . 73.35 109.344 178.404 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 233' ' ' LEU . . . . . 0.634 HD22 ' HB1' ' A' ' 178' ' ' ALA . 24.1 mt -81.65 132.75 35.31 Favored 'General case' 0 CA--C 1.552 1.044 0 C-N-CA 124.088 0.955 . . . . 74.41 110.266 -173.467 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 40.1 ttt180 -89.53 102.97 15.65 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 123.4 0.68 . . . . 63.42 112.35 -169.654 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 235' ' ' LEU . . . . . 0.604 ' HB2' ' HB3' ' A' ' 249' ' ' LEU . 18.0 mt -93.35 97.08 10.35 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 123.057 0.543 . . . . 73.12 110.483 174.679 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 40.8 mtmt -69.49 144.46 53.21 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-O 120.85 0.357 . . . . 74.12 111.192 177.002 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 73.68 1.03 57.48 Favored Glycine 0 N--CA 1.473 1.137 0 CA-C-N 115.237 -0.892 . . . . 72.32 114.949 -177.816 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 76.1 mmtt -106.04 3.87 28.68 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 117.418 0.609 . . . . 70.44 110.525 179.229 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 239' ' ' GLY . . . . . 0.662 ' HA2' HD12 ' A' ' 193' ' ' LEU . . . -101.93 -160.33 26.57 Favored Glycine 0 C--N 1.35 1.318 0 N-CA-C 111.063 -0.815 . . . . 73.44 111.063 164.025 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 71.4 m-85 -95.04 155.03 39.48 Favored Pre-proline 0 N--CA 1.485 1.314 0 C-N-CA 123.826 0.85 . . . . 71.32 110.981 -179.597 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_exo -71.09 130.62 17.98 Favored 'Trans proline' 0 C--N 1.371 1.735 0 C-N-CA 121.764 1.642 . . . . 71.32 111.197 170.933 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -163.54 -121.35 0.56 Allowed Glycine 0 CA--C 1.535 1.325 0 CA-C-O 118.776 -1.013 . . . . 50.42 113.401 -177.829 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 243' ' ' PRO . . . . . 0.651 ' HD2' ' HB3' ' A' ' 191' ' ' GLN . 37.3 Cg_endo -58.96 -42.85 47.99 Favored 'Trans proline' 0 C--N 1.385 2.462 0 C-N-CA 124.379 3.386 . . . . 75.52 112.935 -172.399 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -96.59 -4.88 40.37 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 123.551 0.74 . . . . 65.14 111.044 177.152 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 84.27 -23.39 7.22 Favored Glycine 0 C--N 1.361 1.939 0 C-N-CA 123.142 0.401 . . . . 75.45 113.423 -178.827 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 43.1 ttt85 -128.0 111.58 13.69 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.97 1.308 . . . . 75.34 108.901 -179.649 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -72.48 151.3 46.36 Favored Glycine 0 C--N 1.347 1.145 0 N-CA-C 115.064 0.785 . . . . 61.3 115.064 178.694 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 38.2 m-20 -111.64 127.78 55.86 Favored 'General case' 0 C--O 1.233 0.221 0 C-N-CA 124.295 1.038 . . . . 71.22 109.382 -176.487 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 249' ' ' LEU . . . . . 0.604 ' HB3' ' HB2' ' A' ' 235' ' ' LEU . 58.8 tp -103.76 109.83 21.69 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 108.323 -0.992 . . . . 73.52 108.323 178.526 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 250' ' ' TYR . . . . . . . . . . . . . 4.4 m-85 -88.21 118.65 27.95 Favored 'General case' 0 C--O 1.241 0.646 0 N-CA-C 109.271 -0.64 . . . . 73.43 109.271 -176.267 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 251' ' ' LEU . . . . . 0.502 HD13 HD22 ' A' ' 197' ' ' LEU . 74.3 mt -88.14 103.31 15.64 Favored 'General case' 0 C--N 1.343 0.302 0 N-CA-C 107.935 -1.135 . . . . 62.41 107.935 -177.061 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -83.07 93.11 7.53 Favored 'General case' 0 C--O 1.241 0.638 0 N-CA-C 107.329 -1.36 . . . . 63.13 107.329 -175.53 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 4.9 m -71.94 136.84 24.86 Favored 'Isoleucine or valine' 0 C--N 1.351 0.648 0 CA-C-N 114.959 -1.018 . . . . 73.33 110.819 -170.746 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 24.4 mmm180 -122.05 112.54 18.38 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 106.913 -1.514 . . . . 74.34 106.913 179.737 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 255' ' ' ILE . . . . . 0.413 ' HA ' ' O ' ' A' ' 199' ' ' VAL . 35.2 mt -80.4 115.98 23.8 Favored 'Isoleucine or valine' 0 C--O 1.236 0.382 0 N-CA-C 108.758 -0.83 . . . . 65.14 108.758 173.569 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 9.5 t . . . . . 0 C--O 1.26 1.655 0 N-CA-C 108.349 -0.982 . . . . 74.11 108.349 168.614 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 28.0 ptm . . . . . 0 N--CA 1.481 1.08 0 N-CA-C 111.82 0.304 . . . . 74.32 111.82 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 169' ' ' GLN . . . . . 0.582 ' HG3' HG22 ' A' ' 170' ' ' THR . 12.9 pt20 -112.45 -29.28 7.56 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 123.09 0.556 . . . . 74.32 111.491 -172.743 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . 0.582 HG22 ' HG3' ' A' ' 169' ' ' GLN . 12.6 t -161.46 144.0 12.11 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 123.466 0.707 . . . . 74.1 111.323 -176.897 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -116.9 -70.74 0.77 Allowed 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 123.184 0.594 . . . . 63.11 110.412 -172.262 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 172' ' ' LEU . . . . . 0.539 HD21 ' H ' ' A' ' 222' ' ' ALA . 63.6 mt -134.3 158.86 42.69 Favored 'General case' 0 N--CA 1.484 1.273 0 CA-C-O 122.039 0.923 . . . . 74.42 112.068 -175.076 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 173' ' ' PHE . . . . . 0.485 ' CD1' HD22 ' A' ' 235' ' ' LEU . 19.8 m-85 -136.71 -51.67 0.69 Allowed 'General case' 0 N--CA 1.477 0.919 0 CA-C-N 114.586 -1.188 . . . . 72.34 108.609 -171.343 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 174' ' ' TYR . . . . . 0.44 ' OH ' ' HB ' ' A' ' 221' ' ' VAL . 2.9 p90 -79.3 17.87 0.76 Allowed 'General case' 0 CA--C 1.552 1.04 0 CA-C-N 113.446 -1.706 . . . . 73.15 112.551 -179.213 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 175' ' ' THR . . . . . 0.45 HG23 HD13 ' A' ' 172' ' ' LEU . 0.2 OUTLIER -66.1 -18.57 65.43 Favored 'General case' 0 CA--C 1.552 1.032 0 C-N-CA 124.1 0.96 . . . . 71.41 111.888 -174.936 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 176' ' ' MET . . . . . 0.51 ' SD ' ' N ' ' A' ' 177' ' ' LYS . 0.0 OUTLIER -70.74 -45.36 64.98 Favored 'General case' 0 CA--C 1.554 1.126 0 C-N-CA 123.978 0.911 . . . . 75.21 111.45 173.509 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . 0.51 ' N ' ' SD ' ' A' ' 176' ' ' MET . 35.7 mttp -162.91 134.15 4.93 Favored 'General case' 0 N--CA 1.491 1.599 0 C-N-CA 125.702 1.601 . . . . 54.15 108.681 175.277 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 178' ' ' ALA . . . . . 0.495 ' HB1' HD22 ' A' ' 233' ' ' LEU . . . -147.99 -53.54 0.2 Allowed 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 123.934 0.893 . . . . 75.03 109.839 -172.859 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -85.48 36.9 0.66 Allowed 'General case' 0 CA--C 1.558 1.259 0 C-N-CA 123.876 0.87 . . . . 74.35 109.957 171.341 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -119.93 -175.67 15.76 Favored Glycine 0 C--N 1.354 1.53 0 N-CA-C 110.638 -0.985 . . . . 72.44 110.638 176.766 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 31.8 t -162.37 170.61 18.54 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 123.645 0.778 . . . . 71.1 109.994 178.898 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . 74.58 85.13 0.3 Allowed Glycine 0 C--N 1.347 1.171 0 N-CA-C 112.165 -0.374 . . . . 61.44 112.165 177.88 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -118.13 134.09 10.79 Favored Glycine 0 C--N 1.348 1.22 0 N-CA-C 111.057 -0.817 . . . . 64.42 111.057 177.574 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 28.9 t -73.08 87.97 1.4 Allowed 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 123.397 0.679 . . . . 64.34 109.902 179.751 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 172.71 -173.53 45.5 Favored Glycine 0 C--N 1.345 1.039 0 N-CA-C 112.074 -0.41 . . . . 42.21 112.074 -179.235 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 137.2 -0.61 2.91 Favored Glycine 0 C--N 1.346 1.097 0 CA-C-O 119.766 -0.463 . . . . 54.14 113.39 177.783 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 38.4 m -79.54 -17.13 54.68 Favored 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 122.944 0.498 . . . . 75.03 110.962 177.338 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 65.7 -128.82 32.7 Favored Glycine 0 C--N 1.349 1.261 0 O-C-N 123.78 0.675 . . . . 60.03 113.397 177.75 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 138.64 34.09 0.18 Allowed Glycine 0 C--N 1.345 1.047 0 CA-C-O 119.604 -0.553 . . . . 64.15 112.124 178.223 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 22.9 t 65.07 19.2 11.76 Favored 'General case' 0 N--CA 1.49 1.555 0 C-N-CA 124.214 1.006 . . . . 63.42 111.976 -179.022 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 191' ' ' GLN . . . . . 0.509 ' HB3' ' HD2' ' A' ' 243' ' ' PRO . 2.3 pt20 -99.45 -13.84 19.36 Favored 'General case' 0 N--CA 1.479 1.008 0 CA-C-O 121.391 0.615 . . . . 71.45 111.092 179.118 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -86.32 144.67 27.26 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 124.35 1.06 . . . . 70.03 110.201 -163.501 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . 0.5 HD12 ' HA2' ' A' ' 239' ' ' GLY . 25.4 mt -138.69 163.63 31.62 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 124.27 1.028 . . . . 72.34 109.391 174.363 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 50.6 m-85 -139.36 122.82 17.24 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 123.779 0.832 . . . . 55.21 109.761 -177.543 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . 0.44 ' HB2' HD11 ' A' ' 249' ' ' LEU . . . -133.02 129.13 37.73 Favored 'General case' 0 N--CA 1.466 0.335 0 O-C-N 124.343 1.027 . . . . 31.33 108.6 175.654 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 33.6 m -76.79 130.82 38.2 Favored 'General case' 0 CA--C 1.541 0.617 0 N-CA-C 109.694 -0.484 . . . . 74.42 109.694 178.157 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 0.598 HD22 HD13 ' A' ' 251' ' ' LEU . 15.1 tp -112.21 108.79 18.15 Favored 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 107.61 -1.256 . . . . 72.4 107.61 176.645 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -83.76 132.32 34.85 Favored 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 108.841 -0.8 . . . . 74.45 108.841 174.838 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 199' ' ' VAL . . . . . 0.45 ' O ' ' HA ' ' A' ' 255' ' ' ILE . 4.1 p -144.61 129.88 9.44 Favored Pre-proline 0 CA--C 1.549 0.934 0 C-N-CA 123.866 0.866 . . . . 74.41 108.671 -179.983 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -70.35 153.7 65.98 Favored 'Trans proline' 0 C--N 1.367 1.536 0 C-N-CA 122.21 1.94 . . . . 72.31 110.836 168.49 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 201' ' ' ALA . . . . . 0.465 ' O ' HG23 ' A' ' 205' ' ' VAL . . . -49.88 -51.4 61.28 Favored Pre-proline 0 CA--C 1.555 1.153 0 C-N-CA 124.754 1.222 . . . . 63.02 113.361 -177.729 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_endo -60.85 -35.85 86.58 Favored 'Trans proline' 0 C--N 1.397 3.118 0 C-N-CA 121.771 1.647 . . . . 73.11 113.896 -178.487 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 38.1 mt -70.02 -34.14 58.33 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 C-N-CA 122.587 0.355 . . . . 71.41 110.461 177.418 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -67.1 -38.36 85.52 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 122.342 0.257 . . . . 74.33 111.22 175.838 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . 0.465 HG23 ' O ' ' A' ' 201' ' ' ALA . 92.1 t -69.25 -56.49 11.62 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.125 0 C-N-CA 123.963 0.905 . . . . 55.12 111.083 -179.423 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 18.0 m -75.59 -24.07 16.93 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.133 0 CA-C-N 116.09 -0.504 . . . . 62.51 111.574 -174.883 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 76.15 66.21 1.89 Allowed Glycine 0 C--N 1.345 1.042 0 CA-C-N 115.251 -0.886 . . . . 63.24 111.83 -173.987 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -83.74 -140.46 4.29 Favored Glycine 0 C--N 1.352 1.443 0 N-CA-C 112.161 -0.376 . . . . 41.01 112.161 178.628 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 49.4 mtmt -137.43 137.5 38.83 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.606 0.763 . . . . 63.44 110.414 177.915 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 11.0 m -127.82 165.39 27.03 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 C-N-CA 125.119 1.368 . . . . 71.12 108.742 172.903 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 50.6 ttp180 -101.59 117.47 34.98 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 123.25 0.62 . . . . 71.24 110.323 -178.564 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -101.99 132.59 47.73 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 123.958 0.903 . . . . 73.24 110.239 175.721 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 25.3 mmt -90.91 121.32 32.65 Favored 'General case' 0 N--CA 1.48 1.075 0 N-CA-C 109.343 -0.614 . . . . 74.31 109.343 175.306 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 30.5 p -121.97 -173.54 2.68 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 124.484 1.114 . . . . 62.2 110.371 -174.779 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 83.2 mt -61.65 -30.95 71.05 Favored 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 123.216 0.606 . . . . 70.2 111.097 171.588 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -98.76 21.28 11.65 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 123.498 0.719 . . . . 74.13 111.282 179.791 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 84.49 -159.15 34.76 Favored Glycine 0 C--N 1.356 1.658 0 CA-C-O 119.411 -0.66 . . . . 61.41 113.012 175.359 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -64.76 142.25 75.63 Favored 'Trans proline' 0 C--N 1.369 1.633 0 C-N-CA 122.817 2.345 . . . . 73.2 112.58 178.687 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 4.8 p -140.81 128.53 23.01 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 N-CA-C 108.333 -0.988 . . . . 43.21 108.333 174.323 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 3.8 mp0 -79.28 101.6 8.12 Favored 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 107.28 -1.378 . . . . 72.33 107.28 175.949 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 221' ' ' VAL . . . . . 0.44 ' HB ' ' OH ' ' A' ' 174' ' ' TYR . 2.8 m -99.39 128.25 51.32 Favored 'Isoleucine or valine' 0 C--O 1.24 0.586 0 CA-C-O 121.602 0.715 . . . . 71.21 109.544 -179.675 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . 0.539 ' H ' HD21 ' A' ' 172' ' ' LEU . . . -80.26 104.81 11.07 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 114.407 -1.27 . . . . 52.42 109.26 179.63 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 61.3 t -53.99 134.9 57.93 Favored Pre-proline 0 CA--C 1.558 1.283 0 O-C-N 124.567 1.167 . . . . 54.24 109.707 178.549 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -63.87 149.85 89.73 Favored 'Trans proline' 0 C--N 1.371 1.722 0 C-N-CA 122.068 1.845 . . . . 55.32 111.452 173.474 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -63.23 134.12 43.99 Favored 'Trans proline' 0 C--N 1.373 1.854 0 C-N-CA 121.907 1.738 . . . . 71.01 110.983 174.952 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 33.6 mtm-85 63.82 53.39 1.96 Allowed 'General case' 0 CA--C 1.546 0.817 0 O-C-N 124.68 1.237 . . . . 74.13 111.043 175.858 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 227' ' ' THR . . . . . 0.424 HG23 ' HD2' ' A' ' 231' ' ' ARG . 30.6 m -78.24 145.17 35.62 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 115.444 -0.798 . . . . 72.41 108.945 170.391 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 27.0 mp0 -116.22 145.54 43.04 Favored 'General case' 0 N--CA 1.48 1.061 0 N-CA-C 108.563 -0.902 . . . . 70.51 108.563 176.916 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 229' ' ' ALA . . . . . 0.523 ' HB2' ' HB ' ' A' ' 255' ' ' ILE . . . -60.2 130.72 48.06 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.543 0.737 . . . . 72.2 109.762 -179.48 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 97.85 12.08 48.0 Favored Glycine 0 CA--C 1.522 0.504 0 O-C-N 123.857 0.723 . . . . 74.31 112.852 -178.248 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 231' ' ' ARG . . . . . 0.424 ' HD2' HG23 ' A' ' 227' ' ' THR . 95.1 mtt-85 -84.24 156.14 22.14 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 109.256 -0.646 . . . . 74.4 109.256 165.049 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 232' ' ' LYS . . . . . 0.421 ' HA ' ' O ' ' A' ' 251' ' ' LEU . 42.3 mtmt -130.38 106.84 8.82 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.583 0.753 . . . . 73.44 109.312 -179.735 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 233' ' ' LEU . . . . . 0.526 ' HB2' ' HB2' ' A' ' 251' ' ' LEU . 26.3 mt -80.27 134.04 36.04 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 115.218 -0.901 . . . . 74.45 109.526 -176.677 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 75.3 ttt180 -97.33 109.95 22.6 Favored 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 122.808 0.443 . . . . 73.43 110.93 -170.732 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 235' ' ' LEU . . . . . 0.543 HD12 HD23 ' A' ' 249' ' ' LEU . 15.0 mt -99.77 105.87 17.7 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.265 0.626 . . . . 72.24 111.099 179.522 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 1.9 mtpp -72.09 153.79 41.49 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-O 120.719 0.295 . . . . 70.52 110.563 171.707 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 65.63 13.83 59.4 Favored Glycine 0 N--CA 1.473 1.141 0 O-C-N 124.486 1.116 . . . . 75.43 114.359 -177.198 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 41.1 mmtm -125.53 4.58 7.59 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 123.782 0.833 . . . . 72.23 111.823 -177.968 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 239' ' ' GLY . . . . . 0.5 ' HA2' HD12 ' A' ' 193' ' ' LEU . . . -107.66 -167.64 21.75 Favored Glycine 0 C--N 1.345 1.028 0 N-CA-C 110.879 -0.888 . . . . 70.03 110.879 165.644 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 66.7 m-85 -92.44 166.55 16.78 Favored Pre-proline 0 CA--C 1.548 0.892 0 C-N-CA 123.794 0.837 . . . . 73.44 110.777 178.807 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 241' ' ' PRO . . . . . 0.414 ' HA ' ' O ' ' A' ' 245' ' ' GLY . 55.2 Cg_endo -70.88 146.47 53.33 Favored 'Trans proline' 0 C--N 1.374 1.887 0 C-N-CA 121.756 1.637 . . . . 65.42 111.577 168.068 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -169.74 -117.3 0.41 Allowed Glycine 0 CA--C 1.532 1.103 0 CA-C-O 119.039 -0.867 . . . . 52.11 111.587 178.923 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 243' ' ' PRO . . . . . 0.509 ' HD2' ' HB3' ' A' ' 191' ' ' GLN . 65.6 Cg_endo -66.15 -57.36 0.23 Allowed 'Trans proline' 0 C--N 1.375 1.96 0 C-N-CA 124.246 3.298 . . . . 70.45 112.617 -169.574 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -96.39 18.88 12.99 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.899 0.88 . . . . 74.03 110.463 176.415 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 245' ' ' GLY . . . . . 0.414 ' O ' ' HA ' ' A' ' 241' ' ' PRO . . . 74.66 -103.33 1.52 Allowed Glycine 0 C--N 1.354 1.558 0 N-CA-C 110.322 -1.111 . . . . 71.31 110.322 -170.835 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 31.0 ttm180 -50.42 110.63 0.43 Allowed 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 125.203 1.401 . . . . 74.04 112.559 -176.408 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -89.04 179.46 45.39 Favored Glycine 0 C--N 1.344 0.991 0 CA-C-N 115.898 -0.592 . . . . 65.42 113.478 178.322 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 20.9 m-20 -126.83 152.53 46.86 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 114.598 -0.801 . . . . 71.54 112.504 -168.795 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 249' ' ' LEU . . . . . 0.543 HD23 HD12 ' A' ' 235' ' ' LEU . 55.7 tp -110.17 117.08 32.75 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 114.354 -1.293 . . . . 75.43 108.095 171.117 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 250' ' ' TYR . . . . . . . . . . . . . 3.7 m-85 -90.24 115.16 27.25 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 123.188 0.595 . . . . 53.32 109.404 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 251' ' ' LEU . . . . . 0.598 HD13 HD22 ' A' ' 197' ' ' LEU . 77.2 mt -88.5 105.35 17.56 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-N 114.685 -1.143 . . . . 74.11 108.486 -177.973 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 252' ' ' GLU . . . . . 0.451 ' HG3' ' HD3' ' A' ' 254' ' ' ARG . 12.0 tp10 -79.56 94.06 5.57 Favored 'General case' 0 C--O 1.238 0.486 0 N-CA-C 108.55 -0.907 . . . . 63.32 108.55 -178.746 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 4.4 m -71.67 127.48 33.67 Favored 'Isoleucine or valine' 0 C--N 1.352 0.694 0 CA-C-O 121.619 0.723 . . . . 71.21 109.664 -174.839 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 254' ' ' ARG . . . . . 0.451 ' HD3' ' HG3' ' A' ' 252' ' ' GLU . 22.9 mmm180 -122.87 95.1 4.49 Favored 'General case' 0 C--O 1.239 0.517 0 N-CA-C 107.971 -1.122 . . . . 65.32 107.971 -176.7 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 255' ' ' ILE . . . . . 0.523 ' HB ' ' HB2' ' A' ' 229' ' ' ALA . 40.3 mt -76.6 121.08 28.03 Favored 'Isoleucine or valine' 0 C--O 1.238 0.465 0 CA-C-N 115.589 -0.732 . . . . 72.02 109.669 178.054 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 9.4 t . . . . . 0 C--O 1.254 1.303 0 C-N-CA 123.97 0.908 . . . . 72.33 108.657 175.885 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 23.4 ttt . . . . . 0 N--CA 1.488 1.435 0 CA-C-O 121.228 0.537 . . . . 74.02 110.161 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 13.7 pt20 -147.82 -178.06 6.06 Favored 'General case' 0 C--O 1.241 0.643 0 CA-C-N 115.505 -0.77 . . . . 73.54 110.03 -174.662 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 12.5 t -65.96 157.99 29.33 Favored 'General case' 0 CA--C 1.545 0.788 0 CA-C-N 115.649 -0.705 . . . . 72.42 110.882 173.378 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -99.89 -160.75 0.82 Allowed 'General case' 0 CA--C 1.554 1.123 0 N-CA-C 108.373 -0.973 . . . . 54.15 108.373 179.823 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 172' ' ' LEU . . . . . 0.55 HD21 ' H ' ' A' ' 222' ' ' ALA . 26.0 mt -72.5 173.74 8.44 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.935 0.894 . . . . 62.45 112.012 173.511 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 173' ' ' PHE . . . . . 0.534 ' CD1' HD22 ' A' ' 235' ' ' LEU . 20.2 m-85 -141.1 -71.03 0.36 Allowed 'General case' 0 N--CA 1.481 1.099 0 CA-C-O 121.182 0.515 . . . . 75.32 111.297 -163.799 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 174' ' ' TYR . . . . . 0.468 ' CD2' ' HB3' ' A' ' 233' ' ' LEU . 2.1 p90 -83.25 7.2 17.05 Favored 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 124.589 1.156 . . . . 74.22 112.038 -171.364 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 175' ' ' THR . . . . . 0.503 ' OG1' ' HB3' ' A' ' 172' ' ' LEU . 1.5 m -60.23 -36.82 78.59 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 124.365 1.066 . . . . 74.23 113.149 -160.71 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 176' ' ' MET . . . . . . . . . . . . . 3.0 mpp? -68.08 -27.25 66.33 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 123.676 0.79 . . . . 72.14 111.192 -179.774 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 20.8 tptm -122.56 25.92 8.56 Favored 'General case' 0 CA--C 1.556 1.205 0 C-N-CA 124.367 1.067 . . . . 74.44 109.872 -177.459 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 178' ' ' ALA . . . . . 0.616 ' HB1' ' HB3' ' A' ' 224' ' ' PRO . . . -69.46 132.42 46.29 Favored 'General case' 0 N--CA 1.476 0.867 0 CA-C-N 115.865 -0.607 . . . . 74.11 110.053 -179.761 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . 0.533 ' HB2' ' HB2' ' A' ' 224' ' ' PRO . . . 60.89 30.34 19.58 Favored 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 124.315 1.046 . . . . 63.42 110.779 -170.858 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -79.09 166.73 51.91 Favored Glycine 0 C--N 1.345 1.063 0 CA-C-N 115.198 -0.91 . . . . 60.41 112.496 178.711 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 47.1 t -138.95 162.05 35.83 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 123.737 0.815 . . . . 75.42 109.503 178.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . 91.64 169.0 41.37 Favored Glycine 0 CA--C 1.532 1.119 0 CA-C-N 115.768 -0.651 . . . . 60.04 112.308 -176.133 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -73.85 147.35 38.14 Favored Glycine 0 C--N 1.346 1.123 0 CA-C-O 120.202 -0.221 . . . . 74.43 112.805 -179.789 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 29.7 t -103.37 -56.73 2.16 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 124.046 0.938 . . . . 65.53 109.949 179.511 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 126.56 135.84 4.28 Favored Glycine 0 C--N 1.353 1.503 0 N-CA-C 112.076 -0.41 . . . . 63.31 112.076 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 170.96 108.29 0.21 Allowed Glycine 0 C--N 1.34 0.771 0 N-CA-C 111.148 -0.781 . . . . 61.14 111.148 -176.525 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 13.9 t -166.3 37.97 0.05 OUTLIER 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 123.192 0.597 . . . . 75.21 110.066 -179.42 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -142.56 126.66 2.96 Favored Glycine 0 C--N 1.344 1.013 0 CA-C-N 116.209 -0.451 . . . . 62.44 113.443 -174.907 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 66.48 7.2 38.81 Favored Glycine 0 C--N 1.354 1.535 0 N-CA-C 116.509 1.364 . . . . 52.44 116.509 163.654 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 18.3 m 61.37 30.43 18.99 Favored 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 124.102 0.961 . . . . 52.3 111.927 -178.179 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 191' ' ' GLN . . . . . 0.419 HE22 ' HB3' ' A' ' 244' ' ' ALA . 2.9 pt20 -75.75 -22.92 56.03 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 122.632 0.373 . . . . 64.31 111.278 179.753 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 -75.58 134.98 40.56 Favored 'General case' 0 N--CA 1.47 0.525 0 C-N-CA 123.834 0.854 . . . . 64.33 109.887 -178.294 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 24.2 mt -117.6 162.69 17.6 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 123.568 0.747 . . . . 72.41 110.215 175.46 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 77.0 m-85 -133.17 135.0 44.85 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 123.77 0.828 . . . . 73.41 110.382 -177.751 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . 0.438 ' HB2' HD11 ' A' ' 249' ' ' LEU . . . -147.8 171.16 16.15 Favored 'General case' 0 C--O 1.239 0.53 0 C-N-CA 125.417 1.487 . . . . 73.25 108.494 -179.607 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 34.1 m -129.63 124.42 33.64 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 123.826 0.851 . . . . 71.12 108.717 -178.604 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 0.763 HD22 HD13 ' A' ' 251' ' ' LEU . 15.7 tp -106.66 110.2 22.32 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 108.681 -0.859 . . . . 74.51 108.681 -173.044 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -82.51 122.77 28.49 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 123.091 0.556 . . . . 73.34 109.774 177.703 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 199' ' ' VAL . . . . . 0.443 ' O ' ' HA ' ' A' ' 255' ' ' ILE . 4.3 p -140.71 128.34 12.32 Favored Pre-proline 0 CA--C 1.545 0.764 0 N-CA-C 108.228 -1.027 . . . . 53.25 108.228 -177.927 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -69.39 156.2 65.0 Favored 'Trans proline' 0 C--N 1.366 1.49 0 C-N-CA 121.917 1.745 . . . . 52.53 111.034 171.15 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 201' ' ' ALA . . . . . 0.507 ' O ' HG23 ' A' ' 205' ' ' VAL . . . -48.52 -54.2 28.6 Favored Pre-proline 0 CA--C 1.559 1.321 0 CA-C-O 117.754 -1.117 . . . . 75.41 113.122 -177.761 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -60.69 -37.6 77.9 Favored 'Trans proline' 0 C--N 1.391 2.803 0 C-N-CA 121.94 1.76 . . . . 53.23 113.466 -176.376 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 39.7 mt -68.37 -33.94 63.12 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.389 0 C-N-CA 122.51 0.324 . . . . 73.4 110.404 178.056 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -71.66 -33.54 68.96 Favored 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 122.863 0.465 . . . . 63.32 111.47 176.893 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . 0.507 HG23 ' O ' ' A' ' 201' ' ' ALA . 73.5 t -71.8 -52.43 25.51 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 C-N-CA 123.909 0.884 . . . . 74.2 110.951 -179.776 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 16.2 m -82.89 -27.21 8.1 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.096 0 CA-C-N 116.304 -0.407 . . . . 63.43 111.465 -173.493 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 83.74 62.09 1.8 Allowed Glycine 0 C--N 1.343 0.969 0 CA-C-N 116.121 -0.491 . . . . 61.3 112.224 -174.589 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -83.19 -134.38 2.29 Favored Glycine 0 C--N 1.35 1.346 0 CA-C-O 119.9 -0.389 . . . . 60.52 112.462 177.947 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 46.5 mtmt -138.59 153.11 48.65 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 123.917 0.887 . . . . 72.02 110.916 178.037 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 9.7 m -145.37 170.0 6.72 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.092 0 C-N-CA 125.732 1.613 . . . . 73.33 109.096 175.184 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 29.8 ttp180 -97.8 110.57 23.11 Favored 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 123.72 0.808 . . . . 64.45 110.306 -177.938 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -102.33 112.22 24.83 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 123.485 0.714 . . . . 63.43 109.311 174.121 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 65.5 mtp -86.75 123.47 31.95 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 122.744 0.418 . . . . 61.21 110.071 -178.746 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 31.4 p -127.72 -171.14 2.37 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 124.38 1.072 . . . . 75.15 110.954 -168.4 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 76.9 mt -63.71 -27.91 69.53 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 123.217 0.607 . . . . 74.45 111.236 172.107 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -100.93 21.95 12.92 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.716 0.806 . . . . 75.21 110.615 178.328 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 85.38 -168.56 42.43 Favored Glycine 0 C--N 1.348 1.232 0 CA-C-N 116.008 -0.542 . . . . 52.43 113.702 173.94 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -74.19 121.04 6.59 Favored 'Trans proline' 0 C--N 1.366 1.494 0 C-N-CA 122.975 2.45 . . . . 44.2 112.047 -179.625 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 6.7 p -114.4 134.76 56.32 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 C-N-CA 123.799 0.84 . . . . 60.34 109.39 175.488 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -75.56 102.31 5.23 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 107.741 -1.207 . . . . 74.22 107.741 172.382 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 3.8 p -103.91 130.08 55.05 Favored 'Isoleucine or valine' 0 C--O 1.243 0.72 0 N-CA-C 109.149 -0.686 . . . . 73.04 109.149 -175.058 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . 0.55 ' H ' HD21 ' A' ' 172' ' ' LEU . . . -76.03 106.64 7.74 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 123.261 0.624 . . . . 24.35 110.676 -177.427 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 53.5 t -54.71 137.87 62.81 Favored Pre-proline 0 N--CA 1.477 0.888 0 O-C-N 124.522 1.139 . . . . 71.24 109.994 179.626 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 224' ' ' PRO . . . . . 0.616 ' HB3' ' HB1' ' A' ' 178' ' ' ALA . 12.3 Cg_endo -57.77 152.96 46.2 Favored 'Trans proline' 0 C--N 1.369 1.617 0 C-N-CA 122.355 2.037 . . . . 72.13 112.714 171.343 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -76.18 149.54 32.17 Favored 'Trans proline' 0 C--N 1.367 1.527 0 C-N-CA 121.999 1.799 . . . . 52.23 110.741 171.443 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 35.9 mtm105 60.09 36.23 21.26 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 124.305 1.042 . . . . 73.23 111.143 168.563 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 227' ' ' THR . . . . . 0.457 HG23 ' HD2' ' A' ' 231' ' ' ARG . 21.5 m -76.53 150.03 36.62 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 124.587 1.155 . . . . 62.21 110.576 -178.259 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 27.0 mp0 -120.96 143.01 49.23 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 123.606 0.762 . . . . 72.22 109.151 175.066 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 229' ' ' ALA . . . . . 0.44 ' HB2' ' HB ' ' A' ' 255' ' ' ILE . . . -60.02 125.52 23.99 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 123.859 0.864 . . . . 63.4 111.002 -178.528 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 109.25 -2.02 31.19 Favored Glycine 0 CA--C 1.528 0.844 0 O-C-N 123.774 0.671 . . . . 42.53 113.287 -177.776 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 231' ' ' ARG . . . . . 0.457 ' HD2' HG23 ' A' ' 227' ' ' THR . 89.7 mtt-85 -72.35 157.59 37.38 Favored 'General case' 0 N--CA 1.479 0.985 0 CA-C-N 117.701 0.751 . . . . 74.51 109.854 170.484 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 45.7 mtmt -128.97 122.78 30.86 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 123.189 0.596 . . . . 71.31 110.068 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 233' ' ' LEU . . . . . 0.468 ' HB3' ' CD2' ' A' ' 174' ' ' TYR . 19.5 mt -101.77 153.34 19.89 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 124.949 1.3 . . . . 71.01 108.634 -178.043 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 19.5 ttt180 -120.78 103.17 8.89 Favored 'General case' 0 CA--C 1.546 0.801 0 O-C-N 122.188 -0.32 . . . . 74.42 111.486 -171.85 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 235' ' ' LEU . . . . . 0.569 ' HB2' ' HB3' ' A' ' 249' ' ' LEU . 15.6 mt -82.39 102.58 11.36 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 123.585 0.754 . . . . 72.32 110.582 176.966 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . 0.426 ' H ' ' HB3' ' A' ' 173' ' ' PHE . 43.8 mtmt -71.97 144.44 48.87 Favored 'General case' 0 C--O 1.242 0.68 0 CA-C-O 121.529 0.681 . . . . 72.25 112.421 179.967 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 72.14 3.36 56.45 Favored Glycine 0 CA--C 1.531 1.089 0 CA-C-N 114.183 -1.371 . . . . 61.12 114.283 -176.108 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 47.2 mmtm -107.96 13.85 25.8 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 123.538 0.735 . . . . 74.55 111.63 -176.311 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -116.36 -171.0 15.89 Favored Glycine 0 CA--C 1.528 0.877 0 N-CA-C 110.274 -1.13 . . . . 73.42 110.274 166.51 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 68.9 m-85 -87.73 159.13 49.9 Favored Pre-proline 0 N--CA 1.481 1.079 0 C-N-CA 123.264 0.626 . . . . 61.41 112.149 -173.778 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -71.72 164.21 36.43 Favored 'Trans proline' 0 C--N 1.373 1.858 0 C-N-CA 122.04 1.827 . . . . 64.22 112.732 171.595 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 158.35 -109.09 0.39 Allowed Glycine 0 CA--C 1.532 1.123 0 CA-C-O 118.784 -1.009 . . . . 63.01 112.722 174.244 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -65.16 -49.58 2.61 Favored 'Trans proline' 0 C--N 1.381 2.249 0 C-N-CA 123.454 2.769 . . . . 75.15 112.722 -170.385 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 244' ' ' ALA . . . . . 0.419 ' HB3' HE22 ' A' ' 191' ' ' GLN . . . -90.61 -8.53 49.85 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 123.976 0.91 . . . . 72.22 111.151 178.349 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 83.68 -42.58 3.06 Favored Glycine 0 C--N 1.359 1.828 0 N-CA-C 111.922 -0.471 . . . . 72.35 111.922 -170.864 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 17.3 ttm180 -103.17 114.82 29.42 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 125.077 1.351 . . . . 73.53 110.639 173.17 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -91.1 158.99 26.13 Favored Glycine 0 C--N 1.341 0.843 0 N-CA-C 110.841 -0.904 . . . . 75.45 110.841 163.664 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 26.9 m-20 -134.52 152.55 51.86 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 122.606 0.363 . . . . 74.54 110.065 -171.531 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 249' ' ' LEU . . . . . 0.569 ' HB3' ' HB2' ' A' ' 235' ' ' LEU . 57.2 tp -99.05 139.97 33.91 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 124.543 1.137 . . . . 73.53 109.844 -176.506 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 250' ' ' TYR . . . . . . . . . . . . . 4.3 m-85 -103.66 123.0 46.19 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 123.856 0.862 . . . . 71.11 110.064 177.837 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 251' ' ' LEU . . . . . 0.763 HD13 HD22 ' A' ' 197' ' ' LEU . 92.1 mt -103.7 103.91 13.88 Favored 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 108.211 -1.033 . . . . 74.41 108.211 179.464 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -81.33 100.99 9.5 Favored 'General case' 0 CA--C 1.543 0.691 0 N-CA-C 108.187 -1.042 . . . . 74.12 108.187 175.371 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 10.2 m -65.68 137.34 25.12 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.788 0 CA-C-O 121.359 0.599 . . . . 73.34 110.801 -175.031 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 24.1 mmt85 -128.79 97.65 4.73 Favored 'General case' 0 C--O 1.238 0.468 0 C-N-CA 124.576 1.151 . . . . 75.12 108.246 179.844 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 255' ' ' ILE . . . . . 0.454 HG23 ' HA ' ' A' ' 201' ' ' ALA . 34.5 mt -77.42 120.79 28.62 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 CA-C-N 115.422 -0.808 . . . . 52.12 109.679 179.376 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 7.1 t . . . . . 0 CA--C 1.562 1.412 0 C-N-CA 123.675 0.79 . . . . 62.33 109.497 -179.43 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 23.9 ptp . . . . . 0 N--CA 1.484 1.265 0 N-CA-C 109.973 -0.381 . . . . 72.43 109.973 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 28.5 pt20 -85.15 166.06 16.92 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 123.289 0.636 . . . . 65.32 110.597 174.872 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 8.2 t -67.77 155.16 39.92 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 123.605 0.762 . . . . 62.53 110.234 171.139 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -89.26 -88.51 0.16 Allowed 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 122.42 0.288 . . . . 74.24 111.52 -173.229 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 172' ' ' LEU . . . . . 0.531 HD21 ' HB3' ' A' ' 222' ' ' ALA . 62.9 mt -139.68 160.08 40.7 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.834 0.853 . . . . 70.44 110.802 -165.95 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 173' ' ' PHE . . . . . 0.538 ' CD1' HD22 ' A' ' 235' ' ' LEU . 5.4 m-85 -138.24 -56.24 0.65 Allowed 'General case' 0 N--CA 1.482 1.131 0 CA-C-O 122.023 0.916 . . . . 74.41 108.974 -165.846 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 174' ' ' TYR . . . . . 0.464 ' CD2' ' HB3' ' A' ' 233' ' ' LEU . 1.4 p90 -74.82 4.2 6.8 Favored 'General case' 0 CA--C 1.547 0.865 0 CA-C-N 113.448 -1.705 . . . . 74.33 113.316 -178.79 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 6.2 p -67.29 82.52 0.14 Allowed 'General case' 0 CA--C 1.547 0.853 0 CA-C-O 122.334 1.064 . . . . 62.31 110.705 174.751 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 176' ' ' MET . . . . . 0.456 ' HG3' ' HG2' ' A' ' 177' ' ' LYS . 23.1 ptt? -161.91 -39.61 0.04 OUTLIER 'General case' 0 CA--C 1.541 0.608 0 CA-C-N 113.639 -1.619 . . . . 64.44 108.202 -174.809 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . 0.456 ' HG2' ' HG3' ' A' ' 176' ' ' MET . 18.3 pttp -177.27 34.64 0.0 OUTLIER 'General case' 0 CA--C 1.556 1.179 0 C-N-CA 124.637 1.175 . . . . 71.23 110.052 -178.906 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 178' ' ' ALA . . . . . 0.471 ' HB1' ' HG3' ' A' ' 224' ' ' PRO . . . -59.21 150.44 25.59 Favored 'General case' 0 N--CA 1.487 1.379 0 C-N-CA 124.036 0.935 . . . . 74.01 111.705 178.315 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . 0.411 ' HB1' ' NH1' ' A' ' 231' ' ' ARG . . . 61.75 25.55 15.4 Favored 'General case' 0 N--CA 1.489 1.517 0 C-N-CA 124.169 0.988 . . . . 53.51 110.758 -167.886 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -116.31 90.94 0.53 Allowed Glycine 0 C--N 1.34 0.771 0 CA-C-N 115.43 -0.804 . . . . 73.11 111.128 -176.897 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 15.8 m -69.01 91.73 0.49 Allowed 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 123.672 0.789 . . . . 65.45 109.747 175.764 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -179.69 104.69 0.19 Allowed Glycine 0 C--N 1.345 1.081 0 N-CA-C 111.787 -0.525 . . . . 72.53 111.787 -175.742 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 145.83 166.04 11.73 Favored Glycine 0 C--N 1.346 1.1 0 N-CA-C 112.132 -0.387 . . . . 53.11 112.132 178.076 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 48.8 m -141.32 116.68 10.11 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 124.108 0.963 . . . . 64.02 109.131 -179.205 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -136.0 20.27 3.62 Favored Glycine 0 C--N 1.345 1.036 0 CA-C-O 119.993 -0.337 . . . . 72.42 113.603 -175.959 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -91.3 8.86 78.74 Favored Glycine 0 N--CA 1.476 1.337 0 C-N-CA 122.759 0.218 . . . . 61.4 113.48 179.668 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 50.4 m -125.35 136.36 53.38 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 124.326 1.051 . . . . 74.11 108.828 175.747 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 108.93 94.06 2.31 Favored Glycine 0 C--N 1.344 1.021 0 N-CA-C 110.701 -0.96 . . . . 75.01 110.701 -173.947 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . 0.445 ' HA3' ' HD3' ' A' ' 243' ' ' PRO . . . 68.14 -150.34 50.97 Favored Glycine 0 C--N 1.352 1.424 0 C-N-CA 123.066 0.365 . . . . 73.42 112.964 -178.657 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 24.3 t -146.68 25.09 1.19 Allowed 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 123.649 0.78 . . . . 65.54 109.041 175.993 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 191' ' ' GLN . . . . . 0.528 ' HB3' ' HD2' ' A' ' 243' ' ' PRO . 7.5 pt20 -65.68 -25.69 67.45 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-N 115.192 -0.913 . . . . 63.2 111.445 -176.239 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 -75.31 141.61 43.37 Favored 'General case' 0 C--O 1.242 0.691 0 C-N-CA 124.666 1.186 . . . . 73.32 109.827 -176.475 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . 0.413 HD12 ' HA2' ' A' ' 239' ' ' GLY . 23.3 mt -126.62 176.41 7.23 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 123.922 0.889 . . . . 74.12 110.802 -178.009 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 15.6 m-85 -138.23 122.93 18.69 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 124.33 1.052 . . . . 73.32 110.307 179.945 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -139.64 127.5 22.07 Favored 'General case' 0 C--O 1.239 0.509 0 N-CA-C 107.605 -1.257 . . . . 63.13 107.605 170.966 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 58.6 m -73.66 131.31 41.51 Favored 'General case' 0 C--O 1.241 0.657 0 CA-C-N 115.981 -0.554 . . . . 73.25 109.695 179.475 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 0.647 HD22 HD13 ' A' ' 251' ' ' LEU . 15.8 tp -106.72 108.88 20.61 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 107.884 -1.154 . . . . 72.04 107.884 -179.588 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -78.4 121.09 24.05 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 108.468 -0.938 . . . . 62.13 108.468 177.114 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 199' ' ' VAL . . . . . 0.461 ' O ' ' HA ' ' A' ' 255' ' ' ILE . 4.1 p -140.98 128.53 12.1 Favored Pre-proline 0 CA--C 1.544 0.736 0 C-N-CA 123.733 0.813 . . . . 74.1 108.968 -177.956 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -70.53 156.78 60.62 Favored 'Trans proline' 0 C--N 1.365 1.402 0 C-N-CA 121.914 1.743 . . . . 60.3 111.006 170.919 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 201' ' ' ALA . . . . . 0.488 ' O ' HG23 ' A' ' 205' ' ' VAL . . . -50.97 -51.84 63.62 Favored Pre-proline 0 CA--C 1.56 1.349 0 CA-C-O 117.719 -1.134 . . . . 65.23 112.688 -179.257 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -61.58 -38.99 58.04 Favored 'Trans proline' 0 C--N 1.394 2.935 0 C-N-CA 121.672 1.581 . . . . 54.42 113.48 -177.535 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 34.4 mt -65.52 -34.01 67.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 CA-C-N 118.082 0.401 . . . . 62.42 110.398 176.382 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -71.34 -35.12 71.08 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 122.372 0.269 . . . . 72.32 111.371 177.428 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . 0.488 HG23 ' O ' ' A' ' 201' ' ' ALA . 96.6 t -71.74 -55.78 12.43 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.153 0 C-N-CA 123.588 0.755 . . . . 63.41 110.984 -179.544 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 18.9 m -79.74 -25.53 12.21 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 C-N-CA 122.863 0.465 . . . . 55.41 111.433 -174.607 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 80.1 72.18 1.22 Allowed Glycine 0 C--N 1.342 0.905 0 N-CA-C 111.647 -0.581 . . . . 53.32 111.647 -173.116 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -93.48 -134.21 6.98 Favored Glycine 0 C--N 1.349 1.298 0 N-CA-C 111.361 -0.695 . . . . 52.35 111.361 178.033 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 46.2 mtmt -138.1 152.78 49.08 Favored 'General case' 0 N--CA 1.486 1.37 0 CA-C-N 117.725 0.763 . . . . 74.22 111.662 179.35 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 15.6 m -147.72 158.67 8.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 C-N-CA 124.881 1.272 . . . . 64.22 109.268 178.403 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 43.5 ttm180 -98.3 114.01 26.16 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 123.089 0.556 . . . . 75.11 111.092 -175.627 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -100.3 124.93 46.37 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 124.509 1.123 . . . . 55.34 110.74 178.559 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 22.2 mmt -85.37 110.74 19.33 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 123.466 0.707 . . . . 61.5 109.49 176.841 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 22.2 p -110.94 -178.63 3.52 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 123.973 0.909 . . . . 64.24 109.73 -176.803 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 82.6 mt -57.67 -36.73 72.3 Favored 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 123.375 0.67 . . . . 40.22 112.709 -179.151 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -96.02 -19.33 19.55 Favored 'General case' 0 N--CA 1.482 1.154 0 N-CA-C 112.63 0.604 . . . . 65.31 112.63 -172.468 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 152.6 -168.33 31.6 Favored Glycine 0 C--N 1.352 1.423 0 CA-C-O 119.956 -0.358 . . . . 53.35 113.009 -178.825 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -85.39 132.24 4.3 Favored 'Trans proline' 0 C--N 1.367 1.543 0 C-N-CA 123.058 2.505 . . . . 75.1 112.566 179.086 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 4.1 p -126.44 126.09 68.51 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 N-CA-C 108.563 -0.903 . . . . 72.34 108.563 171.07 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -84.15 102.58 12.68 Favored 'General case' 0 C--O 1.238 0.455 0 N-CA-C 108.212 -1.033 . . . . 74.1 108.212 173.486 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 4.1 p -97.39 139.52 19.63 Favored 'Isoleucine or valine' 0 C--O 1.25 1.093 0 CA-C-N 114.732 -1.122 . . . . 61.03 109.218 -170.723 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . 0.531 ' HB3' HD21 ' A' ' 172' ' ' LEU . . . -78.42 101.27 7.19 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 122.794 0.437 . . . . 75.45 110.684 -177.493 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 47.5 t -53.9 133.08 57.77 Favored Pre-proline 0 N--CA 1.48 1.029 0 C-N-CA 124.28 1.032 . . . . 61.14 109.746 -179.338 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 224' ' ' PRO . . . . . 0.471 ' HG3' ' HB1' ' A' ' 178' ' ' ALA . 35.2 Cg_endo -63.25 147.08 94.15 Favored 'Trans proline' 0 C--N 1.371 1.725 0 C-N-CA 121.574 1.516 . . . . 52.04 110.46 172.029 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -67.33 156.95 64.04 Favored 'Trans proline' 0 C--N 1.361 1.201 0 C-N-CA 121.747 1.631 . . . . 70.42 111.541 177.005 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 40.7 mtt180 64.39 25.61 13.43 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 124.373 1.069 . . . . 72.22 111.634 168.424 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 227' ' ' THR . . . . . 0.59 ' HA ' HH11 ' A' ' 231' ' ' ARG . 94.1 m -75.81 133.99 40.5 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 123.835 0.854 . . . . 72.44 110.628 -179.896 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -99.83 148.71 24.14 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 123.872 0.869 . . . . 75.51 109.746 176.904 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 229' ' ' ALA . . . . . 0.538 ' HB2' ' HB ' ' A' ' 255' ' ' ILE . . . -59.63 128.08 35.23 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 123.989 0.915 . . . . 74.13 111.175 178.028 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 106.1 -5.84 39.43 Favored Glycine 0 N--CA 1.47 0.914 0 O-C-N 123.737 0.648 . . . . 41.25 113.135 -179.8 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 231' ' ' ARG . . . . . 0.59 HH11 ' HA ' ' A' ' 227' ' ' THR . 89.5 mtt180 -72.57 153.99 41.01 Favored 'General case' 0 N--CA 1.479 1.005 0 CA-C-N 117.325 0.563 . . . . 75.2 110.224 173.686 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 232' ' ' LYS . . . . . 0.413 ' HA ' ' O ' ' A' ' 251' ' ' LEU . 53.8 mtmt -130.3 127.32 39.25 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-N 115.99 -0.55 . . . . 64.04 110.044 -178.538 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 233' ' ' LEU . . . . . 0.488 ' HB2' ' HB2' ' A' ' 251' ' ' LEU . 24.1 mt -104.48 150.24 24.75 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 124.852 1.261 . . . . 74.15 108.614 -175.837 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 234' ' ' ARG . . . . . 0.426 ' HG3' ' HB3' ' A' ' 248' ' ' ASP . 56.7 ttm-85 -112.1 120.87 43.3 Favored 'General case' 0 N--CA 1.484 1.254 0 CA-C-N 118.361 0.528 . . . . 70.23 111.404 -170.483 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 235' ' ' LEU . . . . . 0.538 HD22 ' CD1' ' A' ' 173' ' ' PHE . 14.2 mt -110.95 111.73 23.06 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 123.787 0.835 . . . . 64.32 111.621 -176.754 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 31.3 mttp -68.72 141.65 55.22 Favored 'General case' 0 N--CA 1.476 0.875 0 CA-C-O 120.852 0.358 . . . . 64.22 110.914 172.707 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 79.7 -0.58 81.41 Favored Glycine 0 C--N 1.347 1.188 0 CA-C-N 115.18 -0.918 . . . . 50.13 114.658 176.706 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 72.5 mmtt -109.21 1.93 20.59 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 122.788 0.435 . . . . 72.25 110.223 -175.78 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 239' ' ' GLY . . . . . 0.413 ' HA2' HD12 ' A' ' 193' ' ' LEU . . . -112.33 -172.78 18.98 Favored Glycine 0 C--N 1.353 1.52 0 N-CA-C 111.289 -0.724 . . . . 74.23 111.289 166.423 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 86.3 m-85 -86.09 157.39 56.87 Favored Pre-proline 0 N--CA 1.491 1.584 0 C-N-CA 123.361 0.664 . . . . 75.14 111.576 -174.424 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -65.95 131.37 26.99 Favored 'Trans proline' 0 C--N 1.376 2.008 0 C-N-CA 121.826 1.684 . . . . 64.32 111.011 170.614 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -160.43 -125.29 0.77 Allowed Glycine 0 C--N 1.34 0.77 0 CA-C-O 118.629 -1.095 . . . . 73.31 112.28 -179.95 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 243' ' ' PRO . . . . . 0.528 ' HD2' ' HB3' ' A' ' 191' ' ' GLN . 21.4 Cg_endo -54.55 -50.68 12.59 Favored 'Trans proline' 0 C--N 1.377 2.077 0 C-N-CA 124.344 3.363 . . . . 55.43 112.542 -176.589 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -86.59 -11.02 52.67 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 123.254 0.622 . . . . 73.2 111.463 179.938 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 85.43 -21.45 13.39 Favored Glycine 0 C--N 1.357 1.718 0 C-N-CA 122.888 0.28 . . . . 44.22 113.146 -177.941 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 12.7 ttm180 -126.56 113.72 17.14 Favored 'General case' 0 C--O 1.234 0.268 0 C-N-CA 125.038 1.335 . . . . 74.03 107.688 174.219 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -76.79 163.11 52.34 Favored Glycine 0 C--O 1.245 0.794 0 N-CA-C 115.055 0.782 . . . . 45.52 115.055 177.575 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 248' ' ' ASP . . . . . 0.455 ' HA ' ' O ' ' A' ' 235' ' ' LEU . 55.3 m-20 -110.06 159.16 17.56 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 114.101 -1.049 . . . . 75.24 110.354 -176.714 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 249' ' ' LEU . . . . . 0.511 ' HB3' ' HB2' ' A' ' 235' ' ' LEU . 31.3 tp -126.1 126.65 44.53 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 123.457 0.703 . . . . 65.42 109.242 174.452 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 250' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 -90.25 112.19 23.63 Favored 'General case' 0 C--O 1.239 0.532 0 N-CA-C 108.552 -0.907 . . . . 64.45 108.552 -179.628 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 251' ' ' LEU . . . . . 0.647 HD13 HD22 ' A' ' 197' ' ' LEU . 81.2 mt -87.56 101.21 13.41 Favored 'General case' 0 C--O 1.239 0.513 0 N-CA-C 107.072 -1.455 . . . . 73.24 107.072 176.069 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -85.79 91.98 8.48 Favored 'General case' 0 C--O 1.242 0.683 0 N-CA-C 108.013 -1.106 . . . . 72.42 108.013 -176.199 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 4.1 m -61.51 135.76 25.8 Favored 'Isoleucine or valine' 0 C--O 1.243 0.724 0 CA-C-N 115.02 -0.991 . . . . 63.32 109.9 -174.605 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 14.8 mmm180 -131.85 111.22 11.41 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 107.21 -1.404 . . . . 71.13 107.21 178.599 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 255' ' ' ILE . . . . . 0.538 ' HB ' ' HB2' ' A' ' 229' ' ' ALA . 41.8 mt -86.64 116.08 28.69 Favored 'Isoleucine or valine' 0 C--O 1.239 0.531 0 C-N-CA 123.865 0.866 . . . . 65.11 110.086 -176.993 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 2.0 t . . . . . 0 CA--C 1.556 1.201 0 C-N-CA 124.497 1.119 . . . . 73.41 109.577 176.992 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 25.5 ptt? . . . . . 0 N--CA 1.483 1.188 0 CA-C-O 120.392 0.139 . . . . 73.12 111.034 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 4.5 pt20 -103.51 -53.95 2.69 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 123.219 0.608 . . . . 63.43 111.008 -175.445 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 11.0 t -179.77 178.22 0.65 Allowed 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 124.721 1.208 . . . . 70.1 109.408 -177.45 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -132.11 -85.53 0.48 Allowed 'General case' 0 CA--C 1.544 0.734 0 N-CA-C 108.928 -0.768 . . . . 64.04 108.928 173.507 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 31.9 mt -133.25 158.45 42.88 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 123.282 0.633 . . . . 54.41 111.697 -175.664 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 3.9 m-85 -130.06 -56.09 1.11 Allowed 'General case' 0 N--CA 1.475 0.807 0 CA-C-N 114.85 -1.068 . . . . 72.13 109.105 -171.447 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 174' ' ' TYR . . . . . 0.463 ' CE2' HD13 ' A' ' 233' ' ' LEU . 0.6 OUTLIER -80.93 3.32 23.24 Favored 'General case' 0 N--CA 1.476 0.83 0 N-CA-C 114.24 1.2 . . . . 71.14 114.24 -167.711 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 24.0 p -53.49 -23.1 9.32 Favored 'General case' 0 N--CA 1.489 1.522 0 C-N-CA 123.955 0.902 . . . . 61.12 113.158 -176.021 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 176' ' ' MET . . . . . . . . . . . . . 13.9 ptm -56.29 85.03 0.01 OUTLIER 'General case' 0 CA--C 1.56 1.351 0 C-N-CA 124.272 1.029 . . . . 72.41 111.119 165.67 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 66.1 mttm 55.73 47.29 20.76 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 125.15 1.38 . . . . 75.11 111.862 178.003 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -63.89 -32.4 73.91 Favored 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 124.891 1.276 . . . . 35.33 111.856 178.108 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -88.52 24.44 1.96 Allowed 'General case' 0 CA--C 1.55 0.966 0 C-N-CA 123.758 0.823 . . . . 64.52 110.816 175.705 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -120.14 -119.88 2.77 Favored Glycine 0 C--N 1.346 1.117 0 N-CA-C 109.455 -1.458 . . . . 73.53 109.455 166.162 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 22.9 t -165.63 112.59 0.93 Allowed 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 109.26 -0.644 . . . . 62.33 109.26 175.247 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -87.64 16.74 48.58 Favored Glycine 0 C--N 1.352 1.451 0 CA-C-O 119.971 -0.35 . . . . 72.31 112.981 175.308 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -68.29 -39.54 87.82 Favored Glycine 0 C--N 1.358 1.792 0 C-N-CA 123.369 0.509 . . . . 65.13 113.349 -178.321 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 17.3 p -73.7 80.14 1.54 Allowed 'General case' 0 C--O 1.24 0.576 0 CA-C-O 121.698 0.761 . . . . 72.34 109.241 175.619 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -143.92 125.85 2.59 Favored Glycine 0 C--N 1.337 0.634 0 CA-C-N 114.583 -1.19 . . . . 52.21 111.434 -173.684 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -158.51 153.72 24.85 Favored Glycine 0 C--N 1.341 0.81 0 N-CA-C 111.171 -0.772 . . . . 54.43 111.171 177.293 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 49.5 m -148.41 -57.54 0.23 Allowed 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 123.598 0.759 . . . . 72.41 110.371 -178.54 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 158.46 59.12 0.01 OUTLIER Glycine 0 C--N 1.352 1.455 0 CA-C-N 116.541 -0.299 . . . . 62.1 112.388 -178.771 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 156.41 145.85 4.31 Favored Glycine 0 C--N 1.35 1.306 0 N-CA-C 111.901 -0.479 . . . . 53.44 111.901 179.113 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 8.8 t -90.41 63.48 5.63 Favored 'General case' 0 N--CA 1.476 0.854 0 CA-C-O 121.611 0.72 . . . . 62.22 109.969 -179.162 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 191' ' ' GLN . . . . . 0.688 ' HB3' ' HD2' ' A' ' 243' ' ' PRO . 9.6 pt20 -73.93 -30.37 62.53 Favored 'General case' 0 N--CA 1.482 1.153 0 CA-C-N 115.294 -0.866 . . . . 73.15 109.984 175.195 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -79.15 145.95 33.42 Favored 'General case' 0 C--O 1.241 0.618 0 CA-C-N 114.51 -1.223 . . . . 73.42 109.761 -171.435 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 33.5 mt -111.01 173.27 6.41 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 123.925 0.89 . . . . 63.01 110.331 -179.102 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 65.3 m-85 -134.0 121.37 21.51 Favored 'General case' 0 C--O 1.237 0.439 0 C-N-CA 123.596 0.758 . . . . 73.12 110.054 -179.442 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . 0.448 ' O ' ' HA ' ' A' ' 251' ' ' LEU . . . -140.61 146.76 38.4 Favored 'General case' 0 C--O 1.234 0.287 0 N-CA-C 107.538 -1.282 . . . . 63.11 107.538 173.759 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 61.3 m -96.77 140.02 31.96 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 109.918 -0.401 . . . . 50.24 109.918 178.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 0.672 HD22 HD13 ' A' ' 251' ' ' LEU . 16.5 tp -117.45 108.65 15.79 Favored 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 107.749 -1.204 . . . . 75.3 107.749 177.005 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -82.78 132.01 35.18 Favored 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 109.481 -0.563 . . . . 73.33 109.481 177.513 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 199' ' ' VAL . . . . . 0.533 ' O ' ' HA ' ' A' ' 255' ' ' ILE . 7.5 p -144.07 131.59 10.62 Favored Pre-proline 0 CA--C 1.548 0.894 0 N-CA-C 107.461 -1.311 . . . . 75.33 107.461 179.988 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -72.45 161.17 44.97 Favored 'Trans proline' 0 C--N 1.358 1.03 0 C-N-CA 121.829 1.686 . . . . 75.14 111.346 169.172 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -50.13 -50.12 71.59 Favored Pre-proline 0 CA--C 1.564 1.483 0 N-CA-C 114.021 1.119 . . . . 61.25 114.021 -178.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 202' ' ' PRO . . . . . 0.424 ' HA ' HG22 ' A' ' 205' ' ' VAL . 43.2 Cg_endo -64.26 -41.38 21.65 Favored 'Trans proline' 0 C--N 1.396 3.043 0 C-N-CA 121.736 1.624 . . . . 73.24 113.576 -178.779 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 53.2 mt -67.08 -28.25 42.13 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.295 0 CA-C-N 117.898 0.317 . . . . 63.34 110.21 177.296 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -72.83 -50.37 24.5 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 123.209 0.604 . . . . 52.13 111.783 178.534 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . 0.424 HG22 ' HA ' ' A' ' 202' ' ' PRO . 17.1 m -68.62 -43.02 83.67 Favored 'Isoleucine or valine' 0 C--N 1.353 0.729 0 C-N-CA 123.864 0.866 . . . . 72.32 112.574 -173.642 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 206' ' ' VAL . . . . . 0.414 HG22 ' O ' ' A' ' 202' ' ' PRO . 14.2 m -80.01 -36.38 16.82 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.226 0 CA-C-O 120.805 0.336 . . . . 54.45 110.746 175.239 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 83.77 80.05 1.04 Allowed Glycine 0 CA--C 1.528 0.885 0 N-CA-C 111.805 -0.518 . . . . 74.13 111.805 -173.064 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -90.78 -128.81 4.04 Favored Glycine 0 C--N 1.354 1.54 0 N-CA-C 111.447 -0.661 . . . . 64.33 111.447 175.789 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 45.3 mtmt -137.87 147.69 44.69 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 123.598 0.759 . . . . 74.4 110.806 174.599 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 3.6 m -139.94 165.18 22.22 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 C-N-CA 125.277 1.431 . . . . 72.52 109.212 175.033 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 45.0 ttp180 -100.97 122.76 44.08 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 123.179 0.591 . . . . 73.5 110.431 -177.807 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -114.68 112.31 22.67 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 124.05 0.94 . . . . 73.31 109.654 177.607 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 213' ' ' MET . . . . . 0.401 ' HA ' ' HA ' ' A' ' 218' ' ' PRO . 55.7 ttm -82.96 123.45 29.44 Favored 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 109.6 -0.518 . . . . 74.35 109.6 176.547 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 23.1 p -115.6 -171.22 1.93 Allowed 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 125.23 1.412 . . . . 71.24 109.568 -174.658 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 94.8 mt -60.75 -32.17 71.47 Favored 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 123.17 0.588 . . . . 71.34 111.016 170.459 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -99.27 19.28 15.71 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 124.107 0.963 . . . . 72.34 111.316 -175.691 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 93.79 -172.51 32.67 Favored Glycine 0 C--N 1.352 1.472 0 CA-C-O 119.683 -0.509 . . . . 75.25 113.175 177.864 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 218' ' ' PRO . . . . . 0.401 ' HA ' ' HA ' ' A' ' 213' ' ' MET . 73.2 Cg_endo -71.59 143.53 42.55 Favored 'Trans proline' 0 C--N 1.363 1.29 0 C-N-CA 122.622 2.214 . . . . 64.21 112.286 179.287 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 5.1 p -131.19 127.87 61.11 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 N-CA-C 108.605 -0.887 . . . . 52.23 108.605 172.943 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -78.28 100.76 6.83 Favored 'General case' 0 C--O 1.242 0.667 0 N-CA-C 106.66 -1.608 . . . . 73.31 106.66 174.79 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 6.2 p -108.35 129.65 62.32 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.844 0 CA-C-N 115.706 -0.679 . . . . 75.13 109.744 -168.745 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -79.66 110.49 15.05 Favored 'General case' 0 C--O 1.239 0.506 0 C-N-CA 123.714 0.805 . . . . 64.03 111.019 -174.903 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 52.7 t -55.12 136.47 67.68 Favored Pre-proline 0 CA--C 1.556 1.211 0 C-N-CA 125.006 1.322 . . . . 74.2 110.247 177.857 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -69.18 159.24 54.61 Favored 'Trans proline' 0 C--N 1.377 2.061 0 C-N-CA 122.293 1.995 . . . . 75.41 111.784 174.021 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -64.29 142.87 81.38 Favored 'Trans proline' 0 C--N 1.37 1.707 0 C-N-CA 121.75 1.633 . . . . 72.25 111.077 169.799 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 43.0 mtm180 62.78 48.21 4.24 Favored 'General case' 0 C--O 1.241 0.645 0 C-N-CA 124.417 1.087 . . . . 64.32 111.443 171.593 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 227' ' ' THR . . . . . 0.459 ' HA ' ' HE ' ' A' ' 231' ' ' ARG . 28.9 m -81.06 121.66 26.35 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 114.945 -1.025 . . . . 50.03 109.507 175.556 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 2.7 mp0 -106.41 148.4 28.15 Favored 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 123.992 0.917 . . . . 53.1 108.909 177.045 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -57.36 125.44 22.84 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 123.474 0.71 . . . . 64.35 111.88 -176.962 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 104.41 -2.55 43.07 Favored Glycine 0 C--N 1.34 0.786 0 CA-C-N 115.25 -0.886 . . . . 64.42 112.871 -179.619 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 231' ' ' ARG . . . . . 0.459 ' HE ' ' HA ' ' A' ' 227' ' ' THR . 56.4 mtt-85 -59.07 133.61 56.25 Favored 'General case' 0 C--N 1.371 1.505 0 CA-C-N 117.801 0.8 . . . . 65.42 109.695 173.22 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 69.5 mmtt -105.73 97.44 7.26 Favored 'General case' 0 C--O 1.239 0.536 0 CA-C-N 115.072 -0.967 . . . . 72.12 108.476 -172.858 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 233' ' ' LEU . . . . . 0.695 ' HB2' ' HB2' ' A' ' 251' ' ' LEU . 57.5 mt -81.73 142.29 32.79 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 114.713 -1.13 . . . . 63.12 109.046 179.229 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 22.0 ttt180 -122.84 101.28 7.35 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 122.492 0.317 . . . . 75.24 110.547 -171.475 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 235' ' ' LEU . . . . . 0.523 ' HB2' ' HB3' ' A' ' 249' ' ' LEU . 33.3 mt -86.74 105.62 17.1 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 123.57 0.748 . . . . 70.31 110.07 179.132 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 20.8 mttt -67.6 138.43 56.42 Favored 'General case' 0 CA--C 1.541 0.613 0 O-C-N 123.344 0.402 . . . . 71.21 110.921 175.41 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 73.11 16.62 78.51 Favored Glycine 0 C--N 1.348 1.207 0 O-C-N 123.895 0.747 . . . . 74.42 114.577 178.054 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 72.4 mmtt -115.58 7.4 14.83 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 123.211 0.605 . . . . 75.45 111.023 178.639 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -117.81 -167.83 14.31 Favored Glycine 0 C--N 1.348 1.216 0 N-CA-C 111.149 -0.781 . . . . 72.24 111.149 168.727 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 76.0 m-85 -91.34 157.89 41.8 Favored Pre-proline 0 N--CA 1.48 1.031 0 C-N-CA 123.781 0.833 . . . . 72.1 110.797 -175.567 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -64.03 145.38 89.64 Favored 'Trans proline' 0 C--N 1.366 1.487 0 C-N-CA 121.928 1.752 . . . . 74.52 112.833 170.167 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -176.4 -123.78 0.79 Allowed Glycine 0 CA--C 1.536 1.373 0 CA-C-O 118.964 -0.909 . . . . 44.1 112.221 178.161 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 243' ' ' PRO . . . . . 0.688 ' HD2' ' HB3' ' A' ' 191' ' ' GLN . 33.0 Cg_endo -57.75 -46.86 23.9 Favored 'Trans proline' 0 C--N 1.382 2.339 0 C-N-CA 124.889 3.726 . . . . 73.23 113.792 -173.499 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -90.72 -6.09 54.89 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 123.512 0.725 . . . . 72.23 111.153 179.778 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 87.17 -43.73 3.24 Favored Glycine 0 C--N 1.357 1.74 0 N-CA-C 111.966 -0.453 . . . . 72.14 111.966 -176.099 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 26.7 ttm180 -106.37 112.38 25.36 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 125.212 1.405 . . . . 72.12 109.163 175.167 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -74.83 154.27 46.65 Favored Glycine 0 C--N 1.358 1.804 0 N-CA-C 114.388 0.515 . . . . 75.11 114.388 171.282 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -107.43 171.13 7.55 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 124.854 1.262 . . . . 74.14 110.623 -178.52 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 249' ' ' LEU . . . . . 0.523 ' HB3' ' HB2' ' A' ' 235' ' ' LEU . 27.1 tp -128.78 116.76 19.99 Favored 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 108.17 -1.048 . . . . 75.41 108.17 171.009 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 250' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -88.78 108.08 19.31 Favored 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 108.845 -0.798 . . . . 73.42 108.845 -178.31 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 251' ' ' LEU . . . . . 0.695 ' HB2' ' HB2' ' A' ' 233' ' ' LEU . 87.3 mt -90.36 104.83 17.37 Favored 'General case' 0 C--O 1.238 0.453 0 N-CA-C 107.784 -1.191 . . . . 65.2 107.784 174.726 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -82.79 113.06 20.17 Favored 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 108.059 -1.089 . . . . 75.12 108.059 173.685 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 253' ' ' VAL . . . . . 0.428 ' HA ' ' O ' ' A' ' 197' ' ' LEU . 14.0 m -71.67 137.2 24.16 Favored 'Isoleucine or valine' 0 C--O 1.239 0.503 0 N-CA-C 109.677 -0.49 . . . . 65.21 109.677 179.685 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 8.5 mmm180 -123.38 108.54 12.83 Favored 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 108.092 -1.077 . . . . 74.43 108.092 175.902 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 255' ' ' ILE . . . . . 0.533 ' HA ' ' O ' ' A' ' 199' ' ' VAL . 27.3 mt -77.22 127.15 38.2 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 O-C-N 123.566 0.541 . . . . 61.4 109.864 177.792 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 10.7 t . . . . . 0 C--O 1.26 1.608 0 C-N-CA 123.974 0.91 . . . . 73.13 110.073 176.308 . . . . . . . . 0 0 . 1 stop_ save_